PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dodd, KM; Yang, J; Shen, MH; Sampson, JR; Tee, AR				Dodd, K. M.; Yang, J.; Shen, M. H.; Sampson, J. R.; Tee, A. R.			mTORC1 drives HIF-1 alpha and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3	ONCOGENE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; MESSENGER-RNA TRANSLATION; ENDOTHELIAL GROWTH-FACTOR; TUBEROUS SCLEROSIS; MAMMALIAN TARGET; SERINE PHOSPHORYLATION; MAXIMAL ACTIVATION; CANCER-THERAPY; TUMOR-GROWTH; RAPAMYCIN	Recent clinical trials using rapalogues in tuberous sclerosis complex show regression in volume of typically vascularised tumours including angiomyolipomas and subependymal giant cell astrocytomas. By blocking mechanistic/mammalian target of rapamycin complex 1 (mTORC1) signalling, rapalogue efficacy is likely to occur, in part, through suppression of hypoxia-inducible factors (HIFs) and vascular endothelial growth factors (VEGFs). We show that rapamycin reduces HIF-1 alpha protein levels, and to a lesser extent VEGF-A levels, in renal cystadenoma cells in a Tsc2+/- mouse model. We established that mTORC1 drives HIF-1 alpha protein accumulation through enhanced transcription of HIF-1 alpha mRNA, a process that is blocked by either inhibition or knockdown of signal transducer and activation of transcription 3 (STAT3). Furthermore, we demonstrated that STAT3 is directly phosphorylated by mTORC1 on Ser727 during hypoxia, promoting HIF-1 alpha mRNA transcription. mTORC1 also regulates HIF-1 alpha synthesis on a translational level via co-operative regulation of both initiation factor 4E-binding protein 1 (4E-BP1) and ribosomal protein S6 kinase-1 (S6K1), whereas HIF-1 alpha degradation remains unaffected. We therefore proposed that mTORC1 drives HIF-1 alpha synthesis in a multifaceted manner through 4E-BP1/eIF4E, S6K1 and STAT3. Interestingly, we observed a disconnect between HIF-1 alpha protein levels and VEGF-A expression. Although both S6K1 and 4E-BP1 regulate HIF-1 alpha translation, VEGF-A is primarily under the control of 4E-BP1/eIF4E. S6K1 inhibition reduces HIF-1 alpha but not VEGF-A expression, suggesting that mTORC1 mediates VEGF-A expression via both HIF-1 alpha-dependent and -independent mechanisms. Our work has important implications for the treatment of vascularised tumours, where mTORC1 acts as a central mediator of STAT3, HIF-1 alpha, VEGF-A and angiogenesis via multiple signalling mechanisms.	[Dodd, K. M.; Yang, J.; Shen, M. H.; Sampson, J. R.; Tee, A. R.] Cardiff Univ, Inst Canc & Genet, Cardiff CF14 4XN, S Glam, Wales	Cardiff University	Tee, AR (corresponding author), Cardiff Univ, Inst Canc & Genet, Canc & Genet Bldg,Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	teea@cardiff.ac.uk		Tee, Andrew/0000-0002-5577-4631	Association for International Cancer Research Career Development Fellowship [06-914/915]; Tuberous Sclerosis Association [2013-F02]; Cancer Research UK development fund; Welsh Government's National Institute of Social Care and Health Research (NISCHR) through the Wales Gene Park; Tuberous Sclerosis Association; Worldwide Cancer Research [06-0914] Funding Source: researchfish	Association for International Cancer Research Career Development Fellowship; Tuberous Sclerosis Association; Cancer Research UK development fund; Welsh Government's National Institute of Social Care and Health Research (NISCHR) through the Wales Gene Park; Tuberous Sclerosis Association; Worldwide Cancer Research	This research was supported by the Association for International Cancer Research Career Development Fellowship (No. 06-914/915) (to AT), a Junior Fellowship from the Tuberous Sclerosis Association [Ref: 2013-F02: Investigating mTORC1 independent functions of TSC2] (to KD) and a Cancer Research UK development fund (to JS and AT). This work is further supported by the Welsh Government's National Institute of Social Care and Health Research (NISCHR) through the Wales Gene Park and by the Tuberous Sclerosis Association.	Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Arbiser JL, 2002, J AM ACAD DERMATOL, V46, P376, DOI 10.1067/mjd.2002.120530; Barbieri I, 2010, CANCER RES, V70, P2558, DOI 10.1158/0008-5472.CAN-09-2840; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Brugarolas J, 2004, CANCER CELL, V6, P7, DOI 10.1016/j.ccr.2004.06.020; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Choo AY, 2006, CANCER CELL, V9, P77, DOI 10.1016/j.ccr.2006.01.021; Davies DM, 2008, NEW ENGL J MED, V358, P200, DOI 10.1056/NEJMc072500; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Dempsey JM, 2010, ENZYMES, V28, P1, DOI 10.1016/S1874-6047(10)28001-0; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Dodd KM, 2012, AM J PHYSIOL-ENDOC M, V302, pE1329, DOI 10.1152/ajpendo.00525.2011; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Dunlop EA, 2011, EUR J HUM GENET, V19, P789, DOI 10.1038/ejhg.2011.38; Dunlop EA, 2009, CELL SIGNAL, V21, P1073, DOI 10.1016/j.cellsig.2009.02.024; El-Hashemite N, 2005, AM J RESP CELL MOL, V33, P227, DOI 10.1165/rcmb.2005-0152RC; El-Hashemite N, 2004, CANCER RES, V64, P3436, DOI 10.1158/0008-5472.CAN-03-3609; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Garcia M, 2009, KU 0063794 IS SPECIF, V421; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Guo YA, 2013, MOL CANCER RES, V11, P467, DOI 10.1158/1541-7786.MCR-12-0605; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Koh MY, 2008, TRENDS BIOCHEM SCI, V33, P526, DOI 10.1016/j.tibs.2008.08.002; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Li N, 2011, CANCER CELL, V19, P429, DOI 10.1016/j.ccr.2011.03.018; Lin L, 2010, CANCER RES, V70, P2445, DOI 10.1158/0008-5472.CAN-09-2468; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Marimpietri D, 2007, CLIN CANCER RES, V13, P3977, DOI 10.1158/1078-0432.CCR-06-2757; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Minet E, 1999, BIOCHEM BIOPH RES CO, V261, P534, DOI 10.1006/bbrc.1999.0995; Niu GL, 2008, MOL CANCER RES, V6, P1099, DOI 10.1158/1541-7786.MCR-07-2177; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pfander D, 2003, J CELL SCI, V116, P1819, DOI 10.1242/jcs.00385; Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003; Pore N, 2006, CANCER RES, V66, P3197, DOI 10.1158/0008-5472.CAN-05-3090; Preston RS, 2011, ONCOGENE, V30, P1159, DOI 10.1038/onc.2010.497; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Rosser Tena, 2006, Semin Pediatr Neurol, V13, P27, DOI 10.1016/j.spen.2006.01.008; Schalm SS, 2005, J BIOL CHEM, V280, P11101, DOI 10.1074/jbc.M413995200; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Tandon P, 2011, P NATL ACAD SCI USA, V108, P2361, DOI 10.1073/pnas.1013629108; Tee AR, 2004, FEBS LETT, V564, P58, DOI 10.1016/S0014-5793(04)00313-8; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108; Woodrum C, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-14; Yang J, 2014, ONCOGENE; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7	70	171	180	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 23	2015	34	17					2239	2250		10.1038/onc.2014.164	http://dx.doi.org/10.1038/onc.2014.164			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CG7HG	24931163	Green Accepted			2022-12-25	WOS:000353473000009
J	Baer, CE; Iavarone, AT; Alber, T; Sassetti, CM				Baer, Christina E.; Iavarone, Anthony T.; Alber, Tom; Sassetti, Christopher M.			Biochemical and Spatial Coincidence in the Provisional Ser/Thr Protein Kinase Interaction Network of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL SYNTHESIS; SERINE/THREONINE KINASE; ACTIVATION MECHANISM; ALLOSTERIC ACTIVATION; MASS-SPECTROMETRY; PKNB KINASE; PHOSPHORYLATION; GROWTH; DIVISION; IDENTIFICATION	Many Gram-positive bacteria coordinate cellular processes by signaling through Ser/Thr protein kinases (STPKs), but the architecture of these phosphosignaling cascades is unknown. To investigate the network structure of a prokaryotic STPK system, we comprehensively explored the pattern of signal transduction in the Mycobacterium tuberculosis Ser/Thr kinome. Autophosphorylation is the dominant mode of STPK activation, but the 11 M. tuberculosis STPKs also show a specific pattern of efficient cross-phosphorylation in vitro. The biochemical specificity intrinsic to each kinase domain was used to map the provisional signaling network, revealing a three-layer architecture that includes master regulators, signal transducers, and terminal substrates. Fluorescence microscopy revealed that the STPKs are specifically localized in the cell. Master STPKs are concentrated at the same subcellular sites as their substrates, providing additional support for the biochemically defined network. Together, these studies imply a branched functional architecture of the M. tuberculosis Ser/Thr kinome that could enable horizontal signal spreading. This systems-level approach provides a biochemical and spatial framework for understanding Ser/Thr phospho-signaling in M. tuberculosis, which differs fundamentally from previously defined linear histidine kinase cascades.	[Baer, Christina E.; Sassetti, Christopher M.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA; [Iavarone, Anthony T.] Univ Calif Berkeley, Inst QB3, Chem Mass Spectrometry Facil QB3, Berkeley, CA 94720 USA; [Alber, Tom] Univ Calif Berkeley, Inst QB3, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Baer, Christina E.; Sassetti, Christopher M.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Sassetti, CM (corresponding author), Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Sherman Ctr ASC8-2051,368 Plantat St, Worcester, MA 01605 USA.	christopher.sassetti@umassmed.edu		Baer, Christina/0000-0002-8909-2583	National Institutes of Health [AI095208, GM070962]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064282, P01AI095208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Although the cellular roles of these individual STPKs are begin Grants AI095208 (to C. S.) and GM070962 (to T. A.).	Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Bell C, 2012, J PROTEOME RES, V11, P119, DOI 10.1021/pr2007939; Boitel B, 2003, MOL MICROBIOL, V49, P1493, DOI 10.1046/j.1365-2958.2003.03657.x; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chao J, 2010, BBA-PROTEINS PROTEOM, V1804, P620, DOI 10.1016/j.bbapap.2009.09.008; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; Duran R, 2005, BIOCHEM BIOPH RES CO, V333, P858, DOI 10.1016/j.bbrc.2005.05.173; England P, 2009, FEBS LETT, V583, P301, DOI 10.1016/j.febslet.2008.12.036; Fernandez P, 2006, J BACTERIOL, V188, P7778, DOI 10.1128/JB.00963-06; Gee CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002525; Good MC, 2004, J MOL BIOL, V339, P459, DOI 10.1016/j.jmb.2004.03.063; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Greenstein AE, 2007, J BIOL CHEM, V282, P11427, DOI 10.1074/jbc.M610193200; Hatzios SK, 2013, P NATL ACAD SCI USA, V110, pE5069, DOI 10.1073/pnas.1321205110; Jones G, 2006, J BACTERIOL, V188, P7470, DOI 10.1128/JB.00800-06; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koul A, 2001, MICROBIOL-SGM, V147, P2307, DOI 10.1099/00221287-147-8-2307; Kruh NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013938; Lombana TN, 2010, STRUCTURE, V18, P1667, DOI 10.1016/j.str.2010.09.019; Mieczkowski C, 2008, EMBO J, V27, P3186, DOI 10.1038/emboj.2008.236; Mir M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002182; Molle V, 2003, BIOCHEM BIOPH RES CO, V308, P820, DOI 10.1016/S0006-291X(03)01476-1; Molle V, 2006, PROTEOMICS, V6, P3754, DOI 10.1002/pmic.200500900; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Muoz-Dorado J., 1991, CELL, V67, P995, DOI DOI 10.1016/0092-8674(91)90372-6; Narayan A, 2007, PHYSIOL GENOMICS, V29, P66, DOI 10.1152/physiolgenomics.00221.2006; Nariya H, 2005, MOL MICROBIOL, V58, P367, DOI 10.1111/j.1365-2958.2005.04826.x; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Rachman H, 2006, INFECT IMMUN, V74, P1233, DOI 10.1128/IAI.74.2.1233-1242.2006; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Roumestand C, 2011, STRUCTURE, V19, P1525, DOI 10.1016/j.str.2011.07.011; Sajid A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017871; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104; Schultz C, 2009, MOL MICROBIOL, V74, P724, DOI 10.1111/j.1365-2958.2009.06897.x; Sharma K, 2004, FEMS MICROBIOL LETT, V233, P107, DOI 10.1016/j.femsle.2004.01.045; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Thakur M, 2008, J BIOL CHEM, V283, P8023, DOI 10.1074/jbc.M707535200; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897	49	46	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20422	20433		10.1074/jbc.M114.559054	http://dx.doi.org/10.1074/jbc.M114.559054			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24928517	hybrid, Green Published			2022-12-25	WOS:000339396600002
J	Callejas, FD; Martinez-Anton, A; Alobid, I; Fuentes, M; Cortijo, J; Picado, C; Roca-Ferrer, J; Mullol, J				de Borja Callejas, Francisco; Martinez-Anton, Asuncion; Alobid, Isam; Fuentes, Mireya; Cortijo, Julio; Picado, Cesar; Roca-Ferrer, Jordi; Mullol, Joaquim			Reconstituted Human Upper Airway Epithelium as 3-D In Vitro Model for Nasal Polyposis	PLOS ONE			English	Article							MUCIN GENE-EXPRESSION; MUCOCILIARY DIFFERENTIATION; EOSINOPHIL SURVIVAL; STEM-CELLS; GLANDULAR SECRETION; CYTOKINE SECRETION; MESSENGER-RNA; BASAL-CELLS; GM-CSF; CULTURE	Background: Primary human airway epithelial cells cultured in an air-liquid interface (ALI) develop a well-differentiated epithelium. However, neither characterization of mucociliar differentiation overtime nor the inflammatory function of reconstituted nasal polyp (NP) epithelia have been described. Objectives: 1st) To develop and characterize the mucociliar differentiation overtime of human epithelial cells of chronic rhinosinusitis with nasal polyps (CRSwNP) in ALI culture system; 2nd) To corroborate that 3D in vitro model of NP reconstituted epithelium maintains, compared to control nasal mucosa (NM), an inflammatory function. Methods: Epithelial cells were obtained from 9 NP and 7 control NM, and differentiated in ALI culture for 28 days. Mucociliary differentiation was characterized at different times (0, 7, 14, 21, and 28 days) using ultrastructure analysis by electron microscopy; DNp63 (basal stem/progenitor cell), beta-tubulin IV (cilia), and MUC5AC (goblet cell) expression by immunocytochemistry; and mucous (MUC5AC, MUC5B) and serous (Lactoferrin) secretion by ELISA. Inflammatory function of ALI cultures (at days 0, 14, and 28) through cytokine (IL-8, IL-1 beta, IL-6, IL-10, TNF-alpha, and IL-12p70) and chemokine (RANTES, MIG, MCP-1, IP-10, eotaxin-1, and GM-CSF) production was analysed by CBA (Cytometric Bead Array). Results: In both NP and control NM ALI cultures, pseudostratified epithelium with ciliated, mucus-secreting, and basal cells were observed by electron microscopy at days 14 and 28. Displaying epithelial cell re-differentation, b-tubulin IV and MUC5AC positive cells increased, while Delta Np63 positive cells decreased overtime. No significant differences were found overtime in MUC5AC, MUC5B, and lactoferrin secretions between both ALI cultures. IL-8 and GM-CSF were significantly increased in NP compared to control NM regenerated epithelia. Conclusion: Reconstituted epithelia from human NP epithelial cells cultured in ALI system provides a 3D in vitro model that could be useful both for studying the role of epithelium in CRSwNP while developing new therapeutic strategies, including cell therapy, for CRSwNP.	[de Borja Callejas, Francisco; Martinez-Anton, Asuncion; Alobid, Isam; Fuentes, Mireya; Picado, Cesar; Roca-Ferrer, Jordi; Mullol, Joaquim] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain; [de Borja Callejas, Francisco; Martinez-Anton, Asuncion; Fuentes, Mireya; Cortijo, Julio; Picado, Cesar; Roca-Ferrer, Jordi; Mullol, Joaquim] CIBER Resp Dis CIBERES, Barcelona, Spain; [Alobid, Isam; Mullol, Joaquim] Univ Barcelona, Hosp Clin Barcelona, ENT Dept, Rhinol Unit, Barcelona, Catalonia, Spain; [Alobid, Isam; Mullol, Joaquim] Univ Barcelona, Hosp Clin Barcelona, ENT Dept, Smell Clin, Barcelona, Catalonia, Spain; [Picado, Cesar] Univ Barcelona, Hosp Clin Barcelona, Pneumol & Resp Allergy Dept, Barcelona, Catalonia, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Mullol, J (corresponding author), Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain.	jmullol@clinic.ub.es	Roca-Ferrer, Jordi/AFQ-4652-2022; /AFX-9519-2022; Fuentes, Mireya/J-5901-2017; Martinez Anton, Asuncion/A-5806-2017; de Borja Callejas Díaz, Francisco/AAK-3221-2020; Callejas Díaz, Francisco de Borja/G-3252-2014; /AAL-7347-2021	Roca-Ferrer, Jordi/0000-0002-9527-2273; Fuentes, Mireya/0000-0002-1381-5589; Martinez Anton, Asuncion/0000-0001-9758-5911; Callejas Díaz, Francisco de Borja/0000-0001-5292-4334; 	Fondo de Investigaciones de la Seguridad Social [PI08-0188, PI12-01129]; Instituto de Salud Carlos III; MINECO (Ministerio de Economia y Competividad); FEDER, Spain	Fondo de Investigaciones de la Seguridad Social; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); MINECO (Ministerio de Economia y Competividad); FEDER, Spain(European Commission)	This work was funded by research grants (PI08-0188 and PI12-01129) from Fondo de Investigaciones de la Seguridad Social, Instituto de Salud Carlos III (http://www.isciii.es/), MINECO (Ministerio de Economia y Competividad, http://www.idi.mineco.gob.es/portal/site/MICINN/), and co-funded by FEDER (http://ec.europa.eu/regional_policy/thefunds/regional/index_en.cfm), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MS, 2007, LARYNGOSCOPE, V117, P932, DOI 10.1097/MLG.0b013e3180383651; Almstahl A, 2001, ORAL MICROBIOL IMMUN, V16, P345, DOI 10.1034/j.1399-302X.2001.160605.x; Antunes MB, 2007, BIOTECHNIQUES, V43, P195, DOI 10.2144/000112531; Bachert C, 2001, J ALLERGY CLIN IMMUN, V107, P607, DOI 10.1067/mai.2001.112374; Bernacki SH, 1999, AM J RESP CELL MOL, V20, P595, DOI 10.1165/ajrcmb.20.4.3442; Bernstein JM, 1997, J ALLERGY CLIN IMMUN, V99, P165, DOI 10.1016/S0091-6749(97)70091-5; Bleier BS, 2012, J PHARM PHARMACOL, V64, P449, DOI 10.1111/j.2042-7158.2011.01409.x; Bobic S, 2010, RHINOLOGY, V48, P401, DOI 10.4193/Rhino10.033; Booth BW, 2001, AM J RESP CELL MOL, V25, P739, DOI 10.1165/ajrcmb.25.6.4659; Bucheler M, 2003, DNA CELL BIOL, V22, P549, DOI 10.1089/104454903322405446; Calderon MA, 1997, J ALLERGY CLIN IMMUN, V99, P65, DOI 10.1016/S0091-6749(97)70302-6; Crystal Ronald G, 2008, Proc Am Thorac Soc, V5, P772, DOI 10.1513/pats.200805-041HR; Daniely Y, 2004, AM J PHYSIOL-CELL PH, V287, pC171, DOI 10.1152/ajpcell.00226.2003; Callejas FD, 2013, AM J RHINOL ALLERGY, V27, pE69, DOI 10.2500/ajra.2013.27.3908; DEVALIA JL, 1990, RESP MED, V84, P303, DOI 10.1016/S0954-6111(08)80058-3; Dimova S, 2005, TOXICOL IN VITRO, V19, P107, DOI 10.1016/j.tiv.2004.07.003; Dvorak A, 2011, AM J RESP CELL MOL, V44, P465, DOI 10.1165/rcmb.2009-0453OC; Eloy P, 2011, CURR ALLERGY ASTHM R, V11, P146, DOI 10.1007/s11882-011-0180-0; Fernandez-Morata JC, 2000, CLIN EXP ALLERGY, V30, P1275; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gras D, 2012, J ALLERGY CLIN IMMUN, V129, P1259, DOI 10.1016/j.jaci.2012.01.073; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Hackett TL, 2008, STEM CELLS, V26, P2576, DOI 10.1634/stemcells.2008-0171; Hajj R, 2007, STEM CELLS, V25, P139, DOI 10.1634/stemcells.2006-0288; Kesimer M, 2009, AM J PHYSIOL-LUNG C, V296, pL92, DOI 10.1152/ajplung.90388.2008; Kim CH, 2005, ACTA OTO-LARYNGOL, V125, P76, DOI 10.1080/00016480410015785; Kondo M, 2002, AM J RESP CELL MOL, V27, P536, DOI 10.1165/rcmb.4682; Kondo Mitsuko, 2006, Allergol Int, V55, P329, DOI 10.2332/allergolint.55.329; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Laudien M, 2011, RHINOLOGY, V49, P107, DOI 10.4193/Rhino10.036; Lee JT, 2010, AM J RHINOL ALLERGY, V24, P99, DOI 10.2500/ajra.2010.24.3444; Lee MK, 2005, DRUG DELIV, V12, P305, DOI 10.1080/10717540500177009; Martinez-Anton A, 2013, AM J RESP CELL MOL, V49, P384, DOI 10.1165/rcmb.2012-0368OC; McDougall CM, 2008, AM J RESP CELL MOL, V39, P560, DOI 10.1165/rcmb.2007-0325OC; Milara J, 2012, BRIT J PHARMACOL, V166, P2243, DOI 10.1111/j.1476-5381.2012.01929.x; Mullol J, 2010, J BIOL REG HOMEOS AG, V24, P403; MULLOL J, 1995, THORAX, V50, P270, DOI 10.1136/thx.50.3.270; Mullol J, 2002, J ALLERGY CLIN IMMUN, V109, P824, DOI 10.1067/mai.2002.123534; Mullol J, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-23; Nelson WJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000513; Ocampo CJ, 2012, J ALLERGY CLIN IMMUN, V129, pAB43, DOI 10.1016/j.jaci.2011.12.825; Oyer SL, 2013, LARYNGOSCOPE, V123, pE72, DOI 10.1002/lary.24305; Payne SC, 2008, AM J RHINOL, V22, P568, DOI 10.2500/ajr.2008.22.3233; Proud D, 2011, IMMUNOL REV, V242, P186, DOI 10.1111/j.1600-065X.2011.01033.x; Psaltis AJ, 2008, LARYNGOSCOPE, V118, P895, DOI 10.1097/MLG.0b013e31816381d4; Psaltis AJ, 2007, LARYNGOSCOPE, V117, P2030, DOI 10.1097/MLG.0b013e31812e01ab; Reichl S, 2012, J PHARM PHARMACOL, V64, P1621, DOI 10.1111/j.2042-7158.2012.01540.x; Riechelmann H, 2005, CLIN EXP ALLERGY, V35, P1186, DOI 10.1111/j.1365-2222.2005.02316.x; Roca-Ferrer J, 2001, J ALLERGY CLIN IMMUN, V108, P87, DOI 10.1067/mai.2001.115485; Roca-Ferrer J, 2000, J ALLERGY CLIN IMMUN, V106, P1053, DOI 10.1067/mai.2000.110476; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Rowe RK, 2004, IN VITRO CELL DEV-AN, V40, P303; Schleimer RP, 2007, J ALLERGY CLIN IMMUN, V120, P1279, DOI 10.1016/j.jaci.2007.08.046; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Shin SH, 2006, ACTA OTO-LARYNGOL, V126, P1286, DOI 10.1080/00016480500395179; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Stripp Barry R, 2008, Proc Am Thorac Soc, V5, P328, DOI 10.1513/pats.200711-167DR; Thomason HA, 2010, BIOCHEM J, V429, P419, DOI 10.1042/BJ20100567; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Van Bruaene N, 2011, CURR OPIN ALLERGY CL, V11, P8, DOI 10.1097/ACI.0b013e32834233ef; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Wengst A, 2010, EUR J PHARM BIOPHARM, V74, P290, DOI 10.1016/j.ejpb.2009.08.008; Wickstrom C, 2001, J BIOL CHEM, V276, P47116, DOI 10.1074/jbc.M106593200; XAUBET A, 1994, CLIN EXP ALLERGY, V24, P307, DOI 10.1111/j.1365-2222.1994.tb00240.x; Yan Y, 2013, CURR OPIN OTOLARYNGO, V21, P263, DOI 10.1097/MOO.0b013e32835f80a0; Yasuo M, 2006, RESPIRATION, V73, P347, DOI 10.1159/000091391; Yoon JH, 1997, AM J RESP CELL MOL, V16, P724, DOI 10.1165/ajrcmb.16.6.9191474; Yoon JH, 2002, DIFFERENTIATION, V70, P77, DOI 10.1046/j.1432-0436.2002.700202.x; Zhao XN, 2012, AM J RHINOL ALLERGY, V26, P345, DOI 10.2500/ajra.2012.26.3794; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC	73	17	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100537	10.1371/journal.pone.0100537	http://dx.doi.org/10.1371/journal.pone.0100537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945146	Green Published, gold, Green Submitted			2022-12-25	WOS:000340721500089
J	Li, YL; Cheng, DS; Cheng, R; Zhu, XY; Wan, T; Liu, JM; Zhang, RY				Li, Yali; Cheng, Deshu; Cheng, Ran; Zhu, Xinyu; Wan, Tao; Liu, Jianmiao; Zhang, Rongying			Mechanisms of U87 Astrocytoma Cell Uptake and Trafficking of Monomeric versus Protofibril Alzheimer's Disease Amyloid-beta Proteins	PLOS ONE			English	Article							A-BETA; APOLIPOPROTEIN-E; IN-VITRO; CLEARANCE; NEURONS; PEPTIDE; DEGRADATION; OLIGOMERS; MICROGLIA; BRAIN	A significant hallmark of Alzheimer's disease is the formation of senile plaques in the brain due to the unbalanced levels of amyloid-beta (A beta). However, although how A beta is produced from amyloid precursor proteins is well understood, little is known regarding the clearance and metabolism of various A beta aggregates from the brain. Similarly, little is known regarding how astrocytes internalize and degrade A beta, although astrocytes are known to play an important role in plaque maintenance and A beta clearance. The objective of this study is to investigate the cellular mechanisms that mediate the internalization of soluble monomeric versus oligomeric A beta by astrocytes. We used a combination of laser confocal microscopy and genetic and pharmacological experiments to dissect the internalization of sA beta 42 and oA beta 42 and their postendocytic transport by U87 human brain astrocytoma cell line. Both A beta 42 species were internalized by U87 cells through fluid phase macropinocytosis, which required dynamin 2. Depleting LDL receptor-related protein 1 (LRP1) decreased sA beta 42 uptake more significantly than that of oA beta 42. We finally show that both A beta 42 species were rapidly transported to lysosomes through an endolytic pathway and subjected to proteolysis after internalization, which had no significant toxic effects to the U87 cells under relatively low concentrations. We propose that macropinocytic sA beta 42 and oA beta 42 uptake and their subsequent proteolytic degradation in astroglial cells is a significant mechanism underlying A beta clearance from the extracellular milieu. Understanding the molecular events involved in astrocytic A beta internalization may identify potential therapeutic targets for Alzheimer's disease.	[Li, Yali; Cheng, Deshu; Cheng, Ran; Zhu, Xinyu; Wan, Tao; Liu, Jianmiao; Zhang, Rongying] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Key Lab Mol Biophys, Minist Educ, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Zhang, RY (corresponding author), Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Key Lab Mol Biophys, Minist Educ, Wuhan 430074, Hubei, Peoples R China.	ryzhang@mail.hust.edu.cn			Major State Basic Research Program of China [2011CB910402]; National Science Foundation of China [31071249]	Major State Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants from the Major State Basic Research Program of China (2011CB910402) and the National Science Foundation of China (31071249). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2008, NEUROREPORT, V19, P1085, DOI 10.1097/WNR.0b013e328302c858; Basak JM, 2012, J BIOL CHEM, V287, P13959, DOI 10.1074/jbc.M111.288746; Benseny-Cases Nuria, 2012, Subcell Biochem, V65, P53, DOI 10.1007/978-94-007-5416-4_3; Boucrot E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010597; Cha MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034929; Chung HY, 1999, J BIOL CHEM, V274, P32301, DOI 10.1074/jbc.274.45.32301; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Evans NA, 2008, J NEUROSCI METH, V175, P96, DOI 10.1016/j.jneumeth.2008.08.001; Foster JK, 2009, MOL PSYCHIATR, V14, P239, DOI 10.1038/mp.2008.115; Fuentealba RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011884; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Jiang M, 2009, J NEUROSCI, V29, P8063, DOI 10.1523/JNEUROSCI.6139-08.2009; Jin LW, 2004, AM J PATHOL, V164, P975, DOI 10.1016/S0002-9440(10)63185-9; Kanekiyo T, 2012, J NEUROSCI, V32, P16458, DOI 10.1523/JNEUROSCI.3987-12.2012; Kanekiyo T, 2009, J BIOL CHEM, V284, P33352, DOI 10.1074/jbc.M109.015032; Kittelberger KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029940; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Kong Y, 2010, J NEUROSCI, V30, P11848, DOI 10.1523/JNEUROSCI.2985-10.2010; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lee CYD, 2012, J BIOL CHEM, V287, P2032, DOI 10.1074/jbc.M111.295451; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; Li YH, 2003, FEBS LETT, V555, P346, DOI 10.1016/S0014-5793(03)01272-9; Liu YW, 2008, MOL BIOL CELL, V19, P5347, DOI 10.1091/mbc.E08-08-0890; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maezawa I, 2008, J NEUROCHEM, V104, P457, DOI 10.1111/j.1471-4159.2007.04972.x; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Mohamed Amany, 2011, Int J Alzheimers Dis, V2011, P127984, DOI 10.4061/2011/127984; Mulder SD, 2012, EXP NEUROL, V233, P373, DOI 10.1016/j.expneurol.2011.11.001; Nielsen HM, 2010, GLIA, V58, P1235, DOI 10.1002/glia.21004; Nielsen HM, 2009, GLIA, V57, P978, DOI 10.1002/glia.20822; Omtri RS, 2012, MOL PHARMACEUT, V9, P1887, DOI 10.1021/mp200530q; Pichler H, 2004, BBA-BIOMEMBRANES, V1666, P51, DOI 10.1016/j.bbamem.2004.05.011; Pigino G, 2009, P NATL ACAD SCI USA, V106, P5907, DOI 10.1073/pnas.0901229106; Rossello XS, 2012, BRAIN RES, V1444, P87, DOI 10.1016/j.brainres.2012.01.017; Saavedra L, 2007, J BIOL CHEM, V282, P35722, DOI 10.1074/jbc.M701823200; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Song MS, 2011, NEUROSCIENCE, V178, P181, DOI 10.1016/j.neuroscience.2010.12.055; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; Tabira T, 2002, FRONT BIOSCI-LANDMRK, V7, pA44, DOI 10.2741/tabira; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HM, 2010, J ALZHEIMERS DIS, V21, P597, DOI 10.3233/JAD-2010-091207; Wang PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010202; Wang YJ, 2006, DRUG DISCOV TODAY, V11, P931, DOI 10.1016/j.drudis.2006.08.004; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Yang F, 2006, J MOL BIOL, V362, P821, DOI 10.1016/j.jmb.2006.07.059; Yu CJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-19; Zhou XF, 2011, PRION, V5, P161, DOI 10.4161/pri.5.3.16896	52	23	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99939	10.1371/journal.pone.0099939	http://dx.doi.org/10.1371/journal.pone.0099939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941200	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200056
J	Lorca-Oro, C; Lopez-Olvera, JR; Ruiz-Fons, F; Acevedo, P; Garcia-Bocanegra, I; Oleaga, A; Gortazar, C; Pujols, J				Lorca-Oro, Cristina; Ramon Lopez-Olvera, Jorge; Ruiz-Fons, Francisco; Acevedo, Pelayo; Garcia-Bocanegra, Ignacio; Oleaga, Alvaro; Gortazar, Christian; Pujols, Joan			Long-Term Dynamics of Bluetongue Virus in Wild Ruminants: Relationship with Outbreaks in Livestock in Spain, 2006-2011	PLOS ONE			English	Article							DEER CERVUS-ELAPHUS; RED DEER; SEROTYPES 1; EPIDEMIOLOGY; SURVEILLANCE; INFECTION; DISEASE; FRANCE; EUROPE	Wild and domestic ruminants are susceptible to Bluetongue virus (BTV) infection. Three BTV serotypes (BTV-4, BTV-1 and BTV-8) have been detected in Spain in the last decade. Even though control strategies have been applied to livestock, BTV circulation has been frequently detected in wild ruminant populations in Spain. The aim of the present study is to assess the role for wild ruminants in maintaining BTV after the vaccination programs in livestock in mainland Spain. A total of 931 out 1,914 (48.6%) serum samples, collected from eight different wild ruminant species between 2006 and 2011, were BTV positive by ELISA. In order to detect specific antibodies against BTV-1, BTV-4 and BTV-8, positive sera were also tested by serumneutralisation test (SNT). From the ELISA positive samples that could be tested by SNT (687 out of 931), 292 (42.5%) showed neutralising antibodies against one or two BTV serotypes. For each BTV seroptype, the number of outbreaks in livestock (11,857 outbreaks in total) was modelled with pure autoregressive models and the resulting smoothed values, representing the predicted number of BTV outbreaks in livestock at municipality level, were positively correlated with BTV persistence in wild species. The strength of this relationship significantly decreased as red deer (Cervus elaphus) population abundance increased. In addition, BTV RNA was detected by real time RT-PCR in 32 out of 311 (10.3%) spleen samples from seropositive animals. Although BT outbreaks in livestock have decreased substantially after vaccination campaigns, our results indicated that wild ruminants have been exposed to BTV in territories where outbreaks in domestic animals occurred. The detection of BTV RNA and spatial association between BT outbreaks in livestock and BTV rates in red deer are consistent with the hypothesis of virus circulation and BTV maintenance within Iberian wild ruminant populations.	[Lorca-Oro, Cristina; Pujols, Joan] UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Bellaterra, Cerdanyola Del, Spain; [Ramon Lopez-Olvera, Jorge] UAB, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge SEFaS, Barcelona, Spain; [Ruiz-Fons, Francisco; Acevedo, Pelayo; Oleaga, Alvaro; Gortazar, Christian] Inst Invest Recursos Cineget CSIC UCLM JCCM, SaBio IREC, Ciudad Real, Spain; [Acevedo, Pelayo] Univ Porto, InBio Lab Associado, CIBIO, Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal; [Garcia-Bocanegra, Ignacio] UCO, Fac Vet, Dept Sanidad Anim, Cordoba, Spain; [Oleaga, Alvaro] Sociedad Serv Principado Asturias SA, SERPA, Gijon, Asturias, Spain; [Pujols, Joan] IRTA, Barcelona, Spain	IRTA; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Universidade do Porto; Universidad de Cordoba; IRTA	Lorca-Oro, C (corresponding author), UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Campus Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain.	cristina.lorca.oro@gmail.com	Oleaga, Alvaro/S-3966-2018; Pujols, Joan/K-9693-2015; Olvera, Jorge R López/H-8382-2015; Lorca-Oró, Cristina/ABE-7268-2021; Acevedo, Pelayo/L-6737-2013; Pujols, Joan/S-1141-2018; Bocanegra, Ignacio Garcia/G-1443-2016; Pujols, Joan/AAV-6427-2020; Gortazar, Christian/E-7918-2012; Ruiz-Fons, Francisco/K-3161-2014; Oleaga, Alvaro/Q-8070-2019	Oleaga, Alvaro/0000-0002-4080-3057; Pujols, Joan/0000-0002-6940-1529; Olvera, Jorge R López/0000-0002-2999-3451; Lorca-Oró, Cristina/0000-0001-5351-4169; Acevedo, Pelayo/0000-0002-3509-7696; Bocanegra, Ignacio Garcia/0000-0003-3388-2604; Pujols, Joan/0000-0002-6940-1529; Gortazar, Christian/0000-0003-0012-4006; Ruiz-Fons, Francisco/0000-0002-0820-5292; Oleaga, Alvaro/0000-0002-4080-3057	INIA [FAU2008-00019-C03-01]; FI-DGR grant (Agencia de Gestio d'Ajuts Universitaris i de Recerca, AGAUR); Spanish Ministry for the Economy and Competitiveness through a Juan de la Cierva contract; Fundacao para a Ciencia e a Tecnologia (FCT); Programa Operacional Potencial Humano (POPH) - Quadro de Referencia Estrategico Nacional (QREN) from the European Social Fund; Portuguese Ministerio da Educacao e Ciencia [SFRH/BPD/90320/2012]	INIA(Instituto de Investigacion Agropecuaria (INIA)); FI-DGR grant (Agencia de Gestio d'Ajuts Universitaris i de Recerca, AGAUR); Spanish Ministry for the Economy and Competitiveness through a Juan de la Cierva contract; Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Operacional Potencial Humano (POPH) - Quadro de Referencia Estrategico Nacional (QREN) from the European Social Fund; Portuguese Ministerio da Educacao e Ciencia(Portuguese Foundation for Science and Technology)	The following funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was partially supported by the FAU2008-00019-C03-01 INIA research project, "Epidemiologia, control y aspectos entomologicos de la lengua azul (BTV) en rumiantes silvestres en Espana". C Lorca-Oro was funded by a FI-DGR grant (Agencia de Gestio d'Ajuts Universitaris i de Recerca, AGAUR). JF Ruiz-Fons was funded by the Spanish Ministry for the Economy and Competitiveness through a Juan de la Cierva contract. P Acevedo currently holds a post-doctoral grant from Fundacao para a Ciencia e a Tecnologia (FCT) funded by Programa Operacional Potencial Humano (POPH) - Quadro de Referencia Estrategico Nacional (QREN) from the European Social Fund and by the Portuguese Ministerio da Educacao e Ciencia (SFRH/BPD/90320/2012).	Acevedo P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014236; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allepuz A, 2010, PREV VET MED, V96, P263, DOI 10.1016/j.prevetmed.2010.06.005; Bailey T, 1995, INTERACTIVE SPATIAL; CARRANZA J, 1991, APPL ANIM BEHAV SCI, V30, P363, DOI 10.1016/0168-1591(91)90141-J; Casaubon J, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-166; Conraths FJ, 2009, EMERG INFECT DIS, V15, P433, DOI 10.3201/eid1503.081210; Corbiere F, 2012, J WILDLIFE DIS, V48, P1047, DOI 10.7589/2011-12-359; De Curtis M, 2007, SEROLOGICAL MONITORI; Diggle P., 2003, STAT ANAL SPATIAL PO; Durand B, 2010, EMERG INFECT DIS, V16, P1861, DOI 10.3201/eid1612.100412; Enserink M, 2008, SCIENCE, V319, P710, DOI 10.1126/science.319.5864.710; Eschbaumer M, 2009, VACCINE, V27, P4169, DOI 10.1016/j.vaccine.2009.04.056; Falconi C, 2012, VET MICROBIOL, V159, P40, DOI 10.1016/j.vetmic.2012.03.023; Falconi C, 2011, VET MICROBIOL, V151, P209, DOI 10.1016/j.vetmic.2011.02.011; Fernandez-Pacheco P, 2008, VET REC, V162, P659, DOI 10.1136/vr.162.20.659; Garcia I, 2009, EUR J WILDLIFE RES, V55, P173, DOI 10.1007/s10344-008-0231-6; Garcia-Bocanegra I, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-88; Gerdes GH, 2004, VETER ITAL SER, V40, P39; Haining R., 2003, SPATIAL DATA ANAL TH; HOSMER DW, 1989, APPL LOGISTIC REGRES; LeSage JP, 1997, INT REGIONAL SCI REV, V20, P113, DOI 10.1177/016001769702000107; Linden A, 2008, VET REC, V162, P459, DOI 10.1136/vr.162.14.459-a; Linden A, 2010, EMERG INFECT DIS, V16, P833, DOI 10.3201/eid1605.091217; Lorca-Oro C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036380; Lorca-Oro C, 2012, VET MICROBIOL, V154, P240, DOI 10.1016/j.vetmic.2011.07.008; Lorca-Oro C, 2011, VET MICROBIOL, V149, P230, DOI 10.1016/j.vetmic.2010.10.023; Munoz PM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-46; OIE, 2009, BLUET EP HAEM DIS; Oura CAL, 2009, VACCINE, V27, P7326, DOI 10.1016/j.vaccine.2009.09.070; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Lopez-Olvera JR, 2010, VET MICROBIOL, V145, P148, DOI 10.1016/j.vetmic.2010.03.012; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Rodriguez-Sanchez B, 2008, TRANSBOUND EMERG DIS, V55, P205, DOI 10.1111/j.1865-1682.2008.01029.x; Rodriguez-Sanchez B, 2010, VET MICROBIOL, V141, P164, DOI 10.1016/j.vetmic.2009.08.003; Rodriguez-Sanchez B, 2010, EMERG INFECT DIS, V16, P518, DOI 10.3201/eid1603.090626; Rossi S, 2014, TRANSBOUND EMERG DIS, V61, pE12, DOI 10.1111/tbed.12061; Rossi S, 2009, P 29EM RENC GROUP ET; Ruiz-Fons F, 2008, EMERG INFECT DIS, V14, P951, DOI 10.3201/eid1406.071586; Saenz De Buruaga M, 1991, RECONOCIMIENTO SEXO; Spanish Wildlife Disease Surveillance Scheme, 2011, INT REP SPAN MIN AGR; Stallknecht DE, 2004, VETER ITAL SER, V40, P203; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Zanella G, 2014, TRANSBOUND EMERG DIS, V61, P473, DOI 10.1111/tbed.12048	46	28	29	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100027	10.1371/journal.pone.0100027	http://dx.doi.org/10.1371/journal.pone.0100027			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940879	Green Submitted, Green Published, gold			2022-12-25	WOS:000338508200067
J	Roy, D; Paul, A; Roy, A; Ghosh, R; Ganguly, P; Chaudhuri, S				Roy, Dipan; Paul, Amit; Roy, Adrita; Ghosh, Ritesh; Ganguly, Payel; Chaudhuri, Shubho			Differential Acetylation of Histone H3 at the Regulatory Region of OsDREB1b Promoter Facilitates Chromatin Remodelling and Transcription Activation during Cold Stress	PLOS ONE			English	Article							RESPONSIVE GENE-EXPRESSION; LOW-TEMPERATURE; INDUCIBLE GENES; HIGH-SALT; DNASE-I; DROUGHT; RICE; ELEMENTS; BINDING; DOMAIN	The rice ortholog of DREB1, OsDREB1b, is transcriptionally induced by cold stress and over-expression of OsDREB1b results in increase tolerance towards high salt and freezing stress. This spatio-temporal expression of OsDREB1b is preceded by the change in chromatin structure at the promoter and the upstream region for gene activation. The promoter and the upstream region of OsDREB1b genes appear to be arranged into a nucleosome array. Nucleosome mapping of similar to 700bp upstream region of OsDREB1b shows two positioned nucleosomes between -610 to -258 and a weakly positioned nucleosome at the core promoter and the TSS. Upon cold stress, there is a significant change in the nucleosome arrangement at the upstream region with increase in DNasel hypersensitivity or MNase digestion in the vicinity of cis elements and TATA box at the core promoter. ChIP assays shows hyper-acetylation of histone H3K9 throughout the locus whereas region specific increase was observed in H3K14ac and H3K27ac. Moreover, there is an enrichment of RNA PolII occupancy at the promoter region during transcription activation. There is no significant change in the H3 occupancy in OsDREB1b locus negating the possibility of nucleosome loss during cold stress. Interestingly, cold induced enhanced transcript level of OsDREB1b as well as histone H3 acetylation at the upstream region was found to diminish when stressed plants were returned to normal temperature. The result indicates absolute necessity of changes in chromatin conformation for the transcription up-regulation of OsDREB1b gene in response to cold stress. The combined results show the existence of closed chromatin conformation at the upstream and promoter region of OsDREB1b in the transcription "off'' state. During cold stress, changes in region specific histone modification marks promote the alteration of chromatin structure to facilitate the binding of transcription machinery for proper gene expression.	[Roy, Dipan; Paul, Amit; Roy, Adrita; Ganguly, Payel; Chaudhuri, Shubho] Bose Inst, Div Plant Biol, Kolkta 700054, W Bengal, India; [Ghosh, Ritesh] Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea	Department of Science & Technology (India); Bose Institute; Yeungnam University	Chaudhuri, S (corresponding author), Bose Inst, Div Plant Biol, Centenary Campus,P-1-12,CIT Scheme 7 M, Kolkta 700054, W Bengal, India.	shubho@jcbose.ac.in		ROY, DIPAN/0000-0002-6566-8103; Ghosh, Ritesh/0000-0002-2528-7277	Department of Biotechnology; Government of India [BT/AB/05/02/2007]; CSIR; Government of India [09/015(0412)/2010-EMR-I]; Bose Institute	Department of Biotechnology; Government of India(Department of Biotechnology (DBT) India); CSIR; Government of India(Council of Scientific & Industrial Research (CSIR) - India); Bose Institute(Department of Science & Technology (India))	This work was supported by Department of Biotechnology; Government of India; grant number (BT/AB/05/02/2007). Dipan Roy sincerely acknowledges CSIR; Government of India, for his fellowship [09/015(0412)/2010-EMR-I.]. The authors sincerely acknowledge Bose Institute for the institutional fund support. Contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER SS, 1994, PLANT MOL BIOL, V24, P701, DOI 10.1007/BF00029852; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Casati P, 2008, PLANT CELL, V20, P827, DOI 10.1105/tpc.107.056457; Chua YL, 2001, PLANT CELL, V13, P599, DOI 10.1105/tpc.13.3.599; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; CONCONI A, 1993, J BIOL CHEM, V268, P430; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Fenouil R, 2012, GENOME RES, V22, P2399, DOI 10.1101/gr.138776.112; Grativol C, 2012, BBA-GENE REGUL MECH, V1819, P176, DOI 10.1016/j.bbagrm.2011.08.010; Gutha LR, 2008, PLANT MOL BIOL, V68, P533, DOI 10.1007/s11103-008-9391-8; Hu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022132; Hughes Amanda, 2009, J Biol, V8, P96, DOI 10.1186/jbiol207; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Kim JM, 2008, PLANT CELL PHYSIOL, V49, P1580, DOI 10.1093/pcp/pcn133; Kim JM, 2010, PLANT CELL ENVIRON, V33, P604, DOI 10.1111/j.1365-3040.2009.02076.x; Kornberg RD, 1999, CURR OPIN GENET DEV, V9, P148, DOI 10.1016/S0959-437X(99)80022-7; Kwon CS, 2009, PLANT J, V60, P112, DOI 10.1111/j.1365-313X.2009.03938.x; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Lodha M, 2005, PLANT MOL BIOL, V59, P501, DOI 10.1007/s11103-005-0450-0; Maniatis T., 1982, MOL CLONING LAB MANU; Mao F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-76; Pavangadkar K, 2010, PLANT MOL BIOL, V74, P183, DOI 10.1007/s11103-010-9665-9; Qiu Y, 2012, GENE DEV, V26, P1376, DOI 10.1101/gad.188359.112; RoyChoudhury A, 2008, PLANT CELL REP, V27, P779, DOI 10.1007/s00299-007-0498-1; Sokol A, 2007, PLANTA, V227, P245, DOI 10.1007/s00425-007-0612-1; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; SVAREN J, 1994, EMBO J, V13, P4856, DOI 10.1002/j.1460-2075.1994.tb06812.x; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Tsuji H, 2006, PLANT CELL PHYSIOL, V47, P995, DOI 10.1093/pcp/pcj072; VEGAPALAS MA, 1995, PLANT CELL, V7, P1923, DOI 10.1105/tpc.7.11.1923; VENTER U, 1994, EMBO J, V13, P4848, DOI 10.1002/j.1460-2075.1994.tb06811.x; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Zhang WL, 2012, PLANT CELL, V24, P2719, DOI 10.1105/tpc.112.098061; Zhang WL, 2012, GENOME RES, V22, P151, DOI 10.1101/gr.131342.111	44	55	60	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100343	10.1371/journal.pone.0100343	http://dx.doi.org/10.1371/journal.pone.0100343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940877	Green Published, gold, Green Submitted			2022-12-25	WOS:000338508200095
J	Ye, JF; Zhang, L; Chen, Y; Fang, F; Luo, ZC; Zhang, J				Ye, Jiangfeng; Zhang, Lin; Chen, Yan; Fang, Fang; Luo, ZhongCheng; Zhang, Jun			Searching for the Definition of Macrosomia through an Outcome-Based Approach	PLOS ONE			English	Article							PLANNED CESAREAN-SECTION; BIRTH-WEIGHT; PERINATAL-MORTALITY; UNITED-STATES; BREECH PRESENTATION; MATERNAL OUTCOMES; PRETERM DELIVERY; FETAL MACROSOMIA; VAGINAL BIRTH; RISK	Background: Macrosomia has been defined in various ways by obstetricians and researchers. The purpose of the present study was to search for a definition of macrosomia through an outcome-based approach. Methods: In a study of 30,831,694 singleton term live births and 38,053 stillbirths in the U. S. Linked Birth-Infant Death Cohort datasets (1995-2004), we compared the occurrence of stillbirth, neonatal death, and 5-min Apgar score less than four in subgroups of birthweight (4000-4099 g, 4100-4199 g, 4200-4299 g, 4300-4399 g, 4400-4499 g, 4500-4999 g vs. reference group 3500-4000 g) and birthweight percentile for gestational age (90th-94th percentile, 95th-96th, and >= 97th percentile, vs. reference group 75th-90th percentile). Results: There was no significant increase in adverse perinatal outcomes until birthweight exceeded the 97th percentile. Weight-specific odds ratios (ORs) elevated substantially to 2 when birthweight exceeded 4500 g in Whites. In Blacks and Hispanics, the aORs exceeded 2 for 5-min Apgar less than four when birthweight exceeded 4300 g. For vaginal deliveries, the aORs of perinatal morbidity and mortality were larger for most of the subgroups, but the patterns remained the same. Conclusions: A birthweight greater than 4500 g in Whites, or 4300 g in Blacks and Hispanics regardless of gestational age is the optimal threshold to define macrosomia. A birthweight greater than the 97th percentile for a given gestational age, irrespective of race is also reasonable to define macrosomia. The former may be more clinically useful and simpler to apply.	[Ye, Jiangfeng; Chen, Yan; Fang, Fang; Luo, ZhongCheng; Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, MOE Shanghai Key Lab Childrens Environm Hlth, Shanghai 200030, Peoples R China; [Zhang, Lin] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Obstet, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, MOE Shanghai Key Lab Childrens Environm Hlth, Shanghai 200030, Peoples R China.	junjimzhang@gmail.com	Luo, Zhong-Cheng/T-3882-2017	Luo, Zhong-Cheng/0000-0002-1794-1312	Shanghai Municipal Health Bureau, China [GWIII-26.2]	Shanghai Municipal Health Bureau, China	This study was supported by a grant from the Shanghai Municipal Health Bureau, China (No. GWIII-26.2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, ACOG PRACTICE B, V22; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Boulet SL, 2006, AM J OBSTET GYNECOL, V195, P1571, DOI 10.1016/j.ajog.2006.03.069; Boulet SL, 2003, AM J OBSTET GYNECOL, V188, P1372, DOI 10.1067/mob.2003.302; Chauhan SP, 2005, AM J OBSTET GYNECOL, V193, P332, DOI 10.1016/j.ajog.2004.12.020; Dennedy MC, 2013, LANCET, V381, P435, DOI 10.1016/S0140-6736(12)62090-X; Dietz PM, 2007, PAEDIATR PERINAT EP, V21, P62, DOI 10.1111/j.1365-3016.2007.00862.x; Graafmans WC, 2002, EPIDEMIOLOGY, V13, P569, DOI 10.1097/00001648-200209000-00013; Hannah ME, 2004, AM J OBSTET GYNECOL, V191, P917, DOI 10.1016/j.ajog.2004.08.004; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; Haram K, 2002, ACTA OBSTET GYN SCAN, V81, P185, DOI 10.1034/j.1600-0412.2002.810301.x; Harder T, 2009, AM J EPIDEMIOL, V169, P1428, DOI 10.1093/aje/kwp065; Henriksen T, 2008, ACTA OBSTET GYN SCAN, V87, P134, DOI 10.1080/00016340801899289; Khashan AS, 2008, PSYCHOSOM MED, V70, P688, DOI 10.1097/PSY.0b013e318177940d; Koyanagi A, 2013, LANCET, V381, P476, DOI 10.1016/S0140-6736(12)61605-5; Kristensen J, 2005, BJOG-INT J OBSTET GY, V112, P403, DOI 10.1111/j.1471-0528.2005.00437.x; Mathews T J, 2000, Natl Vital Stat Rep, V48, P1; Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4; Morris BH, 2008, NEW ENGL J MED, V359, P1885, DOI 10.1056/NEJMoa0803024; Pasupathy D, 2012, PAEDIATR PERINAT EP, V26, P543, DOI 10.1111/ppe.12002; Qin C, 2007, PAEDIATR PERINAT EP, V21, P41, DOI 10.1111/j.1365-3016.2007.00860.x; Rouse DJ, 1996, JAMA-J AM MED ASSOC, V276, P1480, DOI 10.1001/jama.276.18.1480; Schellong K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047776; Scifres CM, 2008, AM J OBSTET GYNECOL, V198, P603, DOI 10.1016/j.ajog.2008.03.043; Souza JP, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-71; Stotland NE, 2004, INT J GYNECOL OBSTET, V87, P220, DOI 10.1016/j.ijgo.2004.08.010; Vahratian A, 2006, MATERN CHILD HLTH J, V10, P27, DOI 10.1007/s10995-005-0032-4; Vangen S, 2002, INT J EPIDEMIOL, V31, P654, DOI 10.1093/ije/31.3.654; WILCOX A, 1995, JAMA-J AM MED ASSOC, V273, P709, DOI 10.1001/jama.273.9.709; WILCOX AJ, 1986, INT J EPIDEMIOL, V15, P188, DOI 10.1093/ije/15.2.188; WILCOX AJ, 1983, INT J EPIDEMIOL, V12, P319, DOI 10.1093/ije/12.3.319; Yu CKH, 2006, BJOG-INT J OBSTET GY, V113, P1117, DOI 10.1111/j.1471-0528.2006.00991.x; Zhang X, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.12.005	33	18	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100192	10.1371/journal.pone.0100192	http://dx.doi.org/10.1371/journal.pone.0100192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941024	Green Published, gold			2022-12-25	WOS:000338508200082
J	Goldschmidt, P; Degorge, S; Merabet, L; Chaumeil, C				Goldschmidt, Pablo; Degorge, Sandrine; Merabet, Lilia; Chaumeil, Christine			Enzymatic Treatment of Specimens before DNA Extraction Directly Influences Molecular Detection of Infectious Agents	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; RAPID DIAGNOSIS; BLOOD; ENDOPHTHALMITIS; CULTURE; AMPLIFICATION; MICROBIOLOGY; ACANTHAMOEBA; INHIBITOR	Introduction: Biological samples, pharmaceuticals or food contain proteins, lipids, polymers, ammoniums and macromolecules that alter the detection of infectious agents by DNA amplification techniques (PCR). Moreover the targeted DNA has to be released from the complex cell walls and the compact nucleoprotein matrixes and cleared from potential inhibitors. The goal of the present work was to assess the efficiency of enzymatic pretreatments on infectious agents to make DNA available for further extraction and amplification. Methods: Staphylococcus epidermidis, Streptococcus mitis, Propionibacterium acnes, Escherichia coli, Pseudomonas aeruginosa, Candida albicans, Aspergillus niger and Fusarium solani were mixed with an internal control virus and treated with: 1) proteinase K; 2) lyticase and 3) lyticase followed by proteinase K. DNAs was manually extracted using the QIAmp DNA Mini kit or the MagNA Pure Compact automate. DNA extraction yields and the inhibitors were assessed with a phocid Herpesvirus. Bacterial detection was performed using TaqMan real-time PCR and yeasts and filamentous Fungi with HRM (real-time PCR followed by high-resolution melting analysis). Results: Viral DNA was released, extracted and detected using manual and automatic methods without pre enzymatic treatments. Either the manual or the automatic DNA extraction systems did not meet the sensitivity expectations if enzymatic treatments were not performed before: lyticase for Fungi and Proteinase K for Bacteria. The addition of lyticase and proteinase K did not improve results. For Fungi the detection after lyticase was higher than for Proteinase K, for which melting analysis did not allow fungal specification. Discussion: Columns and magnetic beads allowed collecting DNA and separate PCR inhibitors. Detection rates cannot be related to DNA-avidity of beads or to elution but to the lack of proteolysis.	[Goldschmidt, Pablo; Degorge, Sandrine; Merabet, Lilia; Chaumeil, Christine] Lab Ctr Hosp Natl Ophtalmol Quinze Vingts, Paris, France	CHNO des Quinze-Vingts; UDICE-French Research Universities; Sorbonne Universite	Goldschmidt, P (corresponding author), Lab Ctr Hosp Natl Ophtalmol Quinze Vingts, Paris, France.	pablogol@aol.com						Allan EK, 2005, BRIT J HAEMATOL, V128, P578, DOI 10.1111/j.1365-2141.2004.05333.x; Allen SD, 1985, ANAEROBIC BACTERIA M; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Benz MS, 2004, AM J OPHTHALMOL, V137, P38, DOI 10.1016/S0002-9394(03)00896-1; BETZEL C, 1993, J BIOL CHEM, V268, P15854; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bretagne S, 2005, FEMS IMMUNOL MED MIC, V45, P361, DOI 10.1016/j.femsim.2005.05.012; Dauphin LA, 2011, DIAGN MICR INFEC DIS, V70, P299, DOI 10.1016/j.diagmicrobio.2011.02.010; Fairfax MR, 2013, CLIN LAB MED, V33, P787, DOI 10.1016/j.cll.2013.08.003; Fredricks DN, 1998, J CLIN MICROBIOL, V36, P2810, DOI 10.1128/JCM.36.10.2810-2816.1998; Freise J, 2001, ANN RHEUM DIS, V60, P140, DOI 10.1136/ard.60.2.140; Gauduchon V, 2003, J CLIN MICROBIOL, V41, P763, DOI 10.1128/JCM.41.2.763-766.2003; Goldschmidt P, 2008, BRIT J OPHTHALMOL, V92, P112, DOI 10.1136/bjo.2007.125898; Goldschmidt P, 2006, BRIT J OPHTHALMOL, V90, P1425, DOI 10.1136/bjo.2006.096420; Goldschmidt P, 2006, BRIT J OPHTHALMOL, V90, P1354, DOI 10.1136/bjo.2006.098830; Goldschmidt P, 2011, PATHOL BIOL, V59, P248, DOI 10.1016/j.patbio.2009.10.008; Goldschmidt P, 2009, BRIT J OPHTHALMOL, V93, P258, DOI 10.1136/bjo.2008.146639; Goldschmidt P, 2009, BRIT J OPHTHALMOL, V93, P1089, DOI 10.1136/bjo.2008.152181; Goldschmidt P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037660; Goldschmidt P, 2012, OPHTHALMOLOGY, V119, P945, DOI 10.1016/j.ophtha.2011.10.038; GREISEN K, 1994, J CLIN MICROBIOL, V32, P335, DOI 10.1128/JCM.32.2.335-351.1994; Heckenberg Sebastiaan G B, 2014, Handb Clin Neurol, V121, P1361, DOI 10.1016/B978-0-7020-4088-7.00093-6; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Henning L, 1999, ACTA TROP, V72, P149, DOI 10.1016/S0001-706X(98)00090-4; Holt J., 1994, BERGEYS MANUAL DETER; Horvath LL, 2004, J CLIN MICROBIOL, V42, P115, DOI 10.1128/JCM.42.1.115-118.2004; Jeddi F, 2013, PARASITE, V20, DOI 10.1051/parasite/2013051; Loeffler J, 2000, DIAGN MICR INFEC DIS, V38, P207, DOI 10.1016/S0732-8893(00)00201-7; Loffler J, 1997, J CLIN MICROBIOL, V35, P3311; Marr KA, 2002, CLIN INFECT DIS, V34, P909, DOI 10.1086/339202; Martin C, 2000, J CLIN MICROBIOL, V38, P3735, DOI 10.1128/JCM.38.10.3735-3742.2000; Metwally L, 2008, J MED MICROBIOL, V57, P296, DOI 10.1099/jmm.0.47617-0; Millar BC, 2001, J MICROBIOL METH, V47, P255, DOI 10.1016/S0167-7012(01)00334-7; Mohammadi T, 2005, TRANSFUSION, V45, P731, DOI 10.1111/j.1537-2995.2005.04258.x; Molteni CG, 2013, INT J IMMUNOPATH PH, V26, P779, DOI 10.1177/039463201302600324; Ng JQ, 2005, OPHTHALMOLOGY, V112, P1199, DOI 10.1016/j.ophtha.2005.01.050; Obara H, 2011, J INFECT CHEMOTHER, V17, P327, DOI 10.1007/s10156-010-0168-z; Ostrosky-Zeichner L, 2003, ANTIMICROB AGENTS CH, V47, P3149, DOI 10.1128/AAC.47.10.3149-3154.2003; Podnecky NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058032; Poppert S, 2005, J CLIN MICROBIOL, V43, P3390, DOI 10.1128/JCM.43.7.3390-3397.2005; Rabodonirina M, 1999, J CLIN MICROBIOL, V37, P127, DOI 10.1128/JCM.37.1.127-131.1999; Radomski N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078749; Ratanarat R, 2007, BLOOD PURIFICAT, V25, P106, DOI 10.1159/000096406; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; SCOTT JH, 1980, J BACTERIOL, V142, P414, DOI 10.1128/JB.142.2.414-423.1980; Seal D, 2008, J CATARACT REFR SURG, V34, P1439, DOI 10.1016/j.jcrs.2008.05.043; Seitzman GD, 2006, AM J OPHTHALMOL, V141, P756, DOI 10.1016/j.ajo.2005.10.056; Surinder K, 2007, Indian J Med Microbiol, V25, P395; van Doornum GJJ, 2003, J CLIN MICROBIOL, V41, P576, DOI 10.1128/JCM.41.2.576-580.2003; Welinder-Olsson C, 2007, CLIN MICROBIOL INFEC, V13, P879, DOI 10.1111/j.1469-0691.2007.01756.x; White PL, 2003, J MED MICROBIOL, V52, P229, DOI 10.1099/jmm.0.05049-0	53	20	20	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e94886	10.1371/journal.pone.0094886	http://dx.doi.org/10.1371/journal.pone.0094886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936792	gold, Green Submitted, Green Published			2022-12-25	WOS:000338503400003
J	Kim, TN; Park, MS; Kim, YJ; Lee, EJ; Kim, MK; Kim, JM; Ko, KS; Rhee, BD; Won, JC				Kim, Tae Nyun; Park, Man Sik; Kim, You Jeong; Lee, Eun Ju; Kim, Mi-Kyung; Kim, Jung Min; Ko, Kyung Soo; Rhee, Byoung Doo; Won, Jong Chul			Association of Low Muscle Mass and Combined Low Muscle Mass and Visceral Obesity with Low Cardiorespiratory Fitness	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; KOREAN SARCOPENIC OBESITY; ALL-CAUSE MORTALITY; METABOLIC SYNDROME; INSULIN-RESISTANCE; SKELETAL-MUSCLE; POSTMENOPAUSAL WOMEN; PHYSICAL-ACTIVITY; OLDER-ADULTS; INFLAMMATION	Objective: Previous studies have shown that low cardiorespiratory fitness (CRF), visceral obesity and low muscle mass may share pathophysiological mechanisms, such as insulin resistance and chronic inflammation. In this study, we investigated whether low CRF is associated with low muscle mass, visceral obesity, and visceral obesity combined with low muscle mass. Research Design and Methods: The associations between CRF and low muscle mass and combined low muscle mass and visceral obesity were examined in 298 apparently healthy adults aged 20-70 years. Low muscle mass was defined using a skeletal muscle mass index (SMI) that was calculated using dual energy X-ray absorptiometry. Visceral obesity was defined as a visceral fat area (VFA) exceeding 100 cm(2) in women and 130 cm(2) in men. We classified the participants into 4 low muscle mass/visceral obesity groups according to SMI and VFA. CRF was measured using a cycle ergometer test. Results: CRF level correlated positively with SMI and negatively with VFA. Individuals with low muscle mass had lower CRF values than those without low muscle mass. After adjustment for age, sex, lifestyle factors, and markers for insulin resistance and inflammation, participants in the lowest quartile of CRF had an odds ratio (OR) for low muscle mass of 4.98 compared with those in the highest quartile (95% confidence interval (CI) = 1.19-12.99; P for trend = 0.001) and an OR for combined low muscle mass and visceral obesity of 31.46 (95% CI = 4.31-229.68; P for trend = 0.001). Conclusions: Individuals with lower CRF exhibited increased risk of low muscle mass and combined low muscle mass and visceral obesity. These results suggest that low CRF may be a potential indicator for low muscle mass and combined low muscle mass and visceral obesity in Korean adults.	[Kim, Tae Nyun; Kim, You Jeong; Lee, Eun Ju; Kim, Mi-Kyung; Kim, Jung Min; Ko, Kyung Soo; Rhee, Byoung Doo; Won, Jong Chul] Inje Univ, Coll Med, Dept Internal Med, Pusan, South Korea; [Kim, Tae Nyun; Kim, Jung Min; Ko, Kyung Soo; Rhee, Byoung Doo; Won, Jong Chul] Inje Univ, Cardiovasc & Metab Dis Ctr, Div Endocrinol & Metab, Pusan, South Korea; [Park, Man Sik] Sungshin Womens Univ, Coll Nat Sci, Dept Stat, Seoul, South Korea	Inje University; Inje University; Sungshin Women's University	Won, JC (corresponding author), Inje Univ, Coll Med, Dept Internal Med, Pusan, South Korea.	drwonjc@gmail.com	Kim, Tae Nyun/AAV-5521-2020	Kim, Mi-kyung/0000-0003-1111-9122; Kim, Tae Nyun/0000-0001-6568-2469; Won, Jong Chul/0000-0002-2219-4083; Kim, Jung Min/0000-0002-1848-3747	Korea Ministry of Health Welfare; Korean Diabetes Association; Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2010-0020224]; Inje University [20140036]	Korea Ministry of Health Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea); Korean Diabetes Association; Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(National Research Foundation of Korea); Inje University	This study was supported by the Health Promotion Funds from the Korea Ministry of Health & Welfare, Korean Diabetes Association, 2009, and Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0020224). This work was also supported by a grant from Research year of Inje University in 2014 (20140036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenault BJ, 2007, ARCH INTERN MED, V167, P1518, DOI 10.1001/archinte.167.14.1518; Beyer I, 2012, CURR OPIN CLIN NUTR, V15, P12, DOI 10.1097/MCO.0b013e32834dd297; BIOLO G, 1995, J CLIN INVEST, V95, P811, DOI 10.1172/JCI117731; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Blood I, 2005, CARDIOL REV, V13, P322; Carroll S, 2004, SPORTS MED, V34, P371, DOI 10.2165/00007256-200434060-00004; Cesari M, 2005, AM J CLIN NUTR, V82, P428, DOI 10.1093/ajcn/82.2.428; Church TS, 2007, JAMA-J AM MED ASSOC, V297, P2081, DOI 10.1001/jama.297.19.2081; Davidson LE, 2009, ARCH INTERN MED, V169, P122, DOI 10.1001/archinternmed.2008.558; de Oliveira RJ, 2009, J SPORT SCI MED, V8, P337; FLEG JL, 1988, J APPL PHYSIOL, V65, P1147, DOI 10.1152/jappl.1988.65.3.1147; FLETCHER GF, 1992, CIRCULATION, V86, P340, DOI 10.1161/01.CIR.86.1.340; Gerson LS, 2006, MED SCI SPORT EXER, V38, P1709, DOI 10.1249/01.mss.0000228365.31821.22; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Janssen I, 2007, DIABETES CARE, V30, P2143, DOI 10.2337/dc07-0734; Kim TN, 2009, INT J OBESITY, V33, P885, DOI 10.1038/ijo.2009.130; Kim TN, 2010, DIABETES CARE, V33, P1497, DOI 10.2337/dc09-2310; Kim TN, DIABETES RES CLIN PR, V101, P210; Kullo IJ, 2002, AM J CARDIOL, V90, P795, DOI 10.1016/S0002-9149(02)02617-6; Lee ES, 2005, OBES RES, V13, P320, DOI 10.1038/oby.2005.43; Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107; Liu CJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002759.pub2; Messier V, 2008, METABOLISM, V57, P1293, DOI 10.1016/j.metabol.2008.04.026; Proctor DN, 1997, J APPL PHYSIOL, V82, P1411, DOI 10.1152/jappl.1997.82.5.1411; Ryu M, AGE AGEING, V42, P734; Schrager MA, 2007, J APPL PHYSIOL, V102, P919, DOI 10.1152/japplphysiol.00627.2006; Srikanthan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010805; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; Sui XM, 2007, JAMA-J AM MED ASSOC, V298, P2507, DOI 10.1001/jama.298.21.2507; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; World Health Organization, 2000, ASIA PACIFIC PERSPEC; Zamboni M, 2008, NUTR METAB CARDIOVAS, V18, P388, DOI 10.1016/j.numecd.2007.10.002	33	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100118	10.1371/journal.pone.0100118	http://dx.doi.org/10.1371/journal.pone.0100118			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937121	gold, Green Published, Green Submitted			2022-12-25	WOS:000338503400078
J	Kraft, P; Drechsler, C; Gunreben, I; Nieswandt, B; Stoll, G; Heuschmann, PU; Kleinschnitz, C				Kraft, Peter; Drechsler, Christiane; Gunreben, Ignaz; Nieswandt, Bernhard; Stoll, Guido; Heuschmann, Peter Ulrich; Kleinschnitz, Christoph			Von Willebrand Factor Regulation in Patients with Acute and Chronic Cerebrovascular Disease: A Pilot, Case-Control Study	PLOS ONE			English	Article							NONVALVULAR ATRIAL-FIBRILLATION; FACTOR LEVELS INCREASE; ABO BLOOD-GROUP; ISCHEMIC-STROKE; ENDOTHELIAL DYSFUNCTION; THROMBUS FORMATION; SYSTEMIC INFLAMMATION; MYOCARDIAL-INFARCTION; PLATELET ACTIVATION; FACTOR-VIII	Background and Purpose: In animal models, von Willebrand factor (VWF) is involved in thrombus formation and propagation of ischemic stroke. However, the pathophysiological relevance of this molecule in humans, and its potential use as a biomarker for the risk and severity of ischemic stroke remains unclear. This study had two aims: to identify predictors of altered VWF levels and to examine whether VWF levels differ between acute cerebrovascular events and chronic cerebrovascular disease (CCD). Methods: A case-control study was undertaken between 2010 and 2013 at our University clinic. In total, 116 patients with acute ischemic stroke (AIS) or transitory ischemic attack (TIA), 117 patients with CCD, and 104 healthy volunteers (HV) were included. Blood was taken at days 0, 1, and 3 in patients with AIS or TIA, and once in CCD patients and HV. VWF serum levels were measured and correlated with demographic and clinical parameters by multivariate linear regression and ANOVA. Results: Patients with CCD (158 +/- 46%) had significantly higher VWF levels than HV (113 +/- 36%, P<0.001), but lower levels than AIS/TIA patients (200 +/- 95%, P<0.001). Age, sex, and stroke severity influenced VWF levels (P<0.05). Conclusions: VWF levels differed across disease subtypes and patient characteristics. Our study confirms increased VWF levels as a risk factor for cerebrovascular disease and, moreover, suggests that it may represent a potential biomarker for stroke severity, warranting further investigation.	[Kraft, Peter; Gunreben, Ignaz; Stoll, Guido; Kleinschnitz, Christoph] Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany; [Drechsler, Christiane] Univ Hosp Wurzburg, Dept Internal Med, Wurzburg, Germany; [Heuschmann, Peter Ulrich] Univ Hosp Wurzburg, Clin Trial Ctr, Wurzburg, Germany; [Kraft, Peter; Heuschmann, Peter Ulrich] Univ Wurzburg, Comprehens Heart Failure Ctr, Inst Clin Epidemiol & Biometry, D-97070 Wurzburg, Germany; [Nieswandt, Bernhard] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg	Kleinschnitz, C (corresponding author), Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany.	christoph.kleinschnitz@uni-wuerzburg.de		Kleinschnitz, Christoph/0000-0002-1650-8875	German Research Foundation (Deutsche Forschungsgemeinschaft) [Sonderforschungsbereich 688]; German Ministry for Research and Education (Bundesministerium fur Bildung und Forschung, Comprehensive Heart Failure Center, Wurzburg, Germany)	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Ministry for Research and Education (Bundesministerium fur Bildung und Forschung, Comprehensive Heart Failure Center, Wurzburg, Germany)	This publication was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 688) and the German Ministry for Research and Education (Bundesministerium fur Bildung und Forschung, Comprehensive Heart Failure Center, Wurzburg, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Bongers TN, 2006, STROKE, V37, P2672, DOI 10.1161/01.STR.0000244767.39962.f7; Caponnetto P, 2011, EUR J CLIN INVEST, V41, P616, DOI 10.1111/j.1365-2362.2010.02449.x; Catto AJ, 1997, THROMB HAEMOSTASIS, V77, P1104; Claus RA, 2010, CURR MOL MED, V10, P236, DOI 10.2174/156652410790963367; Conway DSG, 2003, CIRCULATION, V107, P3141, DOI 10.1161/01.CIR.0000077912.12202.FC; De Meyer SF, 2012, STROKE, V43, P599, DOI 10.1161/STROKEAHA.111.628867; Della-Morte D, 2012, J NEUROL SCI, V323, P93, DOI 10.1016/j.jns.2012.08.020; Dmitrieva NI, 2014, P NATL ACAD SCI USA, V111, P6485, DOI 10.1073/pnas.1404809111; Faille D, 2014, EUR J NEUROL, V21, P643, DOI 10.1111/ene.12369; Folsom AR, 1999, CIRCULATION, V100, P736, DOI 10.1161/01.CIR.100.7.736; Gauberti M, 2014, J THROMB HAEMOST, V12, P409, DOI 10.1111/jth.12487; GILL JC, 1987, BLOOD, V69, P1691; GRANGER CV, 1979, ARCH PHYS MED REHAB, V60, P14; Hanson E, 2011, J THROMB HAEMOST, V9, P275, DOI 10.1111/j.1538-7836.2010.04134.x; Jenkins PV, 2006, TRANSFUSION, V46, P1836, DOI 10.1111/j.1537-2995.2006.00975.x; Johnsen JM, 2013, BLOOD, V122, P590, DOI 10.1182/blood-2013-02-485094; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; Kleinschnitz C, 2009, BLOOD, V113, P3600, DOI 10.1182/blood-2008-09-180695; Kraft P, 2012, J CEREBR BLOOD F MET, V32, P1831, DOI 10.1038/jcbfm.2012.108; Le Behot A, 2014, BLOOD IN PRESS; Lip GYH, 2002, BLOOD COAGUL FIBRIN, V13, P339, DOI 10.1097/00001721-200206000-00010; Momi S, 2013, BLOOD, V121, P5088, DOI 10.1182/blood-2012-11-464545; Muir KW, 1996, STROKE, V27, P1817, DOI 10.1161/01.STR.27.10.1817; Nieswandt B, 2011, J PHYSIOL-LONDON, V589, P4115, DOI 10.1113/jphysiol.2011.212886; Nilsson TK, 2002, J CARDIOVASC RISK, V9, P215, DOI 10.1097/00043798-200208000-00006; Noto ATW, 2006, THROMB HAEMOSTASIS, V96, P53, DOI 10.1160/TH05-11-0772; Pinto A, 2009, CLIN SCI, V116, P781, DOI 10.1042/CS20080372; Roldan V, 2005, THROMB RES, V116, P321, DOI 10.1016/j.thromres.2005.01.005; Soares AL, 2011, BLOOD COAGUL FIBRIN, V22, P600, DOI 10.1097/MBC.0b013e32834b2fe1; Stegner D, 2011, J MOL MED, V89, P109, DOI 10.1007/s00109-010-0691-5; Stoll G, 2008, BLOOD, V112, P3555, DOI 10.1182/blood-2008-04-144758; Stoll G, 2010, ANN NY ACAD SCI, V1207, P149, DOI 10.1111/j.1749-6632.2010.05730.x; Suadicani P, 2002, J CARDIOVASC RISK, V9, P191, DOI 10.1097/00043798-200208000-00003; Tzoulaki I, 2007, CIRCULATION, V115, P2119, DOI 10.1161/CIRCULATIONAHA.106.635029; Vischer UM, 2006, J THROMB HAEMOST, V4, P1186, DOI 10.1111/j.1538-7836.2006.01949.x; von Beckerath N, 2004, BLOOD COAGUL FIBRIN, V15, P61, DOI 10.1097/00001721-200401000-00010; Westein E, 2013, P NATL ACAD SCI USA, V110, P1357, DOI 10.1073/pnas.1209905110; Wieberdink RG, 2010, STROKE, V41, P2151, DOI 10.1161/STROKEAHA.110.586289; Wu DM, 2002, BLOOD, V99, P3623, DOI 10.1182/blood.V99.10.3623; Xia ZY, 2011, VASA, V40, P199, DOI 10.1024/0301-1526/a000094	42	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99851	10.1371/journal.pone.0099851	http://dx.doi.org/10.1371/journal.pone.0099851			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937073	Green Published, gold			2022-12-25	WOS:000338503400044
J	Hilu, KW; Black, CM; Oza, D				Hilu, Khidir W.; Black, Chelsea M.; Oza, Dipan			Impact of Gene Molecular Evolution on Phylogenetic Reconstruction: A Case Study in the Rosids (Superorder Rosanae, Angiosperms)	PLOS ONE			English	Article							NUCLEOTIDE SUBSTITUTION; SEQUENCE DATA; MATK; INFORMATIVENESS; UTILITY; SIGNAL; DNA; CHARACTER; MODELS; RBCL	Rate of substitution of genomic regions is among the most debated intrinsic features that impact phylogenetic informativeness. However, this variable is also coupled with rates of nonsynonymous substitutions that underscore the nature and degree of selection on the selected genes. To empirically address these variables, we constructed four completely overlapping data sets of plastid matK, atpB, rbcL, and mitochondrial matR genes and used the rosid lineage (angiosperms) as a working platform. The genes differ in combinations of overall rates of nucleotide and amino acid substitutions. Tree robustness, homoplasy, accuracy in contrast to a reference tree, and phylogenetic informativeness are evaluated. The rapidly evolving/unconstrained matK faired best, whereas remaining genes varied in degrees of contribution to rosid phylogenetics across the lineage's 108 million years evolutionary history. Phylogenetic accuracy was low with the slowly evolving/unconstrained matR despite least amount of homoplasy. Third codon positions contributed the highest amount of parsimony informative sites, resolution and informativeness, but magnitude varied with gene mode of evolution. These findings are in clear contrast with the views that rapidly evolving regions and the 3rd codon position have inevitable negative impact on phylogenetic reconstruction at deep historic level due to accumulation of multiple hits and subsequent elevation in homoplasy and saturation. Relaxed evolutionary constraint in rapidly evolving genes distributes substitutions across codon positions, an evolutionary mode expected to reduce the frequency of multiple hits. These findings should be tested at deeper evolutionary histories.	[Hilu, Khidir W.; Black, Chelsea M.; Oza, Dipan] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Hilu, KW (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	hilukw@vt.edu			National Science Foundation, USA, Assembling Tree of Life [EF-043105, REU-4776833]	National Science Foundation, USA, Assembling Tree of Life	This work was supported by grant from the National Science Foundation, USA, Assembling Tree of Life (grant numbers EF-043105 and REU-4776833) to KH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthet MM, 2008, J MOL EVOL, V66, P85, DOI 10.1007/s00239-007-9060-6; Bjorklund M, 1999, CLADISTICS, V15, P191, DOI 10.1111/j.1096-0031.1999.tb00261.x; Blouin MS, 1998, MOL BIOL EVOL, V15, P1719, DOI 10.1093/oxfordjournals.molbev.a025898; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Brockington SF, 2009, INT J PLANT SCI, V170, P627, DOI 10.1086/597785; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Campbell DL, 2000, MOL BIOL EVOL, V17, P684, DOI 10.1093/oxfordjournals.molbev.a026347; Cantino PD, 2007, TAXON, V56, P822, DOI 10.2307/25065865; Collins TM, 2005, SYST BIOL, V54, P493, DOI 10.1080/10635150590947339; Crawley SS, 2012, J SYST EVOL, V50, P387, DOI 10.1111/j.1759-6831.2012.00197.x; Criscuolo A, 2009, J MOL EVOL, V68, P377, DOI 10.1007/s00239-009-9212-y; Dornburg A, 2012, MOL BIOL EVOL, V29, P721, DOI 10.1093/molbev/msr228; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; EDWARDS SV, 1991, P ROY SOC B-BIOL SCI, V243, P99, DOI 10.1098/rspb.1991.0017; FARRIS JS, 1989, CLADISTICS, V5, P417, DOI 10.1111/j.1096-0031.1989.tb00573.x; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fong JJ, 2011, MOL PHYLOGENET EVOL, V61, P300, DOI 10.1016/j.ympev.2011.06.016; Goldman N, 1998, P ROY SOC B-BIOL SCI, V265, P1779, DOI 10.1098/rspb.1998.0502; Goremykin VV, 2003, MOL BIOL EVOL, V20, P1499, DOI 10.1093/molbev/msg159; Graham SW, 2000, AM J BOT, V87, P1712, DOI 10.2307/2656749; GRAYBEAL A, 1994, SYST BIOL, V43, P174, DOI 10.2307/2413460; HASEBE M, 1994, P NATL ACAD SCI USA, V91, P5730, DOI 10.1073/pnas.91.12.5730; Hastad O, 1998, MOL BIOL EVOL, V15, P1381, DOI 10.1093/oxfordjournals.molbev.a025866; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; HILLIS DM, 1987, ANNU REV ECOL SYST, V18, P23, DOI 10.1146/annurev.es.18.110187.000323; Hilu KW, 2008, MOL PHYLOGENET EVOL, V48, P1120, DOI 10.1016/j.ympev.2008.05.021; Hilu KW, 2003, AM J BOT, V90, P1758, DOI 10.3732/ajb.90.12.1758; Hilu KW, 1997, AM J BOT, V84, P830, DOI 10.2307/2445819; Kallersjo M, 1999, CLADISTICS, V15, P91; Kallersjo M, 1998, PLANT SYSTEMATICS EV; Klopfstein S, 2010, SYST BIOL, V59, P226, DOI 10.1093/sysbio/syp105; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Korber B, 2000, COMPUTATIONAL EVOLUT, P52; Lewis LA, 1997, MOL PHYLOGENET EVOL, V7, P377, DOI 10.1006/mpev.1996.0395; LI WH, 1991, FUNDAMENTALS MOL EVO; Lopez-Giraldez F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-152; Magallon S, 2002, AM J BOT, V89, P1991, DOI 10.3732/ajb.89.12.1991; Magallon S, 2013, AM J BOT, V100, P556, DOI 10.3732/ajb.1200416; Milinkovitch MC, 1996, GENETICS, V144, P1817; Moeller AH, 2011, MOL PHYLOGENET EVOL, V60, P271, DOI 10.1016/j.ympev.2011.04.023; Moore MJ, 2010, P NATL ACAD SCI; Mossel E, 2004, MATH BIOSCI, V187, P189, DOI 10.1016/j.mbs.2003.10.004; MRibu HK, 1996, GENET RESOUR CROP EV, V43, P203, DOI 10.1007/BF00123272; Muller KF, 2006, MOL PHYLOGENET EVOL, V41, P99, DOI 10.1016/j.ympev.2006.06.017; Mueller RL, 2006, SYST BIOL, V55, P289, DOI 10.1080/10635150500541672; Muller J, 2003, PLANT MOL BIOL REP, V21, P5; Muller K, 2004, MOL PHYLOGENET EVOL, V31, P780, DOI 10.1016/j.ympev.2003.12.006; NAYLOR GJP, 1995, NATURE, V373, P565, DOI 10.1038/373565b0; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Olmstead R. G., 1998, MOL SYSTEMATICS PLAN, P164; OLMSTEAD RG, 1994, AM J BOT, V81, P1205, DOI 10.2307/2445483; Qiu YL, 2010, J SYST EVOL, V48, P391, DOI 10.1111/j.1759-6831.2010.00097.x; Raja HA, 2011, MYCOKEYS, P63, DOI 10.3897/mycokeys.1.1966; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; Sanderson MJ, 2002, ANNU REV ECOL SYST, V33, P49, DOI 10.1146/annurev.ecolsys.33.010802.150509; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Sennblad B, 2000, SYST BIOL, V49, P101, DOI 10.1080/10635150050207410; Shen XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039256; Shpak M, 2000, MOL PHYLOGENET EVOL, V17, P231, DOI 10.1006/mpev.2000.0846; Simmons MP, 2006, SYST BIOL, V55, P245, DOI 10.1080/10635150500481473; Simmons MP, 2004, CLADISTICS, V20, P191, DOI 10.1111/j.1096-0031.2004.00014.x; Simmons MP, 2002, MOL PHYLOGENET EVOL, V24, P78, DOI 10.1016/S1055-7903(02)00202-6; Sogin ML, 1991, CURR OPIN GENET DEV, V1, P457, DOI 10.1016/S0959-437X(05)80192-3; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Steel M, 2000, MOL BIOL EVOL, V17, P839, DOI 10.1093/oxfordjournals.molbev.a026364; Steel Mike, 2005, P163; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Swofford David L., 1996, P407; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Townsend JP, 2008, J MOL EVOL, V67, P437, DOI 10.1007/s00239-008-9142-0; Townsend JP, 2007, SYSTEMATIC BIOL, V56, P222, DOI 10.1080/10635150701311362; Townsend JP, 2012, SYST BIOL, V61, P835, DOI 10.1093/sysbio/sys036; Townsend JP, 2011, SYST BIOL, V60, P358, DOI 10.1093/sysbio/syq097; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Wenzel JW, 1999, CLADISTICS, V15, P51, DOI 10.1006/clad.1999.0084; WOESSNER JP, 1986, GENE, V44, P17; Worberg A, 2007, ORG DIVERS EVOL, V7, P55, DOI 10.1016/j.ode.2006.08.001; Yang ZH, 1996, J MOL EVOL, V42, P587, DOI 10.1007/BF02352289; Yang ZH, 1998, SYST BIOL, V47, P125, DOI 10.1080/106351598261067; Yoder AD, 1996, MOL BIOL EVOL, V13, P1339, DOI 10.1093/oxfordjournals.molbev.a025580; Young ND, 2000, MOL BIOL EVOL, V17, P1933, DOI 10.1093/oxfordjournals.molbev.a026295; Zhu XY, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-217	84	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99725	10.1371/journal.pone.0099725	http://dx.doi.org/10.1371/journal.pone.0099725			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932884	Green Submitted, Green Published, gold			2022-12-25	WOS:000337738600060
J	Paccosi, S; Musilli, C; Caporale, R; Gelli, AMG; Guasti, D; Clemente, AM; Torcia, MG; Filippelli, A; Romagnoli, P; Parenti, A				Paccosi, Sara; Musilli, Claudia; Caporale, Roberto; Gelli, Anna Maria Grazia; Guasti, Daniele; Clemente, Ann Maria; Torcia, Maria Gabriella; Filippelli, Amelia; Romagnoli, Paolo; Parenti, Astrid			Stimulatory Interactions between Human Coronary Smooth Muscle Cells and Dendritic Cells	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; NEOINTIMA FORMATION; VASCULAR INJURY; INFLAMMATION; ATHEROSCLEROSIS; EXPRESSION; MIGRATION; MECHANISMS; MATURATION; LEUKOCYTES	Despite inflammatory and immune mechanisms participating to atherogenesis and dendritic cells (DCs) driving immune and non-immune tissue injury response, the interactions between DCs and vascular smooth muscle cells (VSMCs) possibly relevant to vascular pathology including atherogenesis are still unclear. To address this issue, immature DCs (iDCs) generated from CD14(+) cells isolated from healthy donors were matured either with cytokines (mDCs), or co-cultured (ccDCs) with human coronary artery VSMCs (CASMCs) using transwell chambers. Co-culture induced DC immunophenotypical and functional maturation similar to cytokines, as demonstrated by flow cytometry and mixed lymphocyte reaction. In turn, factors from mDCs and ccDCs induced CASMC migration. MCP-1 and TNF alpha, secreted from DCs, and IL-6 and MCP-1, secreted from CASMCs, were primarily involved. mDCs adhesion to CASMCs was enhanced by CASMC pre-treatment with IFN gamma and TNF alpha ICAM-1 and VCAM-1 were involved, since the expression of specific mRNAs for these molecules increased and adhesion was inhibited by neutralizing antibodies to the counter-receptors CD11c and CD18. Adhesion was also inhibited by CASMC pre-treatment with the HMG-CoA-reductase inhibitor atorvastatin and the PPAR gamma agonist rosiglitazone, which suggests a further mechanism for the anti-inflammatory action of these drugs. Adhesion of DCs to VSMCs was shown also in vivo in rat carotid 7 to 21 days after crush and incision injury. The findings indicate that DCs and VSMCs can interact with reciprocal stimulation, possibly leading to perpetuate inflammation and vascular wall remodelling, and that the interaction is enhanced by a cytokine-rich inflammatory environment and down-regulated by HMGCoA-reductase inhibitors and PPAR gamma agonists.	[Paccosi, Sara; Musilli, Claudia; Parenti, Astrid] Univ Florence, Dept Hlth Sci, Clin Pharmacol & Oncol Unit, Florence, Italy; [Caporale, Roberto; Gelli, Anna Maria Grazia] Azienda Osped Univ Careggi, Cent Lab, Florence, Italy; [Guasti, Daniele; Romagnoli, Paolo] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Clemente, Ann Maria; Torcia, Maria Gabriella] Univ Florence, Dept Expt & Clin Biomed Sci, Florence, Italy; [Filippelli, Amelia] Univ Salerno, Dept Med & Surg, I-84100 Salerno, Italy	University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; University of Florence; University of Salerno	Parenti, A (corresponding author), Univ Florence, Dept Hlth Sci, Clin Pharmacol & Oncol Unit, Florence, Italy.	astrid.parenti@unifi.it	Romagnoli, Paolo/AAJ-9636-2020; Filippelli, Amelia/AAC-5321-2022; Torcia, Maria Gabriella G/K-1840-2018; Paccosi, Sara/K-5292-2016	Torcia, Maria Gabriella G/0000-0003-4740-4646; DANIELE, GUASTI/0000-0002-2856-6829; ROMAGNOLI, Paolo/0000-0002-9614-7247; Parenti, Astrid/0000-0002-7980-6853; Filippelli, Amelia/0000-0002-8235-9118; Paccosi, Sara/0000-0001-5062-4127	Italian Ministry of University and Scientific and Technological Research [2007LTAJMA_002, 2007LTAJMA_003]; University of Florence; Foemina Foundation	Italian Ministry of University and Scientific and Technological Research(Ministry of Education, Universities and Research (MIUR)); University of Florence; Foemina Foundation	This work was supported by the Italian Ministry of University and Scientific and Technological Research (www.istruzione.it) grants 2007LTAJMA_002 and 2007LTAJMA_003 to AP and PR), the University of Florence (www.unifi.it), Foemina Foundation (www.fondazionefoemina.it/it/home). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babelova A, 2013, CURR OPIN PHARMACOL, V13, P260, DOI 10.1016/j.coph.2013.01.004; Bacci S, 2008, THROMB RES, V122, P657, DOI 10.1016/j.thromres.2008.04.013; Barlic J, 2007, J LEUKOCYTE BIOL, V82, P226, DOI 10.1189/jlb.1206761; Bauriedel G, 2003, J AM COLL CARDIOL, V42, P930, DOI 10.1016/S0735-1097(03)00828-3; Bellik L, 2006, CLIN IMMUNOL, V121, P74, DOI 10.1016/j.clim.2006.06.011; Bellosta S, 1998, ATHEROSCLEROSIS, V137, pS101, DOI 10.1016/S0021-9150(97)00319-5; Bobryshev YV, 1998, CARDIOVASC RES, V37, P799, DOI 10.1016/S0008-6363(97)00229-0; BRAUN M, 1995, J MOL CELL CARDIOL, V27, P2571, DOI 10.1006/jmcc.1995.0044; Ceriello A, 2008, DIABETES-METAB RES, V24, P14, DOI 10.1002/dmrr.790; Choi JH, 2011, IMMUNITY, V35, P819, DOI 10.1016/j.immuni.2011.09.014; COUFFINHAL T, 1994, CIRC RES, V74, P225, DOI 10.1161/01.RES.74.2.225; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Feng WG, 2010, HYPERTENSION, V55, P1381, DOI 10.1161/HYPERTENSIONAHA.110.150995; Fiorina P, 2008, TRANSPLANTATION, V85, P1030, DOI 10.1097/TP.0b013e31816843a0; Forte A, 2001, J CELL PHYSIOL, V186, P307, DOI 10.1002/1097-4652(200002)186:2<307::AID-JCP1029>3.0.CO;2-I; Fotis L, 2012, IN VIVO, V26, P243; Gerlini G, 2008, J IMMUNOL, V181, P2999, DOI 10.4049/jimmunol.181.5.2999; Gouwy M, 2014, IMMUNOBIOLOGY, V219, P218, DOI 10.1016/j.imbio.2013.10.004; Hirase T, 2012, AM J PHYSIOL-HEART C, V302, pH499, DOI 10.1152/ajpheart.00325.2011; Jimenez F, 2010, J IMMUNOL, V184, P5571, DOI 10.4049/jimmunol.0803494; Jin CZ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/357060; Jongstra-Bilen J, 2006, J EXP MED, V203, P2073, DOI 10.1084/jem.20060245; Lee AW, 2002, VACCINE, V20, pA8, DOI 10.1016/S0264-410X(02)00382-1; Lee SJ, 2007, J LEUKOCYTE BIOL, V82, P436, DOI 10.1189/jlb.1206739; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu PY, 2009, CIRCULATION, V119, P131, DOI 10.1161/CIRCULATIONAHA.108.813311; Luo YK, 2004, J CARDIOVASC PHARM, V44, P381, DOI 10.1097/01.fjc.0000138164.88740.f8; Maddaluno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047464; Madhur MS, 2011, ARTERIOSCL THROM VAS, V31, P1565, DOI 10.1161/ATVBAHA.111.227629; Meng L, 2010, AM J PHYSIOL-HEART C, V298, pH736, DOI 10.1152/ajpheart.00935.2009; Moretta L, 2003, VACCINE, V21, pS38, DOI 10.1016/S0264-410X(03)00197-X; Musilli C, 2011, MOL IMMUNOL, V49, P234, DOI 10.1016/j.molimm.2011.08.019; Niessner A, 2010, CLIN IMMUNOL, V134, P25, DOI 10.1016/j.clim.2009.05.006; Parenti A, 2004, AM J PHYSIOL-HEART C, V286, pH1978, DOI 10.1152/ajpheart.00414.2003; Pieri L, 2008, HISTOL HISTOPATHOL, V23, P19, DOI 10.14670/HH-23.19; Raines EW, 2005, J LIPID RES, V46, P1081, DOI 10.1194/jlr.R500004-JLR200; Rinaldi B, 2006, BRIT J PHARMACOL, V147, P175, DOI 10.1038/sj.bjp.0706472; Rinaldi B, 2009, SHOCK, V32, P638, DOI 10.1097/SHK.0b013e3181a5a377; Scimone ML, 2005, IMMUNOLOGY, V114, P375, DOI 10.1111/j.1365-2567.2005.02104.x; Simon DI, 2012, CIRC J, V76, P1811, DOI 10.1253/circj.CJ-12-0801; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; WANG XK, 1995, ATHEROSCLEROSIS, V115, P89, DOI 10.1016/0021-9150(94)05503-B; Wei-Guo Z, 2009, CELL IMMUNOL, V254, P110, DOI 10.1016/j.cellimm.2008.08.001; Weis M, 2002, ARTERIOSCL THROM VAS, V22, P1817, DOI 10.1161/01.ATV.0000036418.04998.D5; Weyand CM, 2008, CURR OPIN LIPIDOL, V19, P469, DOI 10.1097/MOL.0b013e32830bfdc2; Wick G, 1997, FASEB J, V11, P1199, DOI 10.1096/fasebj.11.13.9367355; Yilmaz A, 2004, ATHEROSCLEROSIS, V176, P101, DOI 10.1016/j.atherosclerosis.2004.04.027; Yilmaz A, 2006, J LEUKOCYTE BIOL, V79, P529, DOI 10.1189/jlb.0205064	48	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99652	10.1371/journal.pone.0099652	http://dx.doi.org/10.1371/journal.pone.0099652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932497	Green Submitted, Green Published, gold			2022-12-25	WOS:000337738600053
J	Wang, SQ; Liu, Y; Ma, LY; Liu, HB; Tang, Y; Wu, LP; Wang, Z; Li, YY; Wu, RL; Pang, XM				Wang, Siqi; Liu, Ying; Ma, Liying; Liu, Huabo; Tang, Yan; Wu, Liping; Wang, Zhe; Li, Yingyue; Wu, Rongling; Pang, Xiaoming			Isolation and Characterization of Microsatellite Markers and Analysis of Genetic Diversity in Chinese Jujube (Ziziphus jujuba Mill.)	PLOS ONE			English	Article							SEQUENCE REPEAT MARKERS; SSR MARKERS; LINKAGE MAP; CONSTRUCTION; L.	Chinese jujube (Ziziphus jujuba Mill, 2n = 2x = 24, Rhamnaceae) is an economically important Chinese native species. It has high nutritional value, and its medicinal properties have led to extensive use in traditional oriental medicine. The characterization of genotypes using molecular markers is important for genetic studies and plant breeding. However, few simple sequence repeat (SSR) markers are available for this species. In this study, 1,488 unique SSR clones were isolated from Z. jujuba 'Dongzao' using enriched genomic libraries coupled with a three-primer colony PCR screening strategy, yielding a high enrichment rate of 73.3%. Finally, 1,188 (80.87%) primer pairs were amplified successfully in the size expected for 'Dongzao'. A total of 350 primer pairs were further selected and evaluated for their ability to detect polymorphisms across a panel of six diverse cultivars; among these, 301 primer pairs detected polymorphisms, and the polymorphism information content (PIC) value across all loci ranged from 0.15 to 0.82, with an average of 0.52. An analysis of 76 major cultivars employed in Chinese jujube production using 31 primer pairs revealed comparatively high genetic diversity among these cultivars. Within-population differences among individuals accounted for 98.2% of the observed genetic variation. Neighbor-joining clustering divided the cultivars into three main groups, none of which correspond to major geographic regions, suggesting that the genetics and geographical origin of modern Chinese jujube cultivars might not be linked. The current work firstly reports the large-scale development of Chinese jujube SSR markers. The development of these markers and their polymorphic information represent a significant improvement in the available Chinese jujube genomic resources and will facilitate both genetic and breeding applications, further accelerating the development of new cultivars.	[Wang, Siqi; Liu, Ying; Ma, Liying; Liu, Huabo; Tang, Yan; Wu, Liping; Wang, Zhe; Li, Yingyue; Wu, Rongling; Pang, Xiaoming] Beijing Forestry Univ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Natl Engn Lab Tree Breeding, Ctr Computat Biol,Coll Biol Sci & Biotechnol,Mini, Beijing, Peoples R China	Beijing Forestry University	Pang, XM (corresponding author), Beijing Forestry Univ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Natl Engn Lab Tree Breeding, Ctr Computat Biol,Coll Biol Sci & Biotechnol,Mini, Beijing, Peoples R China.	xmpang@bjfu.edu.cn			State Forestry Administration of China [201004017]; National Natural Science Foundation of China [31372019]; Ministry of Science and Technology of China [2013BAD14B0302]; Ministry of Education of China [JD2010-5]; Thousand-person Plan Award	State Forestry Administration of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education of China(Ministry of Education, China); Thousand-person Plan Award(Chinese Academy of Sciences)	Support for this work came from the following: 1.Special Fund for Forestry-Scientific Research in the Public Welfare (201004017) from the State Forestry Administration of China (www.forestry.gov.cn) to XP; 2.Grant 31372019 from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) to XP; 3.Projects in the National Science & Technology Pillar Program (2013BAD14B0302) from the Ministry of Science and Technology of China (www.most.gov.cn/) to XP; 4.the Fundamental Research Funds for the Central Universities (JD2010-5) from the Ministry of Education of China (www.moe.gov.cn) to XP; and 5.the Thousand-person Plan Award from http://www.1000plan.org/to RW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos W, 2007, MOL ECOL NOTES, V7, P10, DOI 10.1111/j.1471-8286.2006.01560.x; Appleby Nikki, 2009, V513, P19, DOI 10.1007/978-1-59745-427-8_2; Ashworth VETM, 2003, J HERED, V94, P407, DOI 10.1093/jhered/esg076; Bai RX, 2008, THESIS HEBEI AGR U; Barthe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040699; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Butler JM, 2006, J FORENSIC SCI, V51, P253, DOI 10.1111/j.1556-4029.2006.00046.x; Cai HW, 2005, THEOR APPL GENET, V112, P158, DOI 10.1007/s00122-005-0118-9; Cai HW, 2003, THEOR APPL GENET, V107, P1337, DOI 10.1007/s00122-003-1386-x; Cipriani G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-127; CYONG JC, 1980, PHYTOCHEMISTRY, V19, P2747, DOI 10.1016/S0031-9422(00)83955-2; Danin-Poleg Y, 2001, THEOR APPL GENET, V102, P61, DOI 10.1007/s001220051618; Dirlewanger E, 2002, THEOR APPL GENET, V105, P127, DOI 10.1007/s00122-002-0867-7; El-Kassaby YA, 2007, BREEDING BREEDING AP, P43; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Federici CT, 1998, THEOR APPL GENET, V96, P812, DOI 10.1007/s001220050807; Fisher PJ, 1998, THEOR APPL GENET, V96, P969, DOI 10.1007/s001220050828; Gai H.M., 2011, MOL PLANT BREEDING, V9, P1359; Hendre PS, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-51; Hirata M, 2006, THEOR APPL GENET, V113, P270, DOI 10.1007/s00122-006-0292-4; Jena SN, 2012, THEOR APPL GENET, V124, P565, DOI 10.1007/s00122-011-1729-y; Li JW, 2007, FOOD CHEM, V103, P454, DOI 10.1016/j.foodchem.2006.08.016; Li ML, 2009, MOL BREEDING, V24, P41, DOI 10.1007/s11032-009-9270-2; Liu J, 2014, SCI HORTIC-AMSTERDAM, V165, P99, DOI 10.1016/j.scienta.2013.10.033; Liu MJ, 2009, ACTA HORTIC, V840, P25; Liu M.J., 2009, GERMPLASM RESOURCES; Lu JinYing, 2005, Acta Horticulturae Sinica, V32, P680; Ma QH, 2011, SCI HORTIC-AMSTERDAM, V129, P597, DOI 10.1016/j.scienta.2011.04.032; Mahajan R. T., 2009, Pharmacognosy Reviews, V3, P320; Mammadov JA, 2010, THEOR APPL GENET, V121, P577, DOI 10.1007/s00122-010-1331-8; Mir RR, 2009, CROP SCI, V49, P1687, DOI 10.2135/cropsci2008.10.0599; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nunome T, 2006, PLANT MOL BIOL REP, V24, P305, DOI 10.1007/BF02913457; Nunome T, 2009, THEOR APPL GENET, V119, P1143, DOI 10.1007/s00122-009-1116-0; Pang Xiao-Ming, 2003, Acta Genetica Sinica, V30, P81; Park S.D.E., 2001, TRYPANOTOLERANCE W A; Peng JianYing, 2000, Acta Horticulturae Sinica, V27, P171; Perumal R, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-77; Rahimmalek M, 2011, GENES GENOM, V33, P475, DOI 10.1007/s13258-011-0045-x; Rallo P, 2000, THEOR APPL GENET, V101, P984, DOI 10.1007/s001220051571; Richards CM, 2009, TREE GENET GENOMES, V5, P339, DOI 10.1007/s11295-008-0190-9; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sethy NK, 2006, THEOR APPL GENET, V112, P1416, DOI 10.1007/s00122-006-0243-0; Shen LY, 2005, THESIS HEBEI AGR U; SMITH JSC, 1992, ADV AGRON, V47, P85, DOI 10.1016/S0065-2113(08)60489-7; Stagel A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-357; State Forestry Administration, 2011, CHIN FOR STAT YB; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang S, 2002, THEOR APPL GENET, V105, P1124, DOI 10.1007/s00122-002-0989-y; Tsukazaki H, 2007, EUPHYTICA, V157, P83, DOI 10.1007/s10681-007-9398-2; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vosman Ben, 1998, P382; Wang XW, 2007, MOL ECOL NOTES, V7, P558, DOI 10.1111/j.1471-8286.2006.01655.x; Wang YW, 2011, THEOR APPL GENET, V122, P677, DOI 10.1007/s00122-010-1477-4; Wang YL, 2001, EC FOREST RES, V9, P59; Wu YQ, 2007, GENOME, V50, P84, DOI 10.1139/G06-133; Yu KF, 1999, GENOME, V42, P27, DOI 10.1139/gen-42-1-27; Yuan SX, 2013, EUPHYTICA, V189, P393, DOI 10.1007/s10681-012-0788-8; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhang JJ, 2012, PLANT CELL REP, V31, P299, DOI 10.1007/s00299-011-1164-1; Zhang YL, 2005, CHINESE J CLIN REHAB, V9, P247; Zhang ZhiShan, 2010, China Fruits, P5	62	35	45	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99842	10.1371/journal.pone.0099842	http://dx.doi.org/10.1371/journal.pone.0099842			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932973	Green Published, gold, Green Submitted			2022-12-25	WOS:000337738600070
J	Werth, S; Scheidegger, C				Werth, Silke; Scheidegger, Christoph			Gene Flow within and between Catchments in the Threatened Riparian Plant Myricaria germanica	PLOS ONE			English	Article							DISTANCE SEED DISPERSAL; MAXIMUM-LIKELIHOOD-ESTIMATION; POPULATION-STRUCTURE; SPARGANIUM-EMERSUM; SCALE PATTERNS; RIVER SYSTEMS; DIVERSITY; METAPOPULATION; LAXIFLORA; WIND	One of the major distinctions of riparian habitats is their linearity. In linear habitats, gene flow is predicted to follow a one-dimensional stepping stone model, characterized by bidirectional gene flow between neighboring populations. Here, we studied the genetic structure of Myricaria germanica, a threatened riparian shrub which is capable of both wind and water dispersal. Our data led us to reject the 'one catchment - one gene pool' hypothesis as we found support for two gene pools, rather than four as expected in a study area including four catchments. This result also implies that in the history of the studied populations, dispersal across catchments has occurred. Two contemporary catchment-crossing migration events were detected, albeit between spatially proximate catchments. Allelic richness and inbreeding coefficients differed substantially between gene pools. There was significant isolation by distance, and our data confirmed the one-dimensional stepping-stone model of gene flow. Contemporary migration was bidirectional within the studied catchments, implying that dispersal vectors other than water are important for M. germanica.	[Werth, Silke; Scheidegger, Christoph] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Werth, Silke] Univ Iceland, Dept Life & Environm Sci, Reykjavik, Iceland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Iceland	Werth, S (corresponding author), Swiss Fed Res Inst WSL, Birmensdorf, Switzerland.	silke@hi.is	Werth, Silke/I-4757-2012; Werth, Silke/AAB-7138-2020; Scheidegger, Christoph/C-6547-2011	Werth, Silke/0000-0002-4981-7850; Scheidegger, Christoph/0000-0003-3713-5331	Federal Office of the Environment, FOEN [07.0071.PJ/G473-0382]; European Commission [302589]	Federal Office of the Environment, FOEN; European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was funded by the Federal Office of the Environment, FOEN as part of the project "Integrated Rivermanagement'' (07.0071.PJ/G473-0382). SW received funding in form of a Marie Curie IEF ('Lichenomics', grant number 302589), a program funded under the Seventh Framework Programme (FP7) of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alp M., 2011, EAU ENERGIE AIR, V3, P216; ANDERSEN M, 1991, AM NAT, V137, P476, DOI 10.1086/285178; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Beerli Peter, 2009, V17, P42; Bullock JM, 2006, PLANT ECOL, V186, P217, DOI 10.1007/s11258-006-9124-5; Bullock JM, 2000, OECOLOGIA, V124, P506, DOI 10.1007/PL00008876; BUSCH DE, 1995, ECOL MONOGR, V65, P347, DOI 10.2307/2937064; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Chen FQ, 2007, PLANT ECOL, V191, P67, DOI 10.1007/s11258-006-9214-4; DeWoody J, 2004, CONSERV GENET, V5, P603, DOI 10.1007/s10592-004-1985-3; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellenberg H., 1963, VEGETATION MITTELEUR; ENDRESS P K, 1975, Vierteljahrsschrift der Naturforschenden Gesellschaft in Zuerich, V120, P1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Frisendahl A., 1921, ACTA FLORA SUECIAE, V1, P265; Goldstein DB, 1997, J HERED, V88, P335, DOI 10.1093/oxfordjournals.jhered.a023114; He TH, 2004, MOL ECOL, V13, P1099, DOI 10.1111/j.1365-294X.2004.02120.x; Honnay O, 2009, J ECOL, V97, P131, DOI 10.1111/j.1365-2745.2008.01452.x; Honnay O, 2010, J BIOGEOGR, V37, P1730, DOI 10.1111/j.1365-2699.2010.02331.x; Hu LJ, 2010, CONSERV GENET, V11, P77, DOI 10.1007/s10592-009-0004-0; Hulten E., 1986, ATLAS N EUROPEAN VAS, V1-3; Imbert E, 2003, J ECOL, V91, P447, DOI 10.1046/j.1365-2745.2003.00772.x; Jacquemyn H, 2010, BIOL INVASIONS, V12, P553, DOI 10.1007/s10530-009-9461-0; Jakalaniemi A, 2006, CONSERV BIOL, V20, P844, DOI 10.1111/j.1523-1739.2006.00348.x; Jansson R, 2000, ECOL APPL, V10, P203; Jansson R, 2005, J ECOL, V93, P1094, DOI 10.1111/j.1365-2745.2005.01057.x; Jansson R, 2000, ECOLOGY, V81, P899, DOI 10.1890/0012-9658(2000)081[0899:FORFIR]2.0.CO;2; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kondo T, 2009, AM J BOT, V96, P1532, DOI 10.3732/ajb.0800273; Liu YF, 2006, AM J BOT, V93, P206, DOI 10.3732/ajb.93.2.206; Liu YF, 2009, MOL ECOL, V18, P2700, DOI 10.1111/j.1365-294X.2009.04214.x; MANTEL N, 1967, CANCER RES, V27, P209; Markwith SH, 2007, AM J BOT, V94, P151, DOI 10.3732/ajb.94.2.151; Merritt DM, 2010, ECOL MONOGR, V80, P609, DOI 10.1890/09-1533.1; Mitsui Y, 2010, AM J BOT, V97, P101, DOI 10.3732/ajb.0800220; Moor M., 1958, Mitteilungen der Schweizerischen Anstalt fur das forstliche Versuchswesen, V34, P221; Muller N., 2001, STUDIES VEGETATION A, P127; Nei M., 1987, MOL EVOLUTIONARY GEN; Nichols J., 2001, DISPERSAL; Nilsson C, 2010, BIOL REV, V85, P837, DOI 10.1111/j.1469-185X.2010.00129.x; Oksanen J., 2010, VEGAN PACKAGE; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Pfenninger M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-135; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pollux BJA, 2009, AQUAT BOT, V90, P199, DOI 10.1016/j.aquabot.2008.07.002; Pollux BJA, 2009, FRESHWATER BIOL, V54, P64, DOI 10.1111/j.1365-2427.2008.02100.x; Prentis PJ, 2008, FRESHWATER BIOL, V53, P973, DOI 10.1111/j.1365-2427.2008.01953.x; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Ronce Ophelie, 2001, Trends in Ecology and Evolution, V16, P663, DOI 10.1016/S0169-5347(01)02348-5; Sakamoto Y., 1986, AKAIKE INFORM CRITER; Schmidt K, 2000, AM J BOT, V87, P678, DOI 10.2307/2656854; Schweingruber Fritz H., 2007, Bauhinia, P5; Silvertown J., 2001, INTRO PLANT POPULATI; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Smulders MJM, 2008, FOREST ECOL MANAG, V255, P1388, DOI 10.1016/j.foreco.2007.10.063; Sork VL, 2010, MOL ECOL, V19, P3806, DOI 10.1111/j.1365-294X.2010.04726.x; Tackenberg O, 2003, ECOL MONOGR, V73, P173, DOI 10.1890/0012-9615(2003)073[0173:MLDOPD]2.0.CO;2; Tackenberg O, 2003, ECOL MONOGR, V73, P191, DOI 10.1890/0012-9615(2003)073[0191:AOWDPI]2.0.CO;2; Tero N, 2003, MOL ECOL, V12, P2073, DOI 10.1046/j.1365-294X.2003.01898.x; Tikka PM, 2001, LANDSCAPE ECOL, V16, P659, DOI 10.1023/A:1013120529382; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; Van Looy K, 2009, BIOL CONSERV, V142, P870, DOI 10.1016/j.biocon.2008.12.006; Werth S, 2011, CONSERV GENET RESOUR, V3, P445, DOI 10.1007/s12686-010-9376-1; WRIGHT S, 1950, NATURE, V166, P247, DOI 10.1038/166247a0; Wright S, 1943, GENETICS, V28, P114	75	16	17	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99400	10.1371/journal.pone.0099400	http://dx.doi.org/10.1371/journal.pone.0099400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932520	Green Submitted, gold, Green Published			2022-12-25	WOS:000337738600032
J	Buchner, DL; Brenner, JL; Kabakyenga, J; Teddy, K; Maling, S; Barigye, C; Nettel-Aguirre, A; Singhal, N				Buchner, Denise L.; Brenner, Jennifer L.; Kabakyenga, Jerome; Teddy, Kyomuhangi; Maling, Samuel; Barigye, Celestine; Nettel-Aguirre, Alberto; Singhal, Nalini			Stakeholders' Perceptions of Integrated Community Case Management by Community Health Workers: A Post-Intervention Qualitative Study	PLOS ONE			English	Article							CARE-SEEKING; CHILDREN; ACCESS; PNEUMONIA	Background: Integrated community case management (iCCM) involves delivery of simple medicines to children with pneumonia, diarrhea and/or malaria by community health workers (CHWs). Between 2010 and 2012, an iCCM intervention trial was implemented by Healthy Child Uganda. This study used qualitative tools to assess whether project stakeholders perceived that iCCM improved access to care for children under five years of age. Methods: The intervention involved training and equipping 196 CHWs in 98 study villages in one sub-county in Uganda in iCCM. During the eight-month intervention, CHWs assessed sick children, provided antimalarials (coartem) for fever, antibiotics (amoxicillin) for cough and fast breathing, oral rehydration salts/zinc for diarrhea, and referred very sick children to health facilities. In order to examine community perceptions and acceptability of iCCM, post-intervention focus groups and key respondent interviews involving caregivers, health workers, CHWs and local leaders were carried out by experienced facilitators using semi-structured interview guides. Data were analyzed using thematic analysis techniques. Results: Respondents reported increased access to health care for children as a result of iCCM. Access was reportedly closer to home, available more hours in a day, and the availability of CHWs was perceived as more reliable. CHW care was reported to be trustworthy and caring. Families reported saving money especially due to reduced transportation costs, and less time away from home. Respondents also perceived better health outcomes. Linkages between health facilities and communities were reportedly improved by the iCCM intervention due to the presence of trained CHWs in the community. Conclusions: iCCM delivered by CHWs may improve access to health care and is acceptable to families. Policymakers should continue to seek opportunities to implement and support iCCM, particularly in remote communities where there are health worker shortages.	[Buchner, Denise L.; Brenner, Jennifer L.] Univ Calgary, Fac Med, Calgary, AB, Canada; [Kabakyenga, Jerome; Maling, Samuel; Nettel-Aguirre, Alberto; Singhal, Nalini] Mbrara Univ Sci & Technol, Fac Med, Mbrara Dist, Mbrara, Uganda; [Teddy, Kyomuhangi] Hlth Child Uganda, Mbrara Dist, Mbrara, Uganda; [Barigye, Celestine] Govt Uganda, Minist Hlth, Kampala, Uganda	University of Calgary	Buchner, DL (corresponding author), Univ Calgary, Fac Med, Calgary, AB, Canada.	dlbuchne@ucalgary.ca	Nettel-Aguirre, Alberto/ABB-9412-2021	Nettel-Aguirre, Alberto/0000-0001-6604-0652	Global Health Research Initiative [105957-001]; Canadian Institutes of Health Research; Canadian International Development Agency; International Development Research Centre; International Development Research Centre (IDRC), Ottawa, Canada; Government of Canada provided through the Canadian International Development Agency (CIDA)	Global Health Research Initiative; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian International Development Agency; International Development Research Centre; International Development Research Centre (IDRC), Ottawa, Canada; Government of Canada provided through the Canadian International Development Agency (CIDA)	This work (grant number 105957-001) was carried out with support from the Global Health Research Initiative (http://www.idrc.ca/EN/Programs/Global_Health_Policy/Global_Health_Research_Initiative/Pages/default.aspx), a research funding partnership composed of the Canadian Institutes of Health Research, the Canadian International Development Agency, and the International Development Research Centre. This work was carried out with the aid of a grant from the International Development Research Centre (IDRC), Ottawa, Canada, and with the financial support of the Government of Canada provided through the Canadian International Development Agency (CIDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazeley P., 2013, QUALITATIVE DATA ANA, V2nd; Brenner J, THERE IS NO IN PRESS; Brenner JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027997; Buchner D, 2012, FINAL METHODS RESULT; Buchner D, 2011, STORIES ENDINGS ILLN; Callaghan-Koru JA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-55; Ettarh R, 2011, HEALTH PLACE, V17, P320, DOI 10.1016/j.healthplace.2010.11.009; Guenther T, 2012, AM J TROP MED HYG, V87, P77, DOI 10.4269/ajtmh.2012.11-0747; Guest G., 2011, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Healthy Child Uganda, 2009, CAN VILL HLTH VOL TR; Jacobs B, 2012, HEALTH POLICY PLANN, V27, P288, DOI 10.1093/heapol/czr038; Kallander K, 2008, B WORLD HEALTH ORGAN, V86, P332, DOI 10.2471/BLT.07.049353; Kallander K, 2006, T ROY SOC TROP MED H, V100, P956, DOI 10.1016/j.trstmh.2005.11.004; Khanal S, 2011, J HLTH POPULATION NU, V29; Kizito J, 2012, MALARIA J, V11, DOI [10.1186/PREACCEPT-2317562776368437, 10.1186/1475-2875-11-55]; Masanja H, 2005, IMPACT INTEGRATED MA; Ministry of Health (MOH), 2010, INT COMM CAS MAN CHI; Nabudere H, 2011, INT J TECHNOL ASSESS, V27, P173, DOI 10.1017/S0266462311000055; Nanyonjo A, 2012, AM J TROP MED HYG, V87, P97, DOI 10.4269/ajtmh.2012.11-0763; Rand, 2001, MILL RAND DIG 100 00; Rutherford ME, 2010, TROP MED INT HEALTH, V15, P508, DOI 10.1111/j.1365-3156.2010.02497.x; Sasaki S, 2010, TROP MED INT HEALTH, V15, P312, DOI 10.1111/j.1365-3156.2009.02460.x; UNICEF, 2010, UG STAT; UNICEF WHO, 2012, WHO UNICEF JOINT STA	24	16	16	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98610	10.1371/journal.pone.0098610	http://dx.doi.org/10.1371/journal.pone.0098610			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927074	gold, Green Published, Green Submitted			2022-12-25	WOS:000338278100019
J	Hwang, SH; Park, SH; Choi, J; Lee, DC; Oh, JH; Kim, SW; Kim, JB				Hwang, Se Hwan; Park, Sun Hwa; Choi, Jin; Lee, Dong Chang; Oh, Jeong Hoon; Kim, Sung Won; Kim, Jin Bae			Characteristics of Mesenchymal Stem Cells Originating from the Bilateral Inferior Turbinate in Humans with Nasal Septal Deviation	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; DIFFERENTIATION; HISTOPATHOLOGY	Background and objectives: Nasal septal deviation (NSD) is often associated with overgrowth of the unilateral inferior turbinate. In vivo and in vitro studies indicate that human mesenchymal stem cells (MSCs) are able to differentiate into multiple cell types, including osteoblasts. We tested the hypothesis that turbinate size affects human turbinate-derived MSC (hTMSCs) quantity, proliferation, and differentiation into osteogenic lineages, and that hypertrophic turbinates may predispose to NSD on the contralateral side. Subjects and Methods: The hypertrophic and contralateral inferior turbinate tissues used in our study were obtained and cultured from the tissue discarded from 10 patients who underwent septoplasty and partial turbinectomy. After isolating the hTMSCs from both turbinates, the cells were enumerated using an automated cell counter. The expression of surface markers for MSCs over four passages was assessed by fluorescent-activated cell sorting analysis (FACS), and cell proliferation was assessed using a cell counting kit (CCK)-8 according to turbinate size. In addition, osteogenic differentiation of hTMSCs was identified using alkaline phosphatase (ALP) and alizarin red S staining, after which osteoblastic gene expression was evaluated. Results: There was no significant difference in the number of hTMSCs. FACS analysis revealed that the hTMSCs were negative for CD14, CD19, CD34, and HLA-DR, and positive for CD29, CD73, and CD90, representing a characteristic MSC phenotype, with no significant difference between the two groups. The cellular proliferation and osteogenic differentiation potential of the hTMSCs were also not significantly different between the two groups. Conclusions: We conclude that turbinate size does not affect the characterization, proliferation, and osteogenic differentiation potential of hTMSCs in vitro test, and therefore should not affect the clinical decision of whether to use autologous or allogenic hTMSCs. However, more experiments are required to definitively state the relationship of hTMSCs with turbinate size or the process NSD in humans.	[Hwang, Se Hwan; Park, Sun Hwa; Choi, Jin; Lee, Dong Chang; Oh, Jeong Hoon; Kim, Sung Won] Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea; [Kim, Jin Bae] Hallym Univ, Kangnam Sacred Heart Hosp, Dept Internal Med, Div Gastroenterol, Chunchon, South Korea	Catholic University of Korea; Hallym University	Kim, SW (corresponding author), Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	kswent@catholic.ac.kr; jbkim87@hallym.or.kr		Hwang, Se Hwan/0000-0002-2838-7820	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2010-0011249]; Research Fund of Seoul St. Mary's Hospital; Catholic University of Korea, Catholic Institute of Cell Therapy; Otorhinolaryngology Alumni Fund of the Catholic University of Korea made in the program; Research Fund for the Colleague of Catholic University Medical College; Catholic Medical Center Research Foundation made in the program	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Research Fund of Seoul St. Mary's Hospital; Catholic University of Korea, Catholic Institute of Cell Therapy; Otorhinolaryngology Alumni Fund of the Catholic University of Korea made in the program; Research Fund for the Colleague of Catholic University Medical College; Catholic Medical Center Research Foundation made in the program	This research was supported by a Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0011249), Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea, Catholic Institute of Cell Therapy in 2013, the Otorhinolaryngology Alumni Fund of the Catholic University of Korea made in the program year of 2013, the 2012 Research Fund for the Colleague of Catholic University Medical College, and the Catholic Medical Center Research Foundation made in the program year of 2013. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek Wook-Young, 2011, Front Biosci (Schol Ed), V3, P126, DOI 10.2741/s138; Berger G, 2006, ARCH OTOLARYNGOL, V132, P588, DOI 10.1001/archotol.132.6.588; Berger G, 2000, LARYNGOSCOPE, V110, P2100, DOI 10.1097/00005537-200012000-00024; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Egeli E, 2004, LARYNGOSCOPE, V114, P113, DOI 10.1097/00005537-200401000-00020; GRAY LP, 1978, ANN OTO RHINOL LARYN, V87, P3, DOI 10.1177/00034894780873S201; Huang ZN, 2007, TISSUE ENG, V13, P2311, DOI 10.1089/ten.2006.0423; Hwang SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074330; Hwang SH, 2011, TISSUE ENG REGEN MED, V8, P544; Hwang SH, 2011, TISSUE ENG REGEN MED, V8, P536; Jun BC, 2009, EUR ARCH OTO-RHINO-L, V266, P975, DOI 10.1007/s00405-008-0855-x; Kim SW, 2009, INT J ORAL MAX IMPL, V24, P991; Kim SW, 2008, OTOLARYNG HEAD NECK, V139, P143, DOI 10.1016/j.otohns.2008.04.015; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Marom R, 2005, J CELL PHYSIOL, V202, P41, DOI 10.1002/jcp.20109; Min Yang-Gi, 1995, Rhinology (Utrecht), V33, P61; Musina RA, 2005, B EXP BIOL MED+, V139, P504, DOI 10.1007/s10517-005-0331-1; Sakou T, 1998, BONE, V22, P591, DOI 10.1016/S8756-3282(98)00053-2; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Troken A, 2007, P I MECH ENG H, V221, P429, DOI 10.1243/09544119JEIM288; Willatt D, 2009, RHINOLOGY, V47, P227, DOI [10.4193/Rhin.09.017, 10.4193/Rhin09.017]; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x; Zielnik-Jurkiewicz B, 2006, INT J PEDIATR OTORHI, V70, P731, DOI 10.1016/j.ijporl.2004.09.014	25	18	20	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100219	10.1371/journal.pone.0100219	http://dx.doi.org/10.1371/journal.pone.0100219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926874	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100122
J	Edwards, W; Fung-Leung, WP; Huang, CC; Chi, E; Wu, N; Liu, Y; Maher, MP; Bonesteel, R; Connor, J; Fellows, R; Garcia, E; Lee, J; Lu, L; Ngo, K; Scott, B; Zhou, H; Swanson, RV; Wickenden, AD				Edwards, Wilson; Fung-Leung, Wai-Ping; Huang, Chichi; Chi, Ellen; Wu, Nancy; Liu, Yi; Maher, Michael P.; Bonesteel, Rachelle; Connor, Judith; Fellows, Ross; Garcia, Elena; Lee, Jerry; Lu, Lu; Ngo, Karen; Scott, Brian; Zhou, Hong; Swanson, Ronald V.; Wickenden, Alan D.			Targeting the Ion Channel Kv1.3 with Scorpion Venom Peptides Engineered for Potency, Selectivity, and Half-life	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; POTASSIUM CHANNEL; ESCHERICHIA-COLI; MULTIPLE-SCLEROSIS; IMMUNE-RESPONSES; MINIATURE SWINE; DISEASES; TOXIN; BLOCKADE	Ion channels are an attractive class of drug targets, but progress in developing inhibitors for therapeutic use has been limited largely due to challenges in identifying subtype selective small molecules. Animal venoms provide an alternative source of ion channel modulators, and the venoms of several species, such as scorpions, spiders and snails, are known to be rich sources of ion channel modulating peptides. Importantly, these peptides often bind to hyper-variable extracellular loops, creating the potential for subtype selectivity rarely achieved with small molecules. We have engineered scorpion venom peptides and incorporated them in fusion proteins to generate highly potent and selective Kv1.3 inhibitors with long in vivo half-lives. Kv1.3 has been reported to play a role in human T cell activation, and therefore, these Kv1.3 inhibitor fusion proteins may have potential for the treatment of autoimmune diseases. Our results support an emerging approach to generating subtype selective therapeutic ion channel inhibitors.	[Edwards, Wilson; Fung-Leung, Wai-Ping; Huang, Chichi; Chi, Ellen; Wu, Nancy; Liu, Yi; Maher, Michael P.; Bonesteel, Rachelle; Connor, Judith; Fellows, Ross; Garcia, Elena; Lee, Jerry; Lu, Lu; Ngo, Karen; Scott, Brian; Zhou, Hong; Swanson, Ronald V.; Wickenden, Alan D.] Janssen Res & Dev LLC, San Diego, CA 92121 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Edwards, W (corresponding author), Janssen Res & Dev LLC, 3210 Merryfield Row, San Diego, CA 92121 USA.	wedward3@its.jnj.com	Maher, Michael/R-9773-2019	Maher, Michael/0000-0001-9138-0448; Fung-Leung, Wai-Ping/0000-0001-7013-8855; Swanson, Ronald/0000-0002-6486-2676				Abdel-Mottaleb Y, 2008, TOXICON, V51, P1424, DOI 10.1016/j.toxicon.2008.03.027; Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Beeton C, 2001, J IMMUNOL, V166, P936, DOI 10.4049/jimmunol.166.2.936; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; BHANDARI DG, 1986, EUR J BIOCHEM, V160, P349, DOI 10.1111/j.1432-1033.1986.tb09978.x; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; Desir GV, 2005, EXPERT OPIN THER TAR, V9, P571, DOI 10.1517/14728222.9.3.571; Doggrell SA, 2004, EXPERT OPIN INV DRUG, V13, P875, DOI 10.1517/13543784.13.7.875; Evans G., 2003, Method for assembly of a polynucleotide encoding a target polypeptide, Patent No. [US 6670127, 6670127]; Evans GA, 2003, US Patent, Patent No. [6,521,427, 6521427]; EVANS JS, 1986, FEBS LETT, V208, P211, DOI 10.1016/0014-5793(86)81020-1; Ge XY, 2006, BRIT J ORAL MAX SURG, V44, P146, DOI 10.1016/j.bjoms.2005.04.004; Gilhar A, 2011, J INVEST DERMATOL, V131, P118, DOI 10.1038/jid.2010.245; GROSS A, 1994, NEURON, V13, P961, DOI 10.1016/0896-6273(94)90261-5; King GF, 2011, EXPERT OPIN BIOL TH, V11, P1469, DOI 10.1517/14712598.2011.621940; Klint JK, 2012, TOXICON, V60, P478, DOI 10.1016/j.toxicon.2012.04.337; Koo GC, 1997, J IMMUNOL, V158, P5120; LIN CS, 1993, J EXP MED, V177, P637, DOI 10.1084/jem.177.3.637; MacLeod H, 2010, CELL IMMUNOL, V266, P14, DOI 10.1016/j.cellimm.2010.08.005; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; McCormick AL, 2001, J INFECT DIS, V184, P1423, DOI 10.1086/324371; Mouhat S, 2005, BIOCHEM J, V385, P95, DOI 10.1042/BJ20041379; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; PACKMAN LC, 1984, EMBO J, V3, P1315, DOI 10.1002/j.1460-2075.1984.tb01969.x; Ragsdale DS, 1996, P NATL ACAD SCI USA, V93, P9270, DOI 10.1073/pnas.93.17.9270; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; Schmitz A, 2005, MOL PHARMACOL, V68, P1254, DOI 10.1124/mol.105.015669; Tarcha EJ, 2012, J PHARMACOL EXP THER, V342, P642, DOI 10.1124/jpet.112.191890; Triggle D. J., 2006, VOLTAGE GATED ION CH, P219; TURNER SL, 1993, PROTEIN ENG, V6, P101, DOI 10.1093/protein/6.1.101; Vetter I, 2012, CURR TOP MED CHEM, V12, P1546, DOI 10.2174/156802612802652457; Warnecke G, 2005, EUR J CARDIO-THORAC, V28, P454, DOI 10.1016/j.ejcts.2005.05.023	34	21	22	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22704	22714		10.1074/jbc.M114.568642	http://dx.doi.org/10.1074/jbc.M114.568642			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24939846	hybrid, Green Published			2022-12-25	WOS:000341017200016
J	Edagawa, M; Kawauchi, J; Hirata, M; Goshima, H; Inoue, M; Okamoto, T; Murakami, A; Maehara, Y; Kitajima, S				Edagawa, Makoto; Kawauchi, Junya; Hirata, Manabu; Goshima, Hiroto; Inoue, Makoto; Okamoto, Tatsuro; Murakami, Akira; Maehara, Yoshihiko; Kitajima, Shigetaka			Role of Activating Transcription Factor 3 (ATF3) in Endoplasmic Reticulum (ER) Stress-induced Sensitization of p53-deficient Human Colon Cancer Cells to Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-mediated Apoptosis through Up-regulation of Death Receptor 5 (DR5) by Zerumbone and Celecoxib	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; UNFOLDED PROTEIN RESPONSE; TRAIL-INDUCED APOPTOSIS; GENE-EXPRESSION; ENDOTHELIAL-CELLS; DOWN-REGULATION; DNA-DAMAGE; INDUCTION; PROMOTER; KINASE	Death receptor 5 (DR5) is a death domain-containing transmembrane receptor that triggers cell death upon binding to its ligand, TNF-related apoptosis-inducing ligand (TRAIL), and a combination of TRAIL and agents that increase the expression of DR5 is expected to be a novel anticancer therapy. In this report, we demonstrate that the stress response gene ATF3 is required for endoplasmic reticulum stress-mediated DR5 induction upon zerumbone (ZER) and celecoxib (CCB) in human p53-deficient colorectal cancer cells. Both agents activated PERK-eIF2 alpha kinases and induced the expression of activating transcription factor 4 (ATF4)-CCAAT enhancer-binding protein (C/EBP) homologous protein, which were remarkably suppressed by reactive oxygen species scavengers. In the absence of ATF3, the induction of DR5 mRNA and protein was abrogated significantly, and this was associated with reduced cell death by cotreatment of TRAIL with ZER or CCB. By contrast, exogenous expression of ATF3 caused a more rapid and elevated expression of DR5, resulting in enhanced sensitivity to apoptotic cell death by TRAIL/ZER or TRAIL/CCB. A reporter assay demonstrated that at least two ATF/cAMP response element motifs as well as C/EBP homologous protein motif at the proximal region of the human DR5 gene promoter were required for ZER-induced DR5 gene transcription. Taken together, our results provide novel insights into the role of ATF3 as an essential transcription factor for p53-independent DR5 induction upon both ZER and CCB treatment, and this may be a useful biomarker for TRAIL-based anticancer therapy.	[Edagawa, Makoto; Kawauchi, Junya; Hirata, Manabu; Goshima, Hiroto; Inoue, Makoto; Kitajima, Shigetaka] Tokyo Med & Dent Univ, Dept Biochem Genet, Med Res Inst, Tokyo 1138510, Japan; [Edagawa, Makoto; Okamoto, Tatsuro; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan; [Murakami, Akira] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 6068502, Japan	Tokyo Medical & Dental University (TMDU); Kyushu University; Kyoto University	Kitajima, S (corresponding author), Tokyo Med & Dent Univ, Dept Biochem Genet, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	kita.bgen@mri.tmd.ac.jp			JSPS KAKENHI [24590373, 25134708, 24118002]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grants 24590373 and 25134708 (to S. K.) and 24118002 (to J. K.).	Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Dimberg LY, 2013, ONCOGENE, V32, P1341, DOI 10.1038/onc.2012.164; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Farczadi E, 1999, NEOPLASMA, V46, P219; Gao M, 2008, CANCER RES, V68, P9348, DOI 10.1158/0008-5472.CAN-08-1642; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gjymishka A, 2009, BIOCHEM J, V417, P695, DOI 10.1042/BJ20081706; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Grosch S, 2006, JNCI-J NATL CANCER I, V98, P736, DOI 10.1093/jnci/djj206; Grosch S, 2001, FASEB J, V15, P2742, DOI 10.1096/fj.01-0299fje; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Hai T, 1999, GENE EXPRESSION, V7, P321; Hamdulay SS, 2010, FREE RADICAL BIO MED, V48, P1013, DOI 10.1016/j.freeradbiomed.2010.01.017; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He Q, 2008, ONCOGENE, V27, P2656, DOI 10.1038/sj.onc.1210894; Higa A, 2012, CELL SIGNAL, V24, P1548, DOI 10.1016/j.cellsig.2012.03.011; Hua B, 2006, J BIOL CHEM, V281, P1620, DOI 10.1074/jbc.M508471200; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jin ZY, 2004, J BIOL CHEM, V279, P35829, DOI 10.1074/jbc.M405538200; Kardosh A, 2008, CANCER RES, V68, P843, DOI 10.1158/0008-5472.CAN-07-5555; KASZUBSKA W, 1993, MOL CELL BIOL, V13, P7180, DOI 10.1128/MCB.13.11.7180; Kawauchi J, 2002, J BIOL CHEM, V277, P39025, DOI 10.1074/jbc.M202974200; Kim M, 2009, INT J CANCER, V124, P264, DOI 10.1002/ijc.23923; Kim YH, 2004, CARCINOGENESIS, V25, P1813, DOI 10.1093/carcin/bgh188; Kojima Y, 2011, J BIOL CHEM, V286, P43383, DOI 10.1074/jbc.M111.309377; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Moon DO, 2011, BIOCHEM PHARMACOL, V82, P1641, DOI 10.1016/j.bcp.2011.08.019; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Oh YT, 2010, J BIOL CHEM, V285, P41310, DOI 10.1074/jbc.M110.153775; Ohnishi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058641; Ohnishi K, 2013, BIOCHEM BIOPH RES CO, V430, P616, DOI 10.1016/j.bbrc.2012.11.104; Ohnishi K, 2009, BIOSCI BIOTECH BIOCH, V73, P1905, DOI 10.1271/bbb.90265; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Prasannan R, 2012, BIOCHEM PHARMACOL, V84, P1268, DOI 10.1016/j.bcp.2012.07.015; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Ravi R, 2001, NAT CELL BIOL, V3, P409, DOI 10.1038/35070096; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scott N, 1998, EUR J SURG ONCOL, V24, P169, DOI 10.1016/S0748-7983(98)92861-X; Sheikh MS, 1998, CANCER RES, V58, P1593; Shetty S, 2005, MOL CELL BIOL, V25, P5404, DOI 10.1128/MCB.25.13.5404-5416.2005; Shin JW, 2011, CANCER PREV RES, V4, P860, DOI 10.1158/1940-6207.CAPR-10-0354; Sobhan PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059350; Takada Y, 2005, ONCOGENE, V24, P6957, DOI 10.1038/sj.onc.1208845; Taketani K, 2012, ONCOGENE, V31, P2210, DOI 10.1038/onc.2011.397; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wolfgang CD, 1997, MOL CELL BIOL, V17, P6700, DOI 10.1128/MCB.17.11.6700; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Xiang H, 2002, ONCOGENE, V21, P3611, DOI 10.1038/sj.onc.1205449; Xu LY, 2012, MOL CANCER THER, V11, P2174, DOI 10.1158/1535-7163.MCT-12-0602; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yodkeeree S, 2009, CANCER RES, V69, P6581, DOI 10.1158/0008-5472.CAN-09-1161; Zhang C, 2002, BIOCHEM BIOPH RES CO, V297, P1302, DOI 10.1016/S0006-291X(02)02382-3; Zhang C, 2001, BIOCHEM BIOPH RES CO, V289, P718, DOI 10.1006/bbrc.2001.6044	62	73	74	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21544	21561		10.1074/jbc.M114.558890	http://dx.doi.org/10.1074/jbc.M114.558890			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24939851	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000340558300030
J	Bekalu, MA; Eggermont, S; Ramanadhan, S; Viswanath, K				Bekalu, Mesfin Awoke; Eggermont, Steven; Ramanadhan, Shoba; Viswanath, Kasisomayajula			Effect of Media Use on HIV-Related Stigma in Sub-Saharan Africa: A Cross-Sectional Study	PLOS ONE			English	Article							AIDS-RELATED STIGMA; MASS-MEDIA; HIV/AIDS STIGMA; YOUNG-PEOPLE; CAPE-TOWN; PREVENTION; IMPACT; DISCRIMINATION; INTERVENTIONS; SUPPORT	It is known that HIV-related stigma hinders prevention efforts. Previous studies have documented that HIV-related stigma may be associated with socioeconomic and socioecological factors. Mass media use may moderate this association, but there is limited research addressing that possibility. In this study, based on cross-sectional data pooled from the 2006-2011 Demographic and Health Surveys of 11 sub-Saharan African countries (N = 204,343), we investigated the moderating effects of exposure to mass media on HIV-related stigma. Hierarchical regression analysis indicated that HIV-related stigma tends to be higher among rural residents and individuals with low levels of education and HIV knowledge, as well as those who do not know people living with HIV. Media use was generally associated with low levels of HIV-related stigma, and attenuated the gap between individuals with high and low educational levels. However, the effect of mass media was found to be stronger among urbanites rather than among rural residents, which could lead to a widening gap between the two groups in endorsement of HIV-related stigma. The implication of this study regarding the effect of media use on HIV-related stigma in sub-Saharan Africa is twofold: 1) mass media may have the potential to minimize the gap in HIV-related stigma between individuals with high and low educational levels, and hence future efforts of reducing HIV-related stigma in the region may benefit from utilizing media; 2) due perhaps to low media penetration to rural sub-Saharan Africa, mass media could have the unintended effect of widening the urban-rural gap further unless other more customized and rural-focused communication interventions are put in place.	[Bekalu, Mesfin Awoke; Ramanadhan, Shoba; Viswanath, Kasisomayajula] Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA; [Bekalu, Mesfin Awoke; Viswanath, Kasisomayajula] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Bekalu, Mesfin Awoke; Eggermont, Steven] Univ Leuven, Sch Mass Commun Res, Leuven, Belgium; [Bekalu, Mesfin Awoke] Bahir Dar Univ, Dept Journalism & Commun, Bahir Dar, Ethiopia	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; KU Leuven; Bahir Dar University	Bekalu, MA (corresponding author), Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA.	mesfinawoke.bekalu@soc.kuleuven.be	Bekalu, Mesfin Awoke/AAQ-9176-2020; Eggermont, Steven/G-5670-2010	Eggermont, Steven/0000-0003-0428-092X; Bekalu, Mesfin Awoke/0000-0003-1243-5813	Research Foundation Flanders (FWO)	Research Foundation Flanders (FWO)(FWO)	The study was made possible through a long term research stay grant from Research Foundation Flanders (FWO) to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaynew Y, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-8; Adetunji JA, 2011, 6 AFR POP C OUAG BUR; Bekalu MA, 2014, HEALTH PROMOT INT, V29, P739, DOI 10.1093/heapro/dat030; Bertrand JT, 2006, WHO TECH REP SER, V938, P205; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Chen JJ, 2005, AIDS EDUC PREV, V17, P1, DOI 10.1521/aeap.17.1.1.58689; Collins CB, 2010, PUBLIC HEALTH REP, V125, P55, DOI 10.1177/00333549101250S108; Creel AH, 2011, HEALTH EDUC RES, V26, P456, DOI 10.1093/her/cyr012; Fakolade R, 2010, J BIOSOC SCI, V42, P395, DOI 10.1017/S0021932009990538; Fanta W, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-8; Genberg BL, 2008, AIDS BEHAV, V12, P772, DOI 10.1007/s10461-007-9340-6; GERBNER G, 1980, J COMMUN, V30, P10, DOI 10.1111/j.1460-2466.1980.tb01987.x; Goffman E., 1963, BEHAV PUBLIC PLACES; Hendriksen ES, 2009, AIDS BEHAV, V13, P1213, DOI 10.1007/s10461-009-9608-0; Herek GM, 1998, AIDS PUBLIC POLICY J, V13, P36; Herek GM, 2002, AM J PUBLIC HEALTH, V92, P371, DOI 10.2105/AJPH.92.3.371; Jung M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068359; Kalichman SC, 2005, AIDS BEHAV, V9, P135, DOI 10.1007/s10461-005-3895-x; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Kalichman SC, 2004, AIDS CARE, V16, P572, DOI 10.1080/09540120410001716360; Kalichman SC, 2009, AIDS CARE, V21, P87, DOI 10.1080/09540120802032627; Kleinman A, 2009, J EPIDEMIOL COMMUN H, V63, P418, DOI 10.1136/jech.2008.084277; Leta TH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-438; Li L, 2009, J HEALTH COMMUN, V14, P424, DOI 10.1080/10810730903032994; Lifson AR, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-6; Logie CH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001124; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Malcolm A., 1998, CRITICAL PUBLIC HLTH, V8, P347, DOI [10.1080/09581599808402920, DOI 10.1080/09581599808402920]; Martinez J, 2012, AIDS PATIENT CARE ST, V26, P108, DOI 10.1089/apc.2011.0178; Muturi NW, 2005, J HEALTH COMMUN, V10, P77, DOI 10.1080/10810730590904607; Nyamwaya D, 1998, INT J HEALTH PLAN M, V13, P27, DOI 10.1002/(SICI)1099-1751(199801/03)13:1&lt;27::AID-HPM498&gt;3.0.CO;2-B; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Parker R, 2002, HIV AIDS STIGMA DISC; Pitpitan EV, 2012, ANN BEHAV MED, V43, P362, DOI 10.1007/s12160-012-9346-9; Pulerwitz J, 2010, PUBLIC HEALTH REP, V125, P272, DOI 10.1177/003335491012500218; Schulz A.J., 2006, GENDER RACE CLASS HL; Smolak A, 2013, AIDS BEHAV, V17, P2742, DOI 10.1007/s10461-013-0571-4; Stangl AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18734; Stein Jo, 2003, Afr J AIDS Res, V2, P95, DOI 10.2989/16085906.2003.9626564; Stephenson R, 2009, AIDS CARE, V21, P403, DOI 10.1080/09540120802290365; Turan JM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001295; UNAIDS, 2011, EP UPD HLTH SECT PRO; *UNAIDS, 2009, AIDS EP UPD; UNAIDS, 2012, REG FACT SHEET SUBS; UNAIDS, 2010, 26 M UNAIDS PROGR CO; UNAIDS, 2007, RED HIV STIGM DISCR; Vanable PA, 2006, AIDS BEHAV, V10, P473, DOI 10.1007/s10461-006-9099-1; Viswanath K, 2006, J COMMUN, V56, pS238, DOI 10.1111/j.1460-2466.2006.00292.x; VISWANATH K, 2007, MACROSOCIAL DETERMIN; Viswanath K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014550; Waite KR, 2008, J GEN INTERN MED, V23, P1367, DOI 10.1007/s11606-008-0662-5; Williams DR, 2012, HEALTH SERV RES, V47, P1255, DOI 10.1111/j.1475-6773.2012.01404.x; Yebei VN, 2008, AFR HEALTH SCI, V8, P97	53	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100467	10.1371/journal.pone.0100467	http://dx.doi.org/10.1371/journal.pone.0100467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN6QP	24945251	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500078
J	Dighe, SA; Kozminski, KG				Dighe, Shubha A.; Kozminski, Keith G.			Secretory Vesicles Deliver Cdc42p to Sites of Polarized Growth in S. cerevisiae	PLOS ONE			English	Article							POST-GOLGI VESICLES; CELL POLARITY; SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON; BINDING PROTEINS; GTPASE CDC42P; YEAST; LOCALIZATION; SINGULARITY; MECHANISMS	The activation and localization of the Rho-family GTPase Cdc42p at one pole of a cell is necessary for maintaining an axis of polarized growth in many animal and fungal cells. How the asymmetric distribution of this key regulator of polarized morphogenesis is maintained is not fully understood, though divergent models have emerged from a congruence of multiple studies, including one that posits a role for polarized secretion. Here we show with S. cerevisiae that Cdc42p associates with secretory vesicles in vivo.	[Dighe, Shubha A.; Kozminski, Keith G.] Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA; [Kozminski, Keith G.] Univ Virginia, Dept Cell Biol, Charlottesville, VA USA	University of Virginia; University of Virginia	Kozminski, KG (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA.	kkoz@virginia.edu			NSF [0723342]; University of Virginia	NSF(National Science Foundation (NSF)); University of Virginia	Funds for this work were provided by the NSF (grant #0723342) and the University of Virginia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Alfaro G, 2011, TRAFFIC, V12, P1521, DOI 10.1111/j.1600-0854.2011.01265.x; AMIT AG, 1985, NATURE, V313, P156, DOI 10.1038/313156a0; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Ayscough KR, 1999, MOL BIOL CELL, V10, P1061, DOI 10.1091/mbc.10.4.1061; Bergersen LH, 2008, NAT PROTOC, V3, P144, DOI 10.1038/nprot.2007.525; Bi EF, 2012, GENETICS, V191, P347, DOI 10.1534/genetics.111.132886; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; Caviston JP, 2002, P NATL ACAD SCI USA, V99, P12185, DOI 10.1073/pnas.182370299; Dighe SA, 2008, MOL BIOL CELL, V19, P4454, DOI 10.1091/mbc.E08-03-0252; Ellenbroek SIJ, 2012, SEMIN CANCER BIOL, V22, P208, DOI 10.1016/j.semcancer.2012.02.012; Forsmark A, 2011, TRAFFIC, V12, P740, DOI 10.1111/j.1600-0854.2011.01186.x; Goehring NW, 2013, TRENDS CELL BIOL, V23, P72, DOI 10.1016/j.tcb.2012.10.009; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; GOVINDAN B, 1995, J CELL BIOL, V128, P1055, DOI 10.1083/jcb.128.6.1055; HARSAY E, 1995, J CELL BIOL, V131, P297, DOI 10.1083/jcb.131.2.297; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Howell AS, 2012, CELL, V149, P322, DOI 10.1016/j.cell.2012.03.012; Howell AS, 2009, CELL, V139, P731, DOI 10.1016/j.cell.2009.10.024; Irazoqui JE, 2005, MOL BIOL CELL, V16, P1296, DOI 10.1091/mbc.E04-05-0430; Kaiser CA, 2002, METHOD ENZYMOL, V351, P325; Kozminski KG, 2006, TRAFFIC, V7, P1224, DOI 10.1111/j.1600-0854.2006.00467.x; Kozminski KG, 2000, MOL BIOL CELL, V11, P339, DOI 10.1091/mbc.11.1.339; Layton AT, 2011, CURR BIOL, V21, P184, DOI 10.1016/j.cub.2011.01.012; Macias-Sanchez K, 2011, ANTON LEEUW INT J G, V99, P671, DOI 10.1007/s10482-010-9543-0; MCCAFFREY M, 1991, J CELL BIOL, V115, P309, DOI 10.1083/jcb.115.2.309; Moreno-Jimenez R, 2008, MICROBIOL-SGM, V154, P842, DOI 10.1099/mic.0.2007/012179-0; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Orlando K, 2011, MOL BIOL CELL, V22, P624, DOI 10.1091/mbc.E10-06-0484; Osmani N, 2010, J CELL BIOL, V191, P1261, DOI 10.1083/jcb.201003091; Sarry JE, 2007, FEBS J, V274, P4287, DOI 10.1111/j.1742-4658.2007.05959.x; Savage NS, 2012, MOL BIOL CELL, V23, P1998, DOI 10.1091/mbc.E11-10-0837; Thompson BJ, 2013, DEVELOPMENT, V140, P13, DOI 10.1242/dev.083634; WALWORTH NC, 1987, J CELL BIOL, V105, P163, DOI 10.1083/jcb.105.1.163; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Yamamoto T, 2010, MOL BIOL CELL, V21, P1237, DOI 10.1091/mbc.E09-05-0412; Zajac A, 2005, MOL BIOL CELL, V16, P1500, DOI 10.1091/mbc.E04-10-0896; ZIMAN M, 1993, MOL BIOL CELL, V4, P1307, DOI 10.1091/mbc.4.12.1307	39	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99494	10.1371/journal.pone.0099494	http://dx.doi.org/10.1371/journal.pone.0099494			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945395	Green Submitted, Green Published, gold			2022-12-25	WOS:000340721500021
J	Feng, LZ; Li, ZJ; Zhao, SW; Nair, H; Lai, SJ; Xu, WB; Li, MF; Wu, JG; Ren, LL; Liu, W; Yuan, ZH; Chen, Y; Wang, XH; Zhao, Z; Zhang, HL; Li, F; Ye, XF; Li, S; Feikin, D; Yu, HJ; Yang, WZ				Feng, Luzhao; Li, Zhongjie; Zhao, Shiwen; Nair, Harish; Lai, Shengjie; Xu, Wenbo; Li, Mengfeng; Wu, Jianguo; Ren, Lili; Liu, Wei; Yuan, Zhenghong; Chen, Yu; Wang, Xinhua; Zhao, Zhuo; Zhang, Honglong; Li, Fu; Ye, Xianfei; Li, Sa; Feikin, Daniel; Yu, Hongjie; Yang, Weizhong			Viral Etiologies of Hospitalized Acute Lower Respiratory Infection Patients in China, 2009-2013	PLOS ONE			English	Article							SYNCYTIAL VIRUS; YOUNG-CHILDREN; HUMAN METAPNEUMOVIRUS; CHILDHOOD PNEUMONIA; SEASONAL INFLUENZA; GLOBAL BURDEN; MORTALITY; SURVEILLANCE	Background: Acute lower respiratory infections (ALRIs) are an important cause of acute illnesses and mortality worldwide and in China. However, a large-scale study on the prevalence of viral infections across multiple provinces and seasons has not been previously reported from China. Here, we aimed to identify the viral etiologies associated with ALRIs from 22 Chinese provinces. Methods and Findings: Active surveillance for hospitalized ALRI patients in 108 sentinel hospitals in 24 provinces of China was conducted from January 2009-September 2013. We enrolled hospitalized all-age patients with ALRI, and collected respiratory specimens, blood or serum collected for diagnostic testing for respiratory syncytial virus (RSV), human influenza virus, adenoviruses (ADV), human parainfluenza virus (PIV), human metapneumovirus (hMPV), human coronavirus (hCoV) and human bocavirus (hBoV). We included 28,369 ALRI patients from 81 (of the 108) sentinel hospitals in 22 (of the 24) provinces, and 10,387 (36.6%) were positive for at least one etiology. The most frequently detected virus was RSV (9.9%), followed by influenza (6.6%), PIV (4.8%), ADV (3.4%), hBoV (1.9), hMPV (1.5%) and hCoV (1.4%). Co-detections were found in 7.2% of patients. RSV was the most common etiology (17.0%) in young children aged <2 years. Influenza viruses were the main cause of the ALRIs in adults and elderly. PIV, hBoV, hMPV and ADV infections were more frequent in children, while hCoV infection was distributed evenly in all-age. There were clear seasonal peaks for RSV, influenza, PIV, hBoV and hMPV infections. Conclusions: Our findings could serve as robust evidence for public health authorities in drawing up further plans to prevent and control ALRIs associated with viral pathogens. RSV is common in young children and prevention measures could have large public health impact. Influenza was most common in adults and influenza vaccination should be implemented on a wider scale in China.	[Feng, Luzhao; Li, Zhongjie; Lai, Shengjie; Zhang, Honglong; Li, Sa; Yu, Hongjie; Yang, Weizhong] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China; [Zhao, Shiwen] Yunnan Prov Ctr Dis Control & Prevent, Kunming, Peoples R China; [Nair, Harish] Univ Edinburgh, Global Hlth Acad, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Nair, Harish] Publ Hlth Fdn India, New Delhi, India; [Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Li, Mengfeng; Li, Fu] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Jianguo] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Ren, Lili] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Ren, Lili] Peking Union Med Coll, Beijing 100021, Peoples R China; [Liu, Wei] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Yuan, Zhenghong; Ye, Xianfei] Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China; [Chen, Yu] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Xinhua] Gansu Prov Ctr Dis Control & Prevent, Lanzhou, Peoples R China; [Zhao, Zhuo] Liaoning Prov Ctr Dis Control & Prevent, Shenyang, Peoples R China; [Feikin, Daniel] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Chinese Center for Disease Control & Prevention; University of Edinburgh; Public Health Foundation of India; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Sun Yat Sen University; Wuhan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Institute of Microbiology & Epidemiology; Zhejiang University; Centers for Disease Control & Prevention - USA	Yu, HJ (corresponding author), Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China.	yuhj@chinacdc.cn; yangwz@chinacdc.cn	Wang, Xin/AAN-8435-2021; Nair, Harish/E-7431-2010; meng, li/GVT-2063-2022; Yang, Wei/HIA-0360-2022; Yu, Hongjie/GZK-5351-2022; Chen, Yu/Y-3292-2019	Wang, Xin/0000-0002-4457-7376; Nair, Harish/0000-0002-9432-9100; Wu, Jianguo/0000-0002-8326-2895; Lai, Shengjie/0000-0001-9781-8148	National Key Science and Technology Project on Infectious Disease Surveillance Technique Platform of China [2009ZX10004-201, 2009ZX10004-202, 2009ZX10004-204, 2009ZX10004-206, 2009ZX10004-207];  [2009ZX10004-208];  [2009ZX10004-209];  [2009ZX10004-210];  [2009ZX10004-211];  [2009ZX10004-212];  [2009ZX10004-213];  [2012ZX10004-201];  [2013ZX10004-202];  [2012ZX10004-206];  [2012ZX10004-207];  [2012ZX10004-208];  [2012ZX10004-209];  [2012ZX10004-210];  [2012ZX10004-211];  [2012ZX10004-212];  [2012ZX10004-213]	National Key Science and Technology Project on Infectious Disease Surveillance Technique Platform of China; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; 	This work was supported by grants from the National Key Science and Technology Project on Infectious Disease Surveillance Technique Platform of China (2009ZX10004-201, 2009ZX10004-202, 2009ZX10004-204, 2009ZX10004-206, 2009ZX10004-207, 2009ZX10004-208, 2009ZX10004-209, 2009ZX10004-210, 2009ZX10004-211, 2009ZX10004-212, 2009ZX10004-213, 2012ZX10004-201, 2013ZX10004-202, 2012ZX10004-206, 2012ZX10004-207, 2012ZX10004-208, 2012ZX10004-209, 2012ZX10004-210, 2012ZX10004-211, 2012ZX10004-212, 2012ZX10004-213). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; de Mello WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005095; Druce J, 2005, J MED VIROL, V75, P122, DOI 10.1002/jmv.20246; Feikin DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043656; Feng LZ, 2012, B WORLD HEALTH ORGAN, V90, P279, DOI 10.2471/BLT.11.096958; Feng LZ, 2010, VACCINE, V28, P6778, DOI 10.1016/j.vaccine.2010.07.064; Foulongne V, 2006, PEDIATR INFECT DIS J, V25, P354, DOI 10.1097/01.inf.0000207480.55201.f6; Haynes AK, 2013, J INFECT DIS, V208, pS246, DOI 10.1093/infdis/jit515; He J, 2011, J MICROBES INFECT, V6, P90; Huang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064254; Huo X, 2012, J MED VIROL, V84, P1980, DOI 10.1002/jmv.23401; Lau SKP, 2006, J CLIN MICROBIOL, V44, P2063, DOI 10.1128/JCM.02614-05; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luksic I, 2013, CROAT MED J, V54, P122, DOI 10.3325/cmj.2013.54.122; Management Office of National Science and Technology Major Project of China Chinese Center for Disease Control and Prevention, 2009, RESP INF SURV PROT 2; Mizgerd JP, 2006, PLOS MED, V3, P155, DOI 10.1371/journal.pmed.0030076; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Ren L, 2009, CLIN MICROBIOL INFEC, V15, P1146, DOI 10.1111/j.1469-0691.2009.02746.x; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; Wolf DG, 2006, PEDIATR INFECT DIS J, V25, P320, DOI 10.1097/01.inf.0000207395.80657.cf; Yang YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045807; Yu HJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001552; Yu HJ, 2014, INFLUENZA OTHER RESP, V8, P53, DOI 10.1111/irv.12205; Yu HJ, 2013, INFLUENZA OTHER RESP, V7, P1350, DOI 10.1111/irv.12121; Zhang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072606	32	80	119	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99419	10.1371/journal.pone.0099419	http://dx.doi.org/10.1371/journal.pone.0099419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945280	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000340721500019
J	Pang, XH; Chai, YC; Sun, LH; Chen, DY; Chen, Y; Zhang, ZH; Wu, H; Yang, T				Pang, Xiuhong; Chai, Yongchuan; Sun, Lianhua; Chen, Dongye; Chen, Ying; Zhang, Zhihua; Wu, Hao; Yang, Tao			Characterization of Spectrum, de novo Rate and Genotype-Phenotype Correlation of Dominant GJB2 Mutations in Chinese Hans	PLOS ONE			English	Article							SENSORINEURAL HEARING-LOSS; GENE; KERATODERMA; CONNEXIN26	Dominant mutations in GJB2 may lead to various degrees of sensorineural hearing impairment and/or hyperproliferative epidermal disorders. So far studies of dominant GJB2 mutations were mostly limited to case reports of individual patients and families. In this study, we identified 7 families, 11 subjects with dominant GJB2 mutations by sequencing of GJB2 in 2168 Chinese Han probands with sensorineural hearing impairment and characterized the associated spectrum, de novo rate and genotype-phenotype correlation. We identified p.R75Q, p.R75W and p.R184Q as the most frequent dominant GJB2 mutations among Chinese Hans, which had a very high de novo rate (71% of probands). A majority (10/11) of subjects carrying dominant GJB2 mutations exhibited palmoplantar keratoderma in addition to hearing impairment. In two families segregated with additional c.235delC or p.V37I mutations of GJB2, family members with the compound heterozygous mutations exhibited more severe phenotype than those with single dominant GJB2 mutation. Our study suggested that the high de novo mutation rate gives rise to a significant portion of dominant GJB2 mutations. The severity of the hearing and epidermal phenotypes associated with dominant GJB2 mutations may be modified by additional recessive mutations of GJB2.	[Pang, Xiuhong; Chai, Yongchuan; Sun, Lianhua; Chen, Dongye; Chen, Ying; Zhang, Zhihua; Wu, Hao; Yang, Tao] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China; [Pang, Xiuhong; Chai, Yongchuan; Sun, Lianhua; Chen, Dongye; Chen, Ying; Zhang, Zhihua; Wu, Hao; Yang, Tao] Shanghai Jiao Tong Univ, Ear Inst, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wu, H (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China.	wuhao622@sina.cn; yangtfxl@sina.com	zhang, zh/GWV-4677-2022; Pang, Xiuhong/ABE-2751-2021	Yang, Tao/0000-0001-6011-987X	National Science Foundation of China [81222010, 30971596, 81170924]; National Basic Research Program of China [2011CB504501]; Shanghai Municipal Education Commission	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This research was supported by grants from National Science Foundation of China (81222010 and 30971596 to TY, 81170924 to HW), grant from National Basic Research Program of China (2011CB504501 to HW), and the Oriental Scholar project from Shanghai Municipal Education Commission (to TY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Dai P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-26; Heathcote K, 2000, J MED GENET, V37, P50, DOI 10.1136/jmg.37.1.50; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Iossa S, 2011, CURR GENOMICS, V12, P475, DOI 10.2174/138920211797904098; Iossa S, 2009, AM J MED GENET A, V149A, P685, DOI 10.1002/ajmg.a.32462; Kelsell DP, 2001, AM J HUM GENET, V68, P559, DOI 10.1086/318803; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Maestrini E, 1999, HUM MOL GENET, V8, P1237, DOI 10.1093/hmg/8.7.1237; Morle L, 2000, J MED GENET, V37, P368, DOI 10.1136/jmg.37.5.368; Piazza V, 2005, CLIN GENET, V68, P161, DOI 10.1111/j.1399-0004.2005.00468.x; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Snoeckx RL, 2005, AM J HUM GENET, V77, P945, DOI 10.1086/497996; Welch KO, 2007, AM J MED GENET A, V143A, P1567, DOI 10.1002/ajmg.a.31701	14	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100483	10.1371/journal.pone.0100483	http://dx.doi.org/10.1371/journal.pone.0100483			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945352	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500080
J	Marques, DPD; Rosa, FM; Maciel, E; Negrao-Correa, D; Teles, HMS; Caldeira, RL; Jannotti-Passos, LK; Coelho, PMZ				de Almeida Marques, Daisymara Priscila; Rosa, Florence Mara; Maciel, Engels; Negrao-Correa, Deborah; Santana Teles, Horacio Manuel; Caldeira, Roberta Lima; Jannotti-Passos, Liana Konovaloff; Zech Coelho, Paulo Marcos			Reduced Susceptibility of a Biomphalaria tenagophila Population to Schistosoma mansoni after Introducing the Resistant Taim/RS Strain of B-tenagophila into Herivelton Martins Stream	PLOS ONE			English	Article							SAO-PAULO; DOMINANT CHARACTER; BANANAL STATE; INFECTION; BRAZIL; SNAILS; PLANORBIDAE; MORTALITY	Studies performed in the last 30 years demonstrated that a strain of B. tenagophila from the Taim Biological Reserve is completely resistant to Schistosoma mansoni infection. This resistance to parasite infection is a dominant characteristic during crossbreeding with susceptible B. tenagophila strains. These experiments also identified a 350 bp molecular marker that is exclusive to the Taim strain and does not occur in other geographic strains of this snail species. The Taim strain (Taim/RS) of Biomphalaria tenagophila was bred on a large scale, physically marked and introduced into a stream in which previous malacological analyses had revealed the presence of only parasite-susceptible B. tenagophila. Samples of offspring captured 4, 11 and 14 months after the introduction of the Taim strain were examined, and the susceptibility of the snails to S. mansoni infection dropped from 38.6-26.5% to 2.1% during the 14 months after the introduction of the Taim snail strain. A significant correlation was also observed between the absence of infection and the identification of the Taim molecular marker. These results demonstrate that the genetic marker from the Taim strain was successfully introduced into the wild snail population. In addition, a significant relationship exists between the marker and resistance to infection.	[de Almeida Marques, Daisymara Priscila; Zech Coelho, Paulo Marcos] Fiocruz MS, Res Ctr Rene Rachou, Lab Schistosomiasis, Belo Horizonte, MG, Brazil; [Rosa, Florence Mara] Univ Fed Juiz de Fora, Inst Biol Sci, Parasitol Lab, Sao Pedro, MG, Brazil; [Maciel, Engels] Chacara Santa Ines, Sao Paulo, Brazil; [Negrao-Correa, Deborah] Univ Fed Minas Gerais, Inst Biol Sci, Lab Schistosomiasis, Belo Horizonte, MG, Brazil; [Santana Teles, Horacio Manuel] SUCEN, Superintendencia Controle Endemias Estado Sao Pau, Sao Paulo, Brazil; [Caldeira, Roberta Lima] Fiocruz MS, Res Ctr Rene Rachou, Lab Helminthol & Med Malacol, Belo Horizonte, MG, Brazil; [Jannotti-Passos, Liana Konovaloff] Fiocruz MS, Res Ctr Rene Rachou, Mollusk Room Dr Lobato Paraense, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Coelho, PMZ (corresponding author), Fiocruz MS, Res Ctr Rene Rachou, Lab Schistosomiasis, Belo Horizonte, MG, Brazil.	coelhopm@cpqrr.fiocruz.br	Coelho, Paulo Marcos Zech/ABE-6169-2021; Caldeira, Roberta/AAZ-3858-2020; Negrao, Carlos E/C-4281-2012	Coelho, Paulo Marcos Zech/0000-0002-2443-8897; Caldeira, Roberta/0000-0003-4706-0732; 	CNPq; FAPEMIG	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Funding came from CNPq - www.cnpq.br and FAPEMIG - www.fapemig.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Mattos ACA, 2011, MEM I OSWALDO CRUZ, V106, P424, DOI 10.1590/S0074-02762011000400007; Barbosa L, 2006, PARASITE IMMUNOL, V28, P209, DOI 10.1111/j.1365-3024.2006.00827.x; BERNARDINI OJ, 1981, ARQ CATARIN MED, V10, P213; Bezerra F. S. D. M., 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P197, DOI 10.1590/S0036-46651997000400003; Bezerra FSD, 2003, MEM I OSWALDO CRUZ, V98, P73, DOI 10.1590/S0074-02762003000100010; Blair L, 2007, J EVOLUTION BIOL, V20, P54, DOI 10.1111/j.1420-9101.2006.01230.x; Coelho JR, 2006, MEM I OSWALDO CRUZ, V101, P111, DOI 10.1590/S0074-02762006000100022; COELHO PMZ, 1986, REV I MED TROP, V28, P74, DOI 10.1590/S0036-46651986000200002; Coelho PMZ, 2004, MEM I OSWALDO CRUZ, V99, P109, DOI 10.1590/S0074-02762004000900020; CORREA MCR, 1979, REV INST MED TROP SP, V21, P72; de COELHO M V, 1962, Rev Inst Med Trop Sao Paulo, V4, P289; DEFREITAS JR, 1985, REV I MED TROP, V27, P6, DOI 10.1590/S0036-46651985000100002; KANE RA, 1994, MOL BIOCHEM PARASIT, V63, P153, DOI 10.1016/0166-6851(94)90018-3; LOOKER DL, 1979, J PARASITOL, V65, P880, DOI 10.2307/3280241; Martins-Souza RL, 2003, PARASITOL RES, V91, P500, DOI 10.1007/s00436-003-0985-4; Nacif-Pimenta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045637; Negrao-Correa D, 2007, ISJ-INVERT SURVIV J, V4, P101; Negrao-Correa D, 2012, J Parasitol Res, V2012, P743920, DOI 10.1155/2012/743920; PARAENSE W. LOBATO, 1955, MEM INST OSWALDO CRUZ, V53, P277; PARAENSE WL, 1978, J PARASITOL, V64, P822, DOI 10.2307/3279509; PELLEGRINO J, 1955, J PARASITOL, V41, P329, DOI 10.2307/3274230; Pereira CAJ, 2008, PARASITE IMMUNOL, V30, P610, DOI 10.1111/j.1365-3024.2008.01062.x; Rosa FM, 2006, MEM I OSWALDO CRUZ, V101, P247, DOI 10.1590/S0074-02762006000900038; Rosa FM, 2013, REV INST MED TROP SP, V55, P39, DOI 10.1590/S0036-46652013000100007; Rosa FM, 2005, MEM I OSWALDO CRUZ, V100, P19, DOI 10.1590/S0074-02762005000100004; Rosa FM, 2004, MEM I OSWALDO CRUZ, V99, P85, DOI 10.1590/S0074-02762004000100015; Rosa FM, 2008, THESIS U FEDERAL MIN; SANTOS M. B. L., 1979, Revista do Instituto de Medicina Tropical de Sao Paulo, V21, P281; Teles HMS, 2005, REV SOC BRAS MED TRO, V38, P426, DOI 10.1590/S0037-86822005000500013; Teles HMS, 2002, MEM I OSWALDO CRUZ, V97, P181, DOI 10.1590/S0074-02762002000900035; Teles HMS, 2002, MEM I OSWALDO CRUZ, V97, P37, DOI 10.1590/S0074-02762002000900009; TELES HMS, 1991, REV SAUDE PUBL, V25, P350, DOI 10.1590/S0034-89101991000500004; Thiengo SC, 2001, MEM I OSWALDO CRUZ, V96, P177, DOI 10.1590/S0074-02762001000900028; Vidigal THDA, 2000, MEM I OSWALDO CRUZ, V95, P57, DOI 10.1590/S0074-02762000000100009; WOOLHOUSE MEJ, 1989, ANN TROP MED PARASIT, V83, P137, DOI 10.1080/00034983.1989.11812321; Coelho PMZ, 2008, ACTA TROP, V108, P245, DOI 10.1016/j.actatropica.2008.05.028	36	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99573	10.1371/journal.pone.0099573	http://dx.doi.org/10.1371/journal.pone.0099573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941324	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200029
J	Losey, RJ; Jessup, E; Nomokonova, T; Sablin, M				Losey, Robert J.; Jessup, Erin; Nomokonova, Tatiana; Sablin, Mikhail			Craniomandibular Trauma and Tooth Loss in Northern Dogs and Wolves: Implications for the Archaeological Study of Dog Husbandry and Domestication	PLOS ONE			English	Article							CANINE-DISTEMPER VIRUS; SLED DOGS; LESIONS; LUPUS; CARNIVORES; ANOMALIES; BREAKAGE; TEETH; L.	Archaeological dog remains from many areas clearly show that these animals suffered tooth fractures, tooth loss, trauma, and dental defects during their lives. Relatively little research has explored the meanings of these patterns, particularly for ancient dog remains from small-scale societies of the North. One limiting issue is the lack of comparative data on dental health and experiences of trauma among northern wolves and dogs. This paper examines tooth loss, tooth fracture, enamel hypoplasia, and cranial trauma in a large sample of historic dog and wolf remains from North America and Northern Russia. The data indicate that the dogs more commonly experienced tooth loss and tooth fracture than the wolves, despite reportedly being fed mostly soft foods such as blubber and fish. The higher rates observed in the dogs likely is a result of food stress and self-provisioning through scavenging. The ability to self-provision was likely important for the long-term history of dog use in the north. Dogs also more commonly experienced cranial fractures than wolves, particularly depression fractures on their frontal bones, which were likely the result of blows from humans. Hypoplastic lesions are rare in both wolves and dogs, and probably result from multiple causes, including food stress, disease, and trauma.	[Losey, Robert J.; Jessup, Erin; Nomokonova, Tatiana] Univ Alberta, Dept Anthropol, Edmonton, AB, Canada; [Sablin, Mikhail] Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia	University of Alberta; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences	Losey, RJ (corresponding author), Univ Alberta, Dept Anthropol, Edmonton, AB, Canada.	robert.losey@ualberta.ca	Mikhail, Sablin/K-7835-2013	Mikhail, Sablin/0000-0002-2773-7454	ERC [295458]; Russian Foundation for Basic Research [13-04-00203]	ERC(European Research Council (ERC)European Commission); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	Funding for this project was provided by an ERC Advanced Grant (#295458) to Dr. David Anderson, University of Aberdeen (http://erc.europa.eu). Financial support to Mikhail V. Sablin was provided by the Russian Foundation for Basic Research (Grant 13-04-00203; http://www.rfbr.ru/rffi/ru). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Kennel Club, 1975, COMPL DOG BOOK; Andersone Z, 2000, ACTA THERIOL, V45, P549; Arnall L., 1961, Journal of Small Animal Practice, V1, P169, DOI 10.1111/j.1748-5827.1960.tb06078.x; Baker J, 1980, ANIMAL DIARCHAEOLO, V1st; Bartelle BG, 2010, J ARCHAEOL SCI, V37, P2721, DOI 10.1016/j.jas.2010.06.008; BAUMGARTNER W, 1995, VET PATHOL, V32, P702, DOI 10.1177/030098589503200612; Bellars ARM, 1969, BRIT ANTARCTIC SURVE, V21, P1; Berten J, 1895, DTSCH MONATSSCHRIFT, V13, P483; Berten J, 1895, DTSCH MONATSSCHRIFT, V13, P533; Berten J, 1895, DTSCH MONATSSCHRIFT, V13, P587; Berten J, 1895, DTSCH MONATSSCHRIFT, V13, P425; Bibikov DI, 1985, VOLK PROISKHOZHDENIE, P609; Binois A, 2013, INT J PALEOPATHOL, V3, P39, DOI 10.1016/j.ijpp.2013.02.001; BJORGE RR, 1985, J RANGE MANAGE, V38, P483, DOI 10.2307/3899736; Boas F, 1974, CENTRAL ESKIMO; Bogoras W, 1909, MEMOIRS AM MUSEUM NA, V11; Bohm J, 1989, Arctic Med Res, V48, P195; BUCHALCZYK T, 1981, ACTA THERIOL, V26, P23, DOI 10.4098/AT.arch.81-2; Chikachev AG, 2004, EZDOVOE SOBAKOVODSTV; Coppinger R., 2001, DOGS NEW UNDERSTANDI; Croft A, 1937, POLAR REC, V2, P68; Crossley DA, 1995, BSAVA MANUAL SMALL A; Deem SL, 2000, J ZOO WILDLIFE MED, V31, P441, DOI 10.1638/1042-7260(2000)031[0441:CDITCA]2.0.CO;2; Degerbol M, 1976, ZOOLOGY 1 MAMMALS, V2; Dolgov V. A., 1964, Acta Theriologica, V8, P237, DOI 10.4098/AT.arch.64-16; DUBIELZIG RR, 1981, VET PATHOL, V18, P684, DOI 10.1177/030098588101800513; DUBIELZIG RR, 1979, VET PATHOL, V16, P268, DOI 10.1177/030098587901600216; Duffy DL, 2008, APPL ANIM BEHAV SCI, V114, P441, DOI 10.1016/j.applanim.2008.04.006; ELTON CHARLES, 1931, CANADIAN JOUR RES, V5, P673; Fiorello CV, 2006, CONSERV BIOL, V20, P762, DOI 10.1111/j.1523-1739.2006.00466.x; Freeman MMR, 1969, FOLK, V11-12, P155; Gerth N, 2009, J EXP BIOL, V212, P1131, DOI 10.1242/jeb.028324; Hammond KA, 1997, NATURE, V386, P457, DOI 10.1038/386457a0; HILLSON S, 1996, DENT ANTHR; Hillson S., 2005, TEETH; Hinchcliff KW, 1997, AM J VET RES, V58, P1457; Ikeya Kazunobu, 1994, AFRICAN STUDY MONOGR, V15, P119; Jensen B., 1961, FOLK, V3, P43; Jochelson W, 1968, HIST ETHNOLOGY ANTHR; Koster JM, 2008, CURR ANTHROPOL, V49, P935, DOI 10.1086/592021; Koster JM, 2012, P NATL ACAD SCI USA, V109, pE463, DOI 10.1073/pnas.1112515109; Krizan J, 2006, 11 DEP ENV WILDL RES; Labutin IuV, 1972, ZOOLOGICHESKIE PROBL, P413; Lawler DF, 2013, INT J PALEOPATHOL, V3, P282, DOI 10.1016/j.ijpp.2013.06.001; Leonard JA, 2007, CURR BIOL, V17, P1146, DOI 10.1016/j.cub.2007.05.072; Losey RJ, 2011, J ANTHROPOL ARCHAEOL, V30, P174, DOI 10.1016/j.jaa.2011.01.001; Lupo Karen D., 2011, ETHNOZOOARCHAEOLOGY, P4; MacKinnon M., 2006, DOGS PEOPLE SOCIAL W, P38; MacKinnon M, 2010, WORLD ARCHAEOL, V42, P290, DOI 10.1080/00438241003673011; MacNulty DR, 2009, J ANIM ECOL, V78, P532, DOI 10.1111/j.1365-2656.2008.01517.x; MacRury IK, 1991, THESIS U CAMBRIDGE; MALIK R, 1995, AUST VET PRACT, V25, P62; Maxie MG, 2007, PATHOLOGY DOMESTIC A; Mech LD, 1999, CAN J ZOOL, V77, P1196, DOI 10.1139/cjz-77-8-1196; Mellanby M., 1929, DIET TEETH EXPT STUD, P308; Miles AEW, 1990, COLYERS VARIATIONS D; Montcombroux G, 1997, CANADIAN INUIT DOG C; Morehouse AT, 2011, FRONT ECOL ENVIRON, V9, P440, DOI 10.1890/100172; Morey D.F., 2010, DOGS DOMESTICATION D, DOI 10.1017/CBO9780511778360; Morey DF, 2002, ARCTIC, V55, P44; Nielson CA, 1977, WOLF NECROPSY REPORT; O'Keefe FR, 2013, J MAMMAL, V94, P1223, DOI 10.1644/13-MAMM-A-069; PARK RW, 1987, ARCTIC, V40, P184; Pavlovc Dubravka, 2007, Veterinarski Arhiv, V77, P291; Peary RE, 1898, PLOS ONE, V2; Peary RE, 1898, PLOS ONE, V1; Peterson Rolf O., 2003, P104; Raikkonen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067218; Riewe RR, 1977, TRUELOVE LOWLAND DEV, P623; Samar AP, 2010, TRADITSIONNOE SOBAKO; Stephenson RO, 1973, WOLF REPORT 1971 197; Van Valkenburgh B, 2009, BIOL J LINN SOC, V96, P68, DOI 10.1111/j.1095-8312.2008.01108.x; VANVALKENBURGH B, 1988, AM NAT, V131, P291, DOI 10.1086/284790; VANVALKENBURGH B, 1993, SCIENCE, V261, P456, DOI 10.1126/science.261.5120.456; Verstraete FJM, 1999, SELF ASSESSMENT COLO; VILA C, 1993, CAN J ZOOL, V71, P968, DOI 10.1139/z93-127; Warren DM, 2000, DOGS TIME ARCHAEOLOG, P105; Weyer EM, 1932, ESKIMOS THEIR ENV FO; WOBESER G, 1992, J WILDLIFE DIS, V28, P268, DOI 10.7589/0090-3558-28.2.268; Zinoviev AV, 2012, INT J OSTEOARCHAEOL, V22, P145, DOI 10.1002/oa.1191	80	29	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99746	10.1371/journal.pone.0099746	http://dx.doi.org/10.1371/journal.pone.0099746			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941003	Green Submitted, Green Published, gold			2022-12-25	WOS:000338508200040
J	Weir, SM; Talent, LG; Anderson, TA; Salice, CJ				Weir, Scott M.; Talent, Larry G.; Anderson, Todd A.; Salice, Christopher J.			Unraveling the Relative Importance of Oral and Dermal Contaminant Exposure in Reptiles: Insights from Studies Using the Western Fence Lizard (Sceloporus occidentalis)	PLOS ONE			English	Article							NONDIETARY ROUTES; PHTHALATE-ESTERS; ECOLOGICAL RISK; SHED SKINS; EXCRETION; TOXICITY; PESTICIDE; CHEMICALS; RATS; DOGS	Despite widespread recognition of significant data deficiencies, reptiles remain a relatively understudied taxon in ecotoxicology. To conduct ecological risk assessments on reptiles frequently requires using surrogate taxa such as birds, but recent research suggests that reptiles have significantly different exposure profiles and toxicant sensitivity. We exposed western fence lizards, Sceloporus occidentalis, to the same quantities of three model chemicals via oral (gavage) and dermal (ventral skin application) exposure for either 24 or 48 hours. Three phthalate esters (di-methyl phthalate [DMP], di-iso-butyl phthalate [DIBP], and di-n-octyl phthalate [DNOP]) were chosen as model chemicals because they represent a gradient of lipophilicity but are otherwise structurally similar. Overall, the more lipophilic phthalates (DIBP and DNOP) were found to have higher concentrations in tissues than the less lipophilic DMP. Significant differences in tissue concentrations between DIBP and DNOP were tissue-dependent, suggesting that delivery to a site of action following exposure is not only a simple function of lipophilicity. In dermal treatments, DMP usually had fewer detections (except in ventral skin samples), suggesting that lipophilicity (log K-ow>2) is a requirement for uptake across the skin. In general, tissue residues were greater in oral treatments than dermal treatments (significant in adipose and liver tissue), but differences were driven strongly by differences in DMP which did not appear to be absorbed well across skin. When differences in tissue residue concentrations between oral and dermal exposure did occur, the difference was not drastic. Taken together these results suggest that dermal exposure should be considered in risk assessments for reptilian receptors. Dermal exposure may be an especially important route for reptiles as their ectothermic physiology translates to lower energetic demands and dietary exposure compared to birds and mammals.	[Weir, Scott M.; Anderson, Todd A.; Salice, Christopher J.] Texas Tech Univ, Inst Environm & Human Hlth, Dept Environm Toxicol, Lubbock, TX 79409 USA; [Talent, Larry G.] Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA	Texas Tech University System; Texas Tech University; Oklahoma State University System; Oklahoma State University - Stillwater	Weir, SM (corresponding author), Univ Georgia, Savannah River Ecol Lab, Aiken, SC 29802 USA.	smweir@uga.edu	Anderson, Todd A/A-2296-2012	Anderson, Todd A/0000-0001-8176-6339	Helen Jones Foundation; Office of the Provost of Texas Tech University; Permian Basin Petroleum Association	Helen Jones Foundation; Office of the Provost of Texas Tech University; Permian Basin Petroleum Association	SMW was provided funding by the Helen Jones Foundation and the Office of the Provost of Texas Tech University. SMW was partially funded by the Permian Basin Petroleum Association during the period this work took place. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard A, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3290; Alexander GJ, 2002, J ARID ENVIRON, V50, P121, DOI 10.1006/jare.2001.0848; Brooks JE, 1998, WILDLIFE RES, V25, P427, DOI 10.1071/WR97035; Brooks Joe E., 1998, Snake, V28, P33; Campbell KR, 2002, ENVIRON TOXICOL CHEM, V21, P894, DOI 10.1897/1551-5028(2002)021<0894:ALSPFD>2.0.CO;2; CONNELL DW, 1988, ECOTOX ENVIRON SAFE, V16, P242, DOI 10.1016/0147-6513(88)90054-1; Cousins I, 2000, CHEMOSPHERE, V41, P1389, DOI 10.1016/S0045-6535(00)00005-9; DRIVER CJ, 1991, ENVIRON TOXICOL CHEM, V10, P21, DOI 10.1002/etc.5620100104; DuRant SE, 2007, ENVIRON POLLUT, V149, P18, DOI 10.1016/j.envpol.2006.12.025; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; HENDERSON JD, 1994, B ENVIRON CONTAM TOX, V52, P633, DOI 10.1007/BF00195480; Hopkins WA, 2000, ENVIRON TOXICOL CHEM, V19, P2391, DOI 10.1002/etc.5620191001; IKEDA GJ, 1978, FOOD COSMET TOXICOL, V16, P409, DOI 10.1016/S0015-6264(78)80257-0; IKEDA GJ, 1980, FOOD COSMET TOXICOL, V18, P637, DOI 10.1016/S0015-6264(80)80012-5; Jones DE, 2006, ECOTOX ENVIRON SAFE, V64, P221, DOI 10.1016/j.ecoenv.2005.03.018; Jones DE, 2009, ECOTOX ENVIRON SAFE, V72, P2033, DOI 10.1016/j.ecoenv.2008.11.001; Jones DE, 2005, ECOTOX ENVIRON SAFE, V60, P282, DOI 10.1016/j.ecoenv.2004.06.005; McFarland CA, 2011, ENVIRON POLLUT, V159, P466, DOI 10.1016/j.envpol.2010.10.018; MCKIM J, 1985, TOXICOL APPL PHARM, V77, P1, DOI 10.1016/0041-008X(85)90262-5; Mineau Pierre, 2011, Integrated Environmental Assessment and Management, V7, P297, DOI 10.1002/ieam.174; R Development Core Team, 2012, R LANG ENV STAT COMP; Salice Christopher J., 2011, Integrated Environmental Assessment and Management, V7, P687, DOI 10.1002/ieam.266; Salice CJ, 2009, ENVIRON POLLUT, V157, P3457, DOI 10.1016/j.envpol.2009.06.013; Smith PN, 2007, ENVIRON POLLUT, V150, P41, DOI 10.1016/j.envpol.2007.06.009; Sparling DW, 2010, ECOTOXICOLOGY OF AMPHIBIANS AND REPTILES, SECOND EDITION, P1, DOI 10.1201/EBK1420064162-c1; Suski JG, 2008, ENVIRON TOXICOL CHEM, V27, P352, DOI 10.1897/07-149R.1; Talent LG, 2005, ENVIRON TOXICOL CHEM, V24, P3113, DOI 10.1897/05-053R.1; Talent LG, 2002, ENVIRON TOXICOL CHEM, V21, P899, DOI 10.1897/1551-5028(2002)021<0899:EOWFLS>2.0.CO;2; *USEPA, 2004, OV EC RISK ASS PROC; Vyas NB, 2007, ENVIRON MONIT ASSESS, V133, P209, DOI 10.1007/s10661-006-9573-2; Walker JD, 2003, ENVIRON TOXICOL CHEM, V22, P1870, DOI 10.1897/01-454; Weir SM, 2010, ENVIRON POLLUT, V158, P3596, DOI 10.1016/j.envpol.2010.08.011	32	21	23	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99666	10.1371/journal.pone.0099666	http://dx.doi.org/10.1371/journal.pone.0099666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941063	Green Submitted, gold, Green Published			2022-12-25	WOS:000338508200034
J	Chen, C; Han, S; Meng, LX; Li, ZH; Zhang, X; Wu, AH				Chen, Chen; Han, Sheng; Meng, Lingxuan; Li, Zhonghua; Zhang, Xue; Wu, Anhua			TERT Promoter Mutations Lead to High Transcriptional Activity under Hypoxia and Temozolomide Treatment and Predict Poor Prognosis in Gliomas	PLOS ONE			English	Article							NEWLY-DIAGNOSED GLIOBLASTOMA; CLINICAL-IMPLICATIONS; METHYLATION STATUS; TELOMERASE; CANCER; HTERT; CELLS; EXPRESSION; CHEMOSENSITIVITY; RADIOTHERAPY	Objective: This study explored the effects of telomerase reverse transcriptase (TERT) promoter mutations on transcriptional activity of the TERT gene under hypoxic and temozolomide (TMZ) treatment conditions, and investigated the status and prognostic value of these mutations in gliomas. Methods: The effect of TERT promoter mutations on the transcriptional activity of the TERT gene under hypoxic and TMZ treatment conditions was investigated in glioma cells using the luciferase assay. TERT promoter mutations were detected in 101 glioma samples (grades I-IV) and 49 other brain tumors by sequencing. TERT mRNA expression in gliomas was examined by real-time PCR. Hazard ratios from survival analysis of glioma patients were determined relative to the presence of TERT promoter mutations. Results: Mutations in the TERT promoter enhanced gene transcription even under hypoxic and TMZ treatment conditions, inducing upregulation of TERT mRNA expression. Mutations were detected in gliomas, but not in meningiomas, pituitary adenomas, cavernomas, intracranial metastases, normal brain tissues, or peripheral blood of glioma patients. Patients with TERT promoter mutations had lower survival rates, even after adjusting for other known or potential risk factors, and the incidence of mutation was correlated with patient age. Conclusion: TERT promoter mutations were specific to gliomas. TERT promoter mutations maintained its ability of inducing high transcriptional activity even under hypoxic and TMZ treatment conditions, and the presence of mutations was associated with poor prognosis in glioma patients. These findings demonstrate that TERT promoter mutations are novel prognostic markers for gliomas that can inform prospective therapeutic strategies.	[Chen, Chen; Zhang, Xue; Wu, Anhua] China Med Univ, Res Ctr Med Genom, Key Lab Med Cell Biol, Minist Educ,Coll Basic Med Sci, Shenyang, Liaoning, Peoples R China; [Han, Sheng; Meng, Lingxuan; Li, Zhonghua; Wu, Anhua] China Med Univ, Affiliated Hosp 1, Dept Neurosurg, Shenyang, Liaoning, Peoples R China; [Zhang, Xue] Peking Union Med Univ, Dept Med Genet, Beijing, Peoples R China	China Medical University; China Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wu, AH (corresponding author), China Med Univ, Res Ctr Med Genom, Key Lab Med Cell Biol, Minist Educ,Coll Basic Med Sci, Shenyang, Liaoning, Peoples R China.	wuanhua1@yahoo.com	li, zh/HII-5698-2022		Pacific Northwest Udall Center (PANUC; RC); National Institute on Aging [FH: R37 AG006457]; National Multiple Sclerosis Society (Horak) [MB0011]; Oregon Clinical and Translational Research Institute (OCTRI); National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [UL1 RR024140]; NIH Roadmap for Medical Research; NATIONAL INSTITUTE ON AGING [R37AG006457] Funding Source: NIH RePORTER	Pacific Northwest Udall Center (PANUC; RC); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Multiple Sclerosis Society (Horak); Oregon Clinical and Translational Research Institute (OCTRI); National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by pilot awards from the Pacific Northwest Udall Center (PANUC; RC), a MERIT award from the National Institute on Aging (FH: R37 AG006457), and a postdoctoral Mentored Research Award from the National Multiple Sclerosis Society (Horak #MB0011). Additional support was provided from the Oregon Clinical and Translational Research Institute (OCTRI), grant number UL1 RR024140 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beier D, 2008, CANCER RES, V68, P5706, DOI 10.1158/0008-5472.CAN-07-6878; Brandes AA, 2008, J CLIN ONCOL, V26, P2192, DOI 10.1200/JCO.2007.14.8163; Brandes AA, 2012, NAT REV NEUROL, V8, P664, DOI 10.1038/nrneurol.2012.220; Brandes AA, 2010, NEURO-ONCOLOGY, V12, P283, DOI 10.1093/neuonc/nop050; Chen LC, 2012, NEURO-ONCOLOGY, V14, P1026, DOI 10.1093/neuonc/nos122; Clarke JL, 2009, J CLIN ONCOL, V27, P3861, DOI 10.1200/JCO.2008.20.7944; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; Galceran J, 2000, DEVELOPMENT, V127, P469; Guo XL, 2008, CANCER BIOL THER, V7, P1555, DOI 10.4161/cbt.7.10.6539; Han S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076717; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kinde I, 2013, CANCER RES, V73, P7162, DOI 10.1158/0008-5472.CAN-13-2498; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Nagalski A, 2013, BRAIN STRUCT FUNCT, V218, P1531, DOI 10.1007/s00429-012-0474-6; Nishi H, 2004, MOL CELL BIOL, V24, P6076, DOI 10.1128/MCB.24.13.6076-6083.2004; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; Rivera AL, 2010, NEURO-ONCOLOGY, V12, P116, DOI 10.1093/neuonc/nop020; Shay JW, 2001, HUM MOL GENET, V10, P677, DOI 10.1093/hmg/10.7.677; Spiegl-Kreinecker S, 2010, NEURO-ONCOLOGY, V12, P28, DOI 10.1093/neuonc/nop003; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Svensson KJ, 2008, CANCER RES, V68, P9291, DOI 10.1158/0008-5472.CAN-08-2340; Swanson KR, 2011, CANCER RES, V71, P7366, DOI 10.1158/0008-5472.CAN-11-1399; Tang K, 2012, MED ONCOL, V29, P1292, DOI 10.1007/s12032-011-9901-4; Tchirkov A, 2003, BRIT J CANCER, V88, P516, DOI 10.1038/sj.bjc.6600754; Ueda Y, 2011, J PEDIATR SURG, V46, P2221, DOI 10.1016/j.jpedsurg.2011.09.003; Varea O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005153; Vinagre J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3185; Wang L, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-33; Werner C, 2011, ATHEROSCLEROSIS, V216, P23, DOI 10.1016/j.atherosclerosis.2011.02.011; Zhang Y, 2012, J BIOL CHEM, V287, P32494, DOI 10.1074/jbc.M112.368282	32	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100297	10.1371/journal.pone.0100297	http://dx.doi.org/10.1371/journal.pone.0100297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937153	Green Published, Green Submitted, gold			2022-12-25	WOS:000338503400102
J	Demarchi, B; O'Connor, S; Ponzoni, AD; Ponzoni, RDR; Sheridan, A; Penkman, K; Hancock, Y; Wilson, J				Demarchi, Beatrice; O'Connor, Sonia; Ponzoni, Andre de Lima; Ponzoni, Raquel de Almeida Rocha; Sheridan, Alison; Penkman, Kirsty; Hancock, Y.; Wilson, Julie			An Integrated Approach to the Taxonomic Identification of Prehistoric Shell Ornaments	PLOS ONE			English	Article							AMINO-ACID; MOLLUSK EXPLOITATION; QUATERNARY; BEADS; RACEMIZATION; BEHAVIOR; AMINOSTRATIGRAPHY; AURIGNACIAN; ECONOMIES; FRACTION	Shell beads appear to have been one of the earliest examples of personal adornments. Marine shells identified far from the shore evidence long-distance transport and imply networks of exchange and negotiation. However, worked beads lose taxonomic clues to identification, and this may be compounded by taphonomic alteration. Consequently, the significance of this key early artefact may be underestimated. We report the use of bulk amino acid composition of the stable intracrystalline proteins preserved in shell biominerals and the application of pattern recognition methods to a large dataset (777 samples) to demonstrate that taxonomic identification can be achieved at genus level. Amino acid analyses are fast (< 2 hours per sample) and micro-destructive (sample size <2 mg). Their integration with non-destructive techniques provides a valuable and affordable tool, which can be used by archaeologists and museum curators to gain insight into early exploitation of natural resources by humans. Here we combine amino acid analyses, macro-and microstructural observations (by light microscopy and scanning electron microscopy) and Raman spectroscopy to try to identify the raw material used for beads discovered at the Early Bronze Age site of Great Cornard (UK). Our results show that at least two shell taxa were used and we hypothesise that these were sourced locally.	[Demarchi, Beatrice] Univ York, Dept Archaeol, BioArCh, York YO10 5DD, N Yorkshire, England; [O'Connor, Sonia] Univ Bradford, Sch Life Sci, Bradford BD7 1DP, W Yorkshire, England; [Ponzoni, Andre de Lima; Ponzoni, Raquel de Almeida Rocha; Hancock, Y.] Univ York, Dept Phys, York YO10 5DD, N Yorkshire, England; [Sheridan, Alison] Natl Museums Scotland, Edinburgh, Midlothian, Scotland; [Penkman, Kirsty] Univ York, Dept Chem, BioArCh, York YO10 5DD, N Yorkshire, England; [Wilson, Julie] Univ York, Dept Math, York YO10 5DD, N Yorkshire, England; [Wilson, Julie] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England; [Hancock, Y.; Wilson, Julie] Univ York, York Ctr Complex Syst Anal YCCSA, York YO10 5DD, N Yorkshire, England	University of York - UK; University of Bradford; University of York - UK; University of York - UK; University of York - UK; University of York - UK; University of York - UK	Demarchi, B (corresponding author), Univ York, Dept Archaeol, BioArCh, York YO10 5DD, N Yorkshire, England.	beatrice.demarchi@york.ac.uk; julie.wilson@york.ac.uk	Demarchi, Beatrice/P-5107-2019; de Almeida Rocha Ponzoni, Raquel/ABA-8167-2021; Rocha, Raquel/HDN-5721-2022; Penkman, Kirsty E/D-1952-2012; Demarchi, Beatrice/Y-5308-2019	de Almeida Rocha Ponzoni, Raquel/0000-0002-5752-5006; Penkman, Kirsty E/0000-0002-6226-9799; Demarchi, Beatrice/0000-0002-8398-4409	EU [PERG07-GA-2010-268429]; Heritage programme [AH/H032150/1]; AHRC/EPSRC Science; Arts and Humanities Research Council [AH/H032150/1] Funding Source: researchfish; AHRC [AH/H032150/1] Funding Source: UKRI	EU(European Commission); Heritage programme; AHRC/EPSRC Science(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)Engineering & Physical Sciences Research Council (EPSRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	BD was funded by EU FP7 Re(In)tegration grant PERG07-GA-2010-268429 (project: mAARiTIME). URL:ec.europa.eu/research/fp7.2.SOC was jointly funded by the AHRC/EPSRC Science and Heritage programme, Award AH/H032150/1 (Project: Cultural Objects Worked in Skeletal Hard Tissues). URLs:www.ahrc.ac.uk, www.epsrc.ac.uk, www.heritagescience.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELSON PH, 1957, ANN NY ACAD SCI, V69, P276, DOI 10.1111/j.1749-6632.1957.tb49663.x; ANDREWS JT, 1985, GEOL J, V20, P1; AnimalBase project Group, 2005, ANIMALBASE; BADA JL, 1978, EARTH PLANET SC LETT, V41, P67, DOI 10.1016/0012-821X(78)90042-0; BAILEY GN, 1975, J ARCHAEOL SCI, V2, P45, DOI 10.1016/0305-4403(75)90045-X; Bajnoczi B, 2013, J ARCHAEOL SCI, V40, P874, DOI 10.1016/j.jas.2012.09.022; Balme J, 2006, ANTIQUITY, V80, P799, DOI 10.1017/S0003598X00094436; Bar-Yosef O, 1998, EVOL ANTHROPOL, V6, P159, DOI 10.1002/(SICI)1520-6505(1998)6:5<159::AID-EVAN4>3.0.CO;2-7; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Carter J.G., 1989, SKELETAL BIOMINERALI; Cartwright Caroline, 2003, Environmental Archaeology, V8, P85; Colonese AC, 2011, QUATERN INT, V239, P86, DOI 10.1016/j.quaint.2010.09.001; Cuenca-Solana D, 2013, CURR ANTHROPOL, V54, P370, DOI 10.1086/670325; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; Debruyne S, 2014, ENV ARCHAEO IN PRESS; Debruyne S, 2010, ANATOL STUD, V60, P149, DOI 10.1017/S0066154600001071; DEGENS ET, 1967, COMP BIOCHEM PHYSIOL, V20, P553, DOI 10.1016/0010-406X(67)90269-1; Demarchi B, 2013, QUAT GEOCHRONOL, V16, P144, DOI 10.1016/j.quageo.2012.03.016; Demarchi B, 2011, QUATERN INT, V239, P114, DOI 10.1016/j.quaint.2010.05.029; Dimitrijevic V., 2006, DOCUMENTA PRAEHISTOR, VXXXIII, P237, DOI DOI 10.4312/DP.33.21; Eerkens JW, 2007, ACS SYM SER, V968, P167, DOI 10.1021/bk-2007-0968.ch009; ERLANDSON JM, 1988, AM ANTIQUITY, V53, P102, DOI 10.2307/281156; GOODFRIEND GA, 1991, GEOCHIM COSMOCHIM AC, V55, P293, DOI 10.1016/0016-7037(91)90418-5; Hare E., 1969, ORGANIC GEOCHEMISTRY, P438, DOI 10.1007/978-3- 642- 87734- 6_22; HAUGEN JE, 1989, J FORAMIN RES, V19, P38, DOI 10.2113/gsjfr.19.1.38; Hutterer R, 2014, QUATERN INT, V320, P83, DOI 10.1016/j.quaint.2013.12.006; Ifantidis F., 2011, SPONDYLUS PREHISTORY; KAUFMAN DS, 1992, GEOCHIM COSMOCHIM AC, V56, P2445, DOI 10.1016/0016-7037(92)90201-S; Kaufman DS, 1998, QUATERNARY SCI REV, V17, P987, DOI 10.1016/S0277-3791(97)00086-3; Kohonen T., 1992, P INT JOINT C NEUR N, VI, P725; Kuhn SL, 2001, P NATL ACAD SCI USA, V98, P7641, DOI 10.1073/pnas.121590798; Lajoie K.R., 1980, P305; Maier E, 2010, PALAEOGEOGR PALAEOCL, V291, P228, DOI 10.1016/j.palaeo.2010.02.032; Mann K, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-28; Mannino AM, 2002, WORLD ARCHAEOL, V33, P452; Marie B, 2012, P NATL ACAD SCI USA, V109, P20986, DOI 10.1073/pnas.1210552109; Marin F., 2013, RECENTS ADV PEARL RE, V149; Mayer DEBY, 2009, J HUM EVOL, V56, P307, DOI 10.1016/j.jhevol.2008.10.005; Mayer DEB, 1997, J ARCHAEOL SCI, V24, P97; Miller G.H., 1980, P415; Miller G.H., 1989, Quaternary International, V1, P111, DOI 10.1016/1040-6182(89)90011-6; MILLER GH, 1979, NATURE, V281, P539, DOI 10.1038/281539a0; Mitchell PJ., 1996, AFR ARCHAEOL REV, V13, P35, DOI DOI 10.1007/BF01956132; O'Connor S, UNUSUAL FIND S UNPUB; OBIS, 2014, DAT OC BIOG INF SYST; Oliva M, 2010, TECHNOLOGY PRODUCTIO, V66, P146; PARMALEE PW, 1974, AM ANTIQUITY, V39, P421, DOI 10.2307/279431; Penkman KEH, 2007, QUATERNARY SCI REV, V26, P2958, DOI 10.1016/j.quascirev.2007.06.034; Penkman KEH, 2008, QUAT GEOCHRONOL, V3, P2, DOI 10.1016/j.quageo.2007.07.001; Penkman KEH, 2013, QUATERNARY SCI REV, V61, P111, DOI 10.1016/j.quascirev.2012.10.046; Penkman KEH, 2011, NATURE, V476, P446, DOI 10.1038/nature10305; Richter KK, 2011, J ARCHAEOL SCI, V38, P1502, DOI 10.1016/j.jas.2011.02.014; Seferiades M, 2009, LOST WORLD OLD EUROP, P180; Stiner Mary C., 2014, Biology Theory, V9, P51, DOI 10.1007/s13752-013-0157-4; Stiner MC, 1999, ANTIQUITY, V73, P735, DOI 10.1017/S0003598X00065492; Sykes GA, 1995, ORG GEOCHEM, V23, P1059, DOI 10.1016/0146-6380(95)00086-0; Trubitt MBD, 2003, J ARCHAEOL RES, V11, P243, DOI 10.1023/A:1025028814962; Vanhaeren M, 2004, J ARCHAEOL SCI, V31, P1481, DOI 10.1016/j.jas.2004.03.011; Vanhaeren M, 2006, J ARCHAEOL SCI, V33, P1105, DOI 10.1016/j.jas.2005.11.017; Vermeij G.J., 1995, NATURAL HIST SHELLS, VVolume 15; Wehmiller J.F., 1980, P341; WEHMILLER JF, 1977, EARTH PLANET SC LETT, V37, P184, DOI 10.1016/0012-821X(77)90163-7; Wehmiller JF, 2013, QUAT GEOCHRONOL, V16, P3, DOI 10.1016/j.quageo.2012.05.008; WEINER S, 1984, PHILOS T ROY SOC B, V304, P425, DOI 10.1098/rstb.1984.0036; WoRMS Editorial Board, 2014, WORLD REGISTER MARIN	65	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99839	10.1371/journal.pone.0099839	http://dx.doi.org/10.1371/journal.pone.0099839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AK5YM	24936797	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000338503400042
J	Foulds, WL; Lucas, MC				Foulds, William L.; Lucas, Martyn C.			Paradoxical Exploitation of Protected Fishes As Bait for Anglers: Evaluating the Lamprey Bait Market in Europe and Developing Sustainable and Ethical Solutions	PLOS ONE			English	Article							FRESH-WATER FISHES; RIVER LAMPREY; STAKEHOLDER ATTITUDES; PETROMYZON-MARINUS; CONSERVATION; MANAGEMENT; IMPACT; TRADE; EEL; ANGUILLA	A reoccurring conservation problem is the resolution of consumptive use of threatened wildlife and is especially difficult to defend when it occurs for recreational practices. We explored the commercial capture and supply of threatened European river lamprey (Lampetra fluviatilis) to anglers, to determine the extent of exploitation and seek opportunities for improved conservation. The trade began in 1995 from England, but by 2012 involved sale of lamprey from England, The Netherlands and Estonia, including from protected populations. Lamprey are sold frozen for the capture of predatory fish, mostly in freshwater. In the year 2011/2012 9 tonnes (. 90,000 lampreys) of river lamprey were supplied, almost exclusively to British anglers. Although annual catches in the main English lamprey fishery (River Ouse) have varied widely since 1995, catch per unit effort did not decline between 2000 and 2012. Conservation actions since 2011 have included a cap on fishing licenses, catch quotas and restricted fishing seasons. Now, 86% of lamprey bait is imported to Britain. Most bait sellers interviewed would not stock lamprey if they knew they were from threatened populations; many felt their trade would not be impacted if lamprey were not stocked. This facilitates opportunities to enter into dialogue with anglers over alternative baits to threatened lamprey. The study emphasises the need to inform stakeholders about conservation species subjected to market-driven exploitation.	[Foulds, William L.; Lucas, Martyn C.] Univ Durham, Sch Biol & Biomed Sci, Durham, England	Durham University	Foulds, WL (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	will_foulds@hotmail.com			Durham University	Durham University	Mr. William Foulds was supported by a Grevillea Trust scholarship from Durham University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas Oystein, 2000, North American Journal of Fisheries Management, V20, P940, DOI 10.1577/1548-8675(2000)020&lt;0940:ARTPHR&gt;2.0.CO;2; Allan JD, 2005, BIOSCIENCE, V55, P1041, DOI 10.1641/0006-3568(2005)055[1041:OOIW]2.0.CO;2; Andrade NO, 2007, HYDROBIOLOGIA, V582, P121, DOI 10.1007/s10750-006-0540-2; Arlinghaus R, 2008, N AM J FISH MANAGE, V28, P123, DOI 10.1577/M06-263.1; Arlinghaus R, 2002, FISH FISH, V3, P261, DOI 10.1046/j.1467-2979.2002.00102.x; Bark A, 2007, ICES J MAR SCI, V64, P1368, DOI 10.1093/icesjms/fsm117; Beaulaton L, 2008, FISH RES, V92, P90, DOI 10.1016/j.fishres.2008.01.001; BIERNACKI P, 1981, SOCIOL METHOD RES, V10, P141, DOI 10.1177/004912418101000205; Birzaks J, 2011, SCI J RIGA TECHNICAL, V7, P32; Bourque L.B., 2003, CONDUCT TELEPHONE SU; Chan KMA, 2007, CONSERV BIOL, V21, P59, DOI 10.1111/j.1523-1739.2006.00570.x; Close DA, 2002, FISHERIES, V27, P19, DOI 10.1577/1548-8446(2002)027<0019:TEACIO>2.0.CO;2; Cowx IG, 2010, J FISH BIOL, V76, P2194, DOI 10.1111/j.1095-8649.2010.02686.x; CRYER M, 1987, BIOL CONSERV, V42, P83, DOI 10.1016/0006-3207(87)90016-4; Danylchuk AJ, 2011, CONSERV BIOL, V25, P458, DOI 10.1111/j.1523-1739.2010.01631.x; de Nie H., 2003, Nederlandsche Commissie voor Internationale Natuurbescherming Mededelingen, V38, P159; Dekker W, 2003, FISHERIES MANAG ECOL, V10, P365, DOI 10.1111/j.1365-2400.2003.00352.x; Dorow M, 2010, FISHERIES MANAG ECOL, V17, P106, DOI 10.1111/j.1365-2400.2009.00674.x; Dorow M, 2009, BIOL CONSERV, V142, P2973, DOI 10.1016/j.biocon.2009.07.029; Dotinga H, 2009, UTRECHT LAW REV, V5, P21, DOI 10.18352/ulr.93; FAO Fisheries Department, 2010, STAT WORLD FISH AQ 2; Freyhof J, 2010, IUCN 2012 IUCN RED L; Freyhof J., 2008, IUCN 2012 IUCN RED L; Freyhof J, 2011, IUCN 2012 IUCN RED L; Gaudron SM, 2006, J FISH BIOL, V68, P640, DOI 10.1111/j.0022-1112.2006.00937.x; Gelcich S, 2005, CONSERV BIOL, V19, P865, DOI 10.1111/j.1523-1739.2005.00534.x; Gonzalez JA, 2003, BIOL CONSERV, V114, P437, DOI 10.1016/S0006-3207(03)00071-5; Gozlan RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053200; Grabowski JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010188; Granek EF, 2008, CONSERV BIOL, V22, P1125, DOI 10.1111/j.1523-1739.2008.00977.x; Gratwicke B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002544; Hardisty MW, 1986, FRESHWATER FISHES 1, V1, P249; Janson HM, 2007, CO4807 IMARES; Kelly F.L., 2001, BIOL ENVIRON, V101B, P165; Lanzing W.J.R., 1959, STUDIES RIVER LAMPRE; Likert R., 1932, ARCH PSYCHOL, V140, P1, DOI DOI 10.1111/J.1540-5834.2010.00585.X; MAITLAND P, 1997, FRESHWATER FORUM, V6, P57; Marshall G, 2005, RADIOGRAPHY, V11, P131, DOI [10.1016/j.radi.2004.09.002, 10.1016/j.radi.2004.09.001]; Marshall K, 2007, BIODIVERS CONSERV, V16, P3129, DOI 10.1007/s10531-007-9167-5; Masters JEG, 2006, AQUAT CONSERV, V16, P77, DOI 10.1002/aqc.686; Mateus Catarina S., 2012, Endangered Species Research, V16, P183, DOI 10.3354/esr00405; Mintzer VJ, 2013, BIOL CONSERV, V158, P280, DOI 10.1016/j.biocon.2012.10.006; Peterson MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044616; Phelps NBD, 2013, DIS AQUAT ORGAN, V102, P211, DOI 10.3354/dao02549; Raghavan R, 2013, BIOL CONSERV, V164, P158, DOI 10.1016/j.biocon.2013.04.019; Renaud CB, 1997, J APPL ICHTHYOL, V13, P143, DOI 10.1111/j.1439-0426.1997.tb00114.x; Reynolds John D., 2002, P319; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Saat T., 2002, P34; Schlaepfer MA, 2005, BIOSCIENCE, V55, P256, DOI 10.1641/0006-3568(2005)055[0256:CIETIO]2.0.CO;2; Sjoberg K., 2011, J N STUD, V5, P51; Spice EK, 2012, MOL ECOL, V21, P2916, DOI 10.1111/j.1365-294X.2012.05585.x; Stankey GH, 2006, CONSERV BIOL, V20, P29; Thiel Ralf, 2009, Endangered Species Research, V8, P233, DOI 10.3354/esr00222; Thorbjarnarson J, 1999, CONSERV BIOL, V13, P465, DOI 10.1046/j.1523-1739.1999.00011.x; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; Tsounis G, 2010, OCEANOGR MAR BIOL, V48, P161, DOI 10.1201/EBK1439821169-c3; VALTONEN T, 1980, CAN J FISH AQUAT SCI, V37, P1967, DOI 10.1139/f80-237; White PCL, 2005, J APPL ECOL, V42, P421, DOI 10.1111/j.1365-2664.2005.01032.x; WITKOWSKI A, 1992, NETH J ZOOL, V42, P243, DOI 10.1163/156854291X00315; Worthington T, 2010, FISHERIES MANAG ECOL, V17, P465, DOI 10.1111/j.1365-2400.2010.00745.x	61	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99617	10.1371/journal.pone.0099617	http://dx.doi.org/10.1371/journal.pone.0099617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936643	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000338503400026
J	Fuchs, MA; Sato, K; Niedzwiecki, D; Ye, X; Saltz, LB; Mayer, RJ; Mowat, RB; Whittom, R; Hantel, A; Benson, A; Atienza, D; Messino, M; Kindler, H; Venook, A; Ogino, S; Wu, KN; Willett, WC; Giovannucci, EL; Meyerhardt, JA				Fuchs, Michael A.; Sato, Kaori; Niedzwiecki, Donna; Ye, Xing; Saltz, Leonard B.; Mayer, Robert J.; Mowat, Rex B.; Whittom, Renaud; Hantel, Alexander; Benson, Al; Atienza, Daniel; Messino, Michael; Kindler, Hedy; Venook, Alan; Ogino, Shuji; Wu, Kana; Willett, Walter C.; Giovannucci, Edward L.; Meyerhardt, Jeffrey A.			Sugar-Sweetened Beverage Intake and Cancer Recurrence and Survival in CALGB 89803 (Alliance)	PLOS ONE			English	Article							III COLON-CANCER; FOOD FREQUENCY QUESTIONNAIRE; DIETARY GLYCEMIC LOAD; GROWTH-FACTOR-I; COLORECTAL-CANCER; BODY-WEIGHT; EPIDEMIOLOGIC EVIDENCE; PHYSICAL-ACTIVITY; CELL-LINE; C-PEPTIDE	Background: In colon cancer patients, obesity, sedentary lifestyle, and high dietary glycemic load have been associated with increased risk of cancer recurrence. High sugar-sweetened beverage intake has been associated with obesity, diabetes, and cardio-metabolic diseases, but the influence on colon cancer survival is unknown. Methods: We assessed the association between sugar-sweetened beverage consumption on cancer recurrence and mortality in 1,011 stage III colon cancer patients who completed food frequency questionnaires as part of a U.S. National Cancer Institute-sponsored adjuvant chemotherapy trial. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated with Cox proportional hazard models. Results: Patients consuming >= 2 servings of sugar-sweetened beverages per day experienced an adjusted HR for disease recurrence or mortality of 1.67 (95% CI, 1.04-2.68), compared with those consuming <2 servings per month (P-trend = 0.02). The association of sugar-sweetened beverages on cancer recurrence or mortality appeared greater among patients who were both overweight (body mass index >= 25 kg/m(2)) and less physically active (metabolic equivalent task-hours per week < 18) (HR = 2.22; 95% CI, 1.29-3.81, P-trend = 0.0025). Conclusion: Higher sugar-sweetened beverage intake was associated with a significantly increased risk of cancer recurrence and mortality in stage III colon cancer patients.	[Fuchs, Michael A.] Brown Univ, Providence, RI 02912 USA; [Sato, Kaori; Mayer, Robert J.; Ogino, Shuji; Meyerhardt, Jeffrey A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Niedzwiecki, Donna; Ye, Xing] Duke Univ, Med Ctr, Alliance Stat & Data Ctr, Durham, NC USA; [Saltz, Leonard B.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Mowat, Rex B.] Toledo Community Hosp, Oncol Program, Toledo, OH USA; [Whittom, Renaud] Hop Sacre Coeur, Montreal, PQ H4J 1C5, Canada; [Hantel, Alexander] Loyola Univ, Stritch Sch Med, Naperville, IL USA; [Benson, Al] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Atienza, Daniel] Virginia Oncol Associates, Norfolk, VA USA; [Messino, Michael] Mission Hosp Inc, Southeast Canc Control Consortium, Asheville, NC USA; [Kindler, Hedy] Univ Chicago, Chicago, IL 60637 USA; [Venook, Alan] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Wu, Kana; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Willett, Walter C.; Giovannucci, Edward L.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Giovannucci, Edward L.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Giovannucci, Edward L.] Harvard Univ, Sch Med, Boston, MA USA	Brown University; Harvard University; Dana-Farber Cancer Institute; Duke University; Memorial Sloan Kettering Cancer Center; Universite de Montreal; Loyola University Chicago; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Meyerhardt, JA (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	jmeyerhardt@partners.org		Niedzwiecki, Donna/0000-0002-3566-0450; Ogino, Shuji/0000-0002-3909-2323; Saltz, Leonard/0000-0001-8353-4670	National Cancer Institute [CA31946, R01 CA118553, R01 CA149222, R01 CA169141, P50 CA127003, CA33601]; Pfizer Oncology; NATIONAL CANCER INSTITUTE [R01CA118553, R01CA169141, U10CA180888, P50CA127003, U10CA031946, R01CA149222, U10CA033601] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pfizer Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	CALGB 89803 was supported, in part, by grants from the National Cancer Institute (CA31946) to the Alliance for Clinical Trials in Oncology (Monica Bertagnolli, M. D., Chairman) and to the Alliance Statistical Center (Daniel Sargent, PhD, CA33601 as well as support from Pharmacia & Upjohn Company, now Pfizer Oncology. Dr. Meyerhardt is supported in part by grants from the National Cancer Institute (R01 CA118553, R01 CA149222, R01 CA169141, and P50 CA127003). The sponsors did not participate in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Andreyeva T, 2011, PREV MED, V52, P413, DOI 10.1016/j.ypmed.2011.03.013; BJORK J, 1993, SCAND J GASTROENTERO, V28, P879, DOI 10.3109/00365529309103129; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Choi Hyon K., 2010, JAMA (Journal of the American Medical Association), V304, P2270, DOI 10.1001/jama.2010.1638; COX DR, 1972, J R STAT SOC B, V34, P187; de Ruyter JC, 2012, CONTEMP CLIN TRIALS, V33, P247, DOI 10.1016/j.cct.2011.10.007; Demark-Wahnefried W, 2012, CANC EPIDEMIOL BIOMA, V21, P1244; DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; Giovannucci E, 2003, J WOMEN HEALTH GEN-B, V12, P173, DOI 10.1089/154099903321576574; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036; Kaaks R, 2000, JNCI-J NATL CANCER I, V92, P1592, DOI 10.1093/jnci/92.19.1592; KOENUMA M, 1989, JPN J CANCER RES, V80, P51, DOI 10.1111/j.1349-7006.1989.tb02244.x; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2011, AM J CLIN NUTR, V94, P1161, DOI 10.3945/ajcn.111.025676; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Mattes Richard D., 1996, Physiology and Behavior, V59, P179, DOI 10.1016/0031-9384(95)02007-1; Meyerhardt JA, 2005, J CLIN ONCOL, V23, P8453, DOI 10.1200/JCO.2005.02.5460; Meyerhardt J, 2007, JAMA-J AM MED ASSOC, V298, P2263, DOI 10.1001/jama.298.19.2263-b; Meyerhardt JA, 2008, J CLIN ONCOL, V26, P4109, DOI 10.1200/JCO.2007.15.6687; Meyerhardt JA, 2007, JAMA-J AM MED ASSOC, V298, P754, DOI 10.1001/jama.298.7.754; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3535, DOI 10.1200/JCO.2006.06.0863; Meyerhardt JA, 2012, JNCI-J NATL CANCER I, V104, P1702, DOI 10.1093/jnci/djs399; Michaud DS, 2005, CANCER EPIDEM BIOMAR, V14, P138, DOI 10.1158/1055-9965.EPI-05-0428; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; POLLAK MN, 1987, CANCER LETT, V38, P223, DOI 10.1016/0304-3835(87)90218-7; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Saltz LB, 2007, J CLIN ONCOL, V25, P3456, DOI 10.1200/JCO.2007.11.2144; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Samad AKA, 2005, COLORECTAL DIS, V7, P204, DOI 10.1111/j.1463-1318.2005.00747.x; Schoen RE, 1999, JNCI-J NATL CANCER I, V91, P1147, DOI 10.1093/jnci/91.13.1147; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Singh GM, 2013, EPIDEMIOLOGY PREVENT, pMP22; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Theodoratou E, 2013, EUR J CANC PREV; UDo Agriculture, 1989, AGR HDB, V8; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; WATKINS LF, 1990, INT J CANCER, V45, P372, DOI 10.1002/ijc.2910450227; Wei EK, 2005, CANCER EPIDEM BIOMAR, V14, P850, DOI 10.1158/1055-9965.EPI-04-0661; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WILLETT WC, 1987, J AM DIET ASSOC, V87, P43; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Wolpin BM, 2009, J CLIN ONCOL, V27, P176, DOI 10.1200/JCO.2008.17.9945; Zhang XH, 2010, JNCI-J NATL CANCER I, V102, P771, DOI 10.1093/jnci/djq107; Zubrod C.G., 1960, J CHRON DIS, V11, P7	48	52	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99816	10.1371/journal.pone.0099816	http://dx.doi.org/10.1371/journal.pone.0099816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937507	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400040
J	Guerrero-Bosagna, C; Weeks, S; Skinner, MK				Guerrero-Bosagna, Carlos; Weeks, Shelby; Skinner, Michael K.			Identification of Genomic Features in Environmentally Induced Epigenetic Transgenerational Inherited Sperm Epimutations	PLOS ONE			English	Article							CTCF-BINDING SITES; DNA METHYLATION; REGULATORY REGIONS; QUADRUPLEX MOTIFS; PATERNAL LINEAGE; MOUSE; VINCLOZOLIN; DISEASE; EXPOSURE; GENE	A variety of environmental toxicants have been shown to induce the epigenetic transgenerational inheritance of disease and phenotypic variation. The process involves exposure of a gestating female and the developing fetus to environmental factors that promote permanent alterations in the epigenetic programming of the germline. The molecular aspects of the phenomenon involve epigenetic modifications (epimutations) in the germline (e. g. sperm) that are transmitted to subsequent generations. The current study integrates previously described experimental epigenomic transgenerational data and web-based bioinformatic analyses to identify genomic features associated with these transgenerationally transmitted epimutations. A previously identified genomic feature associated with these epimutations is a low CpG density (<12/100bp). The current observations suggest the transgenerational differential DNA methylation regions (DMR) in sperm contain unique consensus DNA sequence motifs, zinc finger motifs and G-quadruplex sequences. Interaction of molecular factors with these sequences could alter chromatin structure and accessibility of proteins with DNA methyltransferases to alter de novo DNA methylation patterns. G-quadruplex regions can promote the opening of the chromatin that may influence the action of DNA methyltransferases, or factors interacting with them, for the establishment of epigenetic marks. Zinc finger binding factors can also promote this chromatin remodeling and influence the expression of non-coding RNA. The current study identified genomic features associated with sperm epimutations that may explain in part how these sites become susceptible for transgenerational programming.	[Guerrero-Bosagna, Carlos; Weeks, Shelby; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA; [Guerrero-Bosagna, Carlos] Linkoping Univ, Dept Phys Biol & Chem, Linkoping, Sweden	Washington State University; Linkoping University	Skinner, MK (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@wsu.edu	Guerrero-Bosagna, Carlos/W-7319-2019	Guerrero-Bosagna, Carlos/0000-0003-1935-5875	NIH NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012974] Funding Source: NIH RePORTER	NIH NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The study was supported by an NIH NIEHS grant to MKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabert C, 2012, NAT REV MOL CELL BIO, V13, P153, DOI 10.1038/nrm3288; Allegrucci C, 2005, REPRODUCTION, V129, P137, DOI 10.1530/rep.1.00360; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Arico JK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001391; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Brander SM, 2012, ENVIRON TOXICOL CHEM, V31, P2848, DOI 10.1002/etc.2019; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cowin PA, 2010, ENDOCRINOLOGY, V151, P783, DOI 10.1210/en.2009-0982; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; Dunn GA, 2011, ENDOCRINOLOGY, V152, P2228, DOI 10.1210/en.2010-1461; Durcova-Hills G, 2006, P NATL ACAD SCI USA, V103, P11184, DOI 10.1073/pnas.0602621103; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Feltus FA, 2006, GENOMICS, V87, P572, DOI 10.1016/j.ygeno.2005.12.016; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guerrero-Bosagna C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059922; Guerrero-Bosagna C, 2012, REPROD TOXICOL, V34, P694, DOI 10.1016/j.reprotox.2012.09.005; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Hackett JA, 2012, TRENDS GENET, V28, P164, DOI 10.1016/j.tig.2012.01.005; Halder R, 2010, MOL BIOSYST, V6, P2439, DOI 10.1039/c0mb00009d; Ichiyanagi K, 2011, GENOME RES, V21, P2058, DOI 10.1101/gr.123679.111; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Kumar P, 2011, NUCLEIC ACIDS RES, V39, P8005, DOI 10.1093/nar/gkr536; Lees-Murdock DJ, 2008, EPIGENETICS-US, V3, P5, DOI 10.4161/epi.3.1.5553; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387; Manikkam M, 2012, REPROD TOXICOL, V34, P708, DOI 10.1016/j.reprotox.2012.08.010; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046249; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; Molaro A, 2011, CELL, V146, P1028, DOI 10.1016/j.cell.2011.08.016; Morgan CP, 2011, J NEUROSCI, V31, P11748, DOI 10.1523/JNEUROSCI.1887-11.2011; Nardone J, 2004, NAT IMMUNOL, V5, P768, DOI 10.1038/ni0804-768; Nilsson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036129; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Pitteloud N, 2008, J CLIN ENDOCR METAB, V93, P784, DOI 10.1210/jc.2007-2156; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reutman SR, 2002, ENVIRON HEALTH PERSP, V110, P805, DOI 10.1289/ehp.02110805; ROBISON AK, 1985, J TOXICOL ENV HEALTH, V16, P493, DOI 10.1080/15287398509530758; Sarkies P, 2010, MOL CELL, V40, P703, DOI 10.1016/j.molcel.2010.11.009; Sasai N, 2010, NUCLEIC ACIDS RES, V38, P5015, DOI 10.1093/nar/gkq280; Saze H, 2012, GENES GENET SYST, V87, P145, DOI 10.1266/ggs.87.145; Singh S, 2012, GENE, V494, P85, DOI 10.1016/j.gene.2011.11.035; Skinner MK, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-228; Skinner MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066318; Skinner MK, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R91, 10.1186/gb-2012-13-10-r91]; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Tamaru H, 2003, MOL CELL BIOL, V23, P2379, DOI 10.1128/MCB.23.7.2379-2394.2003; Tanaka J, 2007, MOL CELL ENDOCRINOL, V272, P38, DOI 10.1016/j.mce.2007.04.008; Tracey R, 2013, REPROD TOXICOL, V36, P104, DOI 10.1016/j.reprotox.2012.11.011; Uzumcu M, 2004, REPROD TOXICOL, V18, P765, DOI 10.1016/j.reprotox.2004.05.008; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; Wen B, 2008, GENOME RES, V18, P1806, DOI 10.1101/gr.067587.108; Wienholz BL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001106; WONG CI, 1995, J BIOL CHEM, V270, P19998, DOI 10.1074/jbc.270.34.19998	64	36	36	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100194	10.1371/journal.pone.0100194	http://dx.doi.org/10.1371/journal.pone.0100194			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937757	Green Published, gold			2022-12-25	WOS:000338503400089
J	Luttikholt, S; Veldhuis, A; van den Brom, R; Moll, L; Lievaart-Peterson, K; Peperkamp, K; van Schaik, G; Vellema, P				Luttikholt, Saskia; Veldhuis, Anouk; van den Brom, Rene; Moll, Lammert; Lievaart-Peterson, Karianne; Peperkamp, Klaas; van Schaik, Gerdien; Vellema, Piet			Risk Factors for Malformations and Impact on Reproductive Performance and Mortality Rates of Schmallenberg Virus in Sheep Flocks in the Netherlands	PLOS ONE			English	Article							AKABANE VIRUS; CONGENITAL-ABNORMALITIES; BLUETONGUE VIRUS; NEWBORN LAMBS; INFECTION; SEROPREVALENCE; ANTIBODIES; CATTLE	In Northwestern Europe, an epizootic outbreak of congenital malformations in newborn lambs due to infection with Schmallenberg virus (SBV) started at the end of 2011. The objectives of this study were to describe clinical symptoms of SBV infection, the effect of infection on mortality rates, and reproductive performance in sheep, as well as to identify and quantify flock level risk factors for SBV infections resulting in malformations in newborn lambs. A case-control study design was used, with 93 case flocks that had notified malformed lambs and 84 control flocks with no such lambs. Overall animal seroprevalence in case flocks was estimated at 82.0% (95% CI: 74.3-87.8), and was not significantly different from the prevalence in control flocks being 76.4% (95% CI: 67.2-83.6). The percentages of stillborn lambs or lambs that died before weaning, repeat breeders, and lambs with abnormal suckling behaviour were significantly higher in case flocks compared to control flocks. However, effect of SBV infection on mortality rates and reproductive performance seemed to be limited. Multivariable analysis showed that sheep flocks with an early start of the mating season, i.e. before August 2011 (OR = 33.1; 95% CI: 10.0-109.8) and in August 2011 (OR = 8.2; 95% CI: 2.7-24.6) had increased odds of malformations in newborn lambs caused by SBV compared to sheep flocks with a start of the mating season in October 2011. Other flock-level risk factors for malformations in newborn lambs were purchase of silage (OR 5.0; 95% CI: 1.7-15.0) and flocks with one or more dogs (OR = 3.3; 95% CI: 1.3-8.3). Delaying mating until October could be a potential preventive measure for naive animals to reduce SBV induced losses. As duration of immunity after infection with SBV is expected to last for several years, future SBV induced congenital malformations are mainly expected in offspring of early mated seronegative animals.	[Luttikholt, Saskia; van den Brom, Rene; Moll, Lammert; Lievaart-Peterson, Karianne; Vellema, Piet] GD Anim Hlth, Dept Small Ruminant Hlth, Deventer, Netherlands; [Veldhuis, Anouk; van Schaik, Gerdien] GD Anim Hlth, Dept Epidemiol, Deventer, Netherlands; [Peperkamp, Klaas] GD Anim Hlth, Dept Pathol, Deventer, Netherlands		Luttikholt, S (corresponding author), GD Anim Hlth, Dept Small Ruminant Hlth, Deventer, Netherlands.	s.luttikholt@gddiergezondheid.nl	van Schaik, Gerdien/AAD-7771-2020; Lievaart-Peterson, Karianne/AAD-9383-2019	Lievaart-Peterson, Karianne/0000-0001-9517-6866; van Schaik, Gerdien/0000-0002-0460-2629	Dutch Ministry of Economic Affairs; European Commission (DG SANCO)	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); European Commission (DG SANCO)(European CommissionEuropean Commission Joint Research Centre)	This study was financially supported by the Dutch Ministry of Economic Affairs and the European Commission (DG SANCO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER KA, 1994, AM J TROP MED HYG, V51, P568, DOI 10.4269/ajtmh.1994.51.568; De Regge N, 2013, VET MICROBIOL, V162, P595, DOI 10.1016/j.vetmic.2012.11.029; Dennis S. M., 1979, Veterinary Bulletin, V49, P233; Elbers ARW, 2013, EMERG INFECT DIS, V19, P106, DOI 10.3201/eid1901.121054; Gache K, 2013, VET REC, V173, P141, DOI 10.1136/vr.101377; HASHIGUCHI Y, 1979, NATL I ANIM HEALTH Q, V19, P1; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; LUEDKE A J, 1985, P71; Martinelle L, 2012, FIELD VET SURVEY CLI; Meroc E, 2013, DISTRIBUTION SCHMALL; Muskens J, 2012, TIJDSCHR DIERGENEESK, V137, P112; NARITA M, 1979, J COMP PATHOL, V89, P229, DOI 10.1016/0021-9975(79)90062-8; OSBURN BI, 1994, COMP IMMUNOL MICROB, V17, P189, DOI 10.1016/0147-9571(94)90042-6; PARSONSON IM, 1977, INFECT IMMUN, V15, P254, DOI 10.1128/IAI.15.1.254-262.1977; ProMed-Mail, 2011, PRO AH EDR SCHM VIR; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Saegerman C, 2013, PRELIMINARY SURVEY I; Sailleau C, 2013, EMERGING INFECT DIS, V19; SHUPE JL, 1983, VET HUM TOXICOL, V25, P415; van den Brom R, 2012, TIJDSCHR DIERGENEESK, V137, P106; van der Heijden HM, 2013, RES VET SCI; van Maanen C, 2012, VET REC, V171, P299, DOI 10.1136/vr.101061; Veldhuis AMB, 2013, PREV VET MED, V112, P35, DOI 10.1016/j.prevetmed.2013.06.010; Wensman JJ, 2013, J CLIN MICROBIOL, V51, P2802, DOI 10.1128/JCM.00877-13; Wernike K, 2013, VET MICROBIOL, V166, P461, DOI 10.1016/j.vetmic.2013.06.030; WinEpiscope2.0, 2000, STAT SOFTW COMP AID	26	18	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100135	10.1371/journal.pone.0100135	http://dx.doi.org/10.1371/journal.pone.0100135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937443	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400080
J	Ma, WP; Gu, S; Wang, Y; Zhang, XJ; Wang, AR; Zhao, NQ; Song, YY				Ma, Wei-ping; Gu, Shuo; Wang, Yi; Zhang, Xian-jing; Wang, Ai-rong; Zhao, Nai-qing; Song, Yan-yan			The Use of Mixed Generalized Additive Modeling to Assess the Effect of Temperature on the Usage of Emergency Electrocardiography Examination among the Elderly in Shanghai	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; DAILY WEATHER CONDITIONS; HOSPITAL ADMISSIONS; HEART-DISEASE	Background: Acute coronary artery diseases have been observed to be associated with some meteorological variables. But few of the previous studies considered autocorrelated outcomes. Electrocardiography is a widely used tool in the initial diagnosis of acute cardiovascular events, and emergency electrocardiography counts were shown to be highly correlated with acute myocardial infarction in our pilot study, hence a good index of prediction for acute cardiovascular events morbidity among the elderly. To indirectly assess the impact of temperature on the number of acute cardiovascular events, we studied the association between temperature and emergency electrocardiography counts while considering autocorrelated nature of the response variables. Methods: We collected daily emergency electrocardiography counts for elderly females and males in Shanghai from 2007 to middle 2012, and studied temperature and other effects on these data using Mixed Generalized Additive Modelling methods. Delayed temperature effect distribution was described as the weighted average of the temperatures within 3 days before the counts was recorded. Autoregressive random effects were used in the model to describe the autocorrelation of the response variables. Main Results: Temperature effect was observed to be piecewise linearly associated with the logarithm of emergency electrocardiography counts. The optimal weights of the delayed temperature effect distribution were obtained from the model estimation. The weights of lag-1 were the maximums, significantly greater than the weights of lag-2 and lag-3 for both females and males. The model showed good fit with R-2 values of 0.860 for females and 0.856 for males. Conclusion: From the mixed generalized additive model, we infer that during cold and mild days, the number of emergency electrocardiography counts increase as temperature effect decreases, while during hot days, counts increase as temperature effect increases. Similar properties could be inferred for the occurrence of cardiovascular events.	[Ma, Wei-ping; Zhao, Nai-qing] Fudan Univ, Sch Publ Hlth, Dept Biostat & Social Med, Shanghai 200433, Peoples R China; [Gu, Shuo] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Shanghai 200030, Peoples R China; [Wang, Yi] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China; [Zhang, Xian-jing; Wang, Ai-rong] Shang Hai Med Insurance Adm, Shanghai, Peoples R China; [Song, Yan-yan] Shanghai Jiao Tong Univ, Sch Med, Dept Biostat, Shanghai 200030, Peoples R China	Fudan University; Shanghai Jiao Tong University; Fudan University; Shanghai Jiao Tong University	Zhao, NQ (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Biostat & Social Med, Shanghai 200433, Peoples R China.	nqzhao@fudan.edu.cn; yanyansong@sjtu.edu.cn		Gu, shuo/0000-0001-5225-6874	National Natural Science Foundation of China [81273187]; Ministry of Science and Technology of the People's Republic of China [2012ZX09303-013-014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This research was supported by National Natural Science Foundation of China (Grant 81273187) and Ministry of Science and Technology of the People's Republic of China (Major Grant 2012ZX09303-013-014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett AG, 2005, J EPIDEMIOL COMMUN H, V59, P551, DOI 10.1136/jech.2004.028514; Benjamin MA, 2003, J AM STAT ASSOC, V98, P214, DOI 10.1198/016214503388619238; Bhaskaran K, 2009, HEART, V95, P1760, DOI 10.1136/hrt.2009.175000; COLLINS KJ, 1986, AGE AGEING, V15, P212, DOI 10.1093/ageing/15.4.212; Danet S, 1999, CIRCULATION, V100, pE11, DOI 10.1161/01.CIR.100.1.e1; De Lorenzo F, 1999, QJM-INT J MED, V92, P747, DOI 10.1093/qjmed/92.12.747; ENQUSELASSIE F, 1993, INT J EPIDEMIOL, V22, P632, DOI 10.1093/ije/22.4.632; Gerber Y, 2006, J AM COLL CARDIOL, V48, P287, DOI 10.1016/j.jacc.2006.02.065; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hopstock LA, 2012, J EPIDEMIOL COMMUN H, V66, P815, DOI 10.1136/jech.2010.131458; Lin S, 2009, EPIDEMIOLOGY, V20, P738, DOI 10.1097/EDE.0b013e3181ad5522; MARCHANT B, 1993, BRIT HEART J, V69, P385; Michelozzi P, 2009, AM J RESP CRIT CARE, V179, P383, DOI 10.1164/rccm.200802-217OC; Morris F, 2002, BRIT MED J, V324, P831, DOI 10.1136/bmj.324.7341.831; PAN WH, 1995, LANCET, V345, P353, DOI 10.1016/S0140-6736(95)90341-0; Pell JP, 1999, QJM-INT J MED, V92, P689, DOI 10.1093/qjmed/92.12.689; Ren CZ, 2006, ENVIRON HEALTH PERSP, V114, P1690, DOI 10.1289/ehp.9266; Schwartz J, 2004, EPIDEMIOLOGY, V15, P755, DOI 10.1097/01.ede.0000134875.15919.0f; Wolf K, 2009, CIRCULATION, V120, P735, DOI 10.1161/CIRCULATIONAHA.108.815860; Yang L, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-165	20	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100284	10.1371/journal.pone.0100284	http://dx.doi.org/10.1371/journal.pone.0100284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936868	gold, Green Published, Green Submitted			2022-12-25	WOS:000338503400100
J	Popovic, N; Caballero-Bleda, M; Popovic, M				Popovic, Natalija; Caballero-Bleda, Maria; Popovic, Miroljub			Post-Training Scopolamine Treatment Induced Maladaptive Behavior in Open Field Habituation Task in Rats	PLOS ONE			English	Article							EXPLORATORY ACTIVITY; MEMORY; ACETYLCHOLINE; MICE; CONSOLIDATION; NOVELTY; ACQUISITION; AVOIDANCE; DRUGS	The effects of scopolamine on memory consolidation are controversial and depend on several factors (i.e. site of administration, time of administration and testing, dose, cognitive task, experimental protocol, specie, strain, etc.). Generally, the range dose of systemic administered scopolamine, used in memory consolidation studies, has varied from 0.05 to 50 mg/kg. However, according to the literature, the most frequently used doses of scopolamine efficient on memory consolidation, are 1 and 30 mg/kg, low and high doses, respectively. In open field habituation studies only lower doses of scopolamine were used to test memory consolidation. Therefore, in the present study we compared the effects of low (1 mg/kg) and high (30 mg/kg) scopolamine dose, on the open field habituation task, in male Wistar rats. Scopolamine was administered immediately after the acquisition task and animals were retested 48 h later on. On the retested day, the ambulation and rearing in the open field decreased in the same manner in all tested groups. In saline- and 1 mg/kg scopolamine-treated animals, the time spent in grooming significantly decreased in the habituation task, while the same parameter significantly increased in animals treated with 30 mg/kg of scopolamine. The defecation rate significantly decreased (control group), maintained (1 mg/kg of scopolamine treated animals) or significantly increased (30 mg/kg of scopolamine treated group) on retention test. In conclusion, the present data suggest that post-training scopolamine administration does not affect locomotion neither exploration in the habituation to a novel environment, but increases defecation and grooming, two behaviours associated with fearful and stressful situations.	[Popovic, Natalija; Caballero-Bleda, Maria; Popovic, Miroljub] Univ Murcia, Fac Med, Dept Human Anat & Psychobiol, Murcia, Spain; [Popovic, Natalija; Caballero-Bleda, Maria; Popovic, Miroljub] Univ Murcia, Res Inst Aging, Murcia, Spain	University of Murcia; University of Murcia	Popovic, M (corresponding author), Univ Murcia, Fac Med, Dept Human Anat & Psychobiol, Murcia, Spain.	miroljub@um.es	Bleda, Maria Caballero/L-5394-2014; Popovic, Natalija/L-5377-2014; Popovic, Miroljub/L-5320-2014	Bleda, Maria Caballero/0000-0002-9900-9819; Popovic, Natalija/0000-0003-2930-4035; Popovic, Miroljub/0000-0002-1326-3876	Consejeria de Sanidad, Region de Murcia, Spain	Consejeria de Sanidad, Region de Murcia, Spain	Funding for this study was provided by the Consejeria de Sanidad, Region de Murcia, Spain (MCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostaras SG, 1999, NEUROPSYCHOPHARMACOL, V21, P731, DOI 10.1016/S0893-133X(99)00083-4; Blake MG, 2011, PHYSIOL BEHAV, V102, P332, DOI 10.1016/j.physbeh.2010.11.026; Brodkin J, 1999, BEHAV PHARMACOL, V10, P445, DOI 10.1097/00008877-199909000-00002; CANDLAND DK, 1969, ANN NY ACAD SCI, V159, P831, DOI 10.1111/j.1749-6632.1969.tb12982.x; CERBONE A, 1994, NEUROSCI BIOBEHAV R, V18, P497, DOI 10.1016/0149-7634(94)90004-3; DUNN AJ, 1979, SCIENCE, V203, P281, DOI 10.1126/science.216073; Giovannini MG, 2001, NEUROSCIENCE, V106, P43, DOI 10.1016/S0306-4522(01)00266-4; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; Miranda MI, 2009, BEHAV BRAIN RES, V202, P19, DOI 10.1016/j.bbr.2009.03.008; Klinkenberg I, 2010, NEUROSCI BIOBEHAV R, V34, P1307, DOI 10.1016/j.neubiorev.2010.04.001; Kucuk A, 2008, BEHAV BRAIN RES, V195, P147, DOI 10.1016/j.bbr.2008.05.023; Larauche M, 2009, J PHYSIOL PHARMACOL, V60, P33; Leussis MP, 2006, NEUROSCI BIOBEHAV R, V30, P1045, DOI 10.1016/j.neubiorev.2006.03.006; Micheau J, 2011, BEHAV BRAIN RES, V221, P424, DOI 10.1016/j.bbr.2010.11.052; Molinengo L, 1999, PHARMACOL BIOCHEM BE, V63, P221, DOI 10.1016/S0091-3057(98)00229-9; PAN SY, 1995, ACTA PHARM SINIC, V16, P125; Pepeu G, 2010, CHEM-BIOL INTERACT, V187, P403, DOI 10.1016/j.cbi.2009.11.018; PLATEL A, 1982, PSYCHOPHARMACOLOGY, V78, P346, DOI 10.1007/BF00433739; RUSH DK, 1988, BEHAV NEURAL BIOL, V50, P255, DOI 10.1016/S0163-1047(88)90938-7; Schildein S, 2000, NEUROBIOL LEARN MEM, V73, P21, DOI 10.1006/nlme.1999.3915; Thiel CM, 1998, NEUROSCIENCE, V85, P1253, DOI 10.1016/S0306-4522(98)00030-X; UKAI M, 1994, GEN PHARMACOL, V25, P433, DOI 10.1016/0306-3623(94)90193-7; UKAI M, 1994, GEN PHARMACOL, V25, P179, DOI 10.1016/0306-3623(94)90030-2; Zhou W, 2009, NUTR NEUROSCI, V12, P57, DOI 10.1179/147683009X388832	26	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100348	10.1371/journal.pone.0100348	http://dx.doi.org/10.1371/journal.pone.0100348			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936785	gold, Green Published, Green Submitted			2022-12-25	WOS:000338503400107
J	Shindo, A; Tanemura, H; Yata, K; Hamada, K; Shibata, M; Umeda, Y; Asakura, F; Toma, N; Sakaida, H; Fujisawa, T; Taki, W; Tomimoto, H				Shindo, Akihiro; Tanemura, Hiroshi; Yata, Kenichiro; Hamada, Kazuhide; Shibata, Masunari; Umeda, Yasuyuki; Asakura, Fumio; Toma, Naoki; Sakaida, Hiroshi; Fujisawa, Takao; Taki, Waro; Tomimoto, Hidekazu			Inflammatory Biomarkers in Atherosclerosis: Pentraxin 3 Can Become a Novel Marker of Plaque Vulnerability	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INTERCELLULAR-ADHESION MOLECULE-1; ACUTE CORONARY SYNDROMES; INTIMA-MEDIA THICKNESS; SOLUBLE E-SELECTIN; ISCHEMIC-STROKE; HIGH-RISK; CAROTID ATHEROSCLEROSIS; EXPRESSION; LESIONS	Inflammation is crucially involved in the development of carotid plaques. We examined the relationship between plaque vulnerability and inflammatory biomarkers using intraoperative blood and tissue specimens. We examined 58 patients with carotid stenosis. Following carotid plaque magnetic resonance imaging, 41 patients underwent carotid artery stenting (CAS) and 17 underwent carotid endarterectomy (CEA). Blood samples were obtained from the femoral artery (systemic) and common carotid artery immediately before and after CAS (local). Seventeen resected CEA tissue samples were embedded in paraffin, and histopathological and immunohistochemical analyses for IL-6, IL-10, E-selectin, adiponectin, and pentraxin 3 (PTX3) were performed. Serum levels of IL-6, IL-1 beta, IL-10, TNF alpha, E-selectin, VCAM-1, adiponectin, hs-CRP, and PTX3 were measured by multiplex bead array system and ELISA. CAS-treated patients were classified as stable plaques (n = 21) and vulnerable plaques (n = 20). The vulnerable group showed upregulation of the proinflammatory cytokines (IL-6 and TNF alpha), endothelial activation markers (E-selectin and VCAM-1), and inflammation markers (hs-CRP and PTX3) and downregulation of the anti-inflammatory markers (adiponectin and IL-10). PTX3 levels in both systemic and intracarotid samples before and after CAS were higher in the vulnerable group than in the stable group. Immunohistochemical analysis demonstrated that IL-6 was localized to inflammatory cells in the vulnerable plaques, and PTX3 was observed in the endothelial and perivascular cells. Our findings reveal that carotid plaque vulnerability is modulated by the upregulation and downregulation of proinflammatory and anti-inflammatory factors, respectively. PTX3 may thus be a potential predictive marker of plaque vulnerability.	[Shindo, Akihiro; Yata, Kenichiro; Shibata, Masunari; Tomimoto, Hidekazu] Mie Univ, Dept Neurol, Grad Sch Med, Tsu, Mie 514, Japan; [Tanemura, Hiroshi; Hamada, Kazuhide; Umeda, Yasuyuki; Asakura, Fumio; Toma, Naoki; Sakaida, Hiroshi; Taki, Waro] Mie Univ, Dept Neurosurg, Grad Sch Med, Tsu, Mie 514, Japan; [Fujisawa, Takao] Mie Natl Hosp, Inst Clin Res, Tsu, Mie, Japan	Mie University; Mie University	Shindo, A (corresponding author), Mie Univ, Dept Neurol, Grad Sch Med, 2-174 Edobasih, Tsu, Mie 514, Japan.	a-shindo@clin.medic.mie-u.ac.jp			Ministry of Health Labour and Welfare, Japan	Ministry of Health Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a grant-in-aid for Comprehensive Research on Aging and Health (HT) from the Ministry of Health Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2010, J CEREBR BLOOD F MET, V30, P857, DOI 10.1038/jcbfm.2009.250; Blann AD, 1996, CORONARY ARTERY DIS, V7, P143, DOI 10.1097/00019501-199602000-00008; Bonacina F, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/725102; Cai JM, 2002, CIRCULATION, V106, P1368, DOI 10.1161/01.CIR.0000028591.44554.F9; Cao JJ, 2003, CIRCULATION, V108, P166, DOI 10.1161/01.CIR.0000079160.07364.6A; Crouse JR, 2006, J LIPID RES, V47, P1677, DOI 10.1194/jlr.R600012-JLR200; Davies MJ, 1996, CIRCULATION, V94, P2013, DOI 10.1161/01.CIR.94.8.2013; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; DEVRIES JE, 1995, ANN MED, V27, P537, DOI 10.3109/07853899509002465; El-Mesallamy HO, 2011, MINERVA ENDOCRINOL, V36, P163; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Folco EJ, 2009, J BIOL CHEM, V284, P25569, DOI 10.1074/jbc.M109.019786; Gardener H, 2012, STROKE, V43, P1123, DOI 10.1161/STROKEAHA.111.641761; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Hermus L, 2011, CLIN BIOCHEM, V44, P1292, DOI 10.1016/j.clinbiochem.2011.08.1141; Kumada M, 2004, CIRCULATION, V109, P2046, DOI 10.1161/01.CIR.0000127953.98131.ED; Libby P, 2002, SCI AM, V286, P47; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Matsuura Y, 2012, J ATHEROSCLER THROMB, V19, P837, DOI 10.5551/jat.12526; MORENO PR, 1994, CIRCULATION, V90, P775, DOI 10.1161/01.CIR.90.2.775; Norata GD, 2010, TRENDS CARDIOVAS MED, V20, P35, DOI 10.1016/j.tcm.2010.03.005; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; OBrien KD, 1996, CIRCULATION, V93, P672, DOI 10.1161/01.CIR.93.4.672; Profumo E, 2007, ATHEROSCLEROSIS, V191, P340, DOI 10.1016/j.atherosclerosis.2006.03.030; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rolph MS, 2002, ARTERIOSCL THROM VAS, V22, pE10, DOI 10.1161/01.ATV.0000015595.95497.2F; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ryu WS, 2012, ATHEROSCLEROSIS, V220, P581, DOI 10.1016/j.atherosclerosis.2011.11.036; Saam T, 2007, RADIOLOGY, V244, P64, DOI 10.1148/radiol.2441051769; Sakurai S, 2009, J ATHEROSCLER THROMB, V16, P339, DOI 10.5551/jat.No182; Savchenko AS, 2008, J PATHOL, V215, P48, DOI 10.1002/path.2314; Shenhar-Tsarfaty S, 2010, INT J STROKE, V5, P16, DOI 10.1111/j.1747-4949.2009.00396.x; Singh U, 2006, ARTERIOSCL THROM VAS, V26, P2469, DOI 10.1161/01.ATV.0000241572.05292.fb; Stary HC, 2000, ARTERIOSCL THROM VAS, V20, P1177, DOI 10.1161/01.ATV.20.5.1177; Tanemura H, 2013, STROKE, V44, P105, DOI 10.1161/STROKEAHA.112.663138; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Wang JYJ, 2006, CEREBROVASC DIS, V21, P67, DOI 10.1159/000090005; Wozniak SE, 2009, DIGEST DIS SCI, V54, P1847, DOI 10.1007/s10620-008-0585-3; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; Yuan C, 2008, J NUCL CARDIOL, V15, P266, DOI 10.1016/j.nuclcard.2008.02.001	41	61	70	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100045	10.1371/journal.pone.0100045	http://dx.doi.org/10.1371/journal.pone.0100045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936646	gold, Green Published, Green Submitted			2022-12-25	WOS:000338503400066
J	Wang, ND; Rizvydeen, S; Vahedi, M; Gonzalez, DMV; Allred, AL; Perry, DW; Mirabito, PM; Kirk, KE				Wang, Nengding; Rizvydeen, Saajidha; Vahedi, Mithaq; Gonzalez, Daysi M. Vargas; Allred, Amanda L.; Perry, Dustin W.; Mirabito, Peter M.; Kirk, Karen E.			Novel Telomere-Anchored PCR Approach for Studying Sexual Stage Telomeres in Aspergillus nidulans	PLOS ONE			English	Article							CHROMOSOME ENDS; MEIOTIC SPINDLE; LENGTH; LOOPS; ORGANIZATION; NUCLEOTIDES; GENERATION; SEQUENCE; COMPLEX; ORYZAE	Telomere length varies between germline and somatic cells of the same organism, leading to the hypothesis that telomeres are lengthened during meiosis. However, little is known about the meiotic telomere length in many organisms. In the filamentous fungus Aspergillus nidulans, the telomere lengths in hyphae and asexual spores are invariant. No study using existing techniques has determined the telomere length of the sexual ascospores due to the relatively low abundance of pure meiotic cells in A. nidulans and the small quantity of DNA present. To address this, we developed a simple and sensitive PCR strategy to measure the telomere length of A. nidulans meiotic cells. This novel technique, termed "telomere-anchored PCR,'' measures the length of the telomere on chromosome II-L using a small fraction of the DNA required for the traditional terminal restriction fragment (TRF) Southern analysis. Using this approach, we determined that the A. nidulans ascospore telomere length is virtually identical to telomeres of other cell types from this organism, approximately 110 bp, indicating that a surprisingly strict telomere length regulation exists in the major cell types of A. nidulans. When the hyphal telomeres were measured in a telomerase reverse transcriptase (TERT) knockout strain, small decreases in length were readily detected. Thus, this technique can detect telomeres in relatively rare cell types and is particularly sensitive in measuring exceptionally short telomeres. This rapid and inexpensive telomere-anchored PCR method potentially can be utilized in other filamentous fungi and types of organisms.	[Wang, Nengding; Rizvydeen, Saajidha; Vahedi, Mithaq; Gonzalez, Daysi M. Vargas; Allred, Amanda L.; Kirk, Karen E.] Lake Forest Coll, Dept Biol, Lake Forest, IL 60045 USA; [Perry, Dustin W.; Mirabito, Peter M.] Univ Kentucky, Dept Biol, Lexington, KY USA	University of Kentucky	Kirk, KE (corresponding author), Lake Forest Coll, Dept Biol, Lake Forest, IL 60045 USA.	kirk@lakeforest.edu			National Science Foundation [MCB 0950957]; Direct For Biological Sciences [0950957] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant from the National Science Foundation (nsf.gov) MCB 0950957 to Karen E. Kirk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Baird DM, 2005, EXP GERONTOL, V40, P363, DOI 10.1016/j.exger.2005.02.008; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; BARRATT RW, 1965, GENETICS, V52, P233; Baumann P, 2010, FEBS LETT, V584, P3779, DOI 10.1016/j.febslet.2010.05.024; Bekaert S, 2004, DEV BIOL, V274, P15, DOI 10.1016/j.ydbio.2004.06.023; Bhattacharyya A, 1997, NUCLEIC ACIDS RES, V25, P1426, DOI 10.1093/nar/25.7.1426; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Cesare AJ, 2008, MOL CELL BIOL, V28, P20, DOI 10.1128/MCB.01122-07; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Ferreira MG, 2004, MOL CELL, V13, P7, DOI 10.1016/S1097-2765(03)00531-8; Forstemann K, 2000, NUCLEIC ACIDS RES, V28, P2690, DOI 10.1093/nar/28.14.2690; Friedman KL, 2003, MOL BIOL CELL, V14, P1, DOI 10.1091/mbc.E02-06-0327; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Heacock M, 2004, EMBO J, V23, P2304, DOI 10.1038/sj.emboj.7600236; Jacob NK, 2003, MOL CELL, V11, P1021, DOI 10.1016/S1097-2765(03)00131-X; Jain D, 2010, ANNU REV GENET, V44, P243, DOI 10.1146/annurev-genet-102108-134841; Keefe DL, 2006, CURR OPIN OBSTET GYN, V18, P280, DOI 10.1097/01.gco.0000193019.05686.49; KIRK KE, 1995, GENE DEV, V9, P59, DOI 10.1101/gad.9.1.59; Kuprys PV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058661; Kusumoto KI, 2003, APPL MICROBIOL BIOT, V61, P247, DOI 10.1007/s00253-002-1193-3; Lin KW, 2005, J CELL MOL MED, V9, P977, DOI 10.1111/j.1582-4934.2005.tb00395.x; Maniatis T., 1982, MOL CLONING LAB MANU; Murti KG, 1999, P NATL ACAD SCI USA, V96, P14436, DOI 10.1073/pnas.96.25.14436; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Osmani AH, 2006, NAT PROTOC, V1, P2517, DOI 10.1038/nprot.2006.406; Pitt CW, 2004, J CELL SCI, V117, P199, DOI 10.1242/jcs.00844; Qi XD, 2013, NUCLEIC ACIDS RES, V41, P450, DOI 10.1093/nar/gks980; Rehmeyer C, 2006, NUCLEIC ACIDS RES, V34, P4685, DOI 10.1093/nar/gkl588; Saint-Andre CD, 2008, BIOCHIMIE, V90, P181, DOI 10.1016/j.biochi.2007.08.0; Sanchez-Alonso P, 2008, FUNGAL GENET BIOL, V45, pS54, DOI 10.1016/j.fgb.2008.04.009; Schaetzlein S, 2004, P NATL ACAD SCI USA, V101, P8034, DOI 10.1073/pnas.0402400101; Sfeir AJ, 2005, CELL CYCLE, V4, P1467, DOI 10.4161/cc.4.11.2161; Sfeir AJ, 2005, MOL CELL, V18, P131, DOI 10.1016/j.molcel.2005.02.035; Siderakis M, 2007, CHROMOSOME RES, V15, P667, DOI 10.1007/s10577-007-1149-7; Todd RB, 2007, NAT PROTOC, V2, P811, DOI 10.1038/nprot.2007.112; Tomita K, 2007, CELL, V130, P113, DOI 10.1016/j.cell.2007.05.024; Tomita K, 2013, EMBO REP, V14, P252, DOI 10.1038/embor.2012.218; Wei C, 2003, CELL MOL LIFE SCI, V60, P2283, DOI 10.1007/s00018-003-3244-z; Wu C, 2009, GENETICS, V181, P1129, DOI 10.1534/genetics.107.084392; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004	42	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99491	10.1371/journal.pone.0099491	http://dx.doi.org/10.1371/journal.pone.0099491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927411	gold, Green Published			2022-12-25	WOS:000338278100046
J	Kother, K; Nordhoff, C; Masemann, D; Varga, G; Bream, JH; Gaestel, M; Wixler, V; Ludwig, S				Koether, Katharina; Nordhoff, Carolin; Masemann, Doerthe; Varga, Georg; Bream, Jay H.; Gaestel, Matthias; Wixler, Viktor; Ludwig, Stephan			MAPKAP kinase 3 suppresses Ifng gene expression and attenuates NK cell cytotoxicity and Th1 CD4 T-cell development upon influenza A virus infection	FASEB JOURNAL			English	Article						interferon-gamma; signal transduction; innate and adaptive immune response	ACTIVATED PROTEIN-KINASE; PHOSPHORYLATION SITES; GAMMA EXPRESSION; IN-VIVO; 3PK; PROTEIN-KINASE-2; RESPONSES; PATHWAY; MICE; MK2	MK2 and MK3 are downstream targets of p38 and ERK1/2. They control the mRNA stability of several inflammatory cytokines, including TNF-alpha and IL-10. Whereas MK2 is expressed ubiquitously, the expression of MK3 is restricted to muscle, liver, and heart tissues and T and NK cells. Using Mk-deficient and wild-type (WT) mice, we demonstrated an inhibitory effect of MK3, but not of MK2, on interferon (IFN)-gamma expression in T and NK lymphocytes. The results provided evidence that the inhibitory effect of MK3 is based on negative feedback phosphorylation of p38 and ERK1/2, which causes decreased binding of Stat4 to the IFN-gamma promoter and reduced expression of IFN-gamma mRNA and protein. Consequently, all Mk3(-/-) mice challenged with the Th1-inducing influenza A virus (IAV) survived the WT LD50 virus dose. The reduced disease severity in the Mk3(-/-) mice was accompanied by a > 10-fold reduction in viral lung titer and an increase in the number of activated NK cells and enhanced Th1 activation of CD4 T cells. Thus, our data describe the protein kinase MK3 as a novel regulator of the innate and adaptive immune responses.	[Koether, Katharina; Nordhoff, Carolin; Masemann, Doerthe; Wixler, Viktor; Ludwig, Stephan] Univ Munster, Ctr Mol Biol Inflammat ZMBE, IMV, D-48149 Munster, Germany; [Varga, Georg] Univ Munster, Dept Pediat Rheumatol & Immunol, D-48149 Munster, Germany; [Bream, Jay H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Gaestel, Matthias] Hannover Med Sch, Inst Biochem, Hannover, Germany; [Wixler, Viktor; Ludwig, Stephan] Univ Munster, Interdisciplinary Ctr Clin Res IZKF, D-48149 Munster, Germany	University of Munster; University of Munster; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Hannover Medical School; University of Munster	Ludwig, S (corresponding author), Univ Munster, Ctr Mol Biol Inflammat ZMBE, IMV, Von Esmarch Str 56, D-48149 Munster, Germany.	ludwigs@uni-muenster.de	Gaestel, Matthias/A-6560-2013	Gaestel, Matthias/0000-0002-4944-4652; Ludwig, Stephan/0000-0003-4490-3052; Bream, Jay/0000-0002-9149-7643	Interdisciplinary Center of Clinical Research (IZKF) at the University of Munster [Lud2/010/11, Lud2/017/13]; Graduate School [GRK1409]; Collaborative Research Center [SFB1009]; Deutsche Forschungsgemeinschaft (DFG); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070594, R56AI070594] Funding Source: NIH RePORTER	Interdisciplinary Center of Clinical Research (IZKF) at the University of Munster; Graduate School; Collaborative Research Center; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge Ludmilla Wixler (University of Munster, Germany) for generation of the IFN-gamma reporter gene construct. This work was supported by the Interdisciplinary Center of Clinical Research (IZKF) at the University of Munster, (grants Lud2/010/11 and Lud2/017/13), as well as by the Graduate School GRK1409 and the Collaborative Research Center SFB1009, funded by the Deutsche Forschungsgemeinschaft (DFG).	BAUMGARTH N, 1994, J VIROL, V68, P7575, DOI 10.1128/JVI.68.11.7575-7581.1994; Baumgarth N, 1996, J VIROL, V70, P4411, DOI 10.1128/JVI.70.7.4411-4418.1996; BENLEVY R, 1995, EMBO J, V14, P5920, DOI 10.1002/j.1460-2075.1995.tb00280.x; Bream JH, 2003, BLOOD, V102, P207, DOI 10.1182/blood-2002-08-2602; Clifton AD, 1996, FEBS LETT, V392, P209, DOI 10.1016/0014-5793(96)00816-2; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; ENGEL K, 1995, J BIOL CHEM, V270, P27213, DOI 10.1074/jbc.270.45.27213; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Guess AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054239; Guo HL, 2009, IMMUNOL CELL BIOL, V87, P579, DOI 10.1038/icb.2009.60; Hegen M, 2006, J IMMUNOL, V177, P1913, DOI 10.4049/jimmunol.177.3.1913; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Johnson PA, 2000, J GEN VIROL, V81, P1737, DOI 10.1099/0022-1317-81-7-1737; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kondadasula SV, 2008, BLOOD, V111, P4173, DOI 10.1182/blood-2007-01-068908; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Liu TG, 2007, AM J RESP CELL MOL, V37, P507, DOI 10.1165/rcmb.2007-0077OC; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; Ludwig S, 1996, MOL CELL BIOL, V16, P6687; Luig C, 2010, FASEB J, V24, P4068, DOI 10.1096/fj.10-158766; Mainiero F, 1998, J EXP MED, V188, P1267, DOI 10.1084/jem.188.7.1267; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Ogilvie RL, 2009, J BIOL CHEM, V284, P11216, DOI 10.1074/jbc.M901229200; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Prickaerts P, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-12; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Seternes OM, 2004, EMBO J, V23, P4780, DOI 10.1038/sj.emboj.7600489; Sithanandam G, 1996, MOL CELL BIOL, V16, P868; Soutto M, 2002, J IMMUNOL, V169, P4205, DOI 10.4049/jimmunol.169.8.4205; Tudor C, 2009, FEBS LETT, V583, P1933, DOI 10.1016/j.febslet.2009.04.039; Visconti R, 2000, BLOOD, V96, P1844, DOI 10.1182/blood.V96.5.1844.h8001844_1844_1852; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Weiss ID, 2010, J INTERF CYTOK RES, V30, P439, DOI 10.1089/jir.2009.0084; Young HA, 2007, CURR TOP MICROBIOL, V316, P97; Zakowski V, 2004, EXP CELL RES, V299, P101, DOI 10.1016/j.yexcr.2004.05.027; Zhao WP, 2011, J INTERF CYTOK RES, V31, P629, DOI 10.1089/jir.2010.0154	40	8	8	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4235	4246		10.1096/fj.14-249599	http://dx.doi.org/10.1096/fj.14-249599			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	24935968	Green Published			2022-12-25	WOS:000342222700005
J	Nifoussi, SK; Ratcliffe, NR; Ornstein, DL; Kasof, G; Strack, S; Craig, RW				Nifoussi, Shanna K.; Ratcliffe, Nora R.; Ornstein, Deborah L.; Kasof, Gary; Strack, Stefan; Craig, Ruth W.			Inhibition of Protein Phosphatase 2A (PP2A) Prevents Mcl-1 Protein Dephosphorylation at the Thr-163/Ser-159 Phosphodegron, Dramatically Reducing Expression in Mcl-1-amplified Lymphoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE; BCL-XL; C-MYC; SIGNALING PATHWAYS; CATALYTIC SUBUNIT; INDUCED APOPTOSIS; TARGETING MCL-1; ALPHA-SUBUNIT; BREAST-CANCER; OKADAIC ACID	Abundant, sustained expression of prosurvival Mcl-1 is an important determinant of viability and drug resistance in cancer cells. The Mcl-1 protein contains PEST sequences (enriched in proline, glutamic acid, serine, and threonine) and is normally subject to rapid turnover via multiple different pathways. One of these pathways involves a phosphodegron in the PEST region, where Thr-163 phosphorylation primes for Ser-159 phosphorylation by glycogen synthase kinase-3. Turnover via this phosphodegron-targeted pathway is reduced in Mcl-1-overexpressing BL41-3 Burkitt lymphoma and other cancer cells; turnover is further slowed in the presence of phorbol ester-induced ERK activation, resulting in Mcl-1 stabilization and an exacerbation of chemoresistance. The present studies focused on Mcl-1 dephosphorylation, which was also found to profoundly influence turnover. Exposure of BL41-3 cells to an inhibitor of protein phosphatase 2A (PP2A), okadaic acid, resulted in a rapid increase in phosphorylation at Thr-163 and Ser-159, along with a precipitous decrease in Mcl-1 expression. The decline in Mcl-1 expression preceded the appearance of cell death markers and was not slowed in the presence of phorbol ester. Upon exposure to calyculin A, which also potently inhibits PP2A, versus tautomycin, which does not, only the former increased Thr163/Ser-159 phosphorylation and decreased Mcl-1 expression. Mcl-1 co-immunoprecipitated with PP2A upon transfection into CHO cells, and PP2A/A alpha knockdown recapitulated the increase in Mcl-1 phosphorylation and decrease in expression. In sum, inhibition of PP2A prevents Mcl-1 dephosphorylation and results in rapid loss of this prosurvival protein in chemoresistant cancer cells.	[Nifoussi, Shanna K.; Craig, Ruth W.] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA; [Ratcliffe, Nora R.; Ornstein, Deborah L.] Geisel Sch Med Dartmouth, Dept Pathol, Hanover, NH 03755 USA; [Nifoussi, Shanna K.; Craig, Ruth W.] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA; [Ratcliffe, Nora R.] Vet Affairs Med Ctr, White River Jct, VT 05001 USA; [Kasof, Gary] Cell Signaling Technol, Danvers, MA 01923 USA; [Strack, Stefan] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA	Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Iowa	Craig, RW (corresponding author), Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, 1 Rope Ferry Rd, Hanover, NH 03755 USA.	Ruth.W.Craig@Dartmouth.edu		Strack, Stefan/0000-0002-6175-7280	National Institutes of Health [R01CA057359]; NATIONAL CANCER INSTITUTE [P30CA023108, R01CA057359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01CA057359 (to R. W. C.).	Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Arnold HK, 2008, CANCER METAST REV, V27, P147, DOI 10.1007/s10555-008-9128-9; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BISSONNETTE RP, 1992, NATURE, V359, P552, DOI 10.1038/359552a0; Bononi A, 2011, ENZYME RES, V2011, DOI [10.4061/2011/329098, DOI 10.4061/2011/329098]; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; Cao XB, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-42; Chatfield K, 2004, BIOCHEM BIOPH RES CO, V323, P1313, DOI 10.1016/j.bbrc.2004.09.003; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Cohen NA, 2012, CHEM BIOL, V19, P1175, DOI 10.1016/j.chembiol.2012.07.018; Craig RW, 2002, LEUKEMIA, V16, P444, DOI 10.1038/sj.leu.2402416; Deng XM, 2009, BLOOD, V113, P422, DOI 10.1182/blood-2008-06-165134; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Doi K, 2012, J BIOL CHEM, V287, P10224, DOI 10.1074/jbc.M111.334532; Domina AM, 2000, J BIOL CHEM, V275, P21688, DOI 10.1074/jbc.M000915200; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Einarson Margret B, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4738; Ertel F, 2013, EMBO REP, V14, P328, DOI 10.1038/embor.2013.20; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Foley TD, 2005, BIOCHEM BIOPH RES CO, V330, P1224, DOI 10.1016/j.bbrc.2005.03.108; Foley TD, 2007, NEUROCHEM RES, V32, P1957, DOI 10.1007/s11064-007-9394-x; Foley TD, 2011, NEUROCHEM RES, V36, P232, DOI 10.1007/s11064-010-0310-4; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Germain M, 2011, EMBO J, V30, P395, DOI 10.1038/emboj.2010.327; Harley ME, 2010, EMBO J, V29, P2407, DOI 10.1038/emboj.2010.112; Huang XA, 2006, CYTOM PART A, V69A, P222, DOI 10.1002/cyto.a.20257; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kelly GL, 2014, GENE DEV, V28, P58, DOI 10.1101/gad.232009.113; Kobayashi S, 2007, J BIOL CHEM, V282, P18407, DOI 10.1074/jbc.M610010200; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Lewy DS, 2002, CURR MED CHEM, V9, P2005, DOI 10.2174/0929867023368809; Magiera MM, 2013, CELL DEATH DIFFER, V20, P281, DOI 10.1038/cdd.2012.124; Marriott HM, 2005, J CLIN INVEST, V115, P359, DOI 10.1172/JCI200521766; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Meric-Bernstam F, 2014, MOL CANCER THER, V13, P1382, DOI 10.1158/1535-7163.MCT-13-0482; Moldoveanu T, 2014, TRENDS BIOCHEM SCI, V39, P101, DOI 10.1016/j.tibs.2013.12.006; Morel C, 2009, MOL CELL BIOL, V29, P3845, DOI 10.1128/MCB.00279-09; Nifoussi SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047060; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Okamoto T, 2014, P NATL ACAD SCI USA, V111, P261, DOI 10.1073/pnas.1321259110; Peddaboina C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-541; Quinn BA, 2011, EXPERT OPIN INV DRUG, V20, P1397, DOI 10.1517/13543784.2011.609167; Ren H, 2013, CANCER LETT, V338, P229, DOI 10.1016/j.canlet.2013.03.032; Reynolds JE, 1996, EXP CELL RES, V225, P430, DOI 10.1006/excr.1996.0194; Rooswinkel RW, 2014, BLOOD, V123, P2806, DOI 10.1182/blood-2013-08-519470; Ruvolo PP, 2011, LEUKEMIA, V25, P1711, DOI 10.1038/leu.2011.146; Ruvolo PP, 2002, J BIOL CHEM, V277, P22847, DOI 10.1074/jbc.M201830200; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Seshacharyulu P, 2013, CANCER LETT, V335, P9, DOI 10.1016/j.canlet.2013.02.036; Sio TT, 2014, J HUM GENET, V59, P124, DOI 10.1038/jhg.2013.132; Stewart DP, 2010, MOL CELL BIOL, V30, P3099, DOI 10.1128/MCB.01266-09; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Swingle Mark, 2007, V365, P23; Thomas S, 2013, EXPERT OPIN THER TAR, V17, P61, DOI 10.1517/14728222.2013.733001; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Vrana JA, 2002, CANCER RES, V62, P892; Wei G, 2012, CANCER CELL, V21, P547, DOI 10.1016/j.ccr.2012.02.028; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; WURM FM, 1986, P NATL ACAD SCI USA, V83, P5414, DOI 10.1073/pnas.83.15.5414; YANG T, 1995, J CELL BIOL, V128, P1173, DOI 10.1083/jcb.128.6.1173; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	70	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21950	21959		10.1074/jbc.M114.587873	http://dx.doi.org/10.1074/jbc.M114.587873			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24939844	Green Published, hybrid			2022-12-25	WOS:000340593500012
J	Albareda, M; Pacios, LF; Manyani, H; Rey, L; Brito, B; Imperial, J; Ruiz-Argueso, T; Palacios, JM				Albareda, Marta; Pacios, Luis F.; Manyani, Hamid; Rey, Luis; Brito, Belen; Imperial, Juan; Ruiz-Argueeso, Tomas; Palacios, Jose M.			Maturation of Rhizobium leguminosarum Hydrogenase in the Presence of Oxygen Requires the Interaction of the Chaperone HypC and the Scaffolding Protein HupK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; NIFE-HYDROGENASE; BV VICIAE; LARGE SUBUNIT; ACTIVE-SITE; I-TASSER; IRON; BIOSYNTHESIS; COFACTOR; GENES	[NiFe] hydrogenases are key enzymes for the energy and redox metabolisms of different microorganisms. Synthesis of these metalloenzymes involves a complex series of biochemical reactions catalyzed by a plethora of accessory proteins, many of them required to synthesize and insert the unique NiFe(CN)(2)CO cofactor. HypC is an accessory protein conserved in all [NiFe] hydrogenase systems and involved in the synthesis and transfer of the Fe(CN)(2)CO cofactor precursor. Hydrogenase accessory proteins from bacteria-synthesizing hydrogenase in the presence of oxygen include HupK, a scaffolding protein with a moderate sequence similarity to the hydrogenase large subunit and proposed to participate as an intermediate chaperone in the synthesis of the NiFe cofactor. The endosymbiotic bacterium Rhizobium leguminosarum contains a single hydrogenase system that can be expressed under two different physiological conditions: free-living microaerobic cells (similar to 12 mu M O-2) and bacteroids from legume nodules (similar to 10-100 nM O-2). We have used bioinformatic tools to model HupK structure and interaction of this protein with HypC. Site-directed mutagenesis at positions predicted as critical by the structural analysis have allowed the identification of HupK and HypC residues relevant for the maturation of hydrogenase. Mutant proteins altered in some of these residues show a different phenotype depending on the physiological condition tested. Modeling of HypC also predicts the existence of a stable HypC dimer whose presence was also demonstrated by immunoblot analysis. This study widens our understanding on the mechanisms for metalloenzyme biosynthesis in the presence of oxygen.	[Albareda, Marta; Manyani, Hamid; Rey, Luis; Brito, Belen; Imperial, Juan; Ruiz-Argueeso, Tomas; Palacios, Jose M.] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Madrid 28223, Spain; [Albareda, Marta; Manyani, Hamid; Rey, Luis; Brito, Belen; Imperial, Juan; Ruiz-Argueeso, Tomas; Palacios, Jose M.] Univ Politecn Madrid, Dept Biotecnol, Escuela Tecn Super Ingn Agronomos, Madrid 28223, Spain; [Pacios, Luis F.] Univ Politecn Madrid, Dept Biotecnol, Escuela Tecn Super Ingn Montes, E-28040 Madrid, Spain; [Imperial, Juan] Univ Politecn Madrid, Consejo Super Invest Cient, Ctr Biotecnol Genom Plantas, Madrid 28223, Spain	Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Politecnica de Madrid	Palacios, JM (corresponding author), Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Campus Montegancedo, Madrid 28223, Spain.	jose.palacios@upm.es	Manyani, Hamid/AFE-8060-2022; Rey, Luis/A-3389-2014; Albareda, Marta/A-6549-2017; Ruiz-Argueso, TOMAS-ANDRES/I-1803-2015; imperial, Juan/G-3925-2015; Pacios, Luis F./AAL-6124-2021; Manyani, Hamid/AAE-9636-2022; Palacios, Jose/K-1435-2017; Pacios, Luis F/I-5164-2015	Rey, Luis/0000-0003-3477-6942; Albareda, Marta/0000-0002-4343-4445; Ruiz-Argueso, TOMAS-ANDRES/0000-0001-9118-3065; imperial, Juan/0000-0002-5002-6458; Pacios, Luis F./0000-0002-0585-4289; Pacios, Luis F/0000-0002-0585-4289; PALACIOS ALBERTI, JOSE MANUEL/0000-0002-2541-8812; Manyani Charroudi, Hamid/0000-0001-6129-2092	Spain's MINECO [BIO2010-15301]; Comunidad Autonoma de Madrid; Fundacion Ramon Areces	Spain's MINECO; Comunidad Autonoma de Madrid(Comunidad de Madrid); Fundacion Ramon Areces	This work was supported by projects from Spain's MINECO (BIO2010-15301; to J. M. P.), Comunidad Autonoma de Madrid (Project Microambiente-CM; to T. R.-A.), and Fundacion Ramon Areces (to J. I.).	Albareda M, 2013, J PHYS CHEM B, V117, P13523, DOI 10.1021/jp407574n; Albareda M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-256; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baginsky C, 2005, APPL ENVIRON MICROB, V71, P7536, DOI 10.1128/AEM.71.11.7536-7538.2005; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BATUT J, 1994, ANTON LEEUW INT J G, V66, P129, DOI 10.1007/BF00871636; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Blokesch M, 2002, J MOL BIOL, V324, P287, DOI 10.1016/S0022-2836(02)01070-7; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Brito B, 1997, P NATL ACAD SCI USA, V94, P6019, DOI 10.1073/pnas.94.12.6019; BRITO B, 1995, MOL PLANT MICROBE IN, V8, P235, DOI 10.1094/MPMI-8-0235; BRITO B, 1994, J BACTERIOL, V176, P5297, DOI 10.1128/JB.176.17.5297-5303.1994; Brito B, 2002, APPL ENVIRON MICROB, V68, P2461, DOI 10.1128/AEM.68.5.2461-2467.2002; Burstel I, 2012, J BIOL CHEM, V287, P38845, DOI 10.1074/jbc.M112.376947; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeLano W. L, 2013, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Drapal N, 1998, BIOCHEMISTRY-US, V37, P2941, DOI 10.1021/bi9720078; Evans H., 1988, WORLD CROPS COOL SEA, P777; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; Fritsch J, 2013, NAT REV MICROBIOL, V11, P106, DOI 10.1038/nrmicro2940; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; IMPERIAL J, 1993, MOL MICROBIOL, V9, P1305, DOI 10.1111/j.1365-2958.1993.tb01260.x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Leach MR, 2007, J BIOL CHEM, V282, P16177, DOI 10.1074/jbc.M610834200; Lenz O, 2010, CHEMPHYSCHEM, V11, P1107, DOI 10.1002/cphc.200901002; LEYVA A, 1987, J BACTERIOL, V169, P4929, DOI 10.1128/jb.169.11.4929-4934.1987; Liu S, 2004, PROTEINS, V56, P93, DOI 10.1002/prot.20019; Lubitz W, 2014, CHEM REV, V114, P4081, DOI 10.1021/cr4005814; Ludwig M, 2009, J BIOL CHEM, V284, P2159, DOI 10.1074/jbc.M808488200; Ludwig M, 2009, J BIOL CHEM, V284, P465, DOI 10.1074/jbc.M803676200; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Magalon A, 2000, J BIOL CHEM, V275, P21114, DOI 10.1074/jbc.M000987200; Manyani H, 2005, J BACTERIOL, V187, P7018, DOI 10.1128/JB.187.20.7018-7026.2005; Maroti G, 2010, INT J HYDROGEN ENERG, V35, P3358, DOI 10.1016/j.ijhydene.2009.10.059; Nyilasi A, 2014, INT J HYDROGEN ENERG, V39, P18556, DOI 10.1016/j.ijhydene.2013.12.173; Ogata H, 2010, J MOL BIOL, V402, P428, DOI 10.1016/j.jmb.2010.07.041; Parkin A, 2012, CURR OPIN CHEM BIOL, V16, P26, DOI 10.1016/j.cbpa.2012.01.012; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierik AJ, 1999, J BIOL CHEM, V274, P3331, DOI 10.1074/jbc.274.6.3331; Reissmann S, 2003, SCIENCE, V299, P1067, DOI 10.1126/science.1080972; REY L, 1992, J MOL BIOL, V228, P998, DOI 10.1016/0022-2836(92)90886-O; ROSSMANN R, 1995, EUR J BIOCHEM, V227, P545, DOI 10.1111/j.1432-1033.1995.tb20422.x; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rubio LM, 2008, ANNU REV MICROBIOL, V62, P93, DOI 10.1146/annurev.micro.62.081307.162737; Ruiz-Argueso T, 2000, PROKARYOTIC NITROGEN FIXATION, P489; RUIZARGUESO T, 1978, ARCH MICROBIOL, V116, P113, DOI 10.1007/BF00406025; Sambrook J, 2001, MOL CLONING LAB MANU; Selwood T, 2012, ARCH BIOCHEM BIOPHYS, V519, P131, DOI 10.1016/j.abb.2011.11.020; Shafaat HS, 2013, BBA-BIOENERGETICS, V1827, P986, DOI 10.1016/j.bbabio.2013.01.015; Simon R., 1983, MOL GENETICS BACTERI, V1st ed., P98; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soboh B, 2013, FEBS LETT, V587, P2512, DOI 10.1016/j.febslet.2013.06.055; Soboh B, 2012, BIOCHEM BIOPH RES CO, V424, P158, DOI 10.1016/j.bbrc.2012.06.096; Stiebritz MT, 2012, CHEM SCI, V3, P1739, DOI 10.1039/c2sc01112c; Stripp ST, 2013, BIOCHEMISTRY-US, V52, P3289, DOI 10.1021/bi400302v; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Watanabe S, 2007, MOL CELL, V27, P29, DOI 10.1016/j.molcel.2007.05.039; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	69	5	5	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21217	21229		10.1074/jbc.M114.577403	http://dx.doi.org/10.1074/jbc.M114.577403			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24942742	Green Published, hybrid			2022-12-25	WOS:000340558300002
J	Daniels, RW; Rossano, AJ; Macleod, GT; Ganetzky, B				Daniels, Richard W.; Rossano, Adam J.; Macleod, Gregory T.; Ganetzky, Barry			Expression of Multiple Transgenes from a Single Construct Using Viral 2A Peptides in Drosophila	PLOS ONE			English	Article							FLUORESCENT PROTEINS; CLEAVAGE; VECTORS	Expression of multiple reporter or effector transgenes in the same cell from a single construct is increasingly necessary in various experimental paradigms. The discovery of short, virus-derived peptide sequences that mediate a ribosome-skipping event enables generation of multiple separate peptide products from one mRNA. Here we describe methods and vectors to facilitate easy production of polycistronic-like sequences utilizing these 2A peptides tailored for expression in Drosophila both in vitro and in vivo. We tested the separation efficiency of different viral 2A peptides in cultured Drosophila cells and in vivo and found that the 2A peptides from porcine teschovirus-1 (P2A) and Thosea asigna virus (T2A) worked best. To demonstrate the utility of this approach, we used the P2A peptide to co-express the red fluorescent protein tdTomato and the genetically-encoded calcium indicator GCaMP5G in larval motorneurons. This technique enabled ratiometric calcium imaging with motion correction allowing us to record synaptic activity at the neuromuscular junction in an intact larval preparation through the cuticle. The tools presented here should greatly facilitate the generation of 2A peptide-mediated expression of multiple transgenes in Drosophila.	[Daniels, Richard W.; Ganetzky, Barry] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [Rossano, Adam J.; Macleod, Gregory T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Health San Antonio	Daniels, RW (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.	rwdaniels@wisc.edu		Rossano, Adam/0000-0001-8959-106X; Macleod, Gregory/0000-0003-3782-6968	National Institutes of Health National Institute on Aging [T32 AG000213, R01 AG033620]; National Science Foundation EAGER [IOS-1147467]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS083031, R01NS061914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033620, T32AG000213] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Science Foundation EAGER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by a National Institutes of Health National Institute on Aging training grant T32 AG000213 (R.W.D), R01 AG033620 (BG), and supported in part by a grant from the National Science Foundation EAGER IOS-1147467 (GTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Cattaert D, 2001, J NEUROBIOL, V48, P58, DOI 10.1002/neu.1042; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chouhan AK, 2010, J NEUROSCI, V30, P1869, DOI 10.1523/JNEUROSCI.4701-09.2010; Diao FQ, 2012, GENETICS, V190, P1139, DOI 10.1534/genetics.111.136291; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Gonzalez M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00075; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Inagaki HK, 2012, CELL, V148, P583, DOI 10.1016/j.cell.2011.12.022; KAUFMAN RJ, 1991, NUCLEIC ACIDS RES, V19, P4485, DOI 10.1093/nar/19.16.4485; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Le T, 2007, BIOTECHNIQUES, V42, P162, DOI 10.2144/000112386; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Masuyama K, 2012, J NEUROGENET, V26, P89, DOI 10.3109/01677063.2011.642910; Minskaia E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/291730; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Rossano AJ, 2013, J PHYSIOL-LONDON, V591, P1691, DOI 10.1113/jphysiol.2012.248377; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	25	73	78	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100637	10.1371/journal.pone.0100637	http://dx.doi.org/10.1371/journal.pone.0100637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945148	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500101
J	Jemec, GBE; Kerihuel, JC; Ousey, K; Lauemoller, SL; Leaper, DJ				Jemec, Gregor B. E.; Kerihuel, Jean Charles; Ousey, Karen; Lauemoller, Sanne Lise; Leaper, David John			Cost-Effective Use of Silver Dressings for the Treatment of Hard-to-Heal Chronic Venous Leg Ulcers	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CHRONIC WOUNDS; COMPRESSION; PREVALENCE; MANAGEMENT; ETIOLOGY; VULCAN	Aim: To estimate the cost-effectiveness of silver dressings using a health economic model based on time-to-wound-healing in hard-to-heal chronic venous leg ulcers (VLUs). Background: Chronic venous ulceration affects 1-3% of the adult population and typically has a protracted course of healing, resulting in considerable costs to the healthcare system. The pathogenesis of VLUs includes excessive and prolonged inflammation which is often related to critical colonisation and early infection. The use of silver dressings to control this bioburden and improve wound healing rates remains controversial. Methods: A decision tree was constructed to evaluate the cost-effectiveness of treatment with silver compared with non-silver dressings for four weeks in a primary care setting. The outcomes: 'Healed ulcer', 'Healing ulcer' or 'No improvement' were developed, reflecting the relative reduction in ulcer area from baseline to four weeks of treatment. A data set from a recent meta-analysis, based on four RCTs, was applied to the model. Results: Treatment with silver dressings for an initial four weeks was found to give a total cost saving (141.57) pound compared with treatment with non-silver dressings. In addition, patients treated with silver dressings had a faster wound closure compared with those who had been treated with non-silver dressings. Conclusion: The use of silver dressings improves healing time and can lead to overall cost savings. These results can be used to guide healthcare decision makers in evaluating the economic aspects of treatment with silver dressings in hard-to-heal chronic VLUs.	[Jemec, Gregor B. E.] Univ Copenhagen, Roskilde Hosp, Fac Hlth Sci, Dept Dermatol, Copenhagen, Denmark; [Kerihuel, Jean Charles] Vertical, Paris, France; [Ousey, Karen; Leaper, David John] Univ Huddersfield, Sch Human & Hlth Sci, Huddersfield HD1 3DH, W Yorkshire, England; [Lauemoller, Sanne Lise] Coloplast AS, Humlebaek, Denmark	University of Copenhagen; University of Huddersfield	Lauemoller, SL (corresponding author), Coloplast AS, Humlebaek, Denmark.	dkslm@coloplast.com	Jemec, Gregor/H-6702-2019; Ousey, Karen/W-1881-2018	Jemec, Gregor/0000-0002-0712-2540; Ousey, Karen/0000-0002-6993-9425	Coloplast A/S	Coloplast A/S	Coloplast A/S funded the work of this study. SLL, employed by Coloplast A/S, participated as an author in the preparation of the manuscript. The funders had no role in study design, data collection and analysis, and decision to publish.	Ashby RL, 2013, LANCET; BAKER SR, 1992, EUR J VASCULAR SURG, V6, P245, DOI 10.1016/S0950-821X(05)80313-5; Barwell JR, 2004, LANCET, V363, P1854, DOI 10.1016/S0140-6736(04)16353-8; Carter MJ, 2010, J AM ACAD DERMATOL, V63, P668, DOI 10.1016/j.jaad.2009.09.007; Chambers H, 2007, WOUND REPAIR REGEN, V15, P165, DOI 10.1111/j.1524-475X.2007.00201.x; CORNWALL JV, 1986, BRIT J SURG, V73, P693, DOI 10.1002/bjs.1800730905; Davies CE, 2007, WOUND REPAIR REGEN, V15, P17, DOI 10.1111/j.1524-475X.2006.00180.x; Gottrup F, 2013, J WOUND CARE, V22, P413, DOI 10.12968/jowc.2013.22.8.413; Gottrup F, 2010, J WOUND CARE, V19, P239; Green Julie, 2010, Br J Community Nurs, V15, pS4; Hermans Michel H, 2007, Adv Skin Wound Care, V20, P166, DOI 10.1097/01.ASW.0000262712.05035.61; International consensus, 2012, WOUNDS INT; Lansdown A B G, 2002, J Wound Care, V11, P125; Leaper D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067083; Leaper D, 2012, INT WOUND J, V9, P461, DOI 10.1111/j.1742-481X.2012.01091.x; Leaper D, 2011, INT WOUND J, V8, P1, DOI 10.1111/j.1742-481X.2010.00766.x; Leaper David J, 2006, Int Wound J, V3, P282, DOI 10.1111/j.1742-481X.2006.00265.x; Leaper DJ, 2012, INT WOUND J, V9, P1, DOI 10.1111/j.1742-481X.2012.01097.x; Lo SF, 2008, J CLIN NURS, V17, P1973, DOI 10.1111/j.1365-2702.2007.02264.x; Lo SF, 2009, J CLIN NURS, V18, P716, DOI 10.1111/j.1365-2702.2008.02534.x; Maddox Debbie, 2012, Nurs Stand, V26, P42; Margolis DJ, 2002, J AM ACAD DERMATOL, V46, P381, DOI 10.1067/mjd.2002.121739; Margolis DJ, 2000, AM J MED, V109, P15, DOI 10.1016/S0002-9343(00)00379-X; Michaels JA, 2009, BRIT J SURG, V96, P1147, DOI 10.1002/bjs.6786; Scanlon Elizabeth, 2005, Int Wound J, V2, P150, DOI 10.1111/j.1742-4801.2005.00083.x; Senet P, 2013, INT WOUND J; Storm-Versloot MN, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006478.pub2; Trengove NJ, 2000, WOUND REPAIR REGEN, V8, P13, DOI 10.1046/j.1524-475x.2000.00013.x; Vermeulen H, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005486.pub2; Vowden K, 2009, J Wound Care, V18, P93; White RJ, 2006, OSTOMY WOUND MANAG, V52, P50	31	13	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100582	10.1371/journal.pone.0100582	http://dx.doi.org/10.1371/journal.pone.0100582			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945381	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000340721500094
J	Casaleggio, A; Hines, ML; Migliore, M				Casaleggio, Aldo; Hines, Michael L.; Migliore, Michele			Computational Model of Erratic Arrhythmias in a Cardiac Cell Network: The Role of Gap Junctions	PLOS ONE			English	Article							REENTRANT VENTRICULAR-TACHYCARDIA; OPEN-CHEST DOGS; ATRIAL-FIBRILLATION; MYOCARDIAL-ISCHEMIA; ION CHANNELS; HUMAN HEART; ELECTROPHYSIOLOGY; CONNEXINS; MUSCLE; TISSUE	Cardiac morbidity and mortality increases with the population age. To investigate the underlying pathological mechanisms, and suggest new ways to reduce clinical risks, computational approaches complementing experimental and clinical investigations are becoming more and more important. Here we explore the possible processes leading to the occasional onset and termination of the (usually) non-fatal arrhythmias widely observed in the heart. Using a computational model of a two-dimensional network of cardiac cells, we tested the hypothesis that an ischemia alters the properties of the gap junctions inside the ischemic area. In particular, in agreement with experimental findings, we assumed that an ischemic episode can alter the gap junctions of the affected cells by reducing their average conductance. We extended these changes to include random fluctuations with time, and modifications in the gap junction rectifying conductive properties of cells along the edges of the ischemic area. The results demonstrate how these alterations can qualitatively give an account of all the main types of non-fatal arrhythmia observed experimentally, and suggest how premature beats can be eliminated in three different ways: a) with a relatively small surgical procedure, b) with a pharmacological reduction of the rectifying conductive properties of the gap-junctions, and c) by pharmacologically decreasing the gap junction conductance. In conclusion, our model strongly supports the hypothesis that non-fatal arrhythmias can develop from post-ischemic alteration of the electrical connectivity in a relatively small area of the cardiac cell network, and suggests experimentally testable predictions on their possible treatments.	[Casaleggio, Aldo] CNR, Inst Biophys, Genoa, Italy; [Hines, Michael L.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Migliore, Michele] CNR, Inst Biophys, Palermo, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Yale University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Casaleggio, A (corresponding author), CNR, Inst Biophys, Genoa, Italy.	casaleggio@ge.ibf.cnr.it	Migliore, Michele/D-7448-2011	Migliore, Michele/0000-0002-7584-6292	Institute of Biophysics of the National Research Council (Italy); NINDS [R01-NS11613]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011613] Funding Source: NIH RePORTER	Institute of Biophysics of the National Research Council (Italy); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work has been supported by the Institute of Biophysics of the National Research Council (Italy) and by NINDS grant R01-NS11613 to MLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLESSIE MA, 1977, CIRC RES, V41, P9, DOI 10.1161/01.RES.41.1.9; [Anonymous], PROG BIOPHYS MOL BIO, V104, P22; ANUMONWO JMB, 1992, CIRC RES, V71, P229, DOI 10.1161/01.RES.71.2.229; Beardslee MA, 2000, CIRC RES, V87, P656, DOI 10.1161/01.RES.87.8.656; BEELER GW, 1977, J PHYSIOL-LONDON, V268, P177, DOI 10.1113/jphysiol.1977.sp011853; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; Casaleggio A, 2007, EUROPACE, V9, P385, DOI 10.1093/europace/eum050; Ch'en FFT, 1998, PROG BIOPHYS MOL BIO, V69, P515, DOI 10.1016/S0079-6107(98)00023-6; Chaldoupi SM, 2009, CARDIOVASC RES, V84, P15, DOI 10.1093/cvr/cvp203; Chen J, 2000, CARDIOVASC RES, V48, P220, DOI 10.1016/S0008-6363(00)00177-2; Cooper J, 2011, PROG BIOPHYS MOL BIO, V107, P74, DOI 10.1016/j.pbiomolbio.2011.06.002; de Boer TP, 2006, CARDIOVASC RES, V71, P704, DOI 10.1016/j.cardiores.2006.06.001; de Groot JR, 2004, CARDIOVASC RES, V62, P323, DOI 10.1016/j.cardiores.2004.01.033; Desplantez T, 2004, PFLUG ARCH EUR J PHY, V448, P363, DOI 10.1007/s00424-004-1250-0; Dupont E, 2001, CIRCULATION, V103, P842, DOI 10.1161/01.CIR.103.6.842; Eckardt Lars, 2002, Heart Fail Monit, V2, P110; Fontes MSC, 2012, BBA-BIOMEMBRANES, V1818, P2020, DOI 10.1016/j.bbamem.2011.07.039; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Gollob MH, 2006, CURR OPIN CARDIOL, V21, P155, DOI 10.1097/01.hco.0000221574.95383.6f; HAN J, 1964, CIRC RES, V14, P44, DOI 10.1161/01.RES.14.1.44; Hennan JK, 2006, J PHARMACOL EXP THER, V317, P236, DOI 10.1124/jpet.105.096933; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Holzem KM, 2012, EUROPACE, V14, pV50, DOI 10.1093/europace/eus275; Huang XD, 1999, J CARDIOVASC ELECTR, V10, P79, DOI 10.1111/j.1540-8167.1999.tb00645.x; Jalife J, 2000, ANNU REV PHYSIOL, V62, P25, DOI 10.1146/annurev.physiol.62.1.25; Jansen JA, 2010, J MOL CELL CARDIOL, V48, P76, DOI 10.1016/j.yjmcc.2009.08.018; Keldermann RH, 2009, AM J PHYSIOL-HEART C, V296, pH370, DOI 10.1152/ajpheart.00952.2008; Kjolbye AL, 2007, BASIC CLIN PHARMACOL, V101, P215, DOI 10.1111/j.1742-7843.2007.00123.x; KLEBER AG, 1987, CIRC RES, V61, P271, DOI 10.1161/01.RES.61.2.271; LUKE RA, 1991, J CLIN INVEST, V87, P1594, DOI 10.1172/JCI115173; Mines GR, 1914, T R SOC CAN, V8, P43; Moody GA, 2001, IEEE ENG MED BIOL, V20, P45, DOI 10.1109/51.932724; Moreno AP, 2004, CARDIOVASC RES, V62, P276, DOI 10.1016/j.cardiores.2004.03.003; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Pandit SV, 2013, CIRC RES, V112, P849, DOI 10.1161/CIRCRESAHA.111.300158; Peters NS, 1997, CIRCULATION, V95, P988; Prasad SM, 2003, J THORAC CARDIOV SUR, V126, P1822, DOI 10.1016/S0022-5223(03)01287-X; Rackauskas M, 2007, BIOPHYS J, V92, P1952, DOI 10.1529/biophysj.106.099358; Rudy Y, 2006, Q REV BIOPHYS, V39, P57, DOI 10.1017/S0033583506004227; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Spitzer Kenneth W, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS8, DOI 10.1111/j.1540-8167.2006.00379.x; Stevenson WG, 1997, J AM COLL CARDIOL, V29, P1180, DOI 10.1016/S0735-1097(97)00065-X; Takemoto Y, 2012, AM J PHYSIOL-HEART C, V303, pH578, DOI 10.1152/ajpheart.00355.2012; Tchou GD, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-102; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; Vaquero M, 2008, HEART RHYTHM, V5, P872, DOI 10.1016/j.hrthm.2008.02.034; Volman V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020572; Wilhelms M, 2013, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00487; WINFREE AT, 1994, SCIENCE, V266, P1003, DOI 10.1126/science.7973648; Winslow RL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003528; Woie L, 2011, EUROPACE, V13, P864, DOI 10.1093/europace/euq466; Worley SJ, 1998, PACE, V21, P1636, DOI 10.1111/j.1540-8159.1998.tb00253.x; Xing DZ, 2003, J CARDIOVASC ELECTR, V14, P510, DOI 10.1046/j.1540-8167.2003.02329.x; Yang L, 2010, BIOPHYS J, V98, P1428, DOI [10.1016/j.bpj.2009.12.4300, 10.1016/j.bpj.09.12.4300]	56	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100288	10.1371/journal.pone.0100288	http://dx.doi.org/10.1371/journal.pone.0100288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941068	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200090
J	Kawaguchi, M; Satoh, Y; Otsubo, Y; Kazama, T				Kawaguchi, Masanori; Satoh, Yasushi; Otsubo, Yukiko; Kazama, Tomiei			Molecular Hydrogen Attenuates Neuropathic Pain in Mice	PLOS ONE			English	Article							RAT MODEL; THERMAL HYPERALGESIA; NITRIC-OXIDE; WATER; CONSUMPTION; STRESS; ANTIOXIDANT; PREVENTS; GROWTH; GAS	Neuropathic pain remains intractable and the development of new therapeutic strategies are urgently required. Accumulating evidence indicates that overproduction of oxidative stress is a key event in the pathogenesis of neuropathic pain. However, repeated intra-peritoneal or intrathecal injections of antioxidants are unsuitable for continuous use in therapy. Here we show a novel therapeutic method against neuropathic pain: drinking water containing molecular hydrogen (H-2) as antioxidant. The effect of hydrogen on neuropathic pain was investigated using a partial sciatic nerve ligation model in mice. As indicators of neuropathic pain, temporal aspects of mechanical allodynia and thermal hyperalgesia were analysed for 3 weeks after ligation. Mechanical allodynia and thermal hyperalgesia were measured using the von Frey test and the plantar test, respectively. When mice were allowed to drink water containing hydrogen at a saturated level ad libitum after ligation, both allodynia and hyperalgesia were alleviated. These symptoms were also alleviated when hydrogen was administered only for the induction phase (from day 0 to 4 after ligation). When hydrogen was administered only for the maintenance phase (from day 4 to 21 after ligation), hyperalgesia but not allodynia was alleviated. Immunohistochemical staining for the oxidative stress marker, 4-hydroxy-2-nonenal and 8-hydroxydeoxyguanosine, showed that hydrogen administration suppressed oxidative stress induced by ligation in the spinal cord and the dorsal root ganglion. In conclusion, oral administration of hydrogen water may be useful for alleviating neuropathic pain in a clinical setting.	[Kawaguchi, Masanori; Satoh, Yasushi; Otsubo, Yukiko; Kazama, Tomiei] Natl Def Med Coll, Dept Anesthesiol, Tokorozawa, Saitama 359, Japan	National Defense Medical College - Japan	Satoh, Y (corresponding author), Natl Def Med Coll, Dept Anesthesiol, Tokorozawa, Saitama 359, Japan.	wndlt3@gmail.com			JSPS (Japan Society for the Promotion of Science, Tokyo, Japan) [25293331]	JSPS (Japan Society for the Promotion of Science, Tokyo, Japan)	This work was supported by JSPS (Japan Society for the Promotion of Science, Tokyo, Japan; Grant number 25293331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen QB, 2013, CAN J NEUROL SCI, V40, P857, DOI 10.1017/S0317167100016024; Fu Y, 2009, NEUROSCI LETT, V453, P81, DOI 10.1016/j.neulet.2009.02.016; Fujita K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007247; Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165; Ishibashi T, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-27; Janes K, 2012, BBA-MOL BASIS DIS, V1822, P815, DOI 10.1016/j.bbadis.2011.12.008; Khalil Z, 1999, PAIN, V79, P31, DOI 10.1016/S0304-3959(98)00143-2; Kikkawa YS, 2009, NEUROREPORT, V20, P689, DOI 10.1097/WNR.0b013e32832a5c68; Kim HK, 2006, PAIN, V122, P53, DOI 10.1016/j.pain.2006.01.013; Kim HK, 2004, PAIN, V111, P116, DOI 10.1016/j.pain.2004.06.008; Ko YK, 2012, KOREAN J ANESTHESIOL, V62, P558, DOI 10.4097/kjae.2012.62.6.558; Lee I, 2007, PAIN, V133, P9, DOI 10.1016/j.pain.2007.01.035; Liu HJ, 2005, CIRC RES, V97, P967, DOI 10.1161/01.RES.0000188210.72062.10; Meeus M, 2013, EXPERT OPIN THER TAR, V17, P1081, DOI 10.1517/14728222.2013.818657; Murad F, 2004, BIOSCIENCE REP, V24, P452, DOI 10.1007/s10540-005-2741-8; Nagata K, 2009, NEUROPSYCHOPHARMACOL, V34, P501, DOI 10.1038/npp.2008.95; Nakashima-Kamimura N, 2009, CANCER CHEMOTH PHARM, V64, P753, DOI 10.1007/s00280-008-0924-2; Narita M, 2005, J NEUROSCI, V25, P10000, DOI 10.1523/JNEUROSCI.2507-05.2005; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ohsawa I, 2008, BIOCHEM BIOPH RES CO, V377, P1195, DOI 10.1016/j.bbrc.2008.10.156; Otsubo Y, 2012, PAIN, V153, P2241, DOI 10.1016/j.pain.2012.07.020; Sauer H, 2001, CELL PHYSIOL BIOCHEM, V11, P173, DOI 10.1159/000047804; Tal M, 1996, NEUROREPORT, V7, P1382, DOI 10.1097/00001756-199605310-00010; Tao F, 2013, STEM CELLS, V31, P83, DOI 10.1002/stem.1258; Tedesco LS, 2002, PAIN, V95, P215, DOI 10.1016/S0304-3959(01)00402-X; Twining CM, 2004, PAIN, V110, P299, DOI 10.1016/j.pain.2004.04.008; Yanagihara T, 2005, BIOSCI BIOTECH BIOCH, V69, P1985, DOI 10.1271/bbb.69.1985; Yonamine R, 2013, ANESTHESIOLOGY, V118, P105, DOI 10.1097/ALN.0b013e318275146d; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	29	26	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100352	10.1371/journal.pone.0100352	http://dx.doi.org/10.1371/journal.pone.0100352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941001	gold, Green Published, Green Submitted			2022-12-25	WOS:000338508200096
J	Low, VL; Adler, PH; Takaoka, H; Ya'cob, Z; Lim, PE; Tan, TK; Lim, YAL; Chen, CD; Norma-Rashid, Y; Sofian-Azirun, M				Low, Van Lun; Adler, Peter H.; Takaoka, Hiroyuki; Ya'cob, Zubaidah; Lim, Phaik Eem; Tiong Kai Tan; Lim, Yvonne A. L.; Chen, Chee Dhang; Norma-Rashid, Yusoff; Sofian-Azirun, Mohd			Mitochondrial DNA Markers Reveal High Genetic Diversity but Low Genetic Differentiation in the Black Fly Simulium tani Takaoka & Davies along an Elevational Gradient in Malaysia	PLOS ONE			English	Article							POPULATION-GENETICS; DIPTERA; NEUTRALITY; EVOLUTION; GROWTH; TESTS	The population genetic structure of Simulium tani was inferred from mitochondria-encoded sequences of cytochrome c oxidase subunits I (COI) and II (COII) along an elevational gradient in Cameron Highlands, Malaysia. A statistical parsimony network of 71 individuals revealed 71 haplotypes in the COI gene and 43 haplotypes in the COII gene; the concatenated sequences of the COI and COII genes revealed 71 haplotypes. High levels of genetic diversity but low levels of genetic differentiation were observed among populations of S. tani at five elevations. The degree of genetic diversity, however, was not in accordance with an altitudinal gradient, and a Mantel test indicated that elevation did not have a limiting effect on gene flow. No ancestral haplotype of S. tani was found among the populations. Pupae with unique structural characters at the highest elevation showed a tendency to form their own haplotype cluster, as revealed by the COII gene. Tajima's D, Fu's Fs, and mismatch distribution tests revealed population expansion of S. tani in Cameron Highlands. A strong correlation was found between nucleotide diversity and the levels of dissolved oxygen in the streams where S. tani was collected.	[Low, Van Lun; Takaoka, Hiroyuki; Ya'cob, Zubaidah; Lim, Phaik Eem; Chen, Chee Dhang; Norma-Rashid, Yusoff; Sofian-Azirun, Mohd] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Adler, Peter H.] Clemson Univ, Sch Agr Forest & Environm Sci, Clemson, SC USA; [Lim, Phaik Eem] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia; [Tiong Kai Tan; Lim, Yvonne A. L.] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia	Universiti Malaya; Clemson University; Universiti Malaya; Universiti Malaya	Low, VL (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.	lucaslow24@gmail.com	Low, Van Lun/C-8045-2013; LIM, YVONNE AL/B-5276-2010; Ya'cob, Zubaidah/R-4012-2019; Tan, Tiong Kai/F-6565-2013; LIM, Phaik Eem/B-5331-2010; Chen, Chee Dhang/C-6482-2011; Ya'cob, Zubaidah/L-7021-2017; Norma-Rashid, Y/B-8028-2010; Takaoka, Hiroyuki/G-6120-2010; AZIRUN, MOHD SOFIAN/B-9127-2010; Chen, Chee Dhang/ABD-9353-2021	Low, Van Lun/0000-0002-4299-5339; LIM, YVONNE AL/0000-0003-4050-6332; Tan, Tiong Kai/0000-0003-0297-1727; LIM, Phaik Eem/0000-0001-9186-1487; Ya'cob, Zubaidah/0000-0002-7178-6122; Norma-Rashid, Y/0000-0002-1450-1995; 	University of Malaya [RP003C-13SUS, RP003A-13SUS, RG164/12SUS]	University of Malaya(Universiti Malaya)	This work was funded by University of Malaya grants (RP003C-13SUS, RP003A-13SUS and RG164/12SUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler P.H., 2014, WORLD BLACKFLIES DIP; Adler PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070765; Adler PH, 2010, INFECT GENET EVOL, V10, P846, DOI 10.1016/j.meegid.2010.07.003; Ahumada JA, 2004, J MED ENTOMOL, V41, P1157, DOI 10.1603/0022-2585-41.6.1157; Anbalagan S, 2012, BIOLOGIA, V67, P1195, DOI 10.2478/s11756-012-0104-z; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrow CJ, 2009, J ENVIRON MANAGE, V10, P89; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Conflitti IM, 2010, MOL PHYLOGENET EVOL, V57, P245, DOI 10.1016/j.ympev.2010.06.024; Finn DS, 2006, FRESHWATER BIOL, V51, P2240, DOI 10.1111/j.1365-2427.2006.01647.x; Finn DS, 2006, MOL ECOL, V15, P3553, DOI 10.1111/j.1365-294X.2006.03034.x; Fu YX, 1997, GENETICS, V147, P915; GOVINDARAJU DR, 1989, J EVOLUTION BIOL, V2, P173, DOI 10.1046/j.1420-9101.1989.2030173.x; Grunewald J., 1981, P227; Guo QF, 2013, SCI REP-UK, V3, DOI 10.1038/srep03007; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MANTEL N, 1967, CANCER RES, V27, P209; McCain C.M., 2010, ENCY LIFE SCI ELS, DOI 10.1002/9780470015902.a0022548; Millest AL, 1999, MED VET ENTOMOL, V13, P139, DOI 10.1046/j.1365-2915.1999.00158.x; Pramual P, 2005, MOL ECOL, V14, P3989, DOI 10.1111/j.1365-294X.2005.02639.x; Pramual P, 2013, ENTOMOL SCI, V16, P298, DOI 10.1111/ens.12008; Pramual P, 2011, ENTOMOL SCI, V14, P428, DOI 10.1111/j.1479-8298.2011.00465.x; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Saadati N, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-130; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Spehn EM, 2010, DATA MINING FOR GLOBAL TRENDS IN MOUNTAIN BIODIVERSITY, P1; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; TAJIMA F, 1989, GENETICS, V123, P585; Takaoka H, 2012, MED VET ENTOMOL, V26, P372, DOI 10.1111/j.1365-2915.2012.01023.x; Takaoka H., 1995, BLACK FLIES DIPTERA; Tangkawanit U, 2009, ZOOL J LINN SOC-LOND, V155, P289, DOI 10.1111/j.1096-3642.2008.00433.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wei XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066928; Wright S., 1978, EVOLUTION GENETICS P, V4	38	26	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100512	10.1371/journal.pone.0100512	http://dx.doi.org/10.1371/journal.pone.0100512			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941043	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000338508200104
J	Schokker, D; Zhang, J; Zhang, LL; Vastenhouw, SA; Heilig, HGHJ; Smidt, H; Rebel, JMJ; Smits, MA				Schokker, Dirkjan; Zhang, Jing; Zhang, Ling-li; Vastenhouw, Stephanie A.; Heilig, Hans G. H. J.; Smidt, Hauke; Rebel, Johanna M. J.; Smits, Mari A.			Early-Life Environmental Variation Affects Intestinal Microbiota and Immune Development in New-Born Piglets	PLOS ONE			English	Article							PHYLOGENETIC MICROARRAY; GUT MICROBIOTA; STAPHYLOCOCCUS-AUREUS; INNATE IMMUNITY; HOMEOSTASIS; DIVERSITY; CYTOSCAPE; RESPONSES; ESTABLISHMENT; COLONIZATION	Background: Early-life environmental variation affects gut microbial colonization and immune competence development; however, the timing and additional specifics of these processes are unknown. The impact of early-life environmental variations, as experienced under real life circumstances, on gut microbial colonization and immune development has not been studied extensively so far. We designed a study to investigate environmental variation, experienced early after birth, to gut microbial colonization and intestinal immune development. Methodology/Principal Findings: To investigate effects of early-life environmental changes, the piglets of 16 piglet litters were divided into 3 groups per litter and experimentally treated on day 4 after birth. During the course of the experiment, the piglets were kept with their mother sow. Group 1 was not treated, group 2 was treated with an antibiotic, and group 3 was treated with an antibiotic and simultaneously exposed to several routine, but stressful management procedures, including docking, clipping and weighing. Thereafter, treatment effects were measured at day 8 after birth in 16 piglets per treatment group by community-scale analysis of gut microbiota and genome-wide intestinal transcriptome profiling. We observed that the applied antibiotic treatment affected the composition and diversity of gut microbiota and reduced the expression of a large number of immune-related processes. The effect of management procedures on top of the use of an antibiotic was limited. Conclusions/Significance: We provide direct evidence that different early-life conditions, specifically focusing on antibiotic treatment and exposure to stress, affect gut microbial colonization and intestinal immune development. This reinforces the notion that the early phase of life is critical for intestinal immune development, also under regular production circumstances.	[Schokker, Dirkjan; Smits, Mari A.] Wageningen UR Livestock Res, Anim Breeding & Genom Ctr, Lelystad, Netherlands; [Zhang, Jing; Zhang, Ling-li; Heilig, Hans G. H. J.; Smidt, Hauke] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Vastenhouw, Stephanie A.; Rebel, Johanna M. J.; Smits, Mari A.] Cent Vet Inst, Lelystad, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Schokker, D (corresponding author), Wageningen UR Livestock Res, Anim Breeding & Genom Ctr, Lelystad, Netherlands.	dirkjan.schokker@wur.nl	Smidt, Hauke/D-7054-2014; Schokker, Dirkjan/AAB-2668-2020; Schokker, Dirkjan/M-6385-2014; smits, mari/J-4892-2013	Smidt, Hauke/0000-0002-6138-5026; Schokker, Dirkjan/0000-0001-6082-7227; Schokker, Dirkjan/0000-0001-6082-7227; smits, mari/0000-0002-3493-291X; Rebel, Annemarie/0000-0003-4765-4215	Dutch Ministry of Economic Affairs; Central Veterinary Institute; Wageningen Livestock Research; China Scholarship Programme; European Union [227549]	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Central Veterinary Institute; Wageningen Livestock Research; China Scholarship Programme; European Union(European Commission)	D.S., S. A. V., J.M.J.R., and M. A. S. were supported by the funding of Dutch Ministry of Economic Affairs, Central Veterinary Institute and Wageningen Livestock Research. J.Z. was supported by a fellowship of the China Scholarship Programme, and J.Z., L.Z. and H. S. were partly supported by the European Union through the Interplay project, Grant agreement no. 227549). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 2009, ACTA PAEDIATR, V98, P229, DOI 10.1111/j.1651-2227.2008.01060.x; Barsky A, 2007, BIOINFORMATICS, V23, P1040, DOI 10.1093/bioinformatics/btm057; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Derrien M, 2010, THESIS WAGENINGEN U, P40; Dominguez-Bello MG, 2011, GASTROENTEROLOGY, V140, P1713, DOI 10.1053/j.gastro.2011.02.011; El Aidy S, 2012, MUCOSAL IMMUNOL, V5, P567, DOI 10.1038/mi.2012.32; Geuking MB, 2011, GUT MICROBES, P2; Gittins R., 1986, ACTA BIOTHEOR, V35, P135; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Hansen CHF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034043; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hulst M, 2012, ARCH VIROLOGY; Inman CF, 2010, CLIN EXP IMMUNOL, V160, P431, DOI 10.1111/j.1365-2249.2010.04090.x; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Janczyk P, 2007, ISME J, V1, P180, DOI 10.1038/ismej.2007.29; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelly D, 2007, MUTAT RES-FUND MOL M, V622, P58, DOI 10.1016/j.mrfmmm.2007.03.011; Konstantinov SR, 2006, ENVIRON MICROBIOL, V8, P1191, DOI 10.1111/j.1462-2920.2006.01009.x; Leps J, 2003, MULTIVARIATE ANAL EC; Lewis MC, 2012, PEDIAT ALLERGY IMMUN; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lindberg E, 2004, J CLIN MICROBIOL, V42, P530, DOI 10.1128/JCM.42.2.530-534.2004; Lindberg E, 2011, CLIN MICROBIOL INFEC, V17, P1209, DOI 10.1111/j.1469-0691.2010.03426.x; Lindberg E, 2000, PEDIATR RES, V48, P741, DOI 10.1203/00006450-200012000-00007; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Mangin I, 2010, ANAEROBE, V16, P433, DOI 10.1016/j.anaerobe.2010.06.005; Mangin I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050257; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mulder IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028279; Mulder IE, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-79; O'Mahony SM, 2009, BIOL PSYCHIAT, V65, P263, DOI 10.1016/j.biopsych.2008.06.026; O'Sullivan O, 2013, J ANTIMICROB CHEMOTH, V68, P214, DOI 10.1093/jac/dks348; Ohnmacht C, 2011, CELL MICROBIOL, V13, P653, DOI 10.1111/j.1462-5822.2011.01577.x; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Perez Gutierrez O., 2010, UNRAVELING PIGLET GU; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2010, MICROBIOL-SGM, V156, P3270, DOI 10.1099/mic.0.042044-0; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Schmidt B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028284; Schreur PJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022299; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; ter Braak C., 1990, UPDATE NOTES CANOCO; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; van Baarlen P, 2013, TRENDS IMMUNOL, V34, P208, DOI 10.1016/j.it.2013.01.005; van Baarlen P, 2011, P NATL ACAD SCI USA, V108, P4562, DOI 10.1073/pnas.1000079107; Van den Abbeele P, 2011, FEMS MICROBIOL REV, V35, P681, DOI 10.1111/j.1574-6976.2011.00270.x; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; Wagner RD, 2008, ADV EXP MED BIOL, V635, P41, DOI 10.1007/978-0-387-09550-9_4; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	63	108	119	5	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100040	10.1371/journal.pone.0100040	http://dx.doi.org/10.1371/journal.pone.0100040			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941112	Green Submitted, Green Published, gold			2022-12-25	WOS:000338508200069
J	Shahab, M; Verma, M; Pathak, M; Mitra, K; Misra-Bhattacharya, S				Shahab, Mohd; Verma, Meenakshi; Pathak, Manisha; Mitra, Kalyan; Misra-Bhattacharya, Shailja			Cloning, Expression and Characterization of UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) from Wolbachia Endosymbiont of Human Lymphatic Filarial Parasite Brugia malayi	PLOS ONE			English	Article							LIPID II BIOSYNTHESIS; CELL-WALL; PEPTIDOGLYCAN BIOSYNTHESIS; BACTERIAL ENDOSYMBIONTS; ANTIFILARIAL ACTIVITY; IDENTIFICATION; PROTEIN; TETRACYCLINE; TARGET; ENDOBACTERIA	Wolbachia, an endosymbiont of filarial nematode, is considered a promising target for treatment of lymphatic filariasis. Although functional characterization of the Wolbachia peptidoglycan assembly has not been fully explored, the Wolbachia genome provides evidence for coding all of the genes involved in lipid II biosynthesis, a part of peptidoglycan biosynthesis pathway. UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) is one of the lipid II biosynthesis pathway enzymes and it has inevitably been recognized as an antibiotic target. In view of the vital role of MurA in bacterial viability and survival, MurA ortholog from Wolbachia endosymbiont of Brugia malayi (wBm-MurA) was cloned, expressed and purified for further molecular characterization. The enzyme kinetics and inhibition studies were undertaken using fosfomycin. wBm-MurA was found to be expressed in all the major life stages of B. malayi and was immunolocalized in Wolbachia within the microfilariae and female adults by the confocal microscopy. Sequence analysis suggests that the amino acids crucial for enzymatic activity are conserved. The purified wBm-MurA was shown to possess the EPSP synthase (3-phosphoshikimate 1-carboxyvinyltransferase) like activity at a broad pH range with optimal activity at pH 7.5 and 37 degrees C temperature. The apparent affinity constant (K-m) for the substrate UDP-N-acetylglucosamine was found to be 0.03149 mM and for phosphoenolpyruvate 0.009198 mM. The relative enzymatic activity was inhibited similar to 2 fold in presence of fosfomycin. Superimposition of the wBm-MurA homology model with the structural model of Haemophilus influenzae (Hi-MurA) suggests binding of fosfomycin at the same active site. The findings suggest wBm-MurA to be a putative antifilarial drug target for screening of novel compounds.	[Shahab, Mohd; Verma, Meenakshi; Mitra, Kalyan; Misra-Bhattacharya, Shailja] AcSIR, New Delhi, India; [Shahab, Mohd; Verma, Meenakshi; Pathak, Manisha; Misra-Bhattacharya, Shailja] CSIR Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India; [Mitra, Kalyan] CSIR Cent Drug Res Inst, Lucknow, Uttar Pradesh, India	Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Misra-Bhattacharya, S (corresponding author), AcSIR, New Delhi, India.	shailja_cdri@rediffmail.com			Indian Council of Medical Research (ICMR), New Delhi, India; CSIR Network Project SPLenDID	Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR)); CSIR Network Project SPLenDID	The financial supports in the form of research fellowships by Indian Council of Medical Research (ICMR), New Delhi, India to MS, MV and MP along with the financial assistance in the form of CSIR Network Project SPLenDID were gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, WKLY EPIDEMIOL REC, V37, P346; Bandi C, 1999, INT J PARASITOL, V29, P357, DOI 10.1016/S0020-7519(98)00200-8; Bandi C, 2001, VET PARASITOL, V98, P215, DOI 10.1016/S0304-4017(01)00432-0; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Baum EZ, 2001, ANTIMICROB AGENTS CH, V45, P3182, DOI 10.1128/AAC.45.11.3182-3188.2001; Blake KL, 2009, MOL MICROBIOL, V72, P335, DOI 10.1111/j.1365-2958.2009.06648.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN ED, 1995, J BACTERIOL, V177, P4194, DOI 10.1128/jb.177.14.4194-4197.1995; BUGG TDH, 1992, NAT PROD REP, V9, P199, DOI 10.1039/np9920900199; De Smet KAL, 1999, MICROBIOL-UK, V145, P3177, DOI 10.1099/00221287-145-11-3177; Du WS, 2000, J BACTERIOL, V182, P4146, DOI 10.1128/JB.182.15.4146-4152.2000; Eschenburg S, 2000, PROTEINS, V40, P290, DOI 10.1002/(SICI)1097-0134(20000801)40:2<290::AID-PROT90>3.0.CO;2-0; Eschenburg S, 2005, J BIOL CHEM, V280, P3757, DOI 10.1074/jbc.M411325200; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Fenn K, 2004, TRENDS ECOL EVOL, V19, P163, DOI 10.1016/j.tree.2004.01.002; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Gautam A, 2011, APPL MICROBIOL BIOT, V92, P211, DOI 10.1007/s00253-011-3512-z; Ghedin E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000525; Haegeman A, 2009, INT J PARASITOL, V39, P1045, DOI 10.1016/j.ijpara.2009.01.006; Henrichfreise B, 2009, MOL MICROBIOL, V73, P913, DOI 10.1111/j.1365-2958.2009.06815.x; Hertig M, 1924, J MED RES, V44, P329; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; James CE, 2009, TRENDS PARASITOL, V25, P328, DOI 10.1016/j.pt.2009.04.004; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; KAHAN FM, 1974, ANN NY ACAD SCI, V235, P364, DOI 10.1111/j.1749-6632.1974.tb43277.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Langworthy NG, 2000, P ROY SOC B-BIOL SCI, V267, P1063, DOI 10.1098/rspb.2000.1110; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Lentz CS, 2013, CHEM BIOL, V20, P177, DOI 10.1016/j.chembiol.2012.11.009; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Li HJ, 2012, J HARD TISSUE BIOL, V21, P17, DOI 10.2485/jhtb.21.17; Li ZR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035834, 10.1371/journal.pone.0051597]; MARQUARDT JL, 1994, BIOCHEMISTRY-US, V33, P10646, DOI 10.1021/bi00201a011; MCCALL JW, 1973, J PARASITOL, V59, P436, DOI 10.2307/3278767; McCoy AJ, 2003, J BACTERIOL, V185, P1218, DOI 10.1128/JB.185.4.1218-1228.2003; Mizyed S, 2005, BIOCHEMISTRY-US, V44, P4011, DOI 10.1021/bi047704w; PADAN E, 1981, BIOCHIM BIOPHYS ACTA, V650, P151, DOI 10.1016/0304-4157(81)90004-6; Pfarr K, 2005, PLOS MED, V2, P289, DOI 10.1371/journal.pmed.0020110; Punkosdy GA, 2001, J INFECT DIS, V184, P385, DOI 10.1086/322023; Rana AK, 2013, ANTIMICROB AGENTS CH, V57, P3843, DOI 10.1128/AAC.02264-12; Samland AK, 1999, BIOCHEMISTRY-US, V38, P13162, DOI 10.1021/bi991041e; SANGER I, 1981, ACTA TROP, V38, P277; Schiefer A, 2013, J ANTIMICROB CHEMOTH, V68, P1790, DOI 10.1093/jac/dkt105; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shahab Mohd, 2012, Current Pharmacogenomics & Personalized Medicine, V10, P148; Shrivastava N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041113; Silver LL, 2006, BIOCHEM PHARMACOL, V71, P996, DOI 10.1016/j.bcp.2005.10.029; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Skarzynski T, 1996, STRUCTURE, V4, P1465, DOI 10.1016/S0969-2126(96)00153-0; SUZUKI T, 1979, JPN J EXP MED, V49, P117; Takahata S, 2010, INT J ANTIMICROB AG, V35, P333, DOI 10.1016/j.ijantimicag.2009.11.011; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8; Taylor MJ, 1999, PARASITOL TODAY, V15, P437, DOI 10.1016/S0169-4758(99)01533-1; Vollmer J, 2013, INT J MED MICROBIOL, V303, P140, DOI 10.1016/j.ijmm.2013.01.002; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Voronin D, 2012, P NATL ACAD SCI USA, V109, pE1638, DOI 10.1073/pnas.1203519109; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; Yoon HJ, 2008, PROTEINS, V71, P1032, DOI 10.1002/prot.21959	63	7	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99884	10.1371/journal.pone.0099884	http://dx.doi.org/10.1371/journal.pone.0099884			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941309	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200050
J	Giacomazzi, J; Graudenz, MS; Osorio, CABT; Koehler-Santos, P; Palmero, EI; Zagonel-Oliveira, M; Michelli, RAD; Neto, CS; Fernandes, GC; Achatz, MIWS; Martel-Planche, G; Soares, FA; Caleffi, M; Goldim, JR; Hainaut, P; Camey, SA; Ashton-Prolla, P				Giacomazzi, Juliana; Graudenz, Marcia S.; Osorio, Cynthia A. B. T.; Koehler-Santos, Patricia; Palmero, Edenir I.; Zagonel-Oliveira, Marcelo; Michelli, Rodrigo A. D.; Neto, Cristovam Scapulatempo; Fernandes, Gabriela C.; Achatz, Maria Isabel W. S.; Martel-Planche, Ghyslaine; Soares, Fernando A.; Caleffi, Maira; Goldim, Jose Roberto; Hainaut, Pierre; Camey, Suzi A.; Ashton-Prolla, Patricia			Prevalence of the TP53 p.R337H Mutation in Breast Cancer Patients in Brazil	PLOS ONE			English	Article							LI-FRAUMENI; SCREENING-PROGRAM; R337H MUTATION; POPULATION; FAMILIES; PH	Germline TP53 mutations predispose individuals to multiple cancers and are associated with Li-Fraumeni/Li-Fraumeni-Like Syndromes (LFS/LFL). The founder mutation TP53 p.R337H is detected in 0.3% of the general population in southern Brazil. This mutation is associated with an increased risk of childhood adrenal cortical carcinoma (ACC) but is also common in Brazilian LFS/LFL families. Breast Cancer (BC) is one of the most common cancers diagnosed in TP53 mutation carriers. We have assessed the prevalence of p.R337H in two groups: (1) 59 BC affected women with a familial history (FH) suggestive of hereditary cancer syndrome but no LFS/LFL features; (2) 815 BC affected women unselected for cancer FH, diagnosed with BC at or before age 45 or at age 55 or older. Among group 1 and group 2 patients, 2/59 (3.4%, CI95%: 0.4%-11.7%) and 70/815 (8.6%, CI95%: 6.8%-10.7%), respectively, were p.R337H carriers in the germline. The prevalence of p.R337H was higher in women diagnosed with BC at or before age 45 (12.1%, CI95%: 9.1%-15.8%) than at age 55 or older (5.1%, CI95%: 3.2%-7.7%), p<0.001). The Brazilian founder p.R337H haplotype was detected in all carriers analysed. These results suggest that inheritance of p.R337H may significantly contribute to the high incidence of BC in Brazil, in addition to its recently demonstrated impact on the risk of childhood ACC.	[Giacomazzi, Juliana; Ashton-Prolla, Patricia] Hosp Clin Porto Alegre HCPA, Expt Res Ctr, Genom Med Lab, Porto Alegre, RS, Brazil; [Giacomazzi, Juliana; Graudenz, Marcia S.; Ashton-Prolla, Patricia] Univ Fed Rio Grande Sul UFRGS, Postgrad Program Med Med Sci, Porto Alegre, RS, Brazil; [Graudenz, Marcia S.] HCPA, Pathol Serv, Porto Alegre, RS, Brazil; [Graudenz, Marcia S.] Inst Patol, Porto Alegre, RS, Brazil; [Osorio, Cynthia A. B. T.; Soares, Fernando A.] Hosp Canc AC Camargo HCACC, Pathol Serv, Sao Paulo, Brazil; [Koehler-Santos, Patricia] HCPA, Expt Res Ctr, Prot & Mol Anal Lab, Porto Alegre, RS, Brazil; [Palmero, Edenir I.; Michelli, Rodrigo A. D.; Neto, Cristovam Scapulatempo; Fernandes, Gabriela C.] Hosp Canc Barretos, Mol Oncol Res Ctr, Sao Paulo, Brazil; [Zagonel-Oliveira, Marcelo; Ashton-Prolla, Patricia] Univ Fed Rio Grande do Sul, Natl Inst Populat Med Genet INAGEMP, Porto Alegre, RS, Brazil; [Achatz, Maria Isabel W. S.] HCACC, Oncogenet Dept, Sao Paulo, Brazil; [Martel-Planche, Ghyslaine; Hainaut, Pierre] Int Agcy Res Canc IARC, Lyon, Rhone, France; [Caleffi, Maira] Hosp Moinhos Vento, Porto Alegre, RS, Brazil; [Goldim, Jose Roberto] HCPA, Bioeth Res Lab, Porto Alegre, RS, Brazil; [Hainaut, Pierre] Int Prevent Res Inst, Lyon, Rhone, France; [Camey, Suzi A.] Univ Fed Rio Grande do Sul, Inst Math, Dept Stat, Porto Alegre, RS, Brazil; [Ashton-Prolla, Patricia] Univ Fed Rio Grande do Sul, Postgrad Program Genet & Mol Biol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; A.C.Camargo Cancer Center; Hospital de Cancer de Barretos; Universidade Federal do Rio Grande do Sul; A.C.Camargo Cancer Center; World Health Organization; International Agency for Research on Cancer (IARC); Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Giacomazzi, J (corresponding author), Hosp Clin Porto Alegre HCPA, Expt Res Ctr, Genom Med Lab, Porto Alegre, RS, Brazil.	jugiacomazzi@gmail.com	Hainaut, Pierre/B-6018-2012; Osório, Cynthia/AAI-7427-2020; Camey, Suzi A/H-2346-2012; Palmero, Edenir/F-4341-2015; Achatz, Maria Isabel/C-5751-2013; Fernandes, Gabriela/GRJ-1743-2022; Ashton-Prolla, Patricia/T-3515-2019; Camey, Suzi Alves/Y-2756-2019; Ashton-Prolla, Patricia/H-2927-2012; de Toledo Osório, Cynthia Bueno/J-9282-2015; GRAUDENZ, MARCIA S/Q-4174-2017; Goldim, Jose R/G-2726-2012; Giacomazzi, Juliana/F-6629-2015	Hainaut, Pierre/0000-0002-1303-1610; Camey, Suzi A/0000-0002-5564-081X; Palmero, Edenir/0000-0003-1904-2158; Achatz, Maria Isabel/0000-0001-6894-1219; Camey, Suzi Alves/0000-0002-5564-081X; de Toledo Osório, Cynthia Bueno/0000-0002-7675-9780; Scapulatempo-Neto, Cristovam/0000-0002-8920-6579; Soares, Fernando Augusto/0000-0003-1647-7842; Goldim, Jose Roberto/0000-0003-2127-6594; Giacomazzi, Juliana/0000-0001-5811-5140; Zagonel de Oliveira, Marcelo/0000-0003-4006-4052; Caleffi, Maira/0000-0002-9494-9457; Soares, Fernando/0000-0002-1212-9093	GlaxoSmithKline Oncology (Ethnic Research Initiative), U.K.; CNPq, Brazil [307779 2009-2]; FAPERGS-PPSUS [09/0103-0]; FAPERGS PRONEX [10/0051-9]; Fundo de Incentivo a Pesquisa e Eventos, Hospital de Clinicas de Porto Alegre (GPPG), Brazil [08080]; CAPES; CNPQ (Brazil)	GlaxoSmithKline Oncology (Ethnic Research Initiative), U.K.; CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERGS-PPSUS; FAPERGS PRONEX(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Fundo de Incentivo a Pesquisa e Eventos, Hospital de Clinicas de Porto Alegre (GPPG), Brazil; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPQ (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was supported in part by grants from GlaxoSmithKline Oncology (Ethnic Research Initiative Grant Award 2009), U.K.; CNPq to PA-P (grant 307779 2009-2), Brazil; FAPERGS-PPSUS (grant # 09/0103-0), FAPERGS PRONEX (grant #10/0051-9) and Fundo de Incentivo a Pesquisa e Eventos, Hospital de Clinicas de Porto Alegre (GPPG # 08080), Brazil. The work of JG was supported by fellowships from CAPES and CNPQ (Brazil). The authors certify that none of the funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assumpcao JG, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-357; BORRESEN AL, 1992, CANCER RES, V52, P3234; Custodio G, 2013, J CLIN ONCOL, V31, P2619, DOI 10.1200/JCO.2012.46.3711; da Silva EM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-449; DiGiammarino EL, 2002, NAT STRUCT BIOL, V9, P12, DOI 10.1038/nsb730; Garritano S, 2010, HUM MUTAT, V31, P143, DOI 10.1002/humu.21151; Giacomazzi J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-187; Ginsburg OM, 2009, FAM CANCER, V8, P563, DOI 10.1007/s10689-009-9287-z; Gomes MCB, 2012, HERED CANCER CLIN PR, V10, DOI 10.1186/1897-4287-10-3; Gonzalez KD, 2009, J CLIN ONCOL, V27, P1250, DOI 10.1200/JCO.2008.16.6959; Hafsi H, 2011, ANTIOXID REDOX SIGN, V15, P1655, DOI 10.1089/ars.2010.3771; Haikel RL, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-32; Lalloo F, 2006, EUR J CANCER, V42, P1143, DOI 10.1016/j.ejca.2005.11.032; Latronico AC, 2001, J CLIN ENDOCR METAB, V86, P4970, DOI 10.1210/jc.86.10.4970; Lee DSC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3172; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; McCuaig JM, 2012, FAM CANCER, V11, P607, DOI 10.1007/s10689-012-9557-z; Meijers-Heijboer H, 2003, AM J HUM GENET, V72, P1308, DOI 10.1086/375121; Mouchawar J, 2010, CANCER RES, V70, P4795, DOI 10.1158/0008-5472.CAN-09-0851; Offit K, 1996, J CLIN ONCOL, V14, P1730, DOI 10.1200/JCO.1996.14.5.1730; Olivier M, 2003, CANCER RES, V63, P6643; Palmero EI, 2008, CANCER LETT, V261, P21, DOI 10.1016/j.canlet.2007.10.044; Ribeiro RC, 2001, P NATL ACAD SCI USA, V98, P9330, DOI 10.1073/pnas.161479898; Seidinger AL, 2011, CANCER-AM CANCER SOC, V117, P2228, DOI 10.1002/cncr.25826; SIDRANSKY D, 1992, CANCER RES, V52, P2984; Tinat J, 2009, J CLIN ONCOL, V27, pE108, DOI 10.1200/JCO.2009.22.7967; Achatz MIW, 2007, CANCER LETT, V245, P96, DOI 10.1016/j.canlet.2005.12.039; Walsh T, 2011, P NATL ACAD SCI USA, V108, P18032, DOI 10.1073/pnas.1115052108; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110	29	43	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99893	10.1371/journal.pone.0099893	http://dx.doi.org/10.1371/journal.pone.0099893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936644	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400050
J	Xu, SF; Zhou, F; Tao, JS; Song, L; Ng, SC; Wang, XB; Chen, LP; Yi, FM; Ran, ZH; Zhou, R; Xia, B				Xu, Shufang; Zhou, Feng; Tao, Jinsheng; Song, Lu; Siew Chien Ng; Wang, Xiaobing; Chen, Liping; Yi, Fengming; Ran, Zhihua; Zhou, Rui; Xia, Bing			Exome Sequencing Identifies DLG1 as a Novel Gene for Potential Susceptibility to Crohn's Disease in a Chinese Family Study	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; HERITABILITY; GENERATION; MUTATIONS; SINGLE; RARE	Background: Genetic variants make some contributions to inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC). More than 100 susceptibility loci were identified in Western IBD studies, but susceptibility gene has not been found in Chinese IBD patients till now. Sequencing of individuals with an IBD family history is a powerful approach toward our understanding of the genetics and pathogenesis of IBD. The aim of this study, which focuses on a Han Chinese CD family, is to identify high-risk variants and potentially novel loci using whole exome sequencing technique. Methods: Exome sequence data from 4 individuals belonging to a same family were analyzed using bioinformatics methods to narrow down the variants associated with CD. The potential risk genes were further analyzed by genotyping and Sanger sequencing in family members, additional 401 healthy controls (HC), 278 sporadic CD patients, 123 UC cases, a pair of monozygotic CD twins and another Chinese CD family. Results: From the CD family in which the father and daughter were affected, we identified a novel single nucleotide variant (SNV) c.374T>C (p.I125T) in exon 4 of discs large homolog 1 (DLG1), a gene has been reported to play mutiple roles in cell proliferation, T cell polarity and T cell receptor signaling. After genotyping among case and controls, a PLINK analysis showed the variant was of significance (P<0.05). 4 CD patients of the other Chinese family bore another non-synonymous variant c.833G>A (p.R278Q) in exon 9 of DLG1. Conclusions: We have discovered novel genetic variants in the coding regions of DLG1 gene, the results support that DLG1 is a novel potential susceptibility gene for CD in Chinese patients.	[Xu, Shufang; Zhou, Feng; Song, Lu; Wang, Xiaobing; Chen, Liping; Yi, Fengming; Xia, Bing] Wuhan Univ, Sch Med, Zhongnan Hosp, Dept Gastroenterol, Wuhan 430072, Peoples R China; [Zhou, Feng; Chen, Liping; Zhou, Rui; Xia, Bing] Hubei Clin Ctr, Wuhan, Peoples R China; [Zhou, Feng; Chen, Liping; Zhou, Rui; Xia, Bing] Key Lab Intestinal & Colorectal Dis, Wuhan, Peoples R China; [Zhou, Feng; Chen, Liping; Zhou, Rui; Xia, Bing] Hubei Key Lab Immune Related Dis, Wuhan, Peoples R China; [Tao, Jinsheng] BGI Shenzhen, Bei Shan Ind Zone, Shenzhen, Peoples R China; [Siew Chien Ng] Chinese Univ Hong Kong, Inst Digest Dis, Dept Med & Therapeut, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Ran, Zhihua] Shanghai Jiao Tong Univ, Sch Med, Dept Gastroenterol, Renji Hosp,Shanghai Inst Digest Dis, Shanghai 200030, Peoples R China	Wuhan University; Beijing Genomics Institute (BGI); Chinese University of Hong Kong; Shanghai Jiao Tong University	Xia, B (corresponding author), Wuhan Univ, Sch Med, Zhongnan Hosp, Dept Gastroenterol, Wuhan 430072, Peoples R China.	bingxia@aliyun.com	Ng, Siew Chien/N-4733-2015	Ng, Siew Chien/0000-0002-6850-4454; Wang, Xiaobing/0000-0002-3134-0556	Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Diseases; Natural Science Foundation of China [81070280]; Ministry of Public Health of China [201002020]	Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Diseases; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Public Health of China	The study was supported by the Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Diseases, the Natural Science Foundation of China (No. 81070280) and a grant from the Ministry of Public Health of China (201002020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Brant SR, 2011, INFLAMM BOWEL DIS, V17, P1, DOI 10.1002/ibd.21385; Brunham LR, 2013, HUM GENET, V132, P603, DOI 10.1007/s00439-013-1286-3; Chatterjee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034343; Cho JH, 2011, GASTROENTEROLOGY, V140, P1704, DOI 10.1053/j.gastro.2011.02.046; Christodoulou K, 2013, GUT, V62, P977, DOI 10.1136/gutjnl-2011-301833; Clarke AJ, 2010, EUR J HUM GENET, V18, P859, DOI 10.1038/ejhg.2010.35; Danese S, 2012, GUT, V61, P918, DOI 10.1136/gutjnl-2011-300904; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Freeman HJ, 2002, J CLIN GASTROENTEROL, V35, P9, DOI 10.1097/00004836-200207000-00004; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gibson G, 2009, NAT REV GENET, V10, P134, DOI 10.1038/nrg2502; Gilissen C, 2012, EUR J HUM GENET, V20, P490, DOI 10.1038/ejhg.2011.258; Glocker EO, 2010, LANCET, V376, P1272, DOI 10.1016/S0140-6736(10)61008-2; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Gmyrek GB, 2013, EUR J IMMUNOL, V43, P1185, DOI 10.1002/eji.201142362; Humphries LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045276; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; MacDonald TT, 2011, GASTROENTEROLOGY, V140, P1768, DOI 10.1053/j.gastro.2011.02.047; Majewski J, 2011, J MED GENET, V48, P580, DOI 10.1136/jmedgenet-2011-100223; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mao H, 2012, GENES IMMUN, V13, P437, DOI 10.1038/gene.2012.8; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mitchell KJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-237; Mowat C, 2011, GUT, V60, P571, DOI 10.1136/gut.2010.224154; Nazarian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044162; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SC, 2013, GASTROENTEROLOGY, V145, P158, DOI 10.1053/j.gastro.2013.04.007; O'Neill AK, 2011, J BIOL CHEM, V286, P43559, DOI 10.1074/jbc.M111.294603; Plevy SE, 2011, GASTROENTEROLOGY, V140, P1838, DOI 10.1053/j.gastro.2011.02.014; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Surena AL, 2009, BBA-MOL CELL RES, V1793, P264, DOI 10.1016/j.bbamcr.2008.09.005; Teer JK, 2010, HUM MOL GENET, V19, pR145, DOI 10.1093/hmg/ddq333; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158; Xavier R, 2004, J CELL BIOL, V166, P173, DOI 10.1083/jcb.200309044; Yi FM, 2012, EUR J GASTROEN HEPAT, V24, P1424, DOI 10.1097/MEG.0b013e3283583e5c; Zhao J, 2013, INFLAMM BOWEL DIS, V19, P1839, DOI 10.1097/MIB.0b013e31828a6551	45	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99807	10.1371/journal.pone.0099807	http://dx.doi.org/10.1371/journal.pone.0099807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937328	Green Published, Green Submitted, gold			2022-12-25	WOS:000338503400039
J	Pabayo, R; Janosz, M; Bisset, S; Kawachi, I				Pabayo, Roman; Janosz, Michel; Bisset, Sherri; Kawachi, Ichiro			School Social Fragmentation, Economic Deprivation and Social Cohesion and Adolescent Physical Inactivity: A Longitudinal Study	PLOS ONE			English	Article							HEALTH; FAMILY; YOUTH; INTERVENTIONS; CONNECTEDNESS; OPPORTUNITIES; INDIVIDUALS; STUDENTS; CLIMATE; CHILD	Objectives: To examine the independent influence of school economic deprivation, social fragmentation, and social cohesion on the likelihood of participating in no physical activity among students. Methods: Data are from a large-scale longitudinal study of schools based in disadvantaged communities in Quebec, Canada. Questionnaires were administered every year between 2002 and 2008 among n = 14,924 students aged 12 to 18 from a sample of 70 schools. Cross-sectional and longitudinal analyses were conducted. Multilevel modeling was utilized to account for the clustering of students within schools. Schools were categorized as being low, moderate or high economic deprivation, social fragmentation and social cohesion. Those who indicated that they do no participate in any physical activity during the week were identified as being physically inactive. Results: In baseline multilevel cross-sectional analyses, adolescents attending schools in the highest (compared to the lowest) levels of socioeconomic deprivation and social fragmentation were more likely to be physically inactive (OR = 1.33, 95% CI = 1.03, 1.72; and OR = 1.24, 95% CI = 0.98, 1.56, respectively). Conversely, students attending schools with the highest cohesion were less likely to be physically inactive (OR = 0.78, 95% CI = 0.61, 0.99). In longitudinal analysis, physically active students who attended schools with the highest social fragmentation were more likely to become physically inactive over two years (OR = 1.65, 95% CI = 1.09, 2.51). Conclusion: The school socioeconomic environment appears to be an important contextual influence on participation in no physical activity among adolescents. Following adolescents beyond two years is necessary to determine if these environments have a lasting effect on physical activity behavior.	[Pabayo, Roman; Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Janosz, Michel] Univ Montreal, Ecole Psychoeduc, Montreal, PQ, Canada; [Janosz, Michel] Univ Montreal, SERG, Montreal, PQ, Canada; [Janosz, Michel] Univ Montreal Publ Hlth Res Inst IRSPUM, Montreal, PQ, Canada; [Bisset, Sherri] Univ Laval, Inst Univ Cardiol & Pneumol Quebec CRIUCPQ, Ctr Rech, Quebec City, PQ, Canada	Harvard University; Harvard T.H. Chan School of Public Health; Universite de Montreal; Universite de Montreal; Universite de Montreal; Laval University	Pabayo, R (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, 665 Huntington Ave, Boston, MA 02115 USA.	rpabayo@hsph.harvard.edu	P, Roman/AAO-3485-2020	P, Roman/0000-0003-4018-4898	Canadian Institutes of Health	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	RP is funded by a Canadian Institutes of Health Postdoctoral Fellowship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison KR, 2007, CAN J PUBLIC HEALTH, V98, P97, DOI 10.1007/BF03404317; Barnett TA, 2009, INT J PUBLIC HEALTH, V54, P150, DOI 10.1007/s00038-009-7110-0; Birnbaum AS, 2005, AM J HEALTH BEHAV, V29, P250, DOI 10.5993/AJHB.29.3.6; Bonell CP, 2010, J ADOLESCENT HEALTH, V47, P555, DOI 10.1016/j.jadohealth.2010.04.011; Bourhis RY, 2012, DECLINE ENGLISH SCH; Colley Rachel C, 2011, Health Rep, V22, P15; Congdon P, 2004, INT J EPIDEMIOL, V33, P741, DOI 10.1093/ije/dyh173; Cradock AL, 2009, SOC SCI MED, V68, P427, DOI 10.1016/j.socscimed.2008.10.028; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Eaton Danice K., 2012, Morbidity and Mortality Weekly Report, V61, P1; Evenson KR, 2007, AM J HEALTH BEHAV, V31, P86, DOI 10.5993/AJHB.31.1.9; Fagg J, 2008, SOC SCI MED, V66, P242, DOI 10.1016/j.socscimed.2007.07.032; Fagg J, 2006, SOC SCI MED, V63, P636, DOI 10.1016/j.socscimed.2006.02.012; Faulkner GEJ, 2009, J SCHOOL HEALTH, V79, P312, DOI 10.1111/j.1746-1561.2009.00415.x; Freudenberg Nicholas, 2007, Prev Chronic Dis, V4, pA107; Fuller D, 2011, J SCHOOL HEALTH, V81, P449, DOI 10.1111/j.1746-1561.2011.00613.x; Haug E, 2010, HEALTH EDUC RES, V25, P248, DOI 10.1093/her/cyn050; Hoy WK, 1996, J EDUC ADMIN, V34, P41, DOI DOI 10.1108/09578239610107156; Ivory VC, 2011, SOC SCI MED, V72, P1993, DOI 10.1016/j.socscimed.2011.04.015; Janosz M., 1998, REV CANADIENNE PSYCH, V27, P285; Janosz M., 2007, RAPPORT VALIDATION Q; Kahn JA, 2008, J ADOLESCENT HEALTH, V42, P369, DOI 10.1016/j.jadohealth.2007.11.143; Kawachi I., 2008, SOCIAL CAPITAL HLTH, P1, DOI DOI 10.1007/978-0-387-71311-3_1; Keresztes N, 2008, J R SOC PROMO HEALTH, V128, P21, DOI 10.1177/1466424007085228; Kirby J, 2011, J PHYS ACT HEALTH, V8, P785, DOI 10.1123/jpah.8.6.785; Lamarre P, 2012, ENGLISH ED QUEBEC IS, P175; Lasheras L, 2001, PREV MED, V32, P455, DOI 10.1006/pmed.2001.0843; Libbey HP, 2004, J SCHOOL HEALTH, V74, P274, DOI 10.1111/j.1746-1561.2004.tb08284.x; Ma X, 2000, EVALUATION REV, V24, P435, DOI 10.1177/0193841X0002400501; Ma X, 2007, SCH EFF SCH IMPROV, V18, P209, DOI 10.1080/09243450600909183; Markham WA, 2003, SOC SCI MED, V56, P1209, DOI 10.1016/S0277-9536(02)00120-X; MCGINNIS JM, 1991, J SCHOOL HEALTH, V61, P292, DOI 10.1111/j.1746-1561.1991.tb07408.x; Mckenzie TL, 2004, MED SCI SPORT EXER, V36, P1382, DOI 10.1249/01.MSS.0000135792.20358.4D; Millstein RA, 2011, PEDIATR EXERC SCI, V23, P487, DOI 10.1123/pes.23.4.487; Molnar BE, 2004, AM J HEALTH PROMOT, V18, P378, DOI 10.4278/0890-1171-18.5.378; Morton KL, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-48; Nelson MC, 2006, PEDIATRICS, V118, pE1627, DOI 10.1542/peds.2006-0926; Pabayo R, 2014, AM J PUBLI IN PRESS; Pabayo R, 2006, HEALTH EDUC BEHAV, V33, P690, DOI 10.1177/1090198105285327; Pabayo Roman, 2012, Am J Public Health, V102, pe30, DOI 10.2105/AJPH.2012.300868; Pabayo R, 2011, SOC SCI MED, V72, P430, DOI 10.1016/j.socscimed.2010.09.039; Reid Robert J, 2006, J Prim Prev, V27, P281, DOI 10.1007/s10935-006-0035-y; Sallis JF, 2003, AM J PREV MED, V24, P209, DOI 10.1016/S0749-3797(02)00646-3; Sallis JF, 2001, AM J PUBLIC HEALTH, V91, P618, DOI 10.2105/AJPH.91.4.618; Sellstrom E, 2006, SCAND J PUBLIC HEALT, V34, P544, DOI 10.1080/14034940600551251; Smith B, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-593; Snijders T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd; Story M, 1999, Adolesc Med, V10, P109; Story M, 1999, ADOLESCENT MED, V10, pvi; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P36, DOI [10.1139/H11-009, 10.1139/H11-010]; van Sluijs EMF, 2011, BRIT J SPORT MED, V45, P914, DOI 10.1136/bjsports-2011-090187; Waters SK, 2009, J SCHOOL HEALTH, V79, P516, DOI 10.1111/j.1746-1561.2009.00443.x; Zammit S, 2010, ARCH GEN PSYCHIAT, V67, P914, DOI 10.1001/archgenpsychiatry.2010.101	53	16	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99154	10.1371/journal.pone.0099154	http://dx.doi.org/10.1371/journal.pone.0099154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ5PV	24932679	Green Submitted, gold, Green Published			2022-12-25	WOS:000337738600023
J	Thomsen, EK; Strode, C; Hemmings, K; Hughes, AJ; Chanda, E; Musapa, M; Kamuliwo, M; Phiri, FN; Muzia, L; Chanda, J; Kandyata, A; Chirwa, B; Poer, K; Hemingway, J; Wondji, CS; Ranson, H; Coleman, M				Thomsen, Edward K.; Strode, Clare; Hemmings, Kay; Hughes, Angela J.; Chanda, Emmanuel; Musapa, Mulenga; Kamuliwo, Mulakwa; Phiri, Faustina N.; Muzia, Lucy; Chanda, Javan; Kandyata, Alister; Chirwa, Brian; Poer, Kathleen; Hemingway, Janet; Wondji, Charles S.; Ranson, Hilary; Coleman, Michael			Underpinning Sustainable Vector Control through Informed Insecticide Resistance Management	PLOS ONE			English	Article							ANOPHELES-FUNESTUS DIPTERA; MALARIA CONTROL; PYRETHROID RESISTANCE; TREATED NETS; GAMBIAE-S.S.; IDENTIFICATION; IMPACT; POPULATIONS; EXPRESSION; ARABIENSIS	Background: There has been rapid scale-up of malaria vector control in the last ten years. Both of the primary control strategies, long-lasting pyrethroid treated nets and indoor residual spraying, rely on the use of a limited number of insecticides. Insecticide resistance, as measured by bioassay, has rapidly increased in prevalence and has come to the forefront as an issue that needs to be addressed to maintain the sustainability of malaria control and the drive to elimination. Zambia's programme reported high levels of resistance to the insecticides it used in 2010, and, as a result, increased its investment in resistance monitoring to support informed resistance management decisions. Methodology/Principal Findings: A country-wide survey on insecticide resistance in Zambian malaria vectors was performed using WHO bioassays to detect resistant phenotypes. Molecular techniques were used to detect target-site mutations and microarray to detect metabolic resistance mechanisms. Anopheles gambiae s.s. was resistant to pyrethroids, DDT and carbamates, with potential organophosphate resistance in one population. The resistant phenotypes were conferred by both target-site and metabolic mechanisms. Anopheles funestus s.s. was largely resistant to pyrethroids and carbamates, with potential resistance to DDT in two locations. The resistant phenotypes were conferred by elevated levels of cytochrome p450s. Conclusions/Significance: Currently, the Zambia National Malaria Control Centre is using these results to inform their vector control strategy. The methods employed here can serve as a template to all malaria-endemic countries striving to create a sustainable insecticide resistance management plan.	[Thomsen, Edward K.; Strode, Clare; Hemmings, Kay; Hughes, Angela J.; Hemingway, Janet; Wondji, Charles S.; Ranson, Hilary; Coleman, Michael] Univ Liverpool, Liverpool Sch Trop Med, Vector Biol Dept, Liverpool L3 5QA, Merseyside, England; [Chanda, Emmanuel; Kamuliwo, Mulakwa; Phiri, Faustina N.; Chanda, Javan; Kandyata, Alister] Natl Malaria Control Ctr, Lusaka, Zambia; [Musapa, Mulenga; Muzia, Lucy; Chirwa, Brian; Poer, Kathleen] Abt Associates Inc, Zambia Integrated Syst Strengthening Program, Lusaka, Zambia	Liverpool School of Tropical Medicine; University of Liverpool; ABT Associates	Thomsen, EK (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Vector Biol Dept, Liverpool L3 5QA, Merseyside, England.	ethomsen@liv.ac.uk	Wondji, Charles/AAG-1510-2020; Thomsen, Edward/AAH-3299-2020	Thomsen, Edward/0000-0003-1136-6430; Strode, Clare/0000-0003-2833-8073; Hemingway, Janet/0000-0002-3200-7173; Coleman, Michael/0000-0003-4186-3526; Ranson, Hilary/0000-0003-2332-8247; Wondji, Charles S./0000-0003-0791-3673	Presidents Malaria Initiative via the Zambia Integrated Systems Strengthening Program; Innovative Vector Control Consortium	Presidents Malaria Initiative via the Zambia Integrated Systems Strengthening Program; Innovative Vector Control Consortium	This work was funded through the Presidents Malaria Initiative via the Zambia Integrated Systems Strengthening Program and the Innovative Vector Control Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abilio AP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-110; Aikpon R, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-192; Amenya DA, 2008, INSECT MOL BIOL, V17, P19, DOI 10.1111/j.1365-2583.2008.00776.x; [Anonymous], PRES MAL IN MAL OP P; [Anonymous], ZAMB 2010 CENS POP H; [Anonymous], NAT MAL CONTR PROGR; [Anonymous], 2005, GLOB STRAT PLAN ROLL; [Anonymous], 1925, J ECON ENTOMOL; [Anonymous], EXTENSIVE ACE2 DUPLI; [Anonymous], ANOPHELINAE AFRICA S; [Anonymous], 1968, ANOPHELINAE AFR S SA; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; Bass C, 2010, PESTIC BIOCHEM PHYS, V96, P80, DOI 10.1016/j.pestbp.2009.09.004; Bass C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-177; Brooke BD, 2001, B ENTOMOL RES, V91, P265, DOI 10.1079/BER2001108; Casimiro S, 2006, J MED ENTOMOL, V43, P267, DOI 10.1603/0022-2585(2006)043[0267:IRIAFD]2.0.CO;2; Casimiro S, 2006, J MED ENTOMOL, V43, P276, DOI 10.1603/0022-2585(2006)043[0276:IRIAAA]2.0.CO;2; Chanda E, 2013, J MED ENTOMOL, V50, P1275, DOI 10.1603/ME13041; Chanda E, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-10; Chanda E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-437; Chanda E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024336; Chiu TL, 2008, P NATL ACAD SCI USA, V105, P8855, DOI 10.1073/pnas.0709249105; Chizema-Kawesha E, 2010, AM J TROP MED HYG, V83, P480, DOI 10.4269/ajtmh.2010.10-0035; Christian RN, 2011, PESTIC BIOCHEM PHYS, V99, P140, DOI 10.1016/j.pestbp.2010.11.010; Coleman M, 2006, J MED ENTOMOL, V43, P663, DOI 10.1093/jmedent/43.4.663; Ding YC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-35; Djogbenou L, 2011, MED VET ENTOMOL, V25, P256, DOI 10.1111/j.1365-2915.2010.00925.x; Eisen L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001016; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Fornadel CM, 2008, AM J TROP MED HYG, V79, P876, DOI 10.4269/ajtmh.2008.79.876; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Hemingway J, 2013, P NATL ACAD SCI USA, V110, P9397, DOI 10.1073/pnas.1307656110; Kelly-Hope L, 2008, LANCET INFECT DIS, V8, P387, DOI 10.1016/S1473-3099(08)70045-8; Koekemoer LL, 1999, J MED ENTOMOL, V36, P125, DOI 10.1093/jmedent/36.2.125; Kwiatkowska RM, 2013, GENE, V519, P98, DOI 10.1016/j.gene.2013.01.036; Maharaj R, 2005, SAMJ S AFR MED J, V95, P871; Masaninga Freddie, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P89, DOI 10.1016/S2221-1691(13)60030-1; Mathias DK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-10; Mitchell SN, 2012, P NATL ACAD SCI USA, V109, P6147, DOI 10.1073/pnas.1203452109; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; N'Guessan R, 2003, MED VET ENTOMOL, V17, P19, DOI 10.1046/j.1365-2915.2003.00406.x; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Oduola AO, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-116; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramphul U, 2009, T ROY SOC TROP MED H, V103, P1121, DOI 10.1016/j.trstmh.2009.02.014; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Riveron JM, 2013, P NATL ACAD SCI USA, V110, P252, DOI 10.1073/pnas.1216705110; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Sharp B, 2002, TROP MED INT HEALTH, V7, P732, DOI 10.1046/j.1365-3156.2002.00928.x; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2013, TEST PROC INREMO; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wondji CS, 2012, P NATL ACAD SCI USA, V109, P19063, DOI 10.1073/pnas.1217229109; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108; Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6; Zambian Ministry of Health, 2012, ZAMB NAT MAL IND SUR	61	41	41	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99822	10.1371/journal.pone.0099822	http://dx.doi.org/10.1371/journal.pone.0099822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932861	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000337738600069
J	An, J; Shen, XF; Ma, QB; Yang, CY; Liu, SM; Chen, Y				An, Jing; Shen, Xuefeng; Ma, Qibin; Yang, Cunyi; Liu, Simin; Chen, Yong			Transcriptome Profiling to Discover Putative Genes Associated with Paraquat Resistance in Goosegrass (Eleusine indica L.)	PLOS ONE			English	Article							SUPPLEMENT TREMBL; SEQUENCE DATABASE; POLYAMINES; TRANSLOCATION; TRANSPORTER; TOLERANCE; TOXICITY; PROTEIN; GENERATION; MECHANISM	Background: Goosegrass (Eleusine indica L.), a serious annual weed in the world, has evolved resistance to several herbicides including paraquat, a non-selective herbicide. The mechanism of paraquat resistance in weeds is only partially understood. To further study the molecular mechanism underlying paraquat resistance in goosegrass, we performed transcriptome analysis of susceptible and resistant biotypes of goosegrass with or without paraquat treatment. Results: The RNA-seq libraries generated 194,716,560 valid reads with an average length of 91.29 bp. De novo assembly analysis produced 158,461 transcripts with an average length of 1153.74 bp and 100,742 unigenes with an average length of 712.79 bp. Among these, 25,926 unigenes were assigned to 65 GO terms that contained three main categories. A total of 13,809 unigenes with 1,208 enzyme commission numbers were assigned to 314 predicted KEGG metabolic pathways, and 12,719 unigenes were categorized into 25 KOG classifications. Furthermore, our results revealed that 53 genes related to reactive oxygen species scavenging, 10 genes related to polyamines and 18 genes related to transport were differentially expressed in paraquat treatment experiments. The genes related to polyamines and transport are likely potential candidate genes that could be further investigated to confirm their roles in paraquat resistance of goosegrass. Conclusion: This is the first large-scale transcriptome sequencing of E. indica using the Illumina platform. Potential genes involved in paraquat resistance were identified from the assembled sequences. The transcriptome data may serve as a reference for further analysis of gene expression and functional genomics studies, and will facilitate the study of paraquat resistance at the molecular level in goosegrass.	[An, Jing; Shen, Xuefeng; Liu, Simin; Chen, Yong] South China Agr Univ, Coll Agr, Weed Res Lab, Guangzhou, Guangdong, Peoples R China; [Ma, Qibin; Yang, Cunyi] South China Agr Univ, Coll Agr, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University	Chen, Y (corresponding author), South China Agr Univ, Coll Agr, Weed Res Lab, Guangzhou, Guangdong, Peoples R China.	chenyong@scau.edu.cn	ma, qibin/HDO-2133-2022	An, Jing/0000-0001-5279-2845	National Natural Science Foundation of China [31272054]; Special Fund for Agro-scientific Research in the Public Interest [201303031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the National Natural Science Foundation of China (No. 31272054) and Special Fund for Agro-scientific Research in the Public Interest (No. 201303031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baerson SR, 2002, PLANT PHYSIOL, V129, P1265, DOI 10.1104/pp.001560; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Benavides MP, 2000, PLANT GROWTH REGUL, V31, P215, DOI 10.1023/A:1006316926002; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bromilow RH, 2004, PEST MANAG SCI, V60, P340, DOI 10.1002/ps.823; CARROLL EW, 1988, PLANT PHYSIOL, V87, P651, DOI 10.1104/pp.87.3.651; Chang CJ, 1997, PLANT GROWTH REGUL, V22, P163, DOI 10.1023/A:1005890312557; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P2261, DOI 10.1073/pnas.2627990100; Chuah TS, 2013, S AFR J BOT, V84, P128, DOI 10.1016/j.sajb.2012.11.003; Dang ZH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-29; DITOMASO JM, 1993, PLANT PHYSIOL, V102, P467, DOI 10.1104/pp.102.2.467; Dori-Bachash M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001106; FOYER CH, 1994, PLANT CELL ENVIRON, V17, P507, DOI 10.1111/j.1365-3040.1994.tb00146.x; Fujita M, 2012, P NATL ACAD SCI USA, V109, P6343, DOI 10.1073/pnas.1121406109; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HART JJ, 1992, PLANT PHYSIOL, V99, P1400, DOI 10.1104/pp.99.4.1400; HART JJ, 1993, PLANT PHYSIOL, V103, P963, DOI 10.1104/pp.103.3.963; HART JJ, 1994, WEED SCI, V42, P277, DOI 10.1017/S0043174500080395; Holm L, 1977, WORLDS WORST WEEDS D, P47; Jori B, 2007, PESTIC BIOCHEM PHYS, V88, P57, DOI 10.1016/j.pestbp.2006.08.013; Jung IL, 2003, CELL BIOL TOXICOL, V19, P29, DOI 10.1023/A:1022065614490; Kashiwagi K, 1997, J BIOL CHEM, V272, P6318, DOI 10.1074/jbc.272.10.6318; Kim HS, 2006, J PLANT BIOL, V49, P237, DOI 10.1007/BF03030539; Koschnick TJ, 2006, WEED SCI, V54, P615, DOI 10.1614/WS-06-002R.1; Kusano T, 2008, PLANTA, V228, P367, DOI 10.1007/s00425-008-0772-7; LEACH GE, 1995, PESTIC BIOCHEM PHYS, V51, P129, DOI 10.1006/pest.1995.1013; Lee J, 2013, PLANTA, V237, P823, DOI 10.1007/s00425-012-1797-5; Lee LJ, 2000, PEST MANAG SCI, V56, P336, DOI 10.1002/(SICI)1526-4998(200004)56:4<336::AID-PS123>3.3.CO;2-#; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; MUDGE LC, 1984, WEED SCI, V32, P591, DOI 10.1017/S0043174500059610; Nefedova LN, 2003, RUSS J GENET+, V39, P264, DOI 10.1023/A:1023256608389; POWLES SB, 1987, AUST J PLANT PHYSIOL, V14, P81, DOI 10.1071/PP9870081; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Seng CT, 2010, WEED BIOL MANAG, V10, P229, DOI 10.1111/j.1445-6664.2010.00388.x; SHAALTIEL Y, 1986, PESTIC BIOCHEM PHYS, V26, P22, DOI 10.1016/0048-3575(86)90058-1; Soar CJ, 2004, PESTIC BIOCHEM PHYS, V80, P94, DOI 10.1016/j.pestbp.2004.07.002; Soar CJ, 2003, PESTIC BIOCHEM PHYS, V76, P91, DOI 10.1016/S0048-3575(03)00069-5; Su YH, 2004, PLANT PHYSIOL, V136, P3104, DOI 10.1104/pp.104.045278; Summers L.A., 1980, BIPYRIDINIUM HERBICI; Szigeti Zoltan, 2005, Acta Biologica Szegediensis, V49, P177; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Xi J, 2012, PLANT J, V69, P782, DOI 10.1111/j.1365-313X.2011.04830.x; Yang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069168; Ye B, 2000, PLANTA, V211, P50, DOI 10.1007/s004250000257; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; Yu Q, 2004, FUNCT PLANT BIOL, V31, P247, DOI 10.1071/FP03234; Yu Q, 2010, PESTIC BIOCHEM PHYS, V98, P104, DOI 10.1016/j.pestbp.2010.05.007; Zhou YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-266	53	43	50	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99940	10.1371/journal.pone.0099940	http://dx.doi.org/10.1371/journal.pone.0099940			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927422	Green Submitted, gold, Green Published			2022-12-25	WOS:000338278100095
J	Chakraborty, S; Adhikary, A; Mazumdar, M; Mukherjee, S; Bhattacharjee, P; Guha, D; Choudhuri, T; Chattopadhyay, S; Sa, G; Sen, A; Das, T				Chakraborty, Samik; Adhikary, Arghya; Mazumdar, Minakshi; Mukherjee, Shravanti; Bhattacharjee, Pushpak; Guha, Deblina; Choudhuri, Tathagata; Chattopadhyay, Samit; Sa, Gaurisankar; Sen, Aparna; Das, Tanya			Capsaicin-Induced Activation of p53-SMAR1 Auto-Regulatory Loop Down-Regulates VEGF in Non-Small Cell Lung Cancer to Restrain Angiogenesis	PLOS ONE			English	Article							MALIGNANT-MELANOMA-CELLS; RECEPTOR-BETA LOCUS; SWISS ALBINO MICE; BREAST-CANCER; COLORECTAL-CANCER; CARCINOMA CELLS; CYCLE ARREST; P53; APOPTOSIS; HYPOXIA	Lung cancer is the leading cause of cancer-related deaths worldwide. Despite decades of research, the treatment options for lung cancer patients remain inadequate, either to offer a cure or even a substantial survival advantage owing to its intrinsic resistance to chemotherapy. Our results propose the effectiveness of capsaicin in down-regulating VEGF expression in non-small cell lung carcinoma (NSCLC) cells in hypoxic environment. Capsaicin-treatment re-activated p53-SMAR1 positive feedback loop in these cells to persuade p53-mediated HIF-1 alpha degradation and SMAR1-induced repression of Cox-2 expression that restrained HIF-1 alpha nuclear localization. Such signal-modulations consequently down regulated VEGF expression to thwart endothelial cell migration and network formation, pre-requisites of angiogenesis in tumor micro-environment. The above results advocate the candidature of capsaicin in exclusively targeting angiogenesis by down-regulating VEGF in tumor cells to achieve more efficient and cogent therapy of resistant NSCLC.	[Chakraborty, Samik; Adhikary, Arghya; Mazumdar, Minakshi; Mukherjee, Shravanti; Bhattacharjee, Pushpak; Guha, Deblina; Sa, Gaurisankar; Das, Tanya] Bose Inst, Div Mol Med, Kolkata, W Bengal, India; [Choudhuri, Tathagata] Viswa Bharati, Dept Biotechnol, Santini Ketan, W Bengal, India; [Chattopadhyay, Samit] Pune Univ, Natl Ctr Cell Sci, Pune, Maharashtra, India; [Sen, Aparna] Lady Brabourne Coll, Dept Microbiol, Kolkata, W Bengal, India	Department of Science & Technology (India); Bose Institute; Visva Bharati University; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Savitribai Phule Pune University	Das, T (corresponding author), Bose Inst, Div Mol Med, Kolkata, W Bengal, India.	tanya@jcbose.ac.in	Bhattacharjee, Pushpak/AFV-4590-2022; Choudhuri, Tathagata/F-8139-2011; Chakraborty, Samik/Q-1779-2018	Chakraborty, Samik/0000-0002-5232-0474	University Grants Commission [UGC 2-8/2002]; Department of Science and Technology [DST R/3393/06]; Department of Biotechnology-DBT-RA; Council of Scientific and Industrial Research [CSIR 09/015(0386)/2010 EMR-1]	University Grants Commission(University Grants Commission, India); Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology-DBT-RA; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	SC- University Grants Commission- UGC 2-8/2002(SA I)(SA-I) dated 06.11.2008. AA- Department of Science and Technology- DST R/3393/06 dated 16.10.2006. MM- Department of Biotechnology-DBT-RA dated 05.06.2009. SM- Council of Scientific and Industrial Research- CSIR 09/015(0386)/2010 EMR-1 dated 22.02.2010. PB- Department of Biotechnology-DBT-RA dated 01.06.2010. DG- University Grants Commission- UGC 2-8/2002(SA I) dated 21.04.2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary A, 2010, FEBS LETT, V584, P7, DOI 10.1016/j.febslet.2009.10.081; Amantini C, 2009, CARCINOGENESIS, V30, P1320, DOI 10.1093/carcin/bgp138; Anandakumar P, 2008, PHYTOTHER RES, V22, P529, DOI 10.1002/ptr.2393; Anandakumar P, 2013, INT IMMUNOPHARMACOL, V17, P254, DOI 10.1016/j.intimp.2013.05.015; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Blagosklonny MV, 1998, J BIOL CHEM, V273, P11995, DOI 10.1074/jbc.273.20.11995; Blagosklonny MV, 2004, CANCER CELL, V5, P13, DOI 10.1016/S1535-6108(03)00336-2; Bottaro DP, 2003, NATURE, V423, P593, DOI 10.1038/423593a; Brown KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010243; Chakraborty S, 2014, FEBS LETT, V588, P549, DOI 10.1016/j.febslet.2013.11.040; Chattopadhyay S, 2000, GENOMICS, V68, P93, DOI 10.1006/geno.2000.6279; Chen D, 2012, INT J UROL, V19, P662, DOI 10.1111/j.1442-2042.2012.02981.x; Chou CC, 2009, ONCOL REP, V21, P665, DOI 10.3892/or_00000269; de Moraes E, 2007, INT J CANCER, V121, P929, DOI 10.1002/ijc.22899; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; Gallo O, 2003, AM J PATHOL, V163, P723, DOI 10.1016/S0002-9440(10)63699-1; Hossain DMS, 2013, IMMUNITY, V39, P1057, DOI 10.1016/j.immuni.2013.11.005; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jalota A, 2005, J BIOL CHEM, V280, P16019, DOI 10.1074/jbc.M413200200; Jung MY, 2001, CANC LETT, V165, P39; Kaul-Ghanekar R, 2005, J BIOL CHEM, V280, P9450, DOI 10.1074/jbc.M412206200; Liu XH, 2002, J BIOL CHEM, V277, P50081, DOI 10.1074/jbc.M201095200; Malonia SK, 2011, BBA-REV CANCER, V1815, P1, DOI 10.1016/j.bbcan.2010.08.003; Mayer RJ, 2004, NEW ENGL J MED, V350, P2406, DOI 10.1056/NEJMe048098; Mazumdar M, 2013, APOPTOSIS, V18, P589, DOI 10.1007/s10495-013-0803-0; Min JK, 2004, CANCER RES, V64, P644, DOI 10.1158/0008-5472.CAN-03-3250; Oyagbemi AA, 2010, INDIAN J CANCER, V47, P53, DOI 10.4103/0019-509X.58860; Papadimitriou A, 2007, CELL PHYSIOL BIOCHEM, V20, P607, DOI 10.1159/000107544; Patel PS, 2002, J INTERF CYTOK RES, V22, P427, DOI 10.1089/10799900252952217; Patel PS, 2002, J CANCER RES CLIN, V128, P461, DOI 10.1007/s00432-002-0368-8; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Ravi R, 2000, GENE DEV, V14, P34; Saha B, 2012, ONCOGENE, V31, P173, DOI 10.1038/onc.2011.234; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sen GS, 2011, J BIOL CHEM, V286, P42232, DOI 10.1074/jbc.M111.262295; Shin DH, 2008, EXP MOL MED, V40, P486, DOI 10.3858/emm.2008.40.5.486; Singh K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000660; Sinha S, 2010, EMBO J, V29, P830, DOI 10.1038/emboj.2009.395; Teel RW, 1999, IN VIVO, V13, P231; Thoennissen NH, 2010, ONCOGENE, V29, P285, DOI 10.1038/onc.2009.335; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Zaidi SK, 2005, EMBO REP, V6, P128, DOI 10.1038/sj.embor.7400337; Zhang J, 2003, LEUKEMIA RES, V27, P275, DOI 10.1016/S0145-2126(02)00164-9	44	50	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99743	10.1371/journal.pone.0099743	http://dx.doi.org/10.1371/journal.pone.0099743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926985	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100074
J	Park, S; Han, JM; Cheon, J; Hwang, JI; Seong, JY				Park, Sumi; Han, Ji Man; Cheon, Jun; Hwang, Jong-Ik; Seong, Jae Young			Apoptotic Death of Prostate Cancer Cells by a Gonadotropin-Releasing Hormone-II Antagonist	PLOS ONE			English	Article							GNRH-II; LUTEINIZING-HORMONE; MITOCHONDRIAL HOMEOSTASIS; GROWTH-FACTOR; RECEPTOR; AUTOPHAGY; PITUITARY; (GNRH)-I; PATHWAY; KINASE	Gonadotropin-releasing hormone-I (GnRH-I) has attracted strong attention as a hormonal therapeutic tool, particularly for androgen-dependent prostate cancer patients. However, the androgen-independency of the cancer in advanced stages has spurred researchers to look for new medical treatments. In previous reports, we developed the GnRH-II antagonist Trp-1 to inhibit proliferation and stimulate the autophagic death of various prostate cancer cells, including androgen-independent cells. We further screened many GnRH-II antagonists to identify molecules with higher efficiency. Here, we investigated the effect of SN09-2 on the growth of PC3 prostate cancer cells. SN09-2 reduced the growth of prostate cancer cells but had no effect on cells derived from other tissues. Compared with Trp-1, SN09-2 conspicuously inhibited prostate cancer cell growth, even at low concentrations. SN09-2-induced PC3 cell growth inhibition was associated with decreased membrane potential in mitochondria where the antagonist was accumulated, and increased mitochondrial and cytosolic reactive oxygen species. SN09-2 induced lactate dehydrogenase release into the media and annexin V-staining on the PC3 cell surface, suggesting that the antagonist stimulated prostate cancer cell death by activating apoptotic signaling pathways. Furthermore, cytochrome c release from mitochondria to the cytosol and caspase-3 activation occurred in a concentration-and time-dependent manner. SN09-2 also inhibited the growth of PC3 cells xenotransplanted into nude mice. These results demonstrate that SN09-2 directly induces mitochondrial dysfunction and the consequent ROS generation, leading to not only growth inhibition but also apoptosis of prostate cancer cells.	[Park, Sumi; Han, Ji Man; Hwang, Jong-Ik; Seong, Jae Young] Korea Univ, Grad Sch Med, Seoul, South Korea; [Cheon, Jun] Korea Univ, Sch Med, Dept Urol, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Hwang, JI (corresponding author), Korea Univ, Grad Sch Med, Seoul, South Korea.	hjibio@korea.ac.kr; jyseong@korea.ac.kr	Seong, Jae Young/A-5794-2012	Seong, Jae Young/0000-0002-3312-6924; Hwang, Jong-Ik/0000-0002-0729-1782	Basic Research Program of the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2013R1A2A2A01068295]; National R&D Program for Cancer Control, Ministry of Health Welfare [0520270-1]; Medical Research Council [MR/K000608/1] Funding Source: researchfish	Basic Research Program of the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning; National R&D Program for Cancer Control, Ministry of Health Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Basic Research Program (2013R1A2A2A01068295) of the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning and the National R&D Program for Cancer Control, Ministry of Health & Welfare (0520270-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Kheir W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026112; Baade PD, 2009, MOL NUTR FOOD RES, V53, P171, DOI 10.1002/mnfr.200700511; Blank M, 2007, CELL CYCLE, V6, P686, DOI 10.4161/cc.6.6.3990; Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502; Burbulla LF, 2010, HUM MOL GENET, V19, P4437, DOI 10.1093/hmg/ddq370; Chalah A, 2008, ADV EXP MED BIOL, V615, P25, DOI 10.1007/978-1-4020-6554-5_3; Chen A, 2002, NAT MED, V8, P1421, DOI 10.1038/nm801; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Comaru-Schally AM, 1998, J CLIN ENDOCR METAB, V83, P3826, DOI 10.1210/jc.83.11.3826; Cook T, 2000, Oncologist, V5, P162, DOI 10.1634/theoncologist.5-2-162; Davidson JS, 1997, BIOCHEMISTRY-US, V36, P12881, DOI 10.1021/bi971377t; Densmore VS, 2003, J CLIN ENDOCR METAB, V88, P2126, DOI 10.1210/jc.2002-021359; Deocaris CC, 2006, CELL STRESS CHAPERON, V11, P116, DOI 10.1379/CSC-144R.1; EISENBERGER MA, 1986, J CLIN ONCOL, V4, P414, DOI 10.1200/JCO.1986.4.3.414; Faurholm B, 2001, GENOMICS, V78, P15, DOI 10.1006/geno.2001.6650; Gault PM, 2003, J NEUROENDOCRINOL, V15, P831, DOI 10.1046/j.1365-2826.2003.01065.x; Grosse R, 2000, J BIOL CHEM, V275, P9193, DOI 10.1074/jbc.275.13.9193; Grundker C, 2004, EUR J ENDOCRINOL, V151, P141, DOI 10.1530/eje.0.1510141; Herman-Antosiewicz A, 2006, CANCER RES, V66, P5828, DOI 10.1158/0008-5472.CAN-06-0139; Illing N, 1999, P NATL ACAD SCI USA, V96, P2526, DOI 10.1073/pnas.96.5.2526; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kang SK, 2001, ENDOCRINOLOGY, V142, P182, DOI 10.1210/en.142.1.182; Kim DK, 2009, CANCER RES, V69, P923, DOI 10.1158/0008-5472.CAN-08-2115; Kim KY, 2006, ENDOCR-RELAT CANCER, V13, P211, DOI 10.1677/erc.1.01033; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kraus S, 2004, CANCER RES, V64, P5736, DOI 10.1158/0008-5472.CAN-04-1156; Leung PCK, 2003, MOL CELL ENDOCRINOL, V202, P145, DOI 10.1016/S0303-7207(03)00076-5; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Maiti K, 2005, J CLIN ENDOCR METAB, V90, P4287, DOI 10.1210/jc.2004-1894; Marelli MM, 1999, ENDOCRINOLOGY, V140, P329; Maudsley S, 2004, CANCER RES, V64, P7533, DOI 10.1158/0008-5472.CAN-04-1360; Millar R, 2001, P NATL ACAD SCI USA, V98, P9636, DOI 10.1073/pnas.141048498; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Moretti RM, 1996, J CLIN ENDOCR METAB, V81, P3930, DOI 10.1210/jc.81.11.3930; Morgan K, 2003, ENDOCRINOLOGY, V144, P423, DOI 10.1210/en.2002-220622; Navarro D, 2002, J STEROID BIOCHEM, V81, P191, DOI 10.1016/S0960-0760(02)00064-X; Okada Y, 2003, BIOL REPROD, V69, P1356, DOI 10.1095/biolreprod.103.016162; Patel AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041394; Sealfon SC, 1997, ENDOCR REV, V18, P180, DOI 10.1210/er.18.2.180; SHERWOOD NM, 1993, ENDOCR REV, V14, P241, DOI 10.1210/er.14.2.241; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sviridonov L, 2013, MOL CELL ENDOCRINOL, V369, P107, DOI 10.1016/j.mce.2013.01.010; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Tiwary BK, 2013, NEUROENDOCRINOLOGY, V97, P242, DOI 10.1159/000342694; Wang L, 2001, P NATL ACAD SCI USA, V98, P361, DOI 10.1073/pnas.011508498; White RB, 1998, P NATL ACAD SCI USA, V95, P305, DOI 10.1073/pnas.95.1.305; Wu HM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-300	47	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99723	10.1371/journal.pone.0099723	http://dx.doi.org/10.1371/journal.pone.0099723			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926857	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100073
J	Hall, MD; Marshall, TS; Kwit, ADT; Jenkins, LMM; Dulcey, AE; Madigan, JP; Pluchino, KM; Goldsborough, AS; Brimacombe, KR; Griffiths, GL; Gottesman, MM				Hall, Matthew D.; Marshall, Travis S.; Kwit, Alexandra D. T.; Jenkins, Lisa M. Miller; Dulcey, Andres E.; Madigan, James P.; Pluchino, Kristen M.; Goldsborough, Andrew S.; Brimacombe, Kyle R.; Griffiths, Gary L.; Gottesman, Michael M.			Inhibition of Glutathione Peroxidase Mediates the Collateral Sensitivity of Multidrug-resistant Cells to Tiopronin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISATIN-BETA-THIOSEMICARBAZONES; HYDROGEN-PEROXIDE; SELECTIVE ACTIVITY; CANCER; DRUG; DETOXIFICATION; MECHANISMS; APOPTOSIS; CATALASE; IDENTIFICATION	Multidrug resistance (MDR) is a major obstacle to the successful chemotherapy of cancer. MDR is often the result of overexpression of ATP-binding cassette transporters following chemotherapy. A common ATP-binding cassette transporter that is overexpressed in MDR cancer cells is P-glycoprotein, which actively effluxes drugs against a concentration gradient, producing an MDR phenotype. Collateral sensitivity (CS), a phenomenon of drug hypersensitivity, is defined as the ability of certain compounds to selectively target MDR cells, but not the drug-sensitive parent cells from which they were derived. The drug tiopronin has been previously shown to elicit CS. However, unlike other CS agents, the mechanism of action was not dependent on the expression of P-glycoprotein in MDR cells. We have determined that the CS activity of tiopronin is mediated by the generation of reactive oxygen species (ROS) and that CS can be reversed by a variety of ROS-scavenging compounds. Specifically, selective toxicity of tiopronin toward MDR cells is achieved by inhibition of glutathione peroxidase (GPx), and the mode of inhibition of GPx1 by tiopronin is shown in this report. Why MDR cells are particularly sensitive to ROS is discussed, as is the difficulty in exploiting this hypersensitivity to tiopronin in the clinic.	[Hall, Matthew D.; Marshall, Travis S.; Kwit, Alexandra D. T.; Jenkins, Lisa M. Miller; Madigan, James P.; Pluchino, Kristen M.; Goldsborough, Andrew S.; Brimacombe, Kyle R.; Gottesman, Michael M.] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Dulcey, Andres E.; Griffiths, Gary L.] NHLBI, Imaging Probe Dev Ctr, NIH, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Gottesman, MM (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	mgottesman@nih.gov	Jenkins, Lisa/AAI-2490-2021		National Institutes of Health Intramural Research Program; NATIONAL CANCER INSTITUTE [ZICBC011430, ZIABC010830] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005090] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program.	Andreadis C, 2007, BLOOD, V109, P3409, DOI 10.1182/blood-2006-09-047621; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; BARTON DHR, 1991, TETRAHEDRON, V47, P6127, DOI 10.1016/S0040-4020(01)86546-7; BATIST G, 1986, J BIOL CHEM, V261, P5544; Brimacombe KR, 2009, ASSAY DRUG DEV TECHN, V7, P233, DOI 10.1089/adt.2008.165; Cabello CM, 2007, CURR OPIN INVEST DR, V8, P1022; Chan DA, 2011, NAT REV DRUG DISCOV, V10, P351, DOI 10.1038/nrd3374; CHAUDIERE J, 1984, J BIOL CHEM, V259, P1043; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Danieli B, 2006, J ORG CHEM, V71, P2848, DOI 10.1021/jo052677g; DEANGELIS L, 1978, DRUG TODAY, V14, P37; Dikalov SI, 2014, ANTIOXID REDOX SIGN, V20, P372, DOI 10.1089/ars.2012.4886; DOROSHOW JH, 1990, PHARMACOL THERAPEUT, V47, P359, DOI 10.1016/0163-7258(90)90062-7; Dringen R, 2005, J NEUROSCI RES, V79, P157, DOI 10.1002/jnr.20280; Dringen R, 1998, BRAIN RES PROTOC, V2, P223, DOI 10.1016/S1385-299X(97)00047-0; Flohe L, 2012, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, THIRD EDITION, P167, DOI 10.1007/978-1-4614-1025-6_13; Fojo T, 2008, ONCOLOGIST, V13, P277, DOI 10.1634/theoncologist.2007-0090; GAETANI GF, 1989, BLOOD, V73, P334; Gillet JP, 2012, CLIN CANCER RES, V18, P3197, DOI 10.1158/1078-0432.CCR-12-0056; Gladyshev VN, 1999, J BIOMED SCI, V6, P151, DOI 10.1007/BF02255899; Goldsborough AS, 2011, J MED CHEM, V54, P4987, DOI 10.1021/jm2001663; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gupte A, 2007, FREE RADICAL BIO MED, V43, P1271, DOI 10.1016/j.freeradbiomed.2007.07.003; Hall MD, 2011, J MED CHEM, V54, P5878, DOI 10.1021/jm2006047; Hall MD, 2009, TRENDS PHARMACOL SCI, V30, P546, DOI 10.1016/j.tips.2009.07.003; Hall MD, 2009, J MED CHEM, V52, P3191, DOI 10.1021/jm800861c; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Henzler T, 2000, J EXP BOT, V51, P2053, DOI 10.1093/jexbot/51.353.2053; Huff LM, 2006, J BIOL CHEM, V281, P36501, DOI 10.1074/jbc.M602998200; Jeitner TM, 2001, TOXICOL SCI, V63, P57, DOI 10.1093/toxsci/63.1.57; JIANG ZY, 1990, FEBS LETT, V268, P69, DOI 10.1016/0014-5793(90)80974-N; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Laberge RM, 2007, BIOCHEM PHARMACOL, V73, P1727, DOI 10.1016/j.bcp.2007.02.005; LOCK RB, 1988, INT J CANCER, V42, P373, DOI 10.1002/ijc.2910420312; Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586; Ludwig JA, 2006, CANCER RES, V66, P4808, DOI 10.1158/0008-5472.CAN-05-3322; Marks KM, 2011, J NAT PROD, V74, P567, DOI 10.1021/np100429s; Minagawa Y, 2001, Hum Cell, V14, P237; Mix H, 2007, NUCLEIC ACIDS RES, V35, P414, DOI 10.1093/nar/gkl1060; MULLER C, 1994, INT J CANCER, V56, P749, DOI 10.1002/ijc.2910560523; Nicholls P, 2012, ARCH BIOCHEM BIOPHYS, V525, P95, DOI 10.1016/j.abb.2012.01.015; Omerovic J, 2008, ONCOGENE, V27, P2754, DOI 10.1038/sj.onc.1210925; Park YS, 2003, FREE RADICAL RES, V37, P205, DOI 10.1080/1071576021000041005; PATRICK TB, 1993, J ORG CHEM, V58, P705, DOI 10.1021/jo00055a026; Pluchino KM, 2012, DRUG RESIST UPDATE, V15, P98, DOI 10.1016/j.drup.2012.03.002; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Saga Y, 2008, ONCOL REP, V20, P1299, DOI 10.3892/or_00000144; SAMUELS BL, 1991, CANCER RES, V51, P521; Sawada T, 1997, IMMUNOPHARMACOLOGY, V35, P195, DOI 10.1016/S0162-3109(96)00145-2; Schulz R, 2012, BIOORG MED CHEM LETT, V22, P6712, DOI 10.1016/j.bmcl.2012.08.091; SHEN DW, 1986, J BIOL CHEM, V261, P7762; SZYBALSKI W, 1952, J BACTERIOL, V64, P489, DOI 10.1128/JB.64.4.489-499.1952; UDUPI V, 1992, FREE RADICAL RES COM, V16, P315, DOI 10.3109/10715769209049184; Vitai M, 1997, CLIN CHIM ACTA, V261, P35, DOI 10.1016/S0009-8981(97)06514-5; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010	58	35	36	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21473	21489		10.1074/jbc.M114.581702	http://dx.doi.org/10.1074/jbc.M114.581702			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24930045	Green Published, hybrid			2022-12-25	WOS:000340558300025
J	Cao, J; Meng, SM; Chang, E; Beckwith-Fickas, K; Xiong, LS; Cole, RN; Radovick, S; Wondisford, FE; He, L				Cao, Jia; Meng, Shumei; Chang, Evan; Beckwith-Fickas, Katherine; Xiong, Lishou; Cole, Robert N.; Radovick, Sally; Wondisford, Fredric E.; He, Ling			Low Concentrations of Metformin Suppress Glucose Production in Hepatocytes through AMP-activated Protein Kinase (AMPK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC GLUCONEOGENESIS; RESPIRATORY-CHAIN; CANCER; PHOSPHORYLATION; RISK; MICE; PHARMACOKINETICS; PHARMACODYNAMICS; INHIBITION; MECHANISM	Metformin is a first-line antidiabetic agent taken by 150 million people across the world every year, yet its mechanism remains only partially understood and controversial. It was proposed that suppression of glucose production in hepatocytes by metformin is AMPK-independent; however, unachievably high concentrations of metformin were employed in these studies. In the current study, we find that metformin, via an AMP-activated protein kinase (AMPK)-dependent mechanism, suppresses glucose production and gluconeogenic gene expression in primary hepatocytes at concentrations found in the portal vein of animals (60-80 mu M). Metformin also inhibits gluconeogenic gene expression in the liver of mice administered orally with metformin. Furthermore, the cAMP-PKA pathway negatively regulates AMPK activity through phosphorylation at Ser-485/497 on the alpha subunit, which in turn reduces net phosphorylation at Thr-172. Because diabetic patients often have hyperglucagonemia, AMPK alpha phosphorylation at Ser-485/497 is a therapeutic target to improve metformin efficacy.	[Cao, Jia; Meng, Shumei; Chang, Evan; Xiong, Lishou; Wondisford, Fredric E.; He, Ling] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Metab, Baltimore, MD 21287 USA; [Cao, Jia; Meng, Shumei; Chang, Evan; Xiong, Lishou; Wondisford, Fredric E.; He, Ling] Johns Hopkins Univ, Sch Med, Dept Physiol, Div Metab, Baltimore, MD 21287 USA; [Cao, Jia; Meng, Shumei; Chang, Evan; Xiong, Lishou; Wondisford, Fredric E.; He, Ling] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Div Metab, Baltimore, MD 21287 USA; [Cao, Jia; Meng, Shumei; Chang, Evan; Xiong, Lishou; Wondisford, Fredric E.; He, Ling] Johns Hopkins Univ, Sch Med, Dept Med, Div Metab, Baltimore, MD 21287 USA; [Beckwith-Fickas, Katherine; Radovick, Sally] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Endocrinol, Baltimore, MD 21287 USA; [Beckwith-Fickas, Katherine; Radovick, Sally] Johns Hopkins Univ, Sch Med, Dept Physiol, Div Endocrinol, Baltimore, MD 21287 USA; [Beckwith-Fickas, Katherine; Radovick, Sally] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Div Endocrinol, Baltimore, MD 21287 USA; [Beckwith-Fickas, Katherine; Radovick, Sally] Johns Hopkins Univ, Sch Med, Dept Med, Div Endocrinol, Baltimore, MD 21287 USA; [Cole, Robert N.] Johns Hopkins Univ, Sch Med, Dept Pediat, Mass Spectrometry & Prote Facil, Baltimore, MD 21287 USA; [Cole, Robert N.] Johns Hopkins Univ, Sch Med, Dept Physiol, Mass Spectrometry & Prote Facil, Baltimore, MD 21287 USA; [Cole, Robert N.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Mass Spectrometry & Prote Facil, Baltimore, MD 21287 USA; [Cole, Robert N.] Johns Hopkins Univ, Sch Med, Dept Med, Mass Spectrometry & Prote Facil, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	He, L (corresponding author), Div Metab, 600 N Wolfe St, Baltimore, MD 21287 USA.	heling@jhmi.edu			National Institutes of Health through the NIDDK [R00DK085142]; Johns Hopkins University-University of Maryland Diabetes Research Center, National Institutes of Health from NIDDK [P60DK079637]; Johns Hopkins Institute for Clinical and Translational Research - National Center for Advancing Translational Sciences [UL1TR000424-06]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, R01DK063349, P30DK089502, R00DK085142, P60DK079637] Funding Source: NIH RePORTER	National Institutes of Health through the NIDDK; Johns Hopkins University-University of Maryland Diabetes Research Center, National Institutes of Health from NIDDK; Johns Hopkins Institute for Clinical and Translational Research - National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part National Institutes of Health Grant R00DK085142 through the NIDDK (to L. H.), The Johns Hopkins University-University of Maryland Diabetes Research Center, National Institutes of Health Grant P60DK079637 from NIDDK, and an award from the Johns Hopkins Institute for Clinical and Translational Research funded by the National Center for Advancing Translational Sciences Grant UL1TR000424-06 (to L. H.).	BROVKO LY, 1994, ANAL BIOCHEM, V220, P410, DOI 10.1006/abio.1994.1358; Dagon Y, 2012, CELL METAB, V16, P104, DOI 10.1016/j.cmet.2012.05.010; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Garcia-Haro L, 2012, FEBS LETT, V586, P4241, DOI 10.1016/j.febslet.2012.10.032; Gorman MW, 2003, LUMINESCENCE, V18, P173, DOI 10.1002/bio.721; He L, 2014, J ENDOCRINOL, V221, P363, DOI 10.1530/JOE-14-0084; He L, 2012, J BIOL CHEM, V287, P32069, DOI 10.1074/jbc.M112.385864; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Higgins JW, 2012, DRUG METAB DISPOS, V40, P1170, DOI 10.1124/dmd.112.044875; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Jang EH, 2010, DRUG METAB PHARMACOK, V25, P392, DOI 10.2133/dmpk.DMPK-10-NT-010; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Larsen S, 2012, DIABETOLOGIA, V55, P443, DOI 10.1007/s00125-011-2340-0; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Ning JY, 2011, ENDOCRINOLOGY, V152, P3143, DOI 10.1210/en.2011-0155; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pulinilkunnil T, 2011, J BIOL CHEM, V286, P8798, DOI 10.1074/jbc.M111.218719; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Soraya H, 2012, INT IMMUNOPHARMACOL, V14, P785, DOI 10.1016/j.intimp.2012.10.014; Stocker SL, 2013, CLIN PHARMACOL THER, V93, P186, DOI 10.1038/clpt.2012.210; Takashima M, 2010, DIABETES, V59, P1608, DOI 10.2337/db09-1679; Tsuchiya Y, 2012, BIOSCIENCE REP, V32, P197, DOI 10.1042/BSR20110076; TUCKER GT, 1981, BRIT J CLIN PHARMACO, V12, P235; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; WITTERS LA, 1992, J BIOL CHEM, V267, P2864; Witters LA, 2001, J CLIN INVEST, V108, P1105, DOI 10.1172/JCI200114178; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	39	124	128	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20435	20446		10.1074/jbc.M114.567271	http://dx.doi.org/10.1074/jbc.M114.567271			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24928508	hybrid, Green Published			2022-12-25	WOS:000339396600003
J	Kohn, KW; Zeeberg, BM; Reinhold, WC; Pommier, Y				Kohn, Kurt W.; Zeeberg, Barry M.; Reinhold, William C.; Pommier, Yves			Gene Expression Correlations in Human Cancer Cell Lines Define Molecular Interaction Networks for Epithelial Phenotype	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; TIGHT JUNCTION PROTEIN; COLORECTAL-CANCER; BREAST-CANCER; MESENCHYMAL TRANSITION; SODIUM-CHANNEL; INTERACTION MAPS; MATRIPTASE; GROWTH; DIFFERENTIATION	Using gene expression data to enhance our knowledge of control networks relevant to cancer biology and therapy is a challenging but urgent task. Based on the premise that genes that are expressed together in a variety of cell types are likely to functions together, we derived mutually correlated genes that function together in various processes in epithelial-like tumor cells. Expression-correlated genes were derived from data for the NCI-60 human tumor cell lines, as well as data from the Broad Institute's CCLE cell lines. NCI-60 cell lines that selectively expressed a mutually correlated subset of tight junction genes served as a signature for epithelial-like cancer cells. Those signature cell lines served as a seed to derive other correlated genes, many of which had various other epithelial-related functions. Literature survey yielded molecular interaction and function information about those genes, from which molecular interaction maps were assembled. Many of the genes had epithelial functions unrelated to tight junctions, demonstrating that new function categories were elicited. The most highly correlated genes were implicated in the following epithelial functions: interactions at tight junctions (CLDN7, CLDN4, CLDN3, MARVELD3, MARVELD2, TJP3, CGN, CRB3, LLGL2, EPCAM, LNX1); interactions at adherens junctions (CDH1, ADAP1, CAMSAP3); interactions at desmosomes (PPL, PKP3, JUP); transcription regulation of cell-cell junction complexes (GRHL1 and 2); epithelial RNA splicing regulators (ESRP1 and 2); epithelial vesicle traffic (RAB25, EPN3, GRHL2, EHF, ADAP1, MYO5B); epithelial Ca(+2) signaling (ATP2C2, S100A14, BSPRY); terminal differentiation of epithelial cells (OVOL1 and 2, ST14, PRSS8, SPINT1 and 2); maintenance of apico-basal polarity (RAB25, LLGL2, EPN3). The findings provide a foundation for future studies to elucidate the functions of regulatory networks specific to epithelial-like cancer cells and to probe for anti-cancer drug targets.	[Kohn, Kurt W.; Zeeberg, Barry M.; Reinhold, William C.; Pommier, Yves] NCI, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kohn, KW (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA.	kohnk@dc37a.nci.nih.gov	Reinhold, William/J-6704-2017	Reinhold, William/0000-0001-5513-9323	budget of the Laboratory of Molecular Pharmacology allocated from the National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC006192] Funding Source: NIH RePORTER	budget of the Laboratory of Molecular Pharmacology allocated from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the budget of the Laboratory of Molecular Pharmacology allocated from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038438; Ahn HJ, 2013, BIOCHEM BIOPH RES CO, V437, P557, DOI 10.1016/j.bbrc.2013.06.114; Ahn HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040293; Aigner K, 2007, FEBS LETT, V581, P1617, DOI 10.1016/j.febslet.2007.03.026; Akhmanova A, 2008, CELL, V135, P791, DOI 10.1016/j.cell.2008.11.002; Aktary Z, 2010, ONCOGENE, V29, P2118, DOI 10.1038/onc.2009.495; Albino D, 2012, CANCER RES, V72, P2889, DOI 10.1158/0008-5472.CAN-12-0212; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bartolome R. A., 2013, ONCOGENE; Bergum C, 2012, J CELL PHYSIOL, V227, P1604, DOI 10.1002/jcp.22877; Biggs LC, 2012, J INVEST DERMATOL, V132, P50, DOI 10.1038/jid.2011.272; Boczonadi V, 2012, FEBS LETT; Botti E, 2011, P NATL ACAD SCI USA, V108, P13710, DOI 10.1073/pnas.1110931108; Chaves-Perez A, 2012, ONCOGENE; Chen HY, 2012, J BIOL CHEM, V287, P17109, DOI 10.1074/jbc.M111.326975; Chen M, 2008, BBA-MOL CELL RES, V1783, P896, DOI 10.1016/j.bbamcr.2007.10.019; Chen MQ, 2010, MOL CELL BIOCHEM, V337, P259, DOI 10.1007/s11010-009-0307-y; Chen W, 2010, J BIOL CHEM, V285, P40852, DOI 10.1074/jbc.M110.103812; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064088; Cheng KW, 2012, EMBO MOL MED, V4, P125, DOI 10.1002/emmm.201100193; Cieply B, 2012, CANCER RES, V72, P2440, DOI 10.1158/0008-5472.CAN-11-4038; Citi S, 2012, ANN NY ACAD SCI, V1257, P125, DOI 10.1111/j.1749-6632.2012.06506.x; Coskun M, 2010, J CELL BIOCHEM, V109, P1118, DOI 10.1002/jcb.22490; D'Angelo R, 2007, MOL BIOL CELL, V18, P4780, DOI 10.1091/mbc.E06-12-1144; de la Garza G, 2013, J INVEST DERMATOL, V133, P68, DOI 10.1038/jid.2012.269; Dong WJ, 2012, DIGEST DIS SCI, V57, P1247, DOI 10.1007/s10620-011-1989-z; Dong WJ, 2009, BIOCHEM BIOPH RES CO, V387, P132, DOI 10.1016/j.bbrc.2009.06.140; Du D, 2010, DEV CELL, V18, P52, DOI 10.1016/j.devcel.2009.12.008; Fanning AS, 2012, MOL BIOL CELL, V23, P577, DOI 10.1091/mbc.E11-09-0791; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Fortier AM, 2013, J BIOL CHEM, V288, P11555, DOI 10.1074/jbc.M112.428920; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Garside VC, 2010, EXP CELL RES, V316, P2859, DOI 10.1016/j.yexcr.2010.06.014; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Griffiths EK, 2003, MOL CELL BIOL, V23, P7708, DOI 10.1128/MCB.23.21.7708-7718.2003; Guo ZG, 2012, J PROTEOME RES, V11, P4847, DOI 10.1021/pr300674c; Hall MP, 2013, RNA, V19, P627, DOI 10.1261/rna.038422.113; Herath NI, 2009, BRIT J CANCER, V100, P1095, DOI 10.1038/sj.bjc.6604970; Inouye K, 2010, J BIOL CHEM, V285, P33394, DOI 10.1074/jbc.M110.115816; Juneja M, 2013, MOL ONCOL; Kandouz M, 2012, CANCER METAST REV, V31, P353, DOI 10.1007/s10555-012-9352-1; Karashima T, 2002, J CELL SCI, V115, P5027, DOI 10.1242/jcs.00191; Karp CM, 2008, CANCER RES, V68, P4105, DOI 10.1158/0008-5472.CAN-07-6814; Kashyap A, 2013, ONCOGENE, V32, P1396, DOI 10.1038/onc.2012.162; Kim G, 2013, PATHOBIOLOGY, V80, P95, DOI 10.1159/000342394; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kohn KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035716; Kohn KW, 2006, MOL BIOL CELL, V17, P1, DOI 10.1091/mbc.E05-09-0824; Kota P, 2012, BIOCHEMISTRY-US, V51, P3460, DOI 10.1021/bi2014773; Kroger C, 2013, J CELL BIOL; Lam L, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.4; Lawrence J, 2005, MOL PHARMACOL, V67, P1822, DOI 10.1124/mol.105.011338; Lefort CT, 2011, J BIOL CHEM, V286, P3149, DOI 10.1074/jbc.M110.115733; Lei Z, 2012, DEV BIOL; Lemmers C, 2004, MOL BIOL CELL, V15, P1324, DOI 10.1091/mbc.E03-04-0235; Lindsay AJ, 2009, CELL MOTIL CYTOSKEL, V66, P1057, DOI 10.1002/cm.20408; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; Lo FY, 2011, CANCER-AM CANCER SOC, V117, P5344, DOI 10.1002/cncr.26153; Luna A, 2011, BIOINFORMATICS, V27, P2165, DOI 10.1093/bioinformatics/btr336; Marino N, 2012, CANCER METAST REV, V31, P593, DOI 10.1007/s10555-012-9374-8; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Micaroni M, 2012, ADV EXP MED BIOL, V740, P439, DOI 10.1007/978-94-007-2888-2_18; Miller GS, 2012, CELL TISSUE RES; Moretti F, 2010, J CLIN INVEST, V120, P1570, DOI 10.1172/JCI40267; Musse AA, 2012, SEMIN CELL DEV BIOL, V23, P429, DOI 10.1016/j.semcdb.2012.01.011; Nair M, 2007, NUCLEIC ACIDS RES, V35, P1687, DOI 10.1093/nar/gkl1141; Nakatsukasa M, 2010, AM J PATHOL, V177, P1344, DOI 10.2353/ajpath.2010.100149; Nam KT, 2010, J CLIN INVEST, V120, P840, DOI 10.1172/JCI40728; Pai R, 2008, CANCER RES, V68, P5086, DOI 10.1158/0008-5472.CAN-07-2325; Paschoud S, 2011, MOL MEMBR BIOL, V28, P123, DOI 10.3109/09687688.2010.538937; Pellon-Cardenas O, 2013, MOL CELL BIOL, V33, P2963, DOI 10.1128/MCB.01698-12; Pestov NB, 2012, BIOCH BIOPHYS RES; Radomska KJ, 2013, HUM MOL GENET, V22, P1373, DOI 10.1093/hmg/dds553; Raleigh DR, 2010, MOL BIOL CELL, V21, P1200, DOI 10.1091/mbc.E09-08-0734; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Restivo G, 2011, EMBO J, V30, P4571, DOI 10.1038/emboj.2011.325; Rodgers LS, 2013, J CELL SCI, V126, P1565, DOI 10.1242/jcs.113399; Samson T, 2010, MOL BIOL CELL, V21, P1629, DOI 10.1091/mbc.E09-09-0809; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Schulzke JD, 2012, ANN NY ACAD SCI, V1257, P1, DOI 10.1111/j.1749-6632.2012.06485.x; Schweitzer JK, 2011, SEMIN CELL DEV BIOL, V22, P39, DOI 10.1016/j.semcdb.2010.09.002; Sen Arpita, 2012, Biomol Concepts, V3, P117; Senga K, 2012, MOL BIOL CELL, V23, P2845, DOI 10.1091/mbc.E12-02-0097; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; Shull GE, 2011, BIOFACTORS, V37, P150, DOI 10.1002/biof.141; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Steed E, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-95; Stein U, 2013, EXPERT OPIN THER TAR, V17, P1039, DOI 10.1517/14728222.2013.815727; Stein U, 2010, J MOL MED, V88, P11, DOI 10.1007/s00109-009-0537-1; Stein U, 2009, CELL CYCLE, V8, P2467, DOI 10.4161/cc.8.15.9018; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; Sumigray KD, 2012, MOL BIOL CELL, V23, P792, DOI 10.1091/mbc.E11-11-0923; Takahashi S, 2009, J CELL SCI, V122, P985, DOI 10.1242/jcs.040055; Thomson S, 2011, CLIN EXP METASTAS, V28, P137, DOI 10.1007/s10585-010-9367-3; Tokonzaba E, 2013, J INVEST DERMATOL; Tomar A, 2009, J BIOL CHEM, V284, P35278, DOI 10.1074/jbc.C109.060830; van de Graaf SFJ, 2006, J AM SOC NEPHROL, V17, P26, DOI 10.1681/ASN.2005101025; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Vuoriluoto K, 2010, ONCOGENE, V30, P1346; Wang HY, 2010, ONCOL REP, V23, P45, DOI 10.3892/or_00000604; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Wang Q, 2007, KIDNEY INT, V72, P1448, DOI 10.1038/sj.ki.5002579; Warzecha CC, 2012, SEMIN CANC BIOL; Weixel KM, 2007, J BIOL CHEM, V282, P36534, DOI 10.1074/jbc.M703970200; Wells J, 2009, J BIOL CHEM, V284, P29125, DOI 10.1074/jbc.M109.008847; Werner S, 2013, J BIOL CHEM, V288, P22993, DOI 10.1074/jbc.M113.456293; Westphal JK, 2010, CELL MOL LIFE SCI, V67, P2057, DOI 10.1007/s00018-010-0313-y; Wolting CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026248; Wu CJ, 2013, J BIOL CHEM; Wu D, 2010, J BIOL CHEM, V285, P28643, DOI 10.1074/jbc.M110.107649; Yamazaki T, 2009, J CELL SCI, V122, P243, DOI 10.1242/jcs.036467; Yokota T, 2006, ACTA NEUROPATHOL, V111, P29, DOI 10.1007/s00401-005-1085-6; Zhang P, 2012, MOL BIOL REP, V39, P1471, DOI 10.1007/s11033-011-0884-1; Zhang Y, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-23	117	59	59	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99269	10.1371/journal.pone.0099269	http://dx.doi.org/10.1371/journal.pone.0099269			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940735	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200017
J	Rice, MW; Smith, KL; Roberts, RC; Perez-Costas, E; Melendez-Ferro, M				Rice, Matthew W.; Smith, Kristen L.; Roberts, Rosalinda C.; Perez-Costas, Emma; Melendez-Ferro, Miguel			Assessment of Cytochrome C Oxidase Dysfunction in the Substantia Nigra/Ventral Tegmental Area in Schizophrenia	PLOS ONE			English	Article							MITOCHONDRIAL COMPLEX-I; OXIDATIVE-PHOSPHORYLATION; BASAL GANGLIA; BIPOLAR DISORDER; SUBUNIT-IV; MUTATION; PROTEIN; BRAIN; NEUROLEPTICS; INHIBITION	Perturbations in metabolism are a well-documented but complex facet of schizophrenia pathology. Optimal cellular performance requires the proper functioning of the electron transport chain, which is constituted by four enzymes located within the inner membrane of mitochondria. These enzymes create a proton gradient that is used to power the enzyme ATP synthase, producing ATP, which is crucial for the maintenance of cellular functioning. Anomalies in a single enzyme of the electron transport chain are sufficient to cause disruption of cellular metabolism. The last of these complexes is the cytochrome c oxidase (COX) enzyme, which is composed of thirteen different subunits. COX is a major site for oxidative phosphorylation, and anomalies in this enzyme are one of the most frequent causes of mitochondrial pathology. The objective of the present report was to assess if metabolic anomalies linked to COX dysfunction may contribute to substantia nigra/ventral tegmental area (SN/VTA) pathology in schizophrenia. We tested COX activity in postmortem SN/VTA from schizophrenia and non-psychiatric controls. We also tested the protein expression of key subunits for the assembly and activity of the enzyme, and the effect of antipsychotic medication on subunit expression. COX activity was not significantly different between schizophrenia and non-psychiatric controls. However, we found significant decreases in the expression of subunits II and IV-I of COX in schizophrenia. Interestingly, these decreases were observed in samples containing the entire rostro-caudal extent of the SN/VTA, while no significant differences were observed for samples containing only mid-caudal regions of the SN/VTA. Finally, rats chronically treated with antipsychotic drugs did not show significant changes in COX subunit expression. These findings suggest that COX subunit expression may be compromised in specific sub-regions of the SN/VTA (i.e. rostral regions), which may lead to a faulty assembly of the enzyme and a greater vulnerability to metabolic insult.	[Rice, Matthew W.; Smith, Kristen L.; Roberts, Rosalinda C.; Perez-Costas, Emma; Melendez-Ferro, Miguel] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Melendez-Ferro, M (corresponding author), Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA.	lampreas@gmail.com		PEREZ-COSTAS, EMMA/0000-0002-9050-9593; Rice, Matthew/0000-0002-8160-3297	NIH R01 grant [MH066123]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066123] Funding Source: NIH RePORTER	NIH R01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Work was supported by NIH R01 grant MH066123 to MMF, EPC and RCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril J, 2008, PROSTATE, V68, P1086, DOI 10.1002/pros.20771; Akil M, 1999, AM J PSYCHIAT, V156, P1580, DOI 10.1176/ajp.156.10.1580; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arnold RS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/239257; Augustine JR, 2008, HUMAN NEUROANATOMY, P49; Babcock DF, 1998, CURR OPIN NEUROBIOL, V8, P398, DOI 10.1016/S0959-4388(98)80067-6; Balijepalli S, 1999, NEUROPHARMACOLOGY, V38, P567, DOI 10.1016/S0028-3908(98)00215-9; Balijepalli S, 2001, NEUROCHEM INT, V38, P425, DOI 10.1016/S0197-0186(00)00108-X; Barksdale KA, 2010, FASEB J, V24, P3590, DOI 10.1096/fj.09-152108; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Ben-Shachar D, 2009, J NEURAL TRANSM, V116, P1383, DOI 10.1007/s00702-009-0319-5; Ben-Shachar D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003676; Brodin L, 1999, PHILOS T R SOC B, V354, P365, DOI 10.1098/rstb.1999.0388; Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546; BURKHARDT C, 1993, ANN NEUROL, V33, P512, DOI 10.1002/ana.410330516; Campbell N.A., 2006, BIOL EXPLORING LIFE; CAVELIER L, 1995, GENOMICS, V29, P217, DOI 10.1006/geno.1995.1234; Clark KM, 1999, AM J HUM GENET, V64, P1330, DOI 10.1086/302361; Crosby EC, 1943, J COMP NEUROL, V78, P441, DOI 10.1002/cne.900780311; DIVAC I, 1995, J NEUROSCI METH, V56, P105, DOI 10.1016/0165-0270(94)00112-T; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Francisconi S, 2006, J NEUROCHEM, V98, P223, DOI 10.1111/j.1471-4159.2006.03864.x; Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008; Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972; Haber SN, 1997, CRIT REV NEUROBIOL, V11, P323, DOI 10.1615/CritRevNeurobiol.v11.i4.40; Hall CN, 2012, J NEUROSCI, V32, P8940, DOI 10.1523/JNEUROSCI.0026-12.2012; Huttemann M, 2001, GENE, V267, P111, DOI 10.1016/S0378-1119(01)00385-7; Ivanova MM, 2011, FASEB J, V25, P1402, DOI 10.1096/fj.10-169029; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1; King L, 1999, SYNAPSE, V31, P67, DOI 10.1002/(SICI)1098-2396(199901)31:1<67::AID-SYN9>3.0.CO;2-#; Kolomeets NS, 1997, ZH NEVROPATOL PSIKH, V97, P39; Lee Y, 2013, NEUROSCI LETT, V535, P134, DOI 10.1016/j.neulet.2012.12.050; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Manatt M, 2011, J MED GENET GENOMIC, V3, P84; Manji H, 2012, NAT REV NEUROSCI, V13, P293, DOI 10.1038/nrn3229; Marin O, 1998, TRENDS NEUROSCI, V21, P487, DOI 10.1016/S0166-2236(98)01297-1; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; Maurer I, 1997, MOL CELL BIOCHEM, V174, P255, DOI 10.1023/A:1006872911332; Maurer I, 2001, SCHIZOPHR RES, V48, P125, DOI 10.1016/S0920-9964(00)00075-X; Melendez-Ferro M, 2013, J NEUROSCI METH, V214, P156, DOI 10.1016/j.jneumeth.2013.01.010; Michel H, 1998, ANNU REV BIOPH BIOM, V27, P329, DOI 10.1146/annurev.biophys.27.1.329; Mitchell T, 2013, BIOCHEM SOC T, V41, P127, DOI 10.1042/BST20120231; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Motulsky HJ, 2010, INTUITIVE BIOSTATIST; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Orth M, 2001, AM J MED GENET, V106, P27, DOI 10.1002/ajmg.1425; Paxinos G., 1995, ATLAS HUMAN BRAINSTE; PEL HJ, 1994, MOL BIOL REP, V19, P183, DOI 10.1007/BF00986960; Perez J, 2010, BIOCHEM J, V428, P255, DOI 10.1042/BJ20100090; Perez-Costas E, 2008, J NEURAL TRANSM, V115, P745, DOI 10.1007/s00702-007-0004-5; Perez-Costas Emma, 2012, Front Psychiatry, V3, P31, DOI 10.3389/fpsyt.2012.00031; Perez-Costas E, 2010, J NEUROCHEM, V113, P287, DOI 10.1111/j.1471-4159.2010.06604.x; Poeggeler B, 1998, DEV NEUROSCI-BASEL, V20, P146, DOI 10.1159/000017309; Prince JA, 1999, NEUROPSYCHOPHARMACOL, V21, P372, DOI 10.1016/S0893-133X(99)00016-0; Prince JA, 1997, J PHARMACOL EXP THER, V280, P261; Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590; Richman TR, 2014, NUCLEIC ACIDS RES, V42, P5483, DOI 10.1093/nar/gku179; Rollins B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004913; Rosenfeld M, 2011, BIOL PSYCHIAT, V69, P980, DOI 10.1016/j.biopsych.2011.01.010; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Saddar S, 2008, J BIOL CHEM, V283, P6677, DOI 10.1074/jbc.M708440200; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Somerville SM, 2012, SYNAPSE, V66, P29, DOI 10.1002/syn.20981; Somerville SM, 2011, SYNAPSE, V65, P215, DOI 10.1002/syn.20838; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Streck EL, 2007, N-S ARCH PHARMACOL, V376, P127, DOI 10.1007/s00210-007-0178-2; Taanman JW, 1997, J BIOENERG BIOMEMBR, V29, P151, DOI 10.1023/A:1022638013825; TAKAHASHI Y, 1953, Folia Psychiatr Neurol Jpn, V6, P244; Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Uranova N, 2001, BRAIN RES BULL, V55, P597, DOI 10.1016/S0361-9230(01)00528-7; URANOVA NA, 1989, ZH NEVROPATOL PSIKH, V89, P56; VANDOMBURG PHMF, 1991, ADV ANAT EMBRYOL CEL, V121, P1; Verkhovsky MI, 1999, NATURE, V400, P480, DOI 10.1038/22813; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Volz HP, 2000, BIOL PSYCHIAT, V47, P954, DOI 10.1016/S0006-3223(00)00235-3; Whatley SA, 1996, NEUROCHEM RES, V21, P995, DOI 10.1007/BF02532409; Whatley SA, 1998, MOL PSYCHIATR, V3, P227, DOI 10.1038/sj.mp.4000375; You KR, 2002, J BIOL CHEM, V277, P3870, DOI 10.1074/jbc.M109284200	81	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100054	10.1371/journal.pone.0100054	http://dx.doi.org/10.1371/journal.pone.0100054			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941246	gold, Green Submitted, Green Published			2022-12-25	WOS:000338508200070
J	Rees, JR; Zens, MS; Gui, J; Celaya, MO; Riddle, BL; Karagas, MR				Rees, Judy R.; Zens, M. Scot; Gui, Jiang; Celaya, Maria O.; Riddle, Bruce L.; Karagas, Margaret R.			Non Melanoma Skin Cancer and Subsequent Cancer Risk	PLOS ONE			English	Article							BASAL-CELL CARCINOMA; 2ND PRIMARY CANCERS; CUTANEOUS MALIGNANT-MELANOMA; IN-SITU; PROSPECTIVE COHORT; GENE VARIANTS; UNITED-STATES; NONMELANOMA; DIAGNOSIS; ASSOCIATION	Introduction: Several studies have shown an increased risk of cancer after non melanoma skin cancers (NMSC) but the individual risk factors underlying this risk have not been elucidated, especially in relation to sun exposure and skin sensitivity to sunlight. Purpose: The aim of this study was to examine the individual risk factors associated with the development of subsequent cancers after non melanoma skin cancer. Methods: Participants in the population-based New Hampshire Skin Cancer Study provided detailed risk factor data, and subsequent cancers were identified via linkage with the state cancer registry. Deaths were identified via state and national death records. A Cox proportional hazard model was used to estimate risk of subsequent malignancies in NMSC patients versus controls and to assess the potential confounding effects of multiple risk factors on this risk. Results: Among 3584 participants, risk of a subsequent cancer (other than NMSC) was higher after basal cell carcinoma (BCC) (adjusted HR 1.40 [95% CI 1.15, 1.71]) than squamous cell carcinoma (SCC) (adjusted HR 1.18 [95% CI 0.95, 1.46]) compared to controls (adjusted for age, sex and current cigarette smoking). After SCC, risk was higher among those diagnosed before age 60 (HR 1.96 [95% CI 1.24, 3.12]). An over 3-fold risk of melanoma after SCC (HR 3.62; 95% CI 1.85, 7.11) and BCC (HR 3.28; 95% CI 1.66, 6.51) was observed, even after further adjustment for sun exposure-related factors and family history of skin cancer. In men, prostate cancer incidence was higher after BCC compared to controls (HR 1.64; 95% CI 1.10, 2.46). Conclusions: Our population-based study indicates an increased cancer risk after NMSC that cannot be fully explained by known cancer risk factors.	[Rees, Judy R.; Zens, M. Scot; Gui, Jiang; Celaya, Maria O.; Riddle, Bruce L.; Karagas, Margaret R.] Geisel Sch Med Dartmouth, Dept Community & Family Med, Biostat & Epidemiol Sect, Lebanon, NH 03756 USA; [Rees, Judy R.; Celaya, Maria O.; Riddle, Bruce L.] New Hampshire State Canc Registry, Hanover, NH USA	Dartmouth College	Rees, JR (corresponding author), Geisel Sch Med Dartmouth, Dept Community & Family Med, Biostat & Epidemiol Sect, Lebanon, NH 03756 USA.	judy.rees@dartmouth.edu			American Cancer Society [RSGHP-08-004-01-CPHPS]; National Cancer Institute, National Institutes of Health [CA057494]; Centers for Disease Control and Prevention [UA/DP003930-01]; NATIONAL CANCER INSTITUTE [R01CA057494, P30CA023108] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by a Research Scholars Grant of the American Cancer Society RSGHP-08-004-01-CPHPS; by Grant CA057494 of the National Cancer Institute, National Institutes of Health, and in part by the Centers for Disease Control and Prevention's National Program of Cancer Registries, cooperative agreement UA/DP003930-01 awarded to the New Hampshire Department of Health and Human Services, Division of Public Health Services, Bureau of Public Health Statistics and Informatics, Office of Health Statistics and Data Management. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or NH Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athas WF, 2003, CANCER EPIDEM BIOMAR, V12, P1105; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P556; Bower CPR, 2000, J AM ACAD DERMATOL, V42, P988, DOI 10.1016/S0190-9622(00)90291-3; Brewster AM, 2004, CANCER EPIDEM BIOMAR, V13, P1271; Chen J, 2008, JNCI-J NATL CANCER I, V100, P1215, DOI 10.1093/jnci/djn260; Cho EY, 2005, CANCER EPIDEM BIOMAR, V14, P1241, DOI 10.1158/1055-9965.EPI-04-0632; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Crocetti E, 2004, EUR J CANCER PREV, V13, P33, DOI 10.1097/00008469-200402000-00006; Efird JT, 2002, ANN EPIDEMIOL, V12, P469, DOI 10.1016/S1047-2797(01)00276-9; Friedman GD, 2000, CANCER CAUSE CONTROL, V11, P891, DOI 10.1023/A:1026591016153; Frisch M, 1996, ANN INTERN MED, V125, P815, DOI 10.7326/0003-4819-125-10-199611150-00005; FRISCH M, 1995, AM J EPIDEMIOL, V141, P916, DOI 10.1093/oxfordjournals.aje.a117358; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Havener LE, 2004, STANDARDS CANC REGIS; Hemminki K, 2000, ARCH DERMATOL, V136, P647, DOI 10.1001/archderm.136.5.647; Hemminki K, 2000, EPIDEMIOLOGY, V11, P309, DOI 10.1097/00001648-200005000-00014; Hemminki K, 2003, CANCER-AM CANCER SOC, V97, P2432, DOI 10.1002/cncr.11372; Hsu LI, 2013, AM J EPIDEMIOL, V177, P202, DOI 10.1093/aje/kws369; Jorgensen TJ, 2012, CANCER EPIDEMIOL, V36, pE288, DOI 10.1016/j.canep.2012.05.001; Jung GW, 2014, BRIT J DERMATOL, V170, P136, DOI 10.1111/bjd.12694; KALDOR J, 1993, INT J CANCER, V53, P886, DOI 10.1002/ijc.2910530603; Karagas MR, 1998, CANCER EPIDEM BIOMAR, V7, P157; Karagas MR, 1999, INT J CANCER, V81, P555, DOI 10.1002/(SICI)1097-0215(19990517)81:4<555::AID-IJC9>3.0.CO;2-R; Levi F, 1996, BRIT J CANCER, V74, P1847, DOI 10.1038/bjc.1996.642; Levi F, 1997, AM J EPIDEMIOL, V146, P734; LINDELOF B, 1991, J AM ACAD DERMATOL, V25, P245, DOI 10.1016/0190-9622(91)70189-9; Maitra SK, 2005, BRIT J CANCER, V92, P570, DOI 10.1038/sj.bjc.6602306; Milan T, 2000, INT J CANCER, V87, P283, DOI 10.1002/1097-0215(20000715)87:2<283::AID-IJC21>3.0.CO;2-I; Nugent Z, 2005, CANCER EPIDEM BIOMAR, V14, P2584, DOI 10.1158/1055-9965.EPI-05-0379; Ong ELH, 2014, CANCER EPIDEM BIOMAR, V23, P490, DOI 10.1158/1055-9965.EPI-13-0902; Robinson SN, 2013, J INVEST DERMATOL, V133, P1950, DOI 10.1038/jid.2013.33; Roh MR, 2012, J DERMATOL, V39, P541, DOI 10.1111/j.1346-8138.2011.01495.x; Rosenberg CA, 2004, CANCER, V100, P130, DOI 10.1002/cncr.11874; Ruczinski I, 2012, CARCINOGENESIS, V33, P1692, DOI 10.1093/carcin/bgs170; Song FJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001433; TEPPO L, 1985, J NATL CANCER I, V75, P207; Thompson CA, 2013, EUR J EPIDEMIOL, V28, P557, DOI 10.1007/s10654-013-9812-0; Thornton M, 2011, STANDARDS CANC REGIS; Troyanova P, 2002, NEOPLASMA, V49, P81; U. S. Cancer Statistics Working Group, 2010, US CANC STAT 1999 20; Walls AC, 2013, AM J EPIDEMIOL, V177, P997, DOI 10.1093/aje/kws335; Wassberg C, 1996, BRIT J CANCER, V73, P255, DOI 10.1038/bjc.1996.45; Wassberg C, 1999, INT J CANCER, V80, P511, DOI 10.1002/(SICI)1097-0215(19990209)80:4<511::AID-IJC5>3.3.CO;2-G; WEINSTOCK MA, 1993, ARCH DERMATOL, V129, P1286, DOI 10.1001/archderm.129.10.1286; Wheless L, 2010, CANCER EPIDEM BIOMAR, V19, P1686, DOI 10.1158/1055-9965.EPI-10-0243	45	52	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99674	10.1371/journal.pone.0099674	http://dx.doi.org/10.1371/journal.pone.0099674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937304	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400031
J	Zeisset, I; Beebee, TJC				Zeisset, Inga; Beebee, Trevor J. C.			Drift Rather than Selection Dominates MHC Class II Allelic Diversity Patterns at the Biogeographical Range Scale in Natterjack Toads Bufo calamita	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; BATRACHOCHYTRIUM-DENDROBATIDIS; MOLECULAR CHARACTERIZATION; POPULATION-STRUCTURE; BETA-CHAIN; AMPHIBIAN CHYTRIDIOMYCOSIS; MICROSATELLITE LOCI; NATURAL-SELECTION; GENETIC-VARIATION; COMMON FROG	Study of major histocompatibility complex (MHC) loci has gained great popularity in recent years, partly due to their function in protecting vertebrates from infections. This is of particular interest in amphibians on account of major threats many species face from emergent diseases such as chytridiomycosis. In this study we compare levels of diversity in an expressed MHC class II locus with neutral genetic diversity at microsatellite loci in natterjack toad (Bufo (Epidalea) calamita) populations across the whole of the species' biogeographical range. Variation at both classes of loci was high in the glacial refugium areas (REF) and much lower in postglacial expansion areas (PGE), especially in range edge populations. Although there was clear evidence that the MHC locus was influenced by positive selection in the past, congruence with the neutral markers suggested that historical demographic events were the main force shaping MHC variation in the PGE area. Both neutral and adaptive genetic variation declined with distance from glacial refugia. Nevertheless, there were also some indications from differential isolation by distance and allele abundance patterns that weak effects of selection have been superimposed on the main drift effect in the PGE zone.	[Zeisset, Inga] Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England; [Zeisset, Inga; Beebee, Trevor J. C.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Brighton; University of Sussex	Zeisset, I (corresponding author), Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England.	i.zeisset@brighton.ac.uk		Zeisset, Inga/0000-0002-4474-1527	Leverhulme trust [F/00230/AH]	Leverhulme trust(Leverhulme Trust)	This research was funded by the Leverhulme trust (http://www.leverhulme.ac.uk). Grant number: F/00230/AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre C, 2011, HEREDITY, V106, P270, DOI 10.1038/hdy.2010.71; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Babik W, 2009, MOL ECOL, V18, P769, DOI 10.1111/j.1365-294X.2008.04057.x; Babik W, 2008, MOL ECOL, V17, P2339, DOI 10.1111/j.1365-294X.2008.03757.x; Babik W, 2010, MOL ECOL RESOUR, V10, P237, DOI 10.1111/j.1755-0998.2009.02788.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; Beebee TJC, 2000, BIOL J LINN SOC, V69, P367, DOI 10.1111/j.1095-8312.2000.tb01211.x; Bonneaud C, 2006, EVOLUTION, V60, P383, DOI 10.1111/j.0014-3820.2006.tb01114.x; Bos DH, 2005, IMMUNOGENETICS, V57, P775, DOI 10.1007/s00251-005-0038-5; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Campos JL, 2006, CONSERV GENET, V7, P515, DOI 10.1007/s10592-005-9063-z; Cheng YY, 2012, IMMUNOGENETICS, V64, P525, DOI 10.1007/s00251-012-0614-4; de Bellocq JG, 2008, J EVOLUTION BIOL, V21, P1144, DOI 10.1111/j.1420-9101.2008.01538.x; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dionne M, 2007, EVOLUTION, V61, P2154, DOI 10.1111/j.1558-5646.2007.00178.x; Eimes JA, 2011, J EVOLUTION BIOL, V24, P1847, DOI 10.1111/j.1420-9101.2011.02311.x; ELLEGREN H, 1993, P NATL ACAD SCI USA, V90, P8150, DOI 10.1073/pnas.90.17.8150; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Froeschke G, 2005, MOL BIOL EVOL, V22, P1254, DOI 10.1093/molbev/msi112; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Gahl MK, 2012, CONSERV BIOL, V26, P135, DOI 10.1111/j.1523-1739.2011.01801.x; Garrigan D, 2003, EVOLUTION, V57, P1707; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Graybeal A, 1997, ZOOL J LINN SOC-LOND, V119, P297, DOI 10.1111/j.1096-3642.1997.tb00139.x; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hauswaldt JS, 2007, IMMUNOGENETICS, V59, P479, DOI 10.1007/s00251-007-0210-1; Hedrick PW, 2001, TRENDS ECOL EVOL, V16, P629, DOI 10.1016/S0169-5347(01)02282-0; HEDRICK PW, 1994, AM NAT, V143, P945, DOI 10.1086/285643; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hidalgo-Vila J, 2012, DIS AQUAT ORGAN, V98, P113, DOI 10.3354/dao02419; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; JUKES T H, 1969, P21; Kiemnec-Tyburczy KM, 2010, IMMUNOGENETICS, V62, P741, DOI 10.1007/s00251-010-0476-6; Kiemnec-Tyburczy KM, 2012, CONSERV GENET, V5, P109; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klein J, 1998, SCAND J IMMUNOL, V47, P199; KOBARI F, 1995, IMMUNOGENETICS, V42, P376, DOI 10.1007/BF00179399; Kobari F., 1995, Zoological Science (Tokyo), V12, P38; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Landry C, 2001, MOL ECOL, V10, P2525, DOI 10.1046/j.1365-294X.2001.01383.x; Langefors A, 2001, P ROY SOC B-BIOL SCI, V268, P479, DOI 10.1098/rspb.2000.1378; Laurens V, 2001, EUR J IMMUNOL, V31, P506, DOI 10.1002/1521-4141(200102)31:2<506::AID-IMMU506>3.0.CO;2-P; Lillie M, 2012, J HERED, V103, P467, DOI 10.1093/jhered/ess012; Male PJG, 2012, BIOL J LINN SOC, V105, P881, DOI 10.1111/j.1095-8312.2011.01799.x; Marsden CD, 2012, MOL ECOL, V21, P1379, DOI 10.1111/j.1365-294X.2012.05477.x; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; May S, 2009, CONSERV GENET RESOUR, V1, P415, DOI 10.1007/s12686-009-9096-6; Meyer-Lucht Y, 2005, MOL ECOL, V14, P2233, DOI 10.1111/j.1365-294X.2005.02557.x; Meyer-Lucht Y, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-39; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 2000, MOL EVOLUTION PHYLOG; Ohashi J, 2006, TISSUE ANTIGENS, V68, P427, DOI 10.1111/j.1399-0039.2006.00688.x; Ohta Y, 2006, J IMMUNOL, V176, P3674, DOI 10.4049/jimmunol.176.6.3674; Oliver MK, 2012, MOL BIOL EVOL, V29, P1713, DOI 10.1093/molbev/mss063; Oliver MK, 2009, MOL ECOL, V18, P80, DOI 10.1111/j.1365-294X.2008.04015.x; Osborne AJ, 2013, HEREDITY, V111, P44, DOI 10.1038/hdy.2013.18; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Ploshnitsa AI, 2012, ECOL EVOL, V2, P165, DOI 10.1002/ece3.42; Posada D, 2002, MOL BIOL EVOL, V19, P708, DOI 10.1093/oxfordjournals.molbev.a004129; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Richmond JQ, 2009, BIOSCIENCE, V59, P311, DOI 10.1525/bio.2009.59.4.9; Rowe G, 2006, MOL PHYLOGENET EVOL, V39, P335, DOI 10.1016/j.ympev.2005.08.021; Sato A, 2011, MOL BIOL EVOL, V28, P1943, DOI 10.1093/molbev/msr015; SATO K, 1993, J IMMUNOL, V150, P2831; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Schad J, 2011, HEREDITY, V107, P115, DOI 10.1038/hdy.2010.173; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Shafer ABA, 2012, J HERED, V103, P371, DOI 10.1093/jhered/esr138; Simkova A, 2006, EVOL ECOL, V20, P465, DOI 10.1007/s10682-006-0014-z; SMITH JM, 1992, J MOL EVOL, V34, P126; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sunnucks P, 2000, MOL ECOL, V9, P1699, DOI 10.1046/j.1365-294x.2000.01084.x; Sutton JT, 2011, MOL ECOL, V20, P4408, DOI 10.1111/j.1365-294X.2011.05292.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036748; Tong Joo Chuan, 2006, Immunome Res, V2, P1, DOI 10.1186/1745-7580-2-1; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Walker SF, 2010, ECOL LETT, V13, P372, DOI 10.1111/j.1461-0248.2009.01434.x; Wegner KM, 2003, J EVOLUTION BIOL, V16, P224, DOI 10.1046/j.1420-9101.2003.00519.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Whittaker JC, 2003, GENETICS, V164, P781; Zeisset I, 2008, HEREDITY, V101, P109, DOI 10.1038/hdy.2008.30; Zeisset I, 2013, ANIM CONSERV, V16, P359, DOI 10.1111/acv.12003; Zeisset I, 2010, HEREDITY, V104, P423, DOI 10.1038/hdy.2009.157; Zeisset I, 2009, MOL ECOL RESOUR, V9, P738, DOI 10.1111/j.1755-0998.2009.02535.x; Zeisset I, 2013, CONSERV GENET RESOUR, V5, P211, DOI 10.1007/s12686-012-9770-y; ZUCKERKANDL EMILE, 1965, P97	104	21	21	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100176	10.1371/journal.pone.0100176	http://dx.doi.org/10.1371/journal.pone.0100176			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937211	gold, Green Submitted, Green Published			2022-12-25	WOS:000338503400086
J	Goncalves, MD; Delattre, C; Balestrino, D; Charbonnel, N; Elboutachfaiti, R; Wadouachi, A; Badel, S; Bernardi, T; Michaud, P; Forestier, C				Goncalves, Marina Dos Santos; Delattre, Cedric; Balestrino, Damien; Charbonnel, Nicolas; Elboutachfaiti, Redouan; Wadouachi, Anne; Badel, Stephanie; Bernardi, Thierry; Michaud, Philippe; Forestier, Christiane			Anti-Biofilm Activity: A Function of Klebsiella pneumoniae Capsular Polysaccharide	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; EXOPOLYSACCHARIDES; INHIBITION; EXPRESSION; BACTERIA	Competition and cooperation phenomena occur within highly interactive biofilm communities and several non-biocides molecules produced by microorganisms have been described as impairing biofilm formation. In this study, we investigated the anti-biofilm capacities of an ubiquitous and biofilm producing bacterium, Klebsiella pneumoniae. Cell-free supernatant from K. pneumoniae planktonic cultures showed anti-biofilm effects on most Gram positive bacteria tested but also encompassed some Gram negative bacilli. The anti-biofilm non-bactericidal activity was further investigated on Staphylococcus epidermidis, by determining the biofilm biomass, microscopic observations and agglutination measurement through a magnetic bead-mediated agglutination test. Cell-free extracts from K. pneumoniae biofilm (supernatant and acellular matrix) also showed an influence, although to a lesser extend. Chemical analyses indicated that the active molecule was a high molecular weight polysaccharide composed of five monosaccharides: galactose, glucose, rhamnose, glucuronic acid and glucosamine and the main following sugar linkage residues [-> 2)-alpha-L-Rhap-(1 ->]; [-> 4)-alpha-L-Rhap-(1 ->]; [alpha-D-Galp-(1 ->]; [-> 2,3)-alpha-D-Galp-(1 ->]; [-> 3)-beta-D-Galp-(1 ->] and, [-> 4)-beta-D-GlcAp-(1 ->]. Characterization of this molecule indicated that this component was more likely capsular polysaccharide (CPS) and precoating of abiotic surfaces with CPS extracts from different serotypes impaired the bacteria-surface interactions. Thus the CPS of Klebsiella would exhibit a pleiotropic activity during biofilm formation, both stimulating the initial adhesion and maturation steps as previously described, but also repelling potential competitors.	[Goncalves, Marina Dos Santos; Balestrino, Damien; Charbonnel, Nicolas; Forestier, Christiane] Univ Auvergne, Lab Microorganismes Genome Environm LMGE, Clermont Univ, CNRS,UMR 6023, Clermont Ferrand, France; [Delattre, Cedric; Michaud, Philippe] Univ Blaise Pascal, Clermont Univ, Inst Pascal, CNRS,Polytech Clermont Ferrand,UMR 6602, Aubiere, France; [Elboutachfaiti, Redouan] Univ Picardie, IUT Amiens GB, EA BioPI Biol Plantes & Innovat 3900, Amiens, France; [Wadouachi, Anne] Univ Picardie, Inst Chim Picardie, Lab Glucides, FRE CNRS 3517,FR 3085, Amiens, France; [Badel, Stephanie; Bernardi, Thierry] BioFilm Control, Biopole Clermont Limagne, St Beauzire, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite Clermont Auvergne (UCA); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Forestier, C (corresponding author), Univ Auvergne, Lab Microorganismes Genome Environm LMGE, Clermont Univ, CNRS,UMR 6023, Clermont Ferrand, France.	christiane.forestier@udamail.fr	Michaud, Philippe/U-1844-2019; Michaud, Philippe/U-1042-2019	Michaud, Philippe/0000-0002-6677-4549; BALESTRINO, Damien/0000-0001-5378-0379; Delattre, cedric/0000-0003-3605-1929; Badel-Berchoux, stephanie/0000-0002-7212-8199	Region Auvergn-FEDER	Region Auvergn-FEDER(Region Auvergne-Rhone-AlpesRegion Bourgogne-Franche-ComteRegion Hauts-de-FranceRegion Nouvelle-Aquitaine)	This work was partially supported by a fellowship from the Region Auvergn-FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Other source of funding was non-specific and internal to our organization.	Augustine N, 2010, ARCH MICROBIOL, V192, P1019, DOI 10.1007/s00203-010-0633-1; Balestrino D, 2005, J BACTERIOL, V187, P2870, DOI 10.1128/JB.187.8.2870-2880.2005; Balestrino D, 2008, ENVIRON MICROBIOL, V10, P685, DOI 10.1111/j.1462-2920.2007.01491.x; Bazaka K, 2011, ADV EXP MED BIOL, V715, P213, DOI 10.1007/978-94-007-0940-9_13; Bendaoud M, 2011, J BACTERIOL, V193, P3879, DOI 10.1128/JB.00311-11; Chavant P, 2007, J MICROBIOL METH, V68, P605, DOI 10.1016/j.mimet.2006.11.010; Chou HC, 2004, INFECT IMMUN, V72, P3783, DOI 10.1128/IAI.72.7.3783-3792.2004; Coghlan A, 1996, NEW SCI, V2045, P34; Cugini C, 2007, MOL MICROBIOL, V65, P896, DOI 10.1111/j.1365-2958.2007.05840.x; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; De Araujo C, 2010, RES MICROBIOL, V161, P595, DOI 10.1016/j.resmic.2010.05.014; DOMENICO P, 1989, J MICROBIOL METH, V9, P211, DOI 10.1016/0167-7012(89)90038-9; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Evrard B, 2010, INFECT IMMUN, V78, P210, DOI 10.1128/IAI.00864-09; Favre-Bonte S., 1998, Journal of Antimicrobial Chemotherapy, V41, P51, DOI 10.1093/jac/41.suppl_2.51; Hennequin C, 2007, RES MICROBIOL, V158, P339, DOI 10.1016/j.resmic.2007.02.005; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Jiang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018514; Kachlany SC, 2001, ENVIRON MICROBIOL, V3, P774, DOI 10.1046/j.1462-2920.2001.00248.x; Kanmani P, 2011, BIORESOURCE TECHNOL, V102, P4827, DOI 10.1016/j.biortech.2010.12.118; Kaplan JB, 2003, J BACTERIOL, V185, P4693, DOI 10.1128/JB.185.16.4693-4698.2003; Karwacki MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063844; Kim Y, 2009, BIOCHEM BIOPH RES CO, V379, P324, DOI 10.1016/j.bbrc.2008.12.053; Kubler-Kielb J, 2013, CARBOHYD RES, V369, P6, DOI 10.1016/j.carres.2012.12.018; McAlester G, 2008, J MED MICROBIOL, V57, P563, DOI 10.1099/jmm.0.47705-0; Moons P, 2009, CRIT REV MICROBIOL, V35, P157, DOI 10.1080/10408410902809431; Murray EGD, 1926, J PATHOL BACTERIOL, V29, P407, DOI 10.1002/path.1700290409; Nielsen AT, 2000, ENVIRON MICROBIOL, V2, P59, DOI 10.1046/j.1462-2920.2000.00084.x; Pihl M, 2010, FEMS IMMUNOL MED MIC, V59, P439, DOI 10.1111/j.1574-695X.2010.00697.x; Qin ZQ, 2009, MICROBIOL-SGM, V155, P2148, DOI 10.1099/mic.0.028001-0; Rendueles O, 2013, ENVIRON MICROBIOL, V15, P334, DOI 10.1111/j.1462-2920.2012.02810.x; Rendueles O, 2012, FEMS MICROBIOL REV, V36, P972, DOI 10.1111/j.1574-6976.2012.00328.x; Rendueles O, 2011, MBIO, V2, DOI 10.1128/mBio.00043-11; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1016/0378-1097(80)90106-8; Sayem S M Abu, 2011, Microb Cell Fact, V10, P74, DOI 10.1186/1475-2859-10-74; Schembri MA, 2005, INFECT IMMUN, V73, P4626, DOI 10.1128/IAI.73.8.4626-4633.2005; Schembri MA, 2004, J BACTERIOL, V186, P1249, DOI 10.1128/JB.186.5.1249-1257.2004; Schollmeyer M, 2012, INT J BIOL MACROMOL, V50, P518, DOI 10.1016/j.ijbiomac.2012.01.003; Stenutz R, 1997, CARBOHYD RES, V302, P79, DOI 10.1016/S0008-6215(97)00106-7; Sugimoto S, 2013, J BACTERIOL, V195, P1645, DOI 10.1128/JB.01672-12; Travier L, 2013, ANTIMICROB AGENTS CH, V57, P3960, DOI 10.1128/AAC.02606-12; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; Valle J, 2006, P NATL ACAD SCI USA, V103, P12558, DOI 10.1073/pnas.0605399103; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Zhao K, 2013, NATURE, V497, P388, DOI 10.1038/nature12155	49	37	38	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99995	10.1371/journal.pone.0099995	http://dx.doi.org/10.1371/journal.pone.0099995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932475	Green Published, gold, Green Submitted			2022-12-25	WOS:000337738600084
J	Das, NS; Usman, J; Choudhury, D; Abu Osman, NA				Das, Nabangshu S.; Usman, Juliana; Choudhury, Dipankar; Abu Osman, Noor Azuan			Nature and Pattern of Cricket Injuries: The Asian Cricket Council Under-19, Elite Cup, 2013	PLOS ONE			English	Article							INTERVENTION; PERIOD	Cricket has over the years gained much popularity in Asia, thus the number of cricket players has also grown in tandem. However, cricket players are not as fortunate as other athletes as they do not always have a standard cricket infrastructure to practice; therefore, the injury prevalence is expected to be high. Unfortunately, very few studies have been conducted to investigate the nature and pattern of cricket injuries prevalent to cricketers in this region. Therefore, a prospective cohort injury surveillance study was conducted during the Asian Cricket Council (ACC) Under-19 Elite Cup held in June 2013 in order to gather more data on the type of injuries sustained by cricket players. Overall, 31 injuries occurred to 28 players throughout the tournament, of which 7 injuries happened during practice sessions. The overall injury incidence rate (IIR) was 292.0 per 10,000 player hours (95% CI 176.9-407.1) and 10.4 per 10,000 balls faced and 2.6 per 1000 overs bowled delivered during batting and bowling, respectively. Injuries to the lower limb (IIR: 146; 95% CI 1.8-98.2) were the most frequent, followed by injuries to the upper limb (97.3; 95% CI 30.2-164.5) and to the trunk and back (IIR: 36.5; 95% CI 0.0-77.7). Sprain/strains (IIR 109.5; 95% CI 38.4-180.7) to muscle/tendon and joint/ligament were the most commonly reported nature of injury. This is the first study investigating injury incidence among the players of the ACC. It provides an overview of injuries sustained by elite players' under-19 years of age from 10 Asian countries. The overall IIR is similar to earlier studies conducted in well-established cricket playing nations.	[Das, Nabangshu S.; Usman, Juliana; Abu Osman, Noor Azuan] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia; [Usman, Juliana; Abu Osman, Noor Azuan] Univ Malaya, Ctr Appl Biomech, Kuala Lumpur, Malaysia; [Choudhury, Dipankar] Brno Univ Technol, Fac Mech Engn, CS-61090 Brno, Czech Republic; [Choudhury, Dipankar] Brno Univ Technol, CEITEC Cent European Inst Technol, CS-61090 Brno, Czech Republic	Universiti Malaya; Universiti Malaya; Brno University of Technology; Brno University of Technology	Usman, J (corresponding author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia.	juliana_78@um.edu.my	USMAN, JULIANA/B-8725-2010; ABU OSMAN, NOOR AZUAN/B-9265-2010	USMAN, JULIANA/0000-0001-8983-0892; ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421	High Impact Research Grant [UM.C/HIR/MOHE/ENG/10]; Bantuan Kecil Penyelidikan (BKP) fund from the University of Malaya [BK024-2012]	High Impact Research Grant; Bantuan Kecil Penyelidikan (BKP) fund from the University of Malaya	These works are supported by the High Impact Research Grant UM.C/HIR/MOHE/ENG/10 and by Bantuan Kecil Penyelidikan (BKP) fund BK024-2012 from the University of Malaya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dennis R, 2005, BRIT J SPORT MED, V39, P834; Dennis RJ, 2008, BRIT J SPORT MED, V42, P477, DOI 10.1136/bjsm.2008.046698; Dhillon MS, 2012, SPORTS MED ARTHROSC, V4, P1; Elliot B, 1995, SPORTS EXERC INJ, V1, P201; Elliott BC, 2007, MED SCI SPORTS EXERC, V34, P1714; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Finch CF, 2010, J SCI MED SPORT, V13, P489, DOI 10.1016/j.jsams.2009.10.489; Frost WL, 2014, BRIT J SPORT MED, V48, P1002, DOI 10.1136/bjsports-2012-091337; Mansingh A, 2006, BRIT J SPORT MED, V40, P119, DOI 10.1136/bjsm.2005.019414; Orchard J, 2005, J SCI MED SPORT, V8, P1, DOI 10.1016/S1440-2440(05)80019-2; Orchard J, 2010, OPEN ACCESS J SPORTS, V1, P63; Orchard JW, 2006, J SCI MED SPORT, V9, P459, DOI 10.1016/j.jsams.2006.05.001; Ranson C, 2011, BRIT J SPORT MED, V47, P637; Ranson C, 2009, SPORT BIOMECH, V8, P261, DOI 10.1080/14763140903469908; Stretch RA, 2003, BRIT J SPORT MED, V37, P250, DOI 10.1136/bjsm.37.3.250; Stretch RA., 2011, S AFR J SPORTS MED, V23, P45; Twomey DM, 2012, J SCI MED SPORT, V15, P110, DOI 10.1016/j.jsams.2011.08.005; Wallis R, 2002, J SPORT SCI, V20, P495, DOI 10.1080/02640410252925161	18	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100028	10.1371/journal.pone.0100028	http://dx.doi.org/10.1371/journal.pone.0100028			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927127	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100108
J	Drouet, V; Ruiz, M; Zala, D; Feyeux, M; Auregan, G; Cambon, K; Troquier, L; Carpentier, J; Aubert, S; Merienne, N; Bourgois-Rocha, F; Hassig, R; Rey, M; Dufour, N; Saudou, F; Perrier, AL; Hantraye, P; Deglon, N				Drouet, Valerie; Ruiz, Marta; Zala, Diana; Feyeux, Maxime; Auregan, Gwennaelle; Cambon, Karine; Troquier, Laetitia; Carpentier, Johann; Aubert, Sophie; Merienne, Nicolas; Bourgois-Rocha, Fany; Hassig, Raymonde; Rey, Maria; Dufour, Noelle; Saudou, Frederic; Perrier, Anselme L.; Hantraye, Philippe; Deglon, Nicole			Allele-Specific Silencing of Mutant Huntingtin in Rodent Brain and Human Stem Cells	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; RNA INTERFERENCE; LENTIVIRAL VECTOR; GENE-THERAPY; NEUROLOGICAL DISORDERS; POLYGLUTAMINE REPEAT; PARKINSONS-DISEASE; MOUSE MODEL; EXPRESSION; DERIVATION	Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder resulting from polyglutamine expansion in the huntingtin (HTT) protein and for which there is no cure. Although suppression of both wild type and mutant HTT expression by RNA interference is a promising therapeutic strategy, a selective silencing of mutant HTT represents the safest approach preserving WT HTT expression and functions. We developed small hairpin RNAs (shRNAs) targeting single nucleotide polymorphisms (SNP) present in the HTT gene to selectively target the disease HTT isoform. Most of these shRNAs silenced, efficiently and selectively, mutant HTT in vitro. Lentiviral-mediated infection with the shRNAs led to selective degradation of mutant HTT mRNA and prevented the apparition of neuropathology in HD rat's striatum expressing mutant HTT containing the various SNPs. In transgenic BACHD mice, the mutant HTT allele was also silenced by this approach, further demonstrating the potential for allele-specific silencing. Finally, the allele-specific silencing of mutant HTT in human embryonic stem cells was accompanied by functional recovery of the vesicular transport of BDNF along microtubules. These findings provide evidence of the therapeutic potential of allele-specific RNA interference for HD.	[Drouet, Valerie; Ruiz, Marta; Auregan, Gwennaelle; Cambon, Karine; Carpentier, Johann; Hassig, Raymonde; Dufour, Noelle; Hantraye, Philippe; Deglon, Nicole] CEA, Inst Biomed Imaging I2BM, Fontenay Aux Roses, France; [Drouet, Valerie; Ruiz, Marta; Auregan, Gwennaelle; Cambon, Karine; Carpentier, Johann; Hassig, Raymonde; Dufour, Noelle; Hantraye, Philippe; Deglon, Nicole] CEA, Mol Imaging Res Ctr MIRCen, Fontenay Aux Roses, France; [Drouet, Valerie; Ruiz, Marta; Auregan, Gwennaelle; Cambon, Karine; Carpentier, Johann; Hassig, Raymonde; Dufour, Noelle; Hantraye, Philippe; Deglon, Nicole] CNRS, URA2210, Fontenay Aux Roses, France; [Zala, Diana; Saudou, Frederic] Inst Curie, F-91405 Orsay, France; [Zala, Diana; Saudou, Frederic] CNRS, UMR3306, F-91405 Orsay, France; [Zala, Diana; Saudou, Frederic] Univ Paris 11, INSERM, U1005, F-91405 Orsay, France; [Feyeux, Maxime; Bourgois-Rocha, Fany; Perrier, Anselme L.] AFM, INSERM, U861, Evry, France; [Feyeux, Maxime; Bourgois-Rocha, Fany; Perrier, Anselme L.] AFM, I STEM, UEVE U861, Evry, France; [Aubert, Sophie] AFM, I STEM, CECS, Evry, France; [Troquier, Laetitia; Merienne, Nicolas; Rey, Maria; Deglon, Nicole] Lausanne Univ Hosp CHUV, Dept Clin Neurosci DNC, Lausanne, Switzerland	CEA; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Deglon, N (corresponding author), CEA, Inst Biomed Imaging I2BM, Fontenay Aux Roses, France.	nicole.deglon@chuv.ch	SAUDOU, Frédéric/L-3454-2014; Deglon, Nicole/A-2265-2012; ZALA, Diana/L-4651-2017; Zala, Diana/R-8196-2019; Perrier, Anselme L/B-2272-2019; Perrier, Anselme/E-3764-2010	SAUDOU, Frédéric/0000-0001-6107-1046; Deglon, Nicole/0000-0003-4475-9476; ZALA, Diana/0000-0002-0052-8011; Zala, Diana/0000-0002-0052-8011; Perrier, Anselme L/0000-0001-7915-1968; Cambon, Karine/0000-0001-9263-4366; Merienne, Nicolas/0000-0002-4934-7211; Gorrichon, Kevin/0000-0002-8974-3286; Troquier, Laetitia/0000-0003-1046-6325; Drouet, Valerie/0000-0001-9958-8470	Agence Nationale de la Recherche [ANR-2006-MRAR-043-01]; FP6-NeuroNe [LSHM-CT-2004-512039]; FP6-Clinigene [LSH-2004-1.2.4-3]; Atomic Energy Commission; FP6 STEM-HD; DIM-STEM POLE Region Ile-de-France fellowship; Swiss National Science Foundation	Agence Nationale de la Recherche(French National Research Agency (ANR)); FP6-NeuroNe(European Commission); FP6-Clinigene; Atomic Energy Commission(French Atomic Energy Commission); FP6 STEM-HD; DIM-STEM POLE Region Ile-de-France fellowship(Region Ile-de-France); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Agence Nationale de la Recherche [ANR-2006-MRAR-043-01], FP6-NeuroNe [LSHM-CT-2004-512039], FP6-Clinigene [LSH-2004-1.2.4-3], the Atomic Energy Commission, FP6 STEM-HD, DIM-STEM POLE Region Ile-de-France fellowship to [F.B-R] and the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003341; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Bowers WJ, 2011, HUM MOL GENET, V20, pR28, DOI 10.1093/hmg/ddr110; Bowles KR, 2012, BRAIN RES BULL, V88, P276, DOI 10.1016/j.brainresbull.2011.07.021; Bradley CK, 2011, STEM CELLS DEV, V20, P495, DOI 10.1089/scd.2010.0120; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Davidson BL, 2012, CELL, V150, P873, DOI 10.1016/j.cell.2012.08.008; Davidson BL, 2011, NAT REV GENET, V12, P329, DOI 10.1038/nrg2968; de Almeida LP, 2002, J NEUROSCI, V22, P3473; Deglon N, 2000, HUM GENE THER, V11, P179, DOI 10.1089/10430340050016256; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Feyeux M, 2012, HUM MOL GENET, V21, P3883, DOI 10.1093/hmg/dds216; Fiszer A, 2011, NUCLEIC ACIDS RES, V39, P5578, DOI 10.1093/nar/gkr156; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Hottinger AF, 2000, J NEUROSCI, V20, P5587, DOI 10.1523/JNEUROSCI.20-15-05587.2000; Hu JX, 2010, CHEM BIOL, V17, P1183, DOI 10.1016/j.chembiol.2010.10.013; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Lee JM, 2012, AM J HUM GENET, V90, P434, DOI 10.1016/j.ajhg.2012.01.005; Lombardi MS, 2009, EXP NEUROL, V217, P312, DOI 10.1016/j.expneurol.2009.03.004; Lundberg C, 2008, CURR GENE THER, V8, P461, DOI 10.2174/156652308786847996; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mandel RJ, 2006, MOL THER, V13, P463, DOI 10.1016/j.ymthe.2005.11.009; Mateizel I, 2006, HUM REPROD, V21, P503, DOI 10.1093/humrep/dei345; Menalled Liliana B, 2005, NeuroRx, V2, P465, DOI 10.1602/neurorx.2.3.465; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ostergaard ME, 2013, NUCLEIC ACIDS RES, V41, P9634, DOI 10.1093/nar/gkt725; Palfi S, 2014, LANCET, V383, P1138, DOI 10.1016/S0140-6736(13)61939-X; Pfister EL, 2009, CURR BIOL, V19, P774, DOI 10.1016/j.cub.2009.03.030; Pouladi MA, 2012, HUM MOL GENET, V21, P2219, DOI 10.1093/hmg/dds037; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Southwell AL, 2013, HUM MOL GENET, V22, P18, DOI 10.1093/hmg/dds397; Taymans JM, 2007, HUM GENE THER, V18, P195, DOI 10.1089/hum.2006.178; Tropel P, 2010, IN VITRO CELL DEV-AN, V46, P376, DOI 10.1007/s11626-010-9300-8; van Bilsen PHJ, 2008, HUM GENE THER, V19, P710, DOI 10.1089/hum.2007.116; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Warby SC, 2011, EUR J HUM GENET, V19, P561, DOI 10.1038/ejhg.2010.229; Warby SC, 2009, AM J HUM GENET, V84, P351, DOI 10.1016/j.ajhg.2009.02.003; Wei N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049309; Wu LG, 2008, CURR BIOL, V18, P1327, DOI 10.1016/j.cub.2008.07.072; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002; Zala D, 2008, HUM MOL GENET, V17, P3837, DOI 10.1093/hmg/ddn281; Zhang Y, 2011, GENE THER, V18, P1139, DOI 10.1038/gt.2011.170	49	38	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99341	10.1371/journal.pone.0099341	http://dx.doi.org/10.1371/journal.pone.0099341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926995	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100035
J	Miranda, JJ; Lopez-Rivera, LA; Quistberg, DA; Rosales-Mayor, E; Gianella, C; Paca-Palao, A; Luna, D; Huicho, L				Jaime Miranda, J.; Lopez-Rivera, Luis A.; Alex Quistberg, D.; Rosales-Mayor, Edmundo; Gianella, Camila; Paca-Palao, Ada; Luna, Diego; Huicho, Luis		PIAT Working Grp	Epidemiology of Road Traffic Incidents in Peru 1973-2008: Incidence, Mortality, and Fatality	PLOS ONE			English	Article							HEALTH-STATISTICS; POLICY; INJURIES; CRASHES; TRENDS	Background: The epidemiological profile and trends of road traffic injuries (RTIs) in Peru have not been well-defined, though this is a necessary step to address this significant public health problem in Peru. The objective of this study was to determine trends of incidence, mortality, and fatality of RTIs in Peru during 1973-2008, as well as their relationship to population trends such as economic growth. Methods and Findings: Secondary aggregated databases were used to estimate incidence, mortality and fatality rate ratios (IRRs) of RTIs. These estimates were standardized to age groups and sex of the 2008 Peruvian population. Negative binomial regression and cubic spline curves were used for multivariable analysis. During the 35-year period there were 952,668 road traffic victims, injured or killed. The adjusted yearly incidence of RTIs increased by 3.59 (95% CI 2.43-5.31) on average. We did not observe any significant trends in the yearly mortality rate. The total adjusted yearly fatality rate decreased by 0.26 (95% CI 0.15-0.43), while among adults the fatality rate increased by 1.25 (95% CI 1.09-1.43). Models fitted with splines suggest that the incidence follows a bimodal curve and closely followed trends in the gross domestic product (GDP) per capita Conclusions: The significant increasing incidence of RTIs in Peru affirms their growing threat to public health. A substantial improvement of information systems for RTIs is needed to create a more accurate epidemiologic profile of RTIs in Peru. This approach can be of use in other similar low and middle-income settings to inform about the local challenges posed by RTIs.	[Jaime Miranda, J.; Lopez-Rivera, Luis A.; Rosales-Mayor, Edmundo; Gianella, Camila; Paca-Palao, Ada; Luna, Diego; Huicho, Luis] Salud Sin Limites Peru, Programa Invest Accidentes Transito, Lima, Peru; [Jaime Miranda, J.; Rosales-Mayor, Edmundo; Huicho, Luis] Univ Peruana Cayetano Heredia, CRONICAS, Ctr Excellence Chron Dis, Lima, Peru; [Jaime Miranda, J.; Huicho, Luis] Univ Peruana Cayetano Heredia, Sch Med, Lima, Peru; [Jaime Miranda, J.; Gianella, Camila] Asociac Civil Educ Derechos Humanos Con Aplica Sa, EDHUCASALUD, Lima, Peru; [Lopez-Rivera, Luis A.] Minist Trabajo & Promoc Empleo, Programa Nacl Empleo Juvenil Jovenes Obra, Lima, Peru; [Alex Quistberg, D.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Alex Quistberg, D.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Rosales-Mayor, Edmundo] Clin Anglo Amer, Ctr Trastornos Resp Suen CENTRES, Lima, Peru; [Rosales-Mayor, Edmundo] GIS, Lima, Peru; [Rosales-Mayor, Edmundo] Hosp Clin Barcelona, Barcelona, Spain; [Luna, Diego] Univ Pacifico, Dept Ciencias Soci & Polit, Lima, Peru; [Luna, Diego] Asociac Civil Gobierno Coherente, Lima, Peru; [Huicho, Luis] Inst Nacl Salud Nino, Dept Pediat, Lima, Peru; [Huicho, Luis] Univ Nacl Mayor San Marcos, Sch Med, Lima 14, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Barcelona; Hospital Clinic de Barcelona; Universidad del Pacifico Peru; Universidad Nacional Mayor de San Marcos	Miranda, JJ (corresponding author), Salud Sin Limites Peru, Programa Invest Accidentes Transito, Lima, Peru.	jaime.miranda@upch.pe	Quistberg, D Alex/P-3538-2019; Rosales-Mayor, Edmundo/E-6728-2019; Huicho, Luis/AAD-7353-2019; Rosales-Mayor, Edmundo/F-9689-2016	Quistberg, D Alex/0000-0001-9730-2686; Rosales-Mayor, Edmundo/0000-0001-9493-1241; Rosales-Mayor, Edmundo/0000-0001-9493-1241; Huicho, Luis/0000-0002-5272-5885; Miranda, J. Jaime/0000-0002-4738-5468; Gianella Malca, Camila/0000-0002-2656-0589	Instituto Nacional Salud de Peru as part of the Programa de Investigacion en Accidentes de Transito (PIAT - Road Traffic Incident Investigation Program); Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health [5T32HD057822]; National Heart, Lung, and Blood Institute Global Health Initiative [268200900033C-1-0-1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD057822] Funding Source: NIH RePORTER	Instituto Nacional Salud de Peru as part of the Programa de Investigacion en Accidentes de Transito (PIAT - Road Traffic Incident Investigation Program); Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung, and Blood Institute Global Health Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by the Instituto Nacional Salud de Peru as part of the Programa de Investigacion en Accidentes de Transito (PIAT - Road Traffic Incident Investigation Program) completed by Salud Sin Limites Peru. Dr. Quistberg is currently supported by The Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health under award number 5T32HD057822. Dr. Miranda and the CRONICAS Center of Excellence in Chronic Diseases are supported by the National Heart, Lung, and Blood Institute Global Health Initiative under the contract Global Health Activities in Developing Countries to Combat Non-Communicable Chronic Diseases under award number 268200900033C-1-0-1. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouZahr C, 2007, LANCET, V369, P1039, DOI 10.1016/S0140-6736(07)60463-2; [Anonymous], VIOL SEG PUBL COMP S; [Anonymous], STAT ANN OUTP NEG BI; [Anonymous], EST ACC NIV NAC 1973; [Anonymous], BANC CENTR RES PER C; Bambarem Alatrista Celso, 2004, Rev Med Hered, V15, P30; Boerma JT, 2007, LANCET, V369, P779, DOI 10.1016/S0140-6736(07)60364-X; Cameron A., 1998, ECONOMETRIC SOC MONO; Chen HY, 2010, TRAFFIC INJ PREV, V11, P8, DOI 10.1080/15389580903434207; Cole TJ, 2009, STAT MED, V28, P880, DOI 10.1002/sim.3504; Davies AR, 2007, EUR HEART J, V28, P2142, DOI 10.1093/eurheartj/ehm272; Direccion Tecnica Demografica Instituto Nacional de Estadistica e Informatica, 2001, PER POBL TOT 1950 20; Direccion Tecnica Demografica Instituto Nacional de Estadistica e Informatica, 2002, I NAC EST INF B ESP; Donroe J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003166; Grundy C, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4469; Huicho L, 2009, ESTUDIO CAP NIVEL SE; Institute for Health Metrics and Evaluation, 2013, GLOB BURD DIS PROF P; Instituto Nacional de Estadistica e Informatica, 2009, SIST CONS DAT 11 CEN; Instituto Nacional de Estadistica e Informatica, 2008, PER COMP EST; Instituto Nacional de Estadistica e Informatica, 2007, 11 CENS POBL 6 VIV; Instituto Nacional de Salud, 2007, PRIOR INV SAL PER AN; Jacobs G., 2000, 445 TRL; Kopits E, 2005, ACCIDENT ANAL PREV, V37, P169, DOI 10.1016/j.aap.2004.04.006; Kuha J, 2004, SOCIOL METHOD RES, V33, P188, DOI 10.1177/0049124103262065; Law T H, 2005, Int J Inj Contr Saf Promot, V12, P9; Medina YR, 2011, REV PANAM SALUD PUBL, V29, P191; Miranda J. Jaime, 2010, Rev. perú. med. exp. salud publica, V27, P273, DOI 10.1590/s1726-46342010000200018; Miranda J. Jaime, 2010, Rev. perú. med. exp. salud publica, V27, P179, DOI 10.1590/s1726-46342010000200004; Mohan D, 2002, INT J EPIDEMIOL, V31, P527, DOI 10.1093/ije/31.3.527; Murray CJL, 2007, LANCET, V369, P862, DOI 10.1016/S0140-6736(07)60415-2; National Cancer Institute, SEER STAT TUT CALC A; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Planzer R, 2005, SEGURIDAD VIAL REGIO; Puig Xavi, 2005, Gac Sanit, V19, P481, DOI 10.1016/S0213-9111(05)71401-1; Quistberg DA, 2013, INJURY PREVENTION; Rahimi-Movaghar V, 2009, INT J INJ CONTROL SA, V16, P179, DOI 10.1080/17457300903024277; Rosales-Mayor E, 2011, CAD SAUDE PUBLICA, V27, P1837, DOI 10.1590/S0102-311X2011000900017; Scuffham PA, 2002, ACCIDENT ANAL PREV, V34, P673, DOI 10.1016/S0001-4575(01)00067-7; Secretaria Tecnica del Consejo de Transporte de Lima y Callao, 2009, VULN PEAT VIAL AR ME; Secretaria Tecnica del Consejo de Transporte de Lima y Callao, 2008, REL PUNT NEGR ACC TR; Sharma BR, 2008, PUBLIC HEALTH, V122, P1399, DOI 10.1016/j.puhe.2008.06.009; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Suriyawongpaisal Paibul, 2003, Inj Control Saf Promot, V10, P95, DOI 10.1076/icsp.10.1.95.14110; Vasquez Cordano A, 2008, ENSAYOS ROL INFRAEST; Walker N, 2007, LANCET, V369, P956, DOI 10.1016/S0140-6736(07)60454-1; World Health Organization, 2004, WORLD REPORT ROAD TR; World Health Organization, 2006, ROAD TRAFF INJ PREV; World Health Organization, 2009, GLOB STAT REP ROAD S	48	9	9	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99662	10.1371/journal.pone.0099662	http://dx.doi.org/10.1371/journal.pone.0099662			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2VQ	24927195	Green Published, gold			2022-12-25	WOS:000338278100061
J	Liu, Y; Lv, QJ; Gao, J; Long, L; Duan, ZJ; Liang, H; Shen, T; Lu, FM				Liu, Yuan; Lv, Quanjun; Gao, Jian; Long, Lu; Duan, Zhaojun; Liang, Hua; Shen, Tao; Lu, Fengmin			Coinfection with HIV-1 Alleviates Iron Accumulation in Patients with Chronic Hepatitis C Virus Infection	PLOS ONE			English	Article							CHRONIC VIRAL-HEPATITIS; HEPCIDIN; THERAPY; DISEASE; FERROPORTIN; METABOLISM; MECHANISMS; LIVER; HCV	Most chronically-infected hepatitis C virus (HCV) patients have increased levels of iron in the liver. Iron overload reduces sustained responses to antiviral therapy, leading to more rapid progression to liver cirrhosis and the development of hepatocellular carcinoma. However, it is still unclear how HIV-1 infection affects iron status in patients chronically infected with HCV. The present study recruited 227 patients from a village in central China. These patients were either monoinfected with HCV (n = 129) or coinfected with HCV/HIV-1 (n = 98). Healthy controls (n = 84) were also recruited from the same village. Indicators of iron status, such as serum levels of iron, ferritin, and transferrin, total iron-binding capacity (TIBC), transferrin saturation (Tfs), and hepcidin, were analyzed and compared across the three groups. The results showed that serum levels of iron (p = 0.001) and ferritin (p = 0.009) and the Tfs (p = 0.002) were significantly higher in HCV-monoinfected patients than in the healthy controls; however, there were no differences in iron levels and Tfs between HCV/HIV-1 coinfected patients and healthy controls. Additionally, although serum hepcidin levels in HCV-monoinfected and HCV/HIV-1-coinfected patients were lower (p<0.001) than those in health controls, the levels in coinfected patients were higher (p = 0.025) than those in HCV-monoinfected patients. Serum iron and ferritin levels in HCV-monoinfected patients were positively correlated with serum ALT/AST. Serum transferrin levels were negatively correlated with ALT/AST levels. The levels of iron in the serum of coinfected patients with a CD4+T-cell count <500/mu l were lower than those in patients with a CD4+T-cell count >= 500/mu l, whereas serum hepcidin levels showed the opposite trend. Taken together, these results suggest that coinfection with HIV-1 alleviates iron accumulation caused by chronic HCV infection. Our study indicated that determining the status of serum iron and other iron-associated parameters will be helpful to understand the complexity of alternations in iron distribution in HCV/HIV-1-coinfected patients.	[Liu, Yuan; Gao, Jian; Long, Lu; Duan, Zhaojun; Shen, Tao; Lu, Fengmin] Peking Univ, Dept Microbiol, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Liu, Yuan; Gao, Jian; Long, Lu; Duan, Zhaojun; Shen, Tao; Lu, Fengmin] Peking Univ, Ctr Infect Dis, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Liu, Yuan; Lv, Quanjun] Zhengzhou Univ, Coll Publ Hlth, Dept Nutr & Food Hyg, Zhengzhou, Henan, Peoples R China; [Liang, Hua] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Ctr AIDS STD Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing, Peoples R China	Peking University; Peking University; Zhengzhou University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Shen, T (corresponding author), Peking Univ, Dept Microbiol, Hlth Sci Ctr, Beijing 100871, Peoples R China.	taoshen@hsc.pku.edu.cn		Lu, fengmin/0000-0002-1832-3209; Shen, Tao/0000-0002-1365-9862	National Natural Science of China [81271826]; National Science Foundation of Beijing [7122108]; National S&T Major Project for Infectious Diseases [2012ZX10002003, 2012ZX10002005]	National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Beijing; National S&T Major Project for Infectious Diseases	This work was supported by grants from the National Natural Science of China (81271826), the National Science Foundation of Beijing (7122108) and the National S&T Major Project for Infectious Diseases (2012ZX10002003 and 2012ZX10002005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonkovsky H L, 2000, Clin Liver Dis, V4, P409, DOI 10.1016/S1089-3261(05)70116-1; Bonkovsky HL, 2002, AM J GASTROENTEROL, V97, P1; Bonkovsky HL, 1997, HEPATOLOGY, V25, P759, DOI 10.1002/hep.510250345; Bonkovsky HL, 2000, CLIN LIVER DIS, V4, pvi; Cohen LA, 2010, BLOOD, V116, P1574, DOI 10.1182/blood-2009-11-253815; Dallalio G, 2006, BLOOD, V107, P2702, DOI 10.1182/blood-2005-07-2854; de Monye C, 1999, AIDS, V13, P375, DOI 10.1097/00002030-199902250-00010; Drakesmith H, 2008, NAT REV MICROBIOL, V6, P541, DOI 10.1038/nrmicro1930; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Fillebeen C, 2005, J BIOL CHEM, V280, P9049, DOI 10.1074/jbc.M412687200; Fujita N, 2007, J GASTROEN HEPATOL, V22, P1886, DOI 10.1111/j.1440-1746.2006.04759.x; Fujita N, 2007, MOL MED, V13, P97, DOI 10.2119/2006-00057.Fujita; Galli A, 2005, HEPATOLOGY, V41, P1074, DOI 10.1002/hep.20683; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Girelli D, 2009, J HEPATOL, V51, P845, DOI 10.1016/j.jhep.2009.06.027; Gordeuk VR, 2001, J CLIN VIROL, V20, P111, DOI 10.1016/S1386-6532(00)00134-7; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; Kagu M B, 2007, Afr J Med Med Sci, V36, P125; McDermid JM, 2007, JAIDS-J ACQ IMM DEF, V46, P498, DOI 10.1097/QAI.0b013e31815b2d4b; Mcnabb J, 2001, CLIN INFECT DIS, V33, P413, DOI 10.1086/321872; Mueller S, 2010, J HEPATOL, V53, P990, DOI 10.1016/j.jhep.2010.08.003; Nelson James E, 2012, Curr Gastroenterol Rep, V14, P8, DOI 10.1007/s11894-011-0234-4; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; OLYNYK JK, 1995, GASTROENTEROLOGY, V108, P1104, DOI 10.1016/0016-5085(95)90209-0; P Kosaralaksa TB, 2011, 6 IAS C HIV PATH TRE; Pietrangelo A, 2007, HEPATOLOGY, V46, P1291, DOI 10.1002/hep.21886; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Stebbing J, 2004, NEW ENGL J MED, V350, P1872, DOI 10.1056/NEJMra032395; Ufearo H, 2010, CLIN CHIM ACTA, V411, P653, DOI 10.1016/j.cca.2010.01.028; Valenti L, 2007, HAEMATOLOGICA, V92, P1037, DOI 10.3324/haematol.11281; Venturini D, 2010, DIGEST DIS SCI, V55, P1120, DOI 10.1007/s10620-009-0833-1; Wisaksana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079904; Wisaksana R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-213; Xu M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-104	35	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98039	10.1371/journal.pone.0098039	http://dx.doi.org/10.1371/journal.pone.0098039			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927015	gold, Green Published, Green Submitted			2022-12-25	WOS:000338278100011
J	Dorfmueller, HC; Ferenbach, AT; Borodkin, VS; van Aalten, DMF				Dorfmueller, Helge C.; Ferenbach, Andrew T.; Borodkin, Vladimir S.; van Aalten, Daan M. F.			A Structural and Biochemical Model of Processive Chitin Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOSACCHARIDE CHAIN-LENGTH; SACCHAROMYCES-CEREVISIAE; INNER-MEMBRANE; SYNTHASE 2; SEQUENCE ALIGNMENT; RHIZOBIUM; NODC; INHIBITOR; CLASSIFICATION; IDENTIFICATION	Chitin synthases (CHS) produce chitin, an essential component of the fungal cell wall. The molecular mechanism of processive chitin synthesis is not understood, limiting the discovery of new inhibitors of this enzyme class. We identified the bacterial glycosyltransferase NodC as an appropriate model system to study the general structure and reaction mechanism of CHS. A high throughput screening-compatible novel assay demonstrates that a known inhibitor of fungal CHS also inhibit NodC. A structural model of NodC, on the basis of the recently published BcsA cellulose synthase structure, enabled probing of the catalytic mechanism by mutagenesis, demonstrating the essential roles of the DD and QXXRW catalytic motifs. The NodC membrane topology was mapped, validating the structural model. Together, these approaches give insight into the CHS structure and mechanism and provide a platform for the discovery of inhibitors for this antifungal target.	[Dorfmueller, Helge C.; Ferenbach, Andrew T.; van Aalten, Daan M. F.] Univ Dundee, Div Mol Microbiol, Coll Life Sci, Dundee DD1 5EH, Scotland; [Borodkin, Vladimir S.; van Aalten, Daan M. F.] Univ Dundee, MRC Prot Phosphorylat & Ubiquitylat Unit, Coll Life Sci, Dundee DD1 5EH, Scotland	University of Dundee; University of Dundee	Dorfmueller, HC (corresponding author), Univ Dundee, Div Mol Microbiol, Coll Life Sci, Dundee DD1 5EH, Scotland.	hczdorfmueller@dundee.ac.uk; dmfvanaalten@dundee.ac.uk		Dorfmueller, Helge/0000-0003-1288-044X; Ferenbach, Andrew/0000-0002-1562-7987; van Aalten, Daan/0000-0002-1499-6908	Wellcome Trust [092193]; Medical Research Council [G0900138/90614]; Medical Research Council [MR/M004139/1, G0900138] Funding Source: researchfish; MRC [G0900138, MR/M004139/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Wellcome Trust Sir Henry Wellcome Postdoctoral Fellowship 092193 and Medical Research Council Program Grant G0900138/90614.	ATKINSON EM, 1992, MOL PLANT MICROBE IN, V5, P439, DOI 10.1094/MPMI-5-439; Barny MA, 1996, MOL MICROBIOL, V19, P443, DOI 10.1046/j.1365-2958.1996.382911.x; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; BOWEN AR, 1992, P NATL ACAD SCI USA, V89, P519, DOI 10.1073/pnas.89.2.519; CABIB E, 1991, ANTIMICROB AGENTS CH, V35, P170, DOI 10.1128/AAC.35.1.170; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; D'Haeze W, 2002, GLYCOBIOLOGY, V12, p79R, DOI 10.1093/glycob/12.6.79R; DEBELLE F, 1992, MOL PLANT MICROBE IN, V5, P443, DOI 10.1094/MPMI-5-443; Drew D, 2002, P NATL ACAD SCI USA, V99, P2690, DOI 10.1073/pnas.052018199; GAUGHRAN JP, 1994, J BACTERIOL, V176, P5857, DOI 10.1128/JB.176.18.5857-5860.1994; Imai T, 2003, BIOCHEM J, V374, P755, DOI 10.1042/BJ20030145; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kamst E, 1997, J BACTERIOL, V179, P2103, DOI 10.1128/jb.179.7.2103-2108.1997; Kamst E, 2000, MOL GEN GENET, V264, P75, DOI 10.1007/s004380000281; Kamst E, 1999, BIOCHEMISTRY-US, V38, P4045, DOI 10.1021/bi982531u; Karnezis T, 2003, GLYCOBIOLOGY, V13, P693, DOI 10.1093/glycob/cwg093; Kathiravan MK, 2012, BIOORGAN MED CHEM, V20, P5678, DOI 10.1016/j.bmc.2012.04.045; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; Martinez-Rucobo FW, 2009, BIOCHEM J, V417, P547, DOI 10.1042/BJ20081475; Masubuchi K, 2000, BIOORG MED CHEM LETT, V10, P1459, DOI 10.1016/S0960-894X(00)00257-2; Mavingui P, 1998, J BACTERIOL, V180, P2866, DOI 10.1128/JB.180.11.2866-2874.1998; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; NAGAHASHI S, 1995, J BIOL CHEM, V270, P13961, DOI 10.1074/jbc.270.23.13961; ORLEAN P, 1987, J BIOL CHEM, V262, P5732; Rao FV, 2005, CHEM BIOL, V12, P65, DOI 10.1016/j.chembiol.2004.10.013; Ruiz-Herrera J., 2003, Current Drug Targets - Infectious Disorders, V3, P77, DOI 10.2174/1568005033342064; SEMINO CE, 1995, P NATL ACAD SCI USA, V92, P3498, DOI 10.1073/pnas.92.8.3498; SHAW JA, 1991, J CELL BIOL, V114, P111, DOI 10.1083/jcb.114.1.111; Streng A, 2011, PLANT SIGNAL BEHAV, V6, P1510, DOI 10.4161/psb.6.10.17444; Sudoh M, 2000, J BIOL CHEM, V275, P32901, DOI 10.1074/jbc.M003634200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uchida Y, 1996, J BIOCHEM, V119, P659; Xie J, 2001, CARBOHYD RES, V334, P177, DOI 10.1016/S0008-6215(01)00191-4; Yabe T, 1998, EUR J BIOCHEM, V258, P941, DOI 10.1046/j.1432-1327.1998.2580941.x	35	35	35	2	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23020	23028		10.1074/jbc.M114.563353	http://dx.doi.org/10.1074/jbc.M114.563353			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24942743	Green Published, hybrid			2022-12-25	WOS:000341017200040
J	El Khoury, N; Mathieu, S; Fiset, C				El Khoury, Nabil; Mathieu, Sophie; Fiset, Celine			Interleukin-1 beta Reduces L-type Ca2+ Current through Protein Kinase C epsilon Activation in Mouse Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA; CARDIAC MYOCYTES; NITRIC-OXIDE; OXIDATIVE STRESS; CULTURED CARDIOMYOCYTES; DILATED CARDIOMYOPATHY; CIRCULATING LEVELS; TRANSGENIC MICE; ANGIOTENSIN-II	Inflammation is now widely recognized as a key component of heart disease. Patients suffering from arrhythmias and heart failure have increased levels of tumor necrosis factor-alpha (TNF alpha) and interleukin-1 beta (IL-1 beta). Evidence suggests that these cytokines are important mediators of cardiac remodeling; however, their effects on ion channels and arrhythmogenesis remain incompletely understood. The L-type Ca2+ current (I-CaL) is a major determinant of the plateau phase of cardiac action potential and has a critical excitation-contraction coupling role. Thus, altering its properties could have detrimental effects on cardiac electrical and contractile functions. Accordingly, the objective of this study was to elucidate the effect of TNF alpha and IL-1 beta on I-CaL, while exploring the underlying regulatory mechanisms. Neonatal mouse ventricular myocytes were treated with a pathophysiological concentration (30 pg/ml) of TNF alpha and IL-1 beta for 24 h. Voltage-clamp recordings showed that TNF alpha had no effect on I-CaL, whereas IL-1 beta decreased the current density by 36%. Although both IL-1 beta -and TNF alpha-treated myocytes showed significant increase in reactive oxidative species (ROS), Western blot experiments revealed that only IL-1 beta increased PKC epsilon membrane translocation. The antioxidant N-acetyl-L-cysteine normalized ROS levels and restored I-CaL density. Furthermore, the PKC epsilon translocation inhibitor epsilon-V1-2 blocked the effect of IL-1 beta on I-CaL. The reduction of I-CaL by IL-1 beta was also seen in cultured adult ventricular myocytes. Overall, chronic IL-1 beta treatment decreased I-CaL density in cardiomyocytes. These effects implicated ROS signaling and PKC epsilon activation. These findings could contribute to explain the role of IL-1 beta in the development of arrhythmia and heart failure.	[El Khoury, Nabil; Mathieu, Sophie; Fiset, Celine] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Mathieu, Sophie; Fiset, Celine] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; [El Khoury, Nabil] Univ Montreal, Fac Med, Dept Physiol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Fiset, C (corresponding author), Montreal Heart Inst, 5000 Belanger, Montreal, PQ H1T 1C8, Canada.	celine.fiset@icm-mhi.org		Fiset, Celine/0000-0003-2309-4823	Canadian Institutes of Health Research [CIHR-MOP-89934]; Fonds de Recherche du Quebec en Sante Ph.D. scholarship; Montreal Heart Institute Foundation scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec en Sante Ph.D. scholarship; Montreal Heart Institute Foundation scholarship	This work was supported in part by Canadian Institutes of Health Research Operating Grant CIHR-MOP-89934 (to C. F.).; Recipient of the Fonds de Recherche du Quebec en Sante Ph.D. scholarship and a Montreal Heart Institute Foundation scholarship.	Aukrust P, 2004, AUTOIMMUN REV, V3, P221, DOI 10.1016/S1568-9972(03)00103-4; Balafanova Z, 2002, J BIOL CHEM, V277, P15021, DOI 10.1074/jbc.M112451200; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Brandman R, 2007, J BIOL CHEM, V282, P4113, DOI 10.1074/jbc.M608521200; Brouillette J, 2007, J MOL CELL CARDIOL, V43, P159, DOI 10.1016/j.yjmcc.2007.05.007; Chahine M, 2008, PFLUG ARCH EUR J PHY, V455, P913, DOI 10.1007/s00424-007-0342-z; Chamberlain J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005073; Combes A, 2002, PFLUG ARCH EUR J PHY, V445, P246, DOI 10.1007/s00424-002-0921-y; Duncan DJ, 2010, CELL CALCIUM, V47, P378, DOI 10.1016/j.ceca.2010.02.002; Fernandez-Velasco M, 2007, AM J PHYSIOL-HEART C, V293, pH238, DOI 10.1152/ajpheart.01122.2006; Ferreira JCB, 2011, J MOL CELL CARDIOL, V51, P980, DOI 10.1016/j.yjmcc.2011.08.025; FINKEL MS, 1992, SCIENCE, V257, P387, DOI 10.1126/science.1631560; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Francis SE, 1998, J MOL CELL CARDIOL, V30, P215, DOI 10.1006/jmcc.1997.0592; Giorgi C, 2010, ANTIOXID REDOX SIGN, V13, P1051, DOI 10.1089/ars.2009.2825; Goonasekera SA, 2012, J CLIN INVEST, V122, P280, DOI 10.1172/JCI58227; Grandy SA, 2007, AM J PHYSIOL-HEART C, V293, pH2168, DOI 10.1152/ajpheart.00521.2007; Grandy SA, 2010, J CARDIOVASC ELECTR, V21, P916, DOI 10.1111/j.1540-8167.2009.01713.x; Grandy SA, 2009, J MOL CELL CARDIOL, V47, P238, DOI 10.1016/j.yjmcc.2009.02.025; GUILLEN I, 1995, AM J PHYSIOL-REG I, V269, pR229, DOI 10.1152/ajpregu.1995.269.2.R229; GULICK T, 1989, P NATL ACAD SCI USA, V86, P6753, DOI 10.1073/pnas.86.17.6753; Hohensinner PJ, 2011, CURR OPIN INFECT DIS, V24, P259, DOI 10.1097/QCO.0b013e328344f50f; Hu KL, 2000, AM J PHYSIOL-HEART C, V279, pH2658, DOI 10.1152/ajpheart.2000.279.6.H2658; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Kawada H, 2006, CIRC J, V70, P605, DOI 10.1253/circj.70.605; Kroncke KD, 1998, CLIN EXP IMMUNOL, V113, P147; Kumar A, 1996, J EXP MED, V183, P949, DOI 10.1084/jem.183.3.949; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Lizotte E, 2005, ANAL BIOCHEM, V345, P47, DOI 10.1016/j.ab.2005.07.001; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Makary S, 2011, CIRC RES, V109, P1031, DOI 10.1161/CIRCRESAHA.111.253120; McTiernan CF, 1997, CIRC RES, V81, P493, DOI 10.1161/01.RES.81.4.493; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Murray DR, 1996, CIRC RES, V78, P154, DOI 10.1161/01.RES.78.1.154; Nakamura K, 1998, CIRCULATION, V98, P794, DOI 10.1161/01.CIR.98.8.794; NUSS HB, 1994, J PHYSIOL-LONDON, V479, P265, DOI 10.1113/jphysiol.1994.sp020294; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Orus J, 2000, J HEART LUNG TRANSPL, V19, P419, DOI 10.1016/S1053-2498(00)00083-8; Petkova-Kirova PS, 2006, AM J PHYSIOL-HEART C, V290, pH2098, DOI 10.1152/ajpheart.00097.2005; Prabhu SD, 2004, CIRC RES, V95, P1140, DOI 10.1161/01.RES.0000150734.79804.92; Rivard K, 2011, AM J PHYSIOL-HEART C, V301, pH2018, DOI 10.1152/ajpheart.01092.2010; Roig E, 1998, AM J CARDIOL, V82, P688, DOI 10.1016/S0002-9149(98)00388-9; Rybin VO, 2004, J BIOL CHEM, V279, P19350, DOI 10.1074/jbc.M311096200; Saba S, 2005, AM J PHYSIOL-HEART C, V289, pH1456, DOI 10.1152/ajpheart.00733.2004; SCHULZ R, 1995, BRIT J PHARMACOL, V114, P27, DOI 10.1111/j.1476-5381.1995.tb14901.x; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Suematsu N, 2003, CIRCULATION, V107, P1418, DOI 10.1161/01.CIR.0000055318.09997.1F; Tanaka H, 1998, COMP BIOCHEM PHYS A, V120, P431, DOI 10.1016/S1095-6433(98)10043-0; Testa M, 1996, J AM COLL CARDIOL, V28, P964, DOI 10.1016/S0735-1097(96)00268-9; THAIK CM, 1995, J CLIN INVEST, V96, P1093, DOI 10.1172/JCI118095; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Yue YK, 2004, BIOCHEM BIOPH RES CO, V314, P749, DOI 10.1016/j.bbrc.2003.12.155	53	39	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21896	21908		10.1074/jbc.M114.549642	http://dx.doi.org/10.1074/jbc.M114.549642			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24936064	Green Published, hybrid			2022-12-25	WOS:000340593500008
J	Moreno, E; Andradas, C; Medrano, M; Caffarel, MM; Perez-Gomez, E; Blasco-Benito, S; Gomez-Canas, M; Pazos, MR; Irving, AJ; Lluis, C; Canela, EI; Fernandez-Ruiz, J; Guzman, M; McCormick, PJ; Sanchez, C				Moreno, Estefania; Andradas, Clara; Medrano, Mireia; Caffarel, Maria M.; Perez-Gomez, Eduardo; Blasco-Benito, Sandra; Gomez-Canas, Maria; Ruth Pazos, M.; Irving, Andrew J.; Lluis, Carme; Canela, Enric I.; Fernandez-Ruiz, Javier; Guzman, Manuel; McCormick, Peter J.; Sanchez, Cristina			Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; PROXIMITY LIGATION ASSAY; CANNABINOID RECEPTORS; LYSOPHOSPHATIDYLINOSITOL RECEPTOR; FUNCTIONAL HETEROMERS; GPR55; CB1; PROLIFERATION; ANTAGONISTS; INHIBITION	The G protein-coupled receptors CB2 (CB2R) and GPR55 are overexpressed in cancer cells and human tumors. Because a modulation of GPR55 activity by cannabinoids has been suggested, we analyzed whether this receptor participates in cannabinoid effects on cancer cells. Here we show that CB2R and GPR55 form heteromers in cancer cells, that these structures possess unique signaling properties, and that modulation of these heteromers can modify the antitumoral activity of cannabinoids in vivo. These findings unveil the existence of previously unknown signaling platforms that help explain the complex behavior of cannabinoids and may constitute new targets for therapeutic intervention in oncology.	[Moreno, Estefania; Medrano, Mireia; Lluis, Carme; Canela, Enric I.; McCormick, Peter J.] Univ Barcelona, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [Moreno, Estefania; Medrano, Mireia; Gomez-Canas, Maria; Ruth Pazos, M.; Lluis, Carme; Canela, Enric I.; Fernandez-Ruiz, Javier; Guzman, Manuel; McCormick, Peter J.] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28031, Spain; [Moreno, Estefania; Medrano, Mireia; Lluis, Carme; Canela, Enric I.; McCormick, Peter J.] Univ Barcelona, Inst Biomed, E-08028 Barcelona, Spain; [Andradas, Clara; Caffarel, Maria M.; Perez-Gomez, Eduardo; Blasco-Benito, Sandra; Guzman, Manuel; Sanchez, Cristina] Univ Complutense, Sch Biol, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain; [Gomez-Canas, Maria; Ruth Pazos, M.; Fernandez-Ruiz, Javier] Univ Complutense, Sch Med, Dept Biochem & Mol Biol 3, Inst Univ Invest Neuroquim, E-28040 Madrid, Spain; [Perez-Gomez, Eduardo; Blasco-Benito, Sandra; Sanchez, Cristina] Hosp 12 Octubre, Inst Invest, E-28041 Madrid, Spain; [Gomez-Canas, Maria; Fernandez-Ruiz, Javier; Guzman, Manuel] IRYCIS, Madrid 28034, Spain; [Irving, Andrew J.] Univ Dundee, Ninewells Hosp, Div Neurosci, Dundee DD1 9SY, Scotland; [McCormick, Peter J.] Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England	University of Barcelona; CIBERNED; University of Barcelona; Complutense University of Madrid; Complutense University of Madrid; Hospital Universitario 12 de Octubre; University of Dundee; University of East Anglia	McCormick, PJ (corresponding author), Univ E Anglia, Sch Pharm, CP 1-44,Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	p.mccormick@uea.ac.uk; cristina.sanchez@quim.ucm.es	Sanchez, Cristina/AFQ-4745-2022; Medrano, Mireia/AFP-3427-2022; Canela, Enric I./M-8726-2013; Pérez-Gómez, Eduardo/GYA-5856-2022; Sanchez, Cristina/H-4980-2017; Pazos, Ruth/D-6797-2019; Medrano, Mireia/GVS-3226-2022; Guillén, Estefanía Moreno/ABE-4371-2020; Perez-gomez, Eduardo/F-5906-2015; FERNANDEZ RUIZ, JOSE JAVIER/S-3875-2018; McCormick, Peter/E-7387-2012	Medrano, Mireia/0000-0002-8707-5501; Canela, Enric I./0000-0003-4992-7440; Pérez-Gómez, Eduardo/0000-0003-0160-5565; Sanchez, Cristina/0000-0002-1428-3078; Pazos, Ruth/0000-0001-7613-795X; Perez-gomez, Eduardo/0000-0003-0160-5565; FERNANDEZ RUIZ, JOSE JAVIER/0000-0002-4490-0604; Gomez Canas, Maria/0000-0002-2520-948X; Moreno, Estefania/0000-0002-2491-5753; Caffarel, Maria/0000-0002-7442-6827; Blasco Benito, Sandra/0000-0002-6714-2340; McCormick, Peter/0000-0002-2225-5181; Guzman, Manuel/0000-0001-7475-118X	Spanish Ministry of Economy and Competitiveness [PI11/00295]; Ramon y Cajal fellowship; Madrid Regional Government [S2010/BMD-2308]; TV3 Marato Project [308/C/2013]; Fundacion Cientifica Asociacion Espanola Contra el Cancer	Spanish Ministry of Economy and Competitiveness(Spanish Government); Ramon y Cajal fellowship(Spanish Government); Madrid Regional Government; TV3 Marato Project; Fundacion Cientifica Asociacion Espanola Contra el Cancer	This work was supported by Spanish Ministry of Economy and Competitiveness Grant PI11/00295 (to C. S.), by a Ramon y Cajal fellowship (to P. J. M.), by Madrid Regional Government Grant S2010/BMD-2308 (to M. G.), and by funds from TV3 Marato Project 308/C/2013 (to P. J. M.).; Recipient of a postdoctoral research contract from the Fundacion Cientifica Asociacion Espanola Contra el Cancer.	Anavi-Goffer S, 2012, J BIOL CHEM, V287, P91, DOI 10.1074/jbc.M111.296020; Andradas C, 2011, ONCOGENE, V30, P245, DOI 10.1038/onc.2010.402; Balenga NAB, 2011, CELL RES, V21, P1452, DOI 10.1038/cr.2011.60; Brown AJ, 2007, BRIT J PHARMACOL, V152, P567, DOI 10.1038/sj.bjp.0707481; Callen L, 2012, J BIOL CHEM, V287, P20851, DOI 10.1074/jbc.M111.335273; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Gonzalez S, 2012, MOL PSYCHIATR, V17, P650, DOI 10.1038/mp.2011.93; Guzman M, 2002, PHARMACOL THERAPEUT, V95, P175, DOI 10.1016/S0163-7258(02)00256-5; Henstridge CM, 2011, MOL ENDOCRINOL, V25, P1835, DOI 10.1210/me.2011-1197; Henstridge CM, 2009, FASEB J, V23, P183, DOI 10.1096/fj.08-108670; Kargl J, 2012, J BIOL CHEM, V287, P44234, DOI 10.1074/jbc.M112.364109; Lorente M, 2011, CELL DEATH DIFFER, V18, P959, DOI 10.1038/cdd.2010.170; Marcellino S, 2008, ANAL CHIM ACTA, V629, P73, DOI 10.1016/j.aca.2008.09.031; Mato S, 2010, MOL PHARMACOL, V77, P424, DOI 10.1124/mol.109.060079; Moreira FA, 2010, CURR TOP BEHAV NEURO, V2, P429, DOI 10.1007/7854_2009_16; Navarro G, 2010, J BIOL CHEM, V285, P27346, DOI 10.1074/jbc.M110.115634; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Perez-Gomez E, 2013, ONCOGENE, V32, P2534, DOI 10.1038/onc.2012.278; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2010, CURR MED CHEM, V17, P1360, DOI 10.2174/092986710790980050; Pertwee RG, 2009, BRIT J PHARMACOL, V156, P397, DOI 10.1111/j.1476-5381.2008.00048.x; Pineiro R, 2011, ONCOGENE, V30, P142, DOI 10.1038/onc.2010.417; Rempel V, 2013, J MED CHEM, V56, P4798, DOI 10.1021/jm4005175; Rios C, 2006, BRIT J PHARMACOL, V148, P387, DOI 10.1038/sj.bjp.0706757; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Ross RA, 2009, TRENDS PHARMACOL SCI, V30, P156, DOI 10.1016/j.tips.2008.12.004; Rozenfeld R, 2011, EMBO J, V30, P2350, DOI 10.1038/emboj.2011.139; Rozenfeld R, 2010, TRENDS PHARMACOL SCI, V31, P124, DOI 10.1016/j.tips.2009.11.008; Sanudo-Pena MC, 2000, EUR J PHARMACOL, V391, P269, DOI 10.1016/S0014-2999(00)00044-3; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Sulcova E, 1998, PHARMACOL BIOCHEM BE, V59, P347, DOI 10.1016/S0091-3057(97)00422-X; Trifilieff P, 2011, BIOTECHNIQUES, V51, P111, DOI 10.2144/000113719; Velasco G, 2012, NAT REV CANCER, V12, P436, DOI 10.1038/nrc3247; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106	38	71	76	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21960	21972		10.1074/jbc.M114.561761	http://dx.doi.org/10.1074/jbc.M114.561761			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24942731	Green Published, hybrid			2022-12-25	WOS:000340593500013
J	Kamath-Loeb, AS; Balakrishna, S; Whittington, D; Shen, JC; Emond, MJ; Okabe, T; Masutani, C; Hanaoka, F; Nishimura, S; Loeb, LA				Kamath-Loeb, Ashwini S.; Balakrishna, Sharath; Whittington, Dale; Shen, Jiang-Cheng; Emond, Mary J.; Okabe, Takayoshi; Masutani, Chikahide; Hanaoka, Fumio; Nishimura, Susumu; Loeb, Lawrence A.			Sphingosine, a Modulator of Human Translesion DNA Polymerase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XERODERMA-PIGMENTOSUM VARIANT; HIGH-FIDELITY; CANCER-CELLS; LUNG-CANCER; POL-KAPPA; ETA; EXPRESSION; CERAMIDE; CHEMOTHERAPY; REPLICATION	Translesion (TLS) DNA polymerases are specialized, error-prone enzymes that synthesize DNA across bulky, replication-stalling DNA adducts. In so doing, they facilitate the progression of DNA synthesis and promote cell proliferation. To potentiate the effect of cancer chemotherapeutic regimens, we sought to identify inhibitors of TLS DNA polymerases. We screened five libraries of similar to 3000 small molecules, including one comprising similar to 600 nucleoside analogs, for their effect on primer extension activity of DNA polymerase eta(Pol eta). We serendipitously identified sphingosine, a lipid-signaling molecule that robustly stimulates the activity of Pol eta by similar to 100-fold at low micromolar concentrations but inhibits it at higher concentrations. This effect is specific to the Y-family DNA polymerases, Pols eta, kappa, and iota. The addition of a single phosphate group on sphingosine completely abrogates this effect. Likewise, the inclusion of other sphingolipids, including ceramide and sphingomyelin to extension reactions does not elicit this response. Sphingosine increases the rate of correct and incorrect nucleotide incorporation while having no effect on polymerase processivity. Endogenous Pol eta activity is modulated similarly as the recombinant enzyme. Importantly, sphingosine-treated cells exhibit increased lesion bypass activity, and sphingosine tethered to membrane lipids mimics the effects of free sphingosine. Our studies have uncovered sphingosine as a modulator of TLS DNA polymerase activity; this property of sphingosine may be associated with its known role as a signaling molecule in regulating cell proliferation in response to cellular stress.	[Kamath-Loeb, Ashwini S.; Balakrishna, Sharath; Shen, Jiang-Cheng; Loeb, Lawrence A.] Univ Washington, Dept Pathol, Gottstein Mem Canc Res Lab, Seattle, WA 98195 USA; [Kamath-Loeb, Ashwini S.; Balakrishna, Sharath; Shen, Jiang-Cheng; Loeb, Lawrence A.] Univ Washington, Dept Biochem, Gottstein Mem Canc Res Lab, Seattle, WA 98195 USA; [Whittington, Dale] Univ Washington, Mass Spectrometry Ctr, Dept Med Chem, Seattle, WA 98195 USA; [Emond, Mary J.] Univ Washington, Seattle, WA 98195 USA; [Emond, Mary J.] Univ Washington, Ctr Biomed Stat, Seattle, WA 98195 USA; [Okabe, Takayoshi] Univ Tokyo, Open Innovat Ctr Drug Discovery, Tokyo 1130033, Japan; [Masutani, Chikahide] Nagoya Univ, Environm Med Res Inst, Dept Genome Dynam, Nagoya, Aichi 4648601, Japan; [Hanaoka, Fumio] Gakushuin Univ, Inst Biomol Sci, Fac Sci, Tokyo 1718588, Japan; [Nishimura, Susumu] Univ Tsukuba, Lab Anim Resource Ctr, Tsukuba, Ibaraki 3058575, Japan	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Tokyo; Nagoya University; Gakushuin University; University of Tsukuba	Loeb, LA (corresponding author), Univ Washington, Dept Pathol, Gottstein Mem Canc Res Lab, Seattle, WA 98195 USA.	laloeb@uw.edu	Masutani, Chikahide/I-6160-2014; Balakrishna, Sharath/AAA-4755-2022; Balakrishna, Sharath/AAC-6450-2020	Balakrishna, Sharath/0000-0002-9734-711X; Masutani, Chikahide/0000-0002-8600-8227	National Institutes of Health [P01-CA 077852, P01-AG 001751]; Grants-in-Aid for Scientific Research [22131008] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [P01CA077852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG001751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01-CA 077852 and P01-AG 001751 (to L. A. L.).	Akagi JI, 2009, DNA REPAIR, V8, P585, DOI 10.1016/j.dnarep.2008.12.006; Albertella MR, 2005, DNA REPAIR, V4, P583, DOI 10.1016/j.dnarep.2005.01.005; Bi XH, 2005, J BIOL CHEM, V280, P22343, DOI 10.1074/jbc.M501562200; Brauze D, 2012, ENVIRON TOXICOL PHAR, V34, P819, DOI 10.1016/j.etap.2012.09.004; Ceppi P, 2009, CLIN CANCER RES, V15, P1039, DOI 10.1158/1078-0432.CCR-08-1227; Chen YW, 2008, P NATL ACAD SCI USA, V105, P16578, DOI 10.1073/pnas.0808589105; Cleaver JE, 1999, CANCER RES, V59, P1102; Doles J, 2010, P NATL ACAD SCI USA, V107, P20786, DOI 10.1073/pnas.1011409107; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Goodman MF, 2000, CURR OPIN GENET DEV, V10, P162, DOI 10.1016/S0959-437X(00)00057-5; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Kamath-Loeb AS, 2012, J BIOL CHEM, V287, P12480, DOI 10.1074/jbc.M111.332577; KamathLoeb AS, 1997, J BIOL CHEM, V272, P5892, DOI 10.1074/jbc.272.9.5892; Kino K., 2004, NUCL ACIDS S SER, V48, P171, DOI [10.1093/nass/48.1.171, DOI 10.1093/NASS/48.1.171]; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lemee F, 2007, ONCOGENE, V26, P3387, DOI 10.1038/sj.onc.1210116; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; O-Wang J, 2001, CANCER RES, V61, P5366; Ohanian J, 2001, CELL MOL LIFE SCI, V58, P2053, DOI 10.1007/PL00000836; Pavlov YI, 2002, P NATL ACAD SCI USA, V99, P9954, DOI 10.1073/pnas.152126799; Ponnusamy S, 2010, FUTURE ONCOL, V6, P1603, DOI 10.2217/FON.10.116; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Salehan MR, 2013, BRIT J BIOMED SCI, V70, P31, DOI 10.1080/09674845.2013.11669927; Sasaki H, 2009, BIOPHYS J, V96, P2727, DOI 10.1016/j.bpj.2008.12.3926; Schmitt MW, 2009, BIOCHIMIE, V91, P1163, DOI 10.1016/j.biochi.2009.06.007; Seber G., 2003, LINEAR REGRESSION AN; Shen JC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04894; SIMBULAN CMG, 1994, BIOCHEMISTRY-US, V33, P9007, DOI 10.1021/bi00196a019; Singer WD, 2013, DNA REPAIR, V12, P817, DOI 10.1016/j.dnarep.2013.07.010; Suzuki N, 2002, BIOCHEMISTRY-US, V41, P6100, DOI 10.1021/bi020049c; Teng KY, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-126; Urs AN, 2006, ENDOCRINOLOGY, V147, P5249, DOI 10.1210/en.2006-0355; Vaisman A, 2000, BIOCHEMISTRY-US, V39, P4575, DOI 10.1021/bi000130k; Velasco-Miguel S, 2003, DNA REPAIR, V2, P91, DOI 10.1016/S1568-7864(02)00189-1; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Xie K, 2010, P NATL ACAD SCI USA, V107, P20792, DOI 10.1073/pnas.1011412107; Yang J, 2004, CANCER RES, V64, P5597, DOI 10.1158/0008-5472.CAN-04-0603; ZHANG H, 1990, J BIOL CHEM, V265, P76; Zorn JA, 2010, NAT CHEM BIOL, V6, P179, DOI 10.1038/NCHEMBIO.318	46	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21663	21672		10.1074/jbc.M114.570242	http://dx.doi.org/10.1074/jbc.M114.570242			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24928506	Green Published, hybrid			2022-12-25	WOS:000340558300040
J	Blodorn, K; Hagglund, S; Fix, J; Dubuquoy, C; Makabi-Panzu, B; Thom, M; Karlsson, P; Roque, JL; Karlstam, E; Pringle, J; Eleouet, JF; Riffault, S; Taylor, G; Valarcher, JF				Blodorn, Krister; Hagglund, Sara; Fix, Jenna; Dubuquoy, Catherine; Makabi-Panzu, Boby; Thom, Michelle; Karlsson, Per; Roque, Jean-Louis; Karlstam, Erika; Pringle, John; Eleouet, Jean-Francois; Riffault, Sabine; Taylor, Geraldine; Valarcher, Jean Francois			Vaccine Safety and Efficacy Evaluation of a Recombinant Bovine Respiratory Syncytial Virus (BRSV) with Deletion of the SH Gene and Subunit Vaccines Based On Recombinant Human RSV Proteins: N-nanorings, P and M2-1, in Calves with Maternal Antibodies	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; FUSION GLYCOPROTEIN; GNOTOBIOTIC CALVES; PROTECTIVE IMMUNITY; CROSS-PRESENTATION; SEQUENCE-ANALYSIS; VIRAL-INFECTION; MESSENGER-RNA; COTTON RATS; DISEASE	The development of safe and effective vaccines against both bovine and human respiratory syncytial viruses (BRSV, HRSV) to be used in the presence of RSV-specific maternally-derived antibodies (MDA) remains a high priority in human and veterinary medicine. Herein, we present safety and efficacy results from a virulent BRSV challenge of calves with MDA, which were immunized with one of three vaccine candidates that allow serological differentiation of infected from vaccinated animals (DIVA): an SH gene-deleted recombinant BRSV (Delta SHrBRSV), and two subunit (SU) formulations based on HRSV-P, -M2- 1, and -N recombinant proteins displaying BRSV-F and -G epitopes, adjuvanted by either oil emulsion (Montanide ISA71(VG), SUMont) or immunostimulating complex matrices (AbISCO-300, SUAbis). Whereas all control animals developed severe respiratory disease and shed high levels of virus following BRSV challenge, Delta SHrBRSV-immunized calves demonstrated almost complete clinical and virological protection five weeks after a single intranasal vaccination. Although mucosal vaccination with DSHrBRSV failed to induce a detectable immunological response, there was a rapid and strong anamnestic mucosal BRSV-specific IgA, virus neutralizing antibody and local T cell response following challenge with virulent BRSV. Calves immunized twice intramuscularly, three weeks apart with SUMont were also well protected two weeks after boost. The protection was not as pronounced as that in Delta SHrBRSV-immunized animals, but superior to those immunized twice subcutaneously three weeks apart with SUAbis. Antibody responses induced by the subunit vaccines were non-neutralizing and not directed against BRSV F or G proteins. When formulated as SUMont but not as SUAbis, the HRSV N, P and M2-1 proteins induced strong systemic cross-protective cell-mediated immune responses detectable already after priming. Delta SHrBRSV and SUMont are two promising DIVA-compatible vaccines, apparently inducing protection by different immune responses that were influenced by vaccine-composition, immunization route and regimen.	[Blodorn, Krister; Hagglund, Sara; Pringle, John; Valarcher, Jean Francois] Swedish Univ Agr Sci, Host Pathogen Interact Grp, Dept Clin Sci, Uppsala, Sweden; [Fix, Jenna; Dubuquoy, Catherine; Eleouet, Jean-Francois; Riffault, Sabine] INRA, Unite Virol & Immunol Mol, Jouy en Josas, France; [Makabi-Panzu, Boby; Thom, Michelle; Taylor, Geraldine] Pirbright Inst, Pirbright, Surrey, England; [Karlsson, Per; Valarcher, Jean Francois] Natl Vet Inst, Dept Virol Immunol & Parasitol, S-75007 Uppsala, Sweden; [Roque, Jean-Louis] Clin Vet Mazets, Riom Es Montagnes, France; [Karlstam, Erika] Natl Vet Inst, Dept Pathol & Wildlife Dis, S-75007 Uppsala, Sweden	Swedish University of Agricultural Sciences; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; National Veterinary Institute SVA; National Veterinary Institute SVA	Hagglund, S (corresponding author), Swedish Univ Agr Sci, Host Pathogen Interact Grp, Dept Clin Sci, Uppsala, Sweden.	sara.hagglund@slu.se	Eléouët, Jean-François/AAD-1994-2019; Hägglund, Sara/AAE-4867-2020; Pringle, John/E-8332-2019; VALARCHER, JEAN FRANCOIS/AAE-4857-2020	Hägglund, Sara/0000-0002-6983-5722; Pringle, John/0000-0003-4013-0363; VALARCHER, JEAN FRANCOIS/0000-0002-8564-5603; Thom, Michelle/0000-0002-5678-8760; ELeouet, Jean-Francois/0000-0002-7361-4885	Swedish Research Council (Formas, Sweden); Biotechnology and Biological Sciences Research Council (BBSRC, UK); L'Agence Nationale de la Recherche (ANR, France), through EMIDA ERA NET [87]; BBSRC [BBS/E/I/00001325, BB/I017216/1, BBS/E/I/00001709] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001325, BBS/E/I/00001709, BB/I017216/1] Funding Source: researchfish	Swedish Research Council (Formas, Sweden); Biotechnology and Biological Sciences Research Council (BBSRC, UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); L'Agence Nationale de la Recherche (ANR, France), through EMIDA ERA NET(French National Research Agency (ANR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Swedish Research Council (Formas, Sweden), the Biotechnology and Biological Sciences Research Council (BBSRC, UK), and L'Agence Nationale de la Recherche (ANR, France), through EMIDA ERA NET (Grant no FP#87). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (http://www.formas.se/; http://www.bbsrc.ac.uk/; http://www.agence-nationale-recherche.fr/; http://emida-era.net/).	Antonis AFG, 2003, J VIROL, V77, P12067, DOI 10.1128/JVI.77.22.12067-12073.2003; ARBIZA J, 1992, J GEN VIROL, V73, P2225, DOI 10.1099/0022-1317-73-9-2225; Aucouturier J, 2001, VACCINE, V19, P2666, DOI 10.1016/S0264-410X(00)00498-9; Bastien N, 1997, VACCINE, V15, P1385, DOI 10.1016/S0264-410X(97)00033-9; Belyakov IM, 2009, J IMMUNOL, V183, P6883, DOI 10.4049/jimmunol.0901466; BRYSON DG, 1993, VET MED-US, V88, P894; Buchholz UJ, 2000, J VIROL, V74, P1187, DOI 10.1128/JVI.74.3.1187-1199.2000; Castagne N, 2004, J GEN VIROL, V85, P1643, DOI 10.1099/vir.0.79830-0; Chargelegue D, 1998, J VIROL, V72, P2040, DOI 10.1128/JVI.72.3.2040-2046.1998; Chase CCL, 2008, VET CLIN N AM-FOOD A, V24, P87, DOI 10.1016/j.cvfa.2007.11.001; Duewell P, 2011, J IMMUNOL; Ellis J, 2007, JAVMA-J AM VET MED A, V230, P233, DOI 10.2460/javma.230.2.233; Ellis JA, 2013, JAVMA-J AM VET MED A, V243, P1602, DOI 10.2460/javma.243.11.1602; Fogg MH, 2001, VACCINE, V19, P3226, DOI 10.1016/S0264-410X(01)00030-5; Fulton Robert W., 2009, Animal Health Research Reviews, V10, P131, DOI 10.1017/S146625230999017X; Furze JM, 1997, VIROLOGY, V231, P48, DOI 10.1006/viro.1997.8490; Gaddum RM, 2003, IMMUNOLOGY, V108, P220, DOI 10.1046/j.1365-2567.2003.01566.x; Hagglund S, 2004, VACCINE, V23, P646, DOI 10.1016/j.vaccine.2004.07.006; Hagglund S, 2014, CLIN VACCINE IMMUNOL, V21, P997, DOI 10.1128/CVI.00162-14; Hagglund S, 2011, VACCINE, V29, P8719, DOI 10.1016/j.vaccine.2011.07.146; Herve PL, 2014, J VIROL, V88, P325, DOI 10.1128/JVI.01141-13; Karger A, 2001, J GEN VIROL, V82, P631, DOI 10.1099/0022-1317-82-3-631; Karron RA, 2005, J INFECT DIS, V191, P1093, DOI 10.1086/427813; KENNEDY HE, 1988, J GEN VIROL, V69, P3023, DOI 10.1099/0022-1317-69-12-3023; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; KIMMAN TG, 1989, VET QUART, V11, P250, DOI 10.1080/01652176.1989.9694231; KIMMAN TG, 1989, VET IMMUNOL IMMUNOP, V22, P145, DOI 10.1016/0165-2427(89)90057-3; KIMMAN TG, 1988, VET REC, V123, P104, DOI 10.1136/vr.123.4.104; KIMMAN TG, 1987, J CLIN MICROBIOL, V25, P1097, DOI 10.1128/JCM.25.6.1097-1106.1987; Larsen LE, 1998, VET MICROBIOL, V62, P265, DOI 10.1016/S0378-1135(98)00226-0; MALLIPEDDI SK, 1992, J GEN VIROL, V73, P2441, DOI 10.1099/0022-1317-73-9-2441; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; Meyer G, 2008, COMP IMMUNOL MICROB, V31, P191, DOI 10.1016/j.cimid.2007.07.008; MOHANTY SB, 1975, AM J VET RES, V36, P417; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Paton DJ, 2006, VACCINE, V24, P6503, DOI 10.1016/j.vaccine.2006.06.032; PIAZZA FM, 1993, J VIROL, V67, P1503, DOI 10.1128/JVI.67.3.1503-1510.1993; Riffault S, 2010, VACCINE, V28, P3722, DOI 10.1016/j.vaccine.2010.03.008; Robson NC, 2008, EUR J IMMUNOL, V38, P1238, DOI 10.1002/eji.200737758; Roux X, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001766; Rudraraju R, 2013, VIRUSES-BASEL, V5, P577, DOI 10.3390/v5020577; SAMAL SK, 1991, VIROLOGY, V180, P453, DOI 10.1016/0042-6822(91)90057-I; Schnurr M, 2009, J IMMUNOL, V182, P1253, DOI 10.4049/jimmunol.182.3.1253; Schreiber P, 2000, J VET MED B, V47, P535, DOI 10.1046/j.1439-0450.2000.00380.x; Seiffert SN, 2013, DRUG RESIST UPDATE, V16, P22, DOI 10.1016/j.drup.2012.12.001; STOTT EJ, 1980, J HYG-CAMBRIDGE, V85, P257, DOI 10.1017/S0022172400063294; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; TAYLOR G, 1995, J VIROL, V69, P6658, DOI 10.1128/JVI.69.11.6658-6664.1995; Taylor G, 2005, VACCINE, V23, P1242, DOI 10.1016/j.vaccine.2004.09.005; Taylor G, 1997, J GEN VIROL, V78, P3195, DOI 10.1099/0022-1317-78-12-3195; Taylor G, 2014, J GEN VIROL, V95, P1244, DOI 10.1099/vir.0.064931-0; THOMAS LH, 1982, RES VET SCI, V33, P170, DOI 10.1016/S0034-5288(18)32331-2; THOMAS LH, 1984, ARCH VIROL, V79, P67, DOI 10.1007/BF01314304; Thomas LH, 1998, J INFECT DIS, V177, P874, DOI 10.1086/515234; Tran TL, 2007, J GEN VIROL, V88, P196, DOI 10.1099/vir.0.82282-0; Tran TL, 2009, J VIROL, V83, P6363, DOI 10.1128/JVI.00335-09; Uttenthal A, 2000, VET MICROBIOL, V76, P329, DOI 10.1016/S0378-1135(00)00261-3; Valarcher JF, 2007, VET RES, V38, P153, DOI 10.1051/vetres:2006053; Valarcher JF, 2000, J VIROL, V74, P10714, DOI 10.1128/JVI.74.22.10714-10728.2000; Valarcher JF, 2003, J VIROL, V77, P8426, DOI 10.1128/JVI.77.15.8426-8439.2003; Viuff B, 1996, VET PATHOL, V33, P383, DOI 10.1177/030098589603300403; WALSH EE, 1987, J INFECT DIS, V155, P1198, DOI 10.1093/infdis/155.6.1198; WESTENBRINK F, 1989, J GEN VIROL, V70, P591, DOI 10.1099/0022-1317-70-3-591; Wu SJ, 2007, J GEN VIROL, V88, P2719, DOI 10.1099/vir.0.82753-0; ZAMORA M, 1992, J GEN VIROL, V73, P737, DOI 10.1099/0022-1317-73-3-737	66	26	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100392	10.1371/journal.pone.0100392	http://dx.doi.org/10.1371/journal.pone.0100392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945377	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500069
J	Duarte, A; Castillo, AF; Podesta, EJ; Poderoso, C				Duarte, Alejandra; Fernanda Castillo, Ana; Podesta, Ernesto J.; Poderoso, Cecilia			Mitochondrial Fusion and ERK Activity Regulate Steroidogenic Acute Regulatory Protein Localization in Mitochondria	PLOS ONE			English	Article							SIDE-CHAIN CLEAVAGE; LEYDIG TUMOR-CELLS; ACYL-COA SYNTHETASE-4; ARACHIDONIC-ACID; STAR PROTEIN; CHOLESTEROL TRANSPORT; HORMONE STIMULATION; PHOSPHORYLATION; EXPRESSION; ACTIVATION	The rate-limiting step in the biosynthesis of steroid hormones, known as the transfer of cholesterol from the outer to the inner mitochondrial membrane, is facilitated by StAR, the Steroidogenic Acute Regulatory protein. We have described that mitochondrial ERK1/2 phosphorylates StAR and that mitochondrial fusion, through the up-regulation of a fusion protein Mitofusin 2, is essential during steroidogenesis. Here, we demonstrate that mitochondrial StAR together with mitochondrial active ERK and PKA are necessary for maximal steroid production. Phosphorylation of StAR by ERK is required for the maintenance of this protein in mitochondria, observed by means of over-expression of a StAR variant lacking the ERK phosphorylation residue. Mitochondrial fusion regulates StAR levels in mitochondria after hormone stimulation. In this study, Mitofusin 2 knockdown and mitochondrial fusion inhibition in MA-10 Leydig cells diminished StAR mRNA levels and concomitantly mitochondrial StAR protein. Together our results unveil the requirement of mitochondrial fusion in the regulation of the localization and mRNA abundance of StAR. We here establish the relevance of mitochondrial phosphorylation events in the correct localization of this key protein to exert its action in specialized cells. These discoveries highlight the importance of mitochondrial fusion and ERK phosphorylation in cholesterol transport by means of directing StAR to the outer mitochondrial membrane to achieve a large number of steroid molecules per unit of StAR.	[Duarte, Alejandra; Fernanda Castillo, Ana; Podesta, Ernesto J.; Poderoso, Cecilia] Univ Buenos Aires, Dept Biochem, Sch Med, Inst Biomed Invest,INBIOMED,UBA CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Poderoso, C (corresponding author), Univ Buenos Aires, Dept Biochem, Sch Med, Inst Biomed Invest,INBIOMED,UBA CONICET, Buenos Aires, DF, Argentina.	cepoderos@yahoo.com		Castillo, Ana Fernanda/0000-0002-1572-4728	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad de Buenos Aires (UBA)	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires (UBA)(University of Buenos Aires)	This investigation was supported by funding from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), grants to E.J.P. and C.P.; from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) to E.J.P. and from the Universidad de Buenos Aires (UBA) to E.J.P., and C.P. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2006, ENDOCRINOLOGY, V147, P3924, DOI 10.1210/en.2005-1204; Alonso M, 2004, J NEUROCHEM, V89, P248, DOI 10.1111/j.1471-4159.2004.02323.x; Arciuch VGA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007523; Anuka E, 2013, MOL CELL ENDOCRINOL, V371, P47, DOI 10.1016/j.mce.2013.02.003; Arakane F, 1997, J BIOL CHEM, V272, P32656, DOI 10.1074/jbc.272.51.32656; Arakane F, 1996, P NATL ACAD SCI USA, V93, P13731, DOI 10.1073/pnas.93.24.13731; Artemenko IP, 2001, J BIOL CHEM, V276, P46583, DOI 10.1074/jbc.M107815200; ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Bey P, 2003, ENDOCRINOLOGY, V144, P1399, DOI 10.1210/en.2002-220987; Bose HS, 2002, NATURE, V417, P87, DOI 10.1038/417087a; Bose M, 2008, J BIOL CHEM, V283, P8837, DOI 10.1074/jbc.M709221200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brion L, 2011, ENDOCRINOLOGY, V152, P2665, DOI 10.1210/en.2011-0021; Castillo AF, 2006, FEBS J, V273, P5011, DOI 10.1111/j.1742-4658.2006.05496.x; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; Duarte A, 2007, FEBS LETT, V581, P4023, DOI 10.1016/j.febslet.2007.07.040; Duarte A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045829; Castillo AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022822; Fleury A, 2004, J STEROID BIOCHEM, V91, P259, DOI 10.1016/j.jsbmb.2004.04.010; Granot Z, 2003, MOL ENDOCRINOL, V17, P2461, DOI 10.1210/me.2003-0074; Granot Z, 2007, MOL CELL ENDOCRINOL, V265, P51, DOI 10.1016/j.mce.2006.12.003; Granot Z, 2007, MOL ENDOCRINOL, V21, P2164, DOI 10.1210/me.2005-0458; Grozdanov PN, 2012, MOL ENDOCRINOL, V26, P2104, DOI 10.1210/me.2012-1123; Gyles SL, 2001, J BIOL CHEM, V276, P34888, DOI 10.1074/jbc.M102063200; Hauet T, 2005, MOL ENDOCRINOL, V19, P540, DOI 10.1210/me.2004-0307; Hirakawa T, 2003, MOL ENDOCRINOL, V17, P2189, DOI 10.1210/me.2003-0205; Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0; Jefcoate C, 2002, J CLIN INVEST, V110, P881, DOI 10.1172/JCI200216771; Kallen CB, 1998, MOL CELL ENDOCRINOL, V145, P39, DOI 10.1016/S0303-7207(98)00167-1; KRUEGER RJ, 1983, J BIOL CHEM, V258, P159; Le T, 2001, ENDOCRINOLOGY, V142, P4282, DOI 10.1210/en.142.10.4282; Lewin TM, 2002, ARCH BIOCHEM BIOPHYS, V404, P263, DOI 10.1016/S0003-9861(02)00247-3; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Maloberti P, 2005, FEBS J, V272, P1804, DOI 10.1111/j.1742-4658.2005.04616.x; Manna PR, 2003, STEROIDS, V68, P1125, DOI 10.1016/j.steroids.2003.07.009; Manna PR, 2013, J BIOL CHEM, V288, P8505, DOI 10.1074/jbc.M112.417873; Martinelle N, 2004, ENDOCRINOLOGY, V145, P4629, DOI 10.1210/en.2004-0496; Miller WL, 2007, MOL CELL ENDOCRINOL, V265, P46, DOI 10.1016/j.mce.2006.12.002; Miller WL, 2013, MOL CELL ENDOCRINOL; Otis M, 2007, MOL CELL ENDOCRINOL, V265, P126, DOI 10.1016/j.mce.2006.12.008; Papanicolaou KN, 2012, AM J PHYSIOL-HEART C, V302, pH167, DOI 10.1152/ajpheart.00833.2011; Poderoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001443; PRIVALLE CT, 1983, P NATL ACAD SCI-BIOL, V80, P702, DOI 10.1073/pnas.80.3.702; PRIVALLE CT, 1987, MOL CELL ENDOCRINOL, V53, P87, DOI 10.1016/0303-7207(87)90195-X; Reinhart AJ, 1999, MOL ENDOCRINOL, V13, P729, DOI 10.1210/me.13.5.729; Rone MB, 2012, MOL ENDOCRINOL, V26, P1868, DOI 10.1210/me.2012-1159; Seger R, 2001, J BIOL CHEM, V276, P13957, DOI 10.1074/jbc.M006852200; SIMPSON ER, 1972, EUR J BIOCHEM, V28, P442, DOI 10.1111/j.1432-1033.1972.tb01931.x; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; STOCCO DM, 1991, J BIOL CHEM, V266, P19731; Tai P, 2011, MOL ENDOCRINOL, V25, P885, DOI 10.1210/me.2010-0489; van der Laan M, 2010, BBA-MOL CELL RES, V1803, P732, DOI 10.1016/j.bbamcr.2010.01.013; Wang XJ, 2000, J BIOL CHEM, V275, P20204, DOI 10.1074/jbc.M003113200; Xu FY, 2010, BBA-BIOMEMBRANES, V1798, P1577, DOI 10.1016/j.bbamem.2010.04.007; Zhao D, 2005, J STEROID BIOCHEM, V96, P155, DOI 10.1016/j.jsbmb.2005.02.011	57	51	52	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100387	10.1371/journal.pone.0100387	http://dx.doi.org/10.1371/journal.pone.0100387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945345	gold, Green Published, Green Submitted			2022-12-25	WOS:000340721500068
J	Marcelli, F; Boisset, G; Schorderet, DF				Marcelli, Fabienne; Boisset, Gaelle; Schorderet, Daniel F.			A Dimerized HMX1 Inhibits EPHA6/epha4b in Mouse and Zebrafish Retinas	PLOS ONE			English	Article							OCULO-AURICULAR SYNDROME; HOMEOBOX GENE FAMILY; INNER-EAR; EXPRESSION; SYSTEM; IDENTIFICATION; PROJECTION; MUTATION; NEURONS; BINDING	HMX1 is a homeobox-containing transcription factor implicated in eye development and responsible for the oculo-auricular syndrome of Schorderet-Munier-Franceschetti. HMX1 is composed of two exons with three conserved domains in exon 2, a homeobox and two domains called SD1 and SD2. The function of the latter two domains remains unknown. During retinal development, HMX1 is expressed in a polarized manner and thus seems to play a role in the establishment of retinal polarity although its exact role and mode of action in eye development are unknown. Here, we demonstrated that HMX1 dimerized and that the SD1 and homeodomains are required for this function. In addition, we showed that proper nuclear localization requires the presence of the homeodomain. We also identified that EPHA6, a gene implicated in retinal axon guidance, is one of its targets in eye development and showed that a dimerized HMX1 is needed to inhibit EPHA6 expression.	[Marcelli, Fabienne; Boisset, Gaelle; Schorderet, Daniel F.] IRO Inst Res Ophthalmol, Sion, Switzerland; [Marcelli, Fabienne; Schorderet, Daniel F.] Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Fac Life Sci, CH-1015 Lausanne, Switzerland; [Schorderet, Daniel F.] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne	Schorderet, DF (corresponding author), IRO Inst Res Ophthalmol, Sion, Switzerland.	daniel.schorderet@irovision.ch			Swiss National Science Foundation [31003A_124990, 31003A_143474]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants from the Swiss National Science Foundation (No 31003A_124990 and 31003A_143474). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdus-Saboor I, 2012, DEV BIOL, V366, P298, DOI 10.1016/j.ydbio.2012.03.015; Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Adamska M, 2000, MECH DEVELOP, V97, P161, DOI 10.1016/S0925-4773(00)00414-7; Adamska M, 2001, DEV GENES EVOL, V211, P338, DOI 10.1007/s004270100162; Amendt BA, 1999, J BIOL CHEM, V274, P11635, DOI 10.1074/jbc.274.17.11635; Boisset G, 2012, EXP EYE RES, V105, P34, DOI 10.1016/j.exer.2012.10.002; Boulling A, 2013, MOL VIS, V19, P1779; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Furlan A, 2013, EMBO J, V32, P1613, DOI 10.1038/emboj.2013.85; Kasahara H, 2001, J BIOL CHEM, V276, P4570, DOI 10.1074/jbc.M004995200; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Meima L, 1997, MOL CELL NEUROSCI, V9, P314, DOI 10.1006/mcne.1997.0621; Munroe RJ, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-27; Quina LA, 2012, DEV BIOL, V365, P152, DOI 10.1016/j.ydbio.2012.02.022; Schorderet DF, 2008, AM J HUM GENET, V82, P1178, DOI 10.1016/j.ajhg.2008.03.007; Schulte D, 2000, DEVELOPMENT, V127, P5033; STADLER HS, 1992, P NATL ACAD SCI USA, V89, P11579, DOI 10.1073/pnas.89.23.11579; STADLER HS, 1995, MAMM GENOME, V6, P383, DOI 10.1007/BF00355637; STADLER HS, 1994, DEV BIOL, V161, P251, DOI 10.1006/dbio.1994.1025; Vaclavik V, 2011, OPHTHALMIC GENET, V32, P114, DOI 10.3109/13816810.2011.562955; Wang WD, 2000, MECH DEVELOP, V99, P123, DOI 10.1016/S0925-4773(00)00488-3; Wang WD, 1998, DEVELOPMENT, V125, P621; Yoshiura K, 1998, GENOMICS, V50, P61, DOI 10.1006/geno.1998.5284	26	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100096	10.1371/journal.pone.0100096	http://dx.doi.org/10.1371/journal.pone.0100096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945320	Green Submitted, Green Published, gold			2022-12-25	WOS:000340721500044
J	Pulliero, A; Seydel, A; Camoirano, A; Sacca, SC; Sandri, M; Izzotti, A				Pulliero, Alessandra; Seydel, Anke; Camoirano, Anna; Sacca, Sergio Claudio; Sandri, Marco; Izzotti, Alberto			Oxidative Damage and Autophagy in the Human Trabecular Meshwork as Related with Ageing	PLOS ONE			English	Article							AQUEOUS-HUMOR DYNAMICS; OPEN-ANGLE GLAUCOMA; MOLECULAR-MECHANISMS; CELLS; P62; AGE; EYE	Autophagy is an intracellular lysosomal degradation process induced under stress conditions. Autophagy also plays a major role in ocular patho-physiology. Molecular aging does occur in the trabecular meshwork, the main regulator of aqueous humor outflow, and trabecular meshwork senescence is accompanied by increased oxidative stress. However, the role of autophagy in trabecular meshwork patho-physiology has not yet been examined in vivo in human ocular tissues. The purpose of the herein presented study is to evaluate autophagy occurrence in ex-vivo collected human trabecular meshwork specimens and to evaluate the relationship between autophagy, oxidative stress, and aging in this tissue. Fresh trabecular meshwork specimens were collected from 28 healthy corneal donors devoid of ocular pathologies and oxidative DNA damage, and LC3 and p62 protein expression analyzed. In a subset of 10 subjects, further to trabecular meshwork proteins, the amounts of cathepesin L and ubiquitin was analyzed by antibody microarray in aqueous humor. Obtained results demonstrate that autophagy activation, measured by LC3II/I ratio, is related with. oxidative damage occurrence during aging in human trabecular meshwork. The expression of autophagy marker p62 was lower in subjects older than 60 years as compared to younger subjects. These findings reflect the occurrence of an agedependent increase in the autophagy as occurring in the trabecular meshwork. Furthermore, we showed that aging promotes trabecular-meshwork senescence due to increased oxidative stress paralleled by autophagy increase. Indeed, both oxidative DNA damage and autophagy were more abundant in subjects older than 60 years. These findings shed new light on the role of oxidative damage and autophagy during trabecular-meshwork aging.	[Pulliero, Alessandra; Camoirano, Anna] Univ Genoa, Dept Hlth Sci, Genoa, Italy; [Seydel, Anke; Sandri, Marco] Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy; [Sacca, Sergio Claudio] St Martino Hosp, Ophthalmol Unit, Dept Head Neck Pathol, Genoa, Italy; [Sacca, Sergio Claudio] Univ Padua, Dept Biomed Sci, Padua, Italy; [Izzotti, Alberto] IRCCS AOU San Martino IST, Genoa, Italy	University of Genoa; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; University of Padua; University of Genoa; IRCCS AOU San Martino IST	Izzotti, A (corresponding author), Univ Genoa, Dept Hlth Sci, Genoa, Italy.	izzotti@unige.it	Saccà, Sergio/AAG-3335-2019; Sacca, Sergio/D-5118-2018	Saccà, Sergio/0000-0001-6973-5978; Sacca, Sergio/0000-0001-6973-5978; izzotti, alberto/0000-0002-8588-0347	Department of Health Sciences University of Genoa; Fondazione Telethon Funding Source: Custom	Department of Health Sciences University of Genoa; Fondazione Telethon(Fondazione Telethon)	The source of funding is the Department of Health Sciences University of Genoa. The funders have contributed to the purchase of consumables with specific reference to reagent s and equipments used for Western blot, 8-oxo-dG, and antibody microarray analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVARADO J, 1984, OPHTHALMOLOGY, V91, P564; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Costello MJ, 2013, EXP EYE RES, V116, P141, DOI 10.1016/j.exer.2013.08.017; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Eiserich Jason P., 1998, Molecular Aspects of Medicine, V19, P221, DOI 10.1016/S0098-2997(99)00002-3; Ferreira SM, 2004, AM J OPHTHALMOL, V137, P62, DOI 10.1016/S0002-9394(03)00788-8; Gabelt BT, 2005, PROG RETIN EYE RES, V24, P612, DOI 10.1016/j.preteyeres.2004.10.003; Gelino S, 2012, J CLIN EXP PATHOL S4; Gibson SB, 2013, METHOD ENZYMOL, V528, P217, DOI 10.1016/B978-0-12-405881-1.00013-6; GRIERSON I, 1987, EYE, V1, P204, DOI 10.1038/eye.1987.38; Guimaraes CA, 2003, J BIOL CHEM, V278, P41938, DOI 10.1074/jbc.M306547200; HORSTMANN HJ, 1983, MECH AGEING DEV, V21, P121, DOI 10.1016/0047-6374(83)90069-6; Izzotti A, 2003, AM J MED, V114, P638, DOI 10.1016/S0002-9343(03)00114-1; Izzotti A, 2010, J PROTEOME RES, V9, P4831, DOI 10.1021/pr1005372; Izzotti A, 2012, EXPERT REV MOL DIAGN, V12, P629, DOI [10.1586/erm.12.57, 10.1586/ERM.12.57]; Izzotti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020110; Izzotti A, 2010, ARCH OPHTHALMOL-CHIC, V128, P724, DOI 10.1001/archophthalmol.2010.87; Izzotti A, 2009, INVEST OPHTH VIS SCI, V50, P5251, DOI 10.1167/iovs.09-3871; JEFFREY M, 1992, ACTA NEUROPATHOL, V84, P559, DOI 10.1007/BF00304476; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaminskyy V, 2012, BBA-PROTEINS PROTEOM, V1824, P44, DOI 10.1016/j.bbapap.2011.05.013; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Korolchuk VI, 2009, AUTOPHAGY, V5, P862, DOI 10.4161/auto.8840; Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liton PB, 2008, INVEST OPHTH VIS SCI, V49, P3961, DOI 10.1167/iovs.08-1915; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Petherick KJ, 2013, EMBO J, V32, P1903, DOI 10.1038/emboj.2013.123; Pinazo-Duran MD, 2013, CURR OPIN PHARMACOL, V13, P98, DOI 10.1016/j.coph.2012.10.007; Porter K, 2013, AUTOPHAGY, V9, P581, DOI 10.4161/auto.23568; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016/j.bbapap.2011.08.016; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Ryter SW, 2013, CURR PHARM DESIGN, V19, P2747; Sacca SC, 2005, ARCH OPHTHALMOL-CHIC, V123, P458, DOI 10.1001/archopht.123.4.458; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; SCHACHTSCHABEL DO, 1989, ARCH GERONTOL GERIAT, V9, P251, DOI 10.1016/0167-4943(89)90044-7; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHWARTZ LM, 1993, P NATL ACAD SCI USA, V90, P980, DOI 10.1073/pnas.90.3.980; Stewart M, 1996, CURR OPIN STRUC BIOL, V6, P162, DOI 10.1016/S0959-440X(96)80070-4; Tan GS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1354, DOI 10.1001/archophthalmol.2009.268; Tasdemir E, 2008, AUTOPHAGY, V4, P810, DOI 10.4161/auto.6486; Toris CB, 1999, AM J OPHTHALMOL, V127, P407, DOI 10.1016/S0002-9394(98)00436-X; Viiri J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069563; Vittal Rao H, 2009, INVEST OPHTHALMOL VI, V50; Wang CH, 2013, EXP BIOL MED, V1; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Yang ZQ, 2013, OXID MED CELL LONGEV, V2013, DOI [10.1155/2013/146860, 10.1155/2013/329183]; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yu BP, 1996, ANN NY ACAD SCI, V786, P1, DOI 10.1111/j.1749-6632.1996.tb39047.x	53	39	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e98106	10.1371/journal.pone.0098106	http://dx.doi.org/10.1371/journal.pone.0098106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945152	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500005
J	Wang, YM; Tsai, IH; Chen, JM; Cheng, AC; Khoo, KH				Wang, Ying-Ming; Tsai, Inn-Ho; Chen, Jin-Mei; Cheng, An-Chun; Khoo, Kay-Hooi			Correlation between the Glycan Variations and Defibrinogenating Activities of Acutobin and Its Recombinant Glycoforms	PLOS ONE			English	Article							THROMBIN-LIKE ENZYME; DEINAGKISTRODON-ACUTUS VENOM; SNAKE-VENOM; SERINE-PROTEASE; FUNCTIONAL-CHARACTERIZATION; CARBOHYDRATE STRUCTURE; CRYSTAL-STRUCTURE; PICHIA-PASTORIS; PURIFICATION; GLYCOSYLATION	Acutobin isolated from Deinagkistrodon acutus venom has been used to prevent or treat stroke in patients. This defibrinogenating serine protease is a 39 kDa glycoprotein containing terminal disialyl-capped N-glycans. After sialidase treatment, the enzyme showed similar catalytic activities toward chromogenic substrate, and cleaved the A alpha chain of fibrinogen as efficiently as the native acutobin did. However, the level of fibrinogen degradation products in mice after i.p.-injection of desialylated-acutobin was significantly lower than the level after acutobin injection, suggesting that the disialyl moieties may improve or prolong the half-life of acutobin. Two recombinant enzymes with identical protein structures and similar amidolytic activities to those of native acutobin were expressed from HEK293T and SW1353 cells and designated as HKATB and SWATB, respectively. Mass spectrometric profiling showed that their glycans differed from those of acutobin. In contrast to acutobin, HKATB cleaved not only the A alpha chain but also the B beta and gamma chains of human fibrinogens, while SWATB showed a reduced alpha-fibrinogenase activity. Non-denaturing deglycosylation of these proteases by peptide N-glycosidase F significantly reduced their fibrinogenolytic activities and thermal stabilities. The in vivo defibrinogenating effect of HKATB was inferior to that of acutobin in mice. Taken together, our results suggest that the conjugated glycans of acutobin are involved in its interaction with fibrinogen, and that the selection of cells optimally expressing efficient glycoforms and further glycosylation engineering are desirable before a recombinant product can replace the native enzyme for clinical use.	[Wang, Ying-Ming; Tsai, Inn-Ho; Chen, Jin-Mei; Cheng, An-Chun; Khoo, Kay-Hooi] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Tsai, Inn-Ho; Khoo, Kay-Hooi] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Tsai, IH (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	bc201@gate.sinica.edu.tw	wang, yan/GSE-6489-2022; wang, yingying/GRS-3058-2022; Khoo, Kay-Hooi/E-1989-2019	Khoo, Kay-Hooi/0000-0003-2906-406X	National Science Council of Taiwan [101-2319-B-001-003]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	NSC grant 101-2319-B-001-003 from National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Castro HC, 2006, TOXIN REV, V25, P291, DOI 10.1080/15569540600567321; Chang HC, 2013, J PROTEOMICS, V89, P141, DOI 10.1016/j.jprot.2013.06.012; Costa FLS, 2009, TOXICON, V54, P725, DOI 10.1016/j.toxicon.2009.05.040; Gregoriadis G, 2005, INT J PHARM, V300, P125, DOI 10.1016/j.ijpharm.2005.06.007; Grewal PK, 2010, METHOD ENZYMOL, V479, P223, DOI 10.1016/S0076-6879(10)79013-3; Hodgson WC, 2009, CURR OPIN PHARMACOL, V9, P173, DOI 10.1016/j.coph.2008.11.007; Jiang XP, 2010, APPL MICROBIOL BIOT, V85, P635, DOI 10.1007/s00253-009-2141-2; LEE RT, 1992, ARCH BIOCHEM BIOPHYS, V299, P129, DOI 10.1016/0003-9861(92)90254-T; Leme AFP, 2008, J THROMB HAEMOST, V6, P1363, DOI 10.1111/j.1538-7836.2008.02995.x; Levy DE, 2009, STROKE, V40, P3796, DOI 10.1161/STROKEAHA.109.565119; Li QB, 2000, TOXICON, V38, P1355, DOI 10.1016/S0041-0101(99)00092-6; Lin CW, 2011, GLYCOBIOLOGY, V21, P530, DOI 10.1093/glycob/cwq195; Lin YX, 2009, PROTEIN EXPRES PURIF, V67, P48, DOI 10.1016/j.pep.2009.03.005; Lindhout T, 2011, P NATL ACAD SCI USA, V108, P7397, DOI 10.1073/pnas.1019266108; Liu S, 2011, STROKE, V42, P3277, DOI 10.1161/STROKEAHA.111.622753; LOCHNIT G, 1995, EUR J BIOCHEM, V228, P805, DOI 10.1111/j.1432-1033.1995.tb20326.x; Lovely RS, 2007, BRIT J HAEMATOL, V139, P494, DOI 10.1111/j.1365-2141.2007.06825.x; Mackessy S., 2011, TOXINS HEMOSTASIS BE, P519; Marsh N, 2005, TOXICON, V45, P1171, DOI 10.1016/j.toxicon.2005.02.016; Mukherjee AK, 2013, BBA-GEN SUBJECTS, V1830, P3476, DOI 10.1016/j.bbagen.2013.02.007; Nicoll G, 1999, J BIOL CHEM, V274, P34089, DOI 10.1074/jbc.274.48.34089; Nikai T, 1995, ARCH BIOCHEM BIOPHYS, V318, P9; Nikandrov NN, 2005, TOXICON, V46, P907, DOI 10.1016/j.toxicon.2005.08.016; NOSE T, 1994, TOXICON, V32, P1509, DOI 10.1016/0041-0101(94)90309-3; Otto VI, 2004, J BIOL CHEM, V279, P35201, DOI 10.1074/jbc.M404947200; OUYANG C, 1976, TOXICON, V14, P49, DOI 10.1016/0041-0101(76)90119-7; Oyama E, 2003, TOXICON, V41, P559, DOI 10.1016/S0041-0101(02)00363-X; PFEIFFER G, 1992, EUR J BIOCHEM, V205, P961, DOI 10.1111/j.1432-1033.1992.tb16863.x; Phillips Don J., 2010, P139; Serrano SMT, 2005, TOXICON, V45, P1115, DOI 10.1016/j.toxicon.2005.02.020; Silva-Junior FP, 2007, TOXICON, V50, P18, DOI 10.1016/j.toxicon.2007.02.018; Smith AA, 2003, THROMB RES, V112, P329, DOI 10.1016/j.thromres.2004.01.001; Ullah A, 2013, PROTEIN SCI, V22, P128, DOI 10.1002/pro.2189; Wang YM, 2001, BIOCHEM J, V354, P161, DOI 10.1042/0264-6021:3540161; Whitton CM, 2000, THROMB HAEMOSTASIS, V84, P258; You WK, 2004, FEBS LETT, V571, P67, DOI 10.1016/j.febslet.2004.06.060; Yu XL, 2007, PROTEIN EXPRES PURIF, V55, P257, DOI 10.1016/j.pep.2007.07.002; Yuen S, 2004, PROTEIN EXPRES PURIF, V38, P51; Zeng FX, 2013, ARCH TOXICOL, V87, P535, DOI 10.1007/s00204-012-0957-5; Zhao P, 2000, CHIN NEW DRUGS J, V9, P267; Zheng Y, 2013, TOXICON, V67, P1, DOI 10.1016/j.toxicon.2013.01.021; Zhu ZL, 2005, J BIOL CHEM, V280, P10524, DOI 10.1074/jbc.M412900200	43	4	4	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100354	10.1371/journal.pone.0100354	http://dx.doi.org/10.1371/journal.pone.0100354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945257	Green Submitted, Green Published, gold			2022-12-25	WOS:000340721500066
J	Gao, LD; Hu, SX; Zhang, H; Luo, KW; Liu, YZ; Xu, QH; Huang, W; Deng, ZH; Zhou, SF; Liu, FQ; Zhang, F; Chen, Y				Gao, Li-Dong; Hu, Shi-Xiong; Zhang, Hong; Luo, Kai-Wei; Liu, Yun-Zhi; Xu, Qiao-Hua; Huang, Wei; Deng, Zhi-Hong; Zhou, Shuai-Feng; Liu, Fu-Qiang; Zhang, Fan; Chen, Yu			Correlation Analysis of EV71 Detection and Case Severity in Hand, Foot, and Mouth Disease in the Hunan Province of China	PLOS ONE			English	Article							INFECTION	An increase in the incidence of hand, foot and mouth disease (HFMD) cases has been observed in the Hunan province of mainland China since 2009 with a particularly higher level of severe cases in 2010-2012. Intestinal viruses of the picornaviridae family are responsible for the human syndrome associated with HFMD with enterovirus 71 (EV71) and Coxsackievirus A16 (Cox A16) being the most common causative strains. HFMD cases associated with EV71 are generally more severe with an increased association of morbidity and mortality. In this study, the etiology surveillance data of HFMD cases in Hunan province from March 2010 to October 2012 were analyzed to determine if there is a statistically relevant linear correlation exists between the detection rate of EV71 in mild cases and the proportion of severe cases among all HFMD patients. As the cases progressed from mild to severe to fatal, the likelihood of EV71 detection increased (25.78%, 52.20% and 84.18%, respectively). For all cases in the timeframe evaluated in this study, the presence of virus was detected in 63.21% of cases; among cases showing positivity for virus, EV71 infection accounted for 50.14%. These results provide evidence to support the observed higher morbidity and mortality associated with this outbreak and emphasizes the importance of early detection in order to implement necessary prevention measures to mitigate disease progression.	[Gao, Li-Dong; Hu, Shi-Xiong; Zhang, Hong; Luo, Kai-Wei; Liu, Yun-Zhi; Xu, Qiao-Hua; Huang, Wei; Deng, Zhi-Hong; Zhou, Shuai-Feng; Liu, Fu-Qiang; Zhang, Fan; Chen, Yu] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China		Luo, KW (corresponding author), Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China.	hncdclbk@163.com			Chinese Preventive Medicine Association [20101801]	Chinese Preventive Medicine Association	This study was supported by the foundation from Chinese Preventive Medicine Association (Grant No: 20101801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Chang Zhao-rui, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P676; China TMoHo, 2010, FOOT MOUTH DIS TREAT; China TMoHo, 2009, FOOT MOUTH DIS CONTR; Edmond M, 2011, PUBLIC HEALTH, V125, P777, DOI 10.1016/j.puhe.2011.09.002; Guo Ru-ning, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P530; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hu Hai-Yun, 2012, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V26, P341; Huang WC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-209; Ji H, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-248; Lin TY, 2002, J INFECT DIS, V186, P1161, DOI 10.1086/343809; Liu Zhong-Qiang, 2012, Zhongguo Dang Dai Er Ke Za Zhi, V14, P589; Mou J, 2013, EPIDEMIOL INFECT, P1; Pan Hao, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P763; Yan Xiu-feng, 2012, Zhonghua Er Ke Za Zhi, V50, P271; Yang TC, 2012, EUR J PEDIATR, V171, P1359, DOI 10.1007/s00431-012-1731-7	16	22	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100003	10.1371/journal.pone.0100003	http://dx.doi.org/10.1371/journal.pone.0100003			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941257	gold, Green Published, Green Submitted			2022-12-25	WOS:000338508200064
J	Jiang, ZQ; Li, WH; Recio, G; Liu, Y; Luo, WB; Zhang, DF; Sun, D				Jiang, Zhongqing; Li, Wenhui; Recio, Guillermo; Liu, Ying; Luo, Wenbo; Zhang, Doufei; Sun, Dan			Time Pressure Inhibits Dynamic Advantage in the Classification of Facial Expressions of Emotion	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; GROUP-PERFORMANCE; SELECTIVE ATTENTION; DECISION-MAKING; ERP; FACE; SPECIFICITY; PERCEPTION; INTENSITY; STIMULI	Recent studies suggest an advantage in the recognition of dynamic over static facial expressions of emotion. Here, we explored the differences in the processing of static and dynamic faces under condition of time pressure. A group of 18 participants classified static and dynamic facial expressions (angry, happy, and neutral). In order to increase the goal-directed attention, instructions emphasized speed and announced time pressure in the interval for the response (maximal 600 ms). Participants responded faster and more accurately in the static than in the dynamic condition. Event-related potentials (ERPs) showed larger amplitude of the P1 (90-130 ms) and LPC (300-600 ms) components for dynamic relative to static stimuli, indicating enhanced early visual processing and emotional attention. On the other hand, the N170 was more negative in static relative to dynamic faces, suggesting better structural encoding for static faces under time pressure. The present study shows some advantages in the processing of static over dynamic facial expressions of emotion when the top-down (goal-driven) attention is strengthened.	[Jiang, Zhongqing; Li, Wenhui; Liu, Ying; Luo, Wenbo; Zhang, Doufei; Sun, Dan] Liaoning Normal Univ, Sch Psychol, Dalian, Peoples R China; [Recio, Guillermo] Humboldt Univ, D-10099 Berlin, Germany	Liaoning Normal University; Humboldt University of Berlin	Jiang, ZQ (corresponding author), Liaoning Normal Univ, Sch Psychol, Dalian, Peoples R China.	jzqcjj@hotmail.com		jiang, zhongqing/0000-0002-3484-2287	National Natural Science Foundation of China [31271107, 31371033]; Humanities and social science project of the China educational ministry [11YJC190010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Humanities and social science project of the China educational ministry	This research was supported by the National Natural Science Foundation of China (No. 31271107, 31371033), Humanities and social science project of the China educational ministry (11YJC190010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Ambadar Z, 2005, PSYCHOL SCI, V16, P403, DOI 10.1111/j.0956-7976.2005.01548.x; [Anonymous], 2006, SINGULAR INVERSIONS; Ashley V, 2004, NEUROREPORT, V15, P211, DOI 10.1097/00001756-200401190-00041; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Blau Vera C, 2007, Behav Brain Funct, V3, P7; Eger E, 2003, NEUROPSYCHOLOGIA, V41, P808, DOI 10.1016/S0028-3932(02)00287-7; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Fichtenholtz HM, 2009, SOC NEUROSCI-UK, V4, P317, DOI 10.1080/17470910902809487; Fiorentini C, 2011, J VISION, V11, DOI 10.1167/11.3.17; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Franconeri SL, 2003, PERCEPT PSYCHOPHYS, V65, P999, DOI 10.3758/BF03194829; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; Junghofer M, 2001, PSYCHOPHYSIOLOGY, V38, P175, DOI 10.1017/S0048577201000762; KARAU SJ, 1992, J EXP SOC PSYCHOL, V28, P542, DOI 10.1016/0022-1031(92)90045-L; Kelly JR, 2004, J EXP SOC PSYCHOL, V40, P185, DOI 10.1016/S0022-1031(03)00094-5; Kelly JR, 1999, PERS SOC PSYCHOL B, V25, P1342, DOI 10.1177/0146167299259002; Kerr NL, 2004, ANNU REV PSYCHOL, V55, P623, DOI 10.1146/annurev.psych.55.090902.142009; Krumhuber EG, 2013, EMOT REV, V5, P41, DOI 10.1177/1754073912451349; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Mangun GR, 1997, HUM BRAIN MAPP, V5, P273, DOI 10.1002/(SICI)1097-0193(1997)5:4<273::AID-HBM12>3.0.CO;2-F; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Pourtois G, 2013, BIOL PSYCHOL, V92, P492, DOI 10.1016/j.biopsycho.2012.02.007; Recio G, 2014, BIOL PSYCHOL, V96, P111, DOI 10.1016/j.biopsycho.2013.12.003; Recio G, 2011, BRAIN RES, V1376, P66, DOI 10.1016/j.brainres.2010.12.041; Sato W, 2007, J NONVERBAL BEHAV, V31, P119, DOI 10.1007/s10919-007-0025-7; Schupp HT, 2003, NEUROREPORT, V14, P1107, DOI 10.1097/00001756-200306110-00002; Schupp HT, 2003, PSYCHOL SCI, V14, P7, DOI 10.1111/1467-9280.01411; SHIMA K, 1991, J NEUROPHYSIOL, V65, P188, DOI 10.1152/jn.1991.65.2.188; Sprengelmeyer R, 2006, NEUROPSYCHOLOGIA, V44, P2899, DOI 10.1016/j.neuropsychologia.2006.06.020; Trautmann SA, 2009, BRAIN RES, V1284, P100, DOI 10.1016/j.brainres.2009.05.075; WEISS F, 1987, MOTIV EMOTION, V11, P67, DOI 10.1007/BF00992214; Weissman DH, 2005, CEREB CORTEX, V15, P229, DOI 10.1093/cercor/bhh125	37	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100162	10.1371/journal.pone.0100162	http://dx.doi.org/10.1371/journal.pone.0100162			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6AC	24941259	Green Submitted, Green Published, gold			2022-12-25	WOS:000338508200078
J	van der Meer, L; Swart, M; van der Velde, J; Pijnenborg, G; Wiersma, D; Bruggeman, R; Aleman, A				van der Meer, Lisette; Swart, Marte; van der Velde, Jorien; Pijnenborg, Gerdina; Wiersma, Durk; Bruggeman, Richard; Aleman, Andre			Neural Correlates of Emotion Regulation in Patients with Schizophrenia and Non-Affected Siblings	PLOS ONE			English	Article							VENTROLATERAL PREFRONTAL CORTEX; NEGATIVE SYNDROME SCALE; INDIVIDUAL-DIFFERENCES; COGNITIVE CONTROL; SOCIAL COGNITION; GENETIC RISK; PSYCHOSIS; FEELINGS; BRAIN; METAANALYSIS	Background: Patients with schizophrenia often experience problems regulating their emotions. Non-affected relatives show similar difficulties, although to a lesser extent, and the neural basis of such difficulties remains to be elucidated. In the current paper we investigated whether schizophrenia patients, non-affected siblings and healthy controls (HC) exhibit differences in brain activation during emotion regulation. Methods: All subjects (n = 20 per group) performed an emotion regulation task while they were in an fMRI scanner. The task contained two experimental conditions for the down-regulation of emotions (reappraise and suppress), in which IAPS pictures were used to generate a negative affect. We also assessed whether the groups differed in emotion regulation strategies used in daily life by means of the emotion regulation questionnaire (ERQ). Results: Though the overall negative affect was higher for patients as well as for siblings compared to HC for all conditions, all groups reported decreased negative affect after both regulation conditions. Nonetheless, neuroimaging results showed hypoactivation relative to HC in VLPFC, insula, middle temporal gyrus, caudate and thalamus for patients when reappraising negative pictures. In siblings, the same pattern was evident as in patients, but only in cortical areas. Conclusions: Given that all groups performed similarly on the emotion regulation task, but differed in overall negative affect ratings and brain activation, our findings suggest reduced levels of emotion regulation processing in neural circuits in patients with schizophrenia. Notably, this also holds for siblings, albeit to a lesser extent, indicating that it may be part and parcel of a vulnerability for psychosis.	[van der Meer, Lisette; van der Velde, Jorien; Aleman, Andre] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands; [van der Meer, Lisette; Swart, Marte] Lentis Psychiat Inst, Dept Rehabil, Zuidlaren, Netherlands; [Swart, Marte] Lentis Psychiat Inst, Res Dept, Groningen, Netherlands; [Pijnenborg, Gerdina; Aleman, Andre] Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands; [Pijnenborg, Gerdina] GGZ Drenthe, Dept Psychot Disorders, Assen, Netherlands; [Bruggeman, Richard] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands; [van der Meer, Lisette; van der Velde, Jorien; Wiersma, Durk; Bruggeman, Richard] Univ Groningen, Univ Med Ctr Groningen, Rob Giel Res Ctr, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	van der Meer, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands.	l.van.der.meer@umcg.nl		Bruggeman, Richard/0000-0002-3238-8471	European Science Foundation EURYI grant (NWO) [044035001]	European Science Foundation EURYI grant (NWO)	This work was supported by a European Science Foundation EURYI grant (NWO no. 044035001) awarded to A. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2005, PROG NEUROBIOL, V77, P283, DOI 10.1016/j.pneurobio.2005.11.005; Barbalat G, 2009, ARCH GEN PSYCHIAT, V66, P377, DOI 10.1001/archgenpsychiatry.2009.10; Boos HBM, 2007, ARCH GEN PSYCHIAT, V64, P297, DOI 10.1001/archpsyc.64.3.297; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Cohen AS, 2010, SCHIZOPHRENIA BULL, V36, P143, DOI 10.1093/schbul/sbn061; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; de Achaval D, 2012, SCHIZOPHR RES, V134, P171, DOI 10.1016/j.schres.2011.11.010; Diekhof EK, 2011, NEUROIMAGE, V58, P275, DOI 10.1016/j.neuroimage.2011.05.073; Fusar-Poli P, 2007, NEUROSCI BIOBEHAV R, V31, P465, DOI 10.1016/j.neubiorev.2006.11.006; Gee DG, 2012, SCHIZOPHR RES, V134, P1, DOI 10.1016/j.schres.2011.10.005; Gibson CM, 2010, SCHIZOPHR RES, V122, P179, DOI 10.1016/j.schres.2010.04.018; Giel R., 1996, SCAN 2 1 SCHEDULES C; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Gottesman II, 2001, AM PSYCHOL, V56, P867, DOI 10.1037/0003-066X.56.11.867; GROSS JJ, 1995, CLIN PSYCHOL-SCI PR, V2, P151, DOI 10.1111/j.1468-2850.1995.tb00036.x; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Habel U, 2004, AM J PSYCHIAT, V161, P1806, DOI 10.1176/appi.ajp.161.10.1806; Hayes JP, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00230; Henry JD, 2008, J ABNORM PSYCHOL, V117, P473, DOI 10.1037/0021-843X.117.2.473; John OP, 2004, J PERS, V72, P1301, DOI 10.1111/j.1467-6494.2004.00298.x; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KAY SR, 1988, PSYCHIAT RES, V23, P99, DOI 10.1016/0165-1781(88)90038-8; Keshavan MS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.062.2009; Korver N, 2012, INT J METH PSYCH RES, V21, P205, DOI 10.1002/mpr.1352; Kring AM, 1996, J ABNORM PSYCHOL, V105, P249, DOI 10.1037/0021-843X.105.2.249; Kring AM, 2010, CURR DIR PSYCHOL SCI, V19, P255, DOI 10.1177/0963721410377599; Leitman DI, 2011, SOC COGN AFFECT NEUR, V6, P66, DOI 10.1093/scan/nsq018; Livingstone K, 2009, CLIN PSYCHOL PSYCHOT, V16, P418, DOI 10.1002/cpp.635; Minzenberg MJ, 2009, ARCH GEN PSYCHIAT, V66, P811, DOI 10.1001/archgenpsychiatry.2009.91; Modinos G, 2010, SCHIZOPHR RES, V118, P88, DOI 10.1016/j.schres.2010.01.030; Morris RW, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.16; Myin-Germeys I, 2000, SCHIZOPHRENIA BULL, V26, P847, DOI 10.1093/oxfordjournals.schbul.a033499; Myin-Germeys I, 2001, ARCH GEN PSYCHIAT, V58, P1137, DOI 10.1001/archpsyc.58.12.1137; Myin-Germeys I, 2007, CLIN PSYCHOL REV, V27, P409, DOI 10.1016/j.cpr.2006.09.005; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; Phillips LK, 2008, SCHIZOPHRENIA BULL, V34, P888, DOI 10.1093/schbul/sbn085; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Ritsner MS, 2007, PSYCHIAT RES, V153, P217, DOI 10.1016/j.psychres.2006.07.003; Sergi MJ, 2007, AM J PSYCHIAT, V164, P1585, DOI 10.1176/appi.ajp.2007.06091515; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sitskoom MM, 2004, SCHIZOPHR RES, V71, P285, DOI 10.1016/j.schres.2004.03.007; Smith MJ, 2008, SCHIZOPHR RES, V104, P198, DOI 10.1016/j.schres.2008.06.025; Stip E, 2005, CAN J PSYCHIAT, V50, P909, DOI 10.1177/070674370505001405; Urry HL, 2009, NEUROIMAGE, V47, P852, DOI 10.1016/j.neuroimage.2009.05.069; van Buuren M, 2011, BIOL PSYCHIAT, V70, P81, DOI 10.1016/j.biopsych.2011.03.011; van der Meer L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067774; van der Meer L, 2011, NEUROIMAGE, V56, P2364, DOI 10.1016/j.neuroimage.2011.03.053; van der Meer L, 2009, PSYCHIAT RES, V170, P108, DOI 10.1016/j.psychres.2009.07.010; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; van 't Wout M, 2007, COMPR PSYCHIAT, V48, P27, DOI 10.1016/j.comppsych.2006.07.003; Vanderhasselt MA, 2012, SOC COGN AFFECT NEUR; Verhage F, 1983, REVISED SCORING METH; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wylie KP, 2010, SCHIZOPHR RES, V123, P93, DOI 10.1016/j.schres.2010.08.027	57	55	55	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99667	10.1371/journal.pone.0099667	http://dx.doi.org/10.1371/journal.pone.0099667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6AC	24941136	Green Published, gold, Green Submitted			2022-12-25	WOS:000338508200035
J	Geml, J; Gravendeel, B; van der Gaag, KJ; Neilen, M; Lammers, Y; Raes, N; Semenova, TA; de Knijff, P; Noordeloos, ME				Geml, Jozsef; Gravendeel, Barbara; van der Gaag, Kristiaan J.; Neilen, Manon; Lammers, Youri; Raes, Niels; Semenova, Tatiana A.; de Knijff, Peter; Noordeloos, Machiel E.			The Contribution of DNA Metabarcoding to Fungal Conservation: Diversity Assessment, Habitat Partitioning and Mapping Red-Listed Fungi in Protected Coastal Salix repens Communities in the Netherlands	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; BIODIVERSITY ASSESSMENT; ECTOMYCORRHIZAL FUNGI; SEASONAL DYNAMICS; RARE BIOSPHERE; PH GRADIENT; SOIL; FOREST; BACTERIAL; BOREAL	Western European coastal sand dunes are highly important for nature conservation. Communities of the creeping willow (Salix repens) represent one of the most characteristic and diverse vegetation types in the dunes. We report here the results of the first kingdom-wide fungal diversity assessment in S. repens coastal dune vegetation. We carried out massively parallel pyrosequencing of ITS rDNA from soil samples taken at ten sites in an extended area of joined nature reserves located along the North Sea coast of the Netherlands, representing habitats with varying soil pH and moisture levels. Fungal communities in Salix repens beds are highly diverse and we detected 1211 non-singleton fungal 97% sequence similarity OTUs after analyzing 688,434 ITS2 rDNA sequences. Our comparison along a north-south transect indicated strong correlation between soil pH and fungal community composition. The total fungal richness and the number OTUs of most fungal taxonomic groups negatively correlated with higher soil pH, with some exceptions. With regard to ecological groups, dark-septate endophytic fungi were more diverse in acidic soils, ectomycorrhizal fungi were represented by more OTUs in calcareous sites, while detected arbuscular mycorrhizal genera fungi showed opposing trends regarding pH. Furthermore, we detected numerous red listed species in our samples often from previously unknown locations, indicating that some of the fungal species currently considered rare may be more abundant in Dutch S. repens communities than previously thought.	[Geml, Jozsef; Gravendeel, Barbara; Neilen, Manon; Lammers, Youri; Raes, Niels; Semenova, Tatiana A.; Noordeloos, Machiel E.] Naturalis Biodivers Ctr, Leiden, Netherlands; [Geml, Jozsef; Gravendeel, Barbara; Semenova, Tatiana A.] Leiden Univ, Fac Sci, Leiden, Netherlands; [Gravendeel, Barbara] Univ Appl Sci Leiden, Leiden, Netherlands; [van der Gaag, Kristiaan J.; de Knijff, Peter] Leiden Univ, Med Ctr, Forens Lab DNA Res, Leiden, Netherlands	Naturalis Biodiversity Center; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Geml, J (corresponding author), Naturalis Biodivers Ctr, Leiden, Netherlands.	Jozsef.Geml@naturalis.nl	Geml, Jozsef/C-2223-2018; de Knijff, Peter/Y-2519-2018; Raes, Niels/A-9645-2011; Geml, Jozsef/AAW-9993-2020	Geml, Jozsef/0000-0001-8745-0423; de Knijff, Peter/0000-0002-0899-771X; Raes, Niels/0000-0002-4329-4892; van der Gaag, Kristiaan/0000-0001-7976-1977; Gravendeel, Barbara/0000-0002-6508-0895; Neilen, Manon/0000-0001-6261-5199	Naturalis Biodiversity Center; Kits van Waveren Postdoctoral Fellowship	Naturalis Biodiversity Center; Kits van Waveren Postdoctoral Fellowship	This research was sponsored by a Next-Generation Sequencing grant from the Naturalis Biodiversity Center to JG and MEN and by the Kits van Waveren Postdoctoral Fellowship to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arnolds E, 2008, BASISRAPPORT; Arnolds E, 1995, OVERZICHT PADDENSTOE; Baath E, 2003, SOIL BIOL BIOCHEM, V35, P955, DOI 10.1016/S0038-0717(03)00154-8; Bakker TWM, 1987, DUIN, V10, P34; Bidartondo MI, 2004, P ROY SOC B-BIOL SCI, V271, P1799, DOI 10.1098/rspb.2004.2807; Bjorbaekmo MFM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-244; Blaalid R, 2012, MOL ECOL, V21, P1897, DOI 10.1111/j.1365-294X.2011.05214.x; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Brown AC, 2002, ENVIRON CONSERV, V29, P62, DOI 10.1017/S037689290200005X; Brown SP, 2013, FEMS MICROBIOL ECOL, V86, P557, DOI 10.1111/1574-6941.12181; Coughlan AP, 2000, CAN J FOREST RES, V30, P1543, DOI 10.1139/cjfr-30-10-1543; De Roman M, 2005, MYCOL RES, V109, P1063, DOI 10.1017/S0953756205003564; Delforge P, 2007, GUIDE ORCHIDEES FRAN; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Feola S, 2011, BIODIVERS CONSERV, V20, P1457, DOI 10.1007/s10531-011-0037-9; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Gardes M, 1996, CAN J BOT, V74, P1572, DOI 10.1139/b96-190; Geml J, 2014, MOL ECOL, V23, P2452, DOI 10.1111/mec.12765; Geml J, 2012, J BIOGEOGR, V39, P74, DOI 10.1111/j.1365-2699.2011.02588.x; Geml J, 2010, NEW PHYTOL, V187, P494, DOI 10.1111/j.1469-8137.2010.03283.x; Geml J, 2009, MOL ECOL, V18, P2213, DOI 10.1111/j.1365-294X.2009.04192.x; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; HARLEY J L, 1987, New Phytologist, V105, P1, DOI 10.1111/j.1469-8137.1987.tb00674.x; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hibbett David S., 2011, Fungal Biology Reviews, V25, P38, DOI 10.1016/j.fbr.2011.01.001; Higgins KL, 2007, MOL PHYLOGENET EVOL, V42, P543, DOI 10.1016/j.ympev.2006.07.012; Jalink LM, 2001, BR MYCOL SY, V22, P89, DOI 10.1017/CBO9780511565168.007; Jumpponen A, 2010, MOL ECOL, V19, P41, DOI 10.1111/j.1365-294X.2009.04483.x; Kauserud H, 2012, MYCORRHIZA, V22, P309, DOI 10.1007/s00572-011-0403-1; Koljalg U, 2000, MOL ECOL, V9, P1985, DOI 10.1046/j.1365-294X.2000.01105.x; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kuiper M, 2009, HOLLANDS DUINEN, V54, P16; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lodge J, 2004, BIODIVERSITY FUNGI I, P128, DOI DOI 10.1016/B978-012509551-8/50011-8; McCune B., 2002, ANAL ECOLOGICAL COMM; Molina R., 1992, Mycorrhizal functioning: an integrative plant-fungal process., P357; Nauta MM, 2001, BR MYCOL SY, V22, P242, DOI 10.1017/CBO9780511565168.022; Nauta MM, 1995, ATLAS NEDERLANDSE PA; Nevarez L, 2009, INT J FOOD MICROBIOL, V130, P166, DOI 10.1016/j.ijfoodmicro.2009.01.013; Nguyen HDT, 2008, PERSOONIA, V21, P57, DOI 10.3767/003158508X361334; Nilsson RH, 2011, NEW PHYTOL, V191, P314, DOI 10.1111/j.1469-8137.2011.03755.x; Nilsson RH, 2011, TOAINFOJ, V5, P81, DOI DOI 10.2174/1874136301005010081; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Perini Claudia, 2008, Coolia, V51, P181; Porter TM, 2008, MOL ECOL, V17, P3037, DOI 10.1111/j.1365-294X.2008.03813.x; PORTER WM, 1987, J APPL ECOL, V24, P659, DOI 10.2307/2403900; Postma JWM, 2007, SOIL BIOL BIOCHEM, V39, P400, DOI 10.1016/j.soilbio.2006.08.007; Reeder J, 2009, NAT METHODS, V6, P636, DOI 10.1038/nmeth0909-636; Rogers PC, 2009, J VEG SCI, V20, P498, DOI 10.1111/j.1654-1103.2009.01064.x; Rousk J, 2008, FEMS MICROBIOL ECOL, V63, P350, DOI 10.1111/j.1574-6941.2008.00440.x; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Salman A, 1991, SANDDUNE INVENTORY E, P28; Schadt CW, 2003, SCIENCE, V301, P1359, DOI 10.1126/science.1086940; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmit JP, 2007, BIODIVERS CONSERV, V16, P99, DOI 10.1007/s10531-006-9129-3; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Tamm H, 2010, MYCOL PROG, V9, P509, DOI 10.1007/s11557-010-0659-4; Taylor DL, 2008, NEW PHYTOL, V177, P1020, DOI 10.1111/j.1469-8137.2007.02320.x; Taylor DL, 2010, CAN J FOREST RES, V40, P1288, DOI 10.1139/X10-081; Taylor DL, 1997, P NATL ACAD SCI USA, V94, P4510, DOI 10.1073/pnas.94.9.4510; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; van der Heijden EW, 2001, MYCORRHIZA, V10, P185, DOI 10.1007/s005720000077; van der Heijden EW, 1999, CAN J BOT, V77, P1821, DOI 10.1139/cjb-77-12-1821; van der Maarel E, 2003, PHYTOCOENOLOGIA, V33, P187, DOI 10.1127/0340-269X/2003/0033-0187; Van der Meulen F, 1996, NATURE CONSERVATION; Van Zadelhoff FJ, 1981, NEDERLANDSE KUSTDUIN; Vare H., 1992, Mycorrhiza, V1, P93, DOI 10.1007/BF00203256; Watling R, 2005, MYCOL RES, V109, P1418, DOI 10.1017/S0953756205004004; Weiss M, 2004, MYCOL RES, V108, P1003, DOI 10.1017/S0953756204000772; WHEELER KA, 1991, INT J FOOD MICROBIOL, V12, P141, DOI 10.1016/0168-1605(91)90063-U	77	50	58	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99852	10.1371/journal.pone.0099852	http://dx.doi.org/10.1371/journal.pone.0099852			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937200	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400045
J	Han, J; Lei, YX; Liu, L; Liu, P; Xia, JK; Zhang, YL; Zeng, H; Wang, L; Wang, L; Zhuang, H				Han, Jian; Lei, Yaxin; Liu, Lin; Liu, Peng; Xia, Junke; Zhang, Yulin; Zeng, Hang; Wang, Lin; Wang, Ling; Zhuang, Hui			SPF Rabbits Infected with Rabbit Hepatitis E Virus Isolate Experimentally Showing the Chronicity of Hepatitis	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; FULL-GENOME; IDENTIFICATION; PATIENT; TRANSMISSION; PREVALENCE; GENOTYPES; DISTINCT; FECES	This study focused on investigating the pathogenesis seen in specific-pathogen-free (SPF) rabbits following infection with a homologous rabbit HEV isolate (CHN-BJ-rb14) and comparing it to that seen following infection with a heterologous swine genotype 4 HEV isolate (CHN-XJ-SW13). Three of the four animals inoculated with the homologous rabbit HEV became infected, exhibiting an intermittent viremia, obvious fluctuations of liver function biomarkers alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and persistent fecal virus shedding throughout the nine month study. In addition, liver histopathology showed both chronic inflammation and some degree of fibrosis. Both positive and negative-stranded HEV RNA and HEV antigen expression were detected in liver, brain, stomach, duodenum and kidney from the necropsied rabbits. Inflammation of extrahepatic tissue (duodenum and kidney) was also observed. Three of the four rabbits inoculated with the heterologous genotype 4 swine HEV also became infected, showing similar levels of anti-HEV antibody to that generated following infection with the homologous virus isolate. The duration of both viremia and fecal shedding of virus was however shorter following infection with the heterologous virus and there was no significant elevation of liver function biomarkers. These results suggest that rabbit HEV infection may cause more severe hepatitis and prolong the course of the disease, with a possible chronic trend of hepatitis in SPF rabbits.	[Han, Jian; Lei, Yaxin; Liu, Lin; Liu, Peng; Xia, Junke; Zhang, Yulin; Zeng, Hang; Wang, Lin; Wang, Ling; Zhuang, Hui] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Sch Basic Med Sci, Beijing 100871, Peoples R China	Peking University	Wang, L (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Microbiol, Sch Basic Med Sci, Beijing 100871, Peoples R China.	lingwang@bjmu.edu.cn	Liu, Peng/AGH-0228-2022		National Science Foundation of China [81271827]; Specialized Research Fund for the Doctoral Program of Higher Education [20120001110098]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was partially supported by the National Science Foundation of China (Grant No. 81271827, http://www.nsfc.gov.cn/Portal0/default152.htm) and Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20120001110098, http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2010, CLIN INFECT DIS, V51, P477, DOI 10.1086/655157; Batts W, 2011, VIRUS RES, V158, P116, DOI 10.1016/j.virusres.2011.03.019; Bodewes R, 2013, J VIROL, V87, P7758, DOI 10.1128/JVI.00568-13; Cheng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051616; Cossaboom CM, 2012, J GEN VIROL, V93, P1687, DOI 10.1099/vir.0.041509-0; Cossaboom CM, 2011, EMERG INFECT DIS, V17, P2047, DOI 10.3201/eid1711.110428; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; Drexler JF, 2012, J VIROL, V86, P9134, DOI 10.1128/JVI.00800-12; Emerson S. U, 2004, VIRUS TAXONOMY, V1st, P851; Feng ZD, 2014, TRENDS MICROBIOL, V22, P59, DOI 10.1016/j.tim.2013.10.005; Fu HW, 2011, INFECT GENET EVOL, V11, P618, DOI 10.1016/j.meegid.2011.01.018; Geng J, 2011, J VIRAL HEPATITIS, V18, P661, DOI 10.1111/j.1365-2893.2010.01341.x; Geng JB, 2011, INFECT GENET EVOL, V11, P2020, DOI 10.1016/j.meegid.2011.09.006; Tallon AIG, 2011, GASTROENT HEPAT-BARC, V34, P398, DOI 10.1016/j.gastrohep.2011.02.011; Grewal P, 2014, HEPATOLOGY, V59, P347, DOI 10.1002/hep.26636; Haqshenas G, 2001, J GEN VIROL, V82, P2449, DOI 10.1099/0022-1317-82-10-2449; Hoofnagle JH, 2012, NEW ENGL J MED, V367, P1237, DOI 10.1056/NEJMra1204512; Johne R, 2010, J GEN VIROL, V91, P750, DOI 10.1099/vir.0.016584-0; Kaba M, 2011, J MED VIROL, V83, P1704, DOI 10.1002/jmv.22177; Kamar N, 2010, AM J TRANSPLANT, V10, P1321, DOI 10.1111/j.1600-6143.2010.03068.x; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Kamar N, 2011, EMERG INFECT DIS, V17, P173, DOI 10.3201/eid1702.100856; KHUROO MS, 1980, AM J MED, V68, P818, DOI 10.1016/0002-9343(80)90200-4; Liu P, 2013, EMERG INFECT DIS, V19, P559, DOI 10.3201/eid1904.120827; Ma HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009160; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Nakamura M, 2006, HEPATOL RES, V34, P137, DOI 10.1016/j.hepres.2005.10.010; Pujhari SK, 2010, ARCH VIROL, V155, P1483, DOI 10.1007/s00705-010-0726-9; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Purdy MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014376; Raj VS, 2012, EMERG INFECT DIS, V18, P1369, DOI 10.3201/eid1808.111659; Shrestha MP, 2007, NEW ENGL J MED, V356, P895, DOI 10.1056/NEJMoa061847; Takahashi M, 2002, J GEN VIROL, V83, P1931, DOI 10.1099/0022-1317-83-8-1931; Takahashi M, 2011, J GEN VIROL, V92, P902, DOI 10.1099/vir.0.029470-0; Tavitian S, 2010, J CLIN VIROL, V49, P141, DOI 10.1016/j.jcv.2010.06.016; Tomiyama D, 2009, J VIRAL HEPATITIS, V16, P524, DOI 10.1111/j.1365-2893.2009.01107.x; Wang YC, 2002, J MED VIROL, V67, P516, DOI 10.1002/jmv.10131; Zhang J, 2003, J MED VIROL, V71, P518, DOI 10.1002/jmv.10523; Zhao CY, 2009, J MED VIROL, V81, P1371, DOI 10.1002/jmv.21536	40	54	57	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99861	10.1371/journal.pone.0099861	http://dx.doi.org/10.1371/journal.pone.0099861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937350	gold, Green Submitted, Green Published			2022-12-25	WOS:000338503400046
J	Nusinovici, S; Monestiez, P; Seegers, H; Beaudeau, F; Fourichon, C				Nusinovici, Simon; Monestiez, Pascal; Seegers, Henri; Beaudeau, Francois; Fourichon, Christine			Using Animal Performance Data to Evidence the Under-Reporting of Case Herds during an Epizootic: Application to an Outbreak of Bluetongue in Cattle	PLOS ONE			English	Article							VIRUS SEROTYPE 8; DAIRY HERDS; INFECTION; FERTILITY; FRANCE; COWS; SERVICE; RISK	Following the emergence of the Bluetongue virus serotype 8 (BTV-8) in France in 2006, a surveillance system (both passive and active) was implemented to detect and follow precociously the progression of the epizootic wave. This system did not allow a precise estimation of the extent of the epizootic. Infection by BTV-8 is associated with a decrease of fertility. The objective of this study was to evaluate whether a decrease in fertility can be used to evidence the under-reporting of cases during an epizootic and to quantify to what extent non-reported cases contribute to the total burden of the epizootic. The cow fertility in herds in the outbreak area (reported or not) was monitored around the date of clinical signs. A geostatistical interpolation method was used to estimate a date of clinical signs for non-reported herds. This interpolation was based on the spatiotemporal dynamic of confirmed case herds reported in 2007. Decreases in fertility were evidenced for both types of herds around the date of clinical signs. In non-reported herds, the decrease fertility was large (60% of the effect in reported herds), suggesting that some of these herds have been infected by the virus during 2007. Production losses in non-reported infected herds could thus contribute to an important part of the total burden of the epizootic. Overall, results indicate that performance data can be used to evidence the under-reporting during an epizootic. This approach could be generalized to pathogens that affect cattle's performance, including zoonotic agents such as Coxiella burnetii or Rift Valley fever virus.	[Nusinovici, Simon; Seegers, Henri; Beaudeau, Francois; Fourichon, Christine] INRA, Biol Epidemiol & Risk Anal Anim Hlth UMR1300, F-44026 Nantes, France; [Nusinovici, Simon; Seegers, Henri; Beaudeau, Francois; Fourichon, Christine] LUNAM Univ, Oniris, Ecole Natl Vet Agroalimentaire & Alimentat Nantes, Nantes, France; [Monestiez, Pascal] INRA, UR 546, Avignon, France	INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE	Nusinovici, S (corresponding author), INRA, Biol Epidemiol & Risk Anal Anim Hlth UMR1300, F-44026 Nantes, France.	simon.nusinovici@oniris-nantes.fr	Fourichon, Christine/B-1265-2010	Fourichon, Christine/0000-0002-7079-0955; Monestiez, Pascal/0000-0001-5851-2699	INRA; Cemagref; Basse-Normandie Council; Bretagne Council; Pays de le Loire Council; Poitou-Charentes Regional Council under SANCRE project	INRA; Cemagref; Basse-Normandie Council; Bretagne Council; Pays de le Loire Council; Poitou-Charentes Regional Council under SANCRE project(Region Nouvelle-Aquitaine)	Financial support for this research was provided by INRA, Cemagref and Basse-Normandie, Bretagne, Pays de le Loire and Poitou-Charentes Regional Councils under SANCRE project, in the framework of "For and About Regional Development'' programs. The authors gratefully acknowledge the Centre de Traitement de l'Information Genetique (INRA, Jouy-en-Josas, France) for providing the performance data and the Ministry of Agriculture (Direction Generale de l'Alimentation) for the BTV case herds data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm JS, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-13; COETZER JAW, 1982, ONDERSTEPOORT J VET, V49, P11; Durand B, 2010, EMERG INFECT DIS, V16, P1861, DOI 10.3201/eid1612.100412; Elbers ARW, 2008, PREV VET MED, V87, P21, DOI 10.1016/j.prevetmed.2008.06.004; HILLERS JK, 1984, J DAIRY SCI, V67, P861, DOI 10.3168/jds.S0022-0302(84)81378-8; Malher X, 2006, THERIOGENOLOGY, V65, P1215, DOI 10.1016/j.theriogenology.2005.08.003; Marce C, 2009, THERIOGENOLOGY, V71, P807, DOI 10.1016/j.theriogenology.2008.10.017; Nusinovici S, 2012, J DAIRY SCI, V95, P3008, DOI 10.3168/jds.2011-4799; Robert A, 2004, THERIOGENOLOGY, V61, P117, DOI 10.1016/S0093-691X(03)00182-1; Saegerman C, 2015, TRANSBOUND EMERG DIS, V62, P46, DOI 10.1111/tbed.12070; Saegerman C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009405; Santman-Berends IMGA, 2011, VET MICROBIOL, V148, P183, DOI 10.1016/j.vetmic.2010.09.010; Santman-Berends IMGA, 2010, THERIOGENOLOGY, V74, P1377, DOI 10.1016/j.theriogenology.2010.06.008; Seegers H, 1998, J NATL GTV, P57; Team R.C, R LANG ENV STAT COMP	15	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100137	10.1371/journal.pone.0100137	http://dx.doi.org/10.1371/journal.pone.0100137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937630	Green Published, gold			2022-12-25	WOS:000338503400081
J	Oberfeld, D; Stahn, P; Kuta, M				Oberfeld, Daniel; Stahn, Patricia; Kuta, Martha			Why Do Forward Maskers Affect Auditory Intensity Discrimination? Evidence from "Molecular Psychophysics"	PLOS ONE			English	Article							SELECTIVE ATTENTION; LOUDNESS ENHANCEMENT; COCHLEAR SENSITIVITY; PRIOR STIMULATION; RESPONSES; MASKING; TIME; CORTEX; RECOVERY; NEURONS	Nonsimultaneous maskers can strongly impair performance in an auditory intensity discrimination task. Using methods of molecular psychophysics, we quantified the extent to which (1) a masker-induced impairment of the representation of target intensity (i.e., increase in internal noise) and (2) a systematic influence of the masker intensities on the decision variable contribute to these effects. In a two-interval intensity discrimination procedure, targets were presented in quiet, and combined with forward maskers. The lateralization of the maskers relative to the targets was varied via the interaural time difference. Intensity difference limens (DLs) were strongly elevated under forward masking but less with contralateral than with ipsilateral maskers. For most listeners and conditions, perceptual weights measuring the relation between the target and masker levels and the response in the intensity discrimination task were positive and significant. Higher perceptual weights assigned to the maskers corresponded to stronger elevations of the intensity DL. The maskers caused only a weak increase in internal noise, unrelated to target level and masker lateralization. The results indicate that the effects of forward masking on intensity discrimination are determined by an inclusion of the masker intensities in the decision variable, compatible with the hypothesis that the impairment in performance is to a large part caused by difficulties in directing selective attention to the targets. The effects of masker lateralization are evidence for top-down influences, and the observed positive signs of the masker weights suggest that the relevant mechanisms are located at higher processing stages rather than in the auditory periphery.	[Oberfeld, Daniel; Stahn, Patricia; Kuta, Martha] Johannes Gutenberg Univ Mainz, Sect Expt Psychol, Dept Psychol, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	Oberfeld, D (corresponding author), Johannes Gutenberg Univ Mainz, Sect Expt Psychol, Dept Psychol, D-55122 Mainz, Germany.	oberfeld@uni-mainz.de	Oberfeld, Daniel/A-7997-2008	Oberfeld, Daniel/0000-0002-6710-3309	Deutsche Forschungsgemeinschaft [OB 346/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from Deutsche Forschungsgemeinschaft (www.dfg.de) to Daniel Oberfeld (OB 346/4-1). No additional external funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBAS PJ, 1981, J ACOUST SOC AM, V69, P492, DOI 10.1121/1.385477; AHUMADA A, 1971, J ACOUST SOC AM, V49, P1751, DOI 10.1121/1.1912577; Ahumada AJ, 2002, J VISION, V2, P121, DOI 10.1167/2.1.8; Alves-Pinto A, 2010, JARO-J ASSOC RES OTO, V11, P477, DOI 10.1007/s10162-010-0215-6; [Anonymous], 1970, 318 IEC; Avissar M, 2007, J NEUROSCI, V27, P6461, DOI 10.1523/JNEUROSCI.5239-06.2007; Baures R, 2014, ACCIDENT ANAL PREV, V65, P72, DOI 10.1016/j.aap.2013.12.013; BEKESY GEORG v., 1947, ACTA OTO LARYNGOL [STOCKHOLM], V35, P411, DOI 10.3109/00016484709123756; BERG BG, 1989, J ACOUST SOC AM, V86, P1743, DOI 10.1121/1.398605; Best V, 2008, P NATL ACAD SCI USA, V105, P13174, DOI 10.1073/pnas.0803718105; Bregman AS, 1990, AUDITORY SCENE ANAL; Brosch M, 2000, CEREB CORTEX, V10, P1155, DOI 10.1093/cercor/10.12.1155; Brosch M, 1999, J NEUROPHYSIOL, V82, P1542, DOI 10.1152/jn.1999.82.3.1542; Brosch M, 2008, EXP BRAIN RES, V184, P349, DOI 10.1007/s00221-007-1109-7; Burton P, 1998, STAT MED, V17, P1261, DOI 10.1002/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z; CARLYON RP, 1993, J ACOUST SOC AM, V93, P2886, DOI 10.1121/1.405808; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; CRAMER H., 1946, Mathematical methods of statistics.; Delano PH, 2007, J NEUROSCI, V27, P4146, DOI 10.1523/JNEUROSCI.3702-06.2007; Deutsch D., 1999, PSYCHOL MUSIC, P299, DOI [10.1016/B978-012213564-4/50010-X, DOI 10.1016/B978-012213564-4/50010-X]; DURLACH NI, 1969, J ACOUST SOC AM, V46, P372, DOI 10.1121/1.1911699; Edwards LJ, 2008, STAT MED, V27, P6137, DOI 10.1002/sim.3429; ELMASIAN R, 1980, J ACOUST SOC AM, V67, P601, DOI 10.1121/1.383937; Fouladi RT, 2004, COMMUN STAT-SIMUL C, V33, P807, DOI 10.1081/SAC-200033260; Fritz JB, 2007, CURR OPIN NEUROBIOL, V17, P437, DOI 10.1016/j.conb.2007.07.011; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Gould M, 2013, J EXP PSYCHOL-APPL, V19, P171, DOI 10.1037/a0033286; GREEN DM, 1964, PSYCHOL REV, V71, P392, DOI 10.1037/h0044520; Griffiths TD, 2004, NAT REV NEUROSCI, V5, P887, DOI 10.1038/nrn1538; HARRIS DM, 1979, J NEUROPHYSIOL, V42, P1083, DOI 10.1152/jn.1979.42.4.1083; Hartmann W. M., 2005, SIGNALS SOUND SENSAT; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Hesketh B, 2002, ECOL PSYCHOL, V14, P111, DOI 10.1207/S15326969ECO1403_1; Jepsen ML, 2008, J ACOUST SOC AM, V124, P422, DOI 10.1121/1.2924135; Kahneman D., 1981, PERCEPTUAL ORG, P181; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Keselman HJ, 2002, MULTIVAR BEHAV RES, V37, P331, DOI 10.1207/S15327906MBR3703_2; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LOVELESS N, 1989, ELECTROEN CLIN NEURO, V74, P217, DOI 10.1016/0013-4694(89)90008-4; Lovie P., 1986, NEW DEV STAT PSYCHOL, P45; LYON DR, 1995, ACTA PSYCHOL, V89, P239, DOI 10.1016/0001-6918(95)98945-Z; Malania M, 2007, J VISION, V7, DOI 10.1167/7.2.1; Manassi M, 2012, J VISION, V12, DOI 10.1167/12.10.13; MCGILL WJ, 1968, J ACOUST SOC AM, V44, P576, DOI 10.1121/1.1911123; MCKENNA TM, 1989, BRAIN RES, V481, P142, DOI 10.1016/0006-8993(89)90494-0; Moore BCJ, 2012, PHILOS T R SOC B, V367, P919, DOI 10.1098/rstb.2011.0355; Nandy AS, 2007, J VISION, V7, DOI 10.1167/7.2.5; Nunez Angel, 2007, Adv Anat Embryol Cell Biol, V187, P1; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Oberfeld D, 2008, J EXP PSYCHOL HUMAN, V34, P605, DOI 10.1037/0096-1523.34.3.605; Oberfeld D, 2008, J ACOUST SOC AM, V123, P1571, DOI 10.1121/1.2837284; Oberfeld D, 2007, J ACOUST SOC AM, V121, P2137, DOI 10.1121/1.2710433; Oberfeld D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079830; Oberfeld D, 2012, HEARING RES, V294, P1, DOI 10.1016/j.heares.2012.09.004; Oberfeld D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048054; Oberfeld D, 2011, ATTEN PERCEPT PSYCHO, V73, P189, DOI 10.3758/s13414-010-0011-8; Oberfeld D, 2010, NEUROPHYSIOLOGICAL BASES OF AUDITORY PERCEPTION, P99, DOI 10.1007/978-1-4419-5686-6_10; Oberfeld D, 2009, J ACOUST SOC AM, V125, P294, DOI 10.1121/1.3021296; Plack CJ, 2006, J NEUROSCI, V26, P8767, DOI 10.1523/JNEUROSCI.1134-06.2006; PLACK CJ, 1995, J ACOUST SOC AM, V97, P1141, DOI 10.1121/1.412227; Plack CJ, 1998, J ACOUST SOC AM, V103, P1598, DOI 10.1121/1.421294; PLACK CJ, 1992, J ACOUST SOC AM, V92, P3097, DOI 10.1121/1.404205; PLOMP R, 1964, J ACOUST SOC AM, V36, P277, DOI 10.1121/1.1918946; RELKIN EM, 1991, HEARING RES, V55, P215, DOI 10.1016/0378-5955(91)90106-J; Rinne T, 2008, J NEUROPHYSIOL, V100, P3323, DOI 10.1152/jn.90607.2008; Rupp A, 2000, NEUROREPORT, V11, P3731, DOI 10.1097/00001756-200011270-00028; Sayim B, 2010, PSYCHOL SCI, V21, P641, DOI 10.1177/0956797610368811; Schaalje GB, 2002, J AGRIC BIOL ENVIR S, V7, P512, DOI 10.1198/108571102726; Schlauch RS, 1997, J ACOUST SOC AM, V102, P461, DOI 10.1121/1.419610; Schreiner CE, 1997, ACTA OTO-LARYNGOL, P54; SHAW B K, 1991, Ecological Psychology, V3, P253, DOI 10.1207/s15326969eco0303_4; SHORE SE, 1995, HEARING RES, V82, P31, DOI 10.1016/0378-5955(94)00160-R; Skene SS, 2010, STAT MED, V29, P2825, DOI 10.1002/sim.4073; SMITH RL, 1977, J NEUROPHYSIOL, V40, P1098, DOI 10.1152/jn.1977.40.5.1098; Srinivasan S, 2012, NEUROSCIENCE, V223, P325, DOI 10.1016/j.neuroscience.2012.07.062; Suga N, 2000, P NATL ACAD SCI USA, V97, P11807, DOI 10.1073/pnas.97.22.11807; SWETS JA, 1959, J ACOUST SOC AM, V31, P514, DOI 10.1121/1.1907745; von Kriegstein K, 2008, CURR BIOL, V18, P1855, DOI 10.1016/j.cub.2008.10.052; Wang J, 2014, NEUROSCIENCE, V256, P309, DOI 10.1016/j.neuroscience.2013.10.042; Winkowski DE, 2006, NATURE, V439, P336, DOI 10.1038/nature04411; Wolfinger RD, 1996, J AGR BIOL ENVIR ST, V1, P205, DOI [10.2307/1400366, DOI 10.2307/1400366]; ZENG FG, 1992, J ACOUST SOC AM, V92, P782, DOI 10.1121/1.403947; ZENG FG, 1991, HEARING RES, V55, P223, DOI 10.1016/0378-5955(91)90107-K; Zhang PXY, 2006, J ACOUST SOC AM, V120, P3471, DOI 10.1121/1.2372456	84	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99745	10.1371/journal.pone.0099745	http://dx.doi.org/10.1371/journal.pone.0099745			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937050	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400037
J	Shi, ML; Shtraizent, N; Polotskaia, A; Bargonetti, J; Matsui, H				Shi, Menglu; Shtraizent, Nataly; Polotskaia, Alla; Bargonetti, Jill; Matsui, Hiroshi			Impedimetric Detection of Mutant p53 Biomarker-Driven Metastatic Breast Cancers under Hyposmotic Pressure	PLOS ONE			English	Article							LI-FRAUMENI-SYNDROME; GENETIC INSTABILITY; GAIN	In cancer cells, the oncogenic mutant p53 (mtp53) protein is present at high levels and gain-of-function (GOF) activities with more expression of mtp53 proteins contribute to tumor growth and metastasis. Robust analytical approaches that probe the degree of metastasis of cancer cells in connection with the mtp53 activity will be extremely useful not only for establishing a better cancer prognosis but also understanding the fundamental mechanism of mtp53 oncogenic action. Here we assessed the influence of mtp53 in breast cancers to the mechanical property of breast cancer cells. Recently, ovarian and kidney cancer cell lines have been shown to have higher cellular elasticity as compared to normal cells assessed by monitoring the degree of deformation under hyposmotic pressure. To make fast detection in large scale, the impedance measurement was applied to monitor the swelling ratio of cells with time. The results showed that knockdown of mtp53 leads to decrease in cell swelling. In addition, by means of two types of impedimetric detection systems we consistently detected enhancement of impedance signal in mtp53-expressing breast cancer cells. Based on this observation we hypothesize that highly expressed mtp53 in metastatic mutant breast cancers can promote tumor progression by making cells more deformable and easier to spread out through extracellular matrix. The identification via the electric measurement can be accomplished within 10 minutes. All results in this report suggest that electric probing for the extent of the mtp53 expression of breast cancer cells may serve as a meaningful fingerprint for the cancer diagnostics, and this outcome will also have an important clinical implication for the development of mtp53-based targeting for tumor detection and treatment.	[Shi, Menglu; Matsui, Hiroshi] CUNY, Hunter Coll, Dept Chem, New York, NY 10021 USA; [Shi, Menglu; Shtraizent, Nataly; Polotskaia, Alla; Bargonetti, Jill; Matsui, Hiroshi] CUNY, Grad Ctr, New York, NY USA; [Shtraizent, Nataly; Polotskaia, Alla; Bargonetti, Jill] CUNY, Hunter Coll, Dept Biol Sci, New York, NY 10021 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY)	Bargonetti, J (corresponding author), CUNY, Hunter Coll, Dept Biol Sci, New York, NY 10021 USA.	Bargonetti@GENECTR.HUNTER.CUNY.edu; hmatsui@hunter.cuny.edu		Bargonetti, Jill/0000-0003-2692-0991	National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health (NIH) [MD007599]; sub-project pilot award; National Institute on Minority Health and Health Disparities [G12MD007599] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health (NIH); sub-project pilot award; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	In this project electric detection of cells with polysilicon transducers and data analysis was supported by Grant Number MD007599 from the National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health (NIH) (HM) and its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIMHD or the NIH. A portion of this project was supported by a sub-project pilot award to JB for collaboration with HM. The generation of the p53 knockdown cell lines was supported by the Breast Cancer Research Foundation (JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Cheung K, 2005, CYTOM PART A, V65A, P124, DOI 10.1002/cyto.a.20141; de la Rica R, 2006, ELECTROCHEM COMMUN, V8, P1239, DOI 10.1016/j.elecom.2006.05.028; de la Rica R, 2009, ANAL CHEM, V81, P10167, DOI 10.1021/ac9021049; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Gualberto A, 1998, P NATL ACAD SCI USA, V95, P5166, DOI 10.1073/pnas.95.9.5166; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Ke N, 2010, ANAL CHEM, V82, P6495, DOI 10.1021/ac1007877; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Liu DP, 2010, ONCOGENE, V29, P949, DOI 10.1038/onc.2009.376; Markx GH, 1999, ENZYME MICROB TECH, V25, P161, DOI 10.1016/S0141-0229(99)00008-3; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Strano S, 2007, ONCOGENE, V26, P2212, DOI 10.1038/sj.onc.1210296; Tong X, 1997, J MEMBRANE BIOL, V156, P131, DOI 10.1007/s002329900195; Walerych D, 2012, CARCINOGENESIS, V33, P2007, DOI 10.1093/carcin/bgs232	17	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99351	10.1371/journal.pone.0099351	http://dx.doi.org/10.1371/journal.pone.0099351			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937470	Green Published, gold			2022-12-25	WOS:000338503400016
J	Tsunoda, T; Kachi, N; Suzuki, JI				Tsunoda, Tomonori; Kachi, Naoki; Suzuki, Jun-Ichirou			Availability and Temporal Heterogeneity of Water Supply Affect the Vertical Distribution and Mortality of a Belowground Herbivore and Consequently Plant Growth	PLOS ONE			English	Article							SOIL-MOISTURE; RESPONSES; GRASSLAND; TEMPERATURE; PERSPECTIVE; SUCCESSION; COLEOPTERA; SURVIVAL; EXTREMES; DEPEND	We examined how the volume and temporal heterogeneity of water supply changed the vertical distribution and mortality of a belowground herbivore, and consequently affected plant biomass. Plantago lanceolata (Plantaginaceae) seedlings were grown at one per pot under different combinations of water volume (large or small volume) and heterogeneity (homogeneous water conditions, watered every day; heterogeneous conditions, watered every 4 days) in the presence or absence of a larva of the belowground herbivorous insect, Anomala cuprea (Coleoptera: Scarabaeidae). The larva was confined in different vertical distributions to top feeding zone (top treatment), middle feeding zone (middle treatment), or bottom feeding zone (bottom treatment); alternatively no larva was introduced (control treatment) or larval movement was not confined (free treatment). Three-way interaction between water volume, heterogeneity, and the herbivore significantly affected plant biomass. With a large water volume, plant biomass was lower in free treatment than in control treatment regardless of heterogeneity. Plant biomass in free treatment was as low as in top treatment. With a small water volume and in free treatment, plant biomass was low (similar to that under top treatment) under homogeneous water conditions but high under heterogeneous ones (similar to that under middle or bottom treatment). Therefore, there was little effect of belowground herbivory on plant growth under heterogeneous water conditions. In other watering regimes, herbivores would be distributed in the shallow soil and reduced root biomass. Herbivore mortality was high with homogeneous application of a large volume or heterogeneous application of a small water volume. Under the large water volume, plant biomass was high in pots in which the herbivore had died. Thus, the combinations of water volume and heterogeneity affected plant growth via the change of a belowground herbivore.	[Tsunoda, Tomonori; Kachi, Naoki; Suzuki, Jun-Ichirou] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo, Japan	Tokyo Metropolitan University	Tsunoda, T (corresponding author), Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo, Japan.	ttsunoda@tmu.ac.jp	Tsunoda, Tomonori/AAH-8628-2020	Tsunoda, Tomonori/0000-0002-1163-2893	Japan Society for the Promotion of Science [11J06132]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported partly by the Japan Society for the Promotion of Science (11J06132 to TT). The funder had no role in study design, data collection and analysis, decision to publish, or preparation to the manuscript. No additional external funding received for this study.	Bardgett R. D., 2005, The biology of soil: a community and ecosystem approach; Bardgett R.D., 2010, AUSTRAL ECOL, V37, P26; Barnett K, 2013, ADV INSECT PHYSIOL, V45, P1, DOI 10.1016/B978-0-12-417165-7.00001-5; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Briones MJI, 1997, APPL SOIL ECOL, V6, P117; Brown V.K., 1990, Advances in Ecological Research, V20, P1, DOI 10.1016/S0065-2504(08)60052-5; BROWN VK, 1992, VEGETATIO, V101, P3, DOI 10.1007/BF00031910; Campbell RE, 1937, ECOLOGY, V18, P479, DOI 10.2307/1930574; Crawley MJ., 2007, R BOOK; DAVIDSON RL, 1969, B ENTOMOL RES, V58, P559, DOI 10.1017/S0007485300057291; De Deyn GB, 2003, NATURE, V422, P711, DOI 10.1038/nature01548; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Erb M, 2013, J EXP BOT, V64, P1295, DOI 10.1093/jxb/ert007; GODFREY L D, 1985, Journal of Agricultural Entomology, V2, P370; Hagiwara Y, 2008, BOTANY, V86, P1111, DOI 10.1139/B08-064; Hagiwara Y, 2010, ANN BOT-LONDON, V106, P173, DOI 10.1093/aob/mcq096; Heisler-White JL, 2008, OECOLOGIA, V158, P129, DOI 10.1007/s00442-008-1116-9; James SE, 2003, J ECOL, V91, P234, DOI 10.1046/j.1365-2745.2003.00758.x; JONES OT, 1979, ECOL ENTOMOL, V4, P327, DOI 10.1111/j.1365-2311.1979.tb00592.x; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Ladd TL, 1979, J ECON ENTOMOL, V32, P341; LAFRANCE J, 1968, CAN ENTOMOL, V100, P801, DOI 10.4039/Ent100801-8; Maestre FT, 2007, ECOLOGY, V88, P501, DOI 10.1890/06-0421; MORAN NA, 1988, ECOLOGY, V69, P1214, DOI 10.2307/1941276; Novoplansky A, 2001, J VEG SCI, V12, P199, DOI 10.2307/3236604; Okuno T, 1978, DIS PESTS FLOWERS VE; R Development Core Team, 2012, R LANG ENV STAT COMP; RAMSELL J, 1993, J ECOL, V81, P777, DOI 10.2307/2261675; REGNIERE J, 1981, ENVIRON ENTOMOL, V10, P654, DOI 10.1093/ee/10.5.654; Reyer CPO, 2013, GLOBAL CHANGE BIOL, V19, P75, DOI 10.1111/gcb.12023; Riis L, 1998, ENVIRON ENTOMOL, V27, P1182, DOI 10.1093/ee/27.5.1182; Sakai K., 2007, ATLAS JAPANESE SCARA, V2; Smith MD, 2011, J ECOL, V99, P656, DOI 10.1111/j.1365-2745.2011.01798.x; Staley JT, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P192, DOI 10.1079/9781845934613.0192; Staley JT, 2007, EUR J SOIL BIOL, V43, P189, DOI 10.1016/j.ejsobi.2007.02.010; Stein C, 2010, ECOLOGY, V91, P1639, DOI 10.1890/09-0600.1; Tsunoda T, 2014, ECOL RES, V29, P351, DOI 10.1007/s11284-014-1133-6; van der Putten WH, 2009, OECOLOGIA, V161, P1, DOI 10.1007/s00442-009-1351-8; Villani M.G., 1988, Bulletin of the Entomological Society of America, V34, P132; VILLANI MG, 1990, ANNU REV ENTOMOL, V35, P249, DOI 10.1146/annurev.en.35.010190.001341; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875	41	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100437	10.1371/journal.pone.0100437	http://dx.doi.org/10.1371/journal.pone.0100437			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937126	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400110
J	Wang, B; Wang, B; Liu, PX; Li, T; Si, W; Xiu, JS; Liu, HG				Wang, Bin; Wang, Bin; Liu, Peixin; Li, Tao; Si, Wei; Xiu, Jinsheng; Liu, Henggui			Package of NDV-Pseudotyped HIV-Luc Virus and Its Application in the Neutralization Assay for NDV Infection	PLOS ONE			English	Article							NEWCASTLE-DISEASE VIRUS; HEMAGGLUTINATION INHIBITION TEST; OSTRICHES STRUTHIO-CAMELUS; LINKED-IMMUNOSORBENT-ASSAY; RECOMBINANT FOWLPOX VIRUS; NEURAMINIDASE HN PROTEIN; MONOCLONAL-ANTIBODIES; FUSION PROTEIN; ENVELOPE GLYCOPROTEINS; PARAMYXOVIRUS FUSION	Newcastle disease virus (NDV) is a member of the Paramyxovirinae subfamily and can infect most species of birds. It has been a great threat for the poultry industry all around the world. In this report, we successfully produced infectious pseudotyped pNL4-3-Luc-R-E- (HIV-Luc) viruses with the HN and F envelope proteins of NDV. Further investigation revealed the cytoplasmic domains of HN and F, especially HN, plays a significant role in the infection efficiency of these pseudotyped HIV-Luc viruses. Replacement of, or direct fusion to the cytoplasmic domain of the HN protein by that of vesicular stomatitis virus G (VSV-G) could greatly enhance or destroy the infective potential of HN and F-pseudotyped (NDV-pseudotyped) HIV-Luc virus. We further established a novel neutralization assay to evaluate neutralizing antibodies against NDV with the NDV-pseudotyped HIV-Luc viruses. Comparative neutralization data indicate that the results determined by using the NDV-pseudotyped HIV-Luc viruses are as reliable as those by the conventional virus-neutralization assay (VN test) with native NDV. Moreover, the results show that the novel neutralization assay is more sensitive than the VN test.	[Wang, Bin; Wang, Bin; Liu, Peixin; Li, Tao; Si, Wei; Liu, Henggui] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China; [Wang, Bin; Li, Tao; Xiu, Jinsheng] Fujian Agr & Forestry Univ, Coll Anim Sci, Fuzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Fujian Agriculture & Forestry University	Liu, HG (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China.	lhg@hvri.ac.cn			Fundamental Research Funds for Central Public Welfare Research Institutes [0302013006]; State Key Laboratory of Veterinary Biotechnology Research Fund [SKLVBP201217]	Fundamental Research Funds for Central Public Welfare Research Institutes; State Key Laboratory of Veterinary Biotechnology Research Fund	This work was supported by grants from the Fundamental Research Funds for Central Public Welfare Research Institutes (0302013006) and State Key Laboratory of Veterinary Biotechnology Research Fund (SKLVBP201217). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN WH, 1974, VET REC, V95, P120, DOI 10.1136/vr.95.6.120; Arita M, 2011, CLIN VACCINE IMMUNOL, V18, P1889, DOI 10.1128/CVI.05225-11; BOURSNELL MEG, 1990, VIROLOGY, V178, P297, DOI 10.1016/0042-6822(90)90408-J; Cadman HF, 1997, AVIAN PATHOL, V26, P357, DOI 10.1080/03079459708419218; Chan SY, 2001, CELL, V106, P117, DOI 10.1016/S0092-8674(01)00418-4; Chang A, 2012, VIRUSES-BASEL, V4, P613, DOI 10.3390/v4040613; Chazal N, 2001, J VIROL, V75, P4014, DOI 10.1128/JVI.75.8.4014-4018.2001; Chen WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076965; Choudhry V, 2007, VIROLOGY, V363, P79, DOI 10.1016/j.virol.2007.01.015; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Cosson P, 1996, EMBO J, V15, P5783, DOI 10.1002/j.1460-2075.1996.tb00964.x; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; Czifra G, 1996, AVIAN PATHOL, V25, P691, DOI 10.1080/03079459608419175; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111; Du L, 2010, BIOCH BIOPHYSICAL RE; FREED EO, 1995, J BIOL CHEM, V270, P23883, DOI 10.1074/jbc.270.41.23883; Funke S, 2008, MOL THER, V16, P1427, DOI 10.1038/mt.2008.128; HE JL, 1995, J VIROL, V69, P4587, DOI 10.1128/JVI.69.7.4587-4592.1995; IORIO RM, 1989, VIRUS RES, V13, P245, DOI 10.1016/0168-1702(89)90019-1; IORIO RM, 1984, J IMMUNOL, V133, P2215; IORIO RM, 1991, J VIROL, V65, P4999, DOI 10.1128/JVI.65.9.4999-5006.1991; IORIO RM, 1983, J VIROL, V48, P440, DOI 10.1128/JVI.48.2.440-450.1983; Jain S, 2007, J VIROL, V81, P2328, DOI 10.1128/JVI.01940-06; Jin J, 2013, J VIROL METHODS, V187, P362, DOI 10.1016/j.jviromet.2012.11.014; KALETA EF, 1979, COMP IMMUNOL MICROB, V2, P485, DOI 10.1016/0147-9571(79)90090-0; Kang YB, 2002, J VIROL, V76, P9378, DOI 10.1128/JVI.76.18.9378-9388.2002; Kang YX, 2012, J BIOL CHEM, V287, P16499, DOI 10.1074/jbc.M112.354084; Khan AR, 2012, POULTRY SCI, V91, P1598, DOI 10.3382/ps.2011-02042; Kishishita N, 2013, J CLIN MICROBIOLOGY; Kobayashi M, 2003, J VIROL, V77, P2607, DOI 10.1128/JVI.77.4.2607-2614.2003; Krishnamurthy S, 1998, J GEN VIROL, V79, P2419, DOI 10.1099/0022-1317-79-10-2419; Kumar S, 2011, J VIROL, V85, P6521, DOI 10.1128/JVI.00367-11; Lagging LM, 1998, J VIROL, V72, P3539, DOI 10.1128/JVI.72.5.3539-3546.1998; Lotery AJ, 2002, HUM GENE THER, V13, P689, DOI 10.1089/104303402317322258; Lu XF, 2012, ANTIMICROB AGENTS CH, V56, P341, DOI 10.1128/AAC.05537-11; McGinnes LW, 2010, J VIROL, V84, P4513, DOI 10.1128/JVI.01931-09; Mirza AM, 2013, J VIROL, V87, P8813, DOI 10.1128/JVI.01066-13; Molesti Eleonora, 2012, J Mol Genet Med, V7, P315; MORGAN RW, 1992, AVIAN DIS, V36, P858, DOI 10.2307/1591544; Morrison TG, 2003, BBA-BIOMEMBRANES, V1614, P73, DOI 10.1016/S0005-2736(03)00164-0; Nefkens I, 2007, J CLIN VIROL, V39, P27, DOI 10.1016/j.jcv.2007.02.005; Nie JH, 2012, J VIROL METHODS, V185, P267, DOI 10.1016/j.jviromet.2012.07.011; Palomares K, 2013, J VIROL, V87, P2094, DOI 10.1128/JVI.02032-12; Porotto M, 2003, J VIROL, V77, P3647, DOI 10.1128/JVI.77.6.3647-3654.2003; Porotto M, 2012, J VIROL, V86, P5730, DOI 10.1128/JVI.06793-11; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reynolds DL, 2000, AVIAN DIS, V44, P138, DOI 10.2307/1592517; Sanders DA, 2002, CURR OPIN BIOTECH, V13, P437, DOI 10.1016/S0958-1669(02)00374-9; Scott Simon, 2012, J Mol Genet Med, V6, P304; Simmons G, 2004, P NATL ACAD SCI USA, V101, P4240, DOI 10.1073/pnas.0306446101; STEWARD M, 1993, J GEN VIROL, V74, P2539, DOI 10.1099/0022-1317-74-12-2539; Sun HL, 2008, AVIAN DIS, V52, P111, DOI 10.1637/7998-041807-Reg; Tang DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043596; TAYLOR J, 1990, J VIROL, V64, P1441, DOI 10.1128/JVI.64.4.1441-1450.1990; Wambura PN, 2011, TROP ANIM HEALTH PRO, V43, P99, DOI 10.1007/s11250-010-9659-2; Williams R, 1997, AVIAN DIS, V41, P864, DOI 10.2307/1592340; Xu H, 1997, J IMMUNOL METHODS, V208, P61, DOI 10.1016/S0022-1759(97)00128-2; YERAMIAN P, 1985, CR ACAD SCI III-VIE, V300, P255; YU XF, 1992, J VIROL, V66, P4966, DOI 10.1128/JVI.66.8.4966-4971.1992; Zhang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044241	61	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99905	10.1371/journal.pone.0099905	http://dx.doi.org/10.1371/journal.pone.0099905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937158	Green Published, Green Submitted, gold			2022-12-25	WOS:000338503400054
J	Zhang, JB; Pan, ZX; Moloney, S; Sheppard, A				Zhang, Jinbi; Pan, Zengxiang; Moloney, Stephanie; Sheppard, Allan			RNA-Seq Analysis Implicates Detoxification Pathways in Ovine Mycotoxin Resistance	PLOS ONE			English	Article							GENE-EXPRESSION; OXIDATIVE STRESS; FACIAL ECZEMA; LIVER; SPORIDESMIN; ENZYMES; IDENTIFICATION; ANNOTATION; MECHANISMS; TOXICITY	Mycotoxin induced hepatoxocity has been linked to oxidative stress, resulting from either an increase in levels of reactive oxygen species (ROS) above normal levels and/or the suppression of antioxidant protective pathways. However, few detailed molecular studies of mycotoxicoses in animals have been carried out. This study use current RNA-seq based approaches to investigate the effects of mycotoxin exposure in a ruminant model. Having first assembled a de novo reference transcriptome, we use RNA-Seq technology to define in vivo hepatic gene expression changes resulting from mycotoxin exposure in relationship to pathological effect. As expected, characteristic oxidative stress related gene expression is markedly different in animals exhibiting poorer outcomes. However, expression of multiple genes critical for detoxification, particularly members of the cytochrome P450 gene family, was significantly higher in animals exhibiting mycotoxin tolerance ('resistance'). Further, we present novel evidence for the amplification of Wnt signalling pathway activity in 'resistant' animals, resulting from the marked suppression of multiple key Wnt inhibitor genes. Notably, 'resistance' may be determined primarily by the ability of an individual to detoxify secondary metabolites generated by the metabolism of mycotoxins and the potentiation of Wnt signalling may be pivotal to achieving a favourable outcome upon challenge.	[Zhang, Jinbi; Pan, Zengxiang; Moloney, Stephanie; Sheppard, Allan] Univ Auckland, Liggins Inst, Auckland 1, New Zealand	University of Auckland	Zhang, JB (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	jinbi.zhang@auckland.ac.nz	Zhang, Jinbi/CAG-1983-2022	zhang, jinbi/0000-0002-9492-3425	Epigenomics Based Prognostics Program - Ministry of Business, Industry and Employment (MBIE) of the New Zealand Government; High Efficiency Sensor Program - Ministry of Business, Industry and Employment (MBIE) of the New Zealand Government; China Scholarship Council; Developmental Epigenetics Lab, Liggins institute, University of Auckland	Epigenomics Based Prognostics Program - Ministry of Business, Industry and Employment (MBIE) of the New Zealand Government; High Efficiency Sensor Program - Ministry of Business, Industry and Employment (MBIE) of the New Zealand Government; China Scholarship Council(China Scholarship Council); Developmental Epigenetics Lab, Liggins institute, University of Auckland	This work was supported in part by the Epigenomics Based Prognostics Program (AS is the PI) and the High Efficiency Sensor Program (AS is a co-PI) both funded by the Ministry of Business, Industry and Employment (MBIE) of the New Zealand Government. JZ acknowledges scholarship support from the China Scholarship Council. The authors would like to further acknowledge the support of the Developmental Epigenetics Lab, Liggins institute, University of Auckland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Braeuning A, 2009, DRUG METAB DISPOS, V37, P1138, DOI 10.1124/dmd.108.026179; Chesire DR, 2004, CANCER RES, V64, P2523, DOI 10.1158/0008-5472.CAN-03-3309; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cruciat C-M, 2013, COLD SPRING HARBOR P, V5; Djordjevic J, 2010, PHYSIOL RES, V59, P729, DOI 10.33549/physiolres.931862; El Golli-Bennour E, 2011, TOXICOLOGY, V287, P1, DOI 10.1016/j.tox.2011.06.002; Fairclough RJ, 1978, STUDIES SPORIDESMIN, P65; Fink-Gremmels J, 2007, ANIM FEED SCI TECH, V137, P326, DOI 10.1016/j.anifeedsci.2007.06.008; Gao J, 2009, BIOINFORMATICS, V25, P137, DOI 10.1093/bioinformatics/btn501; Gardiner DM, 2005, MICROBIOL-SGM, V151, P1021, DOI 10.1099/mic.0.27847-0; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hailfinger S, 2006, HEPATOLOGY, V43, P407, DOI 10.1002/hep.21082; Huwig A, 2001, TOXICOL LETT, V122, P179, DOI 10.1016/S0378-4274(01)00360-5; Ingelman-Sundberg M, 2005, PHARMACOGENOMICS J, V5, P6, DOI 10.1038/sj.tpj.6500285; Ingelman-Sundberg M, 2004, N-S ARCH PHARMACOL, V369, P89, DOI 10.1007/s00210-003-0819-z; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Lade AG, 2011, DEV DYNAM, V240, P486, DOI 10.1002/dvdy.22522; Li D, 2012, MOL PHARMACOL, V81, P86, DOI 10.1124/mol.111.074393; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036592; Ma S, 2012, GASTROENTEROLOGY, V143, P675, DOI 10.1053/j.gastro.2012.06.007; Morgavi DP, 2007, ANIM FEED SCI TECH, V137, P201, DOI 10.1016/j.anifeedsci.2007.06.002; Morris CA, 2004, NEW ZEAL VET J, V52, P205, DOI 10.1080/00480169.2004.36431; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MORTIMER PH, 1968, J COMP PATHOL, V78, P505, DOI 10.1016/0021-9975(68)90050-9; MUNDAY R, 1989, FREE RADICAL BIO MED, V7, P659, DOI 10.1016/0891-5849(89)90147-0; Munday R, 1997, NEW ZEAL VET J, V45, P93, DOI 10.1080/00480169.1997.36002; Omiecinski CJ, 2011, TOXICOL SCI, V120, pS49, DOI 10.1093/toxsci/kfq338; Pamplona R, 2011, AM J PHYSIOL-REG I, V301, pR843, DOI 10.1152/ajpregu.00034.2011; Paterson RRM, 2010, FOOD RES INT, V43, P1902, DOI 10.1016/j.foodres.2009.07.010; Peltonen J, 2013, J BIOCH MOL TOXICOLO; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pestka JJ, 2007, ANIM FEED SCI TECH, V137, P283, DOI 10.1016/j.anifeedsci.2007.06.006; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rustemeyer SM, 2011, J ANIM SCI, V89, P916, DOI 10.2527/jas.2010-3473; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sekine S, 2006, HEPATOLOGY, V43, P817, DOI 10.1002/hep.21131; SMITH BL, 1980, NEW ZEAL VET J, V28, P35, DOI 10.1080/00480169.1980.34686; Stahl S, 2005, HEPATOLOGY, V42, P353, DOI 10.1002/hep.20768; Swales K, 2004, MOL ENDOCRINOL, V18, P1589, DOI 10.1210/me.2003-0397; Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042; TOWERS NR, 1978, NEW ZEAL VET J, V26, P109, DOI 10.1080/00480169.1978.34508; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Voss KA, 2007, ANIM FEED SCI TECH, V137, P299, DOI 10.1016/j.anifeedsci.2007.06.007; Wild CP, 2010, CARCINOGENESIS, V31, P71, DOI 10.1093/carcin/bgp264; Wu F, 2011, WORLD MYCOTOXIN J, V4, P79, DOI 10.3920/WMJ2010.1246; Zaki M.M., 2012, J TOXICOL ENV HLTH, V4, P13, DOI DOI 10.5897/JTEHS11.072; Zhang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089817; Zhang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072686; Zhang YH, 2012, GENOMICS, V100, P35, DOI 10.1016/j.ygeno.2012.05.002; Zhu JH, 2011, BIOCHEM BIOPH RES CO, V404, P559, DOI 10.1016/j.bbrc.2010.12.025	54	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99975	10.1371/journal.pone.0099975	http://dx.doi.org/10.1371/journal.pone.0099975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936865	Green Submitted, Green Published, gold			2022-12-25	WOS:000338503400060
J	Hu, M; Liang, HL				Hu, Meng; Liang, Hualou			Search for Information-Bearing Components in Neural Data	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; NOISE	Multivariate empirical mode decomposition (MEMD) is an important extension of EMD, suitable for processing multichannel data. It can adaptively decompose multivariate data into a set of intrinsic mode functions (IMFs) that are matched both in number and in frequency scale. This method is thus holds great potential for the analysis of multi-channel neural recordings as it is capable of ensuring all the intrinsic oscillatory modes are aligned not only across channels, but also across trials. Given a plethora of IMFs derived by MEMD, a question of significant interest is how to identify which IMFs contain information, and which IMFs are noise. Existing methods that exploit the dyadic filter bank structure of white noise decomposition are insufficient since the IMFs do not always adhere to the presumed dyadic relationship. Here we propose a statistical procedure to identify information-bearing IMFs, which is built upon MEMD that allows adding noise as separate channels to serve as a reference to facilitate IMF identification. In this procedure, Wasserstein distance is used to measure the similarity between the reference IMF and that from data. Simulations are performed to validate the method. Local field potentials from cortex of monkeys while performing visual tasks are used for demonstration.	[Hu, Meng; Liang, Hualou] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA	Drexel University	Liang, HL (corresponding author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.	hualou.liang@drexel.edu						Bin Altaf MU, 2007, INT CONF ACOUST SPEE, P1009; Chen M, 2007, P IEEE WORKSH MACH L, P223; Cichocki A., 2012, ADAPTIVE BLIND SIGNA, DOI DOI 10.1002/0470845899; Dudley R. M., 2002, REAL ANAL PROBABILIT, V74; Efron B., 1994, INTRO BOOTSTRAP; Flandrin P, 2004, IEEE SIGNAL PROC LET, V11, P112, DOI 10.1109/LSP.2003.821662; Flandrin P, 2005, INTERD MATH SCI, V5, P57; Gibbs AL, 2002, INT STAT REV, V70, P419, DOI 10.2307/1403865; Hu M, 2011, COGN NEURODYNAMICS, V5, P277, DOI 10.1007/s11571-011-9159-8; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Liang H, 2000, MED BIOL ENG COMPUT, V38, P35, DOI 10.1007/BF02344686; Liang HL, 2005, BIOL CYBERN, V92, P380, DOI 10.1007/s00422-005-0566-y; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; Nalatore H, 2009, J NEUROSCI METH, V179, P131, DOI 10.1016/j.jneumeth.2009.01.013; Ni K, 2009, INT J COMPUT VISION, V84, P97, DOI 10.1007/s11263-009-0234-0; Rehman N, 2010, P ROY SOC A-MATH PHY, V466, P1291, DOI 10.1098/rspa.2009.0502; Rehman NU, 2013, ADV DATA SCI ADAPT, V5, DOI 10.1142/S1793536913500076; Rehman NU, 2011, IEEE T SIGNAL PROCES, V59, P2421, DOI 10.1109/TSP.2011.2106779; Rehman NU, 2009, INT CONF ACOUST SPEE, P3449, DOI 10.1109/ICASSP.2009.4960367; Rilling G, 2007, IEEE SIGNAL PROC LET, V14, P936, DOI 10.1109/LSP.2007.904710; Rubner Y, 2000, INT J COMPUT VISION, V40, P99, DOI 10.1023/A:1026543900054; Sweeney-Reed CM, 2007, J COMPUT NEUROSCI, V23, P79, DOI 10.1007/s10827-007-0020-3; Tanaka T, 2007, IEEE SIGNAL PROC LET, V14, P101, DOI 10.1109/LSP.2006.882107; ur Rehman N, 2010, IEEE T SIGNAL PROCES, V58, P1059, DOI 10.1109/TSP.2009.2033730; Wilke M, 2006, P NATL ACAD SCI USA, V103, P17507, DOI 10.1073/pnas.0604673103; Wu ZH, 2004, P ROY SOC A-MATH PHY, V460, P1597, DOI 10.1098/rspa.2003.1221; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P339, DOI 10.1142/S1793536909000187; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047	29	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99793	10.1371/journal.pone.0099793	http://dx.doi.org/10.1371/journal.pone.0099793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932596	Green Submitted, Green Published, gold			2022-12-25	WOS:000337738600065
J	Lopez-Sanchez, LM; Jimenez, C; Valverde, A; Hernandez, V; Penarando, J; Martinez, A; Lopez-Pedrera, C; Munoz-Castaneda, JR; De la Haba-Rodriguez, JR; Aranda, E; Rodriguez-Ariza, A				Lopez-Sanchez, Laura M.; Jimenez, Carla; Valverde, Araceli; Hernandez, Vanessa; Penarando, Jon; Martinez, Antonio; Lopez-Pedrera, Chary; Munoz-Castaneda, Juan R.; De la Haba-Rodriguez, Juan R.; Aranda, Enrique; Rodriguez-Ariza, Antonio			CoCl2, a Mimic of Hypoxia, Induces Formation of Polyploid Giant Cells with Stem Characteristics in Colon Cancer	PLOS ONE			English	Article							SELF-RENEWAL; OXYGEN; CYCLE; MAINTENANCE; HIF-1-ALPHA; SENESCENCE; CHALLENGES; RESISTANCE; EXPANSION; DIVISION	The induction of polyploidy is considered the reproductive end of cells, but there is evidence that polyploid giant cancer cells (PGCCs) contribute to cell repopulation during tumor relapse. However, the role of these cells in the development, progression and response to therapy in colon cancer remains undefined. Therefore, the main objective of this study was to investigate the generation of PGCCs in colon cancer cells and identify mechanisms of formation. Treatment of HCT-116 and Caco-2 colon cancer cells with the hypoxia mimic CoCl2 induced the formation of cells with larger cell and nuclear size (PGCCs), while the cells with normal morphology were selectively eliminated. Cytometric analysis showed that CoCl2 treatment induced G2 cell cycle arrest and the generation of a polyploid cell subpopulation with increased cellular DNA content. Polyploidy of hypoxia-induced PGCCs was confirmed by FISH analysis. Furthermore, CoCl2 treatment effectively induced the stabilization of HIF-1 alpha, the differential expression of a truncated form of p53 (p47) and decreased levels of cyclin D1, indicating molecular mechanisms associated with cell cycle arrest at G2. Generation of PGCCs also contributed to expansion of a cell subpopulation with cancer stem cells (CSCs) characteristics, as indicated by colonosphere formation assays, and enhanced chemoresistance to 5-fluorouracil and oxaliplatin. In conclusion, the pharmacological induction of hypoxia in colon cancer cells causes the formation of PGCCs, the expansion of a cell subpopulation with CSC characteristics and chemoresistance. The molecular mechanisms involved, including the stabilization of HIF-1 alpha, the involvement of p53/p47 isoform and cell cycle arrest at G2, suggest novel targets to prevent tumor relapse and treatment failure in colon cancer.	[Lopez-Sanchez, Laura M.; Jimenez, Carla; Valverde, Araceli; Hernandez, Vanessa; Penarando, Jon; Martinez, Antonio; De la Haba-Rodriguez, Juan R.; Aranda, Enrique; Rodriguez-Ariza, Antonio] Univ Cordoba, Reina Sofia Hosp, Dept Oncol, Maimonides Inst Biomed Res IMIBIC, Cordoba, Spain; [Lopez-Sanchez, Laura M.; Jimenez, Carla; Valverde, Araceli; Hernandez, Vanessa; Penarando, Jon; Martinez, Antonio; De la Haba-Rodriguez, Juan R.; Aranda, Enrique; Rodriguez-Ariza, Antonio] Inst Salud Carlos III, Spanish Canc Network RTICC, Madrid, Spain; [Lopez-Pedrera, Chary; Munoz-Castaneda, Juan R.] Univ Cordoba, Reina Sofia Hosp, Res Unit, Maimonides Inst Biomed Res IMIBIC, Cordoba, Spain	Universidad de Cordoba; Instituto de Salud Carlos III; Universidad de Cordoba	Rodriguez-Ariza, A (corresponding author), Univ Cordoba, Reina Sofia Hosp, Dept Oncol, Maimonides Inst Biomed Res IMIBIC, Cordoba, Spain.	antonio.rodriguez.exts@juntadeandalucia.es	Muñoz-Castañeda, Juan R./AFQ-3443-2022; Aranda, Enrique/AAA-4147-2019; Rodriguez-Ariza, Antonio/U-4854-2017; López-Sánchez, Laura María/E-3260-2018; Lopez-Pedrera, Chary/M-4603-2015; Peñarando, Jon/AAB-2890-2021	Rodriguez-Ariza, Antonio/0000-0001-5304-5745; López-Sánchez, Laura María/0000-0002-0763-1804; Lopez-Pedrera, Chary/0000-0003-2067-4603; Haba Rodriguez, Juan Rafael de la/0000-0001-5111-1702; Munoz-Castaneda, Juan R/0000-0002-9341-0724	Programa de Promocion de la Investigacion en Salud del Ministerio de Economia y Competitividad, Instituto de Salud Carlos III [PI10/00428, PI13/00553]	Programa de Promocion de la Investigacion en Salud del Ministerio de Economia y Competitividad, Instituto de Salud Carlos III	Supported by grants to A.R.-A. from Programa de Promocion de la Investigacion en Salud del Ministerio de Economia y Competitividad, Instituto de Salud Carlos III (PI10/00428 and PI13/00553) (http://www.isciii.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccelli I, 2012, J CELL BIOL, V198, P281, DOI 10.1083/jcb.201202014; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bourougaa K, 2010, MOL CELL, V38, P78, DOI 10.1016/j.molcel.2010.01.041; Brenner H, 2012, INT J CANCER, V131, P1649, DOI 10.1002/ijc.26192; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Erenpreisa J, 2007, CELL BIOL INT, V31, P1507, DOI 10.1016/j.cellbi.2007.08.013; Erenpreisa J, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-92; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fox DT, 2013, DEVELOPMENT, V140, P3, DOI 10.1242/dev.080531; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Hashimoto O, 2011, PATHOBIOLOGY, V78, P181, DOI 10.1159/000325538; Ho VT, 1996, BIOCHEM BIOPH RES CO, V223, P175, DOI 10.1006/bbrc.1996.0865; Kanwar SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-212; KASTAN MB, 1991, CANCER RES, V51, P6304; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904; Koumenis C, 2006, CURR MOL MED, V6, P55, DOI 10.2174/156652406775574604; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lu J, 2013, CANCER CELL, V23, P171, DOI 10.1016/j.ccr.2012.12.021; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Puig PE, 2008, CELL BIOL INT, V32, P1031, DOI 10.1016/j.cellbi.2008.04.021; Rajaraman R, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-25; Ravizza R, 2009, EUR J CANCER, V45, P890, DOI 10.1016/j.ejca.2008.12.021; Roberts DL, 2009, BRIT J CANCER, V101, P1290, DOI 10.1038/sj.bjc.6605311; Sandau KB, 2001, BLOOD, V97, P1009, DOI 10.1182/blood.V97.4.1009; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5; Sundaram M, 2004, CANCER BIOL THER, V3, P207, DOI 10.4161/cbt.3.2.663; Thiery JP, 2013, CANCER CELL, V23, P272, DOI 10.1016/j.ccr.2013.03.004; Vermeulen L, 2012, LANCET ONCOL, V13, pE83, DOI 10.1016/S1470-2045(11)70257-1; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Walmsley SR, 2008, AM J RESP CELL MOL, V38, P251, DOI 10.1165/rcmb.2007-0331TR; Wheatley D, 2008, CELL BIOL INT, V32, P1029, DOI 10.1016/j.cellbi.2008.06.001; Yeung TM, 2011, P NATL ACAD SCI USA, V108, P4382, DOI 10.1073/pnas.1014519107; Zhang HJ, 2012, BLOOD, V119, P2595, DOI 10.1182/blood-2011-10-387381; Zhang S, 2013, ONCOGENE	42	83	84	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99143	10.1371/journal.pone.0099143	http://dx.doi.org/10.1371/journal.pone.0099143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932611	Green Submitted, Green Published, gold			2022-12-25	WOS:000337738600022
J	Tasca, G; Monforte, M; Iannaccone, E; Laschena, F; Ottaviani, P; Leoncini, E; Boccia, S; Galluzzi, G; Pelliccioni, M; Masciullo, M; Frusciante, R; Mercuri, E; Ricci, E				Tasca, Giorgio; Monforte, Mauro; Iannaccone, Elisabetta; Laschena, Francesco; Ottaviani, Pierfrancesco; Leoncini, Emanuele; Boccia, Stefania; Galluzzi, Giuliana; Pelliccioni, Marco; Masciullo, Marcella; Frusciante, Roberto; Mercuri, Eugenio; Ricci, Enzo			Upper Girdle Imaging in Facioscapulohumeral Muscular Dystrophy	PLOS ONE			English	Article							ONSET POMPE DISEASE; BODY MUSCLE MRI; MOLECULAR DIAGNOSIS; INVOLVEMENT; PHENOTYPE; CARRIERS	Background: In Facioscapulohumeral muscular dystrophy (FSHD), the upper girdle is early involved and often difficult to assess only relying on physical examination. Our aim was to evaluate the pattern and degree of involvement of upper girdle muscles in FSHD compared with other muscle diseases with scapular girdle impairment. Methods: We propose an MRI protocol evaluating neck and upper girdle muscles. One hundred-eight consecutive symptomatic FSHD patients and 45 patients affected by muscular dystrophies and myopathies with prominent upper girdle involvement underwent this protocol. Acquired scans were retrospectively analyzed. Results: The trapezius (100% of the patients) and serratus anterior (85% of the patients) were the most and earliest affected muscles in FSHD, followed by the latissimus dorsi and pectoralis major, whilst spinati and subscapularis (involved in less than 4% of the patients) were consistently spared even in late disease stages. Asymmetry and hyperintensities on short-tau inversion recovery (STIR) sequences were common features, and STIR hyperintensities could also be found in muscles not showing signs of fatty replacement. The overall involvement appears to be disease-specific in FSHD as it significantly differed from that encountered in the other myopathies. Conclusions: The detailed knowledge of single muscle involvement provides useful information for correctly evaluating patients' motor function and to set a baseline for natural history studies. Upper girdle imaging can also be used as an additional tool helpful in supporting the diagnosis of FSHD in unclear situations, and may contribute with hints on the currently largely unknown molecular pathogenesis of this disease.	[Tasca, Giorgio] Don Carlo Gnocchi Onlus Fdn, Milan, Italy; [Monforte, Mauro; Iannaccone, Elisabetta; Ricci, Enzo] Univ Cattolica Sacro Cuore, Sch Med, Inst Neurol, I-00168 Rome, Italy; [Laschena, Francesco; Ottaviani, Pierfrancesco] IRCCS, Ist Dermopat Immacolata, Dept Radiol, Rome, Italy; [Leoncini, Emanuele; Boccia, Stefania] Univ Cattolica Sacro Cuore, Sch Med, Dept Publ Hlth, Inst Hyg, I-00168 Rome, Italy; [Galluzzi, Giuliana] CNR, Cellular Biol & Neurobiol Inst, Rome, Italy; [Pelliccioni, Marco] Unione Italiana Lotta Distrofia Muscolare UILDM R, Rome, Italy; [Masciullo, Marcella] IRCCS Santa Lucia Fdn, Rome, Italy; [Frusciante, Roberto] Univ Cattolica Sacro Cuore, Sch Med, Columbus Hosp, Neurophysiopathol Unit, I-00168 Rome, Italy; [Mercuri, Eugenio] Univ Cattolica Sacro Cuore, Sch Med, Pediat Neurol Unit, I-00168 Rome, Italy	IRCCS Fondazione Don Carlo Gnocchi Onlus; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Istituto Dermopatico dell'Immacolata (IDI); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); IRCCS Santa Lucia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Ricci, E (corresponding author), Univ Cattolica Sacro Cuore, Sch Med, Inst Neurol, I-00168 Rome, Italy.	ericci@rm.unicatt.it	Monforte, Mauro/AAS-7120-2021; Tasca, Giorgio/J-5153-2018; Monforte, Mauro/J-2918-2018; Boccia, Stefania/AFN-1666-2022; Masciullo, Marcella/J-9144-2016; Ricci, Enzo/AAC-4448-2020; Boccia, Stefania/AAB-9533-2022; , emanuele/A-5466-2010; Mercuri, Eugenio/G-1351-2015	Monforte, Mauro/0000-0002-4327-6969; Tasca, Giorgio/0000-0003-0849-9144; Monforte, Mauro/0000-0002-4327-6969; Boccia, Stefania/0000-0002-1864-749X; Masciullo, Marcella/0000-0003-1368-7692; Boccia, Stefania/0000-0002-1864-749X; , emanuele/0000-0002-7669-8535; Mercuri, Eugenio/0000-0002-9851-5365; RICCI, Enzo/0000-0003-3092-3597	Don Carlo Gnocchi Onlus Foundation (Ricerca Corrente); Telethon Foundation [GUP11009M]	Don Carlo Gnocchi Onlus Foundation (Ricerca Corrente); Telethon Foundation(Fondazione Telethon)	This study was supported in part by fundings from Don Carlo Gnocchi Onlus Foundation (Ricerca Corrente 2012) to GT and Telethon Foundation (Grant GUP11009M) to ER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejaldre A, 2012, NEUROMUSCULAR DISORD, V22, pS148, DOI 10.1016/j.nmd.2012.05.011; BROUWER OF, 1992, BRAIN, V115, P1587, DOI 10.1093/brain/115.5.1587; Carlier RY, 2011, NEUROMUSCULAR DISORD, V21, P791, DOI 10.1016/j.nmd.2011.06.748; Cartier PG, 2012, NEUROMUSCULAR DISORD, V22, pS41, DOI 10.1016/j.nmd.2012.08.001; Esposito A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059308; Felice KJ, 1997, MUSCLE NERVE, V20, P1194, DOI 10.1002/(SICI)1097-4598(199709)20:9<1194::AID-MUS19>3.0.CO;2-T; Friedman SD, 2014, MUSCLE NERVE, V49, P257, DOI 10.1002/mus.23911; Friedman SD, 2012, MUSCLE NERVE, V45, P500, DOI 10.1002/mus.22342; Frisullo G, 2011, J CLIN IMMUNOL, V31, P155, DOI 10.1007/s10875-010-9474-6; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Janssen BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085416; Jarraya M, 2012, NEUROMUSCULAR DISORD, V22, pS137, DOI 10.1016/j.nmd.2012.06.347; Kan HE, 2009, NEUROMUSCULAR DISORD, V19, P357, DOI 10.1016/j.nmd.2009.02.009; Kesper K, 2009, ACTA NEUROL SCAND, V120, P111, DOI 10.1111/j.1600-0404.2008.01129.x; Landouzy L, 1885, REV MED, V5, P81; Leidenroth A, 2012, EUR J HUM GENET, V20, P999, DOI 10.1038/ejhg.2012.42; Lemmers Richard J L F, 2012, Neuromuscul Disord, V22, P463, DOI 10.1016/j.nmd.2011.09.004; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Martin RM, 2008, CURR REV MUSCULOSKE, V1, P1, DOI 10.1007/s12178-007-9000-5; Mercuri E, 2007, J MAGN RESON IMAGING, V25, P433, DOI 10.1002/jmri.20804; Monforte M, 2013, NEUROLOGY, V81, pE95, DOI 10.1212/WNL.0b013e3182a4a4e6; Olsen DB, 2006, J NEUROL, V253, P1437, DOI 10.1007/s00415-006-0230-z; Padberg G.W.A.M., 1982, THESIS; Padberg GW, 2009, CURR OPIN NEUROL, V22, P539, DOI 10.1097/WCO.0b013e328330a572; Ricci E, 1999, ANN NEUROL, V45, P751, DOI 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M; Sacconi S, 2012, J MED GENET, V49, P41, DOI 10.1136/jmedgenet-2011-100101; Sarkozy A, 2012, NEUROMUSCULAR DISORD, V22, pS122, DOI 10.1016/j.nmd.2012.05.012; Sarparanta J, 2012, NAT GENET, V44, P450, DOI 10.1038/ng.1103; Scionti I, 2012, AM J HUM GENET, V90, P628, DOI 10.1016/j.ajhg.2012.02.019; Tasca G, 2012, EUR J NEUROL, V19, P1256, DOI 10.1111/j.1468-1331.2012.03753.x; Tasca G, 2011, NEUROMUSCULAR DISORD, V21, P671, DOI 10.1016/j.nmd.2011.06.860; Tasca G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038779; Tawil R, 2014, NEUROMUSCULAR DISORD, V24, P79, DOI 10.1016/j.nmd.2013.07.009; Tonini MMO, 2004, NEUROMUSCULAR DISORD, V14, P33, DOI 10.1016/j.nmd.2003.07.001; Wang CH, 2012, NEUROMUSCULAR DISORD, V22, P331, DOI 10.1016/j.nmd.2011.10.018; Wattjes MP, 2010, EUR RADIOL, V20, P2447, DOI 10.1007/s00330-010-1799-2; Zatz M, 1998, AM J MED GENET, V77, P155, DOI 10.1002/(SICI)1096-8628(19980501)77:2<155::AID-AJMG9>3.3.CO;2-G	37	62	62	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100292	10.1371/journal.pone.0100292	http://dx.doi.org/10.1371/journal.pone.0100292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932477	gold, Green Published, Green Submitted			2022-12-25	WOS:000337738600106
J	Wurth, JJ; Blumenthal, NR; Shastri, VP				Wurth, Jonathan J.; Blumenthal, Nils R.; Shastri, V. Prasad			Hydrophilization of Poly(Caprolactone) Copolymers through Introduction of Oligo(Ethylene Glycol) Moieties	PLOS ONE			English	Article							TISSUE ENGINEERING APPLICATIONS; RING-OPENING POLYMERIZATION; EPSILON-CAPROLACTONE; DRUG-DELIVERY; BIODEGRADABLE POLYMERS; POLY(ETHYLENE GLYCOL); BLOCK-COPOLYMERS; CONTACT-ANGLE; POLYESTERS; BIOMATERIALS	In this study, a new family of poly(e-caprolactone) (PCL) copolymers that bear oligo(ethylene glycol) (OEG) moieties is described. The synthesis of three different oligo(ethylene glycol) functionalized epoxide monomers derived from 2-methyl-4-pentenoic acid, and their copolymerization with epsilon-caprolactone (CL) to poly(CL-co-OEG-MPO) copolymers is presented. The statistical copolymerization initiated with SnOct(2)/BnOH yielded the copolymers with varying OEG content and composition. The linear relationship between feed ratio and incorporation of the OEG co-monomer enables control over backbone functional group density. The introduction of OEG moieties influenced both the thermal and the hydrophilic characteristics of the copolymers. Both increasing OEG length and backbone content resulted in a decrease in static water contact angle. The introduction of OEG side chains in the PCL copolymers had no adverse influence on MC-3TE3-E1 cell interaction. However, changes to cell form factor (W) were observed. While unmodified PCL promoted elongated (anisotropic) morphologies (Phi=0.094), PCL copolymer with tri-ethylene glycol side chains at or above seven percent backbone incorporation induced more isotropic cell morphologies (Phi=0.184) similar to those observed on glass controls (Phi=0.151).	[Wurth, Jonathan J.; Blumenthal, Nils R.; Shastri, V. Prasad] Univ Freiburg, Inst Macromol Chem, Freiburg, Germany; [Wurth, Jonathan J.; Blumenthal, Nils R.; Shastri, V. Prasad] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Shastri, VP (corresponding author), Univ Freiburg, Inst Macromol Chem, Freiburg, Germany.	prasad.shastri@gmail.com			Excellence Initiative of the German Federal and State Governments BIOSS [EXC 294]	Excellence Initiative of the German Federal and State Governments BIOSS	This study was supported by the Excellence Initiative of the German Federal and State Governments (EXC 294) BIOSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsson AC, 2003, BIOMACROMOLECULES, V4, P1466, DOI 10.1021/bm034247a; Bhadra D, 2002, PHARMAZIE, V57, P5; Brostow W, 2008, MATER LETT, V62, P3152, DOI 10.1016/j.matlet.2008.02.008; Cho KY, 2006, POLYM BULL, V57, P849, DOI 10.1007/s00289-006-0658-4; Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064; Deng XM, 1997, J POLYM SCI POL CHEM, V35, P703, DOI 10.1002/(SICI)1099-0518(199703)35:4<703::AID-POLA13>3.0.CO;2-R; Dubois P, 1996, MACROMOLECULES, V29, P1965, DOI 10.1021/ma951738h; GOOD RJ, 1992, J ADHES SCI TECHNOL, V6, P1269, DOI 10.1163/156856192X00629; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Heiny M, 2014, ELSEVIER SCI; Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.3.CO;2-O; Jagur-Grodzinski J, 2003, E-POLYMERS, V012, P25; Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672; Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8; Labet M, 2009, CHEM SOC REV, V38, P3484, DOI 10.1039/b820162p; Lam CNC, 2002, ADV COLLOID INTERFAC, V96, P169, DOI 10.1016/S0001-8686(01)00080-X; Mark James E., 2009, POLYM DATA HDB, P1264; Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0; Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017; Oh SH, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014101; Patel A, 2013, BIOMATERIALS, V34, P3970, DOI 10.1016/j.biomaterials.2013.01.045; Piao LH, 2003, POLYMER, V44, P2025, DOI 10.1016/S0032-3861(03)00087-9; Rieger J, 2004, MACROMOLECULES, V37, P9738, DOI 10.1021/ma048768h; Sabir MI, 2009, J MATER SCI, V44, P5713, DOI 10.1007/s10853-009-3770-7; Schmidmaier G, 2001, J BIOMED MATER RES, V58, P449; Shastri V. P., 2004, US Pat., Patent No. [6,730,772, 6730772, 6,730,772 B2]; Sinha VR, 2004, INT J PHARMACEUT, V278, P1, DOI 10.1016/j.ijpharm.2004.01.044; Stevens MP., 1990, POLYM CHEM-UK; Thire RMSM, 2007, MACROMOL SYMP, V258, P38, DOI 10.1002/masy.200751205; Tokiwa Y, 2007, J POLYM ENVIRON, V15, P259, DOI 10.1007/s10924-007-0066-3; Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0; Vert M, 2005, BIOMACROMOLECULES, V6, P538, DOI 10.1021/bm0494702; Wei XW, 2009, INT J PHARMACEUT, V381, P1, DOI 10.1016/j.ijpharm.2009.07.033; Wurth JJ, 2013, J POLYM SCI POL CHEM, V51, P3375, DOI 10.1002/pola.26734	34	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99157	10.1371/journal.pone.0099157	http://dx.doi.org/10.1371/journal.pone.0099157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932726	Green Published, gold, Green Submitted			2022-12-25	WOS:000337738600024
J	Barbosa, RPA; Salgado, APC; Garcia, CC; Galvao, B; Goncalves, APD; Lima, BHF; Lopes, GAO; Rachid, MA; Peixoto, ACC; de Oliveira, DB; Ataide, MA; Zirke, CA; Cotrim, TM; Costa, EA; Almeida, GMD; Russo, RC; Gazzinelli, RT; Machado, ADV				Alves Barbosa, Rafael Polidoro; Carneiro Salgado, Ana Paula; Garcia, Cristiana Couto; Galvao Filho, Bruno; de Faria Goncalves, Ana Paula; Freire Lima, Braulio Henrique; Oliveira Lopes, Gabriel Augusto; Rachid, Milene Alvarenga; Cardoso Peixoto, Andiara Cristina; de Oliveira, Danilo Bretas; Ataide, Marco Antonio; Zirke, Carla Aparecida; Cotrim, Tatiane Marques; Costa, Erica Azevedo; de Freitas Almeida, Gabriel Magno; Russo, Remo Castro; Gazzinelli, Ricardo Tostes; Vieira Machado, Alexandre de Magalhaes			Protective Immunity and Safety of a Genetically Modified Influenza Virus Vaccine	PLOS ONE			English	Article							T-CELL RESPONSES; A VIRUS; VIRAL VECTORS; LUNG INJURY; PATHOGENESIS; NEUTROPHILS; INTERFERON; MACROPHAGES; INFECTIONS; INDUCTION	Recombinant influenza viruses are promising viral platforms to be used as antigen delivery vectors. To this aim, one of the most promising approaches consists of generating recombinant viruses harboring partially truncated neuraminidase (NA) segments. To date, all studies have pointed to safety and usefulness of this viral platform. However, some aspects of the inflammatory and immune responses triggered by those recombinant viruses and their safety to immunocompromised hosts remained to be elucidated. In the present study, we generated a recombinant influenza virus harboring a truncated NA segment (vNA-Delta) and evaluated the innate and inflammatory responses and the safety of this recombinant virus in wild type or knock-out (KO) mice with impaired innate (Myd88 -/-) or acquired (RAG -/-) immune responses. Infection using truncated neuraminidase influenza virus was harmless regarding lung and systemic inflammatory response in wild type mice and was highly attenuated in KO mice. We also demonstrated that vNA-Delta infection does not induce unbalanced cytokine production that strongly contributes to lung damage in infected mice. In addition, the recombinant influenza virus was able to trigger both local and systemic virus-specific humoral and CD8+ T cellular immune responses which protected immunized mice against the challenge with a lethal dose of homologous A/PR8/34 influenza virus. Taken together, our findings suggest and reinforce the safety of using NA deleted influenza viruses as antigen delivery vectors against human or veterinary pathogens.	[Alves Barbosa, Rafael Polidoro; Carneiro Salgado, Ana Paula; Galvao Filho, Bruno; de Faria Goncalves, Ana Paula; Zirke, Carla Aparecida; Cotrim, Tatiane Marques; Costa, Erica Azevedo; Gazzinelli, Ricardo Tostes; Vieira Machado, Alexandre de Magalhaes] Fiocruz MS, Lab Imunopatol, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Alves Barbosa, Rafael Polidoro; Ataide, Marco Antonio; Gazzinelli, Ricardo Tostes] Univ Fed Minas Gerais, Lab Imunoparasitol, Dept Bioquim & Imunol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Garcia, Cristiana Couto; Freire Lima, Braulio Henrique; Oliveira Lopes, Gabriel Augusto; Cardoso Peixoto, Andiara Cristina; Russo, Remo Castro] Univ Fed Minas Gerais, Lab Imunofarmacol, Dept Bioquim & Imunol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Garcia, Cristiana Couto; Freire Lima, Braulio Henrique; Oliveira Lopes, Gabriel Augusto; Cardoso Peixoto, Andiara Cristina; Russo, Remo Castro] Univ Fed Minas Gerais, Lab Imunol & Mecan Pulm, Dept Fisiol & Biofis, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Rachid, Milene Alvarenga] Univ Fed Minas Gerais, Dept Patol Geral, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [de Oliveira, Danilo Bretas; de Freitas Almeida, Gabriel Magno] Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Lab Virus, Belo Horizonte, MG, Brazil; [Gazzinelli, Ricardo Tostes] Univ Massachusetts, Dept Med, Sch Med, Div Infect Dis & Immunol, Worcester, MA USA	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; University of Massachusetts System; University of Massachusetts Worcester	Machado, ADV (corresponding author), Fiocruz MS, Lab Imunopatol, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.	amarok@cpqrr.fiocruz.br	Garcia, Cristiana Couto/AAE-4290-2022; Garcia, Cristiana C/G-9509-2013; Polidoro, Rafael Barbosa/A-6385-2016; Machado, Alexandre M Vieira/G-2468-2012; Russo, Remo Castro/O-8980-2019; Russo, Remo Castro/F-9048-2010; Rachid, Milene Alvarenga/C-3530-2017; Almeida, Gabriel MF/I-8910-2012; Ataide, Marco/Y-4219-2019; oliveira, danilo/AAX-5520-2021	Garcia, Cristiana Couto/0000-0002-4400-9141; Garcia, Cristiana C/0000-0002-4400-9141; Polidoro, Rafael Barbosa/0000-0003-2982-0072; Machado, Alexandre M Vieira/0000-0003-1506-4093; Russo, Remo Castro/0000-0002-1715-3834; Russo, Remo Castro/0000-0002-1715-3834; Rachid, Milene Alvarenga/0000-0002-3142-6552; Almeida, Gabriel MF/0000-0003-2317-5092; oliveira, danilo/0000-0002-3566-2878; Gazzinelli, Ricardo/0000-0003-2427-7699; Ataide, Marco/0000-0003-4014-0326	FIOCRUZ/PDTIS-Vacinas; National Institute for Vaccine Development and Technology (CNPq/FAPEMIG) [015/2008]; CNPq/MAPA/SDA [064/2008]; Universal FAPEMIG	FIOCRUZ/PDTIS-Vacinas; National Institute for Vaccine Development and Technology (CNPq/FAPEMIG); CNPq/MAPA/SDA(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universal FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by grants from FIOCRUZ/PDTIS-Vacinas, and National Institute for Vaccine Development and Technology (CNPq/FAPEMIG No 015/2008), CNPq/MAPA/SDA No 064/2008, and Universal FAPEMIG. CNPq provided fellowships to RPAB, APCS, CCG, BHFL, GAOL, MAR, ACCP, DBO, MAA, CAZ, TMC, EAC, RCR, RTG and AMVM. CAPES provided fellowship to GMFA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike T, 1996, P NATL ACAD SCI USA, V93, P2448, DOI 10.1073/pnas.93.6.2448; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barbosa RPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061795; Askovich PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074863; Beck CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029249; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Crompton T, 2007, NAT REV IMMUNOL, V7, P726, DOI 10.1038/nri2151; de Goede AL, 2009, VACCINE, V27, P5735, DOI 10.1016/j.vaccine.2009.07.032; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; de Oliveira DB, 2011, INT J RHEUMATOL, V2011, DOI 10.1155/2011/275617; de Wit E, 2004, VIRUS RES, V103, P155, DOI 10.1016/j.virusres.2004.02.028; Ehrhardt C, 2010, MICROBES INFECT, V12, P81, DOI 10.1016/j.micinf.2009.09.007; Fujii Y, 2003, P NATL ACAD SCI USA, V100, P2002, DOI 10.1073/pnas.0437772100; Fukuyama S, 2011, CURR OPIN IMMUNOL, V23, P481, DOI 10.1016/j.coi.2011.07.016; Garcia CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064443; Garcia CC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001171; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; Hamada H, 2013, J IMMUNOL, V190, P296, DOI 10.4049/jimmunol.1200571; Hashimoto Y, 2007, J IMMUNOL, V178, P2448, DOI 10.4049/jimmunol.178.4.2448; Horvat JC, 2007, AM J RESP CRIT CARE, V176, P556, DOI 10.1164/rccm.200607-1005OC; Hufford MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046581; Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; Kuiken T, 2012, CURR OPIN VIROL, V2, P276, DOI 10.1016/j.coviro.2012.02.013; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Laidlaw BJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003207; Lau YF, 2010, VIROLOGY, V406, P80, DOI 10.1016/j.virol.2010.07.008; Li JW, 2013, BIOENGINEERED, V4, P9, DOI 10.4161/bioe.21950; Machado AV, 2010, VACCINE, V28, P3247, DOI 10.1016/j.vaccine.2010.02.003; Machado AV, 2006, VIROLOGY, V345, P73, DOI 10.1016/j.virol.2005.09.050; Machado AV, 2003, VIROLOGY, V313, P235, DOI 10.1016/S0042-6822(03)00289-7; Maines TR, 2012, J INFECT DIS, V205, P474, DOI 10.1093/infdis/jir768; Marsh GA, 2007, J VIROL, V81, P9727, DOI 10.1128/JVI.01144-07; Martina BEE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018995; Narasaraju T, 2010, AM J RESP CELL MOL, V42, P732, DOI 10.1165/rcmb.2008-0423OC; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Peiris JSM, 2009, TRENDS IMMUNOL, V30, P574, DOI 10.1016/j.it.2009.09.004; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Robert-Guroff M, 2007, CURR OPIN BIOTECH, V18, P546, DOI 10.1016/j.copbio.2007.10.010; Rocha CD, 2004, INT MICROBIOL, V7, P83; Rollier CS, 2011, CURR OPIN IMMUNOL, V23, P377, DOI 10.1016/j.coi.2011.03.006; Russo RC, 2011, AM J RESP CELL MOL, V45, P72, DOI 10.1165/rcmb.2009-0406OC; Russo RC, 2011, J LEUKOCYTE BIOL, V89, P269, DOI 10.1189/jlb.0610346; Shen Z, 2013, CLIN MICROBIOL INFEC; Shinya K, 2004, J VIROL, V78, P3083, DOI 10.1128/JVI.78.6.3083-3088.2004; Small JC, 2011, CURR OPIN VIROL, V1, P241, DOI 10.1016/j.coviro.2011.07.009; Sugamata R, 2012, MICROBIOL IMMUNOL, V56, P171, DOI 10.1111/j.1348-0421.2011.00424.x; Suliman HB, 2001, AM J PHYSIOL-LUNG C, V280, pL69, DOI 10.1152/ajplung.2001.280.1.L69; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Walsh KB, 2011, P NATL ACAD SCI USA, V108, P12018, DOI 10.1073/pnas.1107024108; Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111	53	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98685	10.1371/journal.pone.0098685	http://dx.doi.org/10.1371/journal.pone.0098685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927156	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100020
J	Badejo, AC; Chung, WH; Kim, NS; Chai, JC; Lee, YS; Jung, KH; Kim, HJ; Chai, YG				Badejo, Abimbola Comfort; Chung, Won Hyong; Kim, Nam Shin; Chai, Jin Choul; Lee, Young Seek; Jung, Kyoung Hwa; Kim, Hyo Joon; Chai, Young Gyu			Energy Metabolism in Mycobacterium gilvum PYR-GCK: Insights from Transcript Expression Analyses Following Two States of Induction	PLOS ONE			English	Article							RNA-SEQ; DEGRADATION; BIODEGRADATION; RESPIRATION; STARVATION; PATHWAYS; REVEALS; CARBON; GENE	Mycobacterium gilvum PYR-GCK, a pyrene degrading bacterium, has been the subject of functional studies aimed at elucidating mechanisms related to its outstanding pollutant bioremediation/biodegradation activities. Several studies have investigated energy production and conservation in Mycobacterium, however, they all focused on the pathogenic strains using their various hosts as induction sources. To gain greater insight into Mycobacterium energy metabolism, mRNA expression studies focused on respiratory functions were performed under two different conditions using the toxic pollutant pyrene as a test substrate and glucose as a control substrate. This was done using two transcriptomic techniques: global transcriptomic RNA-sequencing and quantitative Real-Time PCR. Growth in the presence of pyrene resulted in upregulated expression of genes associated with limited oxygen or anaerobiosis in M. gilvum PYR-GCK. Upregulated genes included succinate dehydrogenases, nitrite reductase and various electron donors including formate dehydrogenases, fumarate reductases and NADH dehydrogenases. Oxidative phosphorylation genes (with respiratory chain complexes I, III - V) were expressed at low levels compared to the genes coding for the second molecular complex in the bacterial respiratory chain (fumarate reductase); which is highly functional during microaerophilic or anaerobic bacterial growth. This study reveals a molecular adaptation to a hypoxic mode of respiration during aerobic pyrene degradation. This is likely the result of a cellular oxygen shortage resulting from exhaustion of the oxygenase enzymes required for these degradation activities in M. gilvum PYR-GCK.	[Badejo, Abimbola Comfort; Chai, Jin Choul; Lee, Young Seek; Jung, Kyoung Hwa; Kim, Hyo Joon; Chai, Young Gyu] Hanyang Univ, Dept Mol & Life Sci, Ansan, South Korea; [Chung, Won Hyong] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon, South Korea; [Kim, Nam Shin; Chai, Young Gyu] Hanyang Univ, Dept Nanobiotechnol, Seoul 133791, South Korea	Hanyang University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Hanyang University	Kim, HJ (corresponding author), Hanyang Univ, Dept Mol & Life Sci, Ansan, South Korea.	kimhj104@hanyang.ac.kr; ygchai@hanyang.ac.kr	Kim, Namshin/Q-6491-2017	Kim, Namshin/0000-0001-6361-274X	Hanyang University [HY-2013-P]	Hanyang University	The research was funded by Hanyang University under the contract number HY-2013-P; www.hanyang.ac.kr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badejo AC, 2013, BIODEGRADATION, V24, P741, DOI 10.1007/s10532-013-9622-9; Badejo AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058066; Berney M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008614; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; DeanRoss D, 1996, APPL MICROBIOL BIOT, V46, P307, DOI 10.1007/s002530050822; Diaz MP, 2000, MAR BIOTECHNOL, V2, P522, DOI 10.1007/s101260000037; ELMANSI EMT, 1989, J GEN MICROBIOL, V135, P2875; FERRY JG, 1976, ARCH MICROBIOL, V107, P33, DOI 10.1007/BF00427864; Frezza C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024411; FRITZSCHE C, 1994, APPL ENVIRON MICROB, V60, P1687, DOI 10.1128/AEM.60.5.1687-1689.1994; Fuchs G, 2011, NAT REV MICROBIOL, V9, P803, DOI 10.1038/nrmicro2652; JARLIER V, 1994, FEMS MICROBIOL LETT, V123, P11, DOI 10.1111/j.1574-6968.1994.tb07194.x; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Jormakka M, 2003, CURR OPIN STRUC BIOL, V13, P418, DOI 10.1016/S0959-440X(03)00098-8; Kim SJ, 2007, J BACTERIOL, V189, P464, DOI 10.1128/JB.01310-06; Kim YH, 2006, PROTEOMICS, V6, P1301, DOI 10.1002/pmic.200500329; KROGER A, 1992, ARCH MICROBIOL, V158, P311, DOI 10.1007/BF00245358; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Metcalf L., 1991, WASTEWATER ENG TREAT; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Noor E, 2010, MOL CELL, V39, P809, DOI 10.1016/j.molcel.2010.08.031; Omura S, 2001, P NATL ACAD SCI USA, V98, P60, DOI 10.1073/pnas.011524698; Ortega-Calvo JJ, 2010, APPL ENVIRON MICROB, V76, P4430, DOI 10.1128/AEM.00461-10; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; Rozen S, 2000, Methods Mol Biol, V132, P365; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Tang YJ, 2009, BIOTECHNOL LETT, V31, P1233, DOI 10.1007/s10529-009-9991-7; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Widdel F, 2001, CURR OPIN BIOTECH, V12, P259, DOI 10.1016/S0958-1669(00)00209-3	31	2	2	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99464	10.1371/journal.pone.0099464	http://dx.doi.org/10.1371/journal.pone.0099464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927157	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100044
J	Gu, YL; Shen, XH; Zhou, DJ; Wang, ZD; Zhang, N; Shan, ZY; Jin, LH; Lei, L				Gu, Yanli; Shen, Xinghui; Zhou, Dongjie; Wang, Zhendong; Zhang, Na; Shan, Zhiyan; Jin, Lianhong; Lei, Lei			Selection and Expression Profiles of Reference Genes in Mouse Preimplantation Embryos of Different Ploidies at Various Developmental Stages	PLOS ONE			English	Article							REAL-TIME PCR; TETRAPLOID EMBRYOS; HOUSEKEEPING GENES; NORMALIZATION; OPTIMIZATION; MODEL; VITRO	Real-time reverse transcription quantitative polymerase chain reaction (qPCR) has become the most frequently used system for studies of gene expression. Manystudies have provided reliable evidence that the transcription levels of reference genes are not constant at different developmental stages and in different experimental conditions. However, suitable reference genes which are stably expressed in polyploid preimplantation embryos of different developmental stages have not yet been identified. Therefore, it is critical to verify candidate reference genes to analyze gene expression accurately in both diploid and polyploid embryos. We examined the expression levels of 12 candidate reference genes in preimplantation embryos of four different ploidies at six developmental stages. Stability analysis of the reference genes was performed by four independent software programs, and the stability of three genes was evaluated by comparison with the Oct4 expression level during preimplantation development in diploid embryos. The expression levels of most genes in the polyploid embryos were higher than that in the diploid embryos, but the increasing degree were disproportionate with the ploidies. There were no significant difference in reference gene expressions among embryos of different ploidies when they reached the morula stage, and the expression level remained flat until the blastocyst stage. Ubc, Ppia, and Pgk1 were the three most stable reference genes in diploid and polyploid embryos.	[Gu, Yanli; Shen, Xinghui; Zhou, Dongjie; Wang, Zhendong; Zhang, Na; Shan, Zhiyan; Jin, Lianhong; Lei, Lei] Harbin Med Univ, Dept Histol & Embryol, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University	Jin, LH (corresponding author), Harbin Med Univ, Dept Histol & Embryol, Harbin, Heilongjiang Pr, Peoples R China.	wstjlh@126.com; leiys2002@yahoo.com	Shen, Xinghui/ABF-9560-2021		China National Science Fund [31271590]; China Postdoctoral Science Foundation Special Funded Project [201104421]	China National Science Fund; China Postdoctoral Science Foundation Special Funded Project	The work was supported by China National Science Fund (31271590) and China Postdoctoral Science Foundation Special Funded Project (201104421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BilodeauGoeseels S, 1997, MOL REPROD DEV, V47, P413, DOI 10.1002/(SICI)1098-2795(199708)47:4&lt;413::AID-MRD7&gt;3.0.CO;2-N; Chang Z, 2010, ANAL BIOCHEM, V406, P214, DOI 10.1016/j.ab.2010.07.021; EGLITIS MA, 1981, J EMBRYOL EXP MORPH, V66, P91; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jeong YJ, 2005, MOL REPROD DEV, V71, P284, DOI 10.1002/mrd.20269; Kawaguchi J, 2009, J REPROD DEVELOP, V55, P670, DOI 10.1262/jrd.09-127A; Lei L, 2009, ZYGOTE, V17, P125, DOI 10.1017/S0967199409005206; Llobat L, 2012, REPROD DOMEST ANIM, V47, P629, DOI 10.1111/j.1439-0531.2011.01934.x; Lossos IS, 2003, LEUKEMIA, V17, P789, DOI 10.1038/sj.leu.2402880; Luchsinger C, 2013, ZYGOTE, V26, P1; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; Marum L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035113; Miura C, 2012, GENE, V510, P107, DOI 10.1016/j.gene.2012.09.001; Paris DBBP, 2011, REPROD FERT DEVELOP, V23, P353, DOI 10.1071/RD10039; Park MR, 2012, J REPROD DEVELOP, V58, P344, DOI 10.1262/jrd.11-110M; Park MR, 2011, DEV DYNAM, V240, P1660, DOI 10.1002/dvdy.22653; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Robert C, 2002, BIOL REPROD, V67, P1465, DOI 10.1095/biolreprod.102.006320; Saigusa S, 2013, J CANCER RES CLIN, V139, P131, DOI 10.1007/s00432-012-1308-x; Shen B, 2011, EXP THER MED, V2, P1151, DOI 10.3892/etm.2011.331; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tachaudomdach C, 2012, EXP THER MED, V3, P713, DOI 10.3892/etm.2012.473; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wen DH, 2003, ACAD J GUANGZHOU MED, V31, P65; Yuasa K, 2012, FEBS LETT, V586, P3464, DOI 10.1016/j.febslet.2012.07.074; Zhang QJ, 2003, BIRTH DEFECTS RES A, V67, P533, DOI 10.1002/bdra.10075	31	7	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98956	10.1371/journal.pone.0098956	http://dx.doi.org/10.1371/journal.pone.0098956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927500	Green Submitted, Green Published, gold			2022-12-25	WOS:000338278100023
J	Jang, JY; Kim, SJ; Cho, EK; Jeong, SW; Park, EJ; Lee, WC; Lee, SH; Kim, SG; Kim, YS; Kim, HS; Kim, BS; Lin, WY; Chung, RT				Jang, Jae Young; Kim, Seong-Jun; Cho, Eun Kyung; Jeong, Soung Won; Park, Eui Ju; Lee, Woong Cheul; Lee, Sae Hwan; Kim, Sang Gyune; Kim, Young Seok; Kim, Hong Soo; Kim, Boo Sung; Lin, Wenyu; Chung, Raymond T.			TRAIL Enhances Apoptosis of Human Hepatocellular Carcinoma Cells Sensitized by Hepatitis C Virus Infection: Therapeutic Implications	PLOS ONE			English	Article							VIRAL-HEPATITIS; DEATH RECEPTORS; LIVER-INJURY; POLY(ADP-RIBOSE) POLYMERASE; HUMAN HEPATOCYTES; LIGAND; ACTIVATION; CLEAVAGE; MITOCHONDRIA; MODULATION	Hepatitis C virus (HCV) infection causes chronic liver diseases leading to hepatocellular carcinoma (HCC) and liver failure. We have previously shown that HCV sensitizes hepatocytes to mitochondrial apoptosis via the TRAIL death receptors DR4 and DR5. Although TRAIL and its receptors are selective targets for cancer therapy, their potential against HCC with chronic HCV infection has not been explored yet. Here we show that HCV induces DR4/DR5-dependent activation of caspase-8 leading to elevation of apoptotic signaling in infected cells and also present TRAIL effect in HCV-induced apoptotic signaling. HCV induced proteolytic cleavage of caspase-9 by stimulating DR4 and DR5, resulting in subsequent cleavage of caspase-3. Further, HCV-induced proteolytic cleavage in caspase-8, caspase-9, and caspase-3 was enhanced in the presence of recombinant TRAIL. HCV-induced cleavage in caspase-9 and increase in caspase-3/7 activity was completely suppressed by silencing of either DR4 or DR5. Perturbing DR4/DR5-caspase-8 signaling complex by silencing DR4 and DR5 or by chemical inhibitor specific to caspase-8 led to decrease of HCV-induced cleavage of poly(ADP-ribose) polymerase (PARP), a substrate for caspase-3 during apoptosis, indicating the functional role of caspase-8 in HCV-induced apoptotic signaling network. Furthermore, TRAIL enhanced PARP cleavage in apoptotic response induced by HCV infection, indicating the effect of TRAIL for the induction of selective apoptosis of HCC cells infected with HCV. Given the importance of apoptosis in HCC development, our data suggest that HCV-induced DR4 and DR5 may be considered as an attractive target for TRAIL therapy against HCC with chronic HCV infection.	[Jang, Jae Young; Cho, Eun Kyung; Jeong, Soung Won; Park, Eui Ju; Lee, Woong Cheul; Kim, Boo Sung] Soonchunhyang Univ, Inst Digest Res, Ctr Digest Dis, Dept Internal Med,Coll Med, Seoul, South Korea; [Lee, Sae Hwan; Kim, Hong Soo] Soonchunhyang Univ, Dept Internal Med, Coll Med, Cheonan, South Korea; [Kim, Sang Gyune; Kim, Young Seok] Soonchunhyang Univ, Dept Internal Med, Coll Med, Puchon, South Korea; [Kim, Seong-Jun] Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA; [Lin, Wenyu; Chung, Raymond T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit,Dept Med, Boston, MA 02138 USA	Soonchunhyang University; Soonchunhyang University; Soonchunhyang University; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Massachusetts General Hospital	Chung, RT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit,Dept Med, Boston, MA 02138 USA.	rtchung@partners.org	Kim, Sang gyune/AAI-5704-2020	Kim, Sang gyune/0000-0001-8694-777X	National Research Foundation of Korea (NRF) Grant - Korean Government (MOE) [NRF-2011-0010229]; NIH [AI069939]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098079] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) Grant - Korean Government (MOE); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MOE) (No. Grant Number: NRF-2011-0010229) and NIH AI069939 (R.T.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bantel H, 2003, CELL DEATH DIFFER, V10, pS48, DOI 10.1038/sj.cdd.4401119; Bantel H, 2001, HEPATOLOGY, V34, P758, DOI 10.1053/jhep.2001.28229; Calabrese F, 2000, HEPATOLOGY, V31, P1153, DOI 10.1053/he.2000.7123; Canbay A, 2004, HEPATOLOGY, V39, P273, DOI 10.1002/hep.20051; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Deng ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037700; GONZALEZAMARO R, 1994, J EXP MED, V179, P841, DOI 10.1084/jem.179.3.841; Gores GJ, 2001, HEPATOLOGY, V34, P3, DOI 10.1053/jhep.2001.25173; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Harnois DM, 2012, MAYO CLIN PROC, V87, P7, DOI 10.1016/j.mayocp.2011.11.004; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Iio S, 1998, J HEPATOL, V29, P517, DOI 10.1016/S0168-8278(98)80145-1; Jang JY, 2011, J HEPATOL, V54, P612, DOI 10.1016/j.jhep.2010.07.042; Jang Jae Young, 2010, Korean J Hepatol, V16, P263, DOI 10.3350/kjhep.2010.16.3.263; Kanzler S, 2000, SEMIN CANCER BIOL, V10, P173, DOI 10.1006/scbi.2000.0318; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Lan L, 2008, J IMMUNOL, V181, P4926, DOI 10.4049/jimmunol.181.7.4926; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lawrence D, 2001, NAT MED, V7, P383, DOI 10.1038/86397; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Masuoka HC, 2009, CLIN LIVER DIS, V13, P467, DOI 10.1016/j.cld.2009.05.010; Mundt B, 2005, GUT, V54, P1590, DOI 10.1136/gut.2004.056929; Mundt B, 2002, FASEB J, V16, P94, DOI 10.1096/fj.02-0537fje; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pianko S, 2001, J VIRAL HEPATITIS, V8, P406, DOI 10.1046/j.1365-2893.2001.00316.x; Rust C, 2000, AM J MED, V108, P567, DOI 10.1016/S0002-9343(00)00370-3; Saitou Y, 2005, HUM PATHOL, V36, P1066, DOI 10.1016/j.humpath.2005.07.019; Schuchmann M, 2001, EUR J GASTROEN HEPAT, V13, P785, DOI 10.1097/00042737-200107000-00005; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Sedger LM, 1999, J IMMUNOL, V163, P920; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Song JJ, 2008, CELL SIGNAL, V20, P892, DOI 10.1016/j.cellsig.2008.01.001; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Thornberry NA, 1998, CHEM BIOL, V5, pR97, DOI 10.1016/S1074-5521(98)90615-9; Volkmann X, 2007, HEPATOLOGY, V46, P1498, DOI 10.1002/hep.21846; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Zhu HZ, 2007, GASTROENTEROLOGY, V133, P1649, DOI 10.1053/j.gastro.2007.09.017	45	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98171	10.1371/journal.pone.0098171	http://dx.doi.org/10.1371/journal.pone.0098171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927176	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100013
J	Kumar, N; Palmer, GR; Shah, V; Walker, VK				Kumar, Niraj; Palmer, Gerald R.; Shah, Vishal; Walker, Virginia K.			The Effect of Silver Nanoparticles on Seasonal Change in Arctic Tundra Bacterial and Fungal Assemblages	PLOS ONE			English	Article							SOIL BACTERIAL; MICROBIAL COMMUNITY; ANTIFUNGAL ACTIVITY; ETHIDIUM MONOAZIDE; ESCHERICHIA-COLI; EXPOSURE; IMPACT; GROWTH; ACCUMULATION; POPULATIONS	The impact of silver nanoparticles (NPs) and microparticles (MPs) on bacterial and fungal assemblages was studied in soils collected from a low arctic site. Two different concentrations (0.066% and 6.6%) of Ag NPs and Ag MPs were tested in microcosms that were exposed to temperatures mimicking a winter to summer transition. Toxicity was monitored by differential respiration, phospholipid fatty acid analysis, polymerase chain reaction-denaturing gradient gel electrophoresis and DNA sequencing. Notwithstanding the effect of Ag MPs, nanosilver had an obvious, additional impact on the microbial community, underscoring the importance of particle size in toxicity. This impact was evidenced by levels of differential respiration in 0.066% Ag NP-treated soil that were only half that of control soils, a decrease in signature bacterial fatty acids, and changes in both richness and evenness in bacterial and fungal DNA sequence assemblages. Prominent after Ag NP-treatment were Hypocreales fungi, which increased to 70%, from only 1% of fungal sequences under control conditions. Genera within this Order known for their antioxidant properties (Cordyceps/Isaria) dominated the fungal assemblage after NP addition. In contrast, sequences attributed to the nitrogen-fixing Rhizobiales bacteria appeared vulnerable to Ag NP-mediated toxicity. This combination of physiological, biochemical and molecular studies clearly demonstrate that Ag NPs can severely disrupt the natural seasonal progression of tundra assemblages.	[Kumar, Niraj; Palmer, Gerald R.; Walker, Virginia K.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Shah, Vishal] Dowling Coll, Dept Biol, Oakdale, NY USA; [Walker, Virginia K.] Queens Univ, Sch Environm Studies, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada	Walker, VK (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	walkervk@queensu.ca			NSERC (Canada); Queen's University Chair; National Science Foundation [0966741]	NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Queen's University Chair; National Science Foundation(National Science Foundation (NSF))	This work was supported by NSERC (Canada) and a Queen's University Chair to VW. VS was supported by a National Science Foundation grant, #0966741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Mi Young, 2008, International Journal of Industrial Entomology, V17, P197; Bailey MT, 2010, INFECT IMMUN, V78, P1509, DOI 10.1128/IAI.00862-09; Bansal V, 2011, AUST J CHEM, V64, P279, DOI 10.1071/CH10343; Bartelt-Ryser J, 2005, PERSPECT PLANT ECOL, V7, P27, DOI 10.1016/j.ppees.2004.11.002; Blaser SA, 2008, SCI TOTAL ENVIRON, V390, P396, DOI 10.1016/j.scitotenv.2007.10.010; Burleson DJ, 2004, J ENVIRON SCI HEAL A, V39, P2707, DOI [10.1081/LESA-200027029, 10.1081/ESE-200027029]; Chu HY, 2011, SOIL SCI SOC AM J, V75, P1756, DOI 10.2136/sssaj2011.0057; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dasari TP, 2010, SCI TOTAL ENVIRON, V408, P5817, DOI 10.1016/j.scitotenv.2010.08.030; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dowd SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-93; Eckhardt S, 2007, ATMOS CHEM PHYS, V7, P4527, DOI 10.5194/acp-7-4527-2007; Eckhardt S, 2013, CHEM REV, V113, P4708, DOI 10.1021/cr300288v; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Gottschalk F, 2009, ENVIRON SCI TECHNOL, V43, P9216, DOI 10.1021/es9015553; Han DW, 2005, WORLD J MICROB BIOT, V21, P921, DOI 10.1007/s11274-004-6721-0; Han X, 2014, SCI TOTAL ENVIRON, V487, P822, DOI 10.1016/j.scitotenv.2013.12.129; Hornung C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055045; Hume ME, 2012, FOODBORNE PATHOG DIS, V9, P853, DOI 10.1089/fpd.2011.1093; Hung H, 2010, SCI TOTAL ENVIRON, V408, P2854, DOI 10.1016/j.scitotenv.2009.10.044; Hyung H, 2007, ENVIRON SCI TECHNOL, V41, P179, DOI 10.1021/es061817g; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Jiang YH, 2005, J FOOD BIOCHEM, V29, P323, DOI 10.1111/j.1745-4514.2005.00040.x; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Klaus T, 1999, P NATL ACAD SCI USA, V96, P13611, DOI 10.1073/pnas.96.24.13611; Koukol O, 2011, FUNGAL DIVERS, V49, P75, DOI 10.1007/s13225-011-0092-2; Kumar Niraj, 2013, Biology (Basel), V2, P356, DOI 10.3390/biology2010356; Kumar N, 2012, ENVIRON TOXICOL CHEM, V31, P131, DOI 10.1002/etc.721; Kumar N, 2011, J HAZARD MATER, V190, P816, DOI 10.1016/j.jhazmat.2011.04.005; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lipson DA, 2004, APPL ENVIRON MICROB, V70, P2867, DOI 10.1128/AEM.70.5.2867-2879.2004; MacCormack TJ, 2008, J IND ECOL, V12, P286, DOI 10.1111/j.1530-9290.2008.00041.x; Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y; McMahon SK, 2011, SOIL BIOL BIOCHEM, V43, P287, DOI 10.1016/j.soilbio.2010.10.013; McMahon SK, 2009, ENV MICROBIOL REP, V1, P162, DOI 10.1111/j.1758-2229.2009.00025.x; Mishra VK, 2009, DIG J NANOMATER BIOS, V4, P587; Moller A, 2011, ENVIRON POLLUT, V159, P1577, DOI 10.1016/j.envpol.2011.02.054; Monteiro DR, 2012, LETT APPL MICROBIOL, V54, P383, DOI 10.1111/j.1472-765X.2012.03219.x; Mueller NC, 2008, ENVIRON SCI TECHNOL, V42, P4447, DOI 10.1021/es7029637; Nasrollahi A, 2011, INT J NANO DIMENS, V1, P233, DOI 10.7508/ijnd.2010.03.007; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Nevin KP, 2000, APPL ENVIRON MICROB, V66, P2248, DOI 10.1128/AEM.66.5.2248-2251.2000; Nobrega S, 2007, ECOSYSTEMS, V10, P419, DOI 10.1007/s10021-007-9033-z; Nogva HK, 2003, BIOTECHNIQUES, V34, P804, DOI 10.2144/03344rr02; Ovreas L, 1997, APPL ENVIRON MICROB, V63, P3367; Panacek A, 2009, BIOMATERIALS, V30, P6333, DOI 10.1016/j.biomaterials.2009.07.065; Ramanathan R, 2011, LANGMUIR, V27, P714, DOI 10.1021/la1036162; Rudi K, 2005, APPL ENVIRON MICROB, V71, P1018, DOI 10.1128/AEM.71.2.1018-1024.2005; Sasser M, 1990, 101 MIDI; Schadt CW, 2003, SCIENCE, V301, P1359, DOI 10.1126/science.1086940; Shah V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026263; Shah V, 2010, J HAZARD MATER, V178, P1141, DOI 10.1016/j.jhazmat.2010.01.141; Shah V, 2009, WATER AIR SOIL POLL, V197, P143, DOI 10.1007/s11270-008-9797-6; SHAVER GR, 1980, ECOLOGY, V61, P662, DOI 10.2307/1937432; Shi W, 2002, APPL ENVIRON MICROB, V68, P3859, DOI 10.1128/AEM.68.8.3859-3866.2002; Sigler WV, 2002, APPL SOIL ECOL, V21, P107, DOI 10.1016/S0929-1393(02)00088-4; Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0; Sinha R, 2011, BIORESOURCE TECHNOL, V102, P1516, DOI 10.1016/j.biortech.2010.07.117; SLAWSON RM, 1992, ARCH MICROBIOL, V158, P398; Soenen SJ, 2011, NANO TODAY, V6, P446, DOI 10.1016/j.nantod.2011.08.001; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; SUUTARI M, 1994, CRIT REV MICROBIOL, V20, P285, DOI 10.3109/10408419409113560; Throback IN, 2007, FEMS MICROBIOL LETT, V270, P189, DOI 10.1111/j.1574-6968.2007.00632.x; Vainio EJ, 2000, MYCOL RES, V104, P927, DOI 10.1017/S0953756200002471; WONG JWC, 1995, ENVIRON TECHNOL, V16, P527, DOI 10.1080/09593331608616294; Yamaguchi Y, 2000, PHYTOTHER RES, V14, P647, DOI 10.1002/1099-1573(200012)14:8&lt;647::AID-PTR670&gt;3.0.CO;2-W; Zhao GJ, 1998, BIOMETALS, V11, P27, DOI 10.1023/A:1009253223055	67	32	36	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99953	10.1371/journal.pone.0099953	http://dx.doi.org/10.1371/journal.pone.0099953			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926877	gold, Green Published, Green Submitted			2022-12-25	WOS:000338278100098
J	Lei, T; Wang, H; Liu, J; Nan, HZ; Liu, Q				Lei, Tao; Wang, Hui; Liu, Jing; Nan, Huizhu; Liu, Qun			ROP18 Is a Key Factor Responsible for Virulence Difference between Toxoplasma gondii and Neospora caninum	PLOS ONE			English	Article							HOST-CELL INVASION; IMMUNE MAPPED PROTEIN-1; PARASITOPHOROUS VACUOLE; RHOPTRY PROTEIN; APICOMPLEXAN; IDENTIFICATION; MACROPHAGES; EXPRESSION; RESISTANCE; PARASITES	Toxoplasma gondii (T. gondii) and Neospora caninum (N. caninum) are both obligate intracellular protozoan parasites and share many common morphological and biological features. Despite these similarities the two parasites differ dramatically in virulence in mice, but the factors involved in virulence differences between the two parasites remain unknown. A secreted serine-threonine kinase called rhoptry protein 18 (ROP18) was identified to play a crucial role on virulence differences among different T. gondii clonal lineages. Intriguingly, we found that ROP18 in Nc1 strain of N. caninum (NcROP18) is a pseudogene due to several interrupting stop codons in the sequence in our previous studies. We assume that the difference of ROP18 leads to virulence difference between T. gondii and N. caninum. We constructed a transgenic N. caninum Nc1 stain by transfecting the TgROP18 from the T. gondii RH strain. Phenotype and virulence assays showed that the expression of TgROP18 in N. caninum did not affect the motility and cell invasion, but resulted in a significant increase in intracellular parasite proliferation and virulence in mice. Immunity-Related GTPase (IRG) phosphorylation assay showed that the transgenic parasite Nc1-TgROP18 was able to phosphorylate IRGs as T. gondii did. The present study indicated that the ROP18 plays a crucial role in virulence of the closely related parasites T. gondii and N. caninum and it is indeed a key factor responsible for the virulence difference between T. gondii and N. caninum.	[Liu, Qun] China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Beijing 100094, Peoples R China; China Agr Univ, Natl Anim Protozoa Lab, Coll Vet Med, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Liu, Q (corresponding author), China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Beijing 100094, Peoples R China.	qunliu@cau.edu.cn			Natural Science Foundation of Beijing [6131001]; Natural Science Foundation of China [31302075]; National Special Research Programs for Non-Profit Trades (Agriculture) [200903036]; Modern Agro-industry Technology Research System	Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Special Research Programs for Non-Profit Trades (Agriculture); Modern Agro-industry Technology Research System	This study was supported by Natural Science Foundation of Beijing (6131001), the Natural Science Foundation of China (31302075), the National Special Research Programs for Non-Profit Trades (Agriculture) (200903036) and the earmarked fund for Modern Agro-industry Technology Research System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckers CJM, 1997, MOL BIOCHEM PARASIT, V89, P209, DOI 10.1016/S0166-6851(97)00120-5; Behnke MS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002992; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Cui X, 2012, PARASITOLOGY, V139, P998, DOI 10.1017/S0031182012000285; Cui X, 2012, VACCINE, V30, P2282, DOI 10.1016/j.vaccine.2012.01.073; Daher W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001132; Dubey JP, 2002, INT J PARASITOL, V32, P929, DOI 10.1016/S0020-7519(02)00094-2; DUBEY JP, 1988, J AM VET MED ASSOC, V192, P1269; El Hajj H, 2007, PLOS PATHOG, V3, P200, DOI 10.1371/journal.ppat.0030014; Fentress SJ, 2011, BIOESSAYS, V33, P693, DOI 10.1002/bies.201100054; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; Howe DK, 1999, INT J PARASITOL, V29, P1489, DOI 10.1016/S0020-7519(99)00099-5; Howe DK, 1996, INFECT IMMUN, V64, P5193, DOI 10.1128/IAI.64.12.5193-5198.1996; Howe DK, 1997, MOL BIOCHEM PARASIT, V86, P29, DOI 10.1016/S0166-6851(96)02838-1; Kaufmann H, 1996, MOL CELL PROBE, V10, P289, DOI 10.1006/mcpr.1996.0038; Khaminets A, 2010, CELL MICROBIOL, V12, P939, DOI 10.1111/j.1462-5822.2010.01443.x; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Nishikawa Y, 2003, INT J PARASITOL, V33, P1525, DOI 10.1016/S0020-7519(03)00204-2; Ong YC, 2010, J BIOL CHEM, V285, P28731, DOI 10.1074/jbc.M110.112359; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Reese ML, 2011, P NATL ACAD SCI USA, V108, P9625, DOI 10.1073/pnas.1015980108; Reid AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002567; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Saeij JPJ, 2005, TRENDS PARASITOL, V21, P476, DOI 10.1016/j.pt.2005.08.001; Santos JM, 2011, SCIENCE, V331, P473, DOI 10.1126/science.1199284; Sheiner L, 2010, MOL MICROBIOL, V77, P912, DOI 10.1111/j.1365-2958.2010.07255.x; Shenoy AR, 2007, IMMUNOBIOLOGY, V212, P771, DOI 10.1016/j.imbio.2007.09.018; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; SIBLEY LD, 1994, P NATL ACAD SCI USA, V91, P5508, DOI 10.1073/pnas.91.12.5508; Steinfeldt T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000576; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Taylor GA, 2007, MICROBES INFECT, V9, P1644, DOI 10.1016/j.micinf.2007.09.004; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053483; Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703; Zhang GH, 2010, VACCINE, V28, P7243, DOI 10.1016/j.vaccine.2010.08.096; Zhang HS, 2007, MOL BIOCHEM PARASIT, V151, P205, DOI 10.1016/j.molbiopara.2006.11.005; Zhao Y, 2009, J IMMUNOL, V182, P3775, DOI 10.4049/jimmunol.0804190	45	26	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99744	10.1371/journal.pone.0099744	http://dx.doi.org/10.1371/journal.pone.0099744			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927100	Green Submitted, Green Published, gold			2022-12-25	WOS:000338278100075
J	Menafra, R; Brinkman, AB; Matarese, F; Franci, G; Bartels, SJJ; Nguyen, L; Shimbo, T; Wade, PA; Hubner, NC; Stunnenberg, HG				Menafra, Roberta; Brinkman, Arie B.; Matarese, Filomena; Franci, Gianluigi; Bartels, Stefanie J. J.; Luan Nguyen; Shimbo, Takashi; Wade, Paul A.; Hubner, Nina C.; Stunnenberg, Hendrik G.			Genome-Wide Binding of MBD2 Reveals Strong Preference for Highly Methylated Loci	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; HUMAN X-CHROMOSOME; DNA METHYLATION; BREAST-CANCER; CPG ISLANDS; XIST GENE; CHROMATIN; TRANSCRIPTION; CELLS; IDENTIFICATION	MBD2 is a subunit of the NuRD complex that is postulated to mediate gene repression via recruitment of the complex to methylated DNA. In this study we adopted an MBD2 tagging-approach to study its genome wide binding characteristics. We show that in vivo MBD2 is mainly recruited to CpG island promoters that are highly methylated. Interestingly, MBD2 binds around 1 kb downstream of the transcription start site of a subset of similar to 400 CpG island promoters that are characterized by the presence of active histone marks, RNA polymerase II (Pol2) and low to medium gene expression levels and H3K36me3 deposition. These tagged-MBD2 binding sites in MCF-7 show increased methylation in a cohort of primary breast cancers but not in normal breast samples, suggesting a putative role for MBD2 in breast cancer.	[Menafra, Roberta; Brinkman, Arie B.; Matarese, Filomena; Franci, Gianluigi; Bartels, Stefanie J. J.; Luan Nguyen; Hubner, Nina C.; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Shimbo, Takashi; Wade, Paul A.] NIEHS, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA	Radboud University Nijmegen; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Stunnenberg, HG (corresponding author), Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands.	H.Stunnenberg@ncmls.ru.nl	Franci, Gianluigi/AAC-6841-2022; Hubner, Nina C/C-4298-2008; Stunnenberg, Hendrik G./D-6875-2012; Wade, Paul A/D-2374-2019; Nguyen, Luan/GYA-2927-2022; Brinkman, Arie/V-1533-2018	Hubner, Nina C/0000-0002-7864-2877; Stunnenberg, Hendrik G./0000-0002-0066-1576; Wade, Paul A/0000-0002-6042-357X; Brinkman, Arie/0000-0002-9875-1835; Franci, Gianluigi/0000-0003-3321-4331	Dutch Cancer Foundation (KWF) grant KUN [20135833]; ATLAS; EC-FP7 project BLUEPRINT [282510]; SYSCOL (EU FP7); Intramural Research Program of the National Institute of Environmental Health Sciences, NIH [ZO1ES101965]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101965, ZIAES101965] Funding Source: NIH RePORTER	Dutch Cancer Foundation (KWF) grant KUN; ATLAS; EC-FP7 project BLUEPRINT; SYSCOL (EU FP7); Intramural Research Program of the National Institute of Environmental Health Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Dutch Cancer Foundation (KWF) grant KUN 20135833, by ATLAS, by the EC-FP7 project BLUEPRINT (n degrees 282510) and by SYSCOL (EU FP7). This work was also supported, in part, by the Intramural Research Program of the National Institute of Environmental Health Sciences, NIH (Project number ZO1ES101965 to PAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIEL M, 1995, NAT GENET, V9, P312, DOI 10.1038/ng0395-312; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Barr H, 2007, MOL CELL BIOL, V27, P3750, DOI 10.1128/MCB.02204-06; Baubec T, 2013, CELL, V153, P480, DOI 10.1016/j.cell.2013.03.011; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Brinkman AB, 2006, EMBO REP, V7, P628, DOI 10.1038/sj.embor.7400686; Costessi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042822; Costessi A, 2011, EMBO J, V30, P3786, DOI 10.1038/emboj.2011.262; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Fournier A, 2012, BRIEF FUNCT GENOMICS, V11, P251, DOI 10.1093/bfgp/elr040; Gunther K, 2013, NUCLEIC ACIDS RES, V41, P3010, DOI 10.1093/nar/gkt035; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Hubner NC, 2011, METHODS, V53, P453, DOI 10.1016/j.ymeth.2010.12.016; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Laget S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011982; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Martin V, 2008, PATHOBIOLOGY, V75, P281, DOI 10.1159/000151708; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Ovaska K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003100; Robertson KD, 2000, CARCINOGENESIS, V21, P461, DOI 10.1093/carcin/21.3.461; Ruike Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-137; Shimbo T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004028; Smits AH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks941; Stefanska B, 2013, CARCINOGENESIS, V34, P2738, DOI 10.1093/carcin/bgt273; Tian B, 2012, METHODS MOL BIOL, V809, P105, DOI 10.1007/978-1-61779-376-9_7; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Veloso A, 2014, GENOME RES; WOLF SF, 1984, P NATL ACAD SCI-BIOL, V81, P2806, DOI 10.1073/pnas.81.9.2806; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhu D, 2011, CANCER RES, V71, P5859, DOI 10.1158/0008-5472.CAN-11-1157	42	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99603	10.1371/journal.pone.0099603	http://dx.doi.org/10.1371/journal.pone.0099603			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927503	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100055
J	Mizukami, Y; Abe, T; Shibata, H; Makimura, Y; Fujishiro, S; Yanase, K; Hishikawa, S; Kobayashi, E; Hanazono, Y				Mizukami, Yoshihisa; Abe, Tomoyuki; Shibata, Hiroaki; Makimura, Yukitoshi; Fujishiro, Shuh-hei; Yanase, Kimihide; Hishikawa, Shuji; Kobayashi, Eiji; Hanazono, Yutaka			MHC-Matched Induced Pluripotent Stem Cells Can Attenuate Cellular and Humoral Immune Responses but Are Still Susceptible to Innate Immunity in Pigs	PLOS ONE			English	Article							SLA CLASS-I; MINIATURE SWINE; NEURAL CELLS; TRANSPLANTATION; COMPLEMENT; ENGRAFTMENT; BANKING; ANEMIA; CD47; SELF	Recent studies have revealed negligible immunogenicity of induced pluripotent stem (iPS) cells in syngeneic mice and in autologous monkeys. Therefore, human iPS cells would not elicit immune responses in the autologous setting. However, given that human leukocyte antigen (HLA)-matched allogeneic iPS cells would likely be used for medical applications, a more faithful model system is needed to reflect HLA-matched allogeneic settings. Here we examined whether iPS cells induce immune responses in the swine leukocyte antigen (SLA)-matched setting. iPS cells were generated from the SLA-defined C1 strain of Clawn miniature swine, which were confirmed to develop teratomas in mice, and transplanted into the testes (n = 4) and ovary (n = 1) of C1 pigs. No teratomas were found in pigs on 47 to 125 days after transplantation. A Mixed lymphocyte reaction revealed that T-cell responses to the transplanted MHC-matched (C1) iPS cells were significantly lower compared to allogeneic cells. The humoral immune responses were also attenuated in the C1-to-C1 setting. More importantly, even MHC-matched iPS cells were susceptible to innate immunity, NK cells and serum complement. iPS cells lacked the expression of SLA class I and sialic acids. The in vitro cytotoxic assay showed that C1 iPS cells were targeted by NK cells and serum complement of C1. In vivo, the C1 iPS cells developed larger teratomas in NK-deficient NOG (T-B-NK-) mice (n = 10) than in NK-competent NOD/SCID (T-B-NK+) mice (n = 8) (p<0.01). In addition, C1 iPS cell failed to form teratomas after incubation with the porcine complement-active serum. Taken together, MHC-matched iPS cells can attenuate cellular and humoral immune responses, but still susceptible to innate immunity in pigs.	[Mizukami, Yoshihisa; Abe, Tomoyuki; Fujishiro, Shuh-hei; Yanase, Kimihide; Hanazono, Yutaka] Jichi Med Univ, Ctr Mol Med, Div Regenerat Med, Shimotsuke, Tochigi, Japan; [Abe, Tomoyuki; Makimura, Yukitoshi; Hishikawa, Shuji; Kobayashi, Eiji; Hanazono, Yutaka] Jichi Med Univ, Ctr Dev Adv Med Technol, Shimotsuke, Tochigi, Japan; [Shibata, Hiroaki] Natl Inst Biomed Innovat, Tsukuba Primate Res Ctr, Ibaraki, Japan; [Hanazono, Yutaka] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Jichi Medical University; Jichi Medical University; National Institute of Health Sciences - Japan; Japan Science & Technology Agency (JST)	Hanazono, Y (corresponding author), Jichi Med Univ, Ctr Mol Med, Div Regenerat Med, Shimotsuke, Tochigi, Japan.	hanazono@jichi.ac.jp			Japan Science and Technology Agency Research Center Network for Realization of Regenerative Medicine; KAKENHI from Ministry of Health, Labour and Welfare of Japan; Jichi Medical University Graduate Student Start-Up Grant	Japan Science and Technology Agency Research Center Network for Realization of Regenerative Medicine; KAKENHI from Ministry of Health, Labour and Welfare of Japan; Jichi Medical University Graduate Student Start-Up Grant	This study was in part supported by Japan Science and Technology Agency Research Center Network for Realization of Regenerative Medicine to YH, by KAKENHI from Ministry of Health, Labour and Welfare of Japan to YH, and by Jichi Medical University Graduate Student Start-Up Grant for Young Investigators to Y Mizukami. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107; Ando A, 2005, XENOTRANSPLANTATION, V12, P121, DOI 10.1111/j.1399-3089.2005.00204.x; Ando A, 2003, IMMUNOGENETICS, V55, P583, DOI 10.1007/s00251-003-0619-0; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Bollen P, 1997, PHARMACOL TOXICOL, V80, P3, DOI 10.1111/j.1600-0773.1997.tb01980.x; Dhodapkar KM, 2010, P NATL ACAD SCI USA, V107, P8718, DOI 10.1073/pnas.0915086107; Dressel R, 2010, FASEB J, V24, P2164, DOI 10.1096/fj.09-134957; Dressel R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002622; Emborg ME, 2013, CELL REP, V3, P646, DOI 10.1016/j.celrep.2013.02.016; Fujishiro S, 2013, STEM CELLS DEV, V22, P473, DOI 10.1089/scd.2012.0173; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Hanekamp JS, 2009, TRANSPLANTATION, V88, P30, DOI 10.1097/TP.0b013e3181a9ed5b; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Kaneko S, 2013, CELL STEM CELL, V12, P385, DOI 10.1016/j.stem.2013.03.008; KAZATCHKINE MD, 1979, J IMMUNOL, V122, P75; Kim D, 2012, LEUKEMIA, V26, P2538, DOI 10.1038/leu.2012.141; Kishi Y, 2008, CELL TRANSPLANT, V17, P1095, DOI 10.3727/096368908786991560; Koch CA, 2006, J IMMUNOL, V177, P4803, DOI 10.4049/jimmunol.177.7.4803; Kurre P, 2003, J PEDIAT HEMATOL ONC, V25, P581, DOI 10.1097/00043426-200307000-00019; Li Y, 2012, BLOOD, V120, P3436, DOI 10.1182/blood-2012-03-420612; Mezrich JD, 2003, TRANSPLANTATION, V75, P904, DOI 10.1097/01.TP.0000054839.43852.BF; Morizane A, 2013, STEM CELL REP, V1, P283, DOI 10.1016/j.stemcr.2013.08.007; NAKANISHI Y, 1991, Japanese Journal of Swine Science, V28, P211; Nakatsuji N, 2008, NAT BIOTECHNOL, V26, P739, DOI 10.1038/nbt0708-739; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Raulet DH, 2006, SEMIN IMMUNOL, V18, P145, DOI 10.1016/j.smim.2006.03.003; SACHS DH, 1994, PATHOL BIOL, V42, P217; SACHS DH, 1976, TRANSPLANTATION, V22, P559, DOI 10.1097/00007890-197612000-00004; Shook DR, 2013, BIOL BLOOD MARROW TR, V19, P291, DOI 10.1016/j.bbmt.2012.10.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taylor CJ, 2012, CELL STEM CELL, V11, P147, DOI 10.1016/j.stem.2012.07.014; Yamaguchi T, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0339; Yanagimachi MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059243; Zimmermann A, 2012, STEM CELLS DEV, V21, P2364, DOI 10.1089/scd.2012.0088	39	26	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98319	10.1371/journal.pone.0098319	http://dx.doi.org/10.1371/journal.pone.0098319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927426	gold, Green Published, Green Submitted			2022-12-25	WOS:000338278100015
J	Moran-Luis, M; Fameli, A; Blanco-Fontao, B; Fernandez-Gil, A; Rodriguez-Munoz, R; Quevedo, M; Mirol, P; Banuelos, MJ				Moran-Luis, Maria; Fameli, Alberto; Blanco-Fontao, Beatriz; Fernandez-Gil, Alberto; Rodriguez-Munoz, Rolando; Quevedo, Mario; Mirol, Patricia; Banuelos, Maria-Jose			Demographic Status and Genetic Tagging of Endangered Capercaillie in NW Spain	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; TETRAO-UROGALLUS-CANTABRICUS; MARK-RECAPTURE; INDIVIDUAL IDENTIFICATION; HABITAT SELECTION; MATING SYSTEM; CONSERVATION; PROGRAM; ADULT; CONSEQUENCES	Counting rare and elusive animals and evaluating their demographic status, are fundamental yet challenging aspects of population ecology and conservation biology. We set out to estimate population size (N-c), genetic effective population size (N-e (gen)), sex ratio, and movements based on genetic tagging for the threatened Cantabrian capercaillie. We used 9 microsatellite loci to genotype 134 droppings collected at 34 display areas during the breeding season. Using genetic capture-mark-recapture, we estimated 93 individuals (N-c, 95% CI: 70-116) in an area of about 500 km(2), with sex ratio biased towards males (1: 1.6). Estimated N-e gen (35.5) was 38% of N-c, notably higher than the published average in wild populations. This capercaillie population is small and well within concern in terms of population viability. By genetic tagging, we detected mostly short movements; just a few males were recaptured between contiguous display areas. Non-invasive surveys of endangered populations have a great potential, yet adequate sample size and location are key to obtain reliable information on conservation status.	[Moran-Luis, Maria; Quevedo, Mario; Banuelos, Maria-Jose] Univ Oviedo, Res Unit Biodivers UO PA CSIC, Mieres, Spain; [Moran-Luis, Maria; Blanco-Fontao, Beatriz; Quevedo, Mario; Banuelos, Maria-Jose] Univ Oviedo, Dept Biol Organisms & Syst, Ecol Unit, Oviedo, Spain; [Fameli, Alberto; Mirol, Patricia] Argentinian Museum Nat Sci Bernardino Rivadavia, Grp Biodivers & Conservat Genet GECOBI, Buenos Aires, DF, Argentina; [Fernandez-Gil, Alberto] CSIC, Donana Biol Stn, Dept Conservat Biol, E-41080 Seville, Spain; [Rodriguez-Munoz, Rolando] Univ Exeter, Sch Biosci, Ctr Ecol & Conservat, Penryn, England	University of Oviedo; University of Oviedo; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Exeter	Banuelos, MJ (corresponding author), Univ Oviedo, Res Unit Biodivers UO PA CSIC, Mieres, Spain.	mariajo.banuelos@gmail.com	Quevedo, Mario/I-2493-2015; Moran-Luis, Maria/ABA-1134-2021; /H-9916-2015	Quevedo, Mario/0000-0002-6067-3237; Fameli, Alberto/0000-0001-6566-405X; Blanco Fontao, Beatriz/0000-0002-5492-2399; Moran-Luis, Maria/0000-0002-6449-2388; /0000-0002-8221-0487	 [IB08-158];  [CGL2010-15990]	; 	This study is a contribution to grants IB08-158 (FICYT,www.ficyt.es) to MJ Banuelos and CGL2010-15990 (MICINN,www.idi.mineco.gob.es) to M. J. Banuelos and M. Quevedo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks SC, 2003, ANIM CONSERV, V6, P101, DOI 10.1017/S1367943003003135; Caizergues A, 2001, MOL ECOL NOTES, V1, P36, DOI 10.1046/j.1471-8278.2000.00015.x; Caro T, 2007, TRENDS ECOL EVOL, V22, P394, DOI 10.1016/j.tree.2007.06.003; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Chenuil A, 2000, FRESHWATER BIOL, V43, P121, DOI 10.1046/j.1365-2427.2000.00531.x; Creel S, 2003, MOL ECOL, V12, P2003, DOI 10.1046/j.1365-294X.2003.01868.x; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; Efford MG, 2011, ECOLOGY, V92, P2202, DOI 10.1890/11-0332.1; Eggert LS, 2003, MOL ECOL, V12, P1389, DOI 10.1046/j.1365-294X.2003.01822.x; Ellis JS, 2011, GENETICA, V139, P353, DOI 10.1007/s10709-011-9554-4; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Frankham R, 2014, BIOL CONSERV, V170, P56, DOI 10.1016/j.biocon.2013.12.036; Frantz AC, 2003, MOL ECOL, V12, P1649, DOI 10.1046/j.1365-294X.2003.01848.x; Garcia D, 2005, FOREST ECOL MANAG, V208, P29, DOI 10.1016/j.foreco.2004.10.071; Gonzalez MA, 2012, IBIS, V154, P260, DOI 10.1111/j.1474-919X.2012.01217.x; Guschanski K, 2009, BIOL CONSERV, V142, P290, DOI 10.1016/j.biocon.2008.10.024; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hoglund J, 2009, EVOLUTIONARY CONSERVATION GENETICS, P1; Hoglund J., 1995, LEKS, DOI DOI 10.1515/9781400864157; Jacob G, 2010, CONSERV GENET, V11, P33, DOI 10.1007/s10592-008-9794-8; Katzner TE, 2011, ANIM CONSERV, V14, P328, DOI 10.1111/j.1469-1795.2011.00444.x; Lee AM, 2011, AM NAT, V177, P301, DOI 10.1086/658344; Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7; Margalida A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026784; Martin J, 2007, CONSERV BIOL, V21, P472, DOI 10.1111/j.1523-1739.2006.00613.x; Martinez AM, 1993, THESIS U LEON; McKelvey KS, 2005, MOL ECOL NOTES, V5, P716, DOI 10.1111/j.1471-8286.2005.01038.x; Miller CR, 2005, MOL ECOL, V14, P1991, DOI 10.1111/j.1365-294X.2005.02577.x; Miller CR, 2002, GENETICS, V160, P357; Mills LS, 2000, ECOL APPL, V10, P283, DOI 10.2307/2641002; Moran P, 2006, ECOL FRESHW FISH, V15, P597, DOI 10.1111/j.1600-0633.2006.00201.x; Neel MC, 2013, HEREDITY, V111, P189, DOI 10.1038/hdy.2013.37; NUNNEY L, 1993, EVOLUTION, V47, P1329, DOI 10.1111/j.1558-5646.1993.tb02158.x; Palsboll PJ, 1997, NATURE, V388, P767, DOI 10.1038/42005; Palsboll PJ, 1999, BIOL J LINN SOC, V68, P3, DOI 10.1111/j.1095-8312.1999.tb01155.x; Palstra FP, 2012, ECOL EVOL, V2, P2357, DOI 10.1002/ece3.329; Peakall R, 2006, J ZOOL, V268, P207, DOI 10.1111/j.1469-7998.2005.00011.x; Perez T, 2011, CONSERV GENET RESOUR, V3, P483, DOI 10.1007/s12686-011-9385-8; Petit E, 2006, CONSERV BIOL, V20, P1062, DOI 10.1111/j.1523-1739.2006.00417.x; PICOZZI N, 1992, J APPL ECOL, V29, P751, DOI 10.2307/2404485; Piertney SB, 2001, MOL ECOL NOTES, V1, P303, DOI 10.1046/j.1471-8278.2001.00118.x; Pollo CJ, 2005, BIRD CONSERV INT, V15, P397, DOI 10.1017/S0959270905000626; Puechmaille SJ, 2007, J APPL ECOL, V44, P843, DOI 10.1111/j.1365-2664.2007.01321.x; Quevedo M, 2006, BIOL CONSERV, V127, P190, DOI 10.1016/j.biocon.2005.07.019; Quevedo M, 2006, WILDLIFE BIOL, V12, P267, DOI 10.2981/0909-6396(2006)12[267:HSBCCT]2.0.CO;2; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rodriguez-Munoz R, 2007, CONSERV GENET, V8, P659, DOI 10.1007/s10592-006-9212-z; Rudnick JA, 2005, MOL ECOL, V14, P2959, DOI 10.1111/j.1365-294X.2005.02641.x; Segelbacher G, 2000, MOL ECOL, V9, P1934, DOI 10.1046/j.1365-294x.2000.0090111934.x; Segelbacher G, 2003, MOL ECOL, V12, P1773, DOI 10.1046/j.1365-294X.2003.01873.x; Smith DA, 2006, MOL ECOL, V15, P387, DOI 10.1111/j.1365-294X.2005.02841.x; Solberg KH, 2006, BIOL CONSERV, V128, P158, DOI 10.1016/j.biocon.2005.09.025; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Storch I, 2006, J ORNITHOL, V147, P653, DOI 10.1007/s10336-006-0101-5; Storch I, 1997, WILDLIFE BIOL, V3, P149, DOI 10.2981/wlb.1997.019; Storz JF, 2001, EVOLUTION, V55, P1224; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Thompson WL, 2004, SAMPLING RARE ELUSIV; Traill LW, 2007, BIOL CONSERV, V139, P159, DOI 10.1016/j.biocon.2007.06.011; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vazquez JF, 2012, J WILDLIFE MANAGE, V76, P957, DOI 10.1002/jwmg.346; Vucetich JA, 1997, EVOLUTION, V51, P2017, DOI 10.1111/j.1558-5646.1997.tb05123.x; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Waples RS, 2005, MOL ECOL, V14, P3335, DOI 10.1111/j.1365-294X.2005.02673.x; Watson A., 2008, GROUSE NATURAL HIST; WEGGE P, 1987, AUK, V104, P481, DOI 10.2307/4087547; WEGGE P, 1986, BEHAV ECOL SOCIOBIOL, V19, P401, DOI 10.1007/BF00300542; Zhan XJ, 2006, CURR BIOL, V16, pR451, DOI 10.1016/j.cub.2006.05.042	77	15	16	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99799	10.1371/journal.pone.0099799	http://dx.doi.org/10.1371/journal.pone.0099799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926790	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100081
J	Wu, CS; Lee, TY; Chou, RH; Yen, CJ; Huang, WC; Wu, CY; Yu, YL				Wu, Chen-Shiou; Lee, Teng-Yu; Chou, Ruey-Hwang; Yen, Chia-Jui; Huang, Wei-Chien; Wu, Chung-Yi; Yu, Yung-Luen			Development of a Highly Sensitive Glycan Microarray for Quantifying AFP-L3 for Early Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma	PLOS ONE			English	Article							SERUM ALPHA-FETOPROTEIN; AGGLUTININ-REACTIVE FRACTION; DES-GAMMA-CARBOXYPROTHROMBIN; D-GLUCOSAMINIDE ALPHA; CARBOXY PROTHROMBIN; CDNA CLONING; DIAGNOSIS; CIRRHOSIS; CANCER; IMMUNOTHERAPY	The alpha-fetoprotein fraction L3 (AFP-L3), which is synthesized by malignant cells and incorporates a fucosylated oligosaccharide, has been investigated as a diagnostic and prognostic marker for hepatocellular carcinoma (HCC). Quantification of AFP-L3 by conventional enzyme-linked immunosorbent assay (ELISA) has not always produced reliable results for serum samples with low AFP, and thus we evaluated the clinical utility of quantifying AFP-L3 using a new and highly sensitive glycan microarray assay. Sera from 9 patients with chronic hepatitis B and 32 patients with hepatitis B virus (HBV)-related HCC were tested for AFP-L3 level using the glycan microarray. Additionally, we compared receiver operator characteristic curves for the ELISA and glycan microarray methods for determination of the AFP-L3: AFP-L1 ratio in patient samples. This ratio was calculated for 8 HCC patients who underwent transarterial embolization therapy pre- or post-treatment with AFP-L3. Glycan microarrays showed that the AFP-L3 ratio of HBV-related HCC patients was significantly higher than that measured for chronic hepatitis B patients. Overall parameters for estimating AFP-L3% in HCC samples were as follows: sensitivity, 53.13%; specificity, 88.89%; and area under the curve, 0.75. The elevated AFP-L3% in the 8 patients with HBV-related HCC was strongly associated with HCC progression. Following one month of transarterial embolization therapy, the relative mean AFP-L3% decreased significantly. In addition, we compared Fut8 gene expression between paired tumor and non-tumor tissues from 24 patients with HBV-related HCC. The Fut8 mRNA expression was significantly increased in tumorous tissues in these patients than that in non-tumor tissue controls. Higher expression of Fut8 mRNA in tumorous tissues in these patients was associated with poor differentiation than well and moderate differentiation. Our results describe a new glycan microarray for the sensitive and rapid quantification of fucosylated AFP; this method is potentially applicable to screening changes in AFP-L3 level for assessment of HCC progression.	[Wu, Chen-Shiou; Chou, Ruey-Hwang; Huang, Wei-Chien; Wu, Chung-Yi; Yu, Yung-Luen] China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Lee, Teng-Yu] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Chou, Ruey-Hwang; Huang, Wei-Chien; Yu, Yung-Luen] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Chou, Ruey-Hwang; Huang, Wei-Chien; Yu, Yung-Luen] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Wu, Chen-Shiou; Wu, Chung-Yi] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lee, Teng-Yu] Chung Shan Med Univ, Dept Med, Taichung, Taiwan; [Lee, Teng-Yu] Taichung Vet Gen Hosp, Div Gastroenterol, Taichung, Taiwan; [Chou, Ruey-Hwang; Huang, Wei-Chien; Yu, Yung-Luen] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Yen, Chia-Jui] Natl Cheng Kung Univ, Grad Inst Clin Med, Tainan 70101, Taiwan; [Yen, Chia-Jui] Natl Cheng Kung Univ Hosp, Dept Internal Med, Div Hematol Oncol, Tainan 70428, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Academia Sinica - Taiwan; Chung Shan Medical University; Taichung Veterans General Hospital; Asia University Taiwan; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital	Yu, YL (corresponding author), China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan.	ylyu@mail.cmu.edu.tw	Huang, Wei-Chien/H-3126-2019; Chou, Ruey-Hwang/K-8541-2013; Wu, Chung-Yi/K-8334-2018	Huang, Wei-Chien/0000-0001-6467-8716; Chou, Ruey-Hwang/0000-0002-2297-2180; Wu, Chen-Shiou/0000-0003-0791-1483	 [NSC101-2321-B-039-004];  [NHRI-EX102-10245BI]	; 	This work was supported by the following grants: NSC101-2321-B-039-004; and NHRI-EX102-10245BI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi Y, 2002, HEPATOL RES, V23, P287, DOI 10.1016/S1386-6346(01)00184-X; Beale G, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-200; Carr BI, 2007, DIGEST DIS SCI, V52, P776, DOI 10.1007/s10620-006-9541-2; Cheng Hau-Tsai, 2007, J Chin Med Assoc, V70, P310, DOI 10.1016/S1726-4901(08)70011-X; Chu KC, 2012, FUTURE MED CHEM, V4, P1767, DOI [10.4155/fmc.12.102, 10.4155/FMC.12.102]; Durazo FA, 2008, J GASTROEN HEPATOL, V23, P1541, DOI 10.1111/j.1440-1746.2008.05395.x; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Gomaa AI, 2009, WORLD J GASTROENTERO, V15, P1301, DOI 10.3748/wjg.15.1301; Huang CY, 2006, P NATL ACAD SCI USA, V103, P15, DOI 10.1073/pnas.0509693102; IKEDA K, 1993, HEPATOLOGY, V17, P1003, DOI 10.1016/0270-9139(93)90114-3; KINOSHITA N, 1989, CLIN CHIM ACTA, V179, P143, DOI 10.1016/0009-8981(89)90160-5; KUROMATSU R, 1993, LIVER, V13, P177; LIAW YF, 1988, HEPATOLOGY, V8, P493, DOI 10.1002/hep.1840080310; LIAW YF, 1986, GASTROENTEROLOGY, V90, P263, DOI 10.1016/0016-5085(86)90919-4; Liu Y, 2013, J ALLERGY CLIN IMMUN, V131, P213, DOI 10.1016/j.jaci.2012.10.018; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Marrero JA, 2009, GASTROENTEROLOGY, V137, P110, DOI 10.1053/j.gastro.2009.04.005; Nakamura K, 1998, ANAL CHEM, V70, P954, DOI 10.1021/ac9711495; OKA H, 1994, HEPATOLOGY, V19, P61, DOI 10.1016/0270-9139(94)90053-1; Park S, 2013, CHEM SOC REV, V42, P4310, DOI 10.1039/c2cs35401b; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sterling RK, 2009, CLIN GASTROENTEROL H, V7, P104, DOI 10.1016/j.cgh.2008.08.041; Stravitz RT, 2008, AM J MED, V121, P119, DOI 10.1016/j.amjmed.2007.09.020; TAKAYASU K, 1995, AM J ROENTGENOL, V164, P885, DOI 10.2214/ajr.164.4.7726041; TAKAYASU K, 1990, AM J ROENTGENOL, V155, P49, DOI 10.2214/ajr.155.1.1693808; TAKETA K, 1993, CANCER RES, V53, P5419; TATSUTA M, 1986, ONCOLOGY, V43, P306, DOI 10.1159/000226388; Tseng SY, 2008, CHEM-ASIAN J, V3, P1395, DOI 10.1002/asia.200800154; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; Uozumi N, 1996, J BIOCHEM, V120, P385; Wang YA, 2012, FISH SHELLFISH IMMUN, V33, P213, DOI 10.1016/j.fsi.2012.04.011; Wu CS, 2014, INT J CANCER, V134, P1638, DOI 10.1002/ijc.28501; Wu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039466; Wu CY, 2009, ORG BIOMOL CHEM, V7, P2247, DOI 10.1039/b902510n; Yanagidani S, 1997, J BIOCHEM-TOKYO, V121, P626; Yiang GT, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-47; Yu YL, 2012, J CELL PHYSIOL, V227, P213, DOI 10.1002/jcp.22719; Yu YL, 2010, INT J ONCOL, V36, P365, DOI 10.3892/ijo_00000508; Zhang JF, 2012, J ATHEROSCLER THROMB, V19, P213, DOI 10.5551/jat.11148	39	21	24	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99959	10.1371/journal.pone.0099959	http://dx.doi.org/10.1371/journal.pone.0099959			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927126	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100100
J	Yokobe, J; Kitahara, M; Matsushima, M; Uezono, S				Yokobe, Junya; Kitahara, Masaki; Matsushima, Masato; Uezono, Shoichi			Preference for Different Anchor Descriptors on Visual Analogue Scales among Japanese Patients with Chronic Pain	PLOS ONE			English	Article							NUMERICAL RATING-SCALES; PSYCHOMETRIC PROPERTIES; COGNITIVE IMPAIRMENT; DEPRESSION SCALE; HOSPITAL ANXIETY; OLDER-ADULTS; CANCER PAIN; INTENSITY; VALIDITY; YOUNGER	Context: Although many previous studies have examined the preference of patients for different pain measurement scales, preference for anchor descriptors has not been thoroughly discussed. Objectives: To examine (1) the preferred end-phrases used in the VAS as anchor labels for Japanese patients with chronic pain, and (2) whether the preference differs according to factors such as age, sex, educational level, duration of pain, and pain intensity. Methods: We performed an observational study in patients suffering from non-cancer chronic pain for more than 3 months at a pain center in Japan. The patients were asked to rate their pain intensity using four types of VAS that used the following different anchor descriptors: "worst pain'' ("Worst''), "worst pain bearable'' ("Bearable''), "worst pain imaginable'' ("Imaginable''), and "worst pain you have ever experienced'' ("Experienced''). They were also asked to rank the four scales according to ease of responding, and asked which descriptor best reflected their perceived pain. Results: In total, 183 patients participated in the study. They consisted of 119 (65.0%) women and 64 (35.0%) men aged 18-84 years with the mean age of 56.9 years. "Experienced'' was most preferred (69.8%), followed by "Bearable'' (66.3%), "Worst'' (48.8%), and "Imaginable'' (16.9%). Factors such as age, sex, educational background, duration of pain, and pain intensity did not significantly affect the results. In 83.1% of patients, the preferred descriptor corresponded to the descriptor that best reflected patients' perceived pain. Conclusion: The frequently used expression "worst pain imaginable'' is considered to be difficult to understand for most patients. Widely preferred descriptors, such as "worst pain you have ever experienced'' and "worst pain bearable'', should be used when evaluating perceived pain. The preference of anchor descriptors was not significantly affected by the factors such as age, sex, educational level, duration of pain, and pain intensity.	[Yokobe, Junya; Kitahara, Masaki; Uezono, Shoichi] Jikei Univ, Sch Med, Dept Anesthesiol, Minato Ku, Tokyo, Japan; [Matsushima, Masato] Jikei Univ, Sch Med, Div Clin Epidemiol, Minato Ku, Tokyo, Japan	Jikei University; Jikei University	Yokobe, J (corresponding author), Jikei Univ, Sch Med, Dept Anesthesiol, Minato Ku, Tokyo, Japan.	yokobejunya@gmail.com						Berthier F, 1998, AM J EMERG MED, V16, P132, DOI 10.1016/S0735-6757(98)90029-8; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bolton JE, 1998, J MANIP PHYSIOL THER, V21, P1; Brunelli C, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-42; CARLSSON AM, 1983, PAIN, V16, P87, DOI 10.1016/0304-3959(83)90088-X; Clark P, 2003, J RHEUMATOL, V30, P1584; Closs SJ, 2004, J PAIN SYMPTOM MANAG, V27, P196, DOI 10.1016/j.jpainsymman.2003.12.010; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Fanurik D, 1998, Clin Nurs Res, V7, P103, DOI 10.1177/105477389800700202; Fanurik D, 1998, CLIN NURS RES, V7, P120; Flaherty S A, 1996, AANA J, V64, P133; Gabre Pia, 2002, Spec Care Dentist, V22, P174, DOI 10.1111/j.1754-4505.2002.tb00267.x; Gagliese L, 2005, PAIN, V117, P412, DOI 10.1016/j.pain.2005.07.004; Grotle M, 2004, SPINE, V29, pE492, DOI 10.1097/01.brs.0000143664.02702.0b; Herr K A, 1993, Appl Nurs Res, V6, P39; Herr KA, 2004, CLIN J PAIN, V20, P207, DOI 10.1097/00002508-200407000-00002; Hjermstad MJ, 2011, J PAIN SYMPTOM MANAG, V41, P1073, DOI 10.1016/j.jpainsymman.2010.08.016; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; KREMER E, 1981, PAIN, V10, P241, DOI 10.1016/0304-3959(81)90199-8; LANGLEY GB, 1985, RHEUMATOL INT, V5, P145, DOI 10.1007/BF00541514; Larroy C, 2002, BEHAV MED, V27, P179, DOI 10.1080/08964280209596043; Loder E, 2012, CEPHALALGIA, V32, P179, DOI 10.1177/0333102411434812; Marquie L., 2008, ACUTE PAIN, V10, P31, DOI DOI 10.1016/J.ACPAIN.2008.01.003; McQuay HJ, 2006, TXB PAIN, V5, P415; Melzack R, 2006, WALL MELZACKS TXB PA, P291; Merskey H., 1994, CLASSIFICATION CHRON, P207, DOI DOI 10.1002/ANA.20394; Paice JA, 1997, CANCER NURS, V20, P88, DOI 10.1097/00002820-199704000-00002; Peters ML, 2007, PAIN MED, V8, P601, DOI 10.1111/j.1526-4637.2007.00311.x; PRICE DD, 1994, PAIN, V56, P217, DOI 10.1016/0304-3959(94)90097-3; Radbruch L, 2000, PALLIATIVE MED, V14, P266, DOI 10.1191/026921600672986600; Rahim-Williams B, 2012, PAIN MED, V13, P522, DOI 10.1111/j.1526-4637.2012.01336.x; Rodriguez CS, 2004, CANCER NURS, V27, P425; SEYMOUR RA, 1982, EUR J CLIN PHARMACOL, V23, P441, DOI 10.1007/BF00605995; Skovlund E, 2005, CLIN J PAIN, V21, P292, DOI 10.1097/01.ajp.0000110636.14355.3e; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Williams ACD, 2000, PAIN, V85, P457, DOI 10.1016/S0304-3959(99)00299-7; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	37	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99891	10.1371/journal.pone.0099891	http://dx.doi.org/10.1371/journal.pone.0099891			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2VQ	24927424	Green Submitted, gold, Green Published			2022-12-25	WOS:000338278100087
J	Yu, XL; Yu, YX; Zeng, Q				Yu, Xinliang; Yu, Yixiong; Zeng, Qun			Support Vector Machine Classification of Streptavidin-Binding Aptamers	PLOS ONE			English	Article							SELECTION; SELEX; DESCRIPTORS; QSAR	Background: Synthesizing and characterizing aptamers with high affinity and specificity have been extensively carried out for analytical and biomedical applications. Few publications can be found that describe structure-activity relationships (SARs) of candidate aptamer sequences. Methodology: This paper reports pattern recognition with support vector machine (SVM) classification techniques for the identification of streptavidin-binding aptamers as "low'' or "high'' affinity aptamers. The SVM parameters C and gamma were optimized using genetic algorithms. Four descriptors, the topological descriptor PW4 (path/walk 4 - Randic shape index), the connectivity index X3A (average connectivity index chi-3), the topological charge index JGI2 (mean topological charge index of order 2), and the free energy E of the secondary structure, were used to describe the structures of candidate aptamer sequences from SELEX selection (Schutze et al. (2011) PLoS ONE (12): e29604). Conclusions: The predicted fractions of winning streptavidin-binding aptamers for ten rounds of SELEX conform to the aptamer evolutionary principles of SELEX-based screening. The feasibility of applying pattern recognition based on SVM and genetic algorithms for streptavidin-binding aptamers has been demonstrated.	[Yu, Xinliang] Hunan Inst Engn, Coll Chem & Chem Engn, Xiangtan, Hunan, Peoples R China; [Yu, Xinliang] Hunan Univ, Coll Chem & Chem Engn, State Key Lab Chemo Biosensing & Chemometr, Changsha 410082, Hunan, Peoples R China; [Yu, Yixiong] Lushan Int Expt Sch, Changsha, Hunan, Peoples R China; [Zeng, Qun] Xiangtan Cent Hosp, Dept Neurol Surg, Xiangtan, Hunan, Peoples R China	Hunan Institute of Engineering; Hunan University	Yu, XL (corresponding author), Hunan Inst Engn, Coll Chem & Chem Engn, Xiangtan, Hunan, Peoples R China.	yxliang5602@sina.com.cn			Hunan Provincial Natural Science Foundation of China [12JJ6011]	Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province)	This work was supported by the Hunan Provincial Natural Science Foundation of China (Contract No. 12JJ6011). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afantitis A, 2010, MOL DIVERS, V14, P225, DOI 10.1007/s11030-009-9163-7; Bing T, 2010, BIOORGAN MED CHEM, V18, P1798, DOI 10.1016/j.bmc.2010.01.054; Birzele F, 2006, BIOINFORMATICS, V22, P2628, DOI 10.1093/bioinformatics/btl453; Bunka DHJ, 2006, NAT REV MICROBIOL, V4, P588, DOI 10.1038/nrmicro1458; Cambridge Soft Inc, 2008, CHEMBIOOFFICE ULTR 1; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Djordjevic M, 2006, PHYS BIOL, V3, P13, DOI 10.1088/1478-3975/3/1/002; Djordjevic M, 2007, BIOMOL ENG, V24, P179, DOI 10.1016/j.bioeng.2007.03.001; GALVEZ J, 1994, J CHEM INF COMP SCI, V34, P520, DOI 10.1021/ci00019a008; Hwang DW, 2010, J NUCL MED, V51, P98, DOI 10.2967/jnumed.109.069880; Karelson M, 1996, CHEM REV, V96, P1027, DOI 10.1021/cr950202r; Levine HA, 2007, COMPUT BIOL CHEM, V31, P11, DOI 10.1016/j.compbiolchem.2006.10.002; Li S, 2007, SAR QSAR ENVIRON RES, V18, P423, DOI 10.1080/10629360701428474; Mandloi M, 2000, J CHEM INF COMP SCI, V40, P57, DOI 10.1021/ci980139h; Nikolaus N, 2014, SENSORS-BASEL, V14, P3737, DOI 10.3390/s140203737; Petrova T, 2011, J NANOPART RES, V13, P3235, DOI 10.1007/s11051-011-0238-x; Plewczynski D, 2006, J MOL MODEL, V12, P453, DOI 10.1007/s00894-005-0070-2; Randic M, 2001, J CHEM INF COMP SCI, V41, P607, DOI 10.1021/ci0001031; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Schutze T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029604; Shangguan DH, 2008, ANAL CHEM, V80, P721, DOI 10.1021/ac701962v; Talete SRL, 2006, DRAGON WIDOWS SOFTWA; Tan WH, 2013, CHEM REV, V113, P2842, DOI 10.1021/cr300468w; Turabekova MA, 2004, MOLECULES, V9, P1194, DOI 10.3390/91201194; Vant-Hull B, 1998, J MOL BIOL, V278, P579, DOI 10.1006/jmbi.1998.1727; Wang B, 2009, QSAR COMB SCI, V28, P561, DOI 10.1002/qsar.200860065; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Yomogida K, 2012, CYTOKINE, V58, P431, DOI 10.1016/j.cyto.2012.02.007; Yu XL, 2013, IND ENG CHEM RES, V52, P11182, DOI 10.1021/ie400001u	29	6	6	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99964	10.1371/journal.pone.0099964	http://dx.doi.org/10.1371/journal.pone.0099964			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927174	Green Submitted, gold, Green Published			2022-12-25	WOS:000338278100101
J	Mamais, A; Chia, R; Beilina, A; Hauser, DN; Hall, C; Lewis, PA; Cookson, MR; Bandopadhyay, R				Mamais, Adamantios; Chia, Ruth; Beilina, Alexandra; Hauser, David N.; Hall, Christine; Lewis, Patrick A.; Cookson, Mark R.; Bandopadhyay, Rina			Arsenite Stress Down-regulates Phosphorylation and 14-3-3 Binding of Leucine-rich Repeat Kinase 2 (LRRK2), Promoting Self-association and Cellular Redistribution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE PATHOLOGY; G2019S MUTATION; GTP-BINDING; ROC DOMAIN; INHIBITION; PROTEINS; LEUCINE-RICH-REPEAT-KINASE-2; LOCALIZATION; DEGRADATION; ACTIVATION	Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) are a common genetic cause of Parkinson disease, but the mechanisms whereby LRRK2 is regulated are unknown. Phosphorylation of LRRK2 at Ser(910)/Ser(935) mediates interaction with 14-3-3. Pharmacological inhibition of its kinase activity abolishes Ser(910)/Ser(935) phosphorylation and 14-3-3 binding, and this effect is also mimicked by pathogenic mutations. However, physiological situations where dephosphorylation occurs have not been defined. Here, we show that arsenite or H2O2-induced stresses promote loss of Ser(910)/Ser(935) phosphorylation, which is reversed by phosphatase inhibition. Arsenite-induced dephosphorylation is accompanied by loss of 14-3-3 binding and is observed in wild type, G2019S, and kinase-dead D2017A LRRK2. Arsenite stress stimulates LRRK2 self-association and association with protein phosphatase 1 alpha, decreases kinase activity and GTP binding in vitro, and induces translocation of LRRK2 to centrosomes. Our data indicate that signaling events induced by arsenite and oxidative stress may regulate LRRK2 function.	[Mamais, Adamantios; Bandopadhyay, Rina] UCL, Inst Neurol, Reta Lila Weston Inst Neurol Studies, London WC1N 1PJ, England; [Mamais, Adamantios; Hall, Christine; Lewis, Patrick A.; Bandopadhyay, Rina] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BJ, England; [Mamais, Adamantios; Chia, Ruth; Beilina, Alexandra; Hauser, David N.; Cookson, Mark R.] NIA, Cell Biol & Gene Express Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Chia, Ruth] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20057 USA; [Hauser, David N.] Brown Univ, Dept Neurosci, Natl Inst Hlth Grad Partnership Program, Providence, RI 02912 USA; [Lewis, Patrick A.] Univ Reading, Sch Pharm, Reading RG6 6AP, Berks, England	University of London; University College London; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Georgetown University; Brown University; National Institutes of Health (NIH) - USA; University of Reading	Mamais, A (corresponding author), NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	adamantios.mamais@nih.gov; rina.bandopadhyay@ucl.ac.uk	Chia, Ruth/AAF-4900-2021; Hauser, David/I-4933-2012; Hauser, David/AAJ-1536-2020; Cookson, Mark/AAW-2516-2021; Bandopadhyay, Rina/C-7926-2009	Chia, Ruth/0000-0002-4709-7423; Hauser, David/0000-0002-9500-5255; Cookson, Mark/0000-0002-1058-3831; Mamais, Adamantios/0000-0002-5546-7084; Lewis, Patrick/0000-0003-4537-0489	National Institutes of Health, NIA, Intramural Research Program; Michael J. Fox Foundation; Reta Lila Weston Institute of Neurological Studies; Wellcome Trust/Medical Research Council Joint Call in Neurodegeneration award [WT089698]; Medical Research Council [MR/L010933/1, MC_G1000735] Funding Source: researchfish; Parkinson&quot;s UK [F-1002] Funding Source: researchfish; MRC [MR/L010933/1, MC_G1000735] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [ZIAAG000948] Funding Source: NIH RePORTER	National Institutes of Health, NIA, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Michael J. Fox Foundation; Reta Lila Weston Institute of Neurological Studies; Wellcome Trust/Medical Research Council Joint Call in Neurodegeneration award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health, NIA, Intramural Research Program. This work was also supported by grants from the Michael J. Fox Foundation (to R. B. and P. A. L.), funding from the Reta Lila Weston Institute of Neurological Studies, and the Wellcome Trust/Medical Research Council Joint Call in Neurodegeneration award (Grant WT089698) to the UK Parkinson's Disease Consortium whose members are from the University College London Institute of Neurology, the University of Sheffield, and the MRC Protein Phosphorylation Unit at the University of Dundee.	Berger Z, 2010, BIOCHEMISTRY-US, V49, P5511, DOI 10.1021/bi100157u; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Biosa A, 2013, HUM MOL GENET, V22, P1140, DOI 10.1093/hmg/dds522; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; BOND U, 1988, J BIOL CHEM, V263, P2384; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Caesar M, 2013, NEUROBIOL DIS, V54, P280, DOI 10.1016/j.nbd.2012.12.019; Civiero L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043472; Cookson MR, 2010, HUM MOL GENET, V19, pR21, DOI 10.1093/hmg/ddq167; Dachsel JC, 2010, ARCH NEUROL-CHICAGO, V67, P542, DOI 10.1001/archneurol.2010.79; Daniels V, 2011, J NEUROCHEM, V116, P304, DOI 10.1111/j.1471-4159.2010.07105.x; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Dusonchet J, 2011, J NEUROSCI, V31, P907, DOI 10.1523/JNEUROSCI.5092-10.2011; Dzamko N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039132; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Fabunmi RP, 2000, J BIOL CHEM, V275, P409, DOI 10.1074/jbc.275.1.409; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gandhi PN, 2008, J NEUROSCI RES, V86, P1711, DOI 10.1002/jnr.21622; Gandhi S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/428010; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Gotthardt K, 2008, EMBO J, V27, P2239, DOI 10.1038/emboj.2008.150; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2007, J NEUROCHEM, V102, P93, DOI 10.1111/j.1471-4159.2007.04523.x; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Halliday G, 2011, MOVEMENT DISORD, V26, P1015, DOI 10.1002/mds.23669; Hardy J, 2010, NEURON, V68, P201, DOI 10.1016/j.neuron.2010.10.014; Hsu CH, 2010, J NEUROCHEM, V112, P1593, DOI 10.1111/j.1471-4159.2010.06568.x; Ito G, 2012, BIOCHEM J, V441, P987, DOI 10.1042/BJ20111215; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; James NG, 2012, BIOPHYS J, V102, pA41, DOI 10.1016/j.bpj.2012.04.046; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jorgensen ND, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008463; Jung DK, 2003, EXP CELL RES, V290, P144, DOI 10.1016/S0014-4827(03)00320-3; Kamikawaji S, 2009, BIOCHEMISTRY-US, V48, P10963, DOI 10.1021/bi9011379; Kapahi P, 2000, J BIOL CHEM, V275, P36062, DOI 10.1074/jbc.M007204200; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kelly SM, 2007, MOL BIOL CELL, V18, P4279, DOI 10.1091/mbc.E07-05-0487; KENNEY LJ, 1988, J BIOL CHEM, V263, P7954; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Korecka JA, 2013, RESTOR NEUROL NEUROS, V31, P155, DOI 10.3233/RNN-110222; Li XJ, 2010, J BIOL CHEM, V285, P29569, DOI 10.1074/jbc.M110.127639; Lobbestael E, 2013, BIOCHEM J, V456, P119, DOI 10.1042/BJ20121772; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Mortiboys H, 2010, NEUROLOGY, V75, P2017, DOI 10.1212/WNL.0b013e3181ff9685; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; Orenstein SJ, 2013, NAT NEUROSCI, V16, P394, DOI 10.1038/nn.3350; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pan-Montojo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008762; Papkovskaia TD, 2012, HUM MOL GENET, V21, P4201, DOI 10.1093/hmg/dds244; Pungaliya PP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013672; Riou P, 2013, CELL, V153, P640, DOI 10.1016/j.cell.2013.03.044; Roussel RR, 2000, ARCH BIOCHEM BIOPHYS, V377, P204, DOI 10.1006/abbi.2000.1770; Rudenko IN, 2012, BIOCHEM J, V446, P99, DOI 10.1042/BJ20120637; Samikkannu T, 2003, CHEM RES TOXICOL, V16, P409, DOI 10.1021/tx025615j; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Sheng ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004485; Taymans JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023207; Waxman EA, 2009, J NEUROPATH EXP NEUR, V68, P785, DOI 10.1097/NEN.0b013e3181aaf4fd; Webber PJ, 2011, J MOL BIOL, V412, P94, DOI 10.1016/j.jmb.2011.07.033; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Wigley WC, 1999, J CELL BIOL, V145, P481; Yuan SS, 2003, TOXICOL IN VITRO, V17, P139, DOI 10.1016/S0887-2333(02)00129-7; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	66	29	29	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21386	21400		10.1074/jbc.M113.528463	http://dx.doi.org/10.1074/jbc.M113.528463			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24942733	Green Submitted, Green Accepted, Green Published, hybrid			2022-12-25	WOS:000340558300018
J	Chen, LW; Yu, N; Lu, Y; Wu, LJ; Chen, DS; Guo, WW; Zhao, LD; Liu, MB; Yang, SM; Sun, XJ; Zhai, SQ				Chen, Liwei; Yu, Ning; Lu, Yan; Wu, Longjun; Chen, Daishi; Guo, Weiwei; Zhao, Lidong; Liu, Mingbo; Yang, Shiming; Sun, Xuejun; Zhai, Suoqiang			Hydrogen-Saturated Saline Protects Intensive Narrow Band Noise-Induced Hearing Loss in Guinea Pigs through an Antioxidant Effect	PLOS ONE			English	Article							FREE-RADICALS; OXIDATIVE STRESS; OXYGEN RADICALS; EXPOSURE; COCHLEA; MECHANISMS; PREVENTION; APOPTOSIS; TRAUMA; GENE	The purpose of the current study was to evaluate hydrogen-saturated saline protecting intensive narrow band noise-induced hearing loss. Guinea pigs were divided into three groups: hydrogen-saturated saline; normal saline; and control. For saline administration, the guinea pigs were given daily abdominal injections (1 ml/100 g) 3 days before and 1 h before narrow band noise exposure (2.5-3.5 kHz 130 dB SPL, 1 h). The guinea pigs in the control group received no treatment. The hearing function was assessed by the auditory brainstem response (ABR) and distortion product otoacoustic emission (DPOAE) recording. The changes of free radicals in the cochlea before noise exposure, and immediately and 7 days after noise exposure were also examined. By Scanning electron microscopy and succinate dehydrogenase staining, we found that pre-treatment with hydrogen-saturated saline significantly reduced noise-induced hair cell damage and hearing loss. We also found that the malondialdehyde, lipid peroxidation, and hydroxyl levels were significantly lower in the hydrogen-saturated saline group after noise trauma, indicating that hydrogen-saturated saline can decrease the amount of harmful free radicals caused by noise trauma. Our findings suggest that hydrogen-saturated saline is effective in preventing intensive narrow band noise-induced hearing loss through the antioxidant effect.	[Chen, Liwei; Yu, Ning; Lu, Yan; Chen, Daishi; Guo, Weiwei; Zhao, Lidong; Liu, Mingbo; Yang, Shiming; Zhai, Suoqiang] Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Wu, Longjun] Wenzhou Med Coll, Dept Otolaryngol Head & Neck Surg, Wenzhou, Zhejiang, Peoples R China; [Sun, Xuejun] Second Mil Med Univ, Fac Naval Med, Dept Diving Med, Shanghai, Peoples R China	Chinese People's Liberation Army General Hospital; Wenzhou Medical University; Naval Medical University	Yu, N (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	yuning12@sina.com; zhaisq@plagh.com.cn	sun, xuejun/A-5561-2010	sun, xuejun/0000-0003-2387-5531; Liu, Mingbo/0000-0002-0540-2573; Zhao, Lidong/0000-0002-0810-0941	National Natural Science Fundation of China [81241034, 81271081, 30971199]	National Natural Science Fundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Fundation of China (No. 81241034, No. 81271081, No. 30971199, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fetoni AR, 2011, EXP GERONTOL, V46, P413, DOI 10.1016/j.exger.2010.12.003; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Hight NG, 2003, HEARING RES, V179, P21, DOI 10.1016/S0378-5955(03)00067-4; Hu BH, 1997, HEARING RES, V113, P198, DOI 10.1016/S0378-5955(97)00143-3; Hu BH, 2002, HEARING RES, V166, P62, DOI 10.1016/S0378-5955(02)00286-1; Kaygusuz I, 2001, HEARING RES, V162, P43, DOI 10.1016/S0378-5955(01)00365-3; Kikkawa YS, 2009, NEUROREPORT, V20, P689, DOI 10.1097/WNR.0b013e32832a5c68; Kopke R, 2005, ACTA OTO-LARYNGOL, V125, P235, DOI 10.1080/00016480410023038; Le Prell CG, 2007, HEARING RES, V226, P22, DOI 10.1016/j.heares.2006.10.006; Le Prell CG, 2007, FREE RADICAL BIO MED, V42, P1454, DOI 10.1016/j.freeradbiomed.2007.02.008; LIM DJ, 1971, ARCHIV OTOLARYNGOL, V94, P294; Lin Y, 2011, NEUROSCI LETT, V487, P12, DOI 10.1016/j.neulet.2010.09.064; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Ohinata Y, 2000, BRAIN RES, V878, P163, DOI 10.1016/S0006-8993(00)02733-5; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P237, DOI 10.1159/000013847; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P229, DOI 10.1159/000013846; Ohlemiller KK, 2000, JARO-J ASSOC RES OTO, V1, P243, DOI 10.1007/s101620010043; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Poirrier AL, 2010, CURR MED CHEM, V17, P3591; Sun QA, 2011, J SURG RES, V165, pE43, DOI 10.1016/j.jss.2010.09.024; Warchol ME, 2010, CURR OPIN OTOLARYNGO, V18, P454, DOI 10.1097/MOO.0b013e32833e05ec; Yamane H, 1995, EUR ARCH OTO-RHINO-L, V252, P504, DOI 10.1007/BF02114761; Yamashita D, 2005, NEUROSCIENCE, V134, P633, DOI 10.1016/j.neuroscience.2005.04.015; Yamashita D, 2004, BRAIN RES, V1019, P201, DOI 10.1016/j.brainres.2004.05.104; Zhang JY, 2012, HEPATO-GASTROENTEROL, V59, P1026, DOI 10.5754/hge11883; Zhou Y, 2012, NEUROSCIENCE, V209, P47, DOI 10.1016/j.neuroscience.2012.02.028	26	12	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100774	10.1371/journal.pone.0100774	http://dx.doi.org/10.1371/journal.pone.0100774			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945316	Green Published, gold			2022-12-25	WOS:000340721500104
J	Cros, A; Fatan, NA; White, A; Teoh, SJ; Tan, S; Handayani, C; Huang, C; Peterson, N; Li, RV; Siry, HY; Fitriana, R; Gove, J; Acoba, T; Knight, M; Acosta, R; Andrew, N; Beare, D				Cros, Annick; Fatan, Nurulhuda Ahamad; White, Alan; Teoh, Shwu Jiau; Tan, Stanley; Handayani, Christian; Huang, Charles; Peterson, Nate; Li, Ruben Venegas; Siry, Hendra Yusran; Fitriana, Ria; Gove, Jamison; Acoba, Tomoko; Knight, Maurice; Acosta, Renerio; Andrew, Neil; Beare, Doug			The Coral Triangle Atlas: An Integrated Online Spatial Database System for Improving Coral Reef Management	PLOS ONE			English	Article							CLIMATE-CHANGE; IMPACTS	In this paper we describe the construction of an online GIS database system, hosted by WorldFish, which stores bio-physical, ecological and socio-economic data for the 'Coral Triangle Area' in South-east Asia and the Pacific. The database has been built in partnership with all six (Timor-Leste, Malaysia, Indonesia, The Philippines, Solomon Islands and Papua New Guinea) of the Coral Triangle countries, and represents a valuable source of information for natural resource managers at the regional scale. Its utility is demonstrated using biophysical data, data summarising marine habitats, and data describing the extent of marine protected areas in the region.	[Cros, Annick; White, Alan] Nature Conservancy, Indo Pacific Div, Honolulu, HI USA; [Fatan, Nurulhuda Ahamad; Teoh, Shwu Jiau; Tan, Stanley; Li, Ruben Venegas; Andrew, Neil; Beare, Doug] Nat Resources Management, Bayan Lepas, Penang, Malaysia; [Handayani, Christian] Coral Triangle Program, WWF Indonesia, South Jakarta, Indonesia; [Huang, Charles] Coral Triangle Program, WWF United States, Washington, DC USA; [Peterson, Nate] Nature Conservancy, Indo Pacific Div, Townsville, Qld, Australia; [Siry, Hendra Yusran] Coral Triangle Initiat Coral Reefs & Food Secur, Jakarta, Indonesia; [Fitriana, Ria] Coral Triangle Ctr, Bali, Indonesia; [Gove, Jamison; Acoba, Tomoko] Natl Ocean & Atmospher Adm, Joint Inst Marine & Atmospher Res, Honolulu, HI USA; [Knight, Maurice] Coral Triangle Support Partnership, WWF Indonesia, Jakarta, Indonesia; [Acosta, Renerio] United States Agcy Int Dev Reg Dev Mission Asia, Reg Environm Off, Bangkok, Thailand	Nature Conservancy; World Wildlife Fund; National Oceanic Atmospheric Admin (NOAA) - USA; World Wildlife Fund; United States Agency for International Development (USAID)	Beare, D (corresponding author), Nat Resources Management, Bayan Lepas, Penang, Malaysia.	dbeare@cgiar.org	andrew, neil/AAG-6360-2020; Venegas Li, Rubén/G-6560-2016	andrew, neil/0000-0002-2337-8722; Venegas Li, Rubén/0000-0003-2085-8269; , Ngobrolgame.com/0000-0001-6815-9112	U.S. Government; CGIAR	U.S. Government; CGIAR(CGIAR)	The CT Atlas (http://ctatlas.reefbase.org) was developed as a partnership between WorldFish, The Nature Conservancy (TNC), World Wildlife Fund (WWF), Wildlife Conservation Society (WCS) and the International Union for Conservation of Nature (IUCN). The design and development of the CT Atlas was supported primarily by the U.S. Government through the 5-year (2009-2013) Coral Triangle Support Partnership (CTSP) in cooperation with other implementing partners of the US Coral Triangle Support Program (USCTI). The production of the current manuscript was also supported by the CGIAR Research Programs on: Climate Change, Agriculture and Food Security (CCAFS); and Aquatic Agricultural Systems (AAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; Anselin L, 2010, ADV SPAT SCI, P35, DOI 10.1007/978-3-642-01976-0_3; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Burke L, 2009, REEFS RISK REVISITED; Carpenter KE, 2010, J MAR BIOL 2011; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Cinner JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074321; Cros A, 2014, COAST MANAGE, V42, P128, DOI 10.1080/08920753.2014.877760; Foale S, 2013, MAR POLICY, V38, P174, DOI 10.1016/j.marpol.2012.05.033; Francini RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054260; Green AL, 2003, REP EXP WORKSH HELD; Heath MR, 2008, MAR ECOL PROG SER, V363, P183, DOI 10.3354/meps07460; Hoegh-Guldberg O., 2009, CORAL TRIANGLE CLIMA; HOWARTH RW, 1988, ANNU REV ECOL SYST, V19, P89, DOI 10.1146/annurev.es.19.110188.000513; Kasper-Fuehrer EC, 2001, J MANAGE, V27, P235, DOI 10.1016/S0149-2063(01)00090-3; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Mcleod E, 2010, SUSTAIN SCI, V5, P207, DOI 10.1007/s11625-010-0105-1; Penaflor EL, 2009, CORAL REEFS, V28, P841, DOI 10.1007/s00338-009-0522-8; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Stein L, 2002, NATURE, V417, P119, DOI 10.1038/417119a; Veron J.E.N., 2009, Galaxea - Tokyo, V11, P91; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009	24	14	15	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e96332	10.1371/journal.pone.0096332	http://dx.doi.org/10.1371/journal.pone.0096332			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941442	Green Published, gold, Green Submitted			2022-12-25	WOS:000338508200001
J	La Scaleia, B; Lacquaniti, F; Zago, M				La Scaleia, Barbara; Lacquaniti, Francesco; Zago, Myrka			Neural Extrapolation of Motion for a Ball Rolling Down an Inclined Plane	PLOS ONE			English	Article							VISUAL GRAVITATIONAL MOTION; MOVING TARGETS; REPRESENTATIONAL MOMENTUM; MANUAL INTERCEPTIONS; INTERNAL-MODELS; FALLING BALL; PERCEPTION; MOVEMENTS; HAND; DYNAMICS	It is known that humans tend to misjudge the kinematics of a target rolling down an inclined plane. Because visuomotor responses are often more accurate and less prone to perceptual illusions than cognitive judgments, we asked the question of how rolling motion is extrapolated for manual interception or drawing tasks. In three experiments a ball rolled down an incline with kinematics that differed as a function of the starting position (4 different positions) and slope (30 degrees, 45 degrees or 60 degrees). In Experiment 1, participants had to punch the ball as it fell off the incline. In Experiment 2, the ball rolled down the incline but was stopped at the end; participants were asked to imagine that the ball kept moving and to punch it. In Experiment 3, the ball rolled down the incline and was stopped at the end; participants were asked to draw with the hand in air the trajectory that would be described by the ball if it kept moving. We found that performance was most accurate when motion of the ball was visible until interception and haptic feedback of hand-ball contact was available (Experiment 1). However, even when participants punched an imaginary moving ball (Experiment 2) or drew in air the imaginary trajectory (Experiment 3), they were able to extrapolate to some extent global aspects of the target motion, including its path, speed and arrival time. We argue that the path and kinematics of a ball rolling down an incline can be extrapolated surprisingly well by the brain using both visual information and internal models of target motion.	[La Scaleia, Barbara; Lacquaniti, Francesco; Zago, Myrka] IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy; [Lacquaniti, Francesco] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Lacquaniti, Francesco] Univ Roma Tor Vergata, Ctr Space Biomed, Rome, Italy	IRCCS Santa Lucia; University of Rome Tor Vergata; University of Rome Tor Vergata	Zago, M (corresponding author), IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy.	m.zago@hsantalucia.it	Zago, Myrka/B-3669-2012; La Scaleia, Barbara/A-5981-2015; Lacquaniti, Francesco/J-9842-2016; La Scaleia, Barbara/AAB-2190-2019	Zago, Myrka/0000-0001-7100-7582; La Scaleia, Barbara/0000-0003-2050-2641; Lacquaniti, Francesco/0000-0003-0896-7315; 	Italian Health Ministry; Italian University Ministry (PRIN project); Italian Space Agency (CRUSOE grant); Italian Space Agency (COREA grant); Italian Space Agency (ARIANNA grant)	Italian Health Ministry(Ministry of Health, Italy); Italian University Ministry (PRIN project); Italian Space Agency (CRUSOE grant); Italian Space Agency (COREA grant); Italian Space Agency (ARIANNA grant)	The work was supported by the Italian Health Ministry, Italian University Ministry (PRIN project), and Italian Space Agency (CRUSOE, COREA and ARIANNA grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGLIOTI S, 1995, CURR BIOL, V5, P679, DOI 10.1016/S0960-9822(95)00133-3; Arce F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004214; Baures R, 2011, PERCEPTION, V40, P674, DOI 10.1068/p6945; Bennett SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063382; BERTAMINI M, 1993, MEM COGNITION, V21, P449, DOI 10.3758/BF03197176; Bertamini M., 2004, MULTIDISCIPLINARY AP, P32; Bosco G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049381; Bozzi P., 1961, AUT AUT, V64, P1; Bozzi P., 1959, RIV PSICOL, VLIII, P337; Brenner E, 1998, EXP BRAIN RES, V122, P467, DOI 10.1007/s002210050535; Brenner E, 2012, ACTA PSYCHOL, V141, P104, DOI 10.1016/j.actpsy.2012.07.002; Cesqui B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031770; de Rugy A, 2012, J NEUROPHYSIOL, V107, P766, DOI 10.1152/jn.00854.2011; De Sa Teixeira N, 2014, ATTEN PERCEPT PSYCHO; Teixeira NAD, 2013, J EXP PSYCHOL HUMAN, V39, P1690, DOI 10.1037/a0031777; Dessing JC, 2004, ECOL PSYCHOL, V16, P1, DOI 10.1207/s15326969eco1601_1; Dessing JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013161; Dessing JC, 2009, EXP BRAIN RES, V192, P669, DOI 10.1007/s00221-008-1588-1; DIEM K., 1962, Documenta Geigy. Scientific tables.; Ebersbach M, 2011, INT J SCI MATH EDUC, V9, P25, DOI 10.1007/s10763-010-9208-5; FREYD JJ, 1987, PSYCHOL REV, V94, P427, DOI 10.1037/0033-295X.94.4.427; Gomez J, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00046; HECHT H, 1993, PERCEPTION, V22, P917, DOI 10.1068/p220917; Hibbard PB, 2003, EXP BRAIN RES, V148, P196, DOI 10.1007/s00221-002-1295-2; Howe CQ, 2005, P NATL ACAD SCI USA, V102, P1228, DOI 10.1073/pnas.0409311102; Hubbard TL, 2005, PSYCHON B REV, V12, P822, DOI 10.3758/BF03196775; HUBBARD TL, 1995, PSYCHON B REV, V2, P322, DOI 10.3758/BF03210971; Indovina I, 2005, SCIENCE, V308, P416, DOI 10.1126/science.1107961; KAISER MK, 1992, J EXP PSYCHOL HUMAN, V18, P669, DOI 10.1037/0096-1523.18.3.669; Katsumata H, 2012, EXP BRAIN RES, V216, P499, DOI 10.1007/s00221-011-2954-y; Khan MA, 2003, MOTOR CONTROL, V7, P290, DOI 10.1123/mcj.7.3.290; LACQUANITI F, 1987, BRAIN RES, V406, P373, DOI 10.1016/0006-8993(87)90810-9; LACQUANITI F, 1993, J NEUROPHYSIOL, V69, P1443, DOI 10.1152/jn.1993.69.5.1443; LACQUANITI F, 1989, J NEUROSCI, V9, P149; Lee D, 1997, EXP BRAIN RES, V116, P421, DOI 10.1007/PL00005770; LEE DN, 1983, Q J EXP PSYCHOL-A, V35, P333, DOI 10.1080/14640748308402138; Magdalon EC, 2011, ACTA PSYCHOL, V138, P126, DOI 10.1016/j.actpsy.2011.05.015; Marinovic W, 2009, EXP PSYCHOL, V56, P265, DOI 10.1027/1618-3169.56.4.265; MCCLOSKEY M, 1980, SCIENCE, V210, P1139, DOI 10.1126/science.210.4474.1139; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; McIntyre J, 1997, J NEUROPHYSIOL, V78, P1601, DOI 10.1152/jn.1997.78.3.1601; MCLEOD P, 1987, PERCEPTION, V16, P49, DOI 10.1068/p160049; Michaels CF, 2001, Q J EXP PSYCHOL-A, V54, P69, DOI 10.1080/02724980042000039; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Morrison D. F., 1990, MULTIVARIATE STAT ME; Mrotek LA, 2007, J NEUROSCI, V27, P7297, DOI 10.1523/JNEUROSCI.2046-07.2007; Mrotek LA, 2007, EXP BRAIN RES, V178, P99, DOI 10.1007/s00221-006-0717-y; Oh S, 2008, PERCEPTION, V37, P317, DOI 10.1068/p5887; Port NL, 1997, EXP BRAIN RES, V116, P406, DOI 10.1007/PL00005769; PROFFITT DR, 1989, J EXP PSYCHOL HUMAN, V15, P384, DOI 10.1037/0096-1523.15.2.384; Proffitt DR, 1995, PSYCHON B REV, V2, P409, DOI 10.3758/BF03210980; PROFFITT DR, 1990, COGNITIVE PSYCHOL, V22, P342, DOI 10.1016/0010-0285(90)90007-Q; Rohrer D, 2002, J EXP PSYCHOL HUMAN, V28, P963, DOI 10.1037//0096-1523.28.4.963; SHEPARD RN, 1984, PSYCHOL REV, V91, P417, DOI 10.1037/0033-295X.91.4.417; Souto D, 2013, J VISION, V13, DOI 10.1167/13.2.9; TEASDALE N, 1993, J MOTOR BEHAV, V25, P97, DOI 10.1080/00222895.1993.9941644; Tijtgat P, 2010, EXP BRAIN RES, V201, P875, DOI 10.1007/s00221-009-2102-0; Tresilian JR, 1997, BRAIN, V120, P2093, DOI 10.1093/brain/120.11.2093; Tresilian JR, 1999, TRENDS COGN SCI, V3, P301, DOI 10.1016/S1364-6613(99)01352-2; Tresilian JR, 2002, EXP BRAIN RES, V142, P193, DOI 10.1007/s00221-001-0920-9; VICARIO GB, 1990, PERCEPTION, V19, P57, DOI 10.1068/p190057; Vishton PM, 2010, EXP BRAIN RES, V202, P661, DOI 10.1007/s00221-010-2172-z; Watamaniuk SNJ, 2003, J VISION, V3, P698, DOI 10.1167/3.11.5; WERKHOVEN P, 1992, VISION RES, V32, P2313, DOI 10.1016/0042-6989(92)90095-Z; Witt JK, 2007, PERCEPTION, V36, P1752, DOI 10.1068/p5617; Witt JK, 2007, PERCEPTION, V36, P249, DOI 10.1068/p5449; Zago M, 2005, J NEUROPHYSIOL, V94, P1346, DOI 10.1152/jn.00215.2005; Zago M, 2005, NEUROPSYCHOLOGIA, V43, P178, DOI 10.1016/j.neuropsychologia.2004.11.005; Zago M, 2005, J NEUROPHYSIOL, V93, P1055, DOI 10.1152/jn.00833.2004; Zago M, 2004, J NEUROPHYSIOL, V91, P1620, DOI 10.1152/jn.00862.2003; Zago M, 2008, VISION RES, V48, P1532, DOI 10.1016/j.visres.2008.04.005; Zago M, 2010, EXP BRAIN RES, V201, P365, DOI 10.1007/s00221-009-2041-9	72	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99837	10.1371/journal.pone.0099837	http://dx.doi.org/10.1371/journal.pone.0099837			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940874	Green Published, gold			2022-12-25	WOS:000338508200046
J	Rodrigues, AM; Bergamaschi, CT; Fernandes, MJS; Paredes-Gamero, EJ; Curi, MV; Ferreira, AT; Araujo, SRR; Punaro, GR; Maciel, FR; Nogueira, GB; Higa, EMS				Rodrigues, Adelson M.; Bergamaschi, Cassia T.; Fernandes, Maria Jose S.; Paredes-Gamero, Edgar J.; Curi, Marcus V.; Ferreira, Alice T.; Araujo, Sergio R. R.; Punaro, Giovana R.; Maciel, Fabiane R.; Nogueira, Guilherme B.; Higa, Elisa M. S.			P2X(7) Receptor in the Kidneys of Diabetic Rats Submitted to Aerobic Training or to N-Acetylcysteine Supplementation	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; REACTIVE OXYGEN; OXIDATIVE STRESS; ENDOTHELIAL-CELLS; EXERCISE; DYSFUNCTION; MUSCLE; TETRAHYDROBIOPTERIN; PROGRESSION; RESTRICTION	Previous studies in our laboratory showed that N-acetylcysteine supplementation or aerobic training reduced oxidative stress and the progression of diabetic nephropathy in rats. The P2X(7) receptor is up-regulated in pathological conditions, such as diabetes mellitus. This up-regulation is related to oxidative stress and induces tissue apoptosis or necrosis. The aim of the present study is to assess the role of P2X(7) receptor in the kidneys of diabetic rats submitted to aerobic training or N-acetylcysteine supplementation. Diabetes was induced in male Wistar rats by streptozotocin (60 mg/kg, i.v.) and the training was done on a treadmill; N-acetylcysteine was given in the drinking water (600 mg/L). By confocal microscopy, as compared to control, the kidneys of diabetic rats showed increased P2X7 receptor expression and a higher activation in response to 2'(3')-O-(4-benzoylbenzoyl) adenosine5'-triphosphate (specific agonist) and adenosine triphosphate (nonspecific agonist) (all p<0.05). All these alterations were reduced in diabetic rats treated with N-acetylcysteine, exercise or both. We also observed measured proteinuria and albuminuria (early marker of diabetic nephropathy) in DM groups. Lipoperoxidation was strongly correlated with P2X(7) receptor expression, which was also correlated to NO center dot, thus associating this receptor to oxidative stress and kidney lesion. We suggest that P2X(7) receptor inhibition associated with the maintenance of redox homeostasis could be useful as coadjuvant treatment to delay the progression of diabetic nephropathy.	[Rodrigues, Adelson M.; Punaro, Giovana R.; Maciel, Fabiane R.; Nogueira, Guilherme B.; Higa, Elisa M. S.] Univ Fed Sao Paulo, Div Nephrol, Dept Med, Sao Paulo, Brazil; [Bergamaschi, Cassia T.] Univ Fed Sao Paulo, Cardiovasc Div, Dept Physiol, Sao Paulo, Brazil; [Fernandes, Maria Jose S.] Univ Fed Sao Paulo, Dept Neurol Neurosurg, Sao Paulo, Brazil; [Paredes-Gamero, Edgar J.; Curi, Marcus V.] Univ Fed Sao Paulo, Dept Biochem, Sao Paulo, Brazil; [Ferreira, Alice T.] Univ Fed Sao Paulo, Div Mol Biol, Dept Biophys, Sao Paulo, Brazil; [Araujo, Sergio R. R.] Univ Fed Sao Paulo, Investigat Pathol Div, Dept Pathol, Sao Paulo, Brazil; [Higa, Elisa M. S.] Univ Fed Sao Paulo, Emergency Div, Dept Med, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Higa, EMS (corresponding author), Univ Fed Sao Paulo, Div Nephrol, Dept Med, Sao Paulo, Brazil.	emshiga@unifesp.br	Paredes-Gamero, Edgar J/C-4791-2012; da Silva Fernandes, Maria Jose/M-5095-2017; Bergamaschi, Cassia/AAZ-9441-2020; Higa, Elisa/I-3672-2013; Rodrigues, Adelson Marcal/D-8745-2014; Buri, Marcus Vinicius/L-4333-2017	Paredes-Gamero, Edgar J/0000-0003-3686-8402; da Silva Fernandes, Maria Jose/0000-0001-6559-3052; Rodrigues, Adelson Marcal/0000-0003-1220-1806; Punaro, Giovana/0000-0002-0833-1344; Buri, Marcus Vinicius/0000-0002-8925-1206; Bergamaschi, Cassia/0000-0002-5741-6993	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Apoio a Universidade Federal de Sao Paulo (FAP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio a Universidade Federal de Sao Paulo (FAP)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Apoio a Universidade Federal de Sao Paulo (FAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afolayan AJ, 2013, AFR J TRADIT COMPLEM, V10, P15, DOI 10.4314/ajtcam.v10i1.3; Annunziato L, 2002, NEUROBIOL AGING, V23, P819, DOI 10.1016/S0197-4580(02)00069-6; BERNHEIM F, 1948, J BIOL CHEM, V174, P257; Bourzac JF, 2013, J CELL PHYSIOL, V228, P120, DOI 10.1002/jcp.24111; Coddou C, 2009, J NEUROSCI, V29, P12284, DOI 10.1523/JNEUROSCI.2096-09.2009; Conti V, 2013, MED SCI SPORT EXER, V45, P644, DOI 10.1249/MSS.0b013e318279fb59; Cosenzi A, 2002, ACTA DIABETOL, V39, P91, DOI 10.1007/s005920200019; da Cunha MJ, 2013, LIFE SCI, V92, P218, DOI 10.1016/j.lfs.2012.12.005; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; Debevec T, 2013, MED SCI SPORTS EXERC; Dona F, 2009, EPILEPSY RES, V83, P157, DOI 10.1016/j.eplepsyres.2008.10.008; Faria AM, 2012, DIABETES, V61, P1838, DOI 10.2337/db11-1241; Forbes SC, 2012, ENDOCRINE, V42, P29, DOI 10.1007/s12020-012-9676-1; Grutzmacher C, 2013, AM J PHYSIOL-RENAL, V304, pF19, DOI 10.1152/ajprenal.00036.2012; HAMPL V, 1996, METHODS NITRIC OXIDE, P310; Hewinson J, 2007, BIOCHEM SOC T, V35, P1168, DOI 10.1042/BST0351168; Hoang HH, 2013, CURR OPIN CLIN NUTR, V16, P76, DOI 10.1097/MCO.0b013e32835ad1ef; JI LL, 1993, J APPL PHYSIOL, V74, P788, DOI 10.1152/jappl.1993.74.2.788; Kukner A, 2009, CLIN REV OPINIONS, V1, P029; Kurdak H, 2010, J SPORT SCI MED, V9, P294; Leandro SM, 2008, PHYSIOL BEHAV, V95, P145, DOI 10.1016/j.physbeh.2008.05.011; Madden KM, 2013, DIABETES METAB SYNDR, V6, P233, DOI 10.2147/DMSO.S32951; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; Manna Prasenjit, 2006, BMC Complement Altern Med, V6, P33, DOI 10.1186/1472-6882-6-33; Shimizu MHM, 2008, NEPHROL DIAL TRANSPL, V23, P3067, DOI 10.1093/ndt/gfn237; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Nogueira GB, 2011, PHIL ASN KIDN WEEK 2, P1; Ochodnicky P, 2006, J AM SOC NEPHROL, V17, pS49, DOI 10.1681/ASN.2005121322; Paredes-Gamero EJ, 2008, J BIOL CHEM, V283, P31909, DOI 10.1074/jbc.M801990200; Punaro GR, 2014, NITRIC OXIDE; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rodrigues AM, 2011, EXP BIOL MED, V236, P1180, DOI 10.1258/ebm.2011.011005; ROMANELLI G, 1991, J HUM HYPERTENS, V5, P167; Roughan JV, 2004, BEHAV PHARMACOL, V15, P461, DOI 10.1097/00008877-200411000-00002; Rocha RER, 2013, ARQ BRAS ENDOCRINOL, V57, P594, DOI 10.1590/S0004-27302013000800003; Santhanam AVR, 2012, J NEUROCHEM, V122, P1211, DOI 10.1111/j.1471-4159.2012.07872.x; Santin K, 2011, BRAIN RES, V1421, P1, DOI 10.1016/j.brainres.2011.08.003; Schulze-Lohoff E, 1998, AM J PHYSIOL-RENAL, V275, pF962, DOI 10.1152/ajprenal.1998.275.6.F962; Sen CK, 2001, MED SCI SPORT EXER, V33, P368, DOI 10.1097/00005768-200103000-00005; Shimamoto K, 2011, J TOXICOL SCI, V36, P775, DOI 10.2131/jts.36.775; Shimizu MHM, 2005, KIDNEY INT, V68, P2208, DOI 10.1111/j.1523-1755.2005.00677.x; Smith JM, 1997, CARDIOVASC RES, V34, P137, DOI 10.1016/S0008-6363(96)00238-6; Song W, 2009, J GERONTOL A-BIOL, V64, P540, DOI 10.1093/gerona/glp021; Souza CO, 2012, BBA-GEN SUBJECTS, V1820, P1867, DOI 10.1016/j.bbagen.2012.08.013; Summers BA, 1999, J NEUROPHYSIOL, V81, P1449, DOI 10.1152/jn.1999.81.4.1449; Thaning P, 2010, DIABETES, V59, P182, DOI 10.2337/db09-1068; Tirkey Naveen, 2005, BMC Pharmacology, V5, P15, DOI 10.1186/1471-2210-5-15; Torres LL, 2011, J ALZHEIMERS DIS, V26, P59, DOI 10.3233/JAD-2011-110284; Trueblood KE, 2011, AM J PHYSIOL-CELL PH, V301, pC1213, DOI 10.1152/ajpcell.00265.2011; Volonte C, 2012, CNS NEUROL DISORD-DR, V11, P705, DOI 10.2174/187152712803581137; Vonend O, 2004, KIDNEY INT, V66, P157, DOI 10.1111/j.1523-1755.2004.00717.x; Winnick JJ, 2008, J CLIN ENDOCR METAB, V93, P771, DOI 10.1210/jc.2007-1524; Xu H, 2013, BRAIN RES B	53	34	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e97452	10.1371/journal.pone.0097452	http://dx.doi.org/10.1371/journal.pone.0097452			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940871	gold, Green Submitted, Green Published			2022-12-25	WOS:000338508200004
J	Giachin, G; Narkiewicz, J; Scaini, D; Ngoc, AT; Margon, A; Sequi, P; Leita, L; Legname, G				Giachin, Gabriele; Narkiewicz, Joanna; Scaini, Denis; Ai Tran Ngoc; Margon, Alja; Sequi, Paolo; Leita, Liviana; Legname, Giuseppe			Prion Protein Interaction with Soil Humic Substances: Environmental Implications	PLOS ONE			English	Article							INSECTICIDAL CRY1AB PROTEIN; FULVIC-ACID; ORGANIC-MATTER; HURNIC ACID; ADSORPTION; TRANSMISSION; FATE; AFM; FRACTIONATION; AGGREGATION	Transmissible spongiform encephalopathies (TSE) are fatal neurodegenerative disorders caused by prions. Animal TSE include scrapie in sheep and goats, and chronic wasting disease (CWD) in cervids. Effective management of scrapie in many parts of the world, and of CWD in North American deer population is complicated by the persistence of prions in the environment. After shedding from diseased animals, prions persist in soil, withstanding biotic and abiotic degradation. As soil is a complex, multi-component system of both mineral and organic components, it is important to understand which soil compounds may interact with prions and thus contribute to disease transmission. Several studies have investigated the role of different soil minerals in prion adsorption and infectivity; we focused our attention on the interaction of soil organic components, the humic substances (HS), with recombinant prion protein (recPrP) material. We evaluated the kinetics of recPrP adsorption, providing a structural and biochemical characterization of chemical adducts using different experimental approaches. Here we show that HS act as potent anti-prion agents in prion infected neuronal cells and in the amyloid seeding assays: HS adsorb both recPrP and prions, thus sequestering them from the prion replication process. We interpreted our findings as highly relevant from an environmental point of view, as the adsorption of prions in HS may affect their availability and consequently hinder the environmental transmission of prion diseases in ruminants.	[Giachin, Gabriele; Narkiewicz, Joanna; Ai Tran Ngoc; Legname, Giuseppe] SISSA, Dept Neurosci, Lab Prion Biol, Trieste, Italy; [Scaini, Denis] Univ Trieste, Dept Life Sci, Trieste, Italy; [Margon, Alja; Sequi, Paolo; Leita, Liviana] Consiglio Ric & Sperimentaz Agr CRA, Gorizia, Italy	International School for Advanced Studies (SISSA); University of Trieste; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Leita, L (corresponding author), Consiglio Ric & Sperimentaz Agr CRA, Gorizia, Italy.	liviana.leita@entecra.it; giuseppe.legname@sissa.it	Giachin, Gabriele/AAE-2348-2020; Legname, Giuseppe/C-1723-2012; Scaini, Denis/HGU-4752-2022	Giachin, Gabriele/0000-0001-7550-0307; Legname, Giuseppe/0000-0003-0716-4393; Scaini, Denis/0000-0001-8398-8074	Italian Ministry of Agricultural, Food and Forestry Policies "Strategie di abbattimento della trasmissibilita delle Scrapie SCRASU" (Scrapie transmissibility reduction strategies)	Italian Ministry of Agricultural, Food and Forestry Policies "Strategie di abbattimento della trasmissibilita delle Scrapie SCRASU" (Scrapie transmissibility reduction strategies)	Italian Ministry of Agricultural, Food and Forestry Policies "Strategie di abbattimento della trasmissibilita delle Scrapie SCRASU" (Scrapie transmissibility reduction strategies) to GL and LL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEYER WN, 1994, J WILDLIFE MANAGE, V58, P375, DOI 10.2307/3809405; Chen CL, 2007, COLLOID SURFACE A, V302, P121, DOI 10.1016/j.colsurfa.2007.02.014; Cheng S, 2008, J MICROSC-OXFORD, V231, P384, DOI 10.1111/j.1365-2818.2008.02051.x; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; Cornejo A, 2011, J ALZHEIMERS DIS, V27, P143, DOI 10.3233/JAD-2011-110623; Corsaro A, 2010, J BIOL REG HOMEOS AG, V24, P27; Ge XP, 2006, SCI CHINA SER B, V49, P256, DOI 10.1007/s11426-006-0256-1; Genovesi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001069; Georgsson G, 2006, J GEN VIROL, V87, P3737, DOI 10.1099/vir.0.82011-0; Gough KC, 2010, PRION, V4, P275, DOI 10.4161/pri.4.4.13678; GREIG J. R., 1940, VET JOUR, V96, P203; Hoang NAT, 2010, NANOSCALE, V2, P2724, DOI 10.1039/c0nr00551g; Ilc G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011715; Imran M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-493; Jacobson KH, 2013, ENVIRON SCI TECHNOL, V47, P6925, DOI 10.1021/es3045899; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Leita L, 2006, SOIL BIOL BIOCHEM, V38, P1638, DOI 10.1016/j.soilbio.2005.11.018; Li Y, 2013, ENVIRON SCI TECHNOL, V47, P5050, DOI 10.1021/es3053027; Liu AG, 2000, COLLOID SURFACE A, V174, P245, DOI 10.1016/S0927-7757(00)00535-5; Liu ZG, 2011, MICROSC MICROANAL, V17, P1015, DOI 10.1017/S1431927611012177; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Moudjou M, 2001, J GEN VIROL, V82, P2017, DOI 10.1099/0022-1317-82-8-2017; Namjesnik-Dejanovic K, 2001, GEOCHIM COSMOCHIM AC, V65, P1047, DOI 10.1016/S0016-7037(00)00542-1; Nebbioso A, 2012, ANAL CHIM ACTA, V720, P77, DOI 10.1016/j.aca.2012.01.027; Nebbioso A, 2011, BIOMACROMOLECULES, V12, P1187, DOI 10.1021/bm101488e; Nichols TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062455; Piccolo A., 2000, ADV ENVIRON RES, V3, P508; Polano M, 2008, BIOCHEM BIOPH RES CO, V367, P323, DOI 10.1016/j.bbrc.2007.12.143; Polano M, 2009, J MOL BIOL, V393, P1033, DOI 10.1016/j.jmb.2009.08.056; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Race BL, 2007, EMERG INFECT DIS, V13, P824, DOI 10.3201/eid1306.070186; Rao MA, 2007, SOIL BIOL BIOCHEM, V39, P493, DOI 10.1016/j.soilbio.2006.08.020; Russo F, 2010, OPEN MAGNETIC RESONA, V3, P84; Sander M, 2012, ENVIRON SCI TECHNOL, V46, P9923, DOI 10.1021/es3022478; Saunders SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044051; Saunders SE, 2011, J VIROL, V85, P5476, DOI 10.1128/JVI.00282-11; Saunders SE, 2009, ENVIRON SCI TECHNOL, V43, P7728, DOI 10.1021/es901385t; Smith CB, 2014, SOIL BIOL BIOCHEM, V68, P309, DOI 10.1016/j.soilbio.2013.10.005; Smith CB, 2011, J ENVIRON QUAL, V40, P449, DOI 10.2134/jeq2010.0412; Stevenson F.J., 1994, HUMUS CHEM GENESIS C; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Surewicz WK, 2011, TOP CURR CHEM, V305, P135, DOI 10.1007/128_2011_165; Sutton R, 2005, ENVIRON SCI TECHNOL, V39, P9009, DOI 10.1021/es050778q; Tan WF, 2008, GEOCHIM COSMOCHIM AC, V72, P2090, DOI 10.1016/j.gca.2008.02.009; Terry LA, 2003, VET REC, V152, P387, DOI 10.1136/vr.152.13.387; Tomaszewski JE, 2012, ENVIRON SCI TECHNOL, V46, P9932, DOI 10.1021/es302248u; Tomaszewski JE, 2011, ENVIRON SCI TECHNOL, V45, P6003, DOI 10.1021/es200663h; Vilette D, 2008, VET RES, V39, DOI 10.1051/vetres:2007049; Walter WD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1203; Weissmann C, 2001, PHILOS T R SOC B, V356, P177, DOI 10.1098/rstb.2000.0763; Wyckoff AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058630; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6	55	14	14	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100016	10.1371/journal.pone.0100016	http://dx.doi.org/10.1371/journal.pone.0100016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937266	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400063
J	Gupta, PSP; Folger, JK; Rajput, SK; Lv, LH; Yao, JB; Ireland, JJ; Smith, GW				Gupta, P. S. P.; Folger, Joseph K.; Rajput, Sandeep K.; Lv, Lihua; Yao, Jianbo; Ireland, James J.; Smith, George W.			Regulation and Regulatory Role of WNT Signaling in Potentiating FSH Action during Bovine Dominant Follicle Selection	PLOS ONE			English	Article							CELL ESTRADIOL PRODUCTION; GRANULOSA-CELLS; STIMULATING-HORMONE; TRANSCRIPT CARTPT; ESTROUS-CYCLE; BETA-CATENIN; COCAINE; EXPRESSION; CATTLE; DEGRADATION	Follicular development occurs in wave like patterns in monotocous species such as cattle and humans and is regulated by a complex interaction of gonadotropins with local intrafollicular regulatory molecules. To further elucidate potential mechanisms controlling dominant follicle selection, granulosa cell RNA harvested from F1 (largest) and F2 (second largest) follicles isolated at predeviation (PD) and onset of diameter deviation (OD) stages of the first follicular wave was subjected to preliminary RNA transcriptome analysis. Expression of numerous WNT system components was observed. Hence experiments were performed to test the hypothesis that WNT signaling modulates FSH action on granulosa cells during follicular waves. Abundance of mRNA for WNT pathway members was evaluated in granulosa cells harvested from follicles at emergence (EM), PD, OD and early dominance (ED) stages of the first follicular wave. In F1 follicles, abundance of CTNNB1 and DVL1 mRNAs was higher and AXIN2 mRNA was lower at ED versus EM stages and DVL1 and FZD6 mRNAs were higher and AXIN2 mRNA was lower in F1 versus F2 follicle at the ED stage. Bovine granulosa cells were treated in vitro with increasing doses of the WNT inhibitor IWR-1+/- maximal stimulatory dose of FSH. IWR-1 treatment blocked the FSH-induced increase in granulosa cell numbers and reduced the FSH-induced increase in estradiol. Granulosa cells were also cultured in the presence or absence of FSH +/- IWR-1 and hormonal regulation of mRNA for WNT pathway members and known FSH targets determined. FSH treatment increased CYP19A1, CCND2, CTNNB1, AXIN2 and FZD6 mRNAs and the stimulatory effect on CYP19A1 mRNA was reduced by IWR-1. In contrast, FSH reduced CARTPT mRNA and IWR-1 partially reversed the inhibitory effect of FSH. Results support temporal and hormonal regulation and a potential role for WNT signaling in potentiating FSH action during dominant follicle selection.	[Gupta, P. S. P.; Folger, Joseph K.; Rajput, Sandeep K.; Smith, George W.] Michigan State Univ, Lab Mammalian Reprod Biol & Genom, E Lansing, MI 48824 USA; [Gupta, P. S. P.; Folger, Joseph K.; Rajput, Sandeep K.; Ireland, James J.; Smith, George W.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Lv, Lihua; Smith, George W.] Shanxi Agr Univ, Coll Anim Sci & Technol, Taigu, Shanxi, Peoples R China; [Yao, Jianbo] W Virginia Univ, Div Anim & Nutr Sci, Lab Anim Biotechnol & Genom, Morgantown, WV 26506 USA	Michigan State University; Michigan State University; Shanxi Agricultural University; West Virginia University	Smith, GW (corresponding author), Michigan State Univ, Lab Mammalian Reprod Biol & Genom, E Lansing, MI 48824 USA.	smithge7@msu.edu	Rajput, Sandeep K/F-8857-2015	Rajput, Sandeep K/0000-0001-6450-7773	Department of Biotechnology, Government of India CREST award; Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2009-65203-05700]; Chinese National Natural Science Fund [31172211]; Michigan State University Reproductive and Developmental Sciences Program; Michigan AgBioResearch	Department of Biotechnology, Government of India CREST award; Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; Chinese National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Michigan State University Reproductive and Developmental Sciences Program; Michigan AgBioResearch	P.S.P. Gupta was supported at Michigan State University by a Department of Biotechnology, Government of India CREST award. This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2009-65203-05700 from the USDA National Institute of Food and Agriculture to G. W. S., Chinese National Natural Science Fund Grant no. 31172211 to L. Lv, and funding from the Michigan State University Reproductive and Developmental Sciences Program and Michigan AgBioResearch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beg MA, 2006, REPRODUCTION, V132, P365, DOI 10.1530/rep.1.01233; Boyer A, 2010, TRENDS ENDOCRIN MET, V21, P25, DOI 10.1016/j.tem.2009.08.005; Castanon BI, 2012, J ANIM SCI, V90, P3789, DOI 10.2527/jas.2011-4696; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Fan HY, 2010, MOL ENDOCRINOL, V24, P1529, DOI 10.1210/me.2010-0141; Folger JK, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111609; Fortune JE, 2001, BIOL REPROD, V65, P648, DOI 10.1095/biolreprod65.3.648; Gifford JAH, 2009, BIOL REPROD, V80, P1282, DOI 10.1095/biolreprod.108.072280; GREENWALD GS, 1994, PHYSL REPRODUCTION, V2, P629, DOI DOI 10.1039/C7RA00224F; Gutierrez CG, 1997, BIOL REPROD, V56, P608, DOI 10.1095/biolreprod56.3.608; Han YY, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105106; Hunzicker-Dunn M, 2006, CELL SIGNAL, V18, P1351, DOI 10.1016/j.cellsig.2006.02.011; IRELAND JJ, 1983, ENDOCRINOLOGY, V112, P150, DOI 10.1210/endo-112-1-150; Ireland JJ, 2000, J DAIRY SCI, V83, P1648, DOI 10.3168/jds.S0022-0302(00)75033-8; Kolben T, 2012, BIOL CHEM, V393, P1433, DOI 10.1515/hsz-2012-0186; Lapointe Evelyne, 2011, Front Biosci (Schol Ed), V3, P276, DOI 10.2741/s151; Lu JM, 2009, BIOORG MED CHEM LETT, V19, P3825, DOI 10.1016/j.bmcl.2009.04.040; Luo WX, 2006, BIOL REPROD, V75, P217, DOI 10.1095/biolreprod.105.047407; Lv LH, 2009, BIOL REPROD, V81, P580, DOI 10.1095/biolreprod.109.077586; SAS Institute Inc, 2009, SAS ONL DOC 9 2; Scheetz D, 2012, REPROD FERT DEVELOP, V24, P327, DOI 10.1071/RD11020; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Selvaraju S, 2013, DOMEST ANIM ENDOCRIN, V44, P115, DOI 10.1016/j.domaniend.2012.10.002; Sen A, 2008, MOL ENDOCRINOL, V22, P2655, DOI 10.1210/me.2008-0077; Sen A, 2007, ENDOCRINOLOGY, V148, P4400, DOI 10.1210/en.2007-0332; Smith GW, 2010, SOC REPROD FERTIL, V67, P105; Stapp AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086432; SUNDERLAND SJ, 1994, J REPROD FERTIL, V101, P547, DOI 10.1530/jrf.0.1010547; Wang HX, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109801; XU ZZ, 1995, BIOL REPROD, V53, P951, DOI 10.1095/biolreprod53.4.951	30	28	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100201	10.1371/journal.pone.0100201	http://dx.doi.org/10.1371/journal.pone.0100201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936794	Green Submitted, Green Published, gold			2022-12-25	WOS:000338503400091
J	Brouwer-Visser, J; Lee, J; McCullagh, K; Cossio, MJ; Wang, YH; Huang, GS				Brouwer-Visser, Jurriaan; Lee, Jiyeon; McCullagh, KellyAnne; Cossio, Maria J.; Wang, Yanhua; Huang, Gloria S.			Insulin-Like Growth Factor 2 Silencing Restores Taxol Sensitivity in Drug Resistant Ovarian Cancer	PLOS ONE			English	Article							IGF-II; CELLS; EFFICACY	Drug resistance is an obstacle to the effective treatment of ovarian cancer. We and others have shown that the insulin-like growth factor (IGF) signaling pathway is a novel potential target to overcome drug resistance. The purpose of this study was to validate IGF2 as a potential therapeutic target in drug resistant ovarian cancer and to determine the efficacy of targeting IGF2 in vivo. An analysis of The Cancer Genome Atlas (TCGA) data in the serous ovarian cancer cohort showed that high IGF2 mRNA expression is significantly associated with shortened interval to disease progression and death, clinical indicators of drug resistance. In a genetically diverse panel of ovarian cancer cell lines, the IGF2 mRNA levels measured in cell lines resistant to various microtubule-stabilizing agents including Taxol were found to be significantly elevated compared to the drug sensitive cell lines. The effect of IGF2 knockdown on Taxol resistance was investigated in vitro and in vivo. Transient IGF2 knockdown significantly sensitized drug resistant cells to Taxol treatment. A Taxol-resistant ovarian cancer xenograft model, developed from HEY-T30 cells, exhibited extreme drug resistance, wherein the maximal tolerated dose of Taxol did not delay tumor growth in mice. Blocking the IGF1R (a transmembrane receptor that transmits signals from IGF1 and IGF2) using a monoclonal antibody did not alter the response to Taxol. However, stable IGF2 knockdown using short-hairpin RNA in HEY-T30 effectively restored Taxol sensitivity. These findings validate IGF2 as a potential therapeutic target in drug resistant ovarian cancer and show that directly targeting IGF2 may be a preferable strategy compared with targeting IGF1R alone.	[Brouwer-Visser, Jurriaan; Lee, Jiyeon; McCullagh, KellyAnne; Cossio, Maria J.; Huang, Gloria S.] Albert Einstein Coll Med, Div Gynecol Oncol, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Brouwer-Visser, Jurriaan; Lee, Jiyeon; McCullagh, KellyAnne; Cossio, Maria J.; Wang, Yanhua; Huang, Gloria S.] Montefiore Med Ctr, Bronx, NY 10467 USA; [Wang, Yanhua] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Huang, Gloria S.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Huang, Gloria S.] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Huang, GS (corresponding author), Albert Einstein Coll Med, Div Gynecol Oncol, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA.	ghuang@montefiore.org	Huang, Gloria/N-6129-2017	Huang, Gloria/0000-0002-0001-888X	National Cancer Institute-National Institute of Child Health and Human Development [K12 HD00849]; American Congress of Obstetricians and Gynecologists through the Reproductive Scientist Development Program award; National Cancer Institute Cancer Center Support grant [P30CA013330]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER	National Cancer Institute-National Institute of Child Health and Human Development; American Congress of Obstetricians and Gynecologists through the Reproductive Scientist Development Program award; National Cancer Institute Cancer Center Support grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant support was provided by the the National Cancer Institute-National Institute of Child Health and Human Development (K12 HD00849) and the American Congress of Obstetricians and Gynecologists through the Reproductive Scientist Development Program award to GSH. The authors acknowledge the use of the Albert Einstein Cancer Center Shared Resources (Flow Cytometry Core, Histology and Comparative Pathology Core), supported by the National Cancer Institute Cancer Center Support grant P30CA013330. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit D, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-134; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Ballester M, 2004, BIOTECHNIQUES, V37, P610, DOI 10.2144/04374ST06; Beauchamp MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/257058; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BUICK RN, 1985, CANCER RES, V45, P3668; Duan Z, 2004, MOL CANC THER; Duguay SJ, 1998, J BIOL CHEM, V273, P18443, DOI 10.1074/jbc.273.29.18443; Eckstein N, 2009, CANCER RES, V69, P2996, DOI 10.1158/0008-5472.CAN-08-3153; EVA A, 1982, NATURE, V295, P116, DOI 10.1038/295116a0; Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Garofalo C, 2011, ONCOGENE, V30, P2730, DOI 10.1038/onc.2010.640; Gotlieb WH, 2006, GYNECOL ONCOL, V100, P389, DOI 10.1016/j.ygyno.2005.09.048; Greenall SA, 2013, J BIOL CHEM, V288, P59, DOI 10.1074/jbc.M112.432013; HAMILTON TC, 1984, SEMIN ONCOL, V11, P285; He LF, 2001, MOL CANCER THER, V1, P3; Hope-Roberts M, 2011, BIOTECH HISTOCHEM, V86, P255, DOI 10.3109/10520291003723426; Huang GS, 2010, CLIN CANCER RES, V16, P2999, DOI 10.1158/1078-0432.CCR-09-3233; Huang GS, 2006, CLIN CANCER RES, V12, P298, DOI 10.1158/1078-0432.CCR-05-0229; LEE AV, 1994, MOL CELL ENDOCRINOL, V99, P211, DOI 10.1016/0303-7207(94)90010-8; Marcelletti JF, 2009, LEUKEMIA RES, V33, P769, DOI 10.1016/j.leukres.2008.09.020; Ogawa T, 2010, EUR ARCH OTO-RHINO-L, V267, P1599, DOI 10.1007/s00405-010-1257-4; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Ratajczak MZ, 2013, LEUKEMIA, V27, P773, DOI 10.1038/leu.2012.322; Shahabi S, 2010, GYNECOL ONCOL, V119, P345, DOI 10.1016/j.ygyno.2010.07.005; Sherman-Baust CA, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-21; Stordal B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040717; Tazearslan C, 2011, AGING CELL, V10, P551, DOI 10.1111/j.1474-9726.2011.00697.x; Torres K, 1998, CANCER RES, V58, P3620; Ulanet DB, 2010, P NATL ACAD SCI USA, V107, P10791, DOI 10.1073/pnas.0914076107; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Wu JD, 2005, CLIN CANCER RES, V11, P3065, DOI 10.1158/1078-0432.CCR-04-1586	33	33	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100165	10.1371/journal.pone.0100165	http://dx.doi.org/10.1371/journal.pone.0100165			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932685	Green Submitted, Green Published, gold			2022-12-25	WOS:000337738600099
J	Chang, A; Chen, CC; Li, HH; Li, CSR				Chang, Andrew; Chen, Chien-Chung; Li, Hsin-Hung; Li, Chiang-Shan R.			Event-Related Potentials for Post-Error and Post-Conflict Slowing	PLOS ONE			English	Article							STOP-SIGNAL TASK; ANTERIOR CINGULATE CORTEX; FALSE DISCOVERY RATE; COGNITIVE CONTROL; RESPONSE-INHIBITION; BRAIN POTENTIALS; CONTROL MECHANISMS; ANTISACCADE TASK; ADJUSTMENTS; NEGATIVITY	In a reaction time task, people typically slow down following an error or conflict, each called post-error slowing (PES) and post-conflict slowing (PCS). Despite many studies of the cognitive mechanisms, the neural responses of PES and PCS continue to be debated. In this study, we combined high-density array EEG and a stop-signal task to examine event-related potentials of PES and PCS in sixteen young adult participants. The results showed that the amplitude of N2 is greater during PES but not PCS. In contrast, the peak latency of N2 is longer for PCS but not PES. Furthermore, error-positivity (Pe) but not error-related negativity (ERN) was greater in the stop error trials preceding PES than non-PES trials, suggesting that PES is related to participants' awareness of the error. Together, these findings extend earlier work of cognitive control by specifying the neural correlates of PES and PCS in the stop signal task.	[Chang, Andrew; Chen, Chien-Chung; Li, Hsin-Hung] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan; [Chen, Chien-Chung] Natl Taiwan Univ, Ctr Neurobiol & Cognit Sci, Taipei 10764, Taiwan; [Li, Chiang-Shan R.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Li, Chiang-Shan R.] Yale Univ, Dept Neurobiol, New Haven, CT USA; [Li, Chiang-Shan R.] Yale Univ, Interdept Neurosci Program, New Haven, CT USA	National Taiwan University; National Taiwan University; Yale University; Yale University; Yale University	Chen, CC (corresponding author), Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan.	c3chen@ntu.edu.tw	Li, Chiang-Shan Ray/J-2813-2016; Chang, Andrew/J-7372-2019	Li, Chiang-Shan Ray/0000-0002-9393-1212; Chang, Andrew/0000-0001-6745-4435; Chen, Chien-Chung/0000-0002-3848-0180; Li, Hsin-Hung/0000-0003-3245-2071	Taiwan MOE [101R892101]; NIH [5K02DA026990]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA026990] Funding Source: NIH RePORTER	Taiwan MOE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Taiwan MOE 101R892101 to CCC and NIH 5K02DA026990 to C-SRL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, ANN STAT, V29, P1165; Beste C, 2009, NEUROSCIENCE, V159, P143, DOI 10.1016/j.neuroscience.2008.12.030; Beyer F, 2012, NEUROPSYCHOLOGIA, V50, P3304, DOI 10.1016/j.neuropsychologia.2012.10.007; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Danielmeier C, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00233; de Bruijn ERA, 2004, PSYCHOPHARMACOLOGY, V177, P151, DOI 10.1007/s00213-004-1915-6; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; Egner T, 2008, TRENDS COGN SCI, V12, P374, DOI 10.1016/j.tics.2008.07.001; Egner T, 2007, NEUROIMAGE, V35, P940, DOI 10.1016/j.neuroimage.2006.11.061; Endrass T, 2007, EUR J NEUROSCI, V26, P1714, DOI 10.1111/j.1460-9568.2007.05785.x; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Farr OM, 2012, NEUROIMAGE, V63, P1070, DOI 10.1016/j.neuroimage.2012.07.049; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Gehring WJ, 2001, J NEUROSCI, V21, P9430, DOI 10.1523/JNEUROSCI.21-23-09430.2001; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gentsch A, 2009, NEUROIMAGE, V47, P2023, DOI 10.1016/j.neuroimage.2009.05.064; Hajcak G, 2003, PSYCHOPHYSIOLOGY, V40, P895, DOI 10.1111/1469-8986.00107; Hendrick OM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013155; Hewig J, 2011, PSYCHOPHYSIOLOGY, V48, P1390, DOI 10.1111/j.1469-8986.2011.01209.x; Hu S, 2012, HUM BRAIN MAPP, V33, P2785, DOI 10.1002/hbm.21399; Hu S, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00004; Ide JS, 2013, J NEUROSCI, V33, P2039, DOI 10.1523/JNEUROSCI.2201-12.2013; Ide JS, 2011, NEUROIMAGE, V54, P455, DOI 10.1016/j.neuroimage.2010.07.042; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; Larson MJ, 2012, NEUROPSYCHOLOGIA, V50, P426, DOI 10.1016/j.neuropsychologia.2011.12.021; Larson MJ, 2011, COGN AFFECT BEHAV NE, V11, P159, DOI 10.3758/s13415-010-0018-6; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Li CSR, 2008, NEUROSCIENCE, V155, P1142, DOI 10.1016/j.neuroscience.2008.06.062; Li CSR, 2008, J COGNITIVE NEUROSCI, V20, P1021, DOI 10.1162/jocn.2008.20071; Li CSR, 2006, DRUG ALCOHOL DEPEN, V85, P205, DOI 10.1016/j.drugalcdep.2006.04.008; Li CSR, 2009, CEREB CORTEX, V19, P839, DOI 10.1093/cercor/bhn132; Li CSR, 2006, J NEUROSCI, V26, P186, DOI 10.1523/JNEUROSCI.3741-05.2006; Li CSR, 2005, EXP BRAIN RES, V167, P305, DOI 10.1007/s00221-005-0110-2; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; Luce R.D., 1991, RESPONSE TIMES THEIR; Manuel AL, 2012, J COGNITIVE NEUROSCI, V24, P1331, DOI 10.1162/jocn_a_00150; Mathalon DH, 2002, J ABNORM PSYCHOL, V111, P22, DOI 10.1037//0021-843X.111.1.22; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Nunez Castellar E, 2010, COGN AFFECT BEHAV NE, V10, P270, DOI DOI 10.3758/CABN.10.2.270; Penny W.D., 2004, HUMAN BRAIN FUNCTION, P843; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Riba J, 2005, COGNITIVE BRAIN RES, V25, P554, DOI 10.1016/j.cogbrainres.2005.08.009; Riba J, 2005, J NEUROSCI, V25, P4370, DOI 10.1523/JNEUROSCI.4437-04.2005; Steinhauser M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00240; Steinhauser M, 2010, J NEUROSCI, V30, P15643, DOI 10.1523/JNEUROSCI.1899-10.2010; Strozyk JV, 2012, BRAIN RES, V1460, P41, DOI 10.1016/j.brainres.2012.04.028; Tieges Z, 2004, COGNITIVE BRAIN RES, V21, P87, DOI 10.1016/j.cogbrainres.2004.06.001; Upton DJ, 2010, EXP BRAIN RES, V206, P351, DOI 10.1007/s00221-010-2369-1; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; Wessel JR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00088; Wessel JR, 2011, NEUROIMAGE, V54, P2105, DOI 10.1016/j.neuroimage.2010.10.033; West R, 2008, CEREB CORTEX, V18, P1112, DOI 10.1093/cercor/bhm142; Yeung N, 2006, PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-9280.2006.01680.x; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]; Zhang S, 2012, HUM BRAIN MAPP, V33, P89, DOI 10.1002/hbm.21197; Zirnheld PJ, 2004, J COGNITIVE NEUROSCI, V16, P1098, DOI 10.1162/0898929041502779	61	29	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99909	10.1371/journal.pone.0099909	http://dx.doi.org/10.1371/journal.pone.0099909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ5PV	24932780	Green Published, gold, Green Submitted			2022-12-25	WOS:000337738600079
J	van Kleef, E; Gasparrini, A; Guy, R; Cookson, B; Hope, R; Jit, M; Robotham, JV; Deeny, SR; Edmunds, WJ				van Kleef, Esther; Gasparrini, Antonio; Guy, Rebecca; Cookson, Barry; Hope, Russell; Jit, Mark; Robotham, Julie V.; Deeny, Sarah R.; Edmunds, W. John			Nosocomial Transmission of C. difficile in English Hospitals from Patients with Symptomatic Infection	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; CLOSTRIDIUM-DIFFICILE; RISK-FACTORS; EPIDEMIOLOGY; SURVEILLANCE; ACQUISITION; DIARRHEA; DISEASES; BURDEN	Background: Recent evidence suggests that less than one-quarter of patients with symptomatic nosocomial Clostridium difficile infections (CDI) are linked to other in-patients. However, this evidence was limited to one geographic area. We aimed to investigate the level of symptomatic CDI transmission in hospitals located across England from 2008 to 2012. Methods: A generalized additive mixed-effects Poisson model was fitted to English hospital-surveillance data. After adjusting for seasonal fluctuations and between-hospital variation in reported CDI over time, possible clustering (transmission between symptomatic in-patients) of CDI cases was identified. We hypothesised that a temporal proximity would be reflected in the degree of correlation between in-hospital CDI cases per week. This correlation was modelled through a latent autoregressive structure of order 1 (AR(1)). Findings: Forty-six hospitals (33 general, seven specialist, and six teaching hospitals) located in all English regions met our criteria. In total, 12,717 CDI cases were identified; seventy-five per cent of these occurred >48 hours after admission. There were slight increases in reports during winter months. We found a low, but statistically significant, correlation between successive weekly CDI case incidences (phi = 0.029, 95% CI: 0.009-0.049). This correlation was five times stronger in a subgroup analysis restricted to teaching hospitals (phi = 0.104, 95% CI: 0.048-0.159). Conclusions: The results suggest that symptomatic patient-to-patient transmission has been a source of CDI-acquisition in English hospitals in recent years, and that this might be a more important transmission route in teaching hospitals. Nonetheless, the weak correlation indicates that, in line with recent evidence, symptomatic cases might not be the primary source of nosocomial CDI in England.	[van Kleef, Esther; Gasparrini, Antonio; Jit, Mark; Edmunds, W. John] London Sch Hyg & Trop Med, London WC1, England; [van Kleef, Esther; Guy, Rebecca; Hope, Russell; Jit, Mark; Robotham, Julie V.; Deeny, Sarah R.] Publ Hlth England, London, England; [Cookson, Barry] UCL, London, England	University of London; London School of Hygiene & Tropical Medicine; Public Health England; University of London; University College London	van Kleef, E (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	esther.vankleef@lshtm.ac.uk	Hope, Russell/CAF-3297-2022; Jit, Mark/HDM-7797-2022; Gasparrini, Antonio/F-7627-2012	Hope, Russell/0000-0003-2838-6833; Gasparrini, Antonio/0000-0002-2271-3568; Deeny, Sarah/0000-0001-5994-1583; Robotham, Julie/0000-0003-2515-4084; Jit, Mark/0000-0001-6658-8255; Guy, Rebecca/0000-0001-5500-5691; van Kleef, Esther/0000-0002-3312-7185	Healthcare Infection Society; MRC [G1002296] Funding Source: UKRI; Medical Research Council [G1002296] Funding Source: researchfish	Healthcare Infection Society; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Healthcare Infection Society which has been granted to EvK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald LK, 2004, J INFECT DIS, V189, P1585, DOI 10.1086/383045; Bootsma MCJ, 2007, AM J EPIDEMIOL, V166, P841, DOI 10.1093/aje/kwm149; Bosker, 2012, MULTILEVEL ANAL INTR; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Department of Health, 2012, UPD GUID DIAGN REP C; Didelot X, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r118; Dubberke ER, 2012, CLIN INFECT DIS, V55, pS88, DOI 10.1093/cid/cis335; Eyre DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078445; Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064; Fekety R, 1997, CLIN INFECT DIS, V24, P324, DOI 10.1093/clinids/24.3.324; Forrester ML, 2007, BIOSTATISTICS, V8, P383, DOI 10.1093/biostatistics/kxl017; Ghantoji SS, 2010, J HOSP INFECT, V74, P309, DOI 10.1016/j.jhin.2009.10.016; Gilca R, 2012, ANTIMICROB AGENTS CH, V56, P639, DOI 10.1128/AAC.05411-11; Goldenberg SD, 2011, J HOSP INFECT, V79, P4, DOI 10.1016/j.jhin.2011.03.030; Goldstein Harvey, 2010, MULTILEVEL STAT MODE; Gould LH, 2010, CLIN INFECT DIS, V51, P577, DOI 10.1086/655692; Guerrero DM, 2013, J HOSP INFECT, V85, P155, DOI 10.1016/j.jhin.2013.07.002; Hsu J, 2010, AM J GASTROENTEROL, V105, P2327, DOI 10.1038/ajg.2010.254; Intelligence dr F, 2013, HOSP GUID; KAATZ GW, 1988, AM J EPIDEMIOL, V127, P1289, DOI 10.1093/oxfordjournals.aje.a114921; Kamboj M, 2011, CLIN INFECT DIS, V53, P1003, DOI 10.1093/cid/cir643; Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398; KIM KH, 1981, J INFECT DIS, V143, P42, DOI 10.1093/infdis/143.1.42; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; McBryde ES, 2007, J R SOC INTERFACE, V4, P745, DOI 10.1098/rsif.2007.0224; MCFARLAND L, 1989, NEW ENGL J MED, V321, P190; Pinheiro J, 2001, MIXED EFFECTS MODELS; Polgreen PM, 2010, INFECT CONT HOSP EP, V31, P382, DOI 10.1086/651095; Public Health England (former Health Protection Agency), 2012, MAND SURV CLOSTR DIF; Public Health England (former Health Protection Agency), 2012, ENGL NAT POINT PREV; Ricciardi R, 2012, J HOSP INFECT, V80, P156, DOI 10.1016/j.jhin.2011.11.002; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Samore MH, 1996, AM J MED, V100, P32, DOI 10.1016/S0002-9343(96)90008-X; SODERLUND N, 1995, J PUBLIC HEALTH MED, V17, P25; Starr JM, 2003, AGE AGEING, V32, P657, DOI 10.1093/ageing/afg112; Thomas C, 2003, J ANTIMICROB CHEMOTH, V51, P1339, DOI 10.1093/jac/dkg254; Vernaz N, 2009, J ANTIMICROB CHEMOTH, V63, P1272, DOI 10.1093/jac/dkp128; Walker AS, 2013, CLIN INFECT DIS, V56, P1589, DOI 10.1093/cid/cit127; Walker AS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001172; Wilcox MH, 2012, CLIN INFECT DIS, V55, P1056, DOI 10.1093/cid/cis614; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	41	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99860	10.1371/journal.pone.0099860	http://dx.doi.org/10.1371/journal.pone.0099860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932484	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000337738600074
J	Duff, P; Bingham, B; Simo, A; Jury, D; Reading, C; Shannon, K				Duff, Putu; Bingham, Brittany; Simo, Annick; Jury, Delores; Reading, Charlotte; Shannon, Kate			The 'Stolen Generations' of Mothers and Daughters: Child Apprehension and Enhanced HIV Vulnerabilities for Sex Workers of Aboriginal Ancestry	PLOS ONE			English	Article							FOSTER-CARE; WOMEN; HEALTH; PREVALENCE; DISORDERS; MINORITY; SERVICES; VIOLENCE; CANADA; RISK	Objectives: The number of children in care of the state continues to grow in BC, Canada with a historical legacy of child apprehension among criminalized and marginalized populations, particularly women of Aboriginal ancestry and sex workers. However, there is a paucity of research investigating child apprehension experiences among marginalized mothers. The objective of the current analysis is to examine the prevalence and correlates of child apprehensions among female sex workers in Vancouver, Canada. Methods: Analyses were drawn from the AESHA (An Evaluation of Sex Workers Health Access, 2010-present), a prospective cohort of street and off-street SWs, through outreach and semi-annual visits to the research office. Bivariate and multivariate logistic regression were used to examine correlates of child apprehension. Results: Of a total of 510 SWs, 350 women who had given birth to at least one child were included in the analyses (median age = 37 yrs: IQR: 31-44 yrs). The prevalence of child apprehension among mothers was 38.3%, with 37.4% reporting having been apprehended themselves by child welfare services. In multivariable analysis, servicing clients in outdoor public spaces (versus formal sex work establishments or informal indoor settings) (adjusted odds ratio, (aOR) = 2.73; 95% CI 1.27-5.90), history of injecting drugs (aOR = 2.53; 95% CI 1.42-4.49), Aboriginal ancestry (aOR = 1.66; 95% CI 1.01-2.74) were associated with increased odds of child apprehension. Discussion/Conclusions: Child apprehension rates are high, particularly among the most marginalized sex workers, including sex workers who use drugs and sex workers of Aboriginal ancestry. Structural reforms to child protection are urgently needed, that support family-based care address the historical legacy of colonization affecting Aboriginal peoples.	[Duff, Putu; Bingham, Brittany; Simo, Annick; Shannon, Kate] British Columbia Ctr Excellence HIV AIDS, Gender & Sexual Hlth Initiat, Vancouver, BC, Canada; [Duff, Putu; Shannon, Kate] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Bingham, Brittany] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada; [Jury, Delores] Sex Workers United Violence SWUAV, Vancouver, BC, Canada; [Reading, Charlotte] Univ Victoria, Sch Publ Hlth & Social Policy, Victoria, BC, Canada; [Shannon, Kate] Univ British Columbia, Dept Med, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; Simon Fraser University; University of Victoria; University of British Columbia	Shannon, K (corresponding author), British Columbia Ctr Excellence HIV AIDS, Gender & Sexual Hlth Initiat, Vancouver, BC, Canada.	gshi@cfenet.ubc.ca	DSILVA, BROOKE/HCI-4879-2022		US National Institutes of Health [R01DA028648]; Canadian Institutes of Health Research [HHP-98835]; PHIRNET (Population Health Interventions Network), an initiative of the Canadian Institutes for Health Research (CIHR); NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028648] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); PHIRNET (Population Health Interventions Network), an initiative of the Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by operating grants from the US National Institutes of Health (R01DA028648) and Canadian Institutes of Health Research (HHP-98835). PD is supported by PHIRNET (Population Health Interventions Network), an initiative of the Canadian Institutes for Health Research (CIHR) KS is supported by US National Institutes of Health (R01DA028648). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett JG, 2007, SOC SCI MED, V65, P2371, DOI 10.1016/j.socscimed.2007.06.011; Bennett D., 2008, BROKEN PROMISES PARE; Benoit C, 2003, SOC SCI MED, V56, P821, DOI 10.1016/S0277-9536(02)00081-3; Benoit C., 2001, DISPELLING MYTHS UND, P134; Bingham B, 2014, CULT HEALTH SEX, V16, P440, DOI 10.1080/13691058.2014.888480; Blackstock C, 2004, VIOLENCE AGAINST WOM, V10, P901, DOI 10.1177/1077801204266312; Bodor R, 2011, PERSPECTIVES HOUSING; Boyd S, 2004, WITCHES CRACK MOMS; Castellano Marlene Brand, 2008, TRUTH RECONCILIATION; Dalla RL, 2010, APPL DEV SCI, P37; Euser S, 2013, CHILD MALTREAT; Farley LJ, 2005, TRANSCULT PSYCHIATRY, V42, P242; Fournier S., 1997, STOLEN OUR EMBRACE A; Guerin B, 2010, PIMATISIWIN J ABORIG, V8; Jeal N, 2008, SEX TRANSM INFECT, V84, P381, DOI 10.1136/sti.2008.030841; Jonson-Reid M, 2000, CHILD ABUSE NEGLECT, V24, P505, DOI 10.1016/S0145-2134(00)00107-1; Lavergne C, 2008, CHILD WELFARE, V87, P59; Lazarus L, 2011, SOC SCI MED, V73, P1600, DOI 10.1016/j.socscimed.2011.09.015; McClelland GT, 2008, J RES NURS, V13, P437, DOI 10.1177/1744987108095409; McMillen JC, 2005, J AM ACAD CHILD PSY, V44, P88, DOI 10.1097/01.chi.0000145806.24274.d2; Mill JE, 1997, WESTERN J NURS RES, V19, P466, DOI 10.1177/019394599701900404; Ministry of Children and Family Development, 2006, NOV 2006 REP CHILDR; Ministry of Children and Family Development, 2008, MAN AB CHILD PROT SE; Ministry of Children and Family Development, 2009, AB CHILDR CAR; National Centre for Youth Law, 2006, BROK PROM CAL IN UN; National Collaborating Centre for Aboriginal Health, 2005, CHILD WELF SERV CAN; Pilowsky DJ, 2006, J ADOLESCENT HEALTH, V38, P351, DOI 10.1016/j.jadohealth.2005.06.014; Poole N, 2000, EVALUATION REPORT SH; Shannon K, 2008, INT J DRUG POLICY, V19, P140, DOI 10.1016/j.drugpo.2007.11.024; Shannon Kate, 2007, Harm Reduct J, V4, P20, DOI 10.1186/1477-7517-4-20; Shannon K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2939; Sharpe TT, 2001, QUAL HEALTH RES, V11, P612, DOI 10.1177/104973201129119334; Sloss CM., 2004, J ASS RES MOTHERING, V6; Smith D, 2005, CAN J NURS RES, V37, P38; Smithgall C., 2005, BEHAV PROBLEMS ED DI; Stueve A, 2001, AM J PUBLIC HEALTH, V91, P922, DOI 10.2105/AJPH.91.6.922; Trocme N, 2004, PATHWAYS OVERREPRESE; Varcoe C, 2008, J ABORIG HEAL, P42; Zlotnick C, 2012, AM J PUBLIC HEALTH, V102, P534, DOI 10.2105/AJPH.2011.300285	39	19	19	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99664	10.1371/journal.pone.0099664	http://dx.doi.org/10.1371/journal.pone.0099664			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2VQ	24927324	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100062
J	Montero-Marin, J; Demarzo, MMP; Stapinski, L; Gili, M; Garcia-Campayo, J				Montero-Marin, Jesus; Piva Demarzo, Marcelo Marcos; Stapinski, Lexine; Gili, Margarita; Garcia-Campayo, Javier			Perceived Stress Latent Factors and the Burnout Subtypes: A Structural Model in Dental Students	PLOS ONE			English	Article							ULCERATIVE-COLITIS; QUESTIONNAIRE; VALIDATION; DEFINITION; VERSION; SIZE	Background: Students of health-professions suffer high levels of stress and burnout. The aim of the present study was to evaluate the relationship between perceived stress latent factors ('tenseness' and 'frustration') and the features ('overload', 'lack of development' and 'neglect') of the three burnout subtypes ('frenetic', 'under-challenged' and 'worn-out', respectively), in a sample of Spanish dental students. Methods: The study employed a cross-sectional design. A sample of Spanish dental students (n = 314) completed the 'Perceived Stress Questionnaire' and the 'Burnout Clinical Subtype Questionnaire Student Survey'. The associations among variables were observed by means of structural equation modelling using the unweighted least squares method from polychoric correlations. Results: Strong associations among perceived stress factors and the burnout characteristics were observed, although a distinct pattern of relations was observed for each burnout subtype. The 'overload' was moderately and positively associated with both 'tenseness' (0.45), and 'frustration' (0.38) dimensions of perceived stress; the 'lack of development' was positively associated with the 'frustration' dimension (0.72), but negatively associated with 'tenseness' (-0.69); the 'neglect' showed a weaker positive associated with 'frustration' (0.41), and a small negative association with 'tenseness' (-0.20). The model was a very good fit to the data (GFI = 0.96; RSMR = 0.07; AGFI = 0.96; NFI = 0.95; RFI = 0.95). Conclusions: The stress factors of 'frustration' and 'tenseness' seems to be related in a distinct way to the burnout subtypes in Spanish dental students. This finding suggests that intervention programs specifically tailored to these subtypes may be a promising future direction.	[Montero-Marin, Jesus] Fac Hlth & Sport Sci, Huesca, Spain; [Piva Demarzo, Marcelo Marcos] Univ Fed Sao Paulo UNIFESP, Dept Prevent Med, Sao Paulo, Brazil; [Stapinski, Lexine] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Stapinski, Lexine] Univ New S Wales, Ctr Res Excellence Mental Hlth & Sustance Use, Sidney, BC, Canada; [Gili, Margarita] Univ Balearic Isl, Inst Univ Invest Ciencies Salut IUNICS, Mallorca, Spain; [Garcia-Campayo, Javier] Univ Zaragoza, Miguel Servet Univ Hosp, Zaragoza, Spain; [Montero-Marin, Jesus; Garcia-Campayo, Javier] Primary Care Prevent & Hlth Promot Res Network Re, Zaragoza, Spain	Universidade Federal de Sao Paulo (UNIFESP); University of Bristol; Universitat de les Illes Balears; Miguel Servet University Hospital; University of Zaragoza	Montero-Marin, J (corresponding author), Fac Hlth & Sport Sci, Huesca, Spain.	jmontero@unizar.es	Demarzo, Marcelo/A-7021-2010; Gili, Margalida/H-7680-2013; Montero-Marin, Jesus/ABG-8919-2020	Demarzo, Marcelo/0000-0002-7447-1839; Gili, Margalida/0000-0002-0535-6773; Montero-Marin, Jesus/0000-0001-5677-1662; Garcia-Campayo, Javier/0000-0002-3797-4218; Stapinski, Lexine/0000-0002-3656-4655	Research Network on Preventative Activities and Health Promotion, Aragon Health Sciences Institute, Faculty of Health and Sports (University of Zaragoza) [RD06/0018/0017]; Faculty of Medicine and Dentistry (University of Santiago de Compostela)	Research Network on Preventative Activities and Health Promotion, Aragon Health Sciences Institute, Faculty of Health and Sports (University of Zaragoza); Faculty of Medicine and Dentistry (University of Santiago de Compostela)	This study was supported by the Research Network on Preventative Activities and Health Promotion (RD06/0018/0017), Aragon Health Sciences Institute, Faculty of Health and Sports (University of Zaragoza) and Faculty of Medicine and Dentistry (University of Santiago de Compostela). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzahem AM, 2011, EUR J DENT EDUC, V15, P8, DOI 10.1111/j.1600-0579.2010.00640.x; [Anonymous], 1998, THE; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; BOLLEN KA, 1986, PSYCHOMETRIKA, V51, P375, DOI 10.1007/BF02294061; Briggs NE, 2003, MULTIVAR BEHAV RES, V38, P25, DOI 10.1207/S15327906MBR3801_2; BROWNE MW, 1992, MULTIVAR BEHAV RES, V27, P269, DOI 10.1207/s15327906mbr2702_13; Bruhlmann T, 2013, SCHMERZ, V27, P521, DOI 10.1007/s00482-013-1312-3; Bruhlmann T, 2012, SCHMERZ, V27, P533; Buunk BP., 1999, EUR REV SOC PSYCHOL, V10, P259, DOI [DOI 10.1080/14792779943000080, 10.1080/14792779943000080]; Byrne B., 2009, STRUCTURAL EQUATION, V2nd ed.; Campos Juliana Alvares Duarte Bonini, 2012, Rev. bras. epidemiol., V15, P155, DOI 10.1590/S1415-790X2012000100014; Dahlin M, 2007, MED TEACH, V29, P43, DOI 10.1080/01421590601175309; Farber BA, 2000, J CLIN PSYCHOL, V56, P675, DOI 10.1002/(SICI)1097-4679(200005)56:5<675::AID-JCLP8>3.0.CO;2-D; Fliege H, 2005, PSYCHOSOM MED, V67, P78, DOI 10.1097/01.psy.0000151491.80178.78; Gabbe Steven G, 2008, Acad Med, V83, P476, DOI 10.1097/ACM.0b013e31816bdb96; Gorter RC, 2007, INT DENT J, V57, P279; Grau A, 2009, REV ESP SALUD PUBLIC, V83, P215, DOI 10.1590/S1135-57272009000200006; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; King G, 2003, INT STUDIES PERSPECT, V4, P100, DOI DOI 10.1111/1528-3577.04105; KNOL DL, 1991, MULTIVAR BEHAV RES, V26, P457, DOI 10.1207/s15327906mbr2603_5; Lazarus R.S., 1984, STRESS APPRAISAL COP; Lee CT, 2012, MULTIVAR BEHAV RES, V47, P314, DOI 10.1080/00273171.2012.658340; Levenstein S, 2000, AM J GASTROENTEROL, V95, P1213, DOI 10.1111/j.1572-0241.2000.02012.x; LEVENSTEIN S, 1993, J PSYCHOSOM RES, V37, P19, DOI 10.1016/0022-3999(93)90120-5; LEVENSTEIN S, 1994, AM J GASTROENTEROL, V89, P1219; MacCallum RC, 2000, ANNU REV PSYCHOL, V51, P201, DOI 10.1146/annurev.psych.51.1.201; MARDIA KV, 1974, SANKHYA SER B, V36, P115; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C., 1996, MASLACH BURNOUT INVE; Mazurkiewicz R, 2012, PSYCHOL HEALTH MED, V17, P188, DOI 10.1080/13548506.2011.597770; Montero-Marin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089090; Montero-Marin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087071; Montero-Marin J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-922; Montero-Marin Jesus, 2011, BMC Med Educ, V11, P103, DOI 10.1186/1472-6920-11-103; Montero-Marin J, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-74; Montero-Marin J, 2011, BMC MED EDUC, V11, DOI [10.1186/1472-6920-11-103, 10.1186/1471-244X-11-49]; Montero-Marin J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-302; Montero-Marin Jesus, 2009, J Occup Med Toxicol, V4, P31, DOI 10.1186/1745-6673-4-31; MUTHEN B, 1992, BRIT J MATH STAT PSY, V45, P19, DOI 10.1111/j.2044-8317.1992.tb00975.x; PARRY CDH, 1991, APPL PSYCH MEAS, V15, P35, DOI 10.1177/014662169101500105; Pohlmann K, 2005, Eur J Dent Educ, V9, P78, DOI 10.1111/j.1600-0579.2004.00359.x; Rajab L D, 2001, J Dent Educ, V65, P232; Rodr?guez G., 2000, ANALISIS FACTORIAL; Ruotsalainen J, 2008, SCAND J WORK ENV HEA, V34, P169, DOI 10.5271/sjweh.1240; Russett B, 2003, INT STUDIES PERSPECT, V4, P88; Sanz-Carrillo C, 2002, J PSYCHOSOM RES, V52, P167, DOI 10.1016/S0022-3999(01)00275-6; Shah M, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-2; Smout M, 2012, AUST FAM PHYSICIAN, V41, P672; Varela J., 2006, MODELIZACION ESTRUCT; Watson R, 2008, INT J NURS STUD, V45, P1534, DOI 10.1016/j.ijnurstu.2007.11.003; Wilf H.S, 1977, STAT METHODS DIGITAL	51	17	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99765	10.1371/journal.pone.0099765	http://dx.doi.org/10.1371/journal.pone.0099765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2VQ	24927260	gold, Green Published			2022-12-25	WOS:000338278100077
J	Pierce, AA; de Roode, JC; Altizer, S; Bartel, RA				Pierce, Amanda A.; de Roode, Jacobus C.; Altizer, Sonia; Bartel, Rebecca A.			Extreme Heterogeneity in Parasitism Despite Low Population Genetic Structure among Monarch Butterflies Inhabiting the Hawaiian Islands	PLOS ONE			English	Article							DANAUS-PLEXIPPUS L; OPHRYOCYSTIS-ELEKTROSCIRRHA; PROTOZOAN PARASITE; INFECTIOUS-DISEASE; HOST-RESISTANCE; DYNAMICS; MIGRATION; PATHOGEN; DIFFERENTIATION; LEPIDOPTERA	Host movement and spatial structure can strongly influence the ecology and evolution of infectious diseases, with limited host movement potentially leading to high spatial heterogeneity in infection. Monarch butterflies (Danaus plexippus) are best known for undertaking a spectacular long-distance migration in eastern North America; however, they also form non-migratory populations that breed year-round in milder climates such as Hawaii and other tropical locations. Prior work showed an inverse relationship between monarch migratory propensity and the prevalence of the protozoan parasite, Ophryocystis elektroscirrha. Here, we sampled monarchs from replicate sites within each of four Hawaiian Islands to ask whether these populations show consistently high prevalence of the protozoan parasite as seen for monarchs from several other non-migratory populations. Counter to our predictions, we observed striking spatial heterogeneity in parasite prevalence, with infection rates per site ranging from 4-85%. We next used microsatellite markers to ask whether the observed variation in infection might be explained by limited host movement and spatial sub-structuring among sites. Our results showed that monarchs across the Hawaiian Islands form one admixed population, supporting high gene flow among sites. Moreover, measures of individual-level genetic diversity did not predict host infection status, as might be expected if more inbred hosts harbored higher parasite loads. These results suggest that other factors such as landscape-level environmental variation or colonization-extinction processes might instead cause the extreme heterogeneity in monarch butterfly infection observed here.	[Pierce, Amanda A.; de Roode, Jacobus C.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Altizer, Sonia; Bartel, Rebecca A.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Bartel, Rebecca A.] US Fish & Wildlife Serv, Red Wolf Recovery Program, Manteo, NC USA	Emory University; University System of Georgia; University of Georgia; United States Department of the Interior; US Fish & Wildlife Service	Pierce, AA (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	amanda.pierce@emory.edu		Pierce, Amanda/0000-0001-9507-0009	National Science Foundation [DEB-0643831, DEB-1019746]; Ruth L. Kirschstein National Research Service Award through the National Institutes of Health (NIH); NIH training grant [5T32AI055404-10]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055404] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Ruth L. Kirschstein National Research Service Award through the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this project was provided by the National Science Foundation (grant DEB-0643831 to S.A., grant DEB-1019746 to J.D.R.), a Ruth L. Kirschstein National Research Service Award through the National Institutes of Health (NIH) to R.A.B., and the NIH training grant 5T32AI055404-10 (L. Real, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2009, P R SOC B, V276, P3523, DOI 10.1098/rspb.2009.1001; Ackery PR, 1984, MILKWEED BUTTERFLIES; Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Almberg ES, 2010, ECOL APPL, V20, P2058, DOI 10.1890/09-1225.1; Altizer S, 2013, MONARCHS CH IN PRESS; Altizer SM, 2004, MONARCH BUTTERFLY BIOLOGY AND CONSERVATION, P203; Altizer SM, 1999, J INVERTEBR PATHOL, V74, P76, DOI 10.1006/jipa.1999.4853; Altizer SM, 2000, ECOL ENTOMOL, V25, P125, DOI 10.1046/j.1365-2311.2000.00246.x; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Altizer S, 2010, EVOLUTION, V64, P1018, DOI 10.1111/j.1558-5646.2010.00946.x; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Bartel RA, 2011, ECOLOGY, V92, P342, DOI 10.1890/10-0489.1; Best A, 2011, P ROY SOC B-BIOL SCI, V278, P2216, DOI 10.1098/rspb.2010.1978; Bradley CA, 2005, ECOL LETT, V8, P290, DOI 10.1111/j.1461-0248.2005.00722.x; BROWER LP, 1991, AM ZOOL, V31, P265; Carlsson-Graner U, 2006, OIKOS, V112, P174, DOI 10.1111/j.0030-1299.2006.13292.x; Carlsson-Graner U, 2002, OIKOS, V97, P97, DOI 10.1034/j.1600-0706.2002.970110.x; Cockrell B.J., 1993, Natural History Museum of Los Angeles County Science Series, P233; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Cronin JT, 2009, ECOLOGY, V90, P196, DOI 10.1890/08-0208.1; de Roode JC, 2007, PARASITOLOGY, V134, P657, DOI 10.1017/S0031182006002009; de Roode JC, 2009, OECOLOGIA, V161, P67, DOI 10.1007/s00442-009-1361-6; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FOLSTAD I, 1991, CAN J ZOOL, V69, P2423, DOI 10.1139/z91-340; Gog J, 2002, P ROY SOC B-BIOL SCI, V269, P671, DOI 10.1098/rspb.2001.1667; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0; Hess G, 1996, ECOLOGY, V77, P1617, DOI 10.2307/2265556; Hess G.R., 2002, P102; Hood G.M., 2010, POPTOOLS VERSION 3 2; Johnson TL, 2011, J WILDLIFE MANAGE, V75, P357, DOI 10.1002/jwmg.40; Leong KLH, 1997, J INVERTEBR PATHOL, V69, P79, DOI 10.1006/jipa.1996.4634; Leong KLH, 1997, PAN-PAC ENTOMOL, V73, P49; Lindsey E, 2009, EVOL ECOL, V23, P607, DOI 10.1007/s10682-008-9258-0; Lyons JI, 2012, MOL ECOL, V21, P3433, DOI 10.1111/j.1365-294X.2012.05613.x; McCallum H, 2002, P ROY SOC B-BIOL SCI, V269, P2041, DOI 10.1098/rspb.2002.2079; MCLAUGHLIN RE, 1970, J PROTOZOOL, V17, P300, DOI 10.1111/j.1550-7408.1970.tb02375.x; Oksanen J., 2016, R PACKAG; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Pritchard JK, 2000, GENETICS, V155, P945; Ravensdale M, 2011, MOL PLANT PATHOL, V12, P93, DOI 10.1111/j.1364-3703.2010.00657.x; Real LA, 2005, DIS ECOLOGY COMMUNIT, P168; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Shephard JM, 2002, BIOL J LINN SOC, V75, P437, DOI 10.1046/j.1095-8312.2002.00034.x; SLATKIN M, 1995, GENETICS, V139, P457; Smith DL, 2002, P NATL ACAD SCI USA, V99, P3668, DOI [10.1073/pnas.042400799, 10.1073/pnas.132272199]; Smith EM, 2012, LIVEST SCI, V143, P293, DOI 10.1016/j.livsci.2011.10.009; Szpiech Z, 2008, BIOINFORMATICS, V24, P1367, DOI DOI 10.1093/BIOINFORMATICS/BTN478); Thrall PH, 1997, J ECOL, V85, P743, DOI 10.2307/2960598; THRALL PH, 1995, CAN J BOT, V73, pS1249, DOI 10.1139/b95-385; URQUHART FA, 1978, CAN J ZOOL, V56, P1759, DOI 10.1139/z78-240; Vane-Wright R.I., 1993, Natural History Museum of Los Angeles County Science Series, P179; Whitehorn PR, 2011, P ROY SOC B-BIOL SCI, V278, P1195, DOI 10.1098/rspb.2010.1550; ZALUCKI MP, 1982, BEHAVIOUR, V80, P174, DOI 10.1163/156853982X00346; Zalucki MP, 2004, BIOL J LINN SOC, V82, P111, DOI 10.1111/j.1095-8312.2004.00322.x	57	10	10	1	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100061	10.1371/journal.pone.0100061	http://dx.doi.org/10.1371/journal.pone.0100061			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926796	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100113
J	Guo, J; Carrington, Y; Alber, A; Ehlting, J				Guo, Jia; Carrington, Yuriko; Alber, Annette; Ehlting, Juergen			Molecular Characterization of Quinate and Shikimate Metabolism in Populus trichocarpa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; Gene Expression; Plant Biochemistry; Plant Defense; Secondary Metabolism; Primary Metabolism; Quinate Biosynthesis; Shikimate Pathway	TRANSGENIC TOBACCO PLANTS; ALICYCLIC ACID METABOLISM; CHLOROGENIC ACID; QUINIC ACID; AROMATIC BIOSYNTHESIS; 5-DEHYDROSHIKIMIC REDUCTASE; PHENYLALANINE BIOSYNTHESIS; PARTIAL-PURIFICATION; GENE FAMILY; PATHWAY	Background: Shikimate is essential for protein biosynthesis. Quinate and its derivatives are protective secondary metabolites. Results: Members of the same gene family encode enzymes with either shikimate or quinate dehydrogenase activity. Conclusion: The molecular genetic basis of plant quinate metabolism has been unraveled in vitro. Significance: Identifying quinate metabolic enzymes will allow testing its ecological function and may enable biotechnological applications. The shikimate pathway leads to the biosynthesis of aromatic amino acids essential for protein biosynthesis and the production of a wide array of plant secondary metabolites. Among them, quinate is an astringent feeding deterrent that can be formed in a single step reaction from 3-dehydroquinate catalyzed by quinate dehydrogenase (QDH). 3-Dehydroquinate is also the substrate for shikimate biosynthesis through the sequential actions of dehydroquinate dehydratase (DQD) and shikimate dehydrogenase (SDH) contained in a single protein in plants. The reaction mechanism of QDH resembles that of SDH. The poplar genome encodes five DQD/SDH-like genes (Poptr1 to Poptr5), which have diverged into two distinct groups based on sequence analysis and protein structure prediction. In vitro biochemical assays proved that Poptr1 and -5 are true DQD/SDHs, whereas Poptr2 and -3 instead have QDH activity with only residual DQD/SDH activity. Poplar DQD/SDHs have distinct expression profiles suggesting separate roles in protein and lignin biosynthesis. Also, the QDH genes are differentially expressed. In summary, quinate (secondary metabolism) and shikimate (primary metabolism) metabolic activities are encoded by distinct members of the same gene family, each having different physiological functions.	[Ehlting, Juergen] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Ehlting, Juergen] Univ Victoria, Ctr Forest Biol, Victoria, BC V8W 2Y2, Canada	University of Victoria; University of Victoria	Ehlting, J (corresponding author), Univ Victoria, Dept Biol, POB 1700 Stn CSC, Victoria, BC V8W 2Y2, Canada.	je@uvic.ca		Ehlting, Jurgen/0000-0003-2302-696X	Canadian Foundation for Innovation	Canadian Foundation for Innovation(Canada Foundation for Innovation)	We thank Johannes Moquenco for technical assistance and Dr. C. Peter Constabel for critical reading of the manuscript. We appreciate the help from Dr. Martin Boulanger with protein structure modeling and interpretation. We are thankful to Dr. Osao Adachi for providing 3-dehydroshikimate prior to it becoming commercially available. Laboratory infrastructure was supported by a Leaders Opportunity Fund from the Canadian Foundation for Innovation (to J.E.).	BALINSKY D, 1971, BIOCHEMISTRY-US, V10, P1947; BALINSKY D, 1961, BIOCHEM J, V80, P292, DOI 10.1042/bj0800292; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Bischoff M, 2001, PLANT PHYSIOL, V125, P1891, DOI 10.1104/pp.125.4.1891; BONNER CA, 1994, BIOCHEM J, V302, P11, DOI 10.1042/bj3020011; BOUDET AM, 1980, PLANT CELL PHYSIOL, V21, P785, DOI 10.1093/oxfordjournals.pcp.a076053; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buschiazzo E, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-8; COLE RA, 1984, ANN APPL BIOL, V105, P129, DOI 10.1111/j.1744-7348.1984.tb02809.x; COLE RA, 1985, ANN APPL BIOL, V106, P211, DOI 10.1111/j.1744-7348.1985.tb03110.x; DAVIES DD, 1972, BIOCHEM J, V127, P335, DOI 10.1042/bj1270335; De Sotillo DR, 1998, J FOOD SCI, V63, P907, DOI 10.1111/j.1365-2621.1998.tb17924.x; DEWICK PM, 1995, NAT PROD REP, V12, P579, DOI 10.1039/np9951200579; Diaz J, 1997, PHYSIOL PLANTARUM, V100, P147, DOI 10.1034/j.1399-3054.1997.1000116.x; Ding L, 2007, J EXP BOT, V58, P2053, DOI 10.1093/jxb/erm059; DOWSETT JR, 1971, BIOCHEM J, V123, pP23; EDWARDS PJ, 1983, OECOLOGIA, V59, P88, DOI 10.1007/BF00388079; Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Floss H. G., 1979, RECENT ADV PHYTOCHEM, V12, P59; FRIEND J, 1973, PHYSIOL PLANT PATHOL, V3, P495, DOI 10.1016/0048-4059(73)90060-X; GAMBORG OL, 1967, PHYTOCHEMISTRY, V6, P1067, DOI 10.1016/S0031-9422(00)86063-X; GAMBORG OL, 1966, BIOCHIM BIOPHYS ACTA, V128, P483, DOI 10.1016/0926-6593(66)90009-9; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Givry S, 2007, CARBOHYD RES, V342, P859, DOI 10.1016/j.carres.2006.12.013; Goldschmidt O., 1964, TAPPI, V47, P528; GRAZIANA A, 1980, PLANT CELL PHYSIOL, V21, P1163, DOI 10.1093/oxfordjournals.pcp.a076115; Graziana A., 1983, GROUP POL JOURN INT, P120; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hamberger Bjoern, 2006, V40, P85; Haruta M, 2001, PLANT MOL BIOL, V46, P347, DOI 10.1023/A:1010654711619; HERRMANN KM, 1995, PLANT CELL, V7, P907; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; HERRMANN KM, 1995, PLANT PHYSIOL, V107, P7, DOI 10.1104/pp.107.1.7; Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297; JOHNSON G, 1952, SCIENCE, V115, P627, DOI 10.1126/science.115.2997.627; KANG XB, 1993, PHYTOCHEMISTRY, V33, P769, DOI 10.1016/0031-9422(93)85272-S; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Leiss KA, 2009, PLANT PHYSIOL, V150, P1567, DOI 10.1104/pp.109.138131; LEUSCHNER C, 1995, PLANT PHYSIOL, V108, P319, DOI 10.1104/pp.108.1.319; LEUSCHNER C, 1991, PHYTOCHEMISTRY, V30, P2203, DOI 10.1016/0031-9422(91)83615-R; Lindner HA, 2005, J BIOL CHEM, V280, P7162, DOI 10.1074/jbc.M412028200; Lou ZX, 2011, J FOOD SCI, V76, pM398, DOI 10.1111/j.1750-3841.2011.02213.x; Ma CM, 2007, BIOORGAN MED CHEM, V15, P6830, DOI 10.1016/j.bmc.2007.07.038; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; MAHER EA, 1994, P NATL ACAD SCI USA, V91, P7802, DOI 10.1073/pnas.91.16.7802; Marsh KB, 2009, FUNCT PLANT BIOL, V36, P463, DOI 10.1071/FP08240; MARUTA Y, 1995, J AGR FOOD CHEM, V43, P2592, DOI 10.1021/jf00058a007; MCCLURE TT, 1960, AM J BOT, V47, P277, DOI 10.2307/2439607; MINAMIKA.T, 1969, PLANT CELL PHYSIOL, V10, P283; MINAMIKAWA T, 1977, PLANT CELL PHYSIOL, V18, P743; Morton LW, 2000, CLIN EXP PHARMACOL P, V27, P152, DOI 10.1046/j.1440-1681.2000.03214.x; MOUSDALE DM, 1985, J CHROMATOGR, V329, P268, DOI 10.1016/S0021-9673(01)81929-4; Muir RM, 2011, PLANT MOL BIOL, V75, P555, DOI 10.1007/s11103-011-9739-3; NANDY M, 1961, ARCH BIOCHEM BIOPHYS, V92, P399, DOI 10.1016/0003-9861(61)90378-2; Nie LD, 2009, TETRAHEDRON-ASYMMETR, V20, P124, DOI 10.1016/j.tetasy.2008.11.027; OCALLAGHAN D, 1988, INFECT IMMUN, V56, P419, DOI 10.1128/IAI.56.2.419-423.1988; OSSIPOV V, 1995, TREES-STRUCT FUNCT, V10, P46, DOI 10.1007/BF00197779; Ossipov V, 2000, PLANT PHYSIOL BIOCH, V38, P923, DOI 10.1016/S0981-9428(00)01203-1; Ossipov V., 1986, BIOKHIMIYA, V51, P230; Paynter NP, 2006, AM J EPIDEMIOL, V164, P1075, DOI 10.1093/aje/kwj323; PILET PE, 1964, PHYTOCHEMISTRY, V3, P617, DOI 10.1016/S0031-9422(00)82937-4; REFENO G, 1982, PLANTA, V154, P193, DOI 10.1007/BF00387863; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Rogiers SY, 1997, CAN J BOT, V75, P1215, DOI 10.1139/b97-835; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; SCHMID J, 1995, PHYTOCHEMISTRY, V39, P737, DOI 10.1016/0031-9422(94)00962-S; SCHMIDT CL, 1991, J PLANT PHYSIOL, V138, P51, DOI 10.1016/S0176-1617(11)80729-7; Singh SA, 2007, CRYST GROWTH DES, V7, P2153, DOI 10.1021/cg7007107; Singh SA, 2006, BIOCHEMISTRY-US, V45, P7787, DOI 10.1021/bi060366+; STEINRUCKEN HC, 1980, BIOCHEM BIOPH RES CO, V94, P1207, DOI 10.1016/0006-291X(80)90547-1; Sung WS, 2010, PURE APPL CHEM, V82, P219, DOI 10.1351/PAC-CON-09-01-08; Tohge T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00062; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Weaver LM, 1997, TRENDS PLANT SCI, V2, P346, DOI 10.1016/S1360-1385(97)84622-5; WEINSTEIN L, 1961, CONTRIB BOYCE THOMPS, V21, P201; YANIV H, 1955, J BIOL CHEM, V213, P787; YOSHIDA S, 1969, ANN REV PLANT PHYSIO, V20, P41, DOI 10.1146/annurev.pp.20.060169.000353; Zhang XL, 2005, J BIOCHEM MOL BIOL, V38, P624	79	30	30	2	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23846	23858		10.1074/jbc.M114.558536	http://dx.doi.org/10.1074/jbc.M114.558536			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24942735	Green Published, hybrid			2022-12-25	WOS:000341505000051
J	Duan, L; Ying, GG; Danzer, B; Perez, RE; Shariat-Madar, Z; Levenson, VV; Maki, CG				Duan, Lei; Ying, Guoguang; Danzer, Brian; Perez, Ricardo E.; Shariat-Madar, Zia; Levenson, Victor V.; Maki, Carl G.			The Prolyl Peptidases PRCP/PREP Regulate IRS-1 Stability Critical for Rapamycin-induced Feedback Activation of PI3K and AKT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; MOLECULAR TARGETED THERAPIES; PANCREATIC-CANCER; PHOSPHOINOSITIDE 3-KINASE; PLASMA PREKALLIKREIN; MTOR; PHOSPHORYLATION; INHIBITION; MECHANISM; OVEREXPRESSION	The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB/AKT)/mammalian target of rapamycin (mTOR) pathway conveys signals from receptor tyrosine kinases (RTKs) to regulate cell metabolism, proliferation, survival, and motility. Previously we found that prolylcarboxypeptidase (PRCP) regulate proliferation and survival in breast cancer cells. In this study, we found that PRCP and the related family member prolylendopeptidase (PREP) are essential for proliferation and survival of pancreatic cancer cells. Depletion/inhibition of PRCP and PREP-induced serine phosphorylation and degradation of IRS-1, leading to inactivation of the cellular PI3K and AKT. Notably, depletion/inhibition of PRCP/PREP destabilized IRS-1 in the cells treated with rapamycin, blocking the feedback activation PI3K/AKT. Consequently, inhibition of PRCP/PREP enhanced rapamycin-induced cytotoxicity. Thus, we have identified PRCP and PREP as a stabilizer of IRS-1 which is critical for PI3K/AKT/mTOR signaling in pancreatic cancer cells.	[Duan, Lei; Danzer, Brian; Perez, Ricardo E.; Maki, Carl G.] Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Ying, Guoguang] Tianjin Med Univ, Canc Inst & Hosp, Canc Cell Biol Lab, Tianjin 300060, Peoples R China; [Shariat-Madar, Zia] Univ Mississippi, Dept Pharmacol, University, MS 38677 USA; [Levenson, Victor V.] US Biomarkers Inc, Buffalo Grove, IL 60089 USA	Rush University; Tianjin Medical University; University of Mississippi	Duan, L (corresponding author), Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA.	lduan@rush.edu; victor@usbiomarkers.com; Carl_Maki@rush.edu			National Institutes of Health from the National Cancer Institute (NCI) [1R01CA137598-01A1]; NATIONAL CANCER INSTITUTE [R01CA137598] Funding Source: NIH RePORTER	National Institutes of Health from the National Cancer Institute (NCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01CA137598-01A1 from the National Cancer Institute (NCI) (to C. G. M.).	Adams GN, 2013, BLOOD, V122, P1522, DOI 10.1182/blood-2012-10-460360; AKT pathway in human cancer, NAT REV CANC, V2, P489; Bao B, 2011, BBA-REV CANCER, V1815, P135, DOI 10.1016/j.bbcan.2010.11.003; Bayraktar S, 2010, MT SINAI J MED, V77, P606, DOI 10.1002/msj.20217; Bergmann U, 1996, BIOCHEM BIOPH RES CO, V220, P886, DOI 10.1006/bbrc.1996.0500; Borja-Cacho D, 2008, AM J SURG, V196, P430, DOI 10.1016/j.amjsurg.2008.04.009; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Darzynkiewicz Z, 2010, ADV EXP MED BIOL, V676, P137; Dearth RK, 2006, MOL CELL BIOL, V26, P9302, DOI 10.1128/MCB.00260-06; Duan L, 2011, J BIOL CHEM, V286, P2864, DOI 10.1074/jbc.M110.143271; Easton JB, 2006, CANCER CELL, V9, P153, DOI 10.1016/j.ccr.2006.02.027; Eser S, 2013, CANCER CELL, V23, P406, DOI 10.1016/j.ccr.2013.01.023; Evers BM, 2005, AM J SURG, V190, P279, DOI 10.1016/j.amjsurg.2005.05.027; Falasca M, 2011, ANTI-CANCER AGENT ME, V11, P455, DOI 10.2174/187152011795677382; Garcia-Horsman JA, 2007, NEUROPEPTIDES, V41, P1, DOI 10.1016/j.npep.2006.10.004; HADARI YR, 1992, J BIOL CHEM, V267, P17483; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Javle MM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-368; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Metz HE, 2011, CLIN CANCER RES, V17, P206, DOI 10.1158/1078-0432.CCR-10-0434; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Philip PA, 2011, LANCET ONCOL, V12, P206, DOI 10.1016/S1470-2045(11)70029-8; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Rieder S, 2011, ANTI-CANCER AGENT ME, V11, P427, DOI 10.2174/187152011795677454; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Rozengurt E, 2010, CLIN CANCER RES, V16, P2505, DOI 10.1158/1078-0432.CCR-09-2229; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schlieman MG, 2003, BRIT J CANCER, V89, P2110, DOI 10.1038/sj.bjc.6601396; Schulz I, 2005, J NEUROCHEM, V94, P970, DOI 10.1111/j.1471-4159.2005.03237.x; Shariat-Madar Z, 2005, AM J PHYSIOL-HEART C, V289, pH2697, DOI 10.1152/ajpheart.00715.2005; Shariat-Madar Z, 2004, BLOOD, V103, P4554, DOI 10.1182/blood-2003-07-2510; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Sun XJ, 2009, VITAM HORM, V80, P351, DOI 10.1016/S0083-6729(08)00613-4; Taniyama Y, 2005, ARTERIOSCL THROM VAS, V25, P1142, DOI 10.1161/01.ATV.0000164313.17167.df; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; Wallingford N, 2009, J CLIN INVEST, V119, P2291, DOI 10.1172/JCI37209; Wilkowski R., 2008, V177, P79; Wong HH, 2009, NAT REV GASTRO HEPAT, V6, P412, DOI 10.1038/nrgastro.2009.89; Yamamoto S, 2004, CLIN CANCER RES, V10, P2846, DOI 10.1158/1078-0432.CCR-02-1441; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484	44	15	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21694	21705		10.1074/jbc.M114.550038	http://dx.doi.org/10.1074/jbc.M114.550038			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24936056	Green Published, hybrid			2022-12-25	WOS:000340558300043
J	Dvorakova-Hortova, K; Sidlova, A; Ded, L; Hladovcova, D; Vieweg, M; Weidner, W; Steger, K; Stopka, P; Paradowska-Dogan, A				Dvorakova-Hortova, Katerina; Sidlova, Adela; Ded, Lukas; Hladovcova, Denisa; Vieweg, Markus; Weidner, Wolfgang; Steger, Klaus; Stopka, Pavel; Paradowska-Dogan, Agnieszka			Toxoplasma gondii Decreases the Reproductive Fitness in Mice	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; TRANSCRIPTION FACTORS; DNA METHYLATION; SERTOLI-CELLS; MALE RATS; SPERMATOGENESIS; PROLIFERATION; INFECTION; HOST; EPIGENETICS	Toxoplasma gondii is a common protozoan parasite that infects warm-blooded animals throughout the world, including mice and humans. During infection, both, the parasite and the host, utilize various mechanisms to maximize their own reproductive success. Mice and humans are both the intermediate hosts for Toxoplasma gondii, which forms specialized vacuoles containing reproductive cysts in the formers' tissue. As half of the human population is infected, developing a disease called toxoplasmosis, along with an ever-growing number of couples suffering with idiopathic infertility, it is therefore surprising that there is a lack of research on how Toxoplasma gondii can alter reproductive parameters. In this study, a detailed histometric screening of the testicular function along with the levels of the pituitary luteinizing hormone (LH) were analysed in infected mice. Data on relative testis and epididymis weight, and sperm count were also collected. Based on the results obtained, the level of LH in the urine of Toxoplasma gondii infected mice was lower compared to the control. In direct correlation with the hormone level, testicular function and sperm production was also significantly lower in Toxoplasma gondii positive group using sperm count and histometric analysis as a marker. Not only were the number of leptotene primary spermatocytes and spermatids lowered, but the number of Sertoli cells and the tubule diameter were elevated. In parallel, a pilot epigenetic study on global testicular methylation, and specific methylation of Crem, Creb1 and Hspa1genes essential for successfully ongoing spermatogenesis was performed. Global methylation was elevated in Toxoplasma infected mice, and differences in the DNA methylation of selected genes were detected between the Toxoplasma positive and control group. These findings demonstrate a direct relation between Toxoplasma gondii infection and the decrease of male reproductive fitness in mice, which may contribute to an increase of idiopathic infertility in humans.	[Dvorakova-Hortova, Katerina; Sidlova, Adela; Hladovcova, Denisa; Stopka, Pavel] Charles Univ Prague, Fac Sci, Dept Zool, Biocev Grp, Prague, Czech Republic; [Ded, Lukas] Acad Sci, Inst Biotechnol, Reprod Biol Lab, Prague, Czech Republic; [Vieweg, Markus; Weidner, Wolfgang; Steger, Klaus; Paradowska-Dogan, Agnieszka] Univ Giessen, Dept Urol Pediat Urol & Androl, D-35390 Giessen, Germany	Charles University Prague; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Justus Liebig University Giessen	Paradowska-Dogan, A (corresponding author), Univ Giessen, Dept Urol Pediat Urol & Androl, D-35390 Giessen, Germany.	Agnieszka.Paradowska@chiru.med.uni-giessen.de	Ded, Lukas/G-9543-2014; Komrsková, Kateřina/P-7920-2019; Dvorakova-Hortova, Katerina/A-8705-2010; Stopka, Pavel/A-6193-2008	Ded, Lukas/0000-0003-1053-4025; Komrsková, Kateřina/0000-0002-6837-2148; Dvorakova-Hortova, Katerina/0000-0002-6837-2148; Stopka, Pavel/0000-0002-1104-1655	Institutional Research Support [SVV 260 087/2014]; Grant Agency of the Czech Republic GACR [P506/12/1046]; "BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University" from the European Regional Development Fund [CZ.1.05/1.1.00/02.0109]	Institutional Research Support; Grant Agency of the Czech Republic GACR(Grant Agency of the Czech Republic); "BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University" from the European Regional Development Fund	The work was supported by the Institutional Research Support grant No. SVV 260 087/2014, by the Grant Agency of the Czech Republic GACR No. P506/12/1046 and by the project "BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University" (CZ.1.05/1.1.00/02.0109), from the European Regional Development Fund. Founding for methylation analysis was provided from LOEWE focus group MIBIE ("Male Infertility during Infection and Inflammation" projects state government of Hessen, Germany). The funders had no influence on study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoli A, 2012, ANDROLOGIA, V44, P679, DOI 10.1111/j.1439-0272.2011.01249.x; Adham IM, 2005, MOL CELL BIOL, V25, P7657, DOI 10.1128/MCB.25.17.7657-7664.2005; Ahmed EA, 2009, BIOL REPROD, V80, P1084, DOI 10.1095/biolreprod.108.071662; Angrisano T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-172; Behr R, 2001, INT J ANDROL, V24, P126, DOI 10.1046/j.1365-2605.2001.00277.x; Brunet J, 2008, CELL MICROBIOL, V10, P908, DOI 10.1111/j.1462-5822.2007.01093.x; Dalimi A, 2013, JUNDISHAPUR J MICROB, V6, DOI 10.5812/jjm.7184; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Don J, 2002, MOL CELL ENDOCRINOL, V187, P115, DOI 10.1016/S0303-7207(01)00696-7; Dong Q, 2004, J ANDROL, V25, P973; Dubey J.P., 1988, TOXOPLASMOSIS ANIMAL; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; FAYER R, 1981, CAN VET J, V22, P344; Fu Y, 2012, J PARASITOL, V98, P310, DOI 10.1645/GE-2825.1; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; HESS RA, 1993, ENDOCRINOLOGY, V132, P2607, DOI 10.1210/en.132.6.2607; HIKIM APS, 1989, ENDOCRINOLOGY, V125, P1829, DOI 10.1210/endo-125-4-1829; Hill D, 2002, CLIN MICROBIOL INFEC, V8, P634, DOI 10.1046/j.1469-0691.2002.00485.x; Holscher C, 2000, INFECT IMMUN, V68, P4075, DOI 10.1128/IAI.68.7.4075-4083.2000; Houshdaran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001289; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Kankova S, 2011, EXP PARASITOL, V128, P181, DOI 10.1016/j.exppara.2011.03.014; Kim JS, 2009, HISTOCHEM CELL BIOL, V131, P501, DOI 10.1007/s00418-009-0554-8; Kodym P, 2002, ACTA PARASITOL, V47, P239; Lambert H, 2010, CELL MICROBIOL, V12, P292, DOI 10.1111/j.1462-5822.2009.01417.x; Lee YH, 1999, EXP PARASITOL, V91, P212, DOI 10.1006/expr.1998.4359; Leng J, 2010, NIH PUBLIC ACCESS, V182, P489; Lim A, 2013, MOL ECOL, V22, P102, DOI 10.1111/mec.12042; Linkenhoker JR, 2013, J AM ASSOC LAB ANIM, V52, P531; MARATHE GK, 1995, ENDOCRINE, V3, P705, DOI 10.1007/BF03000201; Minarovits J, 2009, ACTA MICROBIOL IMM H, V56, P1, DOI 10.1556/AMicr.56.2009.1.1; Nanassy L, 2011, FERTIL STERIL, V95, P2310, DOI 10.1016/j.fertnstert.2011.03.096; O' Shaughnessy, 2001, CIRCULATING DIVALENT, V11203, P237; Paschos K, 2010, TRENDS MICROBIOL, V18, P439, DOI 10.1016/j.tim.2010.07.003; Persengiev SP, 2003, APOPTOSIS, V8, P225, DOI 10.1023/A:1023633704132; Rajender S, 2011, MUTAT RES-REV MUTAT, V727, P62, DOI 10.1016/j.mrrev.2011.04.002; Remington JS., 1995, INFECT DIS FETUS NEW, V4, P140; RIVIER C, 1991, BIOL REPROD, V45, P523, DOI 10.1095/biolreprod45.4.523; Ruwanpura SM, 2010, J ENDOCRINOL, V205, P117, DOI 10.1677/JOE-10-0025; SABIN AB, 1949, PEDIATRICS, V4, P443; Saeij JPJ, 2005, TRENDS PARASITOL, V21, P476, DOI 10.1016/j.pt.2005.08.001; Scobey MJ, 2001, ENDOCRINOLOGY, V142, P948, DOI 10.1210/en.142.2.948; Serafim TD, 2010, MEM I OSWALDO CRUZ, V105, P811, DOI 10.1590/S0074-02762010000600014; Shaha C, 2008, ADV EXP MED BIOL, V636, P42, DOI 10.1007/978-0-387-09597-4_3; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Skallova A, 2006, PARASITOLOGY, V133, P525, DOI 10.1017/S0031182006000886; Sun Li-Hua, 2008, Zhonghua Nan Ke Xue, V14, P55; Tarulli GA, 2006, BIOL REPROD, V74, P798, DOI 10.1095/biolreprod.105.050450; Tarulli GA, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.095091; Terpsidis KI, 2009, EXP PARASITOL, V121, P238, DOI 10.1016/j.exppara.2008.11.006; Trasler JM, 2009, MOL CELL ENDOCRINOL, V306, P33, DOI 10.1016/j.mce.2008.12.018; Unoki M, 2009, BIOCHEM PHARMACOL, V78, P1279, DOI 10.1016/j.bcp.2009.05.035; Vyas A, 2013, J EXP BIOL, V216, P120, DOI 10.1242/jeb.072983; Walker WH, 1996, TRENDS ENDOCRIN MET, V7, P133, DOI 10.1016/1043-2760(96)00035-5; Walker WH, 2003, ENDOCRINOLOGY, V144, P3719, DOI 10.1210/en.2003-0765; Wistuba J, 2007, J ENDOCRINOL, V192, P99, DOI 10.1677/JOE-06-0054; Wu W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013884; Yang R, 2006, CHINESE J ZOONOSES, P2006; Zhou Y, 2003, CHINESE J ZOONOSES, P2003; Zhu HY, 2011, J APPL TOXICOL, V31, P484, DOI 10.1002/jat.1673	61	26	30	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e96770	10.1371/journal.pone.0096770	http://dx.doi.org/10.1371/journal.pone.0096770			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940596	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200002
J	Ebeling, G; Blasche, R; Hofmann, F; Augstein, A; Kasper, M; Barth, K				Ebeling, Georg; Blaesche, Robert; Hofmann, Falk; Augstein, Antje; Kasper, Michael; Barth, Kathrin			Effect of P2X7 Receptor Knockout on AQP-5 Expression of Type I Alveolar Epithelial Cells	PLOS ONE			English	Article							WATER PERMEABILITY; LUNG FIBROSIS; LIPID RAFTS; DECREASED EXPRESSION; P2X(7) RECEPTOR; RAT; PROTEIN; CALMODULIN; CHANNEL; ACTIVATION	P2X7 receptors, ATP-gated cation channels, are specifically expressed in alveolar epithelial cells. The pathophysiological function of this lung cell type, except a recently reported putative involvement in surfactant secretion, is unknown. In addition, P2X7 receptor-deficient mice show reduced inflammation and lung fibrosis after exposure with bleomycin. To elucidate the role of the P2X7 receptor in alveolar epithelial type I cells we characterized the pulmonary phenotype of P2X7 receptor knockout mice by using immunohistochemistry, western blot analysis and real-time RT PCR. No pathomorphological signs of fibrosis were found. Results revealed, however, a remarkable loss of aquaporin-5 protein and mRNA in young knockout animals. Additional in vitro experiments with bleomycin treated precision cut lung slices showed a greater sensitivity of the P2X7 receptor knockout mice in terms of aquaporin-5 reduction as wild type animals. Finally, P2X7 receptor function was examined by using the alveolar epithelial cell lines E10 and MLE-12 for stimulation experiments with bleomycin. The in vitro activation of P2X7 receptor was connected with an increase of aquaporin-5, whereas the inhibition of the receptor with oxidized ATP resulted in down regulation of aquaporin-5. The early loss of aquaporin-5 which can be found in different pulmonary fibrosis models does not implicate a specific pathogenetic role during fibrogenesis.	[Ebeling, Georg; Blaesche, Robert; Hofmann, Falk; Kasper, Michael; Barth, Kathrin] Tech Univ Dresden, Med Fac Carl Custav Carus, Inst Anat, D-01062 Dresden, Germany; [Augstein, Antje] Tech Univ Dresden, Dept Internal Med & Cardiol, D-01062 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Barth, K (corresponding author), Tech Univ Dresden, Med Fac Carl Custav Carus, Inst Anat, D-01062 Dresden, Germany.	kathrin.barth@tu-dresden.de	Barth, Kathrin/AGX-6107-2022					ADAMSON IYR, 1976, ENVIRON HEALTH PERSP, V16, P119, DOI 10.2307/3428592; Almeida C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053628; Barth K, 2007, FEBS J, V274, P3021, DOI 10.1111/j.1742-4658.2007.05830.x; Barth K, 2009, FEBS J, V276, P317, DOI 10.1111/j.1742-4658.2008.06792.x; Blasche R, 2012, INT J BIOCHEM CELL B, V44, P514, DOI 10.1016/j.biocel.2011.12.003; Borok Z, 2002, J APPL PHYSIOL, V93, P2199, DOI 10.1152/japplphysiol.01171.2001; Burnstock Geoffrey, 2013, Keio Journal of Medicine, V62, P63, DOI 10.2302/kjm.2013-0003-RE; Cao XW, 2012, CELL RES, V22, P793, DOI 10.1038/cr.2012.64; CARNEY DN, 1981, P NATL ACAD SCI-BIOL, V78, P3185, DOI 10.1073/pnas.78.5.3185; Chen ZM, 2004, BIOCHEM BIOPH RES CO, V319, P774, DOI 10.1016/j.bbrc.2004.05.048; Dart C, 2010, J PHYSIOL-LONDON, V588, P3169, DOI 10.1113/jphysiol.2010.191585; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; DieckmannSchuppert A, 1997, CELL TISSUE RES, V288, P119, DOI 10.1007/s004410050799; Dobbs LG, 1998, P NATL ACAD SCI USA, V95, P2991, DOI 10.1073/pnas.95.6.2991; Fenton RA, 2013, CURR OPIN NEPHROL HY, V22, P551, DOI 10.1097/MNH.0b013e328364000d; Gabazza EC, 2004, PATHOL INT, V54, P774, DOI 10.1111/j.1440-1827.2004.01754.x; GREEN SJ, 1988, J CELL SCI, V90, P145; Held HD, 1999, BRIT J PHARMACOL, V126, P1191, DOI 10.1038/sj.bjp.0702394; Herzog CR, 1996, ONCOGENE, V13, P1885; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Ishikawa Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1303, DOI 10.1152/ajpcell.00211.2005; Jacob F, 2013, PURINERG SIGNAL, V9, P285, DOI 10.1007/s11302-013-9357-4; Jang AS, 2004, INTENS CARE MED, V30, P489, DOI 10.1007/s00134-003-2129-9; Johnson MD, 2007, MOL BIOSYST, V3, P178, DOI 10.1039/b614348b; Kasper M, 2000, INT J RADIAT BIOL, V76, P493; Kasper M, 1996, HISTOCHEM CELL BIOL, V106, P419; KASPER M, 1995, AM J RESP CELL MOL, V13, P648, DOI 10.1165/ajrcmb.13.6.7576702; Kasper M, 2004, HISTOCHEM CELL BIOL, V121, P131, DOI 10.1007/s00418-003-0612-6; Kasper M, 1998, HISTOCHEM CELL BIOL, V109, P41; Kasper M, 2003, ANN ANAT, V185; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Koslowski R, 1998, EUR RESPIR J, V12, P1397, DOI 10.1183/09031936.98.12061397; Krane CM, 2009, CYTOKINE, V46, P111, DOI 10.1016/j.cyto.2008.12.018; Kuwano K, 2008, INTERNAL MED, V47, P345, DOI 10.2169/internalmedicine.47.0713; Lee M, 2008, BRAIN RES, V1195, P1, DOI 10.1016/j.brainres.2007.12.023; Linge A, 2007, ANTICANCER RES, V27, P1343; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Ma TH, 1998, AM J RESP CELL MOL, V19, P143, DOI 10.1165/ajrcmb.19.1.2953; Maylie J, 2004, J PHYSIOL-LONDON, V554, P255, DOI 10.1113/jphysiol.2003.049072; Menzel EJ, 1998, CANCER LETT, V131, P3, DOI 10.1016/S0304-3835(98)00195-5; Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Panenka W, 2001, J NEUROSCI, V21, P7135, DOI 10.1523/JNEUROSCI.21-18-07135.2001; Peracchia C, 2000, J BIOL CHEM, V275, P26220, DOI 10.1074/jbc.M004007200; RAINA S, 1995, J BIOL CHEM, V270, P1908, DOI 10.1074/jbc.270.4.1908; Ramirez MI, 2003, DEV BIOL, V256, P61, DOI 10.1016/S0012-1606(02)00098-2; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; SAIMI Y, 1990, SCIENCE, V249, P1441, DOI 10.1126/science.2169650; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Sakai N, 2013, BBA-MOL BASIS DIS, V1832, P911, DOI 10.1016/j.bbadis.2013.03.001; Shivshankar P, 2012, AM J RESP CELL MOL, V47, P28, DOI 10.1165/rcmb.2011-0349OC; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Sotkis A, 2001, CELL COMMUN ADHES, V8, P277, DOI 10.3109/15419060109080737; Staubach S, 2011, EXPERT REV PROTEOMIC, V8, P263, DOI [10.1586/EPR.11.2, 10.1586/epr.11.2]; Tan HL, 2002, NATURE, V415, P442, DOI 10.1038/415442a; Varadaraj K, 2005, INVEST OPHTH VIS SCI, V46, P1393, DOI 10.1167/iovs.04-1217; Volonte C, 2012, CNS NEUROL DISORD-DR, V11, P705, DOI 10.2174/187152712803581137; Wang CM, 2003, CELL SIGNAL, V15, P1129, DOI 10.1016/S0898-6568(03)00112-8; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Yamamoto N, 2001, MOL BRAIN RES, V95, P110, DOI 10.1016/S0169-328X(01)00254-6; Zelenina M, 2002, AM J PHYSIOL-RENAL, V283, pF309, DOI 10.1152/ajprenal.00260.2001; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	64	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100282	10.1371/journal.pone.0100282	http://dx.doi.org/10.1371/journal.pone.0100282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941004	Green Submitted, Green Published, gold			2022-12-25	WOS:000338508200089
J	Zhang, L; Ding, ZX; Li, HY; Shen, Y; Lu, JW				Zhang, Lin; Ding, Zhixuan; Li, Hongyu; Shen, Ying; Lu, Jianwei			3D Face Recognition Based on Multiple Keypoint Descriptors and Sparse Representation	PLOS ONE			English	Article							EXPRESSIONS	Recent years have witnessed a growing interest in developing methods for 3D face recognition. However, 3D scans often suffer from the problems of missing parts, large facial expressions, and occlusions. To be useful in real-world applications, a 3D face recognition approach should be able to handle these challenges. In this paper, we propose a novel general approach to deal with the 3D face recognition problem by making use of multiple keypoint descriptors (MKD) and the sparse representation-based classification (SRC). We call the proposed method 3DMKDSRC for short. Specifically, with 3DMKDSRC, each 3D face scan is represented as a set of descriptor vectors extracted from keypoints by meshSIFT. Descriptor vectors of gallery samples form the gallery dictionary. Given a probe 3D face scan, its descriptors are extracted at first and then its identity can be determined by using a multitask SRC. The proposed 3DMKDSRC approach does not require the pre-alignment between two face scans and is quite robust to the problems of missing data, occlusions and expressions. Its superiority over the other leading 3D face recognition schemes has been corroborated by extensive experiments conducted on three benchmark databases, Bosphorus, GavabDB, and FRGC2.0. The Matlab source code for 3DMKDSRC and the related evaluation results are publicly available at http://sse.tongji.edu.cn/linzhang/3dmkdsrcface/3dmkdsrc.htm.	[Zhang, Lin; Ding, Zhixuan; Li, Hongyu; Shen, Ying; Lu, Jianwei] Tongji Univ, Sch Software Engn, Shanghai 200092, Peoples R China; [Lu, Jianwei] Tongji Univ, Adv Inst Translat Med, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Shen, Y (corresponding author), Tongji Univ, Sch Software Engn, Shanghai 200092, Peoples R China.	yingshen@tongji.edu.cn		Zhang, Lin/0000-0002-4360-5523	Natural Science Foundation of China [61201394, 61303112]; Shanghai Pujiang Program [13PJ1408700, 13PJ1433200]; Innovation Program of Shanghai Municipal Education Commission [12ZZ029]; National Basic Research Program of China [2013CB967101]; Jiangsu Key Laboratory of Image and Video Understanding for Social Safety (Nanjing University of Science and Technology) [30920140122007]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); National Basic Research Program of China(National Basic Research Program of China); Jiangsu Key Laboratory of Image and Video Understanding for Social Safety (Nanjing University of Science and Technology)	This work is supported by the Natural Science Foundation of China under grant nos. 61201394 and 61303112, the Shanghai Pujiang Program under grant nos. 13PJ1408700 and 13PJ1433200, the Innovation Program of Shanghai Municipal Education Commission under grant no. 12ZZ029, the National Basic Research Program of China under grant no. 2013CB967101, and the Jiangsu Key Laboratory of Image and Video Understanding for Social Safety (Nanjing University of Science and Technology) under grant No. 30920140122007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyuz N, 2008, P BIOID, P1; Alyuz N., 2008, 2 IEEE INT C BIOM TH, P1; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Benabdelkader C, 2005, IMAGE VISION COMPUT, V23, P339, DOI 10.1016/j.imavis.2004.09.004; Berretti S, 2010, IEEE T PATTERN ANAL, V32, P2162, DOI 10.1109/TPAMI.2010.43; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bowyer KW, 2006, COMPUT VIS IMAGE UND, V101, P1, DOI 10.1016/j.cviu.2005.05.005; Bronstein AM, 2007, IEEE T IMAGE PROCESS, V16, P188, DOI 10.1109/TIP.2006.884940; Bronstein AM, 2005, INT J COMPUT VISION, V64, P5, DOI 10.1007/s11263-005-1085-y; Dibeklioglu H, 2009, LECT NOTES COMPUT SC, V5558, P309, DOI 10.1007/978-3-642-01793-3_32; Donoho DL, 2008, IEEE T INFORM THEORY, V54, P4789, DOI 10.1109/TIT.2008.929958; Donoho DL, 2006, COMMUN PUR APPL MATH, V59, P797, DOI 10.1002/cpa.20132; Elaiwat S, 2014, IEEE SIGNAL PROC LET, V21, P172, DOI 10.1109/LSP.2013.2295119; Faltemier TC, 2008, IEEE T INF FOREN SEC, V3, P62, DOI 10.1109/TIFS.2007.916287; Gupta S, 2010, INT J COMPUT VISION, V90, P331, DOI 10.1007/s11263-010-0360-8; Hajati F, 2012, PATTERN RECOGN, V45, P969, DOI 10.1016/j.patcog.2011.08.025; Heseltine T, 2004, LECT NOTES COMPUT SC, V3212, P684; Hesher C, 2003, SEVENTH INTERNATIONAL SYMPOSIUM ON SIGNAL PROCESSING AND ITS APPLICATIONS, VOL 2, PROCEEDINGS, P201, DOI 10.1109/ISSPA.2003.1224850; Jain Anil K., 2007, HDB BIOMETRICS; Kakadiaris IA, 2007, IEEE T PATTERN ANAL, V29, P640, DOI 10.1109/TPAMI.2007.1017; Kim SJ, 2007, IEEE J-STSP, V1, P606, DOI 10.1109/JSTSP.2007.910971; Kimmel R, 1998, P NATL ACAD SCI USA, V95, P8431, DOI 10.1073/pnas.95.15.8431; Koudelka ML, 2005, P CVPR WORKSH; Lee Y, 2005, LECT NOTES COMPUT SC, V3546, P909; Liao SC, 2013, IEEE T PATTERN ANAL, V35, P1193, DOI 10.1109/TPAMI.2012.191; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Lu XG, 2006, IEEE T PATTERN ANAL, V28, P31, DOI 10.1109/TPAMI.2006.15; Lu XG, 2008, IEEE T PATTERN ANAL, V30, P1346, DOI 10.1109/TPAMI.2007.70784; Mahoor MH, 2009, PATTERN RECOGN, V42, P445, DOI 10.1016/j.patcog.2008.08.012; Mian AS, 2007, IEEE T PATTERN ANAL, V29, P1927, DOI 10.1109/TPAMI.2007.1105; Moreno AB, 2005, ISPA 2005: PROCEEDINGS OF THE 4TH INTERNATIONAL SYMPOSIUM ON IMAGE AND SIGNAL PROCESSING AND ANALYSIS, P185, DOI 10.1109/ISPA.2005.195407; Moreno AB, 2004, GAVABDB 3D FACE DATA; Moreno AB, 2003, P IMVIP; Mousavi MH, 2008, 7TH IEEE/ACIS INTERNATIONAL CONFERENCE ON COMPUTER AND INFORMATION SCIENCE IN CONJUNCTION WITH 2ND IEEE/ACIS INTERNATIONAL WORKSHOP ON E-ACTIVITY, PROCEEDINGS, P208, DOI 10.1109/ICIS.2008.77; Phillips P. J., 2005, P CVPR, P20; Russ T., 2006, P IEEE COMP SOC C CO, P1391, DOI [10.1109/CVPR.2006.13, DOI 10.1109/CVPR.2006.13]; Russ T. D., 2005, P IEEE COMP SOC C CO, V3, P169; Savran A, 2008, LECT NOTES COMPUT SC, V5372, P47, DOI 10.1007/978-3-540-89991-4_6; Smeets D, 2012, PATTERN RECOGN, V45, P2817, DOI 10.1016/j.patcog.2012.01.020; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Wright SJ, 2009, IEEE T SIGNAL PROCES, V57, P2479, DOI 10.1109/TSP.2009.2016892; Xiaoxing Li, 2009, 2009 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2575, DOI 10.1109/CVPRW.2009.5206613; Yang JF, 2011, SIAM J SCI COMPUT, V33, P250, DOI 10.1137/090777761	52	14	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100120	10.1371/journal.pone.0100120	http://dx.doi.org/10.1371/journal.pone.0100120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940876	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200074
J	Meester, I; Rosas-Taraco, AG; Salinas-Carmona, MC				Meester, Irene; Geovanni Rosas-Taraco, Adrian; Cesar Salinas-Carmona, Mario			Nocardia brasiliensis Induces Formation of Foamy Macrophages and Dendritic Cells In Vitro and In Vivo	PLOS ONE			English	Article							PPAR-GAMMA; LIPID-METABOLISM; TUBERCULOSIS; EXPRESSION; ACTINOMYCETOMA; INFLAMMATION; ACTIVATION; GRANULOMAS; INFECTION; PROTEIN	Foamy cells have been described in various infectious diseases, for example in actinomycetoma induced by Nocardia brasiliensis. These cells are generally considered to be macrophages, although they present dendritic cell (DC)-specific surface markers. In this study, we determined and confirmed the lineage of possible precursors of foamy cells in vitro and in vivo using an experimental actinomycetoma model in BALB/c mice. Bone marrow-derived macrophages (BMDM) or DC (BMDC) were infected in vitro with N. brasiliensis or labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE). Both, macrophages and DC, differentiated into foamy cells after in vitro infection. CFSE-labeled BMDM or BMDC were tested for phagocytosis and CD11c/CD11b receptors markers expression before being transferred into the actinomycetoma lesion site of infected mice. In vivo studies showed that BMDM and BMDC were traced at the site where foamy cells are present in the experimental actinomycetoma. Interestingly, many of the transferred BMDM and BMDC were stained with the lipid-droplet fluorophore Nile Red. In conclusion, macrophages and DC cells can be differentiated into foamy cells in vitro and in vivo during N. brasiliensis infection.	[Meester, Irene; Geovanni Rosas-Taraco, Adrian; Cesar Salinas-Carmona, Mario] Univ Autonoma Nuevo Leon, Fac Med, Dept Immunol, San Nicolas De Los Garza, Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon	Salinas-Carmona, MC (corresponding author), Univ Autonoma Nuevo Leon, Fac Med, Dept Immunol, San Nicolas De Los Garza, Nuevo Leon, Mexico.	mario.salinas@uanl.mx	meester, irene/AAG-9879-2020; Salinas-Carmona, Mario C/Y-2456-2019	meester, irene/0000-0002-0609-3207; Salinas-Carmona, Mario C/0000-0002-4239-7363	CONACYT Mexico [99149]; CONACYT [229067]	CONACYT Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was supported by a grant to AGRT from CONACYT Mexico (99149). IM is grateful for the CONACYT study grant 229067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida PE, 2009, J IMMUNOL, V183, P1337, DOI 10.4049/jimmunol.0900365; Ammon C, 2000, IMMUNOLOGY, V100, P364, DOI 10.1046/j.1365-2567.2000.00056.x; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Elamin AA, 2012, J PATHOG, V2012, DOI 10.1155/2012/361374; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Guth AM, 2009, AM J PHYSIOL-LUNG C, V296, pL936, DOI 10.1152/ajplung.90625.2008; Hunter RL, 2006, ANN CLIN LAB SCI, V36, P371; INABA K, 1995, CELL IMMUNOL, V163, P148, DOI 10.1006/cimm.1995.1109; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; Kouoh F, 2000, APMIS, V108, P417, DOI 10.1034/j.1600-0463.2000.d01-77.x; Kruger T, 2004, J AM SOC NEPHROL, V15, P613, DOI 10.1097/01.ASN.0000114553.36258.91; KURUP IG, 1982, J BIOSCIENCES, V4, P307, DOI 10.1007/BF02702743; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu WW, 2014, INFLAMM RES, V63, P33, DOI 10.1007/s00011-013-0667-3; Mahajan S, 2012, J IMMUNOL, V188, P5593, DOI 10.4049/jimmunol.1103038; Martin P, 2000, BLOOD, V96, P2511, DOI 10.1182/blood.V96.7.2511.h8002511_2511_2519; Mattos KA, 2011, J IMMUNOL, V187, P2548, DOI 10.4049/jimmunol.1101344; Mattos KA, 2010, J LEUKOCYTE BIOL, V87, P371, DOI 10.1189/jlb.0609433; McLauchlan J, 2009, BBA-MOL CELL BIOL L, V1791, P552, DOI 10.1016/j.bbalip.2008.12.012; Meester I, 2013, PATHOG DIS, V67, P214, DOI 10.1111/2049-632X.12036; Mei CL, 2009, CELL BIOL INT, V33, P301, DOI 10.1016/j.cellbi.2008.12.002; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Moreno JM, 2002, IMMUNOLOGY, V106, P257, DOI 10.1046/j.1365-2567.2002.01403.x; Noverr MC, 2001, INFECT IMMUN, V69, P2957, DOI 10.1128/IAI.69.5.2957-2963.2001; O'Neill HC, 2004, J LEUKOCYTE BIOL, V75, P600, DOI 10.1189/jlb.0903446; Ordway D, 2005, J IMMUNOL, V175, P3873, DOI 10.4049/jimmunol.175.6.3873; Paulson KE, 2010, CIRC RES, V106, P383, DOI 10.1161/CIRCRESAHA.109.210781; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Rosas-Taraco AG, 2012, INFECT IMMUN, V80, P2493, DOI 10.1128/IAI.06307-11; Saka HA, 2012, ANN REV CELL DEV BIO; Salinas-Carmona MC, 1999, INFECT IMMUN, V67, P2428, DOI 10.1128/IAI.67.5.2428-2432.1999; Salinas-Carmona MC, 2000, MICROBES INFECT, V2, P1373, DOI 10.1016/S1286-4579(00)01291-0; Salinas-Carmona MC, 2012, A VANLEEUWENHOEK; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Sonda S, 2001, J BIOL CHEM, V276, P34434, DOI 10.1074/jbc.M105025200; Tanigawa K, 2009, CLIN EXP IMMUNOL, V156, P495, DOI 10.1111/j.1365-2249.2009.03930.x; TOMIDA M, 1984, J BIOL CHEM, V259, P978; Trevino-Villarreal JH, 2012, INFECT IMMUN; Vera-Cabrera L, 2012, J BACTERIOL, V194, P2761, DOI 10.1128/JB.00210-12; Welsh O V-CL, 2007, ACTINOMICETOMA, P159; Yao J, 2014, IMMUNOL	45	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100064	10.1371/journal.pone.0100064	http://dx.doi.org/10.1371/journal.pone.0100064			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936860	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000338503400068
J	Randall, PA; Lee, CA; Nunes, EJ; Yohn, SE; Nowak, V; Khan, B; Shah, P; Pandit, S; Vemuri, VK; Makriyannis, A; Baqi, Y; Muller, CE; Correa, M; Salamone, JD				Randall, Patrick A.; Lee, Christie A.; Nunes, Eric J.; Yohn, Samantha E.; Nowak, Victoria; Khan, Bilal; Shah, Priya; Pandit, Saagar; Vemuri, V. Kiran; Makriyannis, Alex; Baqi, Younis; Mueller, Christa E.; Correa, Merce; Salamone, John D.			The VMAT-2 Inhibitor Tetrabenazine Affects Effort-Related Decision Making in a Progressive Ratio/Chow Feeding Choice Task: Reversal with Antidepressant Drugs	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS DOPAMINE; MAJOR DEPRESSIVE DISORDER; CATECHOL-O-METHYLTRANSFERASE; ALTER RESPONSE ALLOCATION; A(2A) RECEPTOR ANTAGONISM; FOOD-SEEKING BEHAVIOR; ADENOSINE A(2A); PARKINSONS-DISEASE; NEGATIVE SYMPTOMS; MOVEMENT-DISORDERS	Behavioral activation is a fundamental feature of motivation, and organisms frequently make effort-related decisions based upon evaluations of reinforcement value and response costs. Furthermore, people with major depression and other disorders often show anergia, psychomotor retardation, fatigue, and alterations in effort-related decision making. Tasks measuring effort-based decision making can be used as animal models of the motivational symptoms of depression, and the present studies characterized the effort-related effects of the vesicular monoamine transport (VMAT-2) inhibitor tetrabenazine. Tetrabenazine induces depressive symptoms in humans, and also preferentially depletes dopamine (DA). Rats were assessed using a concurrent progressive ratio (PROG)/chow feeding task, in which they can either lever press on a PROG schedule for preferred high-carbohydrate food, or approach and consume a less-preferred lab chow that is freely available in the chamber. Previous work has shown that the DA antagonist haloperidol reduced PROG work output on this task, but did not reduce chow intake, effects that differed substantially from those of reinforcer devaluation or appetite suppressant drugs. The present work demonstrated that tetrabenazine produced an effort-related shift in responding on the PROG/chow procedure, reducing lever presses, highest ratio achieved and time spent responding, but not reducing chow intake. Similar effects were produced by administration of the subtype selective DA antagonists ecopipam (D1) and eticlopride (D2), but not by the cannabinoid CB1 receptor neutral antagonist and putative appetite suppressant AM 4413, which suppressed both lever pressing and chow intake. The adenosine A(2A) antagonist MSX-3, the antidepressant and catecholamine uptake inhibitor bupropion, and the MAO-B inhibitor deprenyl, all reversed the impairments induced by tetrabenazine. This work demonstrates the potential utility of the PROG/chow procedure as a rodent model of the effort-related deficits observed in depressed patients.	[Randall, Patrick A.; Lee, Christie A.; Nunes, Eric J.; Yohn, Samantha E.; Nowak, Victoria; Khan, Bilal; Shah, Priya; Pandit, Saagar; Correa, Merce; Salamone, John D.] Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA; [Vemuri, V. Kiran; Makriyannis, Alex] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA; [Baqi, Younis; Mueller, Christa E.] Univ Bonn, Inst Pharmazeut, Pharma Zentrum Bonn, Bonn, Germany; [Baqi, Younis] Sultan Qaboos Univ, Fac Sci, Dept Chem, Muscat, Oman; [Correa, Merce] Univ Jaume 1, Area Psicobiol, Castellon de La Plana, Spain	University of Connecticut; Northeastern University; University of Bonn; Sultan Qaboos University; Universitat Jaume I	Salamone, JD (corresponding author), Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA.	john.salamone@uconn.edu	Müller, Christa Elisabeth/C-7748-2014; Salamone, John/H-8165-2015; Baqi, Younis/I-8240-2016; CORREA, MERCE/G-6125-2011; Baqi, Younis/R-8364-2019	Müller, Christa Elisabeth/0000-0002-0013-6624; Salamone, John/0000-0001-6435-9635; Baqi, Younis/0000-0002-9659-8419; CORREA, MERCE/0000-0002-9868-3131; Baqi, Younis/0000-0002-9659-8419; Randall, Christie/0000-0003-4401-6525	National Institute of Mental Health [MH094966]; Fundacio Bancaixa/U. Jaume I. [P1.1B2010-43]; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH094966] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fundacio Bancaixa/U. Jaume I.; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant to J.S. from the National Institute of Mental Health (MH094966), and to M.C. from Fundacio Bancaixa/U. Jaume I. (P1.1B2010-43). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg E, 2011, J AFFECT DISORDERS, V129, P158, DOI 10.1016/j.jad.2010.08.009; Bardgett ME, 2009, BEHAV NEUROSCI, V123, P242, DOI 10.1037/a0014625; Beeler JA, 2012, EUR J NEUROSCI, V35, P146, DOI 10.1111/j.1460-9568.2011.07916.x; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Botvinick MM, 2009, COGN AFFECT BEHAV NE, V9, P16, DOI 10.3758/CABN.9.1.16; BROWN AS, 1993, J NEURAL TRANSM-GEN, V91, P75, DOI 10.1007/BF01245227; Brown RG, 2000, TRENDS NEUROSCI, V23, P412, DOI 10.1016/S0166-2236(00)01626-X; Cagniard B, 2006, NEUROPSYCHOPHARMACOL, V31, P1362, DOI 10.1038/sj.npp.1300966; Cousins MS, 1996, BEHAV BRAIN RES, V74, P189, DOI 10.1016/0166-4328(95)00151-4; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Dantzer R, 2012, NAT REV CLIN ONCOL, V9, P414, DOI 10.1038/nrclinonc.2012.88; Demyttenaere K, 2005, INT J NEUROPSYCHOPH, V8, P93, DOI 10.1017/S1461145704004729; Farrar AM, 2008, NEUROSCIENCE, V152, P321, DOI 10.1016/j.neuroscience.2007.12.034; Farrar AM, 2010, NEUROSCIENCE, V166, P1056, DOI 10.1016/j.neuroscience.2009.12.056; Farrar AM, 2007, PSYCHOPHARMACOLOGY, V191, P579, DOI 10.1007/s00213-006-0554-5; Fava M, 1999, J CLIN PSYCHOPHARM, V19, P329, DOI 10.1097/00004714-199908000-00008; Fava M, 2014, DEPRESS ANXIETY, V31, P250, DOI 10.1002/da.22199; Fervaha G, 2013, NEUROSCI BIOBEHAV R, V37, P2649, DOI 10.1016/j.neubiorev.2013.09.001; Floresco SB, 2008, NEUROPSYCHOPHARMACOL, V33, P1966, DOI 10.1038/sj.npp.1301565; Floresco SB, 2007, CEREB CORTEX, V17, P251, DOI 10.1093/cercor/bhj143; Font L, 2008, PSYCHOPHARMACOLOGY, V199, P515, DOI 10.1007/s00213-008-1174-z; Frank S, 2010, NEUROPSYCH DIS TREAT, V6, P657, DOI 10.2147/NDT.S6430; Frank S, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-62; Fung VSC, 2009, MOVEMENT DISORD, V24, P25, DOI 10.1002/mds.21878; Gold JM, 2013, BIOL PSYCHIAT, V74, P130, DOI 10.1016/j.biopsych.2012.12.022; Guay DRP, 2010, AM J GERIATR PHARMAC, V8, P331, DOI 10.1016/j.amjopharm.2010.08.006; Hanff TC, 2010, ISR J PSYCHIATR REL, V47, P64; Hauber W, 2009, CEREB CORTEX, V19, P2240, DOI 10.1093/cercor/bhn241; Hodgson RA, 2009, J PHARMACOL EXP THER, V330, P294, DOI 10.1124/jpet.108.149617; Jang S, 2013, J AFFECT DISORDERS, V151, P854, DOI 10.1016/j.jad.2013.07.023; KAROUM F, 1994, J NEUROCHEM, V63, P972, DOI 10.1046/j.1471-4159.1994.63030972.x; KENT TA, 1986, BIOL PSYCHIAT, V21, P483, DOI 10.1016/0006-3223(86)90190-3; Keppel G, 1991, DESIGN ANAL RES HDB; Kurniawan IT, 2010, J NEUROPHYSIOL, V104, P313, DOI 10.1152/jn.00027.2010; Mai B, 2012, COGN AFFECT BEHAV NE, V12, P74, DOI 10.3758/s13415-011-0068-4; Markou A, 2013, NEUROSCI BIOBEHAV R, V37, P2149, DOI 10.1016/j.neubiorev.2013.08.007; MARTIN P, 1987, PROG NEURO-PSYCHOPH, V11, P1, DOI 10.1016/0278-5846(87)90026-1; Matsumoto M, 2003, NEUROPSYCHOPHARMACOL, V28, P1521, DOI 10.1038/sj.npp.1300218; McGinty VB, 2013, NEURON, V78, P910, DOI 10.1016/j.neuron.2013.04.010; Milea D, 2010, CLIN THER, V32, P2057, DOI 10.1016/j.clinthera.2010.11.011; Miller AH, 2009, BRAIN BEHAV IMMUN, V23, P149, DOI 10.1016/j.bbi.2008.08.006; Mingote S, 2008, J NEUROSCI, V28, P9037, DOI 10.1523/JNEUROSCI.1525-08.2008; MOREAU JL, 1994, BEHAV PHARMACOL, V5, P344, DOI 10.1097/00008877-199406000-00012; Mott AM, 2009, PSYCHOPHARMACOLOGY, V204, P103, DOI 10.1007/s00213-008-1441-z; Muller T, 2009, PATIENT PREFER ADHER, V3, P51; Nicola SM, 2010, J NEUROSCI, V30, P16585, DOI 10.1523/JNEUROSCI.3958-10.2010; Nowend KL, 2001, PHARMACOL BIOCHEM BE, V69, P373, DOI 10.1016/S0091-3057(01)00524-X; Nunes EJ, 2010, NEUROSCIENCE, V170, P268, DOI 10.1016/j.neuroscience.2010.05.068; Nunes EJ, 2014, PSYCHOPHARMACOLOGY, V231, P727, DOI 10.1007/s00213-013-3285-4; Nunes EJ, 2013, J NEUROSCI, V33, P19120, DOI 10.1523/JNEUROSCI.2730-13.2013; Nunes EJ, 2013, NEUROSCI BIOBEHAV R, V37, P2015, DOI 10.1016/j.neubiorev.2013.04.002; Pae CU, 2007, MED HYPOTHESES, V69, P132, DOI 10.1016/j.mehy.2006.11.009; Papakostas GI, 2008, J CLIN PSYCHIAT, V69, P1287, DOI 10.4088/JCP.v69n0812; Pardo M, 2012, NEUROPHARMACOLOGY, V62, P2068, DOI 10.1016/j.neuropharm.2011.12.033; Pereira M, 2011, PSYCHOPHARMACOLOGY, V213, P69, DOI 10.1007/s00213-010-2015-4; PETTIBONE DJ, 1984, EUR J PHARMACOL, V102, P425, DOI 10.1016/0014-2999(84)90562-4; PRESKORN SH, 1984, PSYCHOPHARMACOLOGY, V84, P196, DOI 10.1007/BF00427445; Randall PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047934; Randall PA, 2011, PSYCHOPHARMACOLOGY, V216, P173, DOI 10.1007/s00213-011-2198-3; Riederer Peter, 2011, Exp Neurobiol, V20, P1, DOI 10.5607/en.2011.20.1.1; Robbins TW, 2007, PSYCHOPHARMACOLOGY, V191, P433, DOI 10.1007/s00213-006-0528-7; Rogers MA, 2000, J CLIN EXP NEUROPSYC, V22, P232, DOI 10.1076/1380-3395(200004)22:2;1-1;FT232; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P461, DOI 10.1007/s00213-006-0668-9; SALAMONE JD, 1991, PSYCHOPHARMACOLOGY, V104, P515, DOI 10.1007/BF02245659; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Salamone JD, 2002, PSYCHOPHARMACOLOGY, V160, P371, DOI 10.1007/s00213-001-0994-x; Salamone JD, 1997, NEUROSCI BIOBEHAV R, V21, P341, DOI 10.1016/S0149-7634(96)00017-6; SALAMONE JD, 1994, BEHAV BRAIN RES, V65, P221, DOI 10.1016/0166-4328(94)90108-2; Salamone JD, 2006, CURR PSYCHIATRY REV, V2, P267, DOI 10.2174/157340006776875914; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Salamone JD, 2009, BEHAV BRAIN RES, V201, P216, DOI 10.1016/j.bbr.2009.02.021; Santerre JL, 2012, PHARMACOL BIOCHEM BE, V102, P477, DOI 10.1016/j.pbb.2012.06.009; Schulz D, 2010, NEUROBIOL LEARN MEM, V93, P291, DOI 10.1016/j.nlm.2009.11.003; Sclar D. A., 2013, PRIM CARE COMPANION, V15; Shafiei N, 2012, NEUROPSYCHOPHARMACOL, V37, P2194, DOI 10.1038/npp.2012.69; Shore DM, 2011, MOVEMENT DISORD, V26, P1887, DOI 10.1002/mds.23736; SHULMAN R, 1978, BRIT J PSYCHIAT, V132, P133, DOI 10.1192/bjp.132.2.133; Sink KS, 2008, PSYCHOPHARMACOLOGY, V196, P565, DOI 10.1007/s00213-007-0988-4; Stahl SM, 2002, J CLIN PSYCHIAT, V63, P7, DOI 10.4088/JCP.v63n0102; TANRA AJ, 1995, PROG NEURO-PSYCHOPH, V19, P963, DOI 10.1016/0278-5846(95)00124-E; Treadway MT, 2012, J ABNORM PSYCHOL, V121, P553, DOI 10.1037/a0028813; Treadway MT, 2012, J NEUROSCI, V32, P6170, DOI 10.1523/JNEUROSCI.6459-11.2012; Treadway MT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006598; Trifilieff P, 2013, MOL PSYCHIATR, V18, P1025, DOI 10.1038/mp.2013.57; Walton ME, 2003, J NEUROSCI, V23, P6475; Wang JL, 2010, NUCL MED BIOL, V37, P479, DOI 10.1016/j.nucmedbio.2010.01.006; Wardle MC, 2011, J NEUROSCI, V31, P16597, DOI 10.1523/JNEUROSCI.4387-11.2011; Winograd-Gurvich C, 2006, BRAIN RES BULL, V70, P312, DOI 10.1016/j.brainresbull.2006.06.007; Worden LT, 2009, PSYCHOPHARMACOLOGY, V203, P489, DOI 10.1007/s00213-008-1396-0; Yamada K, 2013, PHARMACOL BIOCHEM BE, V114, P23, DOI 10.1016/j.pbb.2013.10.022; Yavich L, 2007, J NEUROSCI, V27, P10196, DOI 10.1523/JNEUROSCI.0665-07.2007	92	63	64	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99320	10.1371/journal.pone.0099320	http://dx.doi.org/10.1371/journal.pone.0099320			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK5YM	24937131	Green Submitted, Green Published, gold			2022-12-25	WOS:000338503400014
J	Link, A; Balaguer, F; Nagasaka, T; Boland, CR; Goel, A				Link, Alexander; Balaguer, Francesc; Nagasaka, Takeshi; Boland, C. Richard; Goel, Ajay			MicroRNA miR-J1-5p as a potential Biomarker for JC Virus Infection in the Gastrointestinal Tract	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; T-ANTIGEN EXPRESSION; HUMAN POLYOMAVIRUSES; COLORECTAL CANCERS; COLON-CANCER; HUMAN BRAIN; BK VIRUS; PROTEINS; CELLS; DNA	Introduction: JC virus (JCV), a human polyomavirus that causes progressive multifocal leukoencephalopathy (PML), has been linked to colorectal cancer (CRC). However, determination of JCV infection and its role in carcinogenesis has been challenging, highlighting the need for better diagnostic strategies for this virus. JCV-specific microRNAs (miRNAs) were identified and shown to negatively regulate oncogenic JCV T-Ag. Herein, we determined the pattern of JCV miRNA expression in clinical specimens from healthy subjects and CRC patients. Material and Methods: JCV miRNA expression was validated in CRC cell lines transfected with the JCV T-Ag. Results were confirmed using CRC tissues that were expressed T-Ag. Expression of JCV-specific miR-J1-5p was measured in fresh stool samples from healthy volunteers, and samples from fecal occult blood test kits from healthy subject, and patients with colorectal neoplasms. Results: JCV miR-J1-5p was detected in JCV-transfected, but not vector-transfected, CRC cells, and was stable between cell passages. MiR-J1-5p was present in all six JCV T-Ag+ CRC samples. Surprisingly, JCV miRNA was detectable in all normal tissues, but the expression was much lower in CRC tissues. Similarly, miR-J1-5p expression was present in all fecal samples, but expression was lower in CRCs compared to controls or adenoma patients. Conclusion: JC virus-specific miR-J1-5p miRNA is a potential biomarker for viral infection, and the lower expression in patients with colonic neoplasia highlights its biological role regulating oncogenic T-Ag expression in CRC. Impact: JCV-specific miRNA is a candidate for the development of a non-invasive screening test, as well as therapeutic intervention for JCV-associated diseases.	[Link, Alexander; Balaguer, Francesc; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Baylor Res Inst, Gastrointestinal Canc Res Lab,Div Gastroenterol, Dallas, TX 75246 USA; [Link, Alexander] Otto Von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany; [Balaguer, Francesc] Univ Barcelona, CIBEREHD, Hosp Clin, Dept Gastroenterol, E-08007 Barcelona, Spain; [Nagasaka, Takeshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol Surg & Surg Oncol, Okayama 7008530, Japan	Baylor Scott & White Health; Baylor University; Baylor University Medical Center; Otto von Guericke University; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; Okayama University	Goel, A (corresponding author), Baylor Univ, Med Ctr, Baylor Res Inst, Gastrointestinal Canc Res Lab,Div Gastroenterol, Dallas, TX 75246 USA.	ajay.goel@baylorhealth.edu	Balaguer, Francesc/GPX-7801-2022; BALAGUER, FRANCESC/G-2389-2016	Nagasaka, Takeshi/0000-0002-4236-350X; Balaguer, Francesc/0000-0002-0206-0539; Link, Alexander/0000-0002-9514-4562; Goel, Ajay/0000-0003-1396-6341	National Cancer Institute, National Institutes of Health [R01 CA098572]; Baylor Research Institute; NATIONAL CANCER INSTITUTE [R01CA098572] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Baylor Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The present work was supported by grant R01 CA098572 from the National Cancer Institute, National Institutes of Health, and funds from the Baylor Research Institute. The funding was provided to CRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Balaguer F, 2010, CANCER RES, V70, P6609, DOI 10.1158/0008-5472.CAN-10-0622; Bauman Y, 2011, CELL HOST MICROBE, V9, P93, DOI 10.1016/j.chom.2011.01.008; Boland CR, 2005, GUT, V54, P1321, DOI 10.1136/gut.2004.060079; BOLLAG B, 1992, VIRUS RES, V25, P223, DOI 10.1016/0168-1702(92)90136-W; Bollag B, 2006, J NEUROVIROL, V12, P428, DOI 10.1080/13550280601009553; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Del VL, 2002, J NEUROVIROL S2, V8, P138, DOI [10.1080/13550280290101111, DOI 10.1080/13550280290101111]; Enam S, 2002, CANCER RES, V62, P7093; FRISQUE RJ, 1980, J VIROL, V35, P265, DOI 10.1128/JVI.35.1.265-269.1980; FRISQUE RJ, 1984, J VIROL, V51, P458, DOI 10.1128/JVI.51.2.458-469.1984; Gan DD, 2001, ONCOGENE, V20, P4864, DOI 10.1038/sj.onc.1204670; Gee GV, 2010, BRIT J CANCER, V103, P885, DOI 10.1038/sj.bjc.6605848; Goel A, 2006, GASTROENTEROLOGY, V130, P1950, DOI 10.1053/j.gastro.2006.02.061; Jiang MX, 2009, VIROLOGY, V384, P266, DOI 10.1016/j.virol.2008.09.027; Jung WT, 2008, CANCER-AM CANCER SOC, V112, P1028, DOI 10.1002/cncr.23266; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Khalili K, 2007, NEUROLOGY, V68, P985, DOI 10.1212/01.wnl.0000257832.38943.2b; Knowles WA, 2006, ADV EXP MED BIOL, V577, P19; Laghi L, 1999, P NATL ACAD SCI USA, V96, P7484, DOI 10.1073/pnas.96.13.7484; Link A, 2010, CANCER EPIDEM BIOMAR, V19, P1766, DOI 10.1158/1055-9965.EPI-10-0027; Link A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008146; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; MAJOR EO, 1992, CLIN MICROBIOL REV, V5, P49, DOI 10.1128/CMR.5.1.49-73.1992; McQuaig SM, 2009, APPL ENVIRON MICROB, V75, P3379, DOI 10.1128/AEM.02302-08; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; PADGETT BL, 1971, LANCET, V1, P1257; PADGETT BL, 1977, CANCER RES, V37, P718; Raj GV, 1996, ONCOGENE, V12, P1279; Ricciardiello L, 2000, GASTROENTEROLOGY, V119, P1228, DOI 10.1053/gast.2000.19269; Ricciardiello L, 2003, CANCER RES, V63, P7256; Seo GJ, 2008, J VIROL, V82, P9823, DOI 10.1128/JVI.01144-08; Stolt A, 2003, J GEN VIROL, V84, P1499, DOI 10.1099/vir.0.18842-0	34	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100036	10.1371/journal.pone.0100036	http://dx.doi.org/10.1371/journal.pone.0100036			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932487	Green Published, Green Submitted, gold			2022-12-25	WOS:000337738600085
J	Russo, T; D'Andrea, L; Parisi, A; Cataudella, S				Russo, Tommaso; D'Andrea, Lorenzo; Parisi, Antonio; Cataudella, Stefano			VMSbase: An R-Package for VMS and Logbook Data Management and Analysis in Fisheries Ecology	PLOS ONE			English	Article							VESSEL MONITORING-SYSTEM; SMALL-SCALE FISHERIES; CATCH; INDICATORS; VALIDATION; PROGRESS; MODEL	VMSbase is an R package devised to manage, process and visualize information about fishing vessels activity (provided by the vessel monitoring system - VMS) and catches/landings (as reported in the logbooks). VMSbase is primarily conceived to be user-friendly; to this end, a suite of state-of-the-art analyses is accessible via a graphical interface. In addition, the package uses a database platform allowing large datasets to be stored, managed and processed vey efficiently. Methodologies include data cleaning, that is removal of redundant or evidently erroneous records, and data enhancing, that is interpolation and merging with external data sources. In particular, VMSbase is able to estimate sea bottom depth for single VMS pings using an on-line connection to the National Oceanic and Atmospheric Administration (NOAA) database. It also allows VMS pings to be assigned to whatever geographic partitioning has been selected by users. Standard analyses comprise: 1) metier identification (using a modified CLARA clustering approach on Logbook data or Artificial Neural Networks on VMS data); 2) linkage between VMS and Logbook records, with the former organized into fishing trips; 3) discrimination between steaming and fishing points; 4) computation of spatial effort with respect to user-selected grids; 5) calculation of standard fishing effort indicators within Data Collection Framework; 6) a variety of mapping tools, including an interface for Google viewer; 7) estimation of trawled area. Here we report a sample workflow for the accessory sample datasets (available with the package) in order to explore the potentialities of VMSbase. In addition, the results of some performance tests on two large datasets (1610 5 and 1610 6 VMS signals, respectively) are reported to inform about the time required for the analyses. The results, although merely illustrative, indicate that VMSbase can represent a step forward in extracting and enhancing information from VMS/logbook data for fisheries studies.	[Russo, Tommaso; D'Andrea, Lorenzo; Cataudella, Stefano] Univ Roma Tor Vergata, Dept Biol, Lab Expt Ecol & Aquaculture, I-00173 Rome, Italy; [Parisi, Antonio] Univ Roma Tor Vergata, Fac Econ, Dept Econ & Finance, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata	Russo, T (corresponding author), Univ Roma Tor Vergata, Dept Biol, Lab Expt Ecol & Aquaculture, Via Ric Sci Snc, I-00173 Rome, Italy.	Tommaso.Russo@Uniroma2.it	Russo, Tommaso/C-6157-2014	Russo, Tommaso/0000-0003-4047-959X; D'Andrea, Lorenzo/0000-0002-3795-3601				Acom ICM, 2011, ICES WKCPUEFFORT REP, P5; [Anonymous], 2013, MAPTOOLS TOOLS READI; Bezdek JC, 1981, PATTERN RECOGNITION, DOI 10.1007/978-1-4757-0450-1; Bourgon R, 2013, INTERVALS TOOLS WORK, P1; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Brownrigg R., 2013, MAPDATA EXTRA MAP DA; Campbell M, 2013, SCI AM, V308, P6; Castro J, 2010, FISH RES, V102, P184, DOI 10.1016/j.fishres.2009.11.011; Chang SK, 2014, MAR POLICY, V43, P338, DOI 10.1016/j.marpol.2013.07.003; Chang SK, 2011, MAR POLICY, V35, P116, DOI 10.1016/j.marpol.2010.08.009; Coll M, 2013, REV FISH BIOL FISH; Fmay MP, 2013, INTERVALS WEIGHTED L; Fock HO, 2011, MAR POLICY, V35, P181, DOI 10.1016/j.marpol.2010.09.003; Furrer R, 2013, FIELDS TOOLS SPATIAL; Garcia-Rodriguez M, 2006, FISH RES, V77, P226, DOI 10.1016/j.fishres.2005.09.002; Gerritsen H, 2011, ICES J MAR SCI, V68, P245, DOI 10.1093/icesjms/fsq137; Gerritsen HD, 2013, ICES J MAR SCI, V70, P523, DOI 10.1093/icesjms/fst017; Goslee S., 2013, ECODIST DISSIMILARIT; Grothendieck G., 2012, SQLDF PERFORM SQL SE; Hintzen NT, 2012, FISH RES, V115, P31, DOI 10.1016/j.fishres.2011.11.007; Ihaka R, 2010, R LESSONS LEARNED DI; James D., 2013, CHRON CHRONOLOGICAL; Kahle D, 2013, GGMAP PACKAGE SPATIA; Kidd S., 2011, ECOSYSTEM APPROACH M; Komsta L., 2011, OUTLIERS TESTS OUTLI; Lambert GI, 2012, ICES J MAR SCI, V69, P682, DOI 10.1093/icesjms/fss018; Lawrence M, 2011, CAIRODEVICE CAIRO BA; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lemon JB, 2013, PLOTRIX VARIOUS PLOT; Maechler M., 2013, CLUSTER CLUSTER ANAL; Maechler M, 2013, DOSEGLJIVONA; Marchal P, 2008, ICES J MAR SCI, V65, P674, DOI 10.1093/icesjms/fsn044; Minka T.P., 2013, MAPS DRAW GEOGRAPHIC; Miyamoto S, 2008, STUD FUZZ SOFT COMP, V229, P1; Pante E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073051; Pebesma E., 2013, SP CLASSES METHODS S; Pelletier D, 2000, CAN J FISH AQUAT SCI, V57, P51, DOI 10.1139/cjfas-57-1-51; Piet GJ, 2007, ICES J MAR SCI, V64, P110, DOI 10.1093/icesjms/fsl006; R Core Team, 2021, R LANG ENV STAT COMP; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Russo T, 2013, ECOL INDIC, V26, P141, DOI 10.1016/j.ecolind.2012.11.002; Russo T, 2010, J APPL ICHTHYOL, V26, P360, DOI 10.1111/j.1439-0426.2010.01435.x; Russo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086646; Russo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086222; Russo T, 2011, FISH RES, V111, P53, DOI 10.1016/j.fishres.2011.06.011; Russo T, 2011, FISH RES, V108, P184, DOI 10.1016/j.fishres.2010.12.020; Russo T, 2009, ICES J MAR SCI, V66, P1718, DOI 10.1093/icesjms/fsp204; Russo T, 2009, J THEOR BIOL, V258, P521, DOI 10.1016/j.jtbi.2009.01.033; Scarcella G, 2014, J SEA RES, V89, P12, DOI 10.1016/j.seares.2014.02.002; Schnute J.T., 2013, USERS GUIDE R PACKAG; Schnute JT, 2007, 2549 FISH AQ SCI; Sharples J, 2013, PROG OCEANOGR, V117, P130, DOI 10.1016/j.pocean.2013.06.014; Tsontos V.M., 2000, Oceanography, V13, P25; Tzanatos E, 2005, FISH RES, V73, P147, DOI 10.1016/j.fishres.2004.12.006; Verzani J, 2012, GWIDGETS GWIDGETS AP; Verzani J, 2012, EXAMPLES GWIDGETS AB, P1; Walker E, 2010, ECOL MODEL, V221, P2008, DOI 10.1016/j.ecolmodel.2010.05.007	57	55	56	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100195	10.1371/journal.pone.0100195	http://dx.doi.org/10.1371/journal.pone.0100195			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932915	Green Submitted, Green Published, gold			2022-12-25	WOS:000337738600102
J	Yu, XF; Grace, M; Zou, YC; Yu, XF; Lu, XG; Wang, GP				Yu, Xiaofei; Grace, Michael; Zou, Yuanchun; Yu, Xuefeng; Lu, Xianguo; Wang, Guoping			Surface Sediments in the Marsh-Sandy Land Transitional Area: Sandification in the Western Songnen Plain, China	PLOS ONE			English	Article							NORTHEAST CHINA; USE/COVER CHANGES; DESERT; WETLANDS; DESERTIFICATION; HISTORY; FORMS; DUST; ZONE	The development of sandification process was studied, by monitoring the changes of sediment characteristics, at marsh-sandy land intersections in China's Songnen region. A series of sediment collection plates were deployed in the region; after one year, sediments in these plates were analyzed for changes of mass and chemical characteristics. The sediment flux and the sand content of the sediments decreased with the increasing longitudinal distance between the sampling site and the centre line of a sand dune. The mean sediment flux was 29 +/- 14 kg m(-2) yr(-1) and 0.6 +/- 0.3 kg m(-2) yr(-1) in the sandy land and marsh, respectively. Strong, positive correlations were found between the concentrations of organic matter, total nitrogen, P, Fe, Ti, V and Zr, all of which were also negatively correlated with the sand content. The concentrations of organic matter, total nitrogen, P, Fe, Ti, V and Zr in the marsh sediment samples were all significantly greater than the corresponding concentrations of the sandy land (p<0.001). Sand content and Ti, V and Zr concentrations all proved to be valid indicators of sandification intensity, and they showed that the marsh could be divided into three distinct zones. Sand expansion extended about 88 m into the marsh. The mean sand content in the sediments of the sandy land was 91% and then 64% in the marsh, which in turn was higher than that of marshes outside the influence of sandification, suggesting that the marsh in the marsh-sandy land transitional area has already undergone extensive sandification in the past. The study results provide information on the wetland's function of indicating and buffering the sandification process.	[Yu, Xiaofei; Zou, Yuanchun; Lu, Xianguo; Wang, Guoping] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Wetland Ecol & Environm, Changchun, Peoples R China; [Grace, Michael] Monash Univ, Water Studies Ctr, Clayton, Vic, Australia; [Grace, Michael] Monash Univ, Sch Chem, Clayton, Vic, Australia; [Yu, Xuefeng] Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian, Peoples R China	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Monash University; Monash University; Chinese Academy of Sciences; Institute of Earth Environment, CAS	Wang, GP (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Wetland Ecol & Environm, Changchun, Peoples R China.	wangguoping@iga.ac.cn	Yu, Xuefeng/I-8594-2014; Grace, Mike/AAE-3073-2022; Zou, Yuanchun/B-6666-2008; YU, Xuefeng/B-9332-2009; Grace, Mike/AAE-3376-2021; Wang, Guoping/A-8140-2008	Zou, Yuanchun/0000-0003-1520-9678; Grace, Mike/0000-0002-0982-8133; Wang, Guoping/0000-0002-8350-812X; lu, xian guo/0000-0001-7638-2787; Yu, Xiaofei/0000-0001-6623-0165	National Basic Research Program [2012CB956100]; National Natural Science Foundation of China [41101195]; Science Foundation of State Key Laboratory of Loess and Quaternary Geology [SKLLQG0910]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of State Key Laboratory of Loess and Quaternary Geology	The National Basic Research Program (No. 2012CB956100), the National Natural Science Foundation of China (No. 41101195) and the Science Foundation of State Key Laboratory of Loess and Quaternary Geology (No. SKLLQG0910) supplied the financial supports of this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, WETLAND ECOLOGY PRIN; AZMON E, 1994, SCI TOTAL ENVIRON, V149, P155, DOI 10.1016/0048-9697(94)90176-7; Bao S.D., 2000, SOIL AGROCHEMICAL AN, V3rd Edn; Bian JM, 2008, ENVIRON GEOL, V55, P1421, DOI 10.1007/s00254-007-1092-0; Bian JM, 2003, AREAL RES DEV, V22, P68; Chen B, 2009, J ENVIRON SCI-CHINA, V21, P1363, DOI 10.1016/S1001-0742(08)62427-4; CHESHIRE MV, 1977, GEOCHIM COSMOCHIM AC, V41, P1131, DOI 10.1016/0016-7037(77)90108-9; de Groot AV, 2011, MAR GEOL, V282, P240, DOI 10.1016/j.margeo.2011.03.002; Ding Z.J., 1999, SCI CHINA SER D, V29, P82; Guan QY, 2010, GEOSCI J, V14, P155, DOI 10.1007/s12303-010-0015-3; Kim JG, 2002, CATENA, V48, P267, DOI 10.1016/S0341-8162(02)00031-0; Kokfelt U, 2010, J PALEOLIMNOL, V44, P327, DOI 10.1007/s10933-010-9406-8; [李鱼 Li Yu], 2005, [水土保持通报, Bulletin of Soil and Water Conservation], V25, P83; Liu DW, 2009, CHINESE GEOGR SCI, V19, P299, DOI 10.1007/s11769-009-0299-2; Liu YS, 2005, ENVIRON MANAGE, V36, P691, DOI 10.1007/s00267-004-0285-5; Lombardo U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072746; Maher BA, 2009, GEOLOGY, V37, P279, DOI 10.1130/G25293A.1; Pan MH, 2011, HDB SOIL SCI PROPERT, P20; Pigati JS, 2012, P NATL ACAD SCI USA, V109, P7208, DOI 10.1073/pnas.1200296109; Prospero JM, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000095; Qiu S. W, 2007, HIST EVOLUTION NATUR, P86; Soons MB, 2006, APPL VEG SCI, V9, P271, DOI 10.1658/1402-2001(2006)9[271:WDIFWK]2.0.CO;2; Tang HP, 2003, ACTA BOT SIN, V45, P1166; Tweel AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050528; Wang GP, 2004, WETLANDS, V24, P608, DOI 10.1672/0277-5212(2004)024[0608:HVOHMW]2.0.CO;2; Wang GP, 2008, GEODERMA, V145, P50, DOI 10.1016/j.geoderma.2008.02.004; Wen BL, 2012, CHINESE GEOGR SCI, V22, P167, DOI 10.1007/s11769-012-0519-z; White BL, 2008, WATER RESOUR RES, V44, DOI 10.1029/2006WR005651; Zha Y, 1997, J ARID ENVIRON, V37, P419, DOI 10.1006/jare.1997.0290; Zhai ZL, 2006, THESIS GRADUATE U CH; Zhou WJ, 2002, HOLOCENE, V12, P107, DOI 10.1191/0959683602hl525rr	31	10	12	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99715	10.1371/journal.pone.0099715	http://dx.doi.org/10.1371/journal.pone.0099715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932717	Green Published, Green Submitted, gold			2022-12-25	WOS:000337738600058
J	Jiwaji, M; Sandison, ME; Reboud, J; Stevenson, R; Daly, R; Barkess, G; Faulds, K; Kolch, W; Graham, D; Girolami, MA; Cooper, JM; Pitt, AR				Jiwaji, Meesbah; Sandison, Mairi E.; Reboud, Julien; Stevenson, Ross; Daly, Ronan; Barkess, Grainne; Faulds, Karen; Kolch, Walter; Graham, Duncan; Girolami, Mark A.; Cooper, Jonathan M.; Pitt, Andrew R.			Quantification of Functionalised Gold Nanoparticle-Targeted Knockdown of Gene Expression in HeLa Cells	PLOS ONE			English	Article							SIZE-DEPENDENT ENDOCYTOSIS; METAL-RESPONSIVE ELEMENTS; DRUG-DELIVERY; METALLOTHIONEIN; THERAPY; VECTORS; RNAI; TRANSFECTION; BIOLOGY	Introduction: Gene therapy continues to grow as an important area of research, primarily because of its potential in the treatment of disease. One significant area where there is a need for better understanding is in improving the efficiency of oligonucleotide delivery to the cell and indeed, following delivery, the characterization of the effects on the cell. Methods: In this report, we compare different transfection reagents as delivery vehicles for gold nanoparticles functionalized with DNA oligonucleotides, and quantify their relative transfection efficiencies. The inhibitory properties of small interfering RNA (siRNA), single-stranded RNA (ssRNA) and single-stranded DNA (ssDNA) sequences targeted to human metallothionein hMT-IIa are also quantified in HeLa cells. Techniques used in this study include fluorescence and confocal microscopy, qPCR and Western analysis. Findings: We show that the use of transfection reagents does significantly increase nanoparticle transfection efficiencies. Furthermore, siRNA, ssRNA and ssDNA sequences all have comparable inhibitory properties to ssDNA sequences immobilized onto gold nanoparticles. We also show that functionalized gold nanoparticles can co-localize with autophagosomes and illustrate other factors that can affect data collection and interpretation when performing studies with functionalized nanoparticles. Conclusions: The desired outcome for biological knockdown studies is the efficient reduction of a specific target; which we demonstrate by using ssDNA inhibitory sequences targeted to human metallothionein IIa gene transcripts that result in the knockdown of both the mRNA transcript and the target protein.	[Jiwaji, Meesbah; Sandison, Mairi E.; Kolch, Walter; Pitt, Andrew R.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland; [Sandison, Mairi E.; Reboud, Julien; Cooper, Jonathan M.] Univ Glasgow, Sch Engn, Div Biomed Engn, Glasgow, Lanark, Scotland; [Stevenson, Ross; Faulds, Karen; Graham, Duncan] Univ Strathclyde, Dept Pure & Appl Chem, Ctr Mol Nanometrol, Glasgow, Lanark, Scotland; [Daly, Ronan; Girolami, Mark A.] Univ Glasgow, Sch Comp Sci, Glasgow, Lanark, Scotland; [Barkess, Grainne] Univ Glasgow, Coll Med Vet & Life Sci, Inst Canc Sci, Glasgow, Lanark, Scotland; [Kolch, Walter] Syst Biol Ireland, Dublin, Ireland; [Kolch, Walter] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland; [Girolami, Mark A.] UCL, Dept Stat Sci, London, England; [Jiwaji, Meesbah; Pitt, Andrew R.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	University of Glasgow; University of Glasgow; University of Strathclyde; University of Glasgow; University of Glasgow; University College Dublin; University of London; University College London; Aston University	Pitt, AR (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland.	a.r.pitt@aston.ac.uk	Reboud, Julien/F-1565-2014; Kolch, Walter/ABF-2102-2021; Cooper, Jonathan/E-9000-2010; Admin, SBI/HGB-2738-2022; Cooper, Jonathan/GLS-9195-2022; Graham, Duncan/C-8440-2011; Jiwaji, Meesbah/D-9509-2014	Reboud, Julien/0000-0002-6879-8405; Cooper, Jonathan/0000-0002-2358-1050; Cooper, Jonathan/0000-0002-2358-1050; Sandison, Mairi/0000-0003-1021-1461; Pitt, Andrew R/0000-0003-3619-6503; Graham, Duncan/0000-0002-6079-2105; Jiwaji, Meesbah/0000-0003-3557-4541; Barkess, Grainne/0000-0003-1742-921X; Kolch, Walter/0000-0001-5777-5016; Girolami, Mark/0000-0003-3008-253X; Daly, Ronan/0000-0002-1275-6820; Faulds, Karen/0000-0002-5567-7399	Engineering and Physical Sciences Research Council (EPSRC) Basic Technology Research Grant [EP/E032745/1]; Science Foundation Ireland [06/CE/B1129]; EPSRC [EP/E032745/2, EP/E032745/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E032745/1, EP/E032745/2] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC) Basic Technology Research Grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Engineering and Physical Sciences Research Council (EPSRC) Basic Technology Research Grant [grant number EP/E032745/1]. WK was also supported by Science Foundation Ireland [grant number 06/CE/B1129]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbasi-Porter C, 2006, BIOCONJUGATE CHEM, V17, P1178, DOI 10.1021/bc060100f; Bonetta L, 2004, NAT METHODS, V1, P79, DOI 10.1038/nmeth1004-79; Bonnemann H, 2001, EUR J INORG CHEM, P2455; BRUST M, 1995, J CHEM SOC CHEM COMM, P1655, DOI 10.1039/c39950001655; Chen PC, 2008, NANOTECHNOL SCI APPL, V1, P45; Cheon J, 2008, ACCOUNTS CHEM RES, V41, P1630, DOI 10.1021/ar800045c; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; Ghosh PS, 2008, ACS NANO, V2, P2213, DOI 10.1021/nn800507t; Green JJ, 2008, ACCOUNTS CHEM RES, V41, P749, DOI 10.1021/ar7002336; Gu YJ, 2009, TOXICOL APPL PHARM, V237, P196, DOI 10.1016/j.taap.2009.03.009; Guo X, 2003, ACCOUNTS CHEM RES, V36, P335, DOI 10.1021/ar9703241; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Haes AJ, 2005, J PHYS CHEM B, V109, P11158, DOI 10.1021/jp051178g; Haes AJ, 2004, NANO LETT, V4, P1029, DOI 10.1021/nl049670j; Jiwaji M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-103; Kagi J H, 1987, Experientia Suppl, V52, P25; KARIN M, 1987, MOL CELL BIOL, V7, P606, DOI 10.1128/MCB.7.2.606; KARIN M, 1984, CELL, V36, P371, DOI 10.1016/0092-8674(84)90230-7; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; KERSHAW WC, 1992, TOXICOL APPL PHARM, V112, P24, DOI 10.1016/0041-008X(92)90275-W; Kim DH, 2008, BIOTECHNIQUES, V44, P613, DOI 10.2144/000112792; Kim EY, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl147; Kim JH, 2010, CHEM COMMUN, V46, P4151, DOI 10.1039/c0cc00103a; Kocbek P, 2007, J CONTROL RELEASE, V120, P18, DOI 10.1016/j.jconrel.2007.03.012; Koizumi S, 1999, EUR J BIOCHEM, V259, P635, DOI 10.1046/j.1432-1327.1999.00069.x; Krizkova S, 2009, BRATISL MED J, V110, P93; LEYSHONSORLAND K, 1993, CANCER RES, V53, P4874; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; McCormick F, 2001, NAT REV CANCER, V1, P130, DOI 10.1038/35101008; McKenzie F, 2009, CHEM COMMUN, P2872, DOI 10.1039/b823057a; Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e; Murphy CJ, 2008, ACCOUNTS CHEM RES, V41, P1721, DOI 10.1021/ar800035u; Nordberg M, 1998, TALANTA, V46, P243, DOI 10.1016/S0039-9140(97)00345-7; Opalinska JB, 2002, NAT REV DRUG DISCOV, V1, P503, DOI 10.1038/nrd837; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; Patra HK, 2007, NANOMED-NANOTECHNOL, V3, P111, DOI 10.1016/j.nano.2007.03.005; Plummer M., 2003, P 3 INT WORKSH DISTR; Plummer M, 2006, R NEWS, V6, P11; Prato M, 2008, ACCOUNTS CHEM RES, V41, P60, DOI 10.1021/ar700089b; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Rosi NL, 2006, SCIENCE, V312, P1027, DOI 10.1126/science.1125559; Sandhu KK, 2002, BIOCONJUGATE CHEM, V13, P3, DOI 10.1021/bc015545c; Skroch P, 1993, Prog Clin Biol Res, V380, P113; Slowing II, 2008, ADV DRUG DELIVER REV, V60, P1278, DOI 10.1016/j.addr.2008.03.012; Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/s0168-3659(00)00339-4; Taylor U, 2010, CYTOM PART A, V77A, P439, DOI 10.1002/cyto.a.20846; Tekade RK, 2009, CHEM REV, V109, P49, DOI 10.1021/cr068212n; Templeton AC, 2000, ACCOUNTS CHEM RES, V33, P27, DOI 10.1021/ar9602664; Trewyn BG, 2007, ACCOUNTS CHEM RES, V40, P846, DOI 10.1021/ar600032u; Tsai CY, 2004, NANO LETT, V4, P1209, DOI 10.1021/nl0495231; TURKEVICH J, 1951, DISCUSS FARADAY SOC, P55, DOI 10.1039/df9511100055; Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357; Van de Broek B, 2011, ACS NANO, V5, P4319, DOI 10.1021/nn1023363; Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410; Vijayakumar S, 2012, J NANOMATER, V2012, DOI 10.1155/2012/734398; Wang SH, 2010, J NANOBIOTECHNOL, V8, DOI 10.1186/1477-3155-8-33; Watson P, 2005, ADV DRUG DELIVER REV, V57, P43, DOI 10.1016/j.addr.2004.05.003; Weare WW, 2000, J AM CHEM SOC, V122, P12890, DOI 10.1021/ja002673n; Wrzesien J, 2012, TETRAHEDRON, V68, P1230, DOI 10.1016/j.tet.2011.11.053; Zhang SL, 2009, ADV MATER, V21, P419, DOI 10.1002/adma.200801393	62	8	8	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99458	10.1371/journal.pone.0099458	http://dx.doi.org/10.1371/journal.pone.0099458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926959	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000338278100042
J	Wang, JH; Ni, ZH; Duan, ZP; Wang, GQ; Li, F				Wang, Jihan; Ni, Zhaohui; Duan, Zipeng; Wang, Guoqing; Li, Fan			Altered Expression of Hypoxia-Inducible Factor-1 alpha (HIF-1 alpha) and Its Regulatory Genes in Gastric Cancer Tissues	PLOS ONE			English	Article							NF-KAPPA-B; PROMOTER POLYMORPHISMS; INFLAMMATION; TUMORS; RISK	Tissue hypoxia induces reprogramming of cell metabolism and may result in normal cell transformation and cancer progression. Hypoxia-inducible factor 1-alpha (HIF-1 alpha), the key transcription factor, plays an important role in gastric cancer development and progression. This study aimed to investigate the underlying regulatory signaling pathway in gastric cancer using gastric cancer tissue specimens. The integration of gene expression profile and transcriptional regulatory element database (TRED) was pursued to identify HIF-1 alpha <-> NF kappa B1 -> BRCA1 -> STAT3 <- STAT1 gene pathways and their regulated genes. The data showed that there were 82 differentially expressed genes that could be regulated by these five transcription factors in gastric cancer tissues and these genes formed 95 regulation modes, among which seven genes (MMP1, TIMP1, TLR2, FCGR3A, IRF1, FAS, and TFF3) were hub molecules that are regulated at least by two of these five transcription factors simultaneously and were associated with hypoxia, inflammation, and immune disorder. Real-Time PCR and western blot showed increasing of HIF-1 alpha in mRNA and protein levels as well as TIMP1, TFF3 in mRNA levels in gastric cancer tissues. The data are the first study to demonstrate HIF-1 alpha-regulated transcription factors and their corresponding network genes in gastric cancer. Further study with a larger sample size and more functional experiments is needed to confirm these data and then translate into clinical biomarker discovery and treatment strategy for gastric cancer.	[Wang, Jihan; Ni, Zhaohui; Duan, Zipeng; Wang, Guoqing; Li, Fan] Jilin Univ, Coll Basic Med Sci, Jilin Key Lab Biomed Mat, Dept Pathogenobiol, Changchun 130023, Peoples R China; [Wang, Guoqing; Li, Fan] Jilin Univ, Minist Educ, Key Lab Bion Engn, Changchun 130023, Peoples R China	Jilin University; Jilin University	Wang, GQ (corresponding author), Jilin Univ, Coll Basic Med Sci, Jilin Key Lab Biomed Mat, Dept Pathogenobiol, Changchun 130023, Peoples R China.	qing8110@gmail.com; lifan@jlu.edu.cn			National Natural Science Foundation of China [81320108025, 81271897]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20110061120093]; China Postdoctoral Science Foundation [20110491311, 2012T50285]; Foundation of Jilin Provincial Health Department [2011Z049]; Foundation of Jilin Province Science and Technology Department [20130522013JH, 20140414048GH]; Norman Bethune Program of Jilin University [2012219]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Foundation of Jilin Provincial Health Department; Foundation of Jilin Province Science and Technology Department; Norman Bethune Program of Jilin University	This work was supported in part by grants from National Natural Science Foundation of China (#81320108025 and #81271897), Specialized Research Fund for the Doctoral Program of Higher Education of China (#20110061120093), China Postdoctoral Science Foundation (#20110491311 and #2012T50285), Foundation of Jilin Provincial Health Department (#2011Z049), Foundation of Jilin Province Science and Technology Department (#20130522013JH and #20140414048GH) and the Norman Bethune Program of Jilin University (#2012219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao W, 2010, ARCH BIOCHEM BIOPHYS, V499, P49, DOI 10.1016/j.abb.2010.05.009; Baus-Loncar M, 2005, CELL MOL LIFE SCI, V62, P2921, DOI 10.1007/s00018-005-5480-x; Bournazou Eirini, 2013, JAKSTAT, V2, pe23828, DOI 10.4161/jkst.23828; Bruick RK, 2003, GENE DEV, V17, P2614, DOI 10.1101/gad.1145503; Burchard PR, 2013, CANCER GENET-NY, V206, P130, DOI 10.1016/j.cancergen.2013.03.002; Chen R, 2007, AM J REPROD IMMUNOL, V57, P93, DOI 10.1111/j.1600-0897.2006.00441.x; Compare D, 2010, EUR REV MED PHARMACO, V14, P302; Cui J, 2012, J MOL CELL BIOL, V4, P174, DOI 10.1093/jmcb/mjs017; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Gentner B, 2009, ANTICANCER RES, V29, P67; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13; Murtas D, 2013, BRIT J CANCER, V109, P76, DOI 10.1038/bjc.2013.335; Pawlus MR, 2013, ONCOGENE; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Roukos DH, 2013, EXPERT REV MOL DIAGN, V13, P643, DOI 10.1586/14737159.2013.820540; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Silver-Morse L., 2013, JAK STAT, V2, DOI DOI 10.4161/JKST.26090; Solaini G, 2010, BBA-BIOENERGETICS, V1797, P1171, DOI 10.1016/j.bbabio.2010.02.011; Valibeigi B, 2013, PATHOL ONCOL RES; Xu CC, 2013, PATHOL RES PRACT, V209, P479, DOI 10.1016/j.prp.2013.04.017; Xu Q, 2013, GENE, V529, P104, DOI 10.1016/j.gene.2013.07.070; Zhang ZG, 2013, ASIAN PAC J CANCER P, V14, P4195, DOI 10.7314/APJCP.2013.14.7.4195; Zhang ZQ, 2006, INT J ONCOL, V29, P185; Zhang ZZ, 2009, CARCINOGENESIS, V30, P487, DOI 10.1093/carcin/bgp016; Zhou W, 2013, CANC LETT; Zhu CL, 2013, MOL BIOL REP, V40, P6055, DOI 10.1007/s11033-013-2715-z	32	26	29	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99835	10.1371/journal.pone.0099835	http://dx.doi.org/10.1371/journal.pone.0099835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927122	Green Submitted, Green Published, gold			2022-12-25	WOS:000338278100084
J	Eklund, G; Lang, S; Glindre, J; Ehlen, A; Alvarado-Kristensson, M				Eklund, Greta; Lang, Stefan; Glindre, Johan; Ehlen, Asa; Alvarado-Kristensson, Maria			The Nuclear Localization of gamma-Tubulin Is Regulated by SadB-mediated Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; MICROTUBULE NUCLEATION; GENE-EXPRESSION; RING COMPLEX; PROTEIN; CENTROSOME; TRANSCRIPTION; DUPLICATION; KINASES; PHASE	gamma-Tubulin is an important cell division regulator that arranges microtubule assembly and mitotic spindle formation. Cytosolic gamma-tubulin nucleates alpha- and beta-tubulin in a growing microtubule by forming the ring-shaped protein complex gamma TuRC. Nuclear gamma-tubulin also regulates S-phase progression by moderating the activities of E2 promoter-binding factors. The mechanism that regulates localization of gamma-tubulin is currently unknown. Here, we demonstrate that the human Ser/Thr kinase SadB short localizes to chromatin and centrosomes. We found that SadB-mediated phosphorylation of gamma-tubulin on Ser385 formed chromatin-associated gamma-tubulin complexes that moderate gene expression. In this way, the C-terminal region of gamma-tubulin regulates S-phase progression. In addition, chromatin levels of gamma-tubulin were decreased by the reduction of SadB levels or expression of a non-phosphorylatable Ala(385)-gamma-tubulin but were enhanced by expression of SadB, wild-type gamma-tubulin, or a phosphomimetic Asp(385)-gamma-tubulin mutant. Our results demonstrate that SadB kinases regulate the cellular localization of gamma-tubulin and thereby control S-phase progression.	[Eklund, Greta; Lang, Stefan; Glindre, Johan; Ehlen, Asa; Alvarado-Kristensson, Maria] Lund Univ, Div Mol Pathol, Dept Lab Med, Skane Univ Hosp, SE-20502 Malmo, Sweden	Lund University; Skane University Hospital	Alvarado-Kristensson, M (corresponding author), Lund Univ, SUS Malmo, 59 Jan Waldenstroms St,Floor 2, SE-20502 Malmo, Sweden.	maria.alvarado-kristensson@med.lu.se	Alvarado-Kristensson, Maria T./C-4543-2014	Eklund, Greta/0000-0002-2498-7765; Alvarado Kristensson, Maria Teresa/0000-0003-0598-7986	Swedish Research Council; Swedish Cancer Society; Swedish childhood cancer foundation; Royal Physiographic Society in Lund; Gradfoordska Foundation; Gunnar Nilsson Foundation; Gyllenstiernska Krapperupsstiftelsen; Skane University Hospital in Malmo Cancer Research Fund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish childhood cancer foundation(European Commission); Royal Physiographic Society in Lund; Gradfoordska Foundation; Gunnar Nilsson Foundation; Gyllenstiernska Krapperupsstiftelsen; Skane University Hospital in Malmo Cancer Research Fund	This work was supported by the Swedish Research Council, the Swedish Cancer Society, the Swedish childhood cancer foundation, the Royal Physiographic Society in Lund, the Gradfoordska and Gunnar Nilsson Foundations, Gyllenstiernska Krapperupsstiftelsen, and the Skane University Hospital in Malmo Cancer Research Fund.	Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; Alvarado-Kristensson M, 2009, NAT CELL BIOL, V11, P1081, DOI 10.1038/ncb1921; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Black EP, 2005, P NATL ACAD SCI USA, V102, P15948, DOI 10.1073/pnas.0504300102; Carrera AC, 2009, CELL CYCLE, V8, P4005, DOI 10.4161/cc.8.24.10178; Coppola G, 2011, METHODS MOL BIOL, V793, P417, DOI 10.1007/978-1-61779-328-8_28; Edgerton-Morgan H, 2012, J CELL BIOL, V198, P785, DOI 10.1083/jcb.201203115; Ehlen A, 2012, J BIOL CHEM, V287, P17241, DOI 10.1074/jbc.M112.357038; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Gonsior SM, 1999, J CELL SCI, V112, P797; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Hegemann B, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001993; Hoog G, 2011, FASEB J, V25, P3815, DOI 10.1096/fj.11-187484; Horejsi B, 2012, J CELL PHYSIOL, V227, P367, DOI 10.1002/jcp.22772; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Lesca C, 2005, ONCOGENE, V24, P5165, DOI 10.1038/sj.onc.1208723; Lin TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019700; Lu R, 2004, J BIOL CHEM, V279, P31164, DOI 10.1074/jbc.M404728200; Marques M, 2008, MOL CELL BIOL, V28, P2803, DOI 10.1128/MCB.01786-07; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; MITCHISON T, 1984, NATURE, V312, P232, DOI 10.1038/312232a0; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Pouton CW, 2007, ADV DRUG DELIVER REV, V59, P698, DOI 10.1016/j.addr.2007.06.010; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Vogel J, 2001, DEV CELL, V1, P621, DOI 10.1016/S1534-5807(01)00073-9; Yuba-Kubo A, 2005, DEV BIOL, V282, P361, DOI 10.1016/j.ydbio.2005.03.031; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	31	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21360	21373		10.1074/jbc.M114.562389	http://dx.doi.org/10.1074/jbc.M114.562389			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24942739	Green Published, hybrid			2022-12-25	WOS:000340558300016
J	Makinoshima, H; Takita, M; Matsumoto, S; Yagishita, A; Owada, S; Esumi, H; Tsuchihara, K				Makinoshima, Hideki; Takita, Masahiro; Matsumoto, Shingo; Yagishita, Atsushi; Owada, Satoshi; Esumi, Hiroyasu; Tsuchihara, Katsuya			Epidermal Growth Factor Receptor ( EGFR) Signaling Regulates Global Metabolic Pathways in EGFR-mutated Lung Adenocarcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITRON-EMISSION-TOMOGRAPHY; IONIZATION MASS-SPECTROMETRY; TYROSINE KINASE INHIBITORS; CANCER-CELL METABOLISM; C-MYC; MUTATIONS; GEFITINIB; PROLIFERATION; TRANSLOCATION; TUMORS	Genetic mutations in tumor cells cause several unique metabolic phenotypes that are critical for cancer cell proliferation. Mutations in the tyrosine kinase epidermal growth factor receptor (EGFR) induce oncogenic addiction in lung adenocarcinoma (LAD). However, the linkage between oncogenic mutated EGFR and cancer cell metabolism has not yet been clearly elucidated. Here we show that EGFR signaling plays an important role in aerobic glycolysis in EGFR-mutated LAD cells. EGFR-tyrosine kinase inhibitors (TKIs) decreased lactate production, glucose consumption, and the glucose-induced extracellular acidification rate (ECAR), indicating that EGFR signaling maintained aerobic glycolysis in LAD cells. Metabolomic analysis revealed that metabolites in the glycolysis, pentose phosphate pathway (PPP), pyrimidine biosynthesis, and redox metabolism were significantly decreased after treatment of LAD cells with EGFR-TKI. On a molecular basis, the glucose transport carried out by glucose transporter 3 (GLUT3) was downregulated in TKI-sensitive LAD cells. Moreover, EGFR signaling activated carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (CAD), which catalyzes the first step in de novo pyrimidine synthesis. We conclude that EGFR signaling regulates the global metabolic pathway in EGFR-mutated LAD cells. Our data provide evidence that may link therapeutic response to the regulation of metabolism, which is an attractive target for the development of more effective targeted therapies to treat patients with EGFR-mutated LAD.	[Makinoshima, Hideki; Takita, Masahiro; Matsumoto, Shingo; Yagishita, Atsushi; Tsuchihara, Katsuya] Natl Canc Ctr, Div Translat Res, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba 2778577, Japan; [Takita, Masahiro; Tsuchihara, Katsuya] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778561, Japan; [Matsumoto, Shingo] Natl Canc Ctr Hosp East, Thorac Oncol Div, Kashiwa, Chiba 2778577, Japan; [Owada, Satoshi; Esumi, Hiroyasu] Tokyo Univ Sci, Res Inst Biomed Sci, Noda, Chiba 2780022, Japan	National Cancer Center - Japan; University of Tokyo; National Cancer Center - Japan; Tokyo University of Science	Makinoshima, H (corresponding author), Natl Canc Ctr, Div Translat Res, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba 2778577, Japan.	hmakinos@east.ncc.go.jp			National Cancer Center Research and Development Fund [25-A-6]; JSPS KAKENHI [24300345]	National Cancer Center Research and Development Fund(National Cancer Center - Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Cancer Center Research and Development Fund (25-A-6) and JSPS KAKENHI Grant Number 24300345 (to K. T.).	Babic I, 2013, CELL METAB, V17, P1000, DOI 10.1016/j.cmet.2013.04.013; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cheong H, 2012, NAT BIOTECHNOL, V30, P671, DOI 10.1038/nbt.2285; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Donev IS, 2011, CLIN CANCER RES, V17, P2260, DOI 10.1158/1078-0432.CCR-10-1993; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2014, ONCOGENE, V33, P4279, DOI 10.1038/onc.2013.406; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Irmer D, 2007, ONCOGENE, V26, P5693, DOI 10.1038/sj.onc.1210383; Kami K, 2013, METABOLOMICS, V9, P444, DOI 10.1007/s11306-012-0452-2; Kim SM, 2013, MOL CANCER THER, V12, P2145, DOI 10.1158/1535-7163.MCT-12-1188; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Levitzki A, 2013, ANNU REV PHARMACOL, V53, P161, DOI 10.1146/annurev-pharmtox-011112-140341; Linardou H, 2009, NAT REV CLIN ONCOL, V6, P352, DOI 10.1038/nrclinonc.2009.62; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Mellinghoff I, 2007, PLOS MED, V4, P1620, DOI 10.1371/journal.pmed.0040321; Miller DM, 2012, CLIN CANCER RES, V18, P5546, DOI 10.1158/1078-0432.CCR-12-0977; Miller VA, 2012, LANCET ONCOL, V13, P528, DOI 10.1016/S1470-2045(12)70087-6; Morrish F, 2008, CELL CYCLE, V7, P1054, DOI 10.4161/cc.7.8.5739; Okamoto K, 2010, CANCER RES, V70, P10402, DOI 10.1158/0008-5472.CAN-10-2438; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Santos GD, 2011, ANNU REV PATHOL-MECH, V6, P49, DOI 10.1146/annurev-pathol-011110-130206; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Soga T, 2013, CANCER SCI, V104, P275, DOI 10.1111/cas.12085; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Su H, 2006, CLIN CANCER RES, V12, P5659, DOI 10.1158/1078-0432.CCR-06-0368; Sudo M, 2013, CANCER CHEMOTH PHARM, V71, P1325, DOI 10.1007/s00280-013-2132-y; Suzuki A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073484; Takahashi R, 2012, CLIN CANCER RES, V18, P220, DOI 10.1158/1078-0432.CCR-11-0868; Watson RT, 2006, TRENDS BIOCHEM SCI, V31, P215, DOI 10.1016/j.tibs.2006.02.007; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Wong N, 2015, CANCER LETT, V356, P184, DOI 10.1016/j.canlet.2014.01.031; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Yang WW, 2013, CELL CYCLE, V12, P3154, DOI 10.4161/cc.26182; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zhang C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3935; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	44	121	126	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20813	20823		10.1074/jbc.M114.575464	http://dx.doi.org/10.1074/jbc.M114.575464			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24928511	Green Published, hybrid			2022-12-25	WOS:000339396600036
J	Monecke, S; Muller, E; Buchler, J; Stieber, B; Ehricht, R				Monecke, Stefan; Mueller, Elke; Buechler, Joseph; Stieber, Bettina; Ehricht, Ralf			Staphylococcus aureus In Vitro Secretion of Alpha Toxin (hla) Correlates with the Affiliation to Clonal Complexes	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; METHICILLIN-RESISTANT; STRAINS; PNEUMONIA; VIRULENCE; MRSA; EXPRESSION; HEMOLYSIN	The alpha toxin of Staphylococcus aureus is a pore forming toxin that penetrates host cell membranes causing osmotic swelling, rupture, lysis and subsequently cell death. Haemolysin alpha is toxic to a wide range of different mammalian cells; i.e., neurotoxic, dermonecrotic, haemolytic, and it can cause lethality in a wide variety of animals. In this study, the in vitro alpha toxin production of 648 previously genotyped isolates of S. aureus was measured quantitatively using antibody microarrays. Isolates originated from medical and veterinary settings and were selected in order to represent diverse clonal complexes and defined clinical conditions. Generally, the production of alpha toxin in vitro is related to the clonal complex affiliation. For clonal complexes CC22, CC30, CC45, CC479, CC705 and others, invariably no alpha toxin production was noted under the given in vitro conditions, while others, such as CC1, CC5, CC8, CC15 or CC96 secreted variable or high levels of alpha toxin. There was no correlation between alpha toxin yield and clinical course of the disease, or between alpha toxin yield and host species.	[Monecke, Stefan; Mueller, Elke; Stieber, Bettina; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Monecke, Stefan; Stieber, Bettina] Tech Univ Dresden, Inst Med Microbiol & Hyg, D-01062 Dresden, Germany; [Buechler, Joseph] Alere San Diego Inc, San Diego, CA USA	Alere; Technische Universitat Dresden; Alere	Monecke, S (corresponding author), Alere Technol GmbH, Jena, Germany.	monecke@rocketmail.com						Albrecht N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028189; Anjum MF, 2006, CLIN VACCINE IMMUNOL, V13, P561, DOI 10.1128/CVI.13.5.561-567.2006; Mestre MB, 2010, AUTOPHAGY, V6, P110, DOI 10.4161/auto.6.1.10698; Chen L, 2013, J CLIN MICROBIOL, V51, P914, DOI 10.1128/JCM.03015-12; DeLeo FR, 2011, P NATL ACAD SCI USA, V108, P18091, DOI 10.1073/pnas.1111084108; Ehricht Ralf, 2009, V509, P85, DOI 10.1007/978-1-59745-372-1_6; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Holt DC, 2011, GENOME BIOL EVOL, V3, P881, DOI 10.1093/gbe/evr078; Huelseweh B, 2006, PROTEOMICS, V6, P2972, DOI 10.1002/pmic.200500721; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Lee MH, 2010, J INFECT DIS, V201, P508, DOI 10.1086/650204; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; McCormick CC, 2009, INVEST OPHTH VIS SCI, V50, P2848, DOI 10.1167/iovs.08-3157; Monecke S, 2012, EUR J CLIN MICROBIOL, V31, P1497, DOI 10.1007/s10096-011-1469-6; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1159, DOI 10.1007/s10096-009-0752-2; Monecke S, 2013, SCREENING STAPHYLOCO; Monecke S, PLOS ONE; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066166; Monecke S, 2013, J CLIN MICROBIOL, V51, P487, DOI 10.1128/JCM.02285-12; Monecke S, 2013, VET MICROBIOL, V162, P806, DOI 10.1016/j.vetmic.2012.10.018; Monecke S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-146; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Monecke S, 2011, VET MICROBIOL, V150, P309, DOI 10.1016/j.vetmic.2011.02.001; Monecke S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014025; Montgomery CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015177; Nygaard TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036532; OREILLY M, 1990, MOL MICROBIOL, V4, P1947, DOI 10.1111/j.1365-2958.1990.tb02044.x; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; Scicluna EA, 2010, EUR J CLIN MICROBIOL, V29, P163, DOI 10.1007/s10096-009-0834-1; Sibelius U, 2000, CIRCULATION, V101, P78, DOI 10.1161/01.CIR.101.1.78; Stieber B, 2013, MOL CELL PROBES; Tamber S, 2009, INFECT IMMUN, V77, P419, DOI 10.1128/IAI.00859-08; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06	35	23	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100427	10.1371/journal.pone.0100427	http://dx.doi.org/10.1371/journal.pone.0100427			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940872	Green Submitted, Green Published, gold			2022-12-25	WOS:000338508200102
J	Nyberg, C; Karlsson, T; Hillered, L; Engstrom, ER				Nyberg, Christoffer; Karlsson, Torbjorn; Hillered, Lars; Engstrom, Elisabeth Ronne			Metabolic Pattern of the Acute Phase of Subarachnoid Hemorrhage in a Novel Porcine Model: Studies with Cerebral Microdialysis with High Temporal Resolution	PLOS ONE			English	Article							EARLY BRAIN-INJURY; BLOOD-FLOW; INTRACEREBRAL MICRODIALYSIS; RAT; VASOSPASM; ARTERIES; TOMOGRAPHY; EXPRESSION; GLUTAMATE; BASAL	Background: Aneurysmal subarachnoid hemorrhage (SAH) may produce cerebral ischemia and systemic responses including stress. To study immediate cerebral and systemic changes in response to aneurysm rupture, animal models are needed. Objective: To study early cerebral energy changes in an animal model. Methods: Experimental SAH was induced in 11 pigs by autologous blood injection to the anterior skull base, with simultaneous control of intracranial and cerebral perfusion pressures. Intracerebral microdialysis was used to monitor concentrations of glucose, pyruvate and lactate. Results: In nine of the pigs, a pattern of transient ischemia was produced, with a dramatic reduction of cerebral perfusion pressure soon after blood injection, associated with a quick glucose and pyruvate decrease. This was followed by a lactate increase and a delayed pyruvate increase, producing a marked but short elevation of the lactate/pyruvate ratio. Glucose, pyruvate, lactate and lactate/pyruvate ratio thereafter returned toward baseline. The two remaining pigs had a more severe metabolic reaction with glucose and pyruvate rapidly decreasing to undetectable levels while lactate increased and remained elevated, suggesting persisting ischemia. Conclusion: The animal model simulates the conditions of SAH not only by deposition of blood in the basal cisterns, but also creating the transient global ischemic impact of aneurysmal SAH. The metabolic cerebral changes suggest immediate transient substrate failure followed by hypermetabolism of glucose upon reperfusion. The model has features that resemble spontaneous bleeding, and is suitable for future research of the early cerebral and systemic responses to SAH that are difficult to study in humans.	[Nyberg, Christoffer; Hillered, Lars; Engstrom, Elisabeth Ronne] Uppsala Univ, Neurosurg Sect, Dept Neurosci, Uppsala, Sweden; [Karlsson, Torbjorn] Uppsala Univ, Sect Anesthesiol & Intens Care, Dept Surg Sci, Uppsala, Sweden	Uppsala University; Uppsala University	Nyberg, C (corresponding author), Uppsala Univ, Neurosurg Sect, Dept Neurosci, Uppsala, Sweden.	christoffer.nyberg@neuro.uu.se		Hillered, Lars/0000-0002-2808-9292	Uppsala University Hospital	Uppsala University Hospital	The study was supported financially by Uppsala University Hospital grants for clinical research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruder N, 2011, NEUROCRIT CARE, V15, P257, DOI 10.1007/s12028-011-9598-4; Cesarini KG, 2002, ACTA NEUROCHIR, V144, P1121, DOI 10.1007/s00701-002-1011-9; Dai M, 2010, PHYSIOL MEAS, V31, P1229, DOI 10.1088/0967-3334/31/9/012; EDWARDS DH, 1992, J NEUROSURG, V76, P830, DOI 10.3171/jns.1992.76.5.0830; Enblad P, 2001, STROKE, V32, P1574, DOI 10.1161/01.STR.32.7.1574; Espiner EA, 2002, CLIN ENDOCRINOL, V56, P629, DOI 10.1046/j.1365-2265.2002.01285.x; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Hall C, 2004, EUR J HEART FAIL, V6, P257, DOI 10.1016/j.ejheart.2003.12.015; Hansen-Schwartz J, 2004, NEUROCRIT CARE, V1, P235, DOI 10.1385/NCC:1:2:235; Hansen-Schwartz J, 2003, NEUROSURGERY, V52, P1188, DOI 10.1227/01.NEU.0000058467.82442.64; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Lee JY, 2009, NEUROSURGERY, V65, P331, DOI 10.1227/01.NEU.0000345649.78556.26; Marbacher S, 2012, J NEUROSCI METH, V208, P138, DOI 10.1016/j.jneumeth.2012.05.010; Marbacher S, 2010, J NEUROSCI METH, V191, P227, DOI 10.1016/j.jneumeth.2010.07.004; Marbacher S, 2010, BRIT J NEUROSURG, V24, P415, DOI 10.3109/02688691003746274; Mollmann H, 2010, INT J CARDIOL, V143, P289, DOI 10.1016/j.ijcard.2009.03.012; Morgan CJ, 2004, J NEUROSURG, V101, P1026, DOI 10.3171/jns.2004.101.6.1026; Nordgren A, 2006, ACTA ANAESTH SCAND, V50, P840, DOI 10.1111/j.1399-6576.2006.01071.x; Prunell GF, 2004, NEUROSURGERY, V54, P426, DOI 10.1227/01.NEU.0000103670.09687.7A; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Ronne-Engstrom E, 2001, J NEUROSURG, V94, P397, DOI 10.3171/jns.2001.94.3.0397; RONNEENGSTROM E, 1995, J NEUROCHEM, V65, P257; SALAR G, 1992, ACTA NEUROCHIR, V119, P115, DOI 10.1007/BF01541794; Schubert GA, 2008, J NEUROTRAUM, V25, P539, DOI 10.1089/neu.2007.0500; Westermaier T, 2011, NEUROSURGERY, V68, P223, DOI 10.1227/NEU.0b013e3181fe23c1; Wu CT, 2011, ANESTH ANALG, V112, P666, DOI 10.1213/ANE.0b013e318207c51f; Zetterling M, 2011, BRIT J NEUROSURG, V25, P684, DOI 10.3109/02688697.2011.584638; Zetterling M, 2010, NEUROSURGERY, V66, P1102, DOI 10.1227/01.NEU.0000370893.04586.73; Zhou YL, 2011, ACTA NEUROCHIR SUPPL, V110, P15, DOI 10.1007/978-3-7091-0353-1_3	30	5	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99904	10.1371/journal.pone.0099904	http://dx.doi.org/10.1371/journal.pone.0099904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940881	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200053
J	Suarez, JV; Banks, S; Thomas, PG; Day, A				Suarez, Julio V.; Banks, Stephen; Thomas, Paul G.; Day, Anil			A New F131V Mutation in Chlamydomonas Phytoene Desaturase Locates a Cluster of Norflurazon Resistance Mutations near the FAD-Binding Site in 3D Protein Models	PLOS ONE			English	Article							DOMINANT SELECTABLE MARKER; HERBICIDE NORFLURAZON; NUCLEAR TRANSFORMATION; CAROTENOID SYNTHESIS; GENE-EXPRESSION; PHOTOSYSTEM-II; ZETA-CAROTENE; REINHARDTII; EVOLUTION; SEQUENCE	The green alga Chlamydomonas reinhardtii provides a tractable genetic model to study herbicide mode of action using forward genetics. The herbicide norflurazon inhibits phytoene desaturase, which is required for carotenoid synthesis. Locating amino acid substitutions in mutant phytoene desaturases conferring norflurazon resistance provides a genetic approach to map the herbicide binding site. We isolated a UV-induced mutant able to grow in very high concentrations of norflurazon (150 mu M). The phytoene desaturase gene in the mutant strain contained the first resistance mutation to be localised to the dinucleotide-binding Rossmann-likedomain. A highly conserved phenylalanine amino acid at position 131 of the 564 amino acid precursor protein was changed to a valine in the mutant protein. F131, and two other amino acids whose substitution confers norflurazon resistance in homologous phytoene desaturase proteins, map to distant regions in the primary sequence of the C. reinhardtii protein (V472, L505) but in tertiary models these residues cluster together to a region close to the predicted FAD binding site. The mutant gene allowed direct 5 mM norflurazon based selection of transformants, which were tolerant to other bleaching herbicides including fluridone, flurtamone, and diflufenican but were more sensitive to beflubutamid than wild type cells. Norflurazon resistance and beflubutamid sensitivity allow either positive or negative selection against transformants expressing the mutant phytoene desaturase gene.	[Suarez, Julio V.; Banks, Stephen; Day, Anil] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Thomas, Paul G.] Syngenta, Bracknell, Berks, England	University of Manchester; Syngenta	Day, A (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	anil.day@manchester.ac.uk		Suarez, Julio/0000-0003-0557-4735; Day, Anil/0000-0001-7835-9572	CONACyT (Mexico) [209303]; BBSRC CASE [95/A2/P/00330]; Syngenta; Zeneca Agrochemicals	CONACyT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); BBSRC CASE(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Syngenta(Syngenta); Zeneca Agrochemicals	JVS was supported by CONACyT scholarship 209303 (Mexico), SB was the recipient of a BBSRC CASE studentship 95/A2/P/00330 with Syngenta (formerly Zeneca Agrochemicals). Zeneca Agrochemicals provided support in the form of salaries for author PGT and a stipend supplement to SB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALTINGMEES MA, 1989, NUCLEIC ACIDS RES, V17, P9494, DOI 10.1093/nar/17.22.9494; ANDERSON IC, 1960, PLANT PHYSIOL, V35, P531, DOI 10.1104/pp.35.4.531; Arias RS, 2006, PLANT BIOTECHNOL J, V4, P263, DOI 10.1111/j.1467-7652.2006.00179.x; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BARTELS PG, 1978, WEED SCI, V26, P198, DOI 10.1017/S0043174500049675; Bates PA, 2001, PROTEINS, P39; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; Binda C, 2004, J MED CHEM, V47, P1767, DOI 10.1021/jm031087c; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cao MQ, 2009, PROTOPLASMA, V235, P107, DOI 10.1007/s00709-009-0036-9; CHAMOVITZ D, 1991, PLANT MOL BIOL, V16, P967, DOI 10.1007/BF00016069; CHAMOVITZ D, 1993, J BIOL CHEM, V268, P17348; Contreras-Moreira B, 2002, BIOINFORMATICS, V18, P1141, DOI 10.1093/bioinformatics/18.8.1141; DAVIES DR, 1971, GENET RES, V17, P33, DOI 10.1017/S0016672300012015; DAY A, 1991, J MOL BIOL, V218, P273, DOI 10.1016/0022-2836(91)90712-F; DAY A, 1988, EMBO J, V7, P1917, DOI 10.1002/j.1460-2075.1988.tb03029.x; Day A, 2011, PLANT BIOTECHNOL J, V9, P540, DOI 10.1111/j.1467-7652.2011.00604.x; EBERSOLD WT, 1967, SCIENCE, V157, P447, DOI 10.1126/science.157.3787.447; ERICKSON JM, 1985, SCIENCE, V228, P204, DOI 10.1126/science.228.4696.204; ERICKSON JM, 1984, P NATL ACAD SCI-BIOL, V81, P3617, DOI 10.1073/pnas.81.12.3617; ERICKSON JM, 1989, PLANT CELL, V1, P361, DOI 10.1105/tpc.1.3.361; Erikson O, 2004, NAT BIOTECHNOL, V22, P455, DOI 10.1038/nbt946; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; FERRIS PJ, 1989, GENETICS, V122, P363; Fischer N, 2001, MOL GENET GENOMICS, V265, P888, DOI 10.1007/s004380100485; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; GALLOWAY RE, 1984, PLANT PHYSIOL, V74, P469, DOI 10.1104/pp.74.3.469; Gisby MF, 2012, PLANT PHYSIOL, V160, P2219, DOI 10.1104/pp.112.204107; GOLDSCHMIDTCLERMONT M, 1986, J MOL BIOL, V191, P421, DOI 10.1016/0022-2836(86)90137-3; GROSS CH, 1988, CURR GENET, V13, P503, DOI 10.1007/BF02427756; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; HUGUENEY P, 1992, EUR J BIOCHEM, V209, P399, DOI 10.1111/j.1432-1033.1992.tb17302.x; JOHANNINGMEIER U, 1987, FEBS LETT, V211, P221, DOI 10.1016/0014-5793(87)81440-0; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Kovar JL, 2002, PLANT J, V29, P109, DOI 10.1046/j.1365-313x.2002.01193.x; KRINSKY NI, 1979, PURE APPL CHEM, V51, P649, DOI 10.1351/pac197951030649; Liu J, 2013, PROCESS BIOCHEM, V48, P788, DOI 10.1016/j.procbio.2013.04.020; Liu J, 2010, PLANTA, V232, P61, DOI 10.1007/s00425-010-1132-y; Lumbreras V, 1998, PLANT J, V14, P441, DOI 10.1046/j.1365-313X.1998.00145.x; Madesis P, 2010, J BIOTECHNOL, V145, P377, DOI 10.1016/j.jbiotec.2009.12.001; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; MARTINEZFEREZ I, 1994, PESTIC BIOCHEM PHYS, V48, P185, DOI 10.1006/pest.1994.1019; MARTINEZFEREZ IM, 1992, PLANT MOL BIOL, V18, P981, DOI 10.1007/BF00019213; Maul JE, 2002, PLANT CELL, V14, P2659, DOI 10.1105/tpc.006155; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Michel A, 2004, MOL ECOL, V13, P3229, DOI 10.1111/j.1365-294X.2004.02280.x; Mijit G, 2003, Acta Genetica Sinica, V30, P646; NELSON JAE, 1994, MOL CELL BIOL, V14, P4011, DOI 10.1128/MCB.14.6.4011; Norris SR, 1995, PLANT CELL, V7, P2139, DOI 10.1105/tpc.7.12.2139; OETTMEIER W, 1991, PESTIC SCI, V33, P399, DOI 10.1002/ps.2780330402; PECKER I, 1992, P NATL ACAD SCI USA, V89, P4962, DOI 10.1073/pnas.89.11.4962; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; Randolph-Anderson BL, 1998, PLANT MOL BIOL, V38, P839, DOI 10.1023/A:1006085026294; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; SANDMANN G, 1989, Z NATURFORSCH C, V44, P787; Schaub P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039550; Seetharaman J, CRYSTAL STRUCTURE OX; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3; Stevens DR, 1996, MOL GEN GENET, V251, P23; Tran PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042196; Vallon O, 2000, PROTEINS, V38, P95, DOI 10.1002/(SICI)1097-0134(20000101)38:1<95::AID-PROT10>3.0.CO;2-A; Vartak V, 1997, WEED SCI, V45, P374, DOI 10.1017/S0043174500093000; Vila M, 2008, PROCESS BIOCHEM, V43, P1147, DOI 10.1016/j.procbio.2008.06.014; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; Zhang Z, CRYSTAL STRUCTURE OX	70	13	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99894	10.1371/journal.pone.0099894	http://dx.doi.org/10.1371/journal.pone.0099894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936791	Green Published, Green Submitted, gold			2022-12-25	WOS:000338503400051
J	Merezhko, M; Muggalla, P; Nykanen, NP; Yan, X; Sakha, P; Huttunen, HJ				Merezhko, Maria; Muggalla, Pranuthi; Nykanen, Niko-Petteri; Yan, Xu; Sakha, Prasanna; Huttunen, Henri J.			Multiplex Assay for Live-Cell Monitoring of Cellular Fates of Amyloid-beta Precursor Protein (APP)	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; A-BETA; SECRETASE CLEAVAGE; TERMINAL FRAGMENTS; ENDOCYTOSIS; INHIBITION; IDENTIFICATION; TRAFFICKING; METABOLISM; GENERATION	Amyloid-beta precursor protein (APP) plays a central role in pathogenesis of Alzheimer's disease. APP has a short half-life and undergoes complex proteolytic processing that is highly responsive to various stimuli such as changes in cellular lipid or energy homeostasis. Cellular trafficking of APP is controlled by its large protein interactome, including dozens of cytosolic adaptor proteins, and also by interactions with lipids. Currently, cellular regulation of APP is mostly studied based on appearance of APP-derived proteolytic fragments to conditioned media and cellular extracts. Here, we have developed a novel live-cell assay system based on several indirect measures that reflect altered APP trafficking and processing in cells. Protein-fragment complementation assay technology for detection of APP-BACE1 protein-protein interaction forms the core of the new assay. In a multiplex form, the assay can measure four endpoints: total cellular APP level, total secreted sAPP level in media, APP-BACE1 interaction in cells and in exosomes released by the cells. Functional validation of the assay with pharmacological and genetic tools revealed distinct patterns of cellular fates of APP, with immediate mechanistic implications. This new technology will facilitate functional genomics studies of late-onset Alzheimer's disease, drug discovery efforts targeting APP and characterization of the physiological functions of APP and its proteolytic fragments.	[Merezhko, Maria; Muggalla, Pranuthi; Nykanen, Niko-Petteri; Yan, Xu; Sakha, Prasanna; Huttunen, Henri J.] Univ Helsinki, Ctr Neurosci, Helsinki, Finland	University of Helsinki	Huttunen, HJ (corresponding author), Univ Helsinki, Ctr Neurosci, Helsinki, Finland.	Henri.Huttunen@helsinki.fi		Huttunen, Henri/0000-0002-9867-4438	Academy of Finland [218081, 263762, 126889]; Sigrid Juselius Foundation; Biocentrum Helsinki; Finnish Cultural Foundation; European Union [206918]	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocentrum Helsinki; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); European Union(European Commission)	This work was supported by grants from the Academy of Finland (grant numbers 218081, 263762 and 126889), Sigrid Juselius Foundation, Biocentrum Helsinki and Finnish Cultural Foundation. The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2011) under grant agreement nu 206918. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Bodovitz S, 1996, J BIOL CHEM, V271, P4436; BUXBAUM JD, 1994, P NATL ACAD SCI USA, V91, P4489, DOI 10.1073/pnas.91.10.4489; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; De Strooper B, 2000, J CELL SCI, V113, P1857; Domingues SCTS, 2007, ANN NY ACAD SCI, V1096, P184, DOI 10.1196/annals.1397.085; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; GABUZDA D, 1994, J BIOL CHEM, V269, P13623; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; HAASS C, 1994, J BIOL CHEM, V269, P17741; Hicks DA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00189; Hill TA, 2009, J MED CHEM, V52, P3762, DOI 10.1021/jm900036m; Huttunen HJ, 2009, FASEB J, V23, P3819, DOI 10.1096/fj.09-134999; Huttunen HJ, 2009, J MOL NEUROSCI, V37, P6, DOI 10.1007/s12031-008-9088-0; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Kinoshita A, 2003, J CELL SCI, V116, P3339, DOI 10.1242/jcs.00643; KNOPS J, 1995, J BIOL CHEM, V270, P2419, DOI 10.1074/jbc.270.6.2419; Kohli BM, 2012, J PROTEOME RES, V11, P4075, DOI 10.1021/pr300123g; Koo EH, 1996, J CELL SCI, V109, P991; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kouchi Z, 1998, EUR J BIOCHEM, V258, P291, DOI 10.1046/j.1432-1327.1998.2580291.x; Kyriazis GA, 2008, J BIOL CHEM, V283, P25492, DOI 10.1074/jbc.M802072200; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Milhas D, 2010, FEBS LETT, V584, P1887, DOI 10.1016/j.febslet.2009.10.058; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Perreau VM, 2010, PROTEOMICS, V10, P2377, DOI 10.1002/pmic.200900773; Prabhu Y, 2012, MOL BIOL CELL, V23, P2339, DOI 10.1091/mbc.E11-11-0944; Puglielli L, 2003, J BIOL CHEM, V278, P19777, DOI 10.1074/jbc.M300466200; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Sittampalam G.S., 2004, ASSAY GUIDANCE MANUA; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Sullivan CP, 2011, NEUROBIOL DIS, V43, P338, DOI 10.1016/j.nbd.2011.04.002; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Thomas AV, 2008, METHODS, V44, P299, DOI 10.1016/j.ymeth.2007.02.003; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vella LJ, 2012, FASEB J, V26, P2930, DOI 10.1096/fj.11-200295; Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39; von Arnim CAF, 2006, J NEUROSCI, V26, P9913, DOI 10.1523/JNEUROSCI.2290-06.2006; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang W, 2014, FASEB J, V28, P849, DOI 10.1096/fj.13-239301; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Wen L, 2011, J CELL BIOL, V195, P765, DOI 10.1083/jcb.201105109; Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069824; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616	63	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e98619	10.1371/journal.pone.0098619	http://dx.doi.org/10.1371/journal.pone.0098619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932508	Green Published, Green Submitted, gold			2022-12-25	WOS:000337738600009
J	Wang, YC; Lin, YK				Wang, Yu-Chun; Lin, Yu-Kai			Association between Temperature and Emergency Room Visits for Cardiorespiratory Diseases, Metabolic Syndrome-Related Diseases, and Accidents in Metropolitan Taipei	PLOS ONE			English	Article							HOSPITAL ADMISSIONS; HEAT WAVES; AMBIENT-TEMPERATURE; SEASONAL-VARIATION; AIR-POLLUTION; RENAL-DISEASE; WIND-CHILL; MORTALITY; IMPACT; RISK	Objective: This study evaluated risks of the emergency room visits (ERV) for cerebrovascular diseases, heart diseases, ischemic heart disease, hypertensive diseases, chronic renal failure (CRF), diabetes mellitus (DM), asthma, chronic airway obstruction not elsewhere classified (CAO), and accidents associated with the ambient temperature from 2000 to 2009 in metropolitan Taipei. Methods: The distributed lag non-linear model was used to estimate the cumulative relative risk (RR) and confidence interval (CI) of cause-specific ERV associated with daily temperature from lag 0 to lag 3 after controlling for potential confounders. Results: This study identified that temperatures related to the lowest risk of ERV was 26 degrees C for cerebrovascular diseases, 18 degrees C for CRF, DM, and accidents, and 30 degrees C for hypertensive diseases, asthma, and CAO. These temperatures were used as the reference temperatures to measure RR for the corresponding diseases. A low temperature (14 degrees C) increased the ERV risk for cerebrovascular diseases, hypertensive diseases, and asthma, with respective cumulative 4-day RRs of 1.56 (95% CI: 1.23, 1.97), 1.78 (95% CI: 1.37, 2.34), and 2.93 (95% CI: 1.26, 6.79). The effects were greater on, or after, lag one. At 32 degrees C, the cumulative 4-day RR for ERV was significant for CRF (RR = 2.36; 95% CI: 1.33, 4.19) and accidents (RR = 1.23; 95% CI: 1.14, 1.33) and the highest RR was seen on lag 0 for CRF (RR = 1.69; 95% CI: 1.01, 3.58), DM (RR = 1.69; 95% CI: 1.09, 2.61), and accidents (RR = 1.19; 95% CI: 1.11, 1.27). Conclusions: Higher temperatures are associated with the increased ERV risks for CRF, DM, and accidents and lower temperatures with the increased ERV risks for cerebrovascular diseases, hypertensive diseases, and asthma in the subtropical metropolitan.	[Wang, Yu-Chun] Chung Yuan Christian Univ, Dept Bioenvironm Engn, Coll Engn, Jungli City, Taiwan; [Wang, Yu-Chun] Chung Yuan Christian Univ, Res Ctr Environm Risk Management, Jungli City, Taiwan; [Lin, Yu-Kai] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Environm & Occupat Med & Epidemiol Program, Boston, MA 02115 USA; [Lin, Yu-Kai] Natl Taiwan Univ, Inst Environm Hlth, Coll Publ Hlth, Taipei 10764, Taiwan	Chung Yuan Christian University; Chung Yuan Christian University; Harvard University; Harvard T.H. Chan School of Public Health; National Taiwan University	Lin, YK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Environm & Occupat Med & Epidemiol Program, Boston, MA 02115 USA.	yul620@mail.harvard.edu	王, 玉純/AAP-9936-2021; Wang, Yu-Chun/AAP-8150-2021; Lin, Yu-Kai/AAQ-4642-2020	王, 玉純/0000-0002-4797-7447; 	Taiwan National Science Council [NSC 99-2221-E-033-052, NSC 100-2621-M-039-001, NSC 102-2621-M-033-001]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	The present study was supported by the Taiwan National Science Council (grants NSC 99-2221-E-033-052, NSC 100-2621-M-039-001 and NSC 102-2621-M-033-001). All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2008, EMERG MED J, V25, P769, DOI 10.1136/emj.2007.056960; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Andersen ZJ, 2012, THORAX, V67, P6, DOI 10.1136/thoraxjnl-2011-200711; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Andrade H, 2011, INT J BIOMETEOROL, V55, P665, DOI 10.1007/s00484-010-0379-0; Astrand PO, 2003, TXB WORK PHYSL PHYSL, V4th; Astrom DO, 2011, MATURITAS, V69, P99, DOI 10.1016/j.maturitas.2011.03.008; Basu R, 2012, EPIDEMIOLOGY, V23, P813, DOI 10.1097/EDE.0b013e31826b7f97; BINDER C, 1984, DIABETES CARE, V7, P188, DOI 10.2337/diacare.7.2.188; Bureau of National Health Insurance, 2001, NAT HLTH INS PROF; Carder M, 2005, OCCUP ENVIRON MED, V62, P702, DOI 10.1136/oem.2004.016394; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P172; Cheng MF, 2009, INHAL TOXICOL, V21, P1092, DOI 10.3109/08958370902744855; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; D'Ippoliti D, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-37; Garcia-Donaire JA, 2010, CURR HYPERTENS REP, V12, P307, DOI 10.1007/s11906-010-0129-z; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A, 2011, EPIDEMIOLOGY, V22, P68, DOI 10.1097/EDE.0b013e3181fdcd99; GILL JS, 1988, J CLIN EPIDEMIOL, V41, P225, DOI 10.1016/0895-4356(88)90125-4; Goldberg MS, 2011, ENVIRON RES, V111, P853, DOI 10.1016/j.envres.2011.05.022; Green RS, 2010, INT J PUBLIC HEALTH, V55, P113, DOI 10.1007/s00038-009-0076-0; Grineski SE, 2011, ENVIRON RES, V111, P1148, DOI 10.1016/j.envres.2011.06.007; Hajat S, 2006, EPIDEMIOLOGY, V17, P632, DOI 10.1097/01.ede.0000239688.70829.63; Hansen AL, 2008, INT J EPIDEMIOL, V37, P1359, DOI 10.1093/ije/dyn165; Honda Yasushi, 2007, Environmental Health and Preventive Medicine, V12, P209, DOI 10.1265/ehpm.12.209; Hong YC, 2012, SCI TOTAL ENVIRON, V435, P74, DOI 10.1016/j.scitotenv.2012.02.070; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Keatinge W R, 1995, Arctic Med Res, V54 Suppl 2, P16; Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594; Kovats RS, 2004, OCCUP ENVIRON MED, V61, P893, DOI 10.1136/oem.2003.012047; KUNST AE, 1993, AM J EPIDEMIOL, V137, P331, DOI 10.1093/oxfordjournals.aje.a116680; Kuo HW, 2007, AM J KIDNEY DIS, V49, P46, DOI 10.1053/j.ajkd.2006.10.007; Lavigne E, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-5; Lin S, 2009, EPIDEMIOLOGY, V20, P738, DOI 10.1097/EDE.0b013e3181ad5522; Lin YK, 2013, SCI TOTAL ENVIRON, V443, P812, DOI 10.1016/j.scitotenv.2012.10.108; Lin YK, 2013, ENVIRON RES, V120, P109, DOI 10.1016/j.envres.2012.09.002; Lin YK, 2011, ENVIRON RES, V111, P1156, DOI 10.1016/j.envres.2011.06.008; Linares C, 2008, EUR J PUBLIC HEALTH, V18, P317, DOI 10.1093/eurpub/ckm108; Mastrangelo G, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-200; Michelozzi P, 2009, AM J RESP CRIT CARE, V179, P383, DOI 10.1164/rccm.200802-217OC; Ministry of Health and Welfare, 2008, 2008 STAT CAUS DEATH; Murphy T., 2006, Morbidity and Mortality Weekly Report, V55, P282; National health insurance research database Taiwan, 2014, LONG HLTH INS DAT; Ockene IS, 2004, ARCH INTERN MED, V164, P863, DOI 10.1001/archinte.164.8.863; Ostro B, 2010, AM J EPIDEMIOL, V172, P1053, DOI 10.1093/aje/kwq231; Peel JL, 2005, EPIDEMIOLOGY, V16, P164, DOI 10.1097/01.ede.0000152905.42113.db; Pudpong N, 2011, SCI TOTAL ENVIRON, V409, P5260, DOI 10.1016/j.scitotenv.2011.09.005; Rocklov J, 2009, GLOB HLTH ACTION, V2; Semenza JC, 1999, AM J PREV MED, V16, P269, DOI 10.1016/S0749-3797(99)00025-2; Siple Paul A., 1945, PROC AMER PHIL SOC, V89, P177; Spencer-Hwang R, 2011, AM J KIDNEY DIS, V58, P608, DOI 10.1053/j.ajkd.2011.05.017; Taiwan Central Weather Bureau, 2014, CENTR WEATH BUR ONL; Taiwan Environmental Protection Administration, 2014, TAIW AIR QUAL MON NE; Theoharatos G, 2010, ENVIRON RES, V110, P152, DOI 10.1016/j.envres.2009.12.002; Tong SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012155; Wang XY, 2012, OCCUP ENVIRON MED, V69, P163, DOI 10.1136/oem.2010.062141; Wang YC, 2012, SCI TOTAL ENVIRON, V416, P97, DOI 10.1016/j.scitotenv.2011.11.073; Yamada S, 2010, INTERNAL MED, V49, P171, DOI 10.2169/internalmedicine.49.2661; Yang WC, 2008, NEPHROL DIAL TRANSPL, V23, P3977, DOI 10.1093/ndt/gfn406	59	36	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99599	10.1371/journal.pone.0099599	http://dx.doi.org/10.1371/journal.pone.0099599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932702	Green Published, gold			2022-12-25	WOS:000337738600045
J	Qin, YB; Xin, ZB; Yu, XX; Xiao, YL				Qin, Yunbin; Xin, Zhongbao; Yu, Xinxiao; Xiao, Yuling			Influence of Vegetation Restoration on Topsoil Organic Carbon in a Small Catchment of the Loess Hilly Region, China	PLOS ONE			English	Article							LAND-USE CHANGE; SOIL PROPERTIES; AGRICULTURAL SOILS; PLATEAU; EROSION; STOCKS; SEQUESTRATION; AFFORESTATION; DYNAMICS; NITROGEN	Understanding effects of land-use changes driven by the implementation of the "Grain for Green'' project and the corresponding changes in soil organic carbon (SOC) storage is important in evaluating the environmental benefits of this ecological restoration project. The goals of this study were to quantify the current soil organic carbon density (SOCD) in different land-use types [cultivated land, abandoned land (cessation of farming), woodland, wild grassland and orchards] in a catchment of the loess hilly and gully region of China to evaluate the benefits of SOC sequestration achieved by vegetation restoration in the past 10 years as well as to discuss uncertain factors affecting future SOC sequestration. Based on soil surveys (N = 83) and laboratory analyses, the results show that the topsoil (0-20 cm) SOCD was 20.44 Mg/ha in this catchment. Using the SOCD in cultivated lands (19.08 Mg/ha) as a reference, the SOCD in woodlands and abandoned lands was significantly higher by 33.81% and 8.49%, respectively, whereas in orchards, it was lower by 10.80%. The correlation analysis showed that SOC and total nitrogen (TN) were strongly correlated (R-2 = 0.98) and that the average C:N (SOC:TN) ratio was 9.69. With increasing years since planting, the SOCD in woodlands showed a tendency to increase; however, no obvious difference was observed in orchards. A high positive correlation was found between SOCD and elevation (R-2 = 0.395), but a low positive correlation was found between slope and SOCD (R-2 = 0.170, P = 0.127). In the past 10 years of restoration, SOC storage did not increase significantly (2.74% or 3706.46 t) in the catchment where the conversion of cultivated land to orchards was the primary restoration pattern. However, the potential contribution of vegetation restoration to SOC sequestration in the next several decades would be massive if the woodland converted from the cropland is well managed and maintained.	[Qin, Yunbin; Xin, Zhongbao; Yu, Xinxiao; Xiao, Yuling] Beijing Forestry Univ, Inst Soil & Water Conservat, Beijing, Peoples R China	Beijing Forestry University; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS	Xin, ZB (corresponding author), Beijing Forestry Univ, Inst Soil & Water Conservat, Beijing, Peoples R China.	xinzhongbao@126.com	Xin, Zhongbao/G-5404-2010	XIN, zhongbao/0000-0002-1653-8679	Fundamental Research Funds for the Central Universities [NoTD2011-2]; Open Foundation of Key Laboratory of Soil and Water Loss Process and Control on the Loess Plateau of Ministry of Water Resources [201301]; National Natural Science Foundation of China [41001362]; Beijing Forest University [201210022013]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Open Foundation of Key Laboratory of Soil and Water Loss Process and Control on the Loess Plateau of Ministry of Water Resources; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Forest University	This study was supported by the Fundamental Research Funds for the Central Universities (NoTD2011-2), the Open Foundation of Key Laboratory of Soil and Water Loss Process and Control on the Loess Plateau of Ministry of Water Resources (201301), the National Natural Science Foundation of China (No. 41001362) and the College Student Scientific Research Training Project of Beijing Forest University (No. 201210022013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batterman SA, 2013, NATURE, V502, P224, DOI 10.1038/nature12525; Cao SX, 2009, LAND USE POLICY, V26, P1182, DOI 10.1016/j.landusepol.2009.02.006; Chang RY, 2011, ENVIRON MANAGE, V48, P1158, DOI 10.1007/s00267-011-9682-8; Chartier MP, 2013, J ARID ENVIRON, V88, P43, DOI 10.1016/j.jaridenv.2012.08.011; Chen HS, 2008, GEODERMA, V143, P91, DOI 10.1016/j.geoderma.2007.10.013; Chen LD, 2007, ECOL RES, V22, P641, DOI 10.1007/s11284-006-0065-1; DeGryze S, 2004, GLOBAL CHANGE BIOL, V10, P1120, DOI 10.1111/j.1529-8817.2003.00786.x; Deng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071923; Don A, 2011, GLOBAL CHANGE BIOL, V17, P1658, DOI 10.1111/j.1365-2486.2010.02336.x; Duan FL, 2007, RURAL EC, P16; Feng XM, 2010, GEOMORPHOLOGY, V118, P239, DOI 10.1016/j.geomorph.2010.01.004; Fu B.J., 2002, LAND USE STRUCTURE E, P1; FU BJ, 1989, SOIL USE MANAGE, V5, P76, DOI 10.1111/j.1475-2743.1989.tb00765.x; Fu XL, 2010, GEODERMA, V155, P31, DOI 10.1016/j.geoderma.2009.11.020; Gong J, 2006, LAND DEGRAD DEV, V17, P453, DOI 10.1002/ldr.701; Gregorich EG, 1998, SOIL TILL RES, V47, P291, DOI 10.1016/S0167-1987(98)00117-2; Guimaraes DV, 2013, SOIL TILL RES, V126, P177, DOI 10.1016/j.still.2012.07.010; Guo Guangfen, 2006, Shengtaixue Zazhi, V25, P435; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Houghton RA, 1999, TELLUS B, V51, P298, DOI 10.1034/j.1600-0889.1999.00013.x; Huang C., 2000, SOIL SCI; Institute of Soil Science Chinese Academy of Sciences (ISSCAS), 1978, PHYS CHEM AN METH SO, P7; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 SCI; Laganiere J, 2010, GLOBAL CHANGE BIOL, V16, P439, DOI 10.1111/j.1365-2486.2009.01930.x; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; Lal R, 2004, NUTR CYCL AGROECOSYS, V70, P103, DOI 10.1023/B:FRES.0000048480.24274.0f; Lal R, 2003, ENVIRON INT, V29, P437, DOI 10.1016/S0160-4120(02)00192-7; Lal R, 2009, EUR J SOIL SCI, V60, P158, DOI 10.1111/j.1365-2389.2008.01114.x; Leifeld J, 2005, AGR ECOSYST ENVIRON, V105, P255, DOI 10.1016/j.agee.2004.03.006; Li DJ, 2012, NEW PHYTOL, V195, P172, DOI 10.1111/j.1469-8137.2012.04150.x; [李裕元 LI YuYuan], 2007, [生态学报, Acta Ecologica Sinica], V27, P2279; Li YuYuan, 2006, Acta Prataculturae Sinica, V15, P85; Lu N, 2013, BIOGEOSCIENCES DISCU, V10, P11181, DOI DOI 10.5194/BGD-10-11181-2013; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031782; Luo YQ, 2006, ECOLOGY, V87, P53, DOI 10.1890/04-1724; Morris SJ, 2007, GLOBAL CHANGE BIOL, V13, P1145, DOI 10.1111/j.1365-2486.2007.01359.x; Nelson D. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P961; [牛俊杰 NIU Junjie], 2007, [地理研究, Geographical Research], V26, P773; Novara A, 2013, GEODERMA, V193, P213, DOI 10.1016/j.geoderma.2012.08.036; Pan ZB, 2012, RES SOIL WATER CONSE, V19, P298; [潘占兵 Pan Zhanbing], 2012, [水土保持研究, Research of Soil and Water Conservation], V19, P287; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Powlson D, 2005, NATURE, V433, P204, DOI 10.1038/433204a; Raiesi F, 2012, PLANT SOIL, V351, P161, DOI 10.1007/s11104-011-0941-5; Sauer TJ, 2012, PLANT SOIL, V360, P375, DOI 10.1007/s11104-012-1258-8; Schlesinger WH, 1999, SCIENCE, V284, P2095, DOI 10.1126/science.284.5423.2095; Shi H, 2000, J ARID ENVIRON, V45, P9, DOI 10.1006/jare.1999.0618; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Umali BP, 2012, CATENA, V93, P38, DOI 10.1016/j.catena.2012.01.010; Wang BQ, 1999, SOIL EROSION SOIL WA, V5, P18; Wang Li, 2004, World Forestry Research, V17, P57; Wang QX, 2012, GLOBAL PLANET CHANGE, V92-93, P138, DOI 10.1016/j.gloplacha.2012.05.010; Wang YF, 2011, CATENA, V85, P58, DOI 10.1016/j.catena.2010.12.003; Wang Z, 2012, CATENA, V99, P26, DOI 10.1016/j.catena.2012.07.003; Wei J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040123; Xin ZB, 2011, REG ENVIRON CHANGE, V11, P149, DOI 10.1007/s10113-010-0127-3; Xue Sha, 2011, Scientia Agricultura Sinica, V44, P3154; Yang YuLin, 2008, Plant Nutrition and Fertilizer Science, V14, P685; [余新晓 Yu Xinxiao], 2009, [农业工程学报, Transactions of the Chinese Society of Agricultural Engineering], V25, P219; Zhao Yang, 2013, Journal of Beijing Forestry University, V35, P39; Zheng FL, 2006, PEDOSPHERE, V16, P420, DOI 10.1016/S1002-0160(06)60071-4; Zhou Yan, 2008, Shengtaixue Zazhi, V27, P1901; ZOU HY, 1998, RES SOIL WATER CONSE, V5, P126	63	16	17	3	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e94489	10.1371/journal.pone.0094489	http://dx.doi.org/10.1371/journal.pone.0094489			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926873	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100002
J	Mehne, FMP; Schroder-Tittmann, K; Eijlander, RT; Herzberg, C; Hewitt, L; Kaever, V; Lewis, RJ; Kuipers, OP; Tittmann, K; Stulke, J				Mehne, Felix M. P.; Schroeder-Tittmann, Kathrin; Eijlander, Robyn T.; Herzberg, Christina; Hewitt, Lorraine; Kaever, Volkhard; Lewis, Richard J.; Kuipers, Oscar P.; Tittmann, Kai; Stuelke, Joerg			Control of the Diadenylate Cyclase CdaS in Bacillus subtilis AN AUTOINHIBITORY DOMAIN LIMITS CYCLIC DI-AMP PRODUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA INTEGRITY; CHECKPOINT PROTEIN; GMP; BACTERIA; REVEALS; PATHWAY; GENES; IDENTIFICATION; BIOSYNTHESIS; SPORULATION	The Gram-positive bacterium Bacillus subtilis encodes three diadenylate cyclases that synthesize the essential signaling nucleotide cyclic di-AMP. The activities of the vegetative enzymes DisA and CdaA are controlled by protein-protein interactions with their conserved partner proteins. Here, we have analyzed the regulation of the unique sporulation-specific diadenylate cyclase CdaS. Very low expression of CdaS as the single diadenylate cyclase resulted in the appearance of spontaneous suppressor mutations. Several of these mutations in the cdaS gene affected the N-terminal domain of CdaS. The corresponding CdaS mutant proteins exhibited a significantly increased enzymatic activity. The N-terminal domain of CdaS consists of two alpha-helices and is attached to the C-terminal catalytically active diadenylate cyclase (DAC) domain. Deletion of the first or both helices resulted also in strongly increased activity indicating that the N-terminal domain serves to limit the enzyme activity of the DAC domain. The structure of YojJ, a protein highly similar to CdaS, indicates that the protein forms hexamers that are incompatible with enzymatic activity of the DAC domains. In contrast, the mutations and the deletions of the N-terminal domain result in conformational changes that lead to highly increased enzymatic activity. Although the full-length CdaS protein was found to form hexamers, a truncated version with a deletion of the first N-terminal helix formed dimers with high enzyme activity. To assess the role of CdaS in sporulation, we assayed the germination of wild type and cdaS mutant spores. The results indicate that cyclic di-AMP formed by CdaS is required for efficient germination.	[Mehne, Felix M. P.; Herzberg, Christina; Stuelke, Joerg] Univ Gottingen, Inst Microbiol & Genet, Dept Gen Microbiol, D-37077 Gottingen, Germany; [Schroeder-Tittmann, Kathrin; Tittmann, Kai] Univ Gottingen, Gottingen Ctr Mol Biosci, Albrecht von Haller Inst Plant Sci, Dept Bioanalyt, Groningen, Germany; [Eijlander, Robyn T.; Kuipers, Oscar P.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Genet, NL-9747 AG Groningen, Netherlands; [Hewitt, Lorraine; Lewis, Richard J.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Kaever, Volkhard] Hannover Med Sch, Res Core Unit Mass Spectrometry, D-30625 Hannover, Germany; [Kaever, Volkhard] Hannover Med Sch, Inst Pharmacol, D-30625 Hannover, Germany; [Eijlander, Robyn T.; Kuipers, Oscar P.] Top Inst Food & Nutr TIFN, NL-6709 PA Wageningen, Netherlands	University of Gottingen; University of Gottingen; University of Groningen; Newcastle University - UK; Hannover Medical School; Hannover Medical School; Top Institute Food & Nutrition	Stulke, J (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Dept Gen Microbiol, Grisebachstr 8, D-37077 Gottingen, Germany.	jstuelk@gwdg.de	Kaever, Volkhard/G-3280-2013; Stülke, Jörg/AAD-1600-2021; Kuipers, Oscar/B-6752-2009	lewis, richard/0000-0003-2641-8643; Kuipers, Oscar/0000-0001-5596-7735; Stulke, Jorg/0000-0001-5881-5390	Deutsche Forschungsgemeinschaft [SFB860]; Biotechnology and Biological Sciences Research Council [BB/I004572/1] Funding Source: researchfish; BBSRC [BB/I004572/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (to J. S.).; Supported through SFB860 by the Deutsche Forschungsgemeinschaft.	Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Campos SS, 2014, J BACTERIOL, V196, P568, DOI 10.1128/JB.01259-13; Cannon W, 1999, GENE DEV, V13, P357, DOI 10.1101/gad.13.3.357; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Chen Y, 2012, J BACTERIOL, V194, P5080, DOI 10.1128/JB.01092-12; Commichau FM, 2007, MOL MICROBIOL, V65, P642, DOI 10.1111/j.1365-2958.2007.05816.x; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; de Jong IG, 2011, JOVE-J VIS EXP, DOI 10.3791/3145; Dengler V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073512; Diethmaier C, 2011, J BACTERIOL, V193, P5997, DOI 10.1128/JB.05360-11; Gao XH, 2013, J BACTERIOL, V195, P4782, DOI 10.1128/JB.00373-13; Gardan R, 1997, MOL MICROBIOL, V24, P825, DOI 10.1046/j.1365-2958.1997.3881754.x; Gomelsky M, 2011, MOL MICROBIOL, V79, P562, DOI 10.1111/j.1365-2958.2010.07514.x; Gorke B., 2008, NAT REV MICROBIOL, V6, P613; Green J, 2014, CURR OPIN MICROBIOL, V18, P1, DOI 10.1016/j.mib.2014.01.003; Jervis AJ, 2007, J BACTERIOL, V189, P4534, DOI 10.1128/JB.00130-07; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Linder JU, 2002, J BIOL CHEM, V277, P15271, DOI 10.1074/jbc.M200235200; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Michna RH, 2014, NUCLEIC ACIDS RES, V42, pD692, DOI 10.1093/nar/gkt1002; Neumann P, 2008, P NATL ACAD SCI USA, V105, P17390, DOI 10.1073/pnas.0805027105; Nicholson WL, 1990, SPORULATION GERMINAT, P391; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Niepmann M, 2006, ELECTROPHORESIS, V27, P3949, DOI 10.1002/elps.200600172; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Sambrook J., 2001, MOL CLONING LAB MANU; Segev E, 2012, CELL, V148, P139, DOI 10.1016/j.cell.2011.11.059; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Song JH, 2005, MOL CELLS, V19, P365; Spangler C, 2010, J MICROBIOL METH, V81, P226, DOI 10.1016/j.mimet.2010.03.020; Tews I, 2005, SCIENCE, V308, P1020, DOI 10.1126/science.1107642; van der Voort M, 2010, INT J FOOD MICROBIOL, V139, P108, DOI 10.1016/j.ijfoodmicro.2010.01.028; Witte CE, 2013, MBIO, V4, DOI 10.1128/mBio.00282-13; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Zaprasis A, 2014, ENVIRON MICROBIOL, V16, P701, DOI 10.1111/1462-2920.12193; Zeevi MK, 2013, J BACTERIOL, V195, P5250, DOI 10.1128/JB.00794-13; Zhang L, 2013, J BIOL CHEM, V288, P22426, DOI 10.1074/jbc.M113.464883	46	46	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21098	21107		10.1074/jbc.M114.562066	http://dx.doi.org/10.1074/jbc.M114.562066			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24939848	Green Published, hybrid			2022-12-25	WOS:000339396600060
J	Sheng, R; Zhang, TT; Felice, VD; Qin, T; Qin, ZH; Smith, CD; Sapp, E; Difiglia, M; Waeber, C				Sheng, Rui; Zhang, Tong-Tong; Felice, Valeria D.; Qin, Tao; Qin, Zheng-Hong; Smith, Charles D.; Sapp, Ellen; Difiglia, Marian; Waeber, Christian			Preconditioning Stimuli Induce Autophagy via Sphingosine Kinase 2 in Mouse Cortical Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CELLS; PROTEASOMAL DEGRADATION; ISCHEMIC TOLERANCE; CEREBRAL-ISCHEMIA; ACTIVATION; DEATH; MICE; SPHINGOSINE-1-PHOSPHATE; FTY720; NEUROPROTECTION	Sphingosine kinase 2 (SPK2) and autophagy are both involved in brain preconditioning, but whether preconditioning-induced SPK2 up-regulation and autophagy activation are linked mechanistically remains to be elucidated. In this study, we used in vitro and in vivo models to explore the role of SPK2-mediated autophagy in isoflurane and hypoxic preconditioning. In primary mouse cortical neurons, both isoflurane and hypoxic preconditioning induced autophagy. Isoflurane and hypoxic preconditioning protected against subsequent oxygen glucose deprivation or glutamate injury, whereas pretreatment with autophagy inhibitors (3-methyladenine or KU55933) abolished preconditioning-induced tolerance. Pretreatment with SPK2 inhibitors (ABC294640 and SKI-II) or SPK2 knockdown prevented preconditioning-induced autophagy. Isoflurane also induced autophagy in mouse in vivo as shown by Western blots for LC3 and p62, LC3 immunostaining, and electron microscopy. Isoflurane-induced autophagy in mice lacking the SPK1 isoform (SPK1(-/-)), but not in SPK2(-/-) mice. Sphingosine 1-phosphate and the sphingosine 1-phosphate receptor agonist FTY720 did not protect against oxygen glucose deprivation in cultured neurons and did not alter the expression of LC3 and p62, suggesting that SPK2-mediated autophagy and protections are not S1P-dependent. Beclin 1 knockdown abolished preconditioning-induced autophagy, and SPK2 inhibitors abolished isoflurane-induced disruption of the Beclin 1/Bcl-2 association. These results strongly indicate that autophagy is involved in isoflurane preconditioning both in vivo and in vitro and that SPK2 contributes to preconditioning-induced autophagy, possibly by disrupting the Beclin 1/Bcl-2 interaction.	[Sheng, Rui; Zhang, Tong-Tong; Qin, Zheng-Hong] Soochow Univ, Sch Pharmaceut Sci, Dept Pharmacol, Suzhou 215123, Peoples R China; [Sheng, Rui; Zhang, Tong-Tong; Qin, Zheng-Hong] Soochow Univ, Sch Pharmaceut Sci, Lab Aging & Nervous Dis, Suzhou 215123, Peoples R China; [Sheng, Rui; Qin, Tao; Waeber, Christian] Massachusetts Gen Hosp, Stroke & Neurovascular Regulat Lab, Dept Radiol, Charlestown, MA 02129 USA; [Sapp, Ellen; Difiglia, Marian] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA; [Sapp, Ellen; Difiglia, Marian] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Felice, Valeria D.; Waeber, Christian] Natl Univ Ireland Univ Coll Cork, Sch Pharm, Dept Pharmacol & Therapeut, Cork, Ireland; [Smith, Charles D.] Apogee Biotechnol Corp, Hummelstown, PA 17036 USA	Soochow University - China; Soochow University - China; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University College Cork	Waeber, C (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Pharm, Cavanagh Pharm Bldg,Rm 1-26,Coll Rd, Cork, Ireland.	c.waeber@ucc.ie	Sheng, Rui/AAE-6335-2022; Waeber, Christian/A-8333-2009; Waeber, Christian/B-3171-2016	Waeber, Christian/0000-0001-6078-0027; Waeber, Christian/0000-0001-6078-0027	National Institutes of Health [NS049263, NS055104]; Jiangsu Government Scholarship for Overseas Studies [631246, P30NS045776]; Natural Science Foundation of China [81173057, 81373402]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045776, P01NS055104, R01NS049263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jiangsu Government Scholarship for Overseas Studies; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS049263 and NS055104 (to C. W.). This work was also supported by Marie Curie Career Integration Grant 631246 (to C. W.) and Interdepartmental Neuroscience Center Grant P30NS045776, grants from the Jiangsu Government Scholarship for Overseas Studies, and Natural Science Foundation of China Grants 81173057 and 81373402 (to R. S.).	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Beljanski V, 2010, J PHARMACOL EXP THER, V333, P454, DOI 10.1124/jpet.109.163337; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Blondeau N, 2007, J NEUROCHEM, V103, P509, DOI 10.1111/j.1471-4159.2007.04755.x; Chakrabarti L, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-24; Chang CL, 2009, AM J PHYSIOL-CELL PH, V297, pC451, DOI 10.1152/ajpcell.00586.2008; Di Menna L, 2013, PHARMACOL RES, V67, P1, DOI 10.1016/j.phrs.2012.10.004; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Farkas T, 2011, J BIOL CHEM, V286, P38904, DOI 10.1074/jbc.M111.269134; French KJ, 2006, J PHARMACOL EXP THER, V318, P596, DOI 10.1124/jpet.106.101345; French KJ, 2010, J PHARMACOL EXP THER, V333, P129, DOI 10.1124/jpet.109.163444; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Gottlieb RA, 2010, ANNU REV PHYSIOL, V72, P45, DOI 10.1146/annurev-physiol-021909-135757; Harada J, 2004, J NEUROCHEM, V88, P1026, DOI 10.1046/j.1471-4159.2003.02219.x; Huang CQ, 2010, J CARDIOVASC TRANSL, V3, P365, DOI 10.1007/s12265-010-9189-3; Jin ZQ, 2008, CARDIOVASC RES, V79, P134, DOI 10.1093/cvr/cvn065; Jin ZQ, 2004, CIRCULATION, V110, P1980, DOI 10.1161/01.CIR.0000143632.06471.93; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim M, 2007, AM J PHYSIOL-RENAL, V293, pF1827, DOI 10.1152/ajprenal.00290.2007; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Liu H, 2003, J BIOL CHEM, V278, P40330, DOI 10.1074/jbc.M304455200; Liu JF, 2013, INT J NEUROSCI, V123, P163, DOI 10.3109/00207454.2012.749255; Loveridge C, 2010, J BIOL CHEM, V285, P38841, DOI 10.1074/jbc.M110.127993; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; McMurtrey RJ, 2010, BRAIN RES, V1358, P184, DOI 10.1016/j.brainres.2010.08.015; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Papandreou I, 2005, CANCER RES, V65, P3171, DOI 10.1158/0008-5472.CAN-04-3395; Pattingre S, 2009, AUTOPHAGY, V5, P558, DOI 10.4161/auto.5.4.8390; Payne SG, 2002, FEBS LETT, V531, P54, DOI 10.1016/S0014-5793(02)03480-4; Samy ET, 2007, J IMMUNOL, V179, P5644, DOI 10.4049/jimmunol.179.9.5644; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Schnitzer SE, 2009, MOL CANCER RES, V7, P393, DOI 10.1158/1541-7786.MCR-08-0156; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Sheng R, 2012, AUTOPHAGY, V8, P310, DOI 10.4161/auto.18673; Sheng R, 2010, AUTOPHAGY, V6, P482, DOI 10.4161/auto.6.4.11737; Shimada K, 2012, NEUROBIOL DIS, V46, P101, DOI 10.1016/j.nbd.2011.12.050; Taniguchi M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416552; Tonges L, 2006, RNA, V12, P1431, DOI 10.1261/rna.2252206; Tonelli F, 2010, CELL SIGNAL, V22, P1536, DOI 10.1016/j.cellsig.2010.05.022; Vessey DA, 2008, BIOCHEM BIOPH RES CO, V375, P425, DOI 10.1016/j.bbrc.2008.08.022; Vessey DA, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/961059; Wacker BK, 2012, J NEUROCHEM, V123, P954, DOI 10.1111/jnc.12047; Wacker BK, 2012, J CEREBR BLOOD F MET, V32, P1014, DOI 10.1038/jcbfm.2012.3; Wacker BK, 2009, STROKE, V40, P3342, DOI 10.1161/STROKEAHA.109.560714; Wei Y, 2011, ANN NEUROL, V69, P119, DOI 10.1002/ana.22186; Wick A, 2002, J NEUROSCI, V22, P6401; Xia MQ, 2000, J NEUROIMMUNOL, V108, P227, DOI 10.1016/S0165-5728(00)00285-X; Yung LM, 2012, STROKE, V43, P199, DOI 10.1161/STROKEAHA.111.626911; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang N, 2010, AUTOPHAGY, V6, P1157, DOI 10.4161/auto.6.8.13614; Zhao P, 2004, ANESTHESIOLOGY, V101, P695, DOI 10.1097/00000542-200409000-00018; Zheng S, 2003, NEUROSCIENCE, V118, P99, DOI 10.1016/S0306-4522(02)00767-4	54	33	35	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20845	20857		10.1074/jbc.M114.578120	http://dx.doi.org/10.1074/jbc.M114.578120			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24928515	Green Published, hybrid			2022-12-25	WOS:000339396600039
J	Hager, HA; Sinasac, SE; Gedalof, Z; Newman, JA				Hager, Heather A.; Sinasac, Sarah E.; Gedalof, Ze'ev; Newman, Jonathan A.			Predicting Potential Global Distributions of Two Miscanthus Grasses: Implications for Horticulture, Biofuel Production, and Biological Invasions	PLOS ONE			English	Article							WILL CLIMATE-CHANGE; X GIGANTEUS; SPECIES DISTRIBUTION; C-4 PHOTOSYNTHESIS; COLD TOLERANCE; SINENSIS; RISK; GENOTYPES; SUCCESS; NICHE	In many regions, large proportions of the naturalized and invasive non-native floras were originally introduced deliberately by humans. Pest risk assessments are now used in many jurisdictions to regulate the importation of species and usually include an estimation of the potential distribution in the import area. Two species of Asian grass (Miscanthus sacchariflorus and M. sinensis) that were originally introduced to North America as ornamental plants have since escaped cultivation. These species and their hybrid offspring are now receiving attention for large-scale production as biofuel crops in North America and elsewhere. We evaluated their potential global climate suitability for cultivation and potential invasion using the niche model CLIMEX and evaluated the models' sensitivity to the parameter values. We then compared the sensitivity of projections of future climatically suitable area under two climate models and two emissions scenarios. The models indicate that the species have been introduced to most of the potential global climatically suitable areas in the northern but not the southern hemisphere. The more narrowly distributed species (M. sacchariflorus) is more sensitive to changes in model parameters, which could have implications for modelling species of conservation concern. Climate projections indicate likely contractions in potential range in the south, but expansions in the north, particularly in introduced areas where biomass production trials are under way. Climate sensitivity analysis shows that projections differ more between the selected climate change models than between the selected emissions scenarios. Local-scale assessments are required to overlay suitable habitat with climate projections to estimate areas of cultivation potential and invasion risk.	[Hager, Heather A.; Sinasac, Sarah E.; Newman, Jonathan A.] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada; [Gedalof, Ze'ev] Univ Guelph, Dept Geog, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph	Hager, HA (corresponding author), Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada.	hhager@uoguelph.ca	Hager, Heather/A-2984-2014; Newman, Jonathan/A-5932-2008	Hager, Heather/0000-0002-0066-6844; Newman, Jonathan/0000-0003-3155-4084	Ontario Ministry of Agriculture and Food and Ministry of Rural Affairs [027167]; Mitacs Elevate post-doctoral fellowship; Natural Sciences and Engineering Research Council of Canada	Ontario Ministry of Agriculture and Food and Ministry of Rural Affairs; Mitacs Elevate post-doctoral fellowship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was funded by the Ontario Ministry of Agriculture and Food and Ministry of Rural Affairs (project 027167, www.omafra.gov.on.ca), a Mitacs Elevate post-doctoral fellowship (www.mitacs.ca), and the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Atkinson CJ, 2009, BIOMASS BIOENERG, V33, P752, DOI 10.1016/j.biombioe.2009.01.005; Baker R. H. A., 2012, Bulletin OEPP, V42, P65, DOI [10.1111/j.1365-2338.2012.02545.x, 10.1111/epp.2545]; Barney JN, 2008, BIOSCIENCE, V58, P64, DOI 10.1641/B580111; Barney JN, 2010, BIOMASS BIOENERG, V34, P124, DOI 10.1016/j.biombioe.2009.10.009; BEERLING DJ, 1995, J VEG SCI, V6, P269, DOI 10.2307/3236222; Bellard C, 2013, GLOBAL CHANGE BIOL, V19, P3740, DOI 10.1111/gcb.12344; Bourdot GW, 2012, BIOL INVASIONS, V14, P1545, DOI 10.1007/s10530-010-9905-6; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Chapman SC, 2012, CROP PASTURE SCI, V63, P251, DOI 10.1071/CP11303; Clifton-Brown JC, 2000, NEW PHYTOL, V148, P287, DOI 10.1046/j.1469-8137.2000.00764.x; Clifton-Brown JC, 2002, NEW PHYTOL, V154, P335, DOI 10.1046/j.1469-8137.2002.00381.x; Clifton-Brown JC, 2001, AGRON J, V93, P1013, DOI 10.2134/agronj2001.9351013x; Commonwealth Scientific and Industrial Research Organisation, 2004, DYM SIM APPL 2 0; Daubenmire RF, 1974, PLANTS ENV TXB PLANT; Dore WG, 1980, AGR CANADA MONOGRAPH, V26; Dougherty RF, 2014, INVASIVE PL IN PRESS, V7; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Ewel JJ, 1999, BIOSCIENCE, V49, P619, DOI 10.2307/1313438; Farage PK, 2006, PLANT CELL ENVIRON, V29, P720, DOI 10.1111/j.1365-3040.2005.01460.x; Farrell AD, 2006, ANN APPL BIOL, V149, P337, DOI 10.1111/j.1744-7348.2006.00099.x; Flory SL, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045904; Forster P., 2007, CLIMATE CHANGE 2007; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; Gordon DR, 2008, CONSERV LETT, V1, P227, DOI 10.1111/j.1755-263X.2008.00032.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guo QF, 2012, BIOL INVASIONS, V14, P547, DOI 10.1007/s10530-011-0094-8; Hastings A, 2009, GCB BIOENERGY, V1, P154, DOI 10.1111/j.1757-1707.2009.01007.x; Heaton EA, 2010, ADV BOT RES, V56, P75, DOI 10.1016/S0065-2296(10)56003-8; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hodkinson TR, 2002, J PLANT RES, V115, P381, DOI 10.1007/s10265-002-0049-3; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Horton JL, 2010, CASTANEA, V75, P52, DOI 10.2179/08-040.1; Huang QQ, 2010, BIODIVERS CONSERV, V19, P1251, DOI 10.1007/s10531-009-9751-y; IPCC, 2000, SPECIAL REPORT EMISS; IPPC, 2007, INT STAND PHYT MEAS; Jorgensen U, 2003, ACTA AGR SCAND B-S P, V53, P190, DOI 10.1080/09064710310017605; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Koop AL, 2012, BIOL INVASIONS, V14, P273, DOI 10.1007/s10530-011-0061-4; Kriticos DJ, 2003, BIOL INVASIONS, V5, P147, DOI 10.1023/A:1026193424587; Kriticos DJ, 2011, WEED RES, V51, P85, DOI 10.1111/j.1365-3180.2010.00827.x; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Li F, 2013, LIMNOLOGY, V14, P71, DOI 10.1007/s10201-012-0386-4; Mack RN, 2002, ANN MO BOT GARD, V89, P176, DOI 10.2307/3298562; Mika AM, 2008, GLOBAL CHANGE BIOL, V14, P1721, DOI 10.1111/j.1365-2486.2008.01620.x; Mika AM, 2010, AGR FOREST ENTOMOL, V12, P213, DOI 10.1111/j.1461-9563.2009.00464.x; Naidu SL, 2004, PLANTA, V220, P145, DOI 10.1007/s00425-004-1322-6; Naidu SL, 2003, PLANT PHYSIOL, V132, P1688, DOI 10.1104/pp.103.021790; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Nishiwaki A, 2011, AM J BOT, V98, P154, DOI 10.3732/ajb.1000258; Parker Matthew A., 2001, Diversity and Distributions, V7, P125, DOI 10.1046/j.1472-4642.2001.00103.x; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; POHL RICHARD W., 1963, RHODORA, V65, P146; Pysek P, 2003, OECOLOGIA, V135, P122, DOI 10.1007/s00442-002-1170-7; Pysek P, 2009, DIVERS DISTRIB, V15, P891, DOI 10.1111/j.1472-4642.2009.00602.x; Pyter R, 2009, METHODS MOL BIOL, V581, P41, DOI 10.1007/978-1-60761-214-8_3; Quinn LD, 2012, BIOENERG RES, V5, P139, DOI 10.1007/s12155-011-9163-1; Quinn LD, 2011, INVAS PLANT SCI MANA, V4, P142, DOI 10.1614/IPSM-D-10-00067.1; Quinn LD, 2010, GCB BIOENERGY, V2, P310, DOI 10.1111/j.1757-1707.2010.01062.x; Raghu S, 2006, SCIENCE, V313, P1742, DOI 10.1126/science.1129313; Rahmstorf S, 2007, SCIENCE, V316, P709, DOI 10.1126/science.1136843; Ross JL, 2010, BIOL INVASIONS, V12, P603, DOI 10.1007/s10530-009-9467-7; Schaffner U, 2011, ECOLOGY, V92, P829, DOI 10.1890/10-1230.1; SCOTT JK, 1993, J BIOGEOGR, V20, P87, DOI 10.2307/2845742; Sultan SE, 2013, EVOL APPL, V6, P266, DOI 10.1111/j.1752-4571.2012.00287.x; Sutherst RW, 2007, GLOBAL CHANGE BIOL, V13, P1843, DOI 10.1111/j.1365-2486.2007.01396.x; Sutherst R. W., 2007, TERRESTRIAL ECOSYSTE, P211, DOI DOI 10.1007/978-3-540-32730-1_17; Sutherst RW, 2005, ENVIRON ENTOMOL, V34, P317, DOI 10.1603/0046-225X-34.2.317; Sutherst RW, 2003, J BIOGEOGR, V30, P805, DOI 10.1046/j.1365-2699.2003.00861.x; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Sutherst RW, 2006, CLIMEX VERSION 3 USE; Taylor SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036748; Venette RC, 2006, FOREST ECOL MANAG, V231, P18, DOI 10.1016/j.foreco.2006.04.036; Venette RC, 2010, BIOSCIENCE, V60, P349, DOI 10.1525/bio.2010.60.5.5; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Whitney KD, 2008, DIVERS DISTRIB, V14, P569, DOI 10.1111/j.1472-4642.2008.00473.x; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Woodward F.I., 1987, CLIMATE PLANT DISTRI; Xu CY, 2010, ECOL LETT, V13, P32, DOI 10.1111/j.1461-0248.2009.01395.x; YAMASAKI S, 1990, AQUAT BOT, V36, P367, DOI 10.1016/0304-3770(90)90053-N; Yan J, 2012, GCB BIOENERGY, V4, P49, DOI 10.1111/j.1757-1707.2011.01108.x	84	17	17	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100032	10.1371/journal.pone.0100032	http://dx.doi.org/10.1371/journal.pone.0100032			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945154	Green Submitted, Green Published, gold			2022-12-25	WOS:000340721500041
J	Luo, BH; Xiong, F; Wang, JP; Li, JH; Zhong, M; Liu, QL; Luo, GQ; Yang, XJ; Xiao, N; Xie, B; Xiao, H; Liu, RJ; Dong, CS; Wang, KS; Wen, JF				Luo, Bai-Hua; Xiong, Feng; Wang, Jun-Pu; Li, Jing-He; Zhong, Ming; Liu, Qin-Lai; Luo, Geng-Qiu; Yang, Xiao-Jing; Xiao, Ni; Xie, Bin; Xiao, Heng; Liu, Rui-Jie; Dong, Chang-Sheng; Wang, Kuan-Song; Wen, Ji-Fang			Epidermal Growth Factor-Like Domain-Containing Protein 7 (EGFL7) Enhances EGF Receptor-AKT Signaling, Epithelial-Mesenchymal Transition, and Metastasis of Gastric Cancer Cells	PLOS ONE			English	Article							E-CADHERIN EXPRESSION; ANOIKIS RESISTANCE; POOR-PROGNOSIS; UP-REGULATION; NOTCH; SNAIL; MIGRATION; EMT; ENDOCYTOSIS; ACTIVATION	Epidermal growth factor-like domain-containing protein 7 (EGFL7) is upregulated in human epithelial tumors and so is a potential biomarker for malignancy. Indeed, previous studies have shown that high EGFL7 expression promotes infiltration and metastasis of gastric carcinoma. The epithelial-mesenchymal transition (EMT) initiates the metastatic cascade and endows cancer cells with invasive and migratory capacity; however, it is not known if EGFL7 promotes metastasis by triggering EMT. We found that EGFL7 was overexpressed in multiple human gastric cancer (GC) cell lines and that overexpression promoted cell invasion and migration as revealed by scratch wound and transwell migration assays. Conversely, shRNA-mediated EGFL7 knockdown reduced invasion and migration. Furthermore, EGFL7-overexpressing cells grew into larger tumors and were more likely to metastasize to the liver compared to underexpressing CG cells following subcutaneous injection in mice. EGFL7 overexpression protected GC cell lines against anoikis, providing a plausible mechanism for this enhanced metastatic capacity. In excised human gastric tumors, expression of EGFL7 was positively correlated with expression levels of the mesenchymal marker vimentin and the EMT-associated transcription repressor Snail, and negatively correlated with expression of the epithelial cell marker E-cadherin. In GC cell lines, EGFL7 knockdown reversed morphological signs of EMT and decreased both vimentin and Snail expression. In addition, EGFL7 overexpression promoted EGF receptor (EGFR) and protein kinase B (AKT) phospho-activation, effects markedly suppressed by the EGFR tyrosine kinase inhibitor AG1478. Moreover, AG1478 also reduced the elevated invasive and migratory capacity of GC cell lines overexpressing EGFL7. Collectively, these results strongly suggest that EGFL7 promotes metastasis by activating EMT through an EGFR-AKT-Snail signaling pathway. Disruption of EGFL7-EGFR-AKT-Snail signaling may a promising therapeutic strategy for gastric cancer.	[Luo, Bai-Hua; Wang, Jun-Pu; Li, Jing-He; Zhong, Ming; Luo, Geng-Qiu; Yang, Xiao-Jing; Xiao, Ni; Xie, Bin; Xiao, Heng; Liu, Rui-Jie; Wang, Kuan-Song; Wen, Ji-Fang] Cent South Univ, Xiangya Hosp, Dept Pathol, Changsha, Hunan, Peoples R China; [Luo, Bai-Hua; Wang, Jun-Pu; Li, Jing-He; Zhong, Ming; Luo, Geng-Qiu; Yang, Xiao-Jing; Xiao, Ni; Xie, Bin; Xiao, Heng; Liu, Rui-Jie; Wang, Kuan-Song; Wen, Ji-Fang] Cent South Univ, Sch Basic Med Sci, Dept Pathol, Changsha, Hunan, Peoples R China; [Xiong, Feng] Second Peoples Hosp, Ctr Furong Judicial Authenticat, Changsha, Hunan, Peoples R China; [Liu, Qin-Lai] Taishan Med Coll, Dept Pathol, Tai An, Shandong, Peoples R China; [Dong, Chang-Sheng] Cent South Univ, Affiliated Tumor Hosp, Xiangya Med Coll, Dept Anesthesiol, Changsha, Hunan, Peoples R China	Central South University; Central South University; Shandong First Medical University & Shandong Academy of Medical Sciences; Central South University	Wang, KS (corresponding author), Cent South Univ, Xiangya Hosp, Dept Pathol, Changsha, Hunan, Peoples R China.	13787146109@126.com; jifangw@yahoo.com	Xiao, Heng/GVU-6125-2022		National Natural Science Foundation of China [81001080]; Open-End Fund for the Valuable and Precision Instruments of Central South University [JJ3121]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open-End Fund for the Valuable and Precision Instruments of Central South University	This work was supported by National Natural Science Foundation of China (No. 81001080) and the Open-End Fund for the Valuable and Precision Instruments of Central South University (No. JJ3121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; [Anonymous], 2013, CANCER DISCOV, V3, P1092, DOI 10.1158/2159-8290.CD-RW2013-189; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Boisvert-Adamo K, 2009, MOL CANCER RES, V7, P549, DOI 10.1158/1541-7786.MCR-08-0358; Caja L, 2007, CELL SIGNAL, V19, P683, DOI 10.1016/j.cellsig.2006.09.002; Cheng JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034071; Cheng JC, 2010, MOL ENDOCRINOL, V24, P1569, DOI 10.1210/me.2010-0034; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Chitnis A, 2006, DEV DYNAM, V235, P886, DOI 10.1002/dvdy.20683; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; Espinoza I, 2013, PHARMACOL THERAPEUT, V139, P95, DOI 10.1016/j.pharmthera.2013.02.003; Farges O, 2011, CANCER-AM CANCER SOC, V117, P2170, DOI 10.1002/cncr.25712; Fitch MJ, 2004, DEV DYNAM, V230, P316, DOI 10.1002/dvdy.20063; Geiger TR, 2007, CANCER RES, V67, P6221, DOI 10.1158/0008-5472.CAN-07-0121; Geiger TR, 2005, CANCER RES, V65, P7033, DOI 10.1158/0008-5472.CAN-05-0709; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gill S, 2003, J CLIN ONCOL, V21, P2070, DOI 10.1200/JCO.2003.11.054; Grille SJ, 2003, CANCER RES, V63, P2172; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Guo Y, 2013, WSPOLCZESNA ONKOL, V17, P150, DOI 10.5114/wo.2013.34618; Halmaciu I, 2013, ACTA MED MARISIENSIS, V59, P165; Huang CH, 2010, J CANCER RES CLIN, V136, P1737, DOI 10.1007/s00432-010-0832-9; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jing JJ, 2012, WORLD J GASTROENTERO, V18, P1262, DOI 10.3748/wjg.v18.i11.1262; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kanat O, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0464-4; Kang M, 2012, BIOCHEM J, V443, P691, DOI 10.1042/BJ20111584; Kim MA, 2009, HISTOPATHOLOGY, V54, P442, DOI 10.1111/j.1365-2559.2009.03247.x; Ko H, 2012, MOL CANCER RES, V10, P1032, DOI 10.1158/1541-7786.MCR-12-0261; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lavy R, 2013, GASTRIC CANCER, P1; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Li XH, 2011, MOL CANCER RES, V9, P824, DOI 10.1158/1541-7786.MCR-10-0529; [李景和 LIJinghe], 2011, [世界科技研究与发展, World Sci-Tech R and D], V33, P650; Miele L, 2006, CURR CANCER DRUG TAR, V6, P313, DOI 10.2174/156800906777441771; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Miele L, 2006, CURR MOL MED, V6, P905, DOI 10.2174/156652406779010830; Minard ME, 2006, CLIN EXP METASTAS, V23, P301, DOI 10.1007/s10585-006-9040-z; Nichol D, 2012, BLOOD, V119, P1345, DOI 10.1182/blood-2011-10-322446; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; Parker LH, 2004, NATURE, V428, P754, DOI 10.1038/nature02416; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; REMMELE W, 1986, VIRCHOWS ARCH A, V409, P127, DOI 10.1007/BF00708323; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Schmidt M, 2007, DEVELOPMENT, V134, P2913, DOI 10.1242/dev.002576; Schmidt MHH, 2009, NAT CELL BIOL, V11, P873, DOI 10.1038/ncb1896; Shin NR, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-521; Soncin F, 2003, EMBO J, V22, P5700, DOI 10.1093/emboj/cdg549; Suman S, 2013, MOL CARCINOG; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013; Vergara D, 2011, CANCER LETT, V310, P1, DOI 10.1016/j.canlet.2011.04.009; Wang L, 2013, INT J CANCER, V133, P1419, DOI 10.1002/ijc.28140; Wang ZW, 2008, ANTICANCER RES, V28, P3621; Wu F, 2009, HEPATOLOGY, V50, P1839, DOI 10.1002/hep.23197; Wu Y, 2008, ACTA BIOCH BIOPH SIN, V40, P643, DOI 10.1111/j.1745-7270.2008.00443.x; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0	61	39	42	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99922	10.1371/journal.pone.0099922	http://dx.doi.org/10.1371/journal.pone.0099922			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945379	Green Submitted, Green Published, gold			2022-12-25	WOS:000340721500033
J	Yan, M; Zhao, K; Du, J; Li, LZ; Wu, DL; Xu, SM; Zeng, XC; Wang, GJ; Yu, XF				Yan, Ming; Zhao, Ke; Du, Juan; Li, Linzhang; Wu, Donglin; Xu, Shengming; Zeng, Xiangchao; Wang, Guanjun; Yu, Xiao-Fang			HIV-1 Diversity and Drug-Resistant Mutations in Infected Individuals in Changchun, China	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; LIAONING PROVINCE; SUBTYPE; TRANSMISSION; STRAINS; USERS; RECOMBINANT; SEQUENCES	Objectives: Human immunodeficiency virus type 1 (HIV-1) infection has been detected in all provinces of China. Although epidemiological and phylogenetic studies have been conducted in many regions, such analyses are lacking from Jilin province in northeastern China. Method: Epidemiological and phylogenetic analyses, as well as detection of drug-resistant mutations, were conducted on 57 HIV-1 infected patients from Changchun city identified and confirmed through annual surveillance by local Centers for Disease Control in Jilin province of northeastern China in 2012. Results: Sexual contact was determined to be the major pathway for HIV-1 transmission in Jilin, where hetero- and homosexual activities contributed almost equally. Phylogenetic analyses detected multiple subtypes of HIV-1 including subtype G circulating in Jilin, with multiple origins for each of them. Both subtype B and CRF01_AE were dominant, and evidence of subtype B transmitting between different high-risk groups was observed. Mutations in the viral protease at position 71 indicated the presence of a selective pressure. Several drug-resistant mutations were detected, although they were predicted with low-level resistance to antiviral treatments. Conclusions: Information from this study fills the gap in knowledge of HIV-1 transmission in Changchun city, Jilin province, China. By revealing the origin and evolutionary status of local HIV-1 strains, this work contributes to ongoing efforts in the control and prevention of AIDS.	[Yan, Ming; Zhao, Ke; Du, Juan; Li, Linzhang; Xu, Shengming; Zeng, Xiangchao; Wang, Guanjun; Yu, Xiao-Fang] Jilin Univ, Hosp 1, Changchun 130023, Jilin, Peoples R China; [Wu, Donglin] Jilin Prov Ctr Dis Control & Prevent, Changchun, Jilin, Peoples R China; [Yu, Xiao-Fang] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Jilin University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wang, GJ (corresponding author), Jilin Univ, Hosp 1, Changchun 130023, Jilin, Peoples R China.	gjwang.fhjlu@gmail.com; xfyu@jhsph.edu			Chinese Ministry of Science and Technology [2012CB911100, 2013ZX0001-005]; Chinese Ministry of Education [IRT1016]; Key Laboratory of Molecular Virology, Jilin Province, China [20102209]; National Institute of Allergy and Infectious Diseases [2R56AI62644-6]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Ministry of Education(Ministry of Education, China); Key Laboratory of Molecular Virology, Jilin Province, China; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by funding from the Chinese Ministry of Science and Technology (2012CB911100 and No. 2013ZX0001-005) and Chinese Ministry of Education (IRT1016), the Key Laboratory of Molecular Virology, Jilin Province (20102209), China, and a grant (2R56AI62644-6) from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao LL, 2008, AIDS RES HUM RETROV, V24, P733, DOI 10.1089/aid.2007.0269; Chen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060101; Chu TX, 2005, CELL RES, V15, P865, DOI 10.1038/sj.cr.7290360; Fourati S, 2012, AIDS, V26, P1619, DOI 10.1097/QAD.0b013e3283560703; Han XX, 2007, AIDS RES HUM RETROV, V23, P357, DOI 10.1089/aid.2006.0094; Han XX, 2010, JAIDS-J ACQ IMM DEF, V53, pS27, DOI 10.1097/QAI.0b013e3181c7d5bf; Imade GE, 2014, AIDS RES HUM RETROV, V30, P127, DOI [10.1089/aid.2013.0074, 10.1089/AID.2013.0074]; Laeyendecker O, 2005, JAIDS-J ACQ IMM DEF, V38, P356; Lai S, 2001, J ACQ IMMUN DEF SYND, V26, P365, DOI 10.1097/00126334-200104010-00014; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075777; Li XX, 2013, J APPL MATH, DOI 10.1155/2013/245963; Li XJ, 2005, AIDS RES HUM RETROV, V21, P977, DOI 10.1089/aid.2005.21.977; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Pircher M, 2012, AIDS RES HUM RETROV, V28, P1798, DOI [10.1089/aid.2012.0083, 10.1089/AID.2012.0083]; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Qi HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068656; Rodenburg CM, 2001, AIDS RES HUM RETROV, V17, P161, DOI 10.1089/08892220150217247; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Skar H, 2011, ANN NY ACAD SCI, V1230, P108, DOI 10.1111/j.1749-6632.2011.06128.x; Song YH, 2007, ARCH VIROL, V152, P1553, DOI 10.1007/s00705-007-0973-6; Su QJ, 2012, AIDS RES HUM RETROV, V28, P725, DOI [10.1089/AID.2011.0246, 10.1089/aid.2011.0246]; Su R, 2003, AIDS, V17, P2515, DOI 10.1097/00002030-200311210-00015; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teng T, 2011, Adv Dent Res, V23, P10, DOI 10.1177/0022034511398871; Wang FX, 2007, CHINESE MED J-PEKING, V120, P2006, DOI 10.1097/00029330-200711020-00013; Xu SH, 2010, MOL DIAGN THER, V14, P31, DOI 10.2165/11530900-000000000-00000; Yu ESH, 1996, AM J PUBLIC HEALTH, V86, P1116, DOI 10.2105/AJPH.86.8_Pt_1.1116; Yu XF, 1998, J VIROL, V72, P3412, DOI 10.1128/JVI.72.4.3412-3417.1998; Yu XF, 2002, AIDS RES HUM RETROV, V18, P167, DOI 10.1089/08892220252779719; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zhong P, 2007, AIDS RES HUM RETROV, V23, P847, DOI 10.1089/aid.2006.0196	31	4	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100540	10.1371/journal.pone.0100540	http://dx.doi.org/10.1371/journal.pone.0100540			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945273	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500091
J	Berkunsky, I; Daniele, G; Kacoliris, FP; Diaz-Luque, JA; Frias, CPS; Aramburu, RM; Gilardi, JD				Berkunsky, Igor; Daniele, Gonzalo; Kacoliris, Federico P.; Diaz-Luque, Jose A.; Frias, Carmen P. Silva; Aramburu, Rosana M.; Gilardi, James D.			Reproductive Parameters in the Critically Endangered Blue-Throated Macaw: Limits to the Recovery of a Parrot under Intensive Management	PLOS ONE			English	Article							BREEDING SUCCESS; GROWTH; FOREST	Rediscovered in the wild twenty years ago, the breeding biology of wild Blue-throated Macaws remains largely unexplored, yet is essential to its effective conservation and recovery. Here, we analyse reproductive parameters in an intensively managed wild population of Blue-throated Macaws, providing the first data on the breeding biology of this critically endangered species. During the six-year study period, 2007-2012, the number of active breeding pairs either remained constant or decreased, depending on the site, and no new breeding pairs were discovered despite extensive searching. We documented nesting attempts in natural cavities in dead palms or live hardwoods, and artificial nest boxes. Egg-laying was concentrated during the end of dry season and the beginning of the wet season, August through December. Hatching failure was the greatest cause of egg losses. Half of the breeding attempts of Blue-throated Macaws produced at least one fledging, on average two, after a 85 days nestling period. An average of 4.3 nestlings per year fledged from all known wild nests combined. Each pair lost roughly 65% of its initial reproductive investment at each nesting attempt. In most successful nesting attempts of individualized pairs, a new nesting attempt was not detected the following year. All monitored breeding pairs showed high nest site fidelity, reusing hardwood-tree cavities and nest boxes. Our findings will aid conservation efforts by refining current actions and prompting new approaches towards the conservation and recovery of the Blue-throated Macaw.	[Berkunsky, Igor; Diaz-Luque, Jose A.] Univ Nacl Ctr Provincia Buenos Aires, Inst Multidisciplinario Ecosistemas & Desarrollo, Buenos Aires, DF, Argentina; [Berkunsky, Igor; Daniele, Gonzalo; Kacoliris, Federico P.; Diaz-Luque, Jose A.; Frias, Carmen P. Silva] World Parrot Trust, Proyecto Conservac Paraba Barba Azul, Beni, Bolivia; [Kacoliris, Federico P.; Aramburu, Rosana M.] Univ Nacl La Plata, Div Zool Vertebrados, Museo La Plata, Buenos Aires, DF, Argentina; [Frias, Carmen P. Silva] Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambient & Evolutivas, Valdivia, Chile; [Gilardi, James D.] World Parrot Trust, Lake Alfred, FL USA	National University of La Plata; Museo La Plata; Universidad Austral de Chile	Berkunsky, I (corresponding author), Univ Nacl Ctr Provincia Buenos Aires, Inst Multidisciplinario Ecosistemas & Desarrollo, Buenos Aires, DF, Argentina.	iberkunsky@parrot.org	Kacoliris, Federico/AAA-2535-2021; Berkunsky, Igor/AAS-4517-2020	Berkunsky, Igor/0000-0001-9219-4241	World Parrot Trust; Rufford Small Grants Foundation; Idea Wild; PICT (FONCyT) [2011-0173]; Birder's Exchange; CREOI	World Parrot Trust; Rufford Small Grants Foundation; Idea Wild; PICT (FONCyT); Birder's Exchange; CREOI	This work was supported by the World Parrot Trust, Rufford Small Grants Foundation, Idea Wild, Birder's Exchange, CREOI and PICT 2011-0173 (FONCyT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beissinger SR, 2008, ECOL MONOGR, V78, P185, DOI 10.1890/07-0018.1; Berkunsky I, 2009, IBIS, V151, P145, DOI 10.1111/j.1474-919X.2008.00896.x; BirdLife International, SPEC FACTSH AR GLAUC; Brightsmith DJ, 2005, WILSON BULL, V117, P296, DOI 10.1676/03-087A.1; Collar N. J., 2000, International Zoo Yearbook, V37, P21, DOI 10.1111/j.1748-1090.2000.tb00704.x; Collar NJ, 1996, WORK, V5, P26; Forshaw J, 1989, PARROTS WORLD; Guedes NMR, 1995, ETOL, V13, P274; Hanagarth W, 1996, GEOGR RUNDSCH, V48, P662; Hangarth W, 1990, ECOLOGIA BOLIVIA, V16, P47; Herrera M, 2007, KEMPFFIANA, V3, P18; Hesse AJ, 2000, BIRD CONSERV INT, V10, P255, DOI 10.1017/S0959270900000216; IUCN, 2011, IUCN 2011 IUCN RED L; JORDAN OC, 1993, WILSON BULL, V105, P694; Kuniy A. A., 2006, Braz. J. Biol., V66, P381, DOI 10.1590/S1519-69842006000200021; Langstroth R. P., 1996, FOREST ISLANDS AMAZO; Low R, 1990, COMPLETE BOOK MACAWS; Masello JF, 2002, CONDOR, V104, P574, DOI 10.1650/0010-5422(2002)104[0574:CGABSO]2.0.CO;2; Mayle FE, 2007, PHILOS T R SOC B, V362, P291, DOI 10.1098/rstb.2006.1987; Nice M. M., 1954, Condor, V56, P173, DOI 10.2307/1365113; Nycander E., 1995, LARGE MACAWS THEIR C, P423; Olah G, 2014, J NAT CONSERV, V22, P176, DOI 10.1016/j.jnc.2013.11.003; Renton K, 2009, J FIELD ORNITHOL, V80, P1, DOI 10.1111/j.1557-9263.2009.00198.x; Snyder Noel, 2000, PARROTS STATUS SURVE; Sweeney RG, 2002, MACAWS; Yamashita Carlos, 1997, Ararajuba, V5, P141	26	18	19	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99941	10.1371/journal.pone.0099941	http://dx.doi.org/10.1371/journal.pone.0099941			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941317	Green Published, gold, Green Submitted			2022-12-25	WOS:000338508200057
J	Li, J; Greenwood, PL; Cockett, NE; Hadfield, TS; Vuocolo, T; Byrne, K; White, JD; Tellam, RL; Schirra, HJ				Li, Juan; Greenwood, Paul L.; Cockett, Noelle E.; Hadfield, Tracy S.; Vuocolo, Tony; Byrne, Keren; White, Jason D.; Tellam, Ross L.; Schirra, Horst Joachim			Impacts of the Callipyge Mutation on Ovine Plasma Metabolites and Muscle Fibre Type	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; RETROTRANSPOSON-LIKE GENE; MEAT QUALITY TRAITS; SKELETAL-MUSCLE; PHENOTYPIC CHARACTERIZATION; MYOFIBER CHARACTERISTICS; POLAR OVERDOMINANCE; IMPRINTED GENES; GROWTH-HORMONE; SHEEP RUMEN	The ovine Callipyge mutation causes postnatal muscle hypertrophy localized to the pelvic limbs and torso, as well as body leanness. The mechanism underpinning enhanced muscle mass is unclear, as is the systemic impact of the mutation. Using muscle fibre typing immunohistochemistry, we confirmed muscle specific effects and demonstrated that affected muscles had greater prevalence and hypertrophy of type 2X fast twitch glycolytic fibres and decreased representation of types 1, 2C, 2A and/or 2AX fibres. To investigate potential systemic effects of the mutation, proton NMR spectra of plasma taken from lambs at 8 and 12 weeks of age were measured. Multivariate statistical analysis of plasma metabolite profiles demonstrated effects of development and genotype but not gender. Plasma from Callipyge lambs at 12 weeks of age, but not 8 weeks, was characterized by a metabolic profile consistent with contributions from the affected hypertrophic fast twitch glycolytic muscle fibres. Microarray analysis of the perirenal adipose tissue depot did not reveal a transcriptional effect of the mutation in this tissue. We conclude that there is an indirect systemic effect of the Callipyge mutation in skeletal muscle in the form of changes of blood metabolites, which may contribute to secondary phenotypes such as body leanness.	[Li, Juan; Vuocolo, Tony; Byrne, Keren; Tellam, Ross L.] CSIRO Anim Food & Hlth Sci, Brisbane, Qld, Australia; [Greenwood, Paul L.] CSIRO Anim Food & Hlth Sci, FD McMaster Lab, Armidale, NSW, Australia; [Greenwood, Paul L.] Univ New England, Beef Ind Ctr Excellence, New South Wales Dept Primary Ind, Armidale, NSW, Australia; [Cockett, Noelle E.; Hadfield, Tracy S.] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [White, Jason D.] Univ Melbourne, Sch Vet Sci, Parkville, Vic 3052, Australia; [Schirra, Horst Joachim] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); NSW Department of Primary Industries; University of New England; Utah System of Higher Education; Utah State University; University of Melbourne; University of Queensland	Tellam, RL (corresponding author), CSIRO Anim Food & Hlth Sci, Brisbane, Qld, Australia.	ross.tellam@csiro.au; h.schirra@uq.edu.au	Schirra, Horst Joachim/B-4210-2009; Tellam, Ross/T-2423-2019; Greenwood, Paul L/G-9747-2013; White, Jason/AAF-8712-2020; Byrne, Keren A/H-7552-2013; Tellam, Ross/H-2798-2013	Schirra, Horst Joachim/0000-0002-7541-246X; Greenwood, Paul L/0000-0002-7719-8233; White, Jason/0000-0002-0557-392X; Byrne, Keren A/0000-0003-4759-0645; Tellam, Ross/0000-0003-2353-1640	Queensland State Government; CSIRO Office of the Chief Scientist	Queensland State Government; CSIRO Office of the Chief Scientist	The authors acknowledge financial support provided by the Queensland State Government to the Queensland NMR Network facilities, as well as project and fellowship support (to Juan Li) from the CSIRO Office of the Chief Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Rahman S, 2013, GROWTH HORM IGF RES, V23, P29, DOI 10.1016/j.ghir.2012.12.001; ALWAIZ M, 1992, METABOLISM, V41, P135, DOI 10.1016/0026-0495(92)90140-6; Arguello A, 2001, ANAT RECORD, V264, P284, DOI 10.1002/ar.1165; ASATOOR AM, 1965, BIOCHIM BIOPHYS ACTA, V111, P384, DOI 10.1016/0304-4165(65)90048-6; BAKER JR, 1962, J BIOL CHEM, V237, P1309; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Belanche A, 2010, J ANIM PHYSIOL AN N, V94, P648, DOI 10.1111/j.1439-0396.2009.00952.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bidwell CA, 2001, ANIM GENET, V32, P248, DOI 10.1046/j.1365-2052.2001.00776.x; Bidwell CA, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-17; Bidwell CA, 2012, LIVESTOCK EPIGENETICS, P73; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Byrne K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008638; Caiment F, 2010, GENOME RES, V20, P1651, DOI 10.1101/gr.108787.110; Chadeau-Hyam M, 2013, ENVIRON MOL MUTAGEN, V54, P542, DOI 10.1002/em.21797; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Charlier C, 2004, Bull Mem Acad R Med Belg, V159, P490; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Cockett NE, 2005, GENET SEL EVOL, V37, pS65, DOI 10.1051/gse:2004032; Cockett NE, 1996, SCIENCE, V273, P236, DOI 10.1126/science.273.5272.236; Ellis JL, 2008, J AGR SCI-CAMBRIDGE, V146, P213, DOI 10.1017/S0021859608007752; ETHERTON TD, 1977, J ANIM SCI, V44, P1100, DOI 10.2527/jas1977.4461100x; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fleming-Waddell JN, 2007, ANIM GENET, V38, P28, DOI 10.1111/j.1365-2052.2006.01562.x; Fleming-Waddell JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007399; Freking BA, 1998, J ANIM SCI, V76, P2062; Freking BA, 1998, J ANIM SCI, V76, P2549; Freking BA, 1999, J ANIM SCI, V77, P2336; Freking BA, 2002, GENOME RES, V12, P1496, DOI 10.1101/gr.571002; Goodpaster AM, 2010, ANAL BIOCHEM, V401, P134, DOI 10.1016/j.ab.2010.02.005; Greenwood PL, 2007, AUST J EXP AGR, V47, P1137, DOI 10.1071/EA06324; Greenwood PL, 2006, AUST J AGR RES, V57, P627, DOI 10.1071/AR04318; Greenwood PL, 2006, AUST J AGR RES, V57, P1, DOI 10.1071/AR04316; Haug K, 2013, NUCLEIC ACIDS RES, V41, pD781, DOI 10.1093/nar/gks1004; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; Jackson SP, 1997, J ANIM SCI, V75, P14; Jackson SP, 1997, J ANIM SCI, V75, P125; Jackson SP, 1997, J ANIM SCI, V75, P133; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kerth CR, 2003, J ANIM SCI, V81, P2213; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Koohmaraie M, 1995, J ANIM SCI, V73, P3596; Lane MA, 2000, J ANIM SCI, V78, P1990; Li JA, 2011, J PROTEOME RES, V10, P1073, DOI 10.1021/pr100862t; LOBLEY GE, 1992, J ANIM SCI, V70, P3264; Maccatrozzo L, 2004, EUR J HISTOCHEM, V48, P357; MITCHELL AD, 1979, J ANIM SCI, V49, P764, DOI 10.2527/jas1979.493764x; Murphy SK, 2005, MAMM GENOME, V16, P171, DOI 10.1007/s00335-004-2421-1; NEILL AR, 1978, BIOCHEM J, V170, P529, DOI 10.1042/bj1700529; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; NICHOLSON JK, 1989, PROG NUCL MAG RES SP, V21, P449, DOI 10.1016/0079-6565(89)80008-1; Picard B, 1998, HISTOCHEM J, V30, P473, DOI 10.1023/A:1003207922944; Picard B, 2009, MEAT SCI, V82, P30, DOI 10.1016/j.meatsci.2008.11.022; POL A, 1988, APPL ENVIRON MICROB, V54, P832, DOI 10.1128/AEM.54.3.832-834.1988; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; QUIGLEY JD, 1991, J DAIRY SCI, V74, P250, DOI 10.3168/jds.S0022-0302(91)78167-8; Reggiani C, 2004, MUSCLE DEV LIVESTOCK; Salek R, 2011, METHOD ENZYMOL, V500, P337, DOI 10.1016/B978-0-12-385118-5.00017-7; Sauer U, 2004, METAB ENG, V6, P220, DOI 10.1016/j.ymben.2003.11.004; Schirra HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002764; Schmidt JV, 2000, GENE DEV, V14, P1997; Schulze A, 2003, MOL CELL BIOCHEM, V244, P143, DOI 10.1023/A:1022443503883; Seal C. J., 1993, Nutrition Research Reviews, V6, P185, DOI 10.1079/NRR19930012; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Slupsky CM, 2007, ANAL CHEM, V79, P6995, DOI 10.1021/ac0708588; Smit M, 2003, GENETICS, V163, P453; Takeda H, 2006, P NATL ACAD SCI USA, V103, P8119, DOI 10.1073/pnas.0602844103; Tanabe R, 1998, MAMM GENOME, V9, P1056, DOI 10.1007/s003359900924; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; VARNAM GCE, 1978, BRIT J NUTR, V40, P359, DOI 10.1079/BJN19780132; Vuocolo T, 2005, AUST J EXP AGR, V45, P879, DOI 10.1071/EA05049; Vuocolo T, 2007, PHYSIOL GENOMICS, V28, P253, DOI 10.1152/physiolgenomics.00121.2006; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Whisnant CS, 1998, J ANIM SCI, V76, P1443; White JD, 2008, DIFFERENTIATION, V76, P283, DOI 10.1111/j.1432-0436.2007.00208.x; WILSON MARION K., 1955, JOUR APPL BACT, V18, P294, DOI 10.1111/j.1365-2672.1955.tb02086.x; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wold S., 2006, MULTI MEGAVARIATE DA; Wyss M, 2002, NEUROSCIENCE, V112, P243, DOI 10.1016/S0306-4522(02)00088-X; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Yeung CK, 2007, ARCH BIOCHEM BIOPHYS, V464, P251, DOI 10.1016/j.abb.2007.04.014; ZEISEL SH, 1983, J PHARMACOL EXP THER, V225, P320; ZHANG AQ, 1993, BIOCHEM PHARMACOL, V45, P2185, DOI 10.1016/0006-2952(93)90187-2	85	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99726	10.1371/journal.pone.0099726	http://dx.doi.org/10.1371/journal.pone.0099726			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937646	Green Published, gold			2022-12-25	WOS:000338503400033
J	Jackson, C; Mangtani, P; Fine, P; Vynnycky, E				Jackson, Charlotte; Mangtani, Punam; Fine, Paul; Vynnycky, Emilia			The Effects of School Holidays on Transmission of Varicella Zoster Virus, England and Wales, 1967-2008	PLOS ONE			English	Article							SOCIAL MIXING PATTERNS; CHICKENPOX; EPIDEMIOLOGY; MEASLES; IMPACT; SEROPREVALENCE; VACCINATION; INFECTIONS; DISEASES; CLOSURE	Background: Changes in children's contact patterns between termtime and school holidays affect the transmission of several respiratory-spread infections. Transmission of varicella zoster virus (VZV), the causative agent of chickenpox, has also been linked to the school calendar in several settings, but temporal changes in the proportion of young children attending childcare centres may have influenced this relationship. Methods: We used two modelling methods (a simple difference equations model and a Time series Susceptible Infectious Recovered (TSIR) model) to estimate fortnightly values of a contact parameter (the per capita rate of effective contact between two specific individuals), using GP consultation data for chickenpox in England and Wales from 1967-2008. Results: The estimated contact parameters were 22-31% lower during the summer holiday than during termtime. The relationship between the contact parameter and the school calendar did not change markedly over the years analysed. Conclusions: In England and Wales, reductions in contact between children during the school summer holiday lead to a reduction in the transmission of VZV. These estimates are relevant for predicting how closing schools and nurseries may affect an outbreak of an emerging respiratory-spread pathogen.	[Jackson, Charlotte; Mangtani, Punam; Fine, Paul; Vynnycky, Emilia] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Jackson, Charlotte; Vynnycky, Emilia] Publ Hlth England, Stat Modelling & Econ Dept, London, England	University of London; London School of Hygiene & Tropical Medicine; Public Health England	Jackson, C (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	c.r.jackson@ucl.ac.uk		Jackson, Charlotte/0000-0001-8544-7685; Mangtani, Punam/0000-0001-7074-2999	National Institute for Health Research; National Institute for Health Research [RTF/01/038] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	CJ was supported by a Research Training Fellowship from the National Institute for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBEY HELEN, 1952, HUMAN BIOL, V24, P201; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; ANDERSON R M, 1991; Brisson M., 2003, Journal of Medical Virology, V70, pS9, DOI 10.1002/jmv.10313; Brisson M, 2001, EPIDEMIOL INFECT, V127, P305, DOI 10.1017/S0950268801005921; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Deguen S, 2000, STAT MED, V19, P1207, DOI 10.1002/(SICI)1097-0258(20000515)19:9&lt;1207::AID-SIM423&gt;3.0.CO;2-L; Department of Education and Science, 1989, ED INN LOND ED AUTH; Eames KTD, 2011, EPIDEMICS-NETH, V3, P103, DOI 10.1016/j.epidem.2011.03.003; Fairley CK, 1996, J INFECT DIS, V174, pS314, DOI 10.1093/infdis/174.Supplement_3.S314; Ferguson NM, 1996, P NATL ACAD SCI USA, V93, P7231, DOI 10.1073/pnas.93.14.7231; Ferrari MJ, 2010, P ROY SOC B-BIOL SCI, V277, P2775, DOI 10.1098/rspb.2010.0536; Fine PEM, 2003, AM J EPIDEMIOL, V158, P1039, DOI 10.1093/aje/kwg251; FINE PEM, 1986, INT J EPIDEMIOL, V15, P237, DOI 10.1093/ije/15.2.237; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187; Glass K, 2003, J THEOR BIOL, V223, P19, DOI 10.1016/S0022-5193(03)00031-6; GORDON JE, 1962, AM J MED SCI, V244, P362, DOI 10.1097/00000441-196209000-00013; Heininger U, 2006, VACCINE, V24, P3258, DOI 10.1016/j.vaccine.2006.01.026; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-5; JOSEPH CA, 1988, BMJ-BRIT MED J, V296, P673, DOI 10.1136/bmj.296.6623.673; Kirkbride JB, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001998; Kudesia G, 2002, J CLIN PATHOL, V55, P154, DOI 10.1136/jcp.55.2.154; LONDON WP, 1973, AM J EPIDEMIOL, V98, P453, DOI 10.1093/oxfordjournals.aje.a121575; Metcalf CJE, 2009, P ROY SOC B-BIOL SCI, V276, P4111, DOI 10.1098/rspb.2009.1058; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nardone A, 2007, VACCINE, V25, P7866, DOI 10.1016/j.vaccine.2007.07.036; Office for National Statistics, 2011, REG FORM GOVT OFF RE; Office for National Statistics, 2009, EARL YEARS ED NUMB 3; Office for National Statistics, 2011, BIRTH STAT ENGL WAL; Office for National Statistics, 1981, ONS WEBS KEY POP VIT; Office for National Statistics, 2009, COUNT NONM DISTR UR; Office for National Statistics, 2008, NAM COD ADM GEOGR; Office of Population Censuses and Surveys, 1974, KEY POP VIT STAT; Richardson M, 2001, PEDIATR INFECT DIS J, V20, P380, DOI 10.1097/00006454-200104000-00004; Ross A M, 2000, Commun Dis Public Health, V3, P213; Royal College of General Practitioners, 2009, WEEKL RET SERV ANN R; Schenzle D, 1984, IMA J Math Appl Med Biol, V1, P169; Sengupta N, 2009, CURR PEDIATR REV, V5, P207, DOI 10.2174/157339609791317315; Whitaker HJ, 2004, BIOMETRICS, V60, P615, DOI 10.1111/j.0006-341X.2004.00210.x	42	11	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99762	10.1371/journal.pone.0099762	http://dx.doi.org/10.1371/journal.pone.0099762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932994	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000337738600061
J	Mehta, A; Sidhu, C; Pinnaka, AK; Choudhury, AR				Mehta, Ananya; Sidhu, Chandni; Pinnaka, Anil Kumar; Choudhury, Anirban Roy			Extracellular Polysaccharide Production by a Novel Osmotolerant Marine Strain of Alteromonas macleodii and Its Application towards Biomineralization of Silver	PLOS ONE			English	Article							BACTERIAL EXOPOLYSACCHARIDES; ANTIMICROBIAL ACTIVITY; GEN. NOV.; NANOPARTICLES; GOLD	The present study demonstrates exopolysaccharide production by an osmotolerant marine isolate and also describes further application of the purified polysaccharide for production of colloidal suspension of silver nanoparticles with narrow size distribution. Phylogenetic analysis based on 16S r RNA gene sequencing revealed close affinity of the isolate to Alteromonas macleodii. Unlike earlier reports, where glucose was used as the carbon source, lactose was found to be the most suitable substrate for polysaccharide production. The strain was capable of producing 23.4 gl(-1) exopolysaccharide with a productivity of 7.8 gl(-1) day(-1) when 15% (w/v) lactose was used as carbon source. Furthermore, the purified polysaccharide was able to produce spherical shaped silver nanoparticles of around 70 nm size as characterized by Uv-vis spectroscopy, Dynamic light scattering and Transmission electron microscopy. These observations suggested possible commercial potential of the isolated strain for production of a polysaccharide which has the capability of synthesizing biocompatible metal nanoparticle.	[Mehta, Ananya; Sidhu, Chandni; Pinnaka, Anil Kumar; Choudhury, Anirban Roy] CSIR, Inst Microbial Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Choudhury, AR (corresponding author), CSIR, Inst Microbial Technol, Chandigarh, India.	anirban@imtech.res.in	Pinnaka, Anil Kumar/G-5063-2011	Sidhu, Chandni/0000-0003-1386-1881	CSIR, India	CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	The authors acknowledge CSIR, India, for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bankura KP, 2012, CARBOHYD POLYM, V89, P1159, DOI 10.1016/j.carbpol.2012.03.089; Chi Z, 2007, BIORESOURCE TECHNOL, V98, P1329, DOI 10.1016/j.biortech.2006.05.001; Choudhury AR, 2011, CARBOHYD POLYM, V83, P1547, DOI 10.1016/j.carbpol.2010.10.003; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Cia J, 2009, BIOMACROMOLECULES, V10, P87; DALBOW DG, 1975, BIOCHEM J, V150, P1; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Huang HZ, 2004, CARBOHYD RES, V339, P2627, DOI 10.1016/j.carres.2004.08.005; Kaler A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/872940; Kanmani P, 2013, PROCESS BIOCHEM, V48, P1099, DOI 10.1016/j.procbio.2013.05.011; Kanmani P, 2013, CARBOHYD POLYM, V97, P421, DOI 10.1016/j.carbpol.2013.04.048; Kemp MM, 2009, BIOMACROMOLECULES, V10, P589, DOI 10.1021/bm801266t; Kim SJ, 2007, J MICROBIOL, V45, P510; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Ko SH., 2000, BIOTECHNOL BIOPROC E, V5, P181, DOI DOI 10.1007/BF02936591; Kumar PA, 2010, INT J SYST EVOL MICR, V60, P721, DOI 10.1099/ijs.0.014076; Laurienzo P, 2010, MAR DRUGS, V8, P2435, DOI 10.3390/md8092435; Le Costaouec T, 2012, CARBOHYD POLYM, V90, P49, DOI 10.1016/j.carbpol.2012.04.059; Mandal AK, 2013, J BIOSCI BIOENG, V115, P76, DOI 10.1016/j.jbiosc.2012.08.006; Mittal AK, 2013, BIOTECHNOL ADV, V31, P346, DOI 10.1016/j.biotechadv.2013.01.003; Narayanan KB, 2010, ADV COLLOID INTERFAC, V156, P1, DOI 10.1016/j.cis.2010.02.001; Nichols CAM, 2005, MAR BIOTECHNOL, V7, P253, DOI 10.1007/s10126-004-5118-2; Poli A, 2010, MAR DRUGS, V8, P1779, DOI 10.3390/md8061779; Raguenes G, 1996, APPL ENVIRON MICROB, V62, P67, DOI 10.1128/AEM.62.1.67-73.1996; Raveendran P, 2003, J AM CHEM SOC, V125, P13940, DOI 10.1021/ja029267j; Saha S, 2010, LANGMUIR, V26, P2885, DOI 10.1021/la902950x; Sharma N, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-86; Srinivas TNR, 2011, INT J SYST EVOL MICR, V61, P1521, DOI 10.1099/ijs.0.025429-0; Suresh AK, 2011, ACTA BIOMATER, V7, P2148, DOI 10.1016/j.actbio.2011.01.023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wei DW, 2009, CARBOHYD RES, V344, P2375, DOI 10.1016/j.carres.2009.09.001; [No title captured]	33	26	27	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e98798	10.1371/journal.pone.0098798	http://dx.doi.org/10.1371/journal.pone.0098798			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932690	Green Published, gold, Green Submitted			2022-12-25	WOS:000337738600013
J	Cartier, F; Marcq, I; Douam, F; Ossart, C; Regnier, A; Debuysscher, V; Lavillette, D; Bouhlal, H				Cartier, Flora; Marcq, Ingrid; Douam, Florian; Ossart, Christele; Regnier, Aline; Debuysscher, Veronique; Lavillette, Dimitri; Bouhlal, Hicham			The Expression of the Hepatocyte SLAMF3 (CD229) Receptor Enhances the Hepatitis C Virus Infection	PLOS ONE			English	Article							CELL ENTRY; IDENTIFICATION; BINDING; CD81; CHOLESTEROL; REQUIRES; STEP; SAP	Hepatitis C virus (HCV) is a leading cause of cirrhosis and liver cancer worldwide. We recently characterized for the first time the expression of Signaling Lymphocyte Activating Molecule 3 (SLAMF3) in human hepatocytes and here, we report that SLAMF3 interacts with the HCV viral protein E2 and is implicated in HCV entry process. We found a strong correlation between SLAMF3 expression level and hepatocyte susceptibility to HCV infection. The use of specific siRNAs to down-modulate SLAMF3 expression and SLAMF3-blocking antibodies both decreased the hepatocytes susceptibility to HCV infection. Moreover, SLAMF3 over-expression significantly increased susceptibility to HCV infection. Interestingly, experiments with peptides derived from each SLAMF3 domain showed that the first N-terminal extracellular domain is essential for interaction with HCV particles. Finally, we showed that recombinant HCV envelop protein E2 can bind SLAMF3 and that anti-SLAMF3 antibodies inhibited specifically this interaction. Overall, our results revealed that SLAMF3 plays a role during HCV entry, likely by enhancing entry of viral particle within hepatocytes.	[Cartier, Flora; Marcq, Ingrid; Ossart, Christele; Regnier, Aline; Debuysscher, Veronique; Bouhlal, Hicham] Univ Picardie, CAP Sante FED 4231, EA 4666, UFR Med, Amiens, France; [Cartier, Flora] Univ Bordeaux Segalen, Lab Physiol Canc Foie, INSERM, U1053, Bordeaux, France; [Douam, Florian; Lavillette, Dimitri] Univ Lyon 1, UMR CNRS Ecol Microbienne 5557, F-69622 Villeurbanne, France; [Ossart, Christele; Regnier, Aline; Bouhlal, Hicham] CHU Amiens Sud, Lab Therapie Cellulaire, Amiens, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Bouhlal, H (corresponding author), Univ Picardie, CAP Sante FED 4231, EA 4666, UFR Med, Amiens, France.	hicham.bouhlal@u-picardie.fr		Lavillette, Dimitri/0000-0002-4706-1519	Conseil Regional de Picardie [Imm-HCV]; Amiens University Medical Center CHU Amiens; CHU Amiens; French Ministry of Research	Conseil Regional de Picardie(Region Hauts-de-France); Amiens University Medical Center CHU Amiens; CHU Amiens; French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by the Conseil Regional de Picardie (project reference: Imm-HCV) and the Amiens University Medical Center CHU Amiens. FC received a doctoral fellowship from CHU Amiens. FD received a fellowship from the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Castelain S, 2004, J CLIN VIROL, V31, P227, DOI 10.1016/j.jcv.2004.03.009; Del Valle JM, 2003, J BIOL CHEM, V278, P17430, DOI 10.1074/jbc.M301569200; Douam F, 2013, CRITICAL INTERACTION, DOI [10.1002/hep.26733, DOI 10.1002/HEP.26733]; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Flint Mike, 2009, V510, P265, DOI 10.1007/978-1-59745-394-3_20; Grove J, 2007, J VIROL, V81, P3162, DOI 10.1128/JVI.02356-06; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Marcq I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082918; Martin DN, 2013, P NATL ACAD SCI USA, V110, P10777, DOI 10.1073/pnas.1301764110; Martin M, 2005, J IMMUNOL, V174, P5977, DOI 10.4049/jimmunol.174.10.5977; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2012, CURR OPIN VIROL, V2, P14, DOI 10.1016/j.coviro.2011.12.007; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Romero X, 2005, J IMMUNOL, V174, P7033, DOI 10.4049/jimmunol.174.11.7033; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Sandrin MS, 1996, IMMUNOGENETICS, V43, P13; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004	28	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99601	10.1371/journal.pone.0099601	http://dx.doi.org/10.1371/journal.pone.0099601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927415	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100054
J	Brown, WS; Khalili, JS; Rodriguez-Cruz, TG; Lizee, G; McIntyre, BW				Brown, Wells S.; Khalili, Jahan S.; Rodriguez-Cruz, Tania G.; Lizee, Greg; McIntyre, Bradley W.			B-Raf Regulation of Integrin alpha 4 beta 1-mediated Resistance to Shear Stress through Changes in Cell Spreading and Cytoskeletal Association in T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAYS; KINASE INHIBITOR; BRAF MUTATIONS; ERK PATHWAY; GTPASE RAP1; ADHESION; ACTIVATION; PHOSPHORYLATION; PAXILLIN; AFFINITY	The regulation of integrin-mediated adhesion is of vital importance to adaptive and innate immunity. Integrins are versatile proteins and mediate T cell migration and trafficking by binding to extracellular matrix or other cells as well as initiating intracellular signaling cascades promoting survival or activation. The MAPK pathway is known to be downstream from integrins and to regulate survival, differentiation, and motility. However, secondary roles for canonical MAPK pathway members are being discovered. We show that chemical inhibition of RAF by sorafenib or shRNA-mediated knockdown of B-Raf reduces T cell resistance to shear stress to alpha 4 beta 1 integrin ligands vascular cell adhesion molecule 1 (VCAM-1) and fibronectin, whereas inhibition of MEK/ERK by U0126 had no effect. Microscopy showed that RAF inhibition leads to significant inhibition of T cell spreading on VCAM-1. The association of alpha 4 beta 1 integrin with the actin cytoskeleton was shown to be dependent on B-Raf activity or expression, whereas alpha 4 beta 1 integrin affinity for soluble VCAM-1 was not. These effects were shown to be specific for alpha 4 beta 1 integrin and not other integrins, such as alpha 5 beta 1 or LFA-1, or a variety of membrane proteins. We demonstrate a novel role for B-Raf in the selective regulation of alpha 4 beta 1 integrin-mediated adhesion.	[Brown, Wells S.; McIntyre, Bradley W.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Khalili, Jahan S.; Rodriguez-Cruz, Tania G.; Lizee, Greg] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	McIntyre, BW (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	bmcintyr@mdanderson.org		Lizee, Gregory/0000-0003-4449-7461	National Institutes of Health [2-T32-CA-09598, 1S10RR029552-01]; NCI, National Institutes of Health, Cancer Center Support Grant [P30CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672, T32CA009598] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029552] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health, Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant 2-T32-CA-09598 (to W. S. B.), National Institutes of Health High-End Instrumentation Grant 1S10RR029552-01 (to the Immunology Imaging Core facility), and NCI, National Institutes of Health, Cancer Center Support Grant P30CA16672 (to the Flow Cytometry Core Facility at the University of Texas MD Anderson Cancer Center).	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Alon R, 2005, J CELL BIOL, V171, P1073, DOI 10.1083/jcb.200503155; BEDNARCZYK JL, 1994, J BIOL CHEM, V269, P8348; Boni A, 2010, CANCER RES, V70, P5213, DOI 10.1158/0008-5472.CAN-10-0118; Broustas CG, 2002, J BIOL CHEM, V277, P3053, DOI 10.1074/jbc.M106343200; Cabrera R, 2013, CANCER IMMUNOL IMMUN, V62, P737, DOI 10.1007/s00262-012-1380-8; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Cao MD, 2011, LAB INVEST, V91, P598, DOI 10.1038/labinvest.2010.205; Carey KD, 2003, J BIOL CHEM, V278, P3185, DOI 10.1074/jbc.M207014200; CHAMPE M, 1995, J BIOL CHEM, V270, P1388, DOI 10.1074/jbc.270.3.1388; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; D'Souza-Schorey C, 1998, MOL CELL BIOL, V18, P3936, DOI 10.1128/MCB.18.7.3936; Davidsson J, 2008, LEUKEMIA, V22, P1619, DOI 10.1038/leu.2008.14; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; de Bruyn KMT, 2002, J BIOL CHEM, V277, P29468, DOI 10.1074/jbc.M204990200; Desar IME, 2011, INT J CANCER, V129, P507, DOI 10.1002/ijc.25674; Deswal S, 2013, J IMMUNOL, V190, P1927, DOI 10.4049/jimmunol.1200653; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dillon TJ, 2003, J BIOL CHEM, V278, P35940, DOI 10.1074/jbc.M301506200; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; EYCHENE A, 1995, ONCOGENE, V10, P1159; GEPPERT TD, 1991, J IMMUNOL, V146, P3298; Ghandour H, 2007, BLOOD, V110, P3682, DOI 10.1182/blood-2007-03-077628; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Han JW, 2003, J BIOL CHEM, V278, P34845, DOI 10.1074/jbc.M304691200; Hindley A, 2007, CELL SIGNAL, V19, P547, DOI 10.1016/j.cellsig.2006.08.004; Houben R, 2009, MOL CANCER THER, V8, P433, DOI 10.1158/1535-7163.MCT-08-1051; Hughes PE, 2002, MOL BIOL CELL, V13, P2256, DOI 10.1091/mbc.01-10-0480; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Hyduk SJ, 2007, BLOOD, V109, P176, DOI 10.1182/blood-2006-01-029199; Hyduk SJ, 2011, J IMMUNOL, V187, P4360, DOI 10.4049/jimmunol.1003725; Ibrahim N, 2012, ONCOL REP, V27, P1303, DOI 10.3892/or.2012.1675; Janosch P, 2000, FASEB J, V14, P2008, DOI 10.1096/fj.99-0883com; Jin A, 2006, ONCOGENE, V25, P4332, DOI 10.1038/sj.onc.1209459; Johnson DB, 2013, CURR TREAT OPTION ON, V14, P280, DOI 10.1007/s11864-013-0226-8; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Klein RM, 2008, MOL BIOL CELL, V19, P498, DOI 10.1091/mbc.E07-09-0895; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Liu L, 2002, J BIOL CHEM, V277, P40893, DOI 10.1074/jbc.M206208200; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Maqueda A, 2006, J CELL PHYSIOL, V207, P746, DOI 10.1002/jcp.20624; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Matallanas David, 2011, Genes Cancer, V2, P232, DOI 10.1177/1947601911407323; Mielgo A, 2011, NAT MED, V17, P1641, DOI 10.1038/nm.2464; Mitchell JS, 2009, IMMUNOL CELL BIOL, V87, P324, DOI 10.1038/icb.2008.103; Mitchell JS, 2002, J IMMUNOL, V168, P2737, DOI 10.4049/jimmunol.168.6.2737; Miyamoto YJ, 2001, J IMMUNOL, V166, P5129, DOI 10.4049/jimmunol.166.8.5129; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Nakamura K, 2000, J BIOL CHEM, V275, P27155; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Pribic J, 2012, CELL SIGNAL, V24, P1531, DOI 10.1016/j.cellsig.2012.03.015; Pribila JT, 2004, ANNU REV IMMUNOL, V22, P157, DOI 10.1146/annurev.immunol.22.012703.104649; Pritchard CA, 2004, MOL CELL BIOL, V24, P5937, DOI 10.1128/MCB.24.13.5937-5952.2004; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Ren JG, 2008, J BIOL CHEM, V283, P22972, DOI 10.1074/jbc.M804626200; Romanova LY, 2004, J CELL SCI, V117, P3759, DOI 10.1242/jcs.01206; Rose DM, 2002, IMMUNOL REV, V186, P118, DOI 10.1034/j.1600-065X.2002.18611.x; Rose DM, 2001, J IMMUNOL, V167, P2824, DOI 10.4049/jimmunol.167.5.2824; Rullo J, 2012, J CELL BIOL, V197, P115, DOI 10.1083/jcb.201107140; Simonson WTN, 2006, J IMMUNOL, V177, P7707, DOI 10.4049/jimmunol.177.11.7707; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Tran NH, 2005, J BIOL CHEM, V280, P16244, DOI 10.1074/jbc.M501185200; Tsubouchi A, 2002, J CELL BIOL, V159, P673, DOI 10.1083/jcb.200202117; Tsukamoto H, 2004, J BIOL CHEM, V279, P48457, DOI 10.1074/jbc.M403087200; Tsukamoto H, 2008, EUR J IMMUNOL, V38, P518, DOI 10.1002/eji.200737430; Tsukamoto H, 2006, EUR J IMMUNOL, V36, P1926, DOI 10.1002/eji.200535803; Vial E, 2004, ANN NY ACAD SCI, V1030, P208, DOI 10.1196/annals.1329.027; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Woodrow MA, 2003, EXP CELL RES, V287, P325, DOI 10.1016/S0014-4827(03)00122-8; Woodside DG, 2006, J IMMUNOL, V176, P5041, DOI 10.4049/jimmunol.176.8.5041; Wooten DK, 1999, J LEUKOCYTE BIOL, V65, P127, DOI 10.1002/jlb.65.1.127; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zhao W, 2008, LEUKEMIA, V22, P1226, DOI 10.1038/leu.2008.58	79	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23141	23153		10.1074/jbc.M114.562918	http://dx.doi.org/10.1074/jbc.M114.562918			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24936068	Green Published, hybrid			2022-12-25	WOS:000341017200051
J	Liu, BT; Wang, TS; Mei, WH; Li, DD; Cai, R; Zuo, Y; Cheng, JK				Liu, Bingting; Wang, Tianshi; Mei, Wenhan; Li, Dongdong; Cai, Rong; Zuo, Yong; Cheng, Jinke			Small Ubiquitin-like Modifier (SUMO) Protein-specific Protease 1 De-SUMOylates Sharp-1 Protein and Controls Adipocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE DEVELOPMENT; PPAR-GAMMA; C/EBP-ALPHA; ADIPOGENESIS; EXPRESSION; MYOGENESIS; PATHWAY	Adipocyte differentiation is regulated by a transcriptional cascade that mainly includes CCAAT/enhancer-binding protein family members and the nuclear receptor peroxisome proliferator- activated receptor gamma (PPAR gamma). Here we show the defects in adipocyte differentiation as well as PPAR gamma expression in Senp1(-/-) mouse embryonic fibroblast cells induced by adipogenic stimuli. We further determine that SENP1 is a specific de-SUMOylation protease for Sharp-1, a repressor for PPAR gamma transcription and adipogenesis. SENP1 enhances adipogenesis through de-SUMOylation of Sharp-1, which then releases Sharp-1 repression of PPAR gamma expression and adipocyte differentiation. These results reveal SENP1 as a novel regulator in adipogenesis.	[Liu, Bingting; Wang, Tianshi; Mei, Wenhan; Li, Dongdong; Cai, Rong; Zuo, Yong; Cheng, Jinke] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai 200030, Peoples R China; [Liu, Bingting; Wang, Tianshi; Zuo, Yong; Cheng, Jinke] Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Cheng, JK (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, 280 Chongqing South Rd, Shanghai 200030, Peoples R China.	jkcheng@shsmu.edu.cn			National Basic Research Program of China (973 Program) [2010CB912104, 2012CB910102]; National Natural Science Foundation of China [91019021, 81302296]; Shanghai Jiao Tong University School of Medicine [BXJ201207]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Jiao Tong University School of Medicine	This work was supported by National Basic Research Program of China (973 Program) Grants 2010CB912104 (to J. C.) and 2012CB910102 (to Y. Z.), by National Natural Science Foundation of China Grants 91019021 (to J. C.) and 81302296 (to W. M.), and by Doctoral Innovation Fund of the Shanghai Jiao Tong University School of Medicine Grant BXJ201207 (to B. L.).	Azmi S, 2003, J BIOL CHEM, V278, P20098, DOI 10.1074/jbc.M210427200; Billon N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r80; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Chung SS, 2010, MOL CELL BIOL, V30, P2135, DOI 10.1128/MCB.00852-09; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Gulbagci NT, 2009, EMBO REP, V10, P79, DOI 10.1038/embor.2008.207; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Kamitani T, 1998, J BIOL CHEM, V273, P3117, DOI 10.1074/jbc.273.6.3117; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Liu YF, 2013, STAT INTERFACE, V6, P1; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Scroyen I, 2012, OBESITY, V20, P1168, DOI 10.1038/oby.2011.399; Van Hul M, 2012, CLIN EXP PHARMACOL P, V39, P49, DOI 10.1111/j.1440-1681.2011.05635.x; Vogel G, 2012, RNA BIOL, V9, P1129, DOI 10.4161/rna.21409; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wang YJ, 2013, J BIOL CHEM, V288, P17654, DOI 10.1074/jbc.M113.463257; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Yan X, 2013, INT J OBESITY, V37, P568, DOI 10.1038/ijo.2012.69; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhao X, 2013, GENE, V532, P263, DOI 10.1016/j.gene.2013.08.088	24	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22358	22364		10.1074/jbc.M114.571950	http://dx.doi.org/10.1074/jbc.M114.571950			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24942744	Green Published, hybrid			2022-12-25	WOS:000340593500046
J	Liu, J; Han, L; Li, B; Yang, J; Huen, MSY; Pan, X; Tsao, SW; Cheung, ALM				Liu, Jia; Han, Liang; Li, Bin; Yang, Jie; Huen, Michael S. Y.; Pan, Xin; Tsao, Sai Wah; Cheung, Annie L. M.			F-Box Only Protein 31 (FBXO31) Negatively Regulates p38 Mitogen-activated Protein Kinase (MAPK) Signaling by Mediating Lysine 48-linked Ubiquitination and Degradation of Mitogen-activated Protein Kinase Kinase 6 (MKK6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL REGULATION; LIGASE; GENE; PHOSPHORYLATION; TRANSDUCTION; EXPRESSION; INDUCTION; PATHWAYS	The p38 MAPK signal transduction pathway plays an important role in inflammatory and stress responses. MAPKK6 (MKK6), a dual specificity protein kinase, is a p38 activator. Activation of the MKK6-p38 pathway is kept in check by multiple layers of regulations, including autoinhibition, dimerization, scaffold proteins, and Lys-63-linked polyubiquitination. However, the mechanisms underlying deactivation of MKK6-p38, which is crucial for maintaining the magnitude and duration of signal transduction, are not well understood. Lys-48-linked ubiquitination, which marks substrates for proteasomal degradation, is an important negative posttranslational regulatory machinery for signal pathway transduction. Here we report that the accumulation of F-box only protein 31 (FBXO31), a component of Skp1.Cul1.F-box protein E3 ligase, negatively regulated p38 activation in cancer cells upon genotoxic stresses. Our results show that FBXO31 binds to MKK6 and mediates its Lys-48-linked polyubiquitination and degradation, thereby functioning as a negative regulator of MKK6-p38 signaling and protecting cells from stress-induced cell apoptosis. Taken together, our findings uncover a new mechanism of deactivation of MKK6-p38 and substantiate a novel regulatory role of FBXO31 in stress response.	[Liu, Jia; Han, Liang; Li, Bin; Yang, Jie; Huen, Michael S. Y.; Tsao, Sai Wah; Cheung, Annie L. M.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Pan, Xin] NHLBI, Ctr Mol Med, NIH, Bethesda, MD 20892 USA	University of Hong Kong; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Cheung, ALM (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China.	lmcheung@hku.hk	; /C-4230-2009	Pan, Xin/0000-0002-1982-2261; /0000-0003-3217-1456				Ahn YH, 2009, J BIOL CHEM, V284, P29399, DOI 10.1074/jbc.M109.044958; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Asthagiri AR, 2001, BIOTECHNOL PROGR, V17, P227, DOI 10.1021/bp010009k; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Giasson BI, 2003, CELL, V114, P1, DOI 10.1016/S0092-8674(03)00509-9; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Hui CM, 2006, INT J CANCER, V119, P508, DOI 10.1002/ijc.21874; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Johnson GL, 2005, CURR OPIN CHEM BIOL, V9, P325, DOI 10.1016/j.cbpa.2005.04.004; Kawamata H, 2003, CANCER SCI, V94, P699, DOI 10.1111/j.1349-7006.2003.tb01505.x; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kumar R, 2005, CANCER RES, V65, P11304, DOI 10.1158/0008-5472.CAN-05-0936; Kuo WL, 2004, J BIOL CHEM, V279, P23073, DOI 10.1074/jbc.M313696200; Liu WH, 2005, MOL CELL BIOL, V25, P1367, DOI 10.1128/MCB.25.4.1367-1378.2005; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pan X, 2009, P NATL ACAD SCI USA, V106, P3788, DOI 10.1073/pnas.0810147106; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Santra MK, 2009, NATURE, V459, P722, DOI 10.1038/nature08011; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shiloh Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.296pe73; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wang WH, 2004, MOL CELL BIOL, V24, P10352, DOI 10.1128/MCB.24.23.10352-10365.2004; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yang WL, 2010, ONCOGENE, V29, P4493, DOI 10.1038/onc.2010.190; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	35	36	37	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21508	21518		10.1074/jbc.M114.560342	http://dx.doi.org/10.1074/jbc.M114.560342			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24936062	Green Published, hybrid			2022-12-25	WOS:000340558300027
J	Shestopaloff, YK				Shestopaloff, Yuri K.			Method for Finding Metabolic Properties Based on the General Growth Law. Liver Examples. A General Framework for Biological Modeling	PLOS ONE			English	Article							IN-VITRO; REGENERATION; DYNAMICS; DONORS	We propose a method for finding metabolic parameters of cells, organs and whole organisms, which is based on the earlier discovered general growth law. Based on the obtained results and analysis of available biological models, we propose a general framework for modeling biological phenomena and discuss how it can be used in Virtual Liver Network project. The foundational idea of the study is that growth of cells, organs, systems and whole organisms, besides biomolecular machinery, is influenced by biophysical mechanisms acting at different scale levels. In particular, the general growth law uniquely defines distribution of nutritional resources between maintenance needs and biomass synthesis at each phase of growth and at each scale level. We exemplify the approach considering metabolic properties of growing human and dog livers and liver transplants. A procedure for verification of obtained results has been introduced too. We found that two examined dogs have high metabolic rates consuming about 0.62 and 1 gram of nutrients per cubic centimeter of liver per day, and verified this using the proposed verification procedure. We also evaluated consumption rate of nutrients in human livers, determining it to be about 0.088 gram of nutrients per cubic centimeter of liver per day for males, and about 0.098 for females. This noticeable difference can be explained by evolutionary development, which required females to have greater liver processing capacity to support pregnancy. We also found how much nutrients go to biomass synthesis and maintenance at each phase of liver and liver transplant growth. Obtained results demonstrate that the proposed approach can be used for finding metabolic characteristics of cells, organs, and whole organisms, which can further serve as important inputs and constraints for many applications in biology (such as protein expression), biotechnology (synthesis of substances), and medicine.	Segmentsoft Inc, Toronto, ON, Canada		Shestopaloff, YK (corresponding author), Segmentsoft Inc, Toronto, ON, Canada.	shes169@yahoo.ca						Arias I M, 2008, LIVER BIOL PATHOBIOL; Berg JM, 2006, BIOCHEMISTRY; Bogorodskii V. V., 1985, Soviet Physics - Technical Physics, V30, P1236; Byrne H, 2009, J MATH BIOL, V58, P657, DOI 10.1007/s00285-008-0212-0; Calvetti D, 2008, J PHYS C SERIES, V241; Drasdo D, 2005, PHYS BIOL, V2, P133, DOI 10.1088/1478-3975/2/3/001; Drasdo D, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/055025; Furchtgott LA, 2009, BIOPHYS J, V96, P3926, DOI 10.1016/j.bpj.2009.01.061; Goncalves E, 2013, MOL BIOSYST, V9, P1576, DOI 10.1039/c3mb25489e; Grabin VG, 1989, ORUZHIE POBEDY WEAPO; Guillouzo A, 2007, CHEM-BIOL INTERACT, V168, P66, DOI 10.1016/j.cbi.2006.12.003; Haga J, 2008, LIVER TRANSPLANT, V14, P1718, DOI 10.1002/lt.21622; Hohme S, 2007, CHEM-BIOL INTERACT, V168, P74, DOI 10.1016/j.cbi.2007.01.010; Hoehme S, 2010, P NATL ACAD SCI USA, V107, P10371, DOI 10.1073/pnas.0909374107; Holzhutter HG, 2012, WIRES SYST BIOL MED, V4, P221, DOI 10.1002/wsbm.1158; Huthmacher C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-120; Jones GW, 2012, SIAM REV, V54, P52, DOI 10.1137/080731785; KAM I, 1987, HEPATOLOGY, V7, P362, DOI 10.1002/hep.1840070225; Krauss M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002750; MaalOe O, 1966, CONTROL MACROMOLECUL; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Malmivuo P., 1995, BIOELECTROMAGNETISM, DOI [DOI 10.1093/ACPROF:OSO/9780195058239.001.0001, 10.1093/acprof:oso/9780195058239.001.0001]; Matthias K, 2012, J BIOL CHEM, V287, P36978; Mente C, 2012, ACTA PHYS POL B PR S, V5, P99, DOI 10.5506/APhysPolBSupp.5.99; Mitchell S, 2013, 13085826QBIOMN ARXIV; Ochoa JGD, 2013, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00204; Pollitzer E, 2013, NATURE, V500, P23, DOI 10.1038/500023a; Pomfret EA, 2003, TRANSPLANTATION, V76, P5, DOI 10.1097/01.TP.0000079064.08263.8E; Schwen LO, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/357687; Shestopaloff AY, 2013, MCMC NONLINEAR STATE; Shestopaloff Y. K., 2012, Biophysical Reviews and Letters, V7, P177, DOI 10.1142/S1793048012500075; Shestopaloff Y. K., 2010, PROPERTIES INTERRELA; Shestopaloff YK, 2011, DESIGN IMPLEMENTATIO; Shestopaloff YK, 2011, HYPOTHESIS VALIDATIO; Shestopaloff YK, 2010, PHYS GROWTH REPLICAT; Shestopaloff YK, 2012, LAW REPLICATION GROW; Shestopaloff YK, 2014, GROWTH UNION FORM BI; Shestopaloff YK, 2012, J PERFORMANCE MEASUR, V17, P48; Shestopaloff YK, 2011, COMP MATH MATH PHYS+, V51, P699, DOI 10.1134/S0965542511050162; Shestopaloff YK, 2013, ACTA BIOTHEOR, V61, P499, DOI 10.1007/s10441-013-9202-8; Shestopaloff Yuri K., 2012, Biophysical Reviews and Letters, V7, P71, DOI 10.1142/S1793048012500051; Shestopaloff YK, 2011, APPL OPTICS, V50, P6606, DOI 10.1364/AO.50.006606; Shestopaloff YK, 2011, INT J ELECTRON, V98, P1433, DOI 10.1080/00207217.2011.601441; Shestopaloff YK, 2011, INT J BIOMATH, V4, P35, DOI 10.1142/S1793524511001180; Shestopaloff Yuri K., 2010, Biophysical Reviews and Letters, V5, P43, DOI 10.1142/S1793048010001111; SHESTOPALOV YK, 1993, IEEE T GEOSCI REMOTE, V31, P1060, DOI 10.1109/36.263777; Stephanopoulos G., 1998, METAB ENG; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Tyson JJ, 2002, BIOESSAYS, V24, P1095, DOI 10.1002/bies.10191	49	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99836	10.1371/journal.pone.0099836	http://dx.doi.org/10.1371/journal.pone.0099836			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940740	Green Published, gold, Green Submitted			2022-12-25	WOS:000338508200045
J	Zaniboni, M; Cacciani, F; Lux, RL				Zaniboni, Massimiliano; Cacciani, Francesca; Lux, Robert L.			Beat-to-Beat Cycle Length Variability of Spontaneously Beating Guinea Pig Sinoatrial Cells: Relative Contributions of the Membrane and Calcium Clocks	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; RYANODINE RECEPTOR; CURRENT IF; MODULATION; RELEASE; MECHANISMS; MYOCYTES; CURRENTS; MODEL	The heartbeat arises rhythmically in the sino-atrial node (SAN) and then spreads regularly throughout the heart. The molecular mechanism underlying SAN rhythm has been attributed by recent studies to the interplay between two clocks, one involving the hyperpolarization activated cation current I-f (the membrane clock), and the second attributable to activation of the electrogenic NaCa exchanger by spontaneous sarcoplasmic releases of calcium (the calcium clock). Both mechanisms contain, in principle, sources of beat-to-beat cycle length variability, which can determine the intrinsic variability of SAN firing and, in turn, contribute to the heart rate variability. In this work we have recorded long sequences of action potentials from patch clamped guinea pig SAN cells (SANCs) perfused, in turn, with normal Tyrode solution, with the I-f inhibitor ivabradine (3 mu M), then back to normal Tyrode, and again with the ryanodine channels inhibitor ryanodine (3 mM). We have found that, together with the expected increase in beating cycle length (+25%), the application of ivabradine brought about a significant and dramatic increase in beat-to-beat cycle length variability (+50%). Despite the similar effect on firing rate, ryanodine did not modify significantly beat-to-beat cycle length variability. Acetylcholine was also applied and led to a 131% increase of beating cycle length, with only a 70% increase in beat-to-beat cycle length variability. We conclude that the main source of inter-beat variability of SANCs firing rate is related to the mechanism of the calcium clock, whereas the membrane clock seems to act in stabilizing rate. Accordingly, when the membrane clock is silenced by application of ivabradine, stochastic variations of the calcium clock are free to make SANCs beating rhythm more variable.	[Zaniboni, Massimiliano; Cacciani, Francesca] Univ Parma, Dept Life Sci, I-43100 Parma, Italy; [Zaniboni, Massimiliano] Univ Parma, Ctr Excellence Toxicol Res, I-43100 Parma, Italy; [Lux, Robert L.] Univ Utah, Cardiovasc Res & Training Inst, Salt Lake City, UT USA	University of Parma; University of Parma; Utah System of Higher Education; University of Utah	Zaniboni, M (corresponding author), Univ Parma, Dept Life Sci, I-43100 Parma, Italy.	massimiliano.zaniboni@unipr.it	Zaniboni, Massimiliano/M-8144-2015	Zaniboni, Massimiliano/0000-0001-8808-2239	Chiesi Farmaceutici S.p.A. within the project "Pharmacological modulation of electrophysiological properties of guinea pig SA nodal cells"	Chiesi Farmaceutici S.p.A. within the project "Pharmacological modulation of electrophysiological properties of guinea pig SA nodal cells"	This work has been funded to the corresponding author by Chiesi Farmaceutici S.p.A. within the project "Pharmacological modulation of electrophysiological properties of guinea pig SA nodal cells" 2012-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPEL ML, 1989, J AM COLL CARDIOL, V14, P1139, DOI 10.1016/0735-1097(89)90408-7; Bogdanov KY, 2001, CIRC RES, V88, P1254, DOI 10.1161/hh1201.092095; BROWN HF, 1979, NATURE, V280, P235, DOI 10.1038/280235a0; Bucchi A, 2003, J MOL CELL CARDIOL, V35, P905, DOI 10.1016/S0022-2828(03)00150-0; Bucchi A, 2007, J MOL CELL CARDIOL, V43, P39, DOI 10.1016/j.yjmcc.2007.04.017; Clark RB, 2004, AM J PHYSIOL-HEART C, V286, pH1757, DOI 10.1152/ajpheart.00753.2003; CLAY JR, 1979, BIOPHYS J, V28, P377, DOI 10.1016/S0006-3495(79)85187-5; Costa M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.198102; DIFRANCESCO D, 1986, J PHYSIOL-LONDON, V377, P61, DOI 10.1113/jphysiol.1986.sp016177; DIFRANCESCO D, 1985, PROG BIOPHYS MOL BIO, V46, P163, DOI 10.1016/0079-6107(85)90008-2; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DIFRANCESCO D, 1991, J PHYSIOL-LONDON, V434, P23, DOI 10.1113/jphysiol.1991.sp018457; Frey B, 1996, PACE, V19, P1882, DOI 10.1111/j.1540-8159.1996.tb03245.x; Gao Z, 2010, J MOL CELL CARDIOL, V49, P33, DOI 10.1016/j.yjmcc.2010.03.019; GOLDBERGER AL, 1991, NEWS PHYSIOL SCI, V6, P87, DOI 10.1152/physiologyonline.1991.6.2.87; Huser J, 2000, J PHYSIOL-LONDON, V524, P415, DOI 10.1111/j.1469-7793.2000.00415.x; Johnson DM, 2010, J MOL CELL CARDIOL, V48, P122, DOI 10.1016/j.yjmcc.2009.08.033; JONGSMA HJ, 1983, J MOL CELL CARDIOL, V15, P123, DOI 10.1016/0022-2828(83)90288-2; JOYNER RW, 1986, BIOPHYS J, V50, P1157, DOI 10.1016/S0006-3495(86)83559-7; Koorpelainen JT, 1999, STROKE, V30, P1008, DOI 10.1161/01.STR.30.5.1008; Kucera JP, 2000, CIRC RES, V86, P1140, DOI 10.1161/01.RES.86.11.1140; MALIK M, 1994, BRIT HEART J, V71, P3; Maltsev VA, 2009, AM J PHYSIOL-HEART C, V296, pH594, DOI 10.1152/ajpheart.01118.2008; Manzo A, 2009, LAB ANIM-UK, V43, P41, DOI 10.1258/la.2007.007085; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Monfredi O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067247; NOBLE D, 1992, P ROY SOC B-BIOL SCI, V250, P199, DOI 10.1098/rspb.1992.0150; Papaioannou VE, 2013, CURR CARDIOL REV, V9, P82, DOI 10.2174/1573403X11309010010; Posokhova E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076973; Rigg L, 1996, EXP PHYSIOL, V81, P877, DOI 10.1113/expphysiol.1996.sp003983; Rocchetti M, 2000, J CARDIOVASC ELECTR, V11, P522, DOI 10.1111/j.1540-8167.2000.tb00005.x; Sarkar AX, 2010, PLOS COMPUT BIOL, V2, P6, DOI DOI 10.1371/J0URNAL.PCBI.1000914; SCHECHTMAN VL, 1992, PEDIATR RES, V31, P606, DOI 10.1203/00006450-199206000-00014; Severi S, 2012, J PHYSIOL-LONDON, V590, P4483, DOI 10.1113/jphysiol.2012.229435; Song DK, 1999, PFLUG ARCH EUR J PHY, V438, P147, DOI 10.1007/s004240050892; Spitzer Kenneth W, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS8, DOI 10.1111/j.1540-8167.2006.00379.x; WILDERS R, 1993, BIOPHYS J, V65, P2601, DOI 10.1016/S0006-3495(93)81289-X; Zaniboni M, 2000, AM J PHYSIOL-HEART C, V278, pH677, DOI 10.1152/ajpheart.2000.278.3.H677; Zaniboni M, 2012, IEEE T BIO-MED ENG, V59, P2372, DOI 10.1109/TBME.2012.2204880; Zaniboni M, 2010, MATH BIOSCI, V228, P56, DOI 10.1016/j.mbs.2010.08.007; Zaza A, 2001, CARDIOVASC RES, V50, P434, DOI 10.1016/S0008-6363(01)00240-1	41	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100242	10.1371/journal.pone.0100242	http://dx.doi.org/10.1371/journal.pone.0100242			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940609	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200086
J	Smith, C; Skelly, C; Kung, N; Roberts, B; Field, H				Smith, Craig; Skelly, Chris; Kung, Nina; Roberts, Billie; Field, Hume			Flying-Fox Species Density - A Spatial Risk Factor for Hendra Virus Infection in Horses in Eastern Australia	PLOS ONE			English	Article							PTEROPID BATS; DISEASE; MORBILLIVIRUS; HENIPAVIRUSES; CORONAVIRUSES; PREVALENCE; RESERVOIR	Hendra virus causes sporadic but typically fatal infection in horses and humans in eastern Australia. Fruit-bats of the genus Pteropus (commonly known as flying-foxes) are the natural host of the virus, and the putative source of infection in horses; infected horses are the source of human infection. Effective treatment is lacking in both horses and humans, and notwithstanding the recent availability of a vaccine for horses, exposure risk mitigation remains an important infection control strategy. This study sought to inform risk mitigation by identifying spatial and environmental risk factors for equine infection using multiple analytical approaches to investigate the relationship between plausible variables and reported Hendra virus infection in horses. Spatial autocorrelation (Global Moran's I) showed significant clustering of equine cases at a distance of 40 km, a distance consistent with the foraging 'footprint' of a flying-fox roost, suggesting the latter as a biologically plausible basis for the clustering. Getis-Ord Gi* analysis identified multiple equine infection hot spots along the eastern Australia coast from far north Queensland to central New South Wales, with the largest extending for nearly 300 km from southern Queensland to northern New South Wales. Geographically weighted regression (GWR) showed the density of P. alecto and P. conspicillatus to have the strongest positive correlation with equine case locations, suggesting these species are more likely a source of infection of Hendra virus for horses than P. poliocephalus or P. scapulatus. The density of horses, climate variables and vegetation variables were not found to be a significant risk factors, but the residuals from the GWR suggest that additional unidentified risk factors exist at the property level. Further investigations and comparisons between case and control properties are needed to identify these local risk factors.	[Smith, Craig; Kung, Nina; Field, Hume] Dept Agr Fisheries & Forestry, Queensland Ctr Emerging Infect Dis, Brisbane, Qld, Australia; [Skelly, Chris] Dept Agr Fisheries & Forestry, Biosecur Intelligence Unit, Brisbane, Qld, Australia; [Roberts, Billie] Griffith Univ, Griffith Sch Environm, Brisbane, Qld 4111, Australia; [Field, Hume] EcoHlth Alliance, New York, NY USA; [Skelly, Chris] GIS People Pty Ltd, Brisbane, Qld, Australia	Queensland Department of Agriculture & Fisheries; Queensland Department of Agriculture & Fisheries; Griffith University; EcoHealth Alliance	Smith, C (corresponding author), Dept Agr Fisheries & Forestry, Queensland Ctr Emerging Infect Dis, Brisbane, Qld, Australia.	craig.smith@daff.qld.gov.au	Kung, Nina Y/H-1260-2012		State of Queensland, through the Queensland Centre for Emerging Infectious Diseases; State of New South Wales; Commonwealth of Australia under the National Hendra Virus Research Program; State of Queensland	State of Queensland, through the Queensland Centre for Emerging Infectious Diseases; State of New South Wales; Commonwealth of Australia under the National Hendra Virus Research Program; State of Queensland	The State of Queensland, through the Queensland Centre for Emerging Infectious Diseases, provided funding and logistical support for the project. Additional support was provided the by the State of Queensland, the State of New South Wales and the Commonwealth of Australia under the National Hendra Virus Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida FC, 2014, MOL PHYLOGENET EVOL; [Anonymous], 2004, ECOLOGY HENDRA VIRUS; Baldock F. C., 1996, Singapore Veterinary Journal, V20, P57; BioMedware, 2012, METH DAT STAND; Breed A, 2011, PLOS ONE, V6; Brownstein JS, 2002, VECTOR-BORNE ZOONOT, V2, P157, DOI 10.1089/15303660260613729; Bureau of Meteorology, MAPS AV COND; Bureau of Meteorology, PER US CLIM MAPS STA; Chu DKW, 2006, J GEN VIROL, V87, P2461, DOI 10.1099/vir.0.82203-0; Department of Environment & Heritage Protection, WILDNET; Field H, 2001, MICROBES INFECT, V3, P307, DOI 10.1016/S1286-4579(01)01384-3; Field HE, 2007, AUST VET J, V85, P268, DOI 10.1111/j.1751-0813.2007.00170.x; Field H, 2012, CURR TOP MICROBIOL, V359, P11, DOI 10.1007/82_2012_214; Field H, 2011, CURR OPIN VIROL, V1, P658, DOI 10.1016/j.coviro.2011.10.025; Field H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028678; Field H, 2010, EMERG INFECT DIS, V16, P338, DOI 10.3201/eid1602.090780; Firestone SM, 2012, PREV VET MED, V106, P123, DOI 10.1016/j.prevetmed.2012.01.020; Firestone SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035284; Fogarty R, 2008, VIRUS RES, V132, P140, DOI 10.1016/j.virusres.2007.11.010; Fox S, 2011, BIOLOGY AND CONSERVATION OF AUSTRALASIAN BATS, P136; Geoscience Australia, 1988, VEG POST EUR SETTL; Getis A, 1992, GEOGRAPHICAL ANAL, V24; Gloza-Rausch F, 2008, EMERG INFECT DIS, V14, P626, DOI 10.3201/eid1404.071439; Halpin K., 1996, Communicable Diseases Intelligence, V20, P476; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567; Kitron U, 1997, AM J EPIDEMIOL, V145, P558, DOI 10.1093/oxfordjournals.aje.a009145; Li HF, 2007, GEOGR ANAL, V39, P357, DOI 10.1111/j.1538-4632.2007.00708.x; Markus N, 2004, WILDLIFE RES, V31, P345, DOI 10.1071/WR01117; Martin V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001308; McFarlane R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028374; Middleton D, 2014, EMERG INFECT DIS, V20, P372, DOI 10.3201/eid2003.131159; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; MURRAY K, 1995, EMERG INFECT DIS, V1, P31, DOI 10.3201/eid0101.950107; Nadin-Davis SA, 2001, VIRUS RES, V74, P139, DOI 10.1016/S0168-1702(00)00259-8; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Roberts BJ, 2012, AUSTRAL ECOL, V37, P12, DOI 10.1111/j.1442-9993.2011.02243.x; Scanlan JC, 2015, ECOHEALTH, V12, P121, DOI 10.1007/s10393-014-0920-4; SELVEY LA, 1995, MED J AUSTRALIA, V162, P642, DOI 10.5694/j.1326-5377.1995.tb126050.x; Wacharapluesadee S, 2010, VECTOR-BORNE ZOONOT, V10, P183, DOI 10.1089/vbz.2008.0105; Young PL, 1996, EMERG INFECT DIS, V2, P239, DOI 10.3201/eid0203.960315	44	25	25	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99965	10.1371/journal.pone.0099965	http://dx.doi.org/10.1371/journal.pone.0099965			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936789	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000338503400059
J	Liao, T; Yuan, DY; Zou, F; Gao, C; Yang, Y; Zhang, L; Tan, XF				Liao, Ting; Yuan, De-Yi; Zou, Feng; Gao, Chao; Yang, Ya; Zhang, Lin; Tan, Xiao-Feng			Self-Sterility in Camellia oleifera May Be Due to the Prezygotic Late-Acting Self-Incompatibility	PLOS ONE			English	Article							POLLEN-TUBE GROWTH; IPOMOPSIS-AGGREGATA POLEMONIACEAE; INBREEDING DEPRESSION; POSTPOLLINATION EVENTS; REPRODUCTIVE-BIOLOGY; CROSS-POLLINATION; BIGNONIACEAE; VIABILITY; PAPILIONOIDEAE; LEGUMINOSAE	In this report, self-sterility in Camellia oleifera was explored by comparing structural and statistical characteristics following self-pollination (SP) and cross-pollination (CP). Although slightly delayed pollen germination and pollen tube growth in selfed ovaries compared to crossed ovaries was observed, there was no significant difference in the percentages of pollen that germinated and pollen tubes that grew to the base of the style. There was also no difference in morphological structure after the two pollination treatments. However, the proportions of ovule penetration and double fertilization in selfed ovules were significantly lower than in crossed ovules, indicating that a prezygotic late-acting self-incompatible mechanism may exist in C. oleifera. Callose deposition was observed in selfed abortive ovules, but not in normal. Ovules did not show differences in anatomic structure during embryonic development, whereas significant differences were observed in the final fruit and seed set. In addition, aborted ovules in selfed ovaries occurred within 35 days after SP and prior to zygote division. However, this process did not occur continuously throughout the life cycle, and no zygotes were observed in the selfed abortive ovules. These results indicated that the self-sterility in C. oleifera may be caused by prezygotic late-acting self-incompatibility (LSI).	[Liao, Ting; Yuan, De-Yi; Zou, Feng; Gao, Chao; Yang, Ya; Zhang, Lin; Tan, Xiao-Feng] Cent South Univ Forestry & Technol, Key Lab Cultivat & Protect Nonwood Forest Trees, Minist Educ, Key Lab Nonwood Forest Prod,Forestry Minist, Changsha, Hunan, Peoples R China	Central South University of Forestry & Technology	Yuan, DY (corresponding author), Cent South Univ Forestry & Technol, Key Lab Cultivat & Protect Nonwood Forest Trees, Minist Educ, Key Lab Nonwood Forest Prod,Forestry Minist, Changsha, Hunan, Peoples R China.	yuan-deyi@163.com	tan, xiao/GZL-0264-2022; Zou, Feng/AAB-5985-2020	, Ting/0000-0003-1434-478X; Zou, Feng/0000-0001-5179-2261	National Natural Science Foundation of China [31170639]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 31170639). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN WILLIAM L., 1961, PROC AMER SOC HORT SCI, V77, P265; Asikainen E, 2005, AM J BOT, V92, P487, DOI 10.3732/ajb.92.3.487; Bittencourt NS, 2005, INT J PLANT SCI, V166, P493, DOI 10.1086/428758; Bittencourt NS, 2003, ANN BOT-LONDON, V91, P827, DOI 10.1093/aob/mcg088; BROYLES SB, 1993, AM J BOT, V80, P41, DOI 10.2307/2445118; Bryndum K., 1969, Silvae Genetica, V18, P77; Cao HJ, 1965, ACTA BOT SIN, V13, P44; Chai LJ, 2011, PLANT CELL TISS ORG, V104, P1, DOI 10.1007/s11240-010-9793-6; Chen X, 2012, BIOLOGIA, V67, P347, DOI 10.2478/s11756-012-0018-9; Chung Jeng-Der, 2005, Taiwan Journal of Forest Science, V20, P315; COPE FW, 1962, HEREDITY, V17, P157, DOI 10.1038/hdy.1962.14; de Nettancourt D., 1977, INCOMPATIBILITY ANGI; deNettancourt D, 1997, SEX PLANT REPROD, V10, P185, DOI 10.1007/s004970050087; Deng YY, 2009, THESIS CENTRAL S U F; DUMAS C, 1983, THEOR APPL GENET, V67, P1, DOI 10.1007/BF00303914; Franklin-Tong VE, 2003, PHILOS T R SOC B, V358, P1025, DOI 10.1098/rstb.2003.1287; Gibbs PE, 1999, ANN BOT-LONDON, V84, P449, DOI 10.1006/anbo.1999.0933; GIBBS PE, 1993, BOT ACTA, V106, P64, DOI 10.1111/j.1438-8677.1993.tb00339.x; He C.Y, 2009, THESIS CENTRAL S U F; HERRERO M, 1987, ANN BOT-LONDON, V60, P287, DOI 10.1093/oxfordjournals.aob.a087446; HERRERO M, 1989, AM J BOT, V76, P1441, DOI 10.2307/2444430; HIRATSUKA S, 1987, PLANT CELL PHYSIOL, V28, P293; Hiscock SJ, 2003, TRENDS PLANT SCI, V8, P606, DOI 10.1016/j.tplants.2003.10.007; Hsu Hsin-Wu, 2002, Taiwan Journal of Forest Science, V17, P241; HUSBAND BC, 1995, HEREDITY, V75, P206, DOI 10.1038/hdy.1995.125; HWANG YJ, 1992, J JPN SOC HORTIC SCI, V60, P955, DOI 10.2503/jjshs.60.955; Jiang CJ, 1987, J TEA SCI, V7, P23; KENRICK J, 1986, PLANTA, V169, P245, DOI 10.1007/BF00392321; Koehl V., 2002, THESIS U TORONTO TOR; Lewis G, 1999, PLANT SYST EVOL, V217, P43, DOI 10.1007/BF00984921; [李春林 LI Chunlin], 2011, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V33, P242; [廖婷 Liao Ting], 2012, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V32, P34; Liu ZS, 1987, J TEA SCI, V7, P19; Luo Xiao-ying, 2011, Shengtaixue Zazhi, V30, P552; Mahy G, 1999, ANN BOT-LONDON, V83, P697, DOI 10.1006/anbo.1999.0874; MARTIN FW, 1959, STAIN TECHNOL, V34, P125, DOI 10.3109/10520295909114663; Nettancourt, 2001, INCOMPATIBILITY INCO; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; ONeill SD, 1997, ANNU REV PLANT PHYS, V48, P547, DOI 10.1146/annurev.arplant.48.1.547; PIMIENTA E, 1982, AM J BOT, V69, P913, DOI 10.2307/2442888; PIMIENTA E, 1983, ANN BOT, V71, P469; Pontieri V, 1999, ANN BOT-LONDON, V84, P507, DOI 10.1006/anbo.1999.0947; Pound LM, 2003, SEX PLANT REPROD, V16, P59, DOI 10.1007/s00497-003-0175-7; Pound LM, 2002, ANN BOT-LONDON, V89, P613, DOI 10.1093/aob/mcf089; Rodriguez-Riano T, 1999, CAN J BOT, V77, P809, DOI 10.1139/cjb-77-6-809; Sage TL, 2006, AM J BOT, V93, P254, DOI 10.3732/ajb.93.2.254; Sage TL, 1999, AM J BOT, V86, P855, DOI 10.2307/2656706; Sage TL, 2003, ANN BOT-LONDON, V91, P807, DOI 10.1093/aob/mcg085; SEAVEY SR, 1994, AM J BOT, V81, P331, DOI 10.2307/2445460; SEAVEY SR, 1986, BOT REV, V52, P195, DOI 10.1007/BF02861001; SEKHAR KNC, 1995, SEX PLANT REPROD, V8, P369; SETHI S. BALA, 1965, PROC NAT INST SCI INDIA PART B [BIOL SCI], V31, P24; Silva NF, 2001, CELL MOL LIFE SCI, V58, P1988, DOI 10.1007/PL00000832; STEPHENSON AG, 1981, ANNU REV ECOL SYST, V12, P253, DOI 10.1146/annurev.es.12.110181.001345; Stephenson AG, 2000, ANN BOT-LONDON, V85, P211, DOI 10.1006/anbo.1999.1033; Tan XiaoFeng, 2010, Journal of Zhejiang Forestry College, V27, P941; Tangmitcharoen S, 1997, ANN BOT-LONDON, V80, P401, DOI 10.1006/anbo.1996.0440; Valtuena FJ, 2010, AM J BOT, V97, P123, DOI 10.3732/ajb.0800332; Vaughton G, 2010, ANN BOT-LONDON, V106, P547, DOI 10.1093/aob/mcq149; Vishnyakova M. A., 1991, Phytomorphology, V41, P245; Wachira FN, 2005, J HORTIC SCI BIOTECH, V80, P716, DOI 10.1080/14620316.2005.11512004; Wang XiangNan, 2008, Scientia Silvae Sinicae, V44, P173; Wang Yu, 2008, Journal of Tea Science, V28, P429; WASER NM, 1986, OECOLOGIA, V70, P573, DOI 10.1007/BF00379906; WASER NM, 1991, AM J BOT, V78, P1036, DOI 10.2307/2444892; Yang MZ, 2000, CHINESE HORTICULTURE, V46, P83; Yuan D.Y, 2011, J CENTRAL S U FOR TE, V31, P15; Yuan DeYi, 2010, Journal of Fujian Agriculture and Forestry University (Natural Science Edition), V39, P471; ZAPATA TR, 1978, BIOTROPICA, V10, P221, DOI 10.2307/2387907; Zhou QY, 2012, PLANT SYST EVOL, V298, P457, DOI 10.1007/s00606-011-0558-4; Zhuang R.L, 2008, CAMELLIA OLEIFERA, V2nd ed.	71	36	42	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99639	10.1371/journal.pone.0099639	http://dx.doi.org/10.1371/journal.pone.0099639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926879	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100058
J	Vidal-Castineira, JR; Lopez-Vazquez, A; Martinez-Borra, J; Martinez-Camblor, P; Prieto, J; Lopez-Rodriguez, R; Sanz-Cameno, P; de la Vega, J; Rodrigo, L; Perez-Lopez, R; Perez-Alvarez, R; Lopez-Larrea, C				Ramon Vidal-Castineira, Jose; Lopez-Vazquez, Antonio; Martinez-Borra, Jesus; Martinez-Camblor, Pablo; Prieto, Jesus; Lopez-Rodriguez, Rosario; Sanz-Cameno, Paloma; de la Vega, Juan; Rodrigo, Luis; Perez-Lopez, Rosa; Perez-Alvarez, Ramon; Lopez-Larrea, Carlos			Diversity of Killer Cell Immunoglobulin-Like Receptor (KIR) Genotypes and KIR2DL2/3 Variants in HCV Treatment Outcome	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; MHC CLASS-I; HLA-C; GENE DIVERSITY; HAPLOTYPES CONTAIN; ASSOCIATION; EXPRESSION; CLEARANCE; ALLELES; IL28B	The aim of this study was to analyse the distribution of KIR haplotypes and the KIR2DL2/3 alleles in chronic HCV-infected patients in order to establish the influence on the response to pegylated interferon plus ribavirin classical treatment. The alleles study of previously associated KIR2DL2/3 showed that KIR2DL2*001 was more frequent in non-SVR (NSVR) (42.2% vs. 27.5%, p<0.05) and KIR2DL3*001 was associated with sustained viral response (SVR) (41.6% vs. 61.2%, p<0.005). The KIR2DL3*001-HLA-C1 association was also significant (24.5% vs. 45.7%, p<0.001). From the frequencies of KIR obtained, 35 genotypes were assigned on the basis of previous studies. The centromeric A/A genotype was more frequent in SVR (44.1% vs. 34.5%, p<0.005) and the centromeric B/B genotype was found to be significantly more frequent in NSVR (20.9% vs. 11.2%, p<0.001). The logic regression model showed the importance of KIR genes in predicting the response to combined treatment, since the positive predictive value (PPV) was improved (from 55.9% to 75.3%) when the analysis of KIR was included in addition to the IFNL3 rs12979860 polymorphism. The study of KIR receptors may be a powerful tool for predicting the combined treatment response in patients with chronic HCV infection in association with the determination of IFNL3 polymorphism.	[Ramon Vidal-Castineira, Jose; Lopez-Vazquez, Antonio; Martinez-Borra, Jesus; Lopez-Larrea, Carlos] Hosp Univ Cent Asturias, Serv Immunol, Oviedo, Spain; [Martinez-Camblor, Pablo] OIB, Oviedo, Spain; [Prieto, Jesus] Univ Navarra, Univ Navarra Clin, Liver Unit, E-31080 Pamplona, Spain; [Prieto, Jesus] Univ Navarra, Univ Navarra Clin, Div Hepatol & Gene Therapy, E-31080 Pamplona, Spain; [Lopez-Rodriguez, Rosario; Sanz-Cameno, Paloma] Univ Autonoma Madrid, Inst Invest Sanitaria Princesa IIS IP, Hosp Univ Princesa, Liver Unit,Gastroenterol Serv, Madrid, Spain; [Lopez-Rodriguez, Rosario; Sanz-Cameno, Paloma] Inst Salud Carlos III, CIBERehd, Madrid, Spain; [de la Vega, Juan] Hosp San Agustin, Gastroenterol Serv, Aviles, Spain; [Rodrigo, Luis; Perez-Lopez, Rosa; Perez-Alvarez, Ramon] Hosp Univ Cent Asturias, Gastroenterol Serv, Oviedo, Spain; [Lopez-Larrea, Carlos] Fdn Renal Inigo Alvarez Toledo, Madrid, Spain	Central University Hospital Asturias; University of Navarra; University of Navarra; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Hospital San Agustin; Central University Hospital Asturias	Lopez-Larrea, C (corresponding author), Hosp Univ Cent Asturias, Serv Immunol, Oviedo, Spain.	inmuno@hca.es	Rodrigo, Luis/A-6278-2010; Sanz, Paloma/C-7799-2014; Camblor, Pablo Martinez/Z-4834-2019; Lopez-Rodriguez, Rosario/M-3381-2014; Martinez-Camblor, Pablo/Q-1715-2015; López-Rodríguez, Rosario/AAB-2290-2022; RG, SMABSS/N-3322-2018	Rodrigo, Luis/0000-0003-1717-9345; Camblor, Pablo Martinez/0000-0001-7845-3905; Lopez-Rodriguez, Rosario/0000-0002-4713-0633; López-Rodríguez, Rosario/0000-0002-4713-0633; Vidal-Castineira, Jose Ramon/0000-0003-4877-3566; RG, SMABSS/0000-0001-9944-3861; Lopez-Larrea, Carlos/0000-0001-9988-1730; Prieto, Jesus/0000-0002-1091-9593; Research Group, SMIRE+CoDiRE/0000-0002-8871-4942	Spanish grant from the Instituto de Salud Carlos III [PI12-02587]; RETICS REDiNREN from the Instituto de Salud Carlos III [RD12/0021/0021]; European Union "Fondos FEDER''	Spanish grant from the Instituto de Salud Carlos III(Instituto de Salud Carlos III); RETICS REDiNREN from the Instituto de Salud Carlos III(Instituto de Salud Carlos III); European Union "Fondos FEDER''	Supported by Spanish grant PI12-02587 from the Instituto de Salud Carlos III, RETICS REDiNREN (RD12/0021/0021) from the Instituto de Salud Carlos III and by European Union "Fondos FEDER''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Askar M, 2009, LIVER TRANSPLANT, V15, P1557, DOI 10.1002/lt.21878; Bjorkstrom NK, 2012, BLOOD, V120, P3455, DOI 10.1182/blood-2012-03-416867; Bryceson YT, 2011, J INNATE IMMUN, V3, P216, DOI 10.1159/000325265; Chazara O, 2011, J LEUKOCYTE BIOL, V90, P703, DOI 10.1189/jlb.0511227; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Clausen J, 2012, BONE MARROW TRANSPL, V47, P791, DOI 10.1038/bmt.2011.187; Deng L, 2006, SEMIN IMMUNOL, V18, P159, DOI 10.1016/j.smim.2006.03.004; Diaz-Pena R, 2010, ARTHRITIS RHEUM-US, V62, P1000, DOI 10.1002/art.27332; Dring MM, 2011, P NATL ACAD SCI USA, V108, P5736, DOI 10.1073/pnas.1016358108; Fadda L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002805; Farnik H, 2010, CLIN GASTROENTEROL H, V8, P884, DOI 10.1016/j.cgh.2010.06.019; Faure M, 2002, J IMMUNOL, V168, P6208, DOI 10.4049/jimmunol.168.12.6208; Gallez-Hawkins GM, 2011, BIOL BLOOD MARROW TR, V17, P1662, DOI 10.1016/j.bbmt.2011.04.008; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gomez-Lozano N, 2002, TISSUE ANTIGENS, V59, P184, DOI 10.1034/j.1399-0039.2002.590302.x; Gomez-Lozano N, 2002, IMMUNOGENETICS, V54, P314, DOI 10.1007/s00251-002-0476-2; Gonzalez A, 2008, TISSUE ANTIGENS, V72, P11, DOI 10.1111/j.1399-0039.2008.01050.x; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Hirayasu K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002565; Hsu KC, 2002, J IMMUNOL, V169, P5118, DOI 10.4049/jimmunol.169.9.5118; Hsu KC, 2002, IMMUNOL REV, V190, P40, DOI 10.1034/j.1600-065X.2002.19004.x; Jiang W, 2012, GENOME RES, V22, P1845, DOI 10.1101/gr.137976.112; Jobim M, 2010, INT J IMMUNOGENET, V37, P83, DOI 10.1111/j.1744-313X.2009.00894.x; Jost S, 2013, ANNU REV IMMUNOL, V31, P163, DOI 10.1146/annurev-immunol-032712-100001; Keaney L, 2004, TISSUE ANTIGENS, V64, P188, DOI 10.1111/j.1399-0039.2004.00263.x; Kikuchi-Maki A, 2005, J IMMUNOL, V174, P3859, DOI 10.4049/jimmunol.174.7.3859; Knapp S, 2010, HEPATOLOGY, V51, P1168, DOI 10.1002/hep.23477; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lopez-Rodriguez R, 2011, CLIN PHARMACOL THER, V90, P712, DOI 10.1038/clpt.2011.189; Lopez-Vazquez A, 2005, J INFECT DIS, V192, P162, DOI 10.1086/430351; Lu ZM, 2008, CELL MOL IMMUNOL, V5, P457, DOI 10.1038/cmi.2008.57; Martinez-Camblor P, 2012, J STAT PLAN INFER, V142, P589, DOI 10.1016/j.jspi.2011.09.003; McKiernan SM, 2004, HEPATOLOGY, V40, P108, DOI 10.1002/hep.20261; Middleton D, 2007, HUM IMMUNOL, V68, P128, DOI 10.1016/j.humimm.2006.12.007; Middleton D, 2010, IMMUNOLOGY, V129, P8, DOI 10.1111/j.1365-2567.2009.03208.x; Moesta AK, 2008, J IMMUNOL, V180, P3969, DOI 10.4049/jimmunol.180.6.3969; Nozawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083381; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Passweg JR, 2007, TRENDS IMMUNOL, V28, P437, DOI 10.1016/j.it.2007.07.008; Piasecki BA, 2004, HEPATOLOGY, V40, P892, DOI [10.1002/hep.20384, 10.1002/hep.1840400419]; Pyo CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015115; Rajagopalan S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00258; Rajalingam R, 2008, IMMUNOGENETICS, V60, P207, DOI 10.1007/s00251-008-0286-2; Vidal-Castineira JR, 2012, J HEPATOL, V56, P1230, DOI 10.1016/j.jhep.2012.01.011; Ruczinski I, 2003, J COMPUT GRAPH STAT, V12, P475, DOI 10.1198/1061860032238; Suppiah V, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001092; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Tseng KC, 2013, HUM IMMUNOL, V74, P978, DOI 10.1016/j.humimm.2013.04.023; Uhrberg M, 2002, IMMUNOGENETICS, V54, P221, DOI 10.1007/s00251-002-0463-7; van Bergen J, 2011, AM J TRANSPLANT, V11, P1959, DOI 10.1111/j.1600-6143.2011.03621.x; Vidal-Castineira JR, 2010, J VIROL, V84, P475, DOI 10.1128/JVI.01285-09; Vierra-Green C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047491; Winter CC, 1998, J IMMUNOL, V161, P571	56	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99426	10.1371/journal.pone.0099426	http://dx.doi.org/10.1371/journal.pone.0099426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927414	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100039
J	Akalay, I; Tan, TZ; Kumar, P; Janji, B; Mami-Chouaib, F; Charpy, C; Vielh, P; Larsen, AK; Thiery, JP; Sabbah, M; Chouaib, S				Akalay, I.; Tan, T. Z.; Kumar, P.; Janji, B.; Mami-Chouaib, F.; Charpy, C.; Vielh, P.; Larsen, A. K.; Thiery, J. P.; Sabbah, M.; Chouaib, S.			Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CTL-MEDIATED LYSIS; INVASIVE PHENOTYPES; IMMUNE SURVEILLANCE; TUMOR; INHIBITION; SUPPRESSES; GENERATION; INDUCTION; ESCAPE	The molecular basis for the resistance of tumor cells to cell-mediated cytotoxicity remains poorly understood and thus poses a major challenge for cancer immunotherapy. The present study was designed to determine whether the WNT1-inducible signaling pathway protein 2 (WISP2, also referred to as CCN5), a key regulator of tumor cell plasticity, interferes with tumor susceptibility to cytotoxic T-lymphocyte (CTL)-mediated lysis. We found that silencing WISP2 signaling in human breast adenocarcinoma MCF7 cells impairs CTL-mediated cell killing by a mechanism involving stem cell marker Kruppel-like factor-4 (KLF-4) induction and microRNA-7 (miR-7) downregulation. Inhibition of transforming growth factor beta (TGF-beta) signaling using the A83-01 inhibitor in MCF7-shWISP2 cells resulted in a significant reversal of the epithelial-to-mesenchymal-transitioned (EMT) phenotype, the expression of KLF-4 and a partial recovery of target susceptibility to CTLs. More importantly, we showed that silencing KLF-4 was accompanied by a reduction in MCF7-shWISP2 resistance to CTLs. Using human breast cancer tissues, we demonstrated the coexpression of KLF-beta with EMT markers and TGF-beta pathway signaling components. More importantly, we found that KLF-4 expression was accompanied by miR-7 inhibition, which is partly responsible for impairing CTL-mediated lysis. Thus, our data indicate that WISP2 has a role in regulating tumor cell susceptibility through EMT by inducing the TGF-beta signaling pathway, KLF-4 expression and miR-7 inhibition. These studies indicate for the first time that WISP2 acts as an activator of CTL-induced killing and suggests that the loss of its function promotes evasion of immunosurveillance and the ensuing progression of the tumor.	[Akalay, I.; Mami-Chouaib, F.; Chouaib, S.] Inst Gustave Roussy, INSERM, U753, F-94805 Villejuif, France; [Tan, T. Z.; Kumar, P.; Thiery, J. P.] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Janji, B.] Publ Res Ctr Hlth CRP Sante, Dept Oncol, Lab Expt Hematooncol, Luxembourg, Luxembourg; [Charpy, C.; Vielh, P.] Inst Cancerol Gustave Roussy, Lab Rech Translat Module Histocytopathol, Villejuif, France; [Charpy, C.; Vielh, P.] Inst Cancerol Gustave Roussy, Ctr Ressources Biol, Villejuif, France; [Larsen, A. K.; Sabbah, M.] INSERM, U938, Lab Canc Biol & Therapeut, Ctr Rech St Antoine, Paris, France; [Larsen, A. K.; Sabbah, M.] Univ Paris 06, Paris, France; [Thiery, J. P.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Thiery, J. P.] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Luxembourg Institute of Health; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; National University of Singapore; National University of Singapore	Chouaib, S (corresponding author), Inst Gustave Roussy, INSERM, U753, 114 Rue Edouard Vaillant, F-94805 Villejuif, France.	Salem.CHOUAIB@gustaveroussy.fr	Mami-Chouaib, Fathia/E-5267-2016; Tan, Tuan Zea/I-9227-2019; Sabbah, Michèle/GSN-8858-2022; Thiery, Jean Paul/M-9387-2019; Chouaib, Salem/F-7939-2016; Thiery, Jean Paul/H-1550-2011	Tan, Tuan Zea/0000-0001-6624-1593; Sabbah, Michèle/0000-0001-5368-9022; Thiery, Jean Paul/0000-0003-0478-5020; , Dr. Prashant Kumar/0000-0001-8975-5108; JANJI, Bassam/0000-0002-9763-0943	INSERM; la Ligue Nationale Contre le Cancer; l'Association de Recherche sur le Cancer; A*STAR Institute of Molecular Cell Biology; Cancer Science Institute National University of Singapore; CRP-Sante; Fondation Cancer, Luxembourg	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); la Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); l'Association de Recherche sur le Cancer; A*STAR Institute of Molecular Cell Biology(Agency for Science Technology & Research (A*STAR)); Cancer Science Institute National University of Singapore(National University of Singapore); CRP-Sante; Fondation Cancer, Luxembourg	This work was supported by grants from INSERM, la Ligue Nationale Contre le Cancer, l'Association de Recherche sur le Cancer, A*STAR Institute of Molecular Cell Biology, Cancer Science Institute National University of Singapore core grants, CRP-Sante and Fondation Cancer, Luxembourg.	Akalay I, 2013, AUTOPHAGY, V9, P1104, DOI 10.4161/auto.24728; Akalay I, 2013, CANCER RES, V73, P2418, DOI 10.1158/0008-5472.CAN-12-2432; Anichini A, 1999, J EXP MED, V190, P651, DOI 10.1084/jem.190.5.651; Banerjee S, 2003, NEOPLASIA, V5, P63, DOI 10.1016/S1476-5586(03)80018-0; Banerjee S, 2008, CANCER RES, V68, P7606, DOI 10.1158/0008-5472.CAN-08-1461; Chouaib S, 2003, J CLIN INVEST, V111, P595, DOI 10.1172/JCI200318044; Dhar G, 2008, CANCER RES, V68, P4580, DOI 10.1158/0008-5472.CAN-08-0316; Dorothee G, 2003, ONCOGENE, V22, P7192, DOI 10.1038/sj.onc.1206627; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; El Hage F, 2008, P NATL ACAD SCI USA, V105, P10119, DOI 10.1073/pnas.0802753105; El-Karim EA, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-89; Fang YX, 2012, HEPATOLOGY, V55, P1852, DOI 10.1002/hep.25576; Frewer KA, 2013, BRIT J SURG, V100, P10; Fritah A, 2008, MOL CELL BIOL, V28, P1114, DOI 10.1128/MCB.01335-07; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; Giles KM, 2013, BIOCHEM BIOPH RES CO, V430, P706, DOI 10.1016/j.bbrc.2012.11.086; Hamai A, 2010, TISSUE ANTIGENS, V75, P1, DOI 10.1111/j.1399-0039.2009.01401.x; Hasmim M, 2011, J IMMUNOL, V187, P4031, DOI 10.4049/jimmunol.1101011; Holzel M, 2013, NAT REV CANCER, V13, P365, DOI 10.1038/nrc3498; Hu D, 2011, J BIOL CHEM, V286, P6890, DOI 10.1074/jbc.M110.179952; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liu YN, 2012, MOL CELL BIOL, V32, P941, DOI 10.1128/MCB.06306-11; Magnon C, 2007, J CLIN INVEST, V117, P1844, DOI 10.1172/JCI30269; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mohammad KS, 2011, CANCER RES, V71, P175, DOI 10.1158/0008-5472.CAN-10-2651; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Okuda H, 2013, CANCER RES, V73, P1434, DOI 10.1158/0008-5472.CAN-12-2037; Rebucci M, 2013, BIOCHEM PHARMACOL, V85, P1219, DOI 10.1016/j.bcp.2013.02.017; Reiman JM, 2010, CANCER RES, V70, P3005, DOI 10.1158/0008-5472.CAN-09-4041; Sabbah M, 2011, MOL CELL BIOL, V31, P1459, DOI 10.1128/MCB.01316-10; Shekhani MT, 2013, AM J STEM CELLS, V2, P52; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang L, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt96; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang YZ, 2005, CANCER BIOL THER, V4, P1216, DOI 10.4161/cbt.4.11.2090; Zhang XH, 2012, ARTERIOSCL THROM VAS, V32, P1015, DOI 10.1161/ATVBAHA.111.244962	39	49	49	4	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 23	2015	34	17					2261	2271		10.1038/onc.2014.151	http://dx.doi.org/10.1038/onc.2014.151			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CG7HG	24931170				2022-12-25	WOS:000353473000011
J	Sausgruber, N; Coissieux, MM; Britschgi, A; Wyckoff, J; Aceto, N; Leroy, C; Stadler, MB; Voshol, H; Bonenfant, D; Bentires-Alj, M				Sausgruber, N.; Coissieux, M-M; Britschgi, A.; Wyckoff, J.; Aceto, N.; Leroy, C.; Stadler, M. B.; Voshol, H.; Bonenfant, D.; Bentires-Alj, M.			Tyrosine phosphatase SHP2 increases cell motility in triple-negative breast cancer through the activation of SRC-family kinases	ONCOGENE			English	Article							FOCAL ADHESION KINASE; GROWTH-FACTOR; IN-VIVO; C-SRC; MIGRATION; PAXILLIN; PHOSPHORYLATION; METASTASIS; TUMORS; DEPHOSPHORYLATION	Tumor cell migration has a fundamental role in early steps of metastasis, the fatal hallmark of cancer. In the present study, we investigated the effects of the tyrosine phosphatase, SRC-homology 2 domain-containing phosphatase 2 (SHP2), on cell migration in metastatic triple-negative breast cancer (TNBC), an aggressive disease associated with a poor prognosis for which a targeted therapy is not yet available. Using mouse models and multiphoton intravital imaging, we have identified a crucial effect of SHP2 on TNBC cell motility in vivo. Further, analysis of TNBC cells revealed that SHP2 also influences cell migration, chemotaxis and invasion in vitro. Unbiased phosphoproteomics and biochemical analysis showed that SHP2 activates several SRC-family kinases and downstream targets, most of which are inducers of migration and invasion. In particular, direct interaction between SHP2 and c-SRC was revealed by a fluorescence resonance energy transfer assay. These results suggest that SHP2 is a crucial factor during early steps of TNBC migration to distant organs.	[Sausgruber, N.; Coissieux, M-M; Britschgi, A.; Wyckoff, J.; Aceto, N.; Leroy, C.; Stadler, M. B.; Bentires-Alj, M.] Friedrich Miescher Inst FMI Biomed Res, Mechanisms Canc, CH-4058 Basel, Switzerland; [Wyckoff, J.] MIT, Koch Inst Integrated Canc Res, Cambridge, MA 02139 USA; [Aceto, N.] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA; [Leroy, C.; Voshol, H.; Bonenfant, D.] Novartis Inst Biomed Res, Analyt Sci & Imaging, Basel, Switzerland; [Stadler, M. B.] Swiss Inst Bioinformat, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Novartis; Swiss Institute of Bioinformatics	Bentires-Alj, M (corresponding author), Friedrich Miescher Inst FMI Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	bentires@fmi.ch	Mohamed, Bentires-Alj/F-4484-2015; Aceto, Nicola/O-2484-2014	Mohamed, Bentires-Alj/0000-0001-6344-1127; Aceto, Nicola/0000-0001-9579-6918; Coissieux, Marie-May/0000-0001-5017-5253	FP7 Marie-Curie Fellowship; Novartis Research Foundation; European Research Council (ERC starting grant) [243211-PTPsBDC]; Swiss Cancer League; Krebsliga Beider Basel	FP7 Marie-Curie Fellowship; Novartis Research Foundation; European Research Council (ERC starting grant)(European Research Council (ERC)); Swiss Cancer League; Krebsliga Beider Basel	We thank C Kuperwasser for the SUM159 cells and S Gambhir for the pFU-Luc2-eGFP construct, L Bonapace for technical assistance with the intravital microscope, L Gelman for help with the FRET experiments, S Bourke and M Kirschmann for help with image acquisition and analysis, and I Klebba and H Brinkhaus for technical assistance. M-MC is supported by a FP7 Marie-Curie Fellowship and NA is a fellow of the Swiss National Science Foundation and the Human Frontiers Science Program. Research in the laboratory of MB-A is supported by the Novartis Research Foundation, the European Research Council (ERC starting grant 243211-PTPsBDC), the Swiss Cancer League and the Krebsliga Beider Basel.	Aceto N, 2012, NAT MED, V18, P529, DOI 10.1038/nm.2645; Bonapace L, 2012, J MAMMARY GLAND BIOL, V17, P125, DOI 10.1007/s10911-012-9250-8; Britschgi A, 2012, CANCER CELL, V22, P796, DOI 10.1016/j.ccr.2012.10.023; Dey JH, 2010, CANCER RES, V70, P4151, DOI 10.1158/0008-5472.CAN-09-4479; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Hartman ZR, 2013, MOL CANCER RES, V11, P651, DOI 10.1158/1541-7786.MCR-12-0578; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Iwasaki T, 2002, INT J CANCER, V97, P330, DOI 10.1002/ijc.1609; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Manes S, 1999, MOL CELL BIOL, V19, P3125; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Nakamura K, 2000, J BIOL CHEM, V275, P27155; Patsialou A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3344; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; PENG ZY, 1995, ONCOGENE, V11, P1955; Perou CM, 2010, ONCOLOGIST, V15, P39, DOI 10.1634/theoncologist.2010-S5-39; Ren Y, 2004, J BIOL CHEM, V279, P8497, DOI 10.1074/jbc.M312575200; Roof RW, 1998, MOL CELL BIOL, V18, P7052, DOI 10.1128/MCB.18.12.7052; Sachdev S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-12; Sanders MA, 2005, J BIOL CHEM, V280, P23516, DOI 10.1074/jbc.M413165200; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Wang FM, 2005, BREAST CANCER RES TR, V89, P5, DOI 10.1007/s10549-004-1002-z; Wang WG, 2002, CANCER RES, V62, P6278; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; Zomer A, 2011, CLIN TRANSL ONCOL, V13, P848, DOI 10.1007/s12094-011-0745-3	29	46	46	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 23	2015	34	17					2272	2278		10.1038/onc.2014.170	http://dx.doi.org/10.1038/onc.2014.170			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CG7HG	24931162				2022-12-25	WOS:000353473000012
J	Ilinykh, PA; Tigabu, B; Ivanov, A; Ammosova, T; Obukhov, Y; Garron, T; Kumari, N; Kovalskyy, D; Platonov, MO; Naumchik, VS; Freiberg, AN; Nekhai, S; Bukreyev, A				Ilinykh, Philipp A.; Tigabu, Bersabeh; Ivanov, Andrey; Ammosova, Tatiana; Obukhov, Yuri; Garron, Tania; Kumari, Namita; Kovalskyy, Dmytro; Platonov, Maxim O.; Naumchik, Vasiliy S.; Freiberg, Alexander N.; Nekhai, Sergei; Bukreyev, Alexander			Role of Protein Phosphatase 1 in Dephosphorylation of Ebola Virus VP30 Protein and Its Targeting for the Inhibition of Viral Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY SYNCYTIAL VIRUS; MARBURG-VIRUS; MESSENGER-RNA; P-PROTEIN; ELONGATION-FACTOR; SPLICING FACTOR; PHOSPHORYLATION; REPLICATION; SEQUENCE; COMPLEX	The filovirus Ebola (EBOV) causes the most severe hemorrhagic fever known. The EBOV RNA-dependent polymerase complex includes a filovirus-specific VP30, which is critical for the transcriptional but not replication activity of EBOV polymerase; to support transcription, VP30 must be in a dephosphorylated form. Here we show that EBOV VP30 is phosphorylated not only at the N-terminal serine clusters identified previously but also at the threonine residues at positions 143 and 146. We also show that host cell protein phosphatase 1 (PP1) controls VP30 dephosphorylation because expression of a PP1-binding peptide cdNIPP1 increased VP30 phosphorylation. Moreover, targeting PP1 mRNA by shRNA resulted in the overexpression of SIPP1, a cytoplasm-shuttling regulatory subunit of PP1, and increased EBOV transcription, suggesting that cytoplasmic accumulation of PP1 induces EBOV transcription. Furthermore, we developed a small molecule compound, 1E7-03, that targeted a non-catalytic site of PP1 and increased VP30 dephosphorylation. The compound inhibited the transcription but increased replication of the viral genome and completely suppressed replication of EBOV in cultured cells. Finally, mutations of Thr(143) and Thr(146) of VP30 significantly inhibited EBOV transcription and strongly induced VP30 phosphorylation in the N-terminal Ser residues 29-46, suggesting a novel mechanism of regulation of VP30 phosphorylation. Our findings suggest that targeting PP1 with small molecules is a feasible approach to achieve dysregulation of the EBOV polymerase activity. This novel approach may be used for the development of antivirals against EBOV and other filovirus species.	[Ilinykh, Philipp A.; Tigabu, Bersabeh; Garron, Tania; Freiberg, Alexander N.; Bukreyev, Alexander] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Garron, Tania; Bukreyev, Alexander] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Ilinykh, Philipp A.; Tigabu, Bersabeh; Garron, Tania; Freiberg, Alexander N.; Bukreyev, Alexander] Galveston Natl Lab, Galveston, TX 77555 USA; [Ivanov, Andrey; Ammosova, Tatiana; Obukhov, Yuri; Kumari, Namita; Nekhai, Sergei] Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20059 USA; [Ammosova, Tatiana; Nekhai, Sergei] Howard Univ, Dept Med, Washington, DC 20059 USA; [Nekhai, Sergei] Howard Univ, Dept Microbiol, Washington, DC 20059 USA; [Kovalskyy, Dmytro; Platonov, Maxim O.; Naumchik, Vasiliy S.] Kiev Natl Taras Shevchenko Univ, UA-01601 Kiev, Ukraine; [Kovalskyy, Dmytro; Platonov, Maxim O.; Naumchik, Vasiliy S.] Enamine Ltd, UA-01103 Kiev, Ukraine	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Howard University; Howard University; Howard University; Ministry of Education & Science of Ukraine; Taras Shevchenko National University Kiev; Enamine Ltd	Nekhai, S (corresponding author), Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20059 USA.	snekhai@howard.edu; alexander.bukreyev@utmb.edu	Ilinykh, Philipp/L-5404-2014; , nekhai/AFO-2652-2022; Platonov, Maxim/D-3238-2015; Ammosova, Tatiana/J-7564-2018; Ammosova, Tatiana/HIA-0704-2022; , nekhai/AAW-3105-2021	Platonov, Maxim/0000-0002-3205-3305; Ammosova, Tatiana/0000-0001-8777-1032; Freiberg, Alexander N/0000-0001-8413-8960; Kumari, Namita/0000-0003-0893-9939	National Institutes of Health [1 U19 AI109664-01, 1SC1GM082325, 1P50HL118006-01, 8G12MD007597]; departmental start-up grant from the University of Texas Medical Branch; District of Columbia Developmental Center for AIDS Research Grant [P30AI087714]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL118006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI087714, UC7AI094660, U19AI109664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM082325] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); departmental start-up grant from the University of Texas Medical Branch; District of Columbia Developmental Center for AIDS Research Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants 1 U19 AI109664-01 (to A. B.), 1SC1GM082325, 1P50HL118006-01, 8G12MD007597, and 1 U19 AI109664-01(to S. N.). This work was also supported by a departmental start-up grant from the University of Texas Medical Branch (to A. B.) and by District of Columbia Developmental Center for AIDS Research Grant P30AI087714 (to S. N.).	Allen PB, 1998, J BIOL CHEM, V273, P4089, DOI 10.1074/jbc.273.7.4089; Ammosova T, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-47; Ammosova T, 2005, J BIOL CHEM, V280, P36364, DOI 10.1074/jbc.M503673200; Ammosova T, 2003, J BIOL CHEM, V278, P32189, DOI 10.1074/jbc.M300521200; Ammosova T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039481; Ammosova Tatiana, 2011, PLoS One, V6, pe18985, DOI 10.1371/journal.pone.0018985; Ammosova T, 2011, J BIOL CHEM, V286, P3798, DOI 10.1074/jbc.M110.196493; Ammosova T, 2014, BRIT J PHARMACOL, V171, P5059, DOI 10.1111/bph.12863; Asenjo A, 2005, J GEN VIROL, V86, P1109, DOI 10.1099/vir.0.80692-0; Asenjo A, 2006, J GEN VIROL, V87, P3637, DOI 10.1099/vir.0.82165-0; BARIK S, 1992, J VIROL, V66, P1109, DOI 10.1128/JVI.66.2.1109-1118.1992; BARIK S, 1995, VIROLOGY, V213, P405, DOI 10.1006/viro.1995.0013; Bermingham A, 1999, P NATL ACAD SCI USA, V96, P11259, DOI 10.1073/pnas.96.20.11259; Beullens M, 2000, BIOCHEM J, V352, P651, DOI 10.1042/0264-6021:3520651; Biedenkopf N, 2013, J BIOL CHEM, V288, P11165, DOI 10.1074/jbc.M113.461285; Bollen M, 2002, TRENDS CELL BIOL, V12, P138, DOI 10.1016/S0962-8924(01)02247-4; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; BUKREYEV AA, 1995, BIOCHEM MOL BIOL INT, V35, P605; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Centers for Disease Control and Prevention, 2014, OUTBR EB GUIN LIB SI; Collins PL, 1996, P NATL ACAD SCI USA, V93, P81, DOI 10.1073/pnas.93.1.81; COLLINS PL, 1995, P NATL ACAD SCI USA, V92, P11563, DOI 10.1073/pnas.92.25.11563; Dibben O, 2008, VIRUS RES, V131, P47, DOI 10.1016/j.virusres.2007.08.006; Fujiki H., 2009, V46, P221, DOI 10.1007/978-3-540-87895-7_8; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; JAGIELLO I, 1995, J BIOL CHEM, V270, P17257, DOI 10.1074/jbc.270.29.17257; Kuhn J. H., 2008, FILOVIRUSES, P190; Lesage B, 2007, BIOCHEMISTRY-US, V46, P8909, DOI 10.1021/bi7003119; Llorian M, 2005, J BIOL CHEM, V280, P38862, DOI 10.1074/jbc.M509185200; Llorian M, 2004, BIOCHEM J, V378, P229, DOI 10.1042/BJ20030950; Martinez MJ, 2011, J INFECT DIS, V204, pS934, DOI 10.1093/infdis/jir320; Martinez MJ, 2008, J VIROL, V82, P12569, DOI 10.1128/JVI.01395-08; McKimm-Breschkin JL, 2013, INFLUENZA OTHER RESP, V7, P25, DOI 10.1111/irv.12047; Modrof J, 2002, J BIOL CHEM, V277, P33099, DOI 10.1074/jbc.M203775200; Modrof J, 2001, VIROLOGY, V287, P171, DOI 10.1006/viro.2001.1027; Muhlberger E, 1998, J VIROL, V72, P8756; Muhlberger E, 1999, J VIROL, V73, P2333; Muhlberger E, 1996, VIROLOGY, V223, P376, DOI 10.1006/viro.1996.0490; Neumann G, 2002, J VIROL, V76, P406, DOI 10.1128/JVI.76.1.406-410.2002; O'Connell N, 2012, STRUCTURE, V20, P1746, DOI 10.1016/j.str.2012.08.003; SANCHEZ A, 1993, VIRUS RES, V29, P215, DOI 10.1016/0168-1702(93)90063-S; Stittelaar KJ, 2008, ANTIVIR RES, V80, P225, DOI 10.1016/j.antiviral.2008.06.014; Sugaya N, 2010, ANTIMICROB AGENTS CH, V54, P2575, DOI 10.1128/AAC.01755-09; Towner JS, 2005, VIROLOGY, V332, P20, DOI 10.1016/j.virol.2004.10.048; Washington K, 2002, J BIOL CHEM, V277, P40442, DOI 10.1074/jbc.M205687200; Watanabe S, 2007, J INFECT DIS, V196, pS284, DOI 10.1086/520582; Weik M, 2002, J VIROL, V76, P8532, DOI 10.1128/JVI.76.17.8532-8539.2002	48	62	66	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22723	22738		10.1074/jbc.M114.575050	http://dx.doi.org/10.1074/jbc.M114.575050			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24936058	Green Published, hybrid			2022-12-25	WOS:000341017200018
J	Inoue, Y; Hasegawa, S; Ban, S; Yamada, T; Date, Y; Mizutani, H; Nakata, S; Tanaka, M; Hirashima, N				Inoue, Yu; Hasegawa, Seiji; Ban, Sadanori; Yamada, Takaaki; Date, Yasushi; Mizutani, Hiroshi; Nakata, Satoru; Tanaka, Masahiko; Hirashima, Naohide			ZIP2 Protein, a Zinc Transporter, Is Associated with Keratinocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS; IRON; SKIN; TRANSCRIPTION; EXPRESSION; PSORIASIS; CELLS	Zinc is essential for the proper functioning of various enzymes and transcription factors, and its homeostasis is rigorously controlled by zinc transporters (SLC39/ZIP, importers; SLC30/ZnT, exporters). Skin disease is commonly caused by a zinc deficiency. Dietary and inherited zinc deficiencies are known to cause alopecia and the development of vesicular or pustular dermatitis. A previous study demonstrated that zinc played crucial roles in the survival of keratinocytes and their unique functions. High levels of zinc have been detected in the epidermis. Epidermal layers are considered to use a mechanism that preferentially takes in zinc, which is involved with the unique functions of keratinocytes. However, few studies have investigated the ZIP (Zrt- and Irt-like protein) proteins specifically expressed in keratinocytes and their functions. We explored the ZIP proteins specifically expressed in the epidermis and analyzed their functions. Gene expression analysis showed that the expression of ZIP2 was consistently higher in the epidermis than in the dermis. Immunohistochemistry analysis confirmed the expression of ZIP2 in differentiating keratinocytes. The expression of ZIP2 was found to be up-regulated by the differentiation induction of cultured keratinocytes. Intracellular zinc levels were decreased in keratinocytes when ZIP2 was knocked down by siRNA, and this subsequently inhibited the differentiation of keratinocytes. Moreover, we demonstrated that ZIP2 knockdown inhibited the normal formation of a three-dimensional cultured epidermis. Taken together, the results of this study suggest that ZIP2, a zinc transporter expressed specifically in the epidermis, and zinc taken up by ZIP2 are necessary for the differentiation of keratinocytes.	[Inoue, Yu; Hasegawa, Seiji; Ban, Sadanori; Yamada, Takaaki; Date, Yasushi; Mizutani, Hiroshi; Nakata, Satoru] Nippon Menard Cosmet Co Ltd, Res Labs, Nishi Ku, Nagoya, Aichi 4510071, Japan; [Inoue, Yu; Tanaka, Masahiko; Hirashima, Naohide] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Cellular Biophys, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Hasegawa, Seiji; Yamada, Takaaki] Fujita Hlth Univ, Sch Med, Dept Dermatol, Nagoya, Aichi 4701192, Japan; [Yamada, Takaaki] Fujita Hlth Univ, Sch Med, Dept Appl Cell & Regenerat Med, Nagoya, Aichi 4701192, Japan; [Hasegawa, Seiji] Nagoya Univ, Grad Sch Med, Menard Collaborat Res Chair, Showa Ku, Nagoya, Aichi 4668560, Japan	Nagoya City University; Fujita Health University; Fujita Health University; Nagoya University	Inoue, Y (corresponding author), Nippon Menard Cosmet Co Ltd, Res Labs, Nishi Ku, 2-7 Torimicho, Nagoya, Aichi 4510071, Japan.	inoue.yuu@menard.co.jp	Date, Yasushi/C-5349-2016; Hasegawa, Seiji/A-3514-2016	Hasegawa, Seiji/0000-0001-9797-1900; Inoue, Yu/0000-0002-7540-6940				Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Cao J, 2001, J LEUKOCYTE BIOL, V70, P559; Chew YC, 2013, J BIOL CHEM, V288, P17759, DOI 10.1074/jbc.M113.477133; Deters A, 2003, FORSCH KOMP KLAS NAT, V10, P19, DOI 10.1159/000069903; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; HODGE L, 1977, DRUGS, V13, P288, DOI 10.2165/00003495-197713040-00004; HOFFBRAND AV, 1976, BRIT J HAEMATOL, V33, P517, DOI 10.1111/j.1365-2141.1976.tb03570.x; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kodera H, 2008, ANAL SCI, V24, P1545, DOI 10.2116/analsci.24.1545; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; MICHAELSSON G, 1980, ACTA DERM-VENEREOL, V60, P295; Peters JL, 2007, GENESIS, V45, P339, DOI 10.1002/dvg.20297; Pinheiro T, 2014, ACTA DERM-VENEREOL, V94, P14, DOI 10.2340/00015555-1601; Rezaei KA, 2008, INVEST OPHTH VIS SCI, V49, P1665, DOI 10.1167/iovs.07-0959; SAKAMOTO M, 1980, BIOCHIM BIOPHYS ACTA, V624, P205, DOI 10.1016/0005-2795(80)90239-1; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Stork CJ, 2010, INT J MOL MED, V26, P463, DOI 10.3892/ijmm_00000486; SUN TT, 1979, P NATL ACAD SCI USA, V76, P2813, DOI 10.1073/pnas.76.6.2813; Underwood EJ, 1977, TRACE ELEMENTS HUMAN, P196; VOORHEES JJ, 1977, ANNU REV MED, V28, P467, DOI 10.1146/annurev.me.28.020177.002343; Wilson D, 2006, IMMUNOL CELL BIOL, V84, P28, DOI 10.1111/j.1440-1711.2005.01391.x; Xue ML, 2004, EXP CELL RES, V299, P119, DOI 10.1016/j.yexcr.2004.05.015; Yamazaki T, 2004, J BIOL CHEM, V279, P32191, DOI 10.1074/jbc.M404029200; Ylva W., 1998, SCANNING MICROSCOPY, V12, P599	27	45	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21451	21462		10.1074/jbc.M114.560821	http://dx.doi.org/10.1074/jbc.M114.560821			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24936057	Green Published, hybrid			2022-12-25	WOS:000340558300023
J	Kraemer, BR; Snow, JP; Vollbrecht, P; Pathak, A; Valentine, WM; Deutch, AY; Carter, BD				Kraemer, Bradley R.; Snow, John P.; Vollbrecht, Peter; Pathak, Amrita; Valentine, William M.; Deutch, Ariel Y.; Carter, Bruce D.			A Role for the p75 Neurotrophin Receptor in Axonal Degeneration and Apoptosis Induced by Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED INTRAMEMBRANE PROTEOLYSIS; STRIATAL CHOLINERGIC NEURONS; NERVE GROWTH-FACTOR; CELL-DEATH; SYMPATHETIC NEURONS; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; INTRACELLULAR DOMAIN; DOPAMINERGIC-NEURONS; MEDIATED APOPTOSIS	The p75 neurotrophin receptor (p75(NTR)) mediates the death of specific populations of neurons during the development of the nervous system or after cellular injury. The receptor has also been implicated as a contributor to neurodegeneration caused by numerous pathological conditions. Because many of these conditions are associated with increases in reactive oxygen species, we investigated whether p75(NTR) has a role in neurodegeneration in response to oxidative stress. Here we demonstrate that p75(NTR) signaling is activated by 4-hydroxynonenal (HNE), a lipid peroxidation product generated naturally during oxidative stress. Exposure of sympathetic neurons to HNE resulted in neurite degeneration and apoptosis. However, these effects were reduced markedly in neurons from p75(NTR-/-) mice. The neurodegenerative effects of HNE were not associated with production of neurotrophins and were unaffected by pretreatment with a receptor-blocking antibody, suggesting that oxidative stress activates p75(NTR) via a ligand-independent mechanism. Previous studies have established that proteolysis of p75(NTR) by the metalloprotease TNF alpha-converting enzyme and gamma-secretase is necessary for p75(NTR)-mediated apoptotic signaling. Exposure of sympathetic neurons to HNE resulted in metalloprotease- and gamma-secretase-dependent cleavage of p75(NTR). Pharmacological blockade of p75(NTR) proteolysis protected sympathetic neurons from HNE-induced neurite degeneration and apoptosis, suggesting that cleavage of p75(NTR) is necessary for oxidant-induced neurodegeneration. In vivo, p75(NTR-/-) mice exhibited resistance to axonal degeneration associated with oxidative injury following administration of the neurotoxin 6-hydroxydopamine. Together, these data suggest a novel mechanism linking oxidative stress to ligand-independent cleavage of p75(NTR), resulting in axonal fragmentation and neuronal death.	[Kraemer, Bradley R.; Snow, John P.; Pathak, Amrita; Carter, Bruce D.] Vanderbilt Univ, Sch Med, Dept Biochem, Vanderbilt Brain Inst, Nashville, TN 37232 USA; [Vollbrecht, Peter; Deutch, Ariel Y.] Vanderbilt Univ, Sch Med, Dept Psychiat, Vanderbilt Brain Inst, Nashville, TN 37232 USA; [Vollbrecht, Peter; Deutch, Ariel Y.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Vanderbilt Brain Inst, Nashville, TN 37232 USA; [Valentine, William M.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Vanderbilt Brain Inst, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Carter, BD (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 625 Light Hall, Nashville, TN 37232 USA.	bruce.carter@vanderbilt.edu	Pathak, Amrita/O-2363-2019; Pathak, Amrita/AAV-3371-2020; Pathak, Amrita/O-8190-2017	Pathak, Amrita/0000-0003-1396-9868; Pathak, Amrita/0000-0003-1396-9868; Vollbrecht, Peter/0000-0003-4677-3132	National Institutes of Health [R01NS038220, R01MH077298, R01ES019969]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038220] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS038220 (to B. D. C.), R01MH077298 (to A. Y. D.), and R01ES019969 (to W. M. V.).	Alavian KN, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-11; ANGELETTI PU, 1970, P NATL ACAD SCI USA, V65, P114, DOI 10.1073/pnas.65.1.114; Aronica E, 2012, GLIA, V60, P1258, DOI 10.1002/glia.22312; Babetto E, 2013, CELL REP, V3, P1422, DOI 10.1016/j.celrep.2013.04.013; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Bhakar AL, 2003, J NEUROSCI, V23, P11373; Bloch A, 2006, NEUROPATH APPL NEURO, V32, P284, DOI 10.1111/j.1365-2990.2006.00727.x; Bothwell M, 2014, Handb Exp Pharmacol, V220, P3, DOI 10.1007/978-3-642-45106-5_1; Bove J, 2012, NEUROSCIENCE, V211, P51, DOI 10.1016/j.neuroscience.2011.10.057; Brill A, 2009, CARDIOVASC RES, V84, P137, DOI 10.1093/cvr/cvp176; Bruckner SR, 2002, J NEUROSCI RES, V70, P665, DOI 10.1002/jnr.10437; Caldeira GL, 2013, J ALZHEIMERS DIS, V34, P115, DOI 10.3233/JAD-121444; Causing CG, 1997, NEURON, V18, P257, DOI 10.1016/S0896-6273(00)80266-4; Ceni C, 2010, J CELL SCI, V123, P2299, DOI 10.1242/jcs.062612; Chevion M, 2000, FREE RADICAL RES, V33, pS99; Choi S, 2014, NEUROSCIENCE, V257, P11, DOI 10.1016/j.neuroscience.2013.10.058; Choi S, 2009, ASN NEURO, V1, DOI 10.1042/AN20090009; COHEN G, 1974, J BIOL CHEM, V249, P2447; COHEN S, 1960, P NATL ACAD SCI USA, V46, P302, DOI 10.1073/pnas.46.3.302; Coulson EJ, 2000, J BIOL CHEM, V275, P30537, DOI 10.1074/jbc.M005214200; Dalleau S, 2013, CELL DEATH DIFFER, V20, P1615, DOI 10.1038/cdd.2013.138; Del Tredici K, 2010, ACTA NEUROPATHOL, V119, P703, DOI 10.1007/s00401-010-0665-2; Deppmann CD, 2008, SCIENCE, V320, P369, DOI 10.1126/science.1152677; DEUTCH AY, 1992, NEUROSCIENCE, V46, P49, DOI 10.1016/0306-4522(92)90007-O; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Fischer-Hayes LR, 2013, EXP NEUROL, V246, P6, DOI 10.1016/j.expneurol.2013.05.001; Frade JM, 1999, DEVELOPMENT, V126, P683; Frade JM, 1996, NATURE, V383, P166; Gerdts J, 2011, J BIOL CHEM, V286, P28011, DOI 10.1074/jbc.M111.250472; Giehl KM, 2001, J NEUROSCI, V21, P3492, DOI 10.1523/JNEUROSCI.21-10-03492.2001; Grau Cristina Malagelada, 2012, Methods Mol Biol, V846, P201, DOI 10.1007/978-1-61779-536-7_18; Greferath U, 2002, NEUROSCI LETT, V332, P57, DOI 10.1016/S0304-3940(02)00928-X; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Irmady K, 2014, J NEUROSCI, V34, P3419, DOI 10.1523/JNEUROSCI.1982-13.2014; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kaur C, 2013, J NEUROIMMUNE PHARM, V8, P66, DOI 10.1007/s11481-012-9347-2; Kenchappa RS, 2010, J BIOL CHEM, V285, P20358, DOI 10.1074/jbc.M109.082834; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Kokaia Z, 1998, NEUROSCIENCE, V84, P1113, DOI 10.1016/S0306-4522(97)00579-4; Kommaddi RP, 2011, FASEB J, V25, P2061, DOI 10.1096/fj.10-173740; Kraemer B R, 2014, Handb Exp Pharmacol, V220, P121, DOI 10.1007/978-3-642-45106-5_6; Kruman I, 1997, J NEUROSCI, V17, P5089; Kurangi RF, 2006, LIPIDS, V41, P877, DOI 10.1007/s11745-006-5043-4; Kuru S, 2013, NEUROPATH APPL NEURO, V39, P585, DOI 10.1111/nan.12043; Kutuk O, 2004, BIOFACTORS, V20, P1, DOI 10.1002/biof.5520200101; Lee JY, 2006, TOXICOL LETT, V166, P212, DOI 10.1016/j.toxlet.2006.07.305; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; LEVIMONTALCINI R, 1951, J EXP ZOOL, V116, P321, DOI 10.1002/jez.1401160206; Liu W, 2000, J CELL SCI, V113, P635; Lorentz CU, 2013, EXP NEUROL, V249, P111, DOI 10.1016/j.expneurol.2013.08.015; Manzanero S, 2013, NEUROCHEM INT, V62, P712, DOI 10.1016/j.neuint.2012.11.009; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Myers TJ, 2009, MOL BIOL CELL, V20, P5236, DOI 10.1091/mbc.E08-12-1256; Naumann T, 2002, J NEUROSCI, V22, P2409, DOI 10.1523/JNEUROSCI.22-07-02409.2002; Oh JD, 2000, BRAIN RES, V853, P174, DOI 10.1016/S0006-8993(99)02054-5; Orimo S, 2008, BRAIN, V131, P642, DOI 10.1093/brain/awm302; Overk CR, 2014, BIOCHEM PHARMACOL, V88, P508, DOI 10.1016/j.bcp.2014.01.015; Palmada M, 2002, J CELL BIOL, V158, P453, DOI 10.1083/jcb.200112129; Parakh S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/408681; Park KJ, 2010, NAT NEUROSCI, V13, P559, DOI 10.1038/nn.2513; Perluigi M, 2012, ANTIOXID REDOX SIGN, V17, P1590, DOI 10.1089/ars.2011.4406; Poli G, 2008, MED RES REV, V28, P569, DOI 10.1002/med.20117; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Roux PP, 2001, J BIOL CHEM, V276, P23097, DOI 10.1074/jbc.M011520200; Sachs BD, 2007, J CELL BIOL, V177, P1119, DOI 10.1083/jcb.200701040; SANER A, 1971, MOL PHARMACOL, V7, P147; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Sgado P, 2006, P NATL ACAD SCI USA, V103, P15242, DOI 10.1073/pnas.0602116103; Shin EJ, 2011, NEUROCHEM INT, V59, P122, DOI 10.1016/j.neuint.2011.03.025; Shin JE, 2012, P NATL ACAD SCI USA, V109, pE3696, DOI 10.1073/pnas.1216204109; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; THOENEN H, 1973, ANNU REV PHARMACOL, V13, P169, DOI 10.1146/annurev.pa.13.040173.001125; TRANZER JP, 1968, EXPERIENTIA, V24, P155, DOI 10.1007/BF02146956; Turner BJ, 2003, J NEUROCHEM, V87, P752, DOI 10.1046/j.1471-4159.2003.02053.x; Tyurina YY, 2005, AGING CELL, V4, P187, DOI 10.1111/j.1474-9726.2005.00160.x; Uchida K, 1999, J BIOL CHEM, V274, P2234, DOI 10.1074/jbc.274.4.2234; Vilar M, 2009, J CELL SCI, V122, P3351, DOI 10.1242/jcs.055061; Volosin M, 2008, J NEUROSCI, V28, P9870, DOI 10.1523/JNEUROSCI.2841-08.2008; Wakabayashi K, 2010, ACTA NEUROPATHOL, V120, P1, DOI 10.1007/s00401-010-0706-x; Wang YQ, 2008, NEUROCHEM INT, V53, P56, DOI 10.1016/j.neuint.2008.06.007; Wang Y, 2009, J IMMUNOL, V182, P2449, DOI 10.4049/jimmunol.0802770; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Zeng F, 2011, BIOCHEM PHARMACOL, V82, P1500, DOI 10.1016/j.bcp.2011.06.040; Zhang ZL, 2001, FASEB J, V15, P303; Zuo L, 2013, GENE, V532, P18, DOI 10.1016/j.gene.2013.07.085	87	43	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21205	21216		10.1074/jbc.M114.563403	http://dx.doi.org/10.1074/jbc.M114.563403			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24939843	hybrid, Green Published			2022-12-25	WOS:000340558300001
J	Perez, WB; Kinzy, TG				Perez, Winder B.; Kinzy, Terri Goss			Translation Elongation Factor 1A Mutants with Altered Actin Bundling Activity Show Reduced Aminoacyl-tRNA Binding and Alter Initiation via eIF2 alpha Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; F-ACTIN; NUCLEOTIDE EXCHANGE; GUANINE-NUCLEOTIDE; TERNARY COMPLEX; PROTEIN-SYNTHESIS; OSMOTIC-STRESS; FACTOR TU; YEAST; CYTOSKELETON	Apart from its canonical function in translation elongation, eukaryotic translation elongation factor 1A (eEF1A) has been shown to interact with the actin cytoskeleton. Amino acid substitutions in eEF1A that reduce its ability to bind and bundle actin in vitro cause improper actin organization in vivo and reduce total translation. Initial in vivo analysis indicated the reduced translation was through initiation. The mutant strains exhibit increased levels of phosphorylated initiation factor 2 alpha (eIF2 alpha) dependent on the presence of the general control non-derepressible 2 (Gcn2p) protein kinase. Gcn2p causes down-regulation of total protein synthesis at initiation in response to increases in deacylated tRNA levels in the cell. Increased levels of eIF2 alpha phosphorylation are not due to a general reduction in translation elongation as eEF2 and eEF3 mutants do not exhibit this effect. Deletion of GCN2 from the eEF1A actin bundling mutant strains revealed a second defect in translation. The eEF1A actin-bundling proteins exhibit changes in their elongation activity at the level of aminoacyl-tRNA binding in vitro. These findings implicate eEF1A in a feedback mechanism for regulating translation at initiation.	[Perez, Winder B.; Kinzy, Terri Goss] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Kinzy, TG (corresponding author), 675 Hoes Lane, Piscataway, NJ 08854 USA.	kinzytg@rutgers.edu		Kinzy, Terri/0000-0003-1394-9226	National Institutes of Health [GM57483, T32AI007403, R25 GM055145]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057483, R25GM055145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM57483 (to T. G. K.) and T32AI007403 and R25 GM055145 (Initiative to Maximize Student Diversity) (to W. B. P).	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; ALEXANDER C, 1995, J BIOL CHEM, V270, P14541, DOI 10.1074/jbc.270.24.14541; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; BEKTAS M, 1994, FEBS LETT, V356, P89, DOI 10.1016/0014-5793(94)01239-3; Beznoskova P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003962; Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997; Bretscher A, 2003, J CELL BIOL, V160, P811, DOI 10.1083/jcb.200301035; Carr-Schmid A, 1999, J BIOL CHEM, V274, P30297, DOI 10.1074/jbc.274.42.30297; Cavallius J, 1998, J BIOL CHEM, V273, P28752, DOI 10.1074/jbc.273.44.28752; Chang YWE, 1998, EUR J BIOCHEM, V251, P201, DOI 10.1046/j.1432-1327.1998.2510201.x; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; CHOWDHURY S, 1992, J CELL BIOL, V118, P561, DOI 10.1083/jcb.118.3.561; DANG CV, 1983, J CELL BIOL, V96, P1138, DOI 10.1083/jcb.96.4.1138; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; DUFFY LK, 1981, BIOCHEMISTRY-US, V20, P4663, DOI 10.1021/bi00519a022; Edmonds BT, 1998, J BIOL CHEM, V273, P10288, DOI 10.1074/jbc.273.17.10288; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; HOWE JG, 1984, CELL, V37, P85; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jorgensen R, 2002, ACTA CRYSTALLOGR D, V58, P712, DOI 10.1107/S0907444902003001; KINZY TG, 1992, J BIOL CHEM, V267, P1623; Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001; Li ZH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001175; Lin KW, 2010, CURR BIOL, V20, P1615, DOI 10.1016/j.cub.2010.08.017; Liu G, 2002, MOL BIOL CELL, V13, P579, DOI 10.1091/mbc.01-03-0140; Liu G, 1996, J CELL BIOL, V135, P953, DOI 10.1083/jcb.135.4.953; Matsuda D, 2004, VIROLOGY, V321, P47, DOI 10.1016/j.virol.2003.10.028; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Muaddi H, 2010, MOL BIOL CELL, V21, P3220, DOI 10.1091/mbc.E10-01-0023; Munshi R, 2001, GENETICS, V157, P1425; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Ogle JM, 2003, TRENDS BIOCHEM SCI, V28, P259, DOI 10.1016/S0968-0004(03)00066-5; Ortiz PA, 2006, J BIOL CHEM, V281, P32639, DOI 10.1074/jbc.M607076200; Ozturk SB, 2008, J BIOL CHEM, V283, P23244, DOI 10.1074/jbc.M801095200; PETERS HI, 1995, EUR J BIOCHEM, V234, P550, DOI 10.1111/j.1432-1033.1995.550_b.x; SAFER B, 1975, J BIOL CHEM, V250, P9076; SANDBAKEN MG, 1988, GENETICS, V120, P923; Sasikumar AN, 2014, J BIOL CHEM, V289, P4853, DOI 10.1074/jbc.M113.536201; Shin BS, 2011, NAT STRUCT MOL BIOL, V18, P1227, DOI 10.1038/nsmb.2133; Uesono Y, 2004, MOL BIOL CELL, V15, P1544, DOI 10.1091/mbc.E03-12-0877; Uesono Y, 2002, J BIOL CHEM, V277, P13848, DOI 10.1074/jbc.M108848200; Umikawa M, 1998, ONCOGENE, V16, P2011, DOI 10.1038/sj.onc.1201724; Visweswaraiah J, 2011, J BIOL CHEM, V286, P36568, DOI 10.1074/jbc.M111.248898; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0; Zaborske JM, 2009, J BIOL CHEM, V284, P25254, DOI 10.1074/jbc.M109.000877	50	16	16	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20928	20938		10.1074/jbc.M114.570077	http://dx.doi.org/10.1074/jbc.M114.570077			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24936063	hybrid, Green Published			2022-12-25	WOS:000339396600046
J	Bastiaansen, AJNM; Karper, JC; Wezel, A; de Boer, HC; Welten, SMJ; de Jong, RCM; Peters, EAB; de Vries, MR; van Oeveren-Rietdijk, AM; van Zonneveld, AJ; Hamming, JF; Nossent, AY; Quax, PHA				Bastiaansen, Antonius J. N. M.; Karper, Jacco C.; Wezel, Anouk; de Boer, Hetty C.; Welten, Sabine M. J.; de Jong, Rob C. M.; Peters, Erna A. B.; de Vries, Margreet R.; van Oeveren-Rietdijk, Annemarie M.; van Zonneveld, Anton Jan; Hamming, Jaap F.; Nossent, A. Yael; Quax, Paul H. A.			TLR4 Accessory Molecule RP105 (CD180) Regulates Monocyte-Driven Arteriogenesis in a Murine Hind Limb Ischemia Model	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; COLLATERAL ARTERY GROWTH; BONE-MARROW; INTERLEUKIN-1 RECEPTOR; CIRCULATING MONOCYTES; HOMOLOG RP105; CELLS; EXPRESSION; MICE; ANGIOGENESIS	Aims: We investigated the role of the TLR4-accessory molecule RP105 (CD180) in post-ischemic neovascularization, i.e. arteriogenesis and angiogenesis. TLR4-mediated activation of pro-inflammatory Ly6C(hi) monocytes is crucial for effective neovascularization. Immunohistochemical analyses revealed that RP105(+) monocytes are present in the perivascular space of remodeling collateral arterioles. As RP105 inhibits TLR4 signaling, we hypothesized that RP105 deficiency would lead to an unrestrained TLR4-mediated inflammatory response and hence to enhanced blood flow recovery after ischemia. Methods and Results: RP105(-/-) and wild type (WT) mice were subjected to hind limb ischemia and blood flow recovery was followed by Laser Doppler Perfusion Imaging. Surprisingly, we found that blood flow recovery was severely impaired in RP105(-/-) mice. Immunohistochemistry showed that arteriogenesis was reduced in these mice compared to the WT. However, both in vivo and ex vivo analyses showed that circulatory pro-arteriogenic Ly6C(hi) monocytes were more readily activated in RP105(-/-) mice. FACS analyses showed that Ly6C(hi) monocytes became activated and migrated to the affected muscle tissues in WT mice following induction of hind limb ischemia. Although Ly6C(hi) monocytes were readily activated in RP105(-/-) mice, migration into the ischemic tissues was hampered and instead, Ly6C(hi) monocytes accumulated in their storage compartments, bone marrow and spleen, in RP105(-/-) mice. Conclusions: RP105 deficiency results in an unrestrained inflammatory response and monocyte over-activation, most likely due to the lack of TLR4 regulation. Inappropriate, premature systemic activation of pro-inflammatory Ly6C(hi) monocytes results in reduced infiltration of Ly6C(hi) monocytes in ischemic tissues and in impaired blood flow recovery.	[Bastiaansen, Antonius J. N. M.; Karper, Jacco C.; Wezel, Anouk; Welten, Sabine M. J.; de Jong, Rob C. M.; Peters, Erna A. B.; de Vries, Margreet R.; Hamming, Jaap F.; Nossent, A. Yael; Quax, Paul H. A.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Bastiaansen, Antonius J. N. M.; Karper, Jacco C.; Wezel, Anouk; de Boer, Hetty C.; Welten, Sabine M. J.; de Jong, Rob C. M.; Peters, Erna A. B.; de Vries, Margreet R.; van Oeveren-Rietdijk, Annemarie M.; van Zonneveld, Anton Jan; Nossent, A. Yael; Quax, Paul H. A.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Wezel, Anouk] Leiden Univ, Leiden Acad Ctr Drug Res, Dept Biopharmaceut, Leiden, Netherlands; [de Boer, Hetty C.; van Oeveren-Rietdijk, Annemarie M.; van Zonneveld, Anton Jan] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Nossent, AY (corresponding author), Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands.	a.y.nossent@lumc.nl; p.h.a.quax@lumc.nl	van Zonneveld, Anton Jan/D-8060-2018; Quax, Paul/ABD-5294-2020; Quax, Paul/W-8520-2019; de Vries, Margreet/Z-5653-2019	van Zonneveld, Anton Jan/0000-0002-1676-7738; Quax, Paul/0000-0002-6853-5760; Nossent, Anne Yael/0000-0002-2155-4286	Netherlands Organization for Scientific Research (NWO) [Veni 916.12.041]; BioMedical Materials, Dutch Ministry of Economic Affairs, Agriculture and Innovation (BMM-PENT) [P1.03]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); BioMedical Materials, Dutch Ministry of Economic Affairs, Agriculture and Innovation (BMM-PENT)	This work was supported by BioMedical Materials, Dutch Ministry of Economic Affairs, Agriculture and Innovation (BMM-PENT; P1.03) and the Netherlands Organization for Scientific Research (NWO) (Veni 916.12.041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Arras M, 1998, J CLIN INVEST, V101, P40, DOI 10.1172/JCI119877; Ashida K, 2005, J ATHEROSCLER THROMB, V12, P53, DOI 10.5551/jat.12.53; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bastiaansen AJ, 2013, ARTERIOSCLER THROMB; Bergmann CE, 2006, J LEUKOCYTE BIOL, V80, P59, DOI 10.1189/jlb.0206087; Biscetti F, 2010, DIABETES, V59, P1496, DOI 10.2337/db09-1507; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Capoccia BJ, 2008, J LEUKOCYTE BIOL, V84, P760, DOI 10.1189/jlb.1107756; Chalothorn D, 2007, PHYSIOL GENOMICS, V30, P179, DOI 10.1152/physiolgenomics.00047.2007; Chalothorn D, 2010, PHYSIOL GENOMICS, V42, P469, DOI 10.1152/physiolgenomics.00070.2010; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Cochain C, 2010, CARDIOVASC RES, V88, P186, DOI 10.1093/cvr/cvq153; de Groot D, 2011, J MOL CELL CARDIOL, V50, P25, DOI 10.1016/j.yjmcc.2010.08.006; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Divanovic S, 2007, J LEUKOCYTE BIOL, V82, P265, DOI 10.1189/jlb.0107021; Francke A, 2011, J HISTOCHEM CYTOCHEM, V59, P813, DOI 10.1369/0022155411416007; Freudenberg J, 2010, HUM MOL GENET, V19, P3863, DOI 10.1093/hmg/ddq304; Hansson GK, 2005, ARTERIOSCL THROM VAS, V25, P1085, DOI 10.1161/01.ATV.0000168894.43759.47; Heil M, 2004, CIRC RES, V95, P449, DOI 10.1161/01.RES.0000141145.78900.44; Heil M, 2002, AM J PHYSIOL-HEART C, V283, pH2411, DOI 10.1152/ajpheart.01098.2001; Hellingman A, 2011, J CELL MOL MED; Hellingman AA, 2010, EUR J VASC ENDOVASC, V40, P796, DOI 10.1016/j.ejvs.2010.07.009; Hoefer IE, 2002, CIRCULATION, V105, P1639, DOI 10.1161/01.CIR.0000014987.32865.8E; Hollestelle SCG, 2004, CIRCULATION, V109, P393, DOI 10.1161/01.CIR.0000109140.51366.72; Karper JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067923; Karper JC, 2011, ARTERIOSCL THROM VAS, V31, P1033, DOI 10.1161/ATVBAHA.111.223271; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Koarada S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/259186; Matijevic N, 2011, ANGIOLOGY, V62, P237, DOI 10.1177/0003319710385336; Meisner JK, 2010, MICROCIRCULATION, V17, P583, DOI 10.1111/j.1549-8719.2010.00051.x; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; SCHAPER J, 1976, VIRCHOWS ARCH A, V370, P193, DOI 10.1007/BF00427580; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Stabile E, 2006, CIRCULATION, V113, P118, DOI 10.1161/CIRCULATIONAHA.105.576702; Stabile E, 2003, CIRCULATION, V108, P205, DOI 10.1161/01.CIR.0000079225.50817.71; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tada Y, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2529; van Weel V, 2007, ARTERIOSCL THROM VAS, V27, P2310, DOI 10.1161/ATVBAHA.107.151407; Vink A, 2002, CIRCULATION, V106, P1985, DOI 10.1161/01.CIR.0000032146.75113.EE; Voskuil M, 2004, VASC MED, V9, P287, DOI 10.1191/1358863x04vm571oa; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Wang SL, 2010, CIRC RES, V107, P558, DOI 10.1161/CIRCRESAHA.110.224634; Willems S, 2012, MINERVA MED, V103, P513; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Yoon SI, 2011, NAT STRUCT MOL BIOL, V18, P1028, DOI 10.1038/nsmb.2106; Zhang H, 2010, J CEREBR BLOOD F MET, V30, P923, DOI 10.1038/jcbfm.2010.10; Zouggari Y, 2009, CIRCULATION, V120, P1415, DOI 10.1161/CIRCULATIONAHA.109.875583	51	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99882	10.1371/journal.pone.0099882	http://dx.doi.org/10.1371/journal.pone.0099882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945347	gold, Green Submitted, Green Published			2022-12-25	WOS:000340721500032
J	Gao, XY; Guo, MX; Li, Q; Peng, L; Liu, HY; Zhang, L; Bai, X; Wang, YX; Li, J; Cai, CK				Gao, Xiaoyan; Guo, Mingxing; Li, Qiang; Peng, Long; Liu, Haiyu; Zhang, Li; Bai, Xu; Wang, Yingxin; Li, Jian; Cai, Chengke			Plasma Metabolomic Profiling to Reveal Antipyretic Mechanism of Shuang-Huang-Lian Injection on Yeast-Induced Pyrexia Rats	PLOS ONE			English	Article							BETA-HYDROXYBUTYRIC ACID; DISEASE DIAGNOSIS; MASS-SPECTROMETRY; BAKERS-YEAST; METABONOMICS; FEVER; FAD; FMN; IDENTIFICATION; EXPRESSION	Shuang-huang-lian injection (SHLI) is a famous Chinese patent medicine, which has been wildly used in clinic for the treatment of acute respiratory tract infection, pneumonia, influenza, etc. The existing randomized controlled trial (RCT) studies suggested that SHLI could afford a certain anti-febrile action. However, seldom does research concern the pharmacological mechanisms of SHLI. In the current study, we explored plasma metabolomic profiling technique and selected potential metabolic markers to reveal the antipyretic mechanism of SHLI on yeast-induced pyrexia rat model using UPLC-Q-TOF/MS coupled with multivariate statistical analysis and pattern recognition techniques. We discovered a significant perturbance of metabolic profile in the plasma of fever rats and obvious reversion in SHLI-administered rats. Eight potential biomarkers, i.e. 1) 3-hydeoxybutyric acid, 2) leucine, 3) 16:0 LPC, 4) allocholic acid, 5) vitamin B2, 6) Cys-Lys-His, 7) 18:2 LPC, and 8) 3-hydroxychola-7, 22-dien-24-oic acid, were screened out by OPLS-DA approach. Five potential perturbed metabolic pathways, i.e. 1) valine, leucine, and isoleucine biosynthesis, 2) glycerophospholipid metabolism, 3) ketone bodies synthesis and degradation, 4) bile acid biosynthesis, and 5) riboflavin metabolism, were revealed to relate to the antipyretic mechanisms of SHLI. Overall, we investigated antipyretic mechanisms of SHLI at metabolomic level for the first time, and the obtained results highlights the necessity of adopting metabolomics as a reliable tool for understanding the holism and synergism of Chinese patent drug.	[Gao, Xiaoyan; Guo, Mingxing; Peng, Long; Liu, Haiyu; Zhang, Li] Beijing Univ Chinese Med, Sci Expt Ctr TCM, Beijing, Peoples R China; [Li, Qiang; Cai, Chengke] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China; [Bai, Xu] Waters Technol Shanghai Ltd, Shanghai, Peoples R China; [Wang, Yingxin] 2nd Tradit Chinese Med Factory Harbin Pharm Grp C, Harbin, Peoples R China; [Li, Jian] Beijing Univ Chinese Med, Sch Basic Med Sci, Beijing, Peoples R China	Beijing University of Chinese Medicine; Beijing University of Chinese Medicine; Beijing University of Chinese Medicine	Li, J (corresponding author), Beijing Univ Chinese Med, Sch Basic Med Sci, Beijing, Peoples R China.	lijiancn922@126.com; cck98@126.com			National Science and Technology Major Projects for "Major new drugs innovation and development" [2011ZX09201-201-15]; National Science Foundation of China [81173562]	National Science and Technology Major Projects for "Major new drugs innovation and development"; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by National Science and Technology Major Projects for "Major new drugs innovation and development" (Grant No. 2011ZX09201-201-15), and National Science Foundation of China (Grant No. 81173562). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, PFLUGERS ARCH, V410, P567; Bai Yun-ping WZ-w, 2011, CJTCMP, V26, P5; Biermann M, 2013, AMINO ACIDS, V44, P1225, DOI 10.1007/s00726-013-1459-3; Bjerrum JT, 2010, J PROTEOME RES, V9, P954, DOI 10.1021/pr9008223; Blough ER, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00072; Brkic L, 2012, ATHEROSCLEROSIS, V224, P348, DOI 10.1016/j.atherosclerosis.2012.07.038; Cabezas A, 2005, BIOCHEM BIOPH RES CO, V338, P1682, DOI 10.1016/j.bbrc.2005.10.142; Chen X, 2002, LIFE SCI, V70, P2897, DOI 10.1016/S0024-3205(02)01541-2; Duncker DJ, 1996, AM J PHYSIOL-HEART C, V270, pH1189, DOI 10.1152/ajpheart.1996.270.4.H1189; Fan Y P, 2001, Zhongguo Zhong Xi Yi Jie He Za Zhi, V21, P406; Fraunberger P, 2002, CLIN CHEM LAB MED, V40, P304, DOI 10.1515/CCLM.2002.048; Gao XY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/864747; Gao XY, 2013, CHEM-BIOL INTERACT, V204, P39, DOI 10.1016/j.cbi.2013.04.001; Han R, 2011, J ETHNOPHARMACOL, V135, P522, DOI 10.1016/j.jep.2011.03.060; Haque MM, 2012, J BIOL CHEM, V287, P30105, DOI 10.1074/jbc.M112.339697; Hasegawa S, 1968, Nihon Jibiinkoka Gakkai Kaiho, V71, P1726; Jiang Hong-li, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P9, DOI 10.3736/jcim20090102; Kaufmann TB, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-47; KONG XT, 1993, ARCH DIS CHILD, V68, P468, DOI 10.1136/adc.68.4.468; Laeger T, 2012, J ENDOCRINOL, V213, P193, DOI 10.1530/JOE-11-0457; Laeger T, 2010, APPETITE, V54, P450, DOI 10.1016/j.appet.2010.04.005; Launey Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10097; Li Dong, 2005, Zhong Yao Cai, V28, P796; Lindon JC, 2004, BIOMARKERS, V9, P1, DOI 10.1080/13547500410001668379; Lindon JC, 2007, FEBS J, V274, P1140, DOI 10.1111/j.1742-4658.2007.05673.x; Liu F, 2012, MOL CELL BIOCHEM, V363, P147, DOI 10.1007/s11010-011-1167-9; Lu AP, 2012, CHIN J INTEGR MED, V18, P883, DOI 10.1007/s11655-012-1290-6; LYCHIK GZ, 1987, UKR BIOKHIM ZH+, V59, P55; Pasin JSM, 2010, INFLAMM RES, V59, P189, DOI 10.1007/s00011-009-0085-8; Meng JR, 2012, ANAL CHIM ACTA, V710, P125, DOI 10.1016/j.aca.2011.09.033; MoHot P.R.C, 2009, DIAGNOSIS TREATMENT; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Panousis N, 2012, RES VET SCI, V93, P435, DOI 10.1016/j.rvsc.2011.06.019; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Rao SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065155; Rawat A, 2013, J BIOSCIENCES, V38, P63, DOI 10.1007/s12038-012-9288-1; Rice P, 2005, J IMMUNOL, V174, P3676, DOI 10.4049/jimmunol.174.6.3676; Schober C, 2009, BIOORG CHEM, V37, P202, DOI 10.1016/j.bioorg.2009.09.002; Shevaga V N, 1976, Vrach Delo, P124; SOBRADO J, 1983, INFECT IMMUN, V42, P997, DOI 10.1128/IAI.42.3.997-1005.1983; Song Z. J., 2000, Chinese Medical Sciences Journal, V15, P83; Tsuge H, 2006, SEIKAGAKU, V78, P41; Wang Y, 2011, J ETHNOPHARMACOL, V134, P165, DOI 10.1016/j.jep.2010.11.066; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Yan GY, 2010, EXP BIOL MED, V235, P1356, DOI 10.1258/ebm.2010.009390; Ye J, 2012, J CHROMATOGR B, V898, P130, DOI 10.1016/j.jchromb.2012.04.036; Zhang FS, 2013, J PHARMACEUT BIOMED, V81-82, P168, DOI 10.1016/j.jpba.2013.04.005; Zhang Hai-ying RX-l, 2010, CHINA PHARM, V21, P4; Zhao YY, 2012, BIOMARKERS, V17, P721, DOI 10.3109/1354750X.2012.724450	49	24	27	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100017	10.1371/journal.pone.0100017	http://dx.doi.org/10.1371/journal.pone.0100017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940599	Green Submitted, Green Published, gold			2022-12-25	WOS:000338508200065
J	Liu, M; Wu, QS; Chen, P; Buechele, B; Bian, MH; Dong, SJ; Huang, DK; Ren, CP; Zhang, YX; Hou, X; Simmet, T; Shen, JJ				Liu, Miao; Wu, Qingsi; Chen, Peng; Buechele, Berthold; Bian, Maohong; Dong, Shengjian; Huang, Dake; Ren, Cuiping; Zhang, Yuxia; Hou, Xin; Simmet, Thomas; Shen, Jijia			A Boswellic Acid-Containing Extract Ameliorates Schistosomiasis Liver Granuloma and Fibrosis through Regulating NF-kappa B Signaling in Mice	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; ACETYL-11-KETO-BETA-BOSWELLIC ACID; GROWTH-FACTOR; IN-VITRO; INHIBITION; INFECTION; SERRATA; ACTIVATION; PREVENTION; MORTALITY	Boswellic acid (BA)-containing extracts such as BSE have anti-inflammatory and immunomodulatory activity. In chronic schistosomiasis, the hepatic granuloma and fibrosis induced by egg deposition in the liver is the most serious pathological manifestations. However, little is known regarding the role of BAs in Schistosoma japonicum (S. japonicum) egg-induced liver granuloma and fibrosis. In order to investigate the effect of a water-soluble complex preparation of BSE, BSE-CD, on S. japonicum egg-induced liver pathology, liver granuloma and fibrosis were induced by infecting C57BL/6 mice with 18-22 cercariae of S. japonicum. S. japonicum cercariae infected mice were injected with BSE-CD at the onset of egg granuloma formation (early phase BSE-CD treatment after 4 weeks infection) or after the formation of liver fibrosis (late phase BSE-CD treatment after 7 weeks infection). Our data show that treatment of infected mice with BSE-CD significantly reduced both the extent of hepatic granuloma and fibrosis. Consistent with an inhibition of NF-kappa B signaling as evidenced by reduced I kappa B kinase (IKK) activation, the mRNA expression of VEGF (vascular endothelial growth factor, VEGF), TNF-alpha (tumor necrosis factor-alpha TNF-alpha) and MCP-1 (monocyte chemotactic protein 1, MCP-1) was decreased. Moreover, immunohistochemical analysis (IHC) revealed that the content of alpha-SMA in liver tissue of BSE-CD treated mice was dramatically decreased. Our findings suggest that BSE-CD treatment attenuates S. japonicum egg-induced hepatic granulomas and fibrosis, at least partly due to reduced NF-kappa B signaling and the subsequently decreased expression of VEGF, TNF-alpha, and MCP-1. Suppression of the activation of hepatic stellate cells (HSC) may also be involved in the therapeutic efficacy of BSE-CD.	[Liu, Miao; Wu, Qingsi; Huang, Dake; Ren, Cuiping; Zhang, Yuxia; Hou, Xin; Shen, Jijia] Anhui Med Univ, Dept Microbiol & Parasitol, Hefei, Anhui, Peoples R China; [Liu, Miao; Wu, Qingsi; Huang, Dake; Ren, Cuiping; Hou, Xin; Shen, Jijia] Anhui Med Univ, Anhui Prov Lab Microbiol & Parasitol, Hefei, Anhui, Peoples R China; [Chen, Peng] Anhui Med Univ, Coll Clin Med Sci, Hefei, Anhui, Peoples R China; [Buechele, Berthold; Simmet, Thomas] Univ Ulm, Inst Pharmacol Nat Prod & Clin Pharmacol, D-89069 Ulm, Germany; [Bian, Maohong] Anhui Med Univ, Affiliated Hosp 1, Dept Blood Transfus, Hefei, Anhui, Peoples R China; [Dong, Shengjian] Hefei Second Peoples Hosp, Dept Clin Lab, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Ulm University	Simmet, T (corresponding author), Univ Ulm, Inst Pharmacol Nat Prod & Clin Pharmacol, D-89069 Ulm, Germany.	thomas.simmet@uni-ulm.de; shenjijia@hotmail.com		Syrovets, Tatiana/0000-0002-6751-2233	Natural Science Foundation of China [30901251, 30972569]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China (http://www.nsfc.gov.cn) (grant numbers 30901251 and 30972569). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Tawab M, 2011, CLIN PHARMACOKINET, V50, P349, DOI 10.2165/11586800-000000000-00000; Ali EN, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-36; Ammon HPT, 2010, PHYTOMEDICINE, V17, P862, DOI 10.1016/j.phymed.2010.03.003; Anan A, 2006, HEPATOLOGY, V43, P335, DOI 10.1002/hep.21036; Andrade ZA, 2008, ACTA TROP, V108, P79, DOI 10.1016/j.actatropica.2008.04.003; Bartley PB, 2006, INT J PARASITOL, V36, P993, DOI 10.1016/j.ijpara.2006.04.015; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Caldas IR, 2008, ACTA TROP, V108, P109, DOI 10.1016/j.actatropica.2008.05.027; Cuaz-Perolin C, 2008, ARTERIOSCL THROM VAS, V28, P272, DOI 10.1161/ATVBAHA.107.155606; Fallon PG, 1999, J IMMUNOL, V162, P4122; Fattah NSA, 2012, EXP PARASITOL, V130, P58, DOI 10.1016/j.exppara.2011.09.014; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Friedman SL, 2007, HEPATOLOGY, V45, P242, DOI 10.1002/hep.21459; Friedman SL, 2004, NAT CLIN PRACT GASTR, V1, P98, DOI 10.1038/ncpgasthep0055; Giatromanolaki A, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/67187; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Herbert DR, 2008, J IMMUNOL, V181, P7214, DOI 10.4049/jimmunol.181.10.7214; Hou X, 2009, HEPATOLOGY, V49, P940, DOI 10.1002/hep.22725; Kiela PR, 2005, AM J PHYSIOL-GASTR L, V288, pG798, DOI 10.1152/ajpgi.00433.2004; Kumar A, 2012, BIOORG MED CHEM LETT, V22, P431, DOI 10.1016/j.bmcl.2011.10.112; Latella G, 2008, EUR J CLIN INVEST, V38, P410, DOI 10.1111/j.1365-2362.2008.01955.x; Li Shi-Zhu, 2013, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V25, P557; Liu M, 2013, PARASITOL RES, V112, P1105, DOI 10.1007/s00436-012-3237-7; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Makhlouf Madiha M., 2002, Journal of the Egyptian Society of Parasitology, V32, P907; Mann DA, 2002, GUT, V50, P891, DOI 10.1136/gut.50.6.891; Mohamed-Ali Q, 1999, J INFECT DIS, V180, P1298, DOI 10.1086/314999; Molyneux DH, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-234; Park B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026943; SAFAYHI H, 1995, MOL PHARMACOL, V47, P1212; Sailer ER, 1996, BRIT J PHARMACOL, V117, P615, DOI 10.1111/j.1476-5381.1996.tb15235.x; Saraswati S, 2011, MICROVASC RES, V82, P263, DOI 10.1016/j.mvr.2011.08.002; Shariati F, 2011, EXP PARASITOL, V128, P44, DOI 10.1016/j.exppara.2011.01.016; Shehata AM, 2011, PHYTOMEDICINE, V18, P1037, DOI 10.1016/j.phymed.2011.06.035; Siemoneit U, 2011, BRIT J PHARMACOL, V162, P147, DOI 10.1111/j.1476-5381.2010.01020.x; Silveira-Lemos D, 2008, ACTA TROP, V108, P150, DOI 10.1016/j.actatropica.2008.04.006; Souza PRS, 2008, ACTA TROP, V108, P135, DOI 10.1016/j.actatropica.2008.04.016; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Syrovets T, 2005, J BIOL CHEM, V280, P6170, DOI 10.1074/jbc.M409477200; Syrovets T, 2005, J IMMUNOL, V174, P498, DOI 10.4049/jimmunol.174.1.498; Wang H, 2006, J IMMUNOL, V183, P4755; Wang XH, 2008, ZHONGGUO XUE XI CHON, V28, P314; Weng HL, 2009, HEPATOLOGY, V50, P230, DOI 10.1002/hep.22934; Yu Xin-Ling, 2013, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V31, P307	45	13	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100129	10.1371/journal.pone.0100129	http://dx.doi.org/10.1371/journal.pone.0100129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941000	Green Published, gold, Green Submitted			2022-12-25	WOS:000338508200075
J	Prator, CA; Murayama, KM; Schulz, JR				Prator, Cecilia A.; Murayama, Kellee M.; Schulz, Joseph R.			Venom Variation during Prey Capture by the Cone Snail, Conus textile	PLOS ONE			English	Article							MARINE GASTROPODS; MECHANISM; DIET; SUPERFAMILY; CONOTOXINS; KINEMATICS; DIVERSITY; EVOLUTION; PEPTIDES; DUCTS	Observations of the mollusc-hunting cone snail Conus textile during feeding reveal that prey are often stung multiple times in succession. While studies on the venom peptides injected by fish-hunting cone snails have become common, these approaches have not been widely applied to the analysis of the injected venoms from mollusc-hunters. We have successfully obtained multiple injected venom samples from C. textile individuals, allowing us to investigate venom compositional variation during prey capture. Our studies indicate that C. textile individuals alter the composition of prey-injected venom peptides during single feeding events. The qualitative results obtained by MALDI-ToF mass spectrometry are mirrored by quantitative changes in venom composition observed by reverse-phase high performance liquid chromatography. While it is unclear why mollusc-hunting cone snails inject prey multiple times prior to engulfment, our study establishes for the first time a link between this behavior and compositional changes of the venom during prey capture. Changes in venom composition during hunting may represent a multi-step strategy utilized by these venomous animals to slow and incapacitate prey prior to engulfment.	[Prator, Cecilia A.; Murayama, Kellee M.; Schulz, Joseph R.] Occidental Coll, Dept Biol, Los Angeles, CA 90041 USA	Occidental College	Schulz, JR (corresponding author), Occidental Coll, Dept Biol, Los Angeles, CA 90041 USA.	jschulz@oxy.edu		Prator, Cecilia/0000-0002-9638-7398	NIH [1R15NS059024]; Howard Hughes Medical Institute Award for Undergraduate Research to Occidental College; Science Scholars Program at Occidental College; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS059024] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Award for Undergraduate Research to Occidental College; Science Scholars Program at Occidental College; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the following sources: NIH 1R15NS059024 awarded to J.R. Schulz; Howard Hughes Medical Institute Award for Undergraduate Research to Occidental College; Science Scholars Program at Occidental College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow A, 2009, P ROY SOC B-BIOL SCI, V276, P2443, DOI 10.1098/rspb.2009.0048; Bingham JP, 2012, TOXICON, V60, P1166, DOI 10.1016/j.toxicon.2012.07.014; Bingham JP, 2010, CHEM-BIOL INTERACT, V183, P1, DOI 10.1016/j.cbi.2009.09.021; Corpuz GP, 2005, BIOCHEMISTRY-US, V44, P8176, DOI 10.1021/bi047541b; Daltry JC, 1996, NATURE, V379, P537, DOI 10.1038/379537a0; Dobson R, 2012, TOXICON, V60, P1370, DOI 10.1016/j.toxicon.2012.09.013; Domenici P, 1997, J EXP BIOL, V200, P1165; Duda TF, 2001, BIOL J LINN SOC, V73, P391, DOI 10.1006/bijl.2001.0544; Duda TF, 2008, J MOL EVOL, V67, P315, DOI 10.1007/s00239-008-9155-8; Dutertre S, 2013, MOL CELL PROTEOMICS, V12, P312, DOI 10.1074/mcp.M112.021469; Dutertre S, 2010, TOXICON, V55, P1453, DOI 10.1016/j.toxicon.2010.02.025; Garrett JE, 2005, BIOCHEM BIOPH RES CO, V328, P362, DOI 10.1016/j.bbrc.2004.12.178; GREENE JL, 1989, J ZOOL, V219, P487, DOI 10.1111/j.1469-7998.1989.tb02595.x; Inceoglu B, 2003, P NATL ACAD SCI USA, V100, P922, DOI 10.1073/pnas.242735499; Jakubowski JA, 2005, J EXP BIOL, V208, P2873, DOI 10.1242/jeb.01713; KOHN AJ, 1972, SCIENCE, V176, P49, DOI 10.1126/science.176.4030.49; Kohn Alan J., 2003, P101; Li M, 2005, J MOL EVOL, V60, P81, DOI 10.1007/s00239-004-0138-0; Liu JL, 2007, PEPTIDES, V28, P2313, DOI 10.1016/j.peptides.2007.09.006; Maguire D., 1992, P11; Moller C, 2011, BIOPOLYMERS, V96, P158, DOI 10.1002/bip.21406; Olivera BM, 1999, ANN NY ACAD SCI, V870, P223, DOI 10.1111/j.1749-6632.1999.tb08883.x; Reed JB, 2010, CELL MOL LIFE SCI, V67, P17, DOI [10.1007/s00018-009-0125-0, DOI 10.1007/S00018-009-0125-0]; Rivera-Ortiz JA, 2011, PEPTIDES, V32, P306, DOI 10.1016/j.peptides.2010.11.014; Salisbury SM, 2010, J EXP BIOL, V213, P673, DOI 10.1242/jeb.035550; Schulz JR, 2004, BIOL BULL-US, V207, P77, DOI 10.2307/1543581; Tayo LL, 2010, J PROTEOME RES, V9, P2292, DOI 10.1021/pr901032r; Ueberheide BM, 2009, P NATL ACAD SCI USA, V106, P6910, DOI 10.1073/pnas.0900745106	28	18	18	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e98991	10.1371/journal.pone.0098991	http://dx.doi.org/10.1371/journal.pone.0098991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940882	Green Submitted, gold, Green Published			2022-12-25	WOS:000338508200011
J	Sun, Y; Lee, HJ; Yang, SC; Chen, TF; Lin, KN; Lin, CC; Wang, PN; Tang, LY; Chiu, MJ				Sun, Yu; Lee, Huey-Jane; Yang, Shu-Chien; Chen, Ta-Fu; Lin, Ker-Neng; Lin, Chung-Chih; Wang, Pei-Ning; Tang, Li-Yu; Chiu, Ming-Jang			A Nationwide Survey of Mild Cognitive Impairment and Dementia, Including Very Mild Dementia, in Taiwan	PLOS ONE			English	Article							ALZHEIMERS ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; PREVALENCE; POPULATION; DISEASE; SUBTYPES; EPIDEMIOLOGY; COMMUNITY; CHINA; RECOMMENDATIONS	An increasing population of dementia patients produces substantial societal impacts. We assessed the prevalence of mild cognitive impairment (MCI) and all-cause dementia, including very mild dementia (VMD), in Taiwan. In a nationwide population-based cross-sectional survey, participants were selected by computerized random sampling from all 19 Taiwan counties and were enrolled between December 2011 and March 2013. Cases were identified through in-person interviews based on the National Institute on Aging-Alzheimer's Association clinical criteria. Demographic data and histories involving mental status and function in daily living were collected. The principal objective assessments were the Taiwanese Mental Status Examination and Clinical Dementia Rating. In all, 10,432 people aged 65 years or older (mean age 76.2 +/- 6.7, 52.3% women) were interviewed. The age-adjusted prevalence of all-cause dementia was 8.04% (95% CI 7.47-8.61), including a 3.25% (95% CI 2.89-3.61) prevalence of VMD; that of MCI was 18.76% (95% CI 17.91-19.61). Women had a higher prevalence than men of both all-cause dementia (9.71% vs. 6.36%) and MCI (21.63% vs. 15.57%). MCI affects a considerable portion of the population aged 65 and above in Taiwan. The inclusion of VMD yields dementia prevalence rates higher than those previously reported from Taiwan. Old age, female gender, and a low educational level are significant associated factors.	[Sun, Yu] En Chu Kong Hosp, Dept Neurol, New Taipei City, Taiwan; [Sun, Yu] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Neurol, Taipei 10764, Taiwan; [Lee, Huey-Jane; Yang, Shu-Chien; Tang, Li-Yu] Taiwan Alzheimers Dis Assoc, Taipei, Taiwan; [Chen, Ta-Fu] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Neurol, Taipei 10764, Taiwan; [Lin, Ker-Neng] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan; [Lin, Ker-Neng] Soochow Univ, Dept Psychol, Taipei, Taiwan; [Lin, Chung-Chih] Chang Gung Univ, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan; [Wang, Pei-Ning] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan; [Wang, Pei-Ning] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei 112, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ Hosp, Coll Med, Dept Neurol, Taipei, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ, Grad Inst Brain & Mind Sci, Taipei, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ, Grad Inst Psychol, Taipei, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ, Grad Inst Biomed Engn & Bioinformat, Taipei, Taiwan	En Chu Kong Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Veterans General Hospital; Soochow University; Chang Gung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University	Chiu, MJ (corresponding author), Natl Taiwan Univ Hosp, Coll Med, Dept Neurol, Taipei, Taiwan.	mjchiu@ntu.edu.tw	Chiu, Ming-Jang/AAR-3940-2020	Chiu, Ming-Jang/0000-0002-4158-4423; Chen, Ta-Fu/0000-0003-1988-6924	Ministry of Health and Welfare, Taiwan	Ministry of Health and Welfare, Taiwan	This work was supported by the Ministry of Health and Welfare, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal Neelum T, 2012, Int J Alzheimers Dis, V2012, P171327, DOI 10.1155/2012/171327; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alzheimer's Disease International, 2008, PREV DEM WORLDW; Andersen K, 1999, NEUROLOGY, V52, P85, DOI 10.1212/WNL.52.1.85; Andersen K, 1997, ACTA NEUROL SCAND, V96, P82; [Anonymous], 2013, STAT YB INTERIOR; [Anonymous], 2013, DEMENTIA STAT; Brayne C, 2010, BRAIN, V133, P2210, DOI 10.1093/brain/awq185; Busse A, 2006, NEUROLOGY, V67, P2176, DOI 10.1212/01.wnl.0000249117.23318.e1; Catindig JAS, 2012, J NEUROL SCI, V321, P11, DOI 10.1016/j.jns.2012.07.023; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Das SK, 2007, NEUROLOGY, V68, P2019, DOI 10.1212/01.wnl.0000264424.76759.e6; Dodge Hiroko H, 2012, Int J Alzheimers Dis, V2012, P956354, DOI 10.1155/2012/956354; Fuh Jong-Ling, 2008, Acta Neurol Taiwan, V17, P153; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Ikeda M, 2004, J NEUROL NEUROSUR PS, V75, P146; Jhoo JH, 2008, DEMENT GERIATR COGN, V26, P270, DOI 10.1159/000160960; Kukull WA, 2002, MED CLIN N AM, V86, P573, DOI 10.1016/S0025-7125(02)00010-X; Lam LCW, 2008, INT PSYCHOGERIATR, V20, P135, DOI 10.1017/S1041610207006199; Larrieu S, 2002, NEUROLOGY, V59, P1594, DOI 10.1212/01.WNL.0000034176.07159.F8; Liu CK, 1996, J FORMOS MED ASSOC, V95, P762; Liu CK TC, 2007, RES APPL PSYCHOL, V7, P157; LIU HC, 1994, PSYCHOL MED, V24, P763, DOI 10.1017/S0033291700027914; LIU HC, 1995, J AM GERIATR SOC, V43, P144, DOI 10.1111/j.1532-5415.1995.tb06379.x; Liu HC, 1998, ALZ DIS ASSOC DIS, V12, P127, DOI 10.1097/00002093-199809000-00002; Luck T, 2007, DEMENT GERIATR COGN, V24, P307, DOI 10.1159/000108099; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Nie HW, 2011, INT J GERIATR PSYCH, V26, P558, DOI 10.1002/gps.2579; Nowrangi MA, 2011, PSYCHIAT CLIN N AM, V34, P275, DOI 10.1016/j.psc.2011.02.004; Petersen RC, 2010, NEUROLOGY, V75, P889, DOI 10.1212/WNL.0b013e3181f11d85; Plassman BL, 2008, ANN INTERN MED, V148, P427, DOI 10.7326/0003-4819-148-6-200803180-00005; Ritchie Karen, 2004, Dialogues Clin Neurosci, V6, P401; Rodriguez JJL, 2008, LANCET, V372, P464, DOI 10.1016/S0140-6736(08)61002-8; Shyu YIL, 2001, J FORMOS MED ASSOC, V100, P676; Tognoni G, 2005, ACTA NEUROL SCAND, V112, P65, DOI 10.1111/j.1600-0404.2005.00444.x; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR; Wu YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066252; Zhang YD, 2012, J CLIN NEUROSCI, V19, P1333, DOI 10.1016/j.jocn.2012.01.029	39	154	156	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100303	10.1371/journal.pone.0100303	http://dx.doi.org/10.1371/journal.pone.0100303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6AC	24940604	Green Published, gold, Green Submitted			2022-12-25	WOS:000338508200093
J	Deng, JJ; Dong, Y; Li, C; Zuo, WW; Meng, G; Xu, CP; Li, JJ				Deng, Junjiang; Dong, Yan; Li, Chong; Zuo, Wenwei; Meng, Gang; Xu, Chengping; Li, Jianjun			Decreased Expression of C10orf10 and Its Prognostic Significance in Human Breast Cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENES; MARKERS; CELLS; PROGESTERONE; DEPP	Breast cancer is a common malignant tumor, which severely threatens the health of women with an increasing incidence in many countries. Here, we identified C10orf10 as a novel differentially expression gene using expression microarray screening. The expression analysis indicated that C10orf10 was frequently decreased in human breast cancers compared to noncancerous breast tissues (81/95, P = 0.0063). Kaplan-Meier analysis indicated that patients with low C10orf10 expression showed a poorer prognosis both in mRNA (n = 1115, P = 0.0013) and protein (n = 100, P = 0.003) levels. Univariate and multivariate analysis showed that the C10orf10 expression was an independent prognostic factor for overall survival of breast cancer patients. Further analysis revealed that low expression of C10orf10 was an unfavorable factor for the prognosis of the patients who were luminal A, luminal B, Her2+ subtypes, at histological grade 2, lymph node negative and ER positive. Our data provided the first evidence that C10orf10 expression was frequently decreased in breast cancer tissues, and low expression of C10orf10 may be an important prognostic factor for poorer survival time of breast cancer patients.	[Deng, Junjiang; Dong, Yan; Li, Chong; Zuo, Wenwei; Li, Jianjun] Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China; [Deng, Junjiang] Third Mil Med Univ, Chongqing, Peoples R China; [Meng, Gang; Xu, Chengping] Third Mil Med Univ, Southwest Hosp, Dept Pathol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Li, JJ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China.	jianjunli@tmmu.edu.cn			National Natural Science Foundation of China [81172114]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81172114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2904; Chen SM, 2011, FEBS LETT, V585, P1796, DOI 10.1016/j.febslet.2011.04.024; Cho WCS, 2012, EXPERT REV MOL DIAGN, V12, P315, DOI [10.1586/ERM.12.21, 10.1586/erm.12.21]; ELLEDGE RM, 1992, SEMIN ONCOL, V19, P244; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; HAYES DF, 1993, ANN ONCOL, V4, P807, DOI 10.1093/oxfordjournals.annonc.a058385; Huang YB, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-16; Jiang L, 2013, EUR J RADIOL, V82, P1404, DOI 10.1016/j.ejrad.2013.03.006; Jung SP, 2013, J BREAST CANCER, V16, P16, DOI 10.4048/jbc.2013.16.1.16; Kuroda Y, 2010, HORM METAB RES, V42, P173, DOI 10.1055/s-0029-1241841; Pereira CBL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060576; Liu WB, 2010, MOL CARCINOGEN, V49, P556, DOI 10.1002/mc.20621; Metzger O, 2011, CRIT REV ONCOL HEMAT, V77, P21, DOI 10.1016/j.critrevonc.2010.01.011; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Ragel BT, 2007, NEUROSURG REV, V30, P181, DOI 10.1007/s10143-007-0070-z; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Reyal F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055901; Shin DH, 2005, DEV DYNAM, V233, P1589, DOI 10.1002/dvdy.20479; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Taghipour S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-299; THOMAS F, 1988, RADIOTHER ONCOL, V13, P267, DOI 10.1016/0167-8140(88)90222-8; VISSCHER DW, 1990, PATHOL ANNU, V25, P171; Watanabe H, 2005, MOL HUM REPROD, V11, P471, DOI 10.1093/molehr/gah186; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Zhou L, 2013, HUM PATHOL, V44, P1421, DOI 10.1016/j.humpath.2012.10.027	29	3	4	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99730	10.1371/journal.pone.0099730	http://dx.doi.org/10.1371/journal.pone.0099730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936657	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400034
J	Ip, IB; Bridge, H; Parker, AJ				Ip, Ifan Betina; Bridge, Holly; Parker, Andrew J.			Effects of Spatial and Feature Attention on Disparity-Rendered Structure-From-Motion Stimuli in the Human Visual Cortex	PLOS ONE			English	Article							3-DIMENSIONAL STRUCTURE; AREA MT; QUANTITATIVE-ANALYSIS; PERCEPTUAL LOAD; STEREOPSIS; DEPTH; ORGANIZATION; INTEGRATION; ROBUST; FMRI	that enhances the response to similar features or objects across the visual field. Here we test whether this non-spatial component can co-select individual features that are perceptually bound into a coherent object. We combined human psychophysics and functional magnetic resonance imaging (fMRI) to demonstrate the ability to co-select individual features from perceptually coherent objects. Our study used binocular disparity and visual motion to define disparity structure-from-motion (dSFM) stimuli. Although the spatial attention system induced strong modulations of the fMRI response in visual regions, the non-spatial system's ability to co-select features of the dSFM stimulus was less pronounced and variable across subjects. Our results demonstrate that feature and global feature attention effects are variable across participants, suggesting that the feature attention system may be limited in its ability to automatically select features within the attended object. Careful comparison of the task design suggests that even minor differences in the perceptual task may be critical in revealing the presence of global feature attention.	[Ip, Ifan Betina; Bridge, Holly; Parker, Andrew J.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Ip, Ifan Betina; Bridge, Holly] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford Ctr Funct Magnet Resonance Imaging Brain, Oxford, England	University of Oxford; University of Oxford	Ip, IB (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	ifanbetinaip@gmail.com	Ip, Ifan Betina/HIA-0309-2022; Parker, Andrew J/I-7867-2013	Ip, Ifan Betina/0000-0003-3544-0711; Parker, Andrew J/0000-0001-5800-0407; Bridge, Holly/0000-0002-8089-6198	James S. McDonnell Foundation; Medical Research Council (United Kingdom); Royal Society Wolfson Research Merit Award; Medical Research Council [G0400132, MR/K014382/1, G0802171, G0700399] Funding Source: researchfish; MRC [G0700399, MR/K014382/1, G0802171, G0400132] Funding Source: UKRI	James S. McDonnell Foundation; Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society Wolfson Research Merit Award(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the James S. McDonnell Foundation and the Medical Research Council (United Kingdom). Andrew J. Parker held a Royal Society Wolfson Research Merit Award. Holly Bridge is a Royal Society University Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; Arman AC, 2006, VISION RES, V46, P2968, DOI 10.1016/j.visres.2006.03.003; Ban H, 2012, NAT NEUROSCI, V15, P636, DOI 10.1038/nn.3046; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Bridge H, 2007, J VIS, V7; Brouwer GJ, 2007, J NEUROSCI, V27, P1015, DOI 10.1523/JNEUROSCI.4593-06.2007; Chandrasekaran C, 2007, J NEUROPHYSIOL, V97, P1553, DOI 10.1152/jn.01074.2006; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; DEYOE EA, 1994, J NEUROSCI METH, V54, P171, DOI 10.1016/0165-0270(94)90191-0; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; DOSHER BA, 1986, VISION RES, V26, P973, DOI 10.1016/0042-6989(86)90154-9; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; HE ZJ, 1995, P NATL ACAD SCI USA, V92, P11155, DOI 10.1073/pnas.92.24.11155; HUBEL DH, 1987, J NEUROSCI, V7, P3378; Huk AC, 2002, J NEUROSCI, V22, P7195; Jehee JFM, 2011, J NEUROSCI, V31, P8210, DOI 10.1523/JNEUROSCI.6153-09.2011; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; JOHNSTON EB, 1993, VISION RES, V33, P813, DOI 10.1016/0042-6989(93)90200-G; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kamitani Y, 2006, CURR BIOL, V16, P1096, DOI 10.1016/j.cub.2006.04.003; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Katzner S, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.012.2009; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Larsson J, 2001, IMAGING VISION FUNCT; LAVIE N, 1994, PERCEPT PSYCHOPHYS, V56, P183, DOI 10.3758/BF03213897; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; Melcher D, 2005, NEURON, V46, P723, DOI 10.1016/j.neuron.2005.04.023; Mitchell JF, 2004, NATURE, V429, P410, DOI 10.1038/nature02584; Moradi F, 2004, VISION RES, V44, P2885, DOI 10.1016/j.visres.2004.06.021; NAWROT M, 1991, PERCEPT PSYCHOPHYS, V49, P230, DOI 10.3758/BF03214308; NAWROT M, 1989, SCIENCE, V244, P716, DOI 10.1126/science.2717948; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; PETERHANS E, 1993, EUR J NEUROSCI, V5, P509, DOI 10.1111/j.1460-9568.1993.tb00517.x; Preston TJ, 2008, J NEUROSCI, V28, P11315, DOI 10.1523/JNEUROSCI.2728-08.2008; Preston TJ, 2009, J NEUROSCI, V29, P1688, DOI 10.1523/JNEUROSCI.5021-08.2009; Prince SJD, 2002, J NEUROPHYSIOL, V87, P191, DOI 10.1152/jn.00465.2000; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; ROE AW, 1995, J NEUROSCI, V15, P3689; ROGERS B, 1982, VISION RES, V22, P261, DOI 10.1016/0042-6989(82)90126-2; Rokers B, 2009, NAT NEUROSCI, V12, P1050, DOI 10.1038/nn.2343; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; Saenz M, 2003, VISION RES, V43, P629, DOI 10.1016/S0042-6989(02)00595-3; Serences JT, 2007, NEURON, V55, P301, DOI 10.1016/j.neuron.2007.06.015; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; SIEGEL RM, 1988, NATURE, V331, P259, DOI 10.1038/331259a0; Silver MA, 2007, J NEUROPHYSIOL, V97, P229, DOI 10.1152/jn.00677.2006; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; TREUE S, 1995, VISION RES, V35, P139, DOI 10.1016/0042-6989(94)E0069-W; TREUE S, 1991, VISION RES, V31, P59, DOI 10.1016/0042-6989(91)90074-F; Treue S, 2007, NEURON, V55, P174, DOI 10.1016/j.neuron.2007.07.005; ULLMAN S, 1979, PROC R SOC SER B-BIO, V203, P405, DOI 10.1098/rspb.1979.0006; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880; Wannig A, 2007, NEURON, V54, P639, DOI 10.1016/j.neuron.2007.05.001; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	68	0	0	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100074	10.1371/journal.pone.0100074	http://dx.doi.org/10.1371/journal.pone.0100074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936974	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400069
J	Lee, W; Watters, KE; Troupis, AT; Reinen, NM; Suchy, FP; Moyer, KL; Frederick, RO; Tonelli, M; Aceti, DJ; Palmenberg, AC; Markley, JL				Lee, Woonghee; Watters, Kelly E.; Troupis, Andrew T.; Reinen, Nichole M.; Suchy, Fabian P.; Moyer, Kylie L.; Frederick, Ronnie O.; Tonelli, Marco; Aceti, David J.; Palmenberg, Ann C.; Markley, John L.			Solution Structure of the 2A Protease from a Common Cold Agent, Human Rhinovirus C2, Strain W12	PLOS ONE			English	Article							NMR-SPECTROSCOPY; CLEAVAGE SITE; PROTEINASE; SPECIFICITY; INHIBITION; RESIDUES; ELECTROSTATICS; COXSACKIEVIRUS; AUTOINDUCTION; TRANSCRIPTION	Human rhinovirus strains differ greatly in their virulence, and this has been correlated with the differing substrate specificity of the respective 2A protease (2A(pro)). Rhinoviruses use their 2A(pro) to cleave a spectrum of cellular proteins important to virus replication and anti-host activities. These enzymes share a chymotrypsin-like fold stabilized by a tetra-coordinated zinc ion. The catalytic triad consists of conserved Cys (C105), His (H34), and Asp (D18) residues. We used a semi-automated NMR protocol developed at NMRFAM to determine the solution structure of 2A(pro) (C(105)A variant) from an isolate of the clinically important rhinovirus C species (RV-C). The backbone of C2 2Apro superimposed closely (1.41-1.81 angstrom rmsd) with those of orthologs from RV-A2, coxsackie B4 (CB4), and enterovirus 71 (EV71) having sequence identities between 40% and 60%. Comparison of the structures suggest that the differential functional properties of C2 2A(pro) stem from its unique surface charge, high proportion of surface aromatics, and sequence surrounding the di-tyrosine flap.	[Lee, Woonghee; Tonelli, Marco; Markley, John L.] Univ Wisconsin, Dept Biochem, Natl Magnet Resonance Facil Madison, Madison, WI 53705 USA; [Troupis, Andrew T.; Reinen, Nichole M.; Suchy, Fabian P.; Moyer, Kylie L.; Frederick, Ronnie O.; Aceti, David J.; Markley, John L.] Univ Wisconsin, Dept Biochem, Ctr Eukaryot Struct Genom, Madison, WI 53705 USA; [Watters, Kelly E.; Palmenberg, Ann C.] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Markley, JL (corresponding author), 171A DeLuca Biochem Labs, Madison, WI 53706 USA.	markley@nmrfam.wisc.edu			National Institutes of Health [U19 AI104317, T32 AI078985, U01 GM094622, P41GM103399]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI078985, U19AI104317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094622, P41GM103399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant U19 AI104317 to ACP, NIH training grant T32 AI078985 to KW and NIH grants U01 GM094622, and P41GM103399 to JLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baxter NJ, 2006, J VIROL, V80, P1451, DOI 10.1128/JVI.80.3.1451-1462.2006; BAZAN JF, 1988, P NATL ACAD SCI USA, V85, P7872, DOI 10.1073/pnas.85.21.7872; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Blommel PG, 2007, BIOTECHNOL PROGR, V23, P585, DOI 10.1021/bp070011x; Bochkov YA, 2011, NAT MED, V17, P627, DOI 10.1038/nm.2358; Cai QX, 2013, J VIROL, V87, P7348, DOI 10.1128/JVI.03541-12; Castello A, 2009, J CELL SCI, V122, P3799, DOI 10.1242/jcs.055988; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CLARK ME, 1991, EMBO J, V10, P2941, DOI 10.1002/j.1460-2075.1991.tb07844.x; Cox JD, 2000, BIOCHEMISTRY-US, V39, P13687, DOI 10.1021/bi001649j; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dominguez SR, 2008, J CLIN VIROL, V43, P219, DOI 10.1016/j.jcv.2008.06.007; EISENHABER F, 1993, J COMPUT CHEM, V14, P1272, DOI 10.1002/jcc.540141103; Foeger N, 2003, J BIOL CHEM, V278, P33200, DOI 10.1074/jbc.M304007200; Frederick Ronnie O., 2007, Journal of Structural and Functional Genomics, V8, P153, DOI 10.1007/s10969-007-9032-5; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Goddard T. D., 2008, SPARKY 3; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Gustin KE, 2002, J VIROL, V76, P8787, DOI 10.1128/JVI.76.17.8787-8796.2002; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LAMPHEAR BJ, 1993, J BIOL CHEM, V268, P19200; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000966; Lee W, 2011, BIOINFORMATICS, V27, P1727, DOI 10.1093/bioinformatics/btr200; Lee W, 2009, BIOINFORMATICS, V25, P2085, DOI 10.1093/bioinformatics/btp345; Liebig HD, 2002, FEBS LETT, V523, P53, DOI 10.1016/S0014-5793(02)02933-2; McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10; Mu ZX, 2013, J MOL BIOL, V425, P4530, DOI 10.1016/j.jmb.2013.08.016; Neubauer D, 2013, J GEN VIROL, V94, P1535, DOI 10.1099/vir.0.051201-0; Palmenberg AC, 2010, J ALLERGY CLIN IMMUN, V125, P1190, DOI 10.1016/j.jaci.2010.04.010; Petersen JFW, 1999, EMBO J, V18, P5463, DOI 10.1093/emboj/18.20.5463; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shin J, 2008, EXPERT REV PROTEOMIC, V5, P589, DOI 10.1586/14789450.5.4.589; SKERN T, 1991, VIROLOGY, V181, P46, DOI 10.1016/0042-6822(91)90468-Q; SOMMERGRUBER W, 1992, J BIOL CHEM, V267, P22639; Sousa C, 2006, FEBS LETT, V580, P5713, DOI 10.1016/j.febslet.2006.09.023; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Wang QM, 1998, ARCH BIOCHEM BIOPHYS, V356, P12, DOI 10.1006/abbi.1998.0746; Watters K, 2011, J VIROL, V85, P10874, DOI 10.1128/JVI.00718-11; Yalamanchili P, 1997, J VIROL, V71, P1220, DOI 10.1128/JVI.71.2.1220-1226.1997	46	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e97198	10.1371/journal.pone.0097198	http://dx.doi.org/10.1371/journal.pone.0097198			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937088	gold, Green Published, Green Submitted			2022-12-25	WOS:000338503400005
J	Nolan, KE; Song, YH; Liao, SY; Saeed, NA; Zhang, XY; Rose, RJ				Nolan, Kim E.; Song, Youhong; Liao, Siyang; Saeed, Nasir A.; Zhang, Xiyi; Rose, Ray J.			An Unusual Abscisic Acid and Gibberellic Acid Synergism Increases Somatic Embryogenesis, Facilitates Its Genetic Analysis and Improves Transformation in Medicago truncatula	PLOS ONE			English	Article							ETHYLENE BIOSYNTHESIS; TRANSCRIPTION FACTOR; TISSUE-CULTURE; EXPRESSION; ARABIDOPSIS; PLANT; AGROBACTERIUM; REGENERATION; CELLS; TRIMETHYLATION	Somatic embryogenesis (SE) can be readily induced in leaf explants of the Jemalong 2HA genotype of the model legume Medicago truncatula by auxin and cytokinin, but rarely in wild-type Jemalong. Gibberellic acid (GA), a hormone not included in the medium, appears to act in Arabidopsis as a repressor of the embryonic state such that low ABA (abscisic acid): GA ratios will inhibit SE. It was important to evaluate the GA effect in M. truncatula in order to formulate generic SE mechanisms, given the Arabidopsis information. It was surprising to find that low ABA:GA ratios in M. truncatula acted synergistically to stimulate SE. The unusual synergism between GA and ABA in inducing SE has utility in improving SE for regeneration and transformation in M. truncatula. Expression of genes previously shown to be important in M. truncatula SE was not increased. In investigating genes previously studied in GA investigations of Arabidopsis SE, there was increased expression of GA2ox and decreased expression of PICKLE, a negative regulator of SE in Arabidopsis. We suggest that in M. truncatula there are different ABA:GA ratios required for down-regulating the PICKLE gene, a repressor of the embryonic state. In M. truncatula it is a low ABA:GA ratio while in Arabidopsis it is a high ABA:GA ratio. In different species the expression of key genes is probably related to differences in how the hormone networks optimise their expression.	[Nolan, Kim E.; Song, Youhong; Liao, Siyang; Saeed, Nasir A.; Zhang, Xiyi; Rose, Ray J.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia	University of Newcastle	Rose, RJ (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia.	Ray.Rose@newcastle.edu.au	Nolan, Kim E/B-8794-2008; Song, Youhong/AAD-3654-2020		Australian Research Council [CEO348212]; University of Newcastle	Australian Research Council(Australian Research Council); University of Newcastle	This study was supported by Grant CEO348212 (Australian Research Council www.arc.gov.au); The University of Newcastle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozhkov PV, 2004, CELL DEATH DIFFER, V11, P175, DOI 10.1038/sj.cdd.4401330; Braybrook SA, 2006, P NATL ACAD SCI USA, V103, P3468, DOI 10.1073/pnas.0511331103; Braybrook SA, 2008, TRENDS PLANT SCI, V13, P624, DOI 10.1016/j.tplants.2008.09.008; Chabaud M, 1996, PLANT CELL REP, V15, P305, DOI 10.1007/BF00232361; Chen SK, 2009, PLANTA, V230, P827, DOI 10.1007/s00425-009-0988-1; Curaba J, 2004, PLANT PHYSIOL, V136, P3660, DOI 10.1104/pp.104.047266; DUDITS D, 1991, J CELL SCI, V99, P473; Elhiti M, 2010, J EXP BOT, V61, P4069, DOI 10.1093/jxb/erq222; Feher A, 2003, PLANT CELL TISS ORG, V74, P201, DOI 10.1023/A:1024033216561; Gaj MD, 2006, PLANT GROWTH REGUL, V49, P183, DOI 10.1007/s10725-006-9104-8; Gliwicka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069261; HALPERIN W, 1964, SCIENCE, V146, P408, DOI 10.1126/science.146.3642.408; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; Henderson JT, 2004, PLANT PHYSIOL, V134, P995, DOI 10.1104/pp.103.030148; Ikeda M, 2009, PLANT CELL, V21, P3493, DOI 10.1105/tpc.109.069997; Ikeda-Iwai M, 2003, PLANT J, V34, P107, DOI 10.1046/j.1365-313X.2003.01702.x; Kamada H, 1993, PLANT TISSUE CULTURE, V10, P38, DOI [DOI 10.5511/PLANTBI0TECHN0L0GY1984.10.38, DOI 10.5511/PLANTBIOTECHNOLOGY1984.10.38]; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Mantiri FR, 2008, PLANT PHYSIOL, V146, P1622, DOI 10.1104/pp.107.110379; Mantiri FR, 2008, PLANT SIGNAL BEHAV, V3, P498, DOI 10.4161/psb.3.7.6049; Marino D, 2011, NEW PHYTOL, V189, P580, DOI 10.1111/j.1469-8137.2010.03509.x; Neill S, 2002, CURR OPIN PLANT BIOL, V5, P388, DOI 10.1016/S1369-5266(02)00282-0; Nishiwaki M, 2000, PLANTA, V211, P756, DOI 10.1007/s004250000387; Nolan K. E., 2010, Plant cell culture: essential methods, P39, DOI 10.1002/9780470686522.ch3; Nolan KE, 2003, PLANT PHYSIOL, V133, P218, DOI 10.1104/pp.103.020917; Nolan KE, 1998, AUST J BOT, V46, P151, DOI 10.1071/BT96138; NOLAN KE, 1989, PLANT CELL REP, V8, P278, DOI 10.1007/BF00274129; Nolan KE, 2006, PLANT CELL REP, V25, P711, DOI 10.1007/s00299-006-0135-4; Nolan KE, 2009, J EXP BOT, V60, P1759, DOI 10.1093/jxb/erp046; Ogas J, 1997, SCIENCE, V277, P91, DOI 10.1126/science.277.5322.91; Pasternak TP, 2007, PLANT GROWTH REGUL, V51, P109, DOI 10.1007/s10725-006-9152-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piyatrakul P, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-244; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rieu I, 2008, PLANT CELL, V20, P2420, DOI 10.1105/tpc.108.058818; Rose RJ, 2010, PLANT DEVELOPMENTAL BIOLOGY: BIOTECHNOLOGICAL PERSPECTIVES VOL 2, P3, DOI 10.1007/978-3-642-04670-4_1; Rose R. J., 2013, SOMATIC EMBRYOGENESI, P146; Rose RJ, 2006, J EXP BOT, V57, P2227, DOI 10.1093/jxb/erj187; Rose RJ, 1999, J PLANT PHYSIOL, V155, P788, DOI 10.1016/S0176-1617(99)80097-2; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Sharma SK, 2008, PLANT MOL BIOL, V68, P185, DOI 10.1007/s11103-008-9360-2; Song Y, 2013, THESIS U NEWCASTLE C; Song YH, 2013, METHODS MOL BIOL, V1069, P203, DOI 10.1007/978-1-62703-613-9_14; Su YH, 2009, PLANT J, V59, P448, DOI 10.1111/j.1365-313X.2009.03880.x; THOMAS MR, 1992, PLANT CELL REP, V11, P113, DOI 10.1007/BF00232161; Tokuji Y, 2003, J PLANT PHYSIOL, V160, P133, DOI 10.1078/0176-1617-00892; Verdier J, 2008, PLANT MOL BIOL, V67, P567, DOI 10.1007/s11103-008-9320-x; Wang H, 2004, PLANT CELL, V16, P1206, DOI 10.1105/tpc.021261; Wang JH, 1996, AUST J PLANT PHYSIOL, V23, P265, DOI 10.1071/PP9960265; Weiss D, 2007, PLANT PHYSIOL, V144, P1240, DOI 10.1104/pp.107.100370; Yamada T, 2011, BREEDING SCI, V61, P480, DOI 10.1270/jsbbs.61.480; Zhang H, 2008, J BIOL CHEM, V283, P22637, DOI 10.1074/jbc.M802129200; Zhang H, 2012, PLANT PHYSIOL, V159, P418, DOI 10.1104/pp.112.194878; Zheng QL, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25422; Zheng QL, 2013, PLANT PHYSIOL, V161, P2113, DOI 10.1104/pp.113.216275	56	16	19	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99908	10.1371/journal.pone.0099908	http://dx.doi.org/10.1371/journal.pone.0099908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937316	Green Submitted, Green Published, gold			2022-12-25	WOS:000338503400055
J	Deng, XJ; Zhang, HQ; Wang, Y; He, F; Liu, JL; Xiao, X; Shu, ZF; Li, W; Wang, GH; Wang, GL				Deng, Xiao-juan; Zhang, Hai-qing; Wang, Yue; He, Feng; Liu, Jin-ling; Xiao, Xiao; Shu, Zhi-feng; Li, Wei; Wang, Guo-huai; Wang, Guo-liang			Mapped Clone and Functional Analysis of Leaf-Color Gene Ygl7 in a Rice Hybrid (Oryza sativa L. ssp indica)	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; CHLOROPHYLL-DEFICIENT MUTANT; MG-CHELATASE; MAGNESIUM-CHELATASE; DIVINYL REDUCTASE; H-SUBUNIT; IDENTIFICATION; BIOSYNTHESIS; CHLOROPLASTS; DISRUPTION	Leaf-color is an effective marker to identify the hybridization of rice. Leaf-color related genes function in chloroplast development and the photosynthetic pigment biosynthesis of higher plants. The ygl7 (yellow-green leaf 7) is a mutant with spontaneous yellow-green leaf phenotype across the whole lifespan but with no change to its yield traits. We cloned gene Ygl7 (Os03g59640) which encodes a magnesium-chelatase ChlD protein. Expression of ygl7 turns green-leaves to yellow, whereas RNAi-mediated silence of Ygl7 causes a lethal phenotype of the transgenic plants. This indicates the importance of the gene for rice plant. On the other hand, it corroborates that ygl7 is a non-null mutants. The content of photosynthetic pigment is lower in Ygl7 than the wild type, but its light efficiency was comparatively high. All these results indicated that the mutational YGL7 protein does not cause a complete loss of original function but instead acts as a new protein performing a new function. This new function partially includes its preceding function and possesses an additional feature to promote photosynthesis. Chl1, Ygl98, and Ygl3 are three alleles of the OsChlD gene that have been documented previously. However, mutational sites of OsChlD mutant gene and their encoded protein products were different in the three mutants. The three mutants have suppressed grain output. In our experiment, plant materials of three mutants (ygl7, chl1, and ygl98) all exhibited mutational leaf-color during the whole growth period. This result was somewhat different from previous studies. We used ygl7 as female crossed with chl1 and ygl98, respectively. Both the F-1 and F-2 generation display yellow-green leaf phenotype with their chlorophyll and carotenoid content falling between the values of their parents. Moreover, we noted an important phenomenon: ygl7-NIL's leaf-color is yellow, not yellowy-green, and this is also true of all back-crossed offspring with ygl7.	[Deng, Xiao-juan; Zhang, Hai-qing; Wang, Yue; He, Feng; Liu, Jin-ling; Xiao, Xiao; Shu, Zhi-feng; Wang, Guo-huai; Wang, Guo-liang] Hunan Agr Univ, Coll Agron, Changsha, Hunan, Peoples R China; [Deng, Xiao-juan; Wang, Yue; Wang, Guo-liang] Hunan Agr Univ, Hunan Prov Key Lab Crop Germplasm Innovat & Utili, Changsha, Hunan, Peoples R China; [Zhang, Hai-qing] State Key Lab Hybrid Rice, Wuhan, Hunan, Peoples R China; [He, Feng; Wang, Guo-liang] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Li, Wei] Hunan Agr Univ, Coll Plant Preservat, Changsha, Hunan, Peoples R China; [Wang, Guo-liang] Ohio State Univ, Dept Plant Pathol, Columbus, OH 43210 USA	Hunan Agricultural University; Hunan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Hunan Agricultural University; University System of Ohio; Ohio State University	Zhang, HQ (corresponding author), Hunan Agr Univ, Coll Agron, Changsha, Hunan, Peoples R China.	hunanhongli@aliyun.com		Wang, Guo-Liang/0000-0001-8877-3064	National Natural Science Foundation [30971839]; Hunan Natural Science Foundation [C110203]; Hunan Postgraduate Innovation project [CX2012B276]; Program for Innovative Research Team in University [IRT1239]; Rice Genomics Laboratory of Hunan Agricultural University	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Hunan Natural Science Foundation(Natural Science Foundation of Hunan Province); Hunan Postgraduate Innovation project; Program for Innovative Research Team in University; Rice Genomics Laboratory of Hunan Agricultural University	This study was supported by the National Natural Science Foundation (30971839), the Hunan Natural Science Foundation (C110203), the Hunan Postgraduate Innovation project (CX2012B276), the Program for Innovative Research Team in University (IRT1239), and the Rice Genomics Laboratory of Hunan Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apchelimov AA, 2007, PLANTA, V225, P935, DOI 10.1007/s00425-006-0390-1; Axelsson E, 2006, PLANT CELL, V18, P3606, DOI 10.1105/tpc.106.042374; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; Chai CL, 2011, PLANT MOL BIOL, V75, P211, DOI 10.1007/s11103-010-9719-z; Chen XZ, 2009, ACTA AGR JIANGXI, V9, P008, DOI DOI 10.1371/J0URNAL.P0NE.0072811; [邓晓娟 Deng Xiaojuan], 2012, [杂交水稻, Hybrid Rice], V27, P9; Deng XJ, 2010, CROP RES, V24, P46; Dong H, 2013, PLANT PHYSIOL, V162, P1867, DOI 10.1104/pp.113.217604; Fang J, 2008, PLANT J, V54, P177, DOI 10.1111/j.1365-313X.2008.03411.x; Gong XD, 2013, G3-GENES GENOM GENET, V3, P1769, DOI 10.1534/g3.113.007856; Gothandam KM, 2005, PLANT MOL BIOL, V58, P421, DOI 10.1007/s11103-005-5702-5; Guo RB, 1998, PLANT PHYSIOL, V116, P605, DOI 10.1104/pp.116.2.605; Han SH, 2012, MOL CELLS, V33, P87, DOI 10.1007/s10059-012-2218-0; Hibara K, 2009, DEV BIOL, V334, P345, DOI 10.1016/j.ydbio.2009.07.042; Hu F, 2012, PLANT SCI, V195, P125, DOI 10.1016/j.plantsci.2012.06.006; Huang JL, 2013, PLANT SCI, V210, P241, DOI 10.1016/j.plantsci.2013.06.003; Huang XQ, 2008, RICE SCI, V15, P7, DOI 10.1016/S1672-6308(08)60013-X; Jiang HW, 2007, PLANT J, V52, P197, DOI 10.1111/j.1365-313X.2007.03221.x; Jung KH, 2003, PLANT CELL PHYSIOL, V44, P463, DOI 10.1093/pcp/pcg064; Li JQ, 2013, J PLANT BIOL, V56, P326, DOI 10.1007/s12374-013-0180-9; Li YH, 2003, PLANT CELL, V15, P2020, DOI 10.1105/tpc.011775; Liu Sheng, 2013, Zhongguo Shuidao Kexue, V27, P231, DOI 10.3969/j.issn.1001-7216.2013.03.002; Liu WZ, 2007, PLANTA, V226, P785, DOI 10.1007/s00425-007-0525-z; Masuda T, 2008, PHOTOCH PHOTOBIO SCI, V7, P1131, DOI 10.1039/b807210h; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Mochizuki N, 2008, P NATL ACAD SCI USA, V105, P15184, DOI 10.1073/pnas.0803245105; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; Osanai T, 2009, P NATL ACAD SCI USA, V106, P6860, DOI 10.1073/pnas.0810040106; Park SY, 2007, PLANT CELL, V19, P1649, DOI 10.1105/tpc.106.044891; Peng Y, 2012, J GENET GENOMICS, V39, P385, DOI 10.1016/j.jgg.2012.05.001; PERRY KL, 1992, J GEN VIROL, V73, P2105, DOI 10.1099/0022-1317-73-8-2105; Rodermel S, 2003, BIOESSAYS, V25, P631, DOI 10.1002/bies.10308; Rogers S.O., 1989, EXTRACTION DNA PLANT, P73, DOI [10.1007/978-94-009-0951-9_6, DOI 10.1007/978-94-009-0951-9_6]; Sakuraba Y, 2013, PLANT J, V74, P122, DOI 10.1111/tpj.12110; Shu Q., 1996, ACTA AGRIC NUCL SIN, V10, P6; [宋克堡 SONG Kebao], 2007, [杂交水稻, Hybrid Rice], V22, P71; Stenbaek A, 2010, PHYTOCHEMISTRY, V71, P853, DOI 10.1016/j.phytochem.2010.03.022; Su N, 2012, PLANT PHYSIOL, V159, P227, DOI 10.1104/pp.112.195081; Sun XiaoQiu, 2011, Acta Agronomica Sinica, V37, P991, DOI 10.3724/SP.J.1006.2011.00991; Takai T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02149; Tang YanLin, 2004, Rice Science, V11, P274; Tian XQ, 2013, GENES GENOM, V35, P87, DOI 10.1007/s13258-013-0069-5; Tsuzuki T, 2011, J PLANT RES, V124, P527, DOI 10.1007/s10265-011-0426-x; Wang CT, 2008, CHINA SEED IND, V8, P24; Wang Jing-Fing, 2007, Hunan Shifan Daxue Ziran Kexue Xuebao, V30, P89; [王平荣 Wang Pingrong], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P1305; [王平荣 Wang Pingrong], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P225; Wang PR, 2010, PLANT PHYSIOL, V153, P994, DOI 10.1104/pp.110.158477; Wang ZK, 2013, GENES GENOM, V35, P491, DOI 10.1007/s13258-013-0094-4; Willows RD, 2004, J STRUCT BIOL, V146, P227, DOI 10.1016/j.jsb.2003.11.019; Yang QS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020015; Zhang FT, 2013, RICE, V6, DOI 10.1186/1939-8433-6-7; Zhang HT, 2006, PLANT MOL BIOL, V62, P325, DOI 10.1007/s11103-006-9024-z; [张向前 Zhang Xiangqian], 2010, [科学通报, Chinese Science Bulletin], V55, P2296, DOI 10.1360/972010-396; Zhou KN, 2013, PLANTA, V237, P279, DOI 10.1007/s00425-012-1756-1; Zhou Y, 2013, J OPTIMIZ THEORY APP, V156, P1, DOI 10.1007/s10957-013-0271-2	56	61	82	10	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99564	10.1371/journal.pone.0099564	http://dx.doi.org/10.1371/journal.pone.0099564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932524	gold, Green Published, Green Submitted			2022-12-25	WOS:000337738600042
J	Kling, RC; Tschammer, N; Lanig, H; Clark, T; Gmeiner, P				Kling, Ralf C.; Tschammer, Nuska; Lanig, Harald; Clark, Timothy; Gmeiner, Peter			Active-State Model of a Dopamine D-2 Receptor - G alpha(i) Complex Stabilized by Aripiprazole-Type Partial Agonists	PLOS ONE			English	Article							G-PROTEIN ACTIVATION; BETA(2)-ADRENERGIC RECEPTOR; STRUCTURAL BASIS; DRY MOTIF; EFFICACY; BINDING; CONFORMATIONS; FLEXIBILITY; MUTATIONS; EFFICIENT	Partial agonists exhibit a submaximal capacity to enhance the coupling of one receptor to an intracellular binding partner. Although a multitude of studies have reported different ligand-specific conformations for a given receptor, little is known about the mechanism by which different receptor conformations are connected to the capacity to activate the coupling to G-proteins. We have now performed molecular-dynamics simulations employing our recently described active-state homology model of the dopamine D-2 receptor-G alpha(i) protein-complex coupled to the partial agonists aripiprazole and FAUC350, in order to understand the structural determinants of partial agonism better. We have compared our findings with our model of the D2R-G alpha(i)-complex in the presence of the full agonist dopamine. The two partial agonists are capable of inducing different conformations of important structural motifs, including the extracellular loop regions, the binding pocket and, in particular, intracellular G-protein-binding domains. As G-protein-coupling to certain intracellular epitopes of the receptor is considered the key step of allosterically triggered nucleotide-exchange, it is tempting to assume that impaired coupling between the receptor and the G-protein caused by distinct ligand-specific conformations is a major determinant of partial agonist efficacy.	[Kling, Ralf C.; Tschammer, Nuska; Gmeiner, Peter] Univ Erlangen Nurnberg, Emil Fischer Ctr, Dept Chem & Pharm, D-91054 Erlangen, Germany; [Kling, Ralf C.; Lanig, Harald; Clark, Timothy] Univ Erlangen Nurnberg, Comp Chem Ctr, Dept Chem & Pharm, D-91054 Erlangen, Germany; [Lanig, Harald] Univ Erlangen Nurnberg, Cent Inst Sci Comp, D-91054 Erlangen, Germany; [Clark, Timothy] Univ Portsmouth, Ctr Mol Design, Portsmouth, Hants, England	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Portsmouth	Gmeiner, P (corresponding author), Univ Erlangen Nurnberg, Emil Fischer Ctr, Dept Chem & Pharm, D-91054 Erlangen, Germany.	peter.gmeiner@fau.de	Tschammer, Nuska/A-7359-2008; Gmeiner, Peter/N-5275-2015	Tschammer, Nuska/0000-0003-2433-3355; Clark, Timothy/0000-0001-7931-4659; Gmeiner, Peter/0000-0002-4127-197X; Lanig, Harald/0000-0003-1593-5557				Babin V., 2008, AMBER; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; CHO W, 1995, J NEUROCHEM, V65, P2105, DOI 10.1046/j.1471-4159.1995.65052105.x; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; Coley C, 2000, J NEUROCHEM, V74, P358, DOI 10.1046/j.1471-4159.2000.0740358.x; Daeffler KNM, 2012, J AM CHEM SOC, V134, P14890, DOI 10.1021/ja304560x; DeLeon A, 2004, CLIN THER, V26, P649, DOI 10.1016/S0149-2918(04)90066-5; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Ehrlich K, 2009, J MED CHEM, V52, P4923, DOI 10.1021/jm900690y; Elgeti M, 2011, J AM CHEM SOC, V133, P7159, DOI 10.1021/ja200545n; Fowler JC, 2012, MOL PHARMACOL, V81, P820, DOI 10.1124/mol.111.075457; Freedman R, 2003, NEW ENGL J MED, V349, P1738, DOI 10.1056/NEJMra035458; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Goetz A, 2011, J MOL BIOL; Goncalves JA, 2010, P NATL ACAD SCI USA, V107, P19861, DOI 10.1073/pnas.1009405107; Haberl F, 2009, PROTEINS, V77, P857, DOI 10.1002/prot.22505; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOGGER P, 1995, J BIOL CHEM, V270, P7405; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jantschak F, 2013, J PHARMACOL EXP THER, V347, P57, DOI 10.1124/jpet.113.205997; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kaye RG, 2011, MOL PHARMACOL, V79, P701, DOI 10.1124/mol.110.070177; Kenakin T, 2002, NAT REV DRUG DISCOV, V1, P103, DOI 10.1038/nrd722; Kiss B, 2010, J PHARMACOL EXP THER, V333, P328, DOI 10.1124/jpet.109.160432; Kling RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067244; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; Kobilka B, 2013, ANGEW CHEM INT EDIT, V52, P6380, DOI 10.1002/anie.201302116; Kofuku Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2046; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Lober S, 2011, TRENDS PHARMACOL SCI, V32, P148, DOI 10.1016/j.tips.2010.12.003; Masri B, 2008, P NATL ACAD SCI USA, V105, P13656, DOI 10.1073/pnas.0803522105; Miao YL, 2013, P NATL ACAD SCI USA, V110, P10982, DOI 10.1073/pnas.1309755110; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; MORO O, 1993, J BIOL CHEM, V268, P22273; Nanoff C, 2006, MOL PHARMACOL, V69, P397, DOI 10.1124/mol.105.016725; Niesen MJM, 2011, J AM CHEM SOC, V133, P13197, DOI 10.1021/ja205313h; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Preininger AM, 2013, J MOL BIOL, V425, P2288, DOI 10.1016/j.jmb.2013.04.011; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Schneider EH, 2010, J PHARMACOL EXP THER, V333, P382, DOI 10.1124/jpet.109.163220; Schrodinger L., 2020, PYMOL; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Seifert R, 2001, J PHARMACOL EXP THER, V297, P1218; Shan JF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002473; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Siu SWI, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2897760; Tadori Y, 2005, EUR J PHARMACOL, V515, P10, DOI 10.1016/j.ejphar.2005.02.051; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tschammer N, 2011, MOL PHARMACOL, V79, P575, DOI 10.1124/mol.110.068106; Tschammer N, 2010, ACS CHEM NEUROSCI, V1, P25, DOI 10.1021/cn900001b; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VOSS T, 1993, J BIOL CHEM, V268, P4637; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; West GM, 2011, STRUCTURE, V19, P1424, DOI 10.1016/j.str.2011.08.001; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Woodward R, 1996, J NEUROCHEM, V66, P394, DOI 10.1046/j.1471-4159.1996.66010394.x; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	73	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100069	10.1371/journal.pone.0100069	http://dx.doi.org/10.1371/journal.pone.0100069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932547	gold, Green Submitted, Green Published			2022-12-25	WOS:000337738600088
J	Liu, CL; Wang, JJ; Zhang, XB				Liu, Cuilian; Wang, Jiajia; Zhang, Xiaobo			The Involvement of MiR-1-Clathrin Pathway in the Regulation of Phagocytosis	PLOS ONE			English	Article							MICRORNA TARGET PREDICTIONS; MURINE MACROPHAGES; PROTEINS; SHRIMP; ACTIVATION; EXPRESSION; EVOLUTION; JAPONICUS; RECEPTOR; GTPASE	Phagocytosis, one of the most powerful immune responses, is a complicated process regulated by many factors. However the regulation of phagocytosis mediated by microRNAs has not been extensively investigated. To address this issue, the regulation of phagocytosis by miR-1 was characterized in this study. The results showed that miR-1 played an important role in the phagocytosis regulation in shrimp in vivo. The sequence analysis indicated that miR-1 was highly conserved from invertebrates to mammals, suggesting that miR-1 might share the similar or same functions in phagocytosis of shrimp hemocytes and mammalian macrophages. The data presented that miR-1 was significantly downregulated in cancerous macrophage RAW264.7 cells compared with those in the isolated murine macrophage and in the immortalized macrophage ANA-1. The findings showed that miR-1 had a great effect on the regulation of phagocytosis in cancerous macrophage by the inhibition of clathrin heavy chain 1 (CLTC1) gene. Therefore our study presented a novel miR-1-mediated regulation of phagocytosis both in invertebrate and in vertebrate.	[Zhang, Xiaobo] Zhejiang Univ, Minist Agr, Key Lab Anim Virol, Hangzhou 310003, Zhejiang, Peoples R China; Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University; Zhejiang University	Zhang, XB (corresponding author), Zhejiang Univ, Minist Agr, Key Lab Anim Virol, Hangzhou 310003, Zhejiang, Peoples R China.	zxb0812@zju.edu.cn		Zhang, Xiaobo/0000-0003-4606-212X	China Ocean Mineral Resources R D Association [DY125-15-E-01]; National Basic Research Program of China [2012CB114403]; Hi-Tech Research and Development Program of China (863 program of China) [2012AA092205-2]	China Ocean Mineral Resources R D Association; National Basic Research Program of China(National Basic Research Program of China); Hi-Tech Research and Development Program of China (863 program of China)(National High Technology Research and Development Program of China)	This work was financially supported by China Ocean Mineral Resources R & D Association (DY125-15-E-01), the National Basic Research Program of China (2012CB114403) and Hi-Tech Research and Development Program of China (863 program of China) (2012AA092205-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; BLASI E, 1985, NATURE, V318, P667, DOI 10.1038/318667a0; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Creighton CJ, 2008, RNA, V14, P2290, DOI 10.1261/rna.1188208; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Doran J, 2007, DNA CELL BIOL, V26, P353, DOI 10.1089/dna.2006.0546; Gresham HD, 2000, J EXP MED, V191, P515, DOI 10.1084/jem.191.3.515; Haworth R, 1998, METHOD MICROBIOL, V25, P287; Hayashi A, 2004, J BIOL CHEM, V279, P29450, DOI 10.1074/jbc.M400950200; Heasman SJ, 2003, J ENDOCRINOL, V178, P29, DOI 10.1677/joe.0.1780029; Junker A, 2009, BRAIN, V132, P3342, DOI 10.1093/brain/awp300; Kimbrell DA, 2001, NAT REV GENET, V2, P256, DOI 10.1038/35066006; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Liu WF, 2009, J PROTEOME RES, V8, P1198, DOI 10.1021/pr800840x; Mansfield PJ, 2000, BLOOD, V95, P2407, DOI 10.1182/blood.V95.7.2407.007k02_2407_2412; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Niedergang F, 2005, CURR TOP MICROBIOL, V291, P43; Niwa R, 2007, CURR OPIN GENET DEV, V17, P145, DOI 10.1016/j.gde.2007.02.004; ODIN JA, 1991, SCIENCE, V254, P1785, DOI 10.1126/science.1837175; Perry DG, 1999, J IMMUNOL, V162, P380; RALPH P, 1977, J IMMUNOL, V119, P950; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Rotshenker S, 2003, J MOL NEUROSCI, V21, P65, DOI 10.1385/JMN:21:1:65; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Wu WL, 2008, J PROTEOME RES, V7, P424, DOI 10.1021/pr700639t; Yang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039015; Zong RR, 2008, FISH SHELLFISH IMMUN, V25, P258, DOI 10.1016/j.fsi.2008.05.006	30	7	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e98747	10.1371/journal.pone.0098747	http://dx.doi.org/10.1371/journal.pone.0098747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932654	Green Published, Green Submitted, gold			2022-12-25	WOS:000337738600012
J	Hayashi, H; Terao, A; Kunimatsu, R; Kawata, T				Hayashi, Hidetaka; Terao, Akiko; Kunimatsu, Ryo; Kawata, Toshitsugu			Effects of a Low Level Laser on Periodontal Tissue in Hypofunctional Teeth	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OCCLUSAL STIMULI; ROOT RESORPTION; THERAPY; IRRADIATION; FIBROBLASTS; PROLIFERATION; GINGIVECTOMY; LIGAMENT	Malocclusions, such as an open bite and high canines, are often encountered in orthodontic practice. Teeth without occlusal stimuli are known as hypofunctional teeth, and numerous atrophic changes have been reported in the periodontal tissue, including reductions in blood vessels in the periodontal ligament (PDL), heavy root resorption, and reduced bone mineral density (BMD) in the alveolar bone. Low Level Laser (LLL) has been shown to have a positive effect on bone formation and the vasculature. Although the recovery of hypofunctional teeth remains unclear, LLL is expected to have a positive influence on periodontal tissue in occlusal hypofunction. The aim of the present study was to elucidate the relationship between LLL and periodontal tissue in occlusal hypofunction. Twenty-four male rats aged 5 weeks were randomly divided into control and hypofunctional groups. An anterior metal cap and bite plate were attached to the maxillary and mandibular incisors in the hypofunctional group to simulate occlusal hypofunction in the molars. LLL irradiation was applied to the maxillary first molar through the gingival sulcus in half of the rats. Rats were divided into four groups; control, control+LLL, hypofunctional, and hypofunctional+LLL. Exposure to LLL irradiation was performed for 3 minutes every other day for 2 weeks. Animals were examined by Micro-CT at 5 and 7 weeks and were subsequently sacrificed. Heads were resected and examined histologically and immunohistologically. The hypofunctional group had obvious stricture of the PDL. However, no significant differences were observed in the PDL and alveolar bone between the hypofunctional+LLL and the control groups. In addition, the expression of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF)positive cells were higher in the hypofunctional + LLL group than in the hypofunctional group. These results indicated that LLL enhanced the production of bFGF and VEGF in the periodontal tissue of hypofunctional teeth.	[Hayashi, Hidetaka] Hiroshima Shuccho Dent Clin, Hiroshima, Japan; [Terao, Akiko; Kunimatsu, Ryo] Hiroshima Univ, Dept Orthodont & Craniofacial Dev Biol, Grad Sch Biomed Sci, Hiroshima, Japan; [Kawata, Toshitsugu] Kanagawa Dent Univ, Dept Orthodont, Yokosuka, Kanagawa, Japan	Hiroshima University; Kanagawa Dental College	Hayashi, H (corresponding author), Hiroshima Shuccho Dent Clin, Hiroshima, Japan.	hidetaka423@yahoo.co.jp			ministry of Education, Culture, Sports, Science and Technology of Japan [24890141]	ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was funded by a Grant-in-Aid for Scientific Research from the ministry of Education, Culture, Sports, Science and Technology of Japan (24890141). Hidetaka Hayashi provided support in the form of salaries for author HH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Ministry of Education, Culture, Sports, Science and Technology of Japan had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge SE, 2005, BIOCHEM BIOPH RES CO, V335, P793, DOI 10.1016/j.bbrc.2005.07.145; Barolet D, 2008, SEMIN CUTAN MED SURG, V27, P227, DOI 10.1016/j.sder.2008.08.003; Boonpratham Supatchai, 2007, Journal of Medical and Dental Sciences, V54, P71; Faitova J, 2004, Cesk Fysiol, V53, P92; Amorim JCF, 2006, PHOTOMED LASER SURG, V24, P588; GOSPODAROWICZ D, 1990, CLIN ORTHOP RELAT R, P231; HARRIS EF, 1992, AM J ORTHOD DENTOFAC, V101, P112, DOI 10.1016/0889-5406(92)70002-R; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Khadra M, 2005, J BIOMED MATER RES A, V73A, P55, DOI 10.1002/jbm.a.30270; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Kreisler M, 2003, J CLIN PERIODONTOL, V30, P353, DOI 10.1034/j.1600-051X.2003.00001.x; Kronfeld R, 1931, J AM DENT ASSOC, V18, P1242; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Motokawa M, 2013, ANGLE ORTHOD, V83, P597, DOI 10.2319/081812-661.1; Niida S, 1999, J EXP MED, V190, P293, DOI 10.1084/jem.190.2.293; Ozcelik O, 2008, J CLIN PERIODONTOL, V35, P250, DOI 10.1111/j.1600-051X.2007.01194.x; Saygun I, 2008, LASER MED SCI, V23, P211, DOI 10.1007/s10103-007-0477-3; Seifi M, 2010, LASER MED SCI, V25, P61, DOI 10.1007/s10103-009-0651-x; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Shakouri SK, 2010, LASER MED SCI, V25, P73, DOI 10.1007/s10103-009-0670-7; Shimomoto Y, 2007, J DENT RES, V86, P47, DOI 10.1177/154405910708600107; Sringkarnboriboon S, 2003, J DENT RES, V82, P486, DOI 10.1177/154405910308200616; Tajali SB, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-1; Tanaka A, 1998, ORTHOD WAVES, V57, P180; Tuby H, 2006, LASER SURG MED, V38, P682, DOI 10.1002/lsm.20377	25	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100066	10.1371/journal.pone.0100066	http://dx.doi.org/10.1371/journal.pone.0100066			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927024	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100115
J	Locke, B; Forsgren, E; de Miranda, JR				Locke, Barbara; Forsgren, Eva; de Miranda, Joachim R.			Increased Tolerance and Resistance to Virus Infections: A Possible Factor in the Survival of Varroa destructor-Resistant Honey Bees (Apis mellifera)	PLOS ONE			English	Article							DEFORMED-WING VIRUS; SACBROOD VIRUS; VERTICAL-TRANSMISSION; COLONIES; MITES; INFESTATION; POPULATION; PREVALENCE; JACOBSONI; PATHOGENS	The honey bee ectoparasitic mite, Varroa destructor, has a world-wide distribution and inflicts more damage than all other known apicultural diseases. However, Varroa-induced colony mortality is more accurately a result of secondary virus infections vectored by the mite. This means that honey bee resistance to Varroa may include resistance or tolerance to virus infections. The aim of this study was to see if this is the case for a unique population of mite-resistant (MR) European honey bees on the island of Gotland, Sweden. This population has survived uncontrolled mite infestation for over a decade, developing specific mite-related resistance traits to do so. Using RT-qPCR techniques, we monitored late season virus infections, Varroa mite infestation and honey bee colony population dynamics in the Gotland MR population and compared this to mite-susceptible (MS) colonies in a close by apiary. From summer to autumn the deformed wing virus (DWV) titres increased similarly between the MR and MS populations, while the black queen cell virus (BQCV) and sacbrood virus (SBV) titres decreased substantially in the MR population compared to the MS population by several orders of magnitude. The MR colonies all survived the following winter with high mite infestation, high DWV infection, small colony size and low proportions of autumn brood, while the MS colonies all perished. Possible explanations for these changes in virus titres and their relevance to Varroa resistance and colony winter survival are discussed.	[Locke, Barbara; Forsgren, Eva; de Miranda, Joachim R.] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	Swedish University of Agricultural Sciences	Locke, B (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	Barbara.locke@slu.se	locke, barbara/X-1857-2019	locke, barbara/0000-0001-6083-9981; Rodrigues de Miranda, Joachim/0000-0002-0335-0386; Forsgren, Eva/0000-0002-8244-7265	Swedish Research Council Formas [2012-1060]; EU-funded 7th Framework project BEE DOC [244956]; EC - National Program through the Swedish Board of Agriculture	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); EU-funded 7th Framework project BEE DOC; EC - National Program through the Swedish Board of Agriculture	This work was financially supported both by The Swedish Research Council Formas (grant diarienr. 2012-1060) and by the EU-funded 7th Framework project BEE DOC (grant agreement 244956). Financial support for maintaining the Gotland population was obtained from the EC funded National Program through the Swedish Board of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D., 1993, Australasian Beekeeper, V94, P292; ANDERSON DL, 1992, J ECON ENTOMOL, V85, P47, DOI 10.1093/jee/85.1.47; BAILEY L, 1972, ANN APPL BIOL, V72, P27, DOI 10.1111/j.1744-7348.1972.tb01268.x; Bailey L., 1991, HONEY BEE PATHOLOGY; Boecking O, 2008, J VERBRAUCH LEBENSM, V3, P221, DOI 10.1007/s00003-008-0331-y; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; de Miranda JR, 2008, J INVERTEBR PATHOL, V98, P184, DOI 10.1016/j.jip.2008.02.004; de Miranda J. R., 2013, J APICULTURAL RES, V52; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; DEJONG D, 1982, J APICULT RES, V21, P165, DOI 10.1080/00218839.1982.11100535; Ellis JD, 2005, BEE WORLD, V86, P88, DOI 10.1080/0005772X.2005.11417323; Evans JD, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.11; Freiberg M, 2012, GENET MOL RES, V11, P3310, DOI 10.4238/2012.September.12.14; Fries I, 2003, APIDOLOGIE, V34, P389, DOI 10.1051/apido:2003032; FRIES I, 1991, EXP APPL ACAROL, V10, P279, DOI 10.1007/BF01198656; Fries I, 2006, APIDOLOGIE, V37, P564, DOI 10.1051/apido:2006031; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Imdorf A., 1990, Schweizerische Bienen-Zeitung, V113, P378; Kralj J, 2007, J COMP PHYSIOL A, V193, P363, DOI 10.1007/s00359-006-0192-8; Laidlaw Jr H. H., 1979, CONT QUEEN REARING; Le Conte Y, 2007, APIDOLOGIE, V38, P566, DOI 10.1051/apido:2007040; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Locke B, 2012, ECOL EVOL, V2, P1144, DOI 10.1002/ece3.248; Locke B, 2012, APPL ENVIRON MICROB, V78, P2073, DOI 10.1128/AEM.00086-12; Locke B, 2011, APIDOLOGIE, V42, P533, DOI 10.1007/s13592-011-0029-5; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; Medina LM, 2002, EXP APPL ACAROL, V27, P79, DOI 10.1023/A:1021579113907; Mockel N, 2011, J GEN VIROL, V92, P370, DOI 10.1099/vir.0.025940-0; Nielsen SL, 2008, APIDOLOGIE, V39, P310, DOI 10.1051/apido:2008007; Ribiere M., 2008, VIROLOGY HONEY BEE, P15, DOI DOI 10.1016/J.JVIROMET.2019.04.020; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Seeley TD, 2007, APIDOLOGIE, V38, P19, DOI 10.1051/apido:2006055; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Strauss U, 2013, J INVERTEBR PATHOL, V114, P45, DOI 10.1016/j.jip.2013.05.003; Sumpter DJT, 2004, J ANIM ECOL, V73, P51, DOI 10.1111/j.1365-2656.2004.00776.x; Teixeira EW, 2008, J INVERTEBR PATHOL, V99, P117, DOI 10.1016/j.jip.2008.03.014; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Topolska G, 2008, THESIS WARSAW U LIFE; Winston M.L., 1991, BIOL HONEY BEE; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0; Yue C, 2007, J GEN VIROL, V88, P2329, DOI 10.1099/vir.0.83101-0	48	64	66	1	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99998	10.1371/journal.pone.0099998	http://dx.doi.org/10.1371/journal.pone.0099998			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926792	Green Accepted, gold, Green Published			2022-12-25	WOS:000338278100105
J	Santolini, M; Mora, T; Hakim, V				Santolini, Marc; Mora, Thierry; Hakim, Vincent			A General Pairwise Interaction Model Provides an Accurate Description of In Vivo Transcription Factor Binding Sites	PLOS ONE			English	Article							IDENTIFICATION; NETWORK; STATISTICS; PATTERNS; CONTACTS; ELEMENTS; MODULES	The identification of transcription factor binding sites (TFBSs) on genomic DNA is of crucial importance for understanding and predicting regulatory elements in gene networks. TFBS motifs are commonly described by Position Weight Matrices (PWMs), in which each DNA base pair contributes independently to the transcription factor (TF) binding. However, this description ignores correlations between nucleotides at different positions, and is generally inaccurate: analysing fly and mouse in vivo ChIPseq data, we show that in most cases the PWM model fails to reproduce the observed statistics of TFBSs. To overcome this issue, we introduce the pairwise interaction model (PIM), a generalization of the PWM model. The model is based on the principle of maximum entropy and explicitly describes pairwise correlations between nucleotides at different positions, while being otherwise as unconstrained as possible. It is mathematically equivalent to considering a TF-DNA binding energy that depends additively on each nucleotide identity at all positions in the TFBS, like the PWM model, but also additively on pairs of nucleotides. We find that the PIM significantly improves over the PWM model, and even provides an optimal description of TFBS statistics within statistical noise. The PIM generalizes previous approaches to interdependent positions: it accounts for co-variation of two or more base pairs, and predicts secondary motifs, while outperforming multiple-motif models consisting of mixtures of PWMs. We analyse the structure of pairwise interactions between nucleotides, and find that they are sparse and dominantly located between consecutive base pairs in the flanking region of TFBS. Nonetheless, interactions between pairs of non-consecutive nucleotides are found to play a significant role in the obtained accurate description of TFBS statistics. The PIM is computationally tractable, and provides a general framework that should be useful for describing and predicting TFBSs beyond PWMs.	[Santolini, Marc; Mora, Thierry; Hakim, Vincent] Univ D Diderot, Univ Paris 06, CNRS, Ecole Normale Super,Lab Phys Stat, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite	Hakim, V (corresponding author), Univ D Diderot, Univ Paris 06, CNRS, Ecole Normale Super,Lab Phys Stat, Paris, France.	hakim@lps.ens.fr	Santolini, Marc/N-7530-2018	Santolini, Marc/0000-0003-1491-0120; hakim, vincent/0000-0001-7505-8192	CNRS institutional funds	CNRS institutional funds	This study was funded by CNRS institutional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; BARASH Y, 2003, P 7 ANN INT C RES CO, P28; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Bialek W, 2013, SOCIAL INTERACTIONS; Bialek W, 2012, P NATL ACAD SCI USA, V109, P4786, DOI 10.1073/pnas.1118633109; Bishop C.M., 2006, PATTERN RECOGNITION; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Cavagna A., 2013, DYNAMICAL MAXIMUM EN; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cocco S, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051123; Cocco S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003176; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Hu M, 2010, NUCLEIC ACIDS RES, V38, P2154, DOI 10.1093/nar/gkp1180; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; JAYNES ET, 1957, PHYS REV, V108, P171, DOI 10.1103/PhysRev.108.171; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Lassig M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S7; Man TK, 2001, NUCLEIC ACIDS RES, V29, P2471, DOI 10.1093/nar/29.12.2471; Mathelier A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003214; Mezard M., 1987, SPIN GLASS THEORY IN; Mora T, 2010, P NATL ACAD SCI USA, V107, P5405, DOI 10.1073/pnas.1001705107; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Moses AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r98; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Rivoire O, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.178102; Rouault H, 2010, P NATL ACAD SCI USA, V107, P14615, DOI 10.1073/pnas.1002876107; Roxin A, 2008, J NEUROSCI, V28, P10734, DOI 10.1523/JNEUROSCI.1016-08.2008; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sharon E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000154; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Siddharthan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009722; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stamatoyannopoulos JA, 2012, GENOME RES, V22, P1602, DOI 10.1101/gr.146506.112; Stormo GD, 1998, TRENDS BIOCHEM SCI, V23, P109, DOI 10.1016/S0968-0004(98)01187-6; Thomas MC, 2006, ELEMENTS INFORM THEO; Tkacik G, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003408; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Zhao Y, 2012, GENETICS, V191, P781, DOI 10.1534/genetics.112.138685; Zhou Q, 2004, BIOINFORMATICS, V20, P909, DOI 10.1093/bioinformatics/bth006; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	51	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99015	10.1371/journal.pone.0099015	http://dx.doi.org/10.1371/journal.pone.0099015			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926895	Green Submitted, Green Published, gold			2022-12-25	WOS:000338278100026
J	Mazzaferro, S; Gasparri, F; New, K; Alcaino, C; Faundez, M; Vasquez, PI; Vijayan, R; Biggin, PC; Bermudez, I				Mazzaferro, Simone; Gasparri, Federica; New, Karina; Alcaino, Constanza; Faundez, Manuel; Iturriaga Vasquez, Patricio; Vijayan, Ranjit; Biggin, Philip C.; Bermudez, Isabel			Non-equivalent Ligand Selectivity of Agonist Sites in (alpha 4 beta 2)(2)alpha 4 Nicotinic Acetylcholine Receptors A KEY DETERMINANT OF AGONIST EFFICACY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOKING-CESSATION DRUGS; ACH BINDING-SITE; RB-86(+) EFFLUX; LOW-SENSITIVITY; MOLECULAR DETERMINANTS; SUBUNIT; STOICHIOMETRY; EXPRESSION; INTERFACE; RESIDUES	The alpha 4 beta 2 nicotinic acetylcholine receptor (nAChR) is the most abundant nAChR type in the brain, and this receptor type exists in alternate (alpha 4 beta 2)(2)alpha 4 and (alpha 4 beta 2)(2)beta 2 forms, which are activated by agonists with strikingly differing efficacies. Recent breakthroughs have identified an additional operational agonist binding site in the (alpha 4 beta 2)(2)alpha 4 nAChR that is responsible for the signature sensitivity of this receptor to activation by agonists, yet the structural mechanisms determining agonist efficacy at this receptor type are not yet fully understood. In this study, we characterized the ligand selectivity of the individual agonist sites of the (alpha 4 beta 2)(2)alpha 4 nAChR to determine whether differences in agonist selectivity influence agonist efficacy. Applying the substituted cysteine accessibility method to individual agonist sites in concatenated (alpha 4 beta 2)(2)alpha 4 receptors, we determined the agonist selectivity of the agonist sites of the (alpha 4 beta 2)(2)alpha 4 receptor. We show that (a) accessibility of substituted cysteines to covalent modification by methanesulfonate reagent depends on the agonist site at which the modification occurs and (b) that agonists such as sazetidine-A and TC-2559 are excluded from the site at the alpha 4/alpha 4 interface. Given that additional binding to the agonist site in the alpha 4/alpha 4 interface increases acetylcholine efficacy and that agonists excluded from the agonist site at the alpha 4/alpha 4 interface behave as partial agonists, we conclude that the ability to engage all agonist sites in (alpha 4 beta 2)(2)alpha 4 nAChRs is a key determinant of agonist efficacy. The findings add another level of complexity to the structural mechanisms that govern agonist efficacy in heteromeric nAChRs and related ligand-gated ion channels.	[Bermudez, Isabel] Oxford Brookes Univ, Dept Biol & Med Sci, Fac Hlth & Life Sci, Oxford OX3 0BP, England; [Faundez, Manuel; Iturriaga Vasquez, Patricio] Univ Chile, Fac Sci, Dept Chem, Santiago, Chile; [Vijayan, Ranjit] United Arab Emirates Univ, Dept Biol, Coll Sci, Al Ain, U Arab Emirates; [Biggin, Philip C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Oxford Brookes University; Universidad de Chile; United Arab Emirates University; University of Oxford	Bermudez, I (corresponding author), Oxford Brookes Univ, Dept Biol & Med Sci, Fac Hlth & Life Sci, Gipsy Lane, Oxford OX3 0BP, England.	ibermudez@brookes.ac.uk	Alcaino, Constanza/AAD-9788-2020; Yoo, James J./L-4850-2017; Vijayan, Ranjit/GXF-4345-2022; Vijayan, Ranjit/AAH-6015-2019	Alcaino, Constanza/0000-0001-9595-4330; Vijayan, Ranjit/0000-0002-3830-7409; Vijayan, Ranjit/0000-0002-3830-7409; Faundez Parraguez, Manuel/0000-0002-1621-5327; Mazzaferro, Simone/0000-0003-4402-5325; Bermudez, Isabel/0000-0001-7692-1509; Biggin, Philip/0000-0001-5100-8836	Oxford Brookes University; Comision Nacional de Investigacion Cientifica and Tecnologica (CONiCYT) [1100542]	Oxford Brookes University; Comision Nacional de Investigacion Cientifica and Tecnologica (CONiCYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by Oxford Brookes University funding (to I. B., S. M., C. A. A., and K. N.) and Comision Nacional de Investigacion Cientifica and Tecnologica (CONiCYT) Grant 1100542 (to P. I. V.).	Baumann SW, 2003, J NEUROSCI, V23, P11158; Benallegue N, 2013, BRIT J PHARMACOL, V170, P304, DOI 10.1111/bph.12268; Billen B, 2012, P NATL ACAD SCI USA, V109, P9173, DOI 10.1073/pnas.1116397109; Blum AP, 2013, J BIOL CHEM, V288, P6991, DOI 10.1074/jbc.M112.439968; Brams M, 2011, J BIOL CHEM, V286, P4420, DOI 10.1074/jbc.M110.188730; CACHELIN AB, 1989, J PHYSIOL-LONDON, V415, P159, DOI 10.1113/jphysiol.1989.sp017717; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; ChavezNoriega LE, 1997, J PHARMACOL EXP THER, V280, P346; Durisic N, 2012, J NEUROSCI, V32, P12915, DOI 10.1523/JNEUROSCI.2050-12.2012; Faundez-Parraguez M, 2013, BIOORGAN MED CHEM, V21, P2687, DOI 10.1016/j.bmc.2013.03.024; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gotti C, 2008, MOL PHARMACOL, V73, P1796, DOI 10.1124/mol.108.045203; Hansen SB, 2004, J BIOL CHEM, V279, P24197, DOI 10.1074/jbc.M402452200; Harpsoe K, 2013, J BIOL CHEM, V288, P2559, DOI 10.1074/jbc.M112.436337; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Horenstein NA, 2007, J BIOL CHEM, V282, P5899, DOI 10.1074/jbc.M609202200; Iturriaga-Vasquez P, 2010, MOL PHARMACOL, V78, P366, DOI 10.1124/mol.110.065490; Krashia P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013611; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Mantione E, 2012, FUTURE MED CHEM, V4, P2217, DOI [10.4155/FMC.12.172, 10.4155/fmc.12.172]; Marks MJ, 2007, NEUROPHARMACOLOGY, V53, P390, DOI 10.1016/j.neuropharm.2007.05.021; Marks MJ, 2010, BIOCHEM PHARMACOL, V80, P1238, DOI 10.1016/j.bcp.2010.06.040; Marks MJ, 1999, J PHARMACOL EXP THER, V289, P1090; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; Mercado J, 2006, J NEUROSCI, V26, P2031, DOI 10.1523/JNEUROSCI.4555-05.2006; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; Papke RL, 2011, NEUROPHARMACOLOGY, V60, P159, DOI 10.1016/j.neuropharm.2010.07.014; Rode F, 2012, BRAIN RES, V1458, P67, DOI 10.1016/j.brainres.2012.03.064; Rucktooa P, 2012, J BIOL CHEM, V287, P23283, DOI 10.1074/jbc.M112.360347; Sine SM, 1997, J BIOL CHEM, V272, P23521, DOI 10.1074/jbc.272.38.23521; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Tavares XDS, 2012, J AM CHEM SOC, V134, P11474, DOI 10.1021/ja3011379; Timmermann DB, 2012, BRIT J PHARMACOL, V167, P164, DOI 10.1111/j.1476-5381.2012.01989.x; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Zhang H, 1997, BIOCHEMISTRY-US, V36, P15856, DOI 10.1021/bi972357u	40	33	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21795	21806		10.1074/jbc.M114.555136	http://dx.doi.org/10.1074/jbc.M114.555136			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24936069	hybrid, Green Published			2022-12-25	WOS:000340558300052
J	Shen, SJ; Sun, Q; Liang, ZY; Cui, XJ; Ren, XY; Chen, H; Zhang, X; Zhou, YD				Shen, Songjie; Sun, Qiang; Liang, Zhiyong; Cui, Xiaojiang; Ren, Xinyu; Chen, Huan; Zhang, Xiao; Zhou, Yidong			A Prognostic Model of Triple-Negative Breast Cancer Based on miR-27b-3p and Node Status	PLOS ONE			English	Article							MICRORNA EXPRESSION; METASTASIS; PROGRESSION; MICROARRAY; SIGNATURE; MIRNAS; FROZEN; GROWTH; STAGE; RNA	Objective: Triple-negative breast cancer (TNBC) is an aggressive but heterogeneous subtype of breast cancer. This study aimed to identify and validate a prognostic signature for TNBC patients to improve prognostic capability and to guide individualized treatment. Methods: We retrospectively analyzed the prognostic performance of clinicopathological characteristics and miRNAs in a training set of 58 patients with invasive ductal TNBC diagnosed between 2002 and 2012. A prediction model was developed based on independent clinicopathological and miRNA covariates. The prognostic value of the model was further validated in a separate set of 41 TNBC patients diagnosed between 2007 and 2008. Results: Only lymph node status was marginally significantly associated with poor prognosis of TNBC (P = 0.054), whereas other clinicopathological factors, including age, tumor size, histological grade, lymphovascular invasion, P53 status, Ki-67 index, and type of surgery, were not. The expression levels of miR-27b-3p, miR-107, and miR-103a-3p were significantly elevated in the metastatic group compared with the disease-free group (P value: 0.008, 0.005, and 0.050, respectively). The Cox proportional hazards regression analysis revealed that lymph node status and miR-27b-3p were independent predictors of poor prognosis (P value: 0.012 and 0.027, respectively). A logistic regression model was developed based on these two independent covariates, and the prognostic value of the model was subsequently confirmed in a separate validation set. The two different risk groups, which were stratified according to the model, showed significant differences in the rates of distant metastasis and breast cancer-related death not only in the training set (P value: 0.001 and 0.040, respectively) but also in the validation set (P value: 0.013 and 0.012, respectively). Conclusion: This model based on miRNA and node status covariates may be used to stratify TNBC patients into different prognostic subgroups for potentially individualized therapy.	[Shen, Songjie; Sun, Qiang; Zhou, Yidong] Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Breast Surg, Beijing 100730, Peoples R China; [Liang, Zhiyong; Ren, Xinyu] Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China; [Cui, Xiaojiang] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Womens Canc Program, Dept Surg,Dept Obstet & Gynecol, Los Angeles, CA 90048 USA; [Chen, Huan] Zhejiang Inst Microbiol, Dept Microbiol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Xiao] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Biostat & Bioinformat Core, Los Angeles, CA 90048 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Zhou, YD (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Breast Surg, Beijing 100730, Peoples R China.	zhouyidongpumc@163.com	Chen, Huan/CAH-8180-2022; Sun, Qiangming/GYE-2002-2022		Twelfth Five-year Key Programs for Science and Technology Development of China [2014BAI08B03]; Beijing Municipal Science and Technology Key Development Program [D090507043409009]; Beijing Natural Science Foundation [7132192]; Peking Union Medical College Hospital Youth Science Foundation (PUMCH) [2013-095]; National Institutes of Health [CA151610]; Avon Foundation [02-2010-068]; David Salomon Translational Breast Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA151610] Funding Source: NIH RePORTER	Twelfth Five-year Key Programs for Science and Technology Development of China; Beijing Municipal Science and Technology Key Development Program; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Peking Union Medical College Hospital Youth Science Foundation (PUMCH); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Avon Foundation; David Salomon Translational Breast Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Twelfth Five-year Key Programs for Science and Technology Development of China (2014BAI08B03), Beijing Municipal Science and Technology Key Development Program (D090507043409009), Beijing Natural Science Foundation (7132192), Peking Union Medical College Hospital Youth Science Foundation (PUMCH 2013-095), National Institutes of Health (CA151610), the Avon Foundation (02-2010-068), and David Salomon Translational Breast Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Cascione L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055910; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Constantinidou A, 2010, EXPERT REV ANTICANC, V10, P1197, DOI [10.1586/era.10.50, 10.1586/ERA.10.50]; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Dowsett M, 2013, J CLIN ONCOL, V31, P2783, DOI 10.1200/JCO.2012.46.1558; Ferracin M, 2010, EXPERT REV MOL DIAGN, V10, P297, DOI 10.1586/ERM.10.11; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Hallett RM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00227; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hernandez-Aya LF, 2011, J CLIN ONCOL, V29, P2628, DOI 10.1200/JCO.2010.32.1877; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Jin LJ, 2013, CANCER RES, V73, P2884, DOI 10.1158/0008-5472.CAN-12-2162; Kuo WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045831; Le XF, 2010, CANCER MICROENVIRON, V3, P137, DOI 10.1007/s12307-010-0037-4; Lee JJ, 2012, ONCOGENE, V31, P3818, DOI 10.1038/onc.2011.543; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Mulligan AM, 2008, CLIN CANCER RES, V14, P4168, DOI 10.1158/1078-0432.CCR-07-4543; Negrini M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1867; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Rothe F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020980; Shen Song-jie, 2013, Zhonghua Wai Ke Za Zhi, V51, P1000; Straver ME, 2010, BREAST CANCER RES TR, V119, P551, DOI 10.1007/s10549-009-0333-1; Svoboda M, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-31; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Toyama T, 2012, JPN J CLIN ONCOL, V42, P256, DOI 10.1093/jjco/hys001; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yau C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2753; Yu SL, 2007, DNA CELL BIOL, V26, P283, DOI 10.1089/dna.2006.0555; Zhang X, 2008, J MOL DIAGN, V10, P513, DOI 10.2353/jmoldx.2008.080077	40	32	34	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100664	10.1371/journal.pone.0100664	http://dx.doi.org/10.1371/journal.pone.0100664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945253	Green Published, gold, Green Submitted			2022-12-25	WOS:000340721500102
J	Toselli, C; Hyslop, CM; Hughes, M; Natale, DR; Santamaria, P; Huang, CTL				Toselli, Chiara; Hyslop, Colin M.; Hughes, Martha; Natale, David R.; Santamaria, Pere; Huang, Carol T. L.			Contribution of a Non-beta-Cell Source to beta-Cell Mass during Pregnancy	PLOS ONE			English	Article							ADULT-MOUSE PANCREAS; PROGENITOR CELLS; IN-VITRO; ENDOCRINE; DIFFERENTIATION; NEOGENESIS; MICE; PROLIFERATION; REGENERATION; EXPRESSION	beta-cell mass in the pancreas increases significantly during pregnancy as an adaptation to maternal insulin resistance. Lineage tracing studies in rodents have presented conflicting evidence on the role of cell duplication in the formation of new beta-cells during gestation, while recent human data suggest that new islets are a major contributor to increased beta-cell mass in pregnancy. Here, we aim to: 1) determine whether a non-beta-cell source contributes to the appearance of new beta-cells during pregnancy and 2) investigate whether recapitulation of the embryonic developmental pathway involving high expression of neurogenin 3 (Ngn3) plays a role in the up-regulation of beta-cell mass during pregnancy. Using a mouse beta-cell lineage-tracing model, which labels insulin-producing beta-cells with red fluorescent protein (RFP), we found that the percentage of labeled beta-cells dropped from 97% prior to pregnancy to 87% at mid-pregnancy. This suggests contribution of a non-beta-cell source to the increase in total beta-cell numbers during pregnancy. In addition, we observed a population of hormone-negative, Ngn3-positive cells in islets of both non-pregnant and pregnant mice, and this population dropped from 12% of all islets cells in the non-pregnant mice to 5% by day 8 of pregnancy. Concomitantly, a decrease in expression of Ngn3 and changes in its upstream regulatory network (Sox9 and Hes-1) as well as downstream targets (NeuroD, Nkx2.2, Rfx6 and IA1) were also observed during pregnancy. Our results show that duplication of pre-existing beta-cells is not the sole source of new beta-cells during pregnancy and that Ngn3 may be involved in this process.	[Toselli, Chiara; Hyslop, Colin M.; Hughes, Martha; Huang, Carol T. L.] Univ Calgary, Dept Pediat, Alberta Childrens Hosp, Res Inst,Fac Med, Calgary, AB T2N 1N4, Canada; [Natale, David R.] Univ Calif San Diego, Dept Reprod Med, San Diego, CA 92103 USA; [Santamaria, Pere] Univ Calgary, JMDRC, Calgary, AB, Canada; [Santamaria, Pere] Univ Calgary, Fac Med, Snyder Inst Chron Dis, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Santamaria, Pere] Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain	Alberta Childrens Hospital; University of Calgary; University of California System; University of California San Diego; University of Calgary; University of Calgary; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Huang, CTL (corresponding author), Univ Calgary, Dept Pediat, Alberta Childrens Hosp, Res Inst,Fac Med, Calgary, AB T2N 1N4, Canada.	Carol.Huang@albertahealthservices.ca	Santamaria, Pere/ABF-6823-2021	Natale, David/0000-0001-8365-455X	Canadian Diabetes Association [OG-3-12-3670, OG-3-13-4055-PS]; Alberta Children's Hospital Foundation [2010-014]; summer studentship from Alberta Innovates Health Solutions; Canadian Institutes for Health Research [MOP-43881]; Diabetes Association (Foothills); Canadian Diabetes Association	Canadian Diabetes Association; Alberta Children's Hospital Foundation; summer studentship from Alberta Innovates Health Solutions; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Diabetes Association (Foothills); Canadian Diabetes Association	This work was supported by grants from Canadian Diabetes Association (Grant OG-3-12-3670) and Alberta Children's Hospital Foundation (Grant 2010-014) to CTLH. CT was supported by a summer studentship from Alberta Innovates Health Solutions. P. Santamaria's contribution was supported by the Canadian Institutes for Health Research (Grant; MOP-43881) and the Canadian Diabetes Association (Grant OG-3-13-4055-PS). P. Santamaria is a Scientist of the AIHS and a scholar of the Instituto de Investigaciones Sanitarias Carlos III. The JMDRC was supported by the Diabetes Association (Foothills) and the Canadian Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouna S, 2010, ORGANOGENESIS, V6, P125, DOI 10.4161/org.6.2.10374; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Bar Y, 2008, DIABETES, V57, P2413, DOI 10.2337/db07-1323; Bonner-Weir S, 2008, BIOCHEM SOC T, V36, P353, DOI 10.1042/BST0360353; Bonner-Weir S, 2010, DIABETES, V59, P2340, DOI 10.2337/db10-0084; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Darville MI, 2006, BIOCHEM BIOPH RES CO, V339, P1063, DOI 10.1016/j.bbrc.2005.11.111; De Haro-Hernandez R, 2004, ARCH MED RES, V35, P114, DOI 10.1016/j.arcmed.2003.10.001; Demeterco C, 2009, DIABETES OBES METAB, V11, P46, DOI 10.1111/j.1463-1326.2009.01105.x; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dubois CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023131; Gasa R, 2004, P NATL ACAD SCI USA, V101, P13245, DOI 10.1073/pnas.0405301101; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Gierl MS, 2006, GENE DEV, V20, P2465, DOI 10.1101/gad.381806; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Lee CS, 2006, DIABETES, V55, P269; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Lynn FC, 2007, P NATL ACAD SCI USA, V104, P10500, DOI 10.1073/pnas.0704054104; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; Metzger DE, 2012, DEVELOPMENT, V139, P1447, DOI 10.1242/dev.072892; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Miyatsuka T, 2011, P NATL ACAD SCI USA, V108, P185, DOI 10.1073/pnas.1004842108; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Rooman I, 2006, AM J PATHOL, V169, P1206, DOI 10.2353/ajpath.2006.050926; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Sorenson RL, 2009, ENDOCRINOLOGY, V150, P1566, DOI 10.1210/en.2008-1710; Swales N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037055; Szabat M, 2009, ENDOCRINOLOGY, V150, P1627, DOI 10.1210/en.2008-1224; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Van de Casteele M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.52; Wang S, 2010, DEV BIOL, V339, P26, DOI 10.1016/j.ydbio.2009.12.009; Wang S, 2009, P NATL ACAD SCI USA, V106, P9715, DOI 10.1073/pnas.0904247106; Wilson ME, 2003, MECH DEVELOP, V120, P65, DOI 10.1016/S0925-4773(02)00333-7; Xiao XW, 2013, J CLIN INVEST, V123, P2207, DOI 10.1172/JCI66323; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yamamoto K, 2000, DIABETES, V49, P2021, DOI 10.2337/diabetes.49.12.2021	44	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100398	10.1371/journal.pone.0100398	http://dx.doi.org/10.1371/journal.pone.0100398			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940737	Green Published, gold, Green Submitted			2022-12-25	WOS:000338508200101
J	Tome-Garcia, J; Li, D; Ghazaryan, S; Shu, LM; Wu, LZ				Tome-Garcia, Jessica; Li, Dan; Ghazaryan, Seda; Shu, Limin; Wu, Lizhao			ERBB2 Increases Metastatic Potentials Specifically in Androgen-Insensitive Prostate Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ACTIVATED PROTEIN-KINASE; HER-2/NEU ONCOPROTEIN; PROGNOSTIC VALUE; NEU ONCOGENE; GENE ENCODES; EXPRESSION; C-ERBB-2; PATHWAY; MYC	Despite all the blood-based biomarkers used to monitor prostate cancer patients, prostate cancer remains as the second common cause of cancer mortality in men in the United States. This is largely due to a lack of understanding of the molecular pathways that are responsible for the aggressive forms of prostate cancers, the castrate-resistant prostate cancer and the metastatic prostate cancer. Cell signaling pathways activated by the ERBB2 oncogene or the RAS oncogene are frequently found to be altered in metastatic prostate cancers. To evaluate and define the role of the ERBB2/RAS pathway in prostate cancer metastasis, we have evaluated the impact of ERBB2- or RAS-overexpression on the metastatic potentials for four prostate cancer cell lines derived from tumors with different androgen sensitivities. To do so, we transfected the human DU145, LnCaP, and PC3 prostate cancer cells and the murine Myc-CaP prostate cancer cells with the activated form of ERBB2 or H-RAS and assessed their metastatic potentials by three complementary assays, a wound healing assay, a transwell motility assay, and a transwell invasion assay. We showed that while overexpression of ERBB2 increased the metastatic potential of the androgen-insensitive prostate cancer cells (i.e. PC3 and DU145), it did not affect metastatic potentials of the androgen-sensitive prostate cancer cells (i.e. LnCaP and Myc-CaP). In contrast, overexpression of H-RAS only increased the cell motility of Myc-CaP cells, which overexpress the human c-MYC oncogene. Our data suggest that ERBB2 collaborates with androgen signaling to promote prostate cancer metastasis, and that although RAS is one of the critical downstream effectors of ERBB2, it does not phenocopy ERBB2 for its impact on the metastatic potentials of prostate cancer cell lines.	[Tome-Garcia, Jessica; Li, Dan; Ghazaryan, Seda; Shu, Limin; Wu, Lizhao] Rutgers New Jersey Med Sch Canc Ctr, Newark, NJ 07101 USA; [Wu, Lizhao] Rutgers New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Wu, LZ (corresponding author), Rutgers New Jersey Med Sch Canc Ctr, Newark, NJ 07101 USA.	wuli@njms.rutgers.edu	, 丹丹/I-2223-2019	TOME GARCIA, JESSICA/0000-0003-0554-8676	Rutgers New Jersey Medical School	Rutgers New Jersey Medical School	Start-up funds from Rutgers New Jersey Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2012, CURR MED CHEM, V19, P3748; Bakin RE, 2003, CANCER RES, V63, P1981; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bonaccorsi L, 2004, J CANCER RES CLIN, V130, P604, DOI 10.1007/s00432-004-0581-8; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Chen Hong-Chen, 2004, V294, P15; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Erlich S, 2006, BIOCHEM PHARMACOL, V72, P427, DOI 10.1016/j.bcp.2006.05.007; FOX SB, 1994, BRIT J UROL, V74, P214, DOI 10.1111/j.1464-410X.1994.tb16589.x; GIRI DK, 1993, PROSTATE, V23, P329, DOI 10.1002/pros.2990230406; Grant S, 2002, FRONT BIOSCI-LANDMRK, V7, pD376, DOI 10.2741/grant; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; HUJANEN ES, 1985, CANCER RES, V45, P3517; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ilic D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004720.pub3; Itahana Koji, 2007, Methods Mol Biol, V371, P21; KAIGHN ME, 1979, INVEST UROL, V17, P16; KATOH M, 1993, BIOCHEM BIOPH RES CO, V192, P1189, DOI 10.1006/bbrc.1993.1542; KUHN EJ, 1993, J UROLOGY, V150, P1427, DOI 10.1016/S0022-5347(17)35799-3; Lau KS, 2009, MOL CELLS, V28, P315, DOI 10.1007/s10059-009-0143-7; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; Lyne JC, 1997, CANCER J SCI AM, V3, P21; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Morote J, 1999, INT J CANCER, V84, P421, DOI 10.1002/(SICI)1097-0215(19990820)84:4<421::AID-IJC16>3.0.CO;2-9; Mydlo JH, 1998, EUR UROL, V34, P426, DOI 10.1159/000019777; MYERS RB, 1994, J NATL CANCER I, V86, P1140, DOI 10.1093/jnci/86.15.1140; Nemeth JA, 1999, CANCER RES, V59, P1987; Osman I, 2005, J UROLOGY, V174, P2174, DOI 10.1097/01.ju.0000181205.23233.65; PAIK S, 1990, J CLIN ONCOL, V8, P103, DOI 10.1200/JCO.1990.8.1.103; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Rosello C, 2004, ACTA BIOTHEOR, V52, P343, DOI 10.1023/B:ACBI.0000046602.58202.5e; SADASIVAN R, 1993, J UROLOGY, V150, P126, DOI 10.1016/S0022-5347(17)35413-7; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Schmitt Fernando, 2009, Adv Ther, V26 Suppl 1, pS1, DOI 10.1007/s12325-009-0046-1; Schwartz S, 1998, INT J CANCER, V76, P464, DOI 10.1002/(SICI)1097-0215(19980518)76:4<464::AID-IJC3>3.0.CO;2-P; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Semenas J, 2012, CURR DRUG TARGETS, V13, P1308, DOI 10.2174/138945012802429615; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Signoretti S, 2000, JNCI-J NATL CANCER I, V92, P1918, DOI 10.1093/jnci/92.23.1918; SIKES RA, 1992, CANCER RES, V52, P3174; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; TILLEY WD, 1990, CANCER RES, V50, P5382; TOYOSHIMA K, 1986, COLD SPRING HARB SYM, V51, P977, DOI 10.1101/SQB.1986.051.01.111; Tran PT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002125; Traynor P, 2008, DIS MARKERS, V24, P157, DOI 10.1155/2008/918087; USHIRO H, 1980, J BIOL CHEM, V255, P8363; VISAKORPI T, 1992, MODERN PATHOL, V5, P643; Watson PA, 2005, CANCER RES, V65, P11565, DOI 10.1158/0008-5472.CAN-05-3441; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yin JJ, 2007, MOL CELL BIOL, V27, P7538, DOI 10.1128/MCB.00955-07; ZHAU HE, 1994, J CELL BIOCHEM, P208; Zhau HYE, 1996, PROSTATE, V28, P73	62	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99525	10.1371/journal.pone.0099525	http://dx.doi.org/10.1371/journal.pone.0099525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937171	gold, Green Submitted, Green Published			2022-12-25	WOS:000338503400022
J	Brock, SE; Rendon, BE; Xin, D; Yaddanapudi, K; Mitchell, RA				Brock, Stephanie E.; Rendon, Beatriz E.; Xin, Dan; Yaddanapudi, Kavitha; Mitchell, Robert A.			MIF Family Members Cooperatively Inhibit p53 Expression and Activity	PLOS ONE			English	Article							OXIDATIVE DNA-DAMAGE; CELL LUNG-CANCER; MIGRATION; ACTIVATION; PROMOTES; DEFICIENT; HOMOLOG; PATHWAY; CLONING; CDNA	The tumor suppressor p53 is induced by genotoxic stress in both normal and transformed cells and serves to transcriptionally coordinate cell cycle checkpoint control and programmed cell death responses. Macrophage migration inhibitory factor (MIF) is an autocrine and paracrine acting cytokine/growth factor that promotes lung adenocarcinoma cell motility, anchorage-independence and neo-angiogenic potential. Several recent studies indicate that the only known homolog of MIF, D-dopachrome tautomerase (D-DT - also referred to as MIF-2), has functionally redundant activities with MIF and cooperatively promotes MIF-dependent pro-tumorigenic phenotypes. We now report that MIF and D-DT synergistically inhibit steady state p53 phosphorylation, stabilization and transcriptional activity in human lung adenocarcinoma cell lines. The combined loss of MIF and D-DT by siRNA leads to dramatically reduced cell cycle progression, anchorage independence, focus formation and increased programmed cell death when compared to individual loss of MIF or D-DT. Importantly, p53 mutant and p53 null lung adenocarcinoma cell lines were only nominally rescued from the cell growth effects of MIF/D-DT combined deficiency suggesting only a minor role for p53 in these transformed cell growth phenotypes. Finally, increased p53 activation was found to be independent of aberrantly activated AMP-activated protein kinase (AMPK) that occurs in response to MIF/D-DT-deficiency but is dependent on reactive oxygen species (ROS) that mediate aberrant AMPK activation in these cells. Combined, these findings suggest that both p53 wildtype and mutant human lung adenocarcinoma tumors rely on MIF family members for maximal cell growth and survival.	[Brock, Stephanie E.; Rendon, Beatriz E.; Xin, Dan; Yaddanapudi, Kavitha; Mitchell, Robert A.] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40292 USA	University of Louisville	Mitchell, RA (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40292 USA.	robert.mitchell@louisville.edu			National Institutes of Health National Cancer Institute [CA102285]; Kentucky Lung Cancer Research Program; NATIONAL CANCER INSTITUTE [R01CA102285] Funding Source: NIH RePORTER	National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kentucky Lung Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health National Cancer Institute - CA102285 (RAM), and Kentucky Lung Cancer Research Program (RAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P747, DOI 10.4049/jimmunol.166.2.747; Achanta G, 2004, CANCER RES, V64, P6233, DOI 10.1158/0008-5472.CAN-04-0494; Agarwal ML, 1998, P NATL ACAD SCI USA, V95, P14775, DOI 10.1073/pnas.95.25.14775; Ahrendt SA, 2003, J NATL CANCER I, V95, P961, DOI 10.1093/jnci/95.13.961; Brock SE, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378299; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Coleman AM, 2008, J IMMUNOL, V181, P2330, DOI 10.4049/jimmunol.181.4.2330; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Dessein AF, 2010, CANCER RES, V70, P4644, DOI 10.1158/0008-5472.CAN-09-3828; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Jung H, 2008, J BIOL CHEM, V283, P32669, DOI 10.1074/jbc.M806225200; Jung HY, 2008, J BIOL CHEM, V283, P20383, DOI 10.1074/jbc.M800050200; Maillet A, 2012, ANTIOXID REDOX SIGN, V16, P1285, DOI 10.1089/ars.2011.4434; Martin JL, 2008, FASEB J, V22; McClelland M, 2009, AM J PATHOL, V174, P638, DOI 10.2353/ajpath.2009.080463; Merk M, 2012, CYTOKINE, V59, P10, DOI 10.1016/j.cyto.2012.03.014; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Nemajerova A, 2007, EMBO J, V26, P987, DOI 10.1038/sj.emboj.7601564; Nishihira J, 1998, BIOCHEM BIOPH RES CO, V243, P538, DOI 10.1006/bbrc.1998.8123; Panduri V, 2006, AM J RESP CELL MOL, V34, P443, DOI 10.1165/rcmb.2005-0352OC; Pasupuleti V, 2014, J BIOL CHEM, V289, P3713, DOI 10.1074/jbc.M113.500694; Ren Y, 2004, ONCOGENE, V23, P4146, DOI 10.1038/sj.onc.1207490; Rendon BE, 2007, J BIOL CHEM, V282, P29910, DOI 10.1074/jbc.M704898200; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Robles AI, 2002, ONCOGENE, V21, P6898, DOI 10.1038/sj.onc.1205563; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; RUSSELL KJ, 1995, CANCER RES, V55, P1639; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Soussi T, 2000, ANN NY ACAD SCI, V910, P121; Swope M, 1998, EMBO J, V17, P3534, DOI 10.1093/emboj/17.13.3534; Thiele M, 2005, ANTIOXID REDOX SIGN, V7, P1234, DOI 10.1089/ars.2005.7.1234; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; White ES, 2001, J IMMUNOL, V166, P7549, DOI 10.4049/jimmunol.166.12.7549; Wilson JM, 2005, GASTROENTEROLOGY, V129, P1485, DOI 10.1053/j.gastro.2005.07.061; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xin D, 2010, MOL CANCER RES, V8, P1601, DOI 10.1158/1541-7786.MCR-10-0101; Yaddanapudi K, 2013, J IMMUNOL, V190, P2984, DOI 10.4049/jimmunol.1201650; ZHANG M, 1995, FEBS LETT, V373, P203, DOI 10.1016/0014-5793(95)01041-C; Zhu WG, 2004, J BIOL CHEM, V279, P15161, DOI 10.1074/jbc.M311703200	45	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99795	10.1371/journal.pone.0099795	http://dx.doi.org/10.1371/journal.pone.0099795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932684	Green Submitted, Green Published, gold			2022-12-25	WOS:000337738600066
J	Kim, MH; Lee, SY; Lee, SE; Yang, MS; Jung, JW; Park, CM; Lee, W; Cho, SH; Kang, HR				Kim, Min-Hye; Lee, Suh-Young; Lee, Seung-Eun; Yang, Min-Suk; Jung, Jae-Woo; Park, Chang Min; Lee, Whal; Cho, Sang-Heon; Kang, Hye-Ryun			Anaphylaxis to Iodinated Contrast Media: Clinical Characteristics Related with Development of Anaphylactic Shock	PLOS ONE			English	Article							HYPERSENSITIVITY REACTIONS; SKIN-TESTS; ADVERSE-REACTIONS; RISK-FACTORS; PREVENTION; MANAGEMENT; PATHOPHYSIOLOGY	Objective: Anaphylaxis is the most severe form of radiocontrast media (RCM) induced hypersensitivity and can be life-threatening if profound hypotension is combined. With increased use of iodine based RCM, related hypersensitivity is rapidly growing. However, the clinical characteristics and risk factors of RCM induced anaphylaxis accompanied by hypotension (anaphylactic shock) are not clearly defined. This study was performed to investigate the risk factors of RCM induced anaphylactic shock and the clinical value of RCM skin testing to identify causative agents in affected patients. Methods: We analyzed the data of RCM induced anaphylaxis monitored by an inhospital pharmacovigilance center at a tertiary teaching hospital from January 2005 to December 2012 and compared the clinical features and skin test results according to the accompanying hypotension. Results: Among total of 104 cases of RCM induced anaphylaxis, 34.6% of patients, developed anaphylaxis on their first exposure to RCM. Anaphylactic patients presenting with shock were older (57.4 vs. 50.1 years, p = 0.026) and had a history of more frequently exposure to RCM (5.1 +/- 7.8 vs. 1.9 +/- 3.3, p = 0.004) compared to those without hypotension. Among RCMs, hypotension was more frequent in anaphylaxis related to iopromide compared to other agents (85.0% vs. 61.4%, p = 0.011). Skin tests were performed in 51 patients after development of RCM induced anaphylaxis. Overall skin test positivity to RCM was 64.7% and 81.8% in patients with anaphylactic shock. Conclusion: RCM induced anaphylactic shock is related to multiple exposures to RCM and most patients showed skin test positivity to RCM.	[Kim, Min-Hye; Lee, Suh-Young; Lee, Seung-Eun; Yang, Min-Suk; Cho, Sang-Heon; Kang, Hye-Ryun] Seoul Natl Univ Hosp, Div Allergy & Clin Immunol, Dept Internal Med, Seoul 110744, South Korea; [Kim, Min-Hye; Lee, Suh-Young; Lee, Seung-Eun; Yang, Min-Suk; Jung, Jae-Woo; Cho, Sang-Heon; Kang, Hye-Ryun] Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul, South Korea; [Kim, Min-Hye; Cho, Sang-Heon; Kang, Hye-Ryun] Seoul Natl Univ Hosp, Reg Pharmacovigilance Ctr, Seoul 110744, South Korea; [Kim, Min-Hye] Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea; [Yang, Min-Suk] SMG SNU Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Jung, Jae-Woo] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul 156756, South Korea; [Park, Chang Min; Lee, Whal] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Park, Chang Min; Lee, Whal] Seoul Natl Univ, Coll Med, Inst Radiat Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Ewha Womans University; Seoul National University (SNU); Seoul National University Hospital; Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kang, HR (corresponding author), Seoul Natl Univ Hosp, Div Allergy & Clin Immunol, Dept Internal Med, Seoul 110744, South Korea.	helenmed@snu.ac.kr	Lee, Seung Eun/ABG-1607-2021	Lee, Seung Eun/0000-0002-4266-7722	Ministry of Food and Drug Safety	Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This research was supported by a grant from Ministry of Food and Drug Safety to operation of the regional pharmacovigilance center in 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockow K, 2009, ALLERGY, V64, P234, DOI 10.1111/j.1398-9995.2008.01832.x; Brockow K, 2011, CURR OPIN ALLERGY CL, V11, P326, DOI 10.1097/ACI.0b013e32834877c3; Brockow K, 2010, CHEM IMMUNOL ALLERGY, V95, P157, DOI 10.1159/000315949; Caimmi S, 2010, CLIN EXP ALLERGY, V40, P805, DOI 10.1111/j.1365-2222.2010.03493.x; CASHMAN JD, 1991, MED J AUSTRALIA, V155, P618, DOI 10.5694/j.1326-5377.1991.tb93931.x; Davenport MS, 2009, RADIOLOGY, V253, P372, DOI 10.1148/radiol.2532090465; Dewachter P, 2011, EUR J RADIOL, V77, P495, DOI 10.1016/j.ejrad.2009.09.019; Goksel O, 2011, INT ARCH ALLERGY IMM, V155, P297, DOI 10.1159/000320760; Greenberger PA, 2007, ANN ALLERG ASTHMA IM, V98, P252, DOI 10.1016/S1081-1206(10)60714-4; KATAYAMA H, 1990, INVEST RADIOL, V25, pS16, DOI 10.1097/00004424-199009001-00007; Khan BQ, 2011, CURR OPIN ALLERGY CL, V11, P319, DOI 10.1097/ACI.0b013e3283481ab6; Kim MH, 2012, ANN ALLERG ASTHMA IM, V108, P167, DOI 10.1016/j.anai.2012.01.012; Kim SH, 2013, ANN ALLERG ASTHMA IM, V110, P258, DOI 10.1016/j.anai.2013.01.004; Lee JK, 2011, CLIN EXP ALLERGY, V41, P923, DOI 10.1111/j.1365-2222.2011.03779.x; Maddox TG, 2002, AM FAM PHYSICIAN, V66, P1229; Morcos SK, 2005, BRIT J RADIOL, V78, P686, DOI 10.1259/bjr/26301414; Morcos SK, 2001, EUR RADIOL, V11, P1720, DOI 10.1007/s003300000778; Muraro A, 2007, ALLERGY, V62, P857, DOI 10.1111/j.1398-9995.2007.01421.x; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Thomsen HS, 1998, DRUG SAFETY, V19, P313, DOI 10.2165/00002018-199819040-00006; Trcka J, 2008, AM J ROENTGENOL, V190, P666, DOI 10.2214/AJR.07.2872; Williams AN, 2007, ANN ALLERG ASTHMA IM, V99, P467, DOI 10.1016/S1081-1206(10)60574-1; Wysowski DK, 2006, AM J ROENTGENOL, V186, P613, DOI 10.2214/AJR.04.1790; Yang MS, 2008, ANN ALLERG ASTHMA IM, V100, P31, DOI 10.1016/S1081-1206(10)60401-2	24	54	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100154	10.1371/journal.pone.0100154	http://dx.doi.org/10.1371/journal.pone.0100154			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932635	gold, Green Submitted, Green Published			2022-12-25	WOS:000337738600098
J	Lim, SL; Ricciardelli, C; Oehler, MK; Tan, IMDD; Russell, D; Grutzner, F				Lim, Shu Ly; Ricciardelli, Carmela; Oehler, Martin K.; Tan, Izza M. D. De Arao; Russell, Darryl; Gruetzner, Frank			Overexpression of piRNA Pathway Genes in Epithelial Ovarian Cancer	PLOS ONE			English	Article							NOVO DNA METHYLATION; HIWI GENE; RETROTRANSPOSABLE ELEMENTS; HUMAN COLON; EXPRESSION; PIWI; LINE-1; HYPOMETHYLATION; MAELSTROM; PROTEIN	The importance of the Piwi-interacting RNA (piRNA) pathway for germ cell maintenance, genome integrity, DNA methylation and retrotransposon control raises possible roles of this pathway in cancer. Indeed aberrant expression of human PIWI orthologs and Maelstrom has been observed in various cancers. In this study we explored the expression and function of piRNA pathway genes in human ovarian cancer, based on our recent work, which showed widespread expression of piRNA pathway genes in the mammalian. Our work shows that PIWIL1 and MAEL expression is significantly increased in malignant EOC (n = 25) compared to benign tumor tissues (n = 19) and normal ovarian tissue (n = 8). The expression of PIWIL3 is lower in malignant and benign tissues when compared to normal ovary. Sequencing of PIWIL1 transcript revealed that in many tumors deletion of exon 17 leads to the introduction of a premature stop codon in the PIWI domain, likely due to a splicing error. In situ hybridization on tumor sections revealed that L1, PIWIL1, 2 and MAEL are specifically expressed in epithelial cells (cancerous cells) of EOC. Furthermore, PIWIL2 and MAEL are co-expressed in the stromal cells adjacent to tumor cells. Since PIWIL1 and MAEL are up regulated in malignant EOC and expressed in the epithelial cells, we investigated if these two genes affect invasiveness of ovarian cancer cell lines that do not normally express these genes. PIWIL1 and MAEL were transiently over expressed in the ovarian cancer cell line SKOV3, followed by real-time measurements of cell invasiveness. Surprisingly both PIWIL1 and MAEL over expression decreased the invasiveness of SKOV3 cells. Our findings support a growing body of evidence that shows that genes in this pathway are upregulated in cancer. In ovarian cancer we show for the first time that Piwil1 transcript may often be abnormal result in non functional product. In contrast to what has been observed in other cell types, we found that PIWIL1 and MAEL have a repressive effect on cell invasiveness.	[Lim, Shu Ly; Gruetzner, Frank] Univ Adelaide, Sch Mol & Biomed Sci, Robinson Res Inst, Adelaide, SA, Australia; [Ricciardelli, Carmela; Oehler, Martin K.; Tan, Izza M. D. De Arao; Russell, Darryl] Univ Adelaide, Robinson Res Inst, Discipline Obstet & Gynaecol, Adelaide, SA, Australia	Robinson Research Institute; University of Adelaide; Robinson Research Institute; University of Adelaide	Grutzner, F (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Robinson Res Inst, Adelaide, SA, Australia.	frank.grutzner@adelaide.edu.au	Ricciardelli, Carmela/U-1814-2019; Grutzner, Frank/ABB-2820-2021; Grutzner, Frank/AAD-5834-2020; Ricciardelli, Carmela/K-2212-2015; Russell, Darryl L/I-6654-2012	Ricciardelli, Carmela/0000-0001-7415-1854; Grutzner, Frank/0000-0002-3088-7314; Ricciardelli, Carmela/0000-0001-7415-1854; Russell, Darryl L/0000-0002-4930-7658	University of Adelaide; ARC (Australian Research Council)	University of Adelaide; ARC (Australian Research Council)(Australian Research Council)	This study was funded by the University of Adelaide. F. G. is supported by an ARC (Australian Research Council) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves G, 1996, GENE, V176, P39, DOI 10.1016/0378-1119(96)00205-3; Anttonen M, 2003, BIOL REPROD, V68, P1333, DOI 10.1095/biolreprod.102.008599; Aravin AA, 2008, GENE DEV, V22, P970, DOI 10.1101/gad.1669408; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Asch HL, 1996, ONCOL RES, V8, P239; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Berasain C, 2010, WORLD J GASTROENTERO, V16, P3091, DOI 10.3748/wjg.v16.i25.3091; Brown DC, 2002, HISTOPATHOLOGY, V40, P2, DOI 10.1046/j.1365-2559.2002.01343.x; Chen C, 2013, CANCER BIOMARK, V13, P315, DOI 10.3233/CBM-130360; Cirri P, 2011, AM J CANCER RES, V1, P482; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Eisenberg MC, 2011, P NATL ACAD SCI US; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Foster R, 2013, CANCER LETT, V338, P147, DOI 10.1016/j.canlet.2012.10.023; Gilles C, 1996, INT J CANCER, V65, P209; Grochola LF, 2008, BRIT J CANCER, V99, P1083, DOI 10.1038/sj.bjc.6604653; Gualtieri A, 2013, ONCOTARGET, V4, P1882, DOI 10.18632/oncotarget.1188; Iramaneerat K, 2011, INT J GYNECOL CANCER, V21, P51, DOI 10.1097/IGC.0b013e3182021c1a; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee JH, 2006, MOL REPROD DEV, V73, P173, DOI 10.1002/mrd.20391; Li L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-38; Liang D, 2013, ASIAN PAC J CANCER P, V14, P1067, DOI 10.7314/APJCP.2013.14.2.1067; Lim SL, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111211; Liu JJ, 2010, INT J CLIN EXP PATHO, V3, P328; Liu LL, 2014, HEPATOLOGY, V59, P531, DOI 10.1002/hep.26677; Liu XY, 2006, INT J CANCER, V118, P1922, DOI 10.1002/ijc.21575; Lu ZY, 2012, ONCOL REP, V27, P1587, DOI 10.3892/or.2012.1685; OKADA A, 1995, P NATL ACAD SCI USA, V92, P2730, DOI 10.1073/pnas.92.7.2730; Pek JW, 2009, DEV CELL, V17, P417, DOI 10.1016/j.devcel.2009.07.017; Piskareva O, 2011, CURR MOL MED, V11, P286, DOI 10.2174/156652411795677954; Qiao D, 2002, ONCOGENE, V21, P3988, DOI 10.1038/sj.onc.1205505; Ricciardelli C, 2009, MATURITAS, V62, P270, DOI 10.1016/j.maturitas.2009.01.001; Roman-Gomez J, 2005, ONCOGENE, V24, P7213, DOI 10.1038/sj.onc.1208866; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Shahali M, 2013, CELL J, V15, P250; Sharma A, 2012, ULTRASOUND OBST GYN, V40, P338, DOI 10.1002/uog.12270; Sharma AK, 2001, BLOOD, V97, P426, DOI 10.1182/blood.V97.2.426; Shuangshoti S, 2007, ASIAN PAC J CANCER P, V8, P307; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Smallwood SA, 2012, TRENDS GENET, V28, P33, DOI 10.1016/j.tig.2011.09.004; Soper SFC, 2008, DEV CELL, V15, P285, DOI 10.1016/j.devcel.2008.05.015; Stahtea XN, 2007, INT J CANCER, V121, P2808, DOI 10.1002/ijc.23029; Sun GA, 2011, BRAIN RES, V1373, P183, DOI 10.1016/j.brainres.2010.11.097; Taubert H, 2007, ONCOGENE, V26, P1098, DOI 10.1038/sj.onc.1209880; WOLF CR, 1987, INT J CANCER, V39, P695, DOI 10.1002/ijc.2910390607; Xi Biao, 2008, Biotechnology Journal, V3, P484, DOI 10.1002/biot.200800020; Xiao L, 2010, MOL BIOL REP, V37, P2355, DOI 10.1007/s11033-009-9741-x; Zhang DP, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-48	53	42	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99687	10.1371/journal.pone.0099687	http://dx.doi.org/10.1371/journal.pone.0099687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932571	Green Published, Green Submitted, gold			2022-12-25	WOS:000337738600055
J	Turer, AT; Lewis, GD; O'Sullivan, JF; Elmariah, S; Mega, JL; Addo, TA; Sabatine, MS; de Lemos, JA; Gerszten, RE				Turer, Aslan T.; Lewis, Gregory D.; O'Sullivan, John F.; Elmariah, Sammy; Mega, Jessica L.; Addo, Tayo A.; Sabatine, Marc S.; de Lemos, James A.; Gerszten, Robert E.			Increases in Myocardial Workload Induced by Rapid Atrial Pacing Trigger Alterations in Global Metabolism	PLOS ONE			English	Article							BILE-ACIDS; ISCHEMIA; ADENOSINE; HUMANS; BLOOD; FAT	Objective: To determine whether increases in cardiac work lead to alterations in the plasma metabolome and whether such changes arise from the heart or peripheral organs. Background: There is growing evidence that the heart influences systemic metabolism through endocrine effects and affecting pathways involved in energy homeostasis. Methods: Nineteen patients referred for cardiac catheterization were enrolled. Peripheral and selective coronary sinus (CS) blood sampling was performed at serial timepoints following the initiation of pacing, and metabolite profiling was performed by liquid chromatography-mass spectrometry (LC-MS). Results: Pacing-stress resulted in a 225% increase in the median rate? pressure product from baseline. Increased myocardial work induced significant changes in the peripheral concentration of 43 of 125 metabolites assayed, including large changes in purine [ adenosine (+99%, p = 0.006), ADP (+42%, p = 0.01), AMP (+79%, p = 0.004), GDP (+69%, p = 0.003), GMP (+58%, p = 0.01), IMP (+50%, p = 0.03), xanthine (+61%, p = 0.0006)], and several bile acid metabolites. The CS changes in metabolites qualitatively mirrored those in the peripheral blood in both timing and magnitude, suggesting the heart was not the major source of the metabolite release. Conclusions: Isolated increases in myocardial work can induce changes in the plasma metabolome, but these changes do not appear to be directly cardiac in origin. A number of these dynamic metabolites have known signaling functions. Our study provides additional evidence to a growing body of literature on metabolic 'cross-talk' between the heart and other organs.	[Turer, Aslan T.; de Lemos, James A.] Univ Texas SW Med Ctr Dallas, Dept Med, Div Cardiol, Dallas, TX 75390 USA; [Lewis, Gregory D.; O'Sullivan, John F.; Elmariah, Sammy; Addo, Tayo A.; Gerszten, Robert E.] Massachusetts Gen Hosp, Dept Internal Med, Div Cardiol, Boston, MA 02114 USA; [Mega, Jessica L.; Sabatine, Marc S.] Brigham & Womens Hosp, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Turer, AT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Med, Div Cardiol, Dallas, TX 75390 USA.	aslan.turer@utsouthwestern.edu	Sabatine, Marc/AAJ-6751-2020; de Lemos, James/ABD-6669-2021; Elmariah, Sammy/AAG-8752-2021	Sabatine, Marc/0000-0002-0691-3359; Elmariah, Sammy/0000-0002-8013-8733; O'Sullivan, John/0000-0001-8016-5128	Abbott Laboratories; Ortho-Clinical Diagnostics; Roche Diagnostics; Singulex; National Institutes of Health [K23 HL 091106, R01HL098280, R01DK081572, HHSN268201000033C]; American Heart Association Established Investigator Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098280, K23HL091106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081572] Funding Source: NIH RePORTER	Abbott Laboratories(Abbott Laboratories); Ortho-Clinical Diagnostics; Roche Diagnostics; Singulex; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Established Investigator Award(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Sabatine: Abbott Laboratories, Ortho-Clinical Diagnostics, Roche Diagnostics, Singulex; Dr. de Lemos: Abbott Diagnostics, Roche Diagnostics; Dr Lewis: National Institutes of Health Grant: #K23 HL 091106; Dr Gerszten: National Institutes of Health Grants #R01HL098280 and #R01DK081572, National Institutes of Health contract #HHSN268201000033C, and American Heart Association Established Investigator Award; the other authors have no relevant disclosures. No companies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodi V, 2012, J AM COLL CARDIOL, V59, P1629, DOI 10.1016/j.jacc.2011.09.083; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Brunner MP, 2011, CIRC-CARDIOVASC GENE, V4, P695, DOI 10.1161/CIRCGENETICS.111.960575; Cao RS, 2010, J LIPID RES, V51, P2234, DOI 10.1194/jlr.M004929; ELY SW, 1992, CIRCULATION, V85, P893, DOI 10.1161/01.CIR.85.3.893; Grueter CE, 2012, CELL, V149, P671, DOI 10.1016/j.cell.2012.03.029; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Lewis GD, 2008, J CLIN INVEST, V118, P3503, DOI 10.1172/JCI35111; Lewis GD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001006; MARKHAM RV, 1983, AM J CARDIOL, V51, P1589, DOI 10.1016/0002-9149(83)90192-3; Paganelli F, 2000, EUR J CLIN INVEST, V30, P105; Rhee EP, 2013, J AM SOC NEPHROL, V24, P1330, DOI 10.1681/ASN.2012101006; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Turer AT, 2011, J AM COLL CARDIOL, V57, P2398, DOI 10.1016/j.jacc.2010.11.066; Turer AT, 2009, CIRCULATION, V119, P1736, DOI 10.1161/CIRCULATIONAHA.108.816116; Wang TJ, 2012, NEW ENGL J MED, V367, P377, DOI 10.1056/NEJMcibr1204796	17	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99058	10.1371/journal.pone.0099058	http://dx.doi.org/10.1371/journal.pone.0099058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932507	Green Submitted, Green Published, gold			2022-12-25	WOS:000337738600020
J	Drujont, L; Carretero-Iglesia, L; Bouchet-Delbos, L; Beriou, G; Merieau, E; Hill, M; Delneste, Y; Cuturi, MC; Louvet, C				Drujont, Lucile; Carretero-Iglesia, Laura; Bouchet-Delbos, Laurence; Beriou, Gaelle; Merieau, Emmanuel; Hill, Marcelo; Delneste, Yves; Cuturi, Maria Cristina; Louvet, Cedric			Evaluation of the Therapeutic Potential of Bone Marrow-Derived Myeloid Suppressor Cell (MDSC) Adoptive Transfer in Mouse Models of Autoimmunity and Allograft Rejection	PLOS ONE			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; DIFFERENTIATION; ACCUMULATE; TOLERANCE; MONOCYTES; RESPONSES; SURVIVAL; DISEASE; PGE(2)	Therapeutic use of immunoregulatory cells represents a promising approach for the treatment of uncontrolled immunity. During the last decade, myeloid-derived suppressor cells (MDSC) have emerged as novel key regulatory players in the context of tumor growth, inflammation, transplantation or autoimmunity. Recently, MDSC have been successfully generated in vitro from naive mouse bone marrow cells or healthy human PBMCs using minimal cytokine combinations. In this study, we aimed to evaluate the potential of adoptive transfer of such cells to control auto-and allo-immunity in the mouse. Culture of bone marrow cells with GM-CSF and IL-6 consistently yielded a majority of CD11b(+) Gr1(hi/lo) cells exhibiting strong inhibition of CD8(+) T cell proliferation in vitro. However, adoptive transfer of these cells failed to alter antigen-specific CD8(+) T cell proliferation and cytotoxicity in vivo. Furthermore, MDSC could not prevent the development of autoimmunity in a stringent model of type 1 diabetes. Rather, loading the cells prior to injection with a pancreatic neo-antigen peptide accelerated the development of the disease. Contrastingly, in a model of skin transplantation, repeated injection of MDSC or single injection of LPS-activated MDSC resulted in a significant prolongation of allograft survival. The beneficial effect of MDSC infusions on skin graft survival was paradoxically not explained by a decrease of donor-specific T cell response but associated with a systemic over-activation of T cells and antigen presenting cells, prominently in the spleen. Taken together, our results indicate that in vitro generated MDSC bear therapeutic potential but will require additional in vitro factors or adjunct immunosuppressive treatments to achieve safe and more robust immunomodulation upon adoptive transfer.	[Drujont, Lucile; Carretero-Iglesia, Laura; Bouchet-Delbos, Laurence; Beriou, Gaelle; Merieau, Emmanuel; Hill, Marcelo; Cuturi, Maria Cristina; Louvet, Cedric] INSERM, UMR S 1064, ITUN, Ctr Res Transplantat & Immunol, Nantes, France; [Delneste, Yves] Univ Angers, CHU Angers, INSERM, UMR 892,CNRS 6299,Lab Immunol & Allergol, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Louvet, C (corresponding author), INSERM, UMR S 1064, ITUN, Ctr Res Transplantat & Immunol, Nantes, France.	cedric.louvet@univ-nantes.fr	DELNESTE, Yves/K-7367-2015; Delneste, Yves/O-3956-2016	DELNESTE, Yves/0000-0002-2142-596X; Hill, Marcelo/0000-0002-1589-0320	Labex IGO project - "Investissements d'Avenir" French Government program; IHU-Cesti, region Pays de la Loire et Nantes Metropole; Inserm-Region Pays de la Loire fellowship; Inserm "young researcher'' CDD;  [ANR-11-LABX-0016-01];  [ANR-10-IBHU-005]	Labex IGO project - "Investissements d'Avenir" French Government program(French National Research Agency (ANR)); IHU-Cesti, region Pays de la Loire et Nantes Metropole(Region Pays de la Loire); Inserm-Region Pays de la Loire fellowship(Region Pays de la Loire); Inserm "young researcher'' CDD; ; 	This work has been carried out thanks to the support of the Labex IGO project (no ANR-11-LABX-0016-01) funded by the "Investissements d'Avenir" French Government program, managed by the French National Research Agency (ANR). This work was also supported by funds from IHU-Cesti (Investissement d'Avenir ANR-10-IBHU-005, region Pays de la Loire et Nantes Metropole). LD was supported by an Inserm-Region Pays de la Loire fellowship. CL was supported by an Inserm "young researcher'' CDD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeegbe D, 2011, CELL TRANSPLANT, V20, P941, DOI 10.3727/096368910X540621; Brennan TV, 2011, J SURG RES, V169, pE69, DOI 10.1016/j.jss.2011.03.021; Centuori SM, 2012, J LEUKOCYTE BIOL, V92, P987, DOI 10.1189/jlb.0911465; CHOU HS, 2011, TRANSPLANTATION; Colonna L, 2011, J IMMUNOL, V187, P1516, DOI 10.4049/jimmunol.1190038; Cripps JG, 2011, INT IMMUNOPHARMACOL, V11, P789, DOI 10.1016/j.intimp.2011.01.026; De Wilde V, 2009, AM J TRANSPLANT, V9, P2034, DOI 10.1111/j.1600-6143.2009.02757.x; Dilek N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00208; Dilek N, 2012, J IMMUNOL, V188, P4209, DOI 10.4049/jimmunol.1101512; Dugast AS, 2008, J IMMUNOL, V180, P7898, DOI 10.4049/jimmunol.180.12.7898; Eruslanov E, 2010, J LEUKOCYTE BIOL, V88, P839, DOI 10.1189/jlb.1209821; Fujii W, 2013, J IMMUNOL, V191, P1073, DOI 10.4049/jimmunol.1203535; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Guan QD, 2013, J LEUKOCYTE BIOL, V94, P803, DOI 10.1189/jlb.0113050; Haile LA, 2008, GASTROENTEROLOGY, V135, P871, DOI 10.1053/j.gastro.2008.06.032; Harbers SO, 2007, J CLIN INVEST, V117, P1361, DOI 10.1172/JCI29470; Highfill SL, 2010, BLOOD, V116, P5738, DOI 10.1182/blood-2010-06-287839; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hu CY, 2012, J IMMUNOL, V188, P294, DOI 10.4049/jimmunol.1101590; Ioannou M, 2012, J IMMUNOL, V188, P1136, DOI 10.4049/jimmunol.1101816; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Leslie M, 2011, SCIENCE, V332, P1020, DOI 10.1126/science.332.6033.1020; Luan Y, 2013, AM J TRANSPLANT, V13, P3123, DOI 10.1111/ajt.12461; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Nagaraj S, 2013, J IMMUNOL, V191, P17, DOI 10.4049/jimmunol.1300654; Nefedova Y, 2004, J IMMUNOL, V172, P464, DOI 10.4049/jimmunol.172.1.464; Obermajer N, 2011, BLOOD, V118, P5498, DOI 10.1182/blood-2011-07-365825; Ochando JC, 2012, IMMUNOL RES, V54, P275, DOI 10.1007/s12026-012-8335-1; Pan PY, 2010, CANCER RES, V70, P99, DOI 10.1158/0008-5472.CAN-09-1882; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Ribechini E, 2010, MED MICROBIOL IMMUN, V199, P273, DOI 10.1007/s00430-010-0151-4; Garcia MR, 2010, J CLIN INVEST, V120, P2486, DOI 10.1172/JCI41628; Rossner S, 2005, EUR J IMMUNOL, V35, P3533, DOI 10.1002/eji.200526172; Sade-Feldman M, 2013, IMMUNITY, V38, P541, DOI 10.1016/j.immuni.2013.02.007; Schmidt K, 2013, BLOOD, V121, P1740, DOI 10.1182/blood-2012-06-436568; Singh V, 2011, EUR J IMMUNOL, V41, P2871, DOI 10.1002/eji.201141696; Tang QZ, 2012, J MOL CELL BIOL, V4, P11, DOI 10.1093/jmcb/mjr047; Tomihara K, 2010, J IMMUNOL, V184, P6151, DOI 10.4049/jimmunol.0903519; Turnquist HR, 2011, J IMMUNOL, V187, P4598, DOI 10.4049/jimmunol.1100519; Valaperti A, 2008, J IMMUNOL, V180, P2686, DOI 10.4049/jimmunol.180.4.2686; Wu TT, 2012, J IMMUNOL, V189, P4989, DOI 10.4049/jimmunol.1200068; Yi HF, 2012, J IMMUNOL, V189, P4295, DOI 10.4049/jimmunol.1200086; Yin BJ, 2010, J IMMUNOL, V185, P5828, DOI 10.4049/jimmunol.0903636; Zehntner SP, 2005, J IMMUNOL, V174, P5124, DOI 10.4049/jimmunol.174.8.5124; Zhang W, 2008, TRANSPLANTATION, V86, P1125, DOI 10.1097/TP.0b013e318186fccd; Zhou ZP, 2010, STEM CELLS, V28, P620, DOI 10.1002/stem.301; Zhu B, 2007, J IMMUNOL, V179, P5228, DOI 10.4049/jimmunol.179.8.5228	49	43	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100013	10.1371/journal.pone.0100013	http://dx.doi.org/10.1371/journal.pone.0100013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927018	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100107
J	Mackenzie, CL; Lynch, SA; Culloty, SC; Malham, SK				Mackenzie, Clara L.; Lynch, Sharon A.; Culloty, Sarah C.; Malham, Shelagh K.			Future Oceanic Warming and Acidification Alter Immune Response and Disease Status in a Commercial Shellfish Species, Mytilus edulis L.	PLOS ONE			English	Article							ACID-BASE-BALANCE; HALIOTIS-DIVERSICOLOR-SUPERTEXTA; CLIMATE-CHANGE; SEAWATER ACIDIFICATION; WATER TEMPERATURE; PERKINSUS-MARINUS; CARBONIC-ACID; MUSSEL; HEMOCYTES; PARASITE	Increases in atmospheric carbon dioxide are leading to physical changes in marine environments including parallel decreases in ocean pH and increases in seawater temperature. This study examined the impacts of a six month exposure to combined decreased pH and increased temperature on the immune response and disease status in the blue mussel, Mytilus edulis L. Results provide the first confirmation that exposure to future acidification and warming conditions via aquarium-based simulation may have parallel implications for bivalve health. Collectively, the data suggests that temperature more than pH may be the key driver affecting immune response in M. edulis. Data also suggests that both increases in temperature and/or lowered pH conditions may lead to changes in parasite abundance and diversity, pathological conditions, and bacterial incidence in M. edulis. These results have implications for future management of shellfish under a predicted climate change scenario and future sustainability of shellfisheries. Examination of the combined effects of two stressors over an extended exposure period provides key preliminary data and thus, this work represents a unique and vital contribution to current research efforts towards a collective understanding of expected near-future impacts of climate change on marine environments.	[Mackenzie, Clara L.] Heriot Watt Univ, Ctr Marine Biodivers & Biotechnol, Sch Life Sci, Edinburgh, Midlothian, Scotland; [Lynch, Sharon A.; Culloty, Sarah C.] Natl Univ Ireland Univ Coll Cork, Sch Biol Earth & Environm Sci, Aquaculture & Fisheries Dev Ctr, Cork, Ireland; [Malham, Shelagh K.] Bangor Univ, Ctr Appl Marine Sci, Menai Bridge, Anglesey, Wales	Heriot Watt University; University College Cork; Bangor University	Mackenzie, CL (corresponding author), Heriot Watt Univ, Ctr Marine Biodivers & Biotechnol, Sch Life Sci, Edinburgh, Midlothian, Scotland.	clm32@hw.ac.uk	Malham, Shelagh K/O-9054-2014	Mackenzie, Clara/0000-0002-5797-6106	Shellfish Productivity in the Irish Sea (SUSFISH); European Regional Development Fund (ERDF) through the Ireland Wales Territorial Co-operation (INTERREG 4A) Programme	Shellfish Productivity in the Irish Sea (SUSFISH); European Regional Development Fund (ERDF) through the Ireland Wales Territorial Co-operation (INTERREG 4A) Programme	This work was funded by the project entitled: Shellfish Productivity in the Irish Sea (SUSFISH). SUSFISH is partially funded by the European Regional Development Fund (ERDF) through the Ireland Wales Territorial Co-operation (INTERREG 4A) Programme 2007-2013. INTERREG 4A is managed in Ireland by the Southern and Eastern Regional Assembly on behalf of the Irish Government, the Welsh Government and the European Commission (http://www.irelandwales.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlKurashi M, 2011, VET PARASITOL, V177, P267, DOI 10.1016/j.vetpar.2010.11.053; Amaral V, 2011, ESTUAR COAST SHELF S, V93, P460, DOI 10.1016/j.ecss.2011.05.024; [Anonymous], NATURE; Berge JA, 2006, CHEMOSPHERE, V62, P681, DOI 10.1016/j.chemosphere.2005.04.111; Bibby R, 2008, AQUAT BIOL, V2, P67, DOI 10.3354/ab00037; Bindoff N, 2007, CLIM CHANG 2007; Bussell JA, 2008, J EXP MAR BIOL ECOL, V358, P78, DOI 10.1016/j.jembe.2008.01.018; Callaway R, 2012, AQUAT CONSERV, V22, P389, DOI 10.1002/aqc.2247; Cao A, 2007, AQUACULTURE, V263, P310, DOI 10.1016/j.aquaculture.2006.11.004; Carballal MJ, 1998, J INVERTEBR PATHOL, V72, P304, DOI 10.1006/jipa.1998.4779; Cheng W, 2004, FISH SHELLFISH IMMUN, V17, P235, DOI 10.1016/j.fsi.2004.03.007; Cheng W, 2000, FISH SHELLFISH IMMUN, V10, P387, DOI 10.1006/fsim.2000.0264; Cheng W, 2004, AQUACULTURE, V232, P103, DOI 10.1016/S0044-8486(03)00488-5; Chubb J.C., 1979, Advances in Parasitology, V17, P141, DOI 10.1016/S0065-308X(08)60551-5; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Cook T, 1998, ESTUAR COAST SHELF S, V46, P587, DOI 10.1006/ecss.1997.0283; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Discovering statistics using R, 2012, CHOICE REV ONLINE, V50, DOI [10.5860/choice.50-2114, DOI 10.5860/CHOICE.50-2114]; Ellis RP, 2011, FISH SHELLFISH IMMUN, V30, P1209, DOI 10.1016/j.fsi.2011.03.017; Ellis RP, 2013, THESIS U PLYMOUTH UK; Epstein PR, 1998, B AM METEOROL SOC, V79, P409, DOI 10.1175/1520-0477(1998)079<0409:BAPSOC>2.0.CO;2; FISHER WS, 1987, AQUACULTURE, V67, P179, DOI 10.1016/0044-8486(87)90024-X; Ford SE, 1996, J SHELLFISH RES, V15, P45; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gooding RA, 2009, P NATL ACAD SCI USA, V106, P9316, DOI 10.1073/pnas.0811143106; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Harvell D, 2001, HYDROBIOLOGIA, V460, P97, DOI 10.1023/A:1013169331913; Hay SI, 2002, TRENDS PARASITOL, V18, P530, DOI 10.1016/S1471-4922(02)02374-7; Holmes JC, 1996, BIODIVERS CONSERV, V5, P975, DOI 10.1007/BF00054415; Hooper C, 2007, FISH SHELLFISH IMMUN, V22, P363, DOI 10.1016/j.fsi.2006.06.009; Houghton JT, 2001, CONTRIBUTION WORKING; Inoue K, 1995, BIOL BULL, V189, P370, DOI 10.2307/1542155; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Jung T, 2010, METHODS MOL BIOL, V594, P173, DOI 10.1007/978-1-60761-411-1_13; Katz ML, 2002, ARCH GERONTOL GERIAT, V34, P169, DOI 10.1016/S0167-4943(02)00005-5; Kawai M, 2002, APPL ENVIRON MICROB, V68, P699, DOI 10.1128/AEM.68.2.699-704.2002; Kim K, 2000, MAR BIOL, V136, P259, DOI 10.1007/s002270050684; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Lacoste A, 2002, DEV COMP IMMUNOL, V26, P1, DOI 10.1016/S0145-305X(01)00067-2; Lafferty KD, 2004, ANNU REV ECOL EVOL S, V35, P31, DOI 10.1146/annurev.ecolsys.35.021103.105704; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Lafferty Kevin D., 1997, P316; Le Roux F, 2001, J EUKARYOT MICROBIOL, V48, P449, DOI 10.1111/j.1550-7408.2001.tb00178.x; Lengeler J., 2009, BIOL PROKARYOTES; Lewis E., 1998, PROGRAM DEV CO2 SYST; Lynch SA, 2008, AQUACULTURE, V281, P17, DOI 10.1016/j.aquaculture.2008.06.005; Mackenzie CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086764; MacLeod CD, 2012, TRENDS PARASITOL, V28, P365, DOI 10.1016/j.pt.2012.06.007; Malagoli D, 2007, FISH SHELLFISH IMMUN, V23, P171, DOI 10.1016/j.fsi.2006.10.004; Malham SK, 2009, AQUACULTURE, V287, P128, DOI 10.1016/j.aquaculture.2008.10.006; Malham SK, 2003, J EXP ZOOL PART A, V295A, P136, DOI 10.1002/jez.a.10222; Matozzo V, 2011, ISJ-INVERT SURVIV J, V8, P70; Mayrand E, 2005, AQUAC RES, V36, P962, DOI 10.1111/j.1365-2109.2005.01302.x; McDonald MR, 2009, MAR ECOL PROG SER, V385, P179, DOI 10.3354/meps08099; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Michaelidis B, 2005, MAR ECOL PROG SER, V293, P109, DOI 10.3354/meps293109; Miles H, 2007, MAR POLLUT BULL, V54, P89, DOI 10.1016/j.marpolbul.2006.09.021; Molloy DP, 2012, PARASITOLOGY, V139, P463, DOI 10.1017/S0031182011002101; Monari M, 2007, FISH SHELLFISH IMMUN, V22, P98, DOI 10.1016/j.fsi.2006.03.016; Mortensen SH, 1996, FISH SHELLFISH IMMUN, V6, P111, DOI 10.1006/fsim.1996.0012; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Paillard C, 2004, DIS AQUAT ORGAN, V59, P249, DOI 10.3354/dao059249; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parry HE, 2004, AQUAT TOXICOL, V69, P311, DOI 10.1016/j.aquatox.2004.06.003; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Pietrock M, 2003, TRENDS PARASITOL, V19, P293, DOI 10.1016/S1471-4922(03)00117-X; Pilling P, 2011, 53 FAO CGRFA, P28; PIPE RK, 1992, DEV COMP IMMUNOL, V16, P111, DOI 10.1016/0145-305X(92)90012-2; PIPE RK, 1995, FISH SHELLFISH IMMUN, V5, P581, DOI 10.1016/S1050-4648(95)80043-3; Pipe RK, 1997, CELL TISSUE RES, V289, P537, DOI 10.1007/s004410050899; POJMANSKA T, 1980, Acta Parasitologica Polonica, V27, P319; Porter JW, 2001, HYDROBIOLOGIA, V460, P1, DOI 10.1023/A:1013177617800; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Renault T, 2000, DIS AQUAT ORGAN, V42, P207, DOI 10.3354/dao042207; Renwrantz L, 2013, COMP BIOCHEM PHYS A, V164, P629, DOI 10.1016/j.cbpa.2013.01.021; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; ROBLEDO JAF, 1994, AQUACULTURE, V127, P287, DOI 10.1016/0044-8486(94)90232-1; Rogers DJ, 2006, ADV PARASIT, V62, P345, DOI 10.1016/S0065-308X(05)62010-6; Rohr JR, 2008, NATURE, V455, P1235, DOI 10.1038/nature07281; Rohr JR, 2011, J APPL ECOL, V48, P174, DOI 10.1111/j.1365-2664.2010.01891.x; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; SCOTT M E, 1988, Conservation Biology, V2, P40, DOI 10.1111/j.1523-1739.1988.tb00334.x; SHAW BARBARA L., 1957, CANADIAN JOUR ZOOL, V35, P325, DOI 10.1139/z57-026; Shi SR, 2002, J HISTOCHEM CYTOCHEM, V50, P1005, DOI 10.1177/002215540205000802; Shumway S. E., 2012, WORLD AQUACULT, V34, P15, DOI DOI 10.1097/TA.0b013e318270160d; Smith V.J., 1992, Fish & Shellfish Immunology, V2, P1, DOI 10.1016/S1050-4648(06)80024-0; Sokolova IM, 2012, MAR ENVIRON RES, V79, P1, DOI 10.1016/j.marenvres.2012.04.003; Spicer JI, 2007, MAR BIOL, V151, P1117, DOI 10.1007/s00227-006-0551-6; Stevens Alan, 1996, P243; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Whiteley NM, 2011, MAR ECOL PROG SER, V430, P257, DOI 10.3354/meps09185; WONG P. P, 2007, CLIMATE CHANGE, P315, DOI DOI 10.1017/CB09781107415379; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343; Wootton EC, 2003, FISH SHELLFISH IMMUN, V15, P249, DOI 10.1016/S1050-4648(02)00164-X; Wootton EC, 2003, FISH SHELLFISH IMMUN, V15, P195, DOI 10.1016/S1050-4648(02)00161-4; Zhang H, 2005, J PHYCOL, V41, P411, DOI 10.1111/j.1529-8817.2005.04168.x	103	69	70	4	162	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99712	10.1371/journal.pone.0099712	http://dx.doi.org/10.1371/journal.pone.0099712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927423	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100071
J	Tiansawat, P; Davis, AS; Berhow, MA; Zalamea, PC; Dalling, JW				Tiansawat, Pimonrat; Davis, Adam S.; Berhow, Mark A.; Zalamea, Paul-Camilo; Dalling, James W.			Investment in Seed Physical Defence Is Associated with Species' Light Requirement for Regeneration and Seed Persistence: Evidence from Macaranga Species in Borneo	PLOS ONE			English	Article							CHEMICAL DEFENSE; MECHANICAL DEFENSE; TROPICAL FOREST; SOIL; PREDATION; TREE; RESISTANCE; DISPERSAL; PATTERNS; PLANTS	The seed stage is often critical in determining the regeneration success of plants. Seeds must survive an array of seed predators and pathogens and germinate under conditions favourable for seedling establishment. To maximise recruitment success plants protect seeds using a diverse set of chemical and physical defences. However, the relationship between these defence classes, and their association with other life history traits, is not well understood. Data on seed coat thickness and fracture resistance, and the abundance and diversity of potential defensive compounds were collected for 10 tree species of Macaranga from Borneo. The data were used to test whether there is a trade-off in physical versus chemical defence investment, and to determine how investment varies with seed mass, and light requirement for regeneration. Across species there was no correlation between seed coat thickness and abundance of potential defensive compounds, indicating the absence of a direct trade-off between defence classes. While chemical defences were not correlated to other traits, physical defences were positively correlated with light requirement for regeneration. For a subset of five Macaranga species we evaluated the relative investment in chemical and physical defence to seed persistence in the soil, measured as the time to half initial seed viability (seed half-life). Half-life was negatively related to the ratio of potential defensive compound abundance to seed coat thickness, suggesting that species with long persistence invested in physical defence more than stored chemical defences. These results indicate that investment in seed defences are associated with species' light requirements for regeneration, rather than scaling positively with seed mass. Furthermore, chemical defences, although highly variable among species, do not appear to be critical to long term persistence of Macaranga seeds, and may be important in defending seeds from natural enemies distinct from those found in the soil.	[Tiansawat, Pimonrat; Dalling, James W.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Davis, Adam S.] ARS, Global Change & Photosynthesis Res Unit, United Dept Agr, Urbana, IL USA; [Berhow, Mark A.] ARS, Natl Ctr Agr Utilizat Res, United Dept Agr, Peoria, IL USA; [Zalamea, Paul-Camilo; Dalling, James W.] Smithsonian Trop Res Inst, Ancon, Panama	University of Illinois System; University of Illinois Urbana-Champaign; Smithsonian Institution; Smithsonian Tropical Research Institute	Tiansawat, P (corresponding author), Chiang Mai Univ, Dept Biol, Chiang Mai 50000, Thailand.	tiansawat@yahoo.co.th	Tiansawat, Pimonrat/AAJ-7033-2020	Tiansawat, Pimonrat/0000-0003-1354-1247; Zalamea, Paul-Camilo/0000-0002-0987-4164; Dalling, James/0000-0002-6488-9895; Berhow, Mark/0000-0002-1278-4071; Davis, Adam/0000-0002-7196-1197	Center of Tropical Forest Science; Royal Thai Government; National Science Foundation [1120205]; Direct For Biological Sciences [1120205] Funding Source: National Science Foundation	Center of Tropical Forest Science; Royal Thai Government; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The funding for this work was provided by the Center of Tropical Forest Science (2010 Research Grant) to PT, the Royal Thai Government to PT and The National Science Foundation Grant 1120205 to JWD and ASD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Monaim MF, 2011, AFR J BIOTECHNOL, V10, P10842; [Anonymous], 1995, SEED DEV GERMINATION, DOI DOI 10.1201/9780203740071-1; AUGSPURGER CK, 1984, OECOLOGIA, V61, P211, DOI 10.1007/BF00396763; Barthlott W., 1981, Nordic Journal of Botany, V1, P345, DOI 10.1111/j.1756-1051.1981.tb00704.x; BODMER RE, 1991, BIOTROPICA, V23, P255, DOI 10.2307/2388202; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Cardinal-Aucoin M, 2009, ANN ENTOMOL SOC AM, V102, P717, DOI 10.1603/008.102.0417; Cazetta E, 2008, OECOLOGIA, V155, P277, DOI 10.1007/s00442-007-0917-6; Chen X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032890; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; Conn JS, 2006, WEED SCI, V54, P464, DOI 10.1614/WS-05-161R.1; Dalling JW, 2011, J ECOL, V99, P89, DOI 10.1111/j.1365-2745.2010.01739.x; Dalling JW, 1998, ECOLOGY, V79, P564, DOI 10.1890/0012-9658(1998)079[0564:DPASBD]2.0.CO;2; Davies SJ, 1998, J ECOL, V86, P662, DOI 10.1046/j.1365-2745.1998.00299.x; Davies SJ, 1999, AM J BOT, V86, P1786, DOI 10.2307/2656675; Davies Stuart J., 2001, Harvard Papers in Botany, V6, P371; Davis AS, 2008, WEED SCI, V56, P676, DOI 10.1614/WS-07-196.1; Daws MI, 2005, FUNCT ECOL, V19, P874, DOI 10.1111/j.1365-2435.2005.01034.x; Ding H, 2000, J CHEM ECOL, V26, P969, DOI 10.1023/A:1005412309735; Fenner M., 2005, ECOLOGY SEEDS; Fine PVA, 2011, BIOTROPICA, V43, P265, DOI 10.1111/j.1744-7429.2011.00778.x; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; GALEN C, 1986, AM J BOT, V73, P346, DOI 10.2307/2444077; Gallery RE, 2010, J ECOL, V98, P147, DOI 10.1111/j.1365-2745.2009.01589.x; Gallery RE, 2007, THESIS U ILLINOIS UR; Gardarin A, 2010, SEED SCI RES, V20, P243, DOI 10.1017/S0960258510000255; GARWOOD NC, 1983, ECOL MONOGR, V53, P159, DOI 10.2307/1942493; Goodale UM, 2012, FOREST ECOL MANAG, V277, P54, DOI 10.1016/j.foreco.2012.04.020; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Gower J.C., 2005, ENCY BIOSTATISTICS, DOI 10.1002/0470011815.b2a13070; Grubb PJ, 1998, OIKOS, V82, P467, DOI 10.2307/3546368; Hanley ME, 2002, FUNCT ECOL, V16, P216, DOI 10.1046/j.1365-2435.2002.00612.x; Heil M, 2002, OIKOS, V99, P457, DOI 10.1034/j.1600-0706.2002.11954.x; HENDRY GAF, 1994, FUNCT ECOL, V8, P658, DOI 10.2307/2389929; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JOHNSON HB, 1975, BOT REV, V41, P233, DOI 10.1007/BF02860838; Kestring D, 2009, J PLANT BIOL, V52, P569, DOI 10.1007/s12374-009-9073-3; Koizumi M, 2008, ANN BOT-LONDON, V102, P343, DOI 10.1093/aob/mcn095; Kumagai T, 2005, AGR FOREST METEOROL, V128, P81, DOI 10.1016/j.agrformet.2004.08.006; Kumagai T, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007307; Kuprewicz EK, 2010, J TROP ECOL, V26, P263, DOI 10.1017/S0266467410000039; Metzing D, 2001, BOT J LINN SOC, V137, P65, DOI 10.1111/j.1095-8339.2001.tb01105.x; MOHAMEDYASSEEN Y, 1994, BOT REV, V60, P426, DOI 10.1007/BF02857926; Moles AT, 2013, NEW PHYTOL, V198, P252, DOI 10.1111/nph.12116; Moles AT, 2003, ECOLOGY, V84, P3148, DOI 10.1890/02-0662; O'Hanlon-Manners DL, 2004, OECOLOGIA, V140, P650, DOI 10.1007/s00442-004-1625-0; Phommart S, 2005, J NAT PROD, V68, P927, DOI 10.1021/np0500272; R Core Team, 2016, R FDN STAT COMP; Read J, 2009, ANN BOT-LONDON, V103, P757, DOI 10.1093/aob/mcn246; Rodgerson L, 1998, ECOLOGY, V79, P1669, DOI 10.1890/0012-9658(1998)079[1669:MDISAF]2.0.CO;2; Roitto M, 2003, J CHEM ECOL, V29, P1905, DOI 10.1023/A:1024858413437; Schafer M, 2004, PLANT ECOL, V175, P19, DOI 10.1023/B:VEGE.0000048096.00772.23; Singh A, 1996, BIOL AGRIC HORTIC, V13, P205, DOI 10.1080/01448765.1996.9754782; Souza AJ, 2011, CROP PROT, V30, P651, DOI 10.1016/j.cropro.2010.12.014; STOCK WD, 1991, NEW PHYTOL, V117, P109, DOI 10.1111/j.1469-8137.1991.tb00950.x; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Tiansawat P., 2013, THESIS U ILLINOIS UR; Twigg LE, 1996, OECOLOGIA, V108, P21, DOI 10.1007/BF00333210; Veldman JW, 2007, BIOTROPICA, V39, P87, DOI 10.1111/j.1744-7429.2006.00232.x; VENABLE DL, 1992, AM NAT, V140, P287, DOI 10.1086/285413; Whitmore T.C, 2008, GENUS MACARANGA PROD; Xu Y, 2007, ANAL CHEM, V79, P5633, DOI 10.1021/ac070134w; Yoder B J, 2005, THESIS VIRGINIA POLY; ZHANG J., 1997, TECHNICAL B INSECT P	64	14	14	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99691	10.1371/journal.pone.0099691	http://dx.doi.org/10.1371/journal.pone.0099691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927025	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100067
J	Lee, S; Goldfinger, LE				Lee, Seunghyung; Goldfinger, Lawrence E.			RLIP76 regulates HIF-1 activity, VEGF expression and secretion in tumor cells, and secretome transactivation of endothelial cells	FASEB JOURNAL			English	Article						angiogenesis; transcription factor; growth factors	HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; GROWTH-FACTOR VEGF; PROMOTER ACTIVITY; PI3K-DEPENDENT PATHWAYS; DEPENDENT TRANSPORT; VEGF(120) RELEASE; OXIDATIVE STRESS; CANCER CELLS; LUNG-CANCER; ANGIOGENESIS	This study was undertaken to reveal the mechanisms by which RLIP76 regulates endothelial cell angiogenic responses. RLIP76 is an effector of the angiogenic modulator, R-Ras. RLIP76 is overexpressed in many tumors, required for tumor angiogenesis, and blockade of RLIP76 results in tumor regression in multiple models. We report here that RLIP76 was required for expression and secretion of vascular endothelial growth factor (VEGF) in carcinoma and melanoma cells. Conditioned medium derived from RLIP76-depleted tumor cells, but not control knockdown cells, could not stimulate proliferation, migration, or Matrigel cord formation in endothelial cell cultures, which indicates that RLIP76 regulates angiogenic components of the tumor cell secretome. Recombinant VEGF added to conditioned medium from RLIP76-knockdown tumor cells restored these endothelial cell functions. Transcriptional activity of hypoxia- inducible factor 1 (HIF-1), which drives VEGF expression, was blocked in RLIP76-depleted tumor cells. RLIP76 was required for PI3-kinase activation, known to regulate HIF-1, in these cells. However, HIF-1 alpha expression and nuclear localization were unaffected by RLIP76 knockdown, which suggests that RLIP76 regulates HIF-1 at the functional level. Thus, RLIP76 regulates tumor cell transactivation of endothelial cells via control of VEGF expression and secretion, providing a new important link in the mechanism of tumor cell induction of angiogenesis.	[Lee, Seunghyung; Goldfinger, Lawrence E.] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA; [Goldfinger, Lawrence E.] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Fox Chase Cancer Center	Lee, S (corresponding author), Temple Univ, Sch Med, 3420 N Broad St, Philadelphia, PA 19140 USA.	goldfinger@temple.edu			U.S. National Institutes of Health [HL093416]; American Heart Association [12POST12040257]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093416] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health grant HL093416 to L. E. G. and American Heart Association Postdoctoral Fellowship 12POST12040257 to S. L. The authors thank Jeremy G. T. Wurtzel for technical assistance. The authors declare no conflict of interest.	Aonuma M, 1999, INT J EXP PATHOL, V80, P271, DOI 10.1046/j.1365-2613.1999.00122.x; Awasthi S, 2000, BIOCHEMISTRY-US, V39, P9327, DOI 10.1021/bi992964c; AWASTHI S, 1994, J CLIN INVEST, V93, P958, DOI 10.1172/JCI117102; Awasthi S, 2002, ACTA BIOCHIM POL, V49, P855; Awasthi S, 2001, BIOCHEMISTRY-US, V40, P4159, DOI 10.1021/bi002182f; Awasthi S, 2008, CLIN CANCER RES, V14, P4372, DOI 10.1158/1078-0432.CCR-08-0145; AWASTHI YC, 1991, BIOCHEM BIOPH RES CO, V175, P1090, DOI 10.1016/0006-291X(91)91677-5; Choi KS, 2003, J BIOCHEM MOL BIOL, V36, P120; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Folkman J, 1992, Semin Cancer Biol, V3, P65; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Fukumura D, 1998, CELL, V94, P715, DOI 10.1016/S0092-8674(00)81731-6; Gerber HP, 2000, CANCER RES, V60, P6253; Gille J, 2006, EXP DERMATOL, V15, P175, DOI 10.1111/j.1600-0625.2006.00400.x; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Goldfinger LE, 2006, J CELL BIOL, V174, P877, DOI 10.1083/jcb.200603111; Goldfinger LE, 2013, LUNG CANCER-TARGETS, V4, P61, DOI 10.2147/LCTT.S53672; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473, DOI 10.1074/jbc.270.38.22473; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Kishimoto J, 2000, AM J PATHOL, V157, P103, DOI 10.1016/S0002-9440(10)64522-1; Klement G, 2000, J CLIN INVEST, V105, pR15, DOI 10.1172/JCI8829; Kozin SV, 2001, CANCER RES, V61, P39; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Leake K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034582; Lee CG, 2000, CANCER RES, V60, P5565; Lee S, 2012, CANCER RES, V72, P5165, DOI 10.1158/0008-5472.CAN-12-0468; Limaverde-Sousa G, 2014, CANCER TREAT REV, V40, P548, DOI 10.1016/j.ctrv.2013.11.009; Mahabeleshwar GH, 2007, SEMIN ONCOL, V34, P555, DOI 10.1053/j.seminoncol.2007.09.009; Malo MS, 2006, ANAL BIOCHEM, V350, P307, DOI 10.1016/j.ab.2005.12.018; Margutti P, 2008, BLOOD, V111, P4559, DOI 10.1182/blood-2007-05-092825; Marneros AG, 2009, HEMATOL ONCOL CLIN N, V23, P431, DOI 10.1016/j.hoc.2009.03.007; McMahon G, 2000, Oncologist, V5 Suppl 1, P3; Moriya R, 2014, BIOCHEM BIOPH RES CO, V445, P275, DOI 10.1016/j.bbrc.2014.01.120; Motl S, 2005, AM J HEALTH-SYST PH, V62, P1021, DOI 10.1093/ajhp/62.10.1021; Muz B, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2568; Nagy MA, 2011, J CANC SCI THER, V3, P35, DOI DOI 10.4172/1948-5956.1000054; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Park SH, 1995, ONCOGENE, V11, P2349; Sehrawat A, 2013, BIOCHEM PHARMACOL, V85, P1203, DOI 10.1016/j.bcp.2013.02.012; Semenza GL, 2009, CURR PHARM DESIGN, V15, P3839, DOI 10.2174/138161209789649402; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; SHARMA R, 1990, BIOCHEM BIOPH RES CO, V171, P155, DOI 10.1016/0006-291X(90)91370-8; Singhal SS, 2007, CANCER RES, V67, P4382, DOI 10.1158/0008-5472.CAN-06-4124; Singhal SS, 2009, BIOCHEM PHARMACOL, V77, P1074, DOI 10.1016/j.bcp.2008.11.013; Singhal SS, 2006, CANCER RES, V66, P2354, DOI 10.1158/0008-5472.CAN-05-3534; Singhal SS, 2005, BIOCHEM PHARMACOL, V70, P481, DOI 10.1016/j.bcp.2005.05.005; Sparano JA, 2004, CLIN CANCER RES, V10, P1206, DOI 10.1158/1078-0432.CCR-03-0238; Takahashi K, 2013, OBESITY, V21, P1625, DOI 10.1002/oby.20206; Terman BI, 2001, EINSTEIN Q J BIOL ME, V18, P59; Tsuzuki Y, 2000, CANCER RES, V60, P6248; Volm M, 1997, ANTICANCER RES, V17, P99; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Wurtzel Jeremy G T, 2012, Small GTPases, V3, P139, DOI 10.4161/sgtp.21084; Yan JP, 2013, J ETHNOPHARMACOL, V147, P456, DOI 10.1016/j.jep.2013.03.039; Yi TF, 2013, J BIOL CHEM, V288, P18732, DOI 10.1074/jbc.M113.471466; Zhao WN, 2013, INT J MOL SCI, V14, P13577, DOI 10.3390/ijms140713577; Ziello Jennifer E, 2007, Yale J Biol Med, V80, P51	61	22	22	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2014	28	9					4158	4168		10.1096/fj.14-255711	http://dx.doi.org/10.1096/fj.14-255711			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN8HU	24928198	Green Published			2022-12-25	WOS:000340845900032
J	Ghosh, D; Mueller, GA; Schramm, G; Edwards, LL; Petersen, A; London, RE; Haas, H; Bhattacharya, SG				Ghosh, Debajyoti; Mueller, Geoffrey A.; Schramm, Gabriele; Edwards, Lori L.; Petersen, Arnd; London, Robert E.; Haas, Helmut; Bhattacharya, Swati Gupta			Primary Identification, Biochemical Characterization, and Immunologic Properties of the Allergenic Pollen Cyclophilin Cat r 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETULA-VERRUCOSA POLLEN; CRYSTAL-STRUCTURE; CROSS-REACTIVITY; WEB SERVER; PROTEIN FAMILIES; HIGHER-PLANTS; L. POLLEN; IGE; CLONING; EXPRESSION	Cyclophilin (Cyp) allergens are considered pan-allergens due to frequently reported cross-reactivity. In addition to well studied fungal Cyps, a number of plant Cyps were identified as allergens (e. g. Bet v 7 from birch pollen, Cat r 1 from periwinkle pollen). However, there are conflicting data regarding their antigenic/allergenic cross-reactivity, with no plant Cyp allergen structures available for comparison. Because amino acid residues are fairly conserved between plant and fungal Cyps, it is particularly interesting to check whether they can cross-react. Cat r 1 was identified by immunoblotting using allergic patients' sera followed by N-terminal sequencing. Cat r 1 (similar to 91% sequence identity to Bet v 7) was cloned from a cDNA library and expressed in Escherichia coli. Recombinant Cat r 1 was utilized to confirm peptidyl-prolyl cis-trans-isomerase (PPIase) activity by a PPIase assay and the allergenic property by an IgE-specific immunoblotting and rat basophil leukemia cell (RBL-SX38) mediator release assay. Inhibition-ELISA showed cross-reactive binding of serum IgE from Cat r 1-allergic individuals to fungal allergenic Cyps Asp f 11 and Mala s 6. The molecular structure of Cat r 1 was determined by NMR spectroscopy. The antigenic surface was examined in relation to its plant, animal, and fungal homologues. The structure revealed a typical cyclophilin fold consisting of a compact beta-barrel made up of seven anti-parallel beta-strands along with two surrounding alpha-helices. This is the first structure of an allergenic plant Cyp revealing high conservation of the antigenic surface particularly near the PPIase active site, which supports the pronounced cross-reactivity among Cyps from various sources.	[Ghosh, Debajyoti; Bhattacharya, Swati Gupta] Bose Inst, Kolkata 700009, W Bengal, India; [Mueller, Geoffrey A.; Edwards, Lori L.; London, Robert E.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Schramm, Gabriele; Haas, Helmut] Leibniz Ctr Med & Biosci, Res Ctr Borstel, D-23845 Borstel, Germany; [Petersen, Arnd] Airway Res Ctr North ARCN, Res Ctr Borstel, Div Clin & Mol Allergol, D-23845 Borstel, Germany	Department of Science & Technology (India); Bose Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Forschungszentrum Borstel; Forschungszentrum Borstel	Ghosh, D (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Div Allergy Immunol & Rheumatol, Cincinnati, OH 45267 USA.	djghosh@yahoo.com; swati@jcbose.ac.in	Mueller, Geoffrey A/I-2909-2017; London, Robert E/F-7990-2019	Mueller, Geoffrey A/0000-0001-8361-5323; London, Robert E/0000-0001-9108-8463	National Institutes of Health (NIEHS intramural program) [Z01-ES102885-01]; German Academic Exchange Service (DAAD); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102906] Funding Source: NIH RePORTER	National Institutes of Health (NIEHS intramural program); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health (NIEHS intramural program) Research Project Z01-ES102885-01 (to R. E. L.).; Supported by a fellowship from the German Academic Exchange Service (DAAD). To whom correspondence may be addressed: Division of Allergy, Immunology and Rheumatology, Dept. of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267.	Appenzeller U, 2001, ARCH IMMUNOL THER EX, V49, P19; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BANIK S, 1992, GRANA, V31, P72, DOI 10.1080/00173139209427829; Berjanskii M, 2009, NUCLEIC ACIDS RES, V37, pW670, DOI 10.1093/nar/gkp280; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Cadot P, 2006, MOL IMMUNOL, V43, P226, DOI 10.1016/j.molimm.2005.02.001; CADOT P, 1995, ALLERGY, V50, P431, DOI 10.1111/j.1398-9995.1995.tb01173.x; Cadot P, 2000, J ALLERGY CLIN IMMUN, V105, P286, DOI 10.1016/S0091-6749(00)90078-2; Chakraborty P, 2005, ALLERGY, V60, P920, DOI 10.1111/j.1398-9995.2005.00634.x; Chakraborty P, 2001, ANN AGR ENV MED, V8, P123; Chakraborty P, 2009, INT ARCH ALLERGY IMM, V149, P305, DOI 10.1159/000205576; Chou IT, 1997, PLANT MOL BIOL, V35, P873, DOI 10.1023/A:1005930024796; Clastre M., 1995, PLANT PHYSIOL, V109, P1497; Crameri R, 1999, Contrib Microbiol, V2, P44; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; De Canio M, 2009, J PROTEOME RES, V8, P4383, DOI 10.1021/pr900315a; Dibbern DA, 2003, J IMMUNOL METHODS, V274, P37, DOI 10.1016/S0022-1759(02)00369-1; Fluckiger S, 2002, EUR J IMMUNOL, V32, P10, DOI 10.1002/1521-4141(200201)32:1<10::AID-IMMU10>3.0.CO;2-I; Fujita C, 2001, INT ARCH ALLERGY IMM, V125, P44, DOI 10.1159/000053795; Galat A, 1999, ARCH BIOCHEM BIOPHYS, V371, P149, DOI 10.1006/abbi.1999.1434; GASSER CS, 1990, P NATL ACAD SCI USA, V87, P9519, DOI 10.1073/pnas.87.24.9519; Ghosh D, 2008, MOL IMMUNOL, V45, P456, DOI 10.1016/j.molimm.2007.05.025; Ghosh D, 2007, ANN AGR ENV MED, V14, P39; Glaser AG, 2006, BIOCHEM J, V396, P41, DOI 10.1042/BJ20051708; de Olano DG, 2010, ANN ALLERG ASTHMA IM, V104, P98, DOI 10.1016/j.anai.2009.11.019; HAENDLER B, 1990, EUR J BIOCHEM, V190, P477, DOI 10.1111/j.1432-1033.1990.tb15598.x; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 1996, NUCLEIC ACIDS RES, V24, P206, DOI 10.1093/nar/24.1.206; HORNER WE, 1995, INT ARCH ALLERGY IMM, V107, P298, DOI 10.1159/000237007; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; Limacher A, 2006, STRUCTURE, V14, P185, DOI 10.1016/j.str.2005.10.015; Lindborg M, 1999, J INVEST DERMATOL, V113, P156, DOI 10.1046/j.1523-1747.1999.00661.x; Loeffler PA, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-37; Marin-Menendez A, 2012, MOL BIOCHEM PARASIT, V184, P44, DOI 10.1016/j.molbiopara.2012.04.006; Marzban G, 2008, MOL NUTR FOOD RES, V52, P1497, DOI 10.1002/mnfr.200700518; Mayer C, 1999, J EXP MED, V189, P1507, DOI 10.1084/jem.189.9.1507; Nigro EA, 2009, J IMMUNOL, V183, P4530, DOI 10.4049/jimmunol.0900842; Petersen A, 1996, J ALLERGY CLIN IMMUN, V98, P805, DOI 10.1016/S0091-6749(96)70130-6; Petersen A, 2006, PROTEOMICS, V6, P6317, DOI 10.1002/pmic.200600173; Peterson MR, 2000, J MOL BIOL, V298, P123, DOI 10.1006/jmbi.2000.3633; Radauer C, 2006, J ALLERGY CLIN IMMUN, V117, P141, DOI 10.1016/j.jaci.2005.09.010; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; Radauer C, 2007, J ALLERGY CLIN IMMUN, V120, P518, DOI 10.1016/j.jaci.2007.07.024; Roy D, 2003, BIOCHEM BIOPH RES CO, V307, P422, DOI 10.1016/S0006-291X(03)01193-8; Saunders CW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002701; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; Sedrani R, 2003, J AM CHEM SOC, V125, P3849, DOI 10.1021/ja021327y; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0203S00; Vangelista L, 2005, J IMMUNOL, V174, P5602, DOI 10.4049/jimmunol.174.9.5602; Wang Y, 2013, J AGR FOOD CHEM, V61, P1573, DOI 10.1021/jf303861p; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pW496, DOI 10.1093/nar/gkn305; Yokota E, 2004, PLANTA, V218, P1008, DOI 10.1007/s00425-003-1177-2; Zafred D, 2013, J ALLERGY CLIN IMMUN, V132, P696, DOI 10.1016/j.jaci.2013.03.021; Zhang N, 2011, ALLERGY, V66, P141, DOI 10.1111/j.1398-9995.2010.02448.x	58	22	24	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21374	21385		10.1074/jbc.M114.559971	http://dx.doi.org/10.1074/jbc.M114.559971			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24939849	Green Published, hybrid			2022-12-25	WOS:000340558300017
J	Singh, S; Thakur, N; Oliveira, A; Petruk, AA; Hade, MD; Sethi, D; Bidon-Chanal, A; Marti, MA; Datta, H; Parkesh, R; Estrin, DA; Luque, FJ; Dikshit, KL				Singh, Sandeep; Thakur, Naveen; Oliveira, Ana; Petruk, Ariel A.; Hade, Mangesh Dattu; Sethi, Deepti; Bidon-Chanal, Axel; Marti, Marcelo A.; Datta, Himani; Parkesh, Raman; Estrin, Dario A.; Luque, F. Javier; Dikshit, Kanak L.			Mechanistic Insight into the Enzymatic Reduction of Truncated Hemoglobin N of Mycobacterium tuberculosis ROLE OF THE CD LOOP AND PRE-A MOTIF IN ELECTRON CYCLING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE DIOXYGENASE; ESCHERICHIA-COLI; COMPUTER-SIMULATION; DYNAMICAL REGULATION; TUNNELING PATHWAYS; MOLECULAR-BASIS; CYTOCHROME-C; PROTEIN; FLAVOHEMOGLOBIN; HBN	Many pathogenic microorganisms have evolved hemoglobin-mediated nitric oxide (NO) detoxification mechanisms, where a globin domain in conjunction with a partner reductase catalyzes the conversion of toxic NO to innocuous nitrate. The truncated hemoglobin HbN of Mycobacterium tuberculosis displays a potent NO dioxygenase activity despite lacking a reductase domain. The mechanism by which HbN recycles itself during NO dioxygenation and the reductase that participates in this process are currently unknown. This study demonstrates that the NADH-ferredoxin/flavodoxin system is a fairly efficient partner for electron transfer to HbN with an observed reduction rate of 6.2 mu M/min(-1), which is nearly 3- and 5-fold faster than reported for Vitreoscilla hemoglobin and myoglobin, respectively. Structural docking of the HbN with Escherichia coli NADH-flavodoxin reductase (FdR) together with site-directed mutagenesis revealed that the CD loop of the HbN forms contacts with the reductase, and that Gly(48) may have a vital role. The donor to acceptor electron coupling parameters calculated using the semiempirical pathway method amounts to an average of about 6.4 10(-5) eV, which is lower than the value obtained for E. coli flavoHb (8.0 10(-4) eV), but still supports the feasibility of an efficient electron transfer. The deletion of Pre-A abrogated the heme iron reduction by FdR in the HbN, thus signifying its involvement during intermolecular interactions of the HbN and FdR. The present study, thus, unravels a novel role of the CD loop and Pre-A motif in assisting the interactions of the HbN with the reductase and the electron cycling, which may be vital for its NO-scavenging function.	[Datta, Himani; Parkesh, Raman; Dikshit, Kanak L.] Inst Microbial Technol, CSIR, Chandigarh 160036, India; [Oliveira, Ana; Bidon-Chanal, Axel; Luque, F. Javier] Univ Barcelona, Fac Farm, Dept Fisicoquim, Santa Coloma De Gramenet, Spain; [Oliveira, Ana; Bidon-Chanal, Axel; Luque, F. Javier] Univ Barcelona, Fac Farm, Inst Biomed IBUB, Santa Coloma De Gramenet, Spain; [Petruk, Ariel A.; Marti, Marcelo A.; Estrin, Dario A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Inorgan Analit & Quim Fis, INQUIMAE CONICET, Buenos Aires, DF, Argentina	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); University of Barcelona; University of Barcelona; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Dikshit, KL (corresponding author), Inst Microbial Technol, CSIR, Sect 39A, Chandigarh 160036, India.	kanak@imtech.res.in	Luque, F. Javier/L-9652-2014; Hade, Mangesh/AAF-7217-2019; Estrin, Dario/AAY-7549-2020; Hade, Mangesh/ABD-8535-2021; Bidon-Chanal, Axel/C-4536-2017	Luque, F. Javier/0000-0002-8049-3567; Hade, Mangesh/0000-0002-5937-9049; Bidon-Chanal, Axel/0000-0002-1666-1490; Marti, Marcelo/0000-0002-7911-9340; Estrin, Dario/0000-0002-5006-7225; Singh, Sandeep/0000-0001-9322-2929; Oliveira, Ana/0000-0001-6594-6022	CSIR Supra institutional project [BSC0210]; European Commission under FP7 program on health (NOstress); Spanish Ministerio de Ciencia e Innovacion [SAF2011-27642, PIB2010AR-00455]; Generalitat de Catalunya [2014SGR1189]; CSIR; Dept. of Biotechnology, Government of India	CSIR Supra institutional project; European Commission under FP7 program on health (NOstress); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Dept. of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by CSIR Supra institutional project BSC0210, European Commission under FP7 program on health (NOstress), Spanish Ministerio de Ciencia e Innovacion Grants SAF2011-27642 and PIB2010AR-00455 and Generalitat de Catalunya Grant 2014SGR1189, and fellowships from CSIR and the Dept. of Biotechnology, Government of India (to S. S., D. S., and H. D.).	Alvarez-Paggi D, 2010, J AM CHEM SOC, V132, P5769, DOI 10.1021/ja910707r; Antony J, 2000, J AM CHEM SOC, V122, P1057, DOI 10.1021/ja993784t; Appleby C A, 1978, Methods Enzymol, V52, P157; Arya S, 2013, J BIOL CHEM, V288, P29987, DOI 10.1074/jbc.M113.507301; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Beratan DN, 2008, P NATL ACAD SCI USA, V105, P403, DOI 10.1073/pnas.0711343105; BERATAN DN, 1992, SCIENCE, V258, P1740, DOI 10.1126/science.1334572; BERATAN DN, 1991, SCIENCE, V252, P1285, DOI 10.1126/science.1656523; Bidon-Chanal A, 2007, J AM CHEM SOC, V129, P6782, DOI 10.1021/ja0689987; Bidon-Chanal A, 2006, PROTEINS, V64, P457, DOI 10.1002/prot.21004; Capece L, 2013, BBA-PROTEINS PROTEOM, V1834, P1722, DOI 10.1016/j.bbapap.2013.02.038; Case DA, 2012, AMBER 12; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DIKSHIT KL, 1988, GENE, V70, P377, DOI 10.1016/0378-1119(88)90209-0; DOYLE MP, 1981, J INORG BIOCHEM, V14, P351, DOI 10.1016/S0162-0134(00)80291-3; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Fago A, 2006, FEBS LETT, V580, P4884, DOI 10.1016/j.febslet.2006.08.003; Ferreiro DN, 2013, J INORG BIOCHEM, V119, P75, DOI 10.1016/j.jinorgbio.2012.10.015; Forrester MT, 2012, FREE RADICAL BIO MED, V52, P1620, DOI 10.1016/j.freeradbiomed.2012.01.028; Frey AD, 2005, TRENDS BIOTECHNOL, V23, P69, DOI 10.1016/j.tibtech.2004.12.002; Gardner AM, 2000, J BIOL CHEM, V275, P12581, DOI 10.1074/jbc.275.17.12581; Gardner PR, 2006, J INORG BIOCHEM, V100, P542, DOI 10.1016/j.jinorgbio.2005.12.012; Gardner PR, 2000, J BIOL CHEM, V275, P31581, DOI 10.1074/jbc.M004141200; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Hallstrom CK, 2004, FREE RADICAL BIO MED, V37, P216, DOI 10.1016/j.freeradbiomed.2004.04.031; HAYASHI A, 1973, BIOCHIM BIOPHYS ACTA, V310, P309, DOI 10.1016/0005-2795(73)90110-4; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Ingelman M, 1997, J MOL BIOL, V268, P147, DOI 10.1006/jmbi.1997.0957; Jasaitis A, 2007, P NATL ACAD SCI USA, V104, P20811, DOI 10.1073/pnas.0709876105; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kohlhoff M, 2012, J PROTEOMICS, V75, P2181, DOI 10.1016/j.jprot.2012.01.020; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Lama A, 2009, J BIOL CHEM, V284, P14457, DOI 10.1074/jbc.M807436200; Marti MA, 2008, METHOD ENZYMOL, V437, P477, DOI 10.1016/S0076-6879(07)37024-9; Milani M, 2001, EMBO J, V20, P3902, DOI 10.1093/emboj/20.15.3902; NAGAI M, 1981, J BIOL CHEM, V256, P9195; Oliveira A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049291; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Pathania R, 2002, MOL MICROBIOL, V45, P1303, DOI 10.1046/j.1365-2958.2002.03095.x; Pawaria S, 2007, MICROB PATHOGENESIS, V42, P119, DOI 10.1016/j.micpath.2006.12.001; Petruk AA, 2012, ARCH BIOCHEM BIOPHYS, V525, P82, DOI 10.1016/j.abb.2012.05.012; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Smagghe BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002039; Thomas MT, 2011, ENVIRON MICROBIOL, V13, P48, DOI 10.1111/j.1462-2920.2010.02307.x; Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013; Yeh SR, 2000, J BIOL CHEM, V275, P1679, DOI 10.1074/jbc.275.3.1679	47	13	13	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21573	21583		10.1074/jbc.M114.578187	http://dx.doi.org/10.1074/jbc.M114.578187			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24928505	Green Published, hybrid			2022-12-25	WOS:000340558300032
J	Algars, A; Avoranta, T; Osterlund, P; Lintunen, M; Sundstrom, J; Jokilehto, T; Ristimaki, A; Ristamaki, R; Carpen, O				Algars, Annika; Avoranta, Tuulia; Osterlund, Pia; Lintunen, Minnamaija; Sundstrom, Jari; Jokilehto, Terhi; Ristimaki, Ari; Ristamaki, Raija; Carpen, Olli			Heterogeneous EGFR Gene Copy Number Increase Is Common in Colorectal Cancer and Defines Response to Anti-EGFR Therapy	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CETUXIMAB; KRAS; AMPLIFICATION; EXPRESSION; MARKER	Anti-EGFR therapy is commonly used to treat colorectal cancer (CRC), although only a subset of patients benefit from the treatment. While KRAS mutation predicts non-responsiveness, positive predictive markers are not in clinical practice. We previously showed that immunohistochemistry (IHC)-guided EGFR gene copy number (GCN) analysis may identify CRC patients benefiting from anti-EGFR treatment. Here we tested the predictive value of such analysis in chemorefractory metastatic CRC, elucidated EGFR GCN heterogeneity within the tumors, and evaluated the association between EGFR GCN, KRAS status, and anti-EGFR antibody response in CRC cell lines. The chemorefractory patient cohort consisted of 54 KRAS wild-type (WT) metastatic CRC patients. EGFR GCN status was analyzed by silver in situ hybridization using a cut-off value of 4.0 EGFR gene copies/cell. KRAS-WT and KRAS mutant CRC cell lines with different EGFR GCN were used in in vitro studies. The chemorefractory CRC tumors with EGFR GCN increase (>= 4.0) responded better to anti-EGFR therapy than EGFR GCN (, 4.0) tumors (clinical benefit, P = 0.0004; PFS, HR = 0.23, 95% CI 0.12-0.46). EGFR GCN counted using EGFR IHC guidance was significantly higher than the value from randomly selected areas verifying intratumoral EGFR GCN heterogeneity. In CRC cell lines, EGFR GCN correlated with EGFR expression. Best anti-EGFR response was seen with KRAS-WT, EGFR GCN = 4 cells and poorest response with KRAS-WT, EGFR GCN = 2 cells. Anti-EGFR response was associated with AKT and ERK1/2 phosphorylation, which was effectively inhibited only in cells with KRAS-WT and increased EGFR GCN. In conclusion, IHC-guided EGFR GCN is a promising predictor of anti-EGFR treatment efficacy in chemorefractory CRC.	[Algars, Annika; Avoranta, Tuulia; Ristamaki, Raija] Turku Univ Hosp, Dept Radiotherapy & Oncol, FIN-20520 Turku, Finland; [Osterlund, Pia] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland; [Osterlund, Pia] Univ Helsinki, Dept Oncol, Helsinki, Finland; [Lintunen, Minnamaija; Sundstrom, Jari; Jokilehto, Terhi; Carpen, Olli] Univ Turku, Dept Pathol, Turku, Finland; [Lintunen, Minnamaija; Sundstrom, Jari; Jokilehto, Terhi; Carpen, Olli] Turku Univ Hosp Tyks Sapa, Dept Pathol, Turku, Finland; [Ristimaki, Ari] Univ Helsinki, HUSLAB, Cent Hosp, Div Pathol & Genet, Helsinki, Finland; [Ristimaki, Ari] Univ Helsinki, Haartman Inst & Genome Scale Biol, Dept Pathol, Res Programs Unit, Helsinki, Finland	University of Turku; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Turku; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Carpen, O (corresponding author), Univ Turku, Dept Pathol, Turku, Finland.	ocarpen@utu.fi			The Finnish Medical Foundation; The Finnish Cancer Foundation; The National Graduate School of Clinical Investigations; Turku University Hospital EVO grant; The Academy of Finland; The Cancer Society of South-Western Finland	The Finnish Medical Foundation; The Finnish Cancer Foundation; The National Graduate School of Clinical Investigations; Turku University Hospital EVO grant; The Academy of Finland(Academy of Finland); The Cancer Society of South-Western Finland	This study was supported by The Finnish Medical Foundation, The Finnish Cancer Foundation, The National Graduate School of Clinical Investigations, Turku University Hospital EVO grant, The Academy of Finland, and The Cancer Society of South-Western Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algars A, 2011, BRIT J CANCER, V105, P255, DOI 10.1038/bjc.2011.223; Botta C, 2012, J IMMUNOTHER, V35, P440, DOI 10.1097/CJI.0b013e31825943aa; Bouche O, 2010, CANCER TREAT REV, V36, pS1, DOI 10.1016/S0305-7372(10)00036-8; Chang DZ, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-18; Correale P, 2014, J IMMUNOTHER, V37, P26, DOI 10.1097/CJI.0000000000000004; Correale P, 2010, EUR J CANCER, V46, P1703, DOI 10.1016/j.ejca.2010.03.005; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Feng Y, 2012, CELL PROLIFERAT, V45, P413, DOI 10.1111/j.1365-2184.2012.00837.x; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Kasper S, 2013, ONCOGENE, V32, P2873, DOI 10.1038/onc.2012.302; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Personeni N, 2008, CLIN CANCER RES, V14, P5869, DOI 10.1158/1078-0432.CCR-08-0449; Ruschoff J, 2012, MODERN PATHOL, V25, P637, DOI 10.1038/modpathol.2011.198; Sartore-Bianchi A, 2007, J CLIN ONCOL, V25, P3238, DOI 10.1200/JCO.2007.11.5956; Sartore-Bianchi A, 2012, J CLIN PATHOL, V65, P218, DOI 10.1136/jclinpath-2011-200353; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Tanner M, 2005, ANN ONCOL, V16, P273, DOI 10.1093/annonc/mdi064; Vaiopoulos AG, 2012, STEM CELLS, V30, P363, DOI 10.1002/stem.1031; Yang ZY, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-52; Yoshida T, 2008, INT J CANCER, V122, P1530, DOI 10.1002/ijc.23253	22	15	15	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99590	10.1371/journal.pone.0099590	http://dx.doi.org/10.1371/journal.pone.0099590			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940619	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200030
J	Downey, CM; Aghaei, M; Schwendener, RA; Jirik, FR				Downey, Charlene M.; Aghaei, Mehrnoosh; Schwendener, Reto A.; Jirik, Frank R.			DMXAA Causes Tumor Site-Specific Vascular Disruption in Murine Non-Small Cell Lung Cancer, and like the Endogenous Non-Canonical Cyclic Dinucleotide STING Agonist, 2 ' 3 '-cGAMP, Induces M2 Macrophage Repolarization	PLOS ONE			English	Article							5,6-DIMETHYLXANTHENONE-4-ACETIC ACID DMXAA; ASA404 VADIMEZAN; ANTIVASCULAR AGENT; ANTITUMOR-ACTIVITY; BLOOD-VESSELS; MOUSE MODELS; PHASE-II; DI-GMP; MICE; ACTIVATION	The vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a murine agonist of the stimulator of interferon genes (STING), appears to target the tumor vasculature primarily as a result of stimulating pro-inflammatory cytokine production from tumor-associated macrophages (TAMs). Since there were relatively few reports of DMXAA effects in genetically-engineered mutant mice (GEMM), and models of non-small cell lung cancer (NSCLC) in particular, we examined both the effectiveness and macrophage dependence of DMXAA in various NSCLC models. The DMXAA responses of primary adenocarcinomas in K-ras(LA1/+) transgenic mice, as well as syngeneic subcutaneous and metastatic tumors, generated by a p53(R172HDg/+); K-ras(LA1/+) NSCLC line (344SQ-ELuc), were assessed both by in vivo bioluminescence imaging as well as by histopathology. Macrophage-dependence of DMXAA effects was explored by clodronate liposome-mediated TAM depletion. Furthermore, a comparison of the vascular structure between subcutaneous tumors and metastases was carried out using micro-computed tomography (micro-CT). Interestingly, in contrast to the characteristic hemorrhagic necrosis produced by DMXAA in 344SQ-ELuc subcutaneous tumors, this agent failed to cause hemorrhagic necrosis of either 344SQ-ELuc-derived metastases or autochthonous K-ras(LA1/+) NSCLCs. In addition, we found that clodronate liposome-mediated depletion of TAMs in 344SQ-ELuc subcutaneous tumors led to non-hemorrhagic necrosis due to tumor feeding-vessel occlusion. Since NSCLC were comprised exclusively of TAMs with anti-inflammatory M2-like phenotype, the ability of DMXAA to re-educate M2-polarized macrophages was examined. Using various macrophage phenotypic markers, we found that the STING agonists, DMXAA and the non-canonical endogenous cyclic dinucleotide, 2'3'-cGAMP, were both capable of re-educating M2 cells towards an M1 phenotype. Our findings demonstrate that the choice of preclinical model and the anatomical site of a tumor can determine the vascular disrupting effectiveness of DMXAA, and they also support the idea of STING agonists having therapeutic utility as TAM repolarizing agents.	[Downey, Charlene M.; Aghaei, Mehrnoosh; Jirik, Frank R.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Downey, Charlene M.; Aghaei, Mehrnoosh; Jirik, Frank R.] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada; [Schwendener, Reto A.] Univ Zurich, Inst Mol Canc Res, Lab Liposome Res, Zurich, Switzerland	University of Calgary; University of Calgary; University of Zurich	Jirik, FR (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	jirik@ucalgary.ca	Schwendener, Reto A/F-6373-2011		Canadian Cancer Society Research Institute (CCSRI) [2011-700953, 2012-701470]; Canadian Cancer Society (CCS)	Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS)); Canadian Cancer Society (CCS)(Canadian Cancer Society (CCS))	Support for different aspects of this study came from an Operating Grant (#2011-700953) from the Canadian Cancer Society Research Institute (CCSRI) (http://www.cancer.ca/Research.aspx) with funds raised by the Canadian Cancer Society (CCS). Additional support came from a CCSRI Innovation Grant (#2012-701470) enabled by funds raised on behalf of the CCS by the Women in Insurance Cancer Crusade (WICC) of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2012, CLIN EXP IMMUNOL, V167, P195, DOI 10.1111/j.1365-2249.2011.04515.x; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Baguley BC, 2010, EXPERT OPIN INV DRUG, V19, P1413, DOI 10.1517/13543784.2010.529128; Barber GN, 2014, TRENDS IMMUNOL, V35, P88, DOI 10.1016/j.it.2013.10.010; BIBBY MC, 1989, CANCER CHEMOTH PHARM, V24, P87; Bondareva A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005620; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Ching LM, 2002, BRIT J CANCER, V86, P1937, DOI 10.1038/sj.bjc.6600368; Conlon J, 2013, J IMMUNOL, V190, P5216, DOI 10.4049/jimmunol.1300097; Downey CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041685; Dubensky Thomas W Jr, 2013, Ther Adv Vaccines, V1, P131, DOI 10.1177/2051013613501988; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Fridlender ZG, 2013, BRIT J CANCER, V108, P1288, DOI 10.1038/bjc.2013.93; Fridlender ZG, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26620; Fruh M, 2012, CLIN LUNG CANC; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gobert AP, 2002, J IMMUNOL, V168, P4692, DOI 10.4049/jimmunol.168.9.4692; Guiducci C, 2005, CANCER RES, V65, P3437, DOI 10.1158/0008-5472.CAN-04-4262; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Head M, 2010, EXPERT OPIN INV DRUG, V19, P295, DOI 10.1517/13543780903540214; Jameson MB, 2003, BRIT J CANCER, V88, P1844, DOI 10.1038/sj.bjc.6600992; Jamniczky HA, 2011, EVOL DEV, V13, P28, DOI 10.1111/j.1525-142X.2010.00453.x; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kim S., 2013, ACS CHEM BIOL; Lara PN, 2011, J CLIN ONCOL, V29, P2965, DOI 10.1200/JCO.2011.35.0660; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; Liu JJ, 2007, CANCER CHEMOTH PHARM, V59, P661, DOI 10.1007/s00280-006-0321-7; LoRusso PM, 2011, J CLIN ONCOL, V29, P2952, DOI 10.1200/JCO.2011.36.1311; McKeage MJ, 2008, BRIT J CANCER, V99, P2006, DOI 10.1038/sj.bjc.6604808; McKeage MJ, 2010, CANCER-AM CANCER SOC, V116, P1859, DOI 10.1002/cncr.24975; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Moilanen E, 1998, BRIT J CANCER, V77, P426, DOI 10.1038/bjc.1998.68; Overbergh L, 1999, CYTOKINE, V11, P305, DOI 10.1006/cyto.1998.0426; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pili R, 2010, CLIN CANCER RES, V16, P2906, DOI 10.1158/1078-0432.CCR-09-3026; Politi K, 2011, J CLIN ONCOL, V29, P2273, DOI 10.1200/JCO.2010.30.8304; Prantner D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382986; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ribatti D, 2007, LEUKEMIA, V21, P44, DOI 10.1038/sj.leu.2404402; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Schmieder A, 2012, SEMIN CANCER BIOL, V22, P289, DOI 10.1016/j.semcancer.2012.02.002; Seshadri M, 2009, TRANSL ONCOL, V2, P121, DOI 10.1593/tlo.09103; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Siemann DW, 2002, INT J CANCER, V99, P1, DOI 10.1002/ijc.10316; Singh M, 2012, CANCER RES, V72, P2695, DOI 10.1158/0008-5472.CAN-11-2786; Standiford TJ, 2011, ONCOGENE, V30, P2475, DOI 10.1038/onc.2010.619; Sun J, 2011, BIOCHEM PHARMACOL, V82, P1175, DOI 10.1016/j.bcp.2011.07.086; Tijono SM, 2013, BRIT J CANCER, V108, P1306, DOI 10.1038/bjc.2013.101; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Wang LCS, 2009, NEOPLASIA, V11, P793, DOI 10.1593/neo.09506; Wu Q, 2012, J PHARMACOL EXP THER, V341, P709, DOI 10.1124/jpet.112.191635; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zhao L, 2002, BRIT J CANCER, V87, P465, DOI 10.1038/sj.bjc.6600479; Zheng S, 2007, ONCOGENE, V26, P6896, DOI 10.1038/sj.onc.1210493	55	92	105	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99988	10.1371/journal.pone.0099988	http://dx.doi.org/10.1371/journal.pone.0099988			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940883	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000338508200060
J	Jefferies, JM; Yusof, MYM; Sekaran, SD; Clarke, SC				Jefferies, Johanna M.; Yusof, Mohd Yasim Mohd; Sekaran, Shamala Devi; Clarke, Stuart C.			Novel Clones of Streptococcus pneumoniae Causing Invasive Disease in Malaysia	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; GENOTYPIC CHARACTERIZATION; HAEMOPHILUS-INFLUENZAE; ASIAN COUNTRIES; IDENTIFICATION; SEROTYPES; CARRIAGE; EPIDEMIOLOGY; SURVEILLANCE; PREVALENCE	Although Streptococcus pneumoniae is a leading cause of childhood disease in South East Asia, little has previously been reported regarding the epidemiology of invasive pneumococcal disease in Malaysia and very few studies have explored pneumococcal epidemiology using multilocus sequence typing (MLST). Here we describe serotype, multilocus sequence type (ST), and penicillin susceptibility of thirty pneumococcal invasive disease isolates received by the University of Malaya Medical Centre between February 2000 and January 2007 and relate this to the serotypes included in current pneumococcal conjugate vaccines. A high level of diversity was observed; fourteen serotypes and 26 sequence types (ST), (11 of which were not previously described) were detected from 30 isolates. Penicillin non-susceptible pneumococci accounted for 33% of isolates. The extent of molecular heterogeneity within carried and disease-causing Malaysian pneumococci remains unknown. Larger surveillance and epidemiological studies are now required in this region to provide robust evidence on which to base future vaccine policy.	[Jefferies, Johanna M.; Clarke, Stuart C.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Jefferies, Johanna M.; Clarke, Stuart C.] Univ Southampton, Inst Life Sci, Southampton SO9 5NH, Hants, England; [Jefferies, Johanna M.; Clarke, Stuart C.] NIHR Southampton Resp Biomed Res Unit, Southampton, Hants, England; [Jefferies, Johanna M.; Yusof, Mohd Yasim Mohd; Sekaran, Shamala Devi; Clarke, Stuart C.] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Clarke, Stuart C.] Publ Hlth England, Southampton, Hants, England; [Clarke, Stuart C.] Univ Southampton, Nusajaya, Malaysia	University of Southampton; University of Southampton; Universiti Malaya; Public Health England	Clarke, SC (corresponding author), Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England.	S.C.Clarke@Southampton.ac.uk	Devi, Shamala Devi/B-9735-2010; Sekaran, Shamala Devi/B-8482-2008	Devi, Shamala Devi/0000-0002-0478-0425; Sekaran, Shamala Devi/0000-0002-0478-0425; Clarke, Stuart/0000-0002-7009-1548	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We acknowledge Elita Jauneikaite for helpful discussions. This publication made use of the Multi Locus Sequence Typing website (http://www.mlst.net) at Imperial College London developed by David Aanensen and funded by the Wellcome Trust.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Black SB, 2002, PEDIATR INFECT DIS J, V21, P810, DOI 10.1097/00006454-200209000-00005; Bravo LC, 2009, VACCINE, V27, P7282, DOI 10.1016/j.vaccine.2009.04.046; British Society for Antimicrobial Chemotherapy, 2009, BSAC METH ANT SUSC T; Calix JJ, 2012, CLIN INFECT DIS, V54, P794, DOI 10.1093/cid/cir953; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; Desa Mohd Nasir Mohd, 2003, International Journal of Infectious Diseases, V7, P190, DOI 10.1016/S1201-9712(03)90051-8; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Hanage WP, 2005, INFECT IMMUN, V73, P431, DOI 10.1128/IAI.73.1.431-435.2005; Hausdorff WP, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-4; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Hausdorff WP, 2001, LANCET, V357, P950, DOI 10.1016/S0140-6736(00)04222-7; Isaacman DJ, 2010, INT J INFECT DIS, V14, pE197, DOI 10.1016/j.ijid.2009.05.010; JAMAL F, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P79; Jauneikaite E, 2012, INT J INFECT DIS, V16, pE223, DOI 10.1016/j.ijid.2012.05.825; Jauneikaite E, 2012, VACCINE, V30, P3503, DOI 10.1016/j.vaccine.2012.03.066; Jefferies JMC, 2011, J MED MICROBIOL, V60, P750, DOI 10.1099/jmm.0.030007-0; Jin P, 2009, J INFECT DIS, V200, P1375, DOI 10.1086/606118; JORGENSEN JH, 1991, J CLIN MICROBIOL, V29, P109, DOI 10.1128/JCM.29.1.109-114.1991; Kirkham LAS, 2006, J CLIN MICROBIOL, V44, P151, DOI 10.1128/JCM.44.1.151-159.2006; Le CF, 2012, EXPERT REV ANTI-INFE, V10, P707, DOI [10.1586/eri.12.54, 10.1586/ERI.12.54]; Le CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019547; Lim LH, 2007, J PAEDIATR CHILD H, V43, P366, DOI 10.1111/j.1440-1754.2007.01081.x; Lucero MG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004977.pub2; Nathan JJ, 2014, INFECT GENET EVOL, V21, P391, DOI 10.1016/j.meegid.2013.11.026; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Palmu AAI, 2004, PEDIATR INFECT DIS J, V23, P732, DOI 10.1097/01.inf.0000133049.30299.5d; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Prymula R, 2006, LANCET, V367, P740, DOI 10.1016/S0140-6736(06)68304-9; Rohani MY, 1999, EPIDEMIOL INFECT, V122, P77, DOI 10.1017/S0950268898001605; Rohani MY, 1999, J ANTIMICROB CHEMOTH, V44, P852, DOI 10.1093/jac/44.6.852; Schultsz C, 2007, T ROY SOC TROP MED H, V101, P484, DOI 10.1016/j.trstmh.2006.08.010; Shi ZY, 1998, J CLIN MICROBIOL, V36, P3514, DOI 10.1128/JCM.36.12.3514-3519.1998; Sjostrom K, 2006, CLIN INFECT DIS, V42, P451, DOI 10.1086/499242; Song JH, 1999, CLIN INFECT DIS, V28, P1206, DOI 10.1086/514783; Song JH, 2004, ANTIMICROB AGENTS CH, V48, P2101, DOI 10.1128/AAC.48.6.2101-2107.2004; Song JH, 2004, J ANTIMICROB CHEMOTH, V53, P457, DOI 10.1093/jac/dkh118; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Yasin RM, 2011, VACCINE, V29, P5688, DOI 10.1016/j.vaccine.2011.06.004	41	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e97912	10.1371/journal.pone.0097912	http://dx.doi.org/10.1371/journal.pone.0097912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941079	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000338508200006
J	McCarthy, MJ; Liang, S; Spadoni, AD; Kelsoe, JR; Simmons, AN				McCarthy, Michael J.; Liang, Sherri; Spadoni, Andrea D.; Kelsoe, John R.; Simmons, Alan N.			Whole Brain Expression of Bipolar Disorder Associated Genes: Structural and Genetic Analyses	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; END RULE PATHWAY; GRAY-MATTER VOLUME; GENOME-WIDE ASSOCIATION; FALSE DISCOVERY RATE; CORTICAL THICKNESS; UBIQUITIN LIGASES; MICE LACKING; SCHIZOPHRENIA; ABNORMALITIES	Studies of bipolar disorder (BD) suggest a genetic basis of the illness that alters brain function and morphology. In recent years, a number of genetic variants associated with BD have been identified. However, little is known about the associated genes, or brain circuits that rely upon their function. Using an anatomically comprehensive survey of the human transcriptome (The Allen Brain Atlas), we mapped the expression of 58 genes with suspected involvement in BD based upon their relationship to SNPs identified in genome wide association studies (GWAS). We then conducted a meta-analysis of structural MRI studies to identify brain regions that are abnormal in BD. Of 58 BD associated genes, 22 had anatomically distinct expression patterns that could be categorized into one of three clusters (C1-C3). Brain regions with the highest and lowest expression of these genes did not overlap strongly with anatomical sites identified as abnormal by structural MRI except in the parahippocampal gyrus, the inferior/superior temporal gyrus and the cerebellar vermis, regions where overlap was significant. Using the 22 genes in C1-C3 as reference points, additional genes with correlated expression patterns were identified and organized into sets based on similarity. Further analysis revealed that five of these gene sets were significantly associated with BD, suggesting that anatomical expression profile is correlated with genetic susceptibility to BD, particularly for genes in C2. Our data suggest that expression profiles of BD-associated genes do not explain the majority of structural abnormalities observed in BD, but may be useful in identifying new candidate genes. Our results highlight the complex neuroanatomical basis of BD, and reinforce illness models that emphasize impaired brain connectivity.	[McCarthy, Michael J.; Spadoni, Andrea D.; Kelsoe, John R.; Simmons, Alan N.] Vet Affairs San Diego Healthcare Syst, Res Serv, San Diego, CA 92161 USA; [McCarthy, Michael J.; Liang, Sherri; Spadoni, Andrea D.; Kelsoe, John R.; Simmons, Alan N.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	McCarthy, MJ (corresponding author), Vet Affairs San Diego Healthcare Syst, Res Serv, San Diego, CA 92161 USA.	mmccarthy@ucsd.edu	McCarthy, Michael/K-9302-2017; Simmons, Alan N/A-9815-2008	McCarthy, Michael/0000-0001-6219-4945; Simmons, Alan N/0000-0003-3963-2112; Liang, Sherri/0000-0002-0031-1154; Spadoni, Andrea/0000-0002-8367-6406	Department of Veterans Affairs Office of research and Development [1IK2BX001275, IK2CX000864, I01CX000363, 1I01CX000715]; VA Center of Excellence for Stress and Mental Health; NIMH; Pharmacogenetic Research Network [MH094483, MH092758]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH092758] Funding Source: NIH RePORTER	Department of Veterans Affairs Office of research and Development(US Department of Veterans Affairs); VA Center of Excellence for Stress and Mental Health; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Pharmacogenetic Research Network; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was support by grants from the Department of Veterans Affairs Office of research and Development providing support to M.J.M. (1IK2BX001275), A. D. S. (IK2CX000864), J.R.K. (I01CX000363), and A.N.S. (1I01CX000715), as well funds from the VA Center of Excellence for Stress and Mental Health. J.R.K. has additional support from NIMH and the Pharmacogenetic Research Network (MH094483 and MH092758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CM, 2007, BIOL PSYCHIAT, V61, P776, DOI 10.1016/j.biopsych.2006.05.042; Adler CM, 2005, BIOL PSYCHIAT, V58, P151, DOI 10.1016/j.biopsych.2005.03.022; Almeida JRC, 2009, PSYCHIAT RES-NEUROIM, V171, P54, DOI 10.1016/j.pscychresns.2008.02.001; An JY, 2006, P NATL ACAD SCI USA, V103, P6212, DOI 10.1073/pnas.0601700103; Balogh SA, 2002, GENES BRAIN BEHAV, V1, P223, DOI 10.1034/j.1601-183X.2002.10404.x; Beuckmann CT, 2003, J NEUROSCI, V23, P6793; Brett M, 2001, NEUROIMAGE, V13, pS85; Chen XH, 2007, AUST NZ J PSYCHIAT, V41, P327, DOI 10.1080/00048670701213229; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dickstein DP, 2005, ARCH GEN PSYCHIAT, V62, P734, DOI 10.1001/archpsyc.62.7.734; Doris A, 2004, PSYCHIAT RES-NEUROIM, V130, P153, DOI 10.1016/j.pscychresns.2003.09.002; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Ha TH, 2009, NEUROSCI LETT, V456, P44, DOI 10.1016/j.neulet.2009.03.077; Hallahan B, 2011, BIOL PSYCHIAT, V69, P326, DOI 10.1016/j.biopsych.2010.08.029; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hawrylycz M, 2011, NEURAL NETWORKS, V24, P933, DOI 10.1016/j.neunet.2011.06.012; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Inkster B, 2010, NEUROIMAGE, V53, P908, DOI 10.1016/j.neuroimage.2010.02.065; Janssen J, 2008, J AM ACAD CHILD PSY, V47, P1311, DOI 10.1097/CHI.0b013e318184ff48; Kempton MJ, 2009, AM J PSYCHIAT, V166, P1413, DOI 10.1176/appi.ajp.2009.09050680; Kochunov P, 2002, NEUROIMAGE, V17, P922, DOI 10.1006/nimg.2002.1084; Laird AR, 2005, HUM BRAIN MAPP, V25, P155, DOI 10.1002/hbm.20136; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Li ML, 2011, PSYCHIAT RES-NEUROIM, V191, P92, DOI 10.1016/j.pscychresns.2010.09.006; Linke J, 2012, NEUROIMAGE, V59, P3288, DOI 10.1016/j.neuroimage.2011.10.083; Lochhead RA, 2004, BIOL PSYCHIAT, V55, P1154, DOI 10.1016/j.biopsych.2004.02.026; Lyoo IK, 2004, BIOL PSYCHIAT, V55, P648, DOI 10.1016/j.biopsych.2003.10.017; Mann L, 2008, INT J NEUROPSYCHOPH, V11, P533, DOI 10.1017/S1461145707008395; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; McIntosh AM, 2004, BIOL PSYCHIAT, V56, P544, DOI 10.1016/j.biopsych.2004.07.020; Murakami Manabu, 2008, J Biol Chem, V283, P24554, DOI 10.1074/jbc.M802319200; Nugent AC, 2006, NEUROIMAGE, V30, P485, DOI 10.1016/j.neuroimage.2005.09.029; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Piatkov KI, 2012, P NATL ACAD SCI USA, V109, pE1839, DOI 10.1073/pnas.1207786109; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rimol LM, 2010, BIOL PSYCHIAT, V68, P41, DOI 10.1016/j.biopsych.2010.03.036; Rimol LM, 2010, BIOL PSYCHIAT, V67, P493, DOI 10.1016/j.biopsych.2009.09.032; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Sarrazin S, 2014, JAMA PSYCHIAT, V2014; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Seifuddin F, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-213; Selvaraj S, 2012, BIPOLAR DISORD, V14, P135, DOI 10.1111/j.1399-5618.2012.01000.x; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Smith EN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002134; Sprooten E, 2013, PSYCHIAT RES, V206, P223, DOI 10.1016/j.psychres.2012.11.002; Sprooten E, 2012, MAGN RESON IMAGING, V30, P1373, DOI 10.1016/j.mri.2012.05.013; Stanfield AC, 2009, BIPOLAR DISORD, V11, P135, DOI 10.1111/j.1399-5618.2009.00666.x; Tost H, 2010, J AFFECT DISORDERS, V120, P54, DOI 10.1016/j.jad.2009.04.009; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; Yatham LN, 2007, BIPOLAR DISORD, V9, P693, DOI 10.1111/j.1399-5618.2007.00414.x	54	14	15	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100204	10.1371/journal.pone.0100204	http://dx.doi.org/10.1371/journal.pone.0100204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941232	Green Published, gold, Green Submitted			2022-12-25	WOS:000338508200084
J	Peiro-Velert, C; Valencia-Peris, A; Gonzalez, LM; Garcia-Masso, X; Serra-Ano, P; Devis-Devis, J				Peiro-Velert, Carmen; Valencia-Peris, Alexandra; Gonzalez, Luis M.; Garcia-Masso, Xavier; Serra-Ano, Pilar; Devis-Devis, Jose			Screen Media Usage, Sleep Time and Academic Performance in Adolescents: Clustering a Self-Organizing Maps Analysis	PLOS ONE			English	Article							SCHOOL-AGED CHILDREN; PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; EUROPEAN ADOLESCENTS; SOCIOECONOMIC-STATUS; COMPUTER USE; ACHIEVEMENT; HEALTH; TELEVISION; CHILDHOOD	Screen media usage, sleep time and socio-demographic features are related to adolescents' academic performance, but interrelations are little explored. This paper describes these interrelations and behavioral profiles clustered in low and high academic performance. A nationally representative sample of 3,095 Spanish adolescents, aged 12 to 18, was surveyed on 15 variables linked to the purpose of the study. A Self-Organizing Maps analysis established non-linear interrelationships among these variables and identified behavior patterns in subsequent cluster analyses. Topological interrelationships established from the 15 emerging maps indicated that boys used more passive videogames and computers for playing than girls, who tended to use mobile phones to communicate with others. Adolescents with the highest academic performance were the youngest. They slept more and spent less time using sedentary screen media when compared to those with the lowest performance, and they also showed topological relationships with higher socioeconomic status adolescents. Cluster 1 grouped boys who spent more than 5.5 hours daily using sedentary screen media. Their academic performance was low and they slept an average of 8 hours daily. Cluster 2 gathered girls with an excellent academic performance, who slept nearly 9 hours per day, and devoted less time daily to sedentary screen media. Academic performance was directly related to sleep time and socioeconomic status, but inversely related to overall sedentary screen media usage. Profiles from the two clusters were strongly differentiated by gender, age, sedentary screen media usage, sleep time and academic achievement. Girls with the highest academic results had a medium socioeconomic status in Cluster 2. Findings may contribute to establishing recommendations about the timing and duration of screen media usage in adolescents and appropriate sleep time needed to successfully meet the demands of school academics and to improve interventions targeting to affect behavioral change.	[Peiro-Velert, Carmen; Valencia-Peris, Alexandra; Garcia-Masso, Xavier] Univ Valencia, Dept Didact Expressio Musical Plast & Corporal, Valencia, Spain; [Gonzalez, Luis M.; Devis-Devis, Jose] Univ Valencia, Dept Educ Fis & Esport, Valencia, Spain; [Serra-Ano, Pilar] Univ Valencia, Dept Fisioterapia, Valencia, Spain	University of Valencia; University of Valencia; University of Valencia	Devis-Devis, J (corresponding author), Univ Valencia, Dept Educ Fis & Esport, Valencia, Spain.	jose.devis@uv.es	Serra-Añó, Pilar/L-6085-2014; Valencia-Peris, Alexandra/L-2260-2014; Devis-Devis, Jose/G-8758-2015; García-Massó, Xavier/L-8222-2014; González, Luis-Millán/L-4779-2014; Peiró-Velert, Carmen/N-6056-2015; Valencia-Peris, Alexandra/ABE-5860-2020	Serra-Añó, Pilar/0000-0002-0743-3445; Devis-Devis, Jose/0000-0003-4599-3782; González, Luis-Millán/0000-0002-6478-4014; Peiró-Velert, Carmen/0000-0003-4794-6541; Valencia-Peris, Alexandra/0000-0002-2031-9743; Garcia-Masso, Xavier/0000-0002-5925-4537	Ministry of Science and Innovation (Spain) [EDU2009-13664]	Ministry of Science and Innovation (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Funding for this research (EDU2009-13664) was provided by the Ministry of Science and Innovation (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; Biddle SJH, 2009, INT J BEHAV MED, V16, P278, DOI 10.1007/s12529-008-9028-y; Blair PS, 2012, SLEEP, V35, P353, DOI 10.5665/sleep.1694; Borraccino A, 2009, MED SCI SPORT EXER, V41, P749, DOI 10.1249/MSS.0b013e3181917722; Bowers AJ, 2013, ETR&D-EDUC TECH RES, V61, P51, DOI 10.1007/s11423-012-9274-1; Bradley CB, 2000, MED SCI SPORT EXER, V32, P2071, DOI 10.1097/00005768-200012000-00017; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Chen MY, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-59; Ferrera JMC, 2013, REV EDUC-MADRID, P273, DOI 10.4438/1988-592X-RE-2011-362-161; Costigan SA, 2013, J ADOLESCENT HEALTH, V52, P382, DOI 10.1016/j.jadohealth.2012.07.018; Crespo CJ, 2001, ARCH PEDIAT ADOL MED, V155, P360, DOI 10.1001/archpedi.155.3.360; Currie C, 2008, SOC SCI MED, V66, P1429, DOI 10.1016/j.socscimed.2007.11.024; Devis-Devis J, 2012, J ADOLESCENCE, V35, P213, DOI 10.1016/j.adolescence.2010.11.009; Devis-Devis J, 2009, J ADOLESCENCE, V32, P213, DOI 10.1016/j.adolescence.2008.04.004; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Dworak M, 2007, PEDIATRICS, V120, P978, DOI 10.1542/peds.2007-0476; Foti KE, 2011, AM J PREV MED, V41, P596, DOI 10.1016/j.amepre.2011.08.009; Garcia-Continente X, 2014, EUR J PUBLIC HEALTH, V24, P5, DOI 10.1093/eurpub/ckt013; Gonzalez LM, 2011, HAEMOPHILIA, V17, P676, DOI 10.1111/j.1365-2516.2010.02469.x; Hancox RJ, 2005, ARCH PEDIAT ADOL MED, V159, P614, DOI 10.1001/archpedi.159.7.614; Hardy LL, 2007, PREV MED, V45, P71, DOI 10.1016/j.ypmed.2007.03.014; Hardy LL, 2006, AUST NZ J PUBL HEAL, V30, P534, DOI 10.1111/j.1467-842X.2006.tb00782.x; Hardy LL, 2007, J ADOLESCENT HEALTH, V40, P158, DOI 10.1016/j.jadohealth.2006.09.009; Hardy LL, 2010, ARCH PEDIAT ADOL MED, V164, P643, DOI 10.1001/archpediatrics.2010.88; Hardy LL, 2009, AM J PREV MED, V36, P120, DOI 10.1016/j.amepre.2008.09.034; Haykin S., 1994, NEURAL NETWORKS, DOI 10.5555/521706; Hofferth SL, 2012, J RES ADOLESCENCE, V22, P215, DOI 10.1111/j.1532-7795.2011.00770.x; Jackson LA, 2011, COMPUT HUM BEHAV, V27, P228, DOI 10.1016/j.chb.2010.08.001; Kiang MY, 2001, COMPUT STAT DATA AN, V38, P161, DOI 10.1016/S0167-9473(01)00040-8; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067928, 10.1371/journal.pone.0057604, 10.1371/journal.pone.0083037]; Lubans DR, 2011, OBES REV, V12, P781, DOI 10.1111/j.1467-789X.2011.00896.x; Majem LS, 2003, MED CLIN-BARCELONA, V121, P725, DOI 10.1016/S0025-7753(03)74077-9; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; Guerrero JDM, 2012, EXPERT SYST APPL, V39, P8793, DOI 10.1016/j.eswa.2012.02.001; Martinez-Gomez D, 2011, ARCH DIS CHILD, V96, P240, DOI 10.1136/adc.2010.187161; Mossle T, 2010, BRIT J DEV PSYCHOL, V28, P699, DOI 10.1348/026151009X475307; Morley BC, 2012, MED J AUSTRALIA, V196, P189, DOI 10.5694/mja11.11184; National Sleep Foundation, 2006, SLEEP AM POLL 2006; O'Loughlin EK, 2012, PEDIATRICS, V130, P806, DOI 10.1542/peds.2012-0391; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Oja M., 2003, NEURAL COMPUTING SUR, V3, P1; Rey-Lopez JP, 2010, PREV MED, V51, P50, DOI 10.1016/j.ypmed.2010.03.013; Sanz AB, 2005, AN PEDIATR, V63, P516, DOI 10.1016/S1695-4033(05)70252-6; Serrano-Sanchez JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024453; Sharif I, 2010, J ADOLESCENT HEALTH, V46, P52, DOI 10.1016/j.jadohealth.2009.05.012; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Subrahmanyam K, 2001, J APPL DEV PSYCHOL, V22, P7, DOI 10.1016/S0193-3973(00)00063-0; Tandon PS, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-88; Vesanto J, 2000, IEEE T NEURAL NETWOR, V11, P586, DOI 10.1109/72.846731; Vesanto J., 2000, SOM TOOLBOX MATLAB 5, V57, P60; von Rueden U, 2006, J EPIDEMIOL COMMUN H, V60, P130, DOI 10.1136/jech.2005.039792; Yang CK, 2005, PEDIATRICS, V115, P250, DOI 10.1542/peds.2004-0815G	53	52	54	6	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99478	10.1371/journal.pone.0099478	http://dx.doi.org/10.1371/journal.pone.0099478			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6AC	24941009	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200026
J	Datta, K; Sahoo, G; Krishnan, S; Ganguly, M; Datta, SK				Datta, Karabi; Sahoo, Gayetri; Krishnan, Sellappan; Ganguly, Moumita; Datta, Swapan K.			Genetic Stability Developed for beta-Carotene Synthesis in BR29 Rice Line Using Dihaploid Homozygosity	PLOS ONE			English	Article							GOLDEN INDICA RICE; PHYTOENE SYNTHASE; TRANSGENIC RICE; BIOSYNTHETIC-PATHWAY; EMBRYOGENESIS; RESISTANCE; PROVITAMIN; EXPRESSION; ENDOSPERM; CULTIVARS	Obtaining transgenic crop lines with stable levels of carotenoids is highly desirable. We addressed this issue by employing the anther culture technique to develop dihaploid lines containing genes involved in beta-carotene metabolism. First, we used Agrobacterium- mediated transformation to develop primary transgenic plants containing the beta-carotene biosynthetic genes, phytoene synthase (psy) and phytoene desaturase (crtI), which were engineered for expression and accumulation in the endosperm. Transgenic plants were recovered by selecting for the expression of the phosphomannose isomerase (pmi) gene. Dihaploid plants in addition to haploid and tetraploid plant were generated from anther cultures of these primary transgenic plants. In addition to anatomical features of stomata, pollen of different ploidy-plants, molecular analyses confirmed the stable integration of the genes in the anther culture-derived dihaploid plants, and the yellow color of the polished seeds indicated the accumulation of carotenoids in the endosperm. High performance liquid chromatography (HPLC) analysis of the carotenoid extract further confirmed the levels of beta-carotene accumulation in the endosperms of the transgenic dihaploid rice seeds.	[Datta, Karabi; Ganguly, Moumita; Datta, Swapan K.] Univ Calcutta, Dept Bot, Plant Mol Biol & Biotechnol Lab, Kolkata, India; [Sahoo, Gayetri] Cent Rice Res Inst, Cuttack 753006, Odisha, India; [Krishnan, Sellappan] Goa Univ, Dept Bot, Bambolim, Goa, India; [Datta, Swapan K.] Indian Council Agr Res ICAR, Div Crop Sci, New Delhi, India	University of Calcutta; Indian Council of Agricultural Research (ICAR); ICAR - National Rice Research Institute; Goa University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Datta, K (corresponding author), Univ Calcutta, Dept Bot, Plant Mol Biol & Biotechnol Lab, Kolkata, India.	krbdatta@yahoo.com			Department of Biotechnology, Govt. of India	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	Department of Biotechnology, Govt. of India has provided the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAISAKH N, 2001, RICE GENET NEWSL, V18, P91; Buckner B., 1993, Maize Genetics Cooperation Newsletter, P65; Burkhardt PK, 1997, PLANT J, V11, P1071, DOI 10.1046/j.1365-313X.1997.11051071.x; Datta K, 2003, PLANT BIOTECHNOL J, V1, P81, DOI 10.1046/j.1467-7652.2003.00015.x; Datta K, 1998, THEOR APPL GENET, V97, P20, DOI 10.1007/s001220050862; Datta K, 2006, CURR SCI INDIA, V91, P935; Datta SK, 2005, CURR SCI INDIA, V89, P1870; DATTA SK, 1990, BIO-TECHNOL, V8, P736, DOI 10.1038/nbt0890-736; DATTA SK, 1987, PLANT SCI, V48, P49, DOI 10.1016/0168-9452(87)90069-0; DATTA SK, 1990, PLANT SCI, V67, P83, DOI 10.1016/0168-9452(90)90053-Q; DAYANANDAN P, 1983, AM J BOT, V70, P1079, DOI 10.2307/2442818; Ducreux LJM, 2002, J EXPT BOT, V56, P81; Fraser PD, 2002, P NATL ACAD SCI USA, V99, P1092, DOI 10.1073/pnas.241374598; HAUPTMANN R, 1997, Patent No. 5618988; MISAWA N, 1993, PLANT J, V4, P833, DOI 10.1046/j.1365-313X.1993.04050833.x; MISAWA N, 1990, J BACTERIOL, V172, P6704, DOI 10.1128/jb.172.12.6704-6712.1990; Scolnik PA, 1996, PLANT MOL BIOL REP, V14, P305, DOI 10.1007/BF02673363; Shewmaker CK, 1999, PLANT J, V20, P401, DOI 10.1046/j.1365-313x.1999.00611.x; Tan J, 2005, INT J FOOD SCI TECH, V40, P563, DOI 10.1111/j.1365-2621.2005.00971.x; Vasconcelos M, 2003, PLANT SCI, V164, P371, DOI 10.1016/S0168-9452(02)00421-1; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303	21	9	10	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100212	10.1371/journal.pone.0100212	http://dx.doi.org/10.1371/journal.pone.0100212			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937154	Green Submitted, Green Published, gold			2022-12-25	WOS:000338503400094
J	de Araujo, GS; Pereira, SM; dos Santos, DN; Marinho, JM; Rodrigues, LC; Barreto, ML				de Araujo, Gleide Santos; Pereira, Susan Martins; dos Santos, Darci Neves; Marinho, Jamocyr Moura; Rodrigues, Laura Cunha; Barreto, Mauricio Lima			Common Mental Disorders Associated with Tuberculosis: A Matched Case-Control Study	PLOS ONE			English	Article							HEALTH; POPULATION; CARE	Introduction: Despite the availability of treatment and a vaccine, tuberculosis continues to be a public health problem worldwide. Mental disorders might contribute to the burden of the disease. Objective: The objective of this study was to investigate the association between common mental disorders and tuberculosis. Methods: A matched case-control study was conducted. The study population included symptomatic respiratory patients who attended three referral hospitals and six community clinics in the city of Salvador, Brazil. A doctor's diagnosis defined potential cases and controls. Cases were newly diagnosed tuberculosis cases, and controls were symptomatic respiratory patients for whom tuberculosis was excluded as a diagnosis by the attending physician. Cases and controls were ascertained in the same clinic. Data collection occurred between August 2008 and April 2010. The study instruments included a structured interview, a self-reporting questionnaire for the identification of common mental disorders, and a questionnaire for alcoholism. An univariate analysis included descriptive procedures (with chi-square statistics), and a multivariate analysis used conditional logistic regression. Results: The mean age of the cases was 38 years, and 61% of the cases were males. After adjusting for potential confounders, the odds of tuberculosis were significantly higher in patients dignosed with a common mental disorder (OR: 1.34; 95% CI 1.05-1.70). Conclusion: There appears to be a positive and independent association between common mental disorders and tuberculosis; further epidemiological studies are required to increase our understanding of the possible biological and social mechanisms responsible for this association. Independent of the direction of the association, this finding has implications for the provision of care for mental disorders and for tuberculosis.	[de Araujo, Gleide Santos; Pereira, Susan Martins; dos Santos, Darci Neves; Barreto, Mauricio Lima] Univ Fed Bahia, Inst Collect Hlth, Dept Saude Colet, BR-41170290 Salvador, BA, Brazil; [Rodrigues, Laura Cunha] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England	Universidade Federal da Bahia; University of London; London School of Hygiene & Tropical Medicine	de Araujo, GS (corresponding author), Univ Fed Bahia, Inst Collect Hlth, Dept Saude Colet, BR-41170290 Salvador, BA, Brazil.	gleide23@yahoo.com.br	RODRIGUES, LAURA CUNHA/AAO-4130-2021; Barreto, Mauricio L/B-1752-2008	Barreto, Mauricio L/0000-0002-0215-4930; Rodrigues, Laura Cunha/0000-0001-9008-660X; Marinho, Jamocyr/0000-0003-1032-3260	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - National Council for Scientific and Technological Development) [410 498/2006-8]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Authors would like to thank the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - National Council for Scientific and Technological Development) for funding this research project [grant number 410 498/2006-8] (http://www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola K, 2011, J AFFECT DISORDERS, V134, P365, DOI 10.1016/j.jad.2011.05.028; Araújo Tânia Maria de, 2005, Rev. Bras. Saude Mater. Infant., V5, P337, DOI 10.1590/S1519-38292005000300010; Balaji AL, 2013, ASIAN J PSYCHIATR, V6, P251, DOI 10.1016/j.ajp.2012.12.017; Baxter AJ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-134; Bender A, 2012, CAN J NURS RES, V44, P56; Botti NCL, 2010, BARBAROI, V33, P178, DOI DOI 10.17058/BARBAROI.V0I0.1583; Brazilian Institute of Geography and Statistics, 2010, DEM CENS; Deribew A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-408; Deribew A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-201; Doherty AM, 2013, GEN HOSP PSYCHIAT, V35, P398, DOI 10.1016/j.genhosppsych.2013.03.018; Dourado I, 2007, CAD SAUDE PUBLICA, V23, P25, DOI 10.1590/S0102-311X2007000100004; Fonseca Maria Liana Gesteira, 2008, REV APS, V11, P285; Harling G, 2014, HEALTH PLACE, V25, P56, DOI 10.1016/j.healthplace.2013.10.008; Maher D, 2006, INT J TUBERC LUNG D, V10, P240; MARI JD, 1986, BRIT J PSYCHIAT, V148, P23, DOI 10.1192/bjp.148.1.23; MASUR J, 1983, BRAZ J MED BIOL RES, V16, P215; Pachi Argiro, 2013, Tuberc Res Treat, V2013, P489865, DOI 10.1155/2013/489865; Patel V, 2003, B WORLD HEALTH ORGAN, V81, P609; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Rocha Saulo Vasconcelos, 2010, Rev. bras. epidemiol., V13, P630, DOI 10.1590/S1415-790X2010000400008; Schaaf HS, 2009, TUBERCULOSIS COMPREH; Schneiderman N, 2005, ANNU REV CLIN PSYCHO, V1, P607, DOI 10.1146/annurev.clinpsy.1.102803.144141; STEIN M, 1976, SCIENCE, V191, P435; da Costa JCT, 2011, J BRAS PNEUMOL, V37, P636, DOI 10.1590/S1806-37132011000500011; Udedi M, 2013, INT J SOC PSYCHIAT; Veggi Alessandra Bento, 2004, Rev. Bras. Psiquiatr., V26, P242, DOI 10.1590/S1516-44462004000400007; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	27	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99551	10.1371/journal.pone.0099551	http://dx.doi.org/10.1371/journal.pone.0099551			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK5YM	24937319	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000338503400023
J	Duan, YQ; Gu, HJ; Chen, R; Zhao, ZP; Zhang, LY; Xing, L; Lai, CC; Zhang, PR; Li, ZW; Zhang, KM; Wang, ZH; Zhang, SG; Wang, XL; Yang, PH				Duan, Yueqiang; Gu, Hongjing; Chen, Rui; Zhao, Zhongpeng; Zhang, Liangyan; Xing, Li; Lai, Chengcai; Zhang, Peirui; Li, Zhiwei; Zhang, Keming; Wang, Zhouhai; Zhang, Shaogeng; Wang, Xiliang; Yang, Penghui			Response of Mice and Ferrets to a Monovalent Influenza A (H7N9) Split Vaccine	PLOS ONE			English	Article							REVERSE GENETICS SYSTEM; HUMAN INFECTION; HEMAGGLUTININ CONTENT; VIRUS; ORIGIN; TECHNOLOGIES; GENERATION; H5N1	In early spring 2013, the emergence of the influenza A (H7N9) virus in humans in Eastern China raised concerns of a new influenza pandemic. Development of a safe and effective H7N9 influenza vaccine is urgently needed. To this end, we first synthesized the hemagglutinin (HA) and neuraminidase (NA) genes of the influenza A (H7N9) virus A/AnHui/1/2013. Using reverse genetics, we rescued a reassortant virus (H7N9/PR8) that contained the HA and NA genes from wild-type H7N9 and six genes encoding internal proteins from the A/Puerto Rico/8/34 (PR8) virus. Next, the pathogenicity of the reassortant virus was evaluated both in vivo and in vitro. We found that the virus was non-pathogenic in mice and was stable after serial passaging in eggs. Furthermore, we found that a monovalent influenza A (H7N9) split vaccine prepared from the virus was immunogenic in mice and ferrets. When given intramuscularly, the vaccine (two doses of at least 15-mu g) completely protected mice from normally lethal wild-type H7N9 virus challenge. In summary, our H7N9 vaccine, developed over a short time, is a potential candidate for further clinical evaluation and human use.	[Duan, Yueqiang; Gu, Hongjing; Chen, Rui; Zhao, Zhongpeng; Zhang, Liangyan; Xing, Li; Lai, Chengcai; Wang, Xiliang; Yang, Penghui] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Chen, Rui] Ningxia Med Univ, Sch Basic Med Sci, Dept Pathogen Biol & Med Immunol, Yinchuan, Peoples R China; [Zhang, Peirui; Li, Zhiwei; Zhang, Keming; Wang, Zhouhai; Zhang, Shaogeng; Yang, Penghui] 302 Mil Hosp, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Ningxia Medical University; Fifth Medical Center of Chinese PLA General Hospital	Wang, XL (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	xiliangw@126.com; ypenghuiamms@hotmail.com		zhongpeng, zhao/0000-0002-9147-6252	Ministry of Science and Technology of China [2012CB518905, 2013ZX10004003, SS2012AA020905]; Beijing Nova Program of Science and Technology [Z141107001814054]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Beijing Nova Program of Science and Technology	This work was part-funded by the Ministry of Science and Technology of China (grant nos. 2012CB518905, 2013ZX10004003, and SS2012AA020905). P.H.Y. was supported by Beijing Nova Program of Science and Technology (No. Z141107001814054). No author has any financial or commercial conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang FY, 2013, NEW ENGL J MED, V369, P879, DOI 10.1056/NEJMc1308255; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; De Groot AS, 2013, HUM VACC IMMUNOTHER, V9, P950, DOI 10.4161/hv.24939; Dormitzer PR, 2012, HUM VACC IMMUNOTHER, V8, P45, DOI 10.4161/hv.8.1.18859; Fries LF, 2013, NEW ENGLAND J MED; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Harvey R, 2008, VACCINE, V26, P6550, DOI 10.1016/j.vaccine.2008.09.050; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Jing XH, 2012, VACCINE, V30, P4144, DOI 10.1016/j.vaccine.2012.04.073; Krammer F, 2013, J VIROL; Li Q, 2013, NEW ENGLAND J MED; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Neumann G, 2005, P NATL ACAD SCI USA, V102, P16825, DOI 10.1073/pnas.0505587102; Osterholm MT, 2013, JAMA-J AM MED ASSOC, V309, P2557, DOI 10.1001/jama.2013.6589; Pleschka S, 1996, J VIROL, V70, P4188, DOI 10.1128/JVI.70.6.4188-4192.1996; Shaw A, 2012, VACCINE, V30, P4927, DOI 10.1016/j.vaccine.2012.04.095; Smith GE, 2013, VACCINE, V31, P4305, DOI 10.1016/j.vaccine.2013.07.043; Subbarao K, 2003, VIROLOGY, V305, P192, DOI 10.1006/viro.2002.1742; Wanitchang A, 2010, VIRUS RES, V147, P145, DOI 10.1016/j.virusres.2009.10.010; Webby RJ, 2004, LANCET, V363, P1099, DOI 10.1016/S0140-6736(04)15892-3; Xu L, 2013, J INFECT DIS; Yang PH, 2011, VACCINE, V29, P698, DOI 10.1016/j.vaccine.2010.11.026; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	26	15	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99322	10.1371/journal.pone.0099322	http://dx.doi.org/10.1371/journal.pone.0099322			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937303	Green Submitted, gold, Green Published			2022-12-25	WOS:000338503400015
J	Yang, HB; Wang, QL; Bai, CJ; Li, XX; Liu, GD				Yang, Hubiao; Wang, Qinglong; Bai, Changjun; Li, Xiaoxia; Liu, Guodao			Carex diaoluoshanica (Carex sect. Lageniformes, Cyperaceae), a New Species from Hainan, China	PLOS ONE			English	Article							ZHEJIANG; RHOMBOIDALES	Carex diaoluoshanica, a new species of Carex sect. Lageniformes from Hainan, China, is described and illustrated. The new species is similar to C. breviscapa but differs in having wider leaves with the leaf base gradually narrowed, 5-10 cm long and petiolelike, culms subfiliform, with only two spikes, the lateral female spikes from near the culm base.	[Yang, Hubiao; Wang, Qinglong; Bai, Changjun; Liu, Guodao] Chinese Acad Trop Agr Sci, Trop Crops Genet Resources Inst, Danzhou, Hainan, Peoples R China; [Li, Xiaoxia] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Chinese Academy of Tropical Agricultural Sciences	Yang, HB (corresponding author), Chinese Acad Trop Agr Sci, Trop Crops Genet Resources Inst, Danzhou, Hainan, Peoples R China.	yanghubiao@163.com; liuguodao2008@163.com			Tropical Crops Genetic Resources Institute [1630032014030]; earmarked fund for China Agriculture Research System [CARS-35-03]; Genetic Resource Conservation of Ministry of Agriculture [12RZZY-09]	Tropical Crops Genetic Resources Institute; earmarked fund for China Agriculture Research System; Genetic Resource Conservation of Ministry of Agriculture	This research is supported by the basic scientific research fund of Tropical Crops Genetic Resources Institute (1630032014030); the earmarked fund for China Agriculture Research System (CARS-35-03) and Genetic Resource Conservation of Ministry of Agriculture (12RZZY-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaser HW, 1944, AM J BOT, V31, P53, DOI 10.2307/2437667; Dai L.K., 2010, FLORA CHINA, V23, P285; Frodin DG, 2004, TAXON, V53, P753, DOI 10.2307/4135449; Jin SH, 2012, BRITTONIA, V64, P325, DOI 10.1007/s12228-012-9236-2; Jin XF, 2004, ACTA PHYTOTAXON SIN, V42, P541; Jin XF, 2012, SYST BOT, V37, P929, DOI 10.1600/036364412X656617; Jin XF, 2011, NORD J BOT, V29, P63, DOI 10.1111/j.1756-1051.2010.00977.x; Jin XF, 2010, NORD J BOT, V28, P709, DOI 10.1111/j.1756-1051.2010.00817.x; KOYAMA TETSUO, 1962, JOUR FAC SCI UNIV TOKYO SECT HI BOT, V8, P149; Kukenthal G., 1909, PFLANZENREICH 4; Li PC., 2000, FLORA REIPUBLICAE PO, V12, P56; [李森 Li Sen], 2005, [地理学报, Acta Geographica Sinica], V60, P433; LIAO WB, 2001, ADV PLANT SCI, V4, P57; Liu G.D., 2012, CYPERACEAE HAINAN; NELMES E., 1951, REINWARDTIA, V1, P221; Ohwi J., 1936, MEM COLL SCI KYOTO B, V11, P229; REZNICEK AA, 1990, CAN J BOT, V68, P1409, DOI 10.1139/b90-180; Shimizu Takahiro, 2008, APG Acta Phytotaxonomica et Geobotanica, V59, P67; Wang QL, 2012, PHYTOTAXA, V75, P65; Waterway Marcia J., 2007, Aliso, V23, P165; Waterway MJ, 2009, BOT REV, V75, P138, DOI 10.1007/s12229-008-9024-6; Yu LiYing, 2012, Journal of Tropical and Subtropical Botany, V20, P403	22	7	8	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e97658	10.1371/journal.pone.0097658	http://dx.doi.org/10.1371/journal.pone.0097658			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937208	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400006
J	Zhu, SY; Bing, YT; Wang, XB; Yu, Q; Wang, YP; Xu, SF; Song, L; Wang, XT; Xia, B; Zhu, YQ; Zhou, R				Zhu, Siying; Bing, Yuntao; Wang, Xiaobing; Yu, Qiao; Wang, Yipeng; Xu, Shufang; Song, Lu; Wang, Xintao; Xia, Bing; Zhu, Youqing; Zhou, Rui			CCL25/CCR9 Interactions Regulate the Function of iNKT Cells in Oxazolone-Induced Colitis in Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; THYMUS-EXPRESSED CHEMOKINE; NK-T-CELLS; ULCERATIVE-COLITIS; CROHNS-DISEASE; LAMINA PROPRIA; TUMOR-IMMUNITY; MURINE MODEL; LYMPHOCYTES; RECEPTOR	Background: Natural killer T (NKT) cells share phenotypic and functional properties with both conventional natural killer cells and T cells. These cells might have an important role in the pathogenesis of ulcerative colitis (UC). The interaction of chemokine ligand 25 (CCL25) with chemokine receptor 9 (CCR9) is involved in gut-specific migration of leukocytes and induces regulatory T cells (Tregs) to migrate to the intestine in chronic ileitis. Methodology/Findings: In UC patients, NKT receptor CD161, CCL25, and CCR9 expression levels were evaluated by qRT-PCR. A murine model of oxazolone-induced colitis was induced in BALB/c mice. The mRNA levels of NK1.1, CCL25 and CCR9, and pro-inflammatory cytokines in mice were evaluated. The CCR9 expression on Type I or invariant NKT (iNKT) cells, and the iNKT cells chemotaxis are observed according to flow cytometry. NKT receptor CD161, CCL25 and CCR9 expression levels were significantly increased in UC patients. And, the mRNA expression levels of NK1.1, CCL25 and CCR9 were increased in oxazolone-induced colitis in mice. The production of pro-inflammatory cytokines was significantly increased, especially interleukin 4 (IL-4), IL-10 and IL-13. We observed significantly increased CCR9 expression on iNKT cells. Furthermore, we found an increased iNKT population and enhanced chemotaxis during oxazolone-induced colitis. Conclusions/Significance: Our study suggests that CCL25/CCR9 interactions may promote the induction and function of iNKT cells during oxazolone-induced colitis. These findings may have important implications for UC treatment and suggest a role for CCR9 inhibitors.	[Zhu, Siying; Wang, Xiaobing; Wang, Yipeng; Xu, Shufang; Song, Lu; Wang, Xintao; Xia, Bing; Zhu, Youqing; Zhou, Rui] Wuhan Univ, Zhongnan Hosp, Dept Gastroenterol Hepatol, Wuhan 430072, Hubei, Peoples R China; [Zhu, Siying; Bing, Yuntao; Wang, Xiaobing; Yu, Qiao; Xu, Shufang; Song, Lu; Wang, Xintao; Xia, Bing; Zhu, Youqing; Zhou, Rui] Hubei Clin Ctr, Wuhan, Hubei, Peoples R China; [Zhu, Siying; Bing, Yuntao; Wang, Xiaobing; Yu, Qiao; Xu, Shufang; Song, Lu; Wang, Xintao; Xia, Bing; Zhu, Youqing; Zhou, Rui] Key Lab Intestinal & Colorectal Dis, Wuhan, Hubei, Peoples R China	Wuhan University	Zhu, YQ (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Gastroenterol Hepatol, Wuhan 430072, Hubei, Peoples R China.	uqing_zhu@sina.com; zhourui8310@126.com		Bing, Yuntao/0000-0002-0187-133X; Wang, Xiaobing/0000-0002-3134-0556	National Natural Science Foundation of China [81100266]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 81100266). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Autschbach F, 2002, VIRCHOWS ARCH, V441, P500, DOI 10.1007/s00428-002-0684-z; Badr G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023741; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; Boirivant M, 2005, INFLAMM BOWEL DIS, V11, P48, DOI 10.1097/00054725-200501000-00007; Cohen NR, 2009, ADV IMMUNOL, V102, P1, DOI 10.1016/S0065-2776(09)01201-2; Eksteen B, 2004, J EXP MED, V200, P1511, DOI 10.1084/jem.20041035; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Galitovskiy V, 2011, J IMMUNOL, V187, P2677, DOI 10.4049/jimmunol.1002711; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Hunter MM, 2007, GASTROENTEROLOGY, V132, P1320, DOI 10.1053/j.gastro.2007.01.038; Hunter MM, 2005, J IMMUNOL, V174, P7368, DOI 10.4049/jimmunol.174.11.7368; Juno JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002838; Kihara N, 2003, GUT, V52, P713, DOI 10.1136/gut.52.5.713; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Liao CM, 2013, INFLAMM BOWEL DIS, V19, P1330, DOI 10.1097/MIB.0b013e318280b1e3; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Montbarbon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062208; Nieuwenhuis EES, 2002, NAT MED, V8, P588, DOI 10.1038/nm0602-588; Olaussen RW, 2007, GASTROENTEROLOGY, V132, P2371, DOI 10.1053/j.gastro.2007.04.023; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Papadakis KA, 2000, J IMMUNOL, V165, P5069, DOI 10.4049/jimmunol.165.9.5069; Papadakis KA, 2001, GASTROENTEROLOGY, V121, P246, DOI 10.1053/gast.2001.27154; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Smyth MJ, 2000, NAT IMMUNOL, V1, P459, DOI 10.1038/82698; Stenstad H, 2006, BLOOD, V107, P3447, DOI 10.1182/blood-2005-07-2860; Terabe M, 2008, ADV CANCER RES, V101, P277, DOI 10.1016/S0065-230X(08)00408-9; TRUELOVE SC, 1955, BRIT MED J, V2, P1041, DOI 10.1136/bmj.2.4947.1041; Walters MJ, 2010, J PHARMACOL EXP THER, V335, P61, DOI 10.1124/jpet.110.169714; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Wermers JD, 2011, GASTROENTEROLOGY, V140, P1526, DOI 10.1053/j.gastro.2011.01.044; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wurbel MA, 2007, J IMMUNOL, V178, P7598, DOI 10.4049/jimmunol.178.12.7598; Wurbel MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016442; Yang J, 2009, J BIOMECH, V42, P811, DOI 10.1016/j.jbiomech.2009.01.028; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	40	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100167	10.1371/journal.pone.0100167	http://dx.doi.org/10.1371/journal.pone.0100167			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936795	Green Published, Green Submitted, gold			2022-12-25	WOS:000338503400083
J	Kleine, M; Worbs, T; Schrem, H; Vondran, FWR; Kaltenborn, A; Klempnauer, J; Forster, R; Josenhans, C; Suerbaum, S; Bektas, H				Kleine, Moritz; Worbs, Tim; Schrem, Harald; Vondran, Florian W. R.; Kaltenborn, Alexander; Klempnauer, Juergen; Foerster, Reinhold; Josenhans, Christine; Suerbaum, Sebastian; Bektas, Hueseyin			Helicobacter hepaticus Induces an Inflammatory Response in Primary Human Hepatocytes	PLOS ONE			English	Article							LIVER-INJURY; PORCINE HEPATOCYTES; LEUKOCYTE ADHESION; INNATE IMMUNITY; CYCLOOXYGENASE-2; EXPRESSION; MODEL; MICE; CELL; ASSOCIATION	Helicobacter hepaticus can lead to chronic hepatitis and hepatocellular carcinoma in certain strains of mice. Until now the pathogenic role of Helicobacter species on human liver tissue is still not clarified though Helicobacter species identification in human liver cancer was successful in case controlled studies. Therefore we established an in vitro model to investigate the interaction of primary human hepatocytes (PHH) with Helicobacter hepaticus. Successful co-culturing of PHH with Helicobacter hepaticus was confirmed by visualization of motile bacteria by two-photon-microscopy. Isolated human monocytes were stimulated with PHH conditioned media. Changes in mRNA expression of acute phase cytokines and proteins in PHH and stimulated monocytes were determined by Real-time PCR. Furthermore, cytokines and proteins were analyzed in PHH culture supernatants by ELISA. Co-cultivation with Helicobacter hepaticus induced mRNA expression of Interleukin-1 beta (IL-1 beta), Tumor necrosis factor-alpha, Interleukin-8 (IL-8) and Monocyte chemotactic protein-1 (MCP-1) in PHH (p<0.05) resulting in a corresponding increase of IL-8 and MCP-1 concentrations in PHH supernatants (p<0.05). IL-8 and IL-1 beta mRNA expression was induced in monocytes stimulated with Helicobacter hepaticus infected PHH conditioned media (p<0.05). An increase of Cyclooxygenase-2 mRNA expression was observed, with a concomitant increase of prostaglandin E2 concentration in PHH supernatants at 24 and 48 h (p<0.05). In contrast, at day 7 of co-culture, no persistent elevation of cytokine mRNA could be detected. High expression of intercellular adhesion molecule-1 on PHH cell membranes after co-culture was shown by two-photon-microscopy and confirmed by flow-cytomety. Finally, expression of Cytochrome P450 3A4 and albumin mRNA were downregulated, indicating an impairment of hepatocyte synthesis function by Helicobacter hepaticus presence. This is the first in vitro model demonstrating a pathogenic effect of a Helicobacter spp. on human liver cells, resulting in an inflammatory response with increased synthesis of inflammatory mediators and consecutive monocyte activation.	[Kleine, Moritz; Schrem, Harald; Vondran, Florian W. R.; Kaltenborn, Alexander; Klempnauer, Juergen; Bektas, Hueseyin] Hannover Med Sch, Dept Gen Visceral & Transplant Surg, Hannover, Germany; [Worbs, Tim; Foerster, Reinhold] Hannover Med Sch, Inst Immunol, Hannover, Germany; [Josenhans, Christine; Suerbaum, Sebastian] Hannover Med Sch, Inst Med Microbiol & Hosp Epidemiol, Hannover, Germany; [Kaltenborn, Alexander] Fed Armed Forces Med Ctr, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Kleine, M (corresponding author), Hannover Med Sch, Dept Gen Visceral & Transplant Surg, Hannover, Germany.	kleine.moritz@mh-hannover.de		Forster, Reinhold/0000-0001-6190-7923; Worbs, Tim/0000-0001-9945-3103	Bayer Health Care, Germany; "Verein zur Forderung der Forschung und Lehre in der Allgemein Chirurgie", Germany; German Research Foundation [DFG SFB 621/B8, SFB 900/B6, DFG SFB 900-B1]	Bayer Health Care, Germany(Bayer AGBayer Healthcare Pharmaceuticals); "Verein zur Forderung der Forschung und Lehre in der Allgemein Chirurgie", Germany; German Research Foundation(German Research Foundation (DFG))	Supported by Bayer Health Care, Germany (to M. Kleine and H. Bektas), the "Verein zur Forderung der Forschung und Lehre in der Allgemein Chirurgie" (to M. Kleine), Germany, and grants DFG SFB 621/B8 (to S. Suerbaum), SFB 900/B6 (to C. Josenhans) and DFG SFB 900-B1 (to R. Forster) from the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DH, 2010, TOXICOL SCI, V115, P307, DOI 10.1093/toxsci/kfq009; Avenaud P, 2003, INFECT IMMUN, V71, P3667, DOI 10.1128/IAI.71.6.3667-3672.2003; Bajt ML, 2001, AM J PHYSIOL-GASTR L, V281, pG1188, DOI 10.1152/ajpgi.2001.281.5.G1188; Bartonickova L, 2013, CELL MICROBIOL, V15, P992, DOI 10.1111/cmi.12094; Casado M, 2001, FASEB J, V15, P2016, DOI 10.1096/fj.01-0158fje; Colletti LM, 1996, HEPATOLOGY, V23, P506; Dewhirst FE, 2000, INT J SYST EVOL MICR, V50, P2231, DOI [10.1099/00207713-50-3-1399, 10.1099/00207713-50-3-1401]; ESSANI NA, 1995, HEPATOLOGY, V21, P1632, DOI 10.1002/hep.1840210623; Faouzi S, 2001, J BIOL CHEM, V276, P49077, DOI 10.1074/jbc.M109791200; Fox JG, 1996, INFECT IMMUN, V64, P1548, DOI 10.1128/IAI.64.5.1548-1558.1996; Garcia A, 2011, CANCER RES, V71, P2529, DOI 10.1158/0008-5472.CAN-10-1975; Ge ZM, 2007, CELL MICROBIOL, V9, P2070, DOI 10.1111/j.1462-5822.2007.00939.x; Jaeschke H, 1997, AM J PHYSIOL-GASTR L, V273, pG1169; Jaeschke H, 2008, HEPATOLOGY, V48, P699, DOI 10.1002/hep.22556; Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005; Jeschke MG, 2008, MOL MED, V14, P11, DOI 10.2119/2007-00062.Jeschke; Kleine M, 2008, XENOTRANSPLANTATION, V15, P208, DOI 10.1111/j.1399-3089.2008.00478.x; Koga H, 1999, HEPATOLOGY, V29, P688, DOI 10.1002/hep.510290355; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; LASKIN DL, 1995, HEPATOLOGY, V21, P1045, DOI 10.1002/hep.1840210424; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandell L, 2004, INFECT IMMUN, V72, P6446, DOI 10.1128/IAI.72.11.6446-6454.2004; Nagendra AR, 1997, AM J PHYSIOL-GASTR L, V272, pG408, DOI 10.1152/ajpgi.1997.272.3.G408; Nakagawa H, 2012, WORLD J GASTROENTERO, V18, P4071, DOI 10.3748/wjg.v18.i31.4071; Nilsson HO, 2001, GASTROENTEROLOGY, V120, P323, DOI 10.1053/gast.2001.21382; Nilsson HO, 2000, J CLIN MICROBIOL, V38, P1072, DOI 10.1128/JCM.38.3.1072-1076.2000; Parker GA, 2005, TOXICOL PATHOL, V33, P52, DOI 10.1080/01926230590522365; Pellicano R, 2008, LANCET INFECT DIS, V8, P254, DOI 10.1016/S1473-3099(08)70066-5; Queiroz DMD, 2001, GASTROENTEROLOGY, V121, P1023, DOI [10.1053/gast.2001.28574, 10.1016/S0016-5085(01)96000-7]; Roberts RA, 2007, TOXICOL SCI, V96, P2, DOI 10.1093/toxsci/kfl173; Rocha M, 2005, GUT, V54, P396, DOI 10.1136/gut.2004.042168; Schrem H, 2006, LIVER TRANSPLANT, V12, P1832, DOI 10.1002/lt.20918; Sterzenbach T, 2007, INFECT IMMUN, V75, P2717, DOI 10.1128/IAI.01935-06; Suerbaum S, 2003, P NATL ACAD SCI USA, V100, P7901, DOI 10.1073/pnas.1332093100; WARD JM, 1994, JNCI-J NATL CANCER I, V86, P1222, DOI 10.1093/jnci/86.16.1222; Yin H, 2007, HEPATOLOGY, V45, P159, DOI 10.1002/hep.21493; Zimmermann HW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00056; Zimmermann HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021381	38	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99713	10.1371/journal.pone.0099713	http://dx.doi.org/10.1371/journal.pone.0099713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932686	gold, Green Published, Green Submitted			2022-12-25	WOS:000337738600057
J	Baharia, RK; Tandon, R; Sahasrabuddhe, AA; Sundar, S; Dube, A				Baharia, Rajendra K.; Tandon, Rati; Sahasrabuddhe, Amogh A.; Sundar, Shyam; Dube, Anuradha			Nucleosomal Histone Proteins of L. donovani: A Combination of Recombinant H2A, H2B, H3 and H4 Proteins Were Highly Immunogenic and Offered Optimum Prophylactic Efficacy against Leishmania Challenge in Hamsters	PLOS ONE			English	Article							EXPERIMENTAL VISCERAL LEISHMANIASIS; MURINE CUTANEOUS LEISHMANIASIS; NECROSIS-FACTOR-ALPHA; T-CELL; IMMUNE-RESPONSES; INTERFERON-GAMMA; MAJOR INFECTION; NITRIC-OXIDE; REACTIVE NITROGEN; DNA VACCINES	The present study includes cloning and expression of recombinant Leishmania donovani histone proteins (rLdH2B, rLdH3, rLdH2A and rLdH4), assessment of their immunogenicity in Leishmania infected cured patients/endemic contacts as well as in cured hamsters and finally evaluation of their prophylactic efficacy in hamsters against L. donovani challenge. All recombinant proteins were expressed and purified from the heterologous bacterial host system. Leishmania infected cured patients/endemic contacts as well as cured hamsters exhibited significantly higher proliferative responses to individual recombinant histones and their pooled combination (rLdH2B+rLdH3+rLdH2A+rLdH4) than those of L. donovani infected hosts. The L.donovani soluble antigens (SLD) stimulated PBMCs of cured/exposed and Leishmania patients to produce a mixed Th1/Th2-type cytokine profile, whereas rLdH2B, rLdH3, rLdH2A, rLdH4 and pooled combination (rLdH2-4) stimulated the production of Th1 cytokines IFN-gamma, IL-12 and TNF-alpha but not Th2 cytokines IL-4 or IL-10. The immunogenicity of these histone proteins along with their combination was also checked in cured hamsters where they stimulated higher lymphoproliferation and Nitric oxide production in lymphocytes of cured hamsters than that of infected controls. Moreover, significantly increased IgG2 response, an indicative of cell mediated immunity, was observed in cured hamsters against these individual proteins and their combination as compared to infected hamsters. Further, it was demonstrated that rLdH2B, rLdH3, rLdH2A and rLdH4 and pooled combination were able to provide considerable protection for hamsters against L. donovani challenge. The efficacy was supported by the increased inducible Nitric Oxide Synthase (iNOS) mRNA transcripts and Th1-type cytokines - IFN-gamma, IL-12 and TNF-alpha and down-regulation of IL-4, IL-10 and TGF-beta. Hence, it is inferred that pooled rLdH2-4 elicits Th1-type of immune responses exclusively and confer considerable protection against experimental Visceral Leishmaniasis.	[Baharia, Rajendra K.; Tandon, Rati; Dube, Anuradha] Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India; [Sahasrabuddhe, Amogh A.] Cent Drug Res Inst, Div Mol & Struct Biol, Lucknow 226001, Uttar Pradesh, India; [Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi 221005, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Banaras Hindu University (BHU)	Dube, A (corresponding author), Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India.	anuradha_dube@hotmail.com		Dube, Anuradha/0000-0002-5122-400X	Indian Council for Medical Research (ICMR), New Delhi, India	Indian Council for Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR))	Financial support for this work was given by Indian Council for Medical Research (ICMR), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSREUY J, 1994, EUR J IMMUNOL, V24, P672, DOI 10.1002/eji.1830240328; BELOSEVIC M, 1989, J IMMUNOL, V143, P266; Bhowmick S, 2007, VACCINE, V25, P6544, DOI 10.1016/j.vaccine.2007.05.042; BOGDAN C, 1990, EUR J IMMUNOL, V20, P1131, DOI 10.1002/eji.1830200528; Bosque F, 2000, SCAND J IMMUNOL, V51, P533; BURNS JM, 1991, J IMMUNOL, V146, P742; Carrion J, 2008, VACCINE, V26, P1155, DOI 10.1016/j.vaccine.2007.12.051; Carrion J, 2011, COMP IMMUNOL MICROB, V34, P381, DOI 10.1016/j.cimid.2011.06.002; Chenik M, 2006, VACCINE, V24, P2521, DOI 10.1016/j.vaccine.2005.12.027; CHOMARAT P, 1993, J EXP MED, V177, P523, DOI 10.1084/jem.177.2.523; Coler RN, 2002, INFECT IMMUN, V70, P4215, DOI 10.1128/IAI.70.8.4215-4225.2002; Costa SR, 1999, MEM I OSWALDO CRUZ, V94, P367, DOI 10.1590/S0074-02761999000300015; Cruz I, 2006, INDIAN J MED RES, V123, P357; Desjeux P, 2003, ANN TROP MED PARASIT, V97, P3, DOI 10.1179/000349803225002499; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; DING AH, 1988, J IMMUNOL, V141, P2407; Dube A, 2005, PARASITOL RES, V96, P216, DOI 10.1007/s00436-005-1339-1; Galanti N, 1998, PARASITOL TODAY, V14, P64, DOI 10.1016/S0169-4758(97)01162-9; Garg R, 2005, CLIN EXP IMMUNOL, V140, P149, DOI 10.1111/j.1365-2249.2005.02745.x; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; Gupta SK, 2007, PROTEOMICS, V7, P816, DOI 10.1002/pmic.200600725; Handman E, 2001, CLIN MICROBIOL REV, V14, P229, DOI 10.1128/CMR.14.2.229-243.2001; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; HOLADAY BJ, 1991, J IMMUNOL, V147, P1653; Iborra S, 2004, VACCINE, V22, P3865, DOI 10.1016/j.vaccine.2004.04.015; KEMP M, 1993, INFECT IMMUN, V61, P1069, DOI 10.1128/IAI.61.3.1069-1073.1993; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Kumari S, 2008, VACCINE, V26, P4813, DOI 10.1016/j.vaccine.2008.06.102; LIEW FY, 1989, EUR J IMMUNOL, V19, P1227, DOI 10.1002/eji.1830190712; LIEW FY, 1991, EUR J IMMUNOL, V21, P3009, DOI 10.1002/eji.1830211216; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Melby PC, 1998, INFECT IMMUN, V66, P2135, DOI 10.1128/IAI.66.5.2135-2142.1998; Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741; PIRMEZ C, 1993, J CLIN INVEST, V91, P1390, DOI 10.1172/JCI116341; REED SG, 1993, CURR OPIN IMMUNOL, V5, P524, DOI 10.1016/0952-7915(93)90033-O; RUSSO DM, 1991, J IMMUNOL, V147, P3575; Samant M, 2009, J IMMUNOL, V183, P470, DOI 10.4049/jimmunol.0900265; SCOTT P, 1993, SCIENCE, V260, P496, DOI 10.1126/science.8097337; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Singh VP, 2010, AM J TROP MED HYG, V82, P9, DOI 10.4269/ajtmh.2010.09-0235; Soto M, 1999, CLIN EXP IMMUNOL, V115, P342, DOI 10.1046/j.1365-2249.1999.00796.x; TITUS RG, 1989, J EXP MED, V170, P2097, DOI 10.1084/jem.170.6.2097; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRINCHIERI G, 1993, IMMUNOL TODAY, V14, P335, DOI 10.1016/0167-5699(93)90230-I; WANIDWORANUN C, 1993, J IMMUNOL, V151, P6853; WHITE AC, 1992, AM J TROP MED HYG, V46, P123, DOI 10.4269/ajtmh.1992.46.123	47	19	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e97911	10.1371/journal.pone.0097911	http://dx.doi.org/10.1371/journal.pone.0097911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926878	Green Submitted, Green Published, gold			2022-12-25	WOS:000338278100010
J	Forn-Cuni, G; Reis, ES; Dios, S; Posada, D; Lambris, JD; Figueras, A; Novoa, B				Forn-Cuni, Gabriel; Reis, Edimara S.; Dios, Sonia; Posada, David; Lambris, John D.; Figueras, Antonio; Novoa, Beatriz			The Evolution and Appearance of C3 Duplications in Fish Originate an Exclusive Teleost c3 Gene Form with Anti-Inflammatory Activity	PLOS ONE			English	Article							COMPLEMENT COMPONENT C3; CARP CYPRINUS-CARPIO; MOLECULAR-CLONING; ZEBRAFISH MODEL; PROTEIN; EXPRESSION; ONTOGENY; TREE; IMPROVEMENT; PHYLOGENY	The complement system acts as a first line of defense and promotes organism homeostasis by modulating the fates of diverse physiological processes. Multiple copies of component genes have been previously identified in fish, suggesting a key role for this system in aquatic organisms. Herein, we confirm the presence of three different previously reported complement c3 genes (c3.1, c3.2, c3.3) and identify five additional c3 genes (c3.4, c3.5, c3.6, c3.7, c3.8) in the zebrafish genome. Additionally, we evaluate the mRNA expression levels of the different c3 genes during ontogeny and in different tissues under steady-state and inflammatory conditions. Furthermore, while reconciling the phylogenetic tree with the fish species tree, we uncovered an event of c3 duplication common to all teleost fishes that gave rise to an exclusive c3 paralog (c3.7 and c3.8). These paralogs showed a distinct ability to regulate neutrophil migration in response to injury compared with the other c3 genes and may play a role in maintaining the balance between inflammatory and homeostatic processes in zebrafish.	[Forn-Cuni, Gabriel; Dios, Sonia; Figueras, Antonio; Novoa, Beatriz] CSIC, Inst Marine Res, Vigo, Spain; [Reis, Edimara S.; Lambris, John D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Posada, David] Univ Vigo, Dept Biochem Genet & Immunol, Vigo 36310, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); University of Pennsylvania; Universidade de Vigo	Novoa, B (corresponding author), CSIC, Inst Marine Res, Vigo, Spain.	beatriznovoa@iim.csic.es	Posada, David/C-4502-2008; Dios, Sonia/M-4201-2018; Figueras, Antonio/B-5133-2015; Forn-Cuní, Gabriel/M-8498-2016; Figueras, Antonio/AAB-8921-2019; Novoa, Beatriz/K-3785-2014; Lambris, John/Q-5633-2018	Posada, David/0000-0003-1407-3406; Dios, Sonia/0000-0002-2126-991X; Figueras, Antonio/0000-0002-0617-0030; Forn-Cuní, Gabriel/0000-0001-5976-4759; Figueras, Antonio/0000-0002-0617-0030; Lambris, John/0000-0002-9370-5776; Novoa, Beatriz/0000-0003-4888-8419	Spanish Ministerio de Ciencia e Innovacion [CSD2007-00002]; "FISHFORPHARMA'' (EU) [ITN 289209]; Agencia Estatal Consejo Superior de Investigaciones Cientificas (CSIC) [201230E057]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); "FISHFORPHARMA'' (EU); Agencia Estatal Consejo Superior de Investigaciones Cientificas (CSIC)	This work has been funded by the project CSD2007-00002 "Aquagenomics'' from the Spanish Ministerio de Ciencia e Innovacion, the ITN 289209 "FISHFORPHARMA'' (EU) and project 201230E057 from the Agencia Estatal Consejo Superior de Investigaciones Cientificas (CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Carmona-Fontaine C, 2011, DEV CELL, V21, P1026, DOI 10.1016/j.devcel.2011.10.012; Chondrou M, 2008, DEV COMP IMMUNOL, V32, P1454, DOI 10.1016/j.dci.2008.06.010; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Del Rio-Tsonis K, 1998, J IMMUNOL, V161, P6819; Durand D, 2006, J COMPUT BIOL, V13, P320, DOI 10.1089/cmb.2006.13.320; Ellingsen T, 2005, FISH SHELLFISH IMMUN, V18, P351, DOI 10.1016/j.fsi.2004.09.002; Encinas P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-518; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Gabaldon T, 2013, NAT REV GENET, V14, P360, DOI 10.1038/nrg3456; Gongora R, 1998, SCAND J IMMUNOL, V48, P651; Haynes T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3312; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Kato Y, 2003, IMMUNOGENETICS, V54, P807, DOI 10.1007/s00251-002-0528-7; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kimura A, 2009, DEV COMP IMMUNOL, V33, P77, DOI 10.1016/j.dci.2008.07.005; Kuroda N, 2000, IMMUNOGENETICS, V51, P117, DOI 10.1007/s002510050020; Lange SR, 2004, FISH SHELLFISH IMMUN, V16, P359, DOI 10.1016/j.fsi.2003.06.001; Lovoll M, 2007, FISH SHELLFISH IMMUN, V23, P542, DOI 10.1016/j.fsi.2007.01.002; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Meijer AH, 2005, MOL IMMUNOL, V42, P1185, DOI 10.1016/j.molimm.2004.11.014; Mishra J, 2009, INDIAN J EXP BIOL, V47, P672; Muffato M, 2010, BIOINFORMATICS, V26, P1119, DOI 10.1093/bioinformatics/btq079; Nakao M, 2000, EUR J IMMUNOL, V30, P858, DOI 10.1002/1521-4141(200003)30:3&lt;858::AID-IMMU858&gt;3.0.CO;2-M; Negrisolo E, 2010, MOL BIOL EVOL, V27, P2757, DOI 10.1093/molbev/msq165; Nonaka M, 2006, IMMUNOGENETICS, V58, P701, DOI 10.1007/s00251-006-0142-1; Novoa B, 2012, ADV EXP MED BIOL, V946, P253, DOI 10.1007/978-1-4614-0106-3_15; Nusslein-Volhard C, 2002, ZEBRAFISH; Page RDM, 1997, MOL PHYLOGENET EVOL, V7, P231, DOI 10.1006/mpev.1996.0390; Papanastasiou AD, 2005, IMMUNOGENETICS, V57, P703, DOI 10.1007/s00251-005-0028-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinto MR, 2007, ADV EXP MED BIOL, V598, P372; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rombout JHWM, 2005, FISH SHELLFISH IMMUN, V19, P441, DOI 10.1016/j.fsi.2005.03.007; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozen S, 2000, Methods Mol Biol, V132, P365; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Saxena S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014118; Sennblad B, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-148; Sjostrand J, 2012, BIOINFORMATICS, V28, P2994, DOI 10.1093/bioinformatics/bts548; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tam VK, 2009, J FAC AGR KYUSHU U, V54, P389; Thisse B, 2004, ZFIN DIRECT DATA SUB; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Vernot B, 2008, J COMPUT BIOL, V15, P981, DOI 10.1089/cmb.2008.0092; Wang ZP, 2008, FISH SHELLFISH IMMUN, V25, P264, DOI 10.1016/j.fsi.2008.05.010; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Zarkadis IK, 2001, DEV COMP IMMUNOL, V25, P11, DOI 10.1016/S0145-305X(00)00039-2	55	35	35	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99673	10.1371/journal.pone.0099673	http://dx.doi.org/10.1371/journal.pone.0099673			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926798	gold, Green Submitted, Green Published			2022-12-25	WOS:000338278100065
J	Hu, DF; Wang, CS; Tao, F; Cui, Q; Xu, XM; Shang, WJ; Hu, XP				Hu, Dongfang; Wang, Chunsheng; Tao, Fei; Cui, Qian; Xu, Xiangming; Shang, Wenjing; Hu, Xiaoping			Whole Genome Wide Expression Profiles on Germination of Verticillium dahliae Microsclerotia	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; RNA-SEQ DATA; GENE-EXPRESSION; CONIDIAL GERMINATION; ASPERGILLUS-NIGER; HYDROPHOBIN GENE; ESTERASE; SEQUENCE; GPR1; VDH1	Verticillium dahliae is a fungal pathogen causing Verticillium wilt on a range of economically important crops. Microsclerotia are its main survival and dormancy structures and serve as the primary inoculum on many hosts. Studies were conducted to determine the effect of temperature (5 to 50 degrees C), pH (2 to 12) and nutrient regimes on microsclerotia germination. The optimal condition for microsclerotium germination was 20 degrees C with pH 8.0 whereas nutrient regimes had no significant effect on its germination. The whole genome wide expression profiles during microsclerotium germination were characterized using the Illumina sequencing technology. Approximately 7.4 million of 21-nt cDNA tags were sequenced in the cDNA libraries derived from germinated and non-germinated microsclerotia. About 3.9% and 2.3% of the unique tags were up-regulated and down-regulated at least five-fold, respectively, in the germinated microsclerotia compared with the non-germinated microsclerotia. A total of 1654 genes showing differential expression were identified. Genes that are likely to have played important roles in microsclerotium germination include those encoding G-protein coupled receptor, lipase/esterase, cyclopentanone 1,2-monooxygenase, H(+)/hexose cotransporter 1, fungal Zn(2)-Cys(6) binuclear cluster domain, thymus-specific serine protease, glucan 1,3-beta-glucosidase, and alcohol dehydrogenase. These genes were mainly up-regulated or down-regulated only in germinated microsclerotia, compared with non-germinated microsclerotia. The differential expression of genes was confirmed by qRT-PCR analysis of 20 randomly selected genes from the 40 most differentially expressed genes.	[Hu, Dongfang; Wang, Chunsheng; Tao, Fei; Cui, Qian; Xu, Xiangming; Shang, Wenjing; Hu, Xiaoping] Northwest A&F Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China; [Xu, Xiangming] East Malling Res, East Malling, Kent, England	Northwest A&F University - China	Shang, WJ (corresponding author), Northwest A&F Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China.	shangwj@nwsuaf.edu.cn; xphu@nwsuaf.edu.cn	Xu, Xiangming/I-3050-2014	Xu, Xiangming/0000-0002-4567-7117	National Natural Science Foundation of China [31371888]; 111 project from Education Ministry of China [B07049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 project from Education Ministry of China(Ministry of Education, China - 111 Project)	The study was financially supported by National Natural Science Foundation of China (No. 31371888) and the 111 project from Education Ministry of China (No. B07049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; BENYEPHET Y, 1977, PHYTOPARASITICA, V5, P159, DOI 10.1007/BF02980349; Bloom JS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-221; Chung KS, 2001, J BIOL CHEM, V276, P40190, DOI 10.1074/jbc.M100341200; DEVAY JE, 1974, PHYTOPATHOLOGY, V64, P22, DOI 10.1094/Phyto-64-22; Duressa D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-607; Garcia-Conesa MT, 1999, EUR J BIOCHEM, V266, P644, DOI 10.1046/j.1432-1327.1999.00910.x; Garrett S. D., 1970, PATHOGENIC ROOT INFE; GOTTLIEB D, 1950, BOT REV, V16, P229, DOI 10.1007/BF02873609; HANNAN PJ, 1959, APPL MICROBIOL, V7, P115, DOI 10.1128/AEM.7.2.115-117.1959; HEALE JB, 1965, BR MYCOL SOC TRANS, V48, P39; Hu XP, 2013, EUR J PLANT PATHOL, V136, P225, DOI 10.1007/s10658-013-0170-2; Iwaki H, 2002, APPL ENVIRON MICROB, V68, P5671, DOI 10.1128/AEM.68.11.5671-5684.2002; Klimes A, 2006, FUNGAL GENET BIOL, V43, P283, DOI 10.1016/j.fgb.2005.12.006; Klimes A, 2008, FUNGAL GENET BIOL, V45, P1525, DOI 10.1016/j.fgb.2008.09.014; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Krishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029817; Kulkarni RD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r24; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOO M, 1976, DEV BIOL, V54, P201, DOI 10.1016/0012-1606(76)90299-2; Lorenz MC, 2000, GENETICS, V154, P609; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; NELSON PE, 1958, PHYTOPATHOLOGY, V48, P613; Neumann MJ, 2003, FUNGAL GENET BIOL, V38, P54, DOI 10.1016/S1087-1845(02)00507-8; Osherov N, 2000, GENETICS, V155, P647; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Schnathorst WC, 1981, FUNGAL WILT DIS PLAN, P81, DOI DOI 10.1016/B978-0-12-464450-2.50009-7; Staubmann R, 1999, J BIOTECHNOL, V75, P117, DOI 10.1016/S0168-1656(99)00151-0; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wu JA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-234; Xue CY, 2008, FEMS MICROBIOL REV, V32, P1010, DOI 10.1111/j.1574-6976.2008.00131.x; Xue Y, 1998, EMBO J, V17, P1996, DOI 10.1093/emboj/17.7.1996	39	24	26	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100046	10.1371/journal.pone.0100046	http://dx.doi.org/10.1371/journal.pone.0100046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927478	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100111
J	Jahn, SC; Law, ME; Corsino, PE; Davis, BJ; Harrison, JK; Law, BK				Jahn, Stephan C.; Law, Mary E.; Corsino, Patrick E.; Davis, Bradley J.; Harrison, Jeffrey K.; Law, Brian K.			Signaling Mechanisms that Suppress the Cytostatic Actions of Rapamycin	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MAMMARY-TUMORS; TYROSINE KINASES; PROTEIN-KINASE; BREAST-CANCER; ACTIVATION; AKT; MODEL; PHOSPHORYLATION; INACTIVATION	While rapamycin and the "rapalogs'' Everolimus and Temsirolimus have been approved for clinical use in the treatment of a number of forms of cancer, they have not met overarching success. Some tumors are largely refractory to rapamycin treatment, with some even undergoing an increase in growth rates. However the mechanisms by which this occurs are largely unknown. The results presented here reveal novel cell-signaling mechanisms that may lead to this resistance. The absence of TGF beta signaling results in resistance to rapamycin. Additionally, we observed that treatment of some cancer cell lines with rapamycin and its analogs not only potentiates mitogenic signaling and proliferation induced by HGF, but also stimulates the pro-survival kinase Akt. Together, the data show that the effectiveness of rapamycin treatment can be influenced by a number of factors and bring to light potential biomarkers for the prediction of responsiveness to treatment, and suggest combination therapies to optimize rapalog anticancer efficacy.	[Jahn, Stephan C.; Law, Mary E.; Corsino, Patrick E.; Davis, Bradley J.; Harrison, Jeffrey K.; Law, Brian K.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32611 USA; [Jahn, Stephan C.; Law, Mary E.; Corsino, Patrick E.; Davis, Bradley J.; Harrison, Jeffrey K.; Law, Brian K.] Univ Florida, Hlth Canc Ctr, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Law, BK (corresponding author), Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32611 USA.	bklaw@pharmacology.ufl.edu	Law, Brian/L-6043-2019		Susan G. Komen for the Cure [KG080510]; Bankhead-Coley [4BF03]	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Bankhead-Coley	This work was supported in part by Susan G. Komen for the Cure (KG080510) and Bankhead-Coley (4BF03) grants to B.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Araki K, 2003, ONCOGENE, V22, P7632, DOI 10.1038/sj.onc.1206840; Arencibia JM, 2013, BBA-PROTEINS PROTEOM, V1834, P1302, DOI 10.1016/j.bbapap.2013.03.010; Argyriou Pinelopi, 2012, Adv Hematol, V2012, P435342, DOI 10.1155/2012/435342; BARNARD JA, 1988, AM J MED SCI, V296, P159, DOI 10.1097/00000441-198809000-00003; Bayascas JR, 2005, MOL CELL, V18, P143, DOI 10.1016/j.molcel.2005.03.020; Brennan P, 1999, MOL CELL BIOL, V19, P4729; Chavez-MacGregor M, 2012, EXPERT OPIN INV DRUG, V21, P1835, DOI 10.1517/13543784.2012.726218; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Corsino P, 2007, CANCER RES, V67, P3135, DOI 10.1158/0008-5472.CAN-06-3815; Corsino P, 2009, J BIOL CHEM, V284, P29945, DOI 10.1074/jbc.M109.055251; Corsino PE, 2008, NEOPLASIA, V10, P1240, DOI 10.1593/neo.08710; Dieterle AM, 2013, ONCOGENE; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Forrester E, 2005, CANCER RES, V65, P2296, DOI 10.1158/0008-5472.CAN-04-3272; GONZATTIHACES M, 1988, P NATL ACAD SCI USA, V85, P21, DOI 10.1073/pnas.85.1.21; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Haagensen EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081763; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Jahn SC, 2012, CANCER LETT, V326, P183, DOI 10.1016/j.canlet.2012.08.013; Law BK, 2002, MOL CELL BIOL, V22, P8184, DOI 10.1128/MCB.22.23.8184-8198.2002; Law M, 2006, CANCER RES, V66, P1070, DOI 10.1158/0008-5472.CAN-05-1672; Law ME, 2013, ONCOGENE, V32, P1316, DOI 10.1038/onc.2012.138; Liu P, 2014, NATURE; Liu PD, 2013, NAT CELL BIOL, V15, P1340, DOI 10.1038/ncb2860; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Mahajan K, 2012, J CELL PHYSIOL, V227, P3178, DOI 10.1002/jcp.24065; Marzec M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024849; Meric F, 2002, CLIN CANCER RES, V8, P361; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Muraoka-Cook RS, 2004, CANCER RES, V64, P9002, DOI 10.1158/0008-5472.CAN-04-2111; Najafov A, 2011, BIOCHEM J, V433, P357, DOI 10.1042/BJ20101732; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pool SE, 2013, CANCER RES, V73, P12, DOI 10.1158/0008-5472.CAN-11-2089; Romero-Gallo J, 2005, ONCOGENE, V24, P3028, DOI 10.1038/sj.onc.1208475; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Smith AL, 2012, CLIN CANCER RES, V18, P4514, DOI 10.1158/1078-0432.CCR-11-3224; Sun SY, 2013, CANCER LETT, V340, P1, DOI 10.1016/j.canlet.2013.06.017; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990	40	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99927	10.1371/journal.pone.0099927	http://dx.doi.org/10.1371/journal.pone.0099927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927123	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100092
J	Romo, PA; Zeater, N; Wang, C; Dreher, B				Romo, Phillip A.; Zeater, Natalie; Wang, Chun; Dreher, Bogdan			Binocular Neurons in Parastriate Cortex: Interocular 'Matching' of Receptive Field Properties, Eye Dominance and Strength of Silent Suppression	PLOS ONE			English	Article							CAT STRIATE CORTEX; LATERAL GENICULATE-NUCLEUS; PRIMARY VISUAL-CORTEX; SPATIAL-FREQUENCY SELECTIVITY; OPTIC-NERVE FIBERS; OCULAR-DOMINANCE; ORIENTATION SELECTIVITY; DEPTH DISCRIMINATION; COMPLEX CELLS; SINGLE UNITS	Spike-responses of single binocular neurons were recorded from a distinct part of primary visual cortex, the parastriate cortex (cytoarchitectonic area 18) of anaesthetized and immobilized domestic cats. Functional identification of neurons was based on the ratios of phase-variant (F1) component to the mean firing rate (F0) of their spike-responses to optimized (orientation, direction, spatial and temporal frequencies and size) sine-wave-luminance-modulated drifting grating patches presented separately via each eye. In over 95% of neurons, the interocular differences in the phase-sensitivities (differences in F1F0 spike-response ratios) were small (<= 0.3) and in over 80% of neurons, the interocular differences in preferred orientations were <= 10 degrees. The interocular correlations of the direction selectivity indices and optimal spatial frequencies, like those of the phase sensitivies and optimal orientations, were also strong (coefficients of correlation r >= 0.7005). By contrast, the interocular correlations of the optimal temporal frequencies, the diameters of summation areas of the excitatory responses and suppression indices were weak (coefficients of correlation r <= 0.4585). In cells with high eye dominance indices (HEDI cells), the mean magnitudes of suppressions evoked by stimulation of silent, extra-classical receptive fields via the non-dominant eyes, were significantly greater than those when the stimuli were presented via the dominant eyes. We argue that the well documented 'eye-origin specific' segregation of the lateral geniculate inputs underpinning distinct eye dominance columns in primary visual cortices of mammals with frontally positioned eyes (distinct eye dominance columns), combined with significant interocular differences in the strength of silent suppressive fields, putatively contribute to binocular stereoscopic vision.	[Dreher, Bogdan] Univ Sydney, Discipline Anat & Histol, Sch Med Sci, Sydney, NSW 2006, Australia; Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Dreher, B (corresponding author), Univ Sydney, Discipline Anat & Histol, Sch Med Sci, Sydney, NSW 2006, Australia.	bogdand@anatomy.usyd.edu.au		Zeater, Natalie/0000-0001-8555-6574	National Health and Medical Research Council; Australian Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work has been supported by the grants from the National Health and Medical Research Council and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON PA, 1988, J NEUROSCI, V8, P2183; Anzai A, 1999, J NEUROPHYSIOL, V82, P891, DOI 10.1152/jn.1999.82.2.891; Anzai A, 1999, J NEUROPHYSIOL, V82, P909, DOI 10.1152/jn.1999.82.2.909; Bardy C, 2006, J PHYSIOL-LONDON, V574, P731, DOI 10.1113/jphysiol.2006.110320; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; BAUMAN LA, 1991, VISION RES, V31, P933, DOI 10.1016/0042-6989(91)90201-F; BERMAN N, 1982, J NEUROPHYSIOL, V48, P1362, DOI 10.1152/jn.1982.48.6.1362; BISHOP PO, 1962, J PHYSIOL-LONDON, V163, P466, DOI 10.1113/jphysiol.1962.sp006990; BISHOP PO, 1971, J PHYSIOL-LONDON, V216, P39, DOI 10.1113/jphysiol.1971.sp009508; BISTI S, 1985, J PHYSIOL-LONDON, V359, P259, DOI 10.1113/jphysiol.1985.sp015584; BLAKE R, 1991, TRENDS NEUROSCI, V14, P445, DOI 10.1016/0166-2236(91)90043-T; BLAKEMORE C, 1972, J PHYSIOL-LONDON, V226, P725, DOI 10.1113/jphysiol.1972.sp010006; BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; BLAKEMORE C, 1974, J PHYSIOL-LONDON, V237, P195, DOI 10.1113/jphysiol.1974.sp010478; BLAKEMORE C, 1970, VISION RES, V10, P1181, DOI 10.1016/0042-6989(70)90036-2; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Bridge H, 2001, J NEUROSCI, V21, P7293, DOI 10.1523/JNEUROSCI.21-18-07293.2001; BRUCE CJ, 1981, J NEUROPHYSIOL, V46, P215, DOI 10.1152/jn.1981.46.2.215; BURKE W, 1992, VISUAL NEUROSCI, V9, P47, DOI 10.1017/S0952523800006362; CASANOVA C, 1992, VISUAL NEUROSCI, V9, P581, DOI 10.1017/S0952523800001826; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; CREWTHER SG, 1980, J NEUROPHYSIOL, V44, P97, DOI 10.1152/jn.1980.44.1.97; Cumming BG, 2001, ANNU REV NEUROSCI, V24, P203, DOI 10.1146/annurev.neuro.24.1.203; CYNADER M, 1978, J PHYSIOL-LONDON, V274, P549, DOI 10.1113/jphysiol.1978.sp012166; CYNADER M, 1973, P NATL ACAD SCI USA, V70, P1353, DOI 10.1073/pnas.70.5.1353; CYNADER M, 1982, VISION RES, V22, P967, DOI 10.1016/0042-6989(82)90033-5; DEANGELIS GC, 1995, PERCEPTION, V24, P3, DOI 10.1068/p240003; DEANGELIS GC, 1991, NATURE, V352, P156, DOI 10.1038/352156a0; DERRINGTON AM, 1979, J PHYSIOL-LONDON, V293, P347, DOI 10.1113/jphysiol.1979.sp012893; DEVALOIS KK, 1983, J PHYSIOL-LONDON, V336, P359, DOI 10.1113/jphysiol.1983.sp014586; DiCarlo JJ, 1996, J NEUROSCI METH, V64, P75, DOI 10.1016/0165-0270(95)00113-1; DREHER B, 1980, J NEUROPHYSIOL, V44, P804, DOI 10.1152/jn.1980.44.4.804; DREHER B, 1992, VISUAL NEUROSCI, V9, P65, DOI 10.1017/S0952523800006374; DREHER B, 1975, J NEUROPHYSIOL, V38, P735, DOI 10.1152/jn.1975.38.4.735; Dreher B., 1986, VISUAL NEUROSCI, P290; ERULKAR SD, 1960, J PHYSIOL-LONDON, V154, P206, DOI 10.1113/jphysiol.1960.sp006574; Erwin E, 1998, J NEUROSCI, V18, P9870; Feldman DE, 2012, NEURON, V75, P556, DOI 10.1016/j.neuron.2012.08.001; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1981, J PHYSIOL-LONDON, V311, P623, DOI 10.1113/jphysiol.1981.sp013608; FREGNAC Y, 1984, PHYSIOL REV, V64, P325, DOI 10.1152/physrev.1984.64.1.325; FREUND TF, 1985, J COMP NEUROL, V242, P263, DOI 10.1002/cne.902420208; GALLI L, 1988, EXP BRAIN RES, V71, P1; GARDNER JC, 1986, EXP BRAIN RES, V64, P505, DOI 10.1007/BF00340488; GARDNER JC, 1985, BRAIN RES, V328, P154, DOI 10.1016/0006-8993(85)91335-6; Gardner JL, 1999, VISUAL NEUROSCI, V16, P1115, DOI 10.1017/S0952523899166112; Godecke I, 1996, NATURE, V379, P251, DOI 10.1038/379251a0; HAMMOND P, 1991, EXP BRAIN RES, V85, P631; Hammond P, 1996, J NEUROPHYSIOL, V75, P1163, DOI 10.1152/jn.1996.75.3.1163; HATA Y, 1988, NATURE, V335, P815, DOI 10.1038/335815a0; HEGGELUND P, 1986, J PHYSIOL-LONDON, V373, P277, DOI 10.1113/jphysiol.1986.sp016047; HIRSCH HVB, 1971, EXP BRAIN RES, V12, P509; Horton JC, 2005, PHILOS T R SOC B, V360, P837, DOI 10.1098/rstb.2005.1623; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; HUMPHREY AL, 1985, J COMP NEUROL, V233, P190, DOI 10.1002/cne.902330204; JOSHUA DE, 1970, EXP BRAIN RES, V10, P389, DOI 10.1007/BF02324766; Kara P, 2009, NATURE, V458, P627, DOI 10.1038/nature07721; KATO H, 1981, J NEUROPHYSIOL, V46, P932, DOI 10.1152/jn.1981.46.5.932; Kimura A, 2013, EUR J NEUROSCI, V37, P1270, DOI 10.1111/ejn.12149; Kuhlmann L, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00081; LEHMKUHLE S, 1980, J NEUROPHYSIOL, V43, P520, DOI 10.1152/jn.1980.43.2.520; LEVAY S, 1988, VISUAL NEUROSCI, V1, P395, DOI 10.1017/S0952523800004168; LEVAY S, 1975, J COMP NEUROL, V159, P559, DOI 10.1002/cne.901590408; LEVAY S, 1977, J COMP NEUROL, V172, P563, DOI 10.1002/cne.901720402; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Ma WP, 2013, J NEUROSCI, V33, P11276, DOI 10.1523/JNEUROSCI.5598-12.2013; MACY A, 1982, EXP BRAIN RES, V48, P401; MASKE R, 1984, VISION RES, V24, P1921, DOI 10.1016/0042-6989(84)90026-9; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; MOVSHON JA, 1976, J PHYSIOL-LONDON, V261, P125, DOI 10.1113/jphysiol.1976.sp011551; NELSON JI, 1977, J NEUROPHYSIOL, V40, P260, DOI 10.1152/jn.1977.40.2.260; NIKARA T, 1968, EXP BRAIN RES, V6, P353; Ninomiya T, 2012, J NEUROPHYSIOL, V107, P2220, DOI 10.1152/jn.00832.2010; OHZAWA I, 1988, J NEUROSCI, V8, P2507; OHZAWA I, 1986, J NEUROPHYSIOL, V56, P243, DOI 10.1152/jn.1986.56.1.243; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Payne BR, 2002, CAT PRIMARY VISUAL C, P1, DOI [10.1016/b978-012552104-8/50002-x, DOI 10.1016/B978-012552104-8/50002-X]; PETTIGRE.JD, 1973, NATURE-NEW BIOL, V241, P123, DOI 10.1038/newbio241123a0; PETTIGREW JD, 1987, PROC R SOC SER B-BIO, V232, P297, DOI 10.1098/rspb.1987.0076; PETTIGREW JD, 1968, EXP BRAIN RES, V6, P391; PETTIGREW JD, 1979, INVEST OPHTH VIS SCI, V18, P490; RAMOA AS, 1986, NATURE, V321, P237, DOI 10.1038/321237a0; RAUSCHECKER JP, 1991, PHYSIOL REV, V71, P587, DOI 10.1152/physrev.1991.71.2.587; Read JCA, 2003, J NEUROPHYSIOL, V90, P2795, DOI 10.1152/jn.01110.2002; REGAN D, 1979, PROC R SOC SER B-BIO, V204, P485, DOI 10.1098/rspb.1979.0042; Regan D, 1991, VISION VISUAL DYSFUN, P137; Ringach DL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000251; Ringach DL, 2004, J NEUROPHYSIOL, V92, P468, DOI 10.1152/jn.01202.2003; Ringach DL, 2002, J NEUROPHYSIOL, V87, P1018, DOI 10.1152/jn.00614.2001; RODIECK RW, 1979, EXP BRAIN RES, V35, P465; RODIECK RW, 1967, VISION RES, V7, P107, DOI 10.1016/0042-6989(67)90031-4; Romo PA, 2011, J NEUROPHYSIOL, V106, P1688, DOI 10.1152/jn.00894.2010; Rosenquist AC., 1985, CEREB CORTEX, P81; Sanada TM, 2006, J NEUROPHYSIOL, V95, P2768, DOI 10.1152/jn.00955.2005; SANDERSON KJ, 1969, VISION RES, V9, P1297, DOI 10.1016/0042-6989(69)90117-5; SANDERSON KJ, 1971, J NEUROPHYSIOL, V34, P453, DOI 10.1152/jn.1971.34.3.453; Sarnaik R, 2013, CEREB CORTEX, P1, DOI 101093/cercor/bht027; Scholl B, 2013, J NEUROPHYSIOL, V109, P3013, DOI 10.1152/jn.01021.2012; Sengpiel F, 1998, NEUROPHARMACOLOGY, V37, P607, DOI 10.1016/S0028-3908(98)00034-3; SENGPIEL F, 1995, VISION RES, V35, P179, DOI 10.1016/0042-6989(94)00125-6; SHATZ CJ, 1977, BRAIN RES, V131, P103, DOI 10.1016/0006-8993(77)90031-2; SHERK H, 1978, J NEUROPHYSIOL, V41, P204, DOI 10.1152/jn.1978.41.1.204; SHINKMAN PG, 1983, J NEUROPHYSIOL, V49, P717, DOI 10.1152/jn.1983.49.3.717; SIEGEL S., 1956, NONPARAMETRIC STAT B; SILLITO AM, 1979, J PHYSIOL-LONDON, V289, P33, DOI 10.1113/jphysiol.1979.sp012723; SILLITO AM, 1980, EXP BRAIN RES, V41, P1; SINGER W, 1970, BRAIN RES, V18, P165, DOI 10.1016/0006-8993(70)90463-4; SKOTTUN BC, 1984, EXP BRAIN RES, V56, P206; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; SPILEERS W, 1990, J NEUROPHYSIOL, V63, P936, DOI 10.1152/jn.1990.63.4.936; STONE J, 1973, J NEUROPHYSIOL, V36, P551, DOI 10.1152/jn.1973.36.3.551; STONE J, 1979, BRAIN RES REV, V1, P345, DOI 10.1016/0165-0173(79)90010-9; STRYKER MP, 1978, J NEUROPHYSIOL, V41, P896, DOI 10.1152/jn.1978.41.4.896; TIEMAN SB, 1983, BRAIN RES, V267, P35, DOI 10.1016/0006-8993(83)91037-5; Vidyasagar TR, 1996, TRENDS NEUROSCI, V19, P272, DOI 10.1016/S0166-2236(96)20027-X; Wang BS, 2010, NEURON, V65, P246, DOI 10.1016/j.neuron.2010.01.002; WANG C, 1994, EXP BRAIN RES, V97, P451; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; WIESEL TN, 1974, BRAIN RES, V79, P273, DOI 10.1016/0006-8993(74)90416-8; WILSON HR, 1976, VISION RES, V16, P983, DOI 10.1016/0042-6989(76)90230-3; Yao HS, 2004, P NATL ACAD SCI USA, V101, P5081, DOI 10.1073/pnas.0302510101	124	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99600	10.1371/journal.pone.0099600	http://dx.doi.org/10.1371/journal.pone.0099600			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927276	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100053
J	Tavernier, A; Cavin, JB; Le Gall, M; Ducroc, R; Denis, RGP; Cluzeaud, F; Guilmeau, S; Sakar, Y; Barbot, L; Kapel, N; Le Beyec, J; Joly, F; Chua, S; Luquet, S; Bado, A				Tavernier, Annabelle; Cavin, Jean-Baptiste; Le Gall, Maude; Ducroc, Robert; Denis, Raphael G. P.; Cluzeaud, Francoise; Guilmeau, Sandra; Sakar, Yassine; Barbot, Laurence; Kapel, Nathalie; Le Beyec, Johanne; Joly, Francisca; Chua, Streamson; Luquet, Serge; Bado, Andre			Intestinal deletion of leptin signaling alters activity of nutrient transporters and delayed the onset of obesity in mice	FASEB JOURNAL			English	Article						gut mucosa; energy expenditure; absorption; high-fat diet; hypothalamic neuropeptides	SHORT-BOWEL SYNDROME; FOOD-INTAKE; GLUCOSE-HOMEOSTASIS; RECEPTOR EXPRESSION; WEIGHT HOMEOSTASIS; GASTRIC LEPTIN; LUMINAL LEPTIN; BODY-WEIGHT; GUT LEPTIN; BETA-CELL	The importance of B-isoform of leptin receptor (LEPR-B) signaling in the hypothalamus, pancreas, or liver has been well characterized, but in the intestine, a unique site of entry for dietary nutrition into the body, it has been relatively ignored. To address this question, we characterized a mouse model deficient for LEPR-B specifically in intestinal epithelial cells (IECs). (LEPR)-L-IEC-B-knockout (KO) and wild-type (WT) mice were generated by Cre-Lox strategy and fed a normal or high-fat diet (HFD). The analyses of the animals involved histology and immunohistochemistry of intestinal mucosa, indirect calorimetric measurements, whole-body composition, and expression and activities of nutrient transporters. (LEPR)-L-IEC-B-KO mice exhibited a 2-fold increase in length of jejunal villi and have normal growth on a normal diet but were less susceptible (P<0.01) to HFD-induced obesity. No differences occurred in energy intake and expenditure between (LEPR)-L-IEC-B-WT and -KO mice, but (LEPR)-L-IEC-B-KO mice fed an HFD showed increased excreted fats (P<0.05). Activities of the Na+/glucose cotransporter SGLT-1 and GLUT2 were unaffected in LEPR-B-KO jejunum, while GLUT5-mediated fructose transport and PepT1-mediated peptide transport were substantially reduced (P<0.01). These data demonstrate that intestinal LEPR-B signaling is important for the onset of diet-induced obesity. They suggest that intestinal LEPR-B could be a potential per os target for prevention against obesity.	[Tavernier, Annabelle; Cavin, Jean-Baptiste; Le Gall, Maude; Ducroc, Robert; Cluzeaud, Francoise; Guilmeau, Sandra; Sakar, Yassine; Le Beyec, Johanne; Joly, Francisca; Bado, Andre] INSERM, UMRS 1149, UFR Med Paris Diderot, Sorbonne Paris Cite, F-75890 Paris 18, France; [Denis, Raphael G. P.; Luquet, Serge] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, Unit Biol Fonct & Adaptat,UMR 8521, Paris, France; [Barbot, Laurence; Kapel, Nathalie] Hop La Pitie Salpetriere, Serv Coprol Fonct, Paris, France; [Le Beyec, Johanne] Univ Paris 06, Paris, France; [Joly, Francisca] Hop Beaujon, Serv Gastroenterol & Assistance Nutr, Clichy, France; [Chua, Streamson] Albert Einstein Coll Med, Dept Med Neurosci, New York, NY USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Yeshiva University	Bado, A (corresponding author), INSERM, UFR Med Paris Diderot, CRI, UMRS 1149, 16 Rue Henri Huchard, F-75890 Paris 18, France.	andre.bado@inserm.fr	Le Gall, Maude/C-3917-2017; Luquet, serge/AAT-1809-2021; Le Gall, Maude/W-2593-2019; Denis, Raphael/ABE-1758-2020; Guilmeau, Sandra/P-2318-2017	Le Gall, Maude/0000-0002-5372-4585; Luquet, serge/0000-0001-8668-6645; Le Gall, Maude/0000-0002-5372-4585; Denis, Raphael/0000-0002-7677-7460; BADO, Andre/0000-0002-8007-1460; Le Beyec - Le Bihan, johanne/0000-0002-5647-2002; Tavernier, Annabelle/0000-0002-5744-2876; Guilmeau, Sandra/0000-0002-8260-1218	Institut National de la Sant et de la Recherche Medicale (INSERM); Assistance Publique-Hopitaux de Paris (AP-HP); Institute Benjamin Delessert, Fonds d'Aide a la Recherche-Societe Nationale Francaise de Gastro-Enterologie (FARE-SNFGE), Agence Nationale de la Recherche (ANR) [Alia R10004HH]; Ile-de-France region; University Paris Diderot; U.S. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [P30-DK-026687]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687] Funding Source: NIH RePORTER	Institut National de la Sant et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Assistance Publique-Hopitaux de Paris (AP-HP); Institute Benjamin Delessert, Fonds d'Aide a la Recherche-Societe Nationale Francaise de Gastro-Enterologie (FARE-SNFGE), Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ile-de-France region(Region Ile-de-France); University Paris Diderot; U.S. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Nathalie Ialy-Rado and Anissa Bouhalfia [Core Animal Facilities, Unit Mixte de Recherche en Sant (UMRS) 1149, Paris, France], and Nicolas Sorhaindo for blood analyses. Metabolic analyses in vivo were performed on the Functional and Physiological Exploration (FPE) Platform [University Paris Diderot, Sorbonne Paris Cite, Biologie Fonctionnelle et Adaptative, Centre National de la Recherche Scientifique (CNRS) Unite Mixte de Recherche (UMR) 8251, Paris, France]. Part of this work was presented at Digestive Disease Week/American Gastroenterological Association 2013 (39). A.T. was a Master Training Student, and J.-B.C. is a Ph.D. student, both under the supervision of M.L.G. This research was supported by Institut National de la Sant et de la Recherche Medicale (INSERM), Assistance Publique-Hopitaux de Paris (AP-HP), and grants from Institute Benjamin Delessert, Fonds d'Aide a la Recherche-Societe Nationale Francaise de Gastro-Enterologie (FARE-SNFGE), Agence Nationale de la Recherche (ANR)-Alia R10004HH. The FPE Platform is supported by the Ile-de-France region and University Paris Diderot. This study was partially funded by U.S. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases grant P30-DK-026687 (to S.C.). The authors declare no conflicts of interest. Author contributions: A. B. initiated the study; A.T., J.-B.C., M.L.G., R.D., Y.S., and J.L.B. contributed to the design of the study and acquisition and interpretation of the data; F.C. and S.G. performed experiments; F.J., L.B., and N.K. performed bomb calorimetric analysis of stools; R.G.P.D. and S.L. performed indirect calorimetric and whole-body analysis; S.C. provided materials; J.L.B., R.D., F.J., S.C., and S.L. critically read the paper; M.L.G. and A.B. wrote the paper.	Acosta A, 2014, GUT, V63, P687, DOI 10.1136/gutjnl-2013-306235; Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; Buyse M, 2001, J CLIN INVEST, V108, P1483, DOI 10.1172/JCI13219; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Cohen P, 2001, J CLIN INVEST, V108, P1113, DOI 10.1172/JCI200113914; Covey SD, 2006, CELL METAB, V4, P291, DOI 10.1016/j.cmet.2006.09.005; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Drucker DJ, 2007, J CLIN INVEST, V117, P24, DOI 10.1172/JCI30076; Ducroc R, 2005, DIABETES, V54, P348, DOI 10.2337/diabetes.54.2.348; Ducroc R, 2013, GASTROENTEROLOGY, V144, pS712; Duggal P, 2011, J CLIN INVEST, V121, P1191, DOI 10.1172/JCI45294; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Guilmeau S, 2004, CURR OPIN PHARMACOL, V4, P561, DOI 10.1016/j.coph.2004.06.008; Guo KY, 2007, ENDOCRINOLOGY, V148, P3987, DOI 10.1210/en.2007-0261; Guo X, 2011, MUCOSAL IMMUNOL, V4, P294, DOI 10.1038/mi.2010.76; Huynh FK, 2010, DIABETES, V59, P3032, DOI 10.2337/db10-0074; Iqbal J, 2010, J LIPID RES, V51, P1929, DOI 10.1194/jlr.M005744; Joly F, 2009, GASTROENTEROLOGY, V136, P824, DOI 10.1053/j.gastro.2008.10.084; Joly-Amado A, 2012, EMBO J, V31, P4276, DOI 10.1038/emboj.2012.250; Layec S, 2013, AM J CLIN NUTR, V97, P100, DOI 10.3945/ajcn.112.042606; Le Gall M, 2007, J CELL PHYSIOL, V213, P834, DOI 10.1002/jcp.21245; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Leturque A, 2012, PROG MOL BIOL TRANSL, V108, P113, DOI 10.1016/B978-0-12-398397-8.00005-8; McMinn JE, 2005, AM J PHYSIOL-ENDOC M, V289, pE403, DOI 10.1152/ajpendo.00535.2004; Morioka T, 2007, J CLIN INVEST, V117, P2860, DOI 10.1172/JCI30910; Morton NM, 1998, J BIOL CHEM, V273, P26194, DOI 10.1074/jbc.273.40.26194; Pico C, 2003, BRIT J NUTR, V90, P735, DOI 10.1079/BJN2003945; Rasmussen BA, 2014, CELL METAB, V19, P155, DOI 10.1016/j.cmet.2013.11.014; Ring LE, 2010, J CLIN INVEST, V120, P2931, DOI 10.1172/JCI41985; Sakar Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007935; Scott MM, 2011, J CLIN INVEST, V121, P2413, DOI 10.1172/JCI43703; Stan S, 2001, FEBS LETT, V508, P80, DOI 10.1016/S0014-5793(01)03032-0; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	39	22	22	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2014	28	9					4100	4110		10.1096/fj.14-255158	http://dx.doi.org/10.1096/fj.14-255158			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN8HU	24928195	Green Published			2022-12-25	WOS:000340845900027
J	Bai, Y; Tan, XG; Zhang, HF; Liu, CD; Zhao, BB; Li, Y; Lu, L; Liu, YZ; Zhou, JF				Bai, Yan; Tan, Xungang; Zhang, Haifeng; Liu, Chengdong; Zhao, Beibei; Li, Yun; Lu, Ling; Liu, Yunzhang; Zhou, Jianfeng			Ror2 Receptor Mediates Wnt11 Ligand Signaling and Affects Convergence and Extension Movements in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANAR CELL POLARITY; TYROSINE KINASE ROR2; NEURAL-TUBE DEFECTS; GASTRULATION MOVEMENTS; XENOPUS GASTRULATION; ACTS DOWNSTREAM; MORPHOGENESIS; PATHWAY; WNT5A; FRIZZLED-7	The receptor-tyrosine kinase Ror2 acts as an alternative receptor or co-receptor for Wnt5a and mediates Wnt5a-induced convergent extension movements during embryogenesis in mice and Xenopus as well as the polarity and migration of several cell types during development. However, little is known about whether Ror2 function is conserved in other vertebrates or is involved in other non-canonical Wnt ligands in vivo. In this study we demonstrated that overexpression of dominant-negative ror2 (ror2-TM) mRNA in zebrafish embryos resulted in convergence and extension defects and incompletely separated eyes, which is consistent with observations from slb/wnt11 mutants or wnt11 knockdown morphants. Moreover, the co-injection of ror2-TM mRNA and a wnt11 morpholino or the coexpression of ror2 and wnt11 in zebrafish embryos synergetically induced more severe convergence and extension defects. Transplantation studies further demonstrated that the Ror2 receptor responded to the Wnt11 ligand and regulated cell migration and cell morphology during gastrulation. DnRor2 inhibited the action of Wnt11, which was revealed by a decreased percentage of Wnt11-induced convergence and extension defects. Ror2 physically interacts with Wnt11. The intracellular Tyr-647 and Ser-863 sites of Ror2 are essential for mediating the action of Wnt11. Dishevelled and RhoA act downstream of Wnt11-Ror2 to regulate convergence and extension movements. Overall, our data suggest an important role of Ror2 in mediating Wnt11 signaling and in regulating convergence and extension movements in zebrafish.	[Bai, Yan; Zhang, Haifeng; Liu, Chengdong; Zhao, Beibei; Li, Yun; Lu, Ling; Liu, Yunzhang; Zhou, Jianfeng] Ocean Univ China, Chinese Minist Educ, Key Lab Marine Drugs, Qingdao 266003, Shandong, Peoples R China; [Bai, Yan; Zhang, Haifeng; Liu, Chengdong; Zhao, Beibei; Li, Yun; Lu, Ling; Liu, Yunzhang; Zhou, Jianfeng] Ocean Univ China, Sch Med & Pharm, Qingdao 266003, Shandong, Peoples R China; [Tan, Xungang] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao 266071, Peoples R China	Ocean University of China; Ocean University of China; Chinese Academy of Sciences; Institute of Oceanology, CAS	Zhou, JF (corresponding author), Ocean Univ China, Chinese Minist Educ, Key Lab Marine Drugs, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China.	jfzhou@ouc.edu.cn			Major Science Programs of China [2011CB943800]; National Science Foundation of China [30972238, 40876064, 30970357, 30928021]	Major Science Programs of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Major Science Programs of China Grant 2011CB943800 and National Science Foundation of China Grants 30972238, 40876064, 30970357, and 30928021.	Carreira-Barbosa F, 2003, DEVELOPMENT, V130, P4037, DOI 10.1242/dev.00567; Cohen ED, 2002, DEV CELL, V2, P437, DOI 10.1016/S1534-5807(02)00142-9; Djiane A, 2000, DEVELOPMENT, V127, P3091; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; Heisenberg CP, 2002, SEMIN CELL DEV BIOL, V13, P471, DOI 10.1016/S1084952102001003; Hikasa H, 2002, DEVELOPMENT, V129, P5227; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Jia SJ, 2008, J BIOL CHEM, V283, P2418, DOI 10.1074/jbc.M707578200; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; Kim C, 2003, DEV BIOL, V264, P376, DOI 10.1016/j.ydbio.2003.09.007; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Kim Gun-Hwa, 2012, Methods Mol Biol, V839, P79, DOI 10.1007/978-1-61779-510-7_7; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kuhl M, 2002, SEMIN CELL DEV BIOL, V13, P243, DOI 10.1016/S1084-9521(02)00050-2; Li X, 2013, DEVELOPMENT, V140, P3028, DOI 10.1242/dev.094839; Li Y, 2005, J BIOL CHEM, V280, P3613, DOI 10.1074/jbc.M411479200; Lin F, 2005, J CELL BIOL, V169, P777, DOI 10.1083/jcb.200501104; Lin SD, 2010, J CELL BIOL, V190, P263, DOI 10.1083/jcb.200912128; Macheda ML, 2012, J BIOL CHEM, V287, P29312, DOI 10.1074/jbc.M112.362681; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Matsui T, 2005, GENE DEV, V19, P164, DOI 10.1101/gad.1253605; Maures TJ, 2002, ENDOCRINOLOGY, V143, P2722, DOI 10.1210/en.143.7.2722; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mikels A, 2009, J BIOL CHEM, V284, P30167, DOI 10.1074/jbc.M109.041715; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Miyagi C, 2004, J CELL BIOL, V166, P975, DOI 10.1083/jcb.200403110; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Myers DC, 2002, TRENDS GENET, V18, P447, DOI 10.1016/S0168-9525(02)02725-7; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Ossipova O, 2011, DEVELOPMENT, V138, P5441, DOI 10.1242/dev.067280; Roszko I, 2009, SEMIN CELL DEV BIOL, V20, P986, DOI 10.1016/j.semcdb.2009.09.004; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Skoglund P., 2000, PHILOS T R SOC LON B, V355, P897; Smith JC, 2000, PHILOS T ROY SOC B, V355, P923, DOI 10.1098/rstb.2000.0627; Solnica-Krezel L, 2005, CURR BIOL, V15, pR213, DOI 10.1016/j.cub.2005.03.016; Stemple DL, 1996, DEVELOPMENT, V123, P117; Tada M, 2002, SEMIN CELL DEV BIOL, V13, P251, DOI 10.1016/S1084-9521(02)00052-6; Tahinci E, 2003, DEV BIOL, V259, P318, DOI 10.1016/S0012-1606(03)00206-9; Ulrich F, 2003, DEVELOPMENT, V130, P5375, DOI 10.1242/dev.00758; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wallingford JB, 2006, HUM MOL GENET, V15, pR227, DOI 10.1093/hmg/ddl216; Witzel S, 2006, J CELL BIOL, V175, P791, DOI 10.1083/jcb.200606017; Yamamoto H, 2007, GENES CELLS, V12, P1215, DOI 10.1111/j.1365-2443.2007.01128.x; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007; Zeng XXI, 2007, DEV CELL, V12, P391, DOI 10.1016/j.devcel.2007.01.011; Zhu SZ, 2006, CELL SIGNAL, V18, P359, DOI 10.1016/j.cellsig.2005.05.019	52	29	29	4	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20664	20676		10.1074/jbc.M114.586099	http://dx.doi.org/10.1074/jbc.M114.586099			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24928507	hybrid, Green Published			2022-12-25	WOS:000339396600025
J	Uno, Y; Mizukami, H; Ando, M; Yukihiro, R; Iwasaki, Y; Ozaki, N				Uno, Yota; Mizukami, Hitomi; Ando, Masahiko; Yukihiro, Ryoji; Iwasaki, Yoko; Ozaki, Norio			Reliability and Validity of the New Tanaka B Intelligence Scale Scores: A Group Intelligence Test	PLOS ONE			English	Article							INTELLECTUAL DISABILITY; MENTAL-HEALTH; OFFENDERS; PERFORMANCE; PREVALENCE; DISORDERS; BEHAVIOR; JAPAN; IQ	Objective: The present study evaluated the reliability and concurrent validity of the new Tanaka B Intelligence Scale, which is an intelligence test that can be administered on groups within a short period of time. Methods: The new Tanaka B Intelligence Scale and Wechsler Intelligence Scale for Children-Third Edition were administered to 81 subjects (mean age +/- SD 15.2 +/- 0.7 years) residing in a juvenile detention home; reliability was assessed using Cronbach's alpha coefficient, and concurrent validity was assessed using the one-way analysis of variance intraclass correlation coefficient. Moreover, receiver operating characteristic analysis for screening for individuals who have a deficit in intellectual function (an FIQ<70) was performed. In addition, stratum-specific likelihood ratios for detection of intellectual disability were calculated. Results: The Cronbach's alpha for the new Tanaka B Intelligence Scale IQ (BIQ) was 0.86, and the intraclass correlation coefficient with FIQ was 0.83. Receiver operating characteristic analysis demonstrated an area under the curve of 0.89 (95% CI: 0.85-0.96). In addition, the stratum-specific likelihood ratio for the BIQ <= 65 stratum was 13.8 (95% CI: 3.9-48.9), and the stratum-specific likelihood ratio for the BIQ >= 76 stratum was 0.1 (95% CI: 0.03-0.4). Thus, intellectual disability could be ruled out or determined. Conclusion: The present results demonstrated that the new Tanaka B Intelligence Scale score had high reliability and concurrent validity with the Wechsler Intelligence Scale for Children-Third Edition score. Moreover, the post-test probability for the BIQ could be calculated when screening for individuals who have a deficit in intellectual function. The new Tanaka B Intelligence Test is convenient and can be administered within a variety of settings. This enables evaluation of intellectual development even in settings where performing intelligence tests have previously been difficult.	[Uno, Yota; Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Child & Adolescent Psychiat, Nagoya, Aichi 4648601, Japan; [Mizukami, Hitomi] Chiba Juvenile Detent Home, Dept Psychol, Chiba, Japan; [Ando, Masahiko] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Yukihiro, Ryoji] Kyoto Gakuen Univ, Dept Psychol, Kyoto, Japan; [Iwasaki, Yoko] Saitama Juvenile Detent Home, Dept Psychol, Saitama, Japan	Nagoya University; Nagoya University	Uno, Y (corresponding author), Nagoya Univ, Grad Sch Med, Dept Child & Adolescent Psychiat, Nagoya, Aichi 4648601, Japan.	yota.uno@med.nagoya-u.ac.jp	Ozaki, Norio/M-8908-2014; UNO, Yota/M-8928-2014; ANDO, Masahiko/F-7035-2015	Ozaki, Norio/0000-0002-7360-4898; 				AHMANN JS, 1985, MEAS EVAL COUNS DEV, V17, P226, DOI 10.1080/07481756.1985.12022780; Anckarsater Henrik, 2007, Dev Neurorehabil, V10, P57, DOI 10.1080/13638490600864157; Benson S, 1997, J AM ACAD CHILD ADOL, V36, p122S; Borum R., 2003, J CONTEMP CRIM JUST, V19, P114, DOI [10.1177/1043986202239745, DOI 10.1177/1043986202239745]; Breckon SE, 2013, RES DEV DISABIL, V34, P1408, DOI 10.1016/j.ridd.2013.02.009; Burke MM, 2012, J INTELL DISABIL RES, V56, P305, DOI 10.1111/j.1365-2788.2011.01422.x; Court J., 1998, MANUAL RAVENS PROGRE; Donders J, 1997, PSYCHOL ASSESSMENT, V9, P15; Douma JCH, 2007, AM J MENT RETARD, V112, P207, DOI 10.1352/0895-8017(2007)112[207:AADBIY]2.0.CO;2; FRICK PJ, 1991, J CONSULT CLIN PSYCH, V59, P289, DOI 10.1037/0022-006X.59.2.289; Furukawa TA, 1997, J AFFECT DISORDERS, V46, P1, DOI 10.1016/S0165-0327(97)00079-7; GOODMAN R, 1995, J CHILD PSYCHOL PSYC, V36, P409, DOI 10.1111/j.1469-7610.1995.tb01299.x; Harris KR, 2003, J PAEDIATR CHILD H, V39, P528, DOI 10.1046/j.1440-1754.2003.00208.x; Herrington V, 2009, J INTELL DISABIL RES, V53, P397, DOI 10.1111/j.1365-2788.2008.01150.x; Kaslow FW, 1990, AM J FAM THER, V18, P197, DOI DOI 10.1080/01926189008250804; Kroll L, 2002, LANCET, V359, P1975, DOI 10.1016/S0140-6736(02)08829-3; Kuhlmann F, 1953, J CONSULT PSYCHOL, V17, P320; Lindsay WR, 2013, J INTELL DISABIL RES, V57, P172, DOI 10.1111/j.1365-2788.2012.01600.x; Lindsay WR, 2002, J APPL RES INTELLECT, V15, P111, DOI 10.1046/j.1468-3148.2002.00112.x; Liu JH, 2011, PERS INDIV DIFFER, V50, P1222, DOI 10.1016/j.paid.2011.02.013; Lohman D. F., 2002, COGAT FORM 6 RES HDB; LYNAM D, 1993, J ABNORM PSYCHOL, V102, P187, DOI 10.1037/0021-843X.102.2.187; Mannynsalo L, 2009, J INTELL DISABIL RES, V53, P279, DOI 10.1111/j.1365-2788.2008.01125.x; Matsuura N, 2009, CHILD YOUTH SERV REV, V31, P577, DOI 10.1016/j.childyouth.2008.10.016; MOFFITT TE, 1993, DEV PSYCHOPATHOL, V5, P135, DOI 10.1017/S0954579400004302; Raven J, 2000, COGNITIVE PSYCHOL, V41, P1, DOI 10.1006/cogp.1999.0735; Rayner J, 2005, J FORENSIC PSYCHI PS, V16, P248, DOI 10.1080/14789940512331309821; SHEINER LB, 1981, J PHARMACOKINET BIOP, V9, P503, DOI 10.1007/BF01060893; Shipley W.C., 2009, SHIPLEY 2 MANUAL; STATTIN H, 1993, J ABNORM PSYCHOL, V102, P369, DOI 10.1037/0021-843X.102.3.369; Tanaka K, 2003, NEW TANAKA B INTELLI; Vanny KA, 2009, J INTELL DISABIL RES, V53, P289, DOI 10.1111/j.1365-2788.2008.01148.x; Weschler D., 1991, WECHSLER INTELLIGENC; Yang HJ, 2004, J AFFECT DISORDERS, V82, P419, DOI 10.1016/j.jad.2004.04.008	34	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100262	10.1371/journal.pone.0100262	http://dx.doi.org/10.1371/journal.pone.0100262			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6AC	24940880	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200088
J	Zhang, BS; Zhou, M; Li, CB; Zhou, JX; Li, HQ; Zhu, D; Wang, Z; Chen, AQ; Zhao, Q				Zhang, Busheng; Zhou, Mi; Li, Canbo; Zhou, Jingxin; Li, Haiqing; Zhu, Dan; Wang, Zhe; Chen, Anqing; Zhao, Qiang			MicroRNA-92a Inhibition Attenuates Hypoxia/Reoxygenation-Induced Myocardiocyte Apoptosis by Targeting Smad7	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ISCHEMIA/REPERFUSION INJURY; CARDIAC DYSFUNCTION; EXPRESSION; ANGIOGENESIS; PROMOTES; GENE; ACTIVATION; INFARCTION; REPAIR	Background: MicroRNAs (miRNAs) regulate a lot of physiological and pathological processes, including myocardial ischemia/reperfusion. Recent studies reported that knockdown of miR-92a could attenuate ischemia/reperfusion-induced myocardial injury. In the present study, we examined the potential anti-apoptotic effects of miR-92a in a rat myocardiocyte cell line, and the possible role of Smad7 in such actions. Methodology and Results: In a preliminary bioinformatic analysis, we identified SMAD family member 7 (Smad7) as a potential target for miR-92a. A luciferase reporter assay indeed demonstrated that miR-92a could inhibit Smad7 expression. Myocardial ischemia/reperfusion was simulated in rat H9c2 cells with 24-h hypoxia followed by 12-h reoxygenation. Prior to hypoxia/reoxygenation, cells were transfected by miR-92a inhibitor. In some experiments, cells were co-transfected with siRNA-Smad7. The miR-92a inhibitor dramatically reduced the release of lactate dehydrogenase and malonaldehyde, and attenuated cardiomyocyte apoptosis. The miR-92a inhibitor increased SMAD7 protein level and decreased nuclear NF-kappa B p65 protein. Effects of the miR-92a inhibitor were attenuated by co-transfection with siRNA-Smad7. Conclusion: Inhibiting miR-92a can attenuate myocardiocyte apoptosis induced by hypoxia/reoxygenation by targeting Smad7.	[Zhang, Busheng; Zhou, Mi; Li, Canbo; Zhou, Jingxin; Li, Haiqing; Zhu, Dan; Wang, Zhe; Chen, Anqing; Zhao, Qiang] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Cardiac Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zhao, Q (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Cardiac Surg, Shanghai 200030, Peoples R China.	zq11607@rjh.com.cn		Zhou, Jingxin/0000-0003-0471-1961	Science and Technology Commission of Shanghai Municipality of China [11JC1408000]; National Natural Science Foundation of China [81200093]	Science and Technology Commission of Shanghai Municipality of China(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Science and Technology Commission of Shanghai Municipality of China (11JC1408000) and the National Natural Science Foundation of China (Grant No. 81200093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Danielson LS, 2013, FASEB J, V27, P1460, DOI 10.1096/fj.12-221994; Ding HS, 2013, GENE, V527, P389, DOI 10.1016/j.gene.2013.05.041; Fang J, 2012, APOPTOSIS, V17, P410, DOI 10.1007/s10495-011-0683-0; Goren Y, 2014, AM J CARDIOL, V113, P976, DOI 10.1016/j.amjcard.2013.11.060; Guo J, 2013, ATHEROSCLEROSIS, V231, P384, DOI 10.1016/j.atherosclerosis.2013.10.003; Haahr-Pedersen S, 2009, J INVASIVE CARDIOL, V21, P13; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Heymans S, 2013, CIRCULATION, V128, P1420, DOI 10.1161/CIRCULATIONAHA.112.001357; Hinkel R, 2013, CIRCULATION, V128, P1066, DOI 10.1161/CIRCULATIONAHA.113.001904; Hong S, 2007, CANCER RES, V67, P9577, DOI 10.1158/0008-5472.CAN-07-1179; Ka SM, 2012, DIABETOLOGIA, V55, P509, DOI 10.1007/s00125-011-2364-5; Kortekaas KA, 2012, EUR J CARDIO-THORAC, V41, pe117, DOI 10.1093/ejcts/ezs088; Li ML, 2014, EXP CELL RES, V323, P1, DOI 10.1016/j.yexcr.2013.12.025; Li Q, 2013, CANCER LETT, V335, P168, DOI 10.1016/j.canlet.2013.02.029; Li Y, 2014, ACTA BIOCH BIOPH SIN, V46, P48, DOI 10.1093/abbs/gmt124; Liu LF, 2014, APOPTOSIS, V19, P19, DOI 10.1007/s10495-013-0899-2; Lorenzen JM, 2013, FREE RADICAL BIO MED, V64, P78, DOI 10.1016/j.freeradbiomed.2013.06.044; Meloni M, 2013, MOL THER, V21, P1390, DOI 10.1038/mt.2013.89; Pan ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050515; Qin H, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-154; Sharifi M, 2014, MOL BIOL REP; Tian L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075885; Tu YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075872; Wang NP, 2012, BRIT J PHARMACOL, V167, P1550, DOI 10.1111/j.1476-5381.2012.02109.x; Wang ZF, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0318-9; Ye YM, 2011, PHYSIOL GENOMICS, V43, P534, DOI 10.1152/physiolgenomics.00130.2010; Zeiger AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037904; Zhang L, 2014, BIOCHEM BIOPH RES CO, V446, P952, DOI 10.1016/j.bbrc.2014.03.035; Zhang L, 2014, APOPTOSIS, V19, P975, DOI 10.1007/s10495-014-0987-y; Zhou LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079805; Zhou M, 2013, MED HYPOTHESES, V81, P108, DOI 10.1016/j.mehy.2013.03.043; Zhu HY, 2012, CARDIOVASC RES, V94, P284, DOI 10.1093/cvr/cvr291	34	56	59	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100298	10.1371/journal.pone.0100298	http://dx.doi.org/10.1371/journal.pone.0100298			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941323	Green Submitted, Green Published, gold			2022-12-25	WOS:000338508200092
J	Eckroth, JR; Aas-Hansen, O; Sneddon, LU; Bichao, H; Doving, KB				Eckroth, Jared R.; Aas-Hansen, Oyvind; Sneddon, Lynne U.; Bichao, Helena; Doving, Kjell B.			Physiological and Behavioural Responses to Noxious Stimuli in the Atlantic Cod (Gadus morhua)	PLOS ONE			English	Article							RAINBOW-TROUT; COPING STYLES; TELEOST FISH; PAIN; CAPSAICIN; STRESS; NOCICEPTION; ANESTHESIA; MORPHINE; GOLDFISH	In the present study, our aim was to compare physiological and behavioural responses to different noxious stimuli to those of a standardized innocuous stimulus, to possibly identify aversive responses indicative of injury detection in a commercially important marine teleost fish, the Atlantic cod. Individual fish were administered with a noxious stimulus to the lip under short-term general anaesthesia (MS-222). The noxious treatments included injection of 0.1% or 2% acetic acid, 0.005% or 0.1% capsaicin, or piercing the lip with a commercial fishing hook. Counts of opercular beat rate (OBR) at 10, 30, 60, 90 and 120 min and observations of behaviour at 30 and 90 min post-treatment were compared with pre-treatment values and with control fish injected with physiological saline, an innocuous stimulus. Circulatory levels of physiological stress indicators were determined in all fish at 120 minutes post-treatment. All treatments evoked temporarily increased OBR that returned to pre-treatment levels at 60 minutes (saline, 0.005% capsaicin, hook), 90 minutes (0.1% acetic acid, 0.1% capsaicin), or 120 minutes (2% acetic acid), but with no significant differences from the control group at any time point. Fish treated with 0.1% and 2% acetic acid and 0.1% capsaicin displayed increased hovering close to the bottom of the aquaria and fish given 2% acetic acid and 0.1% capsaicin also displayed a reduced use of shelter. The only effect seen in hooked fish was brief episodes of lateral head shaking which were not seen pre-treatment or in the other groups, possibly reflecting a resiliency to tissue damage in the mouth area related to the tough nature of the Atlantic cod diet. There were no differences between groups in circulatory stress indicators two hours after treatment. This study provides novel data on behavioural indicators that could be used to assess potentially aversive events in Atlantic cod.	[Eckroth, Jared R.; Doving, Kjell B.] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Aas-Hansen, Oyvind; Bichao, Helena] Nofima, Norwegian Inst Food Fisheries & Aquaculture Res, Tromso, Norway; [Sneddon, Lynne U.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England	University of Oslo; Nofima; University of Liverpool	Aas-Hansen, O (corresponding author), Nofima, Norwegian Inst Food Fisheries & Aquaculture Res, Tromso, Norway.	oyvind.aas-hansen@nofima.no		Higgs, Dennis/0000-0002-0771-4642; Sneddon, Lynne/0000-0001-9787-3948	Norwegian Research Council, NRC [18745/E40]; National Centre for the Replacement [NC/K000888/1] Funding Source: researchfish	Norwegian Research Council, NRC(Research Council of Norway); National Centre for the Replacement	This study was funded by the Norwegian Research Council (http://www.forskningsradet.no/) through the project "Nociception and potential pain perception in the Atlantic cod (Gadus morhua)", NRC project number 18745/E40. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlinghaus R, 2007, REV FISH SCI, V15, P75, DOI 10.1080/10641260601149432; Artigas ML, 2005, J FISH BIOL, V67, P384, DOI 10.1111/j.0022-1112.2005.00745.x; Ashley PJ, 2007, BRAIN RES, V1166, P47, DOI 10.1016/j.brainres.2007.07.011; Ashley PJ, 2009, ANIM BEHAV, V77, P403, DOI 10.1016/j.anbehav.2008.10.015; BEUKEMA J J, 1970, Netherlands Journal of Zoology, V20, P81; BEUKEMA JJ, 1970, J FISH BIOL, V2, P155, DOI 10.1111/j.1095-8649.1970.tb03268.x; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Bossus M, 2011, COMP BIOCHEM PHYS A, V160, P43, DOI 10.1016/j.cbpa.2011.04.014; Braithwaite VA, 2004, ANIM WELFARE, V13, pS87; Brown JA, 2008, AQUACULTURE, V285, P135, DOI 10.1016/j.aquaculture.2008.08.027; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chandroo KP, 2004, APPL ANIM BEHAV SCI, V86, P225, DOI 10.1016/j.applanim.2004.02.004; Chervova L.S., 1997, J ICHTHYOL+, V37, P98; Chung G, 2010, PHARM PAIN, P327; COSEWIC, 2003, ASS UPD REP GAD MORH; Council of the European Union, 1998, EUR CONV PROT VERT A; FERNO A, 1983, FISH RES, V2, P19, DOI 10.1016/0165-7836(83)90100-5; Foss A, 2006, AQUACULTURE, V256, P255, DOI 10.1016/j.aquaculture.2006.02.032; Gallagher AJ, 2010, J AQUAT ANIM HEALTH, V22, P229, DOI 10.1577/H10-012.1; Herbert NA, 2005, MAR BIOL, V147, P1403, DOI 10.1007/s00227-005-0003-8; HOLZER P, 1991, PHARMACOL REV, V43, P143; Huntingford FA, 2006, J FISH BIOL, V68, P332, DOI 10.1111/j.0022-1112.2006.001046.x; IASP, 2011, IASP TAX INT ASS STU; Johansen JL, 2006, J FISH BIOL, V68, P1918, DOI 10.1111/j.1095-8649.2006.01080.x; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Karlsson A, 2011, FISH PHYSIOL BIOCHEM, p1 ; KAVALIERS M, 1988, BRAIN RES BULL, V21, P923, DOI 10.1016/0361-9230(88)90030-5; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Le Bars D, 2001, PHARMACOL REV, V53, P597; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Loeser J, 2008, KYOTO PROTOCOL IASP, V137, P5; Magerl W, 2001, BRAIN, V124, P1754, DOI 10.1093/brain/124.9.1754; Mangos S, 2007, GENE EXPR PATTERNS, V7, P480, DOI 10.1016/j.modgep.2006.10.011; McMahon SB, 2006, INFLAMMATORY MEDIATO, P49; Melzack R, 2006, WALL MELZACKS TXB PA, P291; Mettam JJ, 2011, APPL ANIM BEHAV SCI, V133, P265, DOI 10.1016/j.applanim.2011.06.009; Meyer RA, 2006, WALL MELZACKS TXB PA, V5, P3; Molony V, 1997, J ANIM SCI, V75, P266; Newby NC, 2009, CAN J ZOOL, V87, P388, DOI 10.1139/Z09-023; Newby NC, 2008, APPL ANIM BEHAV SCI, V114, P260, DOI 10.1016/j.applanim.2007.12.006; Nilsson J, 2008, ANIM COGN, V11, P215, DOI 10.1007/s10071-007-0103-6; Nordgreen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092116; Nordgreen J, 2009, APPL ANIM BEHAV SCI, V119, P101, DOI 10.1016/j.applanim.2009.03.015; Olsen RE, 2010, NORWEGIAN SCI COMMIT, V09, P1; Overli O, 2007, NEUROSCI BIOBEHAV R, V31, P396, DOI 10.1016/j.neubiorev.2006.10.006; PARK KM, 1995, PAIN, V63, P163, DOI 10.1016/0304-3959(95)00029-R; Reilly SC, 2008, APPL ANIM BEHAV SCI, V114, P248, DOI 10.1016/j.applanim.2008.01.016; Roques JAC, 2010, PHYSIOL BEHAV, V101, P533, DOI 10.1016/j.physbeh.2010.08.001; Rose JD, 2007, DIS AQUAT ORGAN, V75, P139, DOI 10.3354/dao075139; Rose JD, 2002, REV FISH SCI, V10, P1, DOI 10.1080/20026491051668; Rose JD, 2012, FISH FISH, P1; Ross LG, 2008, ANAESTHETIC AND SEDATIVE TECHNIQUES FOR AQUATIC ANIMALS, 3RD EDITION, P1, DOI 10.1002/9781444302264; Schjolden J, 2007, BRAIN BEHAV EVOLUT, V70, P227, DOI 10.1159/000105486; Schmelz M, 2000, BRAIN, V123, P560, DOI 10.1093/brain/123.3.560; SCHULZ R, 1985, STEROIDS, V46, P717, DOI 10.1016/0039-128X(85)90051-0; Sherrington CS, 1903, J PHYSIOL-LONDON, V30, P39; SIMONE DA, 1989, PAIN, V38, P99, DOI 10.1016/0304-3959(89)90079-1; Sneddon LU, 2003, J PAIN, V4, P431, DOI 10.1067/S1526-5900(03)00717-X; Sneddon LU, 2003, APPL ANIM BEHAV SCI, V83, P153, DOI 10.1016/S0168-1591(03)00113-8; Sneddon LU, 2003, P ROY SOC B-BIOL SCI, V270, P1115, DOI 10.1098/rspb.2003.2349; Sneddon LU, 2003, BRAIN RES, V972, P44, DOI 10.1016/S0006-8993(03)02483-1; Sneddon LU, 2002, NEUROSCI LETT, V319, P167, DOI 10.1016/S0304-3940(01)02584-8; Sneddon LU, 2012, J EXOT PET MED, V21, P32, DOI 10.1053/j.jepm.2011.11.009; Sneddon LU, 2011, J CONSCIOUSNESS STUD, V18, P209; Tveiten H, 2010, J FISH BIOL, V76, P2318, DOI 10.1111/j.1095-8649.2010.02636.x; Zahl IH, 2010, FISH PHYSIOL BIOCHEM, V36, P719, DOI 10.1007/s10695-009-9346-2; Zahl IH, 2009, AQUACULTURE, V295, P52, DOI 10.1016/j.aquaculture.2009.06.019; Zimov S, 2004, J NEUROCYTOL, V33, P441, DOI 10.1007/s11068-004-4209-3	69	13	13	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100150	10.1371/journal.pone.0100150	http://dx.doi.org/10.1371/journal.pone.0100150			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936652	Green Submitted, Green Published, gold			2022-12-25	WOS:000338503400082
J	Jagielski, T; Ignatowska, H; Bakula, Z; Dziewit, L; Napiorkowska, A; Augustynowicz-Kopec, E; Zwolska, Z; Bielecki, J				Jagielski, Tomasz; Ignatowska, Helena; Bakula, Zofia; Dziewit, Lukasz; Napiorkowska, Agnieszka; Augustynowicz-Kopec, Ewa; Zwolska, Zofia; Bielecki, Jacek			Screening for Streptomycin Resistance-Conferring Mutations in Mycobacterium tuberculosis Clinical Isolates from Poland	PLOS ONE			English	Article							DRUG-RESISTANCE; MULTIDRUG-RESISTANT; MOLECULAR CHARACTERIZATION; RRS MUTATIONS; NORTH-INDIA; STRAINS; RPSL; LEVEL; IDENTIFICATION; MECHANISMS	Currently, mutations in three genes, namely rrs, rpsL, and gidB, encoding 16S rRNA, ribosomal protein S12, and 16S rRNA-specific methyltransferase, respectively, are considered to be involved in conferring resistance to streptomycin (STR) in Mycobacterium tuberculosis. The aim of this study was to investigate the spectrum and frequency of these mutations in M. tuberculosis clinical isolates, both resistant and susceptible to STR. Sixty-four M. tuberculosis isolates recovered from as many TB patients from Poland in 2004 were included in the study. Within the sample were 50 multidrug-resistant (32 STR-resistant and 18 STR-susceptible) and 14 pan-susceptible isolates. Preliminary testing for STR resistance was performed with the 1% proportion method. The MICs of STR were determined by the Etest method. Mutation profiling was carried out by amplifying and sequencing the entire rrs, rpsL, and gidB genes. Non-synonymous mutations in either rrs or rpsL gene were detected in 23 (71.9%) of the STR-resistant and none of the STR-susceptible isolates. Mutations in the gidB gene were distributed among 12 (37.5%) STR-resistant and 13 (40.6%) STR-susceptible isolates. Four (12.5%) STR-resistant isolates were wild-type at all three loci examined. None of the rrs, rpsL or gidB mutations could be linked to low, intermediate or high level of STR resistance. In accordance with previous findings, the gidB 47T -> G (L16R) mutation was associated with the Latin American-Mediterranean genotype family, whereas 276A -> C (E92D) and 615A -> G (A205A) mutations of the gidB gene were associated with the Beijing lineage. The study underlines the usefulness of rrs and rpsL mutations as molecular markers for STR resistance yet not indicative of its level. The gidB polymorphisms can serve as phylogenetic markers.	[Jagielski, Tomasz; Ignatowska, Helena; Bakula, Zofia; Bielecki, Jacek] Univ Warsaw, Fac Biol, Inst Microbiol, Dept Appl Microbiol, Warsaw, Poland; [Dziewit, Lukasz] Univ Warsaw, Fac Biol, Inst Microbiol, Dept Bacterial Genet, Warsaw, Poland; [Napiorkowska, Agnieszka; Augustynowicz-Kopec, Ewa; Zwolska, Zofia] Natl TB & Lung Dis Res Inst, Dept Microbiol, Warsaw, Poland	University of Warsaw; University of Warsaw	Jagielski, T (corresponding author), Univ Warsaw, Fac Biol, Inst Microbiol, Dept Appl Microbiol, Warsaw, Poland.	t.jagielski@biol.uw.edu.pl	Jagielski, Tomasz/AAB-9099-2021; Augustynowicz-Kopeć, Ewa/AAL-1757-2020; Dziewit, Lukasz/L-1131-2016	Augustynowicz-Kopeć, Ewa/0000-0001-6162-8748; Dziewit, Lukasz/0000-0002-5057-2811; Jagielski, Tomasz/0000-0001-9553-5742; Bakula, Zofia/0000-0001-7560-2100; Zwolska, Zofia/0000-0003-3836-0776; Bielecki, Jacek/0000-0001-6533-2282	Iuventus Plus grant from the Polish Ministry of Science and Higher Education [IP2011018771]; Faculty of Biology, University of Warsaw intramural grant DSM [104934]	Iuventus Plus grant from the Polish Ministry of Science and Higher Education; Faculty of Biology, University of Warsaw intramural grant DSM	This work was supported by the "Iuventus Plus grant from the Polish Ministry of Science and Higher Education (IP2011018771; http://www.nauka.gov.pl/en/) and the Faculty of Biology, University of Warsaw intramural grant DSM (104934; http://www.biol.uw.edu.pl/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006; Abbadi SH, 2009, INT J INFECT DIS, V13, P673, DOI 10.1016/j.ijid.2008.10.006; Augustynowicz-Kopec E, 2003, INT J TUBERC LUNG D, V7, P645; Ballif M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-191; Brzostek A, 2004, INT J TUBERC LUNG D, V8, P1032; Cooksey RC, 1996, ANTIMICROB AGENTS CH, V40, P1186, DOI 10.1128/AAC.40.5.1186; Cuevas-Cordoba B, 2013, J MICROBIOL IMMUNOL, V46, P30, DOI 10.1016/j.jmii.2012.08.020; Dobner P, 1997, MOL CELL PROBE, V11, P123, DOI 10.1006/mcpr.1996.0086; Feuerriegel S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-90; Hazon MH, 2000, J CLIN MICROBIOL, V38, P4599; Homolka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039855; Homolka S, 2009, J CLIN MICROBIOL, V47, P223, DOI 10.1128/JCM.01237-08; Ignatova A, 2006, J MED MICROBIOL, V55, P1413, DOI 10.1099/jmm.0.46575-0; Jagielski T, 2010, J CLIN MICROBIOL, V48, P3899, DOI 10.1128/JCM.00572-10; Jnawali HN, 2013, DIAGN MICR INFEC DIS, V76, P187, DOI 10.1016/j.diagmicrobio.2013.02.035; Jnawali HN, 2013, WORLD J MICROB BIOT, V29, P975, DOI 10.1007/s11274-013-1256-x; Joloba ML, 2000, J CLIN MICROBIOL, V38, P3834, DOI 10.1128/JCM.38.10.3834-3836.2000; Katsukawa E, 1997, J APPL MICROBIOL, V83, P634, DOI 10.1046/j.1365-2672.1997.00279.x; Meier A, 1996, ANTIMICROB AGENTS CH, V40, P2452, DOI 10.1128/AAC.40.11.2452; MUSSER JM, 1995, CLIN MICROBIOL REV, V8, P496, DOI 10.1128/CMR.8.4.496; Nhu NTQ, 2012, INT J TUBERC LUNG D, V16, P527, DOI 10.5588/ijtld.11.0202; Okamoto S, 2007, MOL MICROBIOL, V63, P1096, DOI 10.1111/j.1365-2958.2006.05585.x; Pardini M, 2009, TUBERCULOSIS, V89, P317, DOI 10.1016/j.tube.2009.04.002; Perdigao J, 2008, MICROB DRUG RESIST, V14, P133, DOI 10.1089/mdr.2008.0798; Ramaswamy SV, 2004, J MED MICROBIOL, V53, P107, DOI 10.1099/jmm.0.05343-0; Shi RR, 2007, MICROBES INFECT, V9, P1538, DOI 10.1016/j.micinf.2007.08.009; Siddiqi N, 2002, ANTIMICROB AGENTS CH, V46, P443, DOI 10.1128/AAC.46.2.443-450.2002; Spies FS, 2008, ANTIMICROB AGENTS CH, V52, P2947, DOI 10.1128/AAC.01570-07; Spies FS, 2013, TUBERCULOSIS, V93, P150, DOI 10.1016/j.tube.2012.11.004; Spies FS, 2011, J CLIN MICROBIOL, V49, P2625, DOI 10.1128/JCM.00168-11; Sreevatsan S, 1996, ANTIMICROB AGENTS CH, V40, P1024, DOI 10.1128/AAC.40.4.1024; Sun YJ, 2010, CLIN MICROBIOL INFEC, V16, P287, DOI 10.1111/j.1469-0691.2009.02800.x; Tudo G, 2010, J ANTIMICROB CHEMOTH, V65, P2341, DOI 10.1093/jac/dkq322; Van Rie A, 2001, J CLIN MICROBIOL, V39, P636, DOI 10.1128/JCM.39.2.636-641.2001; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Vitol I, 2006, INFECT GENET EVOL, V6, P491, DOI 10.1016/j.meegid.2006.03.003; *WHO, 2003, WHOTB2003320; Wong SY, 2011, ANTIMICROB AGENTS CH, V55, P2515, DOI 10.1128/AAC.01814-10; World Health Organization (WHO), 2010, GUIDELINES TREATMENT, V2nd; Yadav R, 2013, INT J TUBERC LUNG D, V17, P251, DOI 10.5588/ijtld.12.0319	40	47	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100078	10.1371/journal.pone.0100078	http://dx.doi.org/10.1371/journal.pone.0100078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937123	Green Submitted, Green Published, gold			2022-12-25	WOS:000338503400070
J	Laurin, GV; Chan, JCW; Chen, Q; Lindsell, JA; Coomes, DA; Guerriero, L; Del Frate, F; Miglietta, F; Valentini, R				Laurin, Gaia Vaglio; Chan, Jonathan Cheung-Wai; Chen, Qi; Lindsell, Jeremy A.; Coomes, David A.; Guerriero, Leila; Del Frate, Fabio; Miglietta, Franco; Valentini, Riccardo			Biodiversity Mapping in a Tropical West African Forest with Airborne Hyperspectral Data	PLOS ONE			English	Article							SPECTRAL BAND SELECTION; PLANT-SPECIES RICHNESS; LEAF PIGMENT CONTENT; IMAGING SPECTROSCOPY; FLORISTIC COMPOSITION; SATELLITE IMAGERY; RAIN-FORESTS; VEGETATION; DIVERSITY; CLASSIFICATION	Tropical forests are major repositories of biodiversity, but are fast disappearing as land is converted to agriculture. Decision-makers need to know which of the remaining forests to prioritize for conservation, but the only spatial information on forest biodiversity has, until recently, come from a sparse network of ground-based plots. Here we explore whether airborne hyperspectral imagery can be used to predict the alpha diversity of upper canopy trees in a West African forest. The abundance of tree species were collected from 64 plots (each 1250 m(2) in size) within a Sierra Leonean national park, and Shannon-Wiener biodiversity indices were calculated. An airborne spectrometer measured reflectances of 186 bands in the visible and near-infrared spectral range at 1 m(2) resolution. The standard deviations of these reflectance values and their first-order derivatives were calculated for each plot from the c. 1250 pixels of hyperspectral information within them. Shannon-Wiener indices were then predicted from these plot-based reflectance statistics using a machine-learning algorithm (Random Forest). The regression model fitted the data well (pseudo-R-2 = 84.9%), and we show that standard deviations of green-band reflectances and infra-red region derivatives had the strongest explanatory powers. Our work shows that airborne hyperspectral sensing can be very effective at mapping canopy tree diversity, because its high spatial resolution allows within-plot heterogeneity in reflectance to be characterized, making it an effective tool for monitoring forest biodiversity over large geographic scales.	[Laurin, Gaia Vaglio; Valentini, Riccardo] Euromediterranean Ctr Climate Change, Impacts Agr Forest & Nat Ecosyst Div, Viterbo, Italy; [Chan, Jonathan Cheung-Wai; Miglietta, Franco] Fdn Edmund Mach, Foxlab, San Michele All Adige, Italy; [Chen, Qi] Univ Hawaii Manoa, Dept Geog, Honolulu, HI 96822 USA; [Lindsell, Jeremy A.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Coomes, David A.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Laurin, Gaia Vaglio; Guerriero, Leila; Del Frate, Fabio] Univ Roma Tor Vergata, Dept Civil Engn & Comp Sci Engn, Rome, Italy; [Valentini, Riccardo] Univ Tuscia, Dept Forest Resources & Environm, Viterbo, Italy; [Lindsell, Jeremy A.] Rocha Int, Cambridge, England; [Miglietta, Franco] CNR, Inst Biometeorol, Florence, Italy; [Miglietta, Franco] Ecole Polytech Fed Lausanne, Lab Ecohydrol Civil & Environm Engn, Lausanne, Switzerland; [Chan, Jonathan Cheung-Wai] Vrije Univ Brussel, Dept Elect & Informat, Brussels, Belgium; [Miglietta, Franco] Fdn EMach, MountFor Project Ctr European Forest Inst, San Michele All Adige, Italy	Centro Euro-Mediterraneo sui Cambiamenti Climatici (CMCC); Fondazione Edmund Mach; University of Hawaii System; University of Hawaii Manoa; Royal Society for Protection of Birds; University of Cambridge; University of Rome Tor Vergata; Tuscia University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biometeorologia (IBIMET-CNR); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Vrije Universiteit Brussel	Laurin, GV (corresponding author), Euromediterranean Ctr Climate Change, Impacts Agr Forest & Nat Ecosyst Div, Viterbo, Italy.	gaia.vagliolaurin@cmcc.it	Miglietta, Franco/B-6137-2008; Valentini, Riccardo/D-1226-2010; Cumming, Graeme S./B-6551-2008	Miglietta, Franco/0000-0003-1474-8143; Valentini, Riccardo/0000-0002-6756-5634; Cumming, Graeme S./0000-0002-3678-1326; Lindsell, Jeremy/0000-0003-2088-8927; Coomes, David/0000-0002-8261-2582; VAGLIO LAURIN, Gaia/0000-0002-6728-3557; Chan, Jonathan/0000-0002-3741-1124	ERC grant Africa GHG [247349]; Cambridge Conservation Initiative; Industry-Academia Partnerships and Pathways programme of the European Commission, Project AIRFORS [286079]	ERC grant Africa GHG; Cambridge Conservation Initiative; Industry-Academia Partnerships and Pathways programme of the European Commission, Project AIRFORS	The authors acknowledge the ERC grant Africa GHG #247349 and the Cambridge Conservation Initiative for providing support to the investigation. This work is also supported by the Industry-Academia Partnerships and Pathways programme of the European Commission, Project AIRFORS, contract no: 286079. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman EM, 2013, INT J REMOTE SENS, V34, P712, DOI 10.1080/01431161.2012.713142; Asner GP, 2008, REMOTE SENS ENVIRON, V112, P1912, DOI 10.1016/j.rse.2007.02.043; Asner GP, 2008, REMOTE SENS ENVIRON, V112, P1942, DOI 10.1016/j.rse.2007.11.016; Balmford A, 2003, ORYX, V37, P238, DOI 10.1017/S0030605303000413; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carlson KM, 2007, ECOSYSTEMS, V10, P536, DOI 10.1007/s10021-007-9041-z; Chambers JQ, 2007, TRENDS ECOL EVOL, V22, P414, DOI 10.1016/j.tree.2007.05.001; Chan JCW, 2008, REMOTE SENS ENVIRON, V112, P2999, DOI 10.1016/j.rse.2008.02.011; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Clark ML, 2012, REMOTE SENS-BASEL, V4, P1820, DOI 10.3390/rs4061820; Clark ML, 2005, REMOTE SENS ENVIRON, V96, P375, DOI 10.1016/j.rse.2005.03.009; Cole NHA, 1993, J PURE APPL SCI, V2, P35; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Dalponte M, 2008, IEEE T GEOSCI REMOTE, V46, P1416, DOI 10.1109/TGRS.2008.916480; DEMETRIADESSHAH TH, 1990, REMOTE SENS ENVIRON, V33, P55, DOI 10.1016/0034-4257(90)90055-Q; Diaz S, 2009, CURR OPIN ENV SUST, V1, P55, DOI 10.1016/j.cosust.2009.08.001; Feilhauer H, 2009, APPL VEG SCI, V12, P429, DOI 10.1111/j.1654-109X.2009.01037.x; Felde GW, 2003, INT GEOSCI REMOTE SE, P90; Feret JB, 2014, ECOLOGICAL IN PRESS; Feret JB, 2012, REMOTE SENS-BASEL, V4, P2457, DOI 10.3390/rs4082457; Feret JB, 2011, REMOTE SENS ENVIRON, V115, P2415, DOI 10.1016/j.rse.2011.05.004; Foody GM, 2006, ECOL MODEL, V195, P37, DOI 10.1016/j.ecolmodel.2005.11.007; Foody GM, 2003, INT J REMOTE SENS, V24, P4035, DOI 10.1080/0143116031000103853; Foody GM, 2003, J BIOGEOGR, V30, P1053, DOI 10.1046/j.1365-2699.2003.00887.x; Gamon JA, 1999, NEW PHYTOL, V143, P105, DOI 10.1046/j.1469-8137.1999.00424.x; GAMON JA, 1992, REMOTE SENS ENVIRON, V41, P35, DOI 10.1016/0034-4257(92)90059-S; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Genuer R., 2010, PATTERN RECOGN LETT, V31, P2225, DOI [10.1038/nature08649, DOI 10.1038/nature08649, DOI 10.1016/j.patrec.2010.03.014]; Gitelson AA, 2001, PHOTOCHEM PHOTOBIOL, V74, P38, DOI 10.1562/0031-8655(2001)074&lt;0038:OPANEO&gt;2.0.CO;2; Gong P, 1997, REMOTE SENS ENVIRON, V62, P189, DOI 10.1016/S0034-4257(97)00094-1; Gould W, 2000, ECOL APPL, V10, P1861, DOI 10.1890/1051-0761(2000)010[1861:RSOVPS]2.0.CO;2; GREEN AA, 1988, IEEE T GEOSCI REMOTE, V26, P65, DOI 10.1109/36.3001; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Han J, 1997, REMOTE SENS ENVIRON, V62, P253; He KS, 2011, DIVERS DISTRIB, V17, P381, DOI 10.1111/j.1472-4642.2011.00761.x; Jones TG, 2010, REMOTE SENS ENVIRON, V114, P2841, DOI 10.1016/j.rse.2010.07.002; Jurgens N, 2012, ENVIRON MONIT ASSESS, V184, P655, DOI 10.1007/s10661-011-1993-y; Kalacska M, 2007, REMOTE SENS ENVIRON, V108, P82, DOI 10.1016/j.rse.2006.11.007; Kaufman YJ, 1996, REMOTE SENS ENVIRON, V55, P65, DOI 10.1016/0034-4257(95)00193-X; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; Kumar L, 2001, RE S D I PR, V4, P111; Laurin GV, 2013, INT J APPL EARTH OBS, V21, P7, DOI 10.1016/j.jag.2012.08.002; Leutner BF, 2012, REMOTE SENS-BASEL, V4, P2818, DOI 10.3390/rs4092818; Levin N, 2007, DIVERS DISTRIB, V13, P692, DOI 10.1111/j.1472-4642.2007.00372.x; Leyequien E, 2007, INT J APPL EARTH OBS, V9, P1, DOI 10.1016/j.jag.2006.08.002; Lindsell JA, 2013, FOREST ECOL MANAG, V289, P10, DOI 10.1016/j.foreco.2012.09.045; Lucas Richard, 2008, P47, DOI 10.1201/9781420053432.ch3; Magurran A.E, 2004, MEASURING BIOL DIVER; Martin ME, 1997, ECOL APPL, V7, P431, DOI 10.1890/1051-0761(1997)007[0431:HSRRSO]2.0.CO;2; Nagendra H, 2001, INT J REMOTE SENS, V22, P2377, DOI 10.1080/01431160117096; Nagendra H, 2008, BIODIVERS CONSERV, V17, P3431, DOI 10.1007/s10531-008-9479-0; Oldeland J, 2010, ECOL INDIC, V10, P390, DOI 10.1016/j.ecolind.2009.07.012; Palmer MW, 2002, ENVIRONMETRICS, V13, P121, DOI 10.1002/env.516; Paoli GD, 2010, CARBON BAL MANAGE, V23, P5; Rocchini D, 2007, APPL VEG SCI, V10, P325, DOI 10.1111/j.1654-109X.2007.tb00431.x; Rocchini D, 2004, ACTA OECOL, V26, P117, DOI 10.1016/j.actao.2004.03.008; Rocchini D, 2010, INT J REMOTE SENS, V31, P2745, DOI 10.1080/01431160903085651; SELLERS PJ, 1985, INT J REMOTE SENS, V6, P1335, DOI 10.1080/01431168508948283; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Simonson WD, 2012, CONSERV BIOL, V26, P840, DOI 10.1111/j.1523-1739.2012.01869.x; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; Somers B, 2013, REMOTE SENS ENVIRON, V136, P14, DOI 10.1016/j.rse.2013.04.006; Somers B, 2012, REMOTE SENS-BASEL, V4, P2510, DOI 10.3390/rs4092510; Thenkabail PS, 2004, REMOTE SENS ENVIRON, V91, P354, DOI 10.1016/j.rse.2004.03.013; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Townsend AR, 2008, TRENDS ECOL EVOL, V23, P424, DOI 10.1016/j.tree.2008.04.009; Tsai F, 1998, REMOTE SENS ENVIRON, V66, P41, DOI 10.1016/S0034-4257(98)00032-7; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; Ustin SL, 2004, BIOSCIENCE, V54, P523, DOI 10.1641/0006-3568(2004)054[0523:UISTSE]2.0.CO;2; VOGELMANN JE, 1993, INT J REMOTE SENS, V14, P1563, DOI 10.1080/01431169308953986; Walton JT, 2008, PHOTOGRAMM ENG REM S, V74, P1213, DOI 10.14358/PERS.74.10.1213; Zhang JK, 2006, REMOTE SENS ENVIRON, V105, P129, DOI 10.1016/j.rse.2006.06.010	73	54	55	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e97910	10.1371/journal.pone.0097910	http://dx.doi.org/10.1371/journal.pone.0097910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937407	Green Published, Green Submitted, gold			2022-12-25	WOS:000338503400007
J	Lund, SH; Gudbjartsson, DF; Rafnar, T; Sigurdsson, A; Gudjonsson, SA; Gudmundsson, J; Stefansson, K; Stefansson, G				Lund, Sigrun Helga; Gudbjartsson, Daniel Fannar; Rafnar, Thorunn; Sigurdsson, Asgeir; Gudjonsson, Sigurjon Axel; Gudmundsson, Julius; Stefansson, Kari; Stefansson, Gunnar			A Method for Detecting Long Non-Coding RNAs with Tiled RNA Expression Microarrays	PLOS ONE			English	Article							TILING ARRAY DATA; GENE-EXPRESSION; PROSTATE-CANCER; GENOME; REPRODUCIBILITY; ASSOCIATION; BIOMARKERS; SEARCH; ISSUES; LINKS	Long non-coding ribonucleic acids (lncRNAs) have been proposed as biomarkers in prostate cancer. This paper proposes a selection method which uses data from tiled microarrays to identify relatively long regions of moderate expression independent of the microarray platform and probe design. The method is used to search for candidate long non-coding ribonucleic acids (lncRNAs) at locus 8q24 and is run on three independent experiments which all use samples from prostate cancer patients. The robustness of the method is tested by utilizing repeated copies of tiled probes. The method shows high consistency between experiments that used the same samples, but different probe layout. There also is statistically significant consistency when comparing experiments with different samples. The method selected the long non-coding ribonucleic acid PCNCR1 in all three experiments.	[Lund, Sigrun Helga; Stefansson, Gunnar] Univ Iceland, Fac Phys Sci, Reykjavik, Iceland; [Gudbjartsson, Daniel Fannar; Rafnar, Thorunn; Sigurdsson, Asgeir; Gudjonsson, Sigurjon Axel; Gudmundsson, Julius; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland	University of Iceland	Lund, SH (corresponding author), Univ Iceland, Fac Phys Sci, Reykjavik, Iceland.	sigrunhl@hi.is	Stefansson, Gunnar/A-2209-2008; Lund, Sigrun Helga/K-9144-2015; Stefansson, Gunnar/AAV-9432-2020; Stefansson, Kari/AAE-7187-2019; Lund, Sigrún Helga/AAG-6042-2019	Stefansson, Gunnar/0000-0002-2693-9142; Lund, Sigrun Helga/0000-0002-3806-2296; Stefansson, Gunnar/0000-0002-2693-9142; Lund, Sigrún Helga/0000-0002-3806-2296; Gudjonsson, Sigurjon A./0000-0001-9314-7412	National Cancer Institute (NCI) [5R01CA129991-02]; FS-Grant from the Icelandic Centre for Research (RANNIS); NATIONAL CANCER INSTITUTE [R01CA129991] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FS-Grant from the Icelandic Centre for Research (RANNIS); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research project was funded in part by grant 5R01CA129991-02 from the National Cancer Institute (NCI) and by an FS-Grant from the Icelandic Centre for Research (RANNIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-383; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Baker M, 2011, NAT METHODS, V8, P379, DOI 10.1038/nmeth0511-379; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; BUTTYAN R, 1987, PROSTATE, V11, P327, DOI 10.1002/pros.2990110405; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; Chen JJ, 2007, BMC BIOINFORMATICS, V8, P1, DOI 10.1186/1471-2105-8-412; Chung SY, 2011, CANCER SCI, V102, P245, DOI 10.1111/j.1349-7006.2010.01737.x; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Dinger ME, 2009, NUCLEIC ACIDS RES, V37, pD122, DOI 10.1093/nar/gkn617; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ellatif S, 2012, REGULATORY RNAS, P197; Gibb EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025915; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Huppi Konrad, 2012, Frontiers in Genetics, V3, P69, DOI 10.3389/fgene.2012.00069; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Kapranov P, 2012, FRONTIERS GENETICS, V3; Karpikov A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-57; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Lund SH, 2014, ESTIMATING ROBUSTNES; Lund SH, 2009, JSM P, P4628; Mitra Sheetal A., 2012, Frontiers in Genetics, V3, P17, DOI 10.3389/fgene.2012.00017; Mockler TC, 2005, GENOMICS, V85, P1, DOI 10.1016/j.ygeno.2004.10.005; Otto C, 2012, BIOINFORMATICS, V28, P1471, DOI 10.1093/bioinformatics/bts142; Pozhitkov Alex E., 2007, Briefings in Functional Genomics & Proteomics, V6, P141, DOI 10.1093/bfgp/elm014; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reis E, 2012, FRONTIERS GENETICS, V3; Risueno A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-221; Royce TE, 2005, TRENDS GENET, V21, P466, DOI 10.1016/j.tig.2005.06.007; Schmitt AM, 2013, NATURE, V500, P536, DOI 10.1038/nature12548; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shore AN, 2012, J MAMMARY GLAND BIOL, V17, P43, DOI 10.1007/s10911-012-9247-3; Spizzo R, 2012, ONCOGENE, V31, P4577, DOI 10.1038/onc.2011.621; Tahira AC, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-141; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Vergara Ismael A., 2012, Frontiers in Genetics, V3, P23, DOI 10.3389/fgene.2012.00023; Wang XT, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003756; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Weile C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-244; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willard SS, 2012, AM J CANCER RES, V2, P620; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	51	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99899	10.1371/journal.pone.0099899	http://dx.doi.org/10.1371/journal.pone.0099899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937006	Green Submitted, gold, Green Published			2022-12-25	WOS:000338503400053
J	Na, KS; Park, YG; Han, K; Mok, JW; Joo, CK				Na, Kyung-Sun; Park, Yong-Gyu; Han, Kyungdo; Mok, Jee Won; Joo, Choun-Ki			Prevalence of and Risk Factors for Age-Related and Anterior Polar Cataracts in a Korean Population	PLOS ONE			English	Article							POSTERIOR SUBCAPSULAR CATARACTS; LENS OPACITIES; NUCLEAR; EPIDEMIOLOGY; DISEASE; EYE	Objective: To investigate the potential risk factors associated with nuclear, cortical, posterior subcapsular, and anterior polar cataracts (APC) in the Korean population. Research Design and Methods: This was a population-based, cross-sectional study of 7992 adults (over 40 years of age) from the data of the fourth annual Korea National Health and Nutrition Examination Survey, performed from 2007 to 2009. The presence of lens opacity was examined by slit-lamp biomicroscopy and evaluated according to LOCS II standard photographs. The subtype of cataract present, including nuclear, cortical, posterior subcapsular, and anterior polar cataracts, was noted. Multivariable adjusted logistic regression analysis was conducted to examine the odds ratio (OR) and 95% confidence interval (CI) for association of each specific type of cataract with age, sex, health examination, and medical history. Results: The prevalence of nuclear, cortical, and posterior subcapsular cataract increased gradually with increasing age. However, the prevalence of APC peaked in the 50-to 59-year-old subjects. All types of cataract except for APCs were more prevalent in women. Oral steroid use was associated with a lower risk of APC. Conclusions: These findings showed the unique characteristics of APC in the Korean population.	[Na, Kyung-Sun; Joo, Choun-Ki] Catholic Univ Korea, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Coll Med, Seoul, South Korea; [Park, Yong-Gyu; Han, Kyungdo] Catholic Univ Korea, Dept Biostat, Seoul, South Korea; [Na, Kyung-Sun; Mok, Jee Won] Catholic Univ Korea, Catholic Inst Visual Sci, Seoul, South Korea; [Na, Kyung-Sun] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Hlth Promot Ctr, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Joo, CK (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Coll Med, Seoul, South Korea.	ckjoo@catholic.ac.kr		Park, Yong Gyu/0000-0002-8721-3230	National Research of Korea, Seoul, Korea [2011-0027157]	National Research of Korea, Seoul, Korea	This study was funded by the National Research of Korea (2011-0027157), Seoul, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang JR, 2011, OPHTHALMOLOGY, V118, P2113, DOI 10.1016/j.ophtha.2011.03.032; CHYLACK LT, 1989, ARCH OPHTHALMOL-CHIC, V107, P991, DOI 10.1001/archopht.1989.01070020053028; Delcourt C, 2000, AM J EPIDEMIOL, V151, P497; Foster PJ, 2003, BRIT J OPHTHALMOL, V87, P1112, DOI 10.1136/bjo.87.9.1112; Graw J, 2011, INVEST OPHTH VIS SCI, V52, P7778, DOI 10.1167/iovs.10-7113; HIRVELA H, 1995, OPHTHALMOLOGY, V102, P108; Joo CK, 1999, J CATARACT REFR SURG, V25, P652, DOI 10.1016/S0886-3350(99)00009-7; Kim Hyojin, 2008, Korean J Ophthalmol, V22, P77, DOI 10.3341/kjo.2008.22.2.77; Landers J, 2010, CLIN EXP OPHTHALMOL, V38, P387, DOI 10.1111/j.1442-9071.2010.02257.x; Leske MC, 1997, ARCH OPHTHALMOL-CHIC, V115, P105, DOI 10.1001/archopht.1997.01100150107018; Lindblad BE, 2010, OPHTHALMOLOGY, V117, P424, DOI 10.1016/j.ophtha.2009.07.046; Maraini G, 2008, OPHTHALMOLOGY, V115, P599, DOI 10.1016/j.ophtha.2008.01.005; Mares JA, 2010, ARCH OPHTHALMOL-CHIC, V128, P738, DOI 10.1001/archophthalmol.2010.84; McCarty CA, 1999, AM J OPHTHALMOL, V128, P446, DOI 10.1016/S0002-9394(99)00218-4; Nirmalan PK, 2004, BRIT J OPHTHALMOL, V88, P989, DOI 10.1136/bjo.2003.038380; Richter GM, 2012, OPHTHALMOLOGY, V119, P547, DOI 10.1016/j.ophtha.2011.09.005; Sperduto RD, 2001, OPHTHALMOLOGY, V108, P1400; Tan JSL, 2008, OPHTHAL EPIDEMIOL, V15, P317, DOI 10.1080/09286580802105806; Taylor HR, 1999, EYE, V13, P445, DOI 10.1038/eye.1999.119; Vashist P, 2011, OPHTHALMOLOGY, V118, P272, DOI 10.1016/j.ophtha.2010.05.020; WEST SK, 1995, SURV OPHTHALMOL, V39, P323; Wu RY, 2010, ARCH OPHTHALMOL-CHIC, V128, P1029, DOI 10.1001/archophthalmol.2010.147; Zhang JS, 2011, OPHTHALMOLOGY, V118, P711, DOI 10.1016/j.ophtha.2010.08.021	23	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e96461	10.1371/journal.pone.0096461	http://dx.doi.org/10.1371/journal.pone.0096461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936893	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400004
J	Shaw, C; Nitsch, D; Steenkamp, R; Junghans, C; Shah, S; O'Donoghue, D; Fogarty, D; Weston, C; Sharpe, CC				Shaw, Catriona; Nitsch, Dorothea; Steenkamp, Retha; Junghans, Cornelia; Shah, Sapna; O'Donoghue, Donal; Fogarty, Damian; Weston, Clive; Sharpe, Claire C.			Inpatient Coronary Angiography and Revascularisation following Non-ST-Elevation Acute Coronary Syndrome in Patients with Renal Impairment: A Cohort Study Using the Myocardial Ischaemia National Audit Project	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CONSERVATIVE MANAGEMENT; HEART-DISEASE; INFARCTION; OUTCOMES; RISK; INTERVENTION; GUIDELINE; THERAPIES; PATTERNS	Background: International guidelines support an early invasive management strategy (including early coronary angiography and revascularisation) for non-ST-elevation acute coronary syndrome (NSTE-ACS) in patients with renal impairment. However, evidence from outside the UK suggests that this approach is underutilised. We aimed to describe practice within the NHS, and to determine whether the severity of renal dysfunction influenced the provision of angiography and modified the association between early revascularisation and survival. Methods: We performed a cohort study, using multivariable logistic regression and propensity score analyses, of data from the Myocardial Ischaemia National Audit Project for patients presenting with NSTE-ACS to English or Welsh hospitals between 2008 and 2010. Findings: Of 35 881 patients diagnosed with NSTE-ACS, eGFR of <60 ml/minute/1.73 m(2) was present in 15 680 (43.7%). There was a stepwise decline in the odds of undergoing inpatient angiography with worsening renal dysfunction. Compared with an eGFR. 90 ml/minute/1.73 m(2), patients with an eGFR between 45-59 ml/minute/1.73 m(2) were 33% less likely to undergo angiography (adjusted OR 0.67, 95% CI 0.55-0.81); those with an eGFR, 30/minute/1.73 m(2) had a 64% reduction in odds of undergoing angiography (adjusted OR 0.36, 95% CI 0.29-0.43). Of 16 646 patients who had inpatient coronary angiography, 58.5% underwent inpatient revascularisation. After adjusting for co-variables, inpatient revascularisation was associated with approximately a 30% reduction in death within 1 year compared with those managed medically after coronary angiography (adjusted OR 0.66, 95% CI 0.57-0.77), with no evidence of modification by renal function (p interaction = 0.744). Interpretation: Early revascularisation may offer a similar survival benefit in patients with and without renal dysfunction, yet renal impairment is an important determinant of the provision of coronary angiography following NSTE-ACS. A randomised controlled trial is needed to evaluate the efficacy of an early invasive approach in patients with severe renal dysfunction to ensure that all patients who may benefit are offered this treatment option.	[Shaw, Catriona; Steenkamp, Retha] Southmead Hosp, UK Renal Registry, Bristol, Avon, England; [Shaw, Catriona; Sharpe, Claire C.] Kings Coll London, Div Transplantat Immunol & Mucosal Biol, Dept Renal Sci, London WC2R 2LS, England; [Nitsch, Dorothea] London Sch Hyg & Trop Med, London WC1, England; [Junghans, Cornelia] UCL, Dept Epidemiol & Publ Hlth, London, England; [Shah, Sapna] Kings Coll Hosp London, Dept Renal Med, London, England; [O'Donoghue, Donal] Salford Royal NHS Fdn Trust, Dept Renal Med, Salford, Lancs, England; [Fogarty, Damian] Belfast Hlth & Social CareTrust, Dept Renal Med, Belfast, Antrim, North Ireland; [Weston, Clive] Swansea Univ, Coll Med, Myocardial Ischaemia Natl Audit Project, Swansea, W Glam, Wales	Southmead Hospital; University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; King's College Hospital NHS Foundation Trust; King's College Hospital; Salford Royal NHS Foundation Trust; Swansea University	Shaw, C (corresponding author), Southmead Hosp, UK Renal Registry, Bristol, Avon, England.	catriona.shaw@nbt.nhs.uk	Sharpe, Claire/B-5619-2015; Junghans, Cornelia/ABG-4494-2020	Sharpe, Claire/0000-0003-1704-8492; Junghans, Cornelia/0000-0002-0663-3090; Nitsch, Dorothea/0000-0001-5767-248X; shah, Sapna/0000-0002-8748-6191; Weston, Clive/0000-0002-8995-8199	FOGARTY INTERNATIONAL CENTER [R25TW009337] Funding Source: NIH RePORTER; FIC NIH HHS [R25 TW009337] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Birkhead JS, 2000, HEART, V84, P116, DOI 10.1136/heart.84.2.116; Birkhead JS, 2002, J CLIN EXCELLENCE, V4, P379; Blicher TM, 2013, EUR HEART J, V34, P2916, DOI 10.1093/eurheartj/eht220; Boden WE, 1998, NEW ENGL J MED, V338, P1785, DOI 10.1056/NEJM199806183382501; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Charytan DM, 2009, CLIN J AM SOC NEPHRO, V4, P1032, DOI 10.2215/CJN.05551008; Chertow GM, 2004, J AM SOC NEPHROL, V15, P2462, DOI 10.1097/01.ASN.0000135969.33773.0B; Coca SG, 2006, JAMA-J AM MED ASSOC, V296, P1377, DOI 10.1001/jama.296.11.1377; Damman P, 2010, J AM COLL CARDIOL, V55, P858, DOI 10.1016/j.jacc.2009.11.026; Department for Communities and Local Government, 2010, ENGL IND DEPR; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Fox CS, 2010, CIRCULATION, V121, P357, DOI 10.1161/CIRCULATIONAHA.109.865352; Fox KAA, 2007, HEART, V93, P177, DOI 10.1136/hrt.2005.084830; Fox KAA, 2010, J AM COLL CARDIOL, V55, P2435, DOI 10.1016/j.jacc.2010.03.007; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Herrett E, 2010, HEART, V96, P1264, DOI 10.1136/hrt.2009.192328; Herzog CA, 2003, J AM SOC NEPHROL, V14, P2556, DOI 10.1097/01.ASN.0000087640.94746.47; Hoenig MR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004815.pub3; James MT, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4151; Jneid H, 2012, CIRCULATION, V126, P875, DOI 10.1161/CIR.0b013e318256f1e0; Kanderian AS, 2006, KIDNEY INT, V69, P1112, DOI 10.1038/sj.ki.5000174; Kerr M, 2012, NEPHROLOGY DIALYS S3, V27, P373; Kumar N, 2009, CLIN J AM SOC NEPHRO, V4, P1907, DOI 10.2215/CJN.01480209; Lee CH, 2008, ARCH INTERN MED, V168, P291, DOI 10.1001/archinternmed.2007.78; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT, V83, P1001, DOI 10.1038/ki.2013.91; Lopez-Sendon J, 2004, EUR HEART J, V25, P1341, DOI 10.1016/j.ehj.2004.06.002; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubin DB, 2004, MULTIPLE IMPUTATION; Szummer K, 2009, CIRCULATION, V120, P851, DOI 10.1161/CIRCULATIONAHA.108.838169; Wickenbrock I, 2009, CLIN RES CARDIOL, V98, P765, DOI 10.1007/s00392-009-0058-5; Wong JA, 2009, EUR HEART J, V30, P549, DOI 10.1093/eurheartj/ehp014; Yan AT, 2007, ARCH INTERN MED, V167, P1009, DOI 10.1001/archinte.167.10.1009	37	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99925	10.1371/journal.pone.0099925	http://dx.doi.org/10.1371/journal.pone.0099925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937680	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000338503400057
J	Aurin, TH; Munshi, SK; Kamal, SMM; Rahman, MM; Hossain, MS; Marma, T; Rahman, F; Noor, R				Aurin, Tafsina Haque; Munshi, Saurab Kishore; Kamal, S. M. Mostofa; Rahman, Md. Mostafizur; Hossain, Md. Shamim; Marma, Thaythayhla; Rahman, Farjana; Noor, Rashed			Molecular Approaches for Detection of the Multi-Drug Resistant Tuberculosis (MDR-TB) in Bangladesh	PLOS ONE			English	Article							GENOTYPE MTBDR ASSAY; XPERT MTB/RIF ASSAY; LINE PROBE ASSAY; MYCOBACTERIUM-TUBERCULOSIS; DRUG-RESISTANCE; PULMONARY TUBERCULOSIS; RIFAMPICIN-RESISTANCE; ISONIAZID RESISTANCE; SOUTH-AFRICA; DIAGNOSIS	The principal obstacles in the treatment of tuberculosis (TB) are delayed and inaccurate diagnosis which often leads to the onset of the drug resistant TB cases. To avail the appropriate treatment of the patients and to hinder the transmission of drug-resistant TB, accurate and rapid detection of resistant isolates is critical. Present study was designed to demonstrate the efficacy of molecular techniques inclusive of line probe assay (LPA) and GeneXpert MTB/RIF methods for the detection of multi-drug resistant (MDR) TB. Sputum samples from 300 different categories of treated and new TB cases were tested for the detection of possible mutation in the resistance specific genes (rpoB, inhA and katG) through Genotype MTBDRplus assay or LPA and GeneXpert MTB/RIF tests. Culture based conventional drug susceptibility test (DST) was also carried out to measure the efficacy of the molecular methods employed. Among 300 samples, 191 (63.7%) and 193 (64.3%) cases were found to be resistant against rifampicin in LPA and GeneXpert methods, respectively; while 189 (63%) cases of rifampicin resistance were detected by conventional DST methods. On the other hand, 196 (65.3%) and 191 (63.7%) isolates showed isoniazid resistance as detected by LPA and conventional drug susceptibility test (DST), respectively. Among the drug resistant isolates (collectively 198 in LPA and 193 in conventional DST), 189 (95.6%) and 187 (96.9%) were considered to be MDR as examined by LPA and conventional DST, respectively. Category-II and -IV patients encountered higher frequency of drug resistance compared to those from category-I and new cases. Considering the higher sensitivity, specificity and accuracy along with the required time to results significantly shorter, our study supports the adoption of LPA and GeneXpert assay as efficient tools in detecting drug resistant TB in Bangladesh.	[Aurin, Tafsina Haque; Munshi, Saurab Kishore; Rahman, Farjana; Noor, Rashed] Stamford Univ Bangladesh, Dept Microbiol, Dhaka, Bangladesh; [Kamal, S. M. Mostofa; Hossain, Md. Shamim; Marma, Thaythayhla] NIDCH, NTRL, Dhaka, Bangladesh; [Rahman, Md. Mostafizur] Univ Res Co LLC URC, Dhaka, Bangladesh	Stamford University Bangladesh	Noor, R (corresponding author), Stamford Univ Bangladesh, Dept Microbiol, Dhaka, Bangladesh.	noor.rashed@yahoo.com	Munshi, Saurab Kishore/Q-2705-2018; Noor, Rashed/GVU-1664-2022; Noor, Rashed/Q-7687-2019	Munshi, Saurab Kishore/0000-0003-3950-7741; Noor, Rashed/0000-0003-4837-221X; 				Armand S, 2011, J CLIN MICROBIOL, V49, P1772, DOI 10.1128/JCM.02157-10; Baker LV, 2005, ANTIMICROB AGENTS CH, V49, P1455, DOI 10.1128/AAC.49.4.1455-1464.2005; Bang H, 2011, J MED MICROBIOL, V60, P1447, DOI 10.1099/jmm.0.032292-0; Barnard M, 2012, J CLIN MICROBIOL, V50, P3712, DOI 10.1128/JCM.01958-12; Barnard M, 2010, LAB MANUAL MOL DETEC; Barnard M., 2012, MOL DETECTION DRUG R; Barnard M, 2007, INT J TUBERC LUNG D, V11, pS229; Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC; Bengisun JS, 2000, SCAND J INFECT DIS, V32, P507, DOI 10.1080/003655400458785; Bwanga F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-67; Cavusoglu C, 2002, J CLIN MICROBIOL, V40, P4435, DOI 10.1128/JCM.40.12.4435-4438.2002; Davies GR, 2010, TUBERCULOSIS, V90, P171, DOI 10.1016/j.tube.2010.03.007; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hillemann D, 2006, INT J TUBERC LUNG D, V10, P1057; Hillemann D, 2007, J CLIN MICROBIOL, V45, P2635, DOI 10.1128/JCM.00521-07; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Iqbal R, 2008, PAK J MED RES, V47, P26; Islam S, 2012, BANGLADESH J MED SCI, V11, P322, DOI 10.3329/bjms.v11i4.12605; Jou R, 2005, J CLIN MICROBIOL, V43, P1390, DOI 10.1128/JCM.43.3.1390-1394.2005; Kiepiela P, 2000, TUBERCLE LUNG DIS, V80, P47, DOI 10.1054/tuld.1999.0231; Kim BJ, 1999, J CLIN MICROBIOL, V37, P1714, DOI 10.1128/JCM.37.6.1714-1720.1999; Kumar V., 2007, ROBBINS BASIC PATHOL, P516; Lutfor AB, 2009, J MED MICROBIOL, V3, P1; Mahadev B, 2010, IND J TUB, V48, P129; Mahmud AM, 2008, RESPIROLOGY, V13, P106; Makinen J, 2006, J CLIN MICROBIOL, V44, P350, DOI 10.1128/JCM.44.2.350-352.2006; McAdam AJ, 2004, ROBBINS COTRAN PATHO, P381; Miotto P, 2006, J CLIN MICROBIOL, V44, P2485, DOI 10.1128/JCM.00083-06; Mokrousov I, 2002, ANTIMICROB AGENTS CH, V46, P1417, DOI 10.1128/AAC.46.5.1417-1424.2002; Munshi SK, 2012, INT J MYCOBACT, V1, P190, DOI 10.1016/j.ijmyco.2012.10.004; Noor R, 2013, J INFECT CHEMOTHER, V19, P818, DOI 10.1007/s10156-013-0566-0; Noor R, 2013, J INFECT CHEMOTHER, V19, P243, DOI [10.1007/s10156-012-0490-8, 10.1007/]; Piatek AS, 2000, ANTIMICROB AGENTS CH, V44, P103, DOI 10.1128/AAC.44.1.103-110.2000; Rahman A.M., 1970, STAMFORD J MICROBIOL, V1, P46, DOI [10.3329/sjm.v1i1.9133, DOI 10.3329/SJM.V1I1.9133, DOI 10.3329/sjm.v1i1.9133]; Richter Elvira, 2009, Expert Rev Respir Med, V3, P497, DOI 10.1586/ers.09.45; Sabouni R, 2008, ANN MICROBIOL, V58, P749, DOI 10.1007/BF03175585; Salim AH, 2006, INT J TUBERC LUNG D, V10, P1248; Shiferaw G, 2007, J CLIN MICROBIOL, V45, P1093, DOI 10.1128/JCM.01949-06; Somoskovi A, 2006, J CLIN MICROBIOL, V44, P4459, DOI 10.1128/JCM.01506-06; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Telenti A, 1997, J CLIN MICROBIOL, V35, P719, DOI 10.1128/JCM.35.3.719-723.1997; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Van Rie A, 2001, J CLIN MICROBIOL, V39, P636, DOI 10.1128/JCM.39.2.636-641.2001; Van Rie A, 2012, INT J TUBERC LUNG D, V16, P206, DOI 10.5588/ijtld.11.0395; Warren RM, 2009, TUBERCULOSIS, V89, P199, DOI 10.1016/j.tube.2009.03.001; WHO, 2009, GLOB TUB CONTR 2009; WHO, 2010, GLOB TUB CONTR 2010; Wilson ML, 2011, MED MICROBIOL, V52, P1352; World Health Organization, 2008, MOL LIN PROB ASS RAP; World Health Organization, 2011, RAP IMPL XPERT MTB R; World Health Organization, 2011, DRUG RES TUB S E AS; Zaman K, 2005, SCAND J INFECT DIS, V37, P21, DOI 10.1080/00365540410026095	53	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99810	10.1371/journal.pone.0099810	http://dx.doi.org/10.1371/journal.pone.0099810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932706	Green Published, Green Submitted, gold			2022-12-25	WOS:000337738600067
J	Burgess, GH; Bruce, BD; Cailliet, GM; Goldman, KJ; Grubbs, RD; Lowe, CG; MacNeil, MA; Mollet, HF; Weng, KC; O'Sullivan, JB				Burgess, George H.; Bruce, Barry D.; Cailliet, Gregor M.; Goldman, Kenneth J.; Grubbs, R. Dean; Lowe, Christopher G.; MacNeil, M. Aaron; Mollet, Henry F.; Weng, Kevin C.; O'Sullivan, John B.			A Re-Evaluation of the Size of the White Shark (Carcharodon carcharias) Population off California, USA	PLOS ONE			English	Article							BEHAVIOR; MOVEMENTS; CONSEQUENCES; DEMOGRAPHY; MIGRATION; ABUNDANCE; COLLAPSE; ISLANDS; HABITAT; BIOLOGY	White sharks are highly migratory and segregate by sex, age and size. Unlike marine mammals, they neither surface to breathe nor frequent haul-out sites, hindering generation of abundance data required to estimate population size. A recent tag-recapture study used photographic identifications of white sharks at two aggregation sites to estimate abundance in "central California'' at 219 mature and sub-adult individuals. They concluded this represented approximately one-half of the total abundance of mature and sub-adult sharks in the entire eastern North Pacific Ocean (ENP). This low estimate generated great concern within the conservation community, prompting petitions for governmental endangered species designations. We critically examine that study and find violations of model assumptions that, when considered in total, lead to population underestimates. We also use a Bayesian mixture model to demonstrate that the inclusion of transient sharks, characteristic of white shark aggregation sites, would substantially increase abundance estimates for the adults and sub-adults in the surveyed sub-population. Using a dataset obtained from the same sampling locations and widely accepted demographic methodology, our analysis indicates a minimum all-life stages population size of >2000 individuals in the California subpopulation is required to account for the number and size range of individual sharks observed at the two sampled sites. Even accounting for methodological and conceptual biases, an extrapolation of these data to estimate the white shark population size throughout the ENP is inappropriate. The true ENP white shark population size is likely several-fold greater as both our study and the original published estimate exclude non-aggregating sharks and those that independently aggregate at other important ENP sites. Accurately estimating the central California and ENP white shark population size requires methodologies that account for biases introduced by sampling a limited number of sites and that account for all life history stages across the species' range of habitats.	[Burgess, George H.] Univ Florida, Florida Museum Nat Hist, Florida Program Shark Res, Gainesville, FL 32611 USA; [Bruce, Barry D.] Commonwealth Sci & Ind Res Org Wealth Oceans Flag, Hobart, Tas, Australia; [Cailliet, Gregor M.; Mollet, Henry F.] Moss Landing Marine Lab, Moss Landing, CA USA; [Goldman, Kenneth J.] Alaska Dept Fish & Game, Homer, AK USA; [Grubbs, R. Dean] Florida State Univ, Coastal & Marine Lab, St Teresa, FL USA; [Lowe, Christopher G.] Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA; [MacNeil, M. Aaron] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Weng, Kevin C.] Univ Hawaii Manoa, Dept Oceanog, Pelag Fisheries Res Program, Honolulu, HI 96822 USA; [Mollet, Henry F.; O'Sullivan, John B.] Monterey Bay Aquarium, Monterey, CA USA	State University System of Florida; University of Florida; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Moss Landing Marine Laboratories; Alaska Department of Fish & Game; State University System of Florida; Florida State University; California State University System; California State University Long Beach; Australian Institute of Marine Science; University of Hawaii System; University of Hawaii Manoa; Monterey Bay Aquarium Research Institute	Burgess, GH (corresponding author), Univ Florida, Florida Museum Nat Hist, Florida Program Shark Res, Gainesville, FL 32611 USA.	gburgess@flmnh.ufl.edu	MacNeil, Aaron/E-8196-2017; MacNeil, M. Aaron/ABD-6444-2021; Weng, Kevin Chi-Ming/C-4709-2013	MacNeil, Aaron/0000-0001-8406-325X; MacNeil, M. Aaron/0000-0001-8406-325X; Weng, Kevin Chi-Ming/0000-0002-7069-7152	Australian Government's National Environmental Research Program, Marine Biodiversity Hub; Joint Institute for Marine and Atmospheric Research	Australian Government's National Environmental Research Program, Marine Biodiversity Hub(Australian Government); Joint Institute for Marine and Atmospheric Research	We are grateful for thoughts shared by numerous colleagues during informal discussions. We thank Malcolm Francis, Colin Simpfendorfer, Scott Meyer and two anonymous reviewers for their valuable comments on this manuscript, which helped to greatly improve it. Time on this paper for BDB was supported by the Australian Government's National Environmental Research Program, Marine Biodiversity Hub and for KCW by the Joint Institute for Marine and Atmospheric Research.	Aires-da-Silva AM, 2008, FISH RES, V92, P41, DOI 10.1016/j.fishres.2007.12.019; Anderson SD, 2008, CALIF FISH GAME, V94, P33; Anderson SD, 2011, MAR BIOL, V158, P1233, DOI 10.1007/s00227-011-1643-5; Anderson SD, 2003, CALIF FISH GAME, V89, P96; Anderson SD, 1996, CALIF FISH GAME, V82, P182; [Anonymous], 2004, MARINE FISHERIES REV; Barrett-Lennard LG, 2001, 2001065 DEP FISH OC; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Blower DC, 2012, MAR ECOL PROG SER, V455, P229, DOI 10.3354/meps09659; Boustany AM, 2002, NATURE, V415, P35, DOI 10.1038/415035b; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; Bruce BD, 2013, MAR BIOL, V160, P889, DOI 10.1007/s00227-012-2142-z; Bruce Barry D., 2012, P225; BRUCE BD, 1992, AUST J MAR FRESH RES, V43, P1; Burgess GH, 2005, FISHERIES, V30, P19, DOI 10.1577/1548-8446(2005)30[19:ITCOSP]2.0.CO;2; Cailliet G.M., 1985, Memoirs of the Southern California Academy of Sciences, V9, P49; CAILLIET GM, 1992, AUST J MAR FRESH RES, V43, P1313; Cailliet GM, 1996, GREAT WHITE SHARKS, P415, DOI 10.1016/B978-012415031-7/50039-2; Campana S, 2001, 2001067 CAN STOCK AS; CAREY FG, 1982, COPEIA, P254; Carlisle AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030492; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chapple TK, 2011, BIOL LETTERS, V7, P581, DOI 10.1098/rsbl.2011.0124; Chapple TK, 2010, THESIS U CALIFORNIA; Cliff G, 1996, GREAT WHITE SHARKS, P393, DOI 10.1016/B978-012415031-7/50037-9; Cortes E, 2007, MAR FRESHWATER RES, V58, P4, DOI 10.1071/MF06191; Daly-Engel TS, 2010, MAR ECOL PROG SER, V403, P255, DOI 10.3354/meps08417; Dawson S, 2008, MAMMAL REV, V38, P19, DOI 10.1111/j.1365-2907.2008.00119.x; Delaney DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034753; Dewar H, 2004, ENVIRON BIOL FISH, V70, P133, DOI 10.1023/B:EBFI.0000029343.54027.6a; Dewar H., 2013, STATUS REV NE PACIFI; Domeier M. L., 2013, Animal Biotelemetry, V1, P1; Domeier Michael L., 2012, P133; Duffy Clinton A.J., 2012, P301; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fearnbach H, 2012, ECOL APPL, V22, P1689; Fergusson IK, 1996, GREAT WHITE SHARKS, P321, DOI 10.1016/B978-012415031-7/50031-8; Fergusson IK, 2000, ENVIRON BIOL FISH, V58, P447, DOI 10.1023/A:1007639324360; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Francis MP, 1996, GREAT WHITE SHARKS, P157, DOI 10.1016/B978-012415031-7/50016-1; Francis MP, 1997, IUCN SHARK SPECIALIS, V9, P8; GalvuYn-Magaua F., 2010, MAR BIODIV REC, V3, P1; Goldman KJ, 1999, ENVIRON BIOL FISH, V56, P351, DOI 10.1023/A:1007520931105; Gubili C, 2009, MAR BIOL, V156, P2199, DOI 10.1007/s00227-009-1233-y; Hamady LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084006; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2010, CRC MAR BIOL SER, P611; Hines, 2017, OCCUPANCY ESTIMATION; Hussey NE, 2012, GLOBAL PERSPECTIVES, P225; Jorgensen Salvador J., 2012, P159; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Kendall WL, 1999, ECOLOGY, V80, P2517, DOI 10.1890/0012-9658(1999)080[2517:ROCCRM]2.0.CO;2; Kerr LA, 2006, ENVIRON BIOL FISH, V77, P337, DOI 10.1007/s10641-006-9125-1; Kim SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030501, 10.1371/journal.pone.0045068]; KLIMLEY AP, 1994, AM SCI, V82, P122; Kock A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055048; Krebs C., 1985, Q REV BIOL, DOI DOI 10.1086/407551; Laroche RK, 2007, MAR ECOL PROG SER, V338, P199, DOI 10.3354/meps338199; Le Boeuf Burney J., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P89; Lowe Christopher G., 2012, P169; Malcolm H, 2001, REP ENV AUST MAR SPE; Marshall AD, 2012, J FISH BIOL, V80, P1361, DOI 10.1111/j.1095-8649.2012.03244.x; McDonald TL, 2003, WILDLIFE SOC B, V31, P814; Mollet HF, 2000, FISH B-NOAA, V98, P299; Mollet HF, 2002, MAR FRESHWATER RES, V53, P503, DOI 10.1071/MF01083; Nasby-Lucas Nicole, 2012, P381; OTIS DL, 1978, WILDLIFE MONOGR, P1; Pardini AT, 2001, NATURE, V412, P139, DOI 10.1038/35084125; Pyle P, 1996, GREAT WHITE SHARKS, P375, DOI 10.1016/B978-012415031-7/50035-5; Robbins R, 2012, MAR FRESHWATER RES, V63, P1215, DOI 10.1071/MF12208; Robbins Rachel L., 2012, P287; Robbins W, 2012, IND INVESTMENT NSW F, V132, P1; Santana-Morales Omar, 2012, P187; Sosa-Nishizaki Oscar, 2012, P393; Sperone E, 2010, MAR BIOL RES, V6, P408, DOI 10.1080/17451000903078648; Strong WR, 1996, GREAT WHITE SHARKS, P401, DOI 10.1016/B978-012415031-7/50038-0; Towner AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066035; TRICAS T C, 1984, Proceedings of the California Academy of Sciences, V43, P221; WENG K, 2013, J MAR BIOL, V2013, pNIL1, DOI DOI 10.1155/2013/598745; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; Weng KC, 2007, MAR ECOL PROG SER, V338, P211, DOI 10.3354/meps338211; Williams TM, 2004, ECOLOGY, V85, P3373, DOI 10.1890/03-0696; Wilson E. O., 1971, PRIMER POPULATION BI; Wintner SP, 1999, FISH B-NOAA, V97, P153; Wirsing AJ, 2008, MAR MAMMAL SCI, V24, P1, DOI 10.1111/j.1748-7692.2007.00167.x; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	86	39	39	5	160	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e98078	10.1371/journal.pone.0098078	http://dx.doi.org/10.1371/journal.pone.0098078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932483	Green Published, gold, Green Submitted			2022-12-25	WOS:000337738600007
J	Maksimovic, M; Vekovischeva, OY; Aitta-aho, T; Korpi, ER				Maksimovic, Milica; Vekovischeva, Olga Y.; Aitta-aho, Teemu; Korpi, Esa R.			Chronic Treatment with Mood-Stabilizers Attenuates Abnormal Hyperlocomotion of GluA1-Subunit Deficient Mice	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; MEDIAL TEMPORAL-LOBE; C-FOS EXPRESSION; BIPOLAR DISORDER; GLUTAMATE RECEPTORS; ENVIRONMENTAL ENRICHMENT; MESSENGER-RNAS; ANIMAL-MODELS; LONG-TERM; WILD-TYPE	Abnormal excitatory glutamate neurotransmission and plasticity have been implicated in schizophrenia and affective disorders. Gria1-/- mice lacking GluA1 subunit (encoded by Gria1 gene) of AMPA-type glutamate receptor show robust novelty-induced hyperactivity, social deficits and heightened approach features, suggesting that they could be used to test for anti-manic activity of drugs. Here, we tested the efficacy of chronic treatment with established anti-manic drugs on behavioural properties of the Gria1-/- mice. The mice received standard mood stabilizers (lithium and valproate) and novel ones (topiramate and lamotrigine, used more as anticonvulsants) as supplements in rodent chow for at least 4 weeks. All drugs attenuated novelty-induced locomotor hyperactivity of the Gria1-/- mice, especially by promoting the habituation, while none of them attenuated 2-mg/kg amphetamine-induced hyperactivity as compared to control diet. Treatment with lithium and valproate reversed the elevated exploratory activity of Gria1-/- mice. Valproate treatment also reduced struggling behaviour in tail suspension test and restored reciprocally-initiated social contacts of Gria12/2 mice to the level shown by the wild-type Gria1+/+ mice. Gria1-/- mice consumed slightly more sucrose during intermittent sucrose exposure than the wild-types, but ran similar distances on running wheels. These behaviours were not consistently affected by lithium and valproate in the Gria1-/- mice. The efficacy of various anti-manic drug treatments on novelty-induced hyperactivity suggests that the Gria1-/- mouse line can be utilized in screening for new therapeutics.	[Maksimovic, Milica; Vekovischeva, Olga Y.; Aitta-aho, Teemu; Korpi, Esa R.] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Korpi, Esa R.] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore, Singapore; [Korpi, Esa R.] Natl Univ Singapore, Inst Life Sci, Neurobiol & Ageing Programme, Singapore 117548, Singapore; [Korpi, Esa R.] SINAPSE, Singapore Inst Neurotechnol, Singapore, Singapore	University of Helsinki; National University of Singapore; National University of Singapore	Korpi, ER (corresponding author), Univ Helsinki, Inst Biomed, Helsinki, Finland.	esa.korpi@helsinki.fi		Korpi, Esa R./0000-0003-0683-4009; Aitta-aho, Teemu/0000-0001-9332-3340	Academy of Finland; Sigrid Juselius Foundation; Orion research foundation; Jane and Aatos Erkko Foundation; FinPharma Doctoral Program Drug Discovery section	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Orion research foundation; Jane and Aatos Erkko Foundation; FinPharma Doctoral Program Drug Discovery section	The study was supported by the Academy of Finland, the Sigrid Juselius Foundation, the Orion research foundation and the Jane and Aatos Erkko Foundation (ERK). The support of the FinPharma Doctoral Program Drug Discovery section (MM) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitta-Aho T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038325; Anand A, 2000, ARCH GEN PSYCHIAT, V57, P270, DOI 10.1001/archpsyc.57.3.270; Bannerman DM, 2004, BEHAV NEUROSCI, V118, P643, DOI 10.1037/0735-7044.118.3.643; Barkus C, 2012, NEUROPHARMACOLOGY, V62, P1263, DOI 10.1016/j.neuropharm.2011.06.005; Basselin M, 2006, NEUROPSYCHOPHARMACOL, V31, P1659, DOI 10.1038/sj.npp.1300920; BERGGREN U, 1985, J NEURAL TRANSM, V64, P239, DOI 10.1007/BF01256470; Bramon E, 2001, Curr Psychiatry Rep, V3, P332; Bureau I, 1999, J NEUROSCI, V19, P653; CHAPOTEAU E, 1992, CLIN CHEM, V38, P1654; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Coyle JT, 2003, NEURON, V38, P157, DOI 10.1016/S0896-6273(03)00195-8; Dubreucq S, 2013, BIOL PSYCHIAT, V73, P895, DOI 10.1016/j.biopsych.2012.10.025; EASTWOOD SL, 1995, MOL BRAIN RES, V29, P211, DOI 10.1016/0169-328X(94)00247-C; Eastwood SL, 1997, BIOL PSYCHIAT, V41, P636, DOI 10.1016/S0006-3223(96)00220-X; Fisahn A, 2004, J NEUROSCI, V24, P9658, DOI 10.1523/JNEUROSCI.2973-04.2004; Fitzgerald PJ, 2010, NEUROBIOL DIS, V40, P608, DOI 10.1016/j.nbd.2010.08.005; Flaisher-Grinberg Shlomit, 2009, Journal of Pharmacological and Toxicological Methods, V59, P141, DOI 10.1016/j.vascn.2009.03.003; Flaisher-Grinberg S, 2009, J NEUROSCI METH, V177, P44, DOI 10.1016/j.jneumeth.2008.09.018; Ghasemi M, 2011, TRENDS PHARMACOL SCI, V32, P420, DOI 10.1016/j.tips.2011.03.006; Ghasemi M, 2010, EPILEPSY BEHAV, V18, P171, DOI 10.1016/j.yebeh.2010.04.002; Gibbs JW, 2000, EPILEPSIA, V41, pS10; Gigante AD, 2012, BIPOLAR DISORD, V14, P478, DOI 10.1111/j.1399-5618.2012.01033.x; Ginsberg SD, 2012, PHARMACOL BIOCHEM BE, V100, P705, DOI 10.1016/j.pbb.2011.09.015; Guilmatre A, 2014, DEV NEUROBIOL, V74, P113, DOI 10.1002/dneu.22128; Hall FS, 1997, PHYSIOL BEHAV, V62, P291, DOI 10.1016/S0031-9384(97)00116-9; Han K, 2013, NATURE, V503, P72, DOI 10.1038/nature12630; HARRISON PJ, 1991, LANCET, V337, P450, DOI 10.1016/0140-6736(91)93392-M; Hashimoto R, 2002, J NEUROCHEM, V80, P589, DOI 10.1046/j.0022-3042.2001.00728.x; Henry BL, 2013, J AFFECT DISORDERS, V150, P948, DOI 10.1016/j.jad.2013.05.020; Ibrahim HM, 2000, AM J PSYCHIAT, V157, P1811, DOI 10.1176/appi.ajp.157.11.1811; Inta D, 2013, HIPPOCAMPUS; Inta D, 2010, NEUROSCI BIOBEHAV R, V34, P285, DOI 10.1016/j.neubiorev.2009.07.010; Kato T, 2007, NEUROSCI BIOBEHAV R, V31, P832, DOI 10.1016/j.neubiorev.2007.03.003; Kelley AE, 2002, J NEUROSCI, V22, P3306; Kerner B, 2009, AM J MED GENET B, V150B, P24, DOI 10.1002/ajmg.b.30780; Krystal JH, 1999, NEUROPSYCHOPHARMACOL, V21, pS143, DOI 10.1016/S0893-133X(99)00102-5; Kubova H, 2010, EPILEPSIA, V51, P469, DOI 10.1111/j.1528-1167.2009.02305.x; Lan MJ, 2008, J MOL NEUROSCI, V35, P225, DOI 10.1007/s12031-008-9056-8; LEACH MJ, 1991, EPILEPSIA, V32, pS4, DOI 10.1111/j.1528-1157.1991.tb05882.x; Li XH, 2012, NEUROPSYCHOPHARMACOL, V37, P77, DOI 10.1038/npp.2011.198; Lin CY, 2012, NEUROBIOL DIS, V45, P48, DOI 10.1016/j.nbd.2011.08.025; Linden AM, 2006, J PHARMACOL EXP THER, V317, P615, DOI 10.1124/jpet.105.098525; Maeng Sungho, 2007, Curr Psychiatry Rep, V9, P467, DOI 10.1007/s11920-007-0063-1; Meador-Woodruff JH, 2001, BRAIN RES BULL, V55, P631, DOI 10.1016/S0361-9230(01)00523-8; Minassian A, 2010, J AFFECT DISORDERS, V120, P200, DOI 10.1016/j.jad.2009.04.018; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; Newcomer JW, 1999, NEUROPSYCHOPHARMACOL, V20, P106, DOI 10.1016/S0893-133X(98)00067-0; NIESINK RJM, 1982, PHYSIOL BEHAV, V29, P819, DOI 10.1016/0031-9384(82)90331-6; O'Donnell KC, 2007, NEUROSCI BIOBEHAV R, V31, P932, DOI 10.1016/j.neubiorev.2007.04.002; Perry W, 2010, PSYCHIAT RES, V178, P84, DOI 10.1016/j.psychres.2010.04.032; Perry W, 2009, ARCH GEN PSYCHIAT, V66, P1072, DOI 10.1001/archgenpsychiatry.2009.58; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Procaccini C, 2013, NEUROSCIENCE, V250, P189, DOI 10.1016/j.neuroscience.2013.07.010; Procaccini C, 2011, EUR J NEUROSCI, V33, P161, DOI 10.1111/j.1460-9568.2010.07485.x; Rada P, 2005, NEUROSCIENCE, V134, P737, DOI 10.1016/j.neuroscience.2005.04.043; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Rao JS, 2010, MOL PSYCHIATR, V15, P384, DOI 10.1038/mp.2009.47; Saal D, 2003, NEURON, V38, P359, DOI 10.1016/S0896-6273(03)00208-3; Sanderson DJ, 2009, LEARN MEMORY, V16, P379, DOI 10.1101/lm.1339109; Shaldubina A, 2002, J NEURAL TRANSM, V109, P433, DOI 10.1007/s007020200035; Shaltiel G, 2008, MOL PSYCHIATR, V13, P858, DOI 10.1038/mp.2008.20; Shibata R, 2009, PHYSIOL BEHAV, V96, P667, DOI 10.1016/j.physbeh.2009.01.002; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Sokolov BP, 1998, J NEUROCHEM, V71, P2454; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Takao K, 2007, NEUROSCI RES, V58, P124, DOI 10.1016/j.neures.2007.02.009; Valdes JJ, 2009, BRAIN RES, V1268, P1, DOI 10.1016/j.brainres.2009.02.066; Van Loo PLP, 2004, LAB ANIM-UK, V38, P178, DOI 10.1258/002367704322968867; VandeWeerd HA, 1997, LAB ANIM, V31, P133, DOI 10.1258/002367797780600152; Varlinskaya EI, 1999, PHYSIOL BEHAV, V67, P475, DOI 10.1016/S0031-9384(98)00285-6; Vashchinkina E, 2012, J NEUROSCI, V32, P5310, DOI 10.1523/JNEUROSCI.4697-11.2012; Vekovischeva OY, 2013, BRIT J NUTR, V110, P1336, DOI 10.1017/S0007114513000238; Vekovischeva OY, 2004, GENES BRAIN BEHAV, V3, P253, DOI 10.1111/j.1601-1848.2004.00075.x; Vekovischeva OY, 2001, J NEUROSCI, V21, P4451, DOI 10.1523/JNEUROSCI.21-12-04451.2001; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x; Voikar V, 2005, GENES BRAIN BEHAV, V4, P240, DOI 10.1111/j.1601-183X.2004.00103.x; Wiedholz LM, 2008, MOL PSYCHIATR, V13, P631, DOI 10.1038/sj.mp.4002056; YAMASHITA S, 1995, J CHROMATOGR B, V670, P354, DOI 10.1016/0378-4347(95)00170-0; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zarate CA, 2006, BIOL PSYCHIAT, V59, P1006, DOI 10.1016/j.biopsych.2005.10.021	80	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100188	10.1371/journal.pone.0100188	http://dx.doi.org/10.1371/journal.pone.0100188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932798	Green Published, gold, Green Submitted			2022-12-25	WOS:000337738600101
J	Navarro, O; Cumplido, R; Villasenor-Pineda, L; Feregrino-Uribe, C; Carrasco-Ochoa, JA				Navarro, Osvaldo; Cumplido, Rene; Villasenor-Pineda, Luis; Feregrino-Uribe, Claudia; Ariel Carrasco-Ochoa, Jesus			A Node Linkage Approach for Sequential Pattern Mining	PLOS ONE			English	Article							FINDING FREQUENT; ALGORITHM	Sequential Pattern Mining is a widely addressed problem in data mining, with applications such as analyzing Web usage, examining purchase behavior, and text mining, among others. Nevertheless, with the dramatic increase in data volume, the current approaches prove inefficient when dealing with large input datasets, a large number of different symbols and low minimum supports. In this paper, we propose a new sequential pattern mining algorithm, which follows a pattern-growth scheme to discover sequential patterns. Unlike most pattern growth algorithms, our approach does not build a data structure to represent the input dataset, but instead accesses the required sequences through pseudo-projection databases, achieving better runtime and reducing memory requirements. Our algorithm traverses the search space in a depth-first fashion and only preserves in memory a pattern node linkage and the pseudo-projections required for the branch being explored at the time. Experimental results show that our new approach, the Node Linkage Depth-First Traversal algorithm (NLDFT), has better performance and scalability in comparison with state of the art algorithms.	[Navarro, Osvaldo; Cumplido, Rene; Villasenor-Pineda, Luis; Feregrino-Uribe, Claudia; Ariel Carrasco-Ochoa, Jesus] Inst Nacl Astrofis Opt & Electr, Dept Ciencias Computac, Puebla, Mexico	Instituto Nacional de Astrofisica, Optica y Electronica	Cumplido, R (corresponding author), Inst Nacl Astrofis Opt & Electr, Dept Ciencias Computac, Puebla, Mexico.	rcumplido@inaoep.mx	Feregrino, Claudia/AAW-2607-2021; Carrasco-Ochoa, Jesús Ariel/AAU-8484-2020; Villasenor-Pineda, Luis/A-2932-2009	Carrasco-Ochoa, Jesús Ariel/0000-0002-9982-7758; Villasenor-Pineda, Luis/0000-0003-1294-9128	CONACyT [106013, 106443, 158135, 51443]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was done under partial support of CONACyT (Project grants 106013, 106443 and 158135). The first author was funded by CONACyT (grant 51443) (www.conacyt.mx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 1995, DAT ENG 1995 P; Ahonen-Myka H., 2002, Pattern Detection and Discovery. ESF Exploratory Workshop Proceedings (Lecture Notes in Artificial Intelligence Vol. 2447), P180; Antunes C, 2003, LECT NOTES ARTIF INT, V2734, P239; Anwar F, 2012, EXPERT SYST APPL, V39, P4511, DOI 10.1016/j.eswa.2011.09.134; Cafaro M, 2011, CONCURR COMP-PRACT E, V23, P1774, DOI 10.1002/cpe.1761; Chen J, 2009, IEEE T KNOWL DATA EN, V22, P913; Coyotl-Morales RM, 2006, LECT NOTES COMPUT SC, V4225, P844; Denicia-Carral C, 2006, LECT NOTES ARTIF INT, V4139, P76; Ea Peterson, 2008, P 46 ANN SE REG C 20, V46, P34; Ezeife C, 2009, P 2009 INT DAT ENG A, P234, DOI [10.1145/ 1620432.1620457, DOI 10.1145/1620432.1620457]; Ezeife CI, 2005, DATA MIN KNOWL DISC, V10, P5, DOI 10.1007/s10618-005-0248-3; Garcia Blasco S, CEUR WORKSHOP P 2011; Garcia-Pedrajas N, 2011, PROGR ARTIFICIAL INT, V1, P71; Gouda K, 2010, J COMPUT SYST SCI, V76, P88, DOI 10.1016/j.jcss.2009.05.008; Hernandez-Reyes E, 2006, LECT NOTES ARTIF INT, V4139, P257; Karp RM, 2003, ACM T DATABASE SYST, V28, P51, DOI 10.1145/762471.762473; Kitsuregawa M, 2005, ICDE WORKSH, P1222; Li Chun, 2008, P SIAM INT C DAT MIN, P313; Mabroukeh NR, 2010, ACM COMPUT SURV, V43, DOI 10.1145/1824795.1824798; Masseglia F, 2009, EXPERT SYST APPL, V36, P2677, DOI 10.1016/j.eswa.2008.01.021; Pei J, 2000, DISCOVERY DATA MININ; Peiyi Tang, 2007, 16th International Conference on Software Engineering and Data Engineering, P247; Peiyi Tang, 2007, Proceedings of the 45th ACM Southeast Conference. ACMSE 07, P226, DOI 10.1145/1233341.1233382; Pitman A, 2011, WEBSITE HOSTING MARK; Shim B, 2012, EXPERT SYST APPL, V39, P7736, DOI 10.1016/j.eswa.2012.01.080; Spiliopoulou M, 1999, LECT NOTES COMPUT SC, V1590, P184; Tan H, 2006, WIT TRANS INFO COMM, V37, P315, DOI 10.2495/DATA060321; Tsai CY, 2012, EXPERT SYST APPL, V39, P3593, DOI 10.1016/j.eswa.2011.09.049; Zaki MJ, 2001, MACH LEARN, V42, P31, DOI 10.1023/A:1007652502315	29	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e95418	10.1371/journal.pone.0095418	http://dx.doi.org/10.1371/journal.pone.0095418			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933123	Green Published, gold			2022-12-25	WOS:000337738600001
J	Boyko-Fabian, M; Niehr, F; Distel, L; Budach, V; Tinhofer, I				Boyko-Fabian, Mariya; Niehr, Franziska; Distel, Luitpold; Budach, Volker; Tinhofer, Ingeborg			Increased Growth-Inhibitory and Cytotoxic Activity of Arsenic Trioxide in Head and Neck Carcinoma Cells with Functional p53 Deficiency and Resistance to EGFR Blockade	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; INDUCED APOPTOSIS; TP53 MUTATIONS; FACTOR RECEPTOR; ORAL-CAVITY; TUMOR; RADIATION; LINES; ACTIVATION; CISPLATIN	Background and Purpose: Mutations in the p53 gene are frequently observed in squamous cell carcinoma of the head and neck region (SCCHN) and have been associated with drug resistance. The potential of arsenic trioxide (ATO) for treatment of p53-deficient tumor cells and those with acquired resistance to cisplatin and cetuximab was determined. Material and Methods: In a panel of 10 SCCHN cell lines expressing either wildtype p53, mutated p53 or which lacked p53 by deletion the interference of p53 deficiency with the growth-inhibitory and radiosensitizing potential of ATO was determined. The causal relationship between p53 deficiency and ATO sensitivity was evaluated by reconstitution of wildtype p53 in p53-deficient SCCHN cells. Interference of ATO treatment with cell cycle, DNA repair and apoptosis and its efficacy in cells with acquired resistance to cisplatin and cetuximab was evaluated. Results: Functional rather than structural defects in the p53 gene predisposed tumor cells to increased sensitivity to ATO. Reconstitution of wt p53 in p53-deficient SCCHN cells rendered them less sensitive to ATO treatment. Combination of ATO with irradiation inhibited clonogenic growth in an additive manner. The inhibitory effect of ATO in p53-deficient tumor cells was mainly associated with DNA damage, G2/M arrest, upregulation of TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) receptors and apoptosis. Increased activity of ATO was observed in cetuximab-resistant SCCHN cells whereas cisplatin resistance was associated with cross-resistance to ATO. Conclusions: Addition of ATO to treatment regimens for p53-deficient SCCHN and tumor recurrence after cetuximab-containing regimens might represent an attractive strategy in SCCHN.	[Boyko-Fabian, Mariya; Niehr, Franziska; Budach, Volker; Tinhofer, Ingeborg] Charite, Translat Radiooncol Lab, Dept Radiooncol & Radiotherapy, Berlin, Germany; [Distel, Luitpold] Univ Erlangen Nurnberg, Dept Radiat Oncol, D-91054 Erlangen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Erlangen Nuremberg	Tinhofer, I (corresponding author), Charite, Translat Radiooncol Lab, Dept Radiooncol & Radiotherapy, Berlin, Germany.	ingeborg.tinhofer@charite.de	Distel, Luitpold/ABD-9880-2020	Distel, Luitpold/0000-0002-8040-3226; Tinhofer, Ingeborg/0000-0002-0512-549X; Budach, Volker/0000-0002-2191-9871	German Cancer Aid [108791]	German Cancer Aid(Deutsche Krebshilfe)	The study was supported by a grant from the German Cancer Aid (grant no. 108791). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Akay C, 2003, CELL CYCLE, V2, P358, DOI 10.4161/cc.2.4.417; Ballo H, 1999, ANTICANCER RES, V19, P3827; Bode AM, 2002, CRIT REV ONCOL HEMAT, V42, P5, DOI 10.1016/S1040-8428(01)00215-3; Bornkamm GW, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni137; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Griffin RJ, 2005, INT J RADIAT ONCOL, V61, P1516, DOI 10.1016/j.ijrobp.2004.12.058; Haraf DJ, 1996, CLIN CANCER RES, V2, P755; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Kim EH, 2008, CANCER RES, V68, P266, DOI 10.1158/0008-5472.CAN-07-2444; Kodigepalli KM, 2013, FEBS LETT, V587, P5, DOI 10.1016/j.febslet.2012.11.003; Kryeziu K, 2013, MOL CANCER THER, V12, P1073, DOI 10.1158/1535-7163.MCT-13-0065; Kumar P, 2008, MOL CANCER THER, V7, P2060, DOI 10.1158/1535-7163.MCT-08-0287; LANSFORD CD, 1999, HUMAN CELL CULTURE, V2, P185; Lee PC, 2010, NEOPLASIA, V12, P376, DOI 10.1593/neo.10110; Lew YS, 2002, CANCER RES, V62, P4202; Lin CJ, 2007, HEAD NECK-J SCI SPEC, V29, P163, DOI 10.1002/hed.20478; Lindenbergh-van der Plas M, 2011, CLIN CANCER RES, V17, P3733, DOI 10.1158/1078-0432.CCR-11-0183; Liu Q, 2003, BLOOD, V101, P4078, DOI 10.1182/blood-2002-10-3231; Liu ZM, 2011, BIOCHEM J, V438, P349, DOI 10.1042/BJ20101653; Ning SC, 2004, INT J RADIAT ONCOL, V60, P197, DOI 10.1016/j.ijrobp.2004.02.013; Ning SC, 2006, INT J RADIAT ONCOL, V65, P493, DOI 10.1016/j.ijrobp.2005.12.015; Perrone F, 2010, J CLIN ONCOL, V28, P761, DOI 10.1200/JCO.2009.22.4170; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Poeta ML, 2009, CLIN CANCER RES, V15, P7658, DOI 10.1158/1078-0432.CCR-09-1433; Raffoux E, 2003, J CLIN ONCOL, V21, P2326, DOI 10.1200/JCO.2003.01.149; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Sertel S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035584; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Simeonova PP, 2002, J BIOL CHEM, V277, P2945, DOI 10.1074/jbc.M109136200; Skinner HD, 2012, CLIN CANCER RES, V18, P290, DOI 10.1158/1078-0432.CCR-11-2260; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; SPITZ DR, 1993, J CELL PHYSIOL, V156, P72, DOI 10.1002/jcp.1041560111; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Tabor MP, 2003, J PATHOL, V199, P354, DOI 10.1002/path.1285; Tanaka-Kagawa T, 2003, BRIT J DERMATOL, V149, P1116, DOI 10.1111/j.1365-2133.2003.05704.x; Tandon S, 2010, CANCER EPIDEM BIOMAR, V19, P574, DOI 10.1158/1055-9965.EPI-09-0981; Taylor BF, 2006, J PHARMACOL EXP THER, V318, P142, DOI 10.1124/jpet.106.103077; VANKUPPEVELD FJM, 1994, APPL ENVIRON MICROB, V60, P149, DOI 10.1128/AEM.60.1.149-152.1994; Wahl AF, 1996, NAT MED, V2, P72, DOI 10.1038/nm0196-72; Waridel F, 1997, ONCOGENE, V14, P163, DOI 10.1038/sj.onc.1200812; Wei LH, 2005, ONCOGENE, V24, P390, DOI 10.1038/sj.onc.1208192; Westra WH, 2008, CLIN CANCER RES, V14, P366, DOI 10.1158/1078-0432.CCR-07-1402; YOKOMIZO A, 1995, CANCER RES, V55, P4293; Zhang LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046255; Zhu J, 2002, NAT REV CANCER, V2, P705, DOI 10.1038/nrc887	46	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98867	10.1371/journal.pone.0098867	http://dx.doi.org/10.1371/journal.pone.0098867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927258	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100021
J	Chen, RJ; Siao, SH; Hsu, CH; Chang, CY; Chang, LW; Wu, CH; Lin, PP; Wang, YJ				Chen, Rong-Jane; Siao, Shih-He; Hsu, Chung-Huei; Chang, Chu-Yung; Chang, Louis W.; Wu, Chih-Hsiung; Lin, Pinpin; Wang, Ying-Jan			TCDD Promotes Lung Tumors via Attenuation of Apoptosis through Activation of the Akt and ERK1/2 Signaling Pathways	PLOS ONE			English	Article							AROMATIC-HYDROCARBON RECEPTOR; EPITHELIAL-CELL LINE; ARYL-HYDROCARBON; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; STRESS-RESPONSE; CANCER; DIOXIN; EXPOSURE; EXPRESSION; INDUCTION	2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a multiple-site, multiple-species carcinogen that induces cancer in multiple organs. The molecular mechanisms underlying TCDD-induced lung tumorigenesis remain unclear. In the present study, a two-stage lung tumorigenesis model was established by administrating a single low dose of 4-(methylnitrosamino)-1-(3-pyridyl)- 1-butanone (NNK) combined with TCDD to female A/J mice. The results indicated that TCDD combined with low-dose NNK has a significant tumor-promoting effect compared with TCDD or low-dose NNK alone. Resistance to apoptosis is a hallmark of cancer and is thought to be one of the tumor-promoting mechanisms regulated by TCDD. We performed an additional series of experiments in the normal human bronchial epithelial cell line Beas2B cells, in which TCDD was combined with the apoptosis inducer staurosporine. Our in vitro results confirmed that TCDD could rescue cells from apoptosis induced by staurosporine. The inhibition of apoptosis is likely mediated by the activation of the Akt and ERK1/2 pathways, as determined by the effectiveness of pathway-specific inhibitors in abrogating the anti-apoptotic activity of TCDD. In conclusion, we demonstrated that TCDD promoted NNK-induced lung tumorigenesis and revealed that TCDD inhibits staurosporine-induced apoptosis, at least in part, through the Akt and ERK1/2 signaling pathways.	[Chen, Rong-Jane; Siao, Shih-He; Chang, Chu-Yung; Wang, Ying-Jan] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Chen, Rong-Jane] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Hsu, Chung-Huei] Taipei Med Univ Hosp, Dept Nucl Med, Taipei, Taiwan; [Chang, Louis W.; Lin, Pinpin] Natl Hlth Res Inst, Natl Environm Hlth Res Ctr, Zhunan Town, Taiwan; [Wu, Chih-Hsiung] Taipei Med Univ, Shuang Ho Hosp, Sch Med, Dept Surg, Taipei, Taiwan; [Wu, Chih-Hsiung] Taipei Med Univ, Ctr Excellence Canc Res, Taipei, Taiwan; [Lin, Pinpin] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan Town, Taiwan; [Wang, Ying-Jan] Asia Univ, Dept Biomed Informat, Taichung, Taiwan	National Cheng Kung University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; National Health Research Institutes - Taiwan; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; National Health Research Institutes - Taiwan; Asia University Taiwan	Lin, PP (corresponding author), Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan Town, Taiwan.	pplin@nhri.org.tw; yjwang@mail.ncku.edu.tw	Lin, PinPin/A-2006-2019; Lin, Pinpin/B-2668-2010	Lin, PinPin/0000-0001-5459-907X; Lin, Pinpin/0000-0001-5459-907X	National Science Council [NSC 102-2314-B-006-034]; Division of Environmental Health and Occupation Medicine (DEHOM), National Health Research Institutes (NHRI), Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Division of Environmental Health and Occupation Medicine (DEHOM), National Health Research Institutes (NHRI), Taiwan	This work is supported by the National Science Council (NSC 102-2314-B-006-034), and by the Division of Environmental Health and Occupation Medicine (DEHOM), National Health Research Institutes (NHRI), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEEBE LE, 1995, CARCINOGENESIS, V16, P1345, DOI 10.1093/carcin/16.6.1345; Bertazzi PA, 2001, AM J EPIDEMIOL, V153, P1031, DOI 10.1093/aje/153.11.1031; Besteman EG, 2007, TOXICOL PATHOL, V35, P786, DOI 10.1080/01926230701584155; Biswas G, 2008, P NATL ACAD SCI USA, V105, P186, DOI 10.1073/pnas.0706183104; Bock KW, 2005, BIOCHEM PHARMACOL, V69, P1403, DOI 10.1016/j.bcp.2005.02.004; Bodner KM, 2003, OCCUP ENVIRON MED, V60, P672, DOI 10.1136/oem.60.9.672; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chen HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089483; Chen RJ, 2012, J AGR FOOD CHEM, V60, P11533, DOI 10.1021/jf302778a; Chen RJ, 2011, J ONCOL, V2011, DOI 10.1155/2011/654931; Choi SS, 2006, TOXICOL SCI, V94, P163, DOI 10.1093/toxsci/kfl090; Chopra M, 2011, CRIT REV TOXICOL, V41, P292, DOI 10.3109/10408444.2010.524635; Chopra M, 2010, CELL BIOL TOXICOL, V26, P391, DOI 10.1007/s10565-010-9151-9; Cole P, 2003, REGUL TOXICOL PHARM, V38, P378, DOI 10.1016/j.yrtph.2003.08.002; Davis JW, 2003, TOXICOL APPL PHARM, V188, P42, DOI 10.1016/S0041-008X(03)00012-7; Davis JW, 2000, CARCINOGENESIS, V21, P881, DOI 10.1093/carcin/21.5.881; Davis JW, 2001, CANCER RES, V61, P3314; De Waard WJ, 2008, FOOD ADDIT CONTAM A, V25, P779, DOI 10.1080/02652030701798880; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Hattis D, 2009, CRIT REV TOXICOL, V39, P97, DOI 10.1080/10408440802307467 ; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kasai A, 2006, CANCER RES, V66, P7143, DOI 10.1158/0008-5472.CAN-05-4541; Knerr S, 2006, MOL NUTR FOOD RES, V50, P897, DOI 10.1002/mnfr.200600006; Kogevinas M, 2000, FOOD ADDIT CONTAM, V17, P317, DOI 10.1080/026520300283388; Lee YC, 2011, AM J RESP CELL MOL, V45, P270, DOI 10.1165/rcmb.2010-0313OC; Li MY, 2010, J MOL MED, V88, P1265, DOI 10.1007/s00109-010-0676-4; Loh AHP, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00093; McGregor DB, 1998, ENVIRON HEALTH PERSP, V106, P755, DOI 10.2307/3433830; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Paajarvi G, 2005, CARCINOGENESIS, V26, P201, DOI 10.1093/carcin/bgh289; Papadimitrakopoulou V, 2012, J THORAC ONCOL, V7, P1315, DOI 10.1097/JTO.0b013e31825493eb; Park S, 2006, TOXICOLOGY, V217, P139, DOI 10.1016/j.tox.2005.09.002; Parzefall W, 2002, FOOD CHEM TOXICOL, V40, P1185, DOI 10.1016/S0278-6915(02)00059-5; Phin S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00240; Pierre S, 2011, BIOCHEM PHARMACOL, V81, P304, DOI 10.1016/j.bcp.2010.10.003; Puga A, 2000, J BIOL CHEM, V275, P2943, DOI 10.1074/jbc.275.4.2943; Raimondi C, 2011, CURR MED CHEM, V18, P2763, DOI 10.2174/092986711796011238; Reyes-Hernandez OD, 2010, BIOCHEM PHARMACOL, V80, P932, DOI 10.1016/j.bcp.2010.05.007; Schecter A, 2001, J TOXICOL ENV HEAL A, V63, P1, DOI 10.1080/152873901750128326; Shimba S, 2002, J BIOCHEM, V132, P795, DOI 10.1093/oxfordjournals.jbchem.a003289; Tan ZQ, 2002, BIOCHEM PHARMACOL, V64, P771, DOI 10.1016/S0006-2952(02)01138-3; Tritscher AM, 2000, TOXICOL PATHOL, V28, P761, DOI 10.1177/019262330002800601; Wang YJ, 2011, J HAZARD MATER, V186, P869, DOI 10.1016/j.jhazmat.2010.11.082; Wu CH, 2004, FOOD CHEM TOXICOL, V42, P1217, DOI 10.1016/j.fct.2004.02.022; Xie GF, 2012, AM J PHYSIOL-GASTR L, V302, pG1006, DOI 10.1152/ajpgi.00427.2011	46	11	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99586	10.1371/journal.pone.0099586	http://dx.doi.org/10.1371/journal.pone.0099586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927102	gold, Green Published, Green Submitted			2022-12-25	WOS:000338278100051
J	de Busserolles, F; Fitzpatrick, JL; Marshall, NJ; Collin, SP				de Busserolles, Fanny; Fitzpatrick, John L.; Marshall, N. Justin; Collin, Shaun P.			The Influence of Photoreceptor Size and Distribution on Optical Sensitivity in the Eyes of Lanternfishes (Myctophidae)	PLOS ONE			English	Article							DEEP-SEA FISH; GANGLION-CELL LAYER; VISUAL PIGMENTS; FAMILY MYCTOPHIDAE; FEEDING ECOLOGY; RETINAL SPECIALIZATIONS; OMMASTREPHES-BARTRAMII; FUNCTIONAL-MORPHOLOGY; TYRANT FLYCATCHERS; VERTICAL MIGRATION	The mesopelagic zone of the deep-sea (200-1000 m) is characterised by exponentially diminishing levels of downwelling sunlight and by the predominance of bioluminescence emissions. The ability of mesopelagic organisms to detect and behaviourally react to downwelling sunlight and/or bioluminescence will depend on the visual task and ultimately on the eyes and their capacity for detecting low levels of illumination and intermittent point sources of bioluminescent light. In this study, we investigate the diversity of the visual system of the lanternfish (Myctophidae). We focus specifically on the photoreceptor cells by examining their size, arrangement, topographic distribution and contribution to optical sensitivity in 53 different species from 18 genera. We also examine the influence(s) of both phylogeny and ecology on these photoreceptor variables using phylogenetic comparative analyses in order to understand the constraints placed on the visual systems of this large group of mesopelagic fishes at the first stage of retinal processing. We report great diversity in the visual system of the Myctophidae at the level of the photoreceptors. Photoreceptor distribution reveals clear interspecific differences in visual specialisations (areas of high rod photoreceptor density), indicating potential interspecific differences in interactions with prey, predators and/or mates. A great diversity in photoreceptor design (length and diameter) and density is also present. Overall, the myctophid eye is very sensitive compared to other teleosts and each species seems to be specialised for the detection of a specific signal (downwelling light or bioluminescence), potentially reflecting different visual demands for survival. Phylogenetic comparative analyses highlight several relationships between photoreceptor characteristics and the ecological variables tested (depth distribution and luminous tissue patterns). Depth distribution at night was a significant factor in most of the models tested, indicating that vision at night is of great importance for lanternfishes and may drive the evolution of their photoreceptor design.	[de Busserolles, Fanny; Collin, Shaun P.] Univ Western Australia, Sch Anim Biol, Crawley, Australia; [de Busserolles, Fanny; Collin, Shaun P.] Univ Western Australia, UWA Oceans Inst, Crawley, Australia; [de Busserolles, Fanny] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Fitzpatrick, John L.] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, Australia; [Fitzpatrick, John L.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Marshall, N. Justin] Univ Queensland, Queensland Brain Inst, Sensory Neurobiol Grp, Brisbane, Qld, Australia	University of Western Australia; University of Western Australia; King Abdullah University of Science & Technology; University of Western Australia; University of Manchester; University of Queensland	de Busserolles, F (corresponding author), Univ Western Australia, Sch Anim Biol, Crawley, Australia.	fanny.debusserolles@kaust.edu.sa	Collin, Shaun/K-8827-2012; de Busserolles, Fanny/A-1769-2013; Fitzpatrick, John/E-8766-2011	Collin, Shaun/0000-0001-6236-0771; de Busserolles, Fanny/0000-0002-4602-9840; Fitzpatrick, John/0000-0002-2834-4409; Marshall, Justin/0000-0001-9006-6713	Australian Research Council; West Australian State Government; Scholarship for International Research Fees (SIRF); University International Stipend (UIS) at the University of Western Australia	Australian Research Council(Australian Research Council); West Australian State Government; Scholarship for International Research Fees (SIRF); University International Stipend (UIS) at the University of Western Australia	This work was funded by the Australian Research Council (Discovery grant to SPC, the Deep-Australia Linkage Grant to NJM and SPC, and a Postdoctoral Fellowship to JLF) and the West Australian State Government (SPC). FdB was supported by a Scholarship for International Research Fees (SIRF) and a University International Stipend (UIS) at the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1977, VISUAL SYSTEM VERTEB, DOI [DOI 10.1007/978-3-642-66468-7, 10.1007/978-3-642-66468-7_11, DOI 10.1007/978-3-642-66468-7_11]; ARNOTT HJ, 1970, SCIENCE, V169, P478, DOI 10.1126/science.169.3944.478; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; BARNES AT, 1974, J EXP MAR BIOL ECOL, V15, P203, DOI 10.1016/0022-0981(74)90046-X; BASSI CJ, 1990, INVEST OPHTH VIS SCI, V31, P2320; CAREY PW, 1992, NEW ZEAL J ECOL, V16, P41; CASE JF, 1977, NATURE, V265, P179, DOI 10.1038/265179a0; Claes JM, 2010, J EXP MAR BIOL ECOL, V388, P28, DOI 10.1016/j.jembe.2010.03.009; CLARKE GL, 1956, DEEP-SEA RES, V3, P189, DOI 10.1016/0146-6313(56)90003-X; Coimbra JP, 2006, BRAIN BEHAV EVOLUT, V68, P15, DOI 10.1159/000092310; Coimbra JP, 2012, BRAIN BEHAV EVOLUT, V80, P254, DOI 10.1159/000341901; Collin S. P., 1997, Society for Neuroscience Abstracts, V23, P729; Collin SP, 2008, CLIN EXP OPTOM, V91, P85, DOI 10.1111/j.1444-0938.2007.00228.x; Collin SP, 1998, BRAIN BEHAV EVOLUT, V51, P291; COLLIN SP, 1988, BRAIN BEHAV EVOLUT, V31, P269, DOI 10.1159/000116594; COLLIN SP, 1988, BRAIN BEHAV EVOLUT, V31, P283, DOI 10.1159/000116595; Collin SP, 1997, ACTA PHYSIOL SCAND, V161, P5; CRESCITELLI F, 1990, J EXP ZOOL, P66; CURCIO CA, 1987, VISION RES, V27, P9, DOI 10.1016/0042-6989(87)90137-4; de Busserolles F, 2014, J COMP NEUROL, V522, P1618, DOI 10.1002/cne.23495; de Busserolles F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058519; DENTON EJ, 1990, LIGHT AND LIFE IN THE SEA, P127; DENTON EJ, 1989, J MAR BIOL ASSOC UK, V69, P409, DOI 10.1017/S0025315400029507; Douglas RH, 1997, J FISH BIOL, V50, P68; Douglas RH, 1998, PROG RETIN EYE RES, V17, P597, DOI 10.1016/S1350-9462(98)00002-0; EDWARDS AS, 1977, MAR BIOL, V41, P59, DOI 10.1007/BF00390582; Esposito V, 2009, SCI MAR, V73, P369, DOI 10.3989/scimar.2009.73n2369; FERNALD RD, 1990, J EXP ZOOL, P167; FITE KV, 1973, VISION RES, V13, P219, DOI 10.1016/0042-6989(73)90101-6; Frank TM, 1997, J PLANKTON RES, V19, P1975, DOI 10.1093/plankt/19.12.1975; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fritsches KA, 2003, MAR FRESHWATER RES, V54, P333, DOI 10.1071/MF02126; Garza-Gisholt E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093485; Glaser EM, 1998, J MICROSC-OXFORD, V192, P163, DOI 10.1046/j.1365-2818.1998.00417.x; Goldsworthy SD, 2002, MAR FRESHWATER RES, V53, P49, DOI 10.1071/MF00075; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; GREEN K, 1991, ANTARCT SCI, V3, P359, DOI 10.1017/S0954102091000457; Green K., 1998, Marine Ornithology, V26, P27; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hasegawa EI, 2008, J FISH BIOL, V72, P937, DOI 10.1111/j.1095-8649.2007.01772.x; HAYGOOD MG, 1994, J EXP ZOOL, V270, P225, DOI 10.1002/jez.1402700212; Herring P.J., 1985, Symposia of the Society for Experimental Biology, P323; Herring PJ, 2007, J MAR BIOL ASSOC UK, V87, P829, DOI 10.1017/S0025315407056433; Herring PJ, 2002, BIOL DEEP SEA; Hoang QV, 2002, VISUAL NEUROSCI, V19, P395, DOI 10.1017/S0952523802194028; Hulley P.A., 1984, FISHES NE ATLANTIC M, V1, P429, DOI DOI 10.1017/CBO9781107415324.004; HULLEY PA, 1981, ARCH FISCHEREIWISS, V31, P1; HULLEY PA, LIVING MARI IN PRESS; Ishihara S, 1997, NIPPON SUISAN GAKK, V63, P522; JACKSON S, 1988, CONDOR, V90, P20, DOI 10.2307/1368428; Karnella C, 1987, BIOL MIDWATER FISHES, V452, P51; Kozlov A.N., 1995, CCAMLR Science, V2, P71; Land M.F., 1981, HDB SENSORY PHYSL, P471, DOI DOI 10.1007/978-3-642-66907-14; Land MF, 2002, ANIMALS EYES; LAWRY JV, 1974, NATURE, V247, P155, DOI 10.1038/247155a0; Litherland L, 2008, VISUAL NEUROSCI, V25, P549, DOI 10.1017/S0952523808080693; Locket N. A., 1977, HDB SENSORY PHYSL  5, P67; LOCKET NA, 1971, J MAR BIOL ASSOC UK, V51, P79, DOI 10.1017/S0025315400006470; LOCKET NA, 1970, EXP EYE RES, V9, P22, DOI 10.1016/S0014-4835(70)80054-9; Madison W., 2011, MESQUITE MODULAR SYS; Marshall N. B., 1954, ASPECTS DEEP SEA BIO; Martin G, 2004, NATURWISSENSCHAFTEN, V91, P26, DOI 10.1007/s00114-003-0495-3; MATTHIESSEN L, 1882, PFLUG ARCH GES PHYS, V38, P521; Matthiessen L., 1882, ARCH GESAMTE PHYSIOL, V27, P510, DOI DOI 10.1007/BF01802978; Munk O., 1974, Videnskabelige Meddr dansk naturh Foren, V137, P65; MUNK OLE, 1966, DANA REP CARLSBERG FOUND, V70, P5; NICOL JAC, 1989, EYES FISHES; Nilsson DE, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0038; ODAY WT, 1976, MAR BIOL, V37, P187, DOI 10.1007/BF00389128; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PANKHURST NW, 1987, ENVIRON BIOL FISH, V19, P269, DOI 10.1007/BF00003228; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parry M, 2006, MAR ECOL PROG SER, V318, P229, DOI 10.3354/meps318229; PARTRIDGE JC, 1989, J COMP PHYSIOL A, V164, P513, DOI 10.1007/BF00610445; PARTRIDGE JC, 1992, J MAR BIOL ASSOC UK, V72, P113, DOI 10.1017/S0025315400048827; Coimbra JP, 2009, J COMP NEUROL, V514, P66, DOI 10.1002/cne.21992; Paxton J.R., 1984, American Society of Ichthyologists and Herpetologists Special Publication, P239; Podrazhanskaya S.G., 1993, Northwest Atlantic Fisheries Organization Scientific Council Studies, V19, P79; Poulsen JY, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-111; Pusch C, 2004, ARCH FISH MAR RES, V51, P251; Schieber NL, 2012, J MORPHOL, V273, P423, DOI 10.1002/jmor.11033; Shreeve RS, 2009, MAR ECOL PROG SER, V386, P221, DOI 10.3354/meps08064; Slomianka L, 2005, NEUROSCIENCE, V136, P757, DOI 10.1016/j.neuroscience.2005.06.086; SOMIYA H, 1980, MAR ECOL PROG SER, V2, P9, DOI 10.3354/meps002009; STEINBERG RH, 1973, J COMP NEUROL, V148, P229, DOI 10.1002/cne.901480209; Stone J, 1981, WHOLE MOUNT HDB GUID; TSUJI FI, 1971, NATURE, V233, P623, DOI 10.1038/233623a0; Turner JR, 2009, DEEP-SEA RES PT I, V56, P1003, DOI 10.1016/j.dsr.2009.01.007; TYLER HR, 1975, MAR BIOL, V32, P7, DOI 10.1007/BF00395156; Ullmann JFP, 2012, BRAIN BEHAV EVOLUT, V79, P26, DOI 10.1159/000332802; VILTER V, 1951, CR SOC BIOL, V145, P52; Wagner HJ, 1998, PROG RETIN EYE RES, V17, P637, DOI 10.1016/S1350-9462(98)00003-2; Wagner HJ, 2001, BRAIN BEHAV EVOLUT, V57, P117, DOI 10.1159/000047231; Warrant E, 2004, J COMP PHYSIOL A, V190, P765, DOI 10.1007/s00359-004-0546-z; Warrant E, 2000, PHILOS T ROY SOC B, V355, P1155, DOI 10.1098/rstb.2000.0658; Warrant EJ, 2004, BIOL REV, V79, P671, DOI 10.1017/S1464793103006420; Warrant EJ, 1998, VISION RES, V38, P195, DOI 10.1016/S0042-6989(97)00151-X; Warrant EJ, 1999, VISION RES, V39, P1611, DOI 10.1016/S0042-6989(98)00262-4; Watanabe H, 1999, FISH OCEANOGR, V8, P115, DOI 10.1046/j.1365-2419.1999.00103.x; Watanabe H, 2008, J MAR BIOL ASSOC UK, V88, P381, DOI 10.1017/S0025315408000635; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Widder EA, 2010, SCIENCE, V328, P704, DOI 10.1126/science.1174269; YOUNG JW, 1986, MAR BIOL, V93, P147, DOI 10.1007/BF00428663; YOUNG RE, 1979, MAR BIOL, V51, P371, DOI 10.1007/BF00389215	106	26	26	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99957	10.1371/journal.pone.0099957	http://dx.doi.org/10.1371/journal.pone.0099957			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927016	Green Published, gold			2022-12-25	WOS:000338278100099
J	Hassanali, N; De Silva, NMG; Robertson, N; Rayner, NW; Barrett, A; Bennett, AJ; Groves, CJ; Matthews, DR; Katulanda, P; Frayling, TM; McCarthy, MI				Hassanali, Neelam; De Silva, N. Maneka G.; Robertson, Neil; Rayner, N. William; Barrett, Amy; Bennett, Amanda J.; Groves, Christopher J.; Matthews, David R.; Katulanda, Prasad; Frayling, Timothy M.; McCarthy, Mark I.			Evaluation of Common Type 2 Diabetes Risk Variants in a South Asian Population of Sri Lankan Descent	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; GENETIC ARCHITECTURE; METAANALYSIS; PREVALENCE; TCF7L2; IMPACT; CLASSIFICATION; REPLICATION; PRO12ALA	Introduction: Most studies seeking common variant associations with type 2 diabetes (T2D) have focused on individuals of European ancestry. These discoveries need to be evaluated in other major ancestral groups, to understand ethnic differences in predisposition, and establish whether these contribute to variation in T2D prevalence and presentation. This study aims to establish whether common variants conferring T2D-risk in Europeans contribute to T2D-susceptibility in the South Asian population of Sri Lanka. Methodology: Lead single nucleotide polymorphism (SNPs) at 37 T2D-risk loci attaining genome-wide significance in Europeans were genotyped in 878 T2D cases and 1523 normoglycaemic controls from Sri Lanka. Association testing was performed by logistic regression adjusting for age and sex and by the Cochran-Mantel-Haenszel test after stratifying according to self-identified ethnolinguistic subgroup. A weighted genetic risk score was generated to examine the combined effect of these SNPs on T2D-risk in the Sri Lankan population. Results: Of the 36 SNPs passing quality control, sixteen showed nominal (p<0.05) association in Sri Lankan samples, fifteen of those directionally-consistent with the original signal. Overall, these association findings were robust to analyses that accounted for membership of ethnolinguistic subgroups. Overall, the odds ratios for 31 of the 36 SNPs were directionally-consistent with those observed in Europeans (p = 3.2x10(-6)). Allelic odds ratios and risk allele frequencies in Sri Lankan subjects were not systematically different to those reported in Europeans. Genetic risk score and risk of T2D were strongly related in Sri Lankans (per allele OR 1.10 [95%CI 1.08-1.13], p = 1.2x10(-17)). Conclusion: Our data indicate that most T2D-risk variants identified in Europeans have similar effects in South Asians from Sri Lanka, and that systematic difference in common variant associations are unlikely to explain inter-ethnic differences in prevalence or presentation of T2D.	[Hassanali, Neelam; Robertson, Neil; Rayner, N. William; Barrett, Amy; Bennett, Amanda J.; Groves, Christopher J.; Matthews, David R.; Katulanda, Prasad; McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [De Silva, N. Maneka G.; Frayling, Timothy M.] Univ Exeter, Sch Med, Exeter, Devon, England; [Robertson, Neil; Rayner, N. William; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Matthews, David R.] Univ Oxford, Harris Manchester Coll, Oxford, England; [Katulanda, Prasad] Univ Colombo, Dept Clin Med, Fac Med, Colombo, Sri Lanka; [McCarthy, Mark I.] Churchill Hosp, Oxford Natl Inst Hlth Res Biomed Res Ctr, Oxford OX3 7LJ, England	University of Oxford; University of Exeter; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Colombo; University of Oxford	McCarthy, MI (corresponding author), Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England.	mark.mccarthy@drl.ox.ac.uk	McCarthy, Mark/M-3763-2015	McCarthy, Mark/0000-0002-4393-0510; Katulanda, Prasad/0000-0003-4313-7528; bennett, amanda/0000-0003-2140-8710	Diabetes UK [09/0003943]; European Commission [ENGAGE: HEALTH-F4-2007-201413]; Diabetes UK PhD studentship award; National Science Foundation of Sri Lanka, the NIHR Biomedical Research Centre and the Sri Lanka Young Diabetes study group; National Institute for Health Research [NF-SI-0611-10099] Funding Source: researchfish	Diabetes UK(Diabetes UK); European Commission(European CommissionEuropean Commission Joint Research Centre); Diabetes UK PhD studentship award; National Science Foundation of Sri Lanka, the NIHR Biomedical Research Centre and the Sri Lanka Young Diabetes study group; National Institute for Health Research(National Institute for Health Research (NIHR))	The authors acknowledge the support provided by Diabetes UK (09/0003943) and by the European Commission (ENGAGE: HEALTH-F4-2007-201413). NH is funded by a Diabetes UK PhD studentship award. Collection of the SLYDS and SLDCS cohorts were supported by (The National Science Foundation of Sri Lanka, the NIHR Biomedical Research Centre and the Sri Lanka Young Diabetes study group). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Chauhan G, 2010, DIABETES, V59, P2068, DOI 10.2337/db09-1386; Chidambaram M, 2010, METABOLISM, V59, P1760, DOI 10.1016/j.metabol.2010.04.024; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gloyn AL, 2004, J CLIN ENDOCR METAB, V89, P3932, DOI 10.1210/jc.2004-0568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gujral UP, 2013, ANN NY ACAD SCI, V1281, P51, DOI 10.1111/j.1749-6632.2012.06838.x; Jayawardena R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-380; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Katulanda P, 2008, DIABETIC MED, V25, P1062, DOI 10.1111/j.1464-5491.2008.02523.x; Katulanda P, 2008, DIABETOLOGIA, V51, P1368, DOI 10.1007/s00125-008-1052-6; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Lin X, 2009, DIABETOLOGIA, V52, P600, DOI 10.1007/s00125-008-1254-y; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Palmer ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029202; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rees SD, 2011, DIABETOLOGIA, V54, P1368, DOI 10.1007/s00125-011-2063-2; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Sanghera DK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-59; Saxena R, 2013, DIABETES, V62, P1746, DOI 10.2337/db12-1077; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tabassum R, 2013, DIABETES, V62, P977, DOI 10.2337/db12-0406; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Waters KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001078; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98608	10.1371/journal.pone.0098608	http://dx.doi.org/10.1371/journal.pone.0098608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926958	gold, Green Published, Green Submitted			2022-12-25	WOS:000338278100018
J	Oh, CM; Park, S; Lee, JY; Won, YJ; Shin, A; Kong, HJ; Choi, KS; Lee, YJ; Chung, KW; Jung, KW				Oh, Chang-Mo; Park, Sohee; Lee, Joo Young; Won, Young-Joo; Shin, Aesun; Kong, Hyun-Joo; Choi, Kui-Sun; Lee, You Jin; Chung, Ki-Wook; Jung, Kyu-Won			Increased Prevalence of Chronic Lymphocytic Thyroiditis in Korean Patients with Papillary Thyroid Cancer	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; HASHIMOTOS-THYROIDITIS; UNITED-STATES; IODINE INTAKE; CARCINOMA; TRENDS; RISK; TIME; MICROCARCINOMA; EPIDEMIOLOGY	Background: In recent years, some reports have suggested that papillary thyroid cancers are more frequently associated with lymphocytic thyroiditis or Hashimoto's thyroiditis. This study investigated a potential increase in the prevalence of chronic lymphocytic thyroiditis among papillary thyroid cancer patients. Materials and Methods: We used national epidemiological survey data on thyroid cancer patients diagnosed in 1999, 2005, and 2008. A retrospective medical record survey was conducted by representative sampling of a national cancer incidence database. The analysis included 5,378 papillary thyroid cancer patients aged 20-79 years. We calculated the age-standardized prevalence and age-adjusted prevalence ratios using a binomial regression model with a log link for the prevalence of chronic lymphocytic thyroiditis among papillary thyroid cancer patients by sex for each year. Results: The prevalence of chronic lymphocytic thyroiditis among papillary thyroid cancer patients was 4.0% and 12.8% for men and women in 1999, 6.5% and 24.6% in 2005, and 10.7% and 27.6% in 2008, respectively. Between 1999 and 2008, the age-standardized prevalence of chronic lymphocytic thyroiditis increased 4.1-fold in male patients and 2.0-fold in female patients with papillary thyroid cancer. The prevalence of other thyroid diseases, however, did not increase in either gender. Conclusions: Among Korean papillary thyroid cancer patients, the prevalence of chronic lymphocytic thyroiditis increased between 1999 and 2008, whereas the prevalence of other thyroid disorders did not change.	[Oh, Chang-Mo; Won, Young-Joo; Kong, Hyun-Joo; Choi, Kui-Sun; Jung, Kyu-Won] Natl Canc Ctr, Natl Canc Control Inst, Goyang, South Korea; [Park, Sohee] Yonsei Univ, Grad Sch Publ Hlth, Dept Epidemiol & Hlth Promot, Seoul 120749, South Korea; [Lee, Joo Young] Natl Med Ctr, Natl Emergency Med Ctr, Seoul, South Korea; [Shin, Aesun] Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Lee, You Jin] Natl Canc Ctr, Ctr Thyroid Canc, Goyang, South Korea; [Chung, Ki-Wook] Asan Med Ctr, Dept Surg, Div Endocrine Surg, Seoul, South Korea	National Cancer Center - Korea (NCC); Yonsei University; Yonsei University Health System; National Medical Center - Korea; Seoul National University (SNU); National Cancer Center - Korea (NCC); University of Ulsan; Asan Medical Center	Jung, KW (corresponding author), Natl Canc Ctr, Natl Canc Control Inst, Goyang, South Korea.	ara@ncc.re.kr	Shin, Aesun/E-9145-2014	Shin, Aesun/0000-0002-6426-1969	National Cancer Center Grant [NCC-1310220]	National Cancer Center Grant	This work was supported by a National Cancer Center Grant (NCC-1310220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benvenga S, 2008, THYROID, V18, P429, DOI 10.1089/thy.2007.0234; Blomberg M, 2012, INT J CANCER, V131, P2360, DOI 10.1002/ijc.27497; Caturegli P, 2013, THYROID, V23, P142, DOI 10.1089/thy.2012.0554; Cho BY, 2013, THYROID, V23, P797, DOI 10.1089/thy.2012.0329; Chow SM, 2003, CANCER-AM CANCER SOC, V98, P31, DOI 10.1002/cncr.11442; Cibas ES, 2009, THYROID, V19, P1159, DOI 10.1089/thy.2009.0274; Cunha LL, 2011, J THROID RES, V2011, DOI 10.4061/2011/387062; Curado MP, 2007, IARC SCI PUBLICATION, VIX; Dong WW, 2013, MED SCI MONITOR, V19, P49, DOI 10.12659/MSM.883736; Elisei R, 2010, J CLIN ENDOCR METAB, V95, P1516, DOI 10.1210/jc.2009-1536; Enewold L, 2009, CANCER EPIDEM BIOMAR, V18, P784, DOI 10.1158/1055-9965.EPI-08-0960; Feldt-Rasmussen U, 2010, HORM-INT J ENDOCRINO, V9, P109, DOI 10.14310/horm.2002.1261; Ferlay JSI, 2013, GLOBOCAN 2012 V1 0 C; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Grodski S, 2008, SURGERY, V144, P1038, DOI 10.1016/j.surg.2008.08.023; Harach HR, 2002, ENDOCR PATHOL, V13, P175, DOI 10.1385/EP:13:3:175; Jung KW, 2013, CANCER RES TREAT, V45, P15, DOI 10.4143/crt.2013.45.1.15; Kilfoy BA, 2009, CANCER CAUSE CONTROL, V20, P525, DOI 10.1007/s10552-008-9260-4; Kim JY, 1998, YONSEI MED J, V39, P355, DOI 10.3349/ymj.1998.39.4.355; Kim YS, 2013, J KOREAN SURG SOC, V85, P20, DOI 10.4174/jkss.2013.85.1.20; Konturek A, 2014, LANGENBECK ARCH SURG, V399, P229, DOI 10.1007/s00423-013-1158-2; Korea Centers for Disease Control and Prevention, 2012, KOR NAT HLTH NUTR EX; Kwak JY, 2008, THYROID, V18, P609, DOI 10.1089/thy.2007.0345; Lee JH, 2013, EUR J ENDOCRINOL, V168, P343, DOI 10.1530/EJE-12-0903; Leese GP, 2008, CLIN ENDOCRINOL, V68, P311, DOI 10.1111/j.1365-2265.2007.03051.x; Li N, 2013, THYROID, V23, P103, DOI 10.1089/thy.2012.0392; Loh KC, 1999, J CLIN ENDOCR METAB, V84, P458, DOI 10.1210/jc.84.2.458; Michikawa T, 2012, EUR J CANCER PREV, V21, P254, DOI 10.1097/CEJ.0b013e32834a8042; Morris LGT, 2013, THYROID, V23, P886, DOI 10.1089/thy.2013.0045; Morris LGT, 2010, AM J SURG, V200, P454, DOI 10.1016/j.amjsurg.2009.11.008; Oh CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072012; Pagano L, 2012, ENDOCRINE, V42, P382, DOI 10.1007/s12020-012-9612-4; Peterson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029177; Rego-Iraeta A, 2009, THYROID, V19, P333, DOI 10.1089/thy.2008.0210; Repplinger D, 2008, J SURG RES, V150, P49, DOI 10.1016/j.jss.2007.09.020; Teng WP, 2006, NEW ENGL J MED, V354, P2783, DOI 10.1056/NEJMoa054022; The Korea Central Cancer Registry NCC, 2012, ANN REP CANC STAT KO; Thompson ML, 1998, OCCUP ENVIRON MED, V55, P272, DOI 10.1136/oem.55.4.272; Zhumadilov Z, 2000, J RADIAT RES, V41, P35, DOI 10.1269/jrr.41.35	39	14	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99054	10.1371/journal.pone.0099054	http://dx.doi.org/10.1371/journal.pone.0099054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927027	gold, Green Published, Green Submitted			2022-12-25	WOS:000338278100027
J	Zhang, C; Casas-Tinto, S; Li, G; Lin, N; Chung, M; Moreno, E; Moberg, KH; Zhou, L				Zhang, C.; Casas-Tinto, S.; Li, G.; Lin, N.; Chung, M.; Moreno, E.; Moberg, K. H.; Zhou, L.			An intergenic regulatory region mediates Drosophila Myc-induced apoptosis and blocks tissue hyperplasia	ONCOGENE			English	Article							C-MYC; CELL-DEATH; ORGAN SIZE; MELANOGASTER; GENES; P53; LYMPHOMAGENESIS; EXPRESSION; ELEMENT; DAMAGE	Induction of cell-autonomous apoptosis following oncogene-induced overproliferation is a major tumor-suppressive mechanism in vertebrates. However, the detailed mechanism mediating this process remains enigmatic. In this study, we demonstrate that dMyc-induced cell-autonomous apoptosis in the fruit fly Drosophila melanogaster relies on an intergenic sequence termed the IRER (irradiation-responsive enhancer region). The IRER mediates the expression of surrounding proapoptotic genes, and we use an in vivo reporter of the IRER chromatin state to gather evidence that epigenetic control of DNA accessibility within the IRER is an important determinant of the strength of this response to excess dMyc. In a previous work, we showed that the IRER also mediates P53-dependent induction of proapoptotic genes following DNA damage, and the chromatin conformation within IRER is regulated by polycomb group-mediated histone modifications. dMyc-induced apoptosis and the P53-mediated DNA damage response thus overlap in a requirement for the IRER. The epigenetic mechanisms controlling IRER accessibility appear to set thresholds for the P53- and dMyc-induced expression of apoptotic genes in vivo and may have a profound impact on cellular sensitivity to oncogene-induced stress.	[Zhang, C.; Li, G.; Lin, N.; Chung, M.; Zhou, L.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Zhang, C.; Li, G.; Lin, N.; Chung, M.; Zhou, L.] Univ Florida, UF Shands Canc Ctr, Gainesville, FL 32610 USA; [Zhang, C.; Moberg, K. H.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA; [Casas-Tinto, S.] Spanish Res Council CSIC, Inst Cajal, Madrid, Spain; [Li, G.; Zhou, L.] Univ Florida, UF Genet Inst, Gainesville, FL 32610 USA; [Moreno, E.] Spanish Natl Canc Ctr CNIO, Mol Oncol Program, Madrid, Spain	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Emory University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); State University System of Florida; University of Florida; Centro Nacional de Investigaciones Oncologicas (CNIO)	Zhou, L (corresponding author), Univ Florida, Dept Mol Genet & Microbiol, 2033 Mowry Rd,Room 261, Gainesville, FL 32610 USA.	leizhou@ufl.edu	Casas-Tinto, Sergio/G-8220-2015; Li, Guangyao/I-8241-2015; Lin, Nianwei/AAD-9805-2019; Moberg, Ken/J-4849-2017	Casas-Tinto, Sergio/0000-0002-9589-9981; Li, Guangyao/0000-0003-0029-3854; Moberg, Ken/0000-0002-9820-5543; moreno, eduardo/0000-0001-5040-452X	NCI NIH HHS [R01 CA095542] Funding Source: Medline; NIGMS NIH HHS [R01 GM106174] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA095542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106174] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bellosta Paola, 2010, Genes Cancer, V1, P542; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Gallant P, 2009, ADV CANCER RES, V103, P111, DOI 10.1016/S0065-230X(09)03005-X; Gambis A, 2011, DEV BIOL, V351, P128, DOI 10.1016/j.ydbio.2010.12.040; Gilchrist AS, 1999, GENETICS, V153, P1775; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; HARRINGTON EA, 1994, EMBO J, V13, P3286, DOI 10.1002/j.1460-2075.1994.tb06630.x; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; HSU B, 1995, ONCOGENE, V11, P175; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Letai A, 2004, CANCER CELL, V6, P241, DOI 10.1016/j.ccr.2004.07.011; Lin NW, 2009, APOPTOSIS, V14, P935, DOI 10.1007/s10495-009-0360-8; Meyer N, 2006, SEMIN CANCER BIOL, V16, P275, DOI 10.1016/j.semcancer.2006.07.011; Montero L, 2008, GENESIS, V46, P104, DOI 10.1002/dvg.20373; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Scott CL, 2004, J CELL BIOL, V164, P89, DOI 10.1083/jcb.200310041; Steller H, 2008, CELL DEATH DIFFER, V15, P1132, DOI 10.1038/cdd.2008.50; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Sullivan W, 2000, DROSOPHILA PROTOCOLS, V1st; Tan Y, 2011, DEVELOPMENT, V138, P2197, DOI 10.1242/dev.058826; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Verghese S, 2012, CELL DEATH DIFFER, V19, P1664, DOI 10.1038/cdd.2012.48; Yamashita M, 2008, J EXP MED, V205, P1109, DOI 10.1084/jem.20072000; Zhang YP, 2008, DEV CELL, V14, P481, DOI 10.1016/j.devcel.2008.01.018; ZHOU L, 1995, CURR BIOL, V5, P784, DOI 10.1016/S0960-9822(95)00155-2	34	12	12	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 30	2015	34	18					2385	2397		10.1038/onc.2014.160	http://dx.doi.org/10.1038/onc.2014.160			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CH2AH	24931167	Green Accepted			2022-12-25	WOS:000353824800011
J	Strader, MB; Hicks, WA; Kassa, T; Singleton, E; Soman, J; Olson, JS; Weiss, MJ; Mollan, TL; Wilson, MT; Alayash, AI				Strader, Michael Brad; Hicks, Wayne A.; Kassa, Tigist; Singleton, Eileen; Soman, Jayashree; Olson, John S.; Weiss, Mitchell J.; Mollan, Todd L.; Wilson, Michael T.; Alayash, Abdu I.			Post-translational Transformation of Methionine to Aspartate Is Catalyzed by Heme Iron and Driven by Peroxide A NOVEL SUBUNIT-SPECIFIC MECHANISM IN HEMOGLOBIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUMMERER REARRANGEMENT; INTRAMOLECULAR CAPTURE; OXIDATION REACTIONS; HB-BRISTOL; BINDING; PROTEINS; ADULT; ALPHA; MYOGLOBIN; ANEMIA	A pathogenic V67M mutation occurs at the E11 helical position within the heme pockets of variant human fetal and adult hemoglobins (Hb). Subsequent post-translational modification of Met to Asp was reported in gamma subunits of human fetal Hb Toms River (gamma 67(E11) Val -> Met) and beta subunits of adult Hb (HbA) Bristol-Alesha (beta 67(E11) Val -> Met) that were associated with hemolytic anemia. Using kinetic, proteomic, and crystal structural analysis, we were able to show that the Met -> Asp transformation involves heme cycling through its oxoferryl state in the recombinant versions of both proteins. The conversion to Met and Asp enhanced the spontaneous autoxidation of the mutants relative to wild-type HbA and human fetal Hb, and the levels of Asp were elevated with increasing levels of hydrogen peroxide (H2O2). Using H-2 O-18(2), we verified incorporation of (18)Ointo the Asp carboxyl side chain confirming the role ofH(2)O(2) in the oxidation of the Met side chain. Under similar experimental conditions, there was no conversion to Asp at the alpha Met(E11) position in the correspondingHbAEvans (alpha 62(E11) Val -> Met). The crystal structures of the three recombinant Met(E11) mutants revealed similar thioether side chain orientations. However, asinthesolutionexperiments, autoxidationof theHbmutantcrystals leads to electron density maps indicative of Asp(E11) formation in beta subunits but not in alpha subunits. This novel post-translational modification highlights the nonequivalence of human Hb alpha, beta, and gamma subunits with respect to redox reactivity and may have direct implications to alpha/beta hemoglobinopathies and design of oxidatively stable Hb-based oxygen therapeutics.	[Mollan, Todd L.; Alayash, Abdu I.] US FDA, Lab Biochem & Vasc Biol, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; [Singleton, Eileen; Soman, Jayashree; Olson, John S.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Weiss, Mitchell J.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Wilson, Michael T.] Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England	US Food & Drug Administration (FDA); Rice University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Essex	Alayash, AI (corresponding author), US FDA, Lab Biochem & Vasc Biol, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA.	abdu.alayash@fda.hhs.gov	Weiss, Mitchell J/W-9814-2018	Weiss, Mitchell J/0000-0003-2460-3036; Olson, John/0000-0002-0760-5403	National Institutes of Health from NHLBI [P01-HL110900]; Welch Grant [C-0612]; United States Food and Drug Administration [MODSCI 2012, P30 DK090969, R01 DK61692]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099993, P01HL110900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061692, P30DK090969, R56DK061692] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Welch Grant; United States Food and Drug Administration; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-HL110900 from NHLBI (to A. I. A. and J. S. O.). This work was also supported by Welch Grant C-0612 (to J. S. O.) and United States Food and Drug Administration Grants MODSCI 2012 (to A. I. A.), P30 DK090969 (to M. J. W.), and R01 DK61692 (to M. J. W.).	Aebi H, 1984, Methods Enzymol, V105, P121; BANERJEE R, 1969, BIOCHEMISTRY-US, V8, P2862, DOI 10.1021/bi00835a025; BATES DK, 1986, J HETEROCYCLIC CHEM, V23, P695, DOI 10.1002/jhet.5570230311; BATES DK, 1992, J ORG CHEM, V57, P3094, DOI 10.1021/jo00037a027; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; BERZOFSKY JA, 1971, J BIOL CHEM, V246, P3367; Birukou I, 2011, J BIOL CHEM, V286, P10515, DOI 10.1074/jbc.M110.176271; Birukou I, 2010, J BIOL CHEM, V285, P8840, DOI 10.1074/jbc.M109.053934; Bonaventura C, 2013, ANTIOXID REDOX SIGN, V18, P2298, DOI 10.1089/ars.2012.4947; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; Buehler P.W., 2007, TRANSFUS ALTERN TRAN, V9, P204, DOI DOI 10.1111/j.1778-428X.2007.00081.x; Bunn HF, 1986, HEMOGLOBIN MOL GENET; Butt OI, 2011, AM J PATHOL, V178, P1316, DOI 10.1016/j.ajpath.2010.12.006; Cooper CE, 2005, DALTON T, P3483, DOI 10.1039/b505786h; Cooper CE, 2013, ANTIOXID REDOX SIGN, V18, P2264, DOI 10.1089/ars.2012.4547; Crowley MA, 2011, NEW ENGL J MED, V364, P1837, DOI 10.1056/NEJMoa1013579; FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521; Guengerich FP, 2007, J BIOCHEM MOL TOXIC, V21, P163, DOI 10.1002/jbt.20174; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; Hersleth HP, 2002, J BIOL INORG CHEM, V7, P299, DOI 10.1007/s007750100296; Jia YP, 2004, BBA-GEN SUBJECTS, V1672, P164, DOI 10.1016/j.bbagen.2004.03.009; JIANG ZY, 1990, FEBS LETT, V268, P69, DOI 10.1016/0014-5793(90)80974-N; Kowalik-Jankowska T, 2006, J INORG BIOCHEM, V100, P1623, DOI 10.1016/j.jinorgbio.2006.05.010; LEVINE RL, 1983, J BIOL CHEM, V258, P1828; Miyazaki A, 1996, J MASS SPECTROM, V31, P1311, DOI 10.1002/(SICI)1096-9888(199611)31:11<1311::AID-JMS427>3.0.CO;2-1; MOLCHANOVA TP, 1993, HEMOGLOBIN, V17, P217, DOI 10.3109/03630269308998896; Mollan TL, 2013, J BIOL CHEM, V288, P4288, DOI 10.1074/jbc.M112.412064; OHBA Y, 1985, HEMOGLOBIN, V9, P79, DOI 10.3109/03630268508996986; Reeder BJ, 2012, J AM CHEM SOC, V134, P7741, DOI 10.1021/ja211745g; Reeder BJ, 2010, ANTIOXID REDOX SIGN, V13, P1087, DOI 10.1089/ars.2009.2974; Reeder BJ, 2008, J BIOL CHEM, V283, P30780, DOI 10.1074/jbc.M804709200; Rees DC, 1996, BLOOD, V88, P341; REISBERG PI, 1980, J BIOL CHEM, V255, P4151; SAKURAGAWA M, 1984, ACTA HAEMATOL JAPON, V47, P896; SHEN TJ, 1993, P NATL ACAD SCI USA, V90, P8108, DOI 10.1073/pnas.90.17.8108; Shen TJ, 1997, PROTEIN ENG, V10, P1085, DOI 10.1093/protein/10.9.1085; Shikama K, 1998, CHEM REV, V98, P1357, DOI 10.1021/cr970042e; Slotta DJ, 2010, PROTEOMICS, V10, P3035, DOI 10.1002/pmic.200900370; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; STEADMAN JH, 1970, BRIT J HAEMATOL, V18, P435, DOI 10.1111/j.1365-2141.1970.tb01457.x; Thom CS, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011858; WIEDERMANN BL, 1975, J BIOL CHEM, V250, P5273; WILSON JB, 1989, HEMOGLOBIN, V13, P557, DOI 10.3109/03630268908993106; Yi J, 2011, ACTA CRYSTALLOGR F, V67, P647, DOI 10.1107/S1744309111012528; Zanotto MI, 2010, ARCH ARGENT PEDIATR, V108, pE130, DOI 10.1590/S0325-00752010000600015; Zurbriggen K, 2005, CLIN CHEM, V51, P989, DOI 10.1373/clinchem.2005.047985	48	24	25	2	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22342	22357		10.1074/jbc.M114.568980	http://dx.doi.org/10.1074/jbc.M114.568980			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24939847	Green Published, hybrid			2022-12-25	WOS:000340593500045
J	Boone, AN; Senatore, A; Chemin, J; Monteil, A; Spafford, JD				Boone, Adrienne N.; Senatore, Adriano; Chemin, Jean; Monteil, Arnaud; Spafford, J. David			Gd3+ and Calcium Sensitive, Sodium Leak Currents Are Features of Weak Membrane-Glass Seals in Patch Clamp Recordings	PLOS ONE			English	Article							KIDNEY HEK293 CELLS; HEK-293 CELLS; NEURONAL EXCITABILITY; CHANNELS; MICROSCOPY; GIGASEAL; ACTIVATION; MECHANISMS; PROTEINS; PIPETTES	The properties of leaky patch currents in whole cell recording of HEK-293T cells were examined as a means to separate these control currents from expressed sodium and calcium leak channel currents from snail NALCN leak channels possessing both sodium (EKEE) and calcium (EEEE) selectivity filters. Leak currents were generated by the weakening of gigaohm patch seals by artificial membrane rupture using the ZAP function on the patch clamp amplifier. Surprisingly, we found that leak currents generated from the weakened membrane/glass seal can be surprisingly stable and exhibit behavior that is consistent with a sodium leak current derived from an expressible channel. Leaky patch currents differing by 10 fold in size were similarly reduced in size when external sodium ions were replaced with the large monovalent ion NMDG(+). Leaky patch currents increased when external Ca2+ (1.2 mM) was lowered to 0.1 mM and were inhibited (>40% to >90%) with 10 mM Gd3+, 100 mu M La3+, 1 mM Co2+ or 1 mM Cd2+. Leaky patch currents were relatively insensitive (<30%) to 1 mM Ni2+ and exhibited a variable amount of block with 1 mM verapamil and were insensitive to 100 mu M mibefradil or 100 mu M nifedipine. We hypothesize that the rapid changes in leak current size in response to changing external cations or drugs relates to their influences on the membrane seal adherence and the electro-osmotic flow of mobile cations channeling in crevices of a particular pore size in the interface between the negatively charged patch electrode and the lipid membrane. Observed sodium leak conductance currents in weak patch seals are reproducible between the electrode glass interface with cell membranes, artificial lipid or Sylgard rubber.	[Boone, Adrienne N.; Senatore, Adriano; Spafford, J. David] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Chemin, Jean; Monteil, Arnaud] Univ Montpellier I, INSERM, CNRS, UMR 5203,Inst Genom Fonctionnelle,U661, Montpellier, France	University of Waterloo; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier	Spafford, JD (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	spafford@uwaterloo.ca	Monteil, Arnaud/G-3113-2012	Monteil, Arnaud/0000-0003-1632-7318; chemin, jean/0000-0002-6089-5964	Heart and Stroke Foundation; NSERC	Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors would like to thank the Heart and Stroke Foundation and NSERC Discovery Operating for operating grant funding to JDS. The authors thank an NSERC-MSFSS award for providing Adriano Senatore an opportunity to examine the functions of NALCN with the CNRS group including Dr. Monteil in Montpellier, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE N, 1994, JPN J PHYSIOL, V44, P433, DOI 10.2170/jjphysiol.44.433; Akinlaja J, 1998, BIOPHYS J, V75, P247, DOI 10.1016/S0006-3495(98)77511-3; [Anonymous], 1994, MICR TECHN PLYM WORK; [Anonymous], 2007, AX GUID EL BIOPH LAB; Bae C, 2011, BIOPHYS J, V101, P2645, DOI 10.1016/j.bpj.2011.11.002; Berjukow S, 1996, BRIT J PHARMACOL, V118, P748, DOI 10.1111/j.1476-5381.1996.tb15463.x; Cremer PS, 1999, J PHYS CHEM B, V103, P2554, DOI 10.1021/jp983996x; Gil Z, 1999, P NATL ACAD SCI USA, V96, P14594, DOI 10.1073/pnas.96.25.14594; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; He BJ, 2010, NEUROSCI LETT, V469, P268, DOI 10.1016/j.neulet.2009.12.012; Huang X, 2010, J EXP BIOL, V213, P2094, DOI 10.1242/jeb.042242; Jiang B, 2002, MOL CELL BIOCHEM, V238, P69, DOI 10.1023/A:1019907104763; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; Molleman A, 2002, PATCH CLAMPING INTRO; NEHER E, 1978, PFLUG ARCH EUR J PHY, V375, P219, DOI 10.1007/BF00584247; NINHAM BW, 1970, BIOPHYS J, V10, P646, DOI 10.1016/S0006-3495(70)86326-3; OPSAHL LR, 1994, BIOPHYS J, V66, P75, DOI 10.1016/S0006-3495(94)80752-0; Priel A, 2007, BIOPHYS J, V92, P3893, DOI 10.1529/biophysj.106.099119; Rasmussen M, 2008, AM J PHYSIOL-CELL PH, V294, pC197, DOI 10.1152/ajpcell.00268.2007; Ren DJ, 2011, NEURON, V72, P899, DOI 10.1016/j.neuron.2011.12.007; RUKNUDIN A, 1991, J CELL BIOL, V112, P125, DOI 10.1083/jcb.112.1.125; SACHS F, 1993, BIOPHYS J, V65, P1101, DOI 10.1016/S0006-3495(93)81149-4; Senatore A, 2011, JOVE-J VIS EXP, DOI 10.3791/2314; Senatore A, 2013, CHANNELS, V7, P60, DOI 10.4161/chan.23981; Senatore A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055088; Senatore A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037409; Senatore A, 2011, CHANNELS, V5, P173, DOI 10.4161/chan.5.2.15141; Senatore A, 2010, J BIOL CHEM, V285, P7447, DOI 10.1074/jbc.M109.090753; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; SOEJIMA M, 1984, PFLUG ARCH EUR J PHY, V400, P424, DOI 10.1007/BF00587544; SOKABE M, 1990, J CELL BIOL, V111, P599, DOI 10.1083/jcb.111.2.599; SOKABE M, 1991, BIOPHYS J, V59, P722, DOI 10.1016/S0006-3495(91)82285-8; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Varghese A, 2006, PROG BIOPHYS MOL BIO, V90, P26, DOI 10.1016/j.pbiomolbio.2005.05.002; Yu SP, 1998, J NEUROSCI RES, V52, P612, DOI 10.1002/(SICI)1097-4547(19980601)52:5<612::AID-JNR13>3.0.CO;2-3; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200	40	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e98808	10.1371/journal.pone.0098808	http://dx.doi.org/10.1371/journal.pone.0098808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945283	gold, Green Published, Green Submitted			2022-12-25	WOS:000340721500007
J	Dolega, ME; Wagh, J; Gerbaud, S; Kermarrec, F; Alcaraz, JP; Martin, DK; Gidrol, X; Picollet-D'hahan, N				Dolega, Monika E.; Wagh, Jayesh; Gerbaud, Sophie; Kermarrec, Frederique; Alcaraz, Jean-Pierre; Martin, Donald K.; Gidrol, Xavier; Picollet-D'hahan, Nathalie			Facile Bench-Top Fabrication of Enclosed Circular Microchannels Provides 3D Confined Structure for Growth of Prostate Epithelial Cells	PLOS ONE			English	Article							IN-VITRO; MORPHOGENESIS; POLYELECTROLYTE; MORPHOLOGY; SECRETION; FORCES; PDMS	We present a simple bench-top method to fabricate enclosed circular channels for biological experiments. Fabricating the channels takes less than 2 hours by using glass capillaries of various diameters (from 100 mm up to 400 mm) as a mould in PDMS. The inner surface of microchannels prepared in this way was coated with a thin membrane of either Matrigel or a layer-by-layer polyelectrolyte to control cellular adhesion. The microchannels were then used as scaffolds for 3D-confined epithelial cell culture. To show that our device can be used with several epithelial cell types from exocrine glandular tissues, we performed our biological studies on adherent epithelial prostate cells (non-malignant RWPE-1 and invasive PC3) and also on breast (non-malignant MCF10A) cells We observed that in static conditions cells adhere and proliferate to form a confluent layer in channels of 150 mu m in diameter and larger, whereas cellular viability decreases with decreasing diameter of the channel. Matrigel and PSS (poly (sodium 4-styrenesulphonate)) promote cell adhesion, whereas the cell proliferation rate was reduced on the PAH (poly (allylamine hydrochloride))-terminated surface. Moreover infusing channels with a continuous flow did not induce any cellular detachment. Our system is designed to simply grow cells in a microchannel structure and could be easily fabricated in any biological laboratory. It offers opportunities to grow epithelial cells that support the formation of a light. This system could be eventually used, for example, to collect cellular secretions, or study cell responses to graduated hypoxia conditions, to chemicals (drugs, siRNA, ...) and/or physiological shear stress.	[Dolega, Monika E.; Wagh, Jayesh; Gerbaud, Sophie; Kermarrec, Frederique; Gidrol, Xavier; Picollet-D'hahan, Nathalie] Univ Grenoble Alpes, iRTSV BGE, Grenoble, France; [Dolega, Monika E.; Wagh, Jayesh; Gerbaud, Sophie; Kermarrec, Frederique; Gidrol, Xavier; Picollet-D'hahan, Nathalie] CEA, iRTSV BGE, Grenoble, France; [Dolega, Monika E.; Wagh, Jayesh; Gerbaud, Sophie; Kermarrec, Frederique; Gidrol, Xavier; Picollet-D'hahan, Nathalie] INSERM, BGE, Grenoble, France; [Alcaraz, Jean-Pierre; Martin, Donald K.] UJF Grenoble 1, CNRS, TIMC IMAG UMR SyNaBi 5525, Grenoble, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Picollet-D'hahan, N (corresponding author), Univ Grenoble Alpes, iRTSV BGE, Grenoble, France.	nathalie.picollet-dhahan@cea.fr	ALCARAZ, jean-pierre/M-6821-2014	ALCARAZ, jean-pierre/0000-0002-5924-9519; Gidrol, Xavier/0000-0002-4233-3749; Dolega, Monika/0000-0003-2081-4709; Picollet-D'hahan, Nathalie/0000-0001-6307-9180; Martin, Donald/0000-0001-5913-2372	French Agence Nationale pour la Recherche [ANR-11-BSV5-009]; CEA IRTELIS international PhD program	French Agence Nationale pour la Recherche(French National Research Agency (ANR)); CEA IRTELIS international PhD program	This research was funded by a grant from the French Agence Nationale pour la Recherche (ANR-11-BSV5-009) and supported by the CEA IRTELIS international PhD program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgawad M, 2011, LAB CHIP, V11, P545, DOI [10.1039/c0lc00093k, 10.1039/c01c00093k]; Bledi Y, 2000, BRAIN RES PROTOC, V5, P282, DOI 10.1016/S1385-299X(00)00024-6; Brown L, 2006, LAB CHIP, V6, P66, DOI 10.1039/b512179e; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Decher G, 1992, THIN SOLID FILMS; Deshiere A, 2013, ONCOGENE, V32, P1373, DOI 10.1038/onc.2012.165; Dhir V, 2009, BIOTECHNOL PROGR, V25, P594, DOI 10.1002/btpr.150; Dolega ME, 2013, BIOSENS BIOELECTRON, V49, P176, DOI 10.1016/j.bios.2013.05.001; Dolega ME, 2012, LAB CHIP, V12, P4022, DOI 10.1039/c2lc40174f; Fiddes LK, 2010, BIOMATERIALS, V31, P3459, DOI 10.1016/j.biomaterials.2010.01.082; Glass NR, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3625605; Godugu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053708; Golden AP, 2007, LAB CHIP, V7, P720, DOI 10.1039/b618409j; Hebner C, 2008, ANNU REV PATHOL-MECH, V3, P313, DOI 10.1146/annurev.pathmechdis.3.121806.151526; Huang NT, 2012, LAB CHIP, V12, P4093, DOI 10.1039/c2lc40619e; Jia YF, 2008, CHINESE SCI BULL, V53, P3928, DOI 10.1007/s11434-008-0528-6; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Mailleux AA, 2008, CELL CYCLE, V7, P57, DOI 10.4161/cc.7.1.5150; Martin PM, 1998, P MICR ENG SANT CLAR, V41/42, P493; McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q; Nicotera TM, 2009, PROSTATE, V69, P1270, DOI 10.1002/pros.20968; Park JY, 2012, SENSOR ACTUAT B-CHEM, V173, P765, DOI 10.1016/j.snb.2012.06.096; Perry H, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2719626; Picollet-D'hahan N, 2013, BIOMATERIALS, V34, P10099, DOI 10.1016/j.biomaterials.2013.08.093; Price GM, 2011, METHODS MOL BIOL, V671, P281, DOI 10.1007/978-1-59745-551-0_17; Rao N, 2013, BIOMED MICRODEVICES, V15, P161, DOI 10.1007/s10544-012-9709-9; Riha GM, 2005, ANN BIOMED ENG, V33, P772, DOI 10.1007/s10439-005-3310-9; Shevkoplyas SS, 2003, MICROVASC RES, V65, P132, DOI 10.1016/S0026-2862(02)00034-1; Song JW, 2011, P NATL ACAD SCI USA, V108, P15342, DOI 10.1073/pnas.1105316108; Su YX, 2013, CARBOHYD POLYM, V92, P2245, DOI 10.1016/j.carbpol.2012.12.003; Ting JHY, 2010, IET NANOBIOTECHNOL, V4, P77, DOI 10.1049/iet-nbt.2009.0016; Ting JHY, 2008, THESIS U TECHNOLOGY; Verma MKS, 2006, LANGMUIR, V22, P10291, DOI 10.1021/la062516n; Vidi Pierre-Alexandre, 2013, Methods Mol Biol, V945, P193, DOI 10.1007/978-1-62703-125-7_13; Webber MM, 1997, CARCINOGENESIS, V18, P1225, DOI 10.1093/carcin/18.6.1225; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wilson ME, 2011, LAB CHIP, V11, P1550, DOI 10.1039/c0lc00561d; Wong KHK, 2012, ANNU REV BIOMED ENG, V14, P205, DOI [10.1146/annurev-bioeng-071811-150052, 10.1146/annurev.bioeng-071811-150052]	38	20	20	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99416	10.1371/journal.pone.0099416	http://dx.doi.org/10.1371/journal.pone.0099416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945245	gold, Green Published, Green Submitted			2022-12-25	WOS:000340721500018
J	Read, TC; Wantiez, L; Werry, JM; Farman, R; Petro, G; Limpus, CJ				Read, Tyffen C.; Wantiez, Laurent; Werry, Jonathan M.; Farman, Richard; Petro, George; Limpus, Colin J.			Migrations of Green Turtles (Chelonia mydas) between Nesting and Foraging Grounds across the Coral Sea	PLOS ONE			English	Article							LONG-DISTANCE MIGRATION; POPULATION-MODEL; CARETTA-CARETTA; SATELLITE; MITOCHONDRIAL; ISLAND; POLYMORPHISMS; HYPOTHESIS; PATTERNS; BEHAVIOR	Marine megafauna tend to migrate vast distances, often crossing national borders and pose a significant challenge to managers. This challenge is particularly acute in the Pacific, which contains numerous small island nations and thousands of kilometers of continental margins. The green sea turtle, Chelonia mydas, is one such megafauna that is endangered in Pacific waters due to the overexploitation of eggs and adults for human consumption. Data from long-term tagging programs in Queensland (Australia) and New Caledonia were analysed to investigate the migrations by C. mydas across the Coral Sea between their nesting site and their feeding grounds. A review of data collected over the last 50 years by different projects identified multiple migrations of C. mydas to and from New Caledonia (n = 97) and indicate that turtles foraging in New Caledonia nest in the Great Barrier Reef (Australia) and vice versa. Several explanations exist for turtles exhibiting this energetically costly movement pattern from breeding to distant foraging grounds (1200-2680 km away) despite viable foraging habitat being available in the local vicinity. These include hatchling drift, oceanic movements and food abundance predictability. Most of the tag recoveries in New Caledonia belonged to females from the south Great Barrier Reef genetic stock. Some females (n = 2) even showed fidelity to foraging sites located 1200 km away from the nesting site located in New Caledonia. This study also reveals previously unknown migrations pathways of turtles within the Coral Sea.	[Read, Tyffen C.; Farman, Richard] Aquarium des Lagons, Lab Marine Biol & Ecol, Noumea, New Caledonia; [Wantiez, Laurent] Univ Nouvelle Caledonie, LIVE EA4243, Noumea, New Caledonia; [Read, Tyffen C.; Werry, Jonathan M.] Griffith Univ, Griffith Ctr Coastal Management, Nathan, Qld 4111, Australia; [Werry, Jonathan M.] Ocean & Coast Res, Main Beach, Qld, Australia; [Petro, George] Wan Smolbag Theatre, Port Vila, Vanuatu; [Limpus, Colin J.] Queensland Govt, Dept Environm & Heritage Protect, Threatened Species Unit, Brisbane, Qld, Australia	Universite Nouvelle Caledonie; Griffith University	Read, TC (corresponding author), Aquarium des Lagons, Lab Marine Biol & Ecol, Noumea, New Caledonia.	tyffen.read@aquarium.nc	Wantiez, Laurent/L-3343-2013	Wantiez, Laurent/0000-0001-5024-2057; Read, Tyffen/0000-0002-4385-0043	Environmental Advisory Customary Committee (CCCE); Vale Inco through the Biodiversity Convention signed with the Southern Province of New Caledonia; Southern Province of NC	Environmental Advisory Customary Committee (CCCE); Vale Inco through the Biodiversity Convention signed with the Southern Province of New Caledonia; Southern Province of NC	This research is funded by the Environmental Advisory Customary Committee (CCCE) and Vale Inco through the Biodiversity Convention signed with the Southern Province of New Caledonia. It takes place in the framework of a PhD from Griffith University jointly supervised by the University of New Caledonia and the Aquarium of the Lagoons. The Southern Province of NC granted a scholarship for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson S, 2007, BIOSCIENCE, V57, P123, DOI 10.1641/B570207; [Anonymous], 1980, TAGGING REARING GREE; Balazs G, 1994, SATELLITE TELEMETRY, P184; BALAZS G H, 1976, Biological Conservation, V9, P125, DOI 10.1016/0006-3207(76)90045-8; Balazs G.H., 1992, P 12 ANN WORKSHOP SE; Bass AL, 2006, J HERED, V97, P346, DOI 10.1093/jhered/esl004; Benson SR, 2007, CHELONIAN CONSERV BI, V6, P7, DOI 10.2744/1071-8443(2007)6[7:BUIMAM]2.0.CO;2; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; BOWEN BW, 1992, EVOLUTION, V46, P865, DOI 10.1111/j.1558-5646.1992.tb00605.x; Boyle MC, 2009, P R SOC B, V276, P1993, DOI 10.1098/rspb.2008.1931; Broderick AC, 2007, P ROY SOC B-BIOL SCI, V274, P1533, DOI 10.1098/rspb.2007.0211; CARR A, 1986, BIOSCIENCE, V36, P92, DOI 10.2307/1310109; CARR A, 1975, COPEIA, P547; CARR AF, 1967, SO EXCELLENT FISHE N; Chaloupka M, 2004, CORAL REEFS, V23, P325, DOI 10.1007/s00338-004-0387-9; Cheng IJ, 2000, MAR BIOL, V137, P747, DOI 10.1007/s002270000375; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Craig P, 2004, BIOL CONSERV, V116, P433, DOI 10.1016/S0006-3207(03)00217-9; Craig Peter, 1994, Marine Turtle Newsletter, V66, P7; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; Dethmers KEM, 2006, MOL ECOL, V15, P3931, DOI 10.1111/j.1365-294X.2006.03070.x; Dethmers KEM, 2010, MAR FRESHWATER RES, V61, P1376, DOI 10.1071/MF10084; Dutton P, 2002, P W PAC SEA TURTL CO, P93; FitzSimmons NN, 1997, P NATL ACAD SCI USA, V94, P8912, DOI 10.1073/pnas.94.16.8912; FitzSimmons NN, 1997, GENETICS, V147, P1843; Freake MJ, 2006, Q REV BIOL, V81, P327, DOI 10.1086/511528; Girard C, 2006, MAR ECOL PROG SER, V322, P281, DOI 10.3354/meps322281; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Hamann M, 2002, J COMP PHYSIOL B, V172, P485, DOI [10.1002/s00360-002-0271-2, 10.1007/s00360-002-0271-2]; Hays GC, 2002, ANIM BEHAV, V64, P895, DOI 10.1006/anbe.2002.1975; Hays GC, 2013, FUNCT ECOL, V27, P748, DOI 10.1111/1365-2435.12073; Hays GC, 2010, CONSERV BIOL, V24, P1636, DOI 10.1111/j.1523-1739.2010.01531.x; Hays GC, 2010, J R SOC INTERFACE, V7, P1319, DOI 10.1098/rsif.2010.0009; Heppell SS, 1996, WILDLIFE RES, V23, P143, DOI 10.1071/WR9960143; Hirth HF., 1997, US FISH WILDLIFE SER; IUCN, 2010, IUCN 2010 IUCN RED L; KOCH AL, 1969, J THEOR BIOL, V22, P163, DOI 10.1016/0022-5193(69)90085-X; Lahanas PN, 1998, MAR BIOL, V130, P345, DOI 10.1007/s002270050254; Limpus C., 2009, BIOL REV AUSTR MARIN; Limpus C.J., 1985, P343; LIMPUS CJ, 1992, WILDLIFE RES, V19, P347, DOI 10.1071/WR9920347; LIMPUS CJ, 1992, WILDLIFE RES, V19, P457, DOI 10.1071/WR9920457; Limpus CJ, 1984, CAPRICORNIA SECTION, P61; Limpus CJ, 2002, P 20 ANN S SEA TURTL, P132; Limpus CJ, 1994, MEMOIRS QUEENSLAND M, P139; LIMPUS CJ, 2005, MONITORING GREEN TUR, P1; Limpus CJ, 1989, FORAGE AREA FIDELITY, P97; Limpus Colin J., 2003, Memoirs of the Queensland Museum, V49, P349; Limpus Colin J., 2009, Marine Turtle Newsletter, P3; Lohmann KJ, 2006, INTEGR COMP BIOL, V46, pE86; Lohmann KJ, 2008, P NATL ACAD SCI USA, V105, P19096, DOI 10.1073/pnas.0801859105; Luschi P, 1998, P ROY SOC B-BIOL SCI, V265, P2279, DOI 10.1098/rspb.1998.0571; Luschi P, 1996, J COMP PHYSIOL A, V178, P447; Luschi P, 2007, CURR BIOL, V17, P126, DOI 10.1016/j.cub.2006.11.062; MEYLAN AB, 1990, SCIENCE, V248, P724, DOI 10.1126/science.2333522; Meylan AB., 1982, BIOL CONSERVATION SE, P91; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Moritz C, 2002, POPULATION GENETICS, P1; MORTIMER JA, 1989, COPEIA, P962; MORTIMER JA, 1987, COPEIA, P103, DOI 10.2307/1446043; NORDENG H, 1977, OIKOS, V28, P155, DOI 10.2307/3543965; NORMAN JA, 1994, MOL ECOL, V3, P363, DOI 10.1111/j.1365-294X.1994.tb00076.x; PAPI F, 1995, MAR BIOL, V122, P171, DOI 10.1007/BF00348929; Pendoley KL, 2014, MAR BIOL, V161, P1455, DOI 10.1007/s00227-014-2433-7; Read TC, 2012, RECIFS DENTRECASTEAU, P1; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schofield G., 2007, ENDANGER SPECIES RES, V3, P71, DOI DOI 10.1111/J.1467-2979.2000.00019.X; Schofield G, 2007, MAR ECOL PROG SER, V336, P267, DOI 10.3354/meps336267; Seminoff Jeffrey A., 2008, Endangered Species Research, V4, P57, DOI 10.3354/esr00066; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Southwood A, 2010, J COMP PHYSIOL B, V180, P1, DOI 10.1007/s00360-009-0415-8; Troeng S, 2005, BIOL CONSERV, V121, P111, DOI 10.1016/j.biocon.2004.04.014; Ward HB, 1921, ECOLOGY, V2, P235, DOI 10.2307/1928977; Werry JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083249; WHITTOW GC, 1982, PAC SCI, V36, P129	75	25	28	2	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100083	10.1371/journal.pone.0100083	http://dx.doi.org/10.1371/journal.pone.0100083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940598	Green Published, gold, Green Submitted			2022-12-25	WOS:000338508200072
J	Dwivedi, P; Khanna, M				Dwivedi, Puneet; Khanna, Madhu			Abatement Cost of GHG Emissions for Wood-Based Electricity and Ethanol at Production and Consumption Levels	PLOS ONE			English	Article							LIFE-CYCLE ASSESSMENT; WILLOW BIOMASS; UNITED-STATES; DILUTE-ACID; CARBON; GASIFICATION; PROFITABILITY; PLANTATIONS; BIOETHANOL; ECONOMICS	Woody feedstocks will play a critical role in meeting the demand for biomass-based energy products in the US. We developed an integrated model using comparable system boundaries and common set of assumptions to ascertain unit cost and greenhouse gas (GHG) intensity of electricity and ethanol derived from slash pine (Pinus elliottii) at the production and consumption levels by considering existing automobile technologies. We also calculated abatement cost of greenhouse gas (GHG) emissions with respect to comparable energy products derived from fossil fuels. The production cost of electricity derived using wood chips was at least cheaper by 1 (sic)MJ(-1) over electricity derived from wood pellets. The production cost of ethanol without any income from cogenerated electricity was costlier by about 0.7 (sic)MJ(-1) than ethanol with income from cogenerated electricity. The production cost of electricity derived from wood chips was cheaper by at least 0.7 (sic)MJ(-1) than the energy equivalent cost of ethanol produced in presence of cogenerated electricity. The cost of using ethanol as a fuel in a flex-fuel vehicle was at least higher by 6 (sic)km(-1) than a comparable electric vehicle. The GHG intensity of per km distance traveled in a flex-fuel vehicle was greater or lower than an electric vehicle running on electricity derived from wood chips depending on presence and absence of GHG credits related with co-generated electricity. A carbon tax of at least $7 Mg CO(2)e(-1) and $30 Mg CO(2)e(-1) is needed to promote wood-based electricity and ethanol production in the US, respectively. The range of abatement cost of GHG emissions is significantly dependent on the harvest age and selected baseline especially for electricity generation.	[Dwivedi, Puneet] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Khanna, Madhu] Univ Illinois, Energy Biosci Inst, Urbana, IL USA	University System of Georgia; University of Georgia; University of Illinois System; University of Illinois Urbana-Champaign	Dwivedi, P (corresponding author), Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	puneetdwivedi@gmail.com		Dwivedi, Puneet/0000-0001-6272-7473	Energy Biosciences Institute at the University of Illinois at Urbana-Champaign/University of California, Berkeley	Energy Biosciences Institute at the University of Illinois at Urbana-Champaign/University of California, Berkeley	The authors are thankful to the funding support provided by the Energy Biosciences Institute at the University of Illinois at Urbana-Champaign/University of California, Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt KL, 2012, FOREST SCI, V58, P523, DOI 10.5849/forsci.11-055; [Anonymous], 2013, AM REN; Bridgwater AV, 2002, RENEW SUST ENERG REV, V6, P181, DOI 10.1016/S1364-0321(01)00010-7; Budsberg E, 2012, FOREST PROD J, V62, P305; Campbell JE, 2009, SCIENCE, V324, P1055, DOI 10.1126/science.1168885; Daigneault A, 2012, ENVIRON SCI TECHNOL, V46, P5664, DOI 10.1021/es2030142; Davis SC, 2012, FORESTS, V3, P370, DOI 10.3390/f3020370; Daystar J, 2012, FOREST PROD J, V62, P314; DSIRE, 2013, DAT STAT INC REN EFF; Dwivedi P, 2012, BIOENERG RES, V5, P470, DOI 10.1007/s12155-012-9179-1; Dwivedi P, 2011, BIOENERG RES, V4, P180, DOI 10.1007/s12155-010-9111-5; Dwivedi P, 2009, CAN J FOREST RES, V39, P990, DOI 10.1139/X09-023; EERE, 2013, ALT FUELS DAT CTR VE; Gonzalez R, 2011, BIOMASS BIOENERG, V35, P767, DOI 10.1016/j.biombioe.2010.10.025; Heller MC, 2004, RENEW ENERG, V29, P1023, DOI 10.1016/j.renene.2003.11.018; Humbird D, 2011, PROCESS DESIGN EC BI; Jenkins JC, 2003, FOREST SCI, V49, P12; Kadam KL, 2000, BIOTECHNOL PROGR, V16, P947, DOI 10.1021/bp000127s; Lemoine DM, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/1/014003; Lemoine DM, 2010, ENVIRON SCI TECHNOL, V44, P7347, DOI 10.1021/es100418p; Lundgren K, 2012, BIGGEST ENGLISH POLL; Mann M, 2001, CLEAN PROD PROCESS, V3, P81, DOI DOI 10.1007/S100980100109; Nesbit TS, 2011, SOUTH J APPL FOR, V35, P61, DOI 10.1093/sjaf/35.2.61; Nuss P, 2013, ENVIRON SCI TECHNOL, V47, P3463, DOI 10.1021/es304312f; ORNL, 2011, US BILL TON UPD BIOM; Peterson SB, 2010, J POWER SOURCES, V195, P2377, DOI 10.1016/j.jpowsour.2009.09.070; Pirraglia A, 2013, BIOENERG RES, V6, P263, DOI 10.1007/s12155-012-9255-6; Pre Consultants, 2013, US LCI DATABASE SIMA; Robinson AL, 2003, ENVIRON SCI TECHNOL, V37, P5081, DOI 10.1021/es034367q; Smith WB., 2009, GEN TECHNICAL REPORT; Spelter H., 2009, N AM WOOD PELLET SEC; Tharakan PJ, 2005, ENERG POLICY, V33, P337, DOI 10.1016/j.enpol.2003.08.004; United States Environmental Protection Agency (USEPA), 2013, INV US GREENH GAS EM; USEIA, 2012, ANN EN OUTL 2012 PRO; USEIA, 2012, MUCH EL IS LOST TRAN; USEIA, 2012, LEV COST NEW GEN RES; USEIA, 2013, REF GAS PRIC GRAD SA; Valatin G, 2012, MARGINAL ABATEMENT C; Wang M, 2013, TREATISE SUSTAINABIL, P231; Wang MQ., 2001, DEV USE GREET 1 6 FU; Wang ZJ, 2012, FUEL, V95, P606, DOI 10.1016/j.fuel.2011.12.032; WDNR, 2010, FOR BIOM AIR EM; Yin RS, 1998, J FOREST, V96, P13	43	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100030	10.1371/journal.pone.0100030	http://dx.doi.org/10.1371/journal.pone.0100030			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937461	gold, Green Submitted, Green Published			2022-12-25	WOS:000338503400064
J	Hu, FL; Li, YN; Zheng, L; Shi, LJ; Liu, HJ; Zhang, XW; Zhu, HU; Tang, SM; Zhu, L; Xu, LL; Yang, YQ; Li, ZG				Hu, Fanlei; Li, Yingni; Zheng, Li; Shi, Lianjie; Liu, Hongjiang; Zhang, Xuewu; Zhu, Huaqun; Tang, Sumei; Zhu, Lei; Xu, Liling; Yang, Yuqin; Li, Zhanguo			Toll-Like Receptors Expressed by Synovial Fibroblasts Perpetuate Th1 and Th17 Cell Responses in Rheumatoid Arthritis	PLOS ONE			English	Article							TISSUE; SYNOVIOCYTES; BLOCKADE; DISEASES; HYPOXIA; ALPHA; FLUID; VIVO; DNA	Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by synovial fibroblast hyperplasia and bone and cartilage erosion. Synovial fibroblast- and T cell-mediated inflammation plays crucial roles in the pathogenesis of RA. However how this inflammation is initiated, propagated, and maintained remains controversial. Here, we systemically examined the contribution of toll-like receptors (TLRs) to the inflammatory mediator production as well as Th1 and Th17 cell hyperactivity in RA. Our results show that rheumatoid arthritis synovial fibroblasts (RASF) express a series of TLRs, including TLR2, TLR3, TLR4, and TLR9, with the predominant expression of TLR3. Moreover, the expression levels of these TLRs were higher than those in osteoarthritis synovial fibroblasts (OASF). Ligation of TLR3, as well as TLR2 and TLR4, resulted in vigorous production of inflammatory cytokines, matrix metalloproteinases (MMPs), and vascular endothelial growth factor (VEGF) in RASF, with activation of the NF-kappa B, MAPK, and IRF3 pathways. More important, activation of these TLRs expressed by RASF exacerbated inflammatory Th1 and Th17 cell expansion both in cell-cell contact-dependent and inflammatory cytokine-dependent manners, which induced more IFN-gamma and IL-17 accumulation. Targeting TLRs may modulate the inflammation in RA and provide new therapeutic strategies for overcoming this persistent disease.	[Hu, Fanlei; Li, Yingni; Zheng, Li; Shi, Lianjie; Liu, Hongjiang; Zhang, Xuewu; Zhu, Huaqun; Tang, Sumei; Zhu, Lei; Xu, Liling; Yang, Yuqin; Li, Zhanguo] Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100871, Peoples R China	Peking University	Li, ZG (corresponding author), Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100871, Peoples R China.	li99@bjmu.edu.cn	zhang, xian/GYA-0290-2022; zhang, xuan/GQO-8953-2022; zhang, xu/GRX-9733-2022; Zhang, xiaoyu/GXA-3206-2022; zhang, xu/GYE-3558-2022; zhang, xuan/AAN-9914-2020	zhang, xuan/0000-0001-8775-1699; zhang, xuan/0000-0001-8775-1699	Natural Science Foundation of China [81302554, 81030057]; 973 program of China [2010CB529100]; Peking University People's Hospital [RDB2012-04, RDB2013-04]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program of China(National Basic Research Program of China); Peking University People's Hospital	This work was supported by grants from the Natural Science Foundation of China (81302554 and 81030057) and the 973 program of China (2010CB529100), as well as by Peking University People's Hospital Research and Development Funds (RDB2012-04 and RDB2013-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JK, 2008, RHEUMATOLOGY, V47, P834, DOI 10.1093/rheumatology/ken086; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Brentano F, 2005, CELL IMMUNOL, V233, P90, DOI 10.1016/j.cellimm.2005.04.018; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Carrion M, 2011, ARTHRITIS RHEUM-US, V63, P1626, DOI 10.1002/art.30294; Chiang EY, 2009, NAT MED, V15, P766, DOI 10.1038/nm.1984; Choe JY, 2003, J EXP MED, V197, P537, DOI 10.1084/jem.20021850; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; Hu F, 2013, ANN RHEUM DIS; Hu FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072650; Hu FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051423; Karpus ON, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035606; Meng LS, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3034; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Ng CT, 2010, ANN RHEUM DIS, V69, P1389, DOI 10.1136/ard.2009.119776; Ospelt C, 2008, ARTHRITIS RHEUM-US, V58, P3684, DOI 10.1002/art.24140; Patel DD, 2001, CURR DIRECT AUTOIMMU, V3, P133; Samson M, 2012, ARTHRITIS RHEUM; Sokka T, 2003, CLIN EXP RHEUMATOL, V21, pS71; Stahl HD, 2000, ANN RHEUM DIS, V59, P342, DOI 10.1136/ard.59.5.342; Taylor PC, 2010, CURR OPIN PHARMACOL, V10, P308, DOI 10.1016/j.coph.2010.01.005; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Ultaigh SNA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3261; van der Heijden IM, 2000, ARTHRITIS RHEUM-US, V43, P593, DOI 10.1002/1529-0131(200003)43:3<593::AID-ANR16>3.0.CO;2-1; van Oosterhout M, 2005, ANN RHEUM DIS, V64, P537, DOI 10.1136/ard.2004.024927	29	49	54	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100266	10.1371/journal.pone.0100266	http://dx.doi.org/10.1371/journal.pone.0100266			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936783	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400099
J	Liu, YW; Liao, TW; Chen, YH; Chiang, YC; Tsai, YC				Liu, Yen-Wenn; Liao, Tan-Wei; Chen, Yu-Han; Chiang, Yi-Chin; Tsai, Ying-Chieh			Oral Administration of Heat-Inactivated Lactobacillus plantarum K37 Modulated Airway Hyperresponsiveness in Ovalbumin-Sensitized BALB/c Mice	PLOS ONE			English	Article							ALLERGIC RHINITIS; IMMUNOGLOBULIN-E; CYTOKINE PRODUCTION; ATOPIC-DERMATITIS; DENDRITIC CELLS; MURINE MODEL; NC/NGA MICE; ASTHMA; INFLAMMATION; RESPONSES	This study aimed to investigate the anti-allergic effects of Lactobacillus plantarum K37 (K37) on airway hyperresponsiveness (AHR) and systemic allergic responses in ovalbumin (OVA)-sensitized and -challenged BALB/c mice. Heat-inactivated K37 (10(5), 10(7), and 10(9) CFU/mouse, day) were orally administered to OVA-sensitized BALB/c mice to investigate their effects on AHR, immunoglobulin (Ig) and cytokine production. The results showed that K37 dose-dependently lowered the serum levels of IgE, OVA-specific IgE and OVA-specific IgG1, ameliorated AHR induced by methacholine and suppressed eosinophil infiltration in bronchoalveolar lavage fluid (BALF). The cytokine production in spleen cells culture and BALF showed that K37 drove the immune responses toward T-helper cell type 1 (Th1) responses, elevated levels of IL-2 and IFN-gamma, and reduced of IL-4, IL-5 and IL-13. K37 also improved cell infiltration in lung sections. Our results demonstrated that oral administration of K37 alleviated effectively the allergic responses in vivo. Thus, K37 can be a good source material and a promising candidate for prophylactic and therapeutic treatments of allergic diseases, like asthma.	[Liu, Yen-Wenn; Liao, Tan-Wei; Chen, Yu-Han; Chiang, Yi-Chin; Tsai, Ying-Chieh] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan	National Yang Ming Chiao Tung University	Tsai, YC (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan.	tsaiyc@ym.edu.tw			Asian Probiotics and Prebiotics Ltd.; Kei Sei Ken Biotechnology Ltd.	Asian Probiotics and Prebiotics Ltd.; Kei Sei Ken Biotechnology Ltd.	This work was supported by the Asian Probiotics and Prebiotics Ltd. and Kei Sei Ken Biotechnology Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CA, 2010, NUTR RES REV, V23, P37, DOI 10.1017/S0954422410000090; Besnard AG, 2012, J MOL CELL BIOL, V4, P3, DOI 10.1093/jmcb/mjr042; Chanez P, 2007, J ALLERGY CLIN IMMUN, V119, P1337, DOI 10.1016/j.jaci.2006.11.702; Chao SH, 2009, INT J FOOD MICROBIOL, V135, P203, DOI 10.1016/j.ijfoodmicro.2009.07.032; Chen C. C., 2011, BRIT J NUTR, V30, P1; Chiang DJ, 2003, AM J RESP CRIT CARE, V168, P575, DOI 10.1164/rccm.2205005; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P434, DOI 10.1164/ajrccm/142.2.434; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Enomoto M, 2009, BIOSCI BIOTECH BIOCH, V73, P457, DOI 10.1271/bbb.80438; Ezendam J, 2008, CLIN EXP IMMUNOL, V154, P424, DOI 10.1111/j.1365-2249.2008.03788.x; Fujiwara D, 2004, INT ARCH ALLERGY IMM, V135, P205, DOI 10.1159/000081305; Gonzalo JA, 1996, J CLIN INVEST, V98, P2332, DOI 10.1172/JCI119045; Hong HJ, 2010, J CLIN IMMUNOL, V30, P449, DOI 10.1007/s10875-010-9375-8; Hong WS, 2011, J AGR FOOD CHEM, V59, P9022, DOI 10.1021/jf201913x; Hougee S, 2010, INT ARCH ALLERGY IMM, V151, P107, DOI 10.1159/000236000; Hsu CY, 2010, J GENE MED, V12, P11, DOI 10.1002/jgm.1408; Hu WX, 2014, MOL IMMUNOL, V58, P139, DOI 10.1016/j.molimm.2013.11.006; Humbert M, 1997, J ALLERGY CLIN IMMUN, V99, P657, DOI 10.1016/S0091-6749(97)70028-9; Inamine A, 2012, CLIN IMMUNOL, V143, P170, DOI 10.1016/j.clim.2012.01.008; Kawakami H, 2012, CLIN EXP ALLERGY, V42, P946, DOI 10.1111/j.1365-2222.2012.04006.x; Kim DS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/769508; Lee MY, 2012, INT IMMUNOPHARMACOL, V12, P117, DOI 10.1016/j.intimp.2011.10.021; Lee YT, 2013, CYTOKINE, V61, P237, DOI 10.1016/j.cyto.2012.09.024; Liu YW, 2011, INT IMMUNOPHARMACOL, V11, P2159, DOI 10.1016/j.intimp.2011.09.013; Magalhaes JG, 2011, P NATL ACAD SCI USA, V108, P14896, DOI 10.1073/pnas.1015063108; Mei HC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/287803; Morisset M, 2011, EUR J CLIN NUTR, V65, P175, DOI 10.1038/ejcn.2010.250; Morokata T, 1999, IMMUNOLOGY, V98, P345, DOI 10.1046/j.1365-2567.1999.00890.x; Nonaka Y, 2008, INT ARCH ALLERGY IMM, V145, P249, DOI 10.1159/000109294; Platts-Mills TAE, 2001, AM J RESP CRIT CARE, V164, pS1, DOI 10.1164/ajrccm.164.supplement_1.2103024; Rothenberg ME, 1998, NEW ENGL J MED, V338, P1592, DOI 10.1056/NEJM199805283382206; Segawa S, 2008, INT J FOOD MICROBIOL, V121, P1, DOI 10.1016/j.ijfoodmicro.2007.10.004; Shida K, 2006, J DAIRY SCI, V89, P3306, DOI 10.3168/jds.S0022-0302(06)72367-0; Shida K, 1998, INT ARCH ALLERGY IMM, V115, P278, DOI 10.1159/000069458; Shida K, 2002, CLIN EXP ALLERGY, V32, P563, DOI 10.1046/j.0954-7894.2002.01354.x; Simon D, 2004, ALLERGY, V59, P561, DOI 10.1111/j.1398-9995.2004.00476.x; Sunada Y, 2007, BIOL PHARM BULL, V30, P2163, DOI 10.1248/bpb.30.2163; Tamura M, 2007, INT ARCH ALLERGY IMM, V143, P75, DOI 10.1159/000098318; Umland SP, 2000, J LEUKOCYTE BIOL, V67, P441, DOI 10.1002/jlb.67.3.441; Wassenberg J, 2011, CLIN EXP ALLERGY, V41, P565, DOI 10.1111/j.1365-2222.2011.03695.x; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Won TJ, 2011, J APPL MICROBIOL, V110, P1195, DOI 10.1111/j.1365-2672.2011.04981.x; Won TJ, 2012, CELL IMMUNOL, V277, P49, DOI 10.1016/j.cellimm.2012.05.013; Yang GY, 2004, CYTOKINE, V28, P224, DOI 10.1016/j.cyto.2004.08.007; Yasui H, 2004, CLIN DIAGN LAB IMMUN, V11, P675, DOI 10.1128/CDLI.11.4.675-679.2004; Yoshida T, 2013, INT ARCH ALLERGY IMM, V162, P283, DOI 10.1159/000354924	46	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100105	10.1371/journal.pone.0100105	http://dx.doi.org/10.1371/journal.pone.0100105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936861	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400076
J	Stoter, M; Kruger, M; Banting, G; Henne-Bruns, D; Knippschild, U				Stoeter, Martin; Krueger, Marc; Banting, George; Henne-Bruns, Doris; Knippschild, Uwe			Microtubules Depolymerization Caused by the CK1 Inhibitor IC261 May Be Not Mediated by CK1 Blockage	PLOS ONE			English	Article							CASEIN-KINASE-I; MITOTIC SPINDLE FORMATION; TRANS-GOLGI-NETWORK; MEMBRANE-PROTEIN; NEGATIVE REGULATION; INDUCED APOPTOSIS; FACTOR RECEPTOR; BETA-CATENIN; BREFELDIN-A; MEIOSIS-I	The ubiquitously expressed serine/threonine specific casein kinase 1 (CK1) family plays important roles in the regulation of various physiological processes. Small-molecule inhibitors, such as the CK1 delta/epsilon selectively inhibitor IC261, have been used to antagonize CK1 phosphorylation events in cells in many studies. Here we present data to show that, similarly to the microtubule destabilizing agent nocodazole, IC261 depolymerizes microtubules in interphase cells. IC261 treatment of interphase cells affects the morphology of the TGN and Golgi apparatus as well as the localization of CK1 delta, which co-localizes with COPI positive membranes. IC261-induced depolymerization of microtubules is rapid, reversible and can be antagonized by pre-treatment of cells with taxol. At lower concentrations of IC261, mitotic spindle microtubule dynamics are affected; this leads to cell cycle arrest and, depending on the cellular background, to apoptosis in a dose-dependent manner. In addition, FACS analysis revealed that IC261 could induce apoptosis independent of cell cycle arrest. In summary this study provides additional and valuable information about various IC261-induced effects that could be caused by microtubule depolymerization rather than by inhibition of CK1. Data from studies that have used IC261 as an inhibitor of CK1 should be interpreted in light of these observations.	[Stoeter, Martin; Krueger, Marc; Henne-Bruns, Doris; Knippschild, Uwe] Ulm Univ Hosp, Dept Gen & Visceral Surg, Ulm, Germany; [Banting, George] Univ Bristol, Sch Biochem, Bristol, Avon, England	Ulm University; University of Bristol	Knippschild, U (corresponding author), Ulm Univ Hosp, Dept Gen & Visceral Surg, Ulm, Germany.	uwe.knippschild@uniklinik-ulm.de		Banting, George/0000-0001-8249-1621	Deutsche Krebshilfe, Dr. Mildred Scheel Stiftung fur Krebsforschung [10-1683-KN2, 10-2237-KN3]; International Graduate School in Molecular Medicine at the Ulm University; DAAD within the ARC program	Deutsche Krebshilfe, Dr. Mildred Scheel Stiftung fur Krebsforschung(Deutsche Krebshilfe); International Graduate School in Molecular Medicine at the Ulm University; DAAD within the ARC program	Deutsche Krebshilfe, Dr. Mildred Scheel Stiftung fur Krebsforschung (http://www.krebshilfe.de/nc/startseite.html), to UK (10-1683-KN2 and 10-2237-KN3). And by funding of the International Graduate School in Molecular Medicine at the Ulm University as well as by a grant from the DAAD to GB and UK within the ARC program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Behrend L, 2000, ONCOGENE, V19, P5303, DOI 10.1038/sj.onc.1203939; Behrend L, 2000, EUR J CELL BIOL, V79, P240, DOI 10.1078/S0171-9335(04)70027-8; Ben-Nissan G, 2008, PLANT PHYSIOL, V148, P1897, DOI 10.1104/pp.108.129346; BEYAERT R, 1995, J BIOL CHEM, V270, P23293, DOI 10.1074/jbc.270.40.23293; Bischof J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068803; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; BROCKMAN JL, 1992, P NATL ACAD SCI USA, V89, P9454, DOI 10.1073/pnas.89.20.9454; Brockschmidt C, 2008, GUT, V57, P799, DOI 10.1136/gut.2007.123695; BURKE B, 1982, EMBO J, V1, P1621, DOI 10.1002/j.1460-2075.1982.tb01364.x; Camacho F, 2001, FEBS LETT, V489, P159, DOI 10.1016/S0014-5793(00)02434-0; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Cheong JK, 2011, ONCOGENE, V30, P2558, DOI 10.1038/onc.2010.627; Cheong JK, 2011, INT J BIOCHEM CELL B, V43, P465, DOI 10.1016/j.biocel.2010.12.004; Cruciat CM, 2013, SCIENCE; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; DHILLON N, 1994, EMBO J, V13, P2777, DOI 10.1002/j.1460-2075.1994.tb06571.x; DONALDSON JG, 1990, J CELL BIOL, V111, P2295, DOI 10.1083/jcb.111.6.2295; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; FISH KJ, 1995, J BIOL CHEM, V270, P14875, DOI 10.1074/jbc.270.25.14875; Flajolet M, 2007, P NATL ACAD SCI USA, V104, P4159, DOI 10.1073/pnas.0611236104; Frank HG, 2000, CANCER GENET CYTOGEN, V116, P16, DOI 10.1016/S0165-4608(99)00107-7; FREEMAN AE, 1975, IN VITRO CELL DEV B, V11, P107; Funayama H., 1997, PLACENTA, V18, P191; Gault WJ, 2012, J CELL BIOL, V196, P605, DOI 10.1083/jcb.201107137; Giamas G, 2007, BIOCHEM J, V406, P389, DOI 10.1042/BJ20070091; Girotti M, 1996, J CELL SCI, V109, P2915; GONATAS JO, 1995, J CELL SCI, V108, P457; GRAVES PR, 1995, J BIOL CHEM, V270, P21689, DOI 10.1074/jbc.270.37.21689; Greer YE, 2014, MOL BIOL CELL; Greer YE, 2011, J CELL BIOL, V192, P993, DOI 10.1083/jcb.201011111; Grietzen KF, 1999, J BIOL CHEM, V274, P32063, DOI 10.1074/jbc.274.45.32063; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; HAMILTON BT, 1982, EUR J CELL BIOL, V28, P190; Hottecke N, 2010, BIOORG MED CHEM LETT, V20, P2958, DOI 10.1016/j.bmcl.2010.02.110; HORN M, 1994, BIOCHEM J, V301, P69, DOI 10.1042/bj3010069; HRONOVSKY V, 1978, ACTA VIROL, V22, P123; Hutchinson JA, 2011, J BIOL CHEM, V286, P8688, DOI 10.1074/jbc.M110.141754; Ikeda K, 2011, MOL BIOL CELL, V22, P1321, DOI 10.1091/mbc.E10-09-0741; Izeradjene K, 2004, CANCER RES, V64, P8036, DOI 10.1158/0008-5472.CAN-04-0762; Kattapuram T, 2005, J BIOL CHEM, V280, P15340, DOI 10.1074/jbc.M500214200; Li GB, 2004, J BIOL CHEM, V279, P15938, DOI 10.1074/jbc.M314116200; LIN CM, 1981, J BIOL CHEM, V256, P9242; LIPPINCOTT S, 1989, BONE, V10, P265, DOI 10.1016/8756-3282(89)90063-X; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Mashhoon N, 2000, J BIOL CHEM, V275, P20052, DOI 10.1074/jbc.M001713200; Milne DM, 2001, EXP CELL RES, V263, P43, DOI 10.1006/excr.2000.5100; Murakami A, 1999, J BIOL CHEM, V274, P3804, DOI 10.1074/jbc.274.6.3804; ORCI L, 1991, CELL, V64, P1183; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; Popoff V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005231; REAVES B, 1992, BIOCHEM J, V283, P313, DOI 10.1042/bj2830313; RISNIK VV, 1988, CELL MOL NEUROBIOL, V8, P315, DOI 10.1007/BF00711173; Rivers A, 1998, J BIOL CHEM, V273, P15980, DOI 10.1074/jbc.273.26.15980; Rumpf C, 2010, CELL CYCLE, V9, P2657, DOI 10.4161/cc.9.13.12146; SAMSON F, 1979, J PHARMACOL EXP THER, V208, P411; Sillibourne JE, 2002, J MOL BIOL, V322, P785, DOI 10.1016/S0022-2836(02)00857-4; SOMERS KD, 1968, J NATL CANCER I, V40, P1053; Stoter M, 2005, ONCOGENE, V24, P7964, DOI 10.1038/sj.onc.1208941; Swiatek W, 2006, J BIOL CHEM, V281, P12233, DOI 10.1074/jbc.M510580200; Swiatek W, 2004, J BIOL CHEM, V279, P13011, DOI 10.1074/jbc.M304682200; Takenaka Y, 2004, MOL CELL BIOL, V24, P4395, DOI 10.1128/MCB.24.10.4395-4406.2004; Toyoshima M, 2012, P NATL ACAD SCI USA, V109, P9545, DOI 10.1073/pnas.1121119109; VANCURA A, 1994, J BIOL CHEM, V269, P19271; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063173; WANG PC, 1992, MOL BIOL CELL, V3, P275, DOI 10.1091/mbc.3.3.275; Wang XM, 1996, MOL CELL BIOL, V16, P5375; Wolff S, 2005, BBA-MOL CELL RES, V1745, P196, DOI 10.1016/j.bbamcr.2005.05.004; Yu S, 2002, MOL BIOL CELL, V13, P2559, DOI 10.1091/mbc.E02-04-0189; Zhao Y, 2004, J BIOL CHEM, V279, P30844, DOI 10.1074/jbc.M404651200; ZIEVE GW, 1980, EXP CELL RES, V126, P397, DOI 10.1016/0014-4827(80)90279-7; Zyss D, 2011, J CELL BIOL, V195, P781, DOI 10.1083/jcb.201106025	77	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100090	10.1371/journal.pone.0100090	http://dx.doi.org/10.1371/journal.pone.0100090			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937750	gold, Green Published, Green Submitted			2022-12-25	WOS:000338503400073
J	Su, HW; McKelvey, J; Rollins, D; Zhang, M; Brightsmith, DJ; Derr, J; Zhang, SP				Su, Hongwen; McKelvey, Jessica; Rollins, Dale; Zhang, Michael; Brightsmith, Donald J.; Derr, James; Zhang, Shuping			Cultivable Bacterial Microbiota of Northern Bobwhite (Colinus virginianus): A New Reservoir of Antimicrobial Resistance?	PLOS ONE			English	Article							ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; CLOACAL MICROBIOTA; INTESTINAL FLORA; GUT MICROBIOTA; WILD; QUAIL; PAENIBACILLUS; PREVALENCE	The northern bobwhite (Colinus virginianus) is an ecologically and economically important avian species. At the present time, little is known about the microbial communities associated with these birds. As the first step to create a quail microbiology knowledge base, the current study conducted an inventory of cultivable quail tracheal, crop, cecal, and cloacal microbiota and associated antimicrobial resistance using a combined bacteriology and DNA sequencing approach. A total of 414 morphologically unique bacterial colonies were selected from nonselective aerobic and anaerobic cultures, as well as selective and enrichment cultures. Analysis of the first 500-bp 16S rRNA gene sequences in conjunction with biochemical identifications revealed 190 non-redundant species-level taxonomic units, representing 160 known bacterial species and 30 novel species. The bacterial species were classified into 4 phyla, 14 orders, 37 families, and 59 or more genera. Firmicutes was the most commonly encountered phylum (57%) followed by Actinobacteria (24%), Proteobacteria (17%) and Bacteroidetes (0.02%). Extensive diversity in the species composition of quail microbiota was observed among individual birds and anatomical locations. Quail microbiota harbored several opportunistic pathogens, such as E. coli and Ps. aeruginosa, as well as human commensal organisms, including Neisseria species. Phenotypic characterization of selected bacterial species demonstrated a high prevalence of resistance to the following classes of antimicrobials: phenicol, macrolide, lincosamide, quinolone, and sulphate. Data from the current investigation warrant further investigation on the source, transmission, pathology, and control of antimicrobial resistance in wild quail populations.	[Su, Hongwen; McKelvey, Jessica; Zhang, Michael; Brightsmith, Donald J.; Derr, James; Zhang, Shuping] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX USA; [Rollins, Dale] Texas AgriLife Res, Rolling Plains Quail Res Fdn, San Angelo, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research	Zhang, SP (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO 65211 USA.	zhangshup@missouri.edu		Brightsmith, Donald/0000-0002-3306-6490	Rolling Plains Quail Research Ranch Foundation	Rolling Plains Quail Research Ranch Foundation	This work was financially supported by the Rolling Plains Quail Research Ranch Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clinical and Laboratory Standards Institute, 2007, PERF STAND ANT SUSC; Cole D, 2005, EMERG INFECT DIS, V11, P935; Collado MC, 2007, J FOOD PROTECT, V70, P2799, DOI 10.4315/0362-028X-70.12.2799; DeMaso SJ, 2002, NATL QUAIL S, P206; Diaz-Sanchez S, 2012, EUR J WILDLIFE RES, V58, P99, DOI 10.1007/s10344-011-0547-5; El-Hadad ME, 2011, BRAZ J MICROBIOL, V42, P105, DOI 10.1590/S1517-83822011000100014; Ferro PJ, 2012, AVIAN DIS, V56, P858, DOI 10.1637/10197-041012-ResNote.1; Girardin H, 2002, J FOOD PROTECT, V65, P806, DOI 10.4315/0362-028X-65.5.806; Glunder G, 2002, DEUT TIERARZTL WOCH, V109, P266; Gollwitzer ES, 2013, PHARM THER; Guenther S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00246; Helm JD, 1999, AVIAN DIS, V43, P788, DOI 10.2307/1592750; Hidasi HW, 2013, J ZOO WILDLIFE MED, V44, P1, DOI 10.1638/1042-7260-44.1.1; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kohl KD, 2012, J COMP PHYSIOL B, V182, P591, DOI 10.1007/s00360-012-0645-z; Kozak GK, 2009, APPL ENVIRON MICROB, V75, P559, DOI 10.1128/AEM.01821-08; Lan PTN, 2002, MICROBIOL IMMUNOL, V46, P371, DOI 10.1111/j.1348-0421.2002.tb02709.x; Lutz JK, 2011, INT J ENV RES PUB HE, V8, P554, DOI 10.3390/ijerph8020554; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; MARKARYAN M, 1975, Veterinarno Meditsinski Nauki, V12, P33; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Nikkari S, 2002, EMERG INFECT DIS, V8, P188, DOI 10.3201/eid0802.010150; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Singh IM, 2004, VET REC, V155, P29, DOI 10.1136/vr.155.1.29; Stedt Johan, 2014, Infection Ecology & Epidemiology, V4, P21565, DOI 10.3402/iee.v4.21565; Stern NJ, 2005, J FOOD PROTECT, V68, P1450, DOI 10.4315/0362-028X-68.7.1450; Terhune TM, 2010, ECOL APPL, V20, P1040, DOI 10.1890/09-1106.1; Texas Quail Study Group, 2009, P 2009 TEX QUAIL STU; U.S. Department of the Interior U.S. Fish and Wildlife Service & U.S. Department of Commerce U.S. Census Bureau, 2013, 2011 NAT SURV FISH H; Urban KN, 2013, J WILDLIFE DIS, V49, P427, DOI 10.7589/2011-05-133; van Dongen WFD, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-11; Waite DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035803; Wang LY, 2013, ANTON LEEUW INT J G, V104, P675, DOI 10.1007/s10482-013-9974-5; Williams HD, 2012, THORAX, V67, P465, DOI 10.1136/thoraxjnl-2011-201498; Xenoulis PG, 2010, VET MICROBIOL, V146, P320, DOI 10.1016/j.vetmic.2010.05.024; Zoetendal EG, 2004, J NUTR, V134, P465, DOI 10.1093/jn/134.2.465	37	18	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99826	10.1371/journal.pone.0099826	http://dx.doi.org/10.1371/journal.pone.0099826			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937705	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400041
J	Zhang, XH; Zhang, ZC; Zhao, H; Wang, Q; Zhu, J				Zhang, Xiaohang; Zhang, Zecong; Zhao, Han; Wang, Qi; Zhu, Ji			Extracting the Globally and Locally Adaptive Backbone of Complex Networks	PLOS ONE			English	Article							COMMUNITY STRUCTURE; SKELETON	A complex network is a useful tool for representing and analyzing complex systems, such as the world-wide web and transportation systems. However, the growing size of complex networks is becoming an obstacle to the understanding of the topological structure and their characteristics. In this study, a globally and locally adaptive network backbone (GLANB) extraction method is proposed. The GLANB method uses the involvement of links in shortest paths and a statistical hypothesis to evaluate the statistical importance of the links; then it extracts the backbone, based on the statistical importance, from the network by filtering the less important links and preserving the more important links; the result is an extracted subnetwork with fewer links and nodes. The GLANB determines the importance of the links by synthetically considering the topological structure, the weights of the links and the degrees of the nodes. The links that have a small weight but are important from the view of topological structure are not belittled. The GLANB method can be applied to all types of networks regardless of whether they are weighted or unweighted and regardless of whether they are directed or undirected. The experiments on four real networks show that the link importance distribution given by the GLANB method has a bimodal shape, which gives a robust classification of the links; moreover, the GLANB method tends to put the nodes that are identified as the core of the network by the k-shell algorithm into the backbone. This method can help us to understand the structure of the networks better, to determine what links are important for transferring information, and to express the network by a backbone easily.	[Zhang, Xiaohang; Zhang, Zecong; Zhao, Han; Wang, Qi] Beijing Univ Posts & Telecommun, Sch Econ & Management, Beijing 100088, Peoples R China; [Zhu, Ji] Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA	Beijing University of Posts & Telecommunications; University of Michigan System; University of Michigan	Zhang, XH (corresponding author), Beijing Univ Posts & Telecommun, Sch Econ & Management, Beijing 100088, Peoples R China.	zhangxiaohang@bupt.edu.cn		Zhang, Xiaohang/0000-0002-5315-8712	NSFC [71371034, 71372194]; National Basic Research Program of China [2012CB315805]; Program for NCET [NCET-13-0687]; Youth Research and Innovation Program in Beijing University of Posts and Telecommunications [2012RC1006]	NSFC(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Program for NCET(Program for New Century Excellent Talents in University (NCET)); Youth Research and Innovation Program in Beijing University of Posts and Telecommunications	This work was partially supported by NSFC (Grant Nos: 71371034 and 71372194; www.nsfc.gov.cn), the National Basic Research Program of China (Grant No: 2012CB315805; www.973.gov.cn), the Program for NCET (Grant No: NCET-13-0687; www.1000plan.org/qrjh/channel/159), and the Youth Research and Innovation Program in Beijing University of Posts and Telecommunications (Grant No: 2012RC1006; www.bupt.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesina S, 2006, ECOL MODEL, V194, P150, DOI 10.1016/j.ecolmodel.2005.10.016; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barthelemy M, 2003, PHYSICA A, V319, P633, DOI 10.1016/S0378-4371(02)01382-1; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Carmi S, 2007, P NATL ACAD SCI USA, V104, P11150, DOI 10.1073/pnas.0701175104; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Foti NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016431; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goh KI, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.018701; Grady D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1847; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Ruimera R, 2003, PHYS REV E, V68; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang X, 2013, PHYSICA A, V392, P1547, DOI 10.1016/j.physa.2012.12.001	22	18	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100428	10.1371/journal.pone.0100428	http://dx.doi.org/10.1371/journal.pone.0100428			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936975	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400109
J	Lo, WT; Yu, SF; Hsieh, HY				Lo, Wen-Tseng; Yu, Shwu-Feng; Hsieh, Hung-Yen			Hydrographic Processes Driven by Seasonal Monsoon System Affect Siphonophore Assemblages in Tropical-Subtropical Waters (Western North Pacific Ocean)	PLOS ONE			English	Article							SOUTH CHINA SEA; GULF-OF-MEXICO; GELATINOUS ZOOPLANKTON; JELLYFISH BLOOMS; EPIPELAGIC SIPHONOPHORES; VERTICAL-DISTRIBUTION; TAIWAN STRAIT; CHEMICAL HYDROGRAPHY; COMMUNITY STRUCTURE; PELAGIC CNIDARIANS	This work is a part of the Taiwan Cooperative Oceanic Fisheries Investigation, the first large scale hydrographic and plankton survey around Taiwan (21-26 degrees N, 119-123 degrees E). The present study examined the influence of hydrodynamic and biological variables driven by monsoon system on the siphonophore assemblages through an annual cycle in 2004. Calycophorans, namely Chelophyes appendiculata, Diphyes chamissonis, Lensia subtiloides, Bassia bassensis, and Muggiaea atlantica, were the most dominant siphonophore species. Maximum abundance of these dominant species generally occurred during the warm period (May and August), while M. atlantica had a significantly peak abundance in February. Although no apparently temporal difference in siphonophore abundance was observed in the study, siphonophore assemblage was more diverse in August than in other sampling times. Result of a cluster analysis indicated that assemblage structure of siphonophores in the waters around Taiwan varied at temporal and spatial scales during the sampling period. The intrusions of the Kuroshio Branch Current and China Coastal Current to the study area play an important role on the transportation of siphonophores. Also, the distribution of siphonophore assemblage was closely related to the hydrographic characteristics, with temperature, chlorophyll a concentration, and zooplankton abundance being the major environmental factors affecting the spatio-temporal variability of siphonophores. This study contributes substantially to the new knowledge of the siphonophore assemblage in the tropical-temperate waters of Taiwan.	[Lo, Wen-Tseng; Yu, Shwu-Feng] Natl Sun Yat Sen Univ, Inst Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan; [Hsieh, Hung-Yen] Natl Dong Hwa Univ, Inst Marine Biodivers & Evolutionary Biol, Checheng, Pingtung, Taiwan; [Hsieh, Hung-Yen] Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan	National Sun Yat Sen University; National Dong Hwa University; National Museum of Marine Biology & Aquarium	Hsieh, HY (corresponding author), Natl Dong Hwa Univ, Inst Marine Biodivers & Evolutionary Biol, Checheng, Pingtung, Taiwan.	hyhsieh@mail.ndhu.edu.tw			National Science Council [NSC98-2611-M 110-002]; Ministry of Education (Kuroshio Project), Taiwan [97C030200]	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education (Kuroshio Project), Taiwan	The study is supported by the National Science Council (NSC98-2611-M 110-002) and the Ministry of Education (Kuroshio Project, 97C030200), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldredge AL, 1984, FLOWS ENERGY MAT MAR, P407; ALVARINO A, 1967, PAC SCI, V21, P474; Alvarino A., 1990, Antarctic Research Series, V49, P1; Arai Mary Needler, 1992, Scientia Marina, V56, P99; Ashjian CJ, 2005, DEEP-SEA RES PT II, V52, P1363, DOI 10.1016/j.dsr2.2005.05.001; Batistic M, 2013, MAR ECOL-EVOL PERSP, V34, P3, DOI 10.1111/maec.12021; Boero F, 2008, MAR ECOL PROG SER, V356, P299, DOI 10.3354/meps07368; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Brodeur RD, 1999, FISH OCEANOGR, V8, P296, DOI 10.1046/j.1365-2419.1999.00115.x; Buecher E, 1999, J SEA RES, V41, P295, DOI 10.1016/S1385-1101(99)00005-2; CARRE C, 1991, PHILOS T ROY SOC B, V334, P27, DOI 10.1098/rstb.1991.0095; Chern C.-S., 1990, TERR ATMOS OCEAN SCI, V1, P297, DOI [10.3319/TAO.1990.1.3.297(O), DOI 10.3319/TAO.1990.1.3.297(O)]; CHERN CS, 1990, J GEOPHYS RES-OCEANS, V95, P16017, DOI 10.1029/JC095iC09p16017; Chuang W.-S., 1993, J OCEANOGR, V49, P581, DOI DOI 10.1007/BF02237464; Chung SW, 2001, J OCEANOGR, V57, P47; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Delizo L, 2007, J PLANKTON RES, V29, P655, DOI 10.1093/plankt/fbm047; Dunn O. J., 1974, Applied statistics: analysis of variance and regression; Fang KL, 1982, ACTA OCEANOGRAPHICA, V13, P140; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Gasca R, 1999, B MAR SCI, V65, P75; Gibbons MJ, 2009, HYDROBIOLOGIA, V616, P51, DOI 10.1007/s10750-008-9593-8; Gibbons MJ, 2002, J MAR BIOL ASSOC UK, V82, P801, DOI 10.1017/S0025315402006161; Gong G.C., 1992, ACTA OCEANOGRAPHICA, V28, P118; Graham WM, 2001, HYDROBIOLOGIA, V451, P199, DOI 10.1023/A:1011876004427; Grossmann MM, 2013, J OCEANOGR, V69, P395, DOI 10.1007/s10872-013-0181-9; Hamner WM, 2009, HYDROBIOLOGIA, V616, P161, DOI 10.1007/s10750-008-9620-9; Hosia A, 2008, J PLANKTON RES, V30, P951, DOI 10.1093/plankt/fbn045; Hsieh HY, 2013, MAR FRESHWATER RES, V64, P348, DOI 10.1071/MF12151; Jan S, 2002, J MARINE SYST, V35, P249, DOI 10.1016/S0924-7963(02)00130-6; Jan S, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2006JC003656; Kirkpatrick PA, 1984, SYNOPSES BRIT FAUNA; Kitamura Minoru, 2003, Plankton Biology and Ecology, V50, P43; Kruskal J. B., 1978, SAGE U PAPER SERIES; Li KZ, 2012, J PLANKTON RES, V34, P636, DOI 10.1093/plankt/fbs035; Li KZ, 2013, CHIN J OCEANOL LIMN, V31, P312, DOI 10.1007/s00343-013-2058-6; Licandro P, 2012, PROG OCEANOGR, V97, P152, DOI 10.1016/j.pocean.2011.11.004; Lin Mao, 2011, Biodiversity Science, V19, P646; LIU KK, 1992, J GEOPHYS RES-OCEANS, V97, P12511, DOI 10.1029/92JC01179; Liu KK, 2000, CONT SHELF RES, V20, P493, DOI 10.1016/S0278-4343(99)00083-7; Lo WT, 2012, ZOOL STUD, V51, P1354; Lo WT, 1996, J PLANKTON RES, V18, P923, DOI 10.1093/plankt/18.6.923; Lopez-Lopez L, 2013, J PLANKTON RES, V35, P677, DOI 10.1093/plankt/fbt005; Lucic D, 2005, J MAR BIOL ASSOC UK, V85, P495, DOI 10.1017/S0025315405011422; Ma XP, 2005, MAR BIOL, V147, P225, DOI 10.1007/s00227-004-1539-8; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mapstone G.M., 2009, SIPHONOPHORA CNIDARI; Mapstone GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087737; Maravelias CD, 1997, MAR ECOL PROG SER, V147, P1, DOI 10.3354/meps147001; MILLS CE, 1984, BIOL BULL, V166, P206, DOI 10.2307/1541442; Mills CE, 2001, HYDROBIOLOGIA, V451, P55, DOI 10.1023/A:1011888006302; MUNK P, 1995, MAR ECOL PROG SER, V125, P21, DOI 10.3354/meps125021; Pages F, 2001, MAR ECOL PROG SER, V210, P13, DOI 10.3354/meps210013; PAGES F, 1991, MAR ECOL PROG SER, V75, P205, DOI 10.3354/meps075205; Palma GS, 1999, INVEST MAR, V27, P19; Palma S, 2006, J PLANKTON RES, V28, P1143, DOI 10.1093/plankt/fbl044; Palma S, 2011, CONT SHELF RES, V31, P260, DOI 10.1016/j.csr.2010.04.007; Pestoric B, 2012, ACTA ADRIAT, V53, P291; PIELOU E. C., 1984, INTERPRETATION ECOLO; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Polovina JJ, 2008, PROG OCEANOGR, V77, P217, DOI 10.1016/j.pocean.2008.03.011; Primo AL, 2012, MAR ENVIRON RES, V79, P152, DOI 10.1016/j.marenvres.2012.06.009; PUGH PR, 1984, PROG OCEANOGR, V13, P461, DOI 10.1016/0079-6611(84)90016-8; PUGH PR, 1974, J MAR BIOL ASSOC UK, V54, P25, DOI 10.1017/S0025315400022086; PURCELL JE, 1982, J EXP MAR BIOL ECOL, V62, P39, DOI 10.1016/0022-0981(82)90215-5; PURCELL JE, 1984, MAR ECOL PROG SER, V19, P189, DOI 10.3354/meps019189; PURCELL JE, 1981, MAR BIOL, V65, P83, DOI 10.1007/BF00397071; Purcell JE, 1997, ANN I OCEANOGR PARIS, V73, P125; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Riemann L, 2011, MAR ECOL PROG SER, V426, P57, DOI 10.3354/meps09001; Sabates A, 2010, HYDROBIOLOGIA, V645, P153, DOI 10.1007/s10750-010-0221-z; Sanvicente-Anorve L, 2007, HYDROBIOLOGIA, V586, P69, DOI 10.1007/s10750-006-0492-6; Sanvicente-Anorve L, 2009, AQUAT ECOL, V43, P423, DOI 10.1007/s10452-008-9172-0; Shannon C.E., 1963, MATH THEORY COMMUNIC; Thibault-Botha D, 2004, J PLANKTON RES, V26, P1115, DOI 10.1093/plankt/fbh104; Totton A. K., 1954, Discovery Reports, V27, P1; Totton AK, 1965, SYNOPSIS SIPHONOPHOR; WANG J, 1988, PROG OCEANOGR, V21, P469; WONG GTF, 1991, ESTUAR COAST SHELF S, V33, P105, DOI 10.1016/0272-7714(91)90001-R; Xian WW, 2005, SCIENCE, V307, P41; Xu Z, 2006, BIODIVERSITY SCI, Vv14, P508, DOI DOI 10.1360/BIODIV.060066; Yu Cun-Gen, 2011, Acta Hydrobiologica Sinica, V35, P183; Zhang Jin-biao, 2001, Journal of Oceanography in Taiwan Strait, V20, P1; Zhang Jin-biao, 2005, Journal of Tropical Oceanography, V24, P41	86	12	12	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100085	10.1371/journal.pone.0100085	http://dx.doi.org/10.1371/journal.pone.0100085			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932727	Green Submitted, Green Published, gold			2022-12-25	WOS:000337738600091
J	Personnic, S; Boudouresque, CF; Astruch, P; Ballesteros, E; Blouet, S; Bellan-Santini, D; Bonhomme, P; Thibault-Botha, D; Feunteun, E; Harmelin-Vivien, M; Pergent, G; Pergent-Martini, C; Pastor, J; Poggiale, JC; Renaud, F; Thibaut, T; Ruitton, S				Personnic, Sebastien; Boudouresque, Charles F.; Astruch, Patrick; Ballesteros, Enric; Blouet, Sylvain; Bellan-Santini, Denise; Bonhomme, Patrick; Thibault-Botha, Delphine; Feunteun, Eric; Harmelin-Vivien, Mireille; Pergent, Gerard; Pergent-Martini, Christine; Pastor, Jeremy; Poggiale, Jean-Christophe; Renaud, Florent; Thibaut, Thierry; Ruitton, Sandrine			An Ecosystem-Based Approach to Assess the Status of a Mediterranean Ecosystem, the Posidonia oceanica Seagrass Meadow	PLOS ONE			English	Article							ECOLOGICAL STATUS; QUALITY ASSESSMENT; ORGANIC DEPOSITS; COASTAL WATERS; ASSEMBLAGES; BAY; DYNAMICS; GROWTH; SEA; POPULATIONS	Biotic indices, which reflect the quality of the environment, are widely used in the marine realm. Sometimes, key species or ecosystem engineers are selected for this purpose. This is the case of the Mediterranean seagrass Posidonia oceanica, widely used as a biological quality element in the context of the European Union Water Framework Directive (WFD). The good quality of a water body and the apparent health of a species, whether or not an ecosystem engineer such as P. oceanica, is not always indicative of the good structure and functioning of the whole ecosystem. A key point of the recent Marine Strategy Framework Directive (MSFD) is the ecosystem-based approach. Here, on the basis of a simplified conceptual model of the P. oceanica ecosystem, we have proposed an ecosystem-based index of the quality of its functioning, compliant with the MSFD requirements. This index (EBQI) is based upon a set of representative functional compartments, the weighting of these compartments and the assessment of the quality of each compartment by comparison of a supposed baseline. The index well discriminated 17 sites in the north-western Mediterranean (French Riviera, Provence, Corsica, Catalonia and Balearic Islands) covering a wide range of human pressure levels. The strong points of the EBQI are that it is easy to implement, non-destructive, relatively robust, according to the selection of the compartments and to their weighting, and associated with confidence indices that indicate possible weakness and biases and therefore the need for further field data acquisition.	[Personnic, Sebastien; Boudouresque, Charles F.; Thibault-Botha, Delphine; Harmelin-Vivien, Mireille; Poggiale, Jean-Christophe; Thibaut, Thierry; Ruitton, Sandrine] Aix Marseille Univ, MIO, Univ Toulon, CNRS,INSU,IRD,UM 110, Marseille, France; [Astruch, Patrick; Bonhomme, Patrick] Aix Marseille Univ, Pytheas Inst, GIS Posidonie, Marseille, France; [Ballesteros, Enric] CSIC, Ctr Estudis Avancats Blanes, Blanes, Spain; [Blouet, Sylvain] Aire Marine Protegee Cote Agathoise, Agde, France; [Bellan-Santini, Denise; Renaud, Florent] Aix Marseille Univ, IMBE, UMR 7263, Stn Marine Endoume, Marseille, France; [Feunteun, Eric] Museum Natl Hist Nat, UMR 7208, Stn Marine Dinard, Paris, France; [Pergent, Gerard; Pergent-Martini, Christine] Univ Corsica, Equipe Ecosyst Littoraux, FRES 3041, Corte, France; [Pastor, Jeremy] Univ Perpignan, Ctr Format & Rech Environm Mediterraneens, UMR 5110, F-66025 Perpignan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite Perpignan Via Domitia	Personnic, S (corresponding author), Aix Marseille Univ, MIO, Univ Toulon, CNRS,INSU,IRD,UM 110, Marseille, France.	sebastien.personnic@univ-amu.fr	Thibault, Delphine/AAR-4300-2020; Ruitton, Sandrine/AAT-4752-2021; Feunteun, Eric/GXV-5964-2022; THIBAUT, Thierry/S-4354-2019; Poggiale, Jean-Christophe/I-4582-2019	Ruitton, Sandrine/0000-0003-4485-9979; Feunteun, Eric/0000-0001-6344-6809; THIBAUT, Thierry/0000-0001-8530-9266; Poggiale, Jean-Christophe/0000-0002-3888-0096; Thibault, Delphine/0000-0002-0528-1062; Pergent-Martini, Christine/0000-0002-9098-6867	French Centre National de la Recherche Scientifique (CNRS); French Reseau des Stations et Observatoires Marins (RESOMAR); Museum National d'Histoire Naturelle (MNHN, Paris); French Agence de l'eau Rhone Mediterranee Corse through the French part of the European MSFD project (in French: Directive Cadre Strategie pour le Milieu Marin, DCSMM)	French Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French Reseau des Stations et Observatoires Marins (RESOMAR); Museum National d'Histoire Naturelle (MNHN, Paris); French Agence de l'eau Rhone Mediterranee Corse through the French part of the European MSFD project (in French: Directive Cadre Strategie pour le Milieu Marin, DCSMM)	This study has been funded by the French Centre National de la Recherche Scientifique (CNRS), the French Reseau des Stations et Observatoires Marins (RESOMAR), the Museum National d'Histoire Naturelle (MNHN, Paris), the French Agence de l'eau Rhone Mediterranee Corse through the French part of the European MSFD project (in French: Directive Cadre Strategie pour le Milieu Marin, DCSMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcoverro T, 2001, MAR ECOL PROG SER, V211, P105, DOI 10.3354/meps211105; [Anonymous], 1979, B MUSEUM HIST NATURE; [Anonymous], 2000, BIOL MAR MEDITERR; Astruch P., 2012, SCI REP PORT CROS NA, V26, P45; Ballesteros E, 2007, MAR POLLUT BULL, V55, P172, DOI 10.1016/j.marpolbul.2006.08.038; BAY D, 1984, AQUAT BOT, V20, P43, DOI 10.1016/0304-3770(84)90026-3; Bazin N, 2012, CORMORAN HUPPE MEDIE; BELL J D, 1982, Tethys, V10, P337; Bellan-Santini D., 1984, P423; Bianchi C.N., 1989, INT WORKSH POS OC BE, P257; Bond W, 2001, SCIENCE, V292, P63, DOI 10.1126/science.1060793; Boudouresque C., 1982, CAHIERS 4 L 8O; Boudouresque C., 2006, BIOL MAR MEDITERR, V13, P109; Boudouresque C.-F., 2012, PROTECTION CONSERVAT; Boudouresque C.F., 1983, J RECH OCEANOGR, V8, P99; Boudouresque CF, 1984, INT WORKSHOP POSIDON, P185; Boudouresque CF, 1983, RAPP PV REUN COMM IN, V28, P111; Boudouresque CF, 2007, DEV AQUAC FISH SCI, V37, P243; Boudouresque CF, 2013, DEV AQUAC FISH SCI, V38, P297, DOI 10.1016/B978-0-12-396491-5.00021-6; Boudouresque CF, 2009, BOT MAR, V52, P395, DOI 10.1515/BOT.2009.057; Christensen V, 2011, ECOSYSTEM APPROACH F; Coles R, 2013, SEAGRASS WATCH, V47, P2; DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458; Di Maida G, 2013, MAR ENVIRON RES, V87-88, P96, DOI [10.1016/j.marenvres.2013.04.001, 10.1016/j.marenvres2013.04.001]; Diaz RJ, 2004, J ENVIRON MANAGE, V73, P165, DOI 10.1016/j.jenvman.2004.06.004; Fernandez-Torquemada Y, 2008, ICES J MAR SCI, V65, P1492, DOI 10.1093/icesjms/fsn146; Ferrari B, 2008, AQUAT BOT, V88, P295, DOI 10.1016/j.aquabot.2007.12.002; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Francour P, 1996, BIRD STUDY, V43, P129, DOI 10.1080/00063659609461004; FRANCOUR P, 1995, HYDROBIOLOGIA, V300, P345, DOI 10.1007/BF00024475; Francour P, 1997, MAR ECOL-P S Z N I, V18, P157, DOI 10.1111/j.1439-0485.1997.tb00434.x; Francour Patrice, 1995, Travaux Scientifiques du Parc Naturel Regional et des Reserves Naturelles de Corse, V53, P11; Gacia E, 1999, AQUAT BOT, V65, P255, DOI 10.1016/S0304-3770(99)00044-3; Garcia-March JR, 2007, MAR BIOL, V150, P861, DOI 10.1007/s00227-006-0386-1; Garcia-March JR, 2011, ACT C 2011 SOC ZOOL, P80; Garcia-Marin P, 2013, MAR POLLUT BULL, V68, P46, DOI 10.1016/j.marpolbul.2012.12.025; Giovannetti E, 2010, MAR POLLUT BULL, V60, P1031, DOI 10.1016/j.marpolbul.2010.01.024; Giovannetti E, 2008, CHEM ECOL, V24, P145; Gobert S, 2009, MAR POLLUT BULL, V58, P1727, DOI 10.1016/j.marpolbul.2009.06.012; Guinda X, 2008, ECOL INDIC, V8, P743, DOI 10.1016/j.ecolind.2008.01.004; Guyot I, 1990, TRAV SCI PARC NAT RE, V28, P1; Harmelin-Vivien M.L., 1982, Travaux Scientifiques du Parc National de Port-Cros, V8, P69; HARMELINVIVIEN ML, 1992, MAR ECOL-P S Z N I, V13, P41, DOI 10.1111/j.1439-0485.1992.tb00338.x; HARMELINVIVIEN ML, 1995, HYDROBIOLOGIA, V300, P309, DOI 10.1007/BF00024471; Hoare JM, 2013, ECOL INDIC, V25, P23, DOI 10.1016/j.ecolind.2012.09.007; Infantes E, 2012, MAR ECOL PROG SER, V456, P63, DOI 10.3354/meps09754; Jimenez S., 1996, P375; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; KARR JR, 1981, FISHERIES, V6, P21, DOI 10.1577/1548-8446(1981)006<0021:AOBIUF>2.0.CO;2; Kenchington E, 2003, ICES J MAR SCI, V60, P1172, DOI 10.1016/S1054-3139(03)00136-X; LAWTON JH, 1994, OIKOS, V71, P367, DOI 10.2307/3545824; Le Direach L, 2007, SCI REP PORT GROS NA, V22, P17; Leriche A, 2006, AQUAT BOT, V84, P287, DOI 10.1016/j.aquabot.2005.10.001; Royo CLY, 2011, ECOL INDIC, V11, P557, DOI 10.1016/j.ecolind.2010.07.012; Royo CLY, 2010, ECOL INDIC, V10, P380, DOI 10.1016/j.ecolind.2009.07.005; Lopez-Saez JA, 2009, PALAEOGEOGR PALAEOCL, V271, P215, DOI 10.1016/j.palaeo.2008.10.020; Mabrouk L, 2013, AQUAT BOT, V108, P33, DOI 10.1016/j.aquabot.2013.03.002; Macquart-Moulin C, 1968, REC TRAV ST MAR END, V43, P311; Marba N, 2013, HYDROBIOLOGIA, V704, P265, DOI 10.1007/s10750-012-1403-7; Martin MA, 1994, TRABAJOS CAMPO RESER, P25; Martinez-Crego B, 2008, MAR ECOL PROG SER, V361, P93, DOI 10.3354/meps07358; Martinez-Crego B, 2010, J ENVIRON MONITOR, V12, P1013, DOI 10.1039/b920937a; Mascaro O, 2013, HYDROBIOLOGIA, V704, P279, DOI 10.1007/s10750-012-1426-0; Mateo MA, 1997, MAR ECOL PROG SER, V151, P43, DOI 10.3354/meps151043; Mateo MA, 2003, ESTUAR COAST SHELF S, V56, P85, DOI 10.1016/S0272-7714(02)00123-3; Mateo MA, 1997, ESTUAR COAST SHELF S, V44, P103, DOI 10.1006/ecss.1996.0116; Mazzuca S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00038; MEINESZ A, 1991, MAR POLLUT BULL, V23, P343, DOI 10.1016/0025-326X(91)90698-R; Mezali K., 2003, Bulletin de la Societe Zoologique de France, V128, P49; Molinier R., 1952, ANN I OCEANOGR PARIS, V27, P157; Montefalcone M, 2007, MAR POLLUT BULL, V54, P206, DOI 10.1016/j.marpolbul.2006.10.005; Montefalcone M, 2009, ECOL INDIC, V9, P595, DOI 10.1016/j.ecolind.2008.09.013; Morat F, 2011, VIE MILIEU, V61, P77; Morat F, 2007, REGIME ALIMENTAIRE P; Morena D, 2001, BIOL CONSERV, V102, P325, DOI 10.1016/S0006-3207(01)00080-5; Naranjo SA, 1996, MAR ECOL PROG SER, V144, P119, DOI 10.3354/meps144119; Oliva S, 2012, ESTUAR COAST SHELF S, V114, P7, DOI 10.1016/j.ecss.2011.08.022; Orfanidis S, 2011, MEDITERR MAR SCI, V12, P199, DOI 10.12681/mms.60; Orfanidis S., 2003, ECOL INDIC, V3, P27, DOI DOI 10.1016/S1470-160X(03)00008-6; Orfanidis S., 2001, MEDITERRANEAN MARINE, V2, P45, DOI [DOI 10.12681/MMS.266, 10.12681/mms.266]; PANAYOTIDIS P, 1981, BOT MAR, V24, P115, DOI 10.1515/botm.1981.24.3.115; Panayotidis P, 1999, ESTUAR COAST SHELF S, V48, P205, DOI 10.1006/ecss.1998.0411; Parravicini V, 2012, ECOL INDIC, V19, P253, DOI 10.1016/j.ecolind.2011.07.027; Peirano A, 2001, SCI MAR, V65, P367, DOI 10.3989/scimar.2001.65n4367; Peres J. M., 1964, Recueil des Travaux de la Station Marine de l'Endoume, VNo. 47, P3; Pergent G, 1997, AQUAT BOT, V59, P307, DOI 10.1016/S0304-3770(97)00052-1; PERGENT G, 1991, AQUAT BOT, V42, P49, DOI 10.1016/0304-3770(91)90105-E; PERGENT G, 1994, MAR ECOL PROG SER, V106, P139, DOI 10.3354/meps106139; PERGENT G, 1989, MAR ECOL-P S Z N I, V10, P221, DOI 10.1111/j.1439-0485.1989.tb00474.x; Pergent G., 2012, MEDITERRANEAN SEAGRA; Pergent G., 1995, M SOG E MARSEILLE, V54, P3; Pergent-Martini C, 2005, ECOL INDIC, V5, P213, DOI 10.1016/j.ecolind.2005.02.004; Pergent-Martini C, 2006, ENVIRON MANAGE, V38, P889, DOI 10.1007/s00267-005-0056-y; PERGENTMARTINI C, 1994, MAR BIOL, V120, P9; PERGENTMARTINI C, 1994, OCEANOL ACTA, V17, P673; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Prado P, 2007, MAR ECOL PROG SER, V340, P63, DOI 10.3354/meps340063; Rice JC, 2005, MAR ECOL PROG SER, V300, P265; ROMERO J, 1992, MAR ECOL-P S Z N I, V13, P69, DOI 10.1111/j.1439-0485.1992.tb00341.x; Romero J, 2012, FONS MARI ILLES MEDE, P81; Romero J, 2007, MAR POLLUT BULL, V55, P196, DOI 10.1016/j.marpolbul.2006.08.032; Rosenberg AA, 2005, MAR ECOL PROG SER, V300, P270; Rouanet E, 2012, SUIVI HERBIER POSIDO; Ruiz JM, 2009, BOT MAR, V52, P369, DOI 10.1515/BOT.2009.058; Sala E, 2004, ECOSYSTEMS, V7, P333, DOI 10.1007/s10021-003-0241-x; Sanchez-Gonzalez JF, 2011, J HYDRAUL RES, V49, P503, DOI 10.1080/00221686.2011.552464; Sartoretto S, 2011, DCSMMEIEEMO224C MIN; Short F.T., 2002, SEAGRASSNET MANUAL S; Thelin I, 1985, RAPP COMM INT MER ME, V29, P247; Thibault J.C., 2001, BALBUZARD PECHEUR CO; Tudela S, 2005, MAR ECOL PROG SER, V300, P282; Turrell B., 2004, EUROGOOS PUBL, V21, P1; UNEP-MAP-RAC/SPA, 2011, 10 M FOC POINTS SPAS; UNEP-MAP-RAC/SPA, 2011, 3599 UNEPDEPIMED WG; Urra J, 2013, ESTUAR COAST SHELF S, V117, P136, DOI 10.1016/j.ecss.2012.11.005; van der Ben D, 1971, MEM I R SCI NAT BELG, V168; Van Hoey G, 2010, MAR POLLUT BULL, V60, P2187, DOI 10.1016/j.marpolbul.2010.09.015; Verlaque M., 1981, Rapports et Proces-Verbaux des Reunions Commission Internationale pour l'Exploration Scientifique de la Mer Mediterranee Monaco, V27, P201; Vicente N, 1993, QUALITE MILIEU MARIN, P141; Ward T. J., 2003, MARINE PROTECTED ARE; White J, 2003, AQUAT CONSERV, V13, P331, DOI 10.1002/aqc.586	121	67	68	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e98994	10.1371/journal.pone.0098994	http://dx.doi.org/10.1371/journal.pone.0098994			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933020	Green Published, gold			2022-12-25	WOS:000337738600017
J	Zhang, ZY; Xu, J; Ren, Y; Li, KKW; Ng, HK; Mao, Y; Zhong, P; Yao, Y; Zhou, LF				Zhang, Zhen-Yu; Xu, Jian; Ren, Yong; Li, Kay Ka-Wai; Ng, Ho-Keung; Mao, Ying; Zhong, Ping; Yao, Yu; Zhou, Liang-Fu			Medulloblastoma in China: Clinicopathologic Analyses of SHH, WNT, and Non-SHH/WNT Molecular Subgroups Reveal Different Therapeutic Responses to Adjuvant Chemotherapy	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; ADULT MEDULLOBLASTOMA; CHILDREN; RADIATION; SERIES; TUMORS	Medulloblastoma (MB) is one of the most common primary central nervous system tumors in children. Data is lacking of a large cohort of medulloblastoma patients in China. Also, our knowledge on the sensitivity of different molecular subgroups of MB to adjuvant radiation therapy (RT) or chemotherapy (CHT) is still limited. The authors performed a retrospective study of 173 medulloblastoma patients treated at two institutions from 2002 to 2011. Formalin-fixed paraffin embedded (FFPE) tissues were available in all the cases and sections were stained to classify histological and molecular subgroups. Univariate and multivariate analyses were used to investigate prognostic factors. Of 173 patients, there were 118 children and 55 adults, 112 males and 61 females. Estimated 5-year overall survival (OS) rates for all patients, children and adults were 52%, 48% and 63%, respectively. After multivariate analysis, postoperative primary radiation therapy (RT) and chemotherapy (CHT) were revealed as favorable prognostic factors influencing OS and EFS. Postoperative primary chemotherapy (CHT) was found significantly improving the survival of children (p<0.001) while it was not a significant prognostic factor for adult patients. Moreover, patients in WNT subtype had better OS (p=0.028) than others (SHH and Non-SHH/WNT subtypes) given postoperative adjuvant therapies. Postoperative primary RT was found to be a strong prognostic factor influencing the survival in all histological and molecular subgroups (p<0.001). Postoperative primary CHT was found significantly to influence the survival of classic medulloblastoma (CMB) (OS p<0.001, EFS p<0.001), SHH subgroup (OS p=0.020, EFS p=0.049) and WNT subgroup (OS p=0.003, EFS p=0.016) but not in desmoplastic/nodular medulloblastoma (DMB) (OS p=0.361, EFS p=0.834) and Non-SHH/WNT subgroup (OS p=0.127, EFS p=0.055). Our study showed postoperative primary CHT significantly influence the survival of CMB, SHH subgroup and WNT subgroup but not in DMB and Non-SHH/WNT subgroup of MB.	[Zhang, Zhen-Yu; Xu, Jian; Mao, Ying; Zhong, Ping; Yao, Yu; Zhou, Liang-Fu] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China; [Ren, Yong] Wuhan Gen Hosp Guangzhou Command, Dept Pathol, Peoples Liberat Army, Wuhan, Peoples R China; [Li, Kay Ka-Wai; Ng, Ho-Keung] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Hong Kong, Peoples R China	Fudan University; Chinese University of Hong Kong; Prince of Wales Hospital	Zhong, P; Yao, Y (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China.	zhp2288991@126.com; yu_yao03@126.com	Ng, Ho Keung/I-3952-2015	Mao, Ying/0000-0001-8055-115X	Shanghai Talents Development Funds [2011063]	Shanghai Talents Development Funds	This study was supported by Shanghai Talents Development Funds (No. 2011063 to YY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright AL, 1996, NEUROSURGERY, V38, P265, DOI 10.1097/00006123-199602000-00007; Brandes AA, 2007, CANCER-AM CANCER SOC, V110, P2035, DOI 10.1002/cncr.23003; CARRIE C, 1994, CANCER-AM CANCER SOC, V74, P2352, DOI 10.1002/1097-0142(19941015)74:8<2352::AID-CNCR2820740821>3.0.CO;2-H; Chan AW, 2000, NEUROSURGERY, V47, P623, DOI 10.1097/00006123-200009000-00018; Choux M, 1983, Clin Neurosurg, V30, P246; Curran EK, 2009, J NEURO-ONCOL, V95, P81, DOI 10.1007/s11060-009-9894-4; del Charco JO, 1998, INT J RADIAT ONCOL, V42, P147, DOI 10.1016/S0360-3016(98)00197-7; Ellison DW, 2011, ACTA NEUROPATHOL, V121, P381, DOI 10.1007/s00401-011-0800-8; FROST PJ, 1995, INT J RADIAT ONCOL, V32, P951, DOI 10.1016/0360-3016(94)00612-O; Gajjar A, 2006, LANCET ONCOL, V7, P813, DOI 10.1016/S1470-2045(06)70867-1; Herrlinger U, 2005, J NEUROL, V252, P291, DOI 10.1007/s00415-005-0560-2; Johnston DL, 2009, J NEURO-ONCOL, V94, P51, DOI 10.1007/s11060-009-9799-2; Johnstone PAS, 2002, CURR PROB CANCER, V26, P317, DOI 10.1067/mcn.2002.130267; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Liu YP, 2005, JPN J CLIN ONCOL, V35, P111, DOI 10.1093/jjco/hyi038; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Malheiros SMF, 2002, J NEURO-ONCOL, V60, P247, DOI 10.1023/A:1021178518361; Menon G, 2008, J CLIN NEUROSCI, V15, P122, DOI 10.1016/j.jocn.2007.06.007; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Packer R J, 1999, Neuro Oncol, V1, P232, DOI 10.1093/neuonc/1.3.232; PACKER RJ, 1994, J NEUROSURG, V81, P690, DOI 10.3171/jns.1994.81.5.0690; PACKER RJ, 1991, J NEUROSURG, V74, P433, DOI 10.3171/jns.1991.74.3.0433; Packer RJ, 2008, ARCH NEUROL-CHICAGO, V65, P1419, DOI 10.1001/archneur.65.11.1419; Padovani L, 2007, INT J RADIAT ONCOL, V68, P433, DOI 10.1016/j.ijrobp.2006.12.030; Rieken S, 2011, INT J RADIAT ONCOL, V81, pE7, DOI 10.1016/j.ijrobp.2010.12.042; Rieken S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-450; Riffaud L, 2009, J NEUROSURG, V111, P478, DOI 10.3171/2009.1.JNS081004; Roldan G, 2008, CAN J NEUROL SCI, V35, P210, DOI 10.1017/S0317167100008659; Sarkar C, 2002, J NEURO-ONCOL, V59, P49, DOI 10.1023/A:1016357731363; Sun LM, 2002, J NEURO-ONCOL, V58, P77, DOI 10.1023/A:1015865614640; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; von Hoff K, 2009, EUR J CANCER, V45, P1209, DOI 10.1016/j.ejca.2009.01.015; Weil MD, 1998, JAMA-J AM MED ASSOC, V279, P1474, DOI 10.1001/jama.279.18.1474; Whelan HT, 1998, PEDIATR NEUROL, V18, P103, DOI 10.1016/S0887-8994(97)00221-X; Wolff JEA, 1998, KLIN PADIATR, V210, P234, DOI 10.1055/s-2008-1043884; Wrensch M, 2002, NEURO-ONCOLOGY, V4, P278, DOI 10.1093/neuonc/4.4.278; Zeltzer PM, 1999, J CLIN ONCOL, V17, P832, DOI 10.1200/JCO.1999.17.3.832	37	15	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99490	10.1371/journal.pone.0099490	http://dx.doi.org/10.1371/journal.pone.0099490			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932704	gold, Green Published			2022-12-25	WOS:000337738600036
J	Brancato, A; Plescia, F; Marino, RAM; Maniaci, G; Navarra, M; Cannizzaro, C				Brancato, Anna; Plescia, Fulvio; Marino, Rosa Anna Maria; Maniaci, Giuseppe; Navarra, Michele; Cannizzaro, Carla			Involvement of Dopamine D2 Receptors in Addictive-Like Behaviour for Acetaldehyde	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; DRUG-ADDICTION; NEGATIVE REINFORCEMENT; ETHANOL OXIDATION; ALCOHOL ADDICTION; NEURONAL-ACTIVITY; IN-VIVO; RAT; BRAIN	Acetaldehyde, the first metabolite of ethanol, is active in the central nervous system, where it exerts motivational properties. Acetaldehyde is able to induce drinking behaviour in operant-conflict paradigms that resemble the core features of the addictive phenotype: drug-intake acquisition and maintenance, drug-seeking, relapse and drug use despite negative consequences. Since acetaldehyde directly stimulates dopamine neuronal firing in the mesolimbic system, the aim of this study was the investigation of dopamine D2-receptors' role in the onset of the operant drinking behaviour for acetaldehyde in different functional stages, by the administration of two different D2-receptor agonists, quinpirole and ropinirole. Our results show that acetaldehyde was able to induce and maintain a drug-taking behaviour, displaying an escalation during training, and a reinstatement behaviour after 1-week forced abstinence. Acetaldehyde operant drinking behaviour involved D2-receptor signalling: in particular, quinpirole administration at 0.03 mg/kg, induced a significant decrease in the number of lever presses both in extinction and in relapse. Ropinirole, administered at 0.03 mg/kg during extinction, did not produce any modification but, when administered during abstinence, induced a strong decrease in acetaldehyde intake in the following relapse session. Taken together, our data suggest that acetaldehyde exerts its own motivational properties, involving the dopaminergic transmission: indeed, activation of pre-synaptic D2-receptors by quinpirole, during extinction and relapse, negatively affects operant behaviour for acetaldehyde, likely decreasing acetaldehyde-induced dopamine release. The activation of post-synaptic D2-receptors by ropinirole, during abstinence, decreases the motivation to the consecutive reinstatement of acetaldehyde drinking behaviour, likely counteracting the reduction in the dopaminergic tone typical of withdrawal. These data further strengthen the evidence that acetaldehyde may play a crucial role as mediator of ethanol's central effects.	[Brancato, Anna; Plescia, Fulvio; Marino, Rosa Anna Maria; Maniaci, Giuseppe; Cannizzaro, Carla] Univ Palermo, Dept Sci Hlth Promot & Mother & Child Care G DAle, Palermo, Italy; [Navarra, Michele] Univ Messina, Dept Drug Sci & Prod Hlth, Messina, Italy	University of Palermo; University of Messina	Cannizzaro, C (corresponding author), Univ Palermo, Dept Sci Hlth Promot & Mother & Child Care G DAle, Palermo, Italy.	carla.cannizzaro@unipa.it	Plescia, Fulvio/AAZ-2591-2020; Brancato, Anna/P-7418-2017	Brancato, Anna/0000-0002-8635-4146; MANIACI, Giuseppe/0000-0001-7484-7704; PLESCIA, Fulvio/0000-0002-4786-8435; CANNIZZARO, Carla/0000-0002-7351-1712; Navarra, Michele/0000-0002-6492-7820	Department of Drug Sciences and Products for Health - University of Messina, Italy	Department of Drug Sciences and Products for Health - University of Messina, Italy	The research was supported by a grant from the Department of Drug Sciences and Products for Health - University of Messina, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao KP, 2012, NEUROPHARMACOLOGY, V62, P882, DOI 10.1016/j.neuropharm.2011.09.017; Ahmed SH, 2005, PSYCHOPHARMACOLOGY, V180, P473, DOI 10.1007/s00213-005-2180-z; Alen F, 2008, EUR J NEUROSCI, V27, P3292, DOI 10.1111/j.1460-9568.2008.06302.x; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Blum K, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-24; Broadbent J, 2005, ALCOHOL, V35, P137, DOI 10.1016/j.alcohol.2005.03.006; Brooks DJ, 1998, CLIN NEUROPHARMACOL, V21, P101; BROWN ZW, 1979, PSYCHOPHARMACOLOGY, V64, P271, DOI 10.1007/BF00427509; BROWN ZW, 1983, ALCOHOL CLIN EXP RES, V7, P276, DOI 10.1111/j.1530-0277.1983.tb05459.x; Cacace S, 2012, ALCOHOL CLIN EXP RES, V36, P1278, DOI 10.1111/j.1530-0277.2011.01725.x; Cannizzaro C., 2011, Malta Medical Journal, V23, P27; Cannizzaro C, 2010, ALCOHOL CLIN EXP RES, V34, P588, DOI 10.1111/j.1530-0277.2009.01127.x; Cohen C, 1998, PSYCHOPHARMACOLOGY, V140, P478, DOI 10.1007/s002130050792; Colombo G, 1998, ALCOHOL ALCOHOLISM, V33, P126; Correa M, 2012, NEUROSCI BIOBEHAV R, V36, P404, DOI 10.1016/j.neubiorev.2011.07.009; De Mei C, 2009, CURR OPIN PHARMACOL, V9, P53, DOI 10.1016/j.coph.2008.12.002; Deehan GA, 2013, ALCOHOL CLIN EXP RES, V37, P722, DOI 10.1111/acer.12034; Deehan GA, 2013, CURR TOP BEHAV NEURO, V13, P163, DOI 10.1007/7854_2011_198; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Diana M, 1998, P NATL ACAD SCI USA, V95, P10269, DOI 10.1073/pnas.95.17.10269; DIANA M, 1993, P NATL ACAD SCI USA, V90, P7966, DOI 10.1073/pnas.90.17.7966; DIANA M, 1995, J PHARMACOL EXP THER, V272, P781; Diana Marco, 2011, Front Psychiatry, V2, P64, DOI 10.3389/fpsyt.2011.00064; Edwards S, 2013, BEHAV PHARMACOL, V24, P356, DOI 10.1097/FBP.0b013e3283644d15; Emilien G, 1999, PHARMACOL THERAPEUT, V84, P133, DOI 10.1016/S0163-7258(99)00029-7; Enrico P, 2009, DRUG ALCOHOL DEPEN, V100, P265, DOI 10.1016/j.drugalcdep.2008.10.010; Epping-Jordan MP, 1998, NATURE, V393, P76, DOI 10.1038/30001; Escrig MA, 2012, PHARMACOL BIOCHEM BE, V100, P404, DOI 10.1016/j.pbb.2011.10.002; Foddai M, 2004, NEUROPSYCHOPHARMACOL, V29, P530, DOI 10.1038/sj.npp.1300326; Franklin KM, 2009, ALCOHOL CLIN EXP RES, V33, P1721, DOI 10.1111/j.1530-0277.2009.01009.x; FURMIDGE L, 1991, J NEURAL TRANSM-GEN, V86, P61, DOI 10.1007/BF01250376; GINGRICH JA, 1993, ANNU REV NEUROSCI, V16, P299, DOI 10.1146/annurev.ne.16.030193.001503; GRACE AA, 1985, BRAIN RES, V333, P285, DOI 10.1016/0006-8993(85)91582-3; Heinz A, 2005, AM J PSYCHIAT, V162, P1515, DOI 10.1176/appi.ajp.162.8.1515; HIETALA J, 1994, PSYCHOPHARMACOLOGY, V116, P285, DOI 10.1007/BF02245330; Hoefer ME, 2006, PHARMACOL BIOCHEM BE, V83, P403, DOI 10.1016/j.pbb.2006.02.023; HOOVER DJ, 1981, CAN J PHYSIOL PHARM, V59, P65, DOI 10.1139/y81-011; Hunt WA, 1996, ALCOHOL, V13, P147, DOI 10.1016/0741-8329(95)02026-8; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; June HL, 2010, CURRENT PROTOCOLS NE, P1; Karahanian E, 2015, ADDICT BIOL, V20, P336, DOI 10.1111/adb.12130; Karahanian E, 2011, ALCOHOL CLIN EXP RES, V35, P606, DOI 10.1111/j.1530-0277.2011.01439.x; Katz JL, 2003, PSYCHOPHARMACOLOGY, V168, P21, DOI 10.1007/s00213-003-1441-y; Koob George F, 2013, Front Psychiatry, V4, P72, DOI 10.3389/fpsyt.2013.00072; Koob GF, 2013, CURR OPIN NEUROBIOL, V23, P559, DOI 10.1016/j.conb.2013.03.011; Koob GF, 2013, CURR TOP BEHAV NEURO, V13, P3, DOI 10.1007/7854_2011_129; LACEY MG, 1987, J PHYSIOL-LONDON, V392, P397, DOI 10.1113/jphysiol.1987.sp016787; Lieber CS, 1999, ALCOHOL CLIN EXP RES, V23, P991, DOI 10.1111/j.1530-0277.1999.tb04217.x; LIEBER CS, 1968, SCIENCE, V162, P917, DOI 10.1126/science.162.3856.917; Maremmani Angelo Giovanni Icro, 2011, Front Psychiatry, V2, P50, DOI 10.3389/fpsyt.2011.00050; Martinez D, 2005, BIOL PSYCHIAT, V58, P779, DOI 10.1016/j.biopsych.2005.04.044; McBride WJ, 2002, ALCOHOL CLIN EXP RES, V26, P114, DOI 10.1097/00000374-200201000-00016; Meini M, 2011, CURR PHARM DESIGN, V17, P1376, DOI 10.2174/138161211796150783; Melis M, 2007, EUR J NEUROSCI, V26, P2824, DOI 10.1111/j.1460-9568.2007.05887.x; Melis M, 2005, INT REV NEUROBIOL, V63, P101, DOI 10.1016/S0074-7742(05)63005-X; Muggironi G, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00087; MYERS WD, 1982, PHARMACOL BIOCHEM BE, V17, P807, DOI 10.1016/0091-3057(82)90364-1; NUUTINEN H, 1983, ALCOHOL CLIN EXP RES, V7, P163, DOI 10.1111/j.1530-0277.1983.tb05432.x; Panin F, 2012, J PHARMACOL TOX MET, V65, P83, DOI 10.1016/j.vascn.2012.01.003; Peana AT, 2011, ALCOHOL, V45, P773, DOI 10.1016/j.alcohol.2011.06.003; Peana Alessandra T, 2010, Front Psychiatry, V1, P23, DOI 10.3389/fpsyt.2010.00023; Perra S, 2011, NEUROPSYCHOPHARMACOL, V36, P993, DOI 10.1038/npp.2010.237; Picetti R, 1997, CRIT REV NEUROBIOL, V11, P121, DOI 10.1615/CritRevNeurobiol.v11.i2-3.20; Plescia F, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00064; Quertemont E, 2005, ALCOHOL CLIN EXP RES, V29, P221, DOI 10.1097/01.ALC.0000156185.39073.D2; Quertemont E, 2004, MOL PSYCHIATR, V9, P570, DOI 10.1038/sj.mp.4001497; Quertemont E, 2001, PHARMACOL BIOCHEM BE, V68, P449, DOI 10.1016/S0091-3057(00)00486-X; Reichel Carmela M, 2009, Curr Drug Abuse Rev, V2, P184; Richtand NM, 2001, J ADDICT DIS, V20, P19, DOI 10.1300/J069v20n03_03; Rodd ZA, 2005, NEUROPSYCHOPHARMACOL, V30, P330, DOI 10.1038/sj.npp.1300561; Rodd-Henricks ZA, 2002, PHARMACOL BIOCHEM BE, V72, P55, DOI 10.1016/S0091-3057(01)00733-X; ROSSETTI ZL, 1992, ALCOHOL CLIN EXP RES, V16, P529, DOI 10.1111/j.1530-0277.1992.tb01411.x; Salamone JD, 1997, NEUROSCI BIOBEHAV R, V21, P341, DOI 10.1016/S0149-7634(96)00017-6; Samson HH, 1998, ALCOHOL CLIN EXP RES, V22, P1783, DOI 10.1097/00000374-199811000-00023; Sanchis-Segura C, 2006, ADDICT BIOL, V11, P2, DOI 10.1111/j.1369-1600.2006.00012.x; Segovia KN, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00048; SESACK SR, 1994, J NEUROSCI, V14, P88; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P1, DOI 10.1007/s00213-003-1469-z; SMITH B R, 1984, Alcohol, V1, P193, DOI 10.1016/0741-8329(84)90097-1; Soderpalm B, 2013, CURR TOP BEHAV NEURO, V13, P127, DOI 10.1007/7854_2011_170; Spanagel R, 2000, ALCOHOL RES HEALTH, V24, P124; TAKAHASHI T, 1993, HEPATOLOGY, V17, P236, DOI 10.1016/0270-9139(93)90083-Y; Thanos PK, 2008, SYNAPSE, V62, P481, DOI 10.1002/syn.20523; Thielen RJ, 2004, J PHARMACOL EXP THER, V309, P216, DOI 10.1124/jpet.103.059790; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; VIDAILHET MJ, 1990, LANCET, V336, P316, DOI 10.1016/0140-6736(90)91855-5; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022; Volkow ND, 2002, PSYCHIAT RES-NEUROIM, V116, P163, DOI 10.1016/S0925-4927(02)00087-2; Ward RJ, 1997, NEUROPHARMACOLOGY, V36, P225, DOI 10.1016/S0028-3908(97)00007-5; Weiss F, 1996, J NEUROSCI, V16, P3474; WESTCOTT JY, 1980, BIOCHEM PHARMACOL, V29, P411, DOI 10.1016/0006-2952(80)90521-3; Westerlund M, 2007, FEBS J, V274, P1212, DOI 10.1111/j.1742-4658.2007.05665.x; WIDZOWSKI DV, 1993, J PHARMACOL EXP THER, V266, P526; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; ZIMATKIN SM, 1991, J NEUROCHEM, V56, P1, DOI 10.1111/j.1471-4159.1991.tb02555.x	98	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99454	10.1371/journal.pone.0099454	http://dx.doi.org/10.1371/journal.pone.0099454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926837	gold, Green Published			2022-12-25	WOS:000338278100041
J	Brossi, MJDL; Mendes, LW; Germano, MG; Lima, AB; Tsai, SM				de Lima Brossi, Maria Julia; Mendes, Lucas William; Germano, Mariana Gomes; Lima, Amanda Barbosa; Tsai, Siu Mui			Assessment of Bacterial bph Gene in Amazonian Dark Earth and Their Adjacent Soils	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; MICROBIAL COMMUNITIES; DIOXYGENASE GENES; HYDROCARBON DEGRADATION; SUSTAINABLE AGRICULTURE; FUNCTIONAL DIVERSITY; TERRA-PRETA; ANTHROSOLS; CLASSIFICATION; IDENTIFICATION	Amazonian Anthrosols are known to harbour distinct and highly diverse microbial communities. As most of the current assessments of these communities are based on taxonomic profiles, the functional gene structure of these communities, such as those responsible for key steps in the carbon cycle, mostly remain elusive. To gain insights into the diversity of catabolic genes involved in the degradation of hydrocarbons in anthropogenic horizons, we analysed the bacterial bph gene community structure, composition and abundance using T-RFLP, 454-pyrosequencing and quantitative PCR essays, respectively. Soil samples were collected in two Brazilian Amazon Dark Earth (ADE) sites and at their corresponding non-anthropogenic adjacent soils (ADJ), under two different land use systems, secondary forest (SF) and manioc cultivation (M). Redundancy analysis of T-RFLP data revealed differences in bph gene structure according to both soil type and land use. Chemical properties of ADE soils, such as high organic carbon and organic matter, as well as effective cation exchange capacity and pH, were significantly correlated with the structure of bph communities. Also, the taxonomic affiliation of bph gene sequences revealed the segregation of community composition according to the soil type. Sequences at ADE sites were mostly affiliated to aromatic hydrocarbon degraders belonging to the genera Streptomyces, Sphingomonas, Rhodococcus, Mycobacterium, Conexibacter and Burkholderia. In both land use sites, shannon's diversity indices based on the bph gene data were higher in ADE than ADJ soils. Collectively, our findings provide evidence that specific properties in ADE soils shape the structure and composition of bph communities. These results provide a basis for further investigations focusing on the bio-exploration of novel enzymes with potential use in the biotechnology/biodegradation industry.	[de Lima Brossi, Maria Julia; Mendes, Lucas William; Lima, Amanda Barbosa; Tsai, Siu Mui] Univ Sao Paulo, Ctr Nucl Energy Agr, Cellular & Mol Biol Lab, Piracicaba, SP, Brazil; [Germano, Mariana Gomes] Embrapa Soybean, Brazilian Agr Res Corp, Londrina, PR, Brazil	Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Brossi, MJDL (corresponding author), Univ Sao Paulo, Ctr Nucl Energy Agr, Cellular & Mol Biol Lab, Piracicaba, SP, Brazil.	majubrossi@gmail.com	Fapesp, Biota/F-8655-2017; Tsai, Siu Mui/C-2793-2012; Mendes, Lucas William/E-5719-2011	Fapesp, Biota/0000-0002-9887-8449; Tsai, Siu Mui/0000-0002-3733-6312; Mendes, Lucas William/0000-0003-0980-7006	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP/Biota 2011/50914-3]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico de Amparo a Pesquisa do Estado de Sao Paulo	Funding provided by 'Conselho Nacional de Desenvolvimento Cientifico e Tecnologico de Amparo a Pesquisa do Estado de Sao Paulo' (FAPESP/Biota 2011/50914-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Anderson CR, 2011, PEDOBIOLOGIA, V54, P309, DOI 10.1016/j.pedobi.2011.07.005; Arthur E, 2012, GEODERMA, V173, P50, DOI 10.1016/j.geoderma.2012.01.007; Bernhard AE, 2005, FEMS MICROBIOL ECOL, V52, P115, DOI 10.1016/j.femsec.2004.10.016; Bissett A, 2013, ECOL LETT, V16, P128, DOI 10.1111/ele.12109; Buckley DH, 2003, ENVIRON MICROBIOL, V5, P441, DOI 10.1046/j.1462-2920.2003.00404.x; Buckley DH, 2001, MICROB ECOL, V42, P11, DOI 10.1007/s002480000108; Bunemann EK, 2008, BIOL FERT SOILS, V44, P717, DOI 10.1007/s00374-007-0254-2; Butler CS, 1997, ADV MICROB PHYSIOL, V38, P47; Cannavan FS, 2012, ESTRUTURA COMPOSICAI; Claessen MEC, 1997, ANAL QUINICAS AVALIA; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Culman SW, 2008, J MICROBIOL METH, V75, P55, DOI 10.1016/j.mimet.2008.04.011; Cunha TJF, 2009, TERRAS PRETAS INDIO, P264; Demaneche S, 2004, APPL ENVIRON MICROB, V70, P6714, DOI 10.1128/AEM.70.11.6714-6725.2004; Ding GC, 2010, APPL ENVIRON MICROB, V76, P4765, DOI 10.1128/AEM.00047-10; Falcao N., 2009, TERRAS PRETAS INDIO, P189; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fitter AH, 2005, FUNCT ECOL, V19, P369, DOI 10.1111/j.0269-8463.2005.00969.x; Flocco CG, 2009, ENVIRON MICROBIOL, V11, P700, DOI 10.1111/j.1462-2920.2008.01858.x; Germano MG, 2012, PESQUI AGROPECU BRAS, V47, P654, DOI 10.1590/S0100-204X2012000500004; Gibson DT, 2000, CURR OPIN BIOTECH, V11, P236, DOI 10.1016/S0958-1669(00)00090-2; Glaser B, 2001, NATURWISSENSCHAFTEN, V88, P37, DOI 10.1007/s001140000193; Glaser B, 2007, PHILOS T R SOC B, V362, P187, DOI 10.1098/rstb.2006.1978; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Goris J, 2004, INT J SYST EVOL MICR, V54, P1677, DOI 10.1099/ijs.0.63101-0; Gregory AS, 2007, EUR J SOIL SCI, V58, P1221, DOI 10.1111/j.1365-2389.2007.00956.x; Grossman JM, 2010, MICROB ECOL, V60, P192, DOI 10.1007/s00248-010-9689-3; Hayaishi O, 1962, OXYGENASES, P1; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Horner-Devine MC, 2004, P ROY SOC B-BIOL SCI, V271, P113, DOI 10.1098/rspb.2003.2549; Iwai S, 2010, ISME J, V4, P279, DOI 10.1038/ismej.2009.104; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; Khan AA, 2001, APPL ENVIRON MICROB, V67, P3577, DOI 10.1128/AEM.67.8.3577-3585.2001; Kim JS, 2007, SOIL BIOL BIOCHEM, V39, P684, DOI 10.1016/j.soilbio.2006.08.010; Krivobok S, 2003, J BACTERIOL, V185, P3828, DOI 10.1128/JB.185.13.3828-3841.2003; Kweon Ohgew, 2008, BMC Biochemistry, V9, P11, DOI 10.1186/1471-2091-9-11; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lehmann J, 2003, PLANT SOIL, V249, P343, DOI 10.1023/A:1022833116184; Leigh MB, 2007, ISME J, V1, P134, DOI 10.1038/ismej.2007.26; Leys NMEJ, 2004, APPL ENVIRON MICROB, V70, P1944, DOI 10.1128/AEM.70.4.1944-1955.2004; Liang BQ, 2010, ORG GEOCHEM, V41, P206, DOI 10.1016/j.orggeochem.2009.09.007; Lima AB, 2012, INFLUENCIA COBERTURA; Luz AP, 2004, CAN J MICROBIOL, V50, P323, DOI 10.1139/W04-008; MASON JR, 1992, ANNU REV MICROBIOL, V46, P277, DOI 10.1146/annurev.mi.46.100192.001425; Miller CD, 2004, MICROB ECOL, V48, P230, DOI 10.1007/s00248-003-1044-5; Murphy DV, 2011, SOIL RES, V49, P582, DOI 10.1071/SR11203; Navarrete A. A., 2010, Diversity, V2, P787; Nicol GW, 2006, ENVIRON MICROBIOL, V8, P1382, DOI 10.1111/j.1462-2920.2006.01031.x; Nielsen UN, 2010, J BIOGEOGR, V37, P1317, DOI 10.1111/j.1365-2699.2010.02281.x; O'Neill B, 2009, MICROB ECOL, V58, P23, DOI 10.1007/s00248-009-9515-y; Ricklefs RE., 1999, ECOLOGY; Rodrigues JLM, 2013, P NATL ACAD SCI USA, V110, P988, DOI 10.1073/pnas.1220608110; Schjonning P, 2004, MANAGING SOIL QUALITY: CHALLENGES IN MODERN AGRICULTURE, P1, DOI 10.1079/9780851996714.0001; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Taketani RG, 2013, ANTON LEEUW INT J G, V104, P233, DOI 10.1007/s10482-013-9942-0; Taketani RG, 2010, MICROB ECOL, V59, P734, DOI 10.1007/s00248-010-9638-1; Tancsics A, 2010, SYST APPL MICROBIOL, V33, P398, DOI 10.1016/j.syapm.2010.08.005; Teixeira WG, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P271, DOI 10.1007/1-4020-2597-1_15; Thies J, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P287, DOI 10.1007/1-4020-2597-1_16; Vogel TM, 2009, NAT REV MICROBIOL, V7, P252, DOI 10.1038/nrmicro2119; Wackett LP, 2004, J BIOL CHEM, V279, P41259, DOI 10.1074/jbc.R400014200; Wawrik B, 2005, APPL ENVIRON MICROB, V71, P6776, DOI 10.1128/AEM.71.11.6776-6783.2005; Wessen E, 2010, SOIL BIOL BIOCHEM, V42, P1759, DOI 10.1016/j.soilbio.2010.06.013; Zhou HW, 2006, FEMS MICROBIOL LETT, V262, P148, DOI 10.1111/j.1574-6968.2006.00379.x; Zhou JZ, 2002, APPL ENVIRON MICROB, V68, P326, DOI 10.1128/AEM.68.1.326-334.2002	67	19	21	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99597	10.1371/journal.pone.0099597	http://dx.doi.org/10.1371/journal.pone.0099597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927167	Green Submitted, Green Published, gold			2022-12-25	WOS:000338278100052
J	Matos, DA; Cole, BJ; Whitney, IP; MacKinnon, KJM; Kay, SA; Hazen, SP				Matos, Dominick A.; Cole, Benjamin J.; Whitney, Ian P.; MacKinnon, Kirk J. -M.; Kay, Steve A.; Hazen, Samuel P.			Daily Changes in Temperature, Not the Circadian Clock, Regulate Growth Rate in Brachypodium distachyon	PLOS ONE			English	Article							LEAF GROWTH; ARABIDOPSIS-THALIANA; DIURNAL-VARIATION; STEM ELONGATION; NATURAL VARIATION; WATER DEFICIT; TOMATO PLANTS; ROOT-GROWTH; MAIZE; LEAVES	Plant growth is commonly regulated by external cues such as light, temperature, water availability, and internal cues generated by the circadian clock. Changes in the rate of growth within the course of a day have been observed in the leaves, stems, and roots of numerous species. However, the relative impact of the circadian clock on the growth of grasses has not been thoroughly characterized. We examined the influence of diurnal temperature and light changes, and that of the circadian clock on leaf length growth patterns in Brachypodium distachyon using high-resolution time-lapse imaging. Pronounced changes in growth rate were observed under combined photocyles and thermocycles or with thermocycles alone. A considerably more rapid growth rate was observed at 28 degrees C than 12 degrees C, irrespective of the presence or absence of light. In spite of clear circadian clock regulated gene expression, plants exhibited no change in growth rate under conditions of constant light and temperature, and little or no effect under photocycles alone. Therefore, temperature appears to be the primary cue influencing observed oscillations in growth rate and not the circadian clock or photoreceptor activity. Furthermore, the size of the leaf meristem and final cell length did not change in response to changes in temperature. Therefore, the nearly five-fold difference in growth rate observed across thermocycles can be attributed to proportionate changes in the rate of cell division and expansion. A better understanding of the growth cues in B. distachyon will further our ability to model metabolism and biomass accumulation in grasses.	[Matos, Dominick A.; Whitney, Ian P.; MacKinnon, Kirk J. -M.; Hazen, Samuel P.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Matos, Dominick A.; Whitney, Ian P.] Univ Massachusetts, Mol & Cellular Biol Grad Program, Amherst, MA 01003 USA; [Cole, Benjamin J.; Kay, Steve A.] Univ So Calif, Mol & Computat Biol Sect, Los Angeles, CA USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Southern California	Hazen, SP (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	hazen@bio.umass.edu	Kay, Steve A/F-6025-2011	Kay, Steve A/0000-0002-0402-2878; Cole, Benjamin/0000-0001-9652-624X; Hazen, Samuel/0000-0001-9131-8994; MacKinnon, Kirk/0000-0001-9698-3985	Office of Science, Biological and Environmental Research, Department of Energy [DE-FG02-08ER64700DE, DE-SC0006621]	Office of Science, Biological and Environmental Research, Department of Energy(United States Department of Energy (DOE))	This work was supported by Office of Science, Biological and Environmental Research, Department of Energy [DE-FG02-08ER64700DE and DE-SC0006621 to S.P.H. and S.A.K.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ACEVEDO E, 1979, PLANT PHYSIOL, V64, P476, DOI 10.1104/pp.64.3.476; Ainsworth EA, 2005, J PLANT RES, V118, P343, DOI 10.1007/s10265-005-0227-1; BENHAJSALAH H, 1995, PLANT PHYSIOL, V109, P861, DOI 10.1104/pp.109.3.861; BERTRAM L, 1994, SCI HORTIC-AMSTERDAM, V58, P139, DOI 10.1016/0304-4238(94)90134-1; Bertram L, 1997, PHOTOCHEM PHOTOBIOL, V66, P396, DOI 10.1111/j.1751-1097.1997.tb03164.x; Brkljacic J, 2011, PLANT PHYSIOL, V157, P3, DOI 10.1104/pp.111.179531; BUSSO CA, 1992, PLANT CELL ENVIRON, V15, P855, DOI 10.1111/j.1365-3040.1992.tb02154.x; Campoli C, 2013, NEW PHYTOL, V199, P1045, DOI 10.1111/nph.12346; Campoli C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-97; Cole B, 2011, PLANT J, V65, P991, DOI 10.1111/j.1365-313X.2010.04476.x; CUTLER JM, 1980, PLANT PHYSIOL, V66, P147, DOI 10.1104/pp.66.1.147; DAVIES WJ, 1983, J EXP BOT, V34, P987, DOI 10.1093/jxb/34.8.987; Devlin PF, 2001, ANNU REV PHYSIOL, V63, P677, DOI 10.1146/annurev.physiol.63.1.677; Dhugga KS, 2007, CROP SCI, V47, P2211, DOI 10.2135/cropsci2007.05.0299; Dohleman FG, 2009, PLANT PHYSIOL, V150, P2104, DOI 10.1104/pp.109.139162; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; DURAND JL, 1995, J EXP BOT, V46, P1147, DOI 10.1093/jxb/46.9.1147; Farre EM, 2012, PLANT BIOLOGY, V14, P401, DOI 10.1111/j.1438-8677.2011.00548.x; Faure S, 2012, P NATL ACAD SCI USA, V109, P8328, DOI 10.1073/pnas.1120496109; GALLAGHER JN, 1978, J AGR SCI-CAMBRIDGE, V91, P47, DOI 10.1017/S0021859600056616; Granier C, 2006, NEW PHYTOL, V169, P623, DOI 10.1111/j.1469-8137.2005.01609.x; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Hong SY, 2010, PLANT MOL BIOL, V72, P485, DOI 10.1007/s11103-009-9586-7; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Iijima M, 2011, J PLANT PHYSIOL, V168, P2072, DOI 10.1016/j.jplph.2011.06.005; Imaizumi T, 2010, CURR OPIN PLANT BIOL, V13, P83, DOI 10.1016/j.pbi.2009.09.007; Izawa T, 2011, PLANT CELL, V23, P1741, DOI 10.1105/tpc.111.083238; Jansen M, 2009, FUNCT PLANT BIOL, V36, P902, DOI 10.1071/FP09095; JOHNSON WC, 1967, AGRON J, V59, P41, DOI 10.2134/agronj1967.00021962005900010012x; KEMP DR, 1980, J EXP BOT, V31, P821, DOI 10.1093/jxb/31.3.821; LANCASHIRE PD, 1991, ANN APPL BIOL, V119, P561, DOI 10.1111/j.1744-7348.1991.tb04895.x; Matsubara K, 2012, PLANT CELL PHYSIOL, V53, P709, DOI 10.1093/pcp/pcs028; MCDONALD AJS, 1992, TREE PHYSIOL, V11, P123, DOI 10.1093/treephys/11.2.123; MEIJER G, 1968, ACTA BOT NEERL, V17, P9, DOI 10.1111/j.1438-8677.1968.tb00060.x; Michael TP, 2008, PLOS BIOL, V6, P1887, DOI 10.1371/journal.pbio.0060225; Miller ND, 2007, PLANT J, V52, P374, DOI 10.1111/j.1365-313X.2007.03237.x; Murakami M, 2003, PLANT CELL PHYSIOL, V44, P1229, DOI 10.1093/pcp/pcg135; Murphy RL, 2011, P NATL ACAD SCI USA, V108, P16469, DOI 10.1073/pnas.1106212108; Nelissen H, 2012, CURR BIOL, V22, P1183, DOI 10.1016/j.cub.2012.04.065; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Nusinow DA, 2011, NATURE, V475, P398, DOI 10.1038/nature10182; Parent B, 2010, J EXP BOT, V61, P2057, DOI 10.1093/jxb/erq003; Poire R, 2010, J EXP BOT, V61, P1751, DOI 10.1093/jxb/erq049; Rooney WL, 2007, BIOFUEL BIOPROD BIOR, V1, P147, DOI 10.1002/bbb.15; Rymen B, 2007, PLANT PHYSIOL, V143, P1429, DOI 10.1104/pp.106.093948; Sadok W, 2007, PLANT CELL ENVIRON, V30, P135, DOI 10.1111/j.1365-3040.2006.01611.x; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Schmundt D, 1998, PLANT J, V16, P505, DOI 10.1046/j.1365-313x.1998.00314.x; SHACKEL KA, 1987, PLANT PHYSIOL, V84, P1166, DOI 10.1104/pp.84.4.1166; Song YH, 2010, CURR OPIN PLANT BIOL, V13, P594, DOI 10.1016/j.pbi.2010.05.004; TAYLOR G, 1986, NEW PHYTOL, V104, P347, DOI 10.1111/j.1469-8137.1986.tb02902.x; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Trabucco GM, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-61; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; TUTTY JR, 1994, J AM SOC HORTIC SCI, V119, P138, DOI 10.21273/JASHS.119.2.138; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Walter A, 2005, GLOBAL CHANGE BIOL, V11, P1207, DOI 10.1111/j.1365-2486.2005.00990.x; Walter A, 2005, ANN BOT-LONDON, V95, P891, DOI 10.1093/aob/mci103; Walter A, 2012, ANN BOT; Walter A, 2009, ANNU REV PLANT BIOL, V60, P279, DOI 10.1146/annurev.arplant.59.032607.092819; WATTS WR, 1971, NATURE, V229, P46, DOI 10.1038/229046a0; Wiese A, 2007, NEW PHYTOL, V174, P752, DOI 10.1111/j.1469-8137.2007.02053.x; Yang Y, 2013, MOL PLANT, V6, P202, DOI 10.1093/mp/sss062; Zakhrabekova S, 2012, P NATL ACAD SCI USA, V109, P4326, DOI 10.1073/pnas.1113009109; Zhao XY, 2005, PLANT MOL BIOL, V58, P53, DOI 10.1007/s11103-005-4162-2	66	26	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100072	10.1371/journal.pone.0100072	http://dx.doi.org/10.1371/journal.pone.0100072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927130	Green Submitted, gold, Green Published			2022-12-25	WOS:000338278100116
J	Shi, WW; Jiang, YL; Zhu, F; Yang, YH; Shao, QY; Yang, HB; Ren, YM; Wu, H; Chen, YX; Zhou, CZ				Shi, Wei-Wei; Jiang, Yong-Liang; Zhu, Fan; Yang, Yi-Hu; Shao, Qiu-Yan; Yang, Hong-Bo; Ren, Yan-Min; Wu, Hui; Chen, Yuxing; Zhou, Cong-Zhao			Structure of a Novel O-Linked N-Acetyl-D-glucosamine (O-GlcNAc) Transferase, GtfA, Reveals Insights into the Glycosylation of Pneumococcal Serine-rich Repeat Adhesins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ENZYME COMPLEX; PROTEINS; FAMILY; DOMAIN; GLYCOSYLTRANSFERASES; GLCNACYLATION; RECOGNITION; BIOGENESIS; MECHANISM	Protein glycosylation catalyzed by the O-GlcNAc transferase (OGT) plays a critical role in various biological processes. In Streptococcus pneumoniae, the core enzyme GtfA and co-activator GtfB form an OGT complex to glycosylate the serine-rich repeat (SRR) of adhesin PsrP (pneumococcal serine-rich repeat protein), which is involved in the infection and pathogenesis. Here we report the 2.0 angstrom crystal structure of GtfA, revealing a beta-meander add-on domain beyond the catalytic domain. It represents a novel add-on domain, which is distinct from the all alpha-tetratricopeptide repeats in the only two structure-known OGTs. Structural analyses combined with binding assays indicate that this add-on domain contributes to forming an active GtfA-GtfB complex and recognizing the acceptor protein. In addition, the in vitro glycosylation system enables us to map the O-linkages to the serine residues within the first SRR of PsrP. These findings suggest that fusion with an add-on domain might be a universal mechanism for diverse OGTs that recognize varying acceptor proteins/peptides.	[Shi, Wei-Wei; Jiang, Yong-Liang; Yang, Yi-Hu; Shao, Qiu-Yan; Yang, Hong-Bo; Ren, Yan-Min; Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Shi, Wei-Wei; Jiang, Yong-Liang; Yang, Yi-Hu; Shao, Qiu-Yan; Yang, Hong-Bo; Ren, Yan-Min; Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Zhu, Fan; Wu, Hui] Univ Alabama Birmingham, Sch Dent, Dept Pediat Dent, Birmingham, AL 35294 USA; [Zhu, Fan; Wu, Hui] Univ Alabama Birmingham, Sch Dent, Dept Microbiol, Birmingham, AL 35294 USA; [Zhu, Fan; Wu, Hui] Univ Alabama Birmingham, Sch Med, Dept Pediat Dent, Birmingham, AL 35294 USA; [Zhu, Fan; Wu, Hui] Univ Alabama Birmingham, Sch Med, Dept Microbiol, Birmingham, AL 35294 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Zhou, CZ (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	hwu@uab.edu; cyxing@ustc.edu.cn; zcz@ustc.edu.cn	Zhou, Cong-Zhao/E-9174-2011; Shao, Qiuyan/J-8765-2019; Chen, Yuxing/P-4156-2014	Zhou, Cong-Zhao/0000-0002-6881-7151; Chen, Yuxing/0000-0002-7560-1922; Jiang, YongLiang/0000-0001-5441-4936; Yang, Hong-Bo/0000-0002-9639-7166	National Institutes of Health [F33DE022215, R01DE 017954]; Ministry of Science and Technology of China [2013CB835300, 2014CB910100, 2009CB918800]; National Natural Science Foundation of China [31270781]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017954, F33DE022215] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants F33DE022215 and R01DE 017954. This work was also supported by the Ministry of Science and Technology of China Grants 2013CB835300, 2014CB910100, and 2009CB918800 and National Natural Science Foundation of China Grant 31270781.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brodersen DE, 2000, ACTA CRYSTALLOGR D, V56, P431, DOI 10.1107/S0907444900000834; Buschiazzo A, 2004, EMBO J, V23, P3196, DOI 10.1038/sj.emboj.7600324; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Cottee MA, 2013, ELIFE, V2, DOI 10.7554/eLife.01071; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Drickamer K, 1998, TRENDS BIOCHEM SCI, V23, P321, DOI 10.1016/S0968-0004(98)01246-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errey JC, 2010, ANGEW CHEM INT EDIT, V49, P1234, DOI 10.1002/anie.200905096; Greenwald J, 2009, MOL MICROBIOL, V72, P1246, DOI 10.1111/j.1365-2958.2009.06721.x; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Hao Q, 2000, J APPL CRYSTALLOGR, V33, P980, DOI 10.1107/S0021889800001424; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hegge FT, 2004, P NATL ACAD SCI USA, V101, P10798, DOI 10.1073/pnas.0402397101; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; Ihara H, 2007, GLYCOBIOLOGY, V17, P455, DOI 10.1093/glycob/cwl079; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kakuta Y, 2008, GLYCOBIOLOGY, V18, P66, DOI 10.1093/glycob/cwm119; Kawai F, 2011, J BIOL CHEM, V286, P38546, DOI 10.1074/jbc.M111.237602; King NP, 2011, MICROBIOL-SGM, V157, P1161, DOI 10.1099/mic.0.047639-0; Kukita K, 2013, INFECT IMMUN, V81, P1870, DOI 10.1128/IAI.00011-13; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lazarus MB, 2012, NAT CHEM BIOL, V8, P966, DOI [10.1038/nchembio.1109, 10.1038/NCHEMBIO.1109]; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Li YR, 2008, MOL MICROBIOL, V70, P1094, DOI 10.1111/j.1365-2958.2008.06456.x; Lizcano A, 2012, MOL ORAL MICROBIOL, V27, P257, DOI 10.1111/j.2041-1014.2012.00653.x; Makabe K, 2006, P NATL ACAD SCI USA, V103, P17753, DOI 10.1073/pnas.0606690103; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsonage D, 2010, BIOCHEMISTRY-US, V49, P8398, DOI 10.1021/bi100698n; Pyburn TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002112; Qasba PK, 2007, GLYCOBIOLOGY, V17, p7G, DOI 10.1093/glycob/cwm013; Ruane KM, 2008, PROTEINS, V73, P784, DOI 10.1002/prot.22171; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Seepersaud R, 2012, J BACTERIOL, V194, P5564, DOI 10.1128/JB.01000-12; Sheen TR, 2011, J BACTERIOL, V193, P6834, DOI 10.1128/JB.00094-11; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shen AM, 2006, GENE DEV, V20, P3283, DOI 10.1101/gad.1492606; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Takamatsu D, 2004, J BACTERIOL, V186, P7100, DOI 10.1128/JB.186.21.7100-7111.2004; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Vaidyanathan K, 2014, CRIT REV BIOCHEM MOL, V49, P140, DOI 10.3109/10409238.2014.884535; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Wu R, 2011, J BIOL CHEM, V286, P34923, DOI 10.1074/jbc.M111.239350; Wu R, 2010, APPL ENVIRON MICROB, V76, P7966, DOI 10.1128/AEM.01434-10; Yang Yong Ryoul, 2014, Advances in Biological Regulation, V54, P68, DOI 10.1016/j.jbior.2013.09.007; Zhou MX, 2009, MICROBIOL-SGM, V155, P317, DOI 10.1099/mic.0.025221-0	61	39	44	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20898	20907		10.1074/jbc.M114.581934	http://dx.doi.org/10.1074/jbc.M114.581934			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24936067	hybrid, Green Published			2022-12-25	WOS:000339396600043
J	Caverzasi, E; Papinutto, N; Amirbekian, B; Berger, MS; Henry, RG				Caverzasi, Eduardo; Papinutto, Nico; Amirbekian, Bagrat; Berger, Mitchel S.; Henry, Roland G.			Q-Ball of Inferior Fronto-Occipital Fasciculus and Beyond	PLOS ONE			English	Article							DIFFUSION-WEIGHTED MRI; SURFACE-BASED ANALYSIS; HUMAN BRAIN; FUNCTIONAL CONNECTIVITY; IN-VIVO; SPHERICAL DECONVOLUTION; FIBER DISSECTION; TENSOR MRI; RECONSTRUCTION; TRACTOGRAPHY	The inferior fronto-occipital fasciculus (IFOF) is historically described as the longest associative bundle in the human brain and it connects various parts of the occipital cortex, temporo-basal area and the superior parietal lobule to the frontal lobe through the external/extreme capsule complex. The exact functional role and the detailed anatomical definition of the IFOF are still under debate within the scientific community. In this study we present a fiber tracking dissection of the right and left IFOF by using a q-ball residual-bootstrap reconstruction of High-Angular Resolution Diffusion Imaging (HARDI) data sets in 20 healthy subjects. By defining a single seed region of interest on the coronal fractional anisotropy (FA) color map of each subject, we investigated all the pathways connecting the parietal, occipital and posterior temporal cortices to the frontal lobe through the external/extreme capsule. In line with recent post-mortem dissection studies we found more extended anterior-posterior association connections than the "classical" fronto-occipital representation of the IFOF. In particular the pathways we evidenced showed: a) diffuse projections in the frontal lobe, b) fronto-parietal lobes connections trough the external capsule in almost all the subjects and c) widespread connections in the posterior regions. Our study represents the first consistent in vivo demonstration across a large group of individuals of these novel anterior and posterior terminations of the IFOF detailed described only by post-mortem anatomical dissection. Furthermore our work establishes the feasibility of consistent in vivo mapping of this architecture with independent in vivo methodologies. In conclusion q-ball tractography dissection supports a more complex definition of IFOF, which includes several subcomponents likely underlying specific function.	[Caverzasi, Eduardo; Papinutto, Nico; Amirbekian, Bagrat; Henry, Roland G.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Amirbekian, Bagrat; Henry, Roland G.] Univ Calif San Francisco, Joint Grad Grp Bioengn, San Francisco, CA USA; [Amirbekian, Bagrat; Henry, Roland G.] Univ Calif Berkeley, San Francisco, CA USA; [Berger, Mitchel S.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Caverzasi, E (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	ecaverzasi@memory.ucsf.edu	Caverzasi, Eduardo/P-1707-2019	Caverzasi, Eduardo/0000-0002-0350-0460	National Institutes of Health (NIH) [R01 NS066654]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066654] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) R01 NS066654. PI: R.G. Henry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aganj I, 2009, LECT NOTES COMPUT SC, V5762, P423, DOI 10.1007/978-3-642-04271-3_52; Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Amirbekian B, 2014, JOINT ANN M ISMRM ES; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bastiani M, 2012, NEUROIMAGE, V62, P1732, DOI 10.1016/j.neuroimage.2012.06.002; Bermnan JI, 2008, NEUROIMAGE, V39, P215, DOI 10.1016/j.neuroimage.2007.08.021; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Bucci M, 2013, NEUROIMAGE-CLIN, V3, P361, DOI 10.1016/j.nicl.2013.08.008; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; De Benedictis A, 2012, J NEUROSURG, V117, P1053, DOI 10.3171/2012.7.JNS12628; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dick AS, 2012, BRAIN, V135, P3529, DOI 10.1093/brain/aws222; Duffau H, 2008, J NEUROL NEUROSUR PS, V79, P492, DOI 10.1136/jnnp.2007.121004; Duffau H, 2005, BRAIN, V128, P797, DOI 10.1093/brain/awh423; Duffau H, 2013, CORTEX; Duffau H, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00044; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Forkel S. J., 2012, CORTEX; Gaudio M, 2009, EUR J PEDIATR, V168, P245, DOI 10.1007/s00431-008-0814-y; Hofer S, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00015; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Lawes INC, 2008, NEUROIMAGE, V39, P62, DOI 10.1016/j.neuroimage.2007.06.041; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Martino J, 2010, CORTEX, V46, P691, DOI 10.1016/j.cortex.2009.07.015; Martino J, 2010, NEUROSURGERY, V66, P4, DOI 10.1227/01.NEU.0000348564.28415.FA; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Petrides M, 2012, CORTEX, V48, P46, DOI 10.1016/j.cortex.2011.07.002; Peuskens D, 2004, NEUROSURGERY, V55, P1174, DOI 10.1227/01.NEU.0000140843.62311.24; POSNER MI, 1984, J NEUROSCI, V4, P1863; Sarubbo S, 2013, BRAIN STRUCT FUNCT, V218, P21, DOI 10.1007/s00429-011-0372-3; Sarubbo S, 2012, NEUROSURG REV, V35, P287, DOI 10.1007/s10143-011-0351-4; Schmahmann JD, 2007, J HIST NEUROSCI, V16, P362, DOI 10.1080/09647040600620468; Seghier ML, 2013, NEUROSCIENTIST, V19, P43, DOI 10.1177/1073858412440596; Tarapore PE, 2012, NEUROSURGERY, V71, P1012, DOI 10.1227/NEU.0b013e31826d2b78; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2002, MAGN RESON MED, V47, P701, DOI 10.1002/mrm.10116; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tristan-Vega A, 2010, NEUROIMAGE, V49, P1301, DOI 10.1016/j.neuroimage.2009.09.070; Tristan-Vega A, 2009, NEUROIMAGE, V47, P638, DOI 10.1016/j.neuroimage.2009.04.049; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Ture U, 2000, NEUROSURGERY, V47, P417, DOI 10.1097/00006123-200008000-00028; Turken AU, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00001	50	55	57	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100274	10.1371/journal.pone.0100274	http://dx.doi.org/10.1371/journal.pone.0100274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945305	gold, Green Published			2022-12-25	WOS:000340721500056
J	Casanova, R; Saldana, S; Chew, EY; Danis, RP; Greven, CM; Ambrosius, WT				Casanova, Ramon; Saldana, Santiago; Chew, Emily Y.; Danis, Ronald P.; Greven, Craig M.; Ambrosius, Walter T.			Application of Random Forests Methods to Diabetic Retinopathy Classification Analyses	PLOS ONE			English	Article							AUTOMATED DETECTION; FRAMEWORK; RISK; HEALTH; EYE	Background: Diabetic retinopathy (DR) is one of the leading causes of blindness in the United States and world-wide. DR is a silent disease that may go unnoticed until it is too late for effective treatment. Therefore, early detection could improve the chances of therapeutic interventions that would alleviate its effects. Methodology: Graded fundus photography and systemic data from 3443 ACCORD-Eye Study participants were used to estimate Random Forest (RF) and logistic regression classifiers. We studied the impact of sample size on classifier performance and the possibility of using RF generated class conditional probabilities as metrics describing DR risk. RF measures of variable importance are used to detect factors that affect classification performance. Principal Findings: Both types of data were informative when discriminating participants with or without DR. RF based models produced much higher classification accuracy than those based on logistic regression. Combining both types of data did not increase accuracy but did increase statistical discrimination of healthy participants who subsequently did or did not have DR events during four years of follow-up. RF variable importance criteria revealed that microaneurysms counts in both eyes seemed to play the most important role in discrimination among the graded fundus variables, while the number of medicines and diabetes duration were the most relevant among the systemic variables. Conclusions and Significance: We have introduced RF methods to DR classification analyses based on fundus photography data. In addition, we propose an approach to DR risk assessment based on metrics derived from graded fundus photography and systemic data. Our results suggest that RF methods could be a valuable tool to diagnose DR diagnosis and evaluate its progression.	[Casanova, Ramon; Saldana, Santiago; Ambrosius, Walter T.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Chew, Emily Y.] NEI, NIH, Bethesda, MD 20892 USA; [Danis, Ronald P.] Univ Wisconsin, Fundus Photograph Reading Ctr, Madison, WI USA; [Greven, Craig M.] Wake Forest Sch Med, Winston Salem, NC USA	Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Wisconsin System; University of Wisconsin Madison; Wake Forest University	Casanova, R (corresponding author), Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC 27157 USA.	Casanova@wakehealth.edu			National Heart, Lung, and Blood Institute [N01-HC-95178, N01-HC-95179, N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184, IAA-Y1-HC-9035, IAA-Y1-HC-1010]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095180, N01HC095178, N01HC095179, N01HC095183, N01HC095181, N01HC095182, N01HC095184] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000485, ZIAEY000410] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by contracts (N01-HC-95178, N01-HC-95179, N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184, IAA-Y1-HC-9035, and IAA-Y1-HC-1010) from the National Heart, Lung, and Blood Institute; by other components of the National Institutes of Health, including the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Aging, and the National Eye Institute; by the Centers for Disease Control and Prevention; and by General Clinical Research Centers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2010, EXPERT REV MED DEVIC, V7, P287, DOI 10.1586/ERD.09.76; Abramoff MD, 2008, DIABETES CARE, V31, P193, DOI 10.2337/dc07-1312; Acharya UR, 2012, J MED SYST, V36, P2011, DOI 10.1007/s10916-011-9663-8; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Bureau A, 2005, GENET EPIDEMIOL, V28, P171, DOI 10.1002/gepi.20041; Casanova R, 2012, Open Neuroimag J, V6, P1, DOI 10.2174/1874440001206010001; Casanova R, 2013, ALZHEIMERS DIS RISK; Casanova R, 2013, ASSESSMENT ALZHEIMER; Casanova R., 2011, INT J BIOMEDICAL DAT, V1, P11; Casanova R, 2013, PLOS ONE IN PRESS; Casanova R, 2012, USING ALZHEIMERS DIS; Casanova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077949; Casanova Ramon, 2011, Front Neuroinform, V5, P22, DOI 10.3389/fninf.2011.00022; Casanova R, 2011, MAGN RESON IMAGING, V29, P546, DOI 10.1016/j.mri.2010.12.001; Chew EY, 2007, AM J CARDIOL, V99, p103I, DOI 10.1016/j.amjcard.2007.03.028; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Diabet Control Complications Trial Res Grp, 1995, OPHTHALMOLOGY, V102, P647; Esteves J, 2008, ARQ BRAS ENDOCRINOL, V52, P431, DOI 10.1590/S0004-27302008000300003; Faust O, 2012, J MED SYST, V36, P145, DOI 10.1007/s10916-010-9454-7; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Gottesman RF, 2012, NEUROLOGY, V78, P936, DOI 10.1212/WNL.0b013e31824de2bc; Haan M, 2012, Neurology, V78, P942, DOI 10.1212/WNL.0b013e31824d9655; Lanckriet GRG, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P300; Lanckriet GRG, 2004, BIOINFORMATICS, V20, P2626, DOI 10.1093/bioinformatics/bth294; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Ng DPK, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/172593; Pantanowitz A, 2009, ADV INTEL SOFT COMPU, V61, P53; Priya R., 2011, International Journal of Applied Engineering Research, V1, P844; Quellec G, 2012, MED IMAGE ANAL, V16, P1228, DOI 10.1016/j.media.2012.06.003; Quellec G, 2011, INVEST OPHTH VIS SCI, V52, P8342, DOI 10.1167/iovs.11-7418; Quellec G, 2011, IEEE T MED IMAGING, V30, P523, DOI 10.1109/TMI.2010.2089383; Rakotomamonjy A, 2008, J MACH LEARN RES, V9, P2491; Siroky DS, 2008, STAT SURVEYS; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; van Leiden HA, 2002, DIABETES CARE, V25, P1320, DOI 10.2337/diacare.25.8.1320; WITTEN IH, 2005, DATA MINING PRACTICA; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909	42	80	81	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e98587	10.1371/journal.pone.0098587	http://dx.doi.org/10.1371/journal.pone.0098587			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940623	Green Published, gold, Green Submitted			2022-12-25	WOS:000338508200009
J	Coppola, N; Zampino, R; Sagnelli, C; Bellini, G; Marrone, A; Stanzione, M; Capoluongo, N; Boemio, A; Minichini, C; Adinolfi, LE; Maione, S; Del Giudice, EM; Sagnelli, E; Rossi, F				Coppola, Nicola; Zampino, Rosa; Sagnelli, Caterina; Bellini, Giulia; Marrone, Aldo; Stanzione, Maria; Capoluongo, Nicolina; Boemio, Adriana; Minichini, Carmine; Adinolfi, Luigi Elio; Maione, Sabatino; Del Giudice, Emanuele Miraglia; Sagnelli, Evangelista; Rossi, Francesca			Cannabinoid Receptor 2-63 QQ Variant Is Associated with Persistently Normal Aminotransferase Serum Levels in Chronic Hepatitis C	PLOS ONE			English	Article							VIRUS CARRIERS; T-CELLS; ENDOCANNABINOID SYSTEM; GENETIC-VARIATION; KUPFFER CELLS; LIVER-DISEASE; HCV; POLYMORPHISM; THERAPY; SUPERINFECTION	Background and Aim: To evaluate in anti-HCV-positive patients the clinical impact of the rs35761398 variant of the CNR2 gene leading to the substitution of Gln (Q) of codon 63 of the cannabinoid receptor 2 (CB2) with Arg (R). Patients and Methods: 253 consecutive anti-HCV-/HCV-RNA-positive patients were enrolled, of whom 53 were HCV carriers with persistently normal ALT (PNALT group) and 200 had a history of steadily abnormal serum ALT values (abnormal ALT group). All patients were naive for antiviral therapy and were screened for the CNR2 rs35761398 polymorphism by a TaqMan assay. Results: Subjects in the PNALT group, compared with those in the abnormal ALT group were older (58.5 +/- 12 vs. 50.7 +/- 12.4 years, p = 0.001), more frequently female (66% vs. 42%, p = 0.003), with lower body massindex (BMI) (24.5 +/- 3.1 vs. 26.6 +/- 4.6, p = 0.003), and more frequently with HCV genotype 2 (43.1% vs 17.7%, p = 0.0002) and CB2-63 QQ variant (34% vs. 11%, p = 0.0001). Considering all 253 patients, no difference in the demographic, biochemical, or virological data was observed between patients in the different CB2-63 variants. The logistic regression analysis identified CB2-63 QQ, HCV genotype 2, older age and lower BMI as independent predictors of PNALT (p<0.00001). Discussion: The CB2-63 QQ variant in HCV patients was independently associated with the PNALT status.	[Coppola, Nicola; Capoluongo, Nicolina; Minichini, Carmine; Sagnelli, Evangelista] Univ Naples 2, Dept Mental Hlth & Publ Med, Naples, Italy; [Zampino, Rosa; Marrone, Aldo; Boemio, Adriana; Adinolfi, Luigi Elio] Univ Naples 2, Naples, Italy; [Sagnelli, Caterina; Stanzione, Maria] Univ Naples 2, Dept Clin & Expt Med & Surg, Naples, Italy; [Bellini, Giulia; Maione, Sabatino] Univ Naples 2, Dept Expt Med, Naples, Italy; [Del Giudice, Emanuele Miraglia] Univ Naples 2, Dept Pediat, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Coppola, N (corresponding author), Univ Naples 2, Dept Mental Hlth & Publ Med, Naples, Italy.	nicola.coppola@unina2.it	del Giudice, Emanuele Muraglia/AAC-2824-2019; Sagnelli, caterina/K-9338-2016; Marrone, Aldo/AAH-3614-2020; Sagnelli, Caterina/AAD-4950-2022	Sagnelli, caterina/0000-0002-6413-7810; Sagnelli, Caterina/0000-0002-6413-7810; Sagnelli, Evangelista/0000-0003-2817-8436; MARRONE, Aldo/0000-0001-7329-4159; ZAMPINO, Rosa/0000-0003-2804-186X; Stanzione, Maria/0000-0002-8706-1310; Rossi, Francesca/0000-0003-2879-6277; Maione, Sabatino/0000-0003-3850-6704; Coppola, Nicola/0000-0001-5897-4949	PRIN, M.I.U.R., Rome, Italy "OTTIMIZZAZIONE DELLA DIAGNOSI EZIOLOGICA DELL'EPATITE ACUTA C E STUDIO DEI FATTORI VIRO-IMMUNOLOGICI DI GUARIGIONE, DI CRONICIZZAZIONE E DI RISPOSTA ALLA TERAPIA CON INTERFERONE"; Regione Campania "Progetti per il miglioramento della qualita dell'assistenza, diagnosi e terapia del paziente affetto da AIDS nei settori: immunologia, coinfezioni, informazione e prevenzione"	PRIN, M.I.U.R., Rome, Italy "OTTIMIZZAZIONE DELLA DIAGNOSI EZIOLOGICA DELL'EPATITE ACUTA C E STUDIO DEI FATTORI VIRO-IMMUNOLOGICI DI GUARIGIONE, DI CRONICIZZAZIONE E DI RISPOSTA ALLA TERAPIA CON INTERFERONE"; Regione Campania "Progetti per il miglioramento della qualita dell'assistenza, diagnosi e terapia del paziente affetto da AIDS nei settori: immunologia, coinfezioni, informazione e prevenzione"	This study was supported by a grant from PRIN 2008, M.I.U.R., Rome, Italy "OTTIMIZZAZIONE DELLA DIAGNOSI EZIOLOGICA DELL'EPATITE ACUTA C E STUDIO DEI FATTORI VIRO-IMMUNOLOGICI DI GUARIGIONE, DI CRONICIZZAZIONE E DI RISPOSTA ALLA TERAPIA CON INTERFERONE" and in part by a grant from Regione Campania "Progetti per il miglioramento della qualita dell'assistenza, diagnosi e terapia del paziente affetto da AIDS nei settori: immunologia, coinfezioni, informazione e prevenzione", 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accapezzato D, 2004, J CLIN INVEST, V113, P963, DOI [10.1172/JCI200420415, 10.1172/JCI200420515]; Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Basu PP, 2014, ALIMENT PHARM THER, V39, P790, DOI 10.1111/apt.12673; Benhamou Y, 2001, HEPATOLOGY, V34, P283, DOI 10.1053/jhep.2001.26517; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Blackburn SD, 2010, J VIROL, V84, P2078, DOI 10.1128/JVI.01579-09; Cable JC, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-129; Cabral G. A., 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P159, DOI 10.2174/187153008785700118; Carrasquer A, 2010, PHARMACOGENET GENOM, V20, P157, DOI 10.1097/FPC.0b013e3283367c6b; Coppola N, 2014, EUR J CLIN MICROBIOL, V33, P559, DOI 10.1007/s10096-013-1985-7; Coppola N, 2014, CLIN GASTROENTEROL H, V12, P334, DOI 10.1016/j.cgh.2013.05.008; Correa F, 2010, GLIA, V58, P135, DOI 10.1002/glia.20907; Dixon LJ, 2013, COMPR PHYSIOL, V3, P785, DOI 10.1002/cphy.c120026; Garcia F, 1996, EUR J CLIN MICROBIOL, V15, P884, DOI 10.1007/BF01691224; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gentile I, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.8352; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Ishida JH, 2008, CLIN GASTROENTEROL H, V6, P69, DOI 10.1016/j.cgh.2007.10.021; Itose I, 2009, J VIRAL HEPATITIS, V16, P844, DOI 10.1111/j.1365-2893.2009.01131.x; Jinushi M, 2003, J IMMUNOL, V170, P1249, DOI 10.4049/jimmunol.170.3.1249; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kondo Y, 2007, VIROLOGY, V361, P161, DOI 10.1016/j.virol.2006.11.009; Kozela E, 2013, J NEUROIMMUNE PHARM, V8, P1265, DOI 10.1007/s11481-013-9493-1; Louvet A, 2011, HEPATOLOGY, V54, P1217, DOI 10.1002/hep.24524; Luongo L, 2013, CNS NEUROL DISORD-DR, V12, P45, DOI 10.2174/1871527311312010009; Machida K, 2008, J VIROL, V82, P6711, DOI 10.1128/JVI.02582-07; McGuinness PH, 1996, HEPATOLOGY, V23, P676, DOI 10.1002/hep.510230404; Nelson DR, 2003, HEPATOLOGY, V38, P859, DOI 10.1053/jhep.2003.50427; Nelson DR, 1997, J IMMUNOL, V158, P1473; Nelson DR, 1998, HEPATOLOGY, V28, P225, DOI 10.1002/hep.510280129; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pasquale G, 2003, EUR J GASTROEN HEPAT, V15, P831, DOI 10.1097/01.meg.0000059137.68845.e2; Persico M, 2000, GASTROENTEROLOGY, V118, P760, DOI 10.1016/S0016-5085(00)70145-4; Prati D, 2010, DIGEST LIVER DIS, V42, P81, DOI 10.1016/j.dld.2009.08.001; Puoti C, 2002, J HEPATOL, V37, P117, DOI 10.1016/S0168-8278(02)00101-0; Romeo R, 1996, J VIRAL HEPATITIS, V3, P183, DOI 10.1111/j.1365-2893.1996.tb00093.x; Rossi F, 2012, PHARMACOL RES, V66, P88, DOI 10.1016/j.phrs.2012.03.011; Rossi F, 2011, HAEMATOL-HEMATOL J, V96, P1883, DOI 10.3324/haematol.2011.045732; Rossi F, 2011, HEPATOLOGY, V54, P1102, DOI 10.1002/hep.24440; Sagnelli E, 2006, J CLIN VIROL, V35, P317, DOI 10.1016/j.jcv.2005.10.006; Sagnelli E, 2013, CLIN GASTROENTEROL H, V11, P1174, DOI 10.1016/j.cgh.2013.03.025; Sagnelli E, 2009, HEPATOLOGY, V49, P1090, DOI 10.1002/hep.22794; Schirren CA, 2000, HEPATOLOGY, V32, P597, DOI 10.1053/jhep.2000.9635; SHINDO M, 1995, HEPATOLOGY, V22, P418, DOI 10.1002/hep.1840220208; Shrivastava S, 2013, J VIROL, V87, P12284, DOI 10.1128/JVI.01962-13; Singh UP, 2012, TOXICOL APPL PHARM, V258, P256, DOI 10.1016/j.taap.2011.11.005; Sipe JC, 2005, J LEUKOCYTE BIOL, V78, P231, DOI 10.1189/jlb.0205111; Tam J, 2011, HEPATOLOGY, V53, P346, DOI 10.1002/hep.24077; Teixeira-Clerc F, 2010, HEPATOLOGY, V52, P1046, DOI 10.1002/hep.23779; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Uto H, 2012, HEPAT MON, V12, P77, DOI [10.5812/hepatmon.4851, 10.5812/hepatmon.829]; Wan JH, 2014, HEPATOLOGY, V59, P130, DOI 10.1002/hep.26607; Wong JB, 2000, AM J PUBLIC HEALTH, V90, P1562, DOI 10.2105/AJPH.90.10.1562; Zampino R, 2013, J VIRAL HEPATITIS, V20, P517, DOI 10.1111/jvh.12053	54	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99450	10.1371/journal.pone.0099450	http://dx.doi.org/10.1371/journal.pone.0099450			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940753	Green Submitted, gold, Green Published			2022-12-25	WOS:000338508200024
J	Hersh, MH; Ostfeld, RS; McHenry, DJ; Tibbetts, M; Brunner, JL; Killilea, ME; LoGiudice, K; Schmidt, KA; Keesing, F				Hersh, Michelle H.; Ostfeld, Richard S.; McHenry, Diana J.; Tibbetts, Michael; Brunner, Jesse L.; Killilea, Mary E.; LoGiudice, Kathleen; Schmidt, Kenneth A.; Keesing, Felicia			Co-Infection of Blacklegged Ticks with Babesia microti and Borrelia burgdorferi Is Higher than Expected and Acquired from Small Mammal Hosts	PLOS ONE			English	Article							HUMAN GRANULOCYTIC EHRLICHIOSIS; IXODES-SCAPULARIS ACARI; ANAPLASMA-PHAGOCYTOPHILUM; LYME-DISEASE; RESERVOIR COMPETENCE; NEW-YORK; TRANSMISSION; INFECTION; EMERGENCE; PARASITE	Humans in the northeastern and midwestern United States are at increasing risk of acquiring tickborne diseases - not only Lyme disease, but also two emerging diseases, human granulocytic anaplasmosis and human babesiosis. Co-infection with two or more of these pathogens can increase the severity of health impacts. The risk of co-infection is intensified by the ecology of these three diseases because all three pathogens (Borrelia burgdorferi, Anaplasma phagocytophilum, and Babesia microti) are transmitted by the same vector, blacklegged ticks (Ixodes scapularis), and are carried by many of the same reservoir hosts. The risk of exposure to multiple pathogens from a single tick bite and the sources of co-infected ticks are not well understood. In this study, we quantify the risk of co-infection by measuring infection prevalence in 4,368 questing nymphs throughout an endemic region for all three diseases (Dutchess County, NY) to determine if co-infections occur at frequencies other than predicted by independent assortment of pathogens. Further, we identify sources of co-infection by quantifying rates of co-infection on 3,275 larval ticks fed on known hosts. We find significant deviations of levels of co-infection in questing nymphs, most notably 83% more co-infection with Babesia microti and Borrelia burgdorferi than predicted by chance alone. Further, this pattern of increased co-infection was observed in larval ticks that fed on small mammal hosts, but not on meso-mammal, sciurid, or avian hosts. Co-infections involving A. phagocytophilum were less common, and fewer co-infections of A. phagocytophilum and B. microti than predicted by chance were observed in both questing nymphs and larvae fed on small mammals. Medical practitioners should be aware of the elevated risk of B. microti/B. burgdorferi co-infection.	[Hersh, Michelle H.; McHenry, Diana J.; Tibbetts, Michael; Keesing, Felicia] Bard Coll, Program Biol, Annandale On Hudson, NY USA; [Hersh, Michelle H.; Ostfeld, Richard S.] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Brunner, Jesse L.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Killilea, Mary E.] NYU, Dept Environm Studies, New York, NY USA; [LoGiudice, Kathleen] Union Coll, Dept Biol, Schenectady, NY 12308 USA; [Schmidt, Kenneth A.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	Cary Institute of Ecosystem Studies; Washington State University; New York University; Union College; Texas Tech University System; Texas Tech University	Hersh, MH (corresponding author), Sarah Lawrence Coll, Dept Biol, Bronxville, NY 10708 USA.	mhersh@sarahlawrence.edu	Brunner, Jesse L./B-1692-2013	Brunner, Jesse L./0000-0003-4894-8274; Hersh, Michelle/0000-0003-1174-7575; Ostfeld, Richard/0000-0002-3707-9301	National Science Foundation [0813041, 0940830]; United States Environmental Protection Agency; Dutchess County, NY; Division Of Environmental Biology [0813035] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); United States Environmental Protection Agency(United States Environmental Protection Agency); Dutchess County, NY; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by National Science Foundation grants 0813041 and 0940830, and from grants from the United States Environmental Protection Agency (to RSO, FK, and CD Canham) and Dutchess County, NY (to RSO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams Y, 2008, J AM BOARD FAM MED, V21, P75, DOI 10.3122/jabfm.2008.01.060182; Belongia EA, 2002, VECTOR-BORNE ZOONOT, V2, P265, DOI 10.1089/153036602321653851; Brunner JL, 2008, ECOLOGY, V89, P2259, DOI 10.1890/07-0665.1; Civitello DJ, 2010, ISR J ECOL EVOL, V56, P417, DOI 10.1560/IJEE.56.3-4.417; Coleman JL, 2005, J INFECT DIS, V192, P1634, DOI 10.1086/496891; Courtney JW, 2004, J CLIN MICROBIOL, V42, P3164, DOI 10.1128/JCM.42.7.3164-3168.2004; Dahlgren FS, 2011, AM J TROP MED HYG, V85, P124, DOI 10.4269/ajtmh.2011.10-0613; Diuk-Wasser MA, 2014, EMERG INFECT DIS, V20, P225, DOI 10.3201/eid2002.130644; Ginsberg HS, 2008, EXP APPL ACAROL, V46, P29, DOI 10.1007/s10493-008-9175-5; Hersh MH, 2012, EMERG INFECT DIS, V18, P1951, DOI 10.3201/eid1812.111392; Hesterberg T., 2011, MATH STAT RESAMPLING; Joseph JT, 2011, EMERG INFECT DIS, V17, P843, DOI 10.3201/eid1705.101334; Keesing F, 2009, P ROY SOC B-BIOL SCI, V276, P3911, DOI 10.1098/rspb.2009.1159; Keesing F, 2012, EMERG INFECT DIS, V18, P2013, DOI 10.3201/eid1812.120919; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Krause PJ, 2003, AM J TROP MED HYG, V68, P431, DOI 10.4269/ajtmh.2003.68.431; Krause PJ, 1996, JAMA-J AM MED ASSOC, V275, P1657, DOI 10.1001/jama.275.21.1657; Krause PJ, 2002, CLIN INFECT DIS, V34, P1184, DOI 10.1086/339813; Levi T, 2012, P NATL ACAD SCI USA, V109, P10942, DOI 10.1073/pnas.1204536109; Levin ML, 2001, VECTOR-BORNE ZOONOT, V1, P139, DOI 10.1089/153036601316977741; Levin ML, 2002, VECTOR-BORNE ZOONOT, V2, P125, DOI 10.1089/15303660260613693; Levin ML, 2000, INFECT IMMUN, V68, P2183, DOI 10.1128/IAI.68.4.2183-2186.2000; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Magnarelli LA, 2013, J WILDLIFE DIS, V49, P294, DOI 10.7589/2012-06-172; Martinez-Balzano C, 2015, QJM-INT J MED, V108, P141, DOI 10.1093/qjmed/hcs100; National Research Council, 2011, GUIDE CARE USE LAB A; Nieto NC, 2009, VECTOR-BORNE ZOONOT, V9, P93, DOI 10.1089/vbz.2008.0072; Oleson CV, 2003, J SPINAL CORD MED, V26, P168, DOI 10.1080/10790268.2003.11754578; Ostfeld RS, 2012, ANNU REV ECOL EVOL S, V43, P157, DOI 10.1146/annurev-ecolsys-102710-145022; Ostfeld RS, 2003, ECOLOGY, V84, P1421, DOI 10.1890/02-3125; Ostfeld RS, 2010, LYME DIS ECOLOGY COM; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; PIESMAN J, 1986, J CLIN MICROBIOL, V24, P446, DOI 10.1128/JCM.24.3.446-447.1986; Rigaud T, 2010, P ROY SOC B-BIOL SCI, V277, P3693, DOI 10.1098/rspb.2010.1163; Schauber EM, 1998, J MED ENTOMOL, V35, P901, DOI 10.1093/jmedent/35.5.901; Schulze TL, 2013, J MED ENTOMOL, V50, P379, DOI 10.1603/ME12088; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Steiner FE, 2008, J MED ENTOMOL, V45, P289, DOI 10.1603/0022-2585(2008)45[289:IACROA]2.0.CO;2; Swanson KI, 2007, J VECTOR ECOL, V32, P243, DOI 10.3376/1081-1710(2007)32[243:CMIQIS]2.0.CO;2; Swanson SJ, 2006, CLIN MICROBIOL REV, V19, P708, DOI 10.1128/CMR.00011-06; Sweeney CJ, 1998, MAYO CLIN PROC, V73, P338; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Tokarz R, 2010, VECTOR-BORNE ZOONOT, V10, P217, DOI 10.1089/vbz.2009.0036; Varde S, 1998, EMERG INFECT DIS, V4, P97, DOI 10.3201/eid0401.980113; Walk ST, 2009, EMERG INFECT DIS, V15, P585, DOI 10.3201/eid1504.080940; Wang TJ, 2000, CLIN INFECT DIS, V31, P1149, DOI 10.1086/317465	46	89	91	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99348	10.1371/journal.pone.0099348	http://dx.doi.org/10.1371/journal.pone.0099348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940999	Green Published, gold			2022-12-25	WOS:000338508200019
J	Lei, J; Li, WH; Yang, Y; Lu, Q; Zhang, N; Bai, GZ; Zhong, DX; Su, K; Liu, BY; Li, XF; Wang, YJ; Wang, XP				Lei, Jie; Li, Wenhai; Yang, Ye; Lu, Qiang; Zhang, Na; Bai, Guangzhen; Zhong, Daixing; Su, Kai; Liu, Boya; Li, Xiaofei; Wang, Yunjie; Wang, Xiaoping			TC-1 Overexpression Promotes Cell Proliferation in Human Non-Small Cell Lung Cancer that Can Be Inhibited by PD173074	PLOS ONE			English	Article							HUMAN BREAST-CANCER; TC1 C8ORF4; GASTRIC-CANCER; THYROID-CANCER; KINASE DOMAIN; TRANSITION; EXPRESSION; AMPLICON; PATHWAY; CHIBBY	Thyroid cancer-1 (TC-1), a natively disordered protein, is widely expressed in vertebrates and overexpressed in many kinds of tumors. However, its exact role and regulation mechanism in human non-small cell lung cancer (NSCLC) are still unclear. In the present study, we found that TC-1 is highly expressed in NSCLC and that its aberrant expression is strongly associated with NSCLC cell proliferation. Exogenous TC-1 overexpression promotes cell proliferation, accelerates the cell G1-to-S-phase transition, and reduces apoptosis in NSCLC. The knockdown of TC-1, however, inhibits NSCLC cell proliferation, cycle transition, and apoptosis resistance. Furthermore, we also demonstrated that PD173074, which functions as an inhibitor of the TC-1 in NSCLC, decreases the expression of TC-1 and inhibits TC-1 overexpression mediated cell proliferation in vitro and in vivo. Nevertheless, the inhibition function of PD173074 on NSCLC cell proliferation was eliminated in cells with TC-1 knockdown. These results suggest that PD173074 plays a significant role in TC-1 overexpression mediated NSCLC cell proliferation and may be a potential intervention target for the prevention of cell proliferation in NSCLC.	[Lei, Jie; Li, Wenhai; Lu, Qiang; Zhang, Na; Bai, Guangzhen; Zhong, Daixing; Su, Kai; Liu, Boya; Li, Xiaofei; Wang, Yunjie; Wang, Xiaoping] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710032, Shaanxi, Peoples R China; [Yang, Ye] Shaanxi Prov Peoples Hosp, Dept Thorac Surg, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Xi'an Medical University	Wang, YJ (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710032, Shaanxi, Peoples R China.	wangyunjiemd@163.com; wxpchest@fmmu.edu.cn	Li, xiaofei/GXF-7187-2022					Byron SA, 2008, CANCER RES, V68, P6902, DOI 10.1158/0008-5472.CAN-08-0770; Chua EL, 2000, GENOMICS, V69, P342, DOI 10.1006/geno.2000.6348; Gall C, 2007, PROTEIN SCI, V16, P2510, DOI 10.1110/ps.073062707; Jung YS, 2006, CANCER RES, V66, P723, DOI 10.1158/0008-5472.CAN-05-3124; Kim B, 2003, CANCER RES, V63, P8248; Kim B, 2006, CLIN CANCER RES, V12, P3541, DOI 10.1158/1078-0432.CCR-05-2440; Kim Y, 2006, FEBS LETT, V580, P3519, DOI 10.1016/j.febslet.2006.05.036; Lamont FR, 2011, BRIT J CANCER, V104, P75, DOI 10.1038/sj.bjc.6606016; Miyake M, 2010, J PHARMACOL EXP THER, V332, P795, DOI 10.1124/jpet.109.162768; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Nallasamy S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002500; Nguyen PT, 2013, BRIT J CANCER, V109, P2248, DOI 10.1038/bjc.2013.550; Pardo OE, 2009, CANCER RES, V69, P8645, DOI 10.1158/0008-5472.CAN-09-1576; Ray ME, 2004, CANCER RES, V64, P40, DOI 10.1158/0008-5472.CAN-03-1022; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sunde M, 2004, CANCER RES, V64, P2766, DOI 10.1158/0008-5472.CAN-03-2093; Traer E, 2014, BLOOD, V123, P1516, DOI 10.1182/blood-2013-07-518381; Wang YD, 2008, BMB REP, V41, P733, DOI 10.5483/BMBRep.2008.41.10.733; Yang ZQ, 2006, CANCER RES, V66, P11632, DOI 10.1158/0008-5472.CAN-06-2946; Yang ZQ, 2007, INT J CANCER, V121, P1265, DOI 10.1002/ijc.22831; Ye TH, 2014, BREAST CANCER RES TR, V143, P435, DOI 10.1007/s10549-013-2829-y; Ye YW, 2013, ONCOL REP, V30, P2777, DOI 10.3892/or.2013.2796; Zhao JB, 2010, CANCER LETT, V290, P238, DOI 10.1016/j.canlet.2009.09.013	23	11	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100075	10.1371/journal.pone.0100075	http://dx.doi.org/10.1371/journal.pone.0100075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941347	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200071
J	Dahl, U; Rise, MB; Kulseng, B; Steinsbekk, A				Dahl, Unni; Rise, Marit By; Kulseng, Bard; Steinsbekk, Aslak			Personnel and Participant Experiences of a Residential Weight-Loss Program. A Qualitative Study	PLOS ONE			English	Article							LOSS MAINTENANCE; OBESE ADULTS; BARIATRIC SURGERY; SELF-EFFICACY; IMPACT; STIGMA; METAANALYSIS; OVERWEIGHT; EXERCISE; MORTALITY	Background: Residential weight-loss programs aim to help persons with obesity lose weight and maintain a long-term healthy lifestyle. Knowledge is needed on the different actors' perceptions and experiences from such programs. The aim of this study was to describe how personnel argued for and perceived a residential weight-loss program, to investigate how the participants experienced the program, and to contrast these perspectives. Methods: This qualitative study took place in an 18-week residential weight-loss program. Exercise, diet, and personal development were the main components in the program. Data was collected through participant observation and individual and focus group interviews with participants and personnel. Results: Program personnel characterized persons with obesity in specific terms, and these formed the basis of the educational aims, teaching principles, and content of the program. According to personnel, persons with obesity typically had problems acknowledging their own resources, lived unstructured lives, had a distorted relationship to food, experienced a range of social problems and featured a lack of personal insight. Program participants reported enthusiasm about their experiences of exercise and appreciated measures of success with the exercise program. They had, however, very different experiences regarding the usefulness and appropriateness of the parts of the program focused on social and personal development. Some felt that weight loss required an engagement with personal development while others viewed it as unnecessary and inappropriate. Conclusion: The reliance in personnel accounts on particular characteristics of persons with obesity as a rationale for the program might lead to stigmatizing and stereotyping. Program activities focused on social and personal development need to be better understood by participants if they are to be viewed as helpful. To achieve this personnel must carefully consider how these parts of the program are communicated and conducted.	[Dahl, Unni] Cent Norway Hlth Author, Stjordal, Norway; [Dahl, Unni; Rise, Marit By; Steinsbekk, Aslak] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Kulseng, Bard] St Olavs Univ Hosp, Reg Ctr Obes Treatment, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Rise, MB (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway.	marit.b.rise@ntnu.no	Steinsbekk, Aslak/E-9223-2012	Steinsbekk, Aslak/0000-0001-9090-0739				Anderson RM, 2008, DIABETES EDUCATOR, V34, P109, DOI 10.1177/0145721707312398; Avenell A., 2004, HLTH TECHNOL ASSESS, P8; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Beach MC, 2007, J GEN INTERN MED, V22, P692, DOI 10.1007/s11606-006-0054-7; Bleich SN, 2010, PATIENT EDUC COUNS, V79, P344, DOI 10.1016/j.pec.2010.01.020; Byrne S, 2012, APPETITE, V58, P695, DOI 10.1016/j.appet.2012.01.005; Byrne SM, 2002, J PSYCHOSOM RES, V53, P1029, DOI 10.1016/S0022-3999(02)00487-7; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Chan RSM, 2009, INT J ENV RES PUB HE, V6, P2608, DOI 10.3390/ijerph6102608; Chang SH, 2014, JAMA SURG, V149, P275, DOI 10.1001/jamasurg.2013.3654; Christiansen B, 2012, INT J QUAL STUD HEAL, V7, DOI 10.3402/qhw.v7i0.17255; Christiansen T, 2007, OBESITY, V15, P413, DOI 10.1038/oby.2007.530; Cochrane G, 2008, CAN FAM PHYSICIAN, V54, P543; Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982; Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x; Fabricatore A. N., 2003, Diabetes Spectrum, V16, P245, DOI 10.2337/diaspect.16.4.245; Ferrante JM, 2010, OBESITY, V18, P1153, DOI 10.1038/oby.2009.481; Foster GD, 2005, AM J CLIN NUTR, V82, p230S, DOI 10.1093/ajcn/82.1.230S; Foster GD, 2003, OBES RES, V11, P1168, DOI 10.1038/oby.2003.161; Foster-Schubert KE, 2012, OBESITY, V20, P1628, DOI 10.1038/oby.2011.76; Grol R, 2004, MED J AUSTRALIA, V180, pS57, DOI 10.5694/j.1326-5377.2004.tb05948.x; Jeffery RW, 2007, DIABETES, V56, P2673, DOI 10.2337/db07-1029; Jones N, 2007, J HUM NUTR DIET, V20, P486, DOI 10.1111/j.1365-277X.2007.00810.x; Kwok CS, 2014, INT J CARDIOL, V173, P20, DOI 10.1016/j.ijcard.2014.02.026; Maldonato A, 2010, PATIENT EDUC COUNS, V79, P287, DOI 10.1016/j.pec.2010.02.010; Martins C, 2011, OBES SURG, V21, P841, DOI 10.1007/s11695-010-0131-1; May CR, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-29; Middleton KMR, 2012, OBES REV, V13, P509, DOI 10.1111/j.1467-789X.2011.00972.x; Mobbs O, 2010, PATIENT EDUC COUNS, V79, P372, DOI 10.1016/j.pec.2010.03.003; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Myers A, 1999, INT J OBESITY, V23, P221, DOI 10.1038/sj.ijo.0800765; Nicholson F, 2010, INT J WOMENS HEALTH, V2, P393, DOI 10.2147/IJWH.S13456; Penn L, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-235; Powell LH, 2007, AM PSYCHOL, V62, P234, DOI 10.1037/0003-066X.62.3.234; Puhl RM, 2006, OBESITY, V14, P1802, DOI 10.1038/oby.2006.208; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Reach G, 2009, PATIENT EDUC COUNS, V77, P192, DOI 10.1016/j.pec.2009.05.005; Romanova M, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120325; Rossner S, 2008, OBES REV, V9, P624, DOI 10.1111/j.1467-789X.2008.00516.x; Schvey NA, 2011, OBESITY, V19, P1957, DOI 10.1038/oby.2011.204; Shay LE, 2008, NURS FORUM, V43, P42, DOI 10.1111/j.1744-6198.2008.00095.x; Sikorski C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-661; Soderlund A, 2009, PERSPECT PUBLIC HEAL, V129, P132, DOI 10.1177/1757913908094805; Vartanian LR, 2011, OBESITY, V19, P757, DOI 10.1038/oby.2010.234; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323	45	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100226	10.1371/journal.pone.0100226	http://dx.doi.org/10.1371/journal.pone.0100226			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK5YM	24937479	Green Published, Green Submitted, gold			2022-12-25	WOS:000338503400096
J	Klomp, A; Hamelink, R; Feenstra, M; Denys, D; Reneman, L				Klomp, Anne; Hamelink, Ralph; Feenstra, Matthijs; Denys, Damiaan; Reneman, Liesbeth			Increased Response to a 5-HT Challenge After Discontinuation of Chronic Serotonin Uptake Inhibition in the Adult and Adolescent Rat Brain	PLOS ONE			English	Article							CHRONIC FLUOXETINE TREATMENT; SELECTIVE SEROTONIN; EXTRACELLULAR SEROTONIN; PREFRONTAL CORTEX; REUPTAKE INHIBITORS; SUICIDAL IDEATION; MONOAMINE LEVELS; FRONTAL-CORTEX; DOPAMINE; RELEASE	Little is known about the effects of chronic fluoxetine on 5-HT transmission in the adolescent brain, even though it is acknowledged that the neuroplasticity of the brain during childhood and adolescence might influence the neurobiological mechanisms underlying treatment response. Also, possible ongoing effects on monoamine function following drug discontinuation are unidentified. We therefore examined the chronic effects of fluoxetine on extracellular 5-HT and dopamine concentrations in the medial prefrontal cortex and studied their responsiveness to an acute 5-HT challenge after a one-week washout period, both in adolescent and adult rats. Noradrenaline was measured in adult animals only. Fluoxetine increased 5-HT to 200-300% of control and DA and NA to 150% of control. Although there were no lasting effects of chronic fluoxetine on basal monoamine levels, we observed a clear potentiating effect of previous treatment on the fluoxetine-induced increase in extracellular 5-HT and, to a lesser extent, extracellular DA. No differential effect was found for noradrenaline. Age-at-treatment did not influence these results. So, after cessation of chronic fluoxetine treatment 5-HT responsiveness remains heightened. This may be indicative of the continuing presence of 5-HT receptor desensitization, at least until one week after drug discontinuation in rats. No apparent age-at-treatment effects on extracellular monoamine concentrations in the medial prefrontal cortex were detected, but age-related differences in 5-HT transmission further down-stream or in the recovery processes cannot be ruled out.	[Klomp, Anne; Reneman, Liesbeth] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Hamelink, Ralph; Feenstra, Matthijs; Denys, Damiaan] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands; [Hamelink, Ralph; Feenstra, Matthijs; Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam	Reneman, L (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Radiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	l.reneman@amc.uva.nl		Reneman, Liesbeth/0000-0002-5912-9971	Netherlands Organisation for Scientific Research (NWO - division ZonMW) [916.86.125]	Netherlands Organisation for Scientific Research (NWO - division ZonMW)	This work is funded by the Netherlands Organisation for Scientific Research (NWO - division ZonMW; www.zonmw.nl) (Veni grant; no. 916.86.125), awarded to LR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex KD, 2007, PHARMACOL THERAPEUT, V113, P296, DOI 10.1016/j.pharmthera.2006.08.004; Amargos-Bosch M, 2005, EUR J PHARMACOL, V516, P235, DOI 10.1016/j.ejphar.2005.05.004; Andersen SL, 2004, INT J DEV NEUROSCI, V22, P423, DOI 10.1016/j.ijdevneu.2004.06.002; Best J, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-34; Beyer CE, 2008, EUR J PHARMACOL, V580, P350, DOI 10.1016/j.ejphar.2007.11.028; Boileau I, 2006, ARCH GEN PSYCHIAT, V63, P1386, DOI 10.1001/archpsyc.63.12.1386; Bouet V, 2012, PSYCHOPHARMACOLOGY, V221, P329, DOI 10.1007/s00213-011-2580-1; Bridge JA, 2007, JAMA-J AM MED ASSOC, V297, P1683, DOI 10.1001/jama.297.15.1683; Bymaster FP, 2002, PSYCHOPHARMACOLOGY, V160, P353, DOI 10.1007/s00213-001-0986-x; Caballero J, 2005, AM J HEALTH-SYST PH, V62, P864, DOI 10.1093/ajhp/62.8.864; CACCIA S, 1990, PSYCHOPHARMACOLOGY, V100, P509, DOI 10.1007/BF02244004; Cheung AH, 2005, J CHILD PSYCHOL PSYC, V46, P735, DOI 10.1111/j.1469-7610.2005.01467.x; CIZEK LJ, 1965, AM J PHYSIOL, V208, P615, DOI 10.1152/ajplegacy.1965.208.4.615; Dawson LA, 2000, NEUROPHARMACOLOGY, V39, P1044, DOI 10.1016/S0028-3908(99)00192-6; de Groote L, 2002, PSYCHOPHARMACOLOGY, V162, P419, DOI 10.1007/s00213-002-1117-z; Descarries L, 2012, PHILOS TRANS R SOC L, P367; DeVane CL, 1999, CELL MOL NEUROBIOL, V19, P443, DOI 10.1023/A:1006934807375; Engelbregt MJT, 2000, PEDIATR RES, V48, P803, DOI 10.1203/00006450-200012000-00017; GARDIER AM, 1994, LIFE SCI, V54, pPL51, DOI 10.1016/0024-3205(94)00821-3; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Hazell P, 2000, COCHRANE DB SYST REV; Hervas I, 1998, EUR J PHARMACOL, V358, P9, DOI 10.1016/S0014-2999(98)00579-2; Hetrick S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004851.pub2; Invernizzi R, 1996, PHARMACOL BIOCHEM BE, V54, P143, DOI 10.1016/0091-3057(95)02159-0; Jureidini JN, 2004, BMJ-BRIT MED J, V328, P879, DOI 10.1136/bmj.328.7444.879; Karanges E, 2011, INT J NEUROPSYCHOPH, V14, P491, DOI 10.1017/S146114571100006X; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Klomp A, 2012, NEUROIMAGE, V59, P218, DOI 10.1016/j.neuroimage.2011.07.082; Li XM, 1999, CHINESE J PHYSIOL, V42, P53; Lubbers LS, 2010, J STEROID BIOCHEM, V122, P310, DOI 10.1016/j.jsbmb.2010.08.005; March JS, 2009, AM J PSYCHIAT, V166, P1118, DOI 10.1176/appi.ajp.2009.08101606; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Newman ME, 2004, EUR J PHARMACOL, V486, P25, DOI 10.1016/j.ejphar.2003.12.008; Norrholm SD, 2000, BRAIN RES, V883, P205, DOI 10.1016/S0006-8993(00)02909-7; Olivier JDA, 2011, PROG NEURO-PSYCHOPH, V35, P1400, DOI 10.1016/j.pnpbp.2010.09.013; PERRY KW, 1992, LIFE SCI, V50, P1683, DOI 10.1016/0024-3205(92)90423-M; Preece MA, 2009, NEUROSCIENCE, V159, P751, DOI 10.1016/j.neuroscience.2008.12.032; Raap DK, 1999, J PHARMACOL EXP THER, V288, P561; Rogoz Z, 2010, PHARMACOL REP, V62, P1015, DOI 10.1016/S1734-1140(10)70363-7; RUTTER JJ, 1994, NEUROSCI LETT, V171, P183, DOI 10.1016/0304-3940(94)90635-1; Sakaue M, 2000, BRIT J PHARMACOL, V129, P1028, DOI 10.1038/sj.bjp.0703139; Sharp T, 2010, HBK BEHAV NEUROSCI, V21, P233, DOI 10.1016/B978-0-12-374634-4.00013-7; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Staiti AM, 2011, NEUROPHARMACOLOGY, V61, P544, DOI 10.1016/j.neuropharm.2011.04.005; STROMINGER JL, 1947, YALE J BIOL MED, V19, P279; Tanda G, 1996, PSYCHOPHARMACOLOGY, V127, P83, DOI 10.1007/BF02805978; Wegerer V, 1999, J CHILD ADOL PSYCHOP, V9, P13, DOI 10.1089/cap.1999.9.13; Weintrob N, 2002, ARCH PEDIAT ADOL MED, V156, P696, DOI 10.1001/archpedi.156.7.696; WhitakerAzmitia PM, 1996, BEHAV BRAIN RES, V73, P19; Wijlaars LPMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033181; Wilens TE, 2003, J CHILD ADOL PSYCHOP, V13, P143, DOI 10.1089/104454603322163862; Wohlfarth TD, 2006, EUR NEUROPSYCHOPHARM, V16, P79, DOI 10.1016/j.euroneuro.2005.10.004; WONG DT, 1983, BIOCHEM PHARMACOL, V32, P1287, DOI 10.1016/0006-2952(83)90284-8; YEN TT, 1992, AM J CLIN NUTR, V55, P177, DOI 10.1093/ajcn/55.1.177s	55	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99873	10.1371/journal.pone.0099873	http://dx.doi.org/10.1371/journal.pone.0099873			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937739	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400048
J	Du, Y; Su, T; Zhao, LJ; Tan, XJ; Chang, WJ; Zhang, HW; Cao, GW				Du, Yan; Su, Tong; Zhao, Lijun; Tan, Xiaojie; Chang, Wenjun; Zhang, Hongwei; Cao, Guangwen			Associations of Polymorphisms in DNA Repair Genes and MDR1 Gene with Chemotherapy Response and Survival of Non-Small Cell Lung Cancer	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; MESSENGER-RNA EXPRESSION; FUNCTIONAL POLYMORPHISMS; BRCA1; ERCC1; PLATINUM; PATHWAY; RISK; CHEMORESISTANCE; RESISTANCE	Objectives: We aimed to determine the associations of genetic polymorphisms of excision repair cross-complementation group 1 (ERCC1) rs11615, xeroderma pigmentosum group D (XPD/ERCC2) rs13181, X-ray repair cross complementing group 1 (XRCC1) rs25487, XRCC3 rs1799794, and breast cancer susceptibility gene 1 (BRCA1) rs1799966 from the DNA repair pathway and multiple drug resistance 1 (MDR1/ABCB1) rs1045642 with response to chemotherapy and survival of non-small cell lung cancer (NSCLC) in a Chinese population. Materials and Methods: A total of 352 NSCLC patients were enrolled to evaluate the associations of the six SNPs with response to chemotherapy and overall survival. Logistic regressions were applied to test the associations of genetic polymorphisms with response to chemotherapy in 161 advanced NSCLC patients. Overall survival was analyzed in 161 advanced and 156 early stage NSCLC patients using the Kaplan-Meier method with log-rank test, respectively. Multivariate Cox proportional hazards model was performed to determine the factors independently associated with NSCLC prognosis. Results: BRCA1 rs1799966 minor allele C (TC+CC vs. TT, OR = 0.402, 95% CI = 0.204-0.794, p = 0.008) and MDR1/ABCB1 rs1045642 minor allele A (GA + AA vs. GG, OR = 0.478, 95% CI = 0.244-0.934, p = 0.030) were associated with a better response to chemotherapy in advanced NSCLC patients. Survival analyses indicated that BRCA1 rs1799966 TC+CC genotypes were associated with a decreased risk of death (HR = 0.617, 95% CI = 0.402-0.948, p = 0.028) in advanced NSCLC patients, and the association was still significant after the adjustment for covariates. Multivariate Cox regression analysis showed that ERCC1 rs11615 AA genotype (P = 0.020) and smoking (p = 0.037) were associated with increased risks of death in early stage NSCLC patients after surgery. Conclusions: Polymorphisms of genes in DNA repair pathway and MDR1 could contribute to chemotherapy response and survival of patients with NSCLC.	[Du, Yan; Su, Tong; Tan, Xiaojie; Chang, Wenjun; Zhang, Hongwei; Cao, Guangwen] Second Mil Med Univ, Dept Epidemiol, Shanghai, Peoples R China; [Zhao, Lijun] Second Mil Med Univ, Changhai Hosp, Dept Pulm Med, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Cao, GW (corresponding author), Second Mil Med Univ, Dept Epidemiol, Shanghai, Peoples R China.	gcao@smmu.edu.cn	Du, Yan/AAD-5510-2020; tan, xiao/GZL-0264-2022	Du, Yan/0000-0001-5413-7836; Cao, Guangwen/0000-0002-8094-1278; chang, wenjun/0000-0002-8476-4731	Shanghai Science and Technology Committee [06DZ19503]; National Natural Science Foundation of China [81025015]	Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Key Project of Shanghai Science and Technology Committee grant (06DZ19503 to G. Cao) and National Natural Science Foundation of China (81025015 to G. Cao). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albino AP, 2009, MUTAT RES-GEN TOX EN, V678, P43, DOI 10.1016/j.mrgentox.2009.06.009; Campa D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032784; Chang JS, 2008, CANCER EPIDEM BIOMAR, V17, P1368, DOI 10.1158/1055-9965.EPI-07-2830; Cobo M, 2007, J CLIN ONCOL, V25, P2747, DOI 10.1200/JCO.2006.09.7915; Dong J, 2012, MOL CARCINOGEN, V51, P546, DOI 10.1002/mc.20819; Hao BT, 2004, CANCER RES, V64, P4378, DOI 10.1158/0008-5472.CAN-04-0372; He J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049308; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Hubner RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025164; Isla D, 2004, ANN ONCOL, V15, P1194, DOI 10.1093/annonc/mdh319; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Joerger M, 2011, CANCER; Kim HT, 2008, J CLIN ONCOL, V26, P5972, DOI 10.1200/JCO.2008.16.6496; Kim M, 2010, CANCER SCI, V101, P2436, DOI 10.1111/j.1349-7006.2010.01699.x; Lafarge S, 2001, ONCOGENE, V20, P6597, DOI 10.1038/sj.onc.1204812; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Lee KM, 2007, GENETICS, V175, P1585, DOI 10.1534/genetics.106.067801; Lord RVN, 2002, CLIN CANCER RES, V8, P2286; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Park J, 2009, CLIN CANCER RES, V15, P1794, DOI 10.1158/1078-0432.CCR-08-1770; Quinn JE, 2003, CANCER RES, V63, P6221; Rosell R, 2002, LUNG CANCER, V38, P217, DOI 10.1016/S0169-5002(02)00224-6; Rosell R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001129; Sekine I, 2008, BRIT J CANCER, V99, P1757, DOI 10.1038/sj.bjc.6604721; Shiraishi K, 2010, J CLIN ONCOL, V28, P4945, DOI 10.1200/JCO.2010.30.5334; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Takenaka T, 2010, LUNG CANCER, V67, P101, DOI 10.1016/j.lungcan.2009.03.007; Tanaka Y, 2010, CANCER-AM CANCER SOC, V116, P896, DOI 10.1002/cncr.24850; Taron M, 2004, HUM MOL GENET, V13, P2443, DOI 10.1093/hmg/ddh260; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tibaldi C, 2008, CLIN CANCER RES, V14, P1797, DOI 10.1158/1078-0432.CCR-07-1364; Vinolas N, 2011, LUNG CANCER, V71, P191, DOI 10.1016/j.lungcan.2010.05.005; Wei HB, 2011, ARCH MED RES, V42, P412, DOI 10.1016/j.arcmed.2011.07.008; Wei QY, 2000, JNCI-J NATL CANCER I, V92, P440, DOI 10.1093/jnci/92.6.440; Wolfe KJ, 2007, PHARMACOGENET GENOM, V17, P897, DOI 10.1097/FPC.0b013e3280115e63; Wu LL, 2010, CLIN CANCER RES, V16, P3760, DOI 10.1158/1078-0432.CCR-10-0193; Yang YL, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-15; Yarden RI, 2006, MOL CANCER THER, V5, P1396, DOI 10.1158/1535-7163.MCT-05-0471; Yin JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038150; Yoo SS, 2009, J CLIN ONCOL, V27, P5823, DOI 10.1200/JCO.2009.23.1738; Yu JJ, 2000, INT J ONCOL, V16, P555; Zhang XM, 2005, CANCER RES, V65, P722; Zheng B, 2013, ANN ONCOL, V24, P1130, DOI [10.1093/annonc/mdt038, 10.1093/annonc/mdt063]; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	44	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99843	10.1371/journal.pone.0099843	http://dx.doi.org/10.1371/journal.pone.0099843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933103	Green Published, Green Submitted, gold			2022-12-25	WOS:000337738600071
J	Gong, JB; Yuan, JJ; Wang, SH; Shi, LJ; Cui, XL; Luo, XR				Gong, Jingbo; Yuan, Jiajin; Wang, Suhong; Shi, Lijuan; Cui, Xilong; Luo, Xuerong			Feedback-Related Negativity in Children with Two Subtypes of Attention Deficit Hyperactivity Disorder	PLOS ONE			English	Article							ALTERED REINFORCEMENT MECHANISMS; DEFICIT/HYPERACTIVITY DISORDER; ELECTROPHYSIOLOGICAL EVIDENCE; ELECTROCORTICAL RESPONSE; AUTOMATIC VIGILANCE; UNPLEASANT PICTURES; SOCIAL INFORMATION; AROUSING PICTURES; VALENCE STRENGTH; GRABBING POWER	Objective: The current model of ADHD suggests abnormal reward and punishment sensitivity, although differences in ADHD subgroups are unclear. This study aimed to investigate the effect of feedback valence (reward or punishment) and punishment magnitude (small or large) on Feedback-Related Negativity (FRN) and Late Positive Potential (LPP) in two subtypes of ADHD (ADHD-C and ADHD-I) compared to typically developing children (TD) during a children's gambling task. Methods: Children with ADHD-C (n = 16), children with ADHD-I (n = 15) and typically developing children (n = 15) performed a children's gambling task under three feedback conditions: large losses, small losses and gains. FRN and LPP components in brain potentials were recorded and analyzed. Results: In TD children and children with ADHD-C, large loss feedback evoked more negative FRN amplitudes than small loss feedback, suggesting that brain sensitivity to the punishment and its magnitude is not impaired in children with ADHD-C. In contrast to these two groups, the FRN effect was absent in children with ADHD-I. The LPP amplitudes were larger in children with ADHD-C in comparison with those with ADHD-I, regardless of feedback valence and magnitude. Conclusion: Children with ADHD-C exhibit intact brain sensitivity to punishment similar to TD children. In contrast, children with ADHD-I are significantly impaired in neural sensitivity to the feedback stimuli and in particular, to punishment, compared to TD and ADHD-C children. Thus, FRN, rather than LPP, is a reliable index of the difference in reward and punishment sensitivity across different ADHD-subcategories.	[Gong, Jingbo; Wang, Suhong; Shi, Lijuan; Cui, Xilong; Luo, Xuerong] Cent S Univ, Mental Hlth Inst, Xiangya Hosp 2, Natl Technol Inst Psychiat,Key Lab Psychiat & Men, Changsha, Hunan, Peoples R China; [Gong, Jingbo] Tradit Chinese Med Univ Hunan, Changsha, Hunan, Peoples R China; [Yuan, Jiajin] Southwest Univ, Sch Psychol, Chongqing, Peoples R China; [Wang, Suhong] Soochow Univ, Affiliated Hosp 3, Dept Neurosci, Changzhou, Peoples R China	Central South University; Hunan University of Chinese Medicine; Southwest University - China; Soochow University - China	Luo, XR (corresponding author), Cent S Univ, Mental Hlth Inst, Xiangya Hosp 2, Natl Technol Inst Psychiat,Key Lab Psychiat & Men, Changsha, Hunan, Peoples R China.	luoxr@vip.sina.com	Cui, Xilong/HHM-6692-2022		Hunan Provincial Natural Science Foundation of China [12JJ5066]; National Natural Science of Foundation of China (NSFC) [81101018, 31371042]; Changzhou Science and Technology Application Project [CJ20112009, CJ20130026]	Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); National Natural Science of Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Changzhou Science and Technology Application Project	This work was supported by grants from the Hunan Provincial Natural Science Foundation of China (No. 12JJ5066), the National Natural Science of Foundation of China (NSFC, No. 81101018; 31371042), and Changzhou Science and Technology Application Project (Nos. CJ20112009, CJ20130026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T., 1991, INTEGRATIVE GUIDE 19; Achenbach TM, 2003, J CLIN CHILD ADOLESC, V32, P328, DOI 10.1207/S15374424JCCP3203_02; Althaus M, 2010, BIOL PSYCHOL, V85, P19, DOI 10.1016/j.biopsycho.2010.04.007; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; AUGUST GJ, 1987, J ABNORM CHILD PSYCH, V15, P429, DOI 10.1007/BF00916459; Barber MA, 1996, J CLIN CHILD PSYCHOL, V25, P66, DOI 10.1207/s15374424jccp2501_8; Barkley RA, 2002, J CLIN PSYCHIAT, V63, P36; BORCHERDING B, 1988, J ABNORM CHILD PSYCH, V16, P333, DOI 10.1007/BF00913804; Cacioppo JT, 1999, ANNU REV PSYCHOL, V50, P191, DOI 10.1146/annurev.psych.50.1.191; Carlson CL, 2002, J LEARN DISABIL-US, V35, P104, DOI 10.1177/002221940203500202; Carlson CL, 2000, COGNITIVE THER RES, V24, P87, DOI 10.1023/A:1005455009154; Carlson CL, 2000, J CONSULT CLIN PSYCH, V68, P73, DOI 10.1037/0022-006X.68.1.73; Centers for Disease Control National Center for Prevention Services (US) Division of Tuberculosis Elimination National Center for HIV, 2001, REP TUB US; Conzelmann A, 2009, BIOL PSYCHIAT, V65, P578, DOI 10.1016/j.biopsych.2008.10.038; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Delplanque S, 2005, BIOL PSYCHOL, V68, P107, DOI 10.1016/j.biopsycho.2004.04.006; Delplanque S, 2004, NEUROSCI LETT, V356, P1, DOI 10.1016/j.neulet.2003.10.014; DOUGLAS VI, 1994, J ABNORM CHILD PSYCH, V22, P281, DOI 10.1007/BF02168075; Edel MA, 2013, J PSYCHIATR RES, V47, P350, DOI 10.1016/j.jpsychires.2012.09.026; Foti D, 2008, J COGNITIVE NEUROSCI, V20, P977, DOI 10.1162/jocn.2008.20066; Frank MJ, 2007, NEUROPSYCHOPHARMACOL, V32, P1583, DOI 10.1038/sj.npp.1301278; Gau SSF, 2005, AM J PSYCHIAT, V162, P1344, DOI 10.1176/appi.ajp.162.7.1344; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Groen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059240; Groen Y, 2008, CLIN NEUROPHYSIOL, V119, P2476, DOI 10.1016/j.clinph.2008.08.004; HAENLEIN M, 1987, J AM ACAD CHILD PSY, V26, P356, DOI 10.1097/00004583-198705000-00014; Hajcak G, 2006, COGN AFFECT BEHAV NE, V6, P291, DOI 10.3758/CABN.6.4.291; Hajcak G, 2006, EMOTION, V6, P517, DOI 10.1037/1528-3542.6.3.517; HANSEN CH, 1988, J PERS SOC PSYCHOL, V54, P917, DOI 10.1037/0022-3514.54.6.917; Huang YX, 2006, NEUROSCI LETT, V398, P91, DOI 10.1016/j.neulet.2005.12.074; Hupp SDA, 2002, BEHAV MODIF, V26, P148, DOI 10.1177/0145445502026002002; Kelly ML, 1995, BEHAV MODIF, V19, P76; Krompinger JW, 2008, EMOTION, V8, P132, DOI 10.1037/1528-3542.8.1.132; Lahey BB, 1997, DSM 4 SOURCEBOOK, V3, P163; Luman M, 2005, CLIN PSYCHOL REV, V25, P183, DOI 10.1016/j.cpr.2004.11.001; Moser JS, 2006, PSYCHOPHYSIOLOGY, V43, P292, DOI 10.1111/j.1469-8986.2006.00402.x; Nigg JT, 2005, DEV PSYCHOPATHOL, V17, P785, DOI 10.1017/S0954579405050376; PATTERSON CM, 1993, PSYCHOL REV, V100, P716, DOI 10.1037/0033-295X.100.4.716; Pelham PA, 1993, J CONSULT CLIN PSYCH, V61, P506; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Power TJ, 2004, J ABNORM CHILD PSYCH, V32, P27, DOI 10.1023/B:JACP.0000007578.30863.93; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Quay H. C., 1988, ATTENTION DEFICIT DI, P117; QUAY HC, 1988, J AM ACAD CHILD PSY, V27, P262, DOI 10.1097/00004583-198803000-00030; Quay HC, 1988, ATTENTION DEFICIT DI, V3, P176; Sagvolden T, 1998, BEHAV BRAIN RES, V94, P61, DOI 10.1016/S0166-4328(97)00170-8; Sagvolden T, 2005, BEHAV BRAIN SCI, V28, P397, DOI 10.1017/S0140525X05000075; Scheres A, 2007, BIOL PSYCHIAT, V61, P720, DOI 10.1016/j.biopsych.2006.04.042; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Sergeant J, 2000, NEUROSCI BIOBEHAV R, V24, P7, DOI 10.1016/S0149-7634(99)00060-3; Sonuga-Barke EJS, 2003, NEUROSCI BIOBEHAV R, V27, P593, DOI 10.1016/j.neubiorev.2003.08.005; Swanson JM, 2001, J AM ACAD CHILD PSY, V40, P168, DOI 10.1097/00004583-200102000-00011; Tripp G, 2008, J CHILD PSYCHOL PSYC, V49, P691, DOI 10.1111/j.1469-7610.2007.01851.x; van Meel CS, 2011, J CHILD PSYCHOL PSYC, V52, P942, DOI 10.1111/j.1469-7610.2010.02352.x; van Meel CS, 2005, NEUROPSYCHOLOGIA, V43, P1946, DOI 10.1016/j.neuropsychologia.2005.03.018; VANDERMEERE J, 1995, J CHILD PSYCHOL PSYC, V36, P697, DOI 10.1111/j.1469-7610.1995.tb02323.x; Wentura D, 2000, J PERS SOC PSYCHOL, V78, P1024, DOI 10.1037//0022-3514.78.6.1024; Woo BSC, 2005, AUST NZ J PSYCHIAT, V39, P344, DOI 10.1080/j.1440-1614.2005.01580.x; Yuan JJ, 2008, NEUROSCIENCE, V157, P524, DOI 10.1016/j.neuroscience.2008.09.023; Yuan JJ, 2007, NEUROPSYCHOLOGIA, V45, P2764, DOI 10.1016/j.neuropsychologia.2007.04.018; Yuan JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089844; Yuan JJ, 2012, BIOL PSYCHOL, V89, P240, DOI 10.1016/j.biopsycho.2011.10.015; Yuan JJ, 2011, BRAIN RES, V1415, P84, DOI 10.1016/j.brainres.2011.07.053	63	14	16	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99570	10.1371/journal.pone.0099570	http://dx.doi.org/10.1371/journal.pone.0099570			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ5PV	24932610	Green Submitted, Green Published, gold			2022-12-25	WOS:000337738600043
J	Schnell, A; Chappuis, S; Schmutz, I; Brai, E; Ripperger, JA; Schaad, O; Welzl, H; Descombes, P; Alberi, L; Albrecht, U				Schnell, Anna; Chappuis, Sylvie; Schmutz, Isabelle; Brai, Emanuele; Ripperger, Juergen A.; Schaad, Olivier; Welzl, Hans; Descombes, Patrick; Alberi, Lavinia; Albrecht, Urs			The Nuclear Receptor REV-ERB alpha Regulates Fabp7 and Modulates Adult Hippocampal Neurogenesis	PLOS ONE			English	Article							FORCED SWIMMING TEST; NEURAL STEM-CELLS; DENTATE GYRUS; MICE LACKING; CIRCADIAN BEHAVIOR; GENE-EXPRESSION; BINDING; CLOCK; PROTEIN; BRAIN	The function of the nuclear receptor Rev-erb alpha (Nr1d1) in the brain is, apart from its role in the circadian clock mechanism, unknown. Therefore, we compared gene expression profiles in the brain between wild-type and Rev-erb alpha knock-out (KO) animals. We identified fatty acid binding protein 7 (Fabp7, Blbp) as a direct target of repression by REV-ERB alpha. Loss of Rev-erb alpha manifested in memory and mood related behavioral phenotypes and led to overexpression of Fabp7 in various brain areas including the subgranular zone (SGZ) of the hippocampus, where neuronal progenitor cells (NPCs) can initiate adult neurogenesis. We found increased proliferation of hippocampal neurons and loss of its diurnal pattern in Rev-erb alpha KO mice. In vitro, proliferation and migration of glioblastoma cells were affected by manipulating either Fabp7 expression or REV-ERB alpha activity. These results suggest an important role of Rev-erb alpha and Fabp7 in adult neurogenesis, which may open new avenues for treatment of gliomas as well as neurological diseases such as depression and Alzheimer.	[Schnell, Anna; Chappuis, Sylvie; Schmutz, Isabelle; Ripperger, Juergen A.; Albrecht, Urs] Univ Fribourg, Dept Biol, Biochem Unit, CH-1700 Fribourg, Switzerland; [Brai, Emanuele; Alberi, Lavinia] Univ Fribourg, Unit Anat, Dept Med, CH-1700 Fribourg, Switzerland; [Schaad, Olivier; Descombes, Patrick] Univ Geneva, NCCR Frontiers Genet, Geneva, Switzerland; [Welzl, Hans] Univ Zurich, Dept Anat, Zurich, Switzerland	University of Fribourg; University of Fribourg; University of Geneva; University of Zurich	Albrecht, U (corresponding author), Univ Fribourg, Dept Biol, Biochem Unit, CH-1700 Fribourg, Switzerland.	urs.albrecht@unifr.ch	Albrecht, Urs/A-9831-2011	Albrecht, Urs/0000-0002-0663-8676; Schnell, Anna/0000-0002-3943-598X	Swiss National Science Foundation; Velux Foundation; State of Fribourg	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Velux Foundation(Velux Fonden); State of Fribourg	Funding by the Swiss National Science Foundation, the Velux Foundation and the State of Fribourg is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Basak O, 2012, J NEUROSCI, V32, P5654, DOI 10.1523/JNEUROSCI.0455-12.2012; Bizon JL, 2001, EUR J NEUROSCI, V14, P1739, DOI 10.1046/j.0953-816x.2001.01781.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borgs L, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-30; Bracko O, 2012, J NEUROSCI, V32, P3376, DOI 10.1523/JNEUROSCI.4248-11.2012; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Chomez P, 2000, DEVELOPMENT, V127, P1489; Crumbley C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017290; De Rosa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052113; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Gerstner JR, 2012, J NEUROSCI, V32, P1383, DOI 10.1523/JNEUROSCI.3228-11.2012; Gerstner JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001631; Giachino C, 2014, STEM CELLS, V32, P70, DOI 10.1002/stem.1520; Gibson EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015267; Gilhooley MJ, 2011, NEUROSCI LETT, V489, P177, DOI 10.1016/j.neulet.2010.12.011; Goergen EM, 2002, J NEUROBIOL, V53, P90, DOI 10.1002/neu.10095; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Gould E, 1997, DEV BRAIN RES, V103, P91, DOI 10.1016/S0165-3806(97)00079-5; Gould E, 1997, J NEUROSCI, V17, P2492; Gu Yan, 2013, Curr Top Behav Neurosci, V15, P31, DOI 10.1007/7854_2012_217; Guzman-Marin R, 2003, J PHYSIOL-LONDON, V549, P563, DOI 10.1113/jphysiol.2003.041665; Hampp G, 2008, CURR BIOL, V18, P678, DOI 10.1016/j.cub.2008.04.012; Hamprecht B, 1977, Int Rev Cytol, V49, P99; Jager J, 2014, MOL ENDOCRINOL, V28, P490, DOI 10.1210/me.2013-1351; Janich P, 2013, CELL STEM CELL, V13, P745, DOI 10.1016/j.stem.2013.09.004; Janich P, 2011, NATURE, V480, P209, DOI 10.1038/nature10649; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kimiwada T, 2009, NEUROCHEM INT, V54, P277, DOI 10.1016/j.neuint.2008.12.005; Kochman LJ, 2006, NEUROSCI LETT, V406, P256, DOI 10.1016/j.neulet.2006.07.058; Kojetin D, 2011, ACS CHEM BIOL, V6, P131, DOI 10.1021/cb1002575; Kott J, 2012, NEUROSCI LETT, V515, P177, DOI 10.1016/j.neulet.2012.03.048; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Langmesser S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-41; Lee SY, 2012, BRAIN RES, V1478, P48, DOI 10.1016/j.brainres.2012.08.035; Li AH, 2013, FEBS LETT, V587, P2455, DOI 10.1016/j.febslet.2013.06.018; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Llaguno SRA, 2009, CLIN CANCER RES, V15, P7124, DOI 10.1158/1078-0432.CCR-09-0433; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Madden MH, 2014, CANCER CAUSE CONTROL, V25, P25, DOI 10.1007/s10552-013-0305-y; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Owada Y, 2006, EUR J NEUROSCI, V24, P175, DOI 10.1111/j.1460-9568.2006.04855.x; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; PONTEN J, 1978, MED BIOL, V56, P184; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Renard CE, 2003, FUND CLIN PHARMACOL, V17, P449, DOI 10.1046/j.1472-8206.2003.00160.x; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Samuels BA, 2011, EUR J NEUROSCI, V33, P1152, DOI 10.1111/j.1460-9568.2011.07614.x; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Singh SK, 2003, CANCER RES, V63, P5821; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Stratmann M, 2010, GENE DEV, V24, P1317, DOI 10.1101/gad.578810; Tamai SI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003835; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Watanabe A, 2007, PLOS BIOL, V5, P2469, DOI 10.1371/journal.pbio.0050297; Wimmer ME, 2012, NEUROBIOL AGING, V33, P2220, DOI 10.1016/j.neurobiolaging.2011.07.007; Young JK, 2013, HIPPOCAMPUS, V23, P1476, DOI 10.1002/hipo.22200; Yun SW, 2012, P NATL ACAD SCI USA, V109, P10214, DOI 10.1073/pnas.1200817109; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	68	65	68	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99883	10.1371/journal.pone.0099883	http://dx.doi.org/10.1371/journal.pone.0099883			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932636	gold, Green Accepted, Green Published			2022-12-25	WOS:000337738600076
J	Winston, ME; Hampton-Marcell, J; Zarraonaindia, I; Owens, SM; Moreau, CS; Gilbert, JA; Hartsel, J; Kennedy, SJ; Gibbons, SM				Winston, Max E.; Hampton-Marcell, Jarrad; Zarraonaindia, Iratxe; Owens, Sarah M.; Moreau, Corrie S.; Gilbert, Jack A.; Hartsel, Josh; Kennedy, Suzanne J.; Gibbons, S. M.			Understanding Cultivar-Specificity and Soil Determinants of the Cannabis Microbiome	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; RHIZOSPHERE BACTERIA; ENDOPHYTIC BACTERIA; PLANT; GROWTH; TUBEROSUM; PHYTOREMEDIATION; COLONIZATION; DIVERSITY; VOLATILE	Understanding microbial partnerships with the medicinally and economically important crop Cannabis has the potential to affect agricultural practice by improving plant fitness and production yield. Furthermore, Cannabis presents an interesting model to explore plant-microbiome interactions as it produces numerous secondary metabolic compounds. Here we present the first description of the endorhiza-, rhizosphere-, and bulk soil-associated microbiome of five distinct Cannabis cultivars. Bacterial communities of the endorhiza showed significant cultivar-specificity. When controlling cultivar and soil type the microbial community structure was significantly different between plant cultivars, soil types, and between the endorhiza, rhizosphere and soil. The influence of soil type, plant cultivar and sample type differentiation on the microbial community structure provides support for a previously published two-tier selection model, whereby community composition across sample types is determined mainly by soil type, while community structure within endorhiza samples is determined mainly by host cultivar.	[Winston, Max E.; Moreau, Corrie S.] Field Museum, Dept Sci & Educ, Chicago, IL 60605 USA; [Winston, Max E.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Hampton-Marcell, Jarrad; Zarraonaindia, Iratxe; Owens, Sarah M.; Gilbert, Jack A.; Gibbons, S. M.] Inst Genom & Syst Biol, Argonne Natl Lab, Lemont, IL USA; [Hampton-Marcell, Jarrad; Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Zarraonaindia, Iratxe] Basque Country Govt, Bilbao, Spain; [Owens, Sarah M.] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Hartsel, Josh] Cannavest, San Diego, CA USA; [Kennedy, Suzanne J.] MO BIO Labs, Carlsbad, CA USA; [Gibbons, S. M.] Univ Chicago, Grad Program Biophys Sci, Chicago, IL 60637 USA	Field Museum of Natural History (Chicago); University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; Basque Government; University of Chicago; University of Chicago	Winston, ME (corresponding author), Field Museum, Dept Sci & Educ, Chicago, IL 60605 USA.	mewinsto@gmail.com	Zarraonaindia, Iratxe/ABF-4618-2020; Gilbert, Jack/AAF-3270-2019; Gibbons, Sean M./ABH-2562-2020	Zarraonaindia, Iratxe/0000-0002-0615-0187; Gibbons, Sean M./0000-0002-8724-7916; Moreau, Corrie/0000-0003-1139-5792	U.S. Dept. of Energy [DE-AC02-06CH11357]; U.S. Department of Education GAANN grant; U.S. Environmental Protection Agency STAR Graduate Fellowship; Amazon Web Services education grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	U.S. Dept. of Energy(United States Department of Energy (DOE)); U.S. Department of Education GAANN grant; U.S. Environmental Protection Agency STAR Graduate Fellowship(United States Environmental Protection Agency); Amazon Web Services education grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by the U.S. Dept. of Energy under Contract DE-AC02-06CH11357. MEW was supported by a U.S. Department of Education GAANN grant. Funding for SMG was provided U.S. Environmental Protection Agency STAR Graduate Fellowship. Computational resources were funded by a Amazon Web Services education grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreote FD, 2009, APPL ENVIRON MICROB, V75, P3396, DOI 10.1128/AEM.00491-09; Bakker P., 2011, MULTITROPHIC INTERAC, V71, P169; Barac T, 2004, NAT BIOTECHNOL, V22, P583, DOI 10.1038/nbt960; Beattie GA, 2006, PLANT-ASSOCIATED BACTERIA, P1; Berendsen R.L., 2012, TRENDS PLANT SCI, P1; BERG B, 1972, J APPL BACTERIOL, V35, P201, DOI 10.1111/j.1365-2672.1972.tb03691.x; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Bezemer TM, 2006, J ECOL, V94, P893, DOI 10.1111/j.1365-2745.2006.01158.x; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Bonanomi G, 2005, PLANT ECOL, V181, P269, DOI 10.1007/s11258-005-7221-5; Bonfante P, 2009, ANNU REV MICROBIOL, V63, P363, DOI 10.1146/annurev.micro.091208.073504; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chiarini L, 1998, APPL SOIL ECOL, V8, P11, DOI 10.1016/S0929-1393(97)00071-1; Citterio S, 2005, CHEMOSPHERE, V59, P21, DOI 10.1016/j.chemosphere.2004.10.009; da Rocha UN, 2009, FEMS MICROBIOL ECOL, V69, P313, DOI 10.1111/j.1574-6941.2009.00702.x; Diaz CL, 1989, NATURE, V4, P338; Duineveld BM, 1998, APPL ENVIRON MICROB, V64, P4950; FROMMEL MI, 1991, PLANT PHYSIOL, V96, P928, DOI 10.1104/pp.96.3.928; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Gilbert JA, 2014, P NATL ACAD SCI USA, V111, P5, DOI 10.1073/pnas.1320471110; Glick BR, 1998, J THEOR BIOL, V190, P63, DOI 10.1006/jtbi.1997.0532; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Jesus ED, 2010, BIOENERG RES, V3, P20, DOI 10.1007/s12155-009-9073-7; Jossi M, 2006, FEMS MICROBIOL ECOL, V55, P339, DOI 10.1111/j.1574-6941.2005.00040.x; Krivtsov V, 2007, ANIM BIOL, V57, P467, DOI 10.1163/157075607782232189; LAMBERT B, 1989, TRENDS BIOTECHNOL, V7, P215, DOI 10.1016/0167-7799(89)90107-8; Lekberg Y, 2013, ISME J, V7, P1424, DOI 10.1038/ismej.2013.41; Liste HH, 2006, CHEMOSPHERE, V62, P1411, DOI 10.1016/j.chemosphere.2005.05.018; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mahaffee WF, 1997, MICROB ECOL, V34, P210, DOI 10.1007/s002489900050; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Marschner P, 2004, PLANT SOIL, V261, P199, DOI 10.1023/B:PLSO.0000035569.80747.c5; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Milling A, 2004, PLANT SOIL, V266, P23; Nelson DR, 2006, AUST J SOIL RES, V44, P319, DOI 10.1071/SR06022; Oksanen J, 2013, COMMUNITY ECOLOGY PA, V2, P1; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Swift MJ, 2004, AGR ECOSYST ENVIRON, V104, P113, DOI 10.1016/j.agee.2004.01.013; Taghavi S, 2005, APPL ENVIRON MICROB, V71, P8500, DOI 10.1128/AEM.71.12.8500-8505.2005; Turpault MP, 2007, GEODERMA, V137, P490, DOI 10.1016/j.geoderma.2006.10.005; van der Lelie D, 2009, CRIT REV PLANT SCI, V28, P346, DOI 10.1080/07352680903241204; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V64, P283, DOI 10.1111/j.1574-6941.2008.00469.x; Verginer M, 2010, J AGR FOOD CHEM, V58, P8344, DOI 10.1021/jf100393w; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whipps JM, 2001, J EXP BOT, V52, P487, DOI 10.1093/jexbot/52.suppl_1.487; Winston M, 2014, FIGSHARE	51	37	40	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99641	10.1371/journal.pone.0099641	http://dx.doi.org/10.1371/journal.pone.0099641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932479	gold, Green Published, Green Submitted			2022-12-25	WOS:000337738600051
J	Radszuweit, M; Engel, H; Bar, M				Radszuweit, Markus; Engel, Harald; Baer, Markus			An Active Poroelastic Model for Mechanochemical Patterns in Protoplasmic Droplets of Physarum polycephalum	PLOS ONE			English	Article							TRUE SLIME-MOLD; PLASMODIAL STRAND; FLOW MODELS; CYTOPLASM; CELL; OSCILLATIONS; DYNAMICS; CONTRACTION; ELASTICITY; MORPHOLOGY	Motivated by recent experimental studies, we derive and analyze a two-dimensional model for the contraction patterns observed in protoplasmic droplets of Physarum polycephalum. The model couples a description of an active poroelastic two-phase medium with equations describing the spatiotemporal dynamics of the intracellular free calcium concentration. The poroelastic medium is assumed to consist of an active viscoelastic solid representing the cytoskeleton and a viscous fluid describing the cytosol. The equations for the poroelastic medium are obtained from continuum force balance and include the relevant mechanical fields and an incompressibility condition for the two-phase medium. The reaction-diffusion equations for the calcium dynamics in the protoplasm of Physarum are extended by advective transport due to the flow of the cytosol generated by mechanical stress. Moreover, we assume that the active tension in the solid cytoskeleton is regulated by the calcium concentration in the fluid phase at the same location, which introduces a mechanochemical coupling. A linear stability analysis of the homogeneous state without deformation and cytosolic flows exhibits an oscillatory Turing instability for a large enough mechanochemical coupling strength. Numerical simulations of the model equations reproduce a large variety of wave patterns, including traveling and standing waves, turbulent patterns, rotating spirals and antiphase oscillations in line with experimental observations of contraction patterns in the protoplasmic droplets.	[Radszuweit, Markus] Leibniz Inst Forschungsverbund Berlin eV, Weierstr Inst Angew Anal & Stochast, Berlin, Germany; [Radszuweit, Markus; Engel, Harald] Tech Univ Berlin, Inst Theoret Phys, Berlin, Germany; [Radszuweit, Markus; Baer, Markus] Phys Tech Bundesanstalt, Berlin, Germany	Weierstrass Institute for Applied Analysis & Stochastics; Technical University of Berlin; Physikalisch-Technische Bundesanstalt (PTB)	Radszuweit, M (corresponding author), Leibniz Inst Forschungsverbund Berlin eV, Weierstr Inst Angew Anal & Stochast, Berlin, Germany.	Markus.Radszuweit@wias-berlin.de	Engel, Harald/ABD-2272-2020; Bär, Markus/B-8396-2011	Bär, Markus/0000-0002-6935-7759	German Science Foundation (DFG) [GRK 1558]	German Science Foundation (DFG)(German Research Foundation (DFG))	Funding was granted by the German Science Foundation (DFG) within the research training group: "Nonequilibrium Collective Dynamics in Condensed Matter and Biological Systems" (GRK 1558) (URL: http://www.dfg.de/en/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt W, 1999, MATH BIOSCI, V156, P207, DOI 10.1016/S0025-5564(98)10067-6; Banerjee S, 2011, SOFT MATTER, V7, P463, DOI 10.1039/c0sm00494d; Banks HT, 2011, ADV APPL MATH MECH, V3, P1, DOI 10.4208/aamm.10-m1030; Baumgarten W, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/2/026003; Baumgarten W, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046113; Bois JS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028103; Borene ML, 2004, ANN BIOMED ENG, V32, P274, DOI 10.1023/B:ABME.0000012747.97620.3a; BRINKMAN HC, 1947, APPL SCI RES, V1, P27; BRIX K, 1987, PROTOPLASMA, V137, P156, DOI 10.1007/BF01281151; Bykov AV, 2009, J BIOPHOTONICS, V2, P540, DOI 10.1002/jbio.200910057; Callan-Jones AC, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/9/093027; Charras GT, 2009, J CELL SCI, V122, P3233, DOI 10.1242/jcs.049262; Cogan NG, 2010, HFSP J, V4, P11, DOI 10.2976/1.3291142; DEMBO M, 1986, BIOPHYS J, V50, P109, DOI 10.1016/S0006-3495(86)83444-0; DONAHUE BS, 1987, CELL CALCIUM, V8, P437, DOI 10.1016/0143-4160(87)90027-3; Fessel A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.078103; Guy RD, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016310; Howard J, 2011, NAT REV MOL CELL BIO, V12, P392, DOI 10.1038/nrm3120; Joanny JF, 2009, HFSP J, V3, P94, DOI 10.2976/1.3054712; KAMIYA N, 1981, ANNU REV PLANT PHYS, V32, P205, DOI 10.1146/annurev.pp.32.060181.001225; KESSLER D, 1976, J CELL BIOL, V69, P393, DOI 10.1083/jcb.69.2.393; Kopf MH, 2013, PHYSICA D, V259, P48; Mitchison TJ, 2008, SEMIN CELL DEV BIOL, V19, P215, DOI 10.1016/j.semcdb.2008.01.008; Moulding DA, 2013, NAT MATER, V12, P253; NAGAI R, 1978, J CELL SCI, V33, P205; NAGAI R, 1975, PROTOPLASMA, V86, P141, DOI 10.1007/BF01275628; Nakagaki T, 1999, J THEOR BIOL, V197, P497, DOI 10.1006/jtbi.1998.0890; Nakagaki T, 2000, NATURE, V407, P470, DOI 10.1038/35035159; Nakagaki T, 2004, P ROY SOC B-BIOL SCI, V271, P2305, DOI 10.1098/rspb.2004.2856; Nakagaki T, 2008, SOFT MATTER, V4, P57, DOI 10.1039/b706317m; Nakagaki T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.068104; Norris CH, 1940, J CELL COMPAR PHYSL, V16, P313, DOI 10.1002/jcp.1030160307; OSTER GF, 1984, CELL MOTIL CYTOSKEL, V4, P469, DOI 10.1002/cm.970040606; Panfilov AV, 2007, P NATL ACAD SCI USA, V104, P7922, DOI 10.1073/pnas.0701895104; Pelletier V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.188303; Radszuweit M, 2010, EUR PHYS J-SPEC TOP, V191, P159, DOI 10.1140/epjst/e2010-01348-2; Radszuweit M, 2013, THESIS; Radszuweit M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.138102; Romanovsky YM, 1995, PHYS USPEKHI, V38, P512; SATO M, 1983, J CELL BIOL, V97, P1089, DOI 10.1083/jcb.97.4.1089; Shewchuk JR, 1996, APPL COMPUTATIONAL G, P203, DOI DOI 10.1007/BFB0014497; SMITH DA, 1992, BIOPHYS J, V61, P368, DOI 10.1016/S0006-3495(92)81843-X; Takagi S, 2008, PHYSICA D, V237, P420, DOI 10.1016/j.physd.2007.09.012; Takagi S, 2010, PHYSICA D, V239, P873, DOI 10.1016/j.physd.2009.06.011; TEPLOV VA, 1991, BIOSYSTEMS, V24, P269, DOI 10.1016/0303-2647(91)90046-N; Tero A, 2005, PHYSICA D, V205, P125, DOI 10.1016/j.physd.2005.01.010; Tero A, 2010, SCIENCE, V327, P439, DOI 10.1126/science.1177894; Tsuda S, 2011, BIOSYSTEMS, V103, P331, DOI 10.1016/j.biosystems.2010.11.001; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Ueda K, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.021916; Ueda T, 2005, NETWORKS INTERACTING, P221; WOHLFARTHBOTTERMANN KE, 1977, J EXP BIOL, V67, P49; Yamada H, 2007, J MATH BIOL, V54, P745, DOI 10.1007/s00285-006-0067-1; YOSHIMOTO Y, 1982, PROTOPLASMA, V110, P63, DOI 10.1007/BF01314683; YOSHIMOTO Y, 1981, CELL MOTIL CYTOSKEL, V1, P433, DOI 10.1002/cm.970010404	55	33	33	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99220	10.1371/journal.pone.0099220	http://dx.doi.org/10.1371/journal.pone.0099220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927427	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100031
J	Yu, S; Klaus, A; Yang, HD; Plenz, D				Yu, Shan; Klaus, Andreas; Yang, Hongdian; Plenz, Dietmar			Scale-Invariant Neuronal Avalanche Dynamics and the Cut-Off in Size Distributions	PLOS ONE			English	Article							SELF-ORGANIZED CRITICALITY; PROPAGATING WAVES; CORTICAL NETWORKS; POWER LAWS; RANGE; POPULATION; CORTEX; MONKEY; PHASE	Identification of cortical dynamics strongly benefits from the simultaneous recording of as many neurons as possible. Yet current technologies provide only incomplete access to the mammalian cortex from which adequate conclusions about dynamics need to be derived. Here, we identify constraints introduced by sub-sampling with a limited number of electrodes, i.e. spatial 'windowing', for well-characterized critical dynamics_neuronal avalanches. The local field potential (LFP) was recorded from premotor and prefrontal cortices in two awake macaque monkeys during rest using chronically implanted 96-microelectrode arrays. Negative deflections in the LFP (nLFP) were identified on the full as well as compact sub-regions of the array quantified by the number of electrodes N (10-95), i.e., the window size. Spatiotemporal nLFP clusters organized as neuronal avalanches, i.e., the probability in cluster size, p(s), invariably followed a power law with exponent -1.5 up to N, beyond which p(s) declined more steeply producing a 'cut-off' that varied with N and the LFP filter parameters. Clusters of size s <= N consisted mainly of nLFPs from unique, non-repeated cortical sites, emerged from local propagation between nearby sites, and carried spatial information about cluster organization. In contrast, clusters of size s>N were dominated by repeated site activations and carried little spatial information, reflecting greatly distorted sampling conditions. Our findings were confirmed in a neuron-electrode network model. Thus, avalanche analysis needs to be constrained to the size of the observation window to reveal the underlying scale-invariant organization produced by locally unfolding, predominantly feed-forward neuronal cascades.	[Yu, Shan; Klaus, Andreas; Yang, Hongdian; Plenz, Dietmar] NIMH, Sect Crit Brain Dynam, Bethesda, MD 20892 USA; [Klaus, Andreas] Karolinska Inst, Nobel Inst Neurophysiol, Dept Neurosci, S-10401 Stockholm, Sweden	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Karolinska Institutet	Yu, S (corresponding author), NIMH, Sect Crit Brain Dynam, Bethesda, MD 20892 USA.	yushan.mail@gmail.com	Yu, Shan/S-3123-2017; Yang, Hongdian/D-1450-2015	yu, shan/0000-0002-4385-6306; Klaus, Andreas/0000-0002-4133-351X	Intramural Research Program of the National Institute of Mental Health; National Institutes of Health/Karolinska Institutet Doctoral Program; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002797] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health/Karolinska Institutet Doctoral Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the Intramural Research Program of the National Institute of Mental Health (http://intramural.nimh.nih.gov/). A.K. was in addition supported by the National Institutes of Health/Karolinska Institutet Doctoral Program (http://intramural.nimh.nih.gov/ ki-nih/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/nmeth.2434, 10.1038/NMETH.2434]; Beggs JM, 2003, J NEUROSCI, V23, P11167; Benayoun M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000846; Burroughs SM, 2001, PURE APPL GEOPHYS, V158, P741, DOI 10.1007/PL00001202; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; de Arcangelis L, 2010, P NATL ACAD SCI USA, V107, P3977, DOI 10.1073/pnas.0912289107; Dehghani N, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00302; Deluca A, 2013, ACTA GEOPHYS, V61, P1351, DOI 10.2478/s11600-013-0154-9; Freeman WJ, 2000, J NEUROPHYSIOL, V84, P1266, DOI 10.1152/jn.2000.84.3.1266; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Hahn G, 2010, J NEUROPHYSIOL, V104, P3312, DOI 10.1152/jn.00953.2009; Harris T. E., 1963, GRUNDLEHREN MATH WIS; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Klaus A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019779; Langlois D, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012709; Larremore DB, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066131; Larremore DB, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.058101; Lauritsen KB, 1996, PHYS REV E, V54, P2483, DOI 10.1103/PhysRevE.54.2483; Levina A, 2007, NAT PHYS, V3, P857, DOI 10.1038/nphys758; Millman D, 2010, NAT PHYS, V6, P801, DOI 10.1038/NPHYS1757; Murphy BK, 2009, NEURON, V61, P635, DOI 10.1016/j.neuron.2009.02.005; Naselaris T, 2005, J NEUROPHYSIOL, V93, P2318, DOI 10.1152/jn.00581.2004; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Pajevic S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000271; Palva JM, 2013, P NATL ACAD SCI USA, V110, P3585, DOI 10.1073/pnas.1216855110; Pasquale V, 2008, NEUROSCIENCE, V153, P1354, DOI 10.1016/j.neuroscience.2008.03.050; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Plenz D, 2012, EUR PHYS J-SPEC TOP, V205, P259, DOI 10.1140/epjst/e2012-01575-5; Reimer A, 2011, CEREB CORTEX, V21, P166, DOI 10.1093/cercor/bhq073; Ribeiro TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014129; Rubino D, 2006, NAT NEUROSCI, V9, P1549, DOI 10.1038/nn1802; Sato TK, 2012, NEURON, V75, P218, DOI 10.1016/j.neuron.2012.06.029; Shew WL, 2013, NEUROSCIENTIST, V19, P88, DOI 10.1177/1073858412445487; Shew WL, 2011, J NEUROSCI, V31, P55, DOI 10.1523/JNEUROSCI.4637-10.2011; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Shriki O, 2013, J NEUROSCI, V33, P7079, DOI 10.1523/JNEUROSCI.4286-12.2013; Stanley HE, 1999, REV MOD PHYS, V71, pS358, DOI 10.1103/RevModPhys.71.S358; Tagliazucchi E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00015; Thiagarajan TC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000278; Truccolo W, 2010, NAT NEUROSCI, V13, P105, DOI 10.1038/nn.2455; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Vincent K, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00086; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Wu JY, 2008, NEUROSCIENTIST, V14, P487, DOI 10.1177/1073858408317066; Xu WF, 2007, NEURON, V55, P119, DOI 10.1016/j.neuron.2007.06.016; Yang HD, 2012, J NEUROSCI, V32, P1061, DOI 10.1523/JNEUROSCI.2771-11.2012; Yu S, 2008, CEREB CORTEX, V18, P2891, DOI 10.1093/cercor/bhn047; Yu S, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00042; Yu S, 2011, J NEUROSCI, V31, P17514, DOI 10.1523/JNEUROSCI.3127-11.2011	54	32	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99761	10.1371/journal.pone.0099761	http://dx.doi.org/10.1371/journal.pone.0099761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927158	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100076
J	Law, SHW; Sargent, TD				Law, Sheran H. W.; Sargent, Thomas D.			The Serine-Threonine Protein Kinase PAK4 Is Dispensable in Zebrafish: Identification of a Morpholino-Generated Pseudophenotype	PLOS ONE			English	Article							ENDODERM FORMATION; RECEPTOR; ACTIVATION; PATHWAYS; SURVIVAL; CASANOVA; EMBRYOS; GENES; PLAYS; ALPHA	TALEN-based inactivation of the zebrafish pak4 gene resulted in embryos and adult fish that appear normal and fertile. This is in contrast to our previously published studies which were based on the use of antisense morpholino oligonucleotides (MOs). We have excluded potential explanations such as gene duplication, alternate splicing, cryptic initiation of translation, and translation-independent RNA function. Our conclusion is that pak4 is dispensable in zebrafish, and that even when corroborated by robust controls, such as RNA rescue, MOs may elicit misleading pseudophenotypes that do not correspond to results obtained by genetic mutations, and should thus be used with caution.	[Law, Sheran H. W.; Sargent, Thomas D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Vertebrate Dev, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Sargent, TD (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Vertebrate Dev, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA.	tsargent@nih.gov			Intramural Research Program, National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001006] Funding Source: NIH RePORTER	Intramural Research Program, National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding provided by Intramural Research Program, National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Alexander J, 1999, DEV BIOL, V215, P343, DOI 10.1006/dbio.1999.9441; Cvejic A, 2008, J CELL SCI, V121, P3196, DOI 10.1242/jcs.032235; den Broeder MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007910; Dickmeis T, 2001, GENE DEV, V15, P1487, DOI 10.1101/gad.196901; Driever W, 1996, DEVELOPMENT, V123, P37; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Ekker SC, 2001, GENESIS, V30, P89, DOI 10.1002/gene.1038; Eswaran J, 2008, TRENDS BIOCHEM SCI, V33, P394, DOI 10.1016/j.tibs.2008.06.002; Gerety SS, 2011, DEV BIOL, V350, P279, DOI 10.1016/j.ydbio.2010.11.030; Gnesutta N, 2003, MOL CELL BIOL, V23, P7838, DOI 10.1128/MCB.23.21.7838-7848.2003; Gnesutta N, 2001, J BIOL CHEM, V276, P14414, DOI 10.1074/jbc.M011046200; Goodale BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029346; Haffter P, 1996, DEVELOPMENT, V123, P1; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Krone PH, 1997, BIOCHEM CELL BIOL, V75, P487, DOI 10.1139/bcb-75-5-487; Law SHW, 2013, MECH DEVELOP, V130, P181, DOI 10.1016/j.mod.2012.09.005; Li XF, 2005, J BIOL CHEM, V280, P41192, DOI 10.1074/jbc.M506884200; Lim S, 2012, DEVELOPMENT, V139, P2903, DOI 10.1242/dev.077081; Liu YY, 2008, MOL CANCER RES, V6, P1215, DOI 10.1158/1541-7786.MCR-08-0087; Luo T, 2007, DEVELOPMENT, V134, P1279, DOI 10.1242/dev.02813; Luo YJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001402; Matthews J, 2005, MOL CELL BIOL, V25, P5317, DOI 10.1128/MCB.25.13.5317-5328.2005; Nichols JT, 2013, DEVELOPMENT, V140, P2765, DOI 10.1242/dev.090639; Prasch AL, 2003, TOXICOL SCI, V76, P138, DOI 10.1093/toxsci/kfg202; Qu J, 2003, MOL CELL BIOL, V23, P7122, DOI 10.1128/MCB.23.20.7122-7133.2003; Reid BS, 2010, DEV DYNAM, V239, P1188, DOI 10.1002/dvdy.22248; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Romano LA, 2006, DEV GROWTH DIFFER, V48, P487, DOI 10.1111/j.1440-169x.2006.00884.x; SARGENT TD, 1986, DEV BIOL, V114, P238, DOI 10.1016/0012-1606(86)90399-4; Sperber SM, 2008, DEV BIOL, V321, P101, DOI 10.1016/j.ydbio.2008.06.004; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tian YM, 2009, MECH DEVELOP, V126, P710, DOI 10.1016/j.mod.2009.05.002; Tucker B, 2006, HUM MOL GENET, V15, P3446, DOI 10.1093/hmg/ddl422; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE	36	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100268	10.1371/journal.pone.0100268	http://dx.doi.org/10.1371/journal.pone.0100268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945275	Green Published, gold, Green Submitted			2022-12-25	WOS:000340721500055
J	Okumura, T; Harada, K; Oue, K; Zhang, J; Asano, S; Hayashiuchi, M; Mizokami, A; Tanaka, H; Irifune, M; Kamata, N; Hirata, M; Kanematsu, T				Okumura, Toshiya; Harada, Kae; Oue, Kana; Zhang, Jun; Asano, Satoshi; Hayashiuchi, Masaki; Mizokami, Akiko; Tanaka, Hiroto; Irifune, Masahiro; Kamata, Nobuyuki; Hirata, Masato; Kanematsu, Takashi			Phospholipase C-Related Catalytically Inactive Protein (PRIP) Regulates Lipolysis in Adipose Tissue by Modulating the Phosphorylation of Hormone-Sensitive Lipase	PLOS ONE			English	Article							PERILIPIN-A; STIMULATED LIPOLYSIS; ADIPOCYTE LIPOLYSIS; MUTATIONAL ANALYSIS; SURFACE EXPRESSION; BINDING-PROTEIN; PHOSPHATASE 2A; RAT ADIPOCYTES; CELL-SURFACE; DEPHOSPHORYLATION	Phosphorylation of hormone-sensitive lipase (HSL) and perilipin by protein kinase A (PKA) promotes the hydrolysis of lipids in adipocytes. Although activation of lipolysis by PKA has been well studied, inactivation via protein phosphatases is poorly understood. Here, we investigated whether phospholipase C-related catalytically inactive protein (PRIP), a binding partner for protein phosphatase 1 and protein phosphatase 2A (PP2A), is involved in lipolysis by regulating phosphatase activity. PRIP knockout (PRIP-KO) mice displayed reduced body-fat mass as compared with wild-type mice fed with standard chow ad libitum. Most other organs appeared normal, suggesting that mutant mice had aberrant fat metabolism in adipocytes. HSL in PRIP-KO adipose tissue was highly phosphorylated compared to that in wild-type mice. Starvation of wild-type mice or stimulation of adipose tissue explants with the catabolic hormone, adrenaline, translocated both PRIP and PP2A from the cytosol to lipid droplets, but the translocation of PP2A was significantly reduced in PRIP-KO adipocytes. Consistently, the phosphatase activity associated with lipid droplet fraction in PRIP-KO adipocytes was significantly reduced and was independent of adrenaline stimulation. Lipolysis activity, as assessed by measurement of non-esterified fatty acids and glycerol, was higher in PRIP-KO adipocytes. When wild-type adipocytes were treated with a phosphatase inhibitor, they showed a high lipolysis activity at the similar level to PRIP-KO adipocytes. Collectively, these results suggest that PRIP promotes the translocation of phosphatases to lipid droplets to trigger the dephosphorylation of HSL and perilipin A, thus reducing PKA-mediated lipolysis.	[Okumura, Toshiya; Harada, Kae; Oue, Kana; Zhang, Jun; Asano, Satoshi; Hayashiuchi, Masaki; Tanaka, Hiroto; Kanematsu, Takashi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Cellular & Mol Pharmacol, Hiroshima, Japan; [Okumura, Toshiya; Kamata, Nobuyuki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Oral Surg, Hiroshima, Japan; [Oue, Kana; Irifune, Masahiro] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Dent Anesthesiol, Hiroshima, Japan; [Mizokami, Akiko; Tanaka, Hiroto; Hirata, Masato] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 812, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Kyushu University	Kanematsu, T (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Cellular & Mol Pharmacol, Hiroshima, Japan.	tkanema2@hiroshima-u.ac.jp	Mizokami, Akiko/AAY-2193-2020; Mizokami, Akiko/ABC-5448-2021; Asano, Satoshi/AAQ-3817-2020; Harada, Kae/AAT-1162-2020	Mizokami, Akiko/0000-0002-7490-5190; Harada, Kae/0000-0001-7620-9212; Asano, Satoshi/0000-0003-1537-4307	Funding Program for Next Generation World-Leading Researchers [LS087]; JSPS KAKENHI [25861757, 25861756, 24229009]; Grants-in-Aid for Scientific Research [26670809, 25861757] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by funding from the Funding Program for Next Generation World-Leading Researchers (LS087) to T.K., and by JSPS KAKENHI (Grant No. 25861757 to K.H., Grant No. 25861756 to S.A., Grant No. 24229009 to M.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Asano S, 2014, BIOL OPEN IN PRESS; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2009, MOL CELL BIOCHEM, V326, P15, DOI 10.1007/s11010-008-9998-8; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; Clifford GM, 1998, FEBS LETT, V435, P125, DOI 10.1016/S0014-5793(98)01052-7; Doira N, 2001, BIOMED RES-TOKYO, V22, P157, DOI 10.2220/biomedres.22.157; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; Fujii M, 2010, J BIOL CHEM, V285, P4837, DOI 10.1074/jbc.M109.070045; Gao J, 2012, J BIOL CHEM, V287, P10565, DOI 10.1074/jbc.M111.294645; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Guo CY, 2002, J BIOL CHEM, V277, P41756, DOI 10.1074/jbc.M207519200; Kanematsu T, 2005, MOL CELLS, V20, P305; Kanematsu T, 1996, BIOCHEM J, V313, P319, DOI 10.1042/bj3130319; KANEMATSU T, 1992, J BIOL CHEM, V267, P6518; Kanematsu T, 2000, EUR J BIOCHEM, V267, P2731, DOI 10.1046/j.1432-1327.2000.01291.x; Kanematsu T, 2002, EMBO J, V21, P1004, DOI 10.1093/emboj/21.5.1004; Kanematsu T, 2007, J PHARMACOL SCI, V104, P285, DOI 10.1254/jphs.CP0070063; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; King TD, 2006, EXP CELL RES, V312, P3693, DOI 10.1016/j.yexcr.2006.08.010; Kinney BP, 2010, ENDOCRINOLOGY, V151, P3624, DOI 10.1210/en.2010-0245; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lampidonis AD, 2011, GENE, V477, P1, DOI 10.1016/j.gene.2011.01.007; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Martin S, 2009, J BIOL CHEM, V284, P32097, DOI 10.1074/jbc.M109.002675; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Michelle AS, 2011, STEM CELLS DEV, V20, P1793; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Mizokami A, 2007, J NEUROSCI, V27, P1692, DOI 10.1523/JNEUROSCI.3155-06.2007; Mizokami A, 2010, J NEUROCHEM, V114, P302, DOI 10.1111/j.1471-4159.2010.06754.x; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Peckett AJ, 2011, METABOLISM, V60, P1500, DOI 10.1016/j.metabol.2011.06.012; Radeau T, 1995, J LIPID RES, V36, P2552; Shen WJ, 1998, BIOCHEMISTRY-US, V37, P8973, DOI 10.1021/bi980545u; Snyder PB, 2005, J LIPID RES, V46, P494, DOI 10.1194/jlr.M400362-JLR200; Su CL, 2003, J BIOL CHEM, V278, P43615, DOI 10.1074/jbc.M301809200; Sugiyama G, 2012, BIOCHEMISTRY-US, V51, P3394, DOI 10.1021/bi2018128; Sutherland LN, 2009, J PHYSIOL-LONDON, V587, P1607, DOI 10.1113/jphysiol.2008.165464; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Takenaka K, 2003, MOL CELL BIOL, V23, P7329, DOI 10.1128/MCB.23.20.7329-7338.2003; Takeuchi H, 1996, BIOCHEM J, V318, P561, DOI 10.1042/bj3180561; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; WOOD SL, 1993, BIOCHEM J, V295, P531, DOI 10.1042/bj2950531; YOSHIDA M, 1994, J BIOCHEM, V115, P973, DOI 10.1093/oxfordjournals.jbchem.a124447; Yoshimura K, 2001, J BIOL CHEM, V276, P17908, DOI 10.1074/jbc.M009677200; Zhang Z, 2013, J BIOL CHEM, V288, P7769, DOI 10.1074/jbc.M112.419317	47	16	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100559	10.1371/journal.pone.0100559	http://dx.doi.org/10.1371/journal.pone.0100559			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945349	Green Published, gold, Green Submitted			2022-12-25	WOS:000340721500093
J	Esterhammer, R; Klug, G; Wolf, C; Mayr, A; Reinstadler, S; Feistritzer, HJ; Metzler, B; Schocke, MFH				Esterhammer, Regina; Klug, Gert; Wolf, Christian; Mayr, Agnes; Reinstadler, Sebastian; Feistritzer, Hans-Josef; Metzler, Bernhard; Schocke, Michael F. H.			Cardiac High-Energy Phosphate Metabolism Alters with Age as Studied in 196 Healthy Males with the Help of 31-Phosphorus 2-Dimensional Chemical Shift Imaging	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; P-31 MR SPECTROSCOPY; LEFT-VENTRICULAR HYPERTROPHY; CREATINE-KINASE; MYOCARDIAL-INFARCTION; HUMAN HEART; EXERCISE; ENERGETICS; DISEASE; ADP	Recently published studies have elucidated alterations of mitochondrial oxidative metabolism during ageing. The intention of the present study was to evaluate the impact of ageing on cardiac high-energy phosphate metabolism and cardiac function in healthy humans. 31-phosphorus 2-dimensional chemical shift imaging (31P 2D CSI) and echocardiography were performed in 196 healthy male volunteers divided into groups of 20 to 40 years (I, n = 43), 40 to 60 years (II, n = 123) and > 60 years (III, n = 27) of age. Left ventricular PCr/beta-ATP ratio, myocardial mass (MM), ejection fraction and E/A ratio were assessed. Mean PCr/beta-ATP ratios were significantly different among the three groups of volunteers (I, 2.10 +/- 0.37; II, 1.77 +/- 0.37; III, 1.45 +/- 0.28; all p < 0.001). PCr/beta-ATP ratios were inversely related to age (r(2) = -0.25; p < 0.001) with a decrease from 2.65 by 0.02 per year of ageing. PCr/beta-ATP ratios further correlated with MM (r = -0.371; p < 0.001) and E/A ratios (r = 0.213; p < 0.02). Moreover, E/A ratios (r = 20.502, p < 0.001), MM (r = 0.304, p < 0.001), glucose-levels (r = 0.157, p < 0.05) and systolic blood pressure (r = 0.224, p < 0.005) showed significant correlations with age. The ejection fraction did not significantly differ between the groups. This study shows that cardiac PCr/beta-ATP ratios decrease moderately with age indicating an impairment of mitochondrial oxidative metabolism due to age. Furthermore, MM increases, and E/A ratio decreases with age. Both correlate with left-ventricular PCr/beta-ATP ratios. The findings of the present study confirm numerous experimental studies showing an impairment of cardiac mitochondrial function with age.	[Esterhammer, Regina; Wolf, Christian; Mayr, Agnes; Schocke, Michael F. H.] Med Univ Innsbruck, Dept Radiol, A-6020 Innsbruck, Austria; [Klug, Gert; Reinstadler, Sebastian; Feistritzer, Hans-Josef; Metzler, Bernhard] Med Univ Innsbruck, Div Cardiol, Dept Internal Med 2, A-6020 Innsbruck, Austria; [Wolf, Christian] Dist Hosp Reutte, Dept Radiol, Ehenbichl, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Schocke, MFH (corresponding author), Med Univ Innsbruck, Dept Radiol, A-6020 Innsbruck, Austria.	michael.schocke@i-med.ac.at	Schocke, Michael/AAC-3666-2020	Klug, Gert/0000-0002-4737-0979; Metzler, Bernhard/0000-0002-5240-2453; , Agnes Mayr/0000-0001-9363-873X; Reinstadler, Sebastian/0000-0002-7700-1357				Bak MI, 1998, J MOL CELL CARDIOL, V30, P661, DOI 10.1006/jmcc.1997.0633; Beer M, 2007, EUR RADIOL, V17, P1275, DOI 10.1007/s00330-006-0492-y; BOTTOMLEY PA, 1994, RADIOLOGY, V191, P593, DOI 10.1148/radiology.191.3.8184033; BOTTOMLEY PA, 1987, RADIOLOGY, V165, P703, DOI 10.1148/radiology.165.3.2961004; Burtscher M, 2013, GERONTOLOGY, V59, P289, DOI 10.1159/000343990; Crilley JG, 2000, J AM COLL CARDIOL, V36, P1953, DOI 10.1016/S0735-1097(00)00960-8; Dahlof Bjorn, 2010, Am J Cardiol, V105, p3A, DOI 10.1016/j.amjcard.2009.10.007; de Souza RR, 2002, BIOGERONTOLOGY, V3, P325, DOI 10.1023/A:1021312027486; Dutta D, 2012, CIRC RES, V110, P1125, DOI 10.1161/CIRCRESAHA.111.246108; Dzeja PP, 2011, J PHYSIOL-LONDON, V589, P5193, DOI 10.1113/jphysiol.2011.212829; Edwards LM, 2011, MOL BIOSYST, V7, P3335, DOI 10.1039/c1mb05310h; Farrall AT, 1997, MAGNET RESON MED, V38, P577, DOI 10.1002/mrm.1910380412; Ferket BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088312; FLAHERTY JT, 1982, CIRCULATION, V65, P561, DOI 10.1161/01.CIR.65.3.561; Fleg JL, 2012, HEART FAIL REV, V17, P545, DOI 10.1007/s10741-011-9270-2; Freeman DM, 1997, NMR BIOMED, V10, P381, DOI 10.1002/(SICI)1099-1492(199712)10:8<381::AID-NBM495>3.0.CO;2-7; Frick M, 2011, INT J CARDIOL, V148, P112, DOI 10.1016/j.ijcard.2011.01.042; Gabr RE, 2006, J MAGN RESON, V179, P152, DOI 10.1016/j.jmr.2005.11.004; Hacker TA, 2006, AM J PHYSIOL-HEART C, V290, pH304, DOI 10.1152/ajpheart.00290.2005; Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003; Hees PS, 2004, AM J PHYSIOL-HEART C, V286, pH782, DOI 10.1152/ajpheart.01092.2002; Hollingsworth KG, 2012, AM J PHYSIOL-HEART C, V302, pH885, DOI 10.1152/ajpheart.00985.2011; Hudsmith LE, 2009, JACC-CARDIOVASC IMAG, V2, P87, DOI 10.1016/j.jcmg.2008.08.005; Ingwall JS, 2004, J MOL CELL CARDIOL, V37, P613, DOI 10.1016/j.yjmcc.2004.05.020; JACOBUS WE, 1982, J BIOL CHEM, V257, P2397; Judge S, 2005, AM J PHYSIOL-REG I, V289, pR1564, DOI 10.1152/ajpregu.00396.2005; Judge S, 2007, AM J PHYSIOL-CELL PH, V292, pC1983, DOI 10.1152/ajpcell.00285.2006; Jung WI, 1998, CIRCULATION, V97, P2536, DOI 10.1161/01.CIR.97.25.2536; KITZMAN DW, 1991, J AM COLL CARDIOL, V18, P1243, DOI 10.1016/0735-1097(91)90542-H; Klug G, 2007, INT J SPORTS MED, V28, P667, DOI 10.1055/s-2007-964862; Klug G, 2011, INT J CARDIOL, V150, P208, DOI 10.1016/j.ijcard.2011.05.006; Kostler H, 2006, MAGN RESON MED, V56, P907, DOI 10.1002/mrm.21027; Lakatta EG, 2002, COMP BIOCHEM PHYS A, V132, P699, DOI 10.1016/S1095-6433(02)00124-1; Lodi R, 2004, BBA-BIOENERGETICS, V1657, P146, DOI 10.1016/j.bbabio.2004.05.003; Lodi R, 2003, ANN NEUROL, V54, P552, DOI 10.1002/ana.10744; Metzler B, 2002, J CARDIOVASC MAGN R, V4, P493, DOI 10.1081/JCMR-120016387; Nahrendorf M, 2005, CARDIOVASC RES, V65, P419, DOI 10.1016/j.cardiores.2004.10.006; Neubauer S, 1997, CIRCULATION, V96, P2190; Nikitin NP, 2006, INT J CARDIOL, V108, P76, DOI 10.1016/j.ijcard.2005.04.009; Okada M, 1998, MAGNET RESON MED, V39, P772, DOI 10.1002/mrm.1910390515; PETERSEN A, 1990, BIOCHIM BIOPHYS ACTA, V1035, P169, DOI 10.1016/0304-4165(90)90112-A; R Core Team, 2022, R LANG ENV STAT COMP; RAO BDN, 1981, J BIOL CHEM, V256, P1716; Robergs RA, 2004, AM J PHYSIOL-REG I, V287, pR502, DOI 10.1152/ajpregu.00114.2004; Saks V, 2006, J PHYSIOL-LONDON, V571, P253, DOI 10.1113/jphysiol.2005.101444; Saks VA, 2004, MOL CELL BIOCHEM, V256, P185, DOI 10.1023/B:MCBI.0000009868.92189.fb; Saupe KW, 2000, J BIOL CHEM, V275, P19742, DOI 10.1074/jbc.M001932200; Scheuermann-Freestone M, 2003, CIRCULATION, V107, P3040, DOI 10.1161/01.CIR.0000072789.89096.10; Schneider-Gold C, 2004, MUSCLE NERVE, V30, P636, DOI 10.1002/mus.20156; Schocke MFH, 2004, MAGN RESON IMAGING, V22, P515, DOI 10.1016/j.mri.2004.01.023; Schocke MFH, 2003, J CARDIOVASC MAGN R, V5, P595, DOI 10.1081/JCMR-120025234; Schocke MFH, 2003, MAGN RESON IMAGING, V21, P553, DOI 10.1016/S0730-725X(03)00079-1; Stubbs M, 1996, BBA-GEN SUBJECTS, V1291, P143, DOI 10.1016/0304-4165(96)00058-X; Suzuki Y, 1998, EUR J BIOCHEM, V257, P466, DOI 10.1046/j.1432-1327.1998.2570466.x; TANOKURA M, 1993, J BIOCHEM-TOKYO, V113, P19, DOI 10.1093/oxfordjournals.jbchem.a123996; Terman A, 2005, CARDIOVASC RES, V68, P355, DOI 10.1016/j.cardiores.2005.08.014; VANDOBBENBURGH JO, 1994, NMR BIOMED, V7, P218, DOI 10.1002/nbm.1940070504; Wallis J, 2005, CIRCULATION, V112, P3131, DOI 10.1161/CIRCULATIONAHA.105.572990; WEISS RG, 1990, NEW ENGL J MED, V323, P1593, DOI 10.1056/NEJM199012063232304; Wolf C, 2008, MOL IMAGING BIOL, V10, P24, DOI 10.1007/s11307-007-0119-y	60	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e97368	10.1371/journal.pone.0097368	http://dx.doi.org/10.1371/journal.pone.0097368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940736	Green Published, gold, Green Submitted			2022-12-25	WOS:000338508200003
J	Castro-Diez, P; Valle, G; Gonzalez-Munoz, N; Alonso, A				Castro-Diez, Pilar; Valle, Guillermo; Gonzalez-Munoz, Noelia; Alonso, Alvaro			Can the Life-History Strategy Explain the Success of the Exotic Trees Ailanthus altissima and Robinia pseudoacacia in Iberian Floodplain Forests?	PLOS ONE			English	Article							ALIEN PLANTS; BLACK LOCUST; FLOWERING PHENOLOGY; INVASION SUCCESS; RIPARIAN ZONES; LOESS PLATEAU; IMPACTS; NICHE; REPRODUCTION; COMMUNITIES	Ailanthus altissima and Robina pseudoacacia are two successful invasive species of floodplains in central Spain. We aim to explain their success as invaders in this habitat by exploring their phenological pattern, vegetative and sexual reproductive growth, and allometric relations, comparing them with those of the dominant native tree Populus alba. During a full annual cycle we follow the timing of vegetative growth, flowering, fruit set, leaf abscission and fruit dispersal. Growth was assessed by harvesting two-year old branches at the peaks of vegetative, flower and fruit production and expressing the mass of current-year leaves, stems, inflorescences and infrutescences per unit of previous-year stem mass. Secondary growth was assessed as the increment of trunk basal area per previous-year basal area. A. altissima and R. pseudoacacia showed reproductive traits (late flowering phenology, insect pollination, late and long fruit set period, larger seeds) different from P. alba and other native trees, which may help them to occupy an empty reproductive niche and benefit from a reduced competition for the resources required by reproductive growth. The larger seeds of the invaders may make them less dependent on gaps for seedling establishment. If so, these invaders may benefit from the reduced gap formation rate of flood-regulated rivers of the study region. The two invasive species showed higher gross production than the native, due to the higher size of pre-existing stems rather than to a faster relative growth rate. The latter was only higher in A. altissima for stems, and in R. pseudoacacia for reproductive organs. A. altissima and R. pseudoacacia showed the lowest and highest reproductive/vegetative mass ratio, respectively. Therefore, A. altissima may outcompete native P. alba trees thanks to a high potential to overtop coexisting plants whereas R. pseudoacacia may do so by means of a higher investment in sexual reproduction.	[Castro-Diez, Pilar; Valle, Guillermo; Gonzalez-Munoz, Noelia; Alonso, Alvaro] Univ Alcala, Dept Life Sci UD Ecol, Madrid, Spain; [Gonzalez-Munoz, Noelia] Univ Paris Sud, Lab Systemat Ecol & Evolut, Paris, France	Universidad de Alcala; UDICE-French Research Universities; Universite Paris Saclay	Castro-Diez, P (corresponding author), Univ Alcala, Dept Life Sci UD Ecol, Madrid, Spain.	mpilar.castro@uah.es	González Muñoz, Noelia/A-3368-2017; Alonso, Álvaro/B-4286-2018; Castro-Diez, Pilar/L-4716-2014	González Muñoz, Noelia/0000-0001-7449-1621; Alonso, Álvaro/0000-0002-7797-8045; Castro-Diez, Pilar/0000-0002-4841-5198	Spanish Ministry of Science and Innovation [CGL2010-16388/BOS]; Junta de Comunidades de Castilla-La Mancha [POII10-0179-4700]; REMEDINAL network of Comunidad de Madrid [S2009/AMB-1783]; CONICYT (Ministry of Education, Chile Government); University of Alcala	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha); REMEDINAL network of Comunidad de Madrid; CONICYT (Ministry of Education, Chile Government); University of Alcala	This study was supported by the grants CGL2010-16388/BOS of the Spanish Ministry of Science and Innovation, POII10-0179-4700 of Junta de Comunidades de Castilla-La Mancha and the REMEDINAL network S2009/AMB-1783 of Comunidad de Madrid. PCD acknowledges CONICYT (Ministry of Education, Chile Government) for funding her stay at Concepcion University ("Concurso de atraccion de Capital Humano Extranjero-MEC" grant). NGM acknowledges the post-doctoral financial support provided by the University of Alcala. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Alonso A, 2010, ECOL RES, V25, P647, DOI 10.1007/s11284-010-0698-y; Alpert Peter, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P52, DOI 10.1078/1433-8319-00004; Andreu J, 2009, ENVIRON MANAGE, V43, P1244, DOI 10.1007/s00267-009-9280-1; Arianoutsou M, 2010, BIOL INVASIONS, V12, P3525, DOI 10.1007/s10530-010-9749-0; Arizpe D., 2008, RIPARIAN TREE SHRUB; Basnou C, 2009, HDB ALIEN SPECIES EU, V3, P357; Bolmgren K, 2003, EVOLUTION, V57, P2001, DOI 10.1111/j.0014-3820.2003.tb00380.x; BORING LR, 1984, J ECOL, V72, P749, DOI 10.2307/2259529; Brown BJ, 2002, ECOLOGY, V83, P2328, DOI 10.1890/0012-9658(2002)083[2328:CFPBAI]2.0.CO;2; Burke MJW, 1996, ECOLOGY, V77, P776, DOI 10.2307/2265501; Cadotte MW, 2001, ECOSCIENCE, V8, P230, DOI 10.1080/11956860.2001.11682649; Castro-Diez P, 2014, ECOL LETT, V17, P1, DOI 10.1111/ele.12197; Castro-Diez P, 2003, PLANT ECOL, V166, P117, DOI 10.1023/A:1023209230303; Castro-Diez P, 2009, BIOL INVASIONS, V11, P1973, DOI 10.1007/s10530-008-9374-3; Castro-Diez P, 1998, PLANT ECOL, V139, P103, DOI DOI 10.1023/A:1009759318927; Castro-Diez P, 2012, PLANT SOIL, V350, P179, DOI 10.1007/s11104-011-0893-9; Castroviejo S., 1993, FLORA IBERICA, V3; Catalan Bachiller G, 1991, SEMILLAS ARBOLES ARB; Catford JA, 2011, J APPL ECOL, V48, P432, DOI 10.1111/j.1365-2664.2010.01945.x; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chytry M, 2008, J APPL ECOL, V45, P448, DOI 10.1111/j.1365-2664.2007.01398.x; Cierjacks A, 2013, J ECOL, V101, P1623, DOI 10.1111/1365-2745.12162; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Constan-Nava S, 2012, BIOL INVASIONS, V14, P2379, DOI 10.1007/s10530-012-0236-7; Crawley MJ, 1996, PHILOS T R SOC B, V351, P1251, DOI 10.1098/rstb.1996.0108; Crawley MJ, 1987, COLONIZATION SUCCESS, P429; D'Antonio CM, 2003, MODELS IN ECOSYSTEM SCIENCE, P363; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Dawson W, 2009, J ECOL, V97, P657, DOI 10.1111/j.1365-2745.2009.01519.x; Dietz H, 1997, J VEG SCI, V8, P839, DOI 10.2307/3237028; Drake JA, 2009, HDB ALIEN SPECIES EU; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100; FOX GA, 1990, EVOLUTION, V44, P1404, DOI 10.1111/j.1558-5646.1990.tb03835.x; Fridley JD, 2012, NATURE, V485, P359, DOI 10.1038/nature11056; Gerlach JD, 2003, ECOL APPL, V13, P167, DOI 10.1890/1051-0761(2003)013[0167:TLHCOI]2.0.CO;2; Glenn EP, 2005, J ARID ENVIRON, V61, P419, DOI 10.1016/j.jaridenv.2004.09.025; Godoy O, 2009, PLANT BIOLOGY, V11, P803, DOI 10.1111/j.1438-8677.2008.00185.x; Godoy O, 2014, J ECOLOGY IN PRESS; Godoy O, 2009, ANN BOT-LONDON, V103, P485, DOI 10.1093/aob/mcn232; Gomez-Aparicio L, 2008, J ECOL, V96, P447, DOI 10.1111/j.1365-2745.2007.01352.x; Gomez-Aparicio L, 2008, ECOL MONOGR, V78, P69, DOI 10.1890/06-2036.1; Gonzalez-Munoz N, 2014, BIOL INVASIONS, V16, P269, DOI 10.1007/s10530-013-0516-x; Gonzalez-Munoz N, 2013, PLANT SOIL, V363, P319, DOI 10.1007/s11104-012-1329-x; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Grotkopp E, 2007, AM J BOT, V94, P526, DOI 10.3732/ajb.94.4.526; Hamerlynck EP, 2001, PHOTOSYNTHETICA, V39, P79, DOI 10.1023/A:1012448019931; Heisey RM, 2003, PLANT SOIL, V256, P85, DOI 10.1023/A:1026209614161; Herbarium W.A., 1998, FLORABASE W AUSTR FL; Hollister RD, 2005, ECOLOGY, V86, P1562, DOI 10.1890/04-0520; Hood WG, 2000, PLANT ECOL, V148, P105, DOI 10.1023/A:1009800327334; Hooper DU, 2010, J ECOL, V98, P764, DOI 10.1111/j.1365-2745.2010.01673.x; HU SY, 1979, ARNOLDIA, V39, P29; Iler AM, 2013, GLOBAL CHANGE BIOL, V19, P2348, DOI 10.1111/gcb.12246; Jung SC, 2009, J FOREST RES-JPN, V14, P101, DOI 10.1007/s10310-008-0109-1; Knapp LB, 2000, J TORREY BOT SOC, V127, P307, DOI 10.2307/3088649; Koretsune S, 2009, J FOREST RES-JPN, V14, P88, DOI 10.1007/s10310-009-0111-2; Kota NL, 2007, BIOL INVASIONS, V9, P197, DOI 10.1007/s10530-006-9026-4; Kowarik I, 2007, PERSPECT PLANT ECOL, V8, P207, DOI 10.1016/j.ppees.2007.03.002; Kozlowski TT., 1971, GROWTH DEV TREES; Kudo G, 2013, ECOLOGY, V94, P2311, DOI 10.1890/12-2003.1; Lara F., 1996, ESTUDIO VEGETACION R; Lloret F, 2005, J ECOL, V93, P512, DOI 10.1111/j.1365-2745.2005.00979.x; MacDougall AS, 2009, J ECOL, V97, P609, DOI 10.1111/j.1365-2745.2009.01514.x; Mack RN, 2003, INT J PLANT SCI, V164, pS185, DOI 10.1086/368399; Masaka K, 2010, FOREST ECOL MANAG, V260, P780, DOI 10.1016/j.foreco.2010.05.036; Masaka K, 2009, J FOREST RES-JPN, V14, P167, DOI 10.1007/s10310-009-0117-9; Melbourne BA, 2007, ECOL LETT, V10, P77, DOI 10.1111/j.1461-0248.2006.00987.x; Milla R, 2006, PLANT BIOLOGY, V8, P103, DOI 10.1055/s-2005-872890; Nel JL, 2004, S AFR J SCI, V100, P53; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Ooi MKJ, 2012, SEED SCI RES, V22, pS53, DOI 10.1017/S0960258511000407; Orshan G, 1989, PLANT PHENO MORPHOLO; Pan E., 1986, J ENV HORTICULTURE, V4, P1, DOI [10.24266/0738-2898-4.1.1, DOI 10.24266/0738-2898-4.1.1]; Parker IM, 1997, ECOLOGY, V78, P1457, DOI 10.1890/0012-9658(1997)078[1457:PLOCSS]2.0.CO;2; Perez Latorre AV, 2007, PHYTOCOENOLOGIA, V37, P239, DOI 10.1127/0340-269x/2007/0037-0239; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Piotto B, 2003, SEED PROPAGATION MED; Putterill J, 2004, BIOESSAYS, V26, P363, DOI 10.1002/bies.20021; Pysek Petr, 2007, V193, P97; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; RATHCKE B, 1985, ANNU REV ECOL SYST, V16, P179, DOI 10.1146/annurev.es.16.110185.001143; Rice SK, 2004, PLANT ECOL, V174, P97, DOI 10.1023/B:VEGE.0000046049.21900.5a; Richardson DM, 2006, PRESLIA, V78, P375; Rinn F., 1996, TSAP TIME SERIES ANA; Saumel I, 2013, PLANT ECOL, V214, P1257, DOI 10.1007/s11258-013-0249-z; Sanz Elorza M., 2004, ATLAS PLANTAS ALOCTO; Sargent RD, 2008, TRENDS ECOL EVOL, V23, P123, DOI 10.1016/j.tree.2007.11.003; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; Seiwa K, 1996, VEGETATIO, V123, P51, DOI 10.1007/BF00044887; Tabacchi E, 2005, RIVER RES APPL, V21, P299, DOI 10.1002/rra.848; Tateno R, 2007, FOREST ECOL MANAG, V241, P84, DOI 10.1016/j.foreco.2006.12.026; Thompson K, 1992, SEEDS ECOLOGY REGENE, P231; Tickner DP, 2001, PROG PHYS GEOG, V25, P22, DOI 10.1177/030913330102500102; Toole E. H., 1946, JOUR AGRIC RES, V72, P201; van Kleunen M, 2010, ECOL LETT, V13, P947, DOI 10.1111/j.1461-0248.2010.01503.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Vila M, 2006, J BIOGEOGR, V33, P853, DOI 10.1111/j.1365-2699.2005.01430.x; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Willis CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008878; Wilson EO, 1967, THEORY ISLAND BIOGEO; Wolkovich EM, 2011, FRONT ECOL ENVIRON, V9, P287, DOI 10.1890/100033; Wright SJ, 1995, J ECOL, V83, P937, DOI 10.2307/2261176; Zar J.H., 1996, BIOSTAT ANAL, V5th	109	26	26	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100254	10.1371/journal.pone.0100254	http://dx.doi.org/10.1371/journal.pone.0100254			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937651	gold, Green Published, Green Submitted			2022-12-25	WOS:000338503400097
J	Eftestol, E; Alver, TN; Gundersen, K; Bruusgaard, JC				Eftestol, Einar; Alver, Tine Norman; Gundersen, Kristian; Bruusgaard, Jo C.			Overexpression of SMPX in Adult Skeletal Muscle Does not Change Skeletal Muscle Fiber Type or Size	PLOS ONE			English	Article							ANABOLIC-STEROIDS; TRAPEZIUS MUSCLE; GENE SMPX; PROTEIN; IDENTIFICATION; HYPERTROPHY; COSTAMERES; MUTATIONS; PATHWAY	Mechanical factors such as stretch are thought to be important in the regulation of muscle phenotype. Small muscle protein X-linked (SMPX) is upregulated by stretch in skeletal muscle and has been suggested to serve both as a transcription factor and a mechanosensor, possibly giving rise to changes in both fiber size and fiber type. We have used in vivo confocal imaging to study the subcellular localization of SMPX in skeletal muscle fibers of adult rats using a SMPX-EGFP fusion protein. The fusion protein was localized predominantly in repetitive double stripes flanking the Z-disc, and was excluded from all nuclei. This localization would be consistent with SMPX being a mechanoreceptor, but not with SMPX playing a role as a transcription factor. In vivo overexpression of ectopic SMPX in skeletal muscle of adult mice gave no significant changes in fiber type distribution or cross sectional area, thus a role of SMPX in regulating muscle phenotype remains unclear.	[Eftestol, Einar; Alver, Tine Norman; Gundersen, Kristian; Bruusgaard, Jo C.] Univ Oslo, Dept Biosci, Oslo, Norway; [Bruusgaard, Jo C.] Atlantis Med Univ Coll, Oslo, Norway	University of Oslo	Bruusgaard, JC (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.	bruusgaard@gmail.com	Eftestøl, Einar/AAC-3221-2021	Eftestøl, Einar/0000-0003-3791-3287; Bruusgaard, Jo Christiansen/0000-0001-8163-5849; Norman Alver, Tine/0000-0002-3681-4511				Abbott KL, 1998, MOL BIOL CELL, V9, P2905, DOI 10.1091/mbc.9.10.2905; Bruusgaard JC, 2010, P NATL ACAD SCI USA, V107, P15111, DOI 10.1073/pnas.0913935107; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Egner IM, 2013, J PHYSIOL-LONDON, V591, P6221, DOI 10.1113/jphysiol.2013.264457; Eriksson A, 2005, HISTOCHEM CELL BIOL, V124, P167, DOI 10.1007/s00418-005-0029-5; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Gundersen K, 1998, ACTA PHYSIOL SCAND, V162, P333, DOI 10.1046/j.1365-201X.1998.0336e.x; Gundersen K, 2011, BIOL REV, V86, P564, DOI 10.1111/j.1469-185X.2010.00161.x; Huebner AK, 2011, AM J HUM GENET, V88, P621, DOI 10.1016/j.ajhg.2011.04.007; Kadi F, 2000, HISTOCHEM CELL BIOL, V113, P99, DOI 10.1007/s004180050012; Kadi F, 1999, HISTOCHEM CELL BIOL, V111, P189, DOI 10.1007/s004180050348; Kemp TJ, 2001, GENOMICS, V72, P260, DOI 10.1006/geno.2000.6461; Lunde IG, 2011, J PHYSIOL-LONDON, V589, P1443, DOI 10.1113/jphysiol.2010.202762; Palmer S, 2001, J CELL BIOL, V153, P985, DOI 10.1083/jcb.153.5.985; PARDO JV, 1983, P NATL ACAD SCI-BIOL, V80, P1008, DOI 10.1073/pnas.80.4.1008; Patzak D, 1999, HUM GENET, V105, P506, DOI 10.1007/s004390051138; Rana ZA, 2004, ACTA PHYSIOL SCAND, V181, P233, DOI 10.1111/j.1365-201X.2004.01282.x; Rana ZA, 2008, P NATL ACAD SCI USA, V105, P5921, DOI 10.1073/pnas.0801330105; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Schindeler A, 2005, EXP CELL RES, V307, P367, DOI 10.1016/j.yexcr.2005.04.006; Schraders M, 2011, AM J HUM GENET, V88, P628, DOI 10.1016/j.ajhg.2011.04.012; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wu MZ, 2011, AGEING RES REV, V10, P1, DOI 10.1016/j.arr.2009.11.002	24	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99232	10.1371/journal.pone.0099232	http://dx.doi.org/10.1371/journal.pone.0099232			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936977	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400013
J	Jung, Y; Kim, M; Soh, H; Lee, S; Kim, J; Park, S; Song, K; Lee, I				Jung, Yusun; Kim, Minsung; Soh, Hyunsu; Lee, Soyoung; Kim, Jungtae; Park, Surim; Song, Kyuyoung; Lee, Inchul			TC1(C8orf4) Regulates Hematopoietic Stem/Progenitor Cells and Hematopoiesis	PLOS ONE			English	Article							STEM-CELLS; TC1 C8ORF4; DISTRIBUTION WIDTH; THYROID-CANCER; DIFFERENTIATION; METAANALYSIS; CONSORTIUM; CYTOKINES; PATHWAYS; SHOCK	Hematopoiesis is a complex process requiring multiple regulators for hematopoietic stem/progenitor cells (HSPC) and differentiation to multi-lineage blood cells. TC1(C8orf4) is implicated in cancers, hematological malignancies and inflammatory activation. Here, we report that Tc1 regulates hematopoiesis in mice. Myeloid and lymphoid cells are increased markedly in peripheral blood of Tc1-deleted mice compared to wild type controls. Red blood cells are small-sized but increased in number. The bone marrow of Tc1(-/-) mice is normocellular histologically. However, Lin(-)Sca-1(+)c-Kit(+) (LSK) cells are expanded in Tc1(-/-) mice compared to wild type controls. The expanded population mostly consists of CD150(-)CD48(+) cells, suggesting the expansion of lineage-restricted hematopoietic progenitor cells. Colony forming units (CFU) are increased in Tc1(-/-) mice bone marrow cells compared to controls. In wild type mice bone marrow, Tc1 is expressed in a limited population of HSPC but not in differentiated cells. Major myeloid transcriptional regulators such as Pu.1 and Cebp alpha are not up-regulated in Tc1(-/-) mice bone marrow. Our findings indicate that TC1 is a novel hematopoietic regulator. The mechanisms of TC1-dependent HSPC regulation and lineage determination are unknown.	[Jung, Yusun; Kim, Minsung; Soh, Hyunsu; Lee, Soyoung; Kim, Jungtae; Park, Surim] Univ Ulsan, Coll Med, Asan Inst Life Sci, Asan Med Ctr, Seoul, South Korea; [Song, Kyuyoung] Univ Ulsan, Coll Med, Dept Biochem & Mol Biol, Asan Med Ctr, Seoul, South Korea; [Lee, Inchul] Univ Ulsan, Coll Med, Dept Pathol, Asan Med Ctr, Seoul, South Korea	University of Ulsan; University of Ulsan; University of Ulsan	Lee, I (corresponding author), Univ Ulsan, Coll Med, Dept Pathol, Asan Med Ctr, Seoul, South Korea.	iclee@amc.seoul.kr	Park, Surim/AAD-4973-2019		National Research Foundation - Korean Ministry of Science, ICT, and Future Planning [2009-79398]	National Research Foundation - Korean Ministry of Science, ICT, and Future Planning	This work was supported by the Mid-career Research Program (2009-79398) through National Research Foundation grant funded by the Korean Ministry of Science, ICT, and Future Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutler E, 2005, BLOOD, V106, P740, DOI 10.1182/blood-2005-02-0713; Biermann H, 1999, J LEUKOCYTE BIOL, V65, P217, DOI 10.1002/jlb.65.2.217; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Chua EL, 2000, GENOMICS, V69, P342, DOI 10.1006/geno.2000.6348; Chung SJ, 2012, PARKINSONISM RELAT D, V18, P881, DOI 10.1016/j.parkreldis.2012.04.025; Clements WK, 2013, NAT REV IMMUNOL, V13, P336, DOI 10.1038/nri3443; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Friedman JB, 2004, INT J CANCER, V111, P72, DOI 10.1002/ijc.20235; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Jung YS, 2006, CANCER RES, V66, P723, DOI 10.1158/0008-5472.CAN-05-3124; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim B, 2006, CLIN CANCER RES, V12, P3541, DOI 10.1158/1078-0432.CCR-05-2440; Kim J, 2009, J IMMUNOL, V183, P3996, DOI 10.4049/jimmunol.0900956; Kim Y, 2006, FEBS LETT, V580, P3519, DOI 10.1016/j.febslet.2006.05.036; Lento W, 2013, COLD SPRING HARB PER, V5; Luc S, 2008, SEMIN IMMUNOL, V20, P213, DOI 10.1016/j.smim.2008.07.005; Mercer EM, 2011, SEMIN IMMUNOL, V23, P317, DOI 10.1016/j.smim.2011.08.004; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Montagnana M, 2012, CLIN CHEM LAB MED, V50, P635, DOI [10.1515/cclm.2011.831, 10.1515/CCLM.2011.831]; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Park J, 2007, BIOCHEM BIOPH RES CO, V360, P447, DOI 10.1016/j.bbrc.2007.06.077; Patel KV, 2010, J GERONTOL A-BIOL, V65, P258, DOI 10.1093/gerona/glp163; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006; Ruiz G, 2004, COMP BIOCHEM PHYS A, V139, P405, DOI 10.1016/j.cbpb.2004.03.003; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Sunde M, 2004, CANCER RES, V64, P2766, DOI 10.1158/0008-5472.CAN-03-2093; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Walter MJ, 2009, P NATL ACAD SCI USA, V106, P12950, DOI 10.1073/pnas.0903091106; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Yang ZQ, 2006, CANCER RES, V66, P11632, DOI 10.1158/0008-5472.CAN-06-2946; Zhang JH, 2011, MED ONCOL, V28, pS647, DOI 10.1007/s12032-010-9698-6	36	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100311	10.1371/journal.pone.0100311	http://dx.doi.org/10.1371/journal.pone.0100311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937306	Green Published, Green Submitted, gold			2022-12-25	WOS:000338503400103
J	Bard, D; Kihal, W; Schillinger, C; Fermanian, C; Segala, C; Glorion, S; Arveiler, D; Weber, C				Bard, Denis; Kihal, Wahida; Schillinger, Charles; Fermanian, Christophe; Segala, Claire; Glorion, Sophie; Arveiler, Dominique; Weber, Christiane			Traffic-Related Air Pollution and the Onset of Myocardial Infarction: Disclosing Benzene as a Trigger? A Small-Area Case-Crossover Study	PLOS ONE			English	Article							PARTICULATE MATTER; HOSPITAL ADMISSIONS; HEART-DISEASE; EXPOSURE; MORTALITY; RISK; POLLUTANTS; EMISSIONS; GASOLINE	Background and Objectives: Exposure to traffic is an established risk factor for the triggering of myocardial infarction (MI). Particulate matter, mainly emitted by diesel vehicles, appears to be the most important stressor. However, the possible influence of benzene from gasoline-fueled cars has not been explored so far. Methods and Results: We conducted a case-crossover study from 2,134 MI cases recorded by the local Coronary Heart Disease Registry (2000-2007) in the Strasbourg Metropolitan Area (France). Available individual data were age, gender, previous history of ischemic heart disease and address of residence at the time of the event. Nitrogen dioxide, particles of median aerodynamic diameter,10 mm (PM10), ozone, carbon monoxide and benzene air concentrations were modeled on an hourly basis at the census block level over the study period using the deterministic ADMS-Urban air dispersion model. Model input data were emissions inventories, background pollution measurements, and meteorological data. We have found a positive, statistically significant association between concentrations of benzene and the onset of MI: per cent increase in risk for a 1 mu g/m(3) increase in benzene concentration in the previous 0, 0-1 and 1 day was 10.4 (95% confidence interval 3-18.2), 10.7 (2.7-19.2) and 7.2 (0.3-14.5), respectively. The associations between the other pollutants and outcome were much lower and in accordance with the literature. Conclusion: We have observed that benzene in ambient air is strongly associated with the triggering of MI. This novel finding needs confirmation. If so, this would mean that not only diesel vehicles, the main particulate matter emitters, but also gasoline-fueled cars-main benzene emitters-, should be taken into account for public health action.	[Bard, Denis; Kihal, Wahida; Fermanian, Christophe; Glorion, Sophie] Ecole Hautes Etud Sante Publ, Dept Epidemiol & Biostat, Rennes, France; [Bard, Denis; Kihal, Wahida; Fermanian, Christophe; Glorion, Sophie] Sorbonne Paris Cite, Paris, France; [Schillinger, Charles] Assoc Surveillance Qual Air Alsace ASPA, Schiltigheim, France; [Segala, Claire] SEPIA Sante, Baud, France; [Arveiler, Dominique] Univ Strasbourg, Dept Epidemiol & Publ Hlth, EA3430, Strasbourg, France; [Weber, Christiane] Univ Strasbourg, CNRS, Fac Geog & Amenagement, LIVE,UMR7362, Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Bard, D (corresponding author), Ecole Hautes Etud Sante Publ, Dept Epidemiol & Biostat, Rennes, France.	denis.bard@ehesp.fr	bard, denis/O-4189-2019		French Agency for Food, Environmental and Occupational Health Safety (ANSES); Institute for Public Health Research (IRESP); Fondation Coeur et Arteres; French Environment and Energy Management Agency (ADEME); SITA Corporation	French Agency for Food, Environmental and Occupational Health Safety (ANSES); Institute for Public Health Research (IRESP); Fondation Coeur et Arteres; French Environment and Energy Management Agency (ADEME); SITA Corporation	This work was supported by French Agency for Food, Environmental and Occupational Health & Safety (ANSES); Institute for Public Health Research (IRESP); Fondation Coeur et Arteres; French Environment and Energy Management Agency (ADEME); and SITA Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarelli A, 2011, LANCET, V377, P694, DOI 10.1016/S0140-6736(10)62348-3; Bhaskaran K, 2009, HEART, V95, P1746, DOI 10.1136/hrt.2009.175018; Bhaskaran K, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8050; Bhatnagar A, 2006, CIRC RES, V99, P692, DOI 10.1161/01.RES.0000243586.99701.cf; Billionnet C, 2012, ANN EPIDEMIOL, V22, P126, DOI 10.1016/j.annepidem.2011.11.004; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Carruthers D, 1998, INT J ENVIRON POLLUT, V14, P2000; Delfino RJ, 2003, ENVIRON HEALTH PERSP, V111, P647, DOI 10.1289/ehp.5992; European Environment Agency, 2012, AIR QUAL EUR 2012 RE; Farron O, 2008, TOXICOL IND HEALTH, V24, P261, DOI 10.1177/0748233708098504; Flahault A, 2006, STAT METHODS MED RES, V15, P413, DOI 10.1177/0962280206071639; Fusco D, 2001, EUR RESPIR J, V17, P1143, DOI 10.1183/09031936.01.00005501; Havard S, 2009, EPIDEMIOLOGY, V20, P223, DOI 10.1097/EDE.0b013e31819464e1; Huang C, 2013, ATMOS ENVIRON, V77, P703, DOI 10.1016/j.atmosenv.2013.05.059; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; Keenan JJ, 2010, CHEM-BIOL INTERACT, V184, P293, DOI 10.1016/j.cbi.2010.01.016; Kotseva K, 1998, INT ARCH OCC ENV HEA, V71, pS87; KURPPA K, 1984, SCAND J WORK ENV HEA, V10, P381, DOI 10.5271/sjweh.2316; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; Marcazzan GM, 2001, ATMOS ENVIRON, V35, P4639, DOI 10.1016/S1352-2310(01)00124-8; McHale CM, 2012, CARCINOGENESIS, V33, P240, DOI 10.1093/carcin/bgr297; Murugesan K, 2013, PROTEOMICS, V13, P3211, DOI 10.1002/pmic.201300126; Mustafic H, 2012, JAMA-J AM MED ASSOC, V307, P713, DOI 10.1001/jama.2012.126; Nawrot TS, 2011, LANCET, V377, P732, DOI 10.1016/S0140-6736(10)62296-9; Pant P, 2013, ATMOS ENVIRON, V77, P78, DOI 10.1016/j.atmosenv.2013.04.028; Peters A, 2004, NEW ENGL J MED, V351, P1721, DOI 10.1056/NEJMoa040203; Peters A, 2002, LANCET, V360, P1184, DOI 10.1016/S0140-6736(02)11289-X; Peters A, 2001, CIRCULATION, V103, P2810; Sacks JD, 2012, AM J EPIDEMIOL, V176, P622, DOI 10.1093/aje/kws135; Schwartz J, 1999, EPIDEMIOLOGY, V10, P17, DOI 10.1097/00001648-199901000-00005; Tsai DH, 2010, SCI TOTAL ENVIRON, V408, P1818, DOI 10.1016/j.scitotenv.2010.01.044; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583	33	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100307	10.1371/journal.pone.0100307	http://dx.doi.org/10.1371/journal.pone.0100307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932584	Green Published, Green Submitted, gold			2022-12-25	WOS:000337738600108
J	Iqbal, SA; Hayton, MJ; Watson, JS; Szczypa, P; Bayat, A				Iqbal, Syed Amir; Hayton, Michael John; Watson, James Stewart; Szczypa, Piotr; Bayat, Ardeshir			First Identification of Resident and Circulating Fibrocytes in Dupuytren's Disease Shown to Be Inhibited by Serum Amyloid P and Xiapex	PLOS ONE			English	Article							PERIPHERAL-BLOOD FIBROCYTES; MESENCHYMAL STEM-CELLS; CLOSTRIDIUM-HISTOLYTICUM; POTENTIAL SOURCE; TISSUE-REPAIR; FIBROBLASTS; FIBROSIS; MYOFIBROBLASTS; EXPRESSION; DIFFERENTIATION	Dupuytren's disease (DD) is a common progressive fibroproliferative disorder causing permanent digital contracture. Proliferative myofibroblasts are thought to be the cells responsible for DD initiation and recurrence, although their source remains unknown. DD tissue has also been shown to harbor mesenchymal and hematopoietic stem cells. Fibrocytes are circulating cells that show characteristics of fibroblasts and they express surface markers for both hematopoietic and mesenchymal stromal cells. Fibrocytes differentiate from peripheral CD14(+) mononuclear cells, which can be inhibited by serum amyloid P (SAP). In this study we have demonstrated the presence of fibrocytes in DD blood and tissue, moreover we have evaluated the effects of SAP and Xiapex (Collagenase Clostridium histolyticum) on fibrocytes derived from DD. H&E staining showed typical Spindle shaped morphology of fibrocytes. FACS analysis based on a unique combination of 3 markers, revealed the increased presence of fibrocytes in blood and tissue of DD patients. Additionally, immunohistology of DD nodule and cord tissue showed the presence of collagen 1(+)/CD34(+) cells. No difference in plasma SAP levels was observed between DD and control. Higher concentrations of SAP significantly inhibited fibrocytes differentiated from DD derived monocytes compared to control. DD fascia derived fibrocytes showed resistance to growth inhibition by SAP, particularly nodule derived fibrocytes showed robust growth even at higher SAP concentrations compared to control. DD derived fibrocytes were positive for typical fibrocyte dual markers, i.e. Collagen 1/LSP-1 and collagen 1/CD34. Xiapex was more effective in inhibiting the growth of nodule derived cells compared to commercially available collagenase A. Our results show for the first time the increased presence of fibrocytes in DD patient's blood and disease tissue compared to control tissue. Additionally, we evaluate the response of these fibrocytes to SAP and Xiapex therapy.	[Iqbal, Syed Amir; Bayat, Ardeshir] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England; [Hayton, Michael John] Wrightington Hosp, Dept Hand & Upper Limb Surg, Wrightington, England; [Watson, James Stewart; Bayat, Ardeshir] Wythenshawe Hosp, Dept Plast & Reconstruct Surg, Univ Hosp South Manchester NHS Fdn Trust, Manchester M23 9LT, Lancs, England; [Szczypa, Piotr] Med Affairs Pfizer Ltd, Tadworth, Surrey, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Pfizer	Bayat, A (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England.	ardeshir.Bayat@manchester.ac.uk		BAYAT, ARDESHIR/0000-0002-4116-6491	Pfizer Pvt. Ltd. UK	Pfizer Pvt. Ltd. UK	The author(s) received funding from Pfizer Pvt. Ltd. UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZZARONE B, 1983, J CELL PHYSIOL, V117, P353, DOI 10.1002/jcp.1041170310; Bayat A, 2006, ANN ROY COLL SURG, V88, P3, DOI 10.1308/003588406X83104; Bayat A, 2007, BRIT J HOSP MED, V68, P604, DOI 10.12968/hmed.2007.68.11.27683; Bayat A, 2010, NAT REV RHEUMATOL, V6, P7, DOI 10.1038/nrrheum.2009.255; Bisson MA, 2003, J HAND SURG-BRIT EUR, V28B, P351, DOI 10.1016/S0266-7681(03)00135-9; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; BURKHARDT K, 1995, TRANSPLANT P, V27, P890; Chesney J, 1997, BIOCHEM SOC T, V25, P520, DOI 10.1042/bst0250520; Chesney J, 2000, Curr Rheumatol Rep, V2, P501, DOI 10.1007/s11926-000-0027-5; Chesney J, 1998, J IMMUNOL, V160, P419; Curnow SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009730; Dibenedetti Dana Britt, 2011, Hand (N Y), V6, P149, DOI 10.1007/s11552-010-9306-4; Grieb G, 2011, INT REV CEL MOL BIO, V291, P1, DOI 10.1016/B978-0-12-386035-4.00001-X; Herzog EL, 2010, EXP HEMATOL, V38, P548, DOI 10.1016/j.exphem.2010.03.004; Hindocha Sandip, 2009, Hand (N Y), V4, P256, DOI 10.1007/s11552-008-9160-9; Holland AJA, 2008, J BURN CARE RES, V29, P619, DOI 10.1097/BCR.0b013e31817db90a; HUESTON J, 1985, ANN ROY COLL SURG, V67, P372; Iqbal SA, 2012, ARCH DERMATOL RES, V304, P665, DOI 10.1007/s00403-012-1225-5; Iqbal SA, 2012, STEM CELLS DEV, V21, P609, DOI 10.1089/scd.2011.0140; Keeley EC, 2010, INT J BIOCHEM CELL B, V42, P535, DOI 10.1016/j.biocel.2009.10.014; Lugering N, 1998, ITAL J GASTROENTEROL, V30, P338; Matsushita O, 1999, J BACTERIOL, V181, P923, DOI 10.1128/JB.181.3.923-933.1999; MCCANN BG, 1993, J HAND SURG-BRIT EUR, V18B, P656, DOI 10.1016/0266-7681(93)90029-F; Oh SJ, 1998, HISTOCHEM CELL BIOL, V109, P349, DOI 10.1007/s004180050235; PEPYS MB, 1978, CLIN EXP IMMUNOL, V32, P119; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Pilling D, 2003, J IMMUNOL, V171, P5537, DOI 10.4049/jimmunol.171.10.5537; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Quan Timothy E, 2006, Curr Rheumatol Rep, V8, P145, DOI 10.1007/s11926-006-0055-x; RABINOWITZ JL, 1983, LIPIDS, V18, P371, DOI 10.1007/BF02537234; Ratajczak-Wielgomas K, 2012, CONNECT TISSUE RES, V53, P469, DOI 10.3109/03008207.2012.686542; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Shih B, 2010, NAT REV RHEUMATOL, V6, P715, DOI 10.1038/nrrheum.2010.180; Starkweather KD, 1996, J HAND SURG-AM, V21A, P490, DOI 10.1016/S0363-5023(96)80368-6; Strieter RM, 2009, J LEUKOCYTE BIOL, V86, P1111, DOI 10.1189/jlb.0309132; Sun L, 2011, AM J PHYSIOL-LUNG C, V300, pL341, DOI 10.1152/ajplung.00122.2010; Syed F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031430; Thomas A, 2010, THER CLIN RISK MANAG, V6, P557, DOI 10.2147/TCRM.S8591; Vakil V, 2009, J MAGN RESON IMAGING, V30, P1284, DOI 10.1002/jmri.21800; Verjee LS, 2009, J HAND SURG-AM, V34A, P1785, DOI 10.1016/j.jhsa.2009.08.005; Wada T, 2007, KIDNEY INT, V72, P269, DOI 10.1038/sj.ki.5002325; Wang JF, 2007, WOUND REPAIR REGEN, V15, P113, DOI 10.1111/j.1524-475X.2006.00192.x; Wang JF, 2007, J LEUKOCYTE BIOL, V82, P1554, DOI 10.1189/0507306; Yang LJ, 2005, WOUND REPAIR REGEN, V13, P398, DOI 10.1111/j.1067-1927.2005.130407.x; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9	45	3	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99967	10.1371/journal.pone.0099967	http://dx.doi.org/10.1371/journal.pone.0099967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933153	gold, Green Submitted, Green Published			2022-12-25	WOS:000337738600082
J	Lukasik, A; Zielenkiewicz, P				Lukasik, Anna; Zielenkiewicz, Piotr			In Silico Identification of Plant miRNAs in Mammalian Breast Milk Exosomes - A Small Step Forward?	PLOS ONE			English	Article							SITE ACCESSIBILITY; ACCESSORY PROTEIN; MICRORNAS; PREDICTION; RECEPTOR; TARGETS; BINDING; MICROBIOME; EXPRESSION; DIAGNOSIS	MicroRNAs (miRNAs) are a class of small RNA molecules that regulate gene expression by inhibiting the protein translation or targeting the mRNA cleavage. They play many important roles in living organism cells; however, the knowledge on miRNAs functions has become more extensive upon their identification in biological fluids and recent reports on plant-origin miRNAs abundance in human plasma and serum. Considering these findings, we performed a rigorous bioinformatics analysis of publicly available, raw data from high-throughput sequencing studies on miRNAs composition in human and porcine breast milk exosomes to identify the fraction of food-derived miRNAs. Several processing and filtering steps were applied to increase the accuracy, and to avoid false positives. Through aforementioned analysis, 35 and 17 miRNA species, belonging to 25 and 11 MIR families, were identified, respectively. In the human samples the highest abundance levels yielded the ath-miR166a, pab-miR951, ptc-miR472a and bdi-miR168, while in the porcine breast milk exosomes, the zma-miR168a, zma-miR156a and ath-miR166a have been identified in the largest amounts. The consensus prediction and annotation of potential human targets for select plant miRNAs suggest that the aforementioned molecules may interact with mRNAs coding several transcription factors, protein receptors, transporters and immune-related proteins, thus potentially influencing human organism. Taken together, the presented analysis shows proof of abundant plant miRNAs in mammal breast milk exosomes, pointing at the same time to the new possibilities arising from this discovery.	[Lukasik, Anna; Zielenkiewicz, Piotr] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Zielenkiewicz, Piotr] Univ Warsaw, Dept Plant Mol Biol, Inst Expt Plant Biol & Biotechnol, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw	Zielenkiewicz, P (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	piotr@ibb.waw.pl		Zielenkiewicz, Piotr/0000-0001-8151-6874	Institute of Biochemistry and Biophysics, Polish Academy of Sciences (IBB PAS)	Institute of Biochemistry and Biophysics, Polish Academy of Sciences (IBB PAS)	This work was supported by the Institute of Biochemistry and Biophysics, Polish Academy of Sciences (IBB PAS). The IBB PAS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Augustin R, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-35; Broderick JA, 2011, GENE THER, V18, P1104, DOI 10.1038/gt.2011.50; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Cheung H, 2005, J IMMUNOL, V174, P5351, DOI 10.4049/jimmunol.174.9.5351; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; De Guire V, 2013, CLIN BIOCHEM, V46, P846, DOI 10.1016/j.clinbiochem.2013.03.015; Debets R, 2000, J IMMUNOL, V165, P4950, DOI 10.4049/jimmunol.165.9.4950; DelValle J, 1997, AM J PHYSIOL-GASTR L, V273, pG987, DOI 10.1152/ajpgi.1997.273.5.G987; Dickinson B, 2013, NAT BIOTECHNOL, V31, P965, DOI 10.1038/nbt.2737; Dugas DV, 2004, CURR OPIN PLANT BIOL, V7, P512, DOI 10.1016/j.pbi.2004.07.011; Enright AJ, 2004, GENOME BIOL, V5; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043691; Hogg M, 2011, ADV GENET, V73, P87, DOI 10.1016/B978-0-12-380860-8.00003-3; Hu WQ, 2012, CELL RES, V22, P1322, DOI 10.1038/cr.2012.80; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Indrio F, 2009, ITAL J PEDIATR, V35, DOI 10.1186/1824-7288-35-39; Jones-Rhoades MW, 2012, PLANT MOL BIOL, V80, P3, DOI 10.1007/s11103-011-9829-2; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Korkmaz G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082556; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kruszka K, 2012, J PLANT PHYSIOL, V169, P1664, DOI 10.1016/j.jplph.2012.03.009; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu B., 2012, BRIEF BIOINFORM; Liu N, 2008, CELL RES, V18, P985, DOI 10.1038/cr.2008.278; Lukasik A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-801; Luzi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039767; Ma YJ, 2012, J CELL MOL MED, V16, P2539, DOI 10.1111/j.1582-4934.2012.01572.x; Mack GS, 2007, NAT BIOTECHNOL, V25, P631, DOI 10.1038/nbt0607-631; Matsumoto S, 2013, CIRC RES, V113, P322, DOI 10.1161/CIRCRESAHA.113.301209; Motameny S, 2010, GENES-BASEL, V1, P70, DOI 10.3390/genes1010070; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Munafo DB, 2010, RNA, V16, P2537, DOI 10.1261/rna.2242610; Noyce RS, 2012, TRENDS MICROBIOL, V20, P429, DOI 10.1016/j.tim.2012.05.006; Oboki Keisuke, 2010, Allergology International, V59, P143, DOI 10.2332/allergolint.10-RAI-0186; Pandey P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-56; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pattichis Katerina, 1995, Drug Metabolism and Drug Interactions, V12, P1; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Peterson SM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00023; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Quackenbush JF, 2014, METHODS MOL BIOL, V1102, P641, DOI 10.1007/978-1-62703-727-3_34; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/nmeth.2330, 10.1038/NMETH.2330]; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; Reczko Martin, 2012, Frontiers in Genetics, V2, P103, DOI 10.3389/fgene.2011.00103; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rekker K, 2014, CLIN BIOCHEM, V47, P135, DOI 10.1016/j.clinbiochem.2013.10.020; Reymond N, 2001, J BIOL CHEM, V276, P43205, DOI 10.1074/jbc.M103810200; Roberts T, 2014, NY TIMES BK REV, V119, P5; SAEKI K, 1975, J PHARMACOL EXP THER, V193, P910; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Sun LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043760; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; Vandenplas Y, 2000, J GASTROEN HEPATOL, V15, P593, DOI 10.1046/j.1440-1746.2000.02169.x; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051009; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; WILLIAMS TM, 1991, SCIENCE, V254, P1791, DOI 10.1126/science.1840704; Xie FL, 2011, GENE, V473, P8, DOI 10.1016/j.gene.2010.09.007; Yan X, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-92; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474; Ying SY, 2008, MOL BIOTECHNOL, V38, P257, DOI 10.1007/s12033-007-9013-8; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhang Y, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-127; Zhang YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-381; Zhang ZH, 2010, NUCLEIC ACIDS RES, V38, pD806, DOI 10.1093/nar/gkp818; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118; Zhu BL, 2010, PROTEIN CELL, V1, P718, DOI 10.1007/s13238-010-0093-z	75	56	56	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99963	10.1371/journal.pone.0099963	http://dx.doi.org/10.1371/journal.pone.0099963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933019	Green Published, gold, Green Submitted			2022-12-25	WOS:000337738600081
J	Ma, L; Shen, CJ; Cohen, EA; Xiong, SD; Wang, JH				Ma, Li; Shen, Chan-Juan; Cohen, Eric A.; Xiong, Si-Dong; Wang, Jian-Hua			miRNA-1236 Inhibits HIV-1 Infection of Monocytes by Repressing Translation of Cellular Factor VprBP	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REPEAT LTR TRANSACTIVATION; E3 UBIQUITIN LIGASE; MICRORNA REGULATION; BLOOD MONOCYTES; HLA-C; REPLICATION; RESTRICTION; COMPLEX; PROTEIN	Primary monocytes are refractory to HIV-1 infection and become permissive upon differentiation into monocyte-derived dendritic cells (MDDCs) or macrophages. Multiple mechanisms have been proposed to interpret HIV-1 restriction in monocytes. Human cellular miRNAs can modulate HIV-1 infection by targeting either conserved regions of the HIV-1 genome or host gene transcripts. We have recently reported that the translation of host protein pur-alpha is repressed by abundant cellular miRNAs to inhibit HIV-1 infection in monocytes. Here, we report that the transcript of another cellular factor, VprBP [Vpr (HIV-1)-binding protein], was repressed by cellular miRNA-1236, which contributes to HIV-1 restriction in monocytes. Transfection of miR-1236 inhibitors enhanced translation of VprBP in monocytes and significantly promoted viral infection; exogenous input of synthesized miR-1236 mimics into MDDCs suppressed translation of VprBP, and, accordingly, significantly impaired viral infection. Our data emphasize the role of miRNA in modulating differentiation-dependent susceptibility of the host cell to HIV-1 infection. Understanding the modulation of HIV-1 infection by cellular miRNAs may provide key small RNAs or the identification of new important protein targets regulated by miRNAs for the development of antiviral strategies.	[Ma, Li; Xiong, Si-Dong] Soochow Univ, Inst Biol & Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou, Peoples R China; [Ma, Li; Shen, Chan-Juan; Wang, Jian-Hua] Chinese Acad Sci, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai, Peoples R China; [Cohen, Eric A.] Inst Rech Clin Montreal, Lab Human Retrovirol, Montreal, PQ H2W 1R7, Canada	Soochow University - China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Wang, JH (corresponding author), Chinese Acad Sci, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai, Peoples R China.	Jh_wang@sibs.ac.cn			Chinese Academy of Sciences; Natural Science Foundation of China [81171567]; National Basic Research Program of China (973 Program) [2012CB519004]; Sanofi-Aventis-SIBS Scholarship Program	Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Sanofi-Aventis-SIBS Scholarship Program	This work was supported by grants to J.H.W. from the Interdisciplinary and Collaboration team of Chinese Academy of Sciences; the Natural Science Foundation of China (No. 81171567), and the National Basic Research Program of China (973 Program) (2012CB519004). J.H.W. gratefully acknowledges the support of the Sanofi-Aventis-SIBS Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia JK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-117; Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Arfi V, 2008, J VIROL, V82, P6557, DOI 10.1128/JVI.02321-07; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, J VIROL, V84, P3320, DOI 10.1128/JVI.02590-09; Bergamaschi A, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-31; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Chiang K, 2013, VIROLOGY, V438, P1, DOI 10.1016/j.virol.2012.12.016; Collini P, 2010, CURR MOL MED, V10, P727, DOI 10.2174/156652410793384141; Detsika MG, 2012, AIDS REV, V14, P188; Dong CS, 2009, J VIROL, V83, P3518, DOI 10.1128/JVI.02665-08; Duan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060170; Duskova K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-250; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; Fowler L, 2013, AIDS REV, V15, P3; Gaulke CA, 2014, J VIROL; Gerard FCA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089195; Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Klase Z, 2012, J BIOL CHEM, V287, P40884, DOI 10.1074/jbc.R112.415448; Kogan M, 2013, J CELL PHYSIOL, V228, P781, DOI 10.1002/jcp.24226; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kulkarni S, 2013, P NATL ACAD SCI USA, V110, P20705, DOI 10.1073/pnas.1312237110; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Laguette N, 2014, CELL, V156, P134, DOI 10.1016/j.cell.2013.12.011; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Mraz M, 2009, LEUKEMIA LYMPHOMA, V50, P506, DOI 10.1080/10428190902763517; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; Neil S, 2001, J VIROL, V75, P5448, DOI 10.1128/JVI.75.12.5448-5456.2001; Qin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027609; Seddiki N, 2013, EUR J IMMUNOL, V43, P510, DOI 10.1002/eji.201242695; Shen CJ, 2012, FASEB J, V26, P4755, DOI 10.1096/fj.12-209023; Sisk JM, 2012, VIRUSES-BASEL, V4, P1844, DOI 10.3390/v4101844; Sonza S, 1996, J VIROL, V70, P3863, DOI 10.1128/JVI.70.6.3863-3869.1996; Sun GH, 2012, NUCLEIC ACIDS RES, V40, P2181, DOI 10.1093/nar/gkr961; Sung TL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000263; Swaminathan G, 2014, J MOL BIOL, V426, P1178, DOI 10.1016/j.jmb.2013.12.017; Swaminathan S, 2012, AIDS; Thapa DR, 2014, J ACQUIR IMMUNE DEFI; Triques K, 2004, J VIROL, V78, P5523, DOI 10.1128/JVI.78.10.5523-5527.2004; Van Lint C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-67; Wang X, 2013, J BIOL CHEM, V288, P15474, DOI 10.1074/jbc.M112.416735; Zhang HS, 2012, FEBS LETT, V586, P4203, DOI 10.1016/j.febslet.2012.10.023; Zhang HS, 2012, BBA-MOL CELL RES, V1823, P1017, DOI 10.1016/j.bbamcr.2012.02.014; Zhang YJ, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-23; Zhang ZN, 2013, CLIN CHEM, V59, P1175, DOI 10.1373/clinchem.2012.197335; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	54	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99535	10.1371/journal.pone.0099535	http://dx.doi.org/10.1371/journal.pone.0099535			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932481	Green Submitted, Green Published, gold			2022-12-25	WOS:000337738600040
J	Huguet-Tapia, JC; Bignell, DRD; Loria, R				Huguet-Tapia, Jose C.; Bignell, Dawn R. D.; Loria, Rosemary			Characterization of the Integration and Modular Excision of the Integrative Conjugative Element PAISt in Streptomyces turgidiscabies Car8	PLOS ONE			English	Article							PLANT PATHOGENICITY; GENUS STREPTOMYCES; BACTERIAL GENOMES; ESCHERICHIA-COLI; SP-NOV; EVOLUTION; SITE; DATABASE; POSSESSES; INTEGRONS	PAISt is a large genomic island located in the chromosome of the plant pathogen Streptomyces turgidiscabies Car8. The island carries clustered virulence genes, transfers to other Streptomyces species, and integrates by site-specific recombination at the 8 bp palindrome TTCATGAA. The palindrome is located at the 3' end of the bacitracin resistance gene (bacA). We demonstrate that PAISt is able to excise in modules by recombination of one internal and two flanking palindromic direct repeats. The gene intSt located at the 3(end of PAISt encodes a tyrosine recombinase. Site-specific recombination activity of intSt was tested and confirmed by heterologous expression in Streptomyces coelicolor. Comparative analysis of PAISt homologues in Streptomyces scabies 87-22 and Streptomyces acidiscabies 84-104 indicates that these islands have been fixed by sequence erosion of intSt and the recombination sites.	[Huguet-Tapia, Jose C.; Loria, Rosemary] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; [Bignell, Dawn R. D.] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada	State University System of Florida; University of Florida; Memorial University Newfoundland	Loria, R (corresponding author), Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA.	rloria@ufl.edu		Bignell, Dawn/0000-0003-1731-5669	United States Department of Agriculture's National Institute of Food and Agriculture [2012-04027]; University of Florida, Institute of Food and Agricultural Sciences	United States Department of Agriculture's National Institute of Food and Agriculture; University of Florida, Institute of Food and Agricultural Sciences(University of Florida)	United States Department of Agriculture's National Institute of Food and Agriculture (http://www.csrees.usda.gov) grant No. 2012-04027. University of Florida, Institute of Food and Agricultural Sciences (http://ifas.ufl.edu) internal funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BIBB MJ, 1985, GENE, V38, P215, DOI 10.1016/0378-1119(85)90220-3; Bukhalid RA, 1998, MOL PLANT MICROBE IN, V11, P960, DOI 10.1094/MPMI.1998.11.10.960; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Du L, 2012, INT J MOL SCI, V13, P4797, DOI 10.3390/ijms13044797; Esposito D, 1997, NUCLEIC ACIDS RES, V25, P3605, DOI 10.1093/nar/25.18.3605; Ghinet MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027846; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; Grohmann E, 2003, MICROBIOL MOL BIOL R, V67, P277, DOI 10.1128/MMBR.67.2.277-301.2003; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall RM, 2012, ANN NY ACAD SCI, V1267, P71, DOI 10.1111/j.1749-6632.2012.06588.x; Hochhut B, 2001, J BACTERIOL, V183, P1124, DOI 10.1128/JB.183.4.1124-1132.2001; Huguet-Tapia JC, 2011, PLASMID, V65, P118, DOI 10.1016/j.plasmid.2010.11.002; Joshi MV, 2007, MOL PLANT MICROBE IN, V20, P751, DOI 10.1094/MPMI-20-7-0751; Kers JA, 2005, MOL MICROBIOL, V55, P1025, DOI 10.1111/j.1365-2958.2004.04461.x; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; LAMBERT DH, 1989, INT J SYST BACTERIOL, V39, P387, DOI 10.1099/00207713-39-4-387; LAMBERT DH, 1989, INT J SYST BACTERIOL, V39, P393, DOI 10.1099/00207713-39-4-393; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CA, 2007, MOL MICROBIOL, V66, P1356, DOI 10.1111/j.1365-2958.2007.06000.x; Loria R, 1997, PLANT DIS, V81, P836, DOI 10.1094/PDIS.1997.81.8.836; Loria R, 2008, ANTON LEEUW INT J G, V94, P3, DOI 10.1007/s10482-008-9240-4; Loria R, 2006, ANNU REV PHYTOPATHOL, V44, P469, DOI 10.1146/annurev.phyto.44.032905.091147; Marra D, 1999, MOL MICROBIOL, V31, P609, DOI 10.1046/j.1365-2958.1999.01201.x; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Miyajima K, 1998, INT J SYST BACTERIOL, V48, P495, DOI 10.1099/00207713-48-2-495; Pavlovic G, 2004, MICROBIOL-SGM, V150, P759, DOI 10.1099/mic.0.26883-0; Poele EMT, 2008, ANTON LEEUW INT J G, V94, P127, DOI 10.1007/s10482-008-9255-x; Quiroz TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026031; Schubert S, 2004, MOL MICROBIOL, V51, P837, DOI 10.1046/j.1365-2958.2003.03870.x; Seipke RF, 2008, J BACTERIOL, V190, P7684, DOI 10.1128/JB.01010-08; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382	35	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99345	10.1371/journal.pone.0099345	http://dx.doi.org/10.1371/journal.pone.0099345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927117	gold, Green Submitted, Green Published			2022-12-25	WOS:000338278100036
J	Saito, PK; Yamakawa, RH; Aparecida, EP; da Silva, WV; Borelli, SD				Saito, Patricia Keiko; Yamakawa, Roger Haruki; Aparecida, Erica Pereira; da Silva Junior, Waldir Verissimo; Borelli, Sueli Donizete			Evaluation of the Humoral Immune Response to Human Leukocyte Antigens in Brazilian Renal Transplant Candidates	PLOS ONE			English	Article							KIDNEY GRAFT FAILURE; HLA-DP ANTIBODIES; CLASS-I; HYPERACUTE REJECTION; MEDIATED REJECTION; VOLUNTEER DONORS; POPULATION; POLYMORPHISM; IMPACT; ALLOANTIBODIES	Pre-transplant sensitization to human leukocyte antigens (HLA) is a risk factor for graft failure. Studies of the immunological profile related to anti-HLA antibodies in Brazilian renal transplant candidates are few. In this study, we evaluated the humoral immune response to HLA antigens in 269 renal transplant candidates, in Parana State, Brazil. The HLA typing was performed by the polymerase chain reaction sequence-specific oligonucleotide method (PCR-SSO) combined with Luminex technology, using an SSO-LABType commercial kit (One Lambda, Inc., Canoga Park, CA, USA). The percentages of panel-reactive antibodies (PRA) and the specificity of anti-HLA antibodies were determined using the LS1PRA and LS2PRA commercial kits (One Lambda, Inc.). The PRA-positive group consisted of 182 (67.7%) patients, and the PRA-negative group of 87 (32.3%) patients. The two groups differed significantly only with respect to gender. Females were the most sensitized. Among the 182 patients with PRA-positive, 62 (34.1%) were positive for class I and negative for class II, 39 (21.4%) were negative for class I and positive for class II, and 81 (44.5%) were positive for both classes I and II. The HLA-A*02, A*24, A*01, B*44, B*35, B*15, DRB1*11, DRB1*04 and DRB1*03 allele groups were the most frequent. The specificities of anti-HLA antibodies were more frequent: A34, B57, Cw15, Cw16, DR51, DQ8 and DP14. This study documented the profile of anti-HLA antibodies in patients with chronic renal failure who were on waiting lists for an organ in Parana, and found high sensitization to HLA antigens in the samples.	[Saito, Patricia Keiko; Yamakawa, Roger Haruki; Borelli, Sueli Donizete] Univ Estadual Maringa, Dept Basic Hlth Sci, Maringa, Parana, Brazil; [Aparecida, Erica Pereira] Histogene Lab Histocompatibil & Genet, Maringa, Parana, Brazil; [da Silva Junior, Waldir Verissimo] Univ Estadual Maringa, Dept Stat, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa	Borelli, SD (corresponding author), Univ Estadual Maringa, Dept Basic Hlth Sci, Maringa, Parana, Brazil.	sueliborelli@gmail.com			National Council for Scientific and Technological Development [830008/2003-9]; Coordination for Enhancement of Higher Education Personnel - CAPES	National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for Enhancement of Higher Education Personnel - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by National Council for Scientific and Technological Development (grant number 830008/2003-9) and Coordination for Enhancement of Higher Education Personnel - CAPES. The funders' websites are http://www.capes.gov.br/ for CAPES, and http://www.cnpq.br/ for CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 1997, TRANSPLANTATION, V63, P1616, DOI 10.1097/00007890-199706150-00014; Assane AAA, 2010, HUM IMMUNOL, V71, P1027, DOI 10.1016/j.humimm.2010.06.017; Bachelet T, 2011, AM J TRANSPLANT, V11, P1543, DOI 10.1111/j.1600-6143.2011.03584.x; Barama A, 2000, CLIN TRANSPLANT, V14, P212, DOI 10.1034/j.1399-0012.2000.140306.x; Bardi Marlene Silva, 2012, Rev. Bras. Hematol. Hemoter., V34, P25, DOI 10.5581/1516-8484.20120010; Bortolotto AS, 2012, HUM IMMUNOL, V73, P180, DOI 10.1016/j.humimm.2011.11.009; CARVALHO AS, 1983, TISSUE ANTIGENS, V21, P39; CHAPMAN JR, 1986, TRANSPLANTATION, V42, P91; Silva Silvia Fernandes Ribeiro da, 2013, Rev. Bras. Hematol. Hemoter., V35, P185, DOI 10.5581/1516-8484.20130043; Dausset Jean, 1954, VOX SANG BASEL, V4, P190; Duquesnoy RJ, 2011, TRANSPL IMMUNOL, V24, P164, DOI 10.1016/j.trim.2010.12.003; Egfjord M, 2003, SCAND J IMMUNOL, V57, P362, DOI 10.1046/j.1365-3083.2003.01203.x; Frohn C, 2001, NEPHROL DIAL TRANSPL, V16, P355, DOI 10.1093/ndt/16.2.355; Fu Q, 2012, TRANSPL P, V44, P217, DOI 10.1016/j.transproceed.2011.12.041; Gilbert M, 2011, TRANSPL P, V43, P3412, DOI 10.1016/j.transproceed.2011.09.023; GOODNOUGH LT, 1994, CLIN NEPHROL, V41, P303; Goral S, 2008, NEPHROL DIAL TRANSPL, V23, P390, DOI 10.1093/ndt/gfm703; HALLORAN PF, 1990, TRANSPLANTATION, V49, P85, DOI 10.1097/00007890-199001000-00019; Heise E, 2001, CLIN TRANSPLANT, V15, P22, DOI 10.1034/j.1399-0012.2001.00004.x; Idica Adam, 2006, Clin Transpl, P139; Karahan GE, 2009, TRANSPL P, V41, P3651, DOI 10.1016/j.transproceed.2009.04.007; KISSMEYE F, 1966, LANCET, V2, P662, DOI 10.1016/S0140-6736(66)92829-7; Kliger AS, 2012, CLIN J AM SOC NEPHRO, V7, P354, DOI 10.2215/CJN.11961111; Krishnan N S, 2012, Indian J Nephrol, V22, P409, DOI 10.4103/0971-4065.106029; Ling M, 2012, HUM IMMUNOL, V73, P879, DOI 10.1016/j.humimm.2012.07.320; Matas AJ, 2000, CLIN TRANSPLANT, V14, P90, DOI 10.1034/j.1399-0012.2000.140117.x; Mota Mariza Aparecida, 2013, Rev. Bras. Hematol. Hemoter., V35, P160, DOI 10.5581/1516-8484.20130046; Nigam P, 2004, TISSUE ANTIGENS, V64, P204, DOI 10.1111/j.1399-0039.2004.00264.x; Ozdemir FN, 2004, TRANSPL IMMUNOL, V12, P185, DOI 10.1016/j.trim.2003.11.003; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; PATEL R, 1969, NEW ENGL J MED, V280, P735, DOI 10.1056/NEJM196904032801401; Paximadis M, 2012, HUM IMMUNOL, V73, P80, DOI 10.1016/j.humimm.2011.10.013; PAYNE R, 1958, J CLIN INVEST, V37, P1756, DOI 10.1172/JCI103768; Phelan PJ, 2012, CLIN TRANSPLANT, V26, P544, DOI 10.1111/j.1399-0012.2011.01581.x; Piazza A, 1989, Gene Geogr, V3, P141; Probst CM, 2000, HUM BIOL, V72, P597; Qiu JX, 2005, TRANSPLANTATION, V80, P1511, DOI 10.1097/01.tp.0000181384.49832.3a; Ribas F, 2008, TISSUE ANTIGENS, V72, P532, DOI 10.1111/j.1399-0039.2008.01142.x; Ruiz TM, 2005, TRANSPL P, V37, P2293, DOI 10.1016/j.transproceed.2005.03.036; Singh P, 2010, TRANSPLANTATION, V90, P220, DOI 10.1097/TP.0b013e3181e1177d; Susal C, 2002, TRANSPLANTATION, V73, P1269; Tanhehco YC, 2012, SEMIN DIALYSIS, V25, P539, DOI 10.1111/j.1525-139X.2012.01089.x; Thaunat O, 2009, TRANSPL IMMUNOL, V20, P209, DOI 10.1016/j.trim.2008.12.006; THICK M, 1984, TRANSPLANTATION, V37, P525, DOI 10.1097/00007890-198405000-00023; Tran TH, 2011, TRANSPLANTATION, V92, P419, DOI 10.1097/TP.0b013e318224c14e; VANROOD JJ, 1958, NATURE, V181, P1735, DOI 10.1038/1811735a0; Vongwiwatana A, 2003, IMMUNOL REV, V196, P197, DOI 10.1046/j.1600-065X.2003.00093.x	47	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100270	10.1371/journal.pone.0100270	http://dx.doi.org/10.1371/journal.pone.0100270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927116	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100124
J	Zhao, B; Fei, J; Chen, Y; Ying, YL; Ma, L; Song, XQ; Wang, L; Chen, EZ; Mao, EQ				Zhao, Bing; Fei, Jian; Chen, Ying; Ying, Yi-Lin; Ma, Li; Song, Xiao-Qin; Wang, Lu; Chen, Er-Zhen; Mao, En-Qiang			Pharmacological Preconditioning with Vitamin C Attenuates Intestinal Injury via the Induction of Heme Oxygenase-1 after Hemorrhagic Shock in Rats	PLOS ONE			English	Article							ASCORBIC-ACID; TISSUE-INJURY; UP-REGULATION; EXPRESSION; PROTEIN; RESUSCITATION; PROTECTION; CELLS; HEME-OXYGENASE-1; PROOXIDANT	Pre-induction of heme oxygenase (HO)-1, which is regarded as an effective method of "organ preconditioning'', exerts beneficial effects during hemorrhagic shock (HS). However, the available HO-1 inducers exhibit disadvantages such as toxicity or complex technical requirements. Therefore, a safe and convenient HO-1 inducer would be promising and could be exploited in the treatment of foreseeable hemorrhaging, such as prior to major surgery. Here we investigated the effect of vitamin C (VitC), a common antioxidant, on intestinal HO-1 expression and examined whether VitC pretreatment prevented HS related intestinal tissue injuries after HO-1 induction. First, we conducted an in vitro study and found that HO-1 expression in rat intestinal epithelial cells (IEC-6) was induced by non-toxic VitC in a time and concentration dependent manner, and the mechanism was related to the activation of extracellular signal-regulated kinase 1/2 (ERK1/2). Next, we conducted an in vivo study and found that VitC induced intestinal HO-1 protein expression (mainly observed in the intestinal epithelial cells) and HO-1 activity in normal SD rats, and that these HO-1 levels were further enhanced by VitC in a rat model of HS. The HS related intestinal injuries, including histological damage, pro-inflammatory cytokine levels (tumor necrosis factor and interleukin-6), neutrophil infiltration and apoptosis decreased after VitC pretreatment, and this alleviating of organ injuries was abrogated after the inhibition of HO-1 activity by zinc protoporphyrin-IX. It was of note that VitC did little histological damage to the intestine of the sham rats. These data suggested that VitC might be applied as a safe inducer of intestinal HO-1 and that VitC pretreatment attenuated HS related intestinal injuries via the induction of HO-1.	[Zhao, Bing; Chen, Ying; Ying, Yi-Lin; Song, Xiao-Qin; Wang, Lu; Chen, Er-Zhen; Mao, En-Qiang] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Emergency Intens Care Unit, Shanghai 200030, Peoples R China; [Fei, Jian] Shanghai Jiao Tong Univ, Sch Med, Dept Surg, Ruijin Hosp, Shanghai 200030, Peoples R China; [Ma, Li] Shanghai Jiao Tong Univ, Sch Med, Dept Emergency Intens Care Unit, Peoples Hosp 3, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, EZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Emergency Intens Care Unit, Shanghai 200030, Peoples R China.	chenerzhen@hotmail.com; maoeq@yeah.net			National Natural Science Foundation of China [81171789]; Science and Technology Commission of Shanghai Municipality [124119a4600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work is supported by National Natural Science Foundation of China projects 81171789 (to En-Qiang Mao) and the Science and Technology Commission of Shanghai Municipality 124119a4600 (to Jian Fei). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angele MK, 2008, CRIT CARE, V12, DOI 10.1186/cc6919; [Anonymous], CANC LETT, V246, P54; Anwar AA, 2005, FREE RADICAL BIO MED, V39, P227, DOI 10.1016/j.freeradbiomed.2005.03.012; Chao XDD, 2013, EXP NEUROL, V239, P163, DOI 10.1016/j.expneurol.2012.09.020; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Coimbra R, 2006, J TRAUMA, V60, P41, DOI 10.1097/01.ta.0000197417.03460.0a; Cooney RN, 2011, J TRAUMA, V71, P24; Cristante AF, 2009, SPINAL CORD, V47, P458, DOI 10.1038/sc.2008.155; Elbirt KK, 1998, J BIOL CHEM, V273, P8922, DOI 10.1074/jbc.273.15.8922; Filomeni G, 2012, BIOCHEM PHARMACOL, V83, P1349, DOI 10.1016/j.bcp.2012.02.003; Food U Administration D, 2002, GUIDANCE INDUSTRY RE; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Hassoun HT, 2001, SHOCK, V15, P1, DOI 10.1097/00024382-200115010-00001; Hu GY, 2011, GUT, V60, P820, DOI 10.1136/gut.2010.215178; Huang J, 2013, STROKE, V44, P190, DOI 10.1161/STROKEAHA.112.670299; Huang YN, 2012, TOXICOL APPL PHARM, V265, P241, DOI 10.1016/j.taap.2012.08.036; Inoue K, 2008, SHOCK, V29, P252, DOI 10.1097/shk.0b013e3180cab913; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kim JH, 2014, STEM CELLS DEV; Kim JY, 2004, LIFE SCI, V75, P2015, DOI 10.1016/j.lfs.2004.06.002; Kubulus D, 2008, SHOCK, V29, P583, DOI 10.1097/SHK.0b013e318157e526; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Leung PS, 2009, ANTIOXID REDOX SIGN, V11, P135, DOI 10.1089/ars.2008.2109; Liu SX, 2012, INT J CARDIOL, V160, P95, DOI 10.1016/j.ijcard.2011.03.033; Maier M, 2003, SHOCK, V19, P457, DOI 10.1097/01.shk.0000056961.48384.f2; Mallick IH, 2010, AM J SURG, V199, P223, DOI 10.1016/j.amjsurg.2009.01.011; Moretti M, 2014, J PSYCHIATR RES, V48, P16, DOI 10.1016/j.jpsychires.2013.10.014; Morin MJ, 1998, CRIT CARE MED, V26, P1258, DOI 10.1097/00003246-199807000-00031; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Raddatz A, 2006, AM J RESP CRIT CARE, V174, P198, DOI 10.1164/rccm.200508-1221OC; Raeburn CD, 2001, ARCH SURG-CHICAGO, V136, P1263, DOI 10.1001/archsurg.136.11.1263; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sakamoto N, 2005, INT J HYPERTHER, V21, P603, DOI 10.1080/02656730500188599; Schipper HM, 1999, NEUROTOX RES, V1, P57, DOI 10.1007/BF03033339; Sonnier DI, 2010, J GASTROINTEST SURG, V14, P1592, DOI 10.1007/s11605-010-1321-9; Tsai MS, 2011, INTENS CARE MED, V37, P2033, DOI 10.1007/s00134-011-2362-6; Umeda K, 2009, SHOCK, V31, P40, DOI 10.1097/SHK.0b013e318177823a; Van PY, 2011, J TRAUMA, V71, P20, DOI 10.1097/TA.0b013e3182214f44; Vilcheze C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2898; Yan Y, 2013, PROTEIN CELL, V4, P620, DOI 10.1007/s13238-013-3030-0; Yasuda H, 2005, BRAIN RES, V1032, P176, DOI 10.1016/j.brainres.2004.11.009; Yu HP, 2011, SHOCK, V35, P517, DOI 10.1097/SHK.0b013e318209e931; Zhang HY, 2012, SURGERY, V151, P594, DOI 10.1016/j.surg.2011.10.001	45	10	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99134	10.1371/journal.pone.0099134	http://dx.doi.org/10.1371/journal.pone.0099134			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927128	gold, Green Published, Green Submitted			2022-12-25	WOS:000338278100028
J	Walsh, LA; Roy, DM; Reyngold, M; Giri, D; Snyder, A; Turcan, S; Badwe, CR; Lyman, J; Bromberg, J; King, TA; Chan, TA				Walsh, L. A.; Roy, D. M.; Reyngold, M.; Giri, D.; Snyder, A.; Turcan, S.; Badwe, C. R.; Lyman, J.; Bromberg, J.; King, T. A.; Chan, T. A.			RECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch	ONCOGENE			English	Article							PLASMINOGEN-ACTIVATOR SYSTEM; ENDOTHELIAL GROWTH-FACTOR; SQUAMOUS-CELL CARCINOMA; VEGF EXPRESSION; MATRIX METALLOPROTEINASE-2; CONSTITUTIVE ACTIVATION; SUPPRESSOR GENES; INHIBITOR RECK; KAZAL MOTIFS; STAT3	Metastasis is the primary cause of cancer-related death in oncology patients. A comprehensive understanding of the molecular mechanisms that cancer cells usurp to promote metastatic dissemination is critical for the development and implementation of novel diagnostic and treatment strategies. Here we show that the membrane protein RECK (Reversion-inducing cysteine-rich protein with kazal motifs) controls breast cancer metastasis by modulating a novel, non-canonical and convergent signal transducer and activator of transcription factor 3 (STAT3)-dependent angiogenic program. Neoangiogenesis and STAT3 hyperactivation are known to be fundamentally important for metastasis, but the root molecular initiators of these phenotypes are poorly understood. Our study identifies loss of RECK as a critical and previously unknown trigger for these hallmarks of metastasis. Using multiple xenograft mouse models, we comprehensively show that RECK inhibits metastasis, concomitant with a suppression of neoangiogenesis at secondary sites, while leaving primary tumor growth unaffected. Further, with functional genomics and biochemical dissection we demonstrate that RECK controls this angiogenic rheostat through a novel complex with cell surface receptors to regulate STAT3 activation, cytokine signaling, and the induction of both vascular endothelial growth factor and urokinase plasminogen activator. In accordance with these findings, inhibition of STAT3 can rescue this phenotype both in vitro and in vivo. Taken together, our study uncovers, for the first time, that RECK is a novel regulator of multiple well-established and robust mediators of metastasis; thus, RECK is a keystone protein that may be exploited in a clinical setting to target metastatic disease from multiple angles.	[Walsh, L. A.; Roy, D. M.; Snyder, A.; Turcan, S.; Chan, T. A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Roy, D. M.] Weill Cornell Rockefeller Sloan Kettering Triinst, New York, NY USA; [Reyngold, M.; Chan, T. A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA; [Giri, D.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Snyder, A.; Bromberg, J.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Badwe, C. R.] Weill Grad Sch Med Sci, New York, NY USA; [Lyman, J.; King, T. A.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center	Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave,Box 20, New York, NY 10065 USA.	chant@mskcc.org	Chan, Timothy A/ABD-5850-2021	Turcan, Sevin/0000-0002-0885-5607; Snyder Charen, Alexandra/0000-0002-2606-3523; Walsh, Logan/0000-0001-8771-2577	Department of Defense (DOD) [BC120568]; Frederick Adler Fund; Avon Foundation; Elsa Pardee foundation; MSKCC Metastasis Center; STARR Cancer Consortium; Canadian Institutes of Health Research PDF Award [MFE-127325]; HHMI Research Fellows Program; NIH MSTP grant [T32GM007739]; Ruth L. Kirschstein National Research Award (NRSA) from the National Cancer Institute [T32CA009512]; NIH [5T32CA160001]; NATIONAL CANCER INSTITUTE [P30CA008748, T32CA160001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Department of Defense (DOD)(United States Department of Defense); Frederick Adler Fund; Avon Foundation; Elsa Pardee foundation; MSKCC Metastasis Center; STARR Cancer Consortium; Canadian Institutes of Health Research PDF Award; HHMI Research Fellows Program; NIH MSTP grant; Ruth L. Kirschstein National Research Award (NRSA) from the National Cancer Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Agnes Viale and Russell Towers for technical assistance. We are indebted to Joan Massague (Memorial Sloan-Kettering Cancer Center) for generously providing cell lines and some constructs. We are grateful to the entire Tumour Procurement Service at MSKCC for facilitating tissue procurement and contributing valuable input. This work was supported by grants from the Department of Defense (DOD) (grant no. BC120568), the Frederick Adler Fund, the Avon Foundation, the Elsa Pardee foundation, the MSKCC Metastasis Center and the STARR Cancer Consortium (all to TAC). LAW was supported by The Canadian Institutes of Health Research PDF Award MFE-127325. DMR was supported by the HHMI Research Fellows Program and NIH MSTP grant T32GM007739. AS was supported by the Ruth L. Kirschstein National Research Award (NRSA) number T32CA009512 from the National Cancer Institute. ST was supported by an NIH T32 grant (5T32CA160001).	Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Benasciutti E, 2004, BLOOD, V104, P256, DOI 10.1182/blood-2003-08-2661; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Bid HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035513; Bournazou Eirini, 2013, JAKSTAT, V2, pe23828, DOI 10.4161/jkst.23828; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Carbajo-Pescador S, 2013, BRIT J CANCER, V109, P83, DOI 10.1038/bjc.2013.285; Cardoso F, 2012, ANN ONCOL, V23, P11, DOI 10.1093/annonc/mds232; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chandana EPS, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-84; Chang CK, 2008, J CELL MOL MED, V12, P2781, DOI 10.1111/j.1582-4934.2008.00215.x; Chang HC, 2006, CANCER RES, V66, P8413, DOI 10.1158/0008-5472.CAN-06-0685; Cho CY, 2007, J CELL PHYSIOL, V213, P65, DOI 10.1002/jcp.21089; Choong PFM, 2003, CLIN ORTHOP RELAT R, pS46, DOI 10.1097/01.blo.0000093845.72468.bd; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; D'Haene N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067029; Cardeal LBD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033585; Dong QA, 2010, INT J EXP PATHOL, V91, P368, DOI 10.1111/j.1365-2613.2010.00724.x; Duffy MJ, 2004, CURR PHARM DESIGN, V10, P39, DOI 10.2174/1381612043453559; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Gu FM, 2011, WORLD J GASTROENTERO, V17, P3922, DOI 10.3748/wjg.v17.i34.3922; Han L, 2012, CNS NEUROSCI THER, V18, P573, DOI 10.1111/j.1755-5949.2012.00344.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hill VK, 2011, CANCER RES, V71, P2988, DOI 10.1158/0008-5472.CAN-10-4026; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Huang C, 2012, CYTOKINE GROWTH F R, V23, P25, DOI 10.1016/j.cytogfr.2012.01.003; Huang GY, 2014, STEM CELLS, V32, P1149, DOI 10.1002/stem.1609; Ishikawa S, 2004, CLIN CANCER RES, V10, P6579, DOI 10.1158/1078-0432.CCR-04-0272; Jeon HW, 2010, MOL CANCER THER, V9, P1361, DOI 10.1158/1535-7163.MCT-09-0717; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Kang SH, 2010, NEUROSURGERY, V67, P1386, DOI 10.1227/NEU.0b013e3181f1c0cd; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kim JH, 2010, BIOCHEM PHARMACOL, V79, P373, DOI 10.1016/j.bcp.2009.09.008; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Le QT, 2005, J CLIN ONCOL, V23, P8932, DOI 10.1200/JCO.2005.02.0206; Lee MMK, 2012, J IMMUNOL, V189, P5266, DOI 10.4049/jimmunol.1103359; Lin HY, 2013, BRIT J CANCER, V109, P731, DOI 10.1038/bjc.2013.349; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Noda M, 2010, FUTURE ONCOL, V6, P1105, DOI [10.2217/fon.10.80, 10.2217/FON.10.80]; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Onishi A, 2008, EXP CELL RES, V314, P377, DOI 10.1016/j.yexcr.2007.09.018; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Prabhu VV, 2012, ASIAN PAC J CANCER P, V13, P3539, DOI 10.7314/APJCP.2012.13.8.3539; Prendergast A, 2012, DEVELOPMENT, V139, P1141, DOI 10.1242/dev.072439; Rabien A, 2012, PROSTATE, V72, P948, DOI 10.1002/pros.21498; Roomi MW, 2009, ONCOL REP, V21, P1323, DOI 10.3892/or_00000358; Rosenkilde MM, 2004, APMIS, V112, P481, DOI 10.1111/j.1600-0463.2004.apm11207-0808.x; Sasahara RM, 2002, CANCER DETECT PREV, V26, P435, DOI 10.1016/S0361-090X(02)00123-X; Selander KS, 2004, CANCER RES, V64, P6924, DOI 10.1158/0008-5472.CAN-03-2516; Shain KH, 2009, CANCER RES, V69, P1009, DOI 10.1158/0008-5472.CAN-08-2419; Shoushtari AN, 2011, NAT REV CLIN ONCOL, V8, P333, DOI 10.1038/nrclinonc.2011.65; Sriuranpong V, 2003, CANCER RES, V63, P2948; Tang LL, 2013, BIOMED PHARMACOTHER, V67, P179, DOI 10.1016/j.biopha.2012.10.003; Thummarati P, 2012, WORLD J GASTROENTERO, V18, P244, DOI 10.3748/wjg.v18.i3.244; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Zarogoulidis Paul, 2013, Immunome Res, V9, P16535, DOI 10.1186/2090-5009-9-1; Zeng L, 2010, CYTOKINE, V49, P294, DOI 10.1016/j.cyto.2009.11.015; Zhang B, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-427; Zhang CS, 2012, INT J BIOL SCI, V8, P451, DOI 10.7150/ijbs.4038; Zhao Y, 2008, BIOCHEM BIOPH RES CO, V369, P1215, DOI 10.1016/j.bbrc.2008.03.038; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097	64	28	32	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 23	2015	34	17					2189	2203		10.1038/onc.2014.175	http://dx.doi.org/10.1038/onc.2014.175			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CG7HG	24931164	Green Accepted			2022-12-25	WOS:000353473000005
J	Orfanelli, U; Jachetti, E; Chiacchiera, F; Grioni, M; Brambilla, P; Briganti, A; Freschi, M; Martinelli-Boneschi, F; Doglioni, C; Montorsi, F; Bellone, M; Casari, G; Pasini, D; Lavorgna, G				Orfanelli, U.; Jachetti, E.; Chiacchiera, F.; Grioni, M.; Brambilla, P.; Briganti, A.; Freschi, M.; Martinelli-Boneschi, F.; Doglioni, C.; Montorsi, F.; Bellone, M.; Casari, G.; Pasini, D.; Lavorgna, G.			Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer	ONCOGENE			English	Article							CELL-DEATH; EXPRESSION SIGNATURE; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; PROGRESSION; CHANNEL; DIFFERENTIATION; ACTIVATION; BIOMARKERS; DISEASE	Overwhelming evidence indicates that cancer is a genetic disease caused by the accumulation of mutations in oncogenes and tumor suppressor genes. It is also increasingly apparent, however, that cancer depends not only on mutations in these coding genes but also on alterations in the large class of non-coding RNAs. Here, we report that one such long non-coding RNA, TRPM2-AS, an antisense transcript of TRPM2, which encodes an oxidative stress-activated ion channel, is overexpressed in prostate cancer (PCa). The high expression of TRPM2-AS and its related gene signature were found to be linked to poor clinical outcome, with the related gene signature working also independently of the patient's Gleason score. Mechanistically, TRPM2-AS knockdown led to PCa cell apoptosis, with a transcriptional profile that indicated an unbearable increase in cellular stress in the dying cells, which was coupled to cell cycle arrest, an increase in intracellular hydrogen peroxide and activation of the sense TRPM2 gene. Moreover, targets of existing drugs and treatments were found to be consistently associated with high TRPM2-AS levels in both targeted cells and patients, ultimately suggesting that the measurement of the expression levels of TRPM2-AS allows not only for the early identification of aggressive PCa tumors, but also identifies a subset of at-risk patients who would benefit from currently available, but mostly differently purposed, therapeutic agents.	[Orfanelli, U.; Briganti, A.; Montorsi, F.; Casari, G.; Lavorgna, G.] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Milan, Italy; [Orfanelli, U.; Casari, G.; Lavorgna, G.] Ctr Translat Genom & Bioinformat, Milan, Italy; [Jachetti, E.; Grioni, M.; Bellone, M.] Ist Sci San Raffaele, Cellular Immunol Unit, I-20132 Milan, Italy; [Chiacchiera, F.; Pasini, D.] European Inst Oncol IEO, Dept Expt Oncol, Milan, Italy; [Brambilla, P.; Martinelli-Boneschi, F.] Ist Sci San Raffaele, Inst Expt Neurol INSPE, Div Neurosci, Lab Genet Neurol Complex Disorders, I-20132 Milan, Italy; [Briganti, A.; Montorsi, F.] Dept Urol, Milan, Italy; [Freschi, M.; Doglioni, C.] Univ Vita Salute San Raffaele, Dept Pathol, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS European Institute of Oncology (IEO); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Lavorgna, G (corresponding author), Ist Sci San Raffaele, Via Olgettina 60, I-20132 Milan, Italy.	matteo.bellone@hsr.it; giovanni.lavorgna@hsr.it	Briganti, Alberto/AAN-1965-2020; Orfanelli, Ugo/AAN-4787-2020; Matteo, Grioni/AAN-5912-2020; Chiacchiera, Fulvio/ABD-6137-2020; Lavorgna, Giovanni/AAN-2575-2020; Jachetti, Elena/C-2145-2017; Montorsi, Francesco/AAN-2473-2020; Bellone, Matteo/B-6922-2013; Casari, Giorgio/J-3070-2018; Chiacchiera, Fulvio/K-6740-2016; Pasini, Diego/J-9674-2012	Matteo, Grioni/0000-0002-9930-042X; Jachetti, Elena/0000-0001-6483-7350; Bellone, Matteo/0000-0002-2586-2569; Casari, Giorgio/0000-0002-0115-8980; Chiacchiera, Fulvio/0000-0003-3830-2090; DOGLIONI, Claudio/0000-0002-4969-5216; Pasini, Diego/0000-0002-9879-6486; Orfanelli, Ugo/0000-0003-3792-9174; martinelli boneschi, filippo/0000-0002-9955-1368	Alleanza Contro il Cancro (AACR); Italian Ministry of Health; Associazione Italiana per la Ricerca sul Cancro (AIRC)	Alleanza Contro il Cancro (AACR); Italian Ministry of Health(Ministry of Health, Italy); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from the Alleanza Contro il Cancro (AACR) to GL, the Italian Ministry of Health to MB and the Associazione Italiana per la Ricerca sul Cancro (AIRC) to MB.	Agell L, 2012, AM J PATHOL, V181, P1585, DOI 10.1016/j.ajpath.2012.08.005; Bai JZ, 2010, NEUROTOXICOLOGY, V31, P204, DOI 10.1016/j.neuro.2010.01.001; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brase JC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-507; Chen SJ, 2013, AM J PHYSIOL-CELL PH, V304, pC548, DOI 10.1152/ajpcell.00069.2012; Cheville JC, 2008, J CLIN ONCOL, V26, P3930, DOI 10.1200/JCO.2007.15.6752; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Cuzick J, 2011, LANCET ONCOL, V12, P245, DOI 10.1016/S1470-2045(10)70295-3; Davidson BL, 2011, NAT REV GENET, V12, P329, DOI 10.1038/nrg2968; Di AK, 2012, NAT IMMUNOL, V13, P29, DOI 10.1038/ni.2171; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hessels D, 2009, NAT REV UROL, V6, P255, DOI 10.1038/nrurol.2009.40; Irshad S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006408; Ishii M, 2007, ANTICANCER RES, V27, P3987; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; Kaneko S, 2006, J PHARMACOL SCI, V101, P66, DOI 10.1254/jphs.FP0060128; Kim K, 2013, ONCOGENE, V32, P1616, DOI 10.1038/onc.2012.193; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Lavorgna G, 2004, TRENDS BIOCHEM SCI, V29, P88, DOI 10.1016/j.tibs.2003.12.002; Lu-Yao GL, 2009, JAMA-J AM MED ASSOC, V302, P1202, DOI 10.1001/jama.2009.1348; Markert EK, 2011, P NATL ACAD SCI USA, V108, P21276, DOI 10.1073/pnas.1117029108; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; Miller BA, 2006, J MEMBRANE BIOL, V209, P31, DOI 10.1007/s00232-005-0839-3; Miller EW, 2007, NAT CHEM BIOL, V3, P263, DOI 10.1038/nchembio871; Modarresi F, 2012, NAT BIOTECHNOL, V30, P453, DOI 10.1038/nbt.2158; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Orfanelli U, 2008, CELL RES, V18, P1128, DOI 10.1038/cr.2008.296; Penney KL, 2011, J CLIN ONCOL, V29, P2391, DOI 10.1200/JCO.2010.32.6421; Petrovics G, 2005, ONCOGENE, V24, P3847, DOI 10.1038/sj.onc.1208518; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Ribeiro FR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022317; Sboner A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-8; Schroder FH, 2012, BJU INT, V110, P3, DOI 10.1111/j.1464-410X.2012.011428.x; Simon RM, 2009, J NATL CANCER I, V101, P1446, DOI 10.1093/jnci/djp335; Stark JR, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3601; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tandefelt DG, 2013, EUR UROL, V64, P941, DOI 10.1016/j.eururo.2013.02.039; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; US Department of Health and Human Services FDA, 2007, CTR DRUG EV RES CTR; Verma S, 2012, NEUROSCI LETT, V530, P41, DOI 10.1016/j.neulet.2012.09.044; Wang GH, 2010, AM J TRANSL RES, V2, P65; Xia J, 2013, JNCI-J NATL CANCER I, V105, P546, DOI 10.1093/jnci/djt017; Xing Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000088; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Zeng X, 2010, PROSTATE CANCER P D, V13, P195, DOI 10.1038/pcan.2009.55; Zhang WY, 2006, AM J PHYSIOL-CELL PH, V290, pC1146, DOI 10.1152/ajpcell.00205.2005	55	61	63	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2015	34	16					2094	2102		10.1038/onc.2014.144	http://dx.doi.org/10.1038/onc.2014.144			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CG3IL	24931166				2022-12-25	WOS:000353173400009
J	Ma, QH; Xu, WX; Zhou, XH; Cui, CX; Pan, CW				Ma, Qinghua; Xu, Wenxin; Zhou, Xiaohua; Cui, Chunxue; Pan, Chen-Wei			The Relationship of Season of Birth with Refractive Error in Very Young Children in Eastern China	PLOS ONE			English	Article							TIME SPENT OUTDOORS; MYOPIA PROGRESSION; LIGHT EXPOSURE; SINGAPORE; NEARWORK; NIGHT; METAANALYSIS; ASSOCIATION; WORK	Purpose: To determine the association of season of birth and refractive error in very young Chinese children in China. Methods: We conducted a population-based study of Chinese children aged 0 to 3 years residing in eastern China. Refraction was determined by non-cyclopegic autorefraction using a hand-held autorefractor. Date of birth was retrieved from birth certificate of the individual subjects. A generalized linear regression model was fitted to estimate the regression coefficient and 95% confidence interval (CI) of refractive error for season of birth, adjusting for confounders. Results: Of the 1385 children eligible to participate, 1222 (88.2%) were examined. Refractive error data were available for 1219 children. The mean spherical equivalent were 1.21 diopters (D) in children born Spring, 1.24 D in those born in Summer, 1.23 D in those born in Autumn, 1.15 D in Winter. After adjusting for age, sex, father's educational level, birth weight and the number of summers between birth and examination date the children have been exposed to, children born in winter had a 0.12 D more myopic refraction compared with those born in summer (regression coefficient: -0.12; 95% CI, -0.27,-0.06; P = 0.006). The association between season of birth and cylinder power was not statistically significant. Conclusions: In China, children born in winter had a more myopic refraction compared with those born in other seasons. The observed association between season of birth and refractive error was independent of parental educational level and birth weight, suggesting that light level may have a small impact on refractive development in early life.	[Ma, Qinghua; Cui, Chunxue; Pan, Chen-Wei] Soochow Univ, Coll Med, Sch Publ Hlth, Suzhou, Peoples R China; [Ma, Qinghua; Xu, Wenxin; Zhou, Xiaohua] 3rd Peoples Hosp Xiangcheng Dist, Suzhou, Peoples R China	Soochow University - China	Pan, CW (corresponding author), Soochow Univ, Coll Med, Sch Publ Hlth, Suzhou, Peoples R China.	pcwonly@gmail.com	Pan, Chen-Wei/E-6205-2015; Pan, Chen-Wei/L-7174-2019	Pan, Chen-Wei/0000-0003-3362-4613	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhouse S, 2013, OPHTHAL PHYSL OPT, V33, P563, DOI 10.1111/opo.12069; Chapell M, 2001, PERCEPT MOTOR SKILL, V92, P640, DOI 10.2466/PMS.92.3.640-642; Cui DM, 2013, OPHTHALMOLOGY, V120, P1074, DOI 10.1016/j.ophtha.2012.10.022; Czepita D, 2004, MED SCI MONITOR, V10, pCR168; Deng L, 2011, OPTOMETRY VISION SCI, V88, P383, DOI 10.1097/OPX.0b013e31820b0517; Dirani M, 2009, BRIT J OPHTHALMOL, V93, P997, DOI 10.1136/bjo.2008.150979; Guggenheim JA, 2012, INVEST OPHTH VIS SCI, V53, P2856, DOI 10.1167/iovs.11-9091; Jones-Jordan LA, 2012, INVEST OPHTH VIS SCI, V53, P7169, DOI 10.1167/iovs.11-8336; Lim LS, 2010, OPHTHALMOLOGY, V117, P993, DOI 10.1016/j.ophtha.2009.10.003; Lim LS, 2010, OPHTHALMOLOGY, V117, P524, DOI 10.1016/j.ophtha.2009.07.044; Low W, 2010, BRIT J OPHTHALMOL, V94, P1012, DOI 10.1136/bjo.2009.173187; Mandel Y, 2008, OPHTHALMOLOGY, V115, P686, DOI 10.1016/j.ophtha.2007.05.040; Marcus MW, 2011, OPHTHALMOLOGY, V118, P1989, DOI 10.1016/j.ophtha.2011.03.012; McMahon G, 2009, OPHTHALMOLOGY, V116, P468, DOI 10.1016/j.ophtha.2008.10.004; Midelfart A, 2002, ARCH OPHTHALMOL-CHIC, V120, P406; Morgan I, 2005, PROG RETIN EYE RES, V24, P1, DOI 10.1016/j.preteyeres.2004.06.004; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Pan CW, 2013, AM J OPHTHALMOL, V156, P1021, DOI 10.1016/j.ajo.2013.06.005; Pan CW, 2013, OPHTHALMOLOGY, V120, P2058, DOI 10.1016/j.ophtha.2013.03.028; Quinn GE, 1999, NATURE, V399, P113, DOI 10.1038/20094; RICHLER A, 1980, ACTA OPHTHALMOL, V58, P468; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Saw SM, 2002, ARCH OPHTHALMOL-CHIC, V120, P620, DOI 10.1001/archopht.120.5.620; Saw SM, 2002, INVEST OPHTH VIS SCI, V43, P332; Saw SM, 2001, BRIT J OPHTHALMOL, V85, P527, DOI 10.1136/bjo.85.5.527; Saw SM, 2001, LANCET, V357, P390, DOI 10.1016/S0140-6736(05)71520-8; Sherwin JC, 2012, OPHTHALMOLOGY, V119, P2141, DOI 10.1016/j.ophtha.2012.04.020; Sherwin JC, 2012, INVEST OPHTH VIS SCI, V53, P4363, DOI 10.1167/iovs.11-8677; Vera-Diaz FA, 2002, CURR EYE RES, V24, P289, DOI 10.1076/ceyr.24.4.289.8418; Zadnik K, 2000, NATURE, V404, P143, DOI 10.1038/35004661; Zhou XT, 2010, PHOTOCHEM PHOTOBIOL, V86, P131, DOI 10.1111/j.1751-1097.2009.00637.x	31	9	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100472	10.1371/journal.pone.0100472	http://dx.doi.org/10.1371/journal.pone.0100472			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945317	Green Submitted, gold, Green Published			2022-12-25	WOS:000340721500079
J	van Tongeren, SP; Roest, HIJ; Degener, JE; Harmsen, HJM				van Tongeren, Sandra P.; Roest, Hendrik I. J.; Degener, John E.; Harmsen, Hermie J. M.			Bacillus anthracis-Like Bacteria and Other B. cereus Group Members in a Microbial Community Within the International Space Station: A Challenge for Rapid and Easy Molecular Detection of Virulent B. anthracis	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; IDENTIFICATION; SEQUENCE; STRAINS; GYRB	For some microbial species, such as Bacillus anthracis, the etiologic agent of the disease anthrax, correct detection and identification by molecular methods can be problematic. The detection of virulent B. anthracis is challenging due to multiple virulence markers that need to be present in order for B. anthracis to be virulent and its close relationship to Bacillus cereus and other members of the B. cereus group. This is especially the case in environments where build-up of Bacillus spores can occur and several representatives of the B. cereus group may be present, which increases the chance for false-positives. In this study we show the presence of B. anthracis-like bacteria and other members of the B. cereus group in a microbial community within the human environment of the International Space Station and their preliminary identification by using conventional culturing as well as molecular techniques including 16S rDNA sequencing, PCR and real-time PCR. Our study shows that when monitoring the microbial hygiene in a given human environment, health risk assessment is troublesome in the case of virulent B. anthracis, especially if this should be done with rapid, easy to apply and on-site molecular methods.	[van Tongeren, Sandra P.; Degener, John E.; Harmsen, Hermie J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Roest, Hendrik I. J.] Wageningen UR, Cent Vet Inst, Dept Bacteriol, Lelystad, Netherlands; [Roest, Hendrik I. J.] Wageningen UR, Cent Vet Inst, TSEs, Lelystad, Netherlands	University of Groningen; Wageningen University & Research; Wageningen University & Research	van Tongeren, SP (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.	s.p.van.tongeren@umcg.nl	van Tongeren, Sandra P./H-3080-2011	van Tongeren, Sandra P./0000-0001-7727-1165	European Space Agency [AO-LS-99-MAP-LSS-018]; SRON [MG-064/MG-068]	European Space Agency(European Space AgencyEuropean Commission); SRON	The project has been supported by the European Space Agency (MAP Project Number AO-LS-99-MAP-LSS-018 'Biofilms'; http://www.esa.int/ESA). The SAMPLE experiments were supported by SRON (MG-064/MG-068; http://www.sron.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antwerpen MH, 2008, MOL CELL PROBE, V22, P313, DOI 10.1016/j.mcp.2008.06.001; Apetroaie C, 2005, ARCH MICROBIOL, V184, P141, DOI 10.1007/s00203-005-0032-1; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Edwards KA, 2006, ANAL BIOANAL CHEM, V384, P73, DOI 10.1007/s00216-005-0090-x; Fasanella A, 2001, VACCINE, V19, P4214, DOI 10.1016/S0264-410X(01)00159-1; Garcia L.S., 2007, CLIN MICROBIOLOGY PR, V2nd; Hadjinicolaou AV, 2009, J MICROBIOL METH, V78, P45, DOI 10.1016/j.mimet.2009.04.005; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HIRAISHI A, 1992, LETT APPL MICROBIOL, V15, P210, DOI 10.1111/j.1472-765X.1992.tb00765.x; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Hoffmaster AR, 2002, EMERG INFECT DIS, V8, P1178, DOI 10.3201/eid0810.020393; Horneck G, 2010, MICROBIOL MOL BIOL R, V74, P121, DOI 10.1128/MMBR.00016-09; Hu XM, 2009, FEMS MICROBIOL ECOL, V70, P344, DOI 10.1111/j.1574-6941.2009.00771.x; Irenge LM, 2012, APPL MICROBIOL BIOT, V93, P1411, DOI 10.1007/s00253-011-3845-7; Klee SR, 2006, J BACTERIOL, V188, P5333, DOI 10.1128/JB.00303-06; Kuske CR, 2006, J FORENSIC SCI, V51, P548, DOI 10.1111/j.1556-4029.2006.00131.x; La Duc MT, 2004, J MICROBIOL METH, V56, P383, DOI 10.1016/j.mimet.2003.11.004; Leendertz FH, 2006, PLOS PATHOG, V2, P632, DOI 10.1371/journal.ppat.0020008; Logan NA., 2009, BERGEYS MANUAL SYSTE, P21; Logan NA, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P455; Merrill L, 2006, J FORENSIC SCI, V51, P559, DOI 10.1111/j.1556-4029.2006.00132.x; Novikova N, 2006, RES MICROBIOL, V157, P5, DOI 10.1016/j.resmic.2005.07.010; Okinaka R, 2006, PLOS PATHOG, V2, P1025, DOI 10.1371/journal.ppat.0020122; Okinaka RT, 1999, J BACTERIOL, V181, P6509, DOI 10.1128/JB.181.20.6509-6515.1999; Pierson D L, 2001, Gravit Space Biol Bull, V14, P1; Pilo P, 2011, INFECT GENET EVOL, V11, P1218, DOI 10.1016/j.meegid.2011.05.013; Rao SS, 2010, J MICROBIOL METH, V82, P1, DOI 10.1016/j.mimet.2010.04.005; Reva ON, 2001, INT J SYST EVOL MICR, V51, P1361, DOI 10.1099/00207713-51-4-1361; Sacchi CT, 2002, EMERG INFECT DIS, V8, P1117, DOI 10.3201/eid0810.020391; TURNBULL PCB, 1992, J APPL BACTERIOL, V72, P21; van Tongeren SP, 2007, MICROGRAVITY SCI TEC, V19, P45, DOI 10.1007/BF02911866; Yamada S, 1999, APPL ENVIRON MICROB, V65, P1483; Zengler K, 2008, ACCESSING UNCULTIVATED MICROORGANISMS: FROM THE ENVIRONMENT TO ORGANISMS AND GENOMES AND BACK, P1; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	36	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e98871	10.1371/journal.pone.0098871	http://dx.doi.org/10.1371/journal.pone.0098871			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945323	Green Published, gold, Green Submitted			2022-12-25	WOS:000340721500008
J	Barbour, A; Philip, K				Barbour, Abdelahhad; Philip, Koshy			Variable Characteristics of Bacteriocin-Producing Streptococcus salivarius Strains Isolated from Malaysian Subjects	PLOS ONE			English	Article							ZYMOMONAS-MOBILIS; ANTIMICROBIAL MECHANISM; GENOME SEQUENCE; MUTACIN 1140; LANTIBIOTICS; LEVAN; PLANTARICIN; NISIN; K12; POLYSACCHARIDE	Background: Salivaricins are bacteriocins produced by Streptococcus salivarius, some strains of which can have significant probiotic effects. S. salivarius strains were isolated from Malaysian subjects showing variable antimicrobial activity, metabolic profile, antibiotic susceptibility and lantibiotic production. Methodology/Principal Findings: In this study we report new S. salivarius strains isolated from Malaysian subjects with potential as probiotics. Safety assessment of these strains included their antibiotic susceptibility and metabolic profiles. Genome sequencing using Illumina's MiSeq system was performed for both strains NU10 and YU10 and demonstrating the absence of any known streptococcal virulence determinants indicating that these strains are safe for subsequent use as probiotics. Strain NU10 was found to harbour genes encoding salivaricins A and 9 while strain YU10 was shown to harbour genes encoding salivaricins A3, G32, streptin and slnA1 lantibiotic-like protein. Strain GT2 was shown to harbour genes encoding a large non-lantibiotic bacteriocin (salivaricin-MPS). A new medium for maximum biomass production buffered with 2-(N-morpholino) ethanesulfonic acid (MES) was developed and showed better biomass accumulation compared with other commercial media. Furthermore, we extracted and purified salivaricin 9 (by strain NU10) and salivaricin G32 (by strain YU10) from S. salivarius cells grown aerobically in this medium. In addition to bacteriocin production, S. salivarius strains produced levan-sucrase which was detected by a specific ESI-LC-MS/MS method which indicates additional health benefits from the developed strains. Conclusion: The current study established the bacteriocin, levan-sucrase production and basic safety features of S. salivarius strains isolated from healthy Malaysian subjects demonstrating their potential for use as probiotics. A new bacteriocin-production medium was developed with potential scale up application for pharmaceuticals and probiotics from S. salivarius generating different	[Barbour, Abdelahhad; Philip, Koshy] Univ Malaya, Fac Sci, Div Microbiol, Inst Biol Sci, Kuala Lumpur, Malaysia	Universiti Malaya	Philip, K (corresponding author), Univ Malaya, Fac Sci, Div Microbiol, Inst Biol Sci, Kuala Lumpur, Malaysia.	kphil@um.edu.my	Barbour, Abdelahhad/AAG-1953-2021; PHILIP, Koshy/B-8803-2010; Barbour, Abdelahhad/C-5168-2015	Barbour, Abdelahhad/0000-0003-0184-8890	High Impact Research - Malaysian Ministry of Higher Education grant [UM.C/625/1/HIR/MOHE/SC/08, F000008-21001]	High Impact Research - Malaysian Ministry of Higher Education grant	The authors wish to acknowledge the support by way of facilities from University of Malaya and the High Impact Research - Malaysian Ministry of Higher Education grant designated as UM.C/625/1/HIR/MOHE/SC/08 with account F000008-21001 under the Principal Investigator Koshy Philip for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abee T, 1995, INT J FOOD MICROBIOL, V28, P169, DOI 10.1016/0168-1605(95)00055-0; Al-Mahrous MM, 2011, EXPERT OPIN DRUG DIS, V6, P155, DOI 10.1517/17460441.2011.545387; Anderssen EL, 1998, APPL ENVIRON MICROB, V64, P2269; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barbour A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077751; Barretto C, 2012, J BACTERIOL, V194, P5959, DOI 10.1128/JB.01268-12; Belghith H, 1996, BIOTECHNOL LETT, V18, P467, DOI 10.1007/BF00143472; Birri DJ, 2012, APPL ENVIRON MICROB, V78, P402, DOI 10.1128/AEM.06588-11; Burton JP, 2006, APPL ENVIRON MICROB, V72, P3050, DOI 10.1128/AEM.72.4.3050-3053.2006; Calazans GMT, 1997, BIOTECHNOL LETT, V19, P19, DOI 10.1023/A:1018350617120; Chaney N, 2009, CAN J MICROBIOL, V55, P1261, DOI [10.1139/w09-091, 10.1139/W09-091]; Chattoraj P, 2010, J BACTERIOL, V192, P1312, DOI 10.1128/JB.01350-09; Chen SR, 2013, APPL ENVIRON MICROB, V79, P4015, DOI 10.1128/AEM.00704-13; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Dahech I, 2011, INT J BIOL MACROMOL, V49, P742, DOI 10.1016/j.ijbiomac.2011.07.007; de Paula VC, 2008, BIORESOURCE TECHNOL, V99, P2466, DOI 10.1016/j.biortech.2007.04.062; HAN YW, 1990, J AGR FOOD CHEM, V38, P393, DOI 10.1021/jf00092a011; Heng NCK, 2011, J BACTERIOL, V193, P6402, DOI 10.1128/JB.06001-11; Holo H, 2001, MICROBIOL-SGM, V147, P643, DOI 10.1099/00221287-147-3-643; Hyink O, 2007, APPL ENVIRON MICROB, V73, P1107, DOI 10.1128/AEM.02265-06; Islam MR, 2012, BIOCHEM SOC T, V40, P1528, DOI 10.1042/BST20120190; JACK RW, 1995, MICROBIOL REV, V59, P171, DOI 10.1128/MMBR.59.2.171-200.1995; Jang KH, 2001, BIOTECHNOL LETT, V23, P339, DOI 10.1023/A:1005641220946; Joo NE, 2012, CANCER MED-US, V1, P295, DOI 10.1002/cam4.35; Karam L, 2013, J PEPT SCI, V19, P377, DOI 10.1002/psc.2512; Kleerebezem M, 2004, PEPTIDES, V25, P1405, DOI 10.1016/j.peptides.2003.10.021; Kristiansen PE, 2005, J BIOL CHEM, V280, P22945, DOI 10.1074/jbc.M501620200; LEIBOVICI J, 1985, CELL MOL BIOL, V31, P337; Lv WH, 2004, BIOTECHNOL LETT, V26, P235, DOI 10.1023/B:BILE.0000013721.78288.1d; Mantovani HC, 2002, MICROBIOL-SGM, V148, P3347, DOI 10.1099/00221287-148-11-3347; Nguyen T, 2009, MICROBIOL-SGM, V155, P551, DOI 10.1099/mic.0.021303-0; RATHSAM C, 1993, J BACTERIOL, V175, P4520, DOI 10.1128/JB.175.14.4520-4527.1993; ROSS KF, 1993, APPL ENVIRON MICROB, V59, P2014, DOI 10.1128/AEM.59.7.2014-2021.1993; Smith L, 2008, BIOCHEMISTRY-US, V47, P3308, DOI 10.1021/bi701262z; Smith L, 2008, CURR OPIN MICROBIOL, V11, P401, DOI 10.1016/j.mib.2008.09.008; Somkuti GA, 2007, CURR MICROBIOL, V55, P173, DOI 10.1007/s00284-007-0179-x; Tabor AB, 2011, ORG BIOMOL CHEM, V9, P7606, DOI 10.1039/c1ob05946g; TAGG JR, 1979, J MED MICROBIOL, V12, P397, DOI 10.1099/00222615-12-4-397; TAGG JR, 1984, J HYG-CAMBRIDGE, V93, P339, DOI 10.1017/S0022172400064883; Tahara T, 1997, FEMS MICROBIOL LETT, V147, P287, DOI 10.1016/S0378-1097(97)00002-5; TRAMER J, 1966, CHEM IND-LONDON, P446; vanDeVen FJM, 1996, ANTON LEEUW INT J G, V69, P99, DOI 10.1007/BF00399415; Wang Y, 2010, THESIS U OTAGO DUNED; Wescombe PA, 2011, MICROBIOL-SGM, V157, P1290, DOI 10.1099/mic.0.044719-0; Wescombe PA, 2006, APPL ENVIRON MICROB, V72, P1459, DOI 10.1128/AEM.72.2.1459-1466.2006; Wescombe PA, 2006, ANTON LEEUW INT J G, V90, P269, DOI 10.1007/s10482-006-9081-y; Wescombe Philip A, 2012, Int J Microbiol, V2012, P738503, DOI 10.1155/2012/738503; Wilson-Stanford Shawanda, 2011, Recent Pat Antiinfect Drug Discov, V6, P175	48	26	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100541	10.1371/journal.pone.0100541	http://dx.doi.org/10.1371/journal.pone.0100541			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941127	Green Published, gold			2022-12-25	WOS:000338508200105
J	Liang, Y; Tang, WZ; Huang, TQ; Gao, Y; Tan, AH; Yang, XB; Zhang, HY; Hu, YL; Qin, X; Li, S; Zhang, SJ; Mo, LJ; Liang, ZJ; Shi, DY; Huang, Z; Guan, YY; Zhou, JC; Winkler, C; O'Brien, SJ; Xu, JF; Mo, ZN; Peng, T				Liang, Yu; Tang, Weizhong; Huang, Tiqiang; Gao, Yong; Tan, Aihua; Yang, Xiaobo; Zhang, Haiying; Hu, Yanling; Qin, Xue; Li, Shan; Zhang, Shijun; Mo, Linjian; Liang, Zhenjia; Shi, Deyi; Huang, Zhang; Guan, Yingyong; Zhou, Jicheng; Winkler, Cheryl; O'Brien, Stephen J.; Xu, Jianfeng; Mo, Zengnan; Peng, Tao			Genetic Variations Affecting Serum Carcinoembryonic Antigen Levels and Status of Regional Lymph Nodes in Patients with Sporadic Colorectal Cancer from Southern China	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; III COLON-CANCER; BODY-MASS INDEX; BLOOD-GROUP; ADJUVANT CHEMOTHERAPY; PANCREATIC-CANCER; TUMOR-MARKERS; CEA LEVELS; CIGARETTE-SMOKING; FREE SURVIVAL	Background: Serum carcinoembryonic antigen (sCEA) level might be an indicator of disease. Indeed, an elevated sCEA level is a prognostic factor in colorectal cancer (CRC) patients. However, the genetic determinants of sCEA level in healthy and CRC population remains unclear. Thus we investigated the genetic markers associated with elevated serum sCEA level in these two populations and its clinical implications. Methods and Findings: Genome-wide association study (GWAS) was conducted in a cohort study with 4,346 healthy male adults using the Illumina Omni 1 M chip. Candidate SNPs associated with elevated sCEA levels were validated in 194 CRC patients on ABI Taqman platform. Eight candidate SNPs were validated in CRC patients. The rs1047781 (chr19-FUT2) (A/T) was associated with elevated sCEA levels, and rs8176746 (chr9-ABO) was associated with the regional lymph metastasis in the CRC patients. The preoperative sCEA level was a risk factor for tumor recurrence in 5 years after operation (OR = 1.427, 95% CI: 1.005& 1.843, P = 0.006). It was also one of the risk factors for regional lymph node metastasis (OR = 2.266, 95% CI: 1.196& 4.293, P = 0.012). The sCEA level in rs1047781-T carriers was higher than that in the A carriers in CRC patients without lymph node metastasis (P = 0.006). The regional lymph node metastasis in patients with homozygote AA of rs8176746 was more common than that in the heterozygote AG carriers (P = 0.022). In addition, rs1047781-AT and TT CRC patients exhibited a worse disease-free survival than AA genotype carriers (P = 0.023). Conclusions: We found candidate SNPs associated with elevated sCEA levels in both healthy males and CRC population. Rs1047781 (chr19-FUT2) may be the susceptible locus for recurrence of CRC in a population from Southern China.	[Liang, Yu; Peng, Tao] Guangxi Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Nanning, Guangxi, Peoples R China; [Tang, Weizhong; Huang, Tiqiang] Guangxi Med Univ, Affiliated Hosp 1, Dept Anal & Colorectal Surg, Nanning, Guangxi, Peoples R China; [Huang, Tiqiang; Gao, Yong; Zhang, Shijun; Mo, Linjian; Xu, Jianfeng; Mo, Zengnan] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi, Peoples R China; [Yang, Xiaobo; Zhang, Haiying] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi, Peoples R China; [Hu, Yanling] Guangxi Med Univ, Med Sci Res Ctr, Nanning, Guangxi, Peoples R China; [Qin, Xue; Li, Shan] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China; [Mo, Linjian; Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi, Peoples R China; [Liang, Zhenjia; Shi, Deyi] Fangchenggang First Peoples Hosp, Med Examinat Ctr, Fangchenggang, Guangxi, Peoples R China; [Huang, Zhang] Guigang First Peoples Hosp, Med Examinat Ctr, Guigang, Guangxi, Peoples R China; [Guan, Yingyong] Yulin First Peoples Hosp, Med Examinat Ctr, Yulin, Guangxi, Peoples R China; [Zhou, Jicheng] Guangxi Med Univ, Affiliated Hosp 1, Dept Hematol, Nanning, Guangxi, Peoples R China; [Winkler, Cheryl] NCI, Mol Genet Epidemiol Sec, Frederick Nat Lab Canc Res, NIH, Frederick, MD USA; [O'Brien, Stephen J.; Peng, Tao] NCI, Lab Genom Divers, NIH, Frederick, MD USA; [O'Brien, Stephen J.] St Petersburg State Univ, Theodosius Dobzhansky Ctr Genome Bioinformat, St Petersburg 199034, Russia; [O'Brien, Stephen J.] Nova SE Univ, Oceanog Ctr, Ft Lauderdale, FL 33314 USA; [Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC USA	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Saint Petersburg State University; Nova Southeastern University; Wake Forest University; Wake Forest Baptist Medical Center	Mo, ZN (corresponding author), Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi, Peoples R China.	zengnanmo@hotmail.com; pengtaocn@hotmail.com	Yang, Xiaobo/G-3854-2016; OBRIEN, STEPHEN/ABD-1346-2020	mo, zengnan/0000-0002-3047-3138; O'Brien, Stephen J./0000-0001-7353-8301; OBRIEN, STEPHEN/0000-0001-7857-0757	General Program of National Natural Science Foundation of China [30945204, 81072321, 81272853, 81360378, 81360099, 81370857, 30760243, 30460143, 30560133]; Ministry of Education, China; Key Program and University Talents Highland Innovation Team of Guangxi [2012012D003, GJR201147-09]; Chairman Science and Technology Fund and Tackle Program of Guangxi [1116-03, GKG1298003-07-01]; Guangxi Natural Science Foundation [2011 GXNSFB018100, 2012GXNSFAA053152, 2013GXNSFFA 019002]; Guangxi Nature Sciences Grant [GuiKeGong 1104003A-7]; Guangxi Provincial Department of Finance and Education [2009GJCJ150]; Guangxi Health Ministry Medicine Grant [Z201018]; Russian Ministry of Science Mega-grant [11.G34.31.0068]; NATIONAL CANCER INSTITUTE [ZIABC010297] Funding Source: NIH RePORTER	General Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education, China(Ministry of Education, China); Key Program and University Talents Highland Innovation Team of Guangxi; Chairman Science and Technology Fund and Tackle Program of Guangxi; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Guangxi Nature Sciences Grant; Guangxi Provincial Department of Finance and Education; Guangxi Health Ministry Medicine Grant; Russian Ministry of Science Mega-grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the General Program of National Natural Science Foundation of China (30945204, 81072321, 81272853, 81360378, 81360099, 81370857, 30760243, 30460143 and 30560133), Ministry of Education, China (Program for New Century Excellent Talents in University, NCET2009), Key Program and University Talents Highland Innovation Team of Guangxi (2012012D003, GJR201147-09), Chairman Science and Technology Fund and Tackle Program of Guangxi (1116-03, GKG1298003-07-01), Guangxi Natural Science Foundation (2011 GXNSFB018100, 2012GXNSFAA053152, 2013GXNSFFA 019002), Guangxi Nature Sciences Grant (GuiKeGong 1104003A-7), the Guangxi Provincial Department of Finance and Education (2009GJCJ150) and Guangxi Health Ministry Medicine Grant (Z201018). This research was supported in part by Russian Ministry of Science Mega-grant no. 11.G34.31.0068; SJ O'Brien Principal Investigator, No funding body had any influence or input into the study design, data collection, analysis, data interpretation, or writing of the report.	ALEXANDER JC, 1976, JAMA-J AM MED ASSOC, V235, P1975; Amemori Sadahiro, 2007, Am J Physiol Gastrointest Liver Physiol, V292, pG923; BEASLEY RP, 1981, LANCET, V2, P1129; BEAUDONNET A, 1981, CLIN CHEM, V27, P771; BENTZEN SM, 1990, EUR J CANCER, V26, P457, DOI 10.1016/0277-5379(90)90016-M; Biagi JJ, 2011, JAMA-J AM MED ASSOC, V305, P2335, DOI 10.1001/jama.2011.749; BOOTH SN, 1973, GUT, V14, P794, DOI 10.1136/gut.14.10.794; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chao A, 2000, JNCI-J NATL CANCER I, V92, P1888, DOI 10.1093/jnci/92.23.1888; Dai JY, 2012, CARCINOGENESIS, V33, P1327, DOI 10.1093/carcin/bgs147; Demetriades H, 2004, Tech Coloproctol, V8 Suppl 1, ps144, DOI 10.1007/s10151-004-0138-5; Edgren G, 2010, AM J EPIDEMIOL, V172, P1280, DOI 10.1093/aje/kwq299; Fietkau R, 2004, STRAHLENTHER ONKOL, V180, P478, DOI 10.1007/s00066-004-1260-z; FLETCHER RH, 1986, ANN INTERN MED, V104, P66, DOI 10.7326/0003-4819-104-1-66; Gangopadhyay A, 1996, CANCER RES, V56, P4805; Garrote LF, 2001, BRIT J CANCER, V85, P46, DOI 10.1054/bjoc.2000.1825; Gobbi PG, 2008, BRIT J CANCER, V98, P328, DOI 10.1038/sj.bjc.6604114; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; Gutierrez DA, 2009, CURR DIABETES REP, V9, P26, DOI 10.1007/s11892-009-0006-9; HAINES AP, 1979, LANCET, V2, P969; He MA, 2014, GUT, V63, P143, DOI 10.1136/gutjnl-2012-303434; HERBETH B, 1980, ONCODEV BIOL MED, V1, P191; Hoffmann D, 1997, J TOXICOL ENV HEALTH, V50, P307, DOI 10.1080/009841097160393; HOLBURN AM, 1974, IMMUNOLOGY, V26, P831; Hong Seung Goun, 2010, Korean J Hepatol, V16, P49, DOI 10.3350/kjhep.2010.16.1.49; Huang Fang, 2008, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V24, P370; Ilantzis C, 1997, LAB INVEST, V76, P703; Ilantzis C, 2002, NEOPLASIA, V4, P151, DOI 10.1038/sj.neo.7900201; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kim CJ, 2007, PATHOL INT, V57, P178, DOI 10.1111/j.1440-1827.2007.02078.x; KIM J, 1992, INT J CANCER, V52, P718, DOI 10.1002/ijc.2910520509; Kim YJ, 2012, CLIN CHIM ACTA, V413, P511, DOI 10.1016/j.cca.2011.11.019; Kudo T, 1996, J BIOL CHEM, V271, P9830, DOI 10.1074/jbc.271.16.9830; Kuebler JP, 2007, J CLIN ONCOL, V25, P2198, DOI 10.1200/JCO.2006.08.2974; Kurokawa H, 1997, J ORAL MAXIL SURG, V55, P964, DOI 10.1016/S0278-2391(97)90071-9; Lee SY, 2011, J KOREAN SURG SOC, V81, P387, DOI 10.4174/jkss.2011.81.6.387; Li Y, 2010, CANCER RES, V70, P8159, DOI 10.1158/0008-5472.CAN-10-1073; Lin XL, 2012, HUM MOL GENET, V21, P2610, DOI 10.1093/hmg/dds062; LOEWENSTEIN MS, 1978, CANCER, V42, P1412, DOI 10.1002/1097-0142(197809)42:3+<1412::AID-CNCR2820420805>3.0.CO;2-8; Maestranzi S, 1998, ANN CLIN BIOCHEM, V35, P99, DOI 10.1177/000456329803500113; MAGOUS R, 1980, MOL IMMUNOL, V17, P1039, DOI 10.1016/0161-5890(80)90098-X; Ni XG, 2005, EJSO-EUR J SURG ONC, V31, P164, DOI 10.1016/j.ejso.2004.09.007; OLSEN GW, 1989, AM J PUBLIC HEALTH, V79, P1016, DOI 10.2105/AJPH.79.8.1016; Coelho MSPH, 2009, ARQ BRAS ENDOCRINOL, V53, P1146, DOI 10.1590/S0004-27302009000900012; Pare G, 2008, PLOS GENET, V4; Park JS, 2010, CANCER EPIDEM BIOMAR, V19, P2461, DOI 10.1158/1055-9965.EPI-10-0569; PFOHLLESZKOWICZ A, 1995, CANCER RES, V55, P5611; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; PRADO IB, 1995, INT J CANCER, V61, P854, DOI 10.1002/ijc.2910610618; Qin X, 2011, INT J BIOL MARKER, V26, P65, DOI 10.5301/JBM.2011.6364; Risch HA, 2012, MOL CARCINOGEN, V51, P109, DOI 10.1002/mc.20826; Sakuma K, 2012, P NATL ACAD SCI USA, V109, P7776, DOI 10.1073/pnas.1111135109; Salgia R, 2001, ANTICANCER RES, V21, P1241; Saltz LB, 2007, J CLIN ONCOL, V25, P3456, DOI 10.1200/JCO.2007.11.2144; Salvini R, 2001, J BIOL CHEM, V276, P3564, DOI 10.1074/jbc.M006662200; Sargent DJ, 2005, J CLIN ONCOL, V23, P8664, DOI 10.1200/JCO.2005.01.6071; Soreide K, 2011, WORLD J SURG, V35, P888, DOI 10.1007/s00268-011-0979-9; Staib L, 2002, WORLD J SURG, V26, P59; TOUITOU Y, 1984, EUR J CANCER CLIN ON, V20, P369, DOI 10.1016/0277-5379(84)90083-X; Vrieling A, 2010, AM J CLIN NUTR, V92, P471, DOI [10.3945/ajcn.2010.29005, 10.3945/ajcn.2009.29005]; Wichmann MW, 2001, BRIT J SURG, V88, P1092, DOI 10.1046/j.0007-1323.2001.01819.x; Yang L, 2004, BRIT J CANCER, V90, P2157, DOI 10.1038/sj.bjc.6601813; Yang XQ, 2011, ASIAN PAC J CANCER P, V12, P1251; ZENG ZS, 1993, DIS COLON RECTUM, V36, P1063, DOI 10.1007/BF02047301; Zimmer R, 2001, CANCER RES, V61, P2822	66	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e97923	10.1371/journal.pone.0097923	http://dx.doi.org/10.1371/journal.pone.0097923			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941225	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200007
J	Maixner, F; Thomma, A; Cipollini, G; Widder, S; Rattei, T; Zink, A				Maixner, Frank; Thomma, Anton; Cipollini, Giovanna; Widder, Stefanie; Rattei, Thomas; Zink, Albert			Metagenomic Analysis Reveals Presence of Treponema denticola in a Tissue Biopsy of the Iceman	PLOS ONE			English	Article							DNA-POLYMERASES; BACTERIAL-DNA; GENOME; SEQUENCE; ANCIENT; PERIODONTITIS; INSIGHTS; HISTORY; MUMMIES; HEALTH	Ancient hominoid genome studies can be regarded by definition as metagenomic analyses since they represent a mixture of both hominoid and microbial sequences in an environment. Here, we report the molecular detection of the oral spirochete Treponema denticola in ancient human tissue biopsies of the Iceman, a 5,300-year-old Copper Age natural ice mummy. Initially, the metagenomic data of the Iceman's genomic survey was screened for bacterial ribosomal RNA ( rRNA) specific reads. Through ranking the reads by abundance a relatively high number of rRNA reads most similar to T. denticola was detected. Mapping of the metagenome sequences against the T. denticola genome revealed additional reads most similar to this opportunistic pathogen. The DNA damage pattern of specifically mapped reads suggests an ancient origin of these sequences. The haematogenous spread of bacteria of the oral microbiome often reported in the recent literature could already explain the presence of metagenomic reads specific for T. denticola in the Iceman's bone biopsy. We extended, however, our survey to an Iceman gingival tissue sample and a mouth swab sample and could thereby detect T. denticola and Porphyrimonas gingivalis, another important member of the human commensal oral microflora. Taken together, this study clearly underlines the opportunity to detect disease-associated microorganisms when applying metagenomics-enabled approaches on datasets of ancient human remains.	[Maixner, Frank; Cipollini, Giovanna] EURAC Res, Inst Mummies & Iceman, Bolzano, Italy; [Thomma, Anton; Widder, Stefanie; Rattei, Thomas; Zink, Albert] Univ Vienna, Dept Microbiol & Ecosyst Sci, CUBE Div Computat Syst Biol, Vienna, Austria	European Academy of Bozen-Bolzano; University of Vienna	Maixner, F (corresponding author), EURAC Res, Inst Mummies & Iceman, Bolzano, Italy.	frank.maixner@eurac.edu	Zink, Albert/P-4024-2015; Maixner, Frank/AAY-7033-2020; Rattei, Thomas/F-1366-2011; Widder, Stefanie/B-9584-2014	Zink, Albert/0000-0002-1461-747X; Rattei, Thomas/0000-0002-0592-7791; Widder, Stefanie/0000-0003-0733-5666; Maixner, Frank/0000-0003-2846-8994	Sudtiroler Sparkasse; South Tyrolean [legge 14]	Sudtiroler Sparkasse; South Tyrolean	The work was supported in part by the Sudtiroler Sparkasse and the South Tyrolean grant legge 14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CJ, 2013, NAT GENET, V45, P450, DOI 10.1038/ng.2536; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ames SK, 2013, BIOINFORMATICS, V29, P2253, DOI 10.1093/bioinformatics/btt389; [Anonymous], 2006, PROKARYOTES, DOI DOI 10.1007/0-387-30747-8_8; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Cano RJ, 2000, AM J PHYS ANTHROPOL, V112, P297; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Cavrini F, 2005, J MED MICROBIOL, V54, P93, DOI 10.1099/jmm.0.45845-0; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; DALDRUP T, 1984, Z RECHTSMED, V92, P121, DOI 10.1007/BF02116221; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Fogg MJ, 2002, NAT STRUCT BIOL, V9, P922, DOI 10.1038/nsb867; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; Grad YH, 2012, P NATL ACAD SCI USA, V109, P3065, DOI 10.1073/pnas.1121491109; Greagg MA, 1999, P NATL ACAD SCI USA, V96, P9045, DOI 10.1073/pnas.96.16.9045; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Green RE, 2009, EMBO J, V28, P2494, DOI 10.1038/emboj.2009.222; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hormozdiari F, 2011, BIOINFORMATICS, V27, P1915, DOI 10.1093/bioinformatics/btr303; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Inaba H, 2010, J PHARMACOL SCI, V113, P103, DOI 10.1254/jphs.09R23FM; International Barley Genome Sequencing Consortium, 2012, Nature, V491, P711, DOI 10.1038/nature11543; Jaenisch Stefanie, 2010, Archiv fuer Kriminologie, V225, P99; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Khairat R, 2013, J APPL GENET, V54, P309, DOI 10.1007/s13353-013-0145-1; Kirsanow K, 2012, ANN ANAT, V194, P121, DOI 10.1016/j.aanat.2011.11.002; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martinez-Pabon MC, 2008, CLIN ORAL INVEST, V12, P73, DOI 10.1007/s00784-007-0147-7; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Murphy WA, 2003, RADIOLOGY, V226, P614, DOI 10.1148/radiol.2263020338; Ohki T, 2012, AM HEART J, V163, P164, DOI 10.1016/j.ahj.2011.10.012; Okuda K, 2001, J CLIN MICROBIOL, V39, P1114, DOI 10.1128/JCM.39.3.1114-1117.2001; Pedersen JS, 2014, GENOME RES, V24, P454, DOI 10.1101/gr.163592.113; Pinar G, 2013, FEMS MICROBIOL ECOL, V86, P341, DOI 10.1111/1574-6941.12165; Prufer K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r47; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Rollo F, 2000, AM J PHYS ANTHROPOL, V111, P211, DOI 10.1002/(SICI)1096-8644(200002)111:2<211::AID-AJPA7>3.0.CO;2-M; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Santamaria M, 2012, BRIEF BIOINFORM, V13, P682, DOI 10.1093/bib/bbs036; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Schuenemann VJ, 2013, SCIENCE, V341, P179, DOI 10.1126/science.1238286; Seiler R, 2013, EUR J ORAL SCI, V121, P137, DOI 10.1111/eos.12037; Stoneking M, 2011, NAT REV GENET, V12, P603, DOI 10.1038/nrg3029; Tang JN, 2008, J MICROBIOL METH, V75, P432, DOI 10.1016/j.mimet.2008.07.014; Wang Y, 2004, NUCLEIC ACIDS RES, V32, P1197, DOI 10.1093/nar/gkh271; Warinner C, 2014, NAT GENET, V46, P336, DOI 10.1038/ng.2906; Wheeler DL, 2000, NUCLEIC ACIDS RES, V28, P10, DOI 10.1093/nar/28.1.10; Yu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038183; Zaremba-Niedzwiedzka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062799	61	18	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99994	10.1371/journal.pone.0099994	http://dx.doi.org/10.1371/journal.pone.0099994			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941044	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200062
J	Perez-Lachaud, G; Lachaud, JP				Perez-Lachaud, Gabriela; Lachaud, Jean-Paul			Arboreal Ant Colonies as 'Hot-Points' of Cryptic Diversity for Myrmecophiles: The Weaver Ant Camponotus sp aff. textor and Its Interaction Network with Its Associates	PLOS ONE			English	Article							HYMENOPTERA CHALCIDOIDEA; ECTATOMMA-TUBERCULATUM; BIODIVERSITY LOSS; 1ST RECORD; FORMICIDAE; INSECT; CONSERVATION; PARASITISM; STREPSIPTERA; EUCHARITIDAE	Introduction: Systematic surveys of macrofaunal diversity within ant colonies are lacking, particularly for ants nesting in microhabitats that are difficult to sample. Species associated with ants are generally small and rarely collected organisms, which makes them more likely to be unnoticed. We assumed that this tendency is greater for arthropod communities in microhabitats with low accessibility, such as those found in the nests of arboreal ants that may constitute a source of cryptic biodiversity. Materials and Methods: We investigated the invertebrate diversity associated with an undescribed, but already threatened, Neotropical Camponotus weaver ant. As most of the common sampling methods used in studies of ant diversity are not suited for evaluating myrmecophile diversity within ant nests, we evaluated the macrofauna within ant nests through exhaustive colony sampling of three nests and examination of more than 80,000 individuals. Results: We identified invertebrates from three classes belonging to 18 taxa, some of which were new to science, and recorded the first instance of the co-occurrence of two brood parasitoid wasp families attacking the same ant host colony. This diversity of ant associates corresponded to a highly complex interaction network. Agonistic interactions prevailed, but the prevalence of myrmecophiles was remarkably low. Conclusions: Our data support the hypothesis of the evolution of low virulence in a variety of symbionts associated with large insect societies. Because most myrmecophiles found in this work are rare, strictly specific, and exhibit highly specialized biology, the risk of extinction for these hitherto unknown invertebrates and their natural enemies is high. The cryptic, far unappreciated diversity within arboreal ant nests in areas at high risk of habitat loss qualifies these nests as 'hotpoints' of biodiversity that urgently require special attention as a component of conservation and management programs.	[Perez-Lachaud, Gabriela; Lachaud, Jean-Paul] El Colegio Frontera Sur, Dept Conservac Biodiversidad, Chetmal, Quintana Roo, Mexico; [Lachaud, Jean-Paul] Univ Toulouse UPS, Ctr Rech Cognit Anim, CNRS UMR 5169, Toulouse, France	El Colegio de la Frontera Sur (ECOSUR); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE)	Lachaud, JP (corresponding author), El Colegio Frontera Sur, Dept Conservac Biodiversidad, Chetmal, Quintana Roo, Mexico.	jean-paul.lachaud@univ-tlse3.fr	LACHAUD, Jean-Paul/ABG-3831-2021; Lachaud, Jean-Paul/H-4266-2019	LACHAUD, Jean-Paul/0000-0002-5082-8987; Perez-Lachaud, Gabriela/0000-0002-8924-1606	El Colegio de la Frontera Sur; Centre de Recherches sur la Cognition Animale UMR5169 (Centre National de la Recherche Scientique - Universite de Toulouse)	El Colegio de la Frontera Sur; Centre de Recherches sur la Cognition Animale UMR5169 (Centre National de la Recherche Scientique - Universite de Toulouse)	This study was supported financially by El Colegio de la Frontera Sur and by Centre de Recherches sur la Cognition Animale UMR5169 (Centre National de la Recherche Scientique - Universite de Toulouse). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti D., 2000, BIOL DIVERSITY HDB S; Allan RA, 2001, AUST J ZOOL, V49, P129, DOI 10.1071/ZO00088; Chase JM, 2013, ECOL LETT, V16, P17, DOI 10.1111/ele.12112; Crozier RH, 2010, MYRMECOL NEWS, V13, P57; Darling DC, 2009, ZOOKEYS, P155, DOI 10.3897/zookeys.20.195; DAVIS LR, 1990, FLA ENTOMOL, V73, P335, DOI 10.2307/3494820; DOROW WHO, 1990, INSECT SOC, V37, P73, DOI 10.1007/BF02223815; DUMPERT K, 1988, Zoologische Beitraege, V32, P217; GASTON KJ, 1991, CONSERV BIOL, V5, P283, DOI 10.1111/j.1523-1739.1991.tb00140.x; Gates MW, 2012, P ENTOMOL SOC WASH, V114, P111, DOI 10.4289/0013-8797.114.1.111; Guenard B, 2012, P NATL ACAD SCI USA, V109, P7368, DOI 10.1073/pnas.1113867109; Hansson C, 2011, ZOOKEYS, P65, DOI 10.3897/zookeys.134.1653; Holldobler B., 1990, pi; Hughes DP, 2008, TRENDS ECOL EVOL, V23, P672, DOI 10.1016/j.tree.2008.07.011; Hughes DP, 2003, INSECT SOC, V50, P148, DOI 10.1007/s00040-003-0637-9; Hughes DP, 2003, INSECT SOC, V50, P62, DOI 10.1007/s000400300010; IUCN, 2013, ICUN RED LIST THREAT; Jenkins CN, 2013, DIVERS DISTRIB, V19, P1084, DOI 10.1111/ddi.12090; Karp DS, 2012, ECOL LETT, V15, P963, DOI 10.1111/j.1461-0248.2012.01815.x; Kathirithamby J, 2002, ANN ENTOMOL SOC AM, V95, P558, DOI 10.1603/0013-8746(2002)095[0558:CFSMPI]2.0.CO;2; Kathirithamby J, 2009, ANNU REV ENTOMOL, V54, P227, DOI 10.1146/annurev.ento.54.110807.090525; Kistner D. H., 1982, Social insects. Vol. III, P1; Kondo T, 2004, NEOTROP ENTOMOL, V33, P717, DOI 10.1590/S1519-566X2004000600009; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Lachaud J. P., 2012, Psyche: A Journal of Entomology, V2012, P342157; Lachaud J-P, 2013, PSYCHE; Lachaud Jean-Paul, 2012, Psyche (Cambridge), V2012; Liefke C, 1998, INSECT SOC, V45, P411, DOI 10.1007/s000400050098; Maeyama T, 1999, AUST J ENTOMOL, V38, P305, DOI 10.1046/j.1440-6055.1999.00130.x; MATHEW A. P., 1954, JOUR BOMBAY NAT HIST SOC, V52, P249; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127; Morrison H., 1922, Psyche Boston Mass, V29, P132, DOI 10.1155/1922/21654; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; MYNHARDT G, 2013, PSYCHE-J ENTOMOL, V2013, pNIL1, DOI DOI 10.1155/2013/696401; Offenberg J, 2006, BIOTROPICA, V38, P782, DOI 10.1111/j.1744-7429.2006.00206.x; Perez-Lachaud G., 2013, Psyche: A Journal of Entomology, V2013, P230601, DOI 10.1155/2013/230601; Perez-Lachaud G, 2006, BIOTROPICA, V38, P574, DOI 10.1111/j.1744-7429.2006.00169.x; Perez-Lachaud G, 2014, BIOL J LINN SOC, V111, P462, DOI 10.1111/bij.12220; Perez-Lachaud G, 2012, FLA ENTOMOL, V95, P1066, DOI 10.1653/024.095.0436; Perez-Lachaud G, 2011, FLA ENTOMOL, V94, P677, DOI 10.1653/024.094.0333; Perfecto I, 2002, CONSERV BIOL, V16, P174, DOI 10.1046/j.1523-1739.2002.99536.x; Philpott SM, 2005, AGROFOREST SYST, V64, P219, DOI 10.1007/s10457-004-2372-2; Philpott SM, 2008, CONSERV BIOL, V22, P1093, DOI 10.1111/j.1523-1739.2008.01029.x; Poinar G, 2006, J INVERTEBR PATHOL, V91, P19, DOI 10.1016/j.jip.2005.10.003; Poinar George Jr, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/192017; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Reemer M., 2013, PSYCHE-CAMBRIDGE, V2013, P1, DOI DOI 10.1155/2013/538316; Rettenmeyer CW, 2011, INSECT SOC, V58, P281, DOI 10.1007/s00040-010-0128-8; Rougerie R, 2011, MOL ECOL, V20, P179, DOI 10.1111/j.1365-294X.2010.04918.x; Settele J, 2009, SCIENCE, V325, P41, DOI 10.1126/science.1176892; Stork NE, 2008, INSECT CONSERV DIVER, V1, P114, DOI 10.1111/j.1752-4598.2008.00016.x; Thomas JA, 2009, SCIENCE, V325, P80, DOI 10.1126/science.1175726; Wanless F.R., 1978, Bulletin of the British Museum (Natural History) Zoology, V33, P1; WAY MJ, 1954, B ENTOMOL RES, V45, P113, DOI 10.1017/S0007485300026833; Wheeler G. C., 1924, Psyche Boston, V31, P49, DOI 10.1155/1924/93136; WHEELER WILLIAM MORTON, 1929, PSYCHE, V36, P102, DOI 10.1155/1929/64398; WHEELER WILLIAM MORTON, 1933, PSYCHE, V40, P20, DOI 10.1155/1933/36308	58	16	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100155	10.1371/journal.pone.0100155	http://dx.doi.org/10.1371/journal.pone.0100155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941047	Green Published, gold, Green Submitted			2022-12-25	WOS:000338508200076
J	Brancucci, NMB; Witmer, K; Schmid, C; Voss, TS				Brancucci, Nicolas M. B.; Witmer, Kathrin; Schmid, Christoph; Voss, Till S.			A var Gene Upstream Element Controls Protein Synthesis at the Level of Translation Initiation in Plasmodium falciparum	PLOS ONE			English	Article							REDUCTASE MESSENGER-RNA; ERYTHROCYTE-MEMBRANE PROTEIN-1; MUTUALLY EXCLUSIVE EXPRESSION; PREGNANCY-ASSOCIATED MALARIA; 5' UNTRANSLATED REGION; ANTIGENIC VARIATION; VIRULENCE GENES; DIHYDROFOLATE-REDUCTASE; INFECTED ERYTHROCYTES; CHONDROITIN SULFATE	Clonally variant protein expression in the malaria parasite Plasmodium falciparum generates phenotypic variability and allows isogenic populations to adapt to environmental changes encountered during blood stage infection. The underlying regulatory mechanisms are best studied for the major virulence factor P. falciparum erythrocyte membrane protein 1 (PfEMP1). PfEMP1 is encoded by the multicopy var gene family and only a single variant is expressed in individual parasites, a concept known as mutual exclusion or singular gene choice. var gene activation occurs in situ and is achieved through the escape of one locus from epigenetic silencing. Singular gene choice is controlled at the level of transcription initiation and var 5' upstream (ups) sequences harbour regulatory information essential for mutually exclusive transcription as well as for the trans-generational inheritance of the var activity profile. An additional level of control has recently been identified for the var2csa gene, where an mRNA element in the 5' untranslated region (5' UTR) is involved in the reversible inhibition of translation of var2csa transcripts. Here, we extend the knowledge on post-transcriptional var gene regulation to the common upsC type. We identified a 5' UTR sequence that inhibits translation of upsC-derived mRNAs. Importantly, this 5' UTR element efficiently inhibits translation even in the context of a heterologous upstream region. Further, we found var 5' UTRs to be significantly enriched in uAUGs which are known to impair the efficiency of protein translation in other eukaryotes. Our findings suggest that regulation at the post-transcriptional level is a common feature in the control of PfEMP1 expression in P. falciparum.	[Brancucci, Nicolas M. B.; Witmer, Kathrin; Schmid, Christoph; Voss, Till S.] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Brancucci, Nicolas M. B.; Witmer, Kathrin; Schmid, Christoph; Voss, Till S.] Univ Basel, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Voss, TS (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland.	till.voss@unibas.ch		Brancucci, Nicolas/0000-0003-0655-3266; Witmer, Kathrin/0000-0002-3159-7386	Swiss National Science Foundation [PP00P3_130203]; Boehringer Ingelheim Fonds	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	This work was supported by the Swiss National Science Foundation (PP00P3_130203; www.snf.ch). N.M.B.B. received a PhD scholarshio from the Boehringer Ingelheim Fonds (www.bifonds.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amulic B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000256; Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Bancells C, 2013, MOL MICROBIOL, V90, P472, DOI 10.1111/mmi.12379; Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Braks JAM, 2008, NUCLEIC ACIDS RES, V36, P1176, DOI 10.1093/nar/gkm1142; Brancucci NMB, 2012, CELL MICROBIOL, V14, P1836, DOI 10.1111/cmi.12004; Bunnik EM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r128; Calderwood MS, 2003, J BIOL CHEM, V278, P34125, DOI 10.1074/jbc.M213065200; Chookajorn T, 2007, P NATL ACAD SCI USA, V104, P899, DOI 10.1073/pnas.0609084103; CHU E, 1993, BIOCHEMISTRY-US, V32, P4756, DOI 10.1021/bi00069a009; Cortes A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002943; Cvijovic M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-295; Daubenberger CA, 2003, BIOL CHEM, V384, P1227, DOI 10.1515/BC.2003.135; Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; Duffy MF, 2002, MOL MICROBIOL, V43, P1285, DOI 10.1046/j.1365-2958.2002.02822.x; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Dzikowski R, 2007, EMBO REP, V8, P959, DOI 10.1038/sj.embor.7401063; Dzikowski R, 2009, CURR GENET, V55, P103, DOI 10.1007/s00294-009-0233-2; Epp C, 2009, RNA, V15, P116, DOI 10.1261/rna.1080109; Ercikan E, 1993, Adv Exp Med Biol, V338, P537; ErcikanAbali EA, 1997, BIOCHEMISTRY-US, V36, P12317, DOI 10.1021/bi971026e; Flueck C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000569; Foth BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r177; Foth BJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006411; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Guizetti J, 2013, CELL MICROBIOL, V15, P718, DOI 10.1111/cmi.12115; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hasenkamp S, 2013, ACTA TROP, V127, P69, DOI 10.1016/j.actatropica.2013.03.007; Hayden CA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-61; Jiang LB, 2013, NATURE, V499, P223, DOI 10.1038/nature12361; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; Kyes S, 2007, MOL MICROBIOL, V63, P1237, DOI 10.1111/j.1365-2958.2007.05587.x; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LANZER M, 1992, NUCLEIC ACIDS RES, V20, P3051, DOI 10.1093/nar/20.12.3051; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; LEECH JH, 1984, J EXP MED, V159, P1567, DOI 10.1084/jem.159.6.1567; Lemieux JE, 2013, MOL MICROBIOL, V90, P519, DOI 10.1111/mmi.12381; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Lopez-Rubio JJ, 2007, MOL MICROBIOL, V66, P1296, DOI 10.1111/j.1365-2958.2007.06009.x; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Mair GR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000767; Marty AJ, 2006, MOL MICROBIOL, V62, P72, DOI 10.1111/j.1365-2958.2006.05364.x; Mok BW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001982; Noviyanti R, 2001, MOL BIOCHEM PARASIT, V114, P227, DOI 10.1016/S0166-6851(01)00266-3; O'Donnell RA, 2001, NUCLEIC ACIDS RES, V29, P716, DOI 10.1093/nar/29.3.716; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Perez-Toledo K, 2009, NUCLEIC ACIDS RES, V37, P2596, DOI 10.1093/nar/gkp115; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Petter M, 2013, MOL MICROBIOL, V87, P1167, DOI 10.1111/mmi.12154; Ralph SA, 2005, P NATL ACAD SCI USA, V102, P5414, DOI 10.1073/pnas.0408883102; Reeder JC, 1999, P NATL ACAD SCI USA, V96, P5198, DOI 10.1073/pnas.96.9.5198; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salcedo-Amaya AM, 2009, P NATL ACAD SCI USA, V106, P9655, DOI 10.1073/pnas.0902515106; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tai NW, 2004, BIOCHEM J, V378, P999, DOI 10.1042/BJ20031396; Taylor HM, 2000, MOL BIOCHEM PARASIT, V110, P391, DOI 10.1016/S0166-6851(00)00286-3; Tonkin CJ, 2009, PLOS BIOL, V7, P771, DOI 10.1371/journal.pbio.1000084; TRAGER W, 1978, NATURE, V273, P621, DOI 10.1038/273621a0; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Voss TS, 2007, MOL MICROBIOL, V66, P139, DOI 10.1111/j.1365-2958.2007.05899.x; Voss TS, 2006, NATURE, V439, P1004, DOI 10.1038/nature04407; Ward CP, 1999, MOL BIOCHEM PARASIT, V102, P167, DOI 10.1016/S0166-6851(99)00106-1; Witmer K, 2012, MOL MICROBIOL, V84, P243, DOI 10.1111/j.1365-2958.2012.08019.x; Zhang K, 2002, SCIENCE, V296, P545, DOI 10.1126/science.1068274; Zhang M, 2010, J EXP MED, V207, P1, DOI 10.1084/jem.20091975	81	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100183	10.1371/journal.pone.0100183	http://dx.doi.org/10.1371/journal.pone.0100183			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937593	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000338503400088
J	Kim, HK; Park, WC; Lee, KM; Hwang, HL; Park, SY; Sorn, S; Chandra, V; Kim, KG; Yoon, WB; Bae, JS; Shin, HD; Shin, JY; Seoh, JY; Kim, JI; Hong, KM				Kim, Hyun-Kyoung; Park, Won Cheol; Lee, Kwang Man; Hwang, Hai-Li; Park, Seong-Yeol; Sorn, Sungbin; Chandra, Vishal; Kim, Kwang Gi; Yoon, Woong-Bae; Bae, Joon Seol; Shin, Hyoung Doo; Shin, Jong-Yeon; Seoh, Ju-Young; Kim, Jong-Il; Hong, Kyeong-Man			Targeted Next-Generation Sequencing at Copy-Number Breakpoints for Personalized Analysis of Rearranged Ends in Solid Tumors	PLOS ONE			English	Article							MINIMAL RESIDUAL DISEASE; BALANCED CHROMOSOME REARRANGEMENTS; COMPETITIVE PCR; BREAST-CANCER; GENE; TRANSLOCATIONS; LEUKEMIA; AMPLIFICATION; ABERRATIONS; VALIDATION	Background: The concept of the utilization of rearranged ends for development of personalized biomarkers has attracted much attention owing to its clinical applicability. Although targeted next-generation sequencing (NGS) for recurrent rearrangements has been successful in hematologic malignancies, its application to solid tumors is problematic due to the paucity of recurrent translocations. However, copy-number breakpoints (CNBs), which are abundant in solid tumors, can be utilized for identification of rearranged ends. Method: As a proof of concept, we performed targeted next-generation sequencing at copy-number breakpoints (TNGS-CNB) in nine colon cancer cases including seven primary cancers and two cell lines, COLO205 and SW620. For deduction of CNBs, we developed a novel competitive single-nucleotide polymorphism (cSNP) microarray method entailing CNB-region refinement by competitor DNA. Result: Using TNGS-CNB, 19 specific rearrangements out of 91 CNBs (20.9%) were identified, and two polymerase chain reaction (PCR)-amplifiable rearrangements were obtained in six cases (66.7%). And significantly, TNGS-CNB, with its high positive identification rate (82.6%) of PCR-amplifiable rearrangements at candidate sites (19/23), just from filtering of aligned sequences, requires little effort for validation. Conclusion: Our results indicate that TNGS-CNB, with its utility for identification of rearrangements in solid tumors, can be successfully applied in the clinical laboratory for cancer-relapse and therapy-response monitoring.	[Kim, Hyun-Kyoung; Hwang, Hai-Li; Park, Seong-Yeol; Sorn, Sungbin; Chandra, Vishal; Kim, Kwang Gi; Yoon, Woong-Bae; Hong, Kyeong-Man] Natl Canc Ctr, Res Inst, Goyang, Gyeonggi Do, South Korea; [Kim, Hyun-Kyoung; Seoh, Ju-Young] Ewha Womans Univ, Sch Med, Dept Microbiol, Seoul, South Korea; [Park, Won Cheol; Lee, Kwang Man] Wonkwang Univ, Sch Med, Dept Surg, Iksan, South Korea; [Bae, Joon Seol] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Lab Translat Genom,Samsung Genome Inst, Seoul, South Korea; [Shin, Hyoung Doo] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Shin, Hyoung Doo] SNP Genet Inc, Dept Genet Epidemiol, Seoul, South Korea; [Shin, Jong-Yeon; Kim, Jong-Il] Seoul Natl Univ, Med Res Ctr, Genom Med Inst, Seoul, South Korea; [Kim, Jong-Il] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Kim, Jong-Il] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea	National Cancer Center - Korea (NCC); Ewha Womans University; Wonkwang University; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Sogang University; SNP Genetics; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Hong, KM (corresponding author), Natl Canc Ctr, Res Inst, Goyang, Gyeonggi Do, South Korea.	kmhong@ncc.re.kr	KIM, JONG-IL/D-1019-2011; Yoon, Woong/A-2606-2016; Chandra, Vishal/AAN-8756-2020	KIM, JONG-IL/0000-0002-7240-3744; Yoon, Woong/0000-0002-8598-3127; SEOH, JU-YOUNG/0000-0002-1168-5354	Basic Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [1031020]; National Cancer Center through the Korean Ministry of Health and Welfare [1110130]	Basic Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; National Cancer Center through the Korean Ministry of Health and Welfare	This work was supported by a grant to K.-M. H. from the Basic Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (1031020), and by a grant to K.-M. H. from the National Cancer Center through the Korean Ministry of Health and Welfare (1110130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysinghe SS, 2003, HUM MUTAT, V22, P229, DOI 10.1002/humu.10254; Andersson A, 2001, LEUKEMIA, V15, P1293, DOI 10.1038/sj.leu.2402189; Buccisano F, 2012, BLOOD, V119, P332, DOI 10.1182/blood-2011-08-363291; Bzymek M, 2001, P NATL ACAD SCI USA, V98, P8319, DOI 10.1073/pnas.111008398; Chendamarai E, 2012, BLOOD, V119, P3413, DOI 10.1182/blood-2011-11-393264; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; Corbacioglu A, 2010, J CLIN ONCOL, V28, P3724, DOI 10.1200/JCO.2010.28.6468; Croce CM, 1999, J CLIN ONCOL, V17, P1618, DOI 10.1200/JCO.1999.17.5.1618; CROSS NCP, 1994, LEUKEMIA, V8, P186; Ding CM, 2003, P NATL ACAD SCI USA, V100, P3059, DOI 10.1073/pnas.0630494100; Duncavage EJ, 2012, MODERN PATHOL, V25, P795, DOI 10.1038/modpathol.2012.29; Duncavage EJ, 2011, J MOL DIAGN, V13, P325, DOI 10.1016/j.jmoldx.2011.01.006; Fan JB, 2002, GENOMICS, V79, P58, DOI 10.1006/geno.2001.6676; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Kim HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069414; Kolomietz E, 2002, GENE CHROMOSOME CANC, V35, P97, DOI 10.1002/gcc.10111; LaFramboise T, 2009, NUCLEIC ACIDS RES, V37, P4181, DOI 10.1093/nar/gkp552; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Li YD, 2012, HUM MOL GENET, V21, P4957, DOI 10.1093/hmg/dds340; Luthra R, 2009, CLIN CHEM, V55, P2077, DOI 10.1373/clinchem.2009.136143; Lyon E, 2001, CLIN CHEM, V47, P844; Marotta M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3362; McBride DJ, 2010, GENE CHROMOSOME CANC, V49, P1062, DOI 10.1002/gcc.20815; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Oosting J, 2007, GENOME RES, V17, P368, DOI 10.1101/gr.5686107; Paietta E, 2012, HEMATOL-AM SOC HEMAT, P35, DOI 10.1182/asheducation-2012.1.35; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Salto-Tellez M, 2003, J MOL DIAGN, V5, P231, DOI 10.1016/S1525-1578(10)60479-5; Sato M, 1998, HUM GENET, V103, P96, DOI 10.1007/s004390050790; Schluth-Bolard C, 2013, J MED GENET, V50, P144, DOI 10.1136/jmedgenet-2012-101351; Sengupta N, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-1; Siraj AK, 2002, CLIN CANCER RES, V8, P3832; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Watanabe A, 2011, P NATL ACAD SCI USA, V108, P12384, DOI 10.1073/pnas.0906930108; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xiao Z, 2001, LEUKEMIA, V15, P1906, DOI 10.1038/sj.leu.2402318	39	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100089	10.1371/journal.pone.0100089	http://dx.doi.org/10.1371/journal.pone.0100089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937453	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400072
J	Manel, S; Couvreur, TLP; Munoz, F; Couteron, P; Hardy, OJ; Sonke, B				Manel, Stephanie; Couvreur, Thomas L. P.; Munoz, Francois; Couteron, Pierre; Hardy, Olivier J.; Sonke, Bonaventure			Characterizing the Phylogenetic Tree Community Structure of a Protected Tropical Rain Forest Area in Cameroon	PLOS ONE			English	Article							BETA-DIVERSITY; DNA-SEQUENCES; MOLECULAR PHYLOGENETICS; FUNCTIONAL TRAITS; SPACER SEQUENCES; INTERACTIVE TREE; APOCYNACEAE S.L.; PLASTID RBCL; TRNL INTRON; FAMILY	Tropical rain forests, the richest terrestrial ecosystems in biodiversity on Earth are highly threatened by global changes. This paper aims to infer the mechanisms governing species tree assemblages by characterizing the phylogenetic structure of a tropical rain forest in a protected area of the Congo Basin, the Dja Faunal Reserve (Cameroon). We re-analyzed a dataset of 11538 individuals belonging to 372 taxa found along nine transects spanning five habitat types. We generated a dated phylogenetic tree including all sampled taxa to partition the phylogenetic diversity of the nine transects into alpha and beta components at the level of the transects and of the habitat types. The variation in phylogenetic composition among transects did not deviate from a random pattern at the scale of the Dja Faunal Reserve, probably due to a common history and weak environmental variation across the park. This lack of phylogenetic structure combined with an isolation-by-distance pattern of taxonomic diversity suggests that neutral dispersal limitation is a major driver of community assembly in the Dja. To assess any lack of sensitivity to the variation in habitat types, we restricted the analyses of transects to the terra firme primary forest and found results consistent with those of the whole dataset at the level of the transects. Additionally to previous analyses, we detected a weak but significant phylogenetic turnover among habitat types, suggesting that species sort in varying environments, even though it is not predominating on the overall phylogenetic structure. Finer analyses of clades indicated a signal of clustering for species from the Annonaceae family, while species from the Apocynaceae family indicated overdispersion. These results can contribute to the conservation of the park by improving our understanding of the processes dictating community assembly in these hyperdiverse but threatened regions of the world.	[Manel, Stephanie] Aix Marseille Univ, IRD, LPED, UMR 151, Marseille, France; [Manel, Stephanie] Ctr Cooperat Int Rech Agron Dev, UMR AMAP, Montpellier, France; [Couvreur, Thomas L. P.] Inst Rech Dev, UMR DIADE, Montpellier, France; [Couvreur, Thomas L. P.; Sonke, Bonaventure] Univ Yaounde I, Ecole Normale Super, Lab Bot Systemat & Ecol, Dept Sci Biol, Yaounde, Cameroon; [Munoz, Francois] Univ Montpellier 2, UMR AMAP, Montpellier, France; [Couteron, Pierre] Inst Rech Dev, UMR AMAP, Montpellier, France; [Hardy, Olivier J.] Univ Libre Bruxelles, Fac Sci Evolutionary Biol & Ecol Brussels, Brussels, Belgium	UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Yaounde I; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite Libre de Bruxelles	Manel, S (corresponding author), Aix Marseille Univ, IRD, LPED, UMR 151, Marseille, France.	stephanie.manel@univ-amu.fr	Couvreur, Thomas LP/D-8172-2011; Munoz, Francois/C-4239-2015	Couvreur, Thomas LP/0000-0002-8509-6587; Munoz, Francois/0000-0001-8776-4705	PEERS ISMOBIAC - Agence inter-etablissements de recherche pour le developpement - Programme Doctorant du Sud (AIRD-DPF)	PEERS ISMOBIAC - Agence inter-etablissements de recherche pour le developpement - Programme Doctorant du Sud (AIRD-DPF)	PC and BS are partly funded by "PEERS ISMOBIAC" through support provided by the Agence inter-etablissements de recherche pour le developpement - Programme Doctorant du Sud (AIRD-DPF). The funders had no role in study design, data collection and analysis, decision to publish or preparation manuscript.	Alverson WS, 1999, AM J BOT, V86, P1474, DOI 10.2307/2656928; Baraloto C, 2012, J ECOL, V100, P690, DOI 10.1111/j.1365-2745.2012.01966.x; Bele MY, 2011, J HORTICULTURE FORES, V10, P307; Bremer B, 2009, INT J PLANT SCI, V170, P766, DOI 10.1086/599077; Bruneau A, 2001, SYST BOT, V26, P487; Buerki S, 2009, MOL PHYLOGENET EVOL, V51, P238, DOI 10.1016/j.ympev.2009.01.012; Burgess N, 2005, BIODIVERS CONSERV, V14, P1877, DOI 10.1007/s10531-004-1299-2; Chatrou LW, 2012, BOT J LINN SOC, V169, P5, DOI 10.1111/j.1095-8339.2012.01235.x; Chave J, 2002, ENVIRON MODEL ASSESS, V7, P115, DOI 10.1023/A:1015601800181; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Couvreur TLP, 2011, J BIOGEOGR, V38, P664, DOI 10.1111/j.1365-2699.2010.02434.x; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Diniz-Filho JAF, 2013, DARWINIAN SHORTFALLS; Eastman JM, 2011, BIOINFORMATICS, V27, P2437, DOI 10.1093/bioinformatics/btr403; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fine PVA, 2011, ECOGRAPHY, V34, P552, DOI 10.1111/j.1600-0587.2010.06548.x; G TAP, 2009, BOT J LINN SOC, V161, P105; GENTRY AH, 1988, P NATL ACAD SCI USA, V85, P156, DOI 10.1073/pnas.85.1.156; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Givnish TJ, 1999, J ECOL, V87, P193, DOI 10.1046/j.1365-2745.1999.00333.x; Groppo M, 2008, AM J BOT, V95, P985, DOI 10.3732/ajb.2007313; Gustafsson MHG, 2002, INT J PLANT SCI, V163, P1045, DOI 10.1086/342521; Hardy O.J., 2010, SPACODI 0 10 PROGRAM; Hardy OJ, 2004, FOREST ECOL MANAG, V197, P191, DOI 10.1016/j.foreco.2004.05.014; Hardy OJ, 2008, J ECOL, V96, P914, DOI 10.1111/j.1365-2745.2008.01421.x; Hardy OJ, 2008, J ECOL, V96, P849, DOI 10.1111/j.1365-2745.2008.01423.x; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; Hardy OJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P1007, DOI 10.1111/j.1466-8238.2011.00742.x; Hubbell Stephen P., 2001, V32, pi; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Koleff P, 2003, GLOBAL ECOL BIOGEOGR, V12, P483, DOI 10.1046/j.1466-822X.2003.00056.x; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Kress WJ, 2010, PLOS ONE, V5; Lahaye R, 2005, AM J BOT, V92, P1381, DOI 10.3732/ajb.92.8.1381; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Lebrun J, 1954, CLASSIFICATION ECCOL, V63, P9; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Lewis SL, 2006, PHILOS T R SOC B, V361, P195, DOI 10.1098/rstb.2005.1711; Maddison, 2019, MESQUITE MODULAR SYS; Malecot V, 2008, SYST BOT, V33, P97, DOI 10.1600/036364408783887384; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McGinley M, 2008, ENCY EARTH; Mouquet N, 2012, BIOL REV, V87, P769, DOI 10.1111/j.1469-185X.2012.00224.x; Muellner AN, 2010, AM J BOT, V97, P511, DOI 10.3732/ajb.0900229; Muellner AN, 2003, AM J BOT, V90, P471, DOI 10.3732/ajb.90.3.471; Munoz F, 2008, AM NAT, V172, P116, DOI 10.1086/587842; Olmstead RG, 2009, AM J BOT, V96, P1731, DOI 10.3732/ajb.0900004; Parmentier I, 2007, J ECOL, V95, P1058, DOI 10.1111/j.1365-2745.2007.01273.x; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Potgieter K, 2001, ANN MO BOT GARD, V88, P523, DOI 10.2307/3298632; Rolland J, 2012, BIOL LETTERS, V8, P692, DOI 10.1098/rsbl.2011.1024; Sauquet H, 2003, BOT J LINN SOC, V142, P125, DOI 10.1046/j.1095-8339.2003.00171.x; Sonke B, 2004, SCRIPTA BOT BELGICA, V32, P1; Sonke B, 1998, THESIS U LIBRE DEBRU, P129; Sonke Bonaventure, 2014, Biodivers Data J, pe1049, DOI 10.3897/BDJ.2.e1049; Swenson NG, 2013, ECOGRAPHY, V36, P264, DOI 10.1111/j.1600-0587.2012.00121.x; Swenson NG, 2012, ECOLOGY, V93, pS112, DOI 10.1890/11-0402.1; Swenson NG, 2012, ECOLOGY, V93, P490, DOI 10.1890/11-1180.1; Swenson NG, 2011, P ROY SOC B-BIOL SCI, V278, P877, DOI 10.1098/rspb.2010.1369; Tan FX, 2002, J PLANT RES, V115, P475, DOI 10.1007/s10265-002-0059-1; Team RC, 2012, R LANG ENV STAT COMP; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; WHITE F, 1983, DESCRIPTIVE MEMOIR A; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wilson PG, 2005, PLANT SYST EVOL, V251, P3, DOI 10.1007/s00606-004-0162-y; Winter M, 2013, TRENDS ECOL EVOL, V28, P199, DOI 10.1016/j.tree.2012.10.015; Wurdack KJ, 2005, AM J BOT, V92, P1397, DOI 10.3732/ajb.92.8.1397; Wurdack KJ, 2004, AM J BOT, V91, P1882, DOI 10.3732/ajb.91.11.1882; Yakandawala D, 2010, ANN MO BOT GARD, V97, P259, DOI 10.3417/2007175	73	7	7	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e98920	10.1371/journal.pone.0098920	http://dx.doi.org/10.1371/journal.pone.0098920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936786	Green Submitted, Green Published, gold			2022-12-25	WOS:000338503400011
J	Robb, CK				Robb, Carolyn K.			Assessing the Impact of Human Activities on British Columbia's Estuaries	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; CLIMATE-CHANGE; COASTAL; MANAGEMENT; CHALLENGES; RECOVERY; LAND	The world's marine and coastal ecosystems are under threat and single-sector management efforts have failed to address those threats. Scientific consensus suggests that management should evolve to focus on ecosystems and their human, ecological, and physical components. Estuaries are recognized globally as one of the world's most productive and most threatened ecosystems and many estuarine areas in British Columbia (BC) have been lost or degraded. To help prioritize activities and areas for regional management efforts, spatial information on human activities that adversely affect BC's estuaries was compiled. Using statistical analyses, estuaries were assigned to groups facing related threats that could benefit from similar management. The results show that estuaries in the most populated marine ecosections have the highest biological importance but also the highest impacts and the lowest levels of protection. This research is timely, as it will inform ongoing marine planning, land acquisition, and stewardship efforts in BC.	Royal Roads Univ, Sch Environm & Management, Victoria, BC, Canada		Robb, CK (corresponding author), Royal Roads Univ, Sch Environm & Management, Victoria, BC, Canada.	ckrobb18@hotmail.com			Living Oceans Society	Living Oceans Society	Living Oceans Society (www.livingoceans.org), an environmental non-profit organization and the author's employer, provided the computer and GIS software used in the completion of this research. No other funding assistance was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardy T, 2011, MAR POLICY, V35, P226, DOI 10.1016/j.marpol.2010.10.006; Austin M.A., 2008, TAKING NATURES PULSE; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Ban NC, 2013, MAR POLICY, V39, P11, DOI 10.1016/j.marpol.2012.10.017; Ban NC, 2010, MAR POLICY, V34, P876, DOI 10.1016/j.marpol.2010.01.010; Barbier EB, 2012, REV ENV ECON POLICY, V6, P1, DOI 10.1093/reep/rer017; Baustian JJ, 2012, GLOBAL CHANGE BIOL, V18, P3377, DOI 10.1111/j.1365-2486.2012.02792.x; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Callaway GC, 2009, WETLAND HABITAT N AM, P285; Campbell CR, 2010, BLUE CARBON BRIT COL; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crowder L, 2008, MAR POLICY, V32, P772, DOI 10.1016/j.marpol.2008.03.012; DFO, 2008, ROL PROV TERR GOV OC; DFO, 2005, CAN OC ACT PLAN PRES; dfo (Department of Fisheries and Ocean), 2002, POL OP FRAM INT MAN; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; Edgar GJ, 2000, BIOL CONSERV, V92, P383, DOI 10.1016/S0006-3207(99)00111-1; Emmett R, 2000, ESTUARIES, V23, P765, DOI 10.2307/1352998; Environment Canada, 1999, DRAFT CAN NAT PROGR; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Galbraith H, 2002, WATERBIRDS, V25, P173, DOI 10.1675/1524-4695(2002)025[0173:GCCASL]2.0.CO;2; Gleason MG, 2006, FRONT ECOL ENVIRON, V4, P249, DOI 10.1890/1540-9295(2006)004[0249:AGIMCI]2.0.CO;2; Google, 2012, GOOGL EARTH V 6 1; Government of Canada, 2011, NAT FRAM CAN NETW MA; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Herr D., 2012, BLUE CARBON POLICY F; Hutchings JA, 2012, SUSTAINING CANADIAN; Imperial MT, 1996, COAST MANAGE, V24, P115, DOI 10.1080/08920759609362286; Jessen S, 2011, SCI BASED GUIDELINES; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Kelsey E, 1995, PACIFIC ESTUARY CONS; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Leschine TM, 2003, ESTUARIES, V26, P1189, DOI 10.1007/BF02803373; Lindeboom H., 2005, GLO CH IGBP, P1, DOI 10.1007/3-540-27851-6_1; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Luck GW, 2009, CONSERV LETT, V2, P179, DOI 10.1111/j.1755-263X.2009.00064.x; McLeod K.L., 2005, SCI CONSENSUS STATEM; Merrifield MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017407; Millennium Ecosystem Assessment, 2005, EC HUM WELLB FRAM AS; Nelleman C, 2009, BLUE CARBON RAPID RE; Nicolas D, 2011, REG ENVIRON CHANGE, V11, P639, DOI 10.1007/s10113-010-0196-3; Okey T., 2012, CLIMATE CHANGE IMPAC; Quigley MP, 1999, AQUAT CONSERV, V9, P63, DOI 10.1002/(SICI)1099-0755(199901/02)9:1<63::AID-AQC327>3.3.CO;2-R; Robb CK, 2011, MAR POLICY, V35, P309, DOI 10.1016/j.marpol.2010.10.010; Ryder JL, 2006, ALIVE INSEPARABLE BR, V35-41; Ryder JL, 2007, INTEGRATED BIOPHYSIC; Scavia D, 2002, ESTUARIES, V25, P149, DOI 10.1007/BF02691304; Sloan NA, 2007, CONSERV BIOL, V21, P897, DOI 10.1111/j.1523-1739.2007.00731.x; Smith H, 2011, J COAST CONSERV, V15, P291, DOI 10.1007/s11852-010-0098-z; Systat Software, 2010, SYST V 13; Teck SJ, 2010, ECOL APPL, V20, P1402, DOI 10.1890/09-1173.1; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Williams G. L., 2002, REV ESTUARY MANAGEME	55	14	15	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99578	10.1371/journal.pone.0099578	http://dx.doi.org/10.1371/journal.pone.0099578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK5YM	24937486	gold, Green Published, Green Submitted			2022-12-25	WOS:000338503400024
J	Yang, FY; Lin, YL; Chou, FI; Lin, YC; Liu, YWH; Chang, LW; Hsieh, YL				Yang, Feng-Yi; Lin, Yi-Li; Chou, Fong-In; Lin, Yu-Chuan; Liu, Yen-Wan Hsueh; Chang, Lun-Wei; Hsieh, Yu-Ling			Pharmacokinetics of BPA in Gliomas with Ultrasound Induced Blood-Brain Barrier Disruption as Measured by Microdialysis	PLOS ONE			English	Article							NEUTRON-CAPTURE THERAPY; NEWLY-DIAGNOSED GLIOBLASTOMA; FOCUSED ULTRASOUND; ENHANCED SURVIVAL; DRUG-DELIVERY; INTRACAROTID INJECTION; LIPOSOMAL DOXORUBICIN; SODIUM BOROCAPTATE; TUMORS; BORONOPHENYLALANINE	The blood-brain barrier (BBB) can be transiently disrupted by focused ultrasound (FUS) in the presence of microbubbles for targeted drug delivery. Previous studies have illustrated the pharmacokinetics of drug delivery across the BBB after sonication using indirect visualization techniques. In this study, we investigated the in vivo extracellular kinetics of boronophenylalanine-fructose (BPA-f) in glioma-bearing rats with FUS-induced BBB disruption by microdialysis. After simultaneous intravenous administration of BPA and FUS exposure, the boron concentration in the treated brains was quantified by inductively coupled plasma mass spectroscopy. With FUS, the mean peak concentration of BPA-f in the glioma dialysate was 3.6 times greater than without FUS, and the area under the concentration-time curve was 2.1 times greater. This study demonstrates that intracerebral microdialysis can be used to assess local BBB transport profiles of drugs in a sonicated site. Applying microdialysis to the study of metabolism and pharmacokinetics is useful for obtaining selective information within a specific brain site after FUS-induced BBB disruption.	[Yang, Feng-Yi; Lin, Yi-Li; Chang, Lun-Wei; Hsieh, Yu-Ling] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Yang, Feng-Yi] Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei 112, Taiwan; [Chou, Fong-In] Natl Tsing Hua Univ, Nucl Sci & Technol Dev Ctr, Hsinchu, Taiwan; [Chou, Fong-In; Lin, Yu-Chuan; Liu, Yen-Wan Hsueh] Natl Tsing Hua Univ, Inst Nucl Engn & Sci, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Tsing Hua University; National Tsing Hua University	Yang, FY (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan.	fyyang@ym.edu.tw			National Science Council of Taiwan [NSC 102-2221-E-010-005-MY3, NSC 101-2320-B-010-036-MY3]; Cheng Hsin General Hospital Foundation [102F218C11, 103F003C17]; Biophotonics & Molecular Imaging Research Center; Ministry of Education, Aim for the Top University Plan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Cheng Hsin General Hospital Foundation; Biophotonics & Molecular Imaging Research Center; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This study was supported by grants from the National Science Council of Taiwan (no. NSC 102-2221-E-010-005-MY3 and NSC 101-2320-B-010-036-MY3), Cheng Hsin General Hospital Foundation (no. 102F218C11 and 103F003C17), Biophotonics & Molecular Imaging Research Center, and the Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkins RD, 2013, NEURO-ONCOLOGY, V15, P1225, DOI 10.1093/neuonc/not052; Barth RF, 2000, INT J RADIAT ONCOL, V47, P209, DOI 10.1016/S0360-3016(00)00421-1; Barth RF, 1996, CANCER INVEST, V14, P534, DOI 10.3109/07357909609076899; Barth RF, 2005, CLIN CANCER RES, V11, P3987, DOI 10.1158/1078-0432.CCR-05-0035; Barth RF, 1998, J NEURO-ONCOL, V36, P91, DOI 10.1023/A:1005805203044; Barth RF, 2002, INT J RADIAT ONCOL, V52, P858, DOI 10.1016/S0360-3016(01)02734-1; Barth RF, 1997, CANCER RES, V57, P1129; BENVENISTE H, 1990, PROG NEUROBIOL, V35, P195, DOI 10.1016/0301-0082(90)90027-E; Bergenheim AT, 2005, J NEURO-ONCOL, V71, P287, DOI 10.1007/s11060-004-1724-0; Evrard PA, 1996, PHARMACEUT RES, V13, P12, DOI 10.1023/A:1016056628685; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Johansen MJ, 1997, PHARMACOTHERAPY, V17, P464; Kabalka GW, 2003, J NEURO-ONCOL, V62, P187, DOI 10.1007/BF02699944; Kawabata S, 2009, J RADIAT RES, V50, P51, DOI 10.1269/jrr.08043; KEHR J, 1993, J NEUROSCI METH, V48, P251, DOI 10.1016/0165-0270(93)90096-A; Kroll RA, 1998, NEUROSURGERY, V42, P1083, DOI 10.1097/00006123-199805000-00082; Miyatake SI, 2009, J NEURO-ONCOL, V91, P199, DOI 10.1007/s11060-008-9699-x; Park J, 2012, J CONTROL RELEASE, V162, P134, DOI 10.1016/j.jconrel.2012.06.012; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; Skold K, 2010, BRIT J RADIOL, V83, P596, DOI 10.1259/bjr/56953620; Smith DR, 2001, CANCER RES, V61, P8179; Vlachos F, 2010, PHYS MED BIOL, V55, P5451, DOI 10.1088/0031-9155/55/18/012; Vlachos F, 2011, MAGN RESON MED, V66, P821, DOI 10.1002/mrm.22848; Wang HE, 2004, J NUCL MED, V45, P302; WESTERINK BHC, 1987, LIFE SCI, V41, P1763, DOI 10.1016/0024-3205(87)90695-3; Yang FY, 2012, FUTURE ONCOL, V8, P1361, DOI [10.2217/fon.12.118, 10.2217/FON.12.118]; Yang FY, 2012, J CONTROL RELEASE, V160, P652, DOI 10.1016/j.jconrel.2012.02.023; Yang FY, 2012, INT J NANOMED, V7, P965, DOI 10.2147/IJN.S29229; Yang FY, 2011, J NUCL MED, V52, P478, DOI 10.2967/jnumed.110.083071; Yang FY, 2011, J CONTROL RELEASE, V150, P111, DOI 10.1016/j.jconrel.2010.10.038; YOSHINO K, 1989, STRAHLENTHER ONKOL, V165, P127	31	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100104	10.1371/journal.pone.0100104	http://dx.doi.org/10.1371/journal.pone.0100104			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936788	Green Submitted, Green Published, gold			2022-12-25	WOS:000338503400075
J	Grundy, A; Cotterchio, M; Kirsh, VA; Kreiger, N				Grundy, Anne; Cotterchio, Michelle; Kirsh, Victoria A.; Kreiger, Nancy			Associations between Anxiety, Depression, Antidepressant Medication, Obesity and Weight Gain among Canadian Women	PLOS ONE			English	Article							NATIONAL EPIDEMIOLOGIC SURVEY; PSYCHIATRIC-DISORDERS; BODY-WEIGHT; PUTATIVE CONTRIBUTORS; ADOLESCENT DEPRESSION; GENDER-DIFFERENCES; MAJOR DEPRESSION; EARLY ADULTHOOD; SYMPTOMS; HEALTH	Purpose: Some mental illnesses have been suggested to be associated with obesity, although results are somewhat inconsistent and research has focused mainly on depression. Methods: Associations between anxiety, depression, medications for these illnesses, and obesity were investigated cross-sectionally among women aged 25-74 (n = 3004) who participated as population controls in a cancer case-control study. Participants self-reported information on anxiety, depression, height, current weight and weight at age 25. Results: No association was observed between either anxiety or depression and either current overweight or obesity status. However, depressed women taking antidepressants were more likely to be obese [OR = 1.71 (95% CI = 1.16-2.52) daily antidepressant use; OR = 1.89 (95% CI = 1.21-2.96) ever tricyclic antidepressant use]. In the full study sample consistent positive associations between anxiety, depression and obesity among women with a history of antidepressant use, and generally negative associations among women without, were suggested. Finally, weight gain was associated with history of anxiety [5-19 kg OR = 1.29 (95% CI = 1.06-1.57); >= 20 kg OR = 1.43 (95% CI = 1.08-1.88)] and depression [>= 20 kg OR = 1.28 (95% CI = 0.99-1.65)]. Conclusions: These results suggest depression and anxiety may be associated with weight gain and antidepressant use may be associated with obesity.	[Grundy, Anne; Cotterchio, Michelle; Kirsh, Victoria A.; Kreiger, Nancy] Canc Care Ontario, Prevent & Canc Control, Toronto, ON, Canada; [Cotterchio, Michelle; Kirsh, Victoria A.; Kreiger, Nancy] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Kreiger, Nancy] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada	Cancer Care Ontario; University of Toronto; University of Toronto	Grundy, A (corresponding author), Canc Care Ontario, Prevent & Canc Control, Toronto, ON, Canada.	anne.l.grundy@gmail.com		Cotterchio, Michelle/0000-0003-2862-7895	Canadian Breast Cancer Research Alliance [007235]; Cancer Care Ontario	Canadian Breast Cancer Research Alliance; Cancer Care Ontario	Funding for the Women's Health Study was provided by the Canadian Breast Cancer Research Alliance (Grant No. 007235). Anne Grundy was supported by a postdoctoral fellowship from Cancer Care Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlberg AC, 2002, PSYCHIAT RES, V112, P101, DOI 10.1016/S0165-1781(02)00192-0; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Andreyeva T, 2007, PUBLIC HEALTH, V121, P497, DOI 10.1016/j.puhe.2006.11.016; Aronne LJ, 2003, J CLIN PSYCHIAT, V64, P22; Bardone AM, 1998, J AM ACAD CHILD PSY, V37, P594, DOI 10.1097/00004583-199806000-00009; Barefoot JC, 1998, INT J OBESITY, V22, P688, DOI 10.1038/sj.ijo.0800647; Barry D, 2008, ANN EPIDEMIOL, V18, P458, DOI 10.1016/j.annepidem.2007.12.009; CASEY VA, 1991, AM J CLIN NUTR, V53, P1493, DOI 10.1093/ajcn/53.6.1493; Chiriboga DE, 2008, OBESITY, V16, P137, DOI 10.1038/oby.2007.38; Cotterchio M, 2001, CANCER EPIDEM BIOMAR, V10, P1213; CRISP AH, 1976, BRIT MED J, V1, P7, DOI 10.1136/bmj.1.6000.7; Faith MS, 2011, OBES REV, V12, pe438, DOI 10.1111/j.1467-789X.2010.00843.x; Fava M, 2000, J CLIN PSYCHIAT, V61, P37; First M.B., 1990, USERS GUIDE STRUCTUR; Franko DL, 2005, PSYCHOL MED, V35, P1505, DOI 10.1017/S0033291705005386; Frise S, 2002, CAN J PSYCHIAT, V47, P849, DOI 10.1177/070674370204700906; Goodman E, 2002, PEDIATRICS, V110, P497, DOI 10.1542/peds.110.3.497; Goodwin RD, 2009, PSYCHOL MED, V39, P301, DOI 10.1017/S0033291708003504; Hasler G, 2005, MOL PSYCHIATR, V10, P842, DOI 10.1038/sj.mp.4001671; Heo M, 2006, INT J OBESITY, V30, P513, DOI 10.1038/sj.ijo.0803122; Keith SW, 2006, INT J OBESITY, V30, P1585, DOI 10.1038/sj.ijo.0803326; Kovalchik S, 2009, PUBLIC HEALTH NUTR, V12, P1072, DOI 10.1017/S1368980008003728; Lee RSC, 2012, J AFFECT DISORDERS, V140, P113, DOI 10.1016/j.jad.2011.10.023; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Mather AA, 2009, J PSYCHOSOM RES, V66, P277, DOI 10.1016/j.jpsychores.2008.09.008; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Nyholm M, 2007, OBESITY, V15, P197, DOI 10.1038/oby.2007.536; Ohayon MM, 2007, J PSYCHIAT RES, V41, P207, DOI 10.1016/j.jpsychires.2006.10.006; Palinkas LA, 1996, J PSYCHOSOM RES, V40, P59, DOI 10.1016/0022-3999(95)00542-0; Papakostas GI, 2014, J CLIN PSYCHIAT, V75, P8, DOI 10.4088/JCP.13r08710; Patten SB, 2011, J AFFECT DISORDERS, V134, P288, DOI 10.1016/j.jad.2011.06.027; Patten SB, 2009, PSYCHOTHER PSYCHOSOM, V78, P182, DOI 10.1159/000209349; PERRY GS, 1995, EPIDEMIOLOGY, V6, P61, DOI 10.1097/00001648-199501000-00012; Petry NM, 2008, PSYCHOSOM MED, V70, P288, DOI 10.1097/PSY.0b013e3181651651; Pine DS, 2001, PEDIATRICS, V107, P1049, DOI 10.1542/peds.107.5.1049; Pine DS, 1997, AM J PUBLIC HEALTH, V87, P1303, DOI 10.2105/AJPH.87.8.1303; Rhew IC, 2008, GEN HOSP PSYCHIAT, V30, P458, DOI 10.1016/j.genhosppsych.2008.06.008; Richardson LP, 2003, ARCH PEDIAT ADOL MED, V157, P739, DOI 10.1001/archpedi.157.8.739; Roberts RE, 2003, INT J OBESITY, V27, P514, DOI 10.1038/sj.ijo.0802204; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; Rohde P, 2008, CHILD ABUSE NEGLECT, V32, P878, DOI 10.1016/j.chiabu.2007.11.004; Rosmond R, 1998, OBES RES, V6, P338, DOI 10.1002/j.1550-8528.1998.tb00361.x; Rothman K., 1998, MODERN EPIDEMIOLOGY, P253; Schwartz T L, 2004, Obes Rev, V5, P115, DOI 10.1111/j.1467-789X.2004.00139.x; Scott KA, 2008, J PSYCHOSOM RES, V64, P97, DOI 10.1016/j.jpsychores.2007.09.006; Shields Margot, 2008, Health Rep, V19, P61; Simon GE, 2008, GEN HOSP PSYCHIAT, V30, P32, DOI 10.1016/j.genhosppsych.2007.09.001; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Steingart A, 2003, INT J EPIDEMIOL, V32, P961, DOI 10.1093/ije/dyg155; STEVENS J, 1990, AM J EPIDEMIOL, V132, P1156, DOI 10.1093/oxfordjournals.aje.a115758; Stice E, 2005, J CONSULT CLIN PSYCH, V73, P195, DOI 10.1037/0022-006X.73.2.195; Tremblay A, 2008, APPL PHYSIOL NUTR ME, V33, P791, DOI 10.1139/H08-038; Vogelzangs N, 2008, ARCH GEN PSYCHIAT, V65, P1386, DOI 10.1001/archpsyc.65.12.1386; Zimmermann U, 2003, J PSYCHIATR RES, V37, P193, DOI 10.1016/S0022-3956(03)00018-9	55	46	48	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99780	10.1371/journal.pone.0099780	http://dx.doi.org/10.1371/journal.pone.0099780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ5PV	24932472	Green Submitted, Green Published, gold			2022-12-25	WOS:000337738600062
J	Jacquier, M; Crauste, F; Soulage, CO; Soula, HA				Jacquier, Marine; Crauste, Fabien; Soulage, Christophe O.; Soula, Hedi A.			A Predictive Model of the Dynamics of Body Weight and Food Intake in Rats Submitted to Caloric Restrictions	PLOS ONE			English	Article							NERVOUS-SYSTEM CONTROL; FAT-FREE MASS; ADAPTIVE THERMOGENESIS; MATHEMATICAL-MODEL; ENERGY-EXPENDITURE; GHRELIN; OBESITY; METABOLISM; APPETITE; LEPTIN	Dynamics of body weight and food intake can be studied by temporally perturbing food availability. This perturbation can be obtained by modifying the amount of available food over time while keeping the overall food quantity constant. To describe food intake dynamics, we developed a mathematical model that describes body weight, fat mass, fat-free mass, energy expenditure and food intake dynamics in rats. In addition, the model considers regulation of food intake by leptin, ghrelin and glucose. We tested our model on rats experiencing temporally variable food availability. Our model is able to predict body weight and food intake variations by taking into account energy expenditure dynamics based on a memory of the previous food intake. This model allowed us to estimate this memory lag to approximately 8 days. It also explains how important variations in food availability during periods longer than these 8 days can induce body weight gains.	[Jacquier, Marine; Crauste, Fabien] Univ Lyon 1, CNRS, Inst Camille Jordan, UMR 5208, F-69622 Villeurbanne, France; [Jacquier, Marine; Crauste, Fabien] Inria Ctr Grenoble Rhone Alpes, Inria Team Dracula, Grenoble Rhone Alpes, France; [Soulage, Christophe O.; Soula, Hedi A.] Univ Lyon 1, CarMeN, INSERM, INSA Lyon,U1060, F-69622 Villeurbanne, France; [Soula, Hedi A.] Inria Ctr Grenoble Rhone Alpes, Project Team Beagle, Grenoble Rhone Alpes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Jacquier, M (corresponding author), Univ Lyon 1, CNRS, Inst Camille Jordan, UMR 5208, F-69622 Villeurbanne, France.	marine.jacquier@inria.fr	SOULAGE, Christophe O/J-2759-2014; Carmen, Team3/Y-7384-2019; Carmen, Team1/Y-7382-2019	SOULAGE, Christophe O/0000-0002-8800-2144; Carmen, Team3/0000-0002-3614-0924; Carmen, Team1/0000-0003-4234-1746; Lab, Carmen/0000-0002-5935-3236; Crauste, Fabien/0000-0002-9979-9638	INSA Lyon, University Lyon 1; Inria; Inserm	INSA Lyon, University Lyon 1; Inria; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was funded by the authors' institutions: INSA Lyon, University Lyon 1, Inria and Inserm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2011, CURR OPIN ENDOCRINOL, V18, P23, DOI 10.1097/MED.0b013e3283424b37; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; Beck B, 2002, BIOCHEM BIOPH RES CO, V292, P1031, DOI 10.1006/bbrc.2002.6737; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; CAMPFIELD LA, 1990, INT J OBESITY, V14, P15; Chow CC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000045; COBELLI C, 1984, MATH BIOSCI, V72, P291, DOI 10.1016/0025-5564(84)90114-7; Covasa M, 2010, AM J PHYSIOL-REG I, V299, pR1423, DOI 10.1152/ajpregu.00126.2010; Cummings DE, 2006, PHYSIOL BEHAV, V89, P71, DOI 10.1016/j.physbeh.2006.05.022; Cummings DE, 2003, ARCH SURG-CHICAGO, V138, P389, DOI 10.1001/archsurg.138.4.389; de Graaf AA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000554; Duca FA, 2012, BRIT J NUTR, V108, P778, DOI 10.1017/S0007114512000529; Duca FA, 2013, HORM BEHAV, V64, P812, DOI 10.1016/j.yhbeh.2013.09.004; Evans SA, 2005, J APPL PHYSIOL, V99, P1336, DOI 10.1152/japplphysiol.01380.2004; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; GARROW JS, 1987, AM J CLIN NUTR, V45, P1114, DOI 10.1093/ajcn/45.5.1114; Greenberg JA, 2000, MECH AGEING DEV, V113, P37, DOI 10.1016/S0047-6374(99)00094-9; Guo JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015961; Guo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000511; Hall KD, 2007, BRIT J NUTR, V97, P1059, DOI 10.1017/S0007114507691946; Hall KD, 2006, AM J PHYSIOL-ENDOC M, V291, pE23, DOI 10.1152/ajpendo.00523.2005; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Hall KD, 2010, BRIT J NUTR, V104, P4, DOI 10.1017/S0007114510000206; Hall KD, 2010, AM J PHYSIOL-ENDOC M, V298, pE449, DOI 10.1152/ajpendo.00559.2009; Higgins SC, 2007, ANN MED, V39, P116, DOI 10.1080/07853890601149179; Horgan GW, 2011, J THEOR BIOL, V270, P1, DOI 10.1016/j.jtbi.2010.11.001; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; MCCARTER RJ, 1992, AM J PHYSIOL, V263, pE448, DOI 10.1152/ajpendo.1992.263.3.E448; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; NELSON KM, 1992, AM J CLIN NUTR, V56, P848, DOI 10.1093/ajcn/56.5.848; NEWBY FD, 1990, AM J PHYSIOL, V259, pR1117, DOI 10.1152/ajpregu.1990.259.6.R1117; Periwal V, 2006, AM J PHYSIOL-ENDOC M, V291, pE929, DOI 10.1152/ajpendo.00122.2006; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Crespo CS, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00058; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Tam J, 2009, CELL METAB, V9, P52, DOI 10.1016/j.cmet.2008.11.005; Tremblay A, 2013, INT J OBESITY, V37, P759, DOI 10.1038/ijo.2012.124; van Leeuwen IMM, 2002, BIOGERONTOLOGY, V3, P373, DOI 10.1023/A:1021336321551; Vestergaard ET, 2007, AM J PHYSIOL-ENDOC M, V292, pE1829, DOI 10.1152/ajpendo.00682.2006; Wijers SLJ, 2009, OBES REV, V10, P218, DOI 10.1111/j.1467-789X.2008.00538.x; Woods SC, 2000, ANNU REV PSYCHOL, V51, P255, DOI 10.1146/annurev.psych.51.1.255; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Zeng JB, 1997, AM J PHYSIOL-ENDOC M, V273, pE1102, DOI 10.1152/ajpendo.1997.273.6.E1102	48	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100073	10.1371/journal.pone.0100073	http://dx.doi.org/10.1371/journal.pone.0100073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932616	Green Published, gold			2022-12-25	WOS:000337738600089
J	Lenda, M; Skorka, P; Knops, JMH; Moron, D; Sutherland, WJ; Kuszewska, K; Woyciechowski, M				Lenda, Magdalena; Skorka, Piotr; Knops, Johannes M. H.; Moron, Dawid; Sutherland, William J.; Kuszewska, Karolina; Woyciechowski, Michal			Effect of the Internet Commerce on Dispersal Modes of Invasive Alien Species	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; BIOLOGICAL INVASIONS; PROPAGULE PRESSURE; PLANT INVASIONS; TRADE; ESTABLISHMENT; ECOSYSTEMS; MANAGEMENT; ECOLOGY; ORIGIN	The spread of invasive alien plants has considerable environmental and economic consequences, and is one of the most challenging ecological problems. The spread of invasive alien plant species depends largely on long-distance dispersal, which is typically linked with human activity. The increasing domination of the internet will have impacts upon almost all components of our lives, including potential consequences for the spread of invasive species. To determine whether the rise of Internet commerce has any consequences for the spread of invasive alien plant species, we studied the sale of thirteen of some of the most harmful Europe invasive alien plant species sold as decorative plants from twenty-eight large, well known gardening shops in Poland that sold both via the Internet and through traditional customer sales. We also analyzed temporal changes in the number of invasive plants sold in the largest Polish internet auction portal. When sold through the Internet invasive alien plant species were transported considerably longer distances than for traditional sales. For internet sales, seeds of invasive alien plant species were transported further than were live plants saplings; this was not the case for traditional sales. Also, with e-commerce the shape of distance distribution were flattened with low skewness comparing with traditional sale where the distributions were peaked and right-skewed. Thus, e-commerce created novel modes of long-distance dispersal, while traditional sale resembled more natural dispersal modes. Moreover, analysis of sale in the biggest Polish internet auction portal showed that the number of alien specimens sold via the internet has increased markedly over recent years. Therefore internet commerce is likely to increase the rate at which ecological communities become homogenized and increase spread of invasive species by increasing the rate of long distance dispersal.	[Lenda, Magdalena; Kuszewska, Karolina; Woyciechowski, Michal] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland; [Skorka, Piotr] Poznan Univ Life Sci, Inst Zool, Poznan, Poland; [Knops, Johannes M. H.] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Moron, Dawid] Polish Acad Sci, Inst Systemat & Evolut Anim, Krakow, Poland; [Sutherland, William J.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England	Jagiellonian University; Poznan University of Life Sciences; University of Nebraska System; University of Nebraska Lincoln; Polish Academy of Sciences; Institute of Systematics & Evolution of Animals of the Polish Academy of Sciences; University of Cambridge	Lenda, M (corresponding author), Jagiellonian Univ, Inst Environm Sci, Krakow, Poland.	lenda.m@vp.pl	Skórka, Piotr/B-7218-2009; Knops, Johannes/AAA-8546-2020; Moroń, Dawid/A-8595-2010	Skórka, Piotr/0000-0002-3221-296X; Moroń, Dawid/0000-0003-3692-7855; Skorka, Piotr/0000-0002-7486-2928; Sutherland, William/0000-0002-6498-0437; kuszewska, Karolina/0000-0001-8104-8740; Lenda, Magdalena/0000-0001-7824-7220	Jagiellonian University [DS/BiNoZ/INoS/756]; Polish National Science Centre [UMO-2011/01/N/NZ8/03211]; Arcadia; Foundation for Polish Science	Jagiellonian University; Polish National Science Centre; Arcadia; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	Funding for this project was partially provided by the Jagiellonian University, DS/BiNoZ/INoS/756, and Polish National Science Centre UMO-2011/01/N/NZ8/03211. WJS is funded by Arcadia. ML and KK were beneficiaries of the Grant for Young Scientists "Start" of the Foundation for Polish Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2009, BIOL INVASIONS, V11, P1145, DOI 10.1007/s10530-008-9382-3; Barton KA, 2012, P ROY SOC B-BIOL SCI, V279, P1194, DOI 10.1098/rspb.2011.1254; Bauer C., 2002, Electronic Markets, V12, P130, DOI 10.1080/10196780252844571; Bouse Derek, 2003, VISUAL STUD, V18, P123, DOI DOI 10.1080/14725860310001631994; Bullock JM, 2000, OECOLOGIA, V124, P506, DOI 10.1007/PL00008876; Cassey P, 2004, J BIOGEOGR, V31, P277, DOI 10.1046/j.0305-0270.2003.00979.x; Chittka L, 2001, NATURE, V411, P653, DOI 10.1038/35079676; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; Czarnecka J, 2012, CENT EUR J BIOL, V7, P895, DOI 10.2478/s11535-012-0081-9; DAISIE, 2009, HDB ALIEN SPECIES EU, DOI [10.1007/978-1-4020-8280-1, DOI 10.1007/978-1-4020-8280-1]; Davis M. A., 2009, INVASION BIOL; Dehnen-Schmutz K, 2007, CONSERV BIOL, V21, P224, DOI 10.1111/j.1523-1739.2006.00538.x; Derraik JGB, 2010, BIOL INVASIONS, V12, P1477, DOI 10.1007/s10530-009-9595-0; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Drake JM, 2004, P ROY SOC B-BIOL SCI, V271, P575, DOI 10.1098/rspb.2003.2629; Elton C. S., 1958, ECOLOGY INVASIONS AN; Essl F, 2012, BIOL INVASIONS, V14, P1331, DOI 10.1007/s10530-011-0156-y; Essl F, 2011, P NATL ACAD SCI USA, V108, P203, DOI 10.1073/pnas.1011728108; Forman Richard T.T., 2002, ROAD ECOLOGY SCI SOL; Frankel SJ, 2008, AUSTRALAS PLANT PATH, V37, P19, DOI 10.1071/AP07088; Freund CL, 2004, J INT ECON, V62, P171, DOI 10.1016/S0022-1996(03)00059-X; Gillespie RG, 2012, TRENDS ECOL EVOL, V27, P47, DOI 10.1016/j.tree.2011.08.009; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Kikillus KH, 2012, BIOL INVASIONS, V14, P2657, DOI 10.1007/s10530-012-0262-5; Lenda M, 2012, P ROY SOC B-BIOL SCI, V279, P1491, DOI 10.1098/rspb.2011.2153; Lewis T, 2008, SMART LIVING LIFESTY, V15; Lines J, 2007, BRIT MED J, V335, P576, DOI 10.1136/bmj.39342.563310.80; Lipinska AM, 2009, NAT CONSERV, V65, P79; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Longley P.A., 2010, GEOGRAPHICAL INFORM; Margolis M, 2005, ECOL ECON, V52, P305, DOI 10.1016/j.ecolecon.2004.07.017; McCullough DG, 2006, BIOL INVASIONS, V8, P611, DOI 10.1007/s10530-005-1798-4; Moron D, 2009, BIOL CONSERV, V142, P1322, DOI 10.1016/j.biocon.2008.12.036; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Pautasso M, 2013, BIOL CONSERV, V158, P37, DOI 10.1016/j.biocon.2012.08.026; Pysek P., 1994, Ecology and management of invasive riverside plants., P19; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Richardson DM, 2008, DIVERS DISTRIB, V14, P161, DOI 10.1111/j.1472-4642.2007.00464.x; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Rieseberg LH, 2007, GENETICA, V129, P149, DOI 10.1007/s10709-006-9011-y; Rixon CAM, 2005, BIODIVERS CONSERV, V14, P1365, DOI 10.1007/s10531-004-9663-9; Saura-Mas S, 2005, ACTA OECOL, V27, P129, DOI 10.1016/j.actao.2004.12.001; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Snaddon JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002579; Tatem AJ, 2009, ECOGRAPHY, V32, P94, DOI 10.1111/j.1600-0587.2008.05588.x; Von der Lippe M, 2007, CONSERV BIOL, V21, P986, DOI 10.1111/j.1523-1739.2007.00722.x; Ward DF, 2006, DIVERS DISTRIB, V12, P601, DOI 10.1111/j.1366-9516.2006.00270.x; White PCL, 2008, WILDLIFE RES, V35, P171, DOI 10.1071/WR08058; Zmihorski M, 2013, OIKOS, V122, P183, DOI 10.1111/j.1600-0706.2012.20486.x	52	41	41	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99786	10.1371/journal.pone.0099786	http://dx.doi.org/10.1371/journal.pone.0099786			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932498	Green Published, gold			2022-12-25	WOS:000337738600063
J	Skardelly, M; Hempel, E; Hirrlinger, J; Wegner, F; Meixensberger, J; Milosevic, J				Skardelly, Marco; Hempel, Eileen; Hirrlinger, Johannes; Wegner, Florian; Meixensberger, Juergen; Milosevic, Javorina			Fluorescent Protein-Expressing Neural Progenitor Cells as a Tool for Transplantation Studies	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; TRANSGENIC MICE; BRAIN; PRECURSORS; NEUROGENESIS; ASTROCYTES; MIGRATION; DELIVERY; NEURONS	The purpose of this study was to generate quadruple fluorescent protein (QFP) transgenic mice as a source for QFP-expressing neural stem and progenitor cells (NSCs/NPCs) that could be utilized as a tool for transplantation research. When undifferentiated, these NSCs only express cyan fluorescent protein (CFP); however, upon neuronal differentiation, the cells express yellow fluorescent protein (YFP). During astrocytic differentiation, the cells express green fluorescent protein (GFP), and during oligodendrocytic differentiation, the cells express red fluorescent protein (DsRed). Using immunocytochemistry, immunoblotting, flow cytometry and electrophysiology, quadruple transgenic NPCs (Q-NPCs) and GFP-sorted NPCs were comprehensively characterized in vitro. Overall, the various transgenes did not significantly affect proliferation and differentiation of transgenic NPCs in comparison to wild-type NPCs. In contrast to a strong CFP and GFP expression in vitro, NPCs did not express YFP and dsRed either during proliferation or after differentiation in vitro. GFP-positive sorted NPCs, expressing GFP under the control of the human GFAP promoter, demonstrated a significant improvement in astroglial differentiation in comparison to GFP-negative sorted NPCs. In contrast to non-sorted and GFP-positive sorted NPCs, GFP-negative sorted NPCs demonstrated a high proportion of neuronal differentiation and proved to be functional in vitro. At 6 weeks after the intracerebroventricular transplantation of Q-NPCs into neonatal wild-type mice, CFP/DCX (doublecortin) double-positive transplanted cells were observed. The Q-NPCs did not express any other fluorescent proteins and did not mature into neuronal or glial cells. Although this model failed to visualize NPC differentiation in vivo, we determined that activation of the NPC glial fibrillary acid protein (GFAP) promoter, as indicated by GFP expression, can be used to separate neuronal and glial progenitors as a valuable tool for transplantation studies.	[Skardelly, Marco; Milosevic, Javorina] Univ Leipzig, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany; [Skardelly, Marco; Hempel, Eileen; Meixensberger, Juergen] Univ Hosp, Dept Neurosurg, Leipzig, Germany; [Hirrlinger, Johannes] Univ Leipzig, Fac Med, Carl Ludwig Inst Physiol, D-04109 Leipzig, Germany; [Wegner, Florian] Hannover Med Sch, Dept Neurol, Hannover, Germany	Leipzig University; Leipzig University; Leipzig University; Hannover Medical School	Skardelly, M (corresponding author), Univ Tubingen Hosp, Dept Neurosurg, Tubingen, Germany.	marco.skardelly@med.uni-tuebingen.de	Skardelly, Marco/AAF-8680-2021; Hirrlinger, Johannes/F-5984-2010		German Federal Ministry of Education and Research (BMBF) [PtJ-Bio 0315883]; Deutsche Forschungsgemeinschaft; Tuebingen University	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tuebingen University	This work was supported by the German Federal Ministry of Education and Research (BMBF, PtJ-Bio 0315883). The authors acknowledge support from Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Bidlingmaier S, 2008, J MOL MED, V86, P1025, DOI 10.1007/s00109-008-0357-8; Bordey A, 2006, CELL CYCLE, V5, P722, DOI 10.4161/cc.5.7.2614; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; Capone C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000373; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Carpenter MK, 2001, EXP NEUROL, V172, P383, DOI 10.1006/exnr.2001.7832; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chazal G, 2000, J NEUROSCI, V20, P1446; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Delaunay D, 2008, J NEUROSCI, V28, P2551, DOI 10.1523/JNEUROSCI.5497-07.2008; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Elkouris M, 2011, STEM CELLS, V29, P89, DOI 10.1002/stem.554; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fuss B, 2000, DEV BIOL, V218, P259, DOI 10.1006/dbio.1999.9574; Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Kim DE, 2004, STROKE, V35, P952, DOI 10.1161/01.STR.0000120308.21946.5D; Kordower JH, 1997, J COMP NEUROL, V387, P96, DOI 10.1002/(SICI)1096-9861(19971013)387:1<96::AID-CNE8>3.0.CO;2-I; Mason JL, 2002, MOL CELL NEUROSCI, V20, P30, DOI 10.1006/mcne.2002.1114; Milosevic J, 2007, J NEUROSCI, V27, P412, DOI 10.1523/JNEUROSCI.2482-06.2007; Milosevic J, 2009, NEUROTOX RES, V15, P367, DOI 10.1007/s12640-009-9043-z; Nieoullon V, 2005, MOL CELL NEUROSCI, V28, P462, DOI 10.1016/j.mcn.2004.10.007; Nolte C, 2001, GLIA, V33, P72; Pfenninger CV, 2007, CANCER RES, V67, P5727, DOI 10.1158/0008-5472.CAN-07-0183; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; SCHMID I, 1994, J IMMUNOL METHODS, V170, P145, DOI 10.1016/0022-1759(94)90390-5; Shen JF, 2008, J CEREBR BLOOD F MET, V28, P1460, DOI 10.1038/jcbfm.2008.37; Thaci B, 2012, CANCER GENE THER, V19, P431, DOI 10.1038/cgt.2012.21; Thu MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007218; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wang C, 2012, CANCER GENE THER, V19, P796, DOI 10.1038/cgt.2012.63; Wegner F, 2009, J NEUROCHEM, V111, P204, DOI 10.1111/j.1471-4159.2009.06315.x; WIGHT PA, 1993, J CELL BIOL, V123, P443, DOI 10.1083/jcb.123.2.443; XUE GP, 1990, DEVELOPMENT, V109, P851; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	41	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99819	10.1371/journal.pone.0099819	http://dx.doi.org/10.1371/journal.pone.0099819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932758	Green Submitted, Green Published, gold			2022-12-25	WOS:000337738600068
J	Korhonen, T; Loukola, A; Wedenoja, J; Nyman, E; Latvala, A; Broms, U; Happola, A; Paunio, T; Schrage, AJ; Vink, JM; Mbarek, H; Boomsma, DI; Penninx, BWJH; Pergadia, ML; Madden, PAF; Kaprio, J				Korhonen, Tellervo; Loukola, Anu; Wedenoja, Juho; Nyman, Emma; Latvala, Antti; Broms, Ulla; Happola, Anja; Paunio, Tiina; Schrage, Andrew J.; Vink, Jaqueline M.; Mbarek, Hamdi; Boomsma, Dorret I.; Penninx, Brenda W. J. H.; Pergadia, Michele L.; Madden, Pamela A. F.; Kaprio, Jaakko			Role of Nicotine Dependence in the Association between the Dopamine Receptor Gene DRD3 and Major Depressive Disorder	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LUNG-CANCER; LINKAGE DISEQUILIBRIUM; SUSCEPTIBILITY LOCUS; QUANTITATIVE TRAITS; D-3 RECEPTOR; POLYMORPHISM; ABUSE; NESDA; TWINS	Background: The aims of this study were to analyze associations of dopamine receptor genes (DRD1-5) with Major Depressive Disorder (MDD) and nicotine dependence (ND), and to investigate whether ND moderates genetic influences on MDD. Methods: The sample was ascertained from the Finnish Twin Cohort. Twin pairs concordant for smoking history were recruited along with their family members, as part of the multisite Nicotine Addiction Genetics consortium. Genetic association analyses were based on 1428 adults. Total of 70 tagging single nucleotide polymorphisms within the dopamine receptor genes were genotyped and analyzed for association with MDD, ND, and MD-ND co-morbidity. Individual level logistic regression analyses were based on 1296 adults with data on ND and MDD diagnoses, as well as on dopamine receptor genotypes adjusted for sex, age, and alcohol use. Four independent samples, such as population-based and casecontrol samples, were used for replication. Results: Rs2399496, located 1.5 kb downstream of DRD3, showed suggestive association for MDD (p = 0.00076) and significant association for MDD-ND co-morbidity (p = 0.000079). Suggestive gene-(rs2399496) by-ND-interaction justified analyses by genetic risk variant and ND status. Individuals with ND and two minor alleles (AA) of rs2399496 had almost sixfold risk for MDD (OR 5.74, 95% CI 3.12-10.5, p = 9.010e-09) compared to individuals without ND and with two major alleles (TT). Conclusions: Significant association between a variant downstream of DRD3 and a co-morbid MDD-ND phenotype was detected. Our results further suggest that nicotine dependence may potentiate the influence of the DRD3 genetic variant on MDD.	[Korhonen, Tellervo; Loukola, Anu; Wedenoja, Juho; Latvala, Antti; Broms, Ulla; Happola, Anja; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Korhonen, Tellervo; Loukola, Anu; Nyman, Emma; Latvala, Antti; Broms, Ulla; Paunio, Tiina; Kaprio, Jaakko] Natl Inst Hlth & Welf, Dept Mental Hlth, Helsinki, Finland; [Korhonen, Tellervo; Loukola, Anu; Nyman, Emma; Latvala, Antti; Broms, Ulla; Paunio, Tiina; Kaprio, Jaakko] Natl Inst Hlth & Welf, Subst Abuse Serv, Helsinki, Finland; [Korhonen, Tellervo] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Nyman, Emma; Paunio, Tiina; Kaprio, Jaakko] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Paunio, Tiina] Univ Helsinki, Dept Psychiat, Cent Hosp, SF-00180 Helsinki, Finland; [Schrage, Andrew J.; Pergadia, Michele L.; Madden, Pamela A. F.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Vink, Jaqueline M.; Mbarek, Hamdi; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Netherlands Twin Register, Amsterdam, Netherlands; [Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr, GGZ, Dept Psychiat, Amsterdam, Netherlands	University of Helsinki; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Eastern Finland; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Washington University (WUSTL); Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Korhonen, T (corresponding author), Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland.	tellervo.korhonen@helsinki.fi	Kaprio, Jaakko/A-1820-2008; Boomsma, Dorret I/AAX-4470-2020; Latvala, Antti/AFK-1462-2022; Penninx, Brenda WJH/S-7627-2017; Wedenoja, Juho/AAX-7008-2020	Kaprio, Jaakko/0000-0002-3716-2455; Penninx, Brenda WJH/0000-0001-7779-9672; Wedenoja, Juho/0000-0002-6155-0378; Latvala, Antti/0000-0001-5695-117X; Korhonen, Tellervo/0000-0003-2838-3085; Loukola, Anu-Maria/0000-0003-0542-5967; Mbarek, Hamdi/0000-0002-1108-0371	Academy of Finland; NIH [DA12854, DA019951]; Doctoral Programs of Public Health; Yrjo Jahnsson Foundation; Juho Vainio Foundation for Post-Doctoral research; Academy of Finland Post-Doctoral Fellowship; Finnish Cultural Foundation; Finnish Medical Foundation; Helsinki Biomedical Graduate School; Global Research Awards for Nicotine Dependence (GRAND) - Pfizer Inc.; Biocentrum Helsinki Foundation; Sigrid Juselius Foundation; University of Helsinki Research Foundation; Orion-Farmos Research Foundation grant; Academy of Finland Center of Excellence in Complex Disease Genetics; ERC [284167]; Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health; Netherlands Organization for Scientific Research (NWO) [Addiction-31160008, 40-0056-98-9032, 985-10-002, 904-61-193]; SPI [56-464-14192]; universities and mental health care institutes involved in NESDA (GGZ InGeest, Rivierduinen, UMC Groningen, GGZ Lentis, GGZ Friesland, GGZ Drenthe) [10-000-1002]; CMSB: Centre for Medical Systems Biology (NWO Genomics); NBIC/BioAssist/RK/024; Institute for Health and Care Research (EMGO+); Neuroscience Campus Amsterdam (NCA); BBMRI [NL-184.021.007]; European Science Council [284167, 230374]; Rutgers University Cell and DNA Repository cooperative agreement [NIMH U24 MH068457-06]; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH068457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012854, R01DA018673, K08DA019951, R56DA012854] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doctoral Programs of Public Health; Yrjo Jahnsson Foundation; Juho Vainio Foundation for Post-Doctoral research; Academy of Finland Post-Doctoral Fellowship(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Medical Foundation; Helsinki Biomedical Graduate School; Global Research Awards for Nicotine Dependence (GRAND) - Pfizer Inc.; Biocentrum Helsinki Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); University of Helsinki Research Foundation; Orion-Farmos Research Foundation grant; Academy of Finland Center of Excellence in Complex Disease Genetics(Academy of Finland); ERC(European Research Council (ERC)European Commission); Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); SPI; universities and mental health care institutes involved in NESDA (GGZ InGeest, Rivierduinen, UMC Groningen, GGZ Lentis, GGZ Friesland, GGZ Drenthe); CMSB: Centre for Medical Systems Biology (NWO Genomics); NBIC/BioAssist/RK/024; Institute for Health and Care Research (EMGO+); Neuroscience Campus Amsterdam (NCA); BBMRI; European Science Council; Rutgers University Cell and DNA Repository cooperative agreement; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported for data collection by Academy of Finland grants to JK and a NIH grant (grant numbers DA12854 to PAFM, DA019951 to MLP). This work was supported by Doctoral Programs of Public Health (UB), the Yrjo Jahnsson Foundation (UB), the Juho Vainio Foundation for Post-Doctoral research (UB), Academy of Finland Post-Doctoral Fellowship (AL), Finnish Cultural Foundation (TK, JW), Finnish Medical Foundation (JW), Helsinki Biomedical Graduate School (JW), a NIH grant (DA019951 to MLP), a Global Research Awards for Nicotine Dependence (GRAND) funded by Pfizer Inc. (to JK), the Biocentrum Helsinki Foundation (EN), the Sigrid Juselius Foundation (EN), the University of Helsinki Research Foundation grant for young researchers (to EN), the Orion-Farmos Research Foundation grant (to EN), and by the Academy of Finland Center of Excellence in Complex Disease Genetics. JV was supported by the ERC starting grant 284167. Finally, the authors would like to thank the NTR and the NESDA studies in the NL for data they used for replication. The work was supported by: Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health; Netherlands Organization for Scientific Research (NWO: MagW/ZonMW) Addiction-31160008; 40-0056-98-9032; 985-10-002; 904-61-193; SPI 56-464-14192; Geestkracht (10-000-1002) and matching funds from universities and mental health care institutes involved in NESDA (GGZ InGeest, Rivierduinen, UMC Groningen, GGZ Lentis, GGZ Friesland, GGZ Drenthe); CMSB: Centre for Medical Systems Biology (NWO Genomics); NBIC/BioAssist/RK/2008.024; Institute for Health and Care Research (EMGO+); Neuroscience Campus Amsterdam (NCA); BBMRI NL-184.021.007; European Science Council 230374, 284167; Rutgers University Cell and DNA Repository cooperative agreement (NIMH U24 MH068457-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Audrain-McGovern J, 2004, AM J PSYCHIAT, V161, P1224, DOI 10.1176/appi.ajp.161.7.1224; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bevilacqua L, 2010, NATURE, V468, P1061, DOI 10.1038/nature09629; Bierut LJ, 2010, TRENDS PHARMACOL SCI, V31, P46, DOI 10.1016/j.tips.2009.10.004; Boomsma DI, 2008, EUR J HUM GENET, V16, P335, DOI 10.1038/sj.ejhg.5201979; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/183242706779462426; Broms U, 2007, DRUG ALCOHOL DEPEN, V89, P42, DOI 10.1016/j.drugalcdep.2006.11.017; Broms U, 2012, NICOTINE TOB RES, V14, P720, DOI 10.1093/ntr/ntr283; BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149; COTTLER LB, 1991, BRIT J PSYCHIAT, V159, P653, DOI 10.1192/bjp.159.5.653; Czermak C, 2004, NICOTINE TOB RES, V6, P49, DOI 10.1080/14622200310001656858; Dani JA, 2005, NAT NEUROSCI, V8, P1465, DOI 10.1038/nn1580; Dannlowski U, 2013, INT J NEUROPSYCHOPH, V16, P1443, DOI 10.1017/S1461145711001659; Dome P, 2010, NEUROSCI BIOBEHAV R, V34, P295, DOI 10.1016/j.neubiorev.2009.07.013; Gelernter J, 2006, HUM MOL GENET, V15, P3498, DOI 10.1093/hmg/ddl426; Goldberg D, 2006, PSYCHOL MED, V36, P1341, DOI 10.1017/S0033291706007665; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; Haddock C K, 1999, Nicotine Tob Res, V1, P59, DOI 10.1080/14622299050011161; Heistaro S, 2008, METHODOLOGY REPORT H, P26; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang WH, 2008, AM J MED GENET B, V147B, P1109, DOI 10.1002/ajmg.b.30731; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Knaapila A, 2011, BEHAV GENET, V41, P512, DOI 10.1007/s10519-010-9403-8; LANDER ES, 1989, GENETICS, V121, P185; Le Foll B, 2005, NEUROPHARMACOLOGY, V49, P525, DOI 10.1016/j.neuropharm.2005.04.022; Lerman C, 1998, HEALTH PSYCHOL, V17, P56, DOI 10.1037/0278-6133.17.1.56; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lopez LS, 2005, BIOL PSYCHIAT, V57, P999, DOI 10.1016/j.biopsych.2005.01.030; Loukola A, 2008, PHARMACOGENOMICS J, V8, P209, DOI 10.1038/sj.tpj.6500464; Nolen-Hoeksema S, 2007, ABNORMAL PSYCHOL, P99; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Nyman ES, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000087; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Ptacek R, 2011, MED SCI MONITOR, V17, pRA215, DOI 10.12659/MSM.881925; Purcell S, 2002, TWIN RES, V5, P554, DOI 10.1375/136905202762342026; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rose RJ, 2010, HANDBOOK OF BEHAVIOR GENETICS, P411, DOI 10.1007/978-0-387-76727-7_28; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; Stapleton JA, 2011, PHARMACOGENET GENOM, V21, P447, DOI 10.1097/FPC.0b013e328347473a; StataCorp, 2019, STATA STAT SOFTWARE; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thornton T, 2007, AM J HUM GENET, V81, P321, DOI 10.1086/519497; Vandenbergh DJ, 2007, ADDICT BIOL, V12, P106, DOI 10.1111/j.1369-1600.2007.00054.x; Verde Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026668; Vink JM, 2009, AM J HUM GENET, V84, P367, DOI 10.1016/j.ajhg.2009.02.001; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; World Health Organization, 2004, NEUR PSYCH SUBST US	53	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98199	10.1371/journal.pone.0098199	http://dx.doi.org/10.1371/journal.pone.0098199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927283	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100014
J	Guo, HT; Gao, JM; Taxman, DJ; Ting, JPY; Su, LS				Guo, Haitao; Gao, Jianmei; Taxman, Debra J.; Ting, Jenny P. Y.; Su, Lishan			HIV-1 Infection Induces Interleukin-1 beta Production via TLR8 Protein-dependent and NLRP3 Inflammasome Mechanisms in Human Monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; SINGLE-STRANDED RNA; NALP3 INFLAMMASOME; IMMUNE ACTIVATION; PORPHYROMONAS-GINGIVALIS; CUTTING EDGE; CELLS; RECOGNITION; EXPRESSION; GENE	The induction of inflammatory cytokines such as IL-1 beta is associated with the progression of human immunodeficiency virus, type 1 (HIV-1) disease or AIDS. Unlike most inflammatory cytokines that are regulated by NF-kappa B at the transcriptional level, production of mature IL-1 beta also depends on inflammasome activation. The mechanism by which HIV-1 induces pro-IL-1 beta expression and activates inflammasomes to cleave pro-IL-1 beta into its bioactive form is not clearly defined. We report here that HIV-1 infection in human monocytes efficiently induced IL-1 beta expression and inflammasome activation. Toll-like receptor 8 (TLR8) was required for inducing pro-IL-1 beta expression, whereas the NLRP3 inflammasome was required for IL-1 beta maturation and release. Furthermore, the lysosomal protease cathepsin B and HIV-1 induced production of reactive oxygen species were critical for HIV-induced inflammasome activation and IL-1 beta production. HIV-1 entry, reverse transcription, and integration were all required for both pro-IL-1 beta expression and inflammasome activation. Finally, we show that HIV-1-derived RNA was sufficient to induce both pro-IL-1 beta expression and inflammasome activation. We conclude that HIV-1 infection induced the expression of pro-IL-1 beta via TLR8-mediated mechanisms and activated caspase-1 through the NLRP3 inflammasome to cleave pro-IL-1 beta into bioactive IL-1 beta. These findings help to elucidate mechanisms of HIV-1 disease progression and identify novel targets for treating HIV-1 induced inflammation and immune activation.	[Guo, Haitao; Gao, Jianmei; Taxman, Debra J.; Ting, Jenny P. Y.; Su, Lishan] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Taxman, Debra J.; Ting, Jenny P. Y.; Su, Lishan] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Su, LS (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	lsu@med.unc.edu			National Institute of Health [AI077454, AI080432, AI095097, AI029564, AI057157, CA156330]; NATIONAL CANCER INSTITUTE [R01CA156330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080432, R01AI077454, R01AI095097, U54AI057157, R37AI029564, R01AI029564, R56AI029564] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institute of Health Grants AI077454, AI080432, and AI095097 (to L. S.) and AI029564, AI057157, and CA156330 (to J. P. T.).	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; ARDITI M, 1991, PEDIATR INFECT DIS J, V10, P450, DOI 10.1097/00006454-199106000-00007; Baenziger S, 2009, BLOOD, V113, P377, DOI 10.1182/blood-2008-04-151712; Barlan AU, 2011, VIROLOGY, V412, P306, DOI 10.1016/j.virol.2011.01.019; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Chackerian B, 1997, J VIROL, V71, P3932, DOI 10.1128/JVI.71.5.3932-3939.1997; Chahroudi A, 2012, SCIENCE, V335, P1188, DOI 10.1126/science.1217550; Chan ML, 2010, P ROY SOC B-BIOL SCI, V277, P3773, DOI 10.1098/rspb.2010.0972; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fischer WB, 2002, BBA-BIOMEMBRANES, V1561, P27, DOI 10.1016/S0304-4157(01)00009-0; GENDELMAN HE, 1990, J EXP MED, V172, P1433, DOI 10.1084/jem.172.5.1433; GLIENKE W, 1994, RES VIROLOGY, V145, P193, DOI 10.1016/S0923-2516(07)80022-7; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Han XB, 2012, J BIOL CHEM, V287, P13778, DOI 10.1074/jbc.M112.342683; Hart OM, 2005, J IMMUNOL, V175, P1636, DOI 10.4049/jimmunol.175.3.1636; Hartigan-O'Connor DJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003941; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huang MTH, 2009, J IMMUNOL, V182, P2395, DOI 10.4049/jimmunol.0800909; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Jiang Q, 2008, BLOOD, V112, P2858, DOI 10.1182/blood-2008-03-145946; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; Meissner EG, 2005, VIROLOGY, V336, P184, DOI 10.1016/j.virol.2005.03.032; Meissner EG, 2004, VIROLOGY, V328, P74, DOI 10.1016/j.virol.2004.07.019; MELTZER MS, 1991, PATHOBIOLOGY, V59, P209, DOI 10.1159/000163647; Mogensen TH, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-54; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; Nixon DE, 2010, CURR OPIN HIV AIDS, V5, P498, DOI 10.1097/COH.0b013e32833ed6f4; Nour AM, 2011, J BIOL CHEM, V286, P17921, DOI 10.1074/jbc.M110.210575; Pontillo A, 2012, AIDS, V26, P11, DOI 10.1097/QAD.0b013e32834d697f; Pontillo A, 2010, JAIDS-J ACQ IMM DEF, V54, P236, DOI 10.1097/QAI.0b013e3181dd17d4; Rahman MM, 2011, J VIROL, V85, P12505, DOI 10.1128/JVI.00410-11; Rajan JV, 2011, J VIROL, V85, P4167, DOI 10.1128/JVI.01687-10; Rotger M, 2011, J CLIN INVEST, V121, P2391, DOI 10.1172/JCI45235; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Segovia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029695; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Taxman DJ, 2006, J IMMUNOL, V177, P4252, DOI 10.4049/jimmunol.177.7.4252; Taxman DJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-7; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Wu MF, 2013, BLOOD, V121, P95, DOI 10.1182/blood-2012-05-430090; Zhang LG, 2007, BLOOD, V109, P2978, DOI 10.1182/blood-2006-07-033159; Zhang LG, 2011, BLOOD, V117, P6184, DOI 10.1182/blood-2011-01-331173	58	94	97	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21716	21726		10.1074/jbc.M114.566620	http://dx.doi.org/10.1074/jbc.M114.566620			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24939850	hybrid, Green Published			2022-12-25	WOS:000340558300045
J	Zhao, KX; Li, SS; Wu, LY; Lai, C; Yang, GD				Zhao, Kexin; Li, Shuangshuang; Wu, Lingyun; Lai, Christopher; Yang, Guangdong			Hydrogen Sulfide Represses Androgen Receptor Transactivation by Targeting at the Second Zinc Finger Module	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; POSTTRANSLATIONAL MODIFICATION; ENDOGENOUS H2S; CANCER; GENE; INACTIVATION; DIMERIZATION; SURVIVAL; DOMAINS; SRC-1	Androgen receptor (AR) signaling is indispensable for the development of prostate cancer from the initial androgen-dependent state to a later aggressive androgen-resistant state. This study examined the role of hydrogen sulfide (H2S), a novel gasotransmitter, in the regulation of AR signaling as well as its mediation in androgen-independent cell growth in prostate cancer cells. Here we found that H2S inhibits cell proliferation of both androgen-dependent (LNCaP) and antiandrogen-resistant prostate cancer cells (LNCaP-B), with more significance on the latter, which was established by long term treatment of parental LNCaP cells with bicalutamide. The expression of cystathionine gamma-lyase(CSE), a major H2S-producing enzyme in prostate tissue, was reduced in both human prostate cancer tissues and LNCaP-B cells. LNCaP-B cells were resistant to bicalutamide-induced cell growth inhibition, and CSE overexpression could rebuild the sensitivity of LNCaP-B cells to bicalutamide. H2S significantly repressed the expression of prostate-specific antigen (PSA) and TMPRSS2, two AR-targeted genes. In addition, H2S inhibited AR binding with PSA promoter and androgen-responsive element(ARE) luciferase activity. We further found that AR is post-translationally modified by H2S through S-sulfhydration. Mutation of cysteine 611 and cysteine 614 in the second zinc finger module of AR-DNA binding domain diminished the effects of H2S on AR S-sulfhydration and AR dimerization. These data suggest that reduced CSE/H2S signaling contributes to antiandrogen-resistant status, and sufficient level of H2S is able to inhibit AR transactivation and treat castration-resistant prostate cancer.	[Zhao, Kexin; Li, Shuangshuang; Wu, Lingyun; Lai, Christopher; Yang, Guangdong] Lakehead Univ, Cardiovasc & Metab Res Unit, Thunder Bay, ON P7B 5E1, Canada; [Zhao, Kexin; Li, Shuangshuang; Yang, Guangdong] Lakehead Univ, Sch Kinesiol, Thunder Bay, ON P7B 5E1, Canada; [Wu, Lingyun] Lakehead Univ, Dept Hlth Sci, Thunder Bay, ON P7B 5E1, Canada; [Wu, Lingyun] Thunder Bay Reg Res Inst, Thunder Bay, ON P7B 6V4, Canada; [Lai, Christopher] Lakehead Univ, Northern Ontario Sch Med, Thunder Bay, ON P7B 5E1, Canada	Lakehead University; Lakehead University; Lakehead University; Northern Ontario School of Medicine; Lakehead University; Northern Ontario School of Medicine	Yang, GD (corresponding author), Lakehead Univ, Sch Kinesiol, 955 Oliver Rd, Thunder Bay, ON P7B 5E1, Canada.	gyang@lakeheadu.ca	Yang, Guangdong/G-4129-2011		Heart and Stroke Foundation of Canada	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This study was supported by a grant-in-aid from the Heart and Stroke Foundation of Canada.; Supported by a New Investigator award from the Heart and Stroke Foundation of Canada. To whom correspondence should be addressed: the School of Kinesiology, Lakehead University, 955 Oliver Rd., Thunder Bay, Ontario P7B 5E1, Canada. Tel.: 807-346-7937; Fax: 807-346-7873; E-mail: gyang@lakeheadu.ca.	Al-Awadi F, 2008, ANTICANCER RES, V28, P2541; Bernard D, 2003, J CLIN INVEST, V112, P1724; Cao QH, 2010, ANTIOXID REDOX SIGN, V12, P1101, DOI 10.1089/ars.2009.2915; Centenera MM, 2008, MOL ENDOCRINOL, V22, P2373, DOI 10.1210/me.2008-0017; Clinckemalie L, 2013, MOL ENDOCRINOL, V27, P2028, DOI 10.1210/me.2013-1098; Edwards BK, 2014, CANCER-AM CANCER SOC, V120, P1290, DOI 10.1002/cncr.28509; Gadalla MM, 2010, J NEUROCHEM, V113, P14, DOI 10.1111/j.1471-4159.2010.06580.x; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Gioeli D, 2012, MOL CELL ENDOCRINOL, V352, P70, DOI 10.1016/j.mce.2011.07.004; Guo H, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.10.013; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Helsen C, 2012, MOL CELL BIOL, V32, P3033, DOI 10.1128/MCB.00151-12; Hirawat S, 2003, CANCER INVEST, V21, P400, DOI 10.1081/CNV-120018232; Kaczmarczyk SJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng087; Kim SH, 2009, MOL CANCER THER, V8, P1946, DOI 10.1158/1535-7163.MCT-09-0104; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; Lallous N, 2013, INT J MOL SCI, V14, P12496, DOI 10.3390/ijms140612496; Lee ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021077; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Ma KU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020525; McCourt C, 2012, CLIN CANCER RES, V18, P3822, DOI 10.1158/1078-0432.CCR-11-3277; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Nazareth LV, 1999, MOL ENDOCRINOL, V13, P2065, DOI 10.1210/me.13.12.2065; Pei YX, 2011, TOXICOL APPL PHARM, V257, P420, DOI 10.1016/j.taap.2011.09.026; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Qin Y, 2013, CANCER RES, V73, P6690, DOI 10.1158/0008-5472.CAN-13-1042; Schoenmakers E, 1999, BIOCHEM J, V341, P515, DOI 10.1042/0264-6021:3410515; Sen U, 2012, AM J PHYSIOL-CELL PH, V303, pC41, DOI 10.1152/ajpcell.00398.2011; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; van der Steen T, 2013, INT J MOL SCI, V14, P14833, DOI 10.3390/ijms140714833; van Royen ME, 2012, J CELL SCI, V125, P1970, DOI 10.1242/jcs.096792; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; WONG CI, 1993, J BIOL CHEM, V268, P19004; Yang G, 2006, FASEB J, V20, P553, DOI 10.1096/fj.05-4712fje; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang GD, 2013, ANTIOXID REDOX SIGN, V18, P1906, DOI 10.1089/ars.2012.4645; Yang GD, 2011, AM J PATHOL, V179, P869, DOI 10.1016/j.ajpath.2011.04.028; Yang GD, 2011, J BIOL CHEM, V286, P26450, DOI 10.1074/jbc.M111.266643; Yu S, 2013, CANCER LETT, V328, P83, DOI 10.1016/j.canlet.2012.09.006	41	49	50	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20824	20835		10.1074/jbc.M114.559518	http://dx.doi.org/10.1074/jbc.M114.559518			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24942741	hybrid, Green Published			2022-12-25	WOS:000339396600037
J	Duarte, CW; Stohn, JP; Wang, QZ; Emery, IF; Prueser, A; Lindner, V				Duarte, Christine W.; Stohn, J. Patrizia; Wang, Qiaozeng; Emery, Ivette F.; Prueser, Andrew; Lindner, Volkhard			Elevated Plasma Levels of the Pituitary Hormone Cthrc1 in Individuals with Red Hair but Not in Patients with Solid Tumors	PLOS ONE			English	Article							TRIPLE-HELIX REPEAT; MELANOCORTIN 1 RECEPTOR; CELL-MIGRATION; CANCER; CONTAINING-1; EXPRESSION; PROTEIN; MC1R; SKIN; METASTASIS	Background: An increasing number of studies report that Cthrc1 is expressed in various cancer cells. The present study sought to identify which cells in tumors and remodeling tissues express Cthrc1 and investigate the range of circulating human Cthrc1 levels in health and disease. Methodology/Principle Findings: Highly specific monoclonal antibodies were generated to detect Cthrc1 by ELISA in plasma and in tissues by immunohistochemistry. In human colon, gastric, breast, endometrial, pancreatic, kidney, lung and skin cancer, Cthrc1 was expressed by activated stromal cells and not the cancer cells themselves. Similarly, conditions evoking tissue remodeling, such as wound repair or angiotensin II-mediated hypertension, induced Cthrc1 expression in interstitial and adventitial fibroblasts and perivascular stromal cells. Levels of Cthrc1 in plasma from healthy subjects were near the lower detection limit except for individuals with red hair, who had up to several hundred fold higher levels. Elevated Cthrc1 was also found in patients with diabetes, inflammatory conditions, and infections, but not solid tumors. Transgenic mouse studies suggested that Cthrc1 expression by stromal cells does not contribute to circulating levels. In human pituitaries, Cthrc1 was expressed in the anterior and intermediate lobes with unencapsulated Cthrc1 accumulations typically surrounded by chromophobe cells. Conclusions: We identify Cthrc1 as a marker for activated stromal cells. Cthrc1 is a pituitary hormone with significantly elevated levels in subjects carrying variant alleles of the melanocortin-1 receptor as wells as in patients with inflammatory conditions.	[Duarte, Christine W.; Stohn, J. Patrizia; Wang, Qiaozeng; Emery, Ivette F.; Prueser, Andrew; Lindner, Volkhard] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME 04102 USA	Maine Medical Center	Lindner, V (corresponding author), Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME 04102 USA.	lindnv@mmc.org			National Institutes of Health [HL69182]; National Center for Research Resources [P20 RR-15555];  [P20RR018789/P20GM103465];  [P30RR030927/P30GM103392]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103392, P30GM106391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by National Institutes of Health grants HL69182 (V. L.) and P20 RR-15555 from the National Center for Research Resources. The Histopathology Core Facility is supported by P20RR018789/P20GM103465 (D. Wojchowski,PI) and P30RR030927/ P30GM103392 (R. Friesel, PI). The Mouse Transgenic and Imaging Core is supported by P30RR030927/P30GM103392 (R. Friesel, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohm M, 2006, J INVEST DERMATOL, V126, P1966, DOI 10.1038/sj.jid.5700421; Bohm M, 2012, ENDOCR REV, V33, P623, DOI 10.1210/er.2011-1016; Catania A, 1999, ANN NY ACAD SCI, V885, P183; Chen YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070324; Cuttler AS, 2011, GENESIS; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Glant TT, 2008, J IMMUNOL, V181, P1307, DOI 10.4049/jimmunol.181.2.1307; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Healy E, 2001, HUM MOL GENET, V10, P2397, DOI 10.1093/hmg/10.21.2397; Healy E, 1999, J INVEST DERMATOL, V112, P512, DOI 10.1046/j.1523-1747.1999.00554.x; Kharaishvili G, 2011, J CLIN PATHOL, V64, P977, DOI 10.1136/jclinpath-2011-200106; Kim JH, 2013, PATHOL ONCOL RES, V19, P731, DOI 10.1007/s12253-013-9636-y; Kimura H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003174; Lee M, 2007, FRONT BIOSCI-LANDMRK, V12, P3994, DOI 10.2741/2366; Lipton JM, 1999, ANN NY ACAD SCI, V885, P173; Liu GL, 2013, J BIOL CHEM, V288, P20217, DOI 10.1074/jbc.M113.473785; Palma M, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-2; Park EH, 2013, CARCINOGENESIS, V34, P694, DOI 10.1093/carcin/bgs378; Pyagay P, 2005, CIRC RES, V96, P261, DOI 10.1161/01.RES.0000154262.07264.12; Rees JL, 2000, PIGM CELL RES, V13, P135, DOI 10.1034/j.1600-0749.2000.130303.x; Spector I, 2013, AM J PATHOL, V182, P905, DOI 10.1016/j.ajpath.2012.11.004; Steller EJA, 2013, NEOPLASIA, V15, P204, DOI 10.1593/neo.121726; Stohn JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047142; Tan F, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0473-3; Tang L, 2006, CLIN CANCER RES, V12, P3716, DOI 10.1158/1078-0432.CCR-06-0030; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Wang L, 2011, BRIT J DERMATOL, V164, P135, DOI 10.1111/j.1365-2133.2010.10050.x; Wang P, 2012, CANCER SCI, V103, P1327, DOI 10.1111/j.1349-7006.2012.02292.x; Williams PF, 2011, INT J CANCER, V129, P1730, DOI 10.1002/ijc.25804; Zhang GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045037	30	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100449	10.1371/journal.pone.0100449	http://dx.doi.org/10.1371/journal.pone.0100449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945147	Green Published, gold, Green Submitted			2022-12-25	WOS:000340721500077
J	Levin, E; Leibinger, M; Andreadaki, A; Fischer, D				Levin, Evgeny; Leibinger, Marco; Andreadaki, Anastasia; Fischer, Dietmar			Neuronal Expression of Muscle LIM Protein in Postnatal Retinae of Rodents	PLOS ONE			English	Article							STARBURST AMACRINE CELLS; RABBIT RETINA; RAT RETINA; CHOLINE-ACETYLTRANSFERASE; HEART-FAILURE; MOUSE RETINA; MLP; DIFFERENTIATION; CARDIOMYOPATHY; IDENTIFICATION	Muscle LIM protein (MLP) is a member of the cysteine rich protein family and has so far been regarded as a muscle-specific protein that is mainly involved in myogenesis and the organization of cytoskeletal structure in myocytes, respectively. The current study demonstrates for the first time that MLP expression is not restricted to muscle tissue, but is also found in the rat naive central nervous system. Using quantitative PCR, Western blot and immunohistochemical analyses we detected MLP in the postnatal rat retina, specifically in the somas and dendritic arbors of cholinergic amacrine cells (AC) of the inner nuclear layer and the ganglion cell layer (displaced AC). Induction of MLP expression started at embryonic day 20 and peaked between postnatal days 7 and 14. It subsequently decreased again to non-detectable protein levels after postnatal day 28. MLP was identified in the cytoplasm and dendrites but not in the nucleus of AC. Thus, retinal MLP expression correlates with the morphologic and functional development of cholinergic AC, suggesting a potential role of this protein in postnatal maturation and making MLP a suitable marker for these neurons.	[Levin, Evgeny; Leibinger, Marco; Andreadaki, Anastasia; Fischer, Dietmar] Univ Dusseldorf, Dept Neurol, Div Expt Neurol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Fischer, D (corresponding author), Univ Dusseldorf, Dept Neurol, Div Expt Neurol, Dusseldorf, Germany.	dietmar.fischer@uni-duesseldorf.de		Fischer, Dietmar/0000-0002-1816-3014	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 1996, GENE DEV, V10, P289, DOI 10.1101/gad.10.3.289; ARBER S, 1994, CELL, V79, P221, DOI 10.1016/0092-8674(94)90192-9; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Bansal A, 2000, J NEUROSCI, V20, P7672; Boateng SY, 2007, AM J PHYSIOL-HEART C, V292, pH259, DOI 10.1152/ajpheart.00766.2006; Buyandelger B, 2011, PFLUG ARCH EUR J PHY, V462, P135, DOI 10.1007/s00424-011-0961-2; ECKENSTEIN F, 1982, EMBO J, V1, P363, DOI 10.1002/j.1460-2075.1982.tb01175.x; Elshatory Y, 2007, J NEUROSCI, V27, P12707, DOI 10.1523/JNEUROSCI.3951-07.2007; Emanuela P, 2009, J COMP NEUROL, V517, P737, DOI 10.1002/cne.22200; FAMIGLIETTI EV, 1987, BRAIN RES, V413, P404, DOI 10.1016/0006-8993(87)91038-9; FAMIGLIETTI EV, 1983, BRAIN RES, V261, P138, DOI 10.1016/0006-8993(83)91293-3; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; FISHER LJ, 1979, J COMP NEUROL, V187, P359, DOI 10.1002/cne.901870207; Flick MJ, 2000, J CELL SCI, V113, P1553; Flick MJ, 2002, BIOCHEM BIOPH RES CO, V295, P910, DOI 10.1016/S0006-291X(02)00768-4; Ford KJ, 2012, VISUAL NEUROSCI, V29, P61, DOI 10.1017/S0952523811000216; Gehmlich K, 2008, J MUSCLE RES CELL M, V29, P155, DOI 10.1007/s10974-008-9159-4; Geier C, 2008, HUM MOL GENET, V17, P2753, DOI 10.1093/hmg/ddn160; Haverkamp S, 2000, J COMP NEUROL, V424, P1; HAYDEN SA, 1980, SCIENCE, V210, P435, DOI 10.1126/science.7433984; Inoue T, 2002, DEVELOPMENT, V129, P831; Kim IB, 2000, J COMP NEUROL, V427, P604, DOI 10.1002/1096-9861(20001127)427:4<604::AID-CNE8>3.0.CO;2-C; Kong YF, 1997, MOL CELL BIOL, V17, P4750, DOI 10.1128/MCB.17.8.4750; Louis HA, 1997, J BIOL CHEM, V272, P27484, DOI 10.1074/jbc.272.43.27484; Macneil MA, 1999, J COMP NEUROL, V413, P305; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; Papalouka V, 2009, MOL CELL BIOL, V29, P6046, DOI 10.1128/MCB.00654-09; Rapaport DH, 2004, J COMP NEUROL, V474, P304, DOI 10.1002/cne.20134; Taylor WR, 2012, VISUAL NEUROSCI, V29, P73, DOI 10.1017/S0952523811000393; VANEY DI, 1981, J COMP NEUROL, V199, P373, DOI 10.1002/cne.901990305; VOIGT T, 1986, J COMP NEUROL, V248, P19, DOI 10.1002/cne.902480103; Wang XH, 2006, J MOL CELL CARDIOL, V40, P503, DOI 10.1016/j.yjmcc.2006.01.005; Wei W, 2011, NATURE, V469, P402, DOI 10.1038/nature09600; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Zhang M, 2005, J COMP NEUROL, V484, P331, DOI 10.1002/cne.20470	36	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100756	10.1371/journal.pone.0100756	http://dx.doi.org/10.1371/journal.pone.0100756			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945278	gold, Green Published, Green Submitted			2022-12-25	WOS:000340721500103
J	Kanzaki, N; Tanaka, R; Giblin-Davis, RM; Davies, KA				Kanzaki, Natsumi; Tanaka, Ryusei; Giblin-Davis, Robin M.; Davies, Kerrie A.			New Plant-Parasitic Nematode from the Mostly Mycophagous Genus Bursaphelenchus Discovered inside Figs in Japan	PLOS ONE			English	Article							N. SP NEMATODA; SP TYLENCHINA APHELENCHOIDIDAE; PHYLOGENETIC-RELATIONSHIPS; PINE WOOD; PARASITAPHELENCHIDAE; FUCHS; DNA; WASPS; XYLOPHILUS; ALGORITHMS	A new nematode species, Bursaphelenchus sycophilus n. sp. is described. The species was found in syconia of a fig species, Ficus variegata during a field survey of fig-associated nematodes in Japan. Because it has a well-developed stylet and pharyngeal glands, the species is considered an obligate plant parasite, and is easily distinguished from all other fungal-feeding species in the genus based upon these characters. Although B. sycophilus n. sp. shares an important typological character, male spicule possessing a strongly recurved condylus, with the "B. eremus group" and the "B. leoni group" of the genus, it was inferred to be monophyletic with the "B. fungivorus group". The uniquely shaped stylet and well-developed pharyngeal glands is reminiscent of the fig-floret parasitic but paraphyletic assemblage of "Schistonchus". Thus, these morphological characters appear to be an extreme example of convergent evolution in the nematode family, Aphelenchoididae, inside figs. Other characters shared by the new species and its close relatives, i.e., lack of ventral P1 male genital papilla, female vulval flap, and papilla-shaped P4 genital papillae in males, corroborate the molecular phylogenetic inference. The unique biological character of obligate plant parasitism and highly derived appearance of the ingestive organs of Bursaphelenchus sycophilus n. sp. expands our knowledge of the potential morphological, physiological and developmental plasticity of the genus Bursaphelenchus.	[Kanzaki, Natsumi] Forestry & Forest Prod Res Inst, Dept Forest Microbiol, Tsukuba, Ibaraki 305, Japan; [Tanaka, Ryusei] Miyazaki Univ, Fac Med, Div Parasitol, Miyazaki, Japan; [Giblin-Davis, Robin M.] Univ Florida IFAS, Ft Lauderdale Res & Educ Ctr, Davie, FL USA; [Davies, Kerrie A.] Univ Adelaide, Ctr Evolutionary Biol & Biodivers, Sch Agr Food & Wine, Glen Osmond, SA, Australia	Forestry & Forest Products Research Institute - Japan; University of Miyazaki; State University System of Florida; University of Florida; University of Adelaide	Kanzaki, N (corresponding author), Forestry & Forest Prod Res Inst, Dept Forest Microbiol, Tsukuba, Ibaraki 305, Japan.	nkanzaki@affrc.go.jp		Giblin-Davis, Robin/0000-0002-8861-8678	Ministry of Education, Culture, Sports, Science and Technology, Japan [22310145, 24658147, 26292178, 259930]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by Grants-in-Aid for Scientific Research, Nos 22310145, 24658147 and 26292178, Grant-in-Aid for JSPS Fellows, No 259930 from The Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen HF, 2012, ECOL EVOL, V2, P247, DOI 10.1002/ece3.58; BAUJARD P, 1989, Revue de Nematologie, V12, P323; Baujard P., 1980, Revue de Nematologie, V3, P167; Braasch H, 2002, NEMATOLOGY, V4, P853, DOI 10.1163/156854102760402621; Braasch H., 2001, Bulletin OEPP, V31, P127, DOI 10.1111/j.1365-2338.2001.tb00982.x; Braasch H., 2009, Journal of Nematode Morphology and Systematics, V12, P65; Center BJ, 1999, J NEMATOL, V31, P393; Cruaud A, 2012, SYST BIOL, V61, P1029, DOI 10.1093/sysbio/sys068; Davies K, 2010, NEMATOLOGY, V12, P935, DOI 10.1163/138855410X498932; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Futai K, 2013, ANNU REV PHYTOPATHOL, V51, P61, DOI 10.1146/annurev-phyto-081211-172910; GIBLIN R M, 1984, Revue de Nematologie, V7, P13; GIBLIN-DAVIS R M, 1989, Revue de Nematologie, V12, P285; Giblin-Davis RM, 2006, ZOOTAXA, P39; Giblin-Davis RM, 2013, CABI INVASIVE SER, P1, DOI 10.1079/9781845938291.0001; Giblin-Davis Robin M., 1993, P302; GIBLINDAVIS RM, 1989, NEMATROPICA, V19, P135; GIBLINDAVIS RM, 1995, J NEMATOL, V27, P1; GRIFFITH R, 1987, PLANT DIS, V71, P193; Gu J, 2006, RUSS J NEMATOL, V14, P91; Gu JF, 2012, RUSS J NEMATOL, V20, P53; Gu JF, 2010, RUSS J NEMATOL, V18, P59; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hembry DH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0361; HERRE EA, 1993, SCIENCE, V259, P1442, DOI 10.1126/science.259.5100.1442; Hooper D. J., 1986, LAB METHODS WORK PLA, P59; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jauharlina J, 2012, AFR ENTOMOL, V20, P101, DOI 10.4001/003.020.0113; Jordal BH, 1998, J TROP ECOL, V14, P153, DOI 10.1017/S0266467498000133; Kanzaki N, 2002, NEMATOLOGY, V4, P35, DOI 10.1163/156854102760082186; Kanzaki N, 2001, NEMATOLOGY, V3, P473, DOI 10.1163/156854101753250809; Kanzaki N, 2013, NEMATOL RES, V43, P43; Kanzaki N., 2008, PINE WILT DISEASE, P44; Kanzaki N., 2012, PRACTICAL PLANT NEMA, P161; Kanzaki N, 2013, NEMATOLOGY, V15, P975, DOI 10.1163/15685411-00002736; Kanzaki N, 2013, NEMATOLOGY, V15, P895, DOI 10.1163/15685411-00002728; Kanzaki N, 2013, J PARASITOL, V99, P639, DOI 10.1645/12-118.1; Kanzaki N, 2012, NEMATOLOGY, V14, P223, DOI 10.1163/138855411X587121; Kanzaki N, 2011, NEMATOLOGY, V13, P787, DOI 10.1163/138855410X552652; Kanzaki N, 2009, NEMATOLOGY, V11, P129, DOI 10.1163/156854108X398480; Kanzaki NK, 2007, NEMATOLOGY, V9, P759, DOI 10.1163/156854107782331216; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kikuchi T, 2009, PHYTOPATHOLOGY, V99, P1365, DOI 10.1094/PHYTO-99-12-1365; KORENTCHENKO EA, 1980, ZOOL ZH, V59, P1768; Lange C., 2007, Journal of Nematode Morphology and Systematics, V9, P95; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; LIEUTIER F, 1978, NEMATOLOGICA, V24, P187, DOI 10.1163/187529278X00399; Machado CA, 2005, P NATL ACAD SCI USA, V102, P6558, DOI 10.1073/pnas.0501840102; Maehara Noritoshi, 2013, Nematological Research, V43, P9, DOI 10.3725/jjn.43.9; MAMIYA Y, 1972, NEMATOLOGICA, V18, P120, DOI 10.1163/187529272X00296; Massey C. L., 1974, BIOL TAXONOMY NEMATO; MASSEY CL, 1971, J NEMATOL, V3, P289; Minagawa Nozomu, 1994, Japanese Journal of Nematology, V24, P75; Molbo D, 2003, P NATL ACAD SCI USA, V100, P5867, DOI 10.1073/pnas.0930903100; Murray EA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0495; POINAR GO, 1979, P K NED AKAD C BIOL, V82, P375; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronsted N, 2005, P ROY SOC B-BIOL SCI, V272, P2593, DOI 10.1098/rspb.2005.3249; Ruhm W., 1956, Parasitologische Schriftenreihe, VNo. 6, P1; Ryss A, 2005, NEMATOLOGY, V7, P393, DOI 10.1163/156854105774355581; Schonfeld U, 2006, RUSS J NEMATOL, V14, P119; Siddiqi M. R., 2000, TYLENCHIDA PARASITES; Skarmoutsos G, 2000, FOREST PATHOL, V30, P149, DOI 10.1046/j.1439-0329.2000.00198.x; Tanaka R, 2012, APPL ENTOMOL ZOOL, V47, P291, DOI 10.1007/s13355-012-0115-9; VOVLAS N, 1992, NEMATOLOGICA, V38, P215, DOI 10.1163/187529292X00180; Walter DE, 2000, AUST J ENTOMOL, V39, P229, DOI 10.1046/j.1440-6055.2000.00184.x; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; WIEBES JT, 1979, ANNU REV ECOL SYST, V10, P1, DOI 10.1146/annurev.es.10.110179.000245; Ye WM, 2007, MOL PHYLOGENET EVOL, V43, P1185, DOI 10.1016/j.ympev.2007.02.006; Yoder M, 2006, NEMATOLOGY, V8, P367, DOI 10.1163/156854106778493448; Zeng YS, 2013, NEMATOLOGY, V15, P771, DOI 10.1163/15685411-00002717; Zeng YS, 2013, ZOOTAXA, V3717, P598, DOI 10.11646/zootaxa.3717.4.9; Zhao ZQ, 2008, NEMATOLOGY, V10, P663, DOI 10.1163/156854108785787299; Zhuo K, 2007, NEMATOLOGY, V9, P237, DOI 10.1163/156854107780739090	74	36	37	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99241	10.1371/journal.pone.0099241	http://dx.doi.org/10.1371/journal.pone.0099241			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940595	Green Published, gold, Green Submitted			2022-12-25	WOS:000338508200016
J	Rampino, A; Walker, RM; Torrance, HS; Anderson, SM; Fazio, L; Di Giorgio, A; Taurisano, P; Gelao, B; Romano, R; Masellis, R; Ursini, G; Caforio, G; Blasi, G; Millar, JK; Porteous, DJ; Thomson, PA; Bertolino, A; Evans, KL				Rampino, Antonio; Walker, Rosie May; Torrance, Helen Scott; Anderson, Susan Maguire; Fazio, Leonardo; Di Giorgio, Annabella; Taurisano, Paolo; Gelao, Barbara; Romano, Raffaella; Masellis, Rita; Ursini, Gianluca; Caforio, Grazia; Blasi, Giuseppe; Millar, J. Kirsty; Porteous, David John; Thomson, Pippa Ann; Bertolino, Alessandro; Evans, Kathryn Louise			Expression of DISC1-Interactome Members Correlates with Cognitive Phenotypes Related to Schizophrenia	PLOS ONE			English	Article							WORKING-MEMORY; PREFRONTAL CORTEX; POSTMORTEM BRAIN; BRODMANN AREA-6; DISC1 PATHWAY; GENES; DEFICITS; ASSOCIATION	Cognitive dysfunction is central to the schizophrenia phenotype. Genetic and functional studies have implicated Disrupted-in-Schizophrenia 1 (DISC1), a leading candidate gene for schizophrenia and related psychiatric conditions, in cognitive function. Altered expression of DISC1 and DISC1-interactors has been identified in schizophrenia. Dysregulated expression of DISC1-interactome genes might, therefore, contribute to schizophrenia susceptibility via disruption of molecular systems required for normal cognitive function. Here, the blood RNA expression levels of DISC1 and DISC1-interacting proteins were measured in 63 control subjects. Cognitive function was assessed using neuropsychiatric tests and functional magnetic resonance imaging was used to assess the activity of prefrontal cortical regions during the N-back working memory task, which is abnormal in schizophrenia. Pairwise correlations between gene expression levels and the relationship between gene expression levels and cognitive function and N-back-elicited brain activity were assessed. Finally, the expression levels of DISC1, AKAP9, FEZ1, NDEL1 and PCM1 were compared between 63 controls and 69 schizophrenic subjects. We found that DISC1-interactome genes showed correlated expression in the blood of healthy individuals. The expression levels of several interactome members were correlated with cognitive performance and N-back-elicited activity in the prefrontal cortex. In addition, DISC1 and NDEL1 showed decreased expression in schizophrenic subjects compared to healthy controls. Our findings highlight the importance of the coordinated expression of DISC1-interactome genes for normal cognitive function and suggest that dysregulated DISC1 and NDEL1 expression might, in part, contribute to susceptibility for schizophrenia via disruption of prefrontal cortex-dependent cognitive functions.	[Rampino, Antonio; Walker, Rosie May; Torrance, Helen Scott; Anderson, Susan Maguire; Millar, J. Kirsty; Porteous, David John; Thomson, Pippa Ann; Evans, Kathryn Louise] Univ Edinburgh, MRC, Inst Genet & Mol Med, Ctr Genom & Expt Med,Med Genet Sect, Edinburgh, Midlothian, Scotland; [Rampino, Antonio; Fazio, Leonardo; Di Giorgio, Annabella; Taurisano, Paolo; Gelao, Barbara; Romano, Raffaella; Masellis, Rita; Ursini, Gianluca; Caforio, Grazia; Blasi, Giuseppe; Bertolino, Alessandro] Univ Bari, Dept Neurosci & Sense Organs, Bari, Italy; [Di Giorgio, Annabella] Ist Ricovero & Cura Carattere Sci Casa Sollievo S, Sect Liaison Psychiat, San Giovanni Rotondo, FG, Italy; [Porteous, David John; Thomson, Pippa Ann; Evans, Kathryn Louise] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Ctr Genom & Expt Med, MRC,Inst Genet & Mol Med,Med Genet Sect, Edinburgh, Midlothian, Scotland; [Bertolino, Alessandro] Hoffmann La Roche Ag, Neurosci Discovery & Translat Area, CH-4002 Basel, Switzerland	University of Edinburgh; Universita degli Studi di Bari Aldo Moro; University of Edinburgh; Roche Holding	Bertolino, A (corresponding author), Univ Bari, Dept Neurosci & Sense Organs, Bari, Italy.	a.bertolino@psichiat.uniba.it; kathy.evans@ed.ac.uk	Di Giorgio, Annabella/AAI-5367-2020; Ursini, Gianluca/AAA-8242-2019; Rampino, Antonio/Q-4465-2016; Taurisano, Paolo/U-1828-2017; Di Giorgio, Annabella/AAS-1137-2020; Blasi, Giuseppe/HHS-5404-2022; Di Giorgio, Annabella/D-7353-2017; Porteous, David/AAA-3446-2021; Taurisano, Paolo/AID-5342-2022	Di Giorgio, Annabella/0000-0001-7876-3495; Rampino, Antonio/0000-0002-9654-3266; Taurisano, Paolo/0000-0001-6140-9326; Di Giorgio, Annabella/0000-0001-7876-3495; Porteous, David/0000-0003-1249-6106; Taurisano, Paolo/0000-0001-6140-9326; Ursini, Gianluca/0000-0002-4733-5196; Evans, Kathryn/0000-0002-7884-5877; Walker, Rosie/0000-0002-1060-4479; Blasi, Giuseppe/0000-0003-0878-1131	Chief Scientist Office [CZB/4/782]; Scottish Funding Council; Research Council UK [G0700704/84698]; Biotechnology and Biosciences Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Medical Research Council; MRC [G0902166, G0100266] Funding Source: UKRI; Medical Research Council [G0100266, MR/K026992/1, G0902166] Funding Source: researchfish	Chief Scientist Office; Scottish Funding Council; Research Council UK(UK Research & Innovation (UKRI)); Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Chief Scientist Office (http://www.cso.scot.nhs.uk/) [grant number CZB/4/782]; the Scottish Funding Council (http://www.sfc.ac.uk/) Strategic Research Development Grant "Biomarkers for Battling Chronic Disease"; and Research Council UK (http://www.rcuk.ac.uk/Pages/Home.aspx) fellowships to PAT and JKM. KLE, PAT and DJP are members of The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology (CCACE), part of the cross-council Lifelong Health and Wellbeing Initiative [grant number G0700704/84698]. CCACE is funded by the Biotechnology and Biosciences Research Council (http://www.bbsrc.ac.uk/home/home.aspx); Engineering and Physical Sciences Research Council (http://www.epsrc.ac.uk/Pages/default.aspx); Economic and Social Research Council (http://www.esrc.ac.uk/); and Medical Research Council (http://www.mrc.ac.uk/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barch DM, 2012, TRENDS COGN SCI, V16, P27, DOI 10.1016/j.tics.2011.11.015; Barch DM, 2002, J ABNORM PSYCHOL, V111, P478, DOI 10.1037//0021-843X.111.3.478; Bertolino A, 2004, AM J PSYCHIAT, V161, P1798, DOI 10.1176/appi.ajp.161.10.1798; Blokland GAM, 2011, J NEUROSCI, V31, P10882, DOI 10.1523/JNEUROSCI.5334-10.2011; Bradshaw NJ, 2012, NEUROPHARMACOLOGY, V62, P1230, DOI 10.1016/j.neuropharm.2010.12.027; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Burns MJ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-31; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Condon B, 1997, APPL NEUROPSYCHOL, V4, P201, DOI 10.1207/s15324826an0404_1; Dickinson D, 2010, SCHIZOPHR B, V37, P1157; Ferrer I, 2008, CELL TISSUE BANK, V9, P181, DOI 10.1007/s10561-008-9077-0; Gadelha A, 2013, J PSYCHIATR RES, V47, P657, DOI 10.1016/j.jpsychires.2013.01.009; Genderson MR, 2007, SCHIZOPHR RES, V94, P231, DOI 10.1016/j.schres.2006.12.031; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Hanakawa T, 2002, CEREB CORTEX, V12, P1157, DOI 10.1093/cercor/12.11.1157; Hennah W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004906; Kumarasinghe N, 2013, INT J NEUROPSYCHOPH, V16, P1483, DOI 10.1017/S1461145713000035; Lai CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021635; Libby LA, 2011, CURR TOP BEHAV NEURO; Lipska BK, 2006, HUM MOL GENET, V15, P1245, DOI 10.1093/hmg/ddl040; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maxwell M., 1992, FAMILY INTERVIEW GEN; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Money TT, 2010, CNS NEUROL DISORD-DR, V9, P241, DOI 10.2174/187152710791012062; Mottaghy FM, 2002, CEREB CORTEX, V12, P369, DOI 10.1093/cercor/12.4.369; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Rastogi A, 2009, SCHIZOPHR RES, V114, P39, DOI 10.1016/j.schres.2009.06.019; Ratta-apha W, 2013, NEUROSCI RES, V77, P222, DOI 10.1016/j.neures.2013.08.010; Richards AL, 2012, MOL PSYCHIATR, V17, P193, DOI 10.1038/mp.2011.11; Snitz BE, 2006, SCHIZOPHRENIA BULL, V32, P179, DOI 10.1093/schbul/sbi048; Takahashi M, 2010, SCHIZOPHR RES, V119, P210, DOI 10.1016/j.schres.2009.12.024; Tanaka S, 2005, J NEUROSCI, V25, P496, DOI 10.1523/JNEUROSCI.4324-04.2005; Thomson Pippa A, 2013, Front Biol (Beijing), V8, P1; Tomita H, 2004, BIOL PSYCHIAT, V55, P346, DOI 10.1016/j.biopsych.2003.10.013; Tomppo L, 2009, BIOL PSYCHIAT, V65, P1055, DOI 10.1016/j.biopsych.2009.01.014; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	39	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99892	10.1371/journal.pone.0099892	http://dx.doi.org/10.1371/journal.pone.0099892			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940743	Green Submitted, Green Published, gold			2022-12-25	WOS:000338508200052
J	Shahana, S; Childers, DS; Ballou, ER; Bohovych, I; Odds, FC; Gow, NAR; Brown, AJP				Shahana, Shahida; Childers, Delma S.; Ballou, Elizabeth R.; Bohovych, Iryna; Odds, Frank C.; Gow, Neil A. R.; Brown, Alistair J. P.			New Clox Systems for Rapid and Disruption in Candida albicans	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; HUMAN FUNGAL PATHOGEN; SELECTABLE MARKER URA3; BETA-TUBULIN GENE; LARGE-SCALE; OROTIDINE-5'-PHOSPHATE DECARBOXYLASE; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL EXPRESSION; MOLECULAR-GENETICS; MYCOPHENOLIC-ACID	Precise genome modification is essential for the molecular dissection of Candida albicans, and is yielding invaluable information about the roles of specific gene functions in this major fungal pathogen of humans. C. albicans is naturally diploid, unable to undergo meiosis, and utilizes a non-canonical genetic code. Hence, specialized tools have had to be developed for gene disruption in C. albicans that permit the deletion of both target alleles, and in some cases, the recycling of the Candida-specific selectable markers. Previously, we developed a tool based on the Cre recombinase, which recycles markers in C. albicans with 90-100% efficiency via site-specific recombination between loxP sites. Ironically, the utility of this system was hampered by the extreme efficiency of Cre, which prevented the construction in Escherichia coli of stable disruption cassettes carrying a methionine-regulatable CaMET3(p)-cre gene flanked by loxP sites. Therefore, we have significantly enhanced this system by engineering new Clox cassettes that carry a synthetic, intron-containing cre gene. The Clox kit facilitates efficient transformation and marker recycling, thereby simplifying and accelerating the process of gene disruption in C. albicans. Indeed, homozygous mutants can be generated and their markers resolved within two weeks. The Clox kit facilitates strategies involving single marker recycling or multi-marker gene disruption. Furthermore, it includes the dominant NAT1 marker, as well as URA3, HIS1 and ARG4 cassettes, thereby permitting the manipulation of clinical isolates as well as genetically marked strains of C. albicans. The accelerated gene disruption strategies afforded by this new Clox system are likely to have a profound impact on the speed with which C. albicans pathobiology can be dissected.	[Shahana, Shahida; Childers, Delma S.; Ballou, Elizabeth R.; Bohovych, Iryna; Odds, Frank C.; Gow, Neil A. R.; Brown, Alistair J. P.] Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland	University of Aberdeen	Brown, AJP (corresponding author), Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland.	al.brown@abdn.ac.uk	GOW, Neil/AAS-5323-2021	GOW, Neil/0000-0002-2776-5850; Brown, Alistair JP/0000-0003-1406-4251; Ballou, Elizabeth/0000-0001-8051-2302	Wellcome Trust [080088, 097377]; European Research Council (STRIFE Advanced Grant) [C-2009-AdG-249793]; European Commission (FINSysB MC-ITN) [PITN-GA-2008-214004]; UK Biotechnology and Biological Research Council [BB/F00513X/1]; BBSRC [BB/K017365/1, BB/F00513X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F00513X/1, BB/K017365/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council (STRIFE Advanced Grant); European Commission (FINSysB MC-ITN)(European CommissionEuropean Commission Joint Research Centre); UK Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust (www.wellcome.ac.uk): S. S., F.C.O., N.A.R.G., A.J.P.B. (080088); N.A.R.G., A.J.P.B. (097377). The authors also received support from the European Research Council [http://erc.europa.eu/]: DSC. ERB, AJPB (STRIFE Advanced Grant; C-2009-AdG-249793). The European Commission also provided funding [http://ec.europa.eu/research/fp7]: I. B., A.J.P.B. (FINSysB MC-ITN; PITN-GA-2008-214004). Also the UK Biotechnology and Biological Research Council provided support [www.bbsrc.ac.uk]: N.A.R.G., A.J.P.B. (Research Grant; BB/F00513X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alby K, 2009, NATURE, V460, P890, DOI 10.1038/nature08252; AUSTIN S, 1981, CELL, V25, P729, DOI 10.1016/0092-8674(81)90180-X; Bain JM, 2001, FEMS MICROBIOL LETT, V204, P323, DOI 10.1111/j.1574-6968.2001.tb10905.x; Barelle CJ, 2004, YEAST, V21, P333, DOI 10.1002/yea.1099; Basso LR, 2010, YEAST, V27, P1039, DOI 10.1002/yea.1813; Beckerman J, 2001, INFECT IMMUN, V69, P108, DOI 10.1128/IAI.69.1.108-114.2001; Bennett RJ, 2005, ANNU REV MICROBIOL, V59, P233, DOI 10.1146/annurev.micro.59.030804.121310; Blackwell C, 2003, YEAST, V20, P1235, DOI 10.1002/yea.1036; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; BROWN AJP, 1991, NUCLEIC ACIDS RES, V19, P4298, DOI 10.1093/nar/19.15.4298; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Calderone RA., 2002, CANDIDA CANDIDIASIS; Care RS, 1999, MOL MICROBIOL, V34, P792, DOI 10.1046/j.1365-2958.1999.01641.x; Cheng SJ, 2003, INFECT IMMUN, V71, P6101, DOI 10.1128/IAI.71.10.6101-6103.2003; De Backer MD, 2000, ANNU REV MICROBIOL, V54, P463, DOI 10.1146/annurev.micro.54.1.463; Dennison PMJ, 2005, FUNGAL GENET BIOL, V42, P737, DOI 10.1016/j.fgb.2005.05.006; Enloe B, 2000, J BACTERIOL, V182, P5730, DOI 10.1128/JB.182.20.5730-5736.2000; FONZI WA, 1993, GENETICS, V134, P717; Gerami-Nejad M, 2001, YEAST, V18, P859, DOI 10.1002/yea.738; Gerami-Nejad M, 2013, MICROBIOL-SGM, V159, P565, DOI 10.1099/mic.0.064097-0; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Hickman MA, 2013, NATURE, V494, P55, DOI 10.1038/nature11865; Inglis DO, 2012, NUCLEIC ACIDS RES, V40, pD667, DOI 10.1093/nar/gkr945; Kohler GA, 1997, J BACTERIOL, V179, P2331; Lay J, 1998, INFECT IMMUN, V66, P5301, DOI 10.1128/IAI.66.11.5301-5306.1998; Legrand M., 2012, Candida and candidiasis, P505; Morschhauser J, 1999, MOL MICROBIOL, V32, P547, DOI 10.1046/j.1365-2958.1999.01393.x; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nakayama H, 2000, INFECT IMMUN, V68, P6712, DOI 10.1128/IAI.68.12.6712-6719.2000; Nobile CJ, 2003, MICROBIOL-SGM, V149, P3629, DOI 10.1099/mic.0.26640-0; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Noble SM, 2007, ANNU REV GENET, V41, P193, DOI 10.1146/annurev.genet.41.042007.170146; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; ODDS FC, 1988, J MED VET MYCOL, V26, P277; OSBORNE BI, 1989, P NATL ACAD SCI USA, V86, P4097, DOI 10.1073/pnas.86.11.4097; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Samaranayake DP, 2011, FUNGAL GENET BIOL, V48, P858, DOI 10.1016/j.fgb.2011.04.003; Sanglard D, 1996, ANTIMICROB AGENTS CH, V40, P2300, DOI 10.1128/AAC.40.10.2300; SANTOS MAS, 1993, EMBO J, V12, P607, DOI 10.1002/j.1460-2075.1993.tb05693.x; SANTOS MAS, 1995, NUCLEIC ACIDS RES, V23, P1481, DOI 10.1093/nar/23.9.1481; Sasse C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025623; SAUER B, 1987, MOL CELL BIOL, V7, P2087, DOI 10.1128/MCB.7.6.2087; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Shen JQ, 2005, INFECT IMMUN, V73, P1239, DOI 10.1128/IAI.73.2.1239-1242.2005; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SMITH HA, 1990, GENE, V90, P115, DOI 10.1016/0378-1119(90)90446-X; SMITH HA, 1988, GENE, V63, P53, DOI 10.1016/0378-1119(88)90545-8; Staib P, 1999, MOL MICROBIOL, V32, P533, DOI 10.1046/j.1365-2958.1999.01367.x; Staib P, 2000, P NATL ACAD SCI USA, V97, P6102, DOI 10.1073/pnas.110031497; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Sundstrom P, 2002, INFECT IMMUN, V70, P3281, DOI 10.1128/IAI.70.6.3281-3283.2002; Uhl MA, 2003, EMBO J, V22, P2668, DOI 10.1093/emboj/cdg256; WEINBURG RA, 1995, MOL MICROBIOL, V16, P241, DOI 10.1111/j.1365-2958.1995.tb02296.x; Wellington M, 2005, YEAST, V22, P57, DOI 10.1002/yea.1191; Wilson RB, 2000, YEAST, V16, P65, DOI 10.1002/(SICI)1097-0061(20000115)16:1&lt;65::AID-YEA508&gt;3.0.CO;2-M; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Wirsching S, 2000, MOL MICROBIOL, V36, P856, DOI 10.1046/j.1365-2958.2000.01899.x; Wirsching S, 2000, J BACTERIOL, V182, P400, DOI 10.1128/JB.182.2.400-404.2000; Xu DM, 2007, PLOS PATHOG, V3, P835, DOI 10.1371/journal.ppat.0030092; Zeng GS, 2014, NAT PROTOC, V9, P464, DOI 10.1038/nprot.2014.029	65	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100390	10.1371/journal.pone.0100390	http://dx.doi.org/10.1371/journal.pone.0100390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940603	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200100
J	Zhou, ZZ; Deng, H; Yan, W; Luo, M; Tu, W; Xia, YJ; He, JY; Han, P; Fu, Y; Tian, DA				Zhou, Zhenzhen; Deng, Huan; Yan, Wei; Luo, Min; Tu, Wei; Xia, Yujia; He, Jiayi; Han, Ping; Fu, Yu; Tian, De'an			AEG-1 Promotes Anoikis Resistance and Orientation Chemotaxis in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							ASTROCYTE-ELEVATED GENE-1; CHEMOKINE RECEPTOR CXCR4; BREAST-CANCER; TUMOR-CELLS; METASTASIS; ACTIVATION; EXPRESSION; GROWTH; BONE; PATHWAY	Metastasis contributes to the poor prognosis of hepatocellular carcinoma (HCC). Anoikis resistance and orientation chemotaxis are two important and sequential events in tumor cell metastasis. The process of tumor metastasis is known to be regulated by AEG-1, an important oncogene that plays a critical role in tumor metastasis, though the effects of this oncogene on anoikis resistance and orientation chemotaxis in HCC cells are currently unknown. To directly assess the role of AEG-1 in these processes, we up-regulated AEG-1 expression via exogenous transfection in SMMC-7721 cells, which express low endogenous levels of AEG-1; and down-regulated AEG-1 expression via siRNA-mediated knockdown in MHCC-97H and HCC-LM3 cells, which express high endogenous levels of AEG-1. Our data directly demonstrate that AEG-1 promotes cell growth as assessed by cell proliferation/viability and cell cycle analysis. Furthermore, the prevention of anoikis by AEG-1 correlates with decreased activation of caspase-3. AEG-1-dependent anoikis resistance is activated via the PI3K/Akt pathway and is characterized by the regulation of Bcl-2 and Bad. The PI3K inhibitor LY294002 reverses the AEG-1 dependent effects on Akt phosphorylation, Bcl-2 expression and anoikis resistance. AEG-1 also promotes orientation chemotaxis of suspension-cultured cells towards supernatant from Human Pulmonary Microvascular Endothelial Cells (HPMECs). Our results show that AEG-1 activates the expression of the metastasis-associated chemokine receptor CXCR4, and that its ligand, CXCL12, is secreted by HPMECs. Furthermore, the CXCR4 antoagonist AMD3100 decreases AEG-1-induced orientation chemotaxis. These results define a pathway by which AEG-1 regulates anoikis resistance and orientation chemotaxis during HCC cell metastasis.	[Zhou, Zhenzhen; Deng, Huan; Yan, Wei; Luo, Min; Tu, Wei; Xia, Yujia; He, Jiayi; Han, Ping; Tian, De'an] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Gastroenterol, Wuhan 430074, Peoples R China; [Fu, Yu] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gastroenterol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Tian, DA (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Gastroenterol, Wuhan 430074, Peoples R China.	tjtiandean@126.com			National Natural Science Foundation of China [81270507, 81372663, 81000159]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China No. 81270507, No. 81372663 and No. 81000159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix-Panabieres C, 2008, CLIN CANCER RES, V14, P5013, DOI 10.1158/1078-0432.CCR-07-5125; Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9; Azab AK, 2009, BLOOD, V113, P4341, DOI 10.1182/blood-2008-10-186668; Boisvert-Adamo K, 2006, ONCOGENE, V25, P4848, DOI 10.1038/sj.onc.1209493; Boyce BF, 1999, ENDOCR-RELAT CANCER, V6, P333, DOI 10.1677/erc.0.0060333; Britt DE, 2004, EXP CELL RES, V300, P134, DOI 10.1016/j.yexcr.2004.06.026; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Cabioglu N, 2005, CANCER RES, V65, P6493, DOI 10.1158/0008-5472.CAN-04-1303; Cabioglu N, 2005, CLIN EXP METASTAS, V22, P39, DOI 10.1007/s10585-005-3222-y; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen J, 2011, J CANCER RES CLIN, V137, P1799, DOI 10.1007/s00432-011-1057-2; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Coll MAL, 2005, ONCOGENE, V24, P1727, DOI 10.1038/sj.onc.1208379; Dedhar S, 2000, CURR OPIN CELL BIOL, V12, P250, DOI 10.1016/S0955-0674(99)00083-6; Derksen PWB, 2011, DIS MODEL MECH, V4, P347, DOI 10.1242/dmm.006395; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; Fidler IJ, 2002, SEMIN CANCER BIOL, V12, P89, DOI 10.1006/scbi.2001.0416; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Frisch SM, 1999, CURR BIOL, V9, P1047, DOI 10.1016/S0960-9822(99)80455-2; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Jost M, 2001, MOL BIOL CELL, V12, P1519, DOI 10.1091/mbc.12.5.1519; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; Kang H, 2005, BREAST, V14, P360, DOI 10.1016/j.breast.2004.12.007; Kang HG, 2007, CANCER RES, V67, P3094, DOI 10.1158/0008-5472.CAN-06-3259; Katyal S, 2000, RADIOLOGY, V216, P698, DOI 10.1148/radiology.216.3.r00se24698; Kikuno N, 2007, ONCOGENE, V26, P7647, DOI 10.1038/sj.onc.1210572; Kim YN, 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/306879; Kochetkova M, 2009, CELL DEATH DIFFER, V16, P664, DOI 10.1038/cdd.2008.190; Lee BC, 2004, MOL CANCER RES, V2, P327; Lee SG, 2008, ONCOGENE, V27, P1114, DOI 10.1038/sj.onc.1210713; Lee SG, 2006, P NATL ACAD SCI USA, V103, P17390, DOI 10.1073/pnas.0608386103; Li JK, 2008, WORLD J GASTROENTERO, V14, P2308, DOI 10.3748/wjg.14.2308; Liu LP, 2010, CANCER RES, V70, P3750, DOI 10.1158/0008-5472.CAN-09-3838; Lu YL, 1999, ONCOGENE, V18, P7034, DOI 10.1038/sj.onc.1203183; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mawji IA, 2007, J NATL CANCER I, V99, P811, DOI 10.1093/jnci/djk182; McFall A, 2001, MOL CELL BIOL, V21, P5488, DOI 10.1128/MCB.21.16.5488-5499.2001; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Mundy GR, 1997, CANCER-AM CANCER SOC, V80, P1546, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.3.CO;2-R; Pattarozzi A, 2008, MOL PHARMACOL, V73, P191, DOI 10.1124/mol.107.039974; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Sarkar D, 2008, CANCER RES, V68, P1478, DOI 10.1158/0008-5472.CAN-07-6164; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Su ZZ, 2002, ONCOGENE, V21, P3592, DOI 10.1038/sj.onc.1205445; Taichman RS, 2002, CANCER RES, V62, P1832; Uchida D, 2003, EXP CELL RES, V290, P289, DOI 10.1016/S0014-4827(03)00344-6; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wendt MK, 2008, GASTROENTEROLOGY, V135, P508, DOI 10.1053/j.gastro.2008.05.033; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460; Yu CP, 2009, CARCINOGENESIS, V30, P894, DOI 10.1093/carcin/bgp064; Zhou ZZ, 2012, J HUAZHONG U SCI-MED, V32, P353, DOI 10.1007/s11596-012-0061-3; Zlotnik A, 2004, SEMIN CANCER BIOL, V14, P181, DOI 10.1016/j.semcancer.2003.10.004	64	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100372	10.1371/journal.pone.0100372	http://dx.doi.org/10.1371/journal.pone.0100372			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941119	gold, Green Published, Green Submitted			2022-12-25	WOS:000338508200098
J	Cecchelli, R; Aday, S; Sevin, E; Almeida, C; Culot, M; Dehouck, L; Coisne, C; Engelhardt, B; Dehouck, MP; Ferreira, L				Cecchelli, Romeo; Aday, Sezin; Sevin, Emmanuel; Almeida, Catarina; Culot, Maxime; Dehouck, Lucie; Coisne, Caroline; Engelhardt, Britta; Dehouck, Marie-Pierre; Ferreira, Lino			A Stable and Reproducible Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; PERICYTES; CNS; INTEGRITY	The human blood brain barrier (BBB) is a selective barrier formed by human brain endothelial cells (hBECs), which is important to ensure adequate neuronal function and protect the central nervous system (CNS) from disease. The development of human in vitro BBB models is thus of utmost importance for drug discovery programs related to CNS diseases. Here, we describe a method to generate a human BBB model using cord blood-derived hematopoietic stem cells. The cells were initially differentiated into ECs followed by the induction of BBB properties by co-culture with pericytes. The brain-like endothelial cells (BLECs) express tight junctions and transporters typically observed in brain endothelium and maintain expression of most in vivo BBB properties for at least 20 days. The model is very reproducible since it can be generated from stem cells isolated from different donors and in different laboratories, and could be used to predict CNS distribution of compounds in human. Finally, we provide evidence that Wnt/beta-catenin signaling pathway mediates in part the BBB inductive properties of pericytes.	[Cecchelli, Romeo; Sevin, Emmanuel; Culot, Maxime; Dehouck, Lucie; Dehouck, Marie-Pierre] Univ Artois, Blood Brain Barrier Lab, Lens, France; [Aday, Sezin; Almeida, Catarina; Ferreira, Lino] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Aday, Sezin; Almeida, Catarina; Ferreira, Lino] Biocant Ctr Innovat Biotechnol, Biomat & Stem Cell Based Therapeut Lab, Cantanhede, Portugal; [Almeida, Catarina] Univ Coimbra IIIUC, Inst Interdisciplinary Res, Coimbra, Portugal; [Coisne, Caroline; Engelhardt, Britta] Univ Bern, Theodor Kocher Inst, Bern, Switzerland	Universite d'Artois; Universidade de Coimbra; Universidade de Coimbra; University of Bern	Ferreira, L (corresponding author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal.	lino@biocant.pt	Engelhardt, Britta/K-7267-2014; Aday, Sezin/I-5901-2019	Engelhardt, Britta/0000-0003-3059-9846; Aday, Sezin/0000-0003-4396-7812; Praca, Catarina/0000-0003-1669-0125; CULOT, Maxime/0000-0001-7452-0867; ferreira, lino/0000-0001-8985-9302	Marie Curie-Reintegration Grant [230929]; funds of FEDER through the "Programa Operacional Factores de Competitividade-Compete"; Portuguese funds through FCT-Science and Technology Foundation [PTDC/CTM/099659/2008, PEst-C/SAU/LA0001/2013-2014, SFRH/BD/42871/2008]; COMPETE [201024, 202213]; PRIM	Marie Curie-Reintegration Grant(European Commission); funds of FEDER through the "Programa Operacional Factores de Competitividade-Compete"; Portuguese funds through FCT-Science and Technology Foundation; COMPETE; PRIM(European Commission)	This work was supported by a Marie Curie-Reintegration Grant (FP7-People-2007-4-3-IRG; contract no 230929), funds of FEDER through the "Programa Operacional Factores de Competitividade-Compete" and Portuguese funds through FCT-Science and Technology Foundation (PTDC/CTM/099659/2008, PEst-C/SAU/LA0001/2013-2014; and SFRH/BD/42871/2008, a fellowship to S. A.), COMPETE funding (Project "Stem cell based platforms for Regenerative and Therapeutic Medicine'', Centro-07-ST24-FEDER-002008), FP7 (contracts 201024 and 202213 (European Stroke Network)) and PRIM (from the region Nord-Pas de Calais (France)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bo L, 1996, J NEUROPATH EXP NEUR, V55, P1060, DOI 10.1097/00005072-199655100-00006; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Culot M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080634; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Friden M, 2007, DRUG METAB DISPOS, V35, P1711, DOI 10.1124/dmd.107.015222; Friden M, 2009, J MED CHEM, V52, P6233, DOI 10.1021/jm901036q; Gulati R, 2003, CIRCULATION, V108, P1520, DOI 10.1161/01.CIR.0000089084.48655.49; He TR, 2004, STROKE, V35, P2378, DOI 10.1161/01.STR.0000141893.33677.5d; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lippmann ES, 2012, NAT BIOTECHNOL; Lippmann ES, 2014, SCI REP-UK, V4, DOI 10.1038/srep04160; Okita K, 2011, PHILOS T R SOC B, V366, P2198, DOI 10.1098/rstb.2011.0016; Pedroso DCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016114; PONIO J, 2014, PLOS ONE, V0009; Prieto P, 2004, ATLA-ALTERN LAB ANIM, V32, P37, DOI 10.1177/026119290403200107; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sano Y, 2010, J CELL PHYSIOL, V225, P519, DOI 10.1002/jcp.22232; Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; SIFLINGERBIRNBOIM A, 1987, J CELL PHYSIOL, V132, P111, DOI 10.1002/jcp.1041320115; Simon R, 2007, CANCER INFORM, V3, P11; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; TATSUTA T, 1992, J BIOL CHEM, V267, P20383; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460	32	186	190	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99733	10.1371/journal.pone.0099733	http://dx.doi.org/10.1371/journal.pone.0099733			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936790	Green Published, Green Submitted, gold			2022-12-25	WOS:000338503400035
J	Kumar, J; Dhar, P; Tayade, AB; Gupta, D; Chaurasia, OP; Upreti, DK; Arora, R; Srivastava, RB				Kumar, Jatinder; Dhar, Priyanka; Tayade, Amol B.; Gupta, Damodar; Chaurasia, Om P.; Upreti, Dalip K.; Arora, Rajesh; Srivastava, Ravi B.			Antioxidant Capacities, Phenolic Profile and Cytotoxic Effects of Saxicolous Lichens from Trans-Himalayan Cold Desert of Ladakh	PLOS ONE			English	Article							RADICAL-SCAVENGING ACTIVITY; ANTIMICROBIAL ACTIVITY; CHEMICAL-COMPOSITION; ANALGESIC ACTIVITIES; XANTHORIA-ELEGANS; METHANOL EXTRACTS; ETHANOL EXTRACTS; CLADONIA-FURCATA; PLANT-EXTRACTS; DIVERSE PANEL	Fourteen saxicolous lichens from trans-Himalayan Ladakh region were identified by morpho-anatomical and chemical characteristics. The n-hexane, methanol and water extracts of the lichens were evaluated for their antioxidant capacities. The lichen extracts showing high antioxidant capacities and rich phenolic content were further investigated to determine their cytotoxic activity on human HepG2 and RKO carcinoma cell lines. The ferric reducing antioxidant power (FRAP), 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS), 1,1-diphenyl-2-picrylhydrazyl (DPPH) and nitric oxide (NO) radical scavenging capacities and beta-carotene-linoleic acid bleaching property exhibited analogous results where the lichen extracts showed high antioxidant action. The lichen extracts were also found to possess good amount of total proanthocyanidin, flavonoid and polyphenol. The methanolic extract of Lobothallia alphoplaca exhibited highest FRAP value. Methanolic extract of Xanthoparmelia stenophylla showed the highest ABTS radical scavenging capacity. The n-hexane extract of Rhizoplaca chrysoleuca exhibited highest DPPH radical scavenging capacity. Highest antioxidant capacity in terms of beta-carotene linoleic acid bleaching property was observed in the water extract of Xanthoria elegans. Similarly, Melanelia disjuncta water extract showed highest NO scavenging capacity. Among n-hexane, methanol and water extracts of all lichens, the methanolic extract of Xanthoparmelia mexicana showed highest total proanthocyanidin, flavonoid and polyphenol content. From cytotoxic assay, it was observed that the methanolic extracts of L. alphoplaca and M. disjuncta were exhibiting high cytotoxic effects against cancer cell growth. Similarly, the water extract of Dermatocarpon vellereum, Umbilicaria vellea, X. elegans and M. disjuncta and the methanolic extract of M. disjuncta and X. stenophylla were found to possess high antioxidant capacities and were non-toxic and may be used as natural antioxidants for stress related problems. Our studies go on to prove that the unique trans-Himalayan lichens are a hitherto untapped bioresource with immense potential for discovery of new chemical entities, and this biodiversity needs to be tapped sustainably.	[Kumar, Jatinder; Dhar, Priyanka; Tayade, Amol B.; Chaurasia, Om P.; Srivastava, Ravi B.] Def Res & Dev Org, Def Inst High Altitude Res, Leh Ladakh, Jammu & Kashmir, India; [Gupta, Damodar; Arora, Rajesh] Def Res & Dev Org, Inst Nucl Med & Allied Sci, Radiat Biotechnol Grp, Med & Aromat Plants Lab, Delhi, India; [Arora, Rajesh] DRDO Bhawan, Off Director Gen Life Sci, New Delhi, India; [Upreti, Dalip K.] Natl Bot Res Inst, CSIR, Plant Biodivers & Conservat Biol Div, Lichenol Lab, Lucknow 226001, Uttar Pradesh, India	Defence Research & Development Organisation (DRDO); Defence Institute of High Altitude Research (DIHAR); Defence Research & Development Organisation (DRDO); Institute of Nuclear Medicine & Allied Sciences (INMAS); Defence Research & Development Organisation (DRDO); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI)	Chaurasia, OP (corresponding author), Def Res & Dev Org, Def Inst High Altitude Res, Leh Ladakh, Jammu & Kashmir, India.	dropchaurasiadihardrdo@gmail.com	CHAURASIA, OM/AAW-6347-2021; CHAURASIA, OM PRAKASH/AAP-3358-2021; Arora, Rajesh/AAE-4596-2021	CHAURASIA, OM PRAKASH/0000-0003-2921-2755; Arora, Rajesh/0000-0001-7307-9221; Srivastava, Rakesh/0000-0002-0065-4069; Srivastava, Rakesh/0000-0003-3112-4252	Defence Research & Development Organisation (DRDO), Ministry of Defence, Government of India	Defence Research & Development Organisation (DRDO), Ministry of Defence, Government of India	The study was entirely supported by Defence Research & Development Organisation (DRDO), Ministry of Defence, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acikgoz B, 2013, Z NATURFORSCH C, V68, P191; AHMADJIAN V, 1995, BIOSCIENCE, V45, P124, DOI 10.1093/bioscience/45.3.124; Anagnostopoulou MA, 2006, FOOD CHEM, V94, P19, DOI 10.1016/j.foodchem.2004.09.047; Ari F, 2014, ENVIRON TOXICOL, V29, P804, DOI 10.1002/tox.21809; Aruoma OI, 1998, J AM OIL CHEM SOC, V75, P199, DOI 10.1007/s11746-998-0032-9; Ashraf MF, 2013, SCI WORLD J, DOI 10.1155/2013/216894; Aslan A, 2012, TOXICOL IND HEALTH, V28, P505, DOI 10.1177/0748233711416944; Aubert S, 2007, PLANTA, V226, P1287, DOI 10.1007/s00425-007-0563-6; Awasthi DD, 2007, COMPENDIUM MACROLICH, P580; Ballabh B, 2007, CURR SCI INDIA, V92, P1664; Bartak M, 2007, POLAR BIOL, V31, P47, DOI 10.1007/s00300-007-0331-x; Behera BC, 2006, LWT-FOOD SCI TECHNOL, V39, P80, DOI 10.1016/j.lwt.2004.11.007; Bezivin C, 2004, PLANTA MED, V70, P874, DOI 10.1055/s-2004-827240; Bezivin C, 2003, PHYTOMEDICINE, V10, P499, DOI 10.1078/094471103322331458; Bhattarai HD, 2008, J NAT MED-TOKYO, V62, P481, DOI 10.1007/s11418-008-0257-9; Boyd MR, 1992, ANTITUMOR DRUG DISCO, P11; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Bucar F, 2004, PHYTOMEDICINE, V11, P602, DOI 10.1016/j.phymed.2004.03.004; Burlando B, 2009, PLANTA MED, V75, P607, DOI 10.1055/s-0029-1185329; Buyukokuroglu ME, 2001, PHARM RES, V44, P1199; Cao GH, 1996, J AGR FOOD CHEM, V44, P3426, DOI 10.1021/jf9602535; Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6; Cesquini M, 2003, BIOMED PHARMACOTHER, V57, P124, DOI 10.1016/S0753-3322(03)00018-0; Chandrasekar MJN, 2006, PHARM BIOL, V44, P100, DOI 10.1080/13880200600592046; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Chopra RN, 1958, INDIGENOUS DRUGS IND, P643; Dapkevicius A, 1998, J SCI FOOD AGR, V77, P140, DOI 10.1002/(SICI)1097-0010(199805)77:1&lt;140::AID-JSFA18&gt;3.0.CO;2-K; de Vera JP, 2010, ASTROBIOLOGY, V10, P215, DOI 10.1089/ast.2009.0362; Dhar P, 2012, J FOOD SCI, V77, pC156, DOI 10.1111/j.1750-3841.2011.02523.x; Dhar P, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-259; Divakar PK., 2005, PARMELIOID LICHENS I, P488; Melo MGD, 2011, TOXICOL IN VITRO, V25, P462, DOI 10.1016/j.tiv.2010.11.014; ELIX JA, 1993, CATALOGUE STANDARDIS; Esimone CO, 2007, J INFECT DEV COUNTR, V1, P315, DOI 10.3855/jidc.370; Esimone CO, 2005, J APPL MICROBIOL, V99, P1346, DOI 10.1111/j.1365-2672.2005.02732.x; Gao XQ, 2000, J SCI FOOD AGR, V80, P2021, DOI 10.1002/1097-0010(200011)80:14&lt;2021::AID-JSFA745&gt;3.0.CO;2-2; GONZALEZTEJERO MR, 1995, ECON BOT, V49, P96, DOI 10.1007/BF02862281; Grujicic D, 2014, CYTOTECHNOL IN PRESS; Gulcin I, 2004, J ETHNOPHARMACOL, V90, P205, DOI 10.1016/j.jep.2003.09.028; Gulcin I, 2003, J ETHNOPHARMACOL, V86, P51, DOI 10.1016/S0378-8741(03)00036-9; Gulluce M, 2006, PHYTOMEDICINE, V13, P515, DOI 10.1016/j.phymed.2005.09.008; Gulluce M, 2011, TOXICOL IND HEALTH, V27, P675, DOI 10.1177/0748233710395343; Halama P, 2004, BIOCONTROL, V49, P95, DOI 10.1023/B:BICO.0000009378.31023.ba; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Halliwell B, 2000, LANCET, V355, P1179, DOI 10.1016/S0140-6736(00)02075-4; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Halliwell B, 1995, BIOCHEM SOC SYMP, P73, DOI 10.1042/bss0610073; Hawksworth DL, 1994, PLANT GALLS, V49; Heinonen IM, 1998, J AGR FOOD CHEM, V46, P25, DOI 10.1021/jf970489o; HIDALGO ME, 1994, PHYTOCHEMISTRY, V37, P1585, DOI 10.1016/S0031-9422(00)89571-0; Hong YP, 2008, PLANT FOOD HUM NUTR, V63, P200, DOI 10.1007/s11130-008-0088-6; Hou WC, 2003, PHYTOMEDICINE, V10, P170, DOI 10.1078/094471103321659898; Hu SY, 1980, ENUMERATION CHINESE, P101; Ikram EHK, 2009, J FOOD COMPOS ANAL, V22, P388, DOI 10.1016/j.jfca.2009.04.001; Ingolfsdottir K, 2000, PHARM BIOL, V38, P313, DOI 10.1076/1388-0209(200009)3841-AFT313; Jeong WY, 2011, J SEP SCI, V34, P2967, DOI 10.1002/jssc.201100524; Kappen L, 2000, ANTARCT SCI, V12, P314, DOI 10.1017/S0954102000000377; Karagoz A, 2005, BIOLOGIA, V60, P281; Kinoshita K, 2010, J NAT MED-TOKYO, V64, P85, DOI 10.1007/s11418-009-0364-2; Korekar G, 2011, ACTA ALIMENT HUNG, V40, P449, DOI 10.1556/AAlim.40.2011.4.4; Korekar G, 2011, PLANT FOOD HUM NUTR, V66, P376, DOI 10.1007/s11130-011-0246-0; Kosanic M, 2013, FOOD CHEM TOXICOL, V53, P112, DOI 10.1016/j.fct.2012.11.034; Kosanic M, 2012, J FOOD SCI, V77, pT20, DOI 10.1111/j.1750-3841.2011.02459.x; Kumar J, 2012, NATURE SCI, V10, P1; Luo H, 2009, POLAR BIOL, V32, P1033, DOI 10.1007/s00300-009-0602-9; Manojlovic N, 2012, PHYTOMEDICINE, V19, P1166, DOI 10.1016/j.phymed.2012.07.012; Meessen J, 2013, ORIGINS LIFE EVOL B, V43, P501, DOI 10.1007/s11084-013-9348-z; Meessen J, 2013, ORIGINS LIFE EVOL B, V43, P283, DOI 10.1007/s11084-013-9337-2; Mensor LL, 2001, PHYTOTHER RES, V15, P127, DOI 10.1002/ptr.687; Mitrovic T., 2011, BIOL NYSSANA, V2, P1; Mitrovic T, 2011, INT J MOL SCI, V12, P5428, DOI 10.3390/ijms12085428; Molnar K, 2010, Z NATURFORSCH C, V65, P157; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; Nash III T.H., 1988, BIBLIOTHECA LICHENOL, V30, P11; Naveena BM, 2008, INT J FOOD SCI TECH, V43, P1807, DOI 10.1111/j.1365-2621.2007.01708.x; Neamati N, 1997, J MED CHEM, V40, P942, DOI 10.1021/jm960759e; Negi HR, 2000, CURR SCI INDIA, V78, P1105; Negi HR, 2000, J BIOSCIENCES, V25, P367, DOI 10.1007/BF02703790; Nickavar B, 2007, PAK J PHARM SCI, V20, P291; Nybakken L, 2004, OECOLOGIA, V140, P211, DOI 10.1007/s00442-004-1583-6; Odabasoglu F, 2005, FITOTERAPIA, V76, P216, DOI 10.1016/j.fitote.2004.05.012; Oksanen I, 2006, APPL MICROBIOL BIOT, V73, P723, DOI 10.1007/s00253-006-0611-3; ORANGE A, 2001, MICROCHEMICAL METHOD; Ordonez AAL, 2006, FOOD CHEM, V97, P452, DOI 10.1016/j.foodchem.2005.05.024; Pasciu V, 2010, TOXICOL SCI, V114, P101, DOI 10.1093/toxsci/kfp301; Paudel B, 2008, POLAR BIOL, V31, P605, DOI 10.1007/s00300-007-0394-8; Paudel B, 2012, BIOL RES, V45, P387, DOI 10.4067/S0716-97602012000400010; Pellegrini N, 1999, METHOD ENZYMOL, V299, P379; Rankovic B, 2007, BRIT J BIOMED SCI, V64, P143, DOI 10.1080/09674845.2007.11732776; Rankovic B, 2010, CENT EUR J BIOL, V5, P649, DOI 10.2478/s11535-010-0043-z; Rankovic BR, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-97; Richardson D. H. S., 1988, CRC HDB LICHENOLOGY, P93; RICHARDSON DHS, 1991, FRONTIERS IN MYCOLOGY, P187; Robinson EE, 1997, FREE RADICAL RES, V26, P291, DOI 10.3109/10715769709097807; Robinson SA, 2003, GLOBAL CHANGE BIOL, V9, P1681, DOI 10.1046/j.1365-2486.2003.00693.x; RUBINSTEIN LV, 1990, J NATL CANCER I, V82, P1113, DOI 10.1093/jnci/82.13.1113; Shukla V, 2010, PHYTOCHEM REV, V9, P303, DOI 10.1007/s11101-010-9189-6; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Souri E, 2008, IRAN J PHARM RES, V7, P149; Stocker-Worgotter E, 2008, NAT PROD REP, V25, P188, DOI 10.1039/b606983p; Sumangala Rao, 2013, British Biotechnology Journal, V3, P377; Sun JS, 1998, BURNS, V24, P225, DOI 10.1016/S0305-4179(97)00115-0; Tanas S, 2010, J NAT MED-TOKYO, V64, P42, DOI 10.1007/s11418-009-0367-z; Tayade AB, 2013, J FOOD SCI, V78, pC402, DOI 10.1111/1750-3841.12054; Teke GN, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-57; Turkez H, 2012, CYTOTECHNOLOGY, V64, P679, DOI 10.1007/s10616-012-9447-0; Ullah MF, 2013, CELL BIOCHEM BIOPHYS, V67, P431, DOI 10.1007/s12013-011-9303-4; Velioglu YS, 1998, J AGR FOOD CHEM, V46, P4113, DOI 10.1021/jf9801973; Wang ZH, 2009, FOOD CHEM, V112, P914, DOI 10.1016/j.foodchem.2008.06.078; Weisburg JH, 2010, ANTI-CANCER AGENT ME, V10, P634; Wong CC, 2006, FOOD CHEM, V97, P705, DOI 10.1016/j.foodchem.2005.05.049; Zambare VP, 2012, PHARM BIOL, V50, P778, DOI 10.3109/13880209.2011.633089; Zeytinoglu H, 2008, PHYTOTHER RES, V22, P118, DOI 10.1002/ptr.2279; Zhang DL, 2004, FOOD CHEM, V88, P503, DOI 10.1016/j.foodchem.2004.01.065; Zhang HH, 2010, FREE RADICAL BIO MED, V49, P2010, DOI 10.1016/j.freeradbiomed.2010.09.031; Zhang WM, 2009, AFR J BIOTECHNOL, V8, P3887; Zheng W, 2001, J AGR FOOD CHEM, V49, P5165, DOI 10.1021/jf010697n	117	23	24	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e98696	10.1371/journal.pone.0098696	http://dx.doi.org/10.1371/journal.pone.0098696			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937759	Green Published, Green Submitted, gold			2022-12-25	WOS:000338503400009
J	Meyer, JL; Paul, VJ; Teplitski, M				Meyer, Julie L.; Paul, Valerie J.; Teplitski, Max			Community Shifts in the Surface Microbiomes of the Coral Porites astreoides with Unusual Lesions	PLOS ONE			English	Article							WHITE PLAGUE DISEASE; REEF-BUILDING CORAL; BACTERIAL COMMUNITIES; CLIMATE-CHANGE; SP NOV.; MONTASTRAEA-FAVEOLATA; INFECTIOUS-DISEASES; PHAGE THERAPY; RED-SEA; HEALTHY	Apical lesions on Porites astreoides were characterized by the appearance of a thin yellow band, which was preceded by bleaching of the coral tissues and followed by a completely denuded coral skeleton, which often harbored secondary macroalgal colonizers. These characteristics have not been previously described in Porites and do not match common Caribbean coral diseases. The lesions were observed only in warmer months and at shallow depths on the fore reef in Belize. Analysis of the microbial community composition based on the V4 hypervariable region of 16S ribosomal RNA genes revealed that the surface microbiomes associated with nonsymptomatic corals were dominated by the members of the genus Endozoicomonas, consistent with other studies. Comparison of the microbiomes of nonsymptomatic and lesioned coral colonies sampled in July and September revealed two distinct groups, inconsistently related to the disease state of the coral, but showing some temporal signal. The loss of Endozoicomonas was characteristic of lesioned corals, which also harbored potential opportunistic pathogens such as Alternaria, Stenotrophomonas, and Achromobacter. The presence of lesions in P. astreoides coincided with a decrease in the relative abundance of Endozoicomonas, rather than the appearance of specific pathogenic taxa.	[Meyer, Julie L.; Teplitski, Max] Univ Florida, Inst Food & Agr Sci, Dept Soil & Water Sci, Gainesville, FL 32611 USA; [Paul, Valerie J.; Teplitski, Max] Smithsonian Marine Stn, Ft Pierce, FL USA	State University System of Florida; University of Florida; Smithsonian Institution; Smithsonian National Museum of Natural History	Teplitski, M (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Soil & Water Sci, Gainesville, FL 32611 USA.	maxtep@ufl.edu	Meyer, Julie L./D-1021-2010	Meyer, Julie L./0000-0003-3382-3321	George E. Burch Fellowship in Theoretical Medicine and Affiliated Sciences at the Smithsonian Institution; National Geographic Society Committee for Research Exploration grant [9184-12]	George E. Burch Fellowship in Theoretical Medicine and Affiliated Sciences at the Smithsonian Institution; National Geographic Society Committee for Research Exploration grant(National Geographic Society)	Support for this research was provided by the George E. Burch Fellowship in Theoretical Medicine and Affiliated Sciences at the Smithsonian Institution; M.T. was a 2012 recipient of this fellowship. Funding for sample collection was provided by the National Geographic Society Committee for Research Exploration grant # 9184-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020370; Aitchison J, 2003, COMP DAT AN WORKSH G; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apprill A, 2013, ENVIRON MICROBIOL, V15, P2063, DOI 10.1111/1462-2920.12107; Arboleda MDM, 2010, DIS AQUAT ORGAN, V90, P93, DOI 10.3354/dao02222; Atad I, 2012, CORAL REEFS, V31, P665, DOI 10.1007/s00338-012-0900-5; Bayer T, 2013, APPL ENVIRON MICROB, V79, P4759, DOI 10.1128/AEM.00695-13; Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Bruckner AW, 2009, DIS AQUAT ORGAN, V87, P19, DOI 10.3354/dao02120; Burge CA, 2014, ANNU REV MAR SCI, V6, P249, DOI 10.1146/annurev-marine-010213-135029; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardenas A, 2012, ISME J, V6, P502, DOI 10.1038/ismej.2011.123; Cohen Y, 2013, MICROBIOLOGYOPEN, V2, P64, DOI 10.1002/mbo3.52; Croquer A, 2013, ENV MICROBIOL REP, V5, P90, DOI 10.1111/j.1758-2229.2012.00397.x; Croquer A, 2009, DIS AQUAT ORGAN, V83, P209, DOI 10.3354/dao02012; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1658/1100-9233(2003)014[0927:VAPORF]2.0.CO;2; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edmunds PJ, 2010, MAR ECOL PROG SER, V418, P87, DOI 10.3354/meps08823; Efrony R, 2007, CORAL REEFS, V26, P7, DOI 10.1007/s00338-006-0170-1; Efrony R, 2009, CURR MICROBIOL, V58, P139, DOI 10.1007/s00284-008-9290-x; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Garrity G., 2005, BERGEYS MANUAL SYSTE; Green DH, 2008, MAR ECOL PROG SER, V359, P1, DOI 10.3354/meps07454; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jessen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062091; Kellogg CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079801; Kellogg CA, 2012, J MICROBIOL METH, V88, P103, DOI 10.1016/j.mimet.2011.10.019; Kim MY, 2009, J NAT PROD, V72, P2065, DOI 10.1021/np900464p; Kimes NE, 2013, ENVIRON MICROBIOL, V15, P2082, DOI 10.1111/1462-2920.12130; Kimes NE, 2010, ENVIRON MICROBIOL, V12, P541, DOI 10.1111/j.1462-2920.2009.02113.x; Krediet CJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2328; Kurahashi M, 2007, SYST APPL MICROBIOL, V30, P202, DOI 10.1016/j.syapm.2006.07.003; LECAMPIONALSUMARD T, 1995, MAR ECOL PROG SER, V117, P137, DOI 10.3354/meps117137; Lee OO, 2012, APPL ENVIRON MICROB, V78, P7173, DOI 10.1128/AEM.01111-12; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Levas SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063267; Li XY, 2013, APPL MICROBIOL BIOT, V97, P6413, DOI 10.1007/s00253-013-5018-3; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Mizrachi I, 2002, NCBI HDB INTERNET; Morrison-Gardiner S, 2002, FUNGAL DIVERS, V9, P105; Morrow KM, 2012, APPL ENVIRON MICROB, V78, P6438, DOI 10.1128/AEM.01162-12; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; Muller EM, 2012, GLOBAL CHANGE BIOL, V18, P3529, DOI 10.1111/gcb.12019; Pike RE, 2013, INT J SYST EVOL MICR, V63, P4294, DOI 10.1099/ijs.0.051490-0; Pollock FJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002183; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Richardson LL, 1998, REV BIOL TROP, V46, P187; Riegl B, 2009, ANN NY ACAD SCI, V1162, P136, DOI 10.1111/j.1749-6632.2009.04493.x; Roder C, 2014, MOL ECOL, V23, P965, DOI 10.1111/mec.12638; Roder C, 2014, ISME J, V8, P31, DOI 10.1038/ismej.2013.127; Rodriguez-Lanetty M, 2013, MOL ECOL, V22, P4349, DOI 10.1111/mec.12392; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Ruiz-Morenol D, 2012, DIS AQUAT ORGAN, V100, P249, DOI 10.3354/dao02488; Sere MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083746; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharp KH, 2012, ISME J, V6, P790, DOI 10.1038/ismej.2011.144; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Sweet MJ, 2011, CORAL REEFS, V30, P39, DOI 10.1007/s00338-010-0695-1; Thomma BPHJ, 2003, MOL PLANT PATHOL, V4, P225, DOI 10.1046/J.1364-3703.2003.00173.X; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; Vezzulli L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067745; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; Weil E, 2012, DIS AQUAT ORGAN, V98, P163, DOI 10.3354/dao02433; Work TM, 2006, DIS AQUAT ORGAN, V70, P155, DOI 10.3354/dao070155; Yang CS, 2010, INT J SYST EVOL MICR, V60, P1158, DOI 10.1099/ijs.0.014357-0; Yu ZS, 2013, FUNGAL DIVERS, V58, P127, DOI 10.1007/s13225-012-0192-7; Zhang Y, 2009, MAR DRUGS, V7, P97, DOI 10.3390/md7020097; Zheng CJ, 2012, J NAT PROD, V75, P189, DOI 10.1021/np200766d	76	71	71	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100316	10.1371/journal.pone.0100316	http://dx.doi.org/10.1371/journal.pone.0100316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937478	gold, Green Submitted, Green Published			2022-12-25	WOS:000338503400104
J	Keleg, S; Titov, A; Heller, A; Giese, T; Tjaden, C; Ahmad, SS; Gaida, MM; Bauer, AS; Werner, J; Giese, NA				Keleg, Shereen; Titov, Alexandr; Heller, Anette; Giese, Thomas; Tjaden, Christine; Ahmad, Sufian S.; Gaida, Matthias M.; Bauer, Andrea S.; Werner, Jens; Giese, Nathalia A.			Chondroitin Sulfate Proteoglycan CSPG4 as a Novel Hypoxia-Sensitive Marker in Pancreatic Tumors	PLOS ONE			English	Article							VON-HIPPEL-LINDAU; PAPILLARY-MUCINOUS NEOPLASMS; IN-VITRO; DUCTAL ADENOCARCINOMA; STEM-CELLS; NG2 PROTEOGLYCAN; UVEAL MELANOMA; CANCER; MOUSE; GENE	CSPG4 marks pericytes, undifferentiated precursors and tumor cells. We assessed whether the shed ectodomain of CSPG4 (sCSPG4) might circulate and reflect potential changes in CSPG4 tissue expression (pCSPG4) due to desmoplastic and malignant aberrations occurring in pancreatic tumors. Serum sCSPG4 was measured using ELISA in test (n = 83) and validation (n = 221) cohorts comprising donors (n = 11+ 26) and patients with chronic pancreatitis (n = 11+ 20) or neoplasms: benign (serous cystadenoma SCA, n = 13+20), premalignant (intraductal dysplastic IPMNs, n = 9+55), and malignant (IPMN-associated invasive carcinomas, n = 4+14; ductal adenocarcinomas, n = 35+86). Pancreatic pCSPG4 expression was evaluated using qRT-PCR (n = 139), western blot analysis and immunohistochemistry. sCSPG4 was found in circulation, but its level was significantly lower in pancreatic patients than in donors. Selective maintenance was observed in advanced IPMNs and PDACs and showed a nodal association while lacking prognostic relevance. Pancreatic pCSPG4 expression was preserved or elevated, whereby neoplastic cells lacked pCSPG4 or tended to overexpress without shedding. Extreme pancreatic overexpression, membranous exposure and tissue(high)/sera(low)-discordance highlighted stroma-poor benign cystic neoplasm. SCA is known to display hypoxic markers and coincide with von-Hippel-Lindau and Peutz-Jeghers syndromes, in which pVHL and LBK1 mutations affect hypoxic signaling pathways. In vitro testing confined pCSPG4 overexpression to normal mesenchymal but not epithelial cells, and a third of tested carcinoma cell lines; however, only the latter showed pCSPG4-responsiveness to chronic hypoxia. siRNA-based knockdowns failed to reduce the malignant potential of either normoxic or hypoxic cells. Thus, overexpression of the newly established conditional hypoxic indicator, CSPG4, is apparently nonpathogenic in pancreatic malignancies but might mark distinct epithelial lineage and contribute to cell polarity disorders. Surficial retention on tumor cells renders CSPG4 an attractive therapeutic target. Systemic 'drop and restoration' alterations accompanying IPMN and PDAC progression indicate that the interference of pancreatic diseases with local and remote shedding/release of sCSPG4 into circulation deserves broad diagnostic exploration.	[Keleg, Shereen; Titov, Alexandr; Heller, Anette; Tjaden, Christine; Ahmad, Sufian S.; Werner, Jens; Giese, Nathalia A.] Univ Heidelberg Hosp, Dept Gen Visceral & Transplantat Surg, European Pancreas Ctr, Heidelberg, Germany; [Giese, Thomas] Univ Heidelberg Hosp, Inst Immunol, Heidelberg, Germany; [Bauer, Andrea S.] German Canc Res Ctr, Dept Funct Genom, Heidelberg, Germany; [Gaida, Matthias M.] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Giese, NA (corresponding author), Univ Heidelberg Hosp, Dept Gen Visceral & Transplantat Surg, European Pancreas Ctr, Heidelberg, Germany.	nathalia.giese@med.uni-heidelberg.de	Ahmad, Sufian S/H-3881-2014	Ahmad, Sufian S/0000-0001-9763-092X	Dietmar Hopp Stiftung; BMBF [NGFN-01GS08114]	Dietmar Hopp Stiftung; BMBF(Federal Ministry of Education & Research (BMBF))	The work was supported by grants from the Dietmar Hopp Stiftung (http://www.dietmar-hopp-stiftung.de/) to N.A. Giese and from the BMBF to N.A. Giese and A. Bauer (NGFN-01GS08114; http://www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichler M, 2012, J PATHOL, V226, P723, DOI 10.1002/path.3017; Amato E, 2014, J PATHOL; Arafat H, 2011, SURGERY, V150, P306, DOI 10.1016/j.surg.2011.05.011; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bartel M, 2008, J PATHOL, V215, P195, DOI 10.1002/path.2348; Carlotti F, 2010, ISLETS, V2, P164, DOI 10.4161/isl.2.3.11449; Ceyhan GO, 2009, GASTROENTEROLOGY, V136, P177, DOI 10.1053/j.gastro.2008.09.029; Chekenya M, 2008, ONCOGENE, V27, P5182, DOI 10.1038/onc.2008.157; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Davies JA, 1996, ACTA ANAT, V156, P187; Erkan M, 2008, CLIN GASTROENTEROL H, V6, P1155, DOI 10.1016/j.cgh.2008.05.006; Erkan M, 2007, GASTROENTEROLOGY, V132, P1447, DOI 10.1053/j.gastro.2007.01.031; Esposito I, 2007, PANCREAS, V35, P212, DOI 10.1097/mpa.0b013e31805d0190; Faubert B, 2014, P NATL ACAD SCI USA, V111, P2554, DOI 10.1073/pnas.1312570111; Furukawa T, 1996, AM J PATHOL, V148, P1763; Geldres C, 2014, CLIN CANCER RES, V20, P962, DOI 10.1158/1078-0432.CCR-13-2218; Girolamo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084883; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Hartwig W, 2011, ANN SURG, V254, P311, DOI 10.1097/SLA.0b013e31821fd334; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; Higuchi Y, 2011, CONGENIT ANOM, V51, P21, DOI 10.1111/j.1741-4520.2010.00307.x; Ideno N, 2013, ANN SURG, V258, P141, DOI 10.1097/SLA.0b013e31828cd008; Ju PJ, 2012, CYTOTHERAPY, V14, P608, DOI 10.3109/14653249.2011.651528; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim SG, 2003, MODERN PATHOL, V16, P1086, DOI 10.1097/01.MP.0000094088.37888.A6; Koh MY, 2012, TRENDS BIOCHEM SCI, V37, P364, DOI 10.1016/j.tibs.2012.06.004; Kong B, 2011, NAT REV GASTRO HEPAT, V8, P467, DOI 10.1038/nrgastro.2011.114; Koninger J, 2004, CLIN CANCER RES, V10, P4776, DOI 10.1158/1078-0432.CCR-1190-03; Konstantinou F, 2013, J PANCREAS, V14, P141, DOI 10.6092/1590-8577/1467; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Landsman L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001143; Legg J, 2003, DEVELOPMENT, V130, P6049, DOI 10.1242/dev.00837; Levine JM, 1996, PERSPECT DEV NEUROBI, V3, P245; Li Y, 2005, INVEST OPHTH VIS SCI, V46, P4365, DOI 10.1167/iovs.05-0559; Liu H, 2012, CURR PHARM DESIGN, V18, P2395, DOI 10.2174/13816128112092395; Lonser RR, 2003, LANCET, V361, P2059, DOI 10.1016/S0140-6736(03)13643-4; Mazumdar J, 2010, P NATL ACAD SCI USA, V107, P14182, DOI 10.1073/pnas.1001296107; Mino-Kenudson M, 2011, GUT, V60, P1712, DOI 10.1136/gut.2010.232272; Mohr VH, 2000, AM J PATHOL, V157, P1615, DOI 10.1016/S0002-9440(10)64799-2; Mohri D, 2012, J GASTROENTEROL, V47, P203, DOI 10.1007/s00535-011-0482-y; Monti P, 2004, VIRCHOWS ARCH, V445, P236, DOI 10.1007/s00428-004-1053-x; Moore PS, 2001, AM J PATHOL, V158, P317, DOI 10.1016/S0002-9440(10)63971-5; Murtaugh LC, 2007, CANCER CELL, V11, P211, DOI 10.1016/j.ccr.2007.02.020; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; NEUMANN HPH, 1991, GASTROENTEROLOGY, V101, P465, DOI 10.1016/0016-5085(91)90026-H; NISHIYAMA A, 1995, MOL BIOL CELL, V6, P1819, DOI 10.1091/mbc.6.12.1819; Ozerdem U, 2006, OPHTHAL RES, V38, P251, DOI 10.1159/000094833; Pankova D, 2012, EUR J CELL BIOL; Perez-Mancera PA, 2012, GASTROENTEROLOGY, V142, P1079, DOI 10.1053/j.gastro.2012.03.002; Poli A, 2013, ONCOTARGET, V4, P1527, DOI 10.18632/oncotarget.1291; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; Sahin F, 2003, MODERN PATHOL, V16, P686, DOI 10.1097/01.MP.0000075645.97329.86; Sato N, 2001, AM J PATHOL, V159, P2017, DOI 10.1016/S0002-9440(10)63053-2; Shackelford DB, 2009, P NATL ACAD SCI USA, V106, P11137, DOI 10.1073/pnas.0900465106; Smith FO, 1996, BLOOD, V87, P1123, DOI 10.1182/blood.V87.3.1123.bloodjournal8731123; Stallcup WB, 2002, J NEUROCYTOL, V31, P423, DOI 10.1023/A:1025731428581; Stanger BZ, 2005, CANCER CELL, V8, P185, DOI 10.1016/j.ccr.2005.07.015; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Svendsen A, 2011, ACTA NEUROPATHOL, V122, P495, DOI 10.1007/s00401-011-0867-2; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023062; Wiesener MS, 2009, J MOL MED-JMM, V87, P871, DOI 10.1007/s00109-009-0504-x	64	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100178	10.1371/journal.pone.0100178	http://dx.doi.org/10.1371/journal.pone.0100178			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932730	Green Published, Green Submitted, gold			2022-12-25	WOS:000337738600100
J	Poznanski, J; Poznanska, A; Shugar, D				Poznanski, Jaroslaw; Poznanska, Anna; Shugar, David			A Protein Data Bank Survey Reveals Shortening of Intermolecular Hydrogen Bonds in Ligand-Protein Complexes When a Halogenated Ligand Is an H-Bond Donor	PLOS ONE			English	Article							RANDOM COIL TRANSITIONS; MEDICINAL CHEMISTRY; C-H...O; DNA; RECOGNITION; COMPETITION; SUBSTITUENT; PARALLEL; ACCEPTOR; BINDING	Halogen bonding in ligand-protein complexes is currently widely exploited, e. g. in drug design or supramolecular chemistry. But little attention has been directed to other effects that may result from replacement of a hydrogen by a strongly electronegative halogen. Analysis of almost 30000 hydrogen bonds between protein and ligand demonstrates that the length of a hydrogen bond depends on the type of donor-acceptor pair. Interestingly, lengths of hydrogen bonds between a protein and a halogenated ligand are visibly shorter than those estimated for the same family of proteins in complexes with non-halogenated ligands. Taking into account the effect of halogenation on hydrogen bonding is thus important when evaluating structural and/or energetic parameters of ligand-protein complexes. All these observations are consistent with the concept that halogenation increases the acidity of the proximal amino/imino/hydroxyl groups and thus makes them better, i.e. stronger, H-bond donors.	[Poznanski, Jaroslaw] Inst Biochem & Biophys PAS, Dept Biophys, Warsaw, Poland; [Poznanska, Anna] Natl Inst Hyg, Ctr Monitoring & Anal Populat Hlth Status, Natl Inst Publ Hlth, PL-00791 Warsaw, Poland; [Shugar, David] Inst Biochem & Biophys PAS, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; National Institute of Hygiene (NIH); National Institute of Public Health (NIPH); Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Poznanski, J (corresponding author), Inst Biochem & Biophys PAS, Dept Biophys, Warsaw, Poland.	jarek@ibb.waw.pl; gwalesshugar@gmail.com	Poznanski, Jaroslaw/F-7705-2014	Poznanski, Jaroslaw/0000-0003-2684-1775; Poznanska, Anna/0000-0002-2026-7293	National Science Centre, Poland [2012/07/B/ST4/01334]	National Science Centre, Poland(National Science Centre, Poland)	This work was supported by National Science Centre, Poland (http://ncn.gov.pl/); Grant number 2012/07/B/ST4/01334. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakeroy CB, 2013, CRYSTENGCOMM, V15, P3125, DOI 10.1039/c2ce26747k; AAKEROY CB, 1993, CHEM SOC REV, V22, P397, DOI 10.1039/cs9932200397; Aakeroy CB, 2010, CRYSTENGCOMM, V12, P22, DOI 10.1039/b919819a; An XL, 2013, J MOL MODEL, V19, P4529, DOI 10.1007/s00894-013-1969-7; ANDERSON TW, 1952, ANN MATH STAT, V23, P193, DOI 10.1214/aoms/1177729437; [Anonymous], 2011, STAT DAT AN SOFTW SY; ATWOOD JL, 1991, NATURE, V349, P683, DOI 10.1038/349683a0; Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Baldrighi M, 2013, MOL PHARMACEUT, V10, P1760, DOI 10.1021/mp300574j; BENT HA, 1968, CHEM REV, V68, P587, DOI 10.1021/cr60255a003; Carter M, 2011, CRYST GROWTH DES, V11, P5087, DOI 10.1021/cg200991v; CULLEN BR, 1976, NUCLEIC ACIDS RES, V3, P49, DOI 10.1093/nar/3.1.49; DESIRAJU GR, 1991, ACCOUNTS CHEM RES, V24, P290, DOI 10.1021/ar00010a002; DESIRAJU GR, 1995, ANGEW CHEM INT EDIT, V34, P2311, DOI 10.1002/anie.199523111; Freidlin B, 2000, AM STAT, V54, P161, DOI 10.2307/2685584; Guerra CF, 2005, STRUCT CHEM, V16, P211, DOI 10.1007/s11224-005-4453-x; Hardegger LA, 2011, ANGEW CHEM INT EDIT, V50, P314, DOI 10.1002/anie.201006781; HASSEL O, 1954, ACTA CHEM SCAND, V8, P873, DOI 10.3891/acta.chem.scand.08-0873; Hauchecorne D, 2010, CHEM PHYS, V374, P30, DOI 10.1016/j.chemphys.2010.06.004; Hernandes MZ, 2010, CURR DRUG TARGETS, V11, P303, DOI 10.2174/138945010790711996; Heshmati E, 2009, BIOORG MED CHEM LETT, V19, P5256, DOI 10.1016/j.bmcl.2009.06.105; INMAN RB, 1962, J MOL BIOL, V5, P185, DOI 10.1016/S0022-2836(62)80083-7; INMAN RB, 1964, J MOL BIOL, V8, P452, DOI 10.1016/S0022-2836(64)80003-6; INMAN RB, 1962, J MOL BIOL, V5, P172, DOI 10.1016/S0022-2836(62)80082-5; Jeffrey GA, 1994, HYDROGEN BONDING BIO; KOSHLAND DE, 1994, ANGEW CHEM INT EDIT, V33, P2375; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kuhn B, 2010, J MED CHEM, V53, P2601, DOI 10.1021/jm100087s; KUOPIO R, 1976, ACTA CHEM SCAND A, V30, P1, DOI 10.3891/acta.chem.scand.30a-0001; Li QZ, 2010, PHYS CHEM CHEM PHYS, V12, P6837, DOI 10.1039/b926355a; Liu XF, 2013, SPECTROCHIM ACTA A, V101, P172, DOI 10.1016/j.saa.2012.09.043; Lozinski T, 2001, ACTA BIOCHIM POL, V48, P495; Lu YX, 2012, EXPERT OPIN DRUG DIS, V7, P375, DOI 10.1517/17460441.2012.678829; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Metrangolo P, 2001, CHEM-EUR J, V7, P2511, DOI 10.1002/1521-3765(20010618)7:12<2511::AID-CHEM25110>3.0.CO;2-T; Metrangolo P, 2005, ACCOUNTS CHEM RES, V38, P386, DOI 10.1021/ar0400995; Metrangolo P, 2008, ANGEW CHEM INT EDIT, V47, P6114, DOI 10.1002/anie.200800128; Metrangolo P, 2011, CRYST GROWTH DES, V11, P4238, DOI 10.1021/cg200888n; Mooibroek TJ, 2013, CRYSTENGCOMM, V15, P4565, DOI 10.1039/c3ce40285a; Mooibroek TJ, 2013, CRYSTENGCOMM, V15, P1802, DOI 10.1039/c2ce26853a; Parisini E, 2011, CHEM SOC REV, V40, P2267, DOI 10.1039/c0cs00177e; Pauletti PM, 2010, MAR DRUGS, V8, P1526, DOI 10.3390/md8051526; Politzer P, 2007, J MOL MODEL, V13, P305, DOI 10.1007/s00894-006-0154-7; Politzer P, 2010, PHYS CHEM CHEM PHYS, V12, P7748, DOI 10.1039/c004189k; Poznanski J, 2013, BBA-PROTEINS PROTEOM, V1834, P1381, DOI 10.1016/j.bbapap.2013.01.026; Raatikainen K, 2010, BEILSTEIN J ORG CHEM, V6, DOI 10.3762/bjoc.6.4; Rendine S, 2011, PHYS CHEM CHEM PHYS, V13, P19508, DOI 10.1039/c1cp22436k; Riley KE, 2013, J MOL MODEL, V19, P2879, DOI 10.1007/s00894-012-1727-2; Rissanen K, 2008, CRYSTENGCOMM, V10, P1107, DOI 10.1039/b803329n; Sarwar MG, 2010, J AM CHEM SOC, V132, P1646, DOI 10.1021/ja9086352; Scholfield MR, 2013, PROTEIN SCI, V22, P139, DOI 10.1002/pro.2201; Seela F, 2005, J AM CHEM SOC, V127, P7739, DOI 10.1021/ja0425785; SIMPSON RT, 1974, BIOCHEMISTRY-US, V13, P4609, DOI 10.1021/bi00719a022; Steiner T, 2001, J MOL BIOL, V305, P535, DOI 10.1006/jmbi.2000.4301; Stryer L., 1995, BIOCHEMISTRY-US, V4th ed.; TAYLOR R, 1982, J AM CHEM SOC, V104, P5063, DOI 10.1021/ja00383a012; Voth AR, 2007, CURR TOP MED CHEM, V7, P1336; Voth AR, 2007, P NATL ACAD SCI USA, V104, P6188, DOI 10.1073/pnas.0610531104; Voth AR, 2009, NAT CHEM, V1, P74, DOI [10.1038/NCHEM.112, 10.1038/nchem.112]; Vulpetti A, 2012, DRUG DISCOV TODAY, V17, P890, DOI 10.1016/j.drudis.2012.03.014; Wang W, 2005, J NAT PROD, V68, P620, DOI 10.1021/np040199j; Wasik R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048898; Wasik R, 2012, J PHYS CHEM B, V116, P7259, DOI 10.1021/jp301561x; Wasik R, 2010, J PHYS CHEM B, V114, P10601, DOI 10.1021/jp102848y; Wilcken R, 2013, J MED CHEM, V56, P1363, DOI 10.1021/jm3012068; Xu ZJ, 2011, J MED CHEM, V54, P5607, DOI 10.1021/jm200644r; Zhou P, 2010, MINI-REV MED CHEM, V10, P309, DOI 10.2174/138955710791331016	68	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99984	10.1371/journal.pone.0099984	http://dx.doi.org/10.1371/journal.pone.0099984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933273	Green Submitted, Green Published, gold			2022-12-25	WOS:000337738600083
J	Rajpathak, SN; Vellarikkal, SK; Patowary, A; Scaria, V; Sivasubbu, S; Deobagkar, DD				Rajpathak, Shriram N.; Vellarikkal, Shamsudheen Karuthedath; Patowary, Ashok; Scaria, Vinod; Sivasubbu, Sridhar; Deobagkar, Deepti D.			Human 45,X Fibroblast Transcriptome Reveals Distinct Differentially Expressed Genes Including Long Noncoding RNAs Potentially Associated with the Pathophysiology of Turner Syndrome	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; PLACENTAL GROWTH-FACTOR; FRIZZLED-RELATED PROTEIN-1; OSTEOGENIC DIFFERENTIATION; LUTEINIZING-HORMONE; X-INACTIVATION; SHORT STATURE; Y-CHROMOSOME; STEM-CELLS; SNORNA U50	Turner syndrome is a chromosomal abnormality characterized by the absence of whole or part of the X chromosome in females. This X aneuploidy condition is associated with a diverse set of clinical phenotypes such as gonadal dysfunction, short stature, osteoporosis and Type II diabetes mellitus, among others. These phenotypes differ in their severity and penetrance among the affected individuals. Haploinsufficiency for a few X linked genes has been associated with some of these disease phenotypes. RNA sequencing can provide valuable insights to understand molecular mechanism of disease process. In the current study, we have analysed the transcriptome profiles of human untransformed 45, X and 46,XX fibroblast cells and identified differential expression of genes in these two karyotypes. Functional analysis revealed that these differentially expressing genes are associated with bone differentiation, glucose metabolism and gonadal development pathways. We also report differential expression of lincRNAs in X monosomic cells. Our observations provide a basis for evaluation of cellular and molecular mechanism(s) in the establishment of Turner syndrome phenotypes.	[Rajpathak, Shriram N.; Deobagkar, Deepti D.] Univ Pune, Dept Zool, Ctr Adv Studies, Pune, Maharashtra, India; [Vellarikkal, Shamsudheen Karuthedath; Sivasubbu, Sridhar] CSIR Inst Genom & Integrat Biol, Delhi, India; [Patowary, Ashok; Scaria, Vinod] CSIR Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India; [Scaria, Vinod; Sivasubbu, Sridhar] Anusandhan Bhawan, Acad Sci & Innovat Res AcSIR, New Delhi, India	Savitribai Phule Pune University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Academy of Scientific & Innovative Research (AcSIR)	Scaria, V (corresponding author), CSIR Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India.	vinods@igib.in; s.sivasubbu@igib.res.in; deepti.deobagkar@gmail.com	Scaria, Vinod/AAS-3151-2021; Patowary, Ashok/AAT-5305-2020; Karuthedath Vellarikkal, Shamsudheen/AAC-4142-2022	Patowary, Ashok/0000-0001-7507-3907; Karuthedath Vellarikkal, Shamsudheen/0000-0002-6384-2948; Scaria, Vinod/0000-0001-7644-7181	University Grants Commission, Government of India; Council of Scientific and Industrial Research, India [BSC0122]	University Grants Commission, Government of India(University Grants Commission, India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	SR is thankful to University Grants Commission, Government of India, for senior research fellowship. SS and VS acknowledge funding from Council of Scientific and Industrial Research, India, through grant BSC0122 (CARDIOMED) for the sequencing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agretti P, 2007, J ENDOCRINOL INVEST, V30, P279, DOI 10.1007/BF03346294; Aksglaede L, 2008, J CLIN ENDOCR METAB, V93, P169, DOI 10.1210/jc.2007-1426; Arthold S, 2011, HUM GENET, V130, P295, DOI 10.1007/s00439-011-1002-0; Bakalov VK, 2009, J CLIN ENDOCR METAB, V94, P3289, DOI 10.1210/jc.2009-0384; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Berger AH, 2011, J PATHOL, V223, P137, DOI 10.1002/path.2800; Bhartiya D, 2012, EXPERT OPIN DRUG DIS, V7, P503, DOI 10.1517/17460441.2012.682055; Bione S, 1998, AM J HUM GENET, V62, P533, DOI 10.1086/301761; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Bottcher Y, 2006, J CLIN ENDOCR METAB, V91, P4948, DOI 10.1210/jc.2006-0540; BURGOYNE PS, 1989, NATURE, V342, P860, DOI 10.1038/342860a0; Carmona-Mora P, 2010, CURR GENOMICS, V11, P607, DOI 10.2174/138920210793360952; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Christiansen J, 2009, J MOL ENDOCRINOL, V43, P187, DOI 10.1677/JME-09-0016; Clement-Jones M, 2000, HUM MOL GENET, V9, P695, DOI 10.1093/hmg/9.5.695; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; DENNY P, 1992, EMBO J, V11, P3705, DOI 10.1002/j.1460-2075.1992.tb05455.x; Di Cunto F, 2013, MOL PATHWAYS SYNDROM; Dong XY, 2008, HUM MOL GENET, V17, P1031, DOI 10.1093/hmg/ddm375; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Edelman EA, 2007, CLIN GENET, V71, P540, DOI 10.1111/j.1399-0004.2007.00815.x; Ellison JW, 1997, HUM MOL GENET, V6, P1341, DOI 10.1093/hmg/6.8.1341; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Farooque A, 2012, PEDIAT BLOOD CANC; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; Gaur T, 2006, J CELL PHYSIOL, V208, P87, DOI 10.1002/jcp.20637; Gerstenfeld Louis C, 2004, Expert Opin Drug Saf, V3, P131, DOI 10.1517/14740338.3.2.131; Goldacre MJ, 2014, ARCH DIS CHILD, V99, P71, DOI 10.1136/archdischild-2013-304617; Gravholt CH, 1999, CLIN ENDOCRINOL, V50, P791; Gravholt CH, 2001, AM J PHYSIOL-ENDOC M, V280, pE308, DOI 10.1152/ajpendo.2001.280.2.E308; Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaushik K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083616; Kelkar A, 2010, EPIGENETICS-US, V5, P612, DOI 10.4161/epi.5.7.12797; Lefebvre W, 2002, J BONE MINER METAB, V20, P121, DOI 10.1007/s007740200017; Li CM, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-24; Li W, 2012, HUM MOL GENET, V21, P32, DOI 10.1093/hmg/ddr435; Liu ZY, 2011, ASIAN PAC J CANCER P, V12, P2819; Lleo A, 2012, AUTOIMMUN REV, V11, pA538, DOI 10.1016/j.autrev.2011.11.015; Lockstone HE, 2007, GENOMICS, V90, P647, DOI 10.1016/j.ygeno.2007.08.005; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Luo CW, 2005, ENDOCRINOLOGY, V146, P469, DOI 10.1210/en.2004-1197; Luo CW, 2004, MOL ENDOCRINOL, V18, P2085, DOI 10.1210/me.2004-0066; Maes C, 2006, J CLIN INVEST, V116, P1230, DOI 10.1172/JCI26772; Marrony S, 2003, BONE, V33, P426, DOI 10.1016/S8756-3282(03)00195-9; McCoy RJ, 2013, STEM CELLS, V31, P2420, DOI 10.1002/stem.1482; Meyre D, 2005, NAT GENET, V37, P863, DOI 10.1038/ng1604; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Myers LK, 2006, BONE, V39, P1048, DOI 10.1016/j.bone.2006.05.015; Obermann-Borst SA, 2011, EUR J CLIN INVEST, V41, P143, DOI 10.1111/j.1365-2362.2010.02388.x; Ogata T, 2001, J MED GENET, V38, P1, DOI 10.1136/jmg.38.1.1; Pacilli A, 2013, INT J MOL SCI, V14, P14923, DOI 10.3390/ijms140714923; Pan JA, 2010, ONCOL REP, V24, P105, DOI 10.3892/or_00000834; Rajpathak SN, 2013, CURR PHARM DES; Rodriguez S, 2006, EUR J HUM GENET, V14, P109, DOI 10.1038/sj.ejhg.5201505; Rovet J, 2004, LEARNING DISABILITIE, V19, P133, DOI DOI 10.1111/J.1540-5826.2004.00097.X; Samur MK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-672; Schoemaker MJ, 2008, LANCET ONCOL, V9, P239, DOI 10.1016/S1470-2045(08)70033-0; Simms D., 1993, FOCUS, V15, P532, DOI DOI 10.1016/0003-267061)80041-X; Sybert VP, 2004, NEW ENGL J MED, V351, P1227, DOI 10.1056/NEJMra030360; Tanaka R, 2000, GENES CELLS, V5, P277, DOI 10.1046/j.1365-2443.2000.00325.x; Tang Y, 2004, ANN NEUROL, V56, P808, DOI 10.1002/ana.20291; Temple CM, 1996, DEV NEUROPSYCHOL, V12, P343, DOI 10.1080/87565649609540657; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Urbach A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004175; Valtorta E, 2013, INT J CANC; Vawter MP, 2007, AM J MED GENET B, V144B, P728, DOI 10.1002/ajmg.b.30454; Visser JA, 2013, HUM REPROD, V28, P1899, DOI 10.1093/humrep/det089; Xu MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080374; Zhang R, 2013, BMC GENOMICS, V14, P1; Zinn AR, 1998, CURR OPIN GENET DEV, V8, P322, DOI 10.1016/S0959-437X(98)80089-0	80	34	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100076	10.1371/journal.pone.0100076	http://dx.doi.org/10.1371/journal.pone.0100076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932682	Green Published, gold, Green Submitted			2022-12-25	WOS:000337738600090
J	Roger, M; Biaso, F; Castelle, CJ; Bauzan, M; Chaspoul, F; Lojou, E; Sciara, G; Caffarri, S; Giudici-Orticoni, MT; Ilbert, M				Roger, Magali; Biaso, Frederic; Castelle, Cindy J.; Bauzan, Marielle; Chaspoul, Florence; Lojou, Elisabeth; Sciara, Giuliano; Caffarri, Stefano; Giudici-Orticoni, Marie-Therese; Ilbert, Marianne			Spectroscopic Characterization of a Green Copper Site in a Single-Domain Cupredoxin	PLOS ONE			English	Article							CONTAINING NITRITE REDUCTASE; EXTREME ACIDIC CONDITIONS; CYTOCHROME-C-OXIDASE; THIOBACILLUS-FERROOXIDANS; ACIDITHIOBACILLUS-FERROOXIDANS; SUPRAMOLECULAR ORGANIZATION; ACHROMOBACTER-CYCLOCLASTES; NITROSOMONAS-EUROPAEA; ELECTRONIC-STRUCTURE; CRYSTAL-STRUCTURES	Cupredoxins are widespread copper-binding proteins, mainly involved in electron transfer pathways. They display a typical rigid greek key motif consisting of an eight stranded beta-sandwich. A fascinating feature of cupredoxins is the natural diversity of their copper center geometry. These geometry variations give rise to drastic changes in their color, such as blue, green, red or purple. Based on several spectroscopic and structural analyses, a connection between the geometry of their copper-binding site and their color has been proposed. However, little is known about the relationship between such diversity of copper center geometry in cupredoxins and possible implications for function. This has been difficult to assess, as only a few naturally occurring green and red copper sites have been described so far. We report herein the spectrocopic characterization of a novel kind of single domain cupredoxin of green color, involved in a respiratory pathway of the acidophilic organism Acidithiobacillus ferrooxidans. Biochemical and spectroscopic characterization coupled to bioinformatics analysis reveal the existence of some unusual features for this novel member of the green cupredoxin sub-family. This protein has the highest redox potential reported to date for a green-type cupredoxin. It has a constrained green copper site insensitive to pH or temperature variations. It is a green-type cupredoxin found for the first time in a respiratory pathway. These unique properties might be explained by a region of unknown function never found in other cupredoxins, and by an unusual length of the loop between the second and the fourth copper ligands. These discoveries will impact our knowledge on non-engineered green copper sites, whose involvement in respiratory chains seems more widespread than initially thought.	[Roger, Magali; Biaso, Frederic; Lojou, Elisabeth; Sciara, Giuliano; Giudici-Orticoni, Marie-Therese; Ilbert, Marianne] Aix Marseille Univ, Inst Microbiol Mediterranee, Unite Bioenerget & Ingn Prot, CNRS,UMR7281, Marseille, France; [Castelle, Cindy J.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Bauzan, Marielle] Aix Marseille Univ, Inst Microbiol Mediterranee, Unite Fermentat, CNRS,FR 3479, Marseille, France; [Chaspoul, Florence] Aix Marseille Univ, Fac Pharm, Unite Chim Phys Prevent Risques & Nuisances Techn, CNRS,UMR 7263, Marseille, France; [Caffarri, Stefano] Aix Marseille Univ, CEA, Unite Biol Vegetale & Microbiol Environm, CNRS,UMR 7265, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite	Ilbert, M (corresponding author), Aix Marseille Univ, Inst Microbiol Mediterranee, Unite Bioenerget & Ingn Prot, CNRS,UMR7281, Marseille, France.	milbert@imm.cnrs.fr	Caffarri, Stefano/AAX-8913-2021; Ilbert, marianne/ABG-5015-2021; sciara, giuliano/AAL-4478-2020	Caffarri, Stefano/0000-0002-4729-7679; Roger, Magali/0000-0001-9696-2762; Castelle, Cindy/0000-0002-0751-9804; ilbert, marianne/0000-0002-9070-2334	National French Network for EPR equipments ("Tres Grands Equipements pour la Resonance Paramagnetique Electronique''); Agence Nationale de la Recherche, Bioenergie, Centre Nationale de la Recherche Scientifique - Aix-Marseille Universitee; French Ministry of Research (Ministere de l'Enseignement Superieur et de la Recherche)	National French Network for EPR equipments ("Tres Grands Equipements pour la Resonance Paramagnetique Electronique''); Agence Nationale de la Recherche, Bioenergie, Centre Nationale de la Recherche Scientifique - Aix-Marseille Universitee(French National Research Agency (ANR)); French Ministry of Research (Ministere de l'Enseignement Superieur et de la Recherche)(Ministry of Research, France)	Financial support from the National French Network for EPR equipments ("Tres Grands Equipements pour la Resonance Paramagnetique Electronique'') for conducting the research is gratefully acknowledged. Additional funding was provided by Agence Nationale de la Recherche, Bioenergie, Centre Nationale de la Recherche Scientifique - Aix-Marseille Universitee. Magali Roger has a fellowship of the French Ministry of Research (Ministere de l'Enseignement Superieur et de la Recherche). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADMAN ET, 1995, J BIOL CHEM, V270, P27458, DOI 10.1074/jbc.270.46.27458; ADMAN ET, 1991, ADV PROTEIN CHEM, V42, P145; Alcaraz LA, 2007, BIOINORG CHEM APPL, V2007, DOI 10.1155/2007/54232; Arciero DM, 2002, BIOCHEMISTRY-US, V41, P1703, DOI 10.1021/bi015908w; Arnesano F, 2003, P NATL ACAD SCI USA, V100, P3814, DOI 10.1073/pnas.0636904100; Arnesano F, 2002, STRUCTURE, V10, P1337, DOI 10.1016/S0969-2126(02)00858-4; Basumallick L, 2005, J AM CHEM SOC, V127, P3531, DOI 10.1021/ja044412+; Berry SM, 2010, J INORG BIOCHEM, V104, P1071, DOI 10.1016/j.jinorgbio.2010.06.004; Bertini I, 2010, COORDIN CHEM REV, V254, P506, DOI 10.1016/j.ccr.2009.07.024; Botuyan MV, 1996, J MOL BIOL, V263, P752, DOI 10.1006/jmbi.1996.0613; Carrell CJ, 2007, BIOCHEMISTRY-US, V46, P1900, DOI 10.1021/bi0619674; Castelle C, 2008, J BIOL CHEM, V283, P25803, DOI 10.1074/jbc.M802496200; Castelle C, 2010, J BIOL CHEM, V285, P21519, DOI 10.1074/jbc.M110.131359; Li C, 2006, P NATL ACAD SCI USA, V103, P7258, DOI 10.1073/pnas.0600774103; Choi M, 2011, METALLOMICS, V3, P140, DOI 10.1039/c0mt00061b; Clark KM, 2010, J AM CHEM SOC, V132, P10093, DOI 10.1021/ja102632p; Deligeer, 2002, J INORG BIOCHEM, V91, P132, DOI 10.1016/S0162-0134(02)00442-7; Dennison C, 2005, COORDIN CHEM REV, V249, P3025, DOI 10.1016/j.ccr.2005.04.021; Dennison C, 2005, DALTON T, P3436, DOI 10.1039/b507440c; Donaire A, 2002, J AM CHEM SOC, V124, P13698, DOI 10.1021/ja0267019; Farver O, 2011, COORDIN CHEM REV, V255, P757, DOI 10.1016/j.ccr.2010.08.005; Fu Y, 2013, NAT CHEM BIOL, V9, P177, DOI [10.1038/NCHEMBIO.1168, 10.1038/nchembio.1168]; Ghosh S, 2009, P NATL ACAD SCI USA, V106, P4969, DOI 10.1073/pnas.0900995106; Gough J, 2004, STRUCTURE, V12, P917, DOI 10.1016/j.str.2004.03.029; GROSSMANN JG, 1995, BIOCHEMISTRY-US, V34, P8406, DOI 10.1021/bi00026a023; Hay M, 1996, P NATL ACAD SCI USA, V93, P461, DOI 10.1073/pnas.93.1.461; Ilbert M, 2013, BBA-BIOENERGETICS, V1827, P161, DOI 10.1016/j.bbabio.2012.10.001; INGLEDEW WJ, 1982, BIOCHIM BIOPHYS ACTA, V683, P89, DOI 10.1016/0304-4173(82)90007-6; Jimenez B, 2003, BIOCHEMISTRY-US, V42, P10396, DOI 10.1021/bi034692q; Jones LH, 2003, J BIOL CHEM, V278, P47269, DOI 10.1074/jbc.M308863200; Kanbi LD, 2002, J MOL BIOL, V320, P263, DOI 10.1016/S0022-2836(02)00443-6; Kataoka K, 2003, BIOCHEM BIOPH RES CO, V303, P519, DOI 10.1016/S0006-291X(03)00381-4; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; King JD, 2013, BIOCHEMISTRY-US, V52, P8267, DOI 10.1021/bi401163g; Kosman DJ, 2010, J BIOL INORG CHEM, V15, P15, DOI 10.1007/s00775-009-0590-9; Kroes SJ, 1996, EUR J BIOCHEM, V240, P342, DOI 10.1111/j.1432-1033.1996.0342h.x; LaCroix LB, 1996, J AM CHEM SOC, V118, P7755, DOI 10.1021/ja961217p; Li H, 2004, J AM CHEM SOC, V126, P8010, DOI 10.1021/ja049345y; Libeu CAP, 1997, BIOCHEMISTRY-US, V36, P13160, DOI 10.1021/bi9704111; Lieberman RL, 2001, BIOCHEMISTRY-US, V40, P5674, DOI 10.1021/bi0102611; Machonkin TE, 1998, BIOCHEMISTRY-US, V37, P9570, DOI 10.1021/bi980434v; Malarte G, 2005, BIOCHEMISTRY-US, V44, P6471, DOI 10.1021/bi048425b; Marshall NM, 2009, NATURE, V462, P113, DOI 10.1038/nature08551; Nersissian AM, 1998, PROTEIN SCI, V7, P1915, DOI 10.1002/pro.5560070907; NUNZI F, 1994, BIOCHEM BIOPH RES CO, V203, P1655, DOI 10.1006/bbrc.1994.2376; Olesen K, 1998, BIOCHEMISTRY-US, V37, P6086, DOI 10.1021/bi971603z; PEISACH J, 1974, ARCH BIOCHEM BIOPHYS, V165, P691, DOI 10.1016/0003-9861(74)90298-7; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Pierloot K, 1998, J AM CHEM SOC, V120, P13156, DOI 10.1021/ja982385f; Roger M, 2014, ANAL BIOANAL CHEM, V406, P1011, DOI 10.1007/s00216-013-7465-1; Roger M, 2012, BIOCHEM SOC T, V40, P1324, DOI 10.1042/BST20120141; Ryde U, 1996, J MOL BIOL, V261, P586, DOI 10.1006/jmbi.1996.0484; RYDEN LG, 1993, J MOL EVOL, V36, P41, DOI 10.1007/BF02407305; Sato K, 2009, P NATL ACAD SCI USA, V106, P5616, DOI 10.1073/pnas.0811324106; Solomon EI, 2006, INORG CHEM, V45, P8012, DOI 10.1021/ic060450d; Solomon EI, 2011, COORDIN CHEM REV, V255, P774, DOI 10.1016/j.ccr.2010.12.008; Solomon EI, 2004, CHEM REV, V104, P419, DOI 10.1021/cr0206317; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Suzuki S, 1999, J BIOL INORG CHEM, V4, P749, DOI 10.1007/s007750050347; Vila AJ, 2001, HANDBOOK ON METALLOPROTEINS, P813; Worrall JAR, 2006, J AM CHEM SOC, V128, P14579, DOI 10.1021/ja064112n; Xie XJ, 2009, J INORG BIOCHEM, V103, P1307, DOI 10.1016/j.jinorgbio.2009.04.012; Yamaguchi K, 2004, BIOCHEMISTRY-US, V43, P14180, DOI 10.1021/bi0492657; Zhang L, 2006, J AM CHEM SOC, V128, P5834, DOI 10.1021/ja058528x	64	23	23	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e98941	10.1371/journal.pone.0098941	http://dx.doi.org/10.1371/journal.pone.0098941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932914	Green Published, Green Submitted, gold			2022-12-25	WOS:000337738600016
J	Smelt, AFH; Louter, MA; Kies, DA; Blom, JW; Terwindt, GM; van der Heijden, GJMG; De Gucht, V; Ferrari, MD; Assendelft, WJJ				Smelt, Antonia F. H.; Louter, Mark A.; Kies, Dennis A.; Blom, Jeanet W.; Terwindt, Gisela M.; van der Heijden, Geert J. M. G.; De Gucht, Veronique; Ferrari, Michel D.; Assendelft, Willem J. J.			What Do Patients Consider to Be the Most Important Outcomes for Effectiveness Studies on Migraine Treatment? Results of a Delphi Study	PLOS ONE			English	Article							QUESTIONNAIRE; GUIDELINES	Background: The outcome measures most frequently used in studies on the effectiveness of migraine treatment are whether the patient is free of pain, nausea, and free of photophobia/phonophobia within two hours. However, no patient-centred outcome measures are available. Therefore, we performed an online Delphi procedure to compile a list of outcome measures deemed most important to migraine patients. Methods: From a large database of migraine patients, we randomly selected 150 males and 150 females patients. We asked the open-ended question: 'If a new medicine was developed for migraine attacks, what would you wish the effect of this medication to be?' In the second and third rounds, we presented the answers of the first round and asked the patients to rate the importance of each item. Results: The initial response rate was 56% (n = 169). In the subsequent rounds the response rates were 90% (n = 152), and 97% (n = 147), respectively. Patients wanted their attack medication to treat the headache within 30 min, to prevent the attack from getting worse, to ensure they could function properly within 1 h, and prevent the recurrence of symptoms during the same day. Conclusions: The currently used outcome measures in migraine research do not sufficiently reflect the wishes of patients. Patients want the medication to work faster, to take away pain at an earlier stage, to make them able to function properly quickly, and to prevent recurrence. These aspects should be considered in future evaluation of new attack medication for migraine.	[Smelt, Antonia F. H.; Blom, Jeanet W.; Assendelft, Willem J. J.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [Louter, Mark A.; Kies, Dennis A.; Terwindt, Gisela M.; Ferrari, Michel D.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Louter, Mark A.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [van der Heijden, Geert J. M. G.] VU Amsterdam Univ, Acad Ctr Dent Amsterdam, Dept Social Dent, Amsterdam, Netherlands; [van der Heijden, Geert J. M. G.] Univ Amsterdam, Amsterdam, Netherlands; [De Gucht, Veronique] Leiden Univ, Dept Psychol, Leiden, Netherlands; [Assendelft, Willem J. J.] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Leiden University; Leiden University - Excl LUMC; Radboud University Nijmegen	Smelt, AFH (corresponding author), Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands.	a.f.h.smelt@lumc.nl	Assendelft, W.J.J./H-8008-2014; Louter, Mark/N-6855-2017; assendelft, willem/AAW-1854-2021; Ferrari, Michel D./ABE-3758-2021; van der Heijden, Geert/M-3733-2013	Assendelft, W.J.J./0000-0002-2966-3778; assendelft, willem/0000-0002-2966-3778; Ferrari, Michel D./0000-0001-9691-9449; van der Heijden, Geert/0000-0003-4979-2099; De Gucht, Veronique/0000-0001-5155-0983				Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bigal M, 2007, HEADACHE, V47, P475, DOI 10.1111/j.1526-4610.2007.00752.x; Coon CD, 2012, HEADACHE, V52, P550, DOI 10.1111/j.1526-4610.2012.02099.x; Hamelsky SW, 2005, CEPHALALGIA, V25, P87, DOI 10.1111/j.1468-2982.2005.00797.x; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Kirwan JR, 2007, J RHEUMATOL, V34, P1174; Lipton RB, 2002, HEADACHE, V42, pS3, DOI 10.1046/j.1526-4610.2002.0420s1003.x; Lipton RB., 1999, HEADACHE, V39, pS20, DOI [10.1111/j.1526-4610.1999.00006.x, DOI 10.1111/J.1526-4610.1999.00006.X]; Selby JV, 2012, JAMA-J AM MED ASSOC, V307, P1583, DOI 10.1001/jama.2012.500; Tfelt-Hansen P, 2012, CEPHALALGIA, V32, P6, DOI 10.1177/0333102411417901; van der Heijden GJMG, 2000, J CLIN EPIDEMIOL, V53, P29, DOI 10.1016/S0895-4356(99)00078-5; van Oosterhout WPJ, 2011, CEPHALALGIA, V31, P1359, DOI 10.1177/0333102411418846	13	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e98933	10.1371/journal.pone.0098933	http://dx.doi.org/10.1371/journal.pone.0098933			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932784	Green Published, gold			2022-12-25	WOS:000337738600015
J	Daniels, J; Komarek, A; Makusha, T; Van Heerden, A; Gray, G; Chingono, A; Mbwambo, JKK; Coates, T; Richter, L				Daniels, Joseph; Komarek, Arnost; Makusha, Tawanda; Van Heerden, Alastair; Gray, Glenda; Chingono, Alfred; Mbwambo, Jessie K. K.; Coates, Thomas; Richter, Linda			Effects of a Community Intervention on HIV Prevention Behaviors among Men Who Experienced Childhood Sexual or Physical Abuse in Four African Settings: Findings from NIMH Project Accept (HPTN 043)	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; RISK BEHAVIOR; POSITIVE ADULTS; HISTORY; PEOPLE; METAANALYSIS; HIV/AIDS; VIOLENCE	Background: There is increased focus on HIV prevention with African men who report experiencing childhood sexual (CSA) or physical abuse (CPA). Objective: To better understand the effects of a community-based intervention (Project Accept HPTN 043) on HIV prevention behaviors among men who report CSA or CPA experiences. Methods: Project Accept compared a community-based voluntary mobile counseling and testing (CBVCT) intervention with standard VCT. The intervention employed individual HIV risk reduction planning with motivational interviewing in 34 African communities (16 communities at 2 sites in South Africa, 10 in Tanzania, and 8 in Zimbabwe). Communities were randomized unblinded in matched pairs to CBVCT or SVCT, delivered over 36 months. The post-intervention assessment was conducted using a single, cross-sectional random survey of 18-32 year-old community members (total N = 43,292). We analyzed the effect of the intervention on men with reported CSA or CPA across the African sites. Men were identified with a survey question asking about having experienced CSA or CPA across the lifespan. The effect of intervention on considered outcomes of the preventive behavior was statistically evaluated using the logistic regression models. Results: Across the sites, the rates of CSA or CPA among men indicated that African men reflected the global prevalence (20%) with a range of 13-24%. The statistically significant effect of the intervention among these men was seen in their increased effort to receive their HIV test results (OR 2.71; CI: (1.08, 6.82); P: 0.034). The intervention effect on the other designated HIV prevention behaviors was less pronounced. Conclusion: The effect of the intervention on these men showed increased motivation to receive their HIV test results. However, more research is needed to understand the effects of community-based interventions on this group, and such interventions need to integrate other keys predictors of HIV including trauma, coping strategies, and intimate partner violence.	[Daniels, Joseph; Coates, Thomas] Univ Calif Los Angeles, UCLA Ctr World Hlth, Los Angeles, CA 90095 USA; [Komarek, Arnost] Charles Univ Prague, Fac Math & Phys, Prague, Czech Republic; [Makusha, Tawanda; Van Heerden, Alastair; Richter, Linda] Human Sci Res Council, Durban, South Africa; [Gray, Glenda] Univ Witwatersrand, Chris Hani Baragwanath Hosp, Fac Hlth Sci, Perinatal HIV Res Unit, Soweto, South Africa; [Chingono, Alfred] Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe; [Mbwambo, Jessie K. K.] Muhimbili Univ, Teaching Hosp, Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Richter, Linda] Univ Witwatersrand, Dev Pathways Hlth Res Unit, Johannesburg, South Africa	University of California System; University of California Los Angeles; Charles University Prague; Human Sciences Research Council-South Africa; University of Witwatersrand; University of Zimbabwe; Muhimbili University of Health & Allied Sciences; University of Witwatersrand	Daniels, J (corresponding author), Univ Calif Los Angeles, UCLA Ctr World Hlth, Los Angeles, CA 90095 USA.	jdaniels@mednet.ucla.edu	Komarek, Arnost/A-5534-2012; Van Heerden, Alastair/AAY-6262-2020; Makusha, Tawanda/AAE-5356-2022	Komarek, Arnost/0000-0001-8778-3762; Van Heerden, Alastair/0000-0003-2530-6885; Makusha, Tawanda/0000-0003-2120-8989	U.S. National Institute of Mental Health through (Johns Hopkins University - David Celentano, PI) [U01MH066687]; Medical University of South Carolina - Michael Sweat, PI [U01MH066688]; University of California Los Angeles - Thomas J. Coates, PI [U01MH066701]; University of California San Francisco - Stephen F. Morin, PI [U01MH066702]; HPTN Protocol 043 through HPTN Network Laboratory - Susan Eshleman, PI [U01AI068613/UM1AI068613]; SCHARP - Deborah Donnell, PI [U01AI068617/UM1AI068617]; Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases [U01AI068619/UM1AI068619]; Office of AIDS Research of the U. S. National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069453, U01AI068617, U01AI068613, U01AI068619, UM1AI069453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH066688, U01MH066687, U01MH066701, U01MH066702] Funding Source: NIH RePORTER	U.S. National Institute of Mental Health through (Johns Hopkins University - David Celentano, PI); Medical University of South Carolina - Michael Sweat, PI; University of California Los Angeles - Thomas J. Coates, PI; University of California San Francisco - Stephen F. Morin, PI; HPTN Protocol 043 through HPTN Network Laboratory - Susan Eshleman, PI; SCHARP - Deborah Donnell, PI; Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of AIDS Research of the U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was sponsored by the U.S. National Institute of Mental Health as a cooperative agreement, through contracts U01MH066687 (Johns Hopkins University - David Celentano, PI); U01MH066688 (Medical University of South Carolina - Michael Sweat, PI); U01MH066701 (University of California Los Angeles - Thomas J. Coates, PI); and U01MH066702 (University of California San Francisco - Stephen F. Morin, PI). In addition, this work was supported as HPTN Protocol 043 through contracts U01AI068613/UM1AI068613 (HPTN Network Laboratory - Susan Eshleman, PI); U01AI068617/UM1AI068617 (SCHARP - Deborah Donnell, PI); and U01AI068619/UM1AI068619 (HIV Prevention Trials Network - Sten Vermund/Wafaa El-Sadr, PIs) of the Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases; and by the Office of AIDS Research of the U. S. National Institutes of Health. Views expressed are those of the authors, and not necessarily those of sponsoring agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arriola KRJ, 2005, CHILD ABUSE NEGLECT, V29, P725, DOI 10.1016/j.chiabu.2004.10.014; Coates TJ, 2014, LANCET GLOB HEALTH, V2, pE267, DOI 10.1016/S2214-109X(14)70032-4; Core Team, 2013, R LANG ENV STAT COMP; Dunkle KL, 2006, AIDS, V20, P2107, DOI 10.1097/01.aids.0000247582.00826.52; Genberg BL, 2008, JAIDS-J ACQ IMM DEF, V49, P309, DOI 10.1097/QAI.0b013e3181893ed0; Hunter M, 2010, HEALTH PLACE, V16, P25, DOI 10.1016/j.healthplace.2009.08.003; Jewkes R., 2009, UNDERSTANDING MENS H; Jones DJ, 2010, J CLIN CHILD ADOLESC, V39, P667, DOI 10.1080/15374416.2010.501286; Khumalo-Sakutukwa G, 2008, JAIDS-J ACQ IMM DEF, V49, P422, DOI 10.1097/QAI.0b013e31818a6cb5; Laeyendecker O, 2013, PLOS ONE, V8; O'Donnell L, 2009, AIDS EDUC PREV, V21, P299, DOI 10.1521/aeap.2009.21.4.299; Parillo KM, 2001, CHILD ABUSE NEGLECT, V25, P335, DOI 10.1016/S0145-2134(00)00253-2; Persons E, 2010, AIDS PATIENT CARE ST, V24, P571, DOI 10.1089/apc.2009.0209; Posel D, 2013, AFRICAN STUDIES REV; Posel D, 2013, APPL ECON, V45, P663, DOI 10.1080/00036846.2011.610749; Richter L, 2014, AIDS BEHAV, V18, P381, DOI 10.1007/s10461-013-0439-7; Sikkema KJ, 2013, J CONSULT CLIN PSYCH, V81, P274, DOI 10.1037/a0030144; Sikkema KJ, 2009, ARCH SEX BEHAV, V38, P121, DOI 10.1007/s10508-007-9238-4; Stoltenborgh M, 2011, CHILD MALTREATMENT, V16, P79, DOI 10.1177/1077559511403920; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; Sweet T, 2012, JAIDS-J ACQ IMM DEF, V59, P400, DOI 10.1097/QAI.0b013e3182400e75; van Rooyen H, 2013, AIDS BEHAV, V17, P2946, DOI 10.1007/s10461-012-0368-x; Williams JK, 2013, AM J PUBLIC HEALTH, V103, P1476, DOI 10.2105/AJPH.2012.301121	23	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99643	10.1371/journal.pone.0099643	http://dx.doi.org/10.1371/journal.pone.0099643			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2VQ	24926999	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100059
J	Krell, J; Frampton, AE; Mirnezami, R; Harding, V; De Giorgio, A; Alonso, LR; Cohen, P; Ottaviani, S; Colombo, T; Jacob, J; Pellegrino, L; Buchanan, G; Stebbing, J; Castellano, L				Krell, Jonathan; Frampton, Adam E.; Mirnezami, Reza; Harding, Victoria; De Giorgio, Alex; Alonso, Laura Roca; Cohen, Patrizia; Ottaviani, Silvia; Colombo, Teresa; Jacob, Jimmy; Pellegrino, Loredana; Buchanan, Gordon; Stebbing, Justin; Castellano, Leandro			Growth Arrest-Specific Transcript 5 Associated snoRNA Levels Are Related to p53 Expression and DNA Damage in Colorectal Cancer	PLOS ONE			English	Article							SMALL-NUCLEOLAR RNAS; HOST GENES; CELL-LINES; PROGNOSTIC-FACTOR; PROSTATE-CANCER; NONCODING RNAS; BREAST-CANCER; GROWTH-ARREST; GAS5; BIOGENESIS	Background: The growth arrest-specific transcript 5 gene (GAS5) encodes a long noncoding RNA (lncRNA) and hosts a number of small nucleolar RNAs (snoRNAs) that have recently been implicated in multiple cellular processes and cancer. Here, we investigate the relationship between DNA damage, p53, and the GAS5 snoRNAs to gain further insight into the potential role of this locus in cell survival and oncogenesis both in vivo and in vitro. Methods: We used quantitative techniques to analyse the effect of DNA damage on GAS5 snoRNA expression and to assess the relationship between p53 and the GAS5 snoRNAs in cancer cell lines and in normal, pre-malignant, and malignant human colorectal tissue and used biological techniques to suggest potential roles for these snoRNAs in the DNA damage response. Results: GAS5-derived snoRNA expression was induced by DNA damage in a p53-dependent manner in colorectal cancer cell lines and their levels were not affected by DICER. Furthermore, p53 levels strongly correlated with GAS5-derived snoRNA expression in colorectal tissue. Conclusions: In aggregate, these data suggest that the GAS5-derived snoRNAs are under control of p53 and that they have an important role in mediating the p53 response to DNA damage, which may not relate to their function in the ribosome. We suggest that these snoRNAs are not processed by DICER to form smaller snoRNA-derived RNAs with microRNA (miRNA)-like functions, but their precise role requires further evaluation. Furthermore, since GAS5 host snoRNAs are often used as endogenous controls in qPCR quantifications we show that their use as housekeeping genes in DNA damage experiments can lead to inaccurate results.	[Krell, Jonathan; Harding, Victoria; De Giorgio, Alex; Alonso, Laura Roca; Ottaviani, Silvia; Jacob, Jimmy; Pellegrino, Loredana; Castellano, Leandro] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Div Canc, Hammersmith Hosp, London, England; [Frampton, Adam E.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, HPB Surg Unit, Hammersmith Hosp, London, England; [Mirnezami, Reza] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, St Marys Hosp Campus, London, England; [Cohen, Patrizia] Hammersmith Hosp, Dept Histopathol, London W12 0HS, England; [Colombo, Teresa] CNR, Inst Comp Applicat Mauro Picone, Rome, Italy; [Buchanan, Gordon] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Colorectal Surg Unit, London, England; [Stebbing, Justin] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Dept Oncol, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London; Consiglio Nazionale delle Ricerche (CNR); Istituto per le Applicazioni del Calcolo "Mauro Picone" (IAC-CNR); Imperial College London; Imperial College London	Krell, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Div Canc, Hammersmith Hosp, London, England.	j.krell@imperial.ac.uk	Colombo, Teresa/P-2959-2018; Castellano, Leandro/AAE-1366-2021	Colombo, Teresa/0000-0003-2415-7507; Ottaviani, Silvia/0000-0002-8830-9947; Stebbing, Justin/0000-0002-1117-6947; Castellano, Leandro/0000-0002-3059-4829	Searle Memorial Charitable trust; Cancer Research UK [14549] Funding Source: researchfish; Medical Research Council [MR/L000172/1, G1100425] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-053, CL-2013-21-012] Funding Source: researchfish; MRC [G1100425, MR/L000172/1] Funding Source: UKRI	Searle Memorial Charitable trust; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to thank The Searle Memorial (2005) Charitable trust, Michael and Lottie Hunter, Peter and Marilyn Cooper, Steve Mobbs and Pauline Thomas, and Denise and Edward Pincheson for their generous support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrover E, 1999, BRIT J CANCER, V81, P122, DOI 10.1038/sj.bjc.6690660; Brameier M, 2011, NUCLEIC ACIDS RES, V39, P675, DOI 10.1093/nar/gkq776; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Chang LS, 2002, BIOCHEM BIOPH RES CO, V299, P196, DOI 10.1016/S0006-291X(02)02623-2; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Deisenroth Chad, 2011, Genes Cancer, V2, P392, DOI 10.1177/1947601911409737; Dieci G, 2009, GENOMICS, V94, P83, DOI 10.1016/j.ygeno.2009.05.002; Dong XY, 2008, HUM MOL GENET, V17, P1031, DOI 10.1093/hmg/ddm375; Dong XY, 2009, J GENET GENOMICS, V36, P447, DOI 10.1016/S1673-8527(08)60134-4; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Gee HE, 2011, BRIT J CANCER, V104, P1168, DOI 10.1038/sj.bjc.6606076; Henras AK, 2004, CURR OPIN STRUC BIOL, V14, P335, DOI 10.1016/j.sbi.2004.05.006; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Kishore S, 2010, HUM MOL GENET, V19, P1153, DOI 10.1093/hmg/ddp585; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Kressner U, 1999, J CLIN ONCOL, V17, P593, DOI 10.1200/JCO.1999.17.2.593; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liao JP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-198; Liu Y, 2006, P NATL ACAD SCI USA, V103, P976, DOI 10.1073/pnas.0510146103; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Mei YP, 2012, ONCOGENE, V31, P2794, DOI 10.1038/onc.2011.449; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Mourtada-Maarabouni M, 2008, J CELL SCI, V121, P939, DOI 10.1242/jcs.024646; Muller AJ, 1998, MAMM GENOME, V9, P773, DOI 10.1007/s003359900862; Nikulenkov F, 2012, CELL DEATH DIFFER, V19, P1992, DOI 10.1038/cdd.2012.89; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Pickard MR, 2013, BBA-MOL BASIS DIS, V1832, P1613, DOI 10.1016/j.bbadis.2013.05.005; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; Sarasqueta AF, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-277; Scott MS, 2011, BIOCHIMIE, V93, P1987, DOI 10.1016/j.biochi.2011.05.026; Scott MS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000507; Smith CM, 1998, MOL CELL BIOL, V18, P6897, DOI 10.1128/MCB.18.12.6897; Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909; Tycowski KT, 1996, NATURE, V379, P464, DOI 10.1038/379464a0; Tycowski KT, 2001, EUR J CELL BIOL, V80, P119, DOI 10.1078/0171-9335-00150; Williams GT, 2012, NAT REV CANCER, V12, P84, DOI 10.1038/nrc3195	39	63	69	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98561	10.1371/journal.pone.0098561	http://dx.doi.org/10.1371/journal.pone.0098561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926850	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000338278100017
J	Hsu, FF; Yeh, CT; Sun, YJ; Chiang, MT; Lan, WM; Li, FA; Lee, WH; Chau, LY				Hsu, F-F; Yeh, C-T; Sun, Y-J; Chiang, M-T; Lan, W-M; Li, F-A; Lee, W-H; Chau, L-Y			Signal peptide peptidase-mediated nuclear localization of heme oxygenase-1 promotes cancer cell proliferation and invasion independent of its enzymatic activity	ONCOGENE			English	Article							CHRONIC MYELOID-LEUKEMIA; VIRUS CORE PROTEIN; INTRAMEMBRANE PROTEOLYSIS; ENDOPLASMIC-RETICULUM; OXIDATIVE STRESS; EXPRESSION; OVEREXPRESSION; IDENTIFICATION; TRANSLOCATION; DEGRADATION	Heme oxygenase-1 (HO-1) is a heme-degrading enzyme anchored in the endoplasmic reticulum by a carboxyl-terminal transmembrane segment (TMS). HO-1 is highly expressed in various cancers and its nuclear localization is associated with the progression of some cancers. Nevertheless, the mechanism underlying HO-1 nuclear translocation and its pathological significance remain elusive. Here we show that the signal peptide peptidase (SPP) catalyzes the intramembrane cleavage of HO-1. Coexpression of HO-1 with wild-type SPP, but not a dominant-negative SPP, promoted the nuclear localization of HO-1 in cells. Mass spectrometry analysis of cytosolic HO-1 isolated from HeLa cells overexpressing HO-1 and SPP revealed two adjacent intramembrane cleavage sites located after S-275 and F-276 within the TMS. Mutations of S275F276 to A(275)L(276) significantly hindered SPP-mediated HO-1 cleavage and nuclear localization. Nuclear HO-1 was detected in A549 and DU145 cancer cell lines expressing high levels of endogenous HO-1 and SPP. SPP knockdown or inhibition significantly reduced nuclear HO-1 localization in A549 and DU145 cells. The positive nuclear HO-1 stain was also evident in lung cancer tissues expressing high levels of HO-1 and SPP. Overexpression of a truncated HO-1 (t-HO-1) lacking the TMS in HeLa and H1299 cells promoted cell proliferation and migration/invasion. The effect of t-HO-1 was not affected by a mutation in the catalytic site. However, blockade of t-HO-1 nuclear localization abolished t-HO-1-mediated effect. The tumorigenic effect of t-HO-1 was also demonstrated in the mouse model. These findings disclose that SPP-mediated intramembrane cleavage of HO-1 promotes HO-1 nuclear localization and cancer progression independent of HO-1 enzymatic activity.	[Hsu, F-F; Sun, Y-J; Chiang, M-T; Lan, W-M; Li, F-A; Chau, L-Y] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Yeh, C-T] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Yeh, C-T; Lee, W-H] Taipei Med Univ, Shuang Ho Hosp, Ctr Canc, Taipei, Taiwan	Academia Sinica - Taiwan; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital	Chau, LY (corresponding author), Acad Sinica, Inst Biomed Sci, 128,Sect 2,Acad Rd, Taipei 115, Taiwan.	lyc@ibms.sinica.edu.tw	Chau, Lee-Young/N-7659-2018; Li, Fu-An/M-8506-2019	Chau, Lee-Young/0000-0002-6316-2328; Li, Fu-An/0000-0002-0580-7765	National Science Council of Taiwan [NSC-100-2320-B-001-010-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a grant from the National Science Council of Taiwan (NSC-100-2320-B-001-010-MY3). We thank the National Center for Genome Medicine at Academia Sinica, Taiwan for polymerase chain reaction of short-tandem repeat sequences analysis, and the IBMS proteomics core for LC-MS analysis.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Berberat PO, 2005, CLIN CANCER RES, V11, P3790, DOI 10.1158/1078-0432.CCR-04-2159; Bindu S, 2011, J BIOL CHEM, V286, P39387, DOI 10.1074/jbc.M111.279893; Chang HT, 2007, J CELL BIOCHEM, V100, P1266, DOI 10.1002/jcb.21120; Collinson EJ, 2011, J BIOL CHEM, V286, P2205, DOI 10.1074/jbc.M110.187062; Converso DP, 2006, FASEB J, V20, P1236, DOI 10.1096/fj.05-4204fje; Degese MS, 2012, LUNG CANCER, V77, P168, DOI 10.1016/j.lungcan.2012.02.016; El Hage F, 2008, P NATL ACAD SCI USA, V105, P10119, DOI 10.1073/pnas.0802753105; Erez E, 2009, NATURE, V459, P371, DOI 10.1038/nature08146; Fluhrer R, 2009, J BIOL CHEM, V284, P13975, DOI 10.1074/jbc.R800040200; Gandini NA, 2012, EXP MOL PATHOL, V93, P237, DOI 10.1016/j.yexmp.2012.05.001; Giordano A, 2000, FEBS LETT, V487, P171, DOI 10.1016/S0014-5793(00)02217-1; Hwang HW, 2009, J BIOL CHEM, V284, P22672, DOI 10.1074/jbc.M109.028001; Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659; Kocanova S, 2007, APOPTOSIS, V12, P731, DOI 10.1007/s10495-006-0016-x; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Li MY, 2008, EUR RESPIR J, V32, P911, DOI 10.1183/09031936.00064508; Li Volti G, 2004, BIOCHEM BIOPH RES CO, V315, P517, DOI 10.1016/j.bbrc.2004.01.090; Lin PH, 2013, ONCOGENE, V32, P2325, DOI 10.1038/onc.2012.244; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Liu ZM, 2004, ONCOGENE, V23, P503, DOI 10.1038/sj.onc.1207173; Mayerhofer M, 2004, CANCER RES, V64, P3148, DOI 10.1158/0008-5472.CAN-03-1200; Mayerhofer M, 2008, BLOOD, V111, P2200, DOI 10.1182/blood-2006-11-055723; Okamoto K, 2004, J VIROL, V78, P6370, DOI 10.1128/JVI.78.12.6370-6380.2004; Okamoto K, 2008, J VIROL, V82, P8349, DOI 10.1128/JVI.00306-08; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Sacca P, 2007, BRIT J CANCER, V97, P1683, DOI 10.1038/sj.bjc.6604081; Sunamura Makoto, 2003, Angiogenesis, V6, P15, DOI 10.1023/A:1025803600840; Suttner DM, 1999, AM J PHYSIOL-LUNG C, V276, pL443, DOI 10.1152/ajplung.1999.276.3.L443; Targett-Adams P, 2006, J BIOL CHEM, V281, P29221, DOI 10.1074/jbc.M605373200; Wang XM, 2009, J IMMUNOL, V182, P3809, DOI 10.4049/jimmunol.0712437; Was H, 2006, AM J PATHOL, V169, P2181, DOI 10.2353/ajpath.2006.051365; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; YOSHIDA T, 1991, EUR J BIOCHEM, V199, P729, DOI 10.1111/j.1432-1033.1991.tb16177.x	34	56	57	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 30	2015	34	18					2360	2370		10.1038/onc.2014.166	http://dx.doi.org/10.1038/onc.2014.166			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CH2AH	24931165				2022-12-25	WOS:000353824800009
J	Tu, LN; Morohaku, K; Manna, PR; Pelton, SH; Butler, WR; Stocco, DM; Selvaraj, V				Tu, Lan N.; Morohaku, Kanako; Manna, Pulak R.; Pelton, Susanne H.; Butler, W. Ronald; Stocco, Douglas M.; Selvaraj, Vimal			Peripheral Benzodiazepine Receptor/Translocator Protein Global Knock-out Mice Are Viable with No Effects on Steroid Hormone Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adrenal; Cholesterol; Gene Knock-out; Mitochondria; Steroidogenesis; STAR; TSPO	ACUTE-REGULATORY-PROTEIN; INNER MITOCHONDRIAL-MEMBRANES; LIPOID ADRENAL-HYPERPLASIA; KDA TRANSLOCATOR PROTEIN; CHOLESTEROL TRANSPORT; TARGETED DISRUPTION; LEYDIG-CELLS; RECEPTOR; TSPO; STEROIDOGENESIS	Background: Translocator protein (TSPO) has been considered a mitochondrial cholesterol transporter critical for steroid hormone production. TSPO knock-out mice were reported to be embryonic lethal. Results: TSPO knock-out mice are viable with no effects on steroidogenesis. Conclusion: TSPO is not essential for steroidogenesis and is not necessary for sustaining life. Significance: This study rectifies a serious inaccuracy in the current understanding that is critical for treating steroid hormone disorders. Translocator protein (TSPO), previously known as the peripheral benzodiazepine receptor, is a mitochondrial outer membrane protein implicated as essential for cholesterol import to the inner mitochondrial membrane, the rate-limiting step in steroid hormone biosynthesis. Previous research on TSPO was based entirely on in vitro experiments, and its critical role was reinforced by an early report that claimed TSPO knock-out mice were embryonic lethal. In a previous publication, we examined Leydig cell-specific TSPO conditional knock-out mice that suggested TSPO was not required for testosterone production in vivo. This raised controversy and several questions regarding TSPO function. To examine the definitive role of TSPO in steroidogenesis and embryo development, we generated global TSPO null (Tspo(-/-)) mice. Contrary to the early report, Tspo(-/-) mice survived with no apparent phenotypic abnormalities and were fertile. Examination of adrenal and gonadal steroidogenesis showed no defects in Tspo(-/-) mice. Adrenal transcriptome comparison of gene expression profiles showed that genes involved in steroid hormone biosynthesis (Star, Cyp11a1, and Hsd3b1) were unchanged in Tspo(-/-) mice. Adrenocortical ultrastructure illustrated no morphological alterations in Tspo(-/-) mice. In an attempt to correlate our in vivo findings to previously used in vitro models, we also determined that siRNA knockdown or the absence of TSPO in different mouse and human steroidogenic cell lines had no effect on steroidogenesis. These findings directly refute the dogma that TSPO is indispensable for steroid hormone biosynthesis and viability. By amending the current model, this study advances our understanding of steroidogenesis with broad implications in biology and medicine.	[Tu, Lan N.; Morohaku, Kanako; Pelton, Susanne H.; Butler, W. Ronald; Selvaraj, Vimal] Cornell Univ, Dept Anim Sci, Coll Agr & Life Sci, Ithaca, NY 14853 USA; [Manna, Pulak R.; Stocco, Douglas M.] Texas Tech Univ, Sch Med, Dept Cell Biol & Biochem, Hlth Sci Ctr, Lubbock, TX 79430 USA	Cornell University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Selvaraj, V (corresponding author), Cornell Univ, Dept Anim Sci, 204 Morrison Hall, Ithaca, NY 14853 USA.	vs88@cornell.edu	Butler, Walter/GQH-5350-2022; Selvaraj, Vimal/AAC-2853-2022	Butler, Walter/0000-0001-5195-7433	National Science Foundation [DMR-112-296]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD017481, R01HD017481] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Dr. Jim Giovannoni and Dr. Zhangjun Fei at the Boyce Thompson Institute for assistance in RNA-seq and data analysis; John Grazul at Cornell Center for Materials Research (supported by National Science Foundation Grant DMR-112-296); University of California at Davis Diagnostic and Research Electron Microscopy Laboratory for assistance in transmission electron microscopy; Dr. Johanna Dela Cruz at the Cornell University Biotechnology Resource Center for assistance in whole animal imaging; and Dr. Mario Ascoli for MA-10 cells.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; ANHOLT RRH, 1985, EUR J PHARMACOL, V110, P41, DOI 10.1016/0014-2999(85)90026-3; ANHOLT RRH, 1985, J PHARMACOL EXP THER, V233, P517; ANHOLT RRH, 1986, J BIOL CHEM, V261, P576; Baker BY, 2006, J CLIN ENDOCR METAB, V91, P4781, DOI 10.1210/jc.2006-1565; Beam SW, 1997, BIOL REPROD, V56, P133, DOI 10.1095/biolreprod56.1.133; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bose HS, 1999, P NATL ACAD SCI USA, V96, P7250, DOI 10.1073/pnas.96.13.7250; Bose HS, 2002, NATURE, V417, P87, DOI 10.1038/417087a; BRAESTRUP C, 1977, NATURE, V269, P702, DOI 10.1038/269702a0; BRAESTRUP C, 1977, P NATL ACAD SCI USA, V74, P3805, DOI 10.1073/pnas.74.9.3805; Caron KM, 1997, P NATL ACAD SCI USA, V94, P11540, DOI 10.1073/pnas.94.21.11540; Chen H, 2009, P NATL ACAD SCI USA, V106, P13838, DOI 10.1073/pnas.0907008106; Chung JY, 2013, ENDOCRINOLOGY, V154, P2156, DOI 10.1210/en.2012-2226; CHURCHILL PF, 1979, J BIOL CHEM, V254, P443; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; Daugherty DJ, 2013, EMBO MOL MED, V5, P891, DOI 10.1002/emmm.201202124; DAVIES LP, 1981, EUR J PHARMACOL, V73, P209, DOI 10.1016/0014-2999(81)90092-3; Decker C, 2012, AM SOC BON MIN RES 2; Fan JJ, 2009, J BIOL CHEM, V284, P30484, DOI 10.1074/jbc.M109.029876; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Gatliff J, 2012, CURR MOL MED, V12, P356; Gavish M, 1999, PHARMACOL REV, V51, P629; Hatty CR, 2014, BBA-BIOMEMBRANES, V1838, P1019, DOI 10.1016/j.bbamem.2013.12.013; Hauet T, 2005, MOL ENDOCRINOL, V19, P540, DOI 10.1210/me.2004-0307; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Korkhov VM, 2010, STRUCTURE, V18, P677, DOI 10.1016/j.str.2010.03.001; KRUEGER KE, 1990, J BIOL CHEM, V265, P15015; Lacapere JJ, 2003, STEROIDS, V68, P569, DOI 10.1016/S0039-128X(03)00101-6; Lacapere JJ, 2001, BIOCHEM BIOPH RES CO, V284, P536, DOI 10.1006/bbrc.2001.4975; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Li RS, 2007, J LIPID RES, V48, P709, DOI 10.1194/jlr.M600501-JLR200; LIN D, 1995, SCIENCE, V267, P1828, DOI 10.1126/science.7892608; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACDONALD R, 1978, NATURE, V271, P563, DOI 10.1038/271563a0; Mack JT, 2007, MOL CELL BIOL, V27, P44, DOI 10.1128/MCB.01824-06; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Manna PR, 2013, J BIOL CHEM, V288, P8505, DOI 10.1074/jbc.M112.417873; Mariani F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054488; Morohaku K, 2014, ENDOCRINOLOGY, V155, P89, DOI 10.1210/en.2013-1556; Morohaku K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074509; MUKHIN AG, 1989, P NATL ACAD SCI USA, V86, P9813, DOI 10.1073/pnas.86.24.9813; Murail S, 2008, BBA-BIOMEMBRANES, V1778, P1375, DOI 10.1016/j.bbamem.2008.03.012; Nieters A, 2012, BLOOD, V120, P4645, DOI 10.1182/blood-2012-05-427989; Papadopoulos V, 1997, J BIOL CHEM, V272, P32129, DOI 10.1074/jbc.272.51.32129; PAPADOPOULOS V, 1990, J BIOL CHEM, V265, P3772; Papadopoulos V, 1997, STEROIDS, V62, P21, DOI 10.1016/S0039-128X(96)00154-7; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Papadopoulos V, 2014, ENDOCRINOLOGY, V155, P15, DOI 10.1210/en.2013-2033; PRIVALLE CT, 1983, P NATL ACAD SCI-BIOL, V80, P702, DOI 10.1073/pnas.80.3.702; Qi XL, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/162934; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; REGAN JW, 1981, LIFE SCI, V28, P991, DOI 10.1016/0024-3205(81)90744-X; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Schaller T, 2007, J VIROL, V81, P11713, DOI 10.1128/JVI.01468-07; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seneviratne MSD, 2012, CURR MOL MED, V12, P476; Sileikyte J, 2014, J BIOL CHEM, V289, P13769, DOI 10.1074/jbc.M114.549634; SIMPSON ER, 1978, J BIOL CHEM, V253, P3135; SIMPSON ER, 1967, EUR J BIOCHEM, V2, P275, DOI 10.1111/j.1432-1033.1967.tb00136.x; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stocco DM, 2014, ENDOCRINOLOGY, V155, P6, DOI 10.1210/en.2013-2041; TAKAHASHI H, 1958, NATURE, V182, P1443, DOI 10.1038/1821443a0; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Veenman L, 2007, CURR PHARM DESIGN, V13, P2385; Vlodavsky E., 2014, CNS NEUROL DISORD-DR, V12, P1; Wang HJ, 2012, CELL TISSUE RES, V350, P261, DOI 10.1007/s00441-012-1478-5; YAGO N, 1969, J BIOCHEM-TOKYO, V65, P215; YELISEEV AA, 1995, J BIOL CHEM, V270, P21167, DOI 10.1074/jbc.270.36.21167; Zhong Silin, 2011, Cold Spring Harb Protoc, V2011, P940, DOI 10.1101/pdb.prot5652	72	167	170	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27444	27454		10.1074/jbc.M114.578286	http://dx.doi.org/10.1074/jbc.M114.578286			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	24936060	Green Published, hybrid			2022-12-25	WOS:000342852800008
J	Pandey, MS; Weigel, PH				Pandey, Madhu S.; Weigel, Paul H.			A Hyaluronan Receptor for Endocytosis (HARE) Link Domain N-Glycan Is Required for Extracellular Signal-regulated Kinase (ERK) and Nuclear Factor-kappa B (NF-kappa B) Signaling in Response to the Uptake of Hyaluronan but Not Heparin, Dermatan Sulfate, or Acetylated Low Density Lipoprotein (LDL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC SINUSOIDAL ENDOTHELIUM; ASIALOGLYCOPROTEIN RECEPTOR; CHONDROITIN SULFATE; BINDING-PROTEINS; CD44 BINDING; GLYCOSYLATION; STABILIN-2; CLEARANCE; ADHESION; LIGAND	The human hyaluronan (HA) receptor for endocytosis (HARE; the 190-kDa C terminus of Stab2) is a major clearance receptor for multiple circulating ligands including HA, heparin (Hep), acetylated LDL (AcLDL), dermatan sulfate (DS), apoptotic debris, and chondroitin sulfate types A, C, D, and E. We previously found that HARE contains an N-glycan in the HA binding Link domain (at Asn(2280)), and cells expressing membrane-bound HARE(N2280A) bind and endocytose HA normally (Harris, E. N., Parry, S., Sutton-Smith, M., Pandey, M. S., Panico, M., Morris, H. R., Haslam, S. M., Dell, A., and Weigel, P. H. (2010) Glycobiology 20, 991-1001). Also, NF-kappa B-mediated signaling is activated by HARE-mediated endocytosis of HA, Hep, AcLDL, or DS but not by chondroitin sulfates (Pandey, M. S., and Weigel, P. H. (2014) J. Biol. Chem. 289, 1756-1767). Here we investigated the role of Link N-glycans in ligand uptake and NF-kappa B and ERK1/2 signaling. HA.HARE-mediated ERK1/2 activation was HA size-dependent, as found for NF-kappa B activation. HARE(N2280A) cells internalized HA, Hep, AcLDL, and DS normally. No ERK1/2 activation occurred during HA endocytosis by HARE(N2280A) cells, but activation did occur with Hep. Dual-luciferase recorder assays showed that NF-kappa B-mediated gene expression occurred normally in HARE(N2280A) cells endocytosing Hep, AcLDL, or DS but did not occur with HA. Activation of NF-kappa B by endogenous degradation of I kappa B-alpha was observed for HARE(N2280A) cells endocytosing Hep, AcLDL, or DS but not HA. We conclude that a Link domain complex N-glycan is required specifically for HARE.HA-mediated activation of ERK1/2 and NF-kappa B-mediated gene expression and that this initial activation mechanism is different from and independent of the initial mechanisms for HARE-mediated signaling in response to Hep, AcLDL, or DS uptake.	[Weigel, Paul H.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Weigel, PH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA.	paul-weigel@ouhsc.edu			National Institutes of Health [GM69961]; Oklahoma Center for the Advancement of Science and Technology (OCAST) from the State of Oklahoma [HR10-074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069961] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science and Technology (OCAST) from the State of Oklahoma; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM69961 (NIGMS). This work was also supported by Oklahoma Center for the Advancement of Science and Technology (OCAST) Grant HR10-074 from the State of Oklahoma.	Baggenstoss BA, 2006, ANAL BIOCHEM, V352, P243, DOI 10.1016/j.ab.2006.01.019; Bartolazzi A, 1996, J CELL BIOL, V132, P1199, DOI 10.1083/jcb.132.6.1199; BENNETT KL, 1995, J CELL BIOL, V131, P1623, DOI 10.1083/jcb.131.6.1623; Bloem K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066266; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREITFELD PP, 1985, INT REV CYTOL, V97, P47, DOI 10.1016/S0074-7696(08)62348-7; CIECHANOVER A, 1983, J BIOL CHEM, V258, P9681; Dasgupta A, 1996, BIOCHEM BIOPH RES CO, V227, P110, DOI 10.1006/bbrc.1996.1475; Elliott AL, 2005, ARTHRITIS RHEUM-US, V52, P105, DOI 10.1002/art.20724; English NM, 1998, CANCER RES, V58, P3736; Falkowski M, 2003, HISTOCHEM CELL BIOL, V120, P361, DOI 10.1007/s00418-003-0585-5; FRASER JRE, 1981, BIOCHEM J, V200, P415, DOI 10.1042/bj2000415; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Hansen B, 2005, EXP CELL RES, V303, P160, DOI 10.1016/j.yexcr.2004.09.017; Harris EN, 2008, GLYCOBIOLOGY, V18, P638, DOI 10.1093/glycob/cwn045; Harris EN, 2008, J BIOL CHEM, V283, P17341, DOI 10.1074/jbc.M710360200; Harris EN, 2010, GLYCOBIOLOGY, V20, P991, DOI 10.1093/glycob/cwq057; Harris EN, 2004, J BIOL CHEM, V279, P36201, DOI 10.1074/jbc.M405322200; Jung MY, 2007, J LEUKOCYTE BIOL, V82, P1156, DOI 10.1189/jlb.0107052; KATOH S, 1995, J EXP MED, V182, P419, DOI 10.1084/jem.182.2.419; Kyosseva SV, 2008, J BIOL CHEM, V283, P15047, DOI 10.1074/jbc.M709921200; LAURENT TC, 1986, BIOCHEM J, V234, P653, DOI 10.1042/bj2340653; LESLEY J, 1995, J EXP MED, V182, P431, DOI 10.1084/jem.182.2.431; Lien EC, 2013, BIOCHEMISTRY-US, V52, P115, DOI 10.1021/bi3009483; MCGARY CT, 1989, BIOCHEM J, V257, P875, DOI 10.1042/bj2570875; McGary CT, 2003, METHOD ENZYMOL, V363, P354; Nightingale TD, 2009, J BIOL CHEM, V284, P3935, DOI 10.1074/jbc.M805105200; OKA JA, 1983, J BIOL CHEM, V258, P253; Pandey MS, 2008, J BIOL CHEM, V283, P21453, DOI 10.1074/jbc.M800886200; Pandey MS, 2014, J BIOL CHEM, V289, P1756, DOI 10.1074/jbc.M113.510339; Pandey MS, 2013, J BIOL CHEM, V288, P14068, DOI 10.1074/jbc.M112.442889; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155; Romero-Fernandez W, 2011, GLYCOBIOLOGY, V21, P1663, DOI 10.1093/glycob/cwr105; Senftleben U, 2002, CRIT CARE MED, V30, pS18, DOI 10.1097/00003246-200201001-00003; Skelton TP, 1998, J CELL BIOL, V140, P431, DOI 10.1083/jcb.140.2.431; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Tamura Y, 2003, J BIOL CHEM, V278, P12613, DOI 10.1074/jbc.M210211200; Weigel P. H., 2012, STRUCTURE FUNCTION B, P293; Weigel P. H., 2002, HYALURONAN 2000, V1, P401; Weigel PH, 2002, BBA-GEN SUBJECTS, V1572, P341, DOI 10.1016/S0304-4165(02)00318-5; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; Wyatt PJ, 1997, LC GC-MAG SEP SCI, V15, P160; YU Q, 1995, BIOTECHNIQUES, V19, P122; Zhou B, 1999, J BIOL CHEM, V274, P33831, DOI 10.1074/jbc.274.48.33831; Zhou B, 2000, J BIOL CHEM, V275, P37733, DOI 10.1074/jbc.M003030200	46	16	16	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21807	21817		10.1074/jbc.M114.565846	http://dx.doi.org/10.1074/jbc.M114.565846			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24942734	Green Published, hybrid			2022-12-25	WOS:000340593500001
J	Bao, Y; Guo, YC; Li, ZX; Fang, WF; Yang, YQ; Li, XH; Li, ZZ; Xiong, BW; Chen, ZG; Wang, JG; Kang, K; Gou, DM; Yang, WC				Bao, Yonghua; Guo, Yongchen; Li, Zexin; Fang, Wenfeng; Yang, Yiqiong; Li, Xuhan; Li, Zhuangzhuang; Xiong, Bowen; Chen, Zhiguo; Wang, Jianguo; Kang, Kang; Gou, Deming; Yang, Wancai			MicroRNA Profiling in Muc2 Knockout Mice of Colitis-Associated Cancer Model Reveals Epigenetic Alterations during Chronic Colitis Malignant Transformation	PLOS ONE			English	Article							INTESTINAL TUMOR-FORMATION; COLORECTAL-CANCER; ULCERATIVE-COLITIS; COLON-CANCER; CELL MATURATION; DOWN-REGULATION; BETA-CATENIN; INFLAMMATION; METASTASIS; METAANALYSIS	Our previous studies have demonstrated that genetic deletion of the Muc2 gene causes colorectal cancers in mice. The current study further showed that at the early stage (<3 months) the Muc2 knockout mice spontaneously developed chronic inflammation in colon and rectum, similar pathological features as human colitis; and at the late stage (>3 months) the mice exhibited colorectal cancer, including a unique phenotype of rectal prolapsed (rectal severe inflammation and adenocarcinoma). Thus, the age of 3 months might be the key point of the transition from chronic inflammation to cancer. To determine the mechanisms of the malignant transformation, we conducted miRNA array on the colonic epithelial cells from the 3-month Muc2(-/-) and (+/+) mice. MicroRNA profiling showed differential expression of miRNAs (i.e. lower or higher expression enrichments) in Muc2(-/-) mice. 15 of them were validated by quantitative PCR. Based on relevance to cytokine and cancer, 4 miRNAs (miR-138, miR-145, miR-146a, and miR-150) were validate and were found significantly downregulated in human colitis and colorectal cancer tissues. The network of the targets of these miRNAs was characterized, and interestedly, miRNA-associated cytokines were significantly increased in Muc2(-/-) mice. This is the first to reveal the importance of aberrant expression of miRNAs in dynamically transformation from chronic colitis to colitis-associated cancer. These findings shed light on revealing the mechanisms of chronic colitis malignant transformation.	[Bao, Yonghua] Xinxiang Med Univ, Dept Immunol, Xinxiang, Peoples R China; [Guo, Yongchen] Xinxiang Med Univ, Dept Lab Med, Xinxiang, Peoples R China; [Li, Zexin; Wang, Jianguo] Xinxiang Med Univ, Affiliated Hosp 1, Dept Surg, Weihui, Peoples R China; [Fang, Wenfeng] Sun Yat Sen Univ, Ctr Canc, Dept Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Yiqiong; Li, Xuhan; Li, Zhuangzhuang; Xiong, Bowen; Chen, Zhiguo; Yang, Wancai] Xinxiang Med Univ, Sch Basic Med Sci, Xinxiang, Peoples R China; [Kang, Kang; Gou, Deming] Shenzhen Univ, Sch Life Sci, Shenzhen, Peoples R China; [Yang, Wancai] Univ Illinois, Dept Pathol, Chicago, IL USA	Xinxiang Medical University; Xinxiang Medical University; Xinxiang Medical University; Sun Yat Sen University; Xinxiang Medical University; Shenzhen University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Yang, WC (corresponding author), Xinxiang Med Univ, Sch Basic Med Sci, Xinxiang, Peoples R China.	wyang06@uic.edu	Yang, Wancai/O-7655-2019	Yang, Wancai/0000-0001-7437-9197	National Natural Science Foundation of China [91229115, 81272251]; Innovative Team of Science and Technology from the Department of Education, Henan Province, China; Doctor Research Fund from Xinxiang Medical University, China [100820, 505011]; Startup Fund from Xinxiang Medical University, China; National College Student Innovative Projects of China [201310472005, 201310472012, 201310472016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Team of Science and Technology from the Department of Education, Henan Province, China; Doctor Research Fund from Xinxiang Medical University, China; Startup Fund from Xinxiang Medical University, China; National College Student Innovative Projects of China	This work was supported in part by the grant from the National Natural Science Foundation of China (grant #91229115 and 81272251), a grant for the Innovative Team of Science and Technology from the Department of Education, Henan Province, China, and Doctor Research Fund (#100820 and 505011) and Startup Fund from Xinxiang Medical University, China. The work was also supported in part by the National College Student Innovative Projects of China (#201310472005 to XL, 201310472012 to BX, and 201310472016 to ZL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianifahanana M, 2006, BBA-REV CANCER, V1765, P189, DOI 10.1016/j.bbcan.2006.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141; Bi XL, 2012, CARCINOGENESIS, V33, P326, DOI 10.1093/carcin/bgr293; Boudiaf-Benmammar C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060895; Bousquet M, 2013, MOL CANCER RES, V11, P912, DOI 10.1158/1541-7786.MCR-13-0002-T; Canavan C, 2006, ALIMENT PHARM THER, V23, P1097, DOI 10.1111/j.1365-2036.2006.02854.x; Danese S, 2010, ONCOGENE, V29, P3313, DOI 10.1038/onc.2010.109; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Fang WF, 2010, CARCINOGENESIS, V31, P1360, DOI 10.1093/carcin/bgq114; Fang WF, 2010, INT J CANCER, V127, P32, DOI 10.1002/ijc.25029; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Gong H, 2013, CLIN CANCER RES, V19, P1083, DOI 10.1158/1078-0432.CCR-12-3169; Grivennikov SI, 2013, SEMIN IMMUNOPATHOL, V35, P229, DOI 10.1007/s00281-012-0352-6; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Jess T, 2012, CLIN GASTROENTEROL H, V10, P639, DOI 10.1016/j.cgh.2012.01.010; Kang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048536; Kanneganti M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/342637; Kawata H, 2003, BIOCHEM J, V373, P747, DOI 10.1042/BJ20030171; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kumar A, 2005, J BIOL CHEM, V280, P37782, DOI 10.1074/jbc.M505278200; Lages E, 2012, FRONT BIOSCI-LANDMRK, V17, P2508, DOI 10.2741/4068; Liu X, 2012, CELL CYCLE, V11, P2495, DOI 10.4161/cc.20898; Long LM, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-275; Mariadason JM, 2005, GASTROENTEROLOGY, V128, P1081, DOI 10.1053/j.gastro.2005.01.054; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Morris VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075815; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Noguchi S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.11; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; Pizzini S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-589; Rustgi AK, 2007, GENE DEV, V21, P2525, DOI 10.1101/gad.1593107; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Sen A, 2014, FEBS LETT, V588, P906, DOI 10.1016/j.febslet.2014.01.033; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Tong C, 2007, AM J PATHOL, V171, P297, DOI 10.2353/ajpath.2007.061036; Trifari S, 2013, P NATL ACAD SCI USA, V110, P18608, DOI 10.1073/pnas.1317191110; Trinchieri G, 2012, ANNU REV IMMUNOL, V30, P677, DOI 10.1146/annurev-immunol-020711-075008; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang DS, 2013, FEBS J, V280, P3340, DOI 10.1111/febs.12323; White NMA, 2011, NAT REV CLIN ONCOL, V8, P75, DOI 10.1038/nrclinonc.2010.173; Yang K, 2008, CANCER RES, V68, P7313, DOI 10.1158/0008-5472.CAN-08-0598; Yang WC, 2005, AM J PATHOL, V166, P1239, DOI 10.1016/S0002-9440(10)62342-5; Ye XW, 2014, CLIN RESP J; Yeh YM, 2013, INT J CANCER, V133, P867, DOI 10.1002/ijc.28086; Yu CC, 2013, CANCER RES, V73, P3425, DOI 10.1158/0008-5472.CAN-12-3840; Zheng QH, 2012, J IMMUNOL, V188, P2118, DOI 10.4049/jimmunol.1103342; Zhou L, 2013, FASEB J, V27, P4929, DOI 10.1096/fj.13-233387; Zhu XS, 2014, MOL CELL BIOCHEM, V390, P75, DOI 10.1007/s11010-013-1958-2	55	19	22	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99132	10.1371/journal.pone.0099132	http://dx.doi.org/10.1371/journal.pone.0099132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941171	Green Published, gold, Green Submitted			2022-12-25	WOS:000338508200014
J	Edmonds, JM; Sabol, JP; Rastogi, VK				Edmonds, Jason M.; Sabol, Jonathan P.; Rastogi, Vipin K.			Decontamination Efficacy of Three Commercial-Off-The-Shelf (COTS) Sporicidal Disinfectants on Medium-Sized Panels Contaminated with Surrogate Spores of Bacillus anthracis	PLOS ONE			English	Article							CHLORINE DIOXIDE GAS; SURFACES; THURINGIENSIS	In the event of a wide area release and contamination of a biological agent in an outdoor environment and to building exteriors, decontamination is likely to consume the Nation's remediation capacity, requiring years to cleanup, and leading to incalculable economic losses. This is in part due to scant body of efficacy data on surface areas larger than those studied in a typical laboratory (5x10-cm), resulting in low confidence for operational considerations in sampling and quantitative measurements of prospective technologies recruited in effective cleanup and restoration response. In addition to well-documented fumigation-based cleanup efforts, agencies responsible for mitigation of contaminated sites are exploring alternative methods for decontamination including combinations of disposal of contaminated items, source reduction by vacuuming, mechanical scrubbing, and low-technology alternatives such as pH-adjusted bleach pressure wash. If proven effective, a pressure wash-based removal of Bacillus anthracis spores from building surfaces with readily available equipment will significantly increase the readiness of Federal agencies to meet the daunting challenge of restoration and cleanup effort following a wide-area biological release. In this inter-agency study, the efficacy of commercial-of-the-shelf sporicidal disinfectants applied using backpack sprayers was evaluated in decontamination of spores on the surfaces of medium-sized (similar to 1.2 m(2)) panels of steel, pressure-treated (PT) lumber, and brick veneer. Of the three disinfectants, pH-amended bleach, Peridox, and CASCAD evaluated; CASCAD was found to be the most effective in decontamination of spores from all three panel surface types.	[Edmonds, Jason M.; Rastogi, Vipin K.] US Army, Edgewood Chem Biol Ctr, Res Dev & Engn Command, Aberdeen Proving Ground, MD 21005 USA; [Sabol, Jonathan P.] EXCET Inc, Springfield, VA USA	United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM)	Rastogi, VK (corresponding author), US Army, Edgewood Chem Biol Ctr, Res Dev & Engn Command, Aberdeen Proving Ground, MD 21005 USA.	vipin.k.rastogi.civ@mail.mil			Joint Science and Technology Office of the Defense Threat Reduction Agency	Joint Science and Technology Office of the Defense Threat Reduction Agency	Funding for this program was provided by the Joint Science and Technology Office of the Defense Threat Reduction Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, CHEM ENG NEWS, V79, P18; Beuchat LR, 2005, J IND MICROBIOL BIOT, V32, P301, DOI 10.1007/s10295-005-0212-7; Brown GS, 2007, J ENVIRON MONITOR, V9, P666, DOI 10.1039/b700163k; Calfee MW, 2010, BIOL AGENT DECONTAMI; Canter DA, 2005, BIOSECUR BIOTERROR, V3, P119, DOI 10.1089/bsp.2005.3.119; Davies A, 2011, J HOSP INFECT, V77, P199, DOI 10.1016/j.jhin.2010.08.012; de Boer HEL, 2006, INFECT CONT HOSP EP, V27, P1120, DOI 10.1086/507966; Edmonds JM, 2009, APPL MICROBIOL BIOT, V84, P811, DOI 10.1007/s00253-009-2136-z; Edmonds JM, 2009, APPL ENVIRON MICROB, V75, P39, DOI 10.1128/AEM.01563-08; Han Y, 2003, J ENVIRON HEALTH, V66, P16; Justice TUSDo, 2010, AM INV SUMM; Otter JA, 2009, INFECT CONT HOSP EP, V30, P574, DOI 10.1086/597544; Rastogi VK, 2009, APPL ENVIRON MICROB, V75, P3688, DOI 10.1128/AEM.02592-08; Ritter S, 2001, CHEM ENG NEWS, V79, P13, DOI 10.1021/cen-v079n050.p013a; Tomasino SF, 2010, J AOAC INT, V93, P259; Wilson SC, 2005, APPL ENVIRON MICROB, V71, P5399, DOI 10.1128/AEM.71.9.5399-5403.2005	16	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99827	10.1371/journal.pone.0099827	http://dx.doi.org/10.1371/journal.pone.0099827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940605	gold, Green Published, Green Submitted			2022-12-25	WOS:000338508200044
J	Heimesaat, MM; Fischer, A; Plickert, R; Wiedemann, T; Loddenkemper, C; Gobel, UB; Bereswill, S; Rieder, G				Heimesaat, Markus M.; Fischer, Andre; Plickert, Rita; Wiedemann, Tobias; Loddenkemper, Christoph; Goebel, Ulf B.; Bereswill, Stefan; Rieder, Gabriele			Helicobacter pylori Induced Gastric Immunopathology Is Associated with Distinct Microbiota Changes in the Large Intestines of Long-Term Infected Mongolian Gerbils	PLOS ONE			English	Article							ACID-SECRETION; COLONIZATION; CARCINOGENESIS; IDENTIFICATION; MICROFLORA; INDUCTION; COLITIS; STOMACH; ILEITIS; TRACT	Background: Gastrointestinal (GI) inflammation in mice and men are frequently accompanied by distinct changes of the GI microbiota composition at sites of inflammation. Helicobacter (H.) pylori infection results in gastric immunopathology accompanied by colonization of stomachs with bacterial species, which are usually restricted to the lower intestine. Potential microbiota shifts distal to the inflammatory process following long-term H. pylori infection, however, have not been studied so far. Methodology/Principal Findings: For the first time, we investigated microbiota changes along the entire GI tract of Mongolian gerbils after 14 months of infection with H. pylori B8 wildtype (WT) or its isogenic Delta cagY mutant (MUT) strain which is defective in the type IV secretion system and thus unable to modulate specific host pathways. Comprehensive cultural analyses revealed that severe gastric diseases such as atrophic pangastritis and precancerous transformations were accompanied by elevated luminal loads of E. coli and enterococci in the caecum and together with Bacteroides/Prevotella spp. in the colon of H. pylori WT, but not MUT infected gerbils as compared to naive animals. Strikingly, molecular analyses revealed that Akkermansia, an uncultivable species involved in mucus degradation, was exclusively abundant in large intestines of H. pylori WT, but not MUT infected nor naive gerbils. Conclusion/Significance: Taken together, long-term infection of Mongolian gerbils with a H. pylori WT strain displaying an intact type IV secretion system leads to distinct shifts of the microbiota composition in the distal uninflamed, but not proximal inflamed GI tract. Hence, H. pylori induced immunopathogenesis of the stomach, including hypochlorhydria and hypergastrinemia, might trigger large intestinal microbiota changes whereas the exact underlying mechanisms need to be further unraveled.	[Heimesaat, Markus M.; Fischer, Andre; Plickert, Rita; Goebel, Ulf B.; Bereswill, Stefan] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany; [Wiedemann, Tobias] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Munich, Germany; [Loddenkemper, Christoph] Charite, Res Ctr ImmunoSci RCIS, Dept Pathol, D-13353 Berlin, Germany; [Rieder, Gabriele] Salzburg Univ, Dept Microbiol, Div Mol Biol, A-5020 Salzburg, Austria	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Salzburg University	Heimesaat, MM (corresponding author), Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany.	markus.heimesaat@charite.de		Heimesaat, Markus/0000-0001-6399-651X	German Research Foun-dation (DFG) [GO363/12-1, CampyGerm, SFB633, TP A7, TP Z1, TP B6, RI972/3-1]; German Federal Ministry of Education and Research (BMBF) [TP 1.1, TP 8.2]	German Research Foun-dation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the German Research Foun-dation (DFG) to UBG (GO363/12-1, CampyGerm; SFB633, TP A7), SB and AF (SFB633, TP A7), CL (SFB633, TP Z1), MMH (SFB633, TP B6), GR (RI972/3-1), and from the German Federal Ministry of Education and Research (BMBF) to SB ("Lab in a hanky" projects TP 1.1 and TP 8.2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer T, 2006, FEMS IMMUNOL MED MIC, V46, P221, DOI 10.1111/rp10.1016-j.femsim.2004.05.008; Chu SJ, 2013, CURR OPIN GASTROEN, V29, P636, DOI 10.1097/MOG.0b013e328365efc7; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; DOOLEY CP, 1989, NEW ENGL J MED, V321, P1562, DOI 10.1056/NEJM198912073212302; Erridge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009125; Farnbacher M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-335; Gaddy JA, 2013, INFECT IMMUN, V81, P2258, DOI 10.1128/IAI.01271-12; Haag LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035988; Hatakeyama M, 2006, INT J HEMATOL, V84, P301, DOI 10.1532/IJH97.06166; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Heimesaat MM, 2010, GUT, V59, P1079, DOI 10.1136/gut.2009.197434; Hirayama F, 1996, J GASTROENTEROL, V31, P24; Hirayama F, 1996, J GASTROENTEROL, V31, P755, DOI 10.1007/BF02347631; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; International Agency for Research on Cancer, 1994, IARC MONOGR EVAL CAR, V61, P1; Jiang W, 2012, CURR HIV RES, V10, P504, DOI 10.2174/157016212802429848; Kavermann H, 2003, J EXP MED, V197, P813, DOI 10.1084/jem.20021531; KUIPERS EJ, 1995, LANCET, V345, P1525, DOI 10.1016/S0140-6736(95)91084-0; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Osaki T, 2012, MICROB PATHOGENESIS, V53, P12, DOI 10.1016/j.micpath.2012.03.008; Poppe M, 2007, ONCOGENE, V26, P3462, DOI 10.1038/sj.onc.1210139; Rieder G, 2005, GASTROENTEROLOGY, V128, P1229, DOI 10.1053/j.gastro.2005.02.064; Saha A, 2010, GASTROENTEROLOGY, V139, P239, DOI 10.1053/j.gastro.2010.03.036; Saha A, 2010, GUT, V59, P874, DOI 10.1136/gut.2009.194795; Selgrad M, 2012, HELICOBACTER, V17, P30, DOI 10.1111/j.1523-5378.2012.00980.x; Sewald X, 2008, CELL HOST MICROBE, V3, P20, DOI 10.1016/j.chom.2007.11.003; Smolka AJ, 2012, J GASTROENTEROL, V47, P609, DOI 10.1007/s00535-012-0592-1; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Sun YQ, 2003, HELICOBACTER, V8, P149, DOI 10.1046/j.1523-5378.2003.00136.x; Tsukamoto T, 2013, SEMIN IMMUNOPATHOL, V35, P177, DOI 10.1007/s00281-012-0357-1; Valeur N, 2004, APPL ENVIRON MICROB, V70, P1176, DOI 10.1128/AEM.70.2.1176-1181.2004; Wessler S, 2008, TRENDS MICROBIOL, V16, P397, DOI 10.1016/j.tim.2008.05.005; Wiedemann T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004754; Yakoob J, 2012, BRIT J BIOMED SCI, V69, P6, DOI 10.1080/09674845.2012.11669914; Yin YN, 2011, HELICOBACTER, V16, P389, DOI 10.1111/j.1523-5378.2011.00862.x; Zaman C, 2010, J GASTROEN HEPATOL, V25, pS11, DOI 10.1111/j.1440-1746.2009.06215.x; Zhang Songhua, 2012, Methods Mol Biol, V921, P89	39	52	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100362	10.1371/journal.pone.0100362	http://dx.doi.org/10.1371/journal.pone.0100362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941045	Green Published, gold, Green Submitted			2022-12-25	WOS:000338508200097
J	Nothnick, WB; Graham, A; Holbert, J; Weiss, MJ				Nothnick, Warren B.; Graham, Amanda; Holbert, Joshua; Weiss, Mitchell J.			miR-451 Deficiency Is Associated with Altered Endometrial Fibrinogen Alpha Chain Expression and Reduced Endometriotic Implant Establishment in an Experimental Mouse Model	PLOS ONE			English	Article							ERYTHROID-DIFFERENTIATION; RETROGRADE MENSTRUATION; MICRORNA-451; MICE; PROLIFERATION; PROGRESSION; INHIBITION; BIOGENESIS; ACTIVATION; PEPTIDES	Endometriosis is defined as the growth of endometrial glandular and stromal components in ectopic locations and affects as many as 10% of all women of reproductive age. Despite its high prevalence, the pathogenesis of endometriosis remains poorly understood. MicroRNAs, small non-coding RNAs that post-transcriptionally regulate gene expression, are mis-expressed in endometriosis but a functional role in the disease pathogenesis remains uncertain. To examine the role of microRNA-451 (miR-451) in the initial development of endometriosis, we utilized a novel mouse model in which eutopic endometrial fragments used to induce endometriosis were deficient for miR-451. After induction of the disease, we evaluated the impact of this deficiency on implant development and survival. Loss of miR-451 expression resulted in a lower number of ectopic lesions established in vivo. Analysis of differential protein profiles between miR-451 deficient and wildtype endometrial fragments revealed that fibrinogen alpha polypeptide isoform 2 precursor was approximately 2-fold higher in the miR-451 null donor endometrial tissue and this elevated expression of the protein was associated with altered expression of the parent fibrinogen alpha chain mRNA and protein. As this polypeptide contains RGD amino acid "cell adhesion" motifs which could impact early establishment of lesion development, we examined and confirmed using a cyclic RGD peptide antagonist, that endometrial cell adhesion and endometriosis establishment could be respectively inhibited both in vitro and in vivo. Collectively, these results suggest that the reduced miR-451 eutopic endometrial expression does not enhance initial establishment of these fragments when displaced into the peritoneal cavity, that loss of eutopic endometrial miR-451 expression is associated with altered expression of fibrinogen alpha chain mRNA and protein, and that RGD cyclic peptide antagonists inhibit establishment of endometriosis development in an experimental mouse model suggesting that this approach may prove useful in the prevention of endometriosis establishment and survival.	[Nothnick, Warren B.; Graham, Amanda; Holbert, Joshua] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA; [Weiss, Mitchell J.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA	University of Kansas; University of Kansas Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Nothnick, WB (corresponding author), Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA.	wnothnic@kumc.edu	Weiss, Mitchell J/W-9814-2018	Weiss, Mitchell J/0000-0003-2460-3036	Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health [R01HD069043]; National Institute of Diabetes and Kidney Disease [R01 DK092318, P30 DK090969]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069043, P30HD002528] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health; National Institute of Diabetes and Kidney Disease; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health under Award Number R01HD069043 (WBN) and from the National Institute of Diabetes and Kidney Disease under award numbers R01 DK092318 and P30 DK090969 (MJW). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apparao KBC, 2001, J CLIN ENDOCR METAB, V86, P4991, DOI 10.1210/jc.86.10.4991; Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bruchova-Votavova H, 2010, LEUKEMIA LYMPHOMA, V51, P686, DOI 10.3109/10428191003629362; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen XM, 1997, BIOCHEM BIOPH RES CO, V234, P594, DOI 10.1006/bbrc.1997.6593; Child TJ, 2001, DRUGS, V61, P1735, DOI 10.2165/00003495-200161120-00005; Cho S, 2012, DNA CELL BIOL, V31, P316, DOI 10.1089/dna.2011.1279; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Ding X, 2010, J INT MED RES, V38, P987, DOI 10.1177/147323001003800325; Ding XY, 2010, FERTIL STERIL, V94, P2528, DOI 10.1016/j.fertnstert.2010.04.054; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; Erson AE, 2008, CLIN GENET, V74, P296, DOI 10.1111/j.1399-0004.2008.01076.x; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Filigheddu N, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/369549; Fu YF, 2009, BLOOD, V113, P1340, DOI 10.1182/blood-2008-08-174854; Godlewski J, 2010, CELL CYCLE, V9, P2742, DOI 10.4161/cc.9.14.12248; Govatati S, 2013, MITOCHONDRION, V13, P782, DOI 10.1016/j.mito.2013.05.003; Govatati S, 2013, FERTIL STERIL, V99, P1980, DOI 10.1016/j.fertnstert.2013.02.021; Govatati S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040668; Haier J, 2002, CLIN EXP METASTAS, V19, P665, DOI 10.1023/A:1021316531912; HALME J, 1984, OBSTET GYNECOL, V64, P151; Hawkins SM, 2011, MOL ENDOCRINOL, V25, P821, DOI 10.1210/me.2010-0371; Healy DL, 1998, HUM REPROD UPDATE, V4, P736, DOI 10.1093/humupd/4.5.736; Iwaya T, 2012, CARCINOGENESIS, V33, P2391, DOI 10.1093/carcin/bgs288; Jin HL, 2012, MOL CELLS, V34, P177, DOI 10.1007/s10059-012-0090-6; Kao SH, 2005, ANN NY ACAD SCI, V1042, P186, DOI 10.1196/annals.1338.021; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028293; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; LIU CY, 1986, THROMB HAEMOSTASIS, V56, P100; LIU DTY, 1986, BRIT J OBSTET GYNAEC, V93, P859, DOI 10.1111/j.1471-0528.1986.tb07995.x; Nothnick WB, 2011, J ENDOMETR PELVIC PA, V3, P135, DOI 10.5301/JE.2011.8910; Nothnick WB, 2010, REPROD SCI, V17, P987, DOI 10.1177/1933719110377472; Pan Q, 2007, MOL HUM REPROD, V13, P797, DOI 10.1093/molehr/gam063; Patrick DM, 2010, GENE DEV, V24, P1614, DOI 10.1101/gad.1942810; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; VANDERLINDEN PJQ, 1995, FERTIL STERIL, V63, P1210, DOI 10.1016/S0015-0282(16)57599-2; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vigano P, 2004, BEST PRACT RES CL OB, V18, P177, DOI 10.1016/j.bpobgyn.2004.01.007; Wang T, 2013, DIGEST DIS SCI, V58, P706, DOI 10.1007/s10620-012-2395-x; Wang WZ, 2011, INT J CANCER, V129, P1624, DOI 10.1002/ijc.25818; Yu DN, 2010, GENE DEV, V24, P1620, DOI 10.1101/gad.1942110; Zhang X, 2009, MOL REPROD DEV, V76, P160, DOI 10.1002/mrd.20938; Zhang Z, 2012, FEBS LETT, V586, P20, DOI 10.1016/j.febslet.2011.07.042; Zhao J, 1995, DI YI JUN DA XUE XUE, V25, P709	46	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100336	10.1371/journal.pone.0100336	http://dx.doi.org/10.1371/journal.pone.0100336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937656	Green Published, Green Submitted, gold			2022-12-25	WOS:000338503400105
J	O'Brien, KR; Kober, T; Hagmann, P; Maeder, P; Marques, J; Lazeyras, F; Krueger, G; Roche, A				O'Brien, Kieran R.; Kober, Tobias; Hagmann, Patric; Maeder, Philippe; Marques, Jose; Lazeyras, Francois; Krueger, Gunnar; Roche, Alexis			Robust T1-Weighted Structural Brain Imaging and Morphometry at 7T Using MP2RAGE	PLOS ONE			English	Article							MRI; SEGMENTATION	Purpose: To suppress the noise, by sacrificing some of the signal homogeneity for numerical stability, in uniform T1 weighted (T1w) images obtained with the magnetization prepared 2 rapid gradient echoes sequence (MP2RAGE) and to compare the clinical utility of these robust T1w images against the uniform T1w images. Materials and Methods: 8 healthy subjects (29.0 +/- 4.1 years; 6 Male), who provided written consent, underwent two scan sessions within a 24 hour period on a 7T head-only scanner. The uniform and robust T1w image volumes were calculated inline on the scanner. Two experienced radiologists qualitatively rated the images for: general image quality; 7T specific artefacts; and, local structure definition. Voxel-based and volume-based morphometry packages were used to compare the segmentation quality between the uniform and robust images. Statistical differences were evaluated by using a positive sided Wilcoxon rank test. Results: The robust image suppresses background noise inside and outside the skull. The inhomogeneity introduced was ranked as mild. The robust image was significantly ranked higher than the uniform image for both observers (observer 1/2, p-value = 0.0006/0.0004). In particular, an improved delineation of the pituitary gland, cerebellar lobes was observed in the robust versus uniform T1w image. The reproducibility of the segmentation results between repeat scans improved (p-value = 0.0004) from an average volumetric difference across structures of approximate to 6.6% to approximate to 2.4% for the uniform image and robust T1w image respectively. Conclusions: The robust T1w image enables MP2RAGE to produce, clinically familiar T1w images, in addition to T1 maps, which can be readily used in uniform morphometry packages.	[O'Brien, Kieran R.; Lazeyras, Francois] Univ Geneva, Dept Radiol, Hop Univ Geneve, Ctr Imagerie BioMed, Geneva, Switzerland; [O'Brien, Kieran R.; Kober, Tobias; Krueger, Gunnar; Roche, Alexis] Ctr Imagerie BioMed Siemens, Adv Clin Imaging Technogoly, Lausanne, Switzerland; [Kober, Tobias; Krueger, Gunnar; Roche, Alexis] Siemens Schweiz AG, Siemens Healthcare, Rennes, Switzerland; [Hagmann, Patric; Maeder, Philippe; Roche, Alexis] CHU Vaudois, Dept Radiol, Lausanne, Switzerland; [Marques, Jose] Univ Lausanne, Dept Radiol, Ctr Imagerie BioMed Anim & Imaging Technol Core, Lausanne, Switzerland	University of Geneva; Siemens AG; Siemens AG; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	O'Brien, KR (corresponding author), Univ Geneva, Dept Radiol, Hop Univ Geneve, Ctr Imagerie BioMed, Geneva, Switzerland.	kieran.obrien@gmail.com	O'Brien, Kieran/B-7276-2016; Marques, José Pedro/R-3616-2018; Marques, Jose/B-4922-2015	O'Brien, Kieran/0000-0003-1996-3563; Marques, José Pedro/0000-0001-8157-8864; Marques, Jose/0000-0001-8157-8864; Roche, Alexis/0000-0002-4821-6893	Centre d'Imagerie BioMedicale (CIBM) of the UNIL; Centre d'Imagerie BioMedicale (CIBM) of the UNIGE; Centre d'Imagerie BioMedicale (CIBM) of the HUG; Centre d'Imagerie BioMedicale (CIBM) of the CHUV; Centre d'Imagerie BioMedicale (CIBM) of the EPFL; Leenaards foundation; Louis-Jeantet foundation	Centre d'Imagerie BioMedicale (CIBM) of the UNIL; Centre d'Imagerie BioMedicale (CIBM) of the UNIGE; Centre d'Imagerie BioMedicale (CIBM) of the HUG; Centre d'Imagerie BioMedicale (CIBM) of the CHUV; Centre d'Imagerie BioMedicale (CIBM) of the EPFL; Leenaards foundation; Louis-Jeantet foundation	This work was supported by the Centre d'Imagerie BioMedicale (CIBM) of the UNIL, UNIGE, HUG, CHUV and EPFL, and the Leenaards and Louis-Jeantet foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACIT, 2013, BRAINMORPH AUT BRAIN; Bazin PL, 2014, NEUROIMAGE, V93, P201, DOI 10.1016/j.neuroimage.2013.03.077; FIL ([Wellcome Trust Centre for Neuroimaging UCL], 1991, SPM STAT PAR MAPP; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; Max Planck Institute for Human Cognitive and Brain Sciences, 2013, CBS HIGH RES BRAIN P; Mueller Susanne G, 2005, Alzheimers Dement, V1, P55, DOI 10.1016/j.jalz.2005.06.003; MUGLER JP, 1991, JMRI-J MAGN RESON IM, V1, P561, DOI 10.1002/jmri.1880010509; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; O'Brien K, 2013, SIMPLE METHOD DENOIS, P269; O'Brien KR, 2014, J MAGNETIC RESONANCE; Roche A, 2011, MED IMAGE ANAL, V15, P830, DOI 10.1016/j.media.2011.05.002; Solomon C.J., 2010, FUNDAMENTALS DIGITAL, Vist; Van De Moortele PF, 2005, MAGN RESON MED, V54, P1503, DOI 10.1002/mrm.20708; Van de Moortele PF, 2009, NEUROIMAGE, V46, P432, DOI 10.1016/j.neuroimage.2009.02.009; Vaughan JT, 2001, MAGN RESON MED, V46, P24, DOI 10.1002/mrm.1156	18	73	73	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99676	10.1371/journal.pone.0099676	http://dx.doi.org/10.1371/journal.pone.0099676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932514	Green Submitted, gold, Green Published			2022-12-25	WOS:000337738600054
J	Yu, K; AI-Nashash, H; Thakor, N; Li, XP				Yu, Ke; AI-Nashash, Hasan; Thakor, Nitish; Li, Xiaoping			The Analytic Bilinear Discrimination of Single-Trial EEG Signals in Rapid Image Triage	PLOS ONE			English	Article							SPATIAL FILTERS; PHASE; P300; FREQUENCY; ODDBALL	The linear discriminant analysis (LDA) method is a classical and commonly utilized technique for dimensionality reduction and classification in brain-computer interface (BCI) systems. Being a first-order discriminator, LDA is usually preceded by the feature extraction of electroencephalogram (EEG) signals, as multi-density EEG data are of second order. In this study, an analytic bilinear classification method which inherits and extends LDA is proposed. This method considers 2-dimentional EEG signals as the feature input and performs classification using the optimized complex-valued bilinear projections. Without being transformed into frequency domain, the complex-valued bilinear projections essentially spatially and temporally modulate the phases and magnitudes of slow event-related potentials (ERPs) elicited by distinct brain states in the sense that they become more separable. The results show that the proposed method has demonstrated its discriminating capability in the development of a rapid image triage (RIT) system, which is a challenging variant of BCIs due to the fast presentation speed and consequently overlapping of ERPs.	[Yu, Ke; AI-Nashash, Hasan; Thakor, Nitish] Natl Univ Singapore, Singapore Inst Neurotechnol, Singapore 117548, Singapore; [AI-Nashash, Hasan] Amer Univ Sharjah, Dept Elect Engn, Sharjah, U Arab Emirates; [Thakor, Nitish] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Li, Xiaoping] Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore	National University of Singapore; American University of Sharjah; Johns Hopkins University; National University of Singapore	Li, XP (corresponding author), Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore.	mpelixp@nus.edu.sg	AL-Nashash, Hasan/AEW-9979-2022; Thakor, Nitish/G-9110-2015; Thakor, Nitish V/A-5878-2008	Thakor, Nitish/0000-0002-9981-9395; Al-Nashash, Hasan/0000-0002-9685-4937				Bernat E, 2001, CLIN NEUROPHYSIOL, V112, P159, DOI 10.1016/S1388-2457(00)00445-4; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; DaSalla CS, 2009, NEURAL NETWORKS, V22, P1334, DOI 10.1016/j.neunet.2009.05.008; Dornhege G, 2006, IEEE T BIO-MED ENG, V53, P2274, DOI 10.1109/TBME.2006.883649; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; Falzon O, 2012, IEEE T BIO-MED ENG, V59, P2486, DOI 10.1109/TBME.2012.2205246; Falzon O, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045009; Falzon O, 2010, IEEE ENG MED BIO, P4707, DOI 10.1109/IEMBS.2010.5626381; Finke A, 2009, NEURAL NETWORKS, V22, P1329, DOI 10.1016/j.neunet.2009.07.003; Gerson AD, 2006, IEEE T NEUR SYS REH, V14, P174, DOI 10.1109/TNSRE.2006.875550; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Huang YH, 2011, NEUROCOMPUTING, V74, P2041, DOI 10.1016/j.neucom.2010.12.025; Hughes G, 2012, NEUROIMAGE; Jia CA, 2011, IEEE T BIO-MED ENG, V58, P200, DOI 10.1109/TBME.2010.2068571; Kruglikov SY, 2003, J NEUROSCI, V23, P10122; Lagerlund TD, 1997, J CLIN NEUROPHYSIOL, V14, P73, DOI 10.1097/00004691-199701000-00007; Lemm S, 2005, IEEE T BIO-MED ENG, V52, P1541, DOI 10.1109/TBME.2005.851521; Leuthardt EC, 2006, NEUROSURGERY, V59, P1, DOI 10.1227/01.NEU.0000221506.06947.AC; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Li J, 2009, IEEE T NEUR SYS REH, V17, P107, DOI 10.1109/TNSRE.2008.2008394; Li M, 2005, PATTERN RECOGN LETT, V26, P527, DOI 10.1016/j.patrec.2004.09.007; Lu HP, 2011, PATTERN RECOGN, V44, P1540, DOI 10.1016/j.patcog.2011.01.004; Makeig S, 1996, ADV NEUR IN, V8, P145; McCleery JP, 2011, J NEUROSCI, V31, P12849, DOI 10.1523/JNEUROSCI.1392-11.2011; Mertens R, 1997, EVOKED POTENTIAL, V104, P488, DOI 10.1016/S0168-5597(97)00041-5; Miwakeichi F, 2004, NEUROIMAGE, V22, P1035, DOI 10.1016/j.neuroimage.2004.03.039; Pohlmeyer EA, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036025; Polich J, 1997, INT J PSYCHOPHYSIOL, V25, P169, DOI 10.1016/S0167-8760(96)00742-8; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Sajda P, 2010, P IEEE, V98, P462, DOI 10.1109/JPROC.2009.2038406; Samek W, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026013; Tomioka R, 2006, SPECTRALLY WEIGHTED; VanRullen R, 2011, FRONTIERS PSYCHOL, V2; Visani M, 2005, NORMALIZED RADIAL BA, P342; Xu P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014634; Ye J., 2004, P ADV NEUR INF PROC, P1569; Yu K, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046013; Yu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076923; Yu K, 2012, J NEUROSCI METH, V204, P288, DOI 10.1016/j.jneumeth.2011.11.023; Yu K, 2011, IEEE T BIO-MED ENG, V58, P2513, DOI 10.1109/TBME.2011.2158542; Zhang R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074433	42	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100097	10.1371/journal.pone.0100097	http://dx.doi.org/10.1371/journal.pone.0100097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933017	gold, Green Submitted, Green Published			2022-12-25	WOS:000337738600094
J	Liljavirta, J; Niku, M; Pessa-Morikawa, T; Ekman, A; Iivanainen, A				Liljavirta, Jenni; Niku, Mikael; Pessa-Morikawa, Tiina; Ekman, Anna; Iivanainen, Antti			Expansion of the Preimmune Antibody Repertoire by Junctional Diversity in Bos taurus	PLOS ONE			English	Article							TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE; EXCEPTIONALLY LONG CDR3H; B-CELL DIFFERENTIATION; ACUTE MYELOID-LEUKEMIA; H GENE FAMILY; N-REGIONS; BONE-MARROW; NUCLEOTIDE ADDITION; V(D)J RECOMBINATION; MOLECULAR-BIOLOGY	Cattle have a limited range of immunoglobulin genes which are further diversified by antigen independent somatic hypermutation in fetuses. Junctional diversity generated during somatic recombination contributes to antibody diversity but its relative significance has not been comprehensively studied. We have investigated the importance of terminal deoxynucleotidyl transferase (TdT) -mediated junctional diversity to the bovine immunoglobulin repertoire. We also searched for new bovine heavy chain diversity (IGHD) genes as the information of the germline sequences is essential to define the junctional boundaries between gene segments. New heavy chain variable genes (IGHV) were explored to address the gene usage in the fetal recombinations. Our bioinformatics search revealed five new IGHD genes, which included the longest IGHD reported so far, 154 bp. By genomic sequencing we found 26 new IGHV sequences that represent potentially new IGHV genes or allelic variants. Sequence analysis of immunoglobulin heavy chain cDNA libraries of fetal bone marrow, ileum and spleen showed 0 to 36 nontemplated N-nucleotide additions between variable, diversity and joining genes. A maximum of 8 N nucleotides were also identified in the light chains. The junctional base profile was biased towards A and T nucleotide additions (64% in heavy chain VD, 52% in heavy chain DJ and 61% in light chain VJ junctions) in contrast to the high G/C content which is usually observed in mice. Sequence analysis also revealed extensive exonuclease activity, providing additional diversity. B-lymphocyte specific TdT expression was detected in bovine fetal bone marrow by reverse transcription-qPCR and immunofluorescence. These results suggest that TdT-mediated junctional diversity and exonuclease activity contribute significantly to the size of the cattle preimmune antibody repertoire already in the fetal period.	[Liljavirta, Jenni; Niku, Mikael; Pessa-Morikawa, Tiina; Ekman, Anna; Iivanainen, Antti] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland	University of Helsinki	Iivanainen, A (corresponding author), Univ Helsinki, Dept Vet Biosci, Helsinki, Finland.	antti.iivanainen@helsinki.fi	Niku, Mikael/F-8490-2011	Niku, Mikael/0000-0003-1087-9859	Academy of Finland; Orion-Farmos Research Foundation; Finnish Veterinary Foundation; Finnish Foundation of Veterinary Research	Academy of Finland(Academy of Finland); Orion-Farmos Research Foundation; Finnish Veterinary Foundation; Finnish Foundation of Veterinary Research	This study was supported by The Academy of Finland, Finnish Veterinary Foundation, Finnish Foundation of Veterinary Research, and Orion-Farmos Research Foundation. JL is a student at the Viikki Graduate School in Molecular Biosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BASU M, 1983, BIOCHEM BIOPH RES CO, V111, P1105, DOI 10.1016/0006-291X(83)91413-4; Benedict CL, 2001, J EXP MED, V193, P89, DOI 10.1084/jem.193.1.89; Benedict CL, 2000, IMMUNOL REV, V175, P150, DOI 10.1034/j.1600-065X.2000.017518.x; Bentolila LA, 1997, J IMMUNOL, V158, P715; BENTOLILA LA, 1995, EMBO J, V14, P4221, DOI 10.1002/j.1460-2075.1995.tb00096.x; Berens SJ, 1997, INT IMMUNOL, V9, P189, DOI 10.1093/intimm/9.1.189; Bertocci B, 2003, IMMUNITY, V19, P203, DOI 10.1016/S1074-7613(03)00203-6; Bertocci B, 2006, IMMUNITY, V25, P31, DOI 10.1016/j.immuni.2006.04.013; Butler JE, 2004, J IMMUNOL, V173, P6794, DOI 10.4049/jimmunol.173.11.6794; Butler JE, 2000, J IMMUNOL, V165, P6999, DOI 10.4049/jimmunol.165.12.6999; CHANG LMS, 1986, CRC CR REV BIOCH MOL, V21, P27, DOI 10.3109/10409238609113608; DEIBEL MR, 1983, J IMMUNOL, V131, P195; DESIDERIO SV, 1984, NATURE, V311, P752, DOI 10.1038/311752a0; DREXLER HG, 1993, LEUKEMIA, V7, P1142; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekman A, 2012, DEV COMP IMMUNOL, V37, P39, DOI 10.1016/j.dci.2011.12.009; Ekman A, 2010, DEV COMP IMMUNOL, V34, P896, DOI 10.1016/j.dci.2010.03.012; Ekman A, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-22; FEENEY AJ, 1990, J EXP MED, V172, P1377, DOI 10.1084/jem.172.5.1377; Galler GR, 2004, J EXP MED, V199, P1523, DOI 10.1084/jem.20031523; Gauss GH, 1996, MOL CELL BIOL, V16, P258; Gilfillan S, 1995, IMMUNOL REV, V148, P201, DOI 10.1111/j.1600-065X.1995.tb00099.x; Gontier E, 2005, VET IMMUNOL IMMUNOP, V103, P31, DOI 10.1016/j.vetimm.2004.08.013; GORE SD, 1991, BLOOD, V77, P1681; Gozalbo-Lopez B, 2009, MOL CELL BIOL, V29, P1266, DOI 10.1128/MCB.01518-08; GREENBERG JM, 1987, BLOOD, V69, P356; GREGOIRE KE, 1979, J IMMUNOL, V123, P1347; Hollander M, 1973, NONPARAMETRIC STAT M; Hosseini A, 2004, INT IMMUNOL, V16, P843, DOI 10.1093/intimm/dxh085; Jenne CN, 2003, J IMMUNOL, V170, P3739, DOI 10.4049/jimmunol.170.7.3739; Jeong Y, 2001, IMMUNOLOGY, V103, P26, DOI 10.1046/j.1365-2567.2001.01227.x; Kaushik AK, 2009, VET IMMUNOL IMMUNOP, V127, P106, DOI 10.1016/j.vetimm.2008.09.024; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; Koti M, 2008, DEV BIOLOGICALS, V132, P307, DOI 10.1159/000317176; Koti M, 2010, MOL IMMUNOL, V47, P2119, DOI 10.1016/j.molimm.2010.02.014; LEFLER CF, 1969, J BIOL CHEM, V244, P594; Lefranc MP, 2001, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.ima01ps40, DOI 10.1002/0471142735.IM-A01PS40]; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; Liljavirta J, 2013, MUCOSAL IMMUNOL, V6, P942, DOI 10.1038/mi.2012.132; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mickelsen S, 1999, J IMMUNOL, V163, P834; Murphy K., 2011, JANEWAYS IMMUNOBIOLO, V8th ed.; Niku M, 2012, DEV COMP IMMUNOL, V37, P457, DOI 10.1016/j.dci.2012.02.006; Pages H, 2014, BIOSTRINGS STRING OB; Patel KP, 2013, MODERN PATHOL, V26, P195, DOI 10.1038/modpathol.2012.142; Pramanik S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-78; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; RILEY LK, 1988, P NATL ACAD SCI USA, V85, P2489, DOI 10.1073/pnas.85.8.2489; Saini SS, 1997, MOL IMMUNOL, V34, P641, DOI 10.1016/S0161-5890(97)00055-2; Saini SS, 1999, EUR J IMMUNOL, V29, P2420, DOI 10.1002/(SICI)1521-4141(199908)29:08&lt;2420::AID-IMMU2420&gt;3.0.CO;2-A; Sandor Z, 2004, NUCLEIC ACIDS RES, V32, P1866, DOI 10.1093/nar/gkh502; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroeder HW, 1995, ANN NY ACAD SCI, V764, P242; Sinclair MC, 1997, J IMMUNOL, V159, P3883; Sinkora M, 2003, J IMMUNOL, V170, P1781, DOI 10.4049/jimmunol.170.4.1781; TAKAHARA K, 1994, BIOSCI BIOTECH BIOCH, V58, P786, DOI 10.1271/bbb.58.786; Thai TH, 2004, J IMMUNOL, V173, P4009, DOI 10.4049/jimmunol.173.6.4009; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Uchiyama Y, 2009, BIOCHIMIE, V91, P165, DOI 10.1016/j.biochi.2008.07.005; Verma S, 2012, VET IMMUNOL IMMUNOP, V145, P14, DOI 10.1016/j.vetimm.2011.10.001; Wang F, 2013, CELL, V153, P1379, DOI 10.1016/j.cell.2013.04.049; Weill JC, 1998, DEV COMP IMMUNOL, V22, P379, DOI 10.1016/S0145-305X(98)00014-7; Wertz N, 2013, MOL IMMUNOL, V55, P319, DOI 10.1016/j.molimm.2013.03.012; Zhao YF, 2006, DEV COMP IMMUNOL, V30, P175, DOI 10.1016/j.dci.2005.06.012; Zhao YF, 2003, J BIOL CHEM, V278, P35024, DOI 10.1074/jbc.M301337200	68	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99808	10.1371/journal.pone.0099808	http://dx.doi.org/10.1371/journal.pone.0099808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926997	gold, Green Submitted, Green Published			2022-12-25	WOS:000338278100083
J	Yadav, S; Verma, PJ; Panda, D				Yadav, Saroj; Verma, Paul J.; Panda, Dulal			C-Terminal Region of MAP7 Domain Containing Protein 3 (MAP7D3) Promotes Microtubule Polymerization by Binding at the C-Terminal Tail of Tubulin	PLOS ONE			English	Article							TAU-PROTEIN; DNA-SEQUENCE; IN-VITRO; ENSCONSIN; IDENTIFICATION; E-MAP-115; STABILIZATION; LOCALIZATION; PURIFICATION; SUBTILISIN	MAP7 domain containing protein 3 (MAP7D3), a newly identified microtubule associated protein, has been shown to promote microtubule assembly and stability. Its microtubule binding region has been reported to consist of two coiled coil motifs located at the N-terminus. It possesses a MAP7 domain near the C-terminus and belongs to the microtubule associated protein 7 (MAP7) family. The MAP7 domain of MAP7 protein has been shown to bind to kinesin-1; however, the role of MAP7 domain in MAP7D3 remains unknown. Based on the bioinformatics analysis of MAP7D3, we hypothesized that the MAP7 domain of MAP7D3 may have microtubule binding activity. Indeed, we found that MAP7 domain of MAP7D3 bound to microtubules as well as enhanced the assembly of microtubules in vitro. Interestingly, a longer fragment MDCT that contained the MAP7 domain (MD) with the C-terminal tail (CT) of the protein promoted microtubule polymerization to a greater extent than MD and CT individually. MDCT stabilized microtubules against dilution induced disassembly. MDCT bound to reconstituted microtubules with an apparent dissociation constant of 3.0 +/- 0.5 mu M. An immunostaining experiment showed that MDCT localized along the length of the preassembled microtubules. Competition experiments with tau indicated that MDCT shares its binding site on microtubules with tau. Further, we present evidence indicating that MDCT binds to the C-terminal tail of tubulin. In addition, MDCT could bind to tubulin in HeLa cell extract. Here, we report a microtubule binding region in the C-terminal region of MAP7D3 that may have a role in regulating microtubule assembly dynamics.	[Yadav, Saroj] Indian Inst Technol, IITB Monash Res Acad, Mumbai 400076, Maharashtra, India; [Verma, Paul J.] Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia; [Panda, Dulal] Indian Inst Technol, Dept Biosci & Bioengn, Mumbai 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Monash University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Panda, D (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Mumbai 400076, Maharashtra, India.	panda@iitb.ac.in	Verma, Paul/AAQ-4657-2021		Department of Biotechnology, Government of India; IITB-Monash Research Academy; IIT-B Monash Research Academy	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); IITB-Monash Research Academy; IIT-B Monash Research Academy	This work was supported by a grant from Department of Biotechnology, Government of India to DP and partly by IITB-Monash Research Academy. SY is supported by fellowship from IIT-B Monash Research Academy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Akhmanova A, 2010, J CELL SCI, V123, P3415, DOI 10.1242/jcs.062414; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Asthana J, 2012, J BIOL CHEM, V287, P40793, DOI 10.1074/jbc.M112.394353; Banerjee A, 2010, ANAL BIOCHEM, V402, P194, DOI 10.1016/j.ab.2010.03.035; Barlan K, 2013, CURR BIOL, V23, P317, DOI 10.1016/j.cub.2013.01.008; Bhattacharya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076286; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bosc C, 2003, BIOCHEMISTRY-US, V42, P12125, DOI 10.1021/bi0352163; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BULINSKI JC, 1979, P NATL ACAD SCI USA, V76, P293, DOI 10.1073/pnas.76.1.293; BULINSKI JC, 1994, J CELL SCI, V107, P2839; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; COFFEY RL, 1995, J BIOL CHEM, V270, P1035, DOI 10.1074/jbc.270.3.1035; Dehmelt L, 2005, GENOME BIOL, V6; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Fabre-Jonca N, 1998, DIFFERENTIATION, V63, P169, DOI 10.1111/j.1432-0436.1998.00169.x; Faire K, 1999, J CELL SCI, V112, P4243; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; HAMEL E, 1981, ARCH BIOCHEM BIOPHYS, V209, P29, DOI 10.1016/0003-9861(81)90253-8; HERNANDEZ MA, 1986, EUR J BIOCHEM, V154, P41, DOI 10.1111/j.1432-1033.1986.tb09356.x; HUBER G, 1990, J CELL SCI, V95, P237; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; LICHTENBERGKRAAG B, 1992, P NATL ACAD SCI USA, V89, P5384, DOI 10.1073/pnas.89.12.5384; Ludin B, 1996, J CELL SCI, V109, P91; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; MASSON D, 1993, J CELL BIOL, V123, P357, DOI 10.1083/jcb.123.2.357; Metzger T, 2012, NATURE, V484, P120, DOI 10.1038/nature10914; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; OOKATA K, 1995, J CELL BIOL, V128, P849, DOI 10.1083/jcb.128.5.849; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; PANDA D, 1995, BIOCHEMISTRY-US, V34, P11117, DOI 10.1021/bi00035a017; Patel K, 2012, CYTOSKELETON, V69, P155, DOI 10.1002/cm.21005; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; RIEDERER B, 1986, J NEUROCYTOL, V15, P763, DOI 10.1007/BF01625193; RODIONOV VI, 1990, J BIOL CHEM, V265, P5702; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Samora CP, 2011, NAT CELL BIOL, V13, P1040, DOI 10.1038/ncb2297; SAOUDI Y, 1995, J CELL SCI, V108, P357; Sato Y, 2013, J CELL SCI, V126, P4671, DOI 10.1242/jcs.127845; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; SCOTT CW, 1992, J NEUROSCI RES, V33, P19, DOI 10.1002/jnr.490330104; SERRANO L, 1985, EUR J BIOCHEM, V153, P595, DOI 10.1111/j.1432-1033.1985.tb09342.x; SERRANO L, 1984, BIOCHEMISTRY-US, V23, P4675, DOI 10.1021/bi00315a024; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Slep KC, 2010, CURR OPIN CELL BIOL, V22, P88, DOI 10.1016/j.ceb.2009.10.009; Sun XO, 2011, CELL CYCLE, V10, P3929, DOI 10.4161/cc.10.22.18106; Sung HH, 2008, DEV CELL, V15, P866, DOI 10.1016/j.devcel.2008.10.006; Tokuraku K, 2003, J BIOL CHEM, V278, P29609, DOI 10.1074/jbc.M302186200; Tortosa E, 2011, J BIOL CHEM, V286, P40638, DOI 10.1074/jbc.M111.271320; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; van der Vaart B, 2009, BIOCHEM SOC T, V37, P1007, DOI 10.1042/BST0371007	58	19	20	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99539	10.1371/journal.pone.0099539	http://dx.doi.org/10.1371/journal.pone.0099539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927501	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100047
J	Cohen, A; Kupiec, M; Weisman, R				Cohen, Adiel; Kupiec, Martin; Weisman, Ronit			Glucose Activates TORC2-Gad8 Protein via Positive Regulation of the cAMP/cAMP-dependent Protein Kinase A (PKA) Pathway and Negative Regulation of the Pmk1 Protein-Mitogen-activated Protein Kinase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOCORTICOID-INDUCIBLE KINASE; CELL INTEGRITY PATHWAY; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; SEXUAL DEVELOPMENT; NITROGEN STARVATION; SIGNALING PATHWAY; GENOME STABILITY; GROWTH-FACTOR	The target of rapamycin (TOR) kinase belongs to the highly conserved eukaryotic family of phosphatidylinositol 3-kinase-related kinases. TOR proteins are found at the core of two evolutionary conserved complexes, known as TORC1 and TORC2. In fission yeast, TORC2 is dispensable for proliferation under optimal growth conditions but is required for starvation and stress responses. TORC2 has been implicated in a wide variety of functions; however, the signals that regulate TORC2 activity have so far remained obscure. TORC2 has one known direct substrate, the AGC kinase Gad8, which is related to AKT in human cells. Gad8 is phosphorylated by TORC2 at Ser-546 (equivalent to AKT Ser-473), leading to its activation. Here, we show that glucose is necessary and sufficient to induce Gad8 Ser-546 phosphorylation in vivo and Gad8 kinase activity in vitro. The glucose signal that activates TORC2-Gad8 is mediated via the cAMP/PKA pathway, a major glucose-sensing pathway. By contrast, Pmk1, similar to human extracellular signal-regulated kinases and a major stress-induced mitogen activated protein kinase (MAPK) in fission yeast, inhibits TORC2-dependent Gad8 phosphorylation and activation. Inhibition of TORC2-Gad8 also occurs in response to ionic or osmotic stress, in a manner dependent on the cAMP/PKA and Pmk1-MAPK signaling pathways. Our findings highlight the significance of glucose availability in regulation of TORC2-Gad8 and indicate a novel link between the cAMP/PKA, Pmk1/MAPK, and TORC2-Gad8 signaling.	[Cohen, Adiel; Weisman, Ronit] Open Univ Israel, Dept Nat & Life Sci, IL-4353701 Ranana, Israel; [Kupiec, Martin] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Open University Israel; Tel Aviv University	Weisman, R (corresponding author), Open Univ Israel, Dept Nat & Life Sci, Univ Rd 1, IL-4353701 Ranana, Israel.	ronitwe@openu.ac.il	weisman, ronit/D-3741-2016; weisman, ronit/R-6969-2016		Association for International Research Grant [11-0281]; Open University of Israel Research Fund Grant [37076]	Association for International Research Grant; Open University of Israel Research Fund Grant	This work was supported by Association for International Research Grant 11-0281 and by Open University of Israel Research Fund Grant 37076 (to R. W.).	Barba G, 2008, CELL SIGNAL, V20, P748, DOI 10.1016/j.cellsig.2007.12.017; Busti S, 2010, SENSORS-BASEL, V10, P6195, DOI 10.3390/s100606195; Chen CH, 2013, J BIOL CHEM, V288, P27019, DOI 10.1074/jbc.M113.498055; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Halova L, 2013, J CELL BIOL, V203, P595, DOI 10.1083/jcb.201305103; Han TX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r60; Hayashi M, 2001, J BIOL CHEM, V276, P8631, DOI 10.1074/jbc.C000838200; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Higuchi T, 2002, MOL CELL BIOL, V22, P1, DOI 10.1128/MCB.22.1.1-11.2002; Hoffman CS, 2005, BIOCHEM SOC T, V33, P257, DOI 10.1042/BST0330257; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Ikai N, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110007; Ikeda K, 2008, CELL CYCLE, V7, P358, DOI 10.4161/cc.7.3.5245; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; JIN M, 1995, GENETICS, V140, P457; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Lang F, 2001, Sci STKE, V2001, pre17, DOI 10.1126/stke.2001.108.re17; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Laor D, 2014, MOL CELL BIOL, V34, P794, DOI 10.1128/MCB.01473-13; Liu PD, 2013, NAT CELL BIOL, V15, P1340, DOI 10.1038/ncb2860; Loewith R, 2011, BIOCHEM SOC T, V39, P437, DOI 10.1042/BST0390437; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Ma Y, 2006, MOL BIOL CELL, V17, P5028, DOI 10.1091/mbc.E06-08-0688; Madrid M, 2006, J BIOL CHEM, V281, P2033, DOI 10.1074/jbc.M506467200; Madrid M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-34; Matsuo T, 2003, EMBO J, V22, P3073, DOI 10.1093/emboj/cdg298; Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06; Matsuzawa T, 2012, EUKARYOT CELL, V11, P159, DOI 10.1128/EC.05268-11; MEGNET R, 1965, J BACTERIOL, V90, P1032, DOI 10.1128/JB.90.4.1032-1035.1965; MOCHIZUKI N, 1992, MOL GEN GENET, V233, P17, DOI 10.1007/BF00587556; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Partovian C, 2008, MOL CELL, V32, P140, DOI 10.1016/j.molcel.2008.09.010; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Rallis C, 2013, AGING CELL, V12, P563, DOI 10.1111/acel.12080; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sanchez-Mir L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088020; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schonbrun M, 2013, J BIOL CHEM, V288, P19649, DOI 10.1074/jbc.M113.464974; Schonbrun M, 2009, MOL CELL BIOL, V29, P4584, DOI 10.1128/MCB.01879-08; Sengar AS, 1997, MOL CELL BIOL, V17, P3508, DOI 10.1128/MCB.17.7.3508; Shimada K, 2013, MOL CELL, V51, P829, DOI 10.1016/j.molcel.2013.08.019; Stiefel J, 2004, EUKARYOT CELL, V3, P610, DOI 10.1128/EC.3.3.610-619.2004; Sugiura R, 2002, GENES CELLS, V7, P619, DOI 10.1046/j.1365-2443.2002.00557.x; Takahara T, 2012, GENES CELLS, V17, P698, DOI 10.1111/j.1365-2443.2012.01618.x; Tatebe H, 2010, CURR BIOL, V20, P1975, DOI 10.1016/j.cub.2010.10.026; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Valbuena N, 2012, J CELL SCI, V125, P2655, DOI 10.1242/jcs.098533; Valbuena N, 2012, J CELL SCI, V125, P1920, DOI 10.1242/jcs.094219; Weisman R, 2005, GENETICS, V169, P539, DOI 10.1534/genetics.104.034983; Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200; Weisman R, 1997, J BACTERIOL, V179, P6325, DOI 10.1128/jb.179.20.6325-6334.1997; Weisman R, 2007, GENETICS, V175, P1153, DOI 10.1534/genetics.106.064170; Welton RM, 2000, GENETICS, V156, P513; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xie JL, 2013, NAT CELL BIOL, V15, P1263, DOI 10.1038/ncb2877; Yanagida M, 2011, PHILOS T R SOC B, V366, P3508, DOI 10.1098/rstb.2011.0124	62	31	31	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21727	21737		10.1074/jbc.M114.573824	http://dx.doi.org/10.1074/jbc.M114.573824			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24928510	Green Published, hybrid			2022-12-25	WOS:000340558300046
J	Jiang, PY; Sun, K; Lun, FMF; Guo, AM; Wang, HT; Chan, KCA; Chiu, RWK; Lo, YMD; Sun, H				Jiang, Peiyong; Sun, Kun; Lun, Fiona M. F.; Guo, Andy M.; Wang, Huating; Chan, K. C. Allen; Chiu, Rossa W. K.; Lo, Y. M. Dennis; Sun, Hao			Methy-Pipe: An Integrated Bioinformatics Pipeline for Whole Genome Bisulfite Sequencing Data Analysis	PLOS ONE			English	Article							DNA-METHYLATION; READ ALIGNMENT; ULTRAFAST	DNA methylation, one of the most important epigenetic modifications, plays a crucial role in various biological processes. The level of DNA methylation can be measured using whole-genome bisulfite sequencing at single base resolution. However, until now, there is a paucity of publicly available software for carrying out integrated methylation data analysis. In this study, we implemented Methy-Pipe, which not only fulfills the core data analysis requirements (e.g. sequence alignment, differential methylation analysis, etc.) but also provides useful tools for methylation data annotation and visualization. Specifically, it uses Burrow-Wheeler Transform (BWT) algorithm to directly align bisulfite sequencing reads to a reference genome and implements a novel sliding window based approach with statistical methods for the identification of differentially methylated regions (DMRs). The capability of processing data parallelly allows it to outperform a number of other bisulfite alignment software packages. To demonstrate its utility and performance, we applied it to both real and simulated bisulfite sequencing datasets. The results indicate that Methy-Pipe can accurately estimate methylation densities, identify DMRs and provide a variety of utility programs for downstream methylation data analysis. In summary, Methy-Pipe is a useful pipeline that can process whole genome bisulfite sequencing data in an efficient, accurate, and user-friendly manner.	[Jiang, Peiyong; Sun, Kun; Lun, Fiona M. F.; Guo, Andy M.; Chan, K. C. Allen; Chiu, Rossa W. K.; Lo, Y. M. Dennis; Sun, Hao] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Shatin, Hong Kong, Peoples R China; [Jiang, Peiyong; Sun, Kun; Lun, Fiona M. F.; Guo, Andy M.; Chan, K. C. Allen; Chiu, Rossa W. K.; Lo, Y. M. Dennis; Sun, Hao] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; [Wang, Huating] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Sun, H (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Shatin, Hong Kong, Peoples R China.	haosun@cuhk.edu.hk	JIANG, Peiyong/AAZ-9898-2020; Sun, Hao/T-5576-2019; Sun, Hao/J-9964-2013; sun, hao/GRS-7732-2022; Wang, Huating/C-6719-2014; Lo, Yuk Ming Dennis/D-4468-2011; Sun, Kun/Q-6479-2018	Sun, Hao/0000-0002-5547-9501; Sun, Hao/0000-0002-5547-9501; Wang, Huating/0000-0001-5474-2905; Lo, Yuk Ming Dennis/0000-0001-8746-0293; Sun, Kun/0000-0002-9883-1616; Jiang, Peiyong/0000-0003-4523-3476	University Grants Committee of the Government of the Hong Kong Special Administrative Region, China, under the Areas of Excellence Scheme [AoE/M-04/06]; Hong Kong Research Grants Council General Research Fund [CUHK473713]; Li Ka Shing Foundation	University Grants Committee of the Government of the Hong Kong Special Administrative Region, China, under the Areas of Excellence Scheme; Hong Kong Research Grants Council General Research Fund(Hong Kong Research Grants Council); Li Ka Shing Foundation	This work is supported by the University Grants Committee of the Government of the Hong Kong Special Administrative Region, China, under the Areas of Excellence Scheme (AoE/M-04/06). The Hong Kong Research Grants Council General Research Fund (CUHK473713). Y.M.D. Lo was supported by an Endowed Chair from the Li Ka Shing Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R87, 10.1186/gb-2012-13-10-r87]; Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Benoukraf T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1281; Chan KC, 2013, P NATL ACAD SCI USA, DOI [10.1073/pnas.1317868110, DOI 10.1073/PNAS.1317868110]; Chen PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-203; Chim SSC, 2008, CLIN CHEM, V54, P500, DOI 10.1373/clinchem.2007.098731; Chiu RWK, 2007, AM J PATHOL, V170, P941, DOI 10.2353/ajpath.2007.060641; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Hansen KD, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r83, 10.1186/gb-2012-13-10-R83]; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lam TW, 2009, IEEE INT C BIOINFORM, P31, DOI 10.1109/BIBM.2009.42; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lim JQ, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r82, 10.1186/gb-2012-13-10-R82]; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lun FMF, 2013, CLIN CHEM, V59, P1583, DOI 10.1373/clinchem.2013.212274; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Ross JP, 2010, EPIGENOMICS-UK, V2, P245, DOI 10.2217/EPI.10.2; Schroeder DI, 2013, P NATL ACAD SCI USA, V110, P6037, DOI 10.1073/pnas.1215145110; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]	28	40	42	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100360	10.1371/journal.pone.0100360	http://dx.doi.org/10.1371/journal.pone.0100360			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945300	Green Published, gold, Green Submitted			2022-12-25	WOS:000340721500067
J	Oizumi, R				Oizumi, Ryo			Unification Theory of Optimal Life Histories and Linear Demographic Models in Internal Stochasticity	PLOS ONE			English	Article							PARTIAL-DIFFERENTIAL-EQUATIONS; OPTIMAL-GROWTH SCHEDULE; VISCOSITY SOLUTIONS; POPULATION-DYNAMICS; PROJECTION MODELS; MAXIMUM PRINCIPLE; NATURAL-SELECTION; SIZE; AGE; PLANT	Life history of organisms is exposed to uncertainty generated by internal and external stochasticities. Internal stochasticity is generated by the randomness in each individual life history, such as randomness in food intake, genetic character and size growth rate, whereas external stochasticity is due to the environment. For instance, it is known that the external stochasticity tends to affect population growth rate negatively. It has been shown in a recent theoretical study using path-integral formulation in structured linear demographic models that internal stochasticity can affect population growth rate positively or negatively. However, internal stochasticity has not been the main subject of researches. Taking account of effect of internal stochasticity on the population growth rate, the fittest organism has the optimal control of life history affected by the stochasticity in the habitat. The study of this control is known as the optimal life schedule problems. In order to analyze the optimal control under internal stochasticity, we need to make use of "Stochastic Control Theory" in the optimal life schedule problem. There is, however, no such kind of theory unifying optimal life history and internal stochasticity. This study focuses on an extension of optimal life schedule problems to unify control theory of internal stochasticity into linear demographic models. First, we show the relationship between the general age-states linear demographic models and the stochastic control theory via several mathematical formulations, such as path-integral, integral equation, and transition matrix. Secondly, we apply our theory to a two-resource utilization model for two different breeding systems: semelparity and iteroparity. Finally, we show that the diversity of resources is important for species in a case. Our study shows that this unification theory can address risk hedges of life history in general age-states linear demographic models.	Univ Tokyo, Grad Sch Math Sci, Tokyo, Japan	University of Tokyo	Oizumi, R (corresponding author), Univ Tokyo, Grad Sch Math Sci, Tokyo, Japan.	oizumi@ms.u-tokyo.ac.jp		Oizumi, Ryo/0000-0001-7813-1236	Japanese Society for the Promotion of Science (JSPS) for Scientic Research [B-21310152, B-23370006, C-22570011]	Japanese Society for the Promotion of Science (JSPS) for Scientic Research	This research was funded in part by Grants-in-Aid from the Japanese Society for the Promotion of Science (JSPS) for Scientic Research (nos. B-21310152, B-23370006 and C-22570011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASE KK, 1984, STOCH PROC APPL, V18, P81, DOI 10.1016/0304-4149(84)90163-7; Allen EJ, 2008, STOCH ANAL APPL, V26, P357, DOI 10.1080/07362990701857319; Allen Edward J., 2009, Journal of Biological Dynamics, V3, P73, DOI 10.1080/17513750802162754; BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; Boltyanskiy V., 1962, MATH THEORY OPTIMAL; Boyce MS, 2006, TRENDS ECOL EVOL, V21, P141, DOI 10.1016/j.tree.2005.11.018; Caswell H., 2006, MATRIX POPULATION MO; COHEN D, 1976, AM NAT, V110, P801, DOI 10.1086/283103; CRANDALL MG, 1992, B AM MATH SOC, V27, P1, DOI 10.1090/S0273-0979-1992-00266-5; CRANDALL MG, 1983, T AM MATH SOC, V277, P1, DOI 10.2307/1999343; Cushing J.M., 1998, SIAM; Diekmann O, 1986, DYNAMICS PHYSL STRUC, V68; Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.1890/0012-9658(2000)081[0694:SSSAAN]2.0.CO;2; Ellner SP, 2007, J MATH BIOL, V54, P227, DOI 10.1007/s00285-006-0044-8; Feller W, 1941, ANN MATH STAT, V12, P243, DOI 10.1214/aoms/1177731708; Figge F, 2004, BIODIVERS CONSERV, V13, P827, DOI 10.1023/B:BIOC.0000011729.93889.34; Goel N., 1974, STOCHASTIC MODELS BI; IWASA Y, 1984, THEOR POPUL BIOL, V25, P78, DOI 10.1016/0040-5809(84)90007-8; IWASA Y, 1989, AM NAT, V133, P480, DOI 10.1086/284931; IWASA Y, 1991, THEOR POPUL BIOL, V40, P246, DOI 10.1016/0040-5809(91)90055-K; JENSEN R, 1988, P AM MATH SOC, V102, P975, DOI 10.2307/2047344; JENSEN R, 1988, ARCH RATION MECH AN, V101, P1, DOI 10.1007/BF00281780; LANGLAIS M, 1988, J MATH BIOL, V26, P319, DOI 10.1007/BF00277394; Lauenroth WK, 2008, J ECOL, V96, P1023, DOI 10.1111/j.1365-2745.2008.01415.x; LEON JA, 1976, J THEOR BIOL, V60, P301, DOI 10.1016/0022-5193(76)90062-X; Lv QM, 2007, J THEOR BIOL, V244, P640, DOI 10.1016/j.jtbi.2006.09.009; MAC ARTHUR ROBERT H., 1967; Morimoto H, 1993, STOCHASTIC CONTROL M; Morris WF, 2008, ECOLOGY, V89, P19, DOI 10.1890/07-0774.1; Oizumi R, 2013, J THEOR BIOL, V323, P76, DOI 10.1016/j.jtbi.2013.01.020; Oksendal B, 2003, STOCHASTIC DIFFERENT; Peng S., 1992, STOCH STOCH REP, V38, P119, DOI [/10.1080/17442509208833749, DOI 10.1080/17442509208833749]; PENG SG, 1990, SIAM J CONTROL OPTIM, V28, P966, DOI 10.1137/0328054; PIANKA ER, 1976, AM ZOOL, V16, P775; Salguero-Gomez R, 2010, J ECOL, V98, P250, DOI 10.1111/j.1365-2745.2009.01635.x; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Suzuki M, 2000, TREE PHYSIOL, V20, P203; TAKADA T, 1994, J MATH BIOL, V32, P789, DOI 10.1007/BF00168798; TAYLOR HM, 1974, THEOR POPUL BIOL, V5, P104, DOI 10.1016/0040-5809(74)90053-7; TULJAPURKAR SD, 1982, THEOR POPUL BIOL, V21, P141, DOI 10.1016/0040-5809(82)90010-7; Webb GF, 2008, LECT NOTES MATH, V1936, P1; Yong J., 1999, STOCHASTIC CONTROLS, V43	42	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e98746	10.1371/journal.pone.0098746	http://dx.doi.org/10.1371/journal.pone.0098746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945258	gold, Green Submitted, Green Published			2022-12-25	WOS:000340721500006
J	Omidbakhsh, N; Ahmadpour, F; Kenny, N				Omidbakhsh, Navid; Ahmadpour, Faraz; Kenny, Nicole			How Reliable Are ATP Bioluminescence Meters in Assessing Decontamination of Environmental Surfaces in Healthcare Settings?	PLOS ONE			English	Article							HYGIENE; SANITIZERS	Background: Meters based on adenosine triphosphate (ATP) bioluminescence measurements in relative light units (RLU) are often used to rapidly assess the level of cleanliness of environmental surfaces in healthcare and other settings. Can such ATP measurements be adversely affected by factors such as soil and cleaner-disinfectant chemistry? Objective: This study tested a number of leading ATP meters for their sensitivity, linearity of the measurements, correlation of the readings to the actual microbial contamination, and the potential disinfectant chemicals' interference in their readings. Methods: First, solutions of pure ATP in various concentrations were used to construct a standard curve and determine linearity and sensitivity. Serial dilutions of a broth culture of Staphylococcus aureus, as a representative nosocomial pathogen, were then used to determine if a given meter's ATP readings correlated with the actual CFUs. Next, various types of disinfectant chemistries were tested for their potential to interfere with the standard ATP readings. Results: All four ATP meters tested herein demonstrated acceptable linearity and repeatability in their readings. However, there were significant differences in their sensitivity to detect the levels of viable microorganisms on experimentally contaminated surfaces. Further, most disinfectant chemistries tested here quenched the ATP readings variably in different ATP meters evaluated. Conclusions: Apart from their limited sensitivity in detecting low levels of microbial contamination, the ATP meters tested were also prone to interference by different disinfectant chemistries.	[Omidbakhsh, Navid; Ahmadpour, Faraz] Virox Technol Inc, Res & Dev, Oakville, ON, Canada; [Kenny, Nicole] Virox Technol Inc, Profess & Tech Serv, Oakville, ON, Canada		Omidbakhsh, N (corresponding author), Virox Technol Inc, Res & Dev, Oakville, ON, Canada.	navid.omidbakhsh@gmail.com		Ahmadpour, Faraz/0000-0002-3861-1224	Virox Technologies Inc.	Virox Technologies Inc.	The authors have the following interests: This study was funded by Virox Technologies Inc. Two of the authors (Faraz Ahmadpour and Nicole Kenny) are employed by Virox Technologies Inc. The third author, Navid Omidbakhsh, used to be an employee of Virox Technologies at the time of submitting this manuscript, but not anymore. The authors hold the following patents, which are owned by Virox Technologies: Hydrogen peroxide disinfectant with increased activity US 6,346,279, US 6,803,057 (CIP), EP 1139762 B1, CA 2344471, AU 741104, AT225128, BR9915987, DE69903347, JP3350526. Enhanced activity hydrogen peroxide disinfectant US 7,632,523, NZ0534352A, AU3245498 AA, CA2475327, EP1473998A1. Enhanced activity hydrogen peroxide disinfectant 13/410737. Hydrogen Peroxide Disinfectant Containing a Cyclic Carboxylic acid and/or an Aromatic Alcohol US 7,354,604, EP1562430B1, CA2503627AA, AU 2003302067, JP 4813059. Hydrogen Peroxide Disinfectant Containing a Cyclic Carboxylic acid and/or an Aromatic Alcohol EP 1 955 593 B1. Low foaming hydrogen peroxide solutions for organic soils US 6,686,324, CA 23661741, CA 2454437. Hydrogen peroxide-based skin disinfectant 13/022683, NZ 550744, AU2005244462, CA 2564763. Antimicrobial compositions 60/955,991, WO 2009021336, EP2182811A1. Concentrated Hydrogen Peroxide disinfecting solutions US 8,591,958 B2, CA 2,733,644, 09817139.0, EP2329002B1, NZ 591314, 2011-528154. Virox is the creator and manufacturer of cleaning and disinfecting chemicals based on our patented accelerated hydrogen peroxide technology. Virox is not directly or indirectly associated with the sale or support ATP meters. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Anderson RE, 2011, J HOSP INFECT, V78, P178, DOI 10.1016/j.jhin.2011.01.030; Bellamy E., 2012, Journal of Infection Prevention, V13, P154; Brown E, 2010, J HOSP INFECT, V74, P193, DOI 10.1016/j.jhin.2009.10.006; Carrick K, 2001, J I BREWING, V107, P31, DOI 10.1002/j.2050-0416.2001.tb00077.x; Chen FC, 2006, J FOOD PROTECT, V69, P2534, DOI 10.4315/0362-028X-69.10.2534; Dancer SJ, 2009, J HOSP INFECT, V73, P378, DOI 10.1016/j.jhin.2009.03.030; Dancer SJ, 1999, J HOSP INFECT, V43, P85, DOI 10.1053/jhin.1999.0616; Green T, 1998, J FOOD; Green TA, 1999, J FOOD PROTECT, V62, P86, DOI 10.4315/0362-028X-62.1.86; Griffith CJ, 2000, J HOSP INFECT, V45, P19, DOI 10.1053/jhin.1999.0717; Hassan Mahmud, 2010, Hosp Top, V88, P82, DOI 10.1080/00185868.2010.507124; Havill NL, 2011, AM J INFECT CONTROL, V39, P602, DOI 10.1016/j.ajic.2010.10.030; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Leon M. B., 2007, Journal of Foodservice, V18, P145, DOI 10.1111/j.1745-4506.2007.00060.x; Lewis T, 2008, J HOSP INFECT, V69, P156, DOI 10.1016/j.jhin.2008.03.013; Moore G, 2012, AM J INFECT CONTROL, V37, P1; Mubiru DN, 2008, ANAL LETT, V41, P2587, DOI 10.1080/00032710802363339; Mulvey D, 2011, J HOSP INFECT, V77, P25, DOI 10.1016/j.jhin.2010.08.006; Murphy SC, 1998, J DAIRY SCI, V81, P817, DOI 10.3168/jds.S0022-0302(98)75639-5; Rampling A, 2001, J HOSP INFECT, V49, P109, DOI 10.1053/jhin.2001.1013; Sciortino CV, 2012, AM J INFECT CONTROL, V40, pE233, DOI 10.1016/j.ajic.2012.04.318; Turner D, 2010, J AM; Velazquez M, 1997, J FOOD PROTECT, V60, P799, DOI 10.4315/0362-028X-60.7.799; Velusamy V, 2010, BIOTECHNOL ADV, V28, P232, DOI 10.1016/j.biotechadv.2009.12.004	24	48	52	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99951	10.1371/journal.pone.0099951	http://dx.doi.org/10.1371/journal.pone.0099951			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940751	Green Published, gold, Green Submitted			2022-12-25	WOS:000338508200059
J	Shiner, EK; Holbrook, BC; Alexander-Miller, MA				Shiner, Erin K.; Holbrook, Beth C.; Alexander-Miller, Martha A.			CD4(+) T Cell Subset Differentiation and Avidity Setpoint Are Dictated by the Interplay of Cytokine and Antigen Mediated Signals	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASES; E3 UBIQUITIN LIGASE; IN-VIVO; INTERLEUKIN-4 IL-4; ADAPTIVE TOLERANCE; TH17 RESPONSE; RECEPTOR; ACTIVATION; EXPRESSION; ANERGY	CD4(+) T cell differentiation has been shown to be regulated by the cytokine milieu present during activation as well as peptide MHC levels. However, the extent to which these two important regulatory signals work in concert to shape CD4(+) T cell function has not been investigated. Using a murine OT-II transgenic TCR model of in vitro differentiation, we demonstrate that the ability of CD4(+) T cells to commit to a distinct lineage, i.e. Th1 vs. Th2 vs. Th17, is restricted by the amount of peptide antigen present in the stimulating environment. In addition, whether cells succumb to inhibitory effects associated with high dose antigen is dependent on the array of cytokine signals encountered. Specifically, stimulation with high dose antigen in Th1 or Th17 conditions promoted efficient generation of functional cells, while Th2 polarizing conditions did not. Finally, we found that the peptide sensitivity of an effector cell was determined by the combined actions of cytokine and peptide level, with Th1 cells exhibiting the highest avidity, followed by Th17 and Th2 cells. Together, these data show that the interplay of antigen and cytokine signals shape both the differentiation fate and avidity setpoint of CD4(+) T cells.	[Holbrook, Beth C.; Alexander-Miller, Martha A.] Wake Forest Sch Med, Sect Rheumatol & Immunol, Dept Microbiol & Immunol, Winston Salem, NC 27157 USA; [Shiner, Erin K.] Wake Forest Sch Med, Sect Rheumatol & Immunol, Dept Internal Med, Winston Salem, NC USA	Wake Forest University; Wake Forest University	Alexander-Miller, MA (corresponding author), Wake Forest Sch Med, Sect Rheumatol & Immunol, Dept Microbiol & Immunol, Winston Salem, NC 27157 USA.	marthaam@wakehealth.edu		Holbrook, Beth/0000-0001-6026-695X	NIH [R01 AI043591]; Department of Internal Medicine at Wake Forest University School of Medicine; Department of Microbiology and Immunology at Wake Forest University School of Medicine; NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Internal Medicine at Wake Forest University School of Medicine; Department of Microbiology and Immunology at Wake Forest University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant R01 AI043591 (M. A. A.-M.) and by funds provided by the Department of Internal Medicine and the Department of Microbiology and Immunology at Wake Forest University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander-Miller MA, 2005, IMMUNOL RES, V31, P13, DOI 10.1385/IR:31:1:13; AlexanderMiller MA, 1996, P NATL ACAD SCI USA, V93, P4102, DOI 10.1073/pnas.93.9.4102; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Balamuth F, 2001, IMMUNITY, V15, P729, DOI 10.1016/S1074-7613(01)00223-0; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Brown DM, 2006, J IMMUNOL, V177, P2888, DOI 10.4049/jimmunol.177.5.2888; Cawthon AG, 2002, J IMMUNOL, V169, P3492, DOI 10.4049/jimmunol.169.7.3492; Cawthon AG, 2001, J IMMUNOL, V167, P2577, DOI 10.4049/jimmunol.167.5.2577; Chiodetti L, 2006, J IMMUNOL, V176, P2279, DOI 10.4049/jimmunol.176.4.2279; Choi S, 2007, SEMIN IMMUNOL, V19, P140, DOI 10.1016/j.smim.2007.02.005; CONNORS M, 1994, J VIROL, V68, P5321, DOI 10.1128/JVI.68.8.5321-5325.1994; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Derby MA, 2001, J IMMUNOL, V166, P1690, DOI 10.4049/jimmunol.166.3.1690; Dienz O, 2009, CLIN IMMUNOL, V130, P27, DOI 10.1016/j.clim.2008.08.018; GAJEWSKI TF, 1990, J IMMUNOL, V144, P4110; Gallimore A, 1998, J EXP MED, V187, P1647; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Jorritsma PJ, 2003, J IMMUNOL, V170, P2427, DOI 10.4049/jimmunol.170.5.2427; Kroger CJ, 2007, IMMUNOLOGY, V122, P167, DOI 10.1111/j.1365-2567.2007.02622.x; Kroger CJ, 2007, J IMMUNOL, V179, P748, DOI 10.4049/jimmunol.179.2.748; McGeachy MJ, 2012, J IMMUNOL, V189, P3285, DOI 10.4049/jimmunol.1201834; McKinstry KK, 2012, J CLIN INVEST, V122, P2847, DOI 10.1172/JCI63689; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Muranski P, 2011, IMMUNITY, V35, P972, DOI 10.1016/j.immuni.2011.09.019; Nakayama T, 2010, SEMIN IMMUNOL, V22, P303, DOI 10.1016/j.smim.2010.04.010; Neveu B, 2008, HEPATOLOGY, V48, P713, DOI 10.1002/hep.22379; Oling V, 2010, AUTOIMMUNITY, V43, P573, DOI 10.3109/08916930903540424; Purvis HA, 2010, BLOOD, V116, P4829, DOI 10.1182/blood-2010-03-272153; QUILL H, 1992, J IMMUNOL, V149, P2887; Ranasinghe C, 2009, EUR J IMMUNOL, V39, P1819, DOI 10.1002/eji.200838995; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Sedlik C, 2000, J VIROL, V74, P5769, DOI 10.1128/JVI.74.13.5769-5775.2000; Seroogy CM, 2004, J IMMUNOL, V173, P79, DOI 10.4049/jimmunol.173.1.79; SloanLancaster J, 1997, J IMMUNOL, V159, P1160; Strutt TM, 2010, NAT MED, V16, P558, DOI 10.1038/nm.2142; TAMURA T, 1995, J IMMUNOL, V155, P4692; Thauland TJ, 2008, J IMMUNOL, V181, P393, DOI 10.4049/jimmunol.181.1.393; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Vella A, 1997, J EXP MED, V186, P325, DOI 10.1084/jem.186.2.325; Waite JC, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/819467; Wurster AL, 2002, MOL CELL BIOL, V22, P117, DOI 10.1128/MCB.22.1.117-126.2002; Yamashita M, 2000, J EXP MED, V191, P1869, DOI 10.1084/jem.191.11.1869; Yee C, 1999, J IMMUNOL, V162, P2227; Yoo JK, 2002, J IMMUNOL, V169, P3637, DOI 10.4049/jimmunol.169.7.3637; Zeh HJ, 1999, J IMMUNOL, V162, P989; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	53	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100175	10.1371/journal.pone.0100175	http://dx.doi.org/10.1371/journal.pone.0100175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940899	gold, Green Submitted, Green Published			2022-12-25	WOS:000338508200081
J	Daw, MA; Shabash, A; El-Bouzedi, A; Dau, AA				Daw, Mohamed A.; Shabash, Amira; El-Bouzedi, Abdallah; Dau, Aghnya A.		Libyan Study Grp Hepatitis HIV	Seroprevalence of HBV, HCV & HIV Co-Infection and Risk Factors Analysis in Tripoli-Libya	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; SUB-SAHARAN AFRICA; B-VIRUS; BLOOD-DONORS; MIDDLE-EAST; DRUG-USERS; INFECTION; PREVALENCE; EPIDEMIOLOGY; POPULATION	Background: In 1998 Libya experienced a major outbreak of multiple blood borne viral hepatitis and HIV infections. Since then, no studies have been done on the epidemic features and risk factors of HBV, HCV, HIV and co-infection among the general population. Methods: A prospective study was carried out using a multi-centre clustering method to collect samples from the general population. The participants were interviewed, and relevant information was collected, including socio-demographic, ethnic, and geographic variables. This information was correlated with the risk factors involved in the transmission of HBV, HCV and HIV. Blood samples were collected and the sera were tested for HBsAg, anti-HCV and anti-HIV using enzyme immunoassay. Results: A total of 9,170 participants from the nine districts of Tripoli were enrolled. The average prevalence of HBsAg was 3.7%, anti-HCV 0.9%, anti-HIV 0.15% and co-infection 0.02%. The prevalence varied from one district to another. HBV was more prevalent among those aged over 50 years and was associated with family history. Anti-HCV and anti-HIV were more prevalent among those aged 20-40 years. Intravenous drug use and blood transfusion were the main risk factors for HCV and HIV infection. Conclusion: HBV, HCV, HIV and co-infection are relatively common in Libya. High prevalence was associated with geographic, ethnic and socioeconomic variability within the community. HCV and HIV infections among the younger age groups are becoming an alarming issue. Regulations and health care education need to be implemented and longer term follow-up should be planned.	[Daw, Mohamed A.; Shabash, Amira] Fac Med, Dept Med Microbiol, Tripoli, Libya; [El-Bouzedi, Abdallah] Fac Biotechnol, Dept Lab Med, Tripoli, Libya; [Daw, Mohamed A.; Dau, Aghnya A.] Tripoli Med Ctr, Dept Surg, Fac Med, Tripoli, Libya		Daw, MA (corresponding author), Fac Med, Dept Med Microbiol, Tripoli, Libya.	mohamedadaw@gmail.com						Abu-Raddad LJ, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000386729.56683.33; Bagasra Omar, 2007, Libyan J Med, V2, P57, DOI 10.4176/070221; Baha W, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-50; Barth RE, 2010, INT J INFECT DIS, V14, pE1024, DOI 10.1016/j.ijid.2010.06.013; Ben Halima S, 2010, N AFRICA VIROL J, V15, P7; Breban R, 2013, J VIRAL HEPATITIS, V20, P294, DOI 10.1111/j.1365-2893.2012.01650.x; Cacoub P, 2000, GASTROEN CLIN BIOL, V24, P169; Dau AA, 2013, E MEDITERR HEALTH J, V19, P4; Daw MA, 2008, LIBYAN J MED, V3, P1, DOI 10.4176/071208; Daw MA, 2002, SAUDI MED J, V23, P1356; Daw MA, 2001, ANN SAUDI MED, V21, P130, DOI 10.5144/0256-4947.2001.130a; Daw MA, 2000, SAUDI MED J, V21, P1157; Daw MA, 2013, VIROLOGY DISCOVERY, V1, P3; Daw MA, 2014, MENTAL DISORDER; Daw MA, 2013, TRACING MODELLING HI, P2874; Daw MA, 2012, SCI WORLD J, V2012; Daw MA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-17; Daw MA, 2012, SCI WORLD J, DOI 10.1100/2012/719494; de Oliveira T, 2006, NATURE, V444, P836, DOI 10.1038/444836a; El-Sherif A, 2009, J GASTROENTEROL, V44, P359, DOI 10.1007/s00535-009-0020-3; Elasifer HA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-317; Ezzikouri S, 2013, J MED VIROL, V85, P1542, DOI 10.1002/jmv.23643; Ezzikouri S, 2013, LIVER INT, V33, P811, DOI 10.1111/liv.12135; Feuth T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059302; Garcia-Calleja JM, 2006, SEX TRANSM INFECT, V82, pIII64, DOI 10.1136/sti.2006.019901; Hatzakis A, 2013, J VIRAL HEPATITIS, V20, P1, DOI 10.1111/jvh.12120; Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4; Jobarteh M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-230; Karatapanis S, 2012, EUR J GASTROEN HEPAT, V24, P878, DOI 10.1097/MEG.0b013e328354834f; Karoney MJ, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.44.2199; MA Daw, 2014, HEPATITIS C VIRUS MO; Maaref F, 2011, PATHOL BIOL, V59, P213, DOI 10.1016/j.patbio.2009.10.004; Mejri S, 2005, J MED VIROL, V76, P185, DOI 10.1002/jmv.20342; Modi AA, 2007, AIDS REV, V9, P25; Mohamoud YA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-288; Muehlberger N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-34; Mumtaz G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000444; Perrin Luc, 2007, Libyan J Med, V2, P55, DOI 10.4176/070219; Quan VM, 2009, AIDS CARE, V21, P7, DOI 10.1080/09540120802017610; Rebbani K, 2013, CLIN MICROBIOL INFEC, V19, pE454, DOI 10.1111/1469-0691.12252; Romano L, 2013, BLOOD TRANSFUS-ITALY, V11, P281, DOI 10.2450/2012.0160-12; Rouabhia S, 2013, WORLD J HEPATOL, V5, P393, DOI 10.4254/wjh.v5.i7.393; Rouabhia S, 2010, WORLD J GASTROENTERO, V16, P3427, DOI 10.3748/wjg.v16.i27.3427; ROUDIFAHIMI F, 2007, TIME INTERVENE PREVE; Rusine J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063303; Schreuder I, 2010, HARM REDUCT J, V7, DOI 10.1186/1477-7517-7-25; Shawky S, 2009, JAIDS-J ACQ IMM DEF, V51, pS83, DOI 10.1097/QAI.0b013e3181aafd3f; Singal AK, 2009, WORLD J GASTROENTERO, V15, P3713, DOI 10.3748/wjg.15.3713	48	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e98793	10.1371/journal.pone.0098793	http://dx.doi.org/10.1371/journal.pone.0098793			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936655	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400010
J	Determan, C; Anderson, R; Becker, A; Witowski, N; Lusczek, E; Mulier, K; Beilman, GJ				Determan, Charles, Jr.; Anderson, Rebecca; Becker, Aaron; Witowski, Nancy; Lusczek, Elizabeth; Mulier, Kristine; Beilman, Greg J.			Fed State Prior to Hemorrhagic Shock and Polytrauma in a Porcine Model Results in Altered Liver Transcriptomic Response	PLOS ONE			English	Article							CELL-VOLUME REGULATION; NO-REFLOW PHENOMENON; ISCHEMIA-REPERFUSION INJURY; COMBAT CASUALTY CARE; HYPERTONIC SALINE; MYOCARDIAL-ISCHEMIA; GENE-EXPRESSION; HYDRATION STATE; TISSUE-DAMAGE; RESUSCITATION	Hemorrhagic shock is a leading cause of trauma-related mortality in both civilian and military settings. Resuscitation often results in reperfusion injury and survivors are susceptible to developing multiple organ failure (MOF). The impact of fed state on the overall response to shock and resuscitation has been explored in some murine models but few clinically relevant large animal models. We have previously used metabolomics to establish that the fed state results in a different metabolic response in the porcine liver following hemorrhagic shock and resuscitation. In this study, we used our clinically relevant model of hemorrhagic shock and polytrauma and the Illumina HiSeq platform to determine if the liver transcriptomic response is also altered with respect to fed state. Functional analysis of the response to shock and resuscitation confirmed several typical responses including carbohydrate metabolism, cytokine inflammation, decreased cholesterol synthesis, and apoptosis. Our findings also suggest that the fasting state, relative to a carbohydrate prefed state, displays decreased carbohydrate metabolism, increased cytoskeleton reorganization and decreased inflammation in response to hemorrhagic shock and reperfusion. Evidence suggests that this is a consequence of a shrunken, catabolic state of the liver cells which provides an anti-inflammatory condition that partially mitigates hepatocellar damage.	[Determan, Charles, Jr.; Anderson, Rebecca; Becker, Aaron; Witowski, Nancy; Lusczek, Elizabeth; Mulier, Kristine; Beilman, Greg J.] Univ Minnesota, Dept Surg, Div Crit Care & Acute Care Surg, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Determan, C (corresponding author), Univ Minnesota, Dept Surg, Div Crit Care & Acute Care Surg, Box 242 UMHC, Minneapolis, MN 55455 USA.	deter088@umn.edu		Lusczek, Elizabeth/0000-0003-4680-965X; Beilman, Gregory/0000-0001-5036-3027	University of Minnesota Department of Surgery Grant; Office of Naval Research [N00014-09-1-0323 P00005]	University of Minnesota Department of Surgery Grant; Office of Naval Research(Office of Naval Research)	This work was funding by the University of Minnesota Department of Surgery Grant and the Office of Naval Research (N00014-09-1-0323 P00005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angele MK, 2008, CRIT CARE, V12, DOI 10.1186/cc6919; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bahrami S, 2006, SHOCK, V25, P283, DOI 10.1097/01.shk.0000208808.03148.ea; Benkhart EM, 2000, J IMMUNOL, V165, P1612, DOI 10.4049/jimmunol.165.3.1612; Benkoel L, 2001, DIGEST DIS SCI, V46, P1663, DOI 10.1023/A:1010693218680; Cinel I, 2009, CRIT CARE MED, V37, P291, DOI 10.1097/CCM.0b013e31819267fb; Coimbra R, 1997, J TRAUMA, V42, P602, DOI 10.1097/00005373-199704000-00004; Determan CE, 2014, METABOLOMICS, V10, P950, DOI 10.1007/s11306-014-0621-6; Dubick Michael A, 2011, US Army Med Dep J, P18; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; FLORES J, 1972, J MEMBRANE BIOL, V10, P331, DOI 10.1007/BF01867864; Gatsios P, 1998, J BIOL CHEM, V273, P22962, DOI 10.1074/jbc.273.36.22962; GAUSSIN V, 1992, BIOCHEM J, V287, P17, DOI 10.1042/bj2870017; GAVIN JB, 1983, VIRCHOWS ARCH A, V399, P325, DOI 10.1007/BF00612950; HAUSSINGER D, 1994, AM J PHYSIOL, V267, pE343, DOI 10.1152/ajpendo.1994.267.3.E343; HAUSSINGER D, 1993, LANCET, V341, P1330, DOI 10.1016/0140-6736(93)90828-5; Haussinger D, 1996, BIOCHEM J, V313, P697; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Holcomb JB, 2006, J TRAUMA, V60, P397, DOI 10.1097/01.ta.0000203581.75241.f1; Holcomb JB, 1999, J TRAUMA, V46, P49, DOI 10.1097/00005373-199901000-00009; Holcomb John, 2007, US Army Med Dep J, P24; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iyegha UP, 2012, J AM COLL SURGEONS, V215, pS52, DOI 10.1016/j.jamcollsurg.2012.06.152; Ke QH, 2006, DIGEST DIS SCI, V51, P2257, DOI 10.1007/s10620-006-9135-6; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; LEAF A, 1973, CIRCULATION, V48, P455, DOI 10.1161/01.CIR.48.3.455; Lexcen DR, 2012, J TRAUMA ACUTE CARE, V73, pS147, DOI 10.1097/TA.0b013e3182609821; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lusczek ER, 2013, METABOLOMICS, V9, P223, DOI 10.1007/s11306-012-0441-5; MANCIET LH, 1994, AM J PHYSIOL, V266, pH1541, DOI 10.1152/ajpheart.1994.266.4.H1541; Molitoris BA, 1997, AM J PHYSIOL-RENAL, V272, pF430, DOI 10.1152/ajprenal.1997.272.4.F430; Murao Y, 2003, SHOCK, V20, P23, DOI 10.1097/01.shk.0000078832.57685.6c; Oreopoulos GD, 2004, HEPATOLOGY, V40, P211, DOI 10.1002/hep.20281; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Pedersen SF, 2001, COMP BIOCHEM PHYS A, V130, P385, DOI 10.1016/S1095-6433(01)00429-9; Peitzman A B, 1995, Curr Probl Surg, V32, P925, DOI 10.1016/S0011-3840(05)80008-5; Rezkalla SH, 2002, CIRCULATION, V105, P656, DOI 10.1161/hc0502.102867; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scribner DM, 2010, J SURG RES, V164, pE131, DOI 10.1016/j.jss.2010.07.046; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; THEODOROPOULOS PA, 1992, FEBS LETT, V311, P241, DOI 10.1016/0014-5793(92)81111-X; TRANUMJENSEN J, 1981, CIRC RES, V49, P364, DOI 10.1161/01.RES.49.2.364; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsan MF, 2004, AM J PHYSIOL-CELL PH, V286, pC739, DOI 10.1152/ajpcell.00364.2003; Yoshidome H, 1999, HEPATOLOGY, V30, P203, DOI 10.1002/hep.510300120	50	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100088	10.1371/journal.pone.0100088	http://dx.doi.org/10.1371/journal.pone.0100088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937255	Green Published, Green Submitted, gold			2022-12-25	WOS:000338503400071
J	Dutta, B; Gitaitis, R; Smith, S; Langston, D				Dutta, Bhabesh; Gitaitis, Ronald; Smith, Samuel; Langston, David, Jr.			Interactions of Seedborne Bacterial Pathogens with Host and Non-Host Plants in Relation to Seed Infestation and Seedling Transmission	PLOS ONE			English	Article							AVENAE SUBSP CITRULLI; CAMPESTRIS PV VESICATORIA; ACIDOVORAX-AVENAE; XANTHOMONAS-CAMPESTRIS; TOMATO; COLONIZATION; WATERMELON; SURVIVAL; ASSOCIATION; DISEASE	The ability of seed-borne bacterial pathogens (Acidovorax citrulli, Clavibacter michiganensis subsp. michiganensis, Pseudomonas syringae pv. tomato, Xanthomonas euvesicatoria, and Pseudomonas syringae pv. glycinea) to infest seeds of host and non-host plants (watermelon, tomato, pepper, and soybean) and subsequent pathogen transmission to seedlings was investigated. A non-pathogenic, pigmented strain of Serratia marcescens was also included to assess a null-interacting situation with the same plant species. Flowers of host and non-host plants were inoculated with 1x10(6) colony forming units (CFUs)/flower for each bacterial species and allowed to develop into fruits or umbels (in case of onion). Seeds harvested from each host/non-host bacterial species combination were assayed for respective bacteria by plating on semi-selective media. Additionally, seedlots for each host/non-host bacterial species combination were also assayed for pathogen transmission by seedling grow-out (SGO) assays under greenhouse conditions. The mean percentage of seedlots infested with compatible and incompatible pathogens was 31.7 and 30.9% (by plating), respectively and they were not significantly different (P = 0.67). The percentage of seedlots infested with null-interacting bacterial species was 16.8% (by plating) and it was significantly lower than the infested lots generated with compatible and incompatible bacterial pathogens (P = 0.03). None of the seedlots with incompatible/null-interacting bacteria developed symptoms on seedlings; however, when seedlings were assayed for epiphytic bacterial presence, 19.5 and 9.4% of the lots were positive, respectively. These results indicate that the seeds of non-host plants can become infested with incompatible and null-interacting bacterial species through flower colonization and they can be transmitted via epiphytic colonization of seedlings. In addition, it was also observed that flowers and seeds of non-host plants can be colonized by compatible/incompatible/null-interacting bacteria to higher populations; however, the level of colonization differed significantly depending on the type of bacterial species used.	[Dutta, Bhabesh; Gitaitis, Ronald; Smith, Samuel; Langston, David, Jr.] Univ Georgia, Coastal Plain Expt Stn, Dept Plant Pathol, Tifton, GA 31793 USA	University System of Georgia; University of Georgia	Dutta, B (corresponding author), Univ Georgia, Coastal Plain Expt Stn, Dept Plant Pathol, Tifton, GA 31793 USA.	bhabesh@uga.edu		Dutta, Bhabesh/0000-0001-9841-257X	Georgia Agricultural Commodity Commission for Vegetables [2631RE682316]; Vidalia Onion Commission [2521RF332621]	Georgia Agricultural Commodity Commission for Vegetables; Vidalia Onion Commission	This work was supported in part by Georgia Agricultural Commodity Commission for Vegetables (Grant# 2631RE682316). The additional funding for this project came from Vidalia Onion Commission (Grant#2521RF332621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNAUDSANTANA E, 1991, PLANT DIS, V75, P952, DOI 10.1094/PD-75-0952; Assouline I, 1997, PHYTOPARASITICA, V25, P117, DOI 10.1007/BF02981192; Bach HJ, 2003, J MICROBIOL METH, V52, P85, DOI 10.1016/S0167-7012(02)00152-5; Burdman S, 2012, MOL PLANT PATHOL, V13, P805, DOI 10.1111/j.1364-3703.2012.00810.x; COOK AA, 1952, PHYTOPATHOLOGY, V42, P316; Cook KA, 2005, J ECON ENTOMOL, V98, P673, DOI 10.1603/0022-0493-98.3.673; Darrasse A, 2010, APPL ENVIRON MICROB, V76, P6787, DOI 10.1128/AEM.01098-10; Darsonval A, 2008, APPL ENVIRON MICROB, V74, P2669, DOI 10.1128/AEM.02906-07; Dutta B, 2014, PHYTOPATHOLOGY, V104, P232, DOI 10.1094/PHYTO-05-13-0138-R; Dutta B, 2013, SEED SCI TECHNOL, V41, P383, DOI 10.15258/sst.2013.41.3.06; Dutta B, 2012, PHYTOPATHOLOGY, V102, P461, DOI 10.1094/PHYTO-10-11-0286-R; Fessehaie A, 2005, PHYTOPATHOLOGY, V95, P413, DOI 10.1094/PHYTO-95-0413; FETT WF, 1979, PLANT DIS REP, V63, P79; GIBSON S, 1978, J CLIN MICROBIOL, V7, P279; Gilbertson R. L., 1992, Plant diseases of international importance. Volume II. Diseases of vegetables and oil seed crops.., P18; GITAITIS R, 1992, PLANT DIS, V76, P651, DOI 10.1094/PD-76-0651; Gitaitis R, 1998, PLANT DIS, V82, P935, DOI 10.1094/PDIS.1998.82.8.935; GITAITIS RD, 1978, PHYTOPATHOLOGY, V68, P227, DOI 10.1094/Phyto-68-227; GITAITIS RD, 1991, PLANT DIS, V75, P834, DOI 10.1094/PD-75-0834; Gitaitis R, 2007, ANNU REV PHYTOPATHOL, V45, P371, DOI 10.1146/annurev.phyto.45.062806.094321; GLEASON ML, 1993, PLANT DIS, V77, P1069, DOI 10.1094/PD-77-1069; Ha Y, 2009, PHYTOPATHOLOGY, V99, P666, DOI 10.1094/PHYTO-99-6-0666; Hopkins DL, 2002, HORTSCIENCE, V37, P924, DOI 10.21273/HORTSCI.37.6.924; Johnson KL, 2011, PLANT DIS, V95, P697, DOI 10.1094/PDIS-09-10-0660; Jones JB, 2000, INT J SYST EVOL MICR, V50, P1211, DOI 10.1099/00207713-50-3-1211; Jones JB, 2004, SYST APPL MICROBIOL, V27, P755, DOI 10.1078/0723202042369884; JONES JB, 1986, PHYTOPATHOLOGY, V76, P430, DOI 10.1094/Phyto-76-430; KAUFFMAN PH, 1974, PHYTOPATHOLOGY, V64, P329, DOI 10.1094/Phyto-64-329; LAMKA GL, 1991, PHYTOPATHOLOGY, V81, P839, DOI 10.1094/Phyto-81-839; MCCARTER SM, 1983, PHYTOPATHOLOGY, V73, P1393, DOI 10.1094/Phyto-73-1393; Nelson EB, 2004, ANNU REV PHYTOPATHOL, V42, P271, DOI 10.1146/annurev.phyto.42.121603.131041; RANE KK, 1992, PLANT DIS, V76, P509, DOI 10.1094/PD-76-0509; ROBERTS DP, 1994, PLANT SCI, V101, P83, DOI 10.1016/0168-9452(94)90167-8; Schaad NW, 2008, SYST APPL MICROBIOL, V31, P434, DOI 10.1016/j.syapm.2008.09.003; SCHAAD NW, 1981, PHYTOPATHOLOGY, V71, P1215, DOI 10.1094/Phyto-71-1215; SCHAAD NW, 1978, INT J SYST BACTERIOL, V28, P117, DOI 10.1099/00207713-28-1-117; SCHAAD NW, 2001, LAB GUIDE IDENTIFICA, P75; SHARON E, 1982, J APPL BACTERIOL, V53, P371, DOI 10.1111/j.1365-2672.1982.tb01285.x; SIJAM K, 1991, PHYTOPATHOLOGY, V81, P831, DOI 10.1094/Phyto-81-831; Spinelli F, 2005, EUR J PLANT PATHOL, V113, P395, DOI 10.1007/s10658-005-4511-7; STALL RE, 1994, INT J SYST BACTERIOL, V44, P47, DOI 10.1099/00207713-44-1-47; Strider D.L., 1969, NC AGR EXP STN TECH, V193, P1; Thri-Murty V.S, 1981, ORYZA, V18, P59; van der Wolf JM, 2010, J PHYTOPATHOL, V158, P726, DOI 10.1111/j.1439-0434.2010.01690.x; Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25; Walcott RR, 2003, PHYTOPATHOLOGY, V93, P528, DOI 10.1094/PHYTO.2003.93.5.528; Walcott RR, 2000, PHYTOPATHOLOGY, V90, P191, DOI 10.1094/PHYTO.2000.90.2.191; Walcott RR, 2000, PLANT DIS, V84, P470, DOI 10.1094/PDIS.2000.84.4.470; Webb R. E., 1965, PLANT DIS REP, V49, P818; Wells ML, 2002, ANN ENTOMOL SOC AM, V95, P719, DOI 10.1603/0013-8746(2002)095[0719:AOTTFF]2.0.CO;2; Zaccardelli M, 2005, EUR J PLANT PATHOL, V111, P85, DOI 10.1007/s10658-004-2734-7; Zhang Q, 2005, APPL ENVIRON MICROB, V71, P7716, DOI 10.1128/AEM.71.12.7716-7723.2005	52	30	33	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99215	10.1371/journal.pone.0099215	http://dx.doi.org/10.1371/journal.pone.0099215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936863	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400012
J	Luo, XQ; Suzuki, M; Ghandhi, SA; Amundson, SA; Boothman, DA				Luo, Xiuquan; Suzuki, Masatoshi; Ghandhi, Shanaz A.; Amundson, Sally A.; Boothman, David A.			ATM Regulates Insulin-Like Growth Factor 1-Secretory Clusterin (IGF-1-sCLU) Expression that Protects Cells against Senescence	PLOS ONE			English	Article							HUMAN-DIPLOID FIBROBLASTS; INDUCED PREMATURE SENESCENCE; DNA-DAMAGE RESPONSE; CELLULAR SENESCENCE; CLUSTERIN/APOLIPOPROTEIN-J; CANCER-CELLS; TRIGGERS SENESCENCE; OXIDATIVE STRESS; APOPTOSIS; SECRETION	Downstream factors that regulate the decision between senescence and cell death have not been elucidated. Cells undergo senescence through three pathways, replicative senescence (RS), stress-induced premature senescence (SIPS) and oncogene-induced senescence. Recent studies suggest that the ataxia telangiectasia mutant (ATM) kinase is not only a key protein mediating cellular responses to DNA damage, but also regulates cellular senescence induced by telomere end exposure (in RS) or persistent DNA damage (in SIPS). Here, we show that expression of secretory clusterin (sCLU), a known pro-survival extracellular chaperone, is transcriptionally up-regulated during both RS and SIPS, but not in oncogene-induced senescence, consistent with a DNA damage-inducible mechanism. We demonstrate that ATM plays an important role in insulin-like growth factor 1 (IGF-1) expression, that in turn, regulates downstream sCLU induction during senescence. Loss of ATM activity, either by genomic mutation (ATM-deficient fibroblasts from an ataxia telangiectasia patient) or by administration of a chemical inhibitor (AAI, an inhibitor of ATM and ATR), blocks IGF-1-sCLU expression in senescent cells. Downstream, sCLU induction during senescence is mediated by IGF-1R/MAPK/Egr-1 signaling, identical to its induction after DNA damage. In contrast, administration of an IGF-1 inhibitor caused apoptosis of senescent cells. Thus, IGF-1 signaling is required for survival, whereas sCLU appears to protect cells from premature senescence, as IMR-90 cells with sCLU knockdown undergo senescence faster than control cells. Thus, the ATM-IGF-1-sCLU pathway protects cells from lethality and suspends senescence.	[Luo, Xiuquan; Suzuki, Masatoshi; Boothman, David A.] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Program Cell Stress & Canc Nanomed, Dept Pharmacol,Lab Mol Cell Stress Responses, Dallas, TX 75390 USA; [Luo, Xiuquan; Suzuki, Masatoshi; Boothman, David A.] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Program Cell Stress & Canc Nanomed, Dept Radiat Oncol,Lab Mol Cell Stress Responses, Dallas, TX 75390 USA; [Ghandhi, Shanaz A.; Amundson, Sally A.] Columbia Univ, Ctr Radiol Res, Med Ctr, New York, NY 10032 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Columbia University	Boothman, DA (corresponding author), Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Program Cell Stress & Canc Nanomed, Dept Pharmacol,Lab Mol Cell Stress Responses, Dallas, TX 75390 USA.	David.Boothman@UTSouthwestern.edu	Ghandhi, Shanaz/C-5930-2016; Boothman, David/Q-7776-2019		DOD [X81XWH-091-0168]; Department of Energy (DOE) [DE-FG-022179-18-21]; NIH [R01 CA139217, U19 AI067773, CA-49062]; NATIONAL CANCER INSTITUTE [R01CA139217, P30CA142543, P01CA049062, R01CA102792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067773] Funding Source: NIH RePORTER	DOD(United States Department of Defense); Department of Energy (DOE)(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by DOD postdoctoral fellowship, X81XWH-091-0168, to XL, and grants DE-FG-022179-18-21 from the Department of Energy (DOE) and R01 CA139217 from the NIH to DAB, and NIH grants U19 AI067773 and CA-49062 to SAA and SAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barascu A, EMBO J, V31, P1080; Bhatti S, 2011, CELL MOL LIFE SCI, V68, P2977, DOI 10.1007/s00018-011-0683-9; Calderwood SK, 2009, GERONTOLOGY, V55, P550, DOI 10.1159/000225957; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Chen QM, 2001, EXP CELL RES, V265, P294, DOI 10.1006/excr.2001.5182; Criswell T, 2005, J BIOL CHEM, V280, P14212, DOI 10.1074/jbc.M412569200; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Di Micco R, NAT CELL BIOL, V13, P292; Frippiat C, 2002, FREE RADICAL BIO MED, V33, P1334, DOI 10.1016/S0891-5849(02)01044-4; Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200; Gabai VL, 2009, MOL CELL BIOL, V29, P559, DOI 10.1128/MCB.01041-08; Goetz EM, 2011, ONCOGENE, V30, P3745, DOI 10.1038/onc.2011.92; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Kitagawa R, 2005, COLD SH Q B, V70, P99, DOI 10.1101/sqb.2005.70.002; Klock G, 1998, J CELL PHYSIOL, V177, P593, DOI 10.1002/(SICI)1097-4652(199812)177:4<593::AID-JCP10>3.3.CO;2-6; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Ksiazek K, 2007, BIOCHEM BIOPH RES CO, V362, P707, DOI 10.1016/j.bbrc.2007.08.047; Lau SH, 2006, ONCOGENE, V25, P1242, DOI 10.1038/sj.onc.1209141; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; MacLaren A, 2004, MOL CELL BIOL, V24, P9006, DOI 10.1128/MCB.24.20.9006-9018.2004; Miura Y, 2011, EXP GERONTOL, V46, P81, DOI 10.1016/j.exger.2010.10.002; Naka K, 2004, J BIOL CHEM, V279, P2030, DOI 10.1074/jbc.M309457200; O'Callaghan-Sunol C, 2007, CANCER RES, V67, P11779, DOI 10.1158/0008-5472.CAN-07-2441; Ogrunc M, 2011, EUR J CANCER, V47, P1616, DOI 10.1016/j.ejca.2011.04.003; Petropoulou C, 2001, FEBS LETT, V509, P287, DOI 10.1016/S0014-5793(01)03150-7; Rai P, 2009, P NATL ACAD SCI USA, V106, P169, DOI 10.1073/pnas.0809834106; Restall IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011076; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Shannan B, 2006, CELL DEATH DIFFER, V13, P12, DOI 10.1038/sj.cdd.4401779; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Suzuki M, 2008, J RADIAT RES, V49, P105, DOI 10.1269/jrr.07081; Trougakos IP, 2002, INT J BIOCHEM CELL B, V34, P1430, DOI 10.1016/S1357-2725(02)00041-9; Trougakos IP, 2004, CANCER RES, V64, P1834, DOI 10.1158/0008-5472.CAN-03-2664; Volonte D, 2009, AGING-US, V1, P831, DOI 10.18632/aging.100079; Volonte D, 2009, J BIOL CHEM, V284, P5462, DOI 10.1074/jbc.C800225200; von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034; Yaglom JA, 2007, CANCER RES, V67, P2373, DOI 10.1158/0008-5472.CAN-06-3796; Zhan H, 2010, J BIOL CHEM, V285, P29662, DOI 10.1074/jbc.M110.125138; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291	41	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99983	10.1371/journal.pone.0099983	http://dx.doi.org/10.1371/journal.pone.0099983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937130	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400062
J	Albers, DJ; Elhadad, N; Tabak, E; Perotte, A; Hripcsak, G				Albers, D. J.; Elhadad, Noemie; Tabak, E.; Perotte, A.; Hripcsak, George			Dynamical Phenotyping: Using Temporal Analysis of Clinically Collected Physiologic Data to Stratify Populations	PLOS ONE			English	Article							CONTROL-ORIENTED MODEL; GLUCOSE DYNAMICS; INSULIN	Using glucose time series data from a well measured population drawn from an electronic health record (EHR) repository, the variation in predictability of glucose values quantified by the time-delayed mutual information (TDMI) was explained using a mechanistic endocrine model and manual and automated review of written patient records. The results suggest that predictability of glucose varies with health state where the relationship (e. g., linear or inverse) depends on the source of the acuity. It was found that on a fine scale in parameter variation, the less insulin required to process glucose, a condition that correlates with good health, the more predictable glucose values were. Nevertheless, the most powerful effect on predictability in the EHR subpopulation was the presence or absence of variation in health state, specifically, in-and out-of-control glucose versus in-control glucose. Both of these results are clinically and scientifically relevant because the magnitude of glucose is the most commonly used indicator of health as opposed to glucose dynamics, thus providing for a connection between a mechanistic endocrine model and direct insight to human health via clinically collected data.	[Albers, D. J.; Elhadad, Noemie; Perotte, A.; Hripcsak, George] Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA; [Tabak, E.] NYU, Courant Inst Math Sci, Dept Math, New York, NY USA	Columbia University; New York University	Albers, DJ (corresponding author), Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA.	dja2119@cumc.columbia.edu		Perotte, Adler/0000-0002-6695-0282	NIH-NLM [RO1 LM06910]; NATIONAL LIBRARY OF MEDICINE [R01LM006910] Funding Source: NIH RePORTER	NIH-NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	DA and GH acknowledge the financial support provided by NIH-NLM Grant No. RO1 LM06910. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli JP, 2010, SIAM MMS; Albers D, 2013, TIME SERIES AN UNPUB; Albers DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048058; Albers DJ, 2012, CHAOS, V22, DOI 10.1063/1.3675621; [Anonymous], 2011, PRECISION MED BUILDI; Astrom K. J., 2008, FEEDBACK SYSTEMS INT; Bishop C. M., 2006, J ELECT IMAG, V16, P140; Bodenreider O, 2003, J BIOMED INFORM, V36, P414, DOI 10.1016/j.jbi.2003.11.002; Brunetti P, 2003, ARTIF CELL BLOOD SUB, V31, P127, DOI 10.1081/BIO-120020169; Christopher D.M., 2008, MANNING PRABHAKAR RA; Demner-Fushman D, 2009, J BIOMED INFORM, V42, P760, DOI 10.1016/j.jbi.2009.08.007; Fabietti PG, 2007, DIABETES TECHNOL THE, V9, P327, DOI 10.1089/dia.2006.0030; Fabietti PG, 2006, MED BIOL ENG COMPUT, V44, P69, DOI 10.1007/s11517-005-0012-2; Friedman C, 2013, BIOMEDICAL INFORM CO; Gray AG, 2003, OINT STAT M; Hagar Y, 2014, STAT ANAL D IN PRESS; Hirata Y, 2010, CHAOS, V20, DOI DOI 10.1063/1.3526968; Hripcsak G, 2012, J AM MED INFORM ASSN, V10, P1, DOI DOI 10.1136/AMIAJN1-2012-001145; Hripcsak G., 2013, J AM MED INFORM ASSN, P1; Hripcsak G, 2011, J AM MED INFORM ASSN, V18, pI109, DOI 10.1136/amiajnl-2011-000463; Hripcsak G, 2009, J AM MED INFORM ASSN, V16, P220, DOI 10.1197/jamia.M3007; Kantz H., 2003, NONLINEAR TIME SERIE; Keener J, 2008, MATH PHYSL; Kirk D, 1988, OPTIMAL CONTROL THEO; Kjaer M, 1998, ADV EXP MED BIOL, V441, P117; Kovatchev Boris P, 2009, J Diabetes Sci Technol, V3, P44; Lai Albert M, 2008, AMIA Annu Symp Proc, P374; Liao TW, 2005, PATTERN RECOGN, V38, P1857, DOI 10.1016/j.patcog.2005.01.025; LINDBERG DAB, 1993, METHOD INFORM MED, V32, P281, DOI 10.1055/s-0038-1634945; Lorenc A, 1988, Q J ROY METEOR SOC, V112, P1177; Pivovarov R, 2014, J BIOMEDICA IN PRESS; ROWLANDS G, 1992, PHYSICA D, V58, P251, DOI 10.1016/0167-2789(92)90113-2; SCHIFF S. J., 2011, NEURAL CONTROL ENG E; Sedigh-Sarvestan M, 2012, 34 ANN INT IEEE EMBS; SHAW CT, 1992, PHYSICA D, V58, P288, DOI 10.1016/0167-2789(92)90117-6; Sprott JC, 2003, CHAOS TIME SERIES AN; Stengel R. F., 1994, OPTIMAL CONTROL ESTI; STURIS J, 1991, AM J PHYSIOL, V260, pE801, DOI 10.1152/ajpendo.1991.260.5.E801	38	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e96443	10.1371/journal.pone.0096443	http://dx.doi.org/10.1371/journal.pone.0096443			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933368	Green Submitted, Green Published, gold			2022-12-25	WOS:000337738600003
J	Godinho, RMD; Matassoli, FL; Lucas, CGD; Rigato, PO; Goncalves, JLS; Sato, MN; Maciel, M; Pecanha, LMT; August, JT; Marques, ETA; de Arruda, LB				da Costa Godinho, Rodrigo Maciel; Matassoli, Flavio Lemos; de Oliveira Lucas, Carolina Goncalves; Rigato, Paula Ordonhez; Santos Goncalves, Jorge Luiz; Sato, Maria Notomi; Maciel, Milton, Jr.; Torres Pecanha, Ligia Maria; Thomas August, J.; de Azevedo Marques, Ernesto Torres, Jr.; de Arruda, Luciana Barros			Regulation of HIV-Gag Expression and Targeting to the Endolysosomal/Secretory Pathway by the Luminal Domain of Lysosomal-Associated Membrane Protein (LAMP-1) Enhance Gag-Specific Immune Response	PLOS ONE			English	Article							T-CELL RESPONSES; VIRUS TYPE-1 GAG; CLASS-II COMPARTMENT; MHC CLASS-I; DNA VACCINATION; LYMPHOCYTE RESPONSES; ANTIGEN PRESENTATION; CODON USAGE; LONGITUDINAL ANALYSIS; ELITE CONTROLLERS	We have previously demonstrated that a DNA vaccine encoding HIV-p55gag in association with the lysosomal associated membrane protein-1 (LAMP-1) elicited a greater Gag-specific immune response, in comparison to a DNA encoding the native gag. In vitro studies have also demonstrated that LAMP/Gag was highly expressed and was present in MHCII containing compartments in transfected cells. In this study, the mechanisms involved in these processes and the relative contributions of the increased expression and altered traffic for the enhanced immune response were addressed. Cells transfected with plasmid DNA constructs containing p55gag attached to truncated sequences of LAMP-1 showed that the increased expression of gag mRNA required p55gag in frame with at least 741 bp of the LAMP-1 luminal domain. LAMP luminal domain also showed to be essential for Gag traffic through lysosomes and, in this case, the whole sequence was required. Further analysis of the trafficking pathway of the intact LAMP/Gag chimera demonstrated that it was secreted, at least in part, associated with exosome-like vesicles. Immunization of mice with LAMP/gag chimeric plasmids demonstrated that high expression level alone can induce a substantial transient antibody response, but targeting of the antigen to the endolysosomal/secretory pathways was required for establishment of cellular and memory response. The intact LAMP/gag construct induced polyfunctional CD4(+) T cell response, which presence at the time of immunization was required for CD8(+) T cell priming. LAMP-mediated targeting to endolysosomal/secretory pathway is an important new mechanistic element in LAMP-mediated enhanced immunity with applications to the development of novel anti-HIV vaccines and to general vaccinology field.	[da Costa Godinho, Rodrigo Maciel; Matassoli, Flavio Lemos; de Oliveira Lucas, Carolina Goncalves; de Arruda, Luciana Barros] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio De Janeiro, Brazil; [Rigato, Paula Ordonhez; Sato, Maria Notomi] Univ Sao Paulo, Fac Med, Dept Dermatol, Lab Dermatol Imunodeficiencias,LIM 56, Sao Paulo, Brazil; [Santos Goncalves, Jorge Luiz; Torres Pecanha, Ligia Maria] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Imunol, Rio De Janeiro, Brazil; [Maciel, Milton, Jr.] Naval Med Res Ctr, Infect Dis Directorate, Enter Dis Dept, Silver Spring, MD USA; [Maciel, Milton, Jr.; Thomas August, J.; de Azevedo Marques, Ernesto Torres, Jr.] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD USA; [de Azevedo Marques, Ernesto Torres, Jr.] Ctr Vaccine Res, Dept Infect Dis & Microbiol, Pittsburgh, PA USA; [de Azevedo Marques, Ernesto Torres, Jr.] Fiocruz Pernambuco, Dept Virol, Recife, PE, Brazil	Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Naval Medical Research Center (NMRC); Johns Hopkins University; Johns Hopkins Medicine; Fundacao Oswaldo Cruz	de Arruda, LB (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio De Janeiro, Brazil.	arruda@micro.ufrj.br	Ordonhez Rigato, Paula/J-3618-2012; Marques, Ernesto T. A/L-4967-2013; iMed.ULisboa, M2B/B-5277-2014; Sato, Maria N/C-1196-2012; Arruda, Luciana B/N-9086-2013; Sato, Maria N/C-2853-2012; Godinho, Rodrigo/G-5135-2015	Marques, Ernesto T. A/0000-0003-3826-9358; iMed.ULisboa, M2B/0000-0002-1245-3715; Sato, Maria N/0000-0002-7911-1824; RIGATO, PAULA ORDONHEZ/0000-0002-4416-3544; Lucas, Carolina/0000-0003-4590-2756	National Institute of Allergy and Infectious Diseases, National Institutes of Health [R37-AI41908, R21-AI44317]; Brazilian Ministry of Health; CAPES; CNPq; FAPERJ; FINEP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI044317] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Brazilian Ministry of Health; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FINEP(Financiadora de Inovacao e Pesquisa (Finep)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grants R37-AI41908 and R21-AI44317 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health; and by Brazilian Ministry of Health, CAPES, CNPq, FAPERJ, and FINEP. R. M. C. Godinho and F. L. Matassoli were the recipients of a CNPq fellowship; C.G.O. Lucas was the recipient of a FAPERJ fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MOL IMMUNOL, V47, P1507; Arruda LB, 2006, J IMMUNOL, V177, P2265, DOI 10.4049/jimmunol.177.4.2265; Bazhan SI, 2010, MOL IMMUNOL, V47, P1507, DOI 10.1016/j.molimm.2010.01.020; Bertoletti A, 1998, J VIROL, V72, P2439, DOI 10.1128/JVI.72.3.2439-2448.1998; Bivas-Benita M, 2013, MUCOSAL IMMUNOL, V6, P156, DOI 10.1038/mi.2012.59; Bockl K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034723; Bojak A, 2002, INTERVIROLOGY, V45, P275, DOI 10.1159/000067919; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; CHANG DD, 1989, CELL, V59, P789, DOI 10.1016/0092-8674(89)90602-8; Chikhlikar P, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000135; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; COCHRANE AW, 1991, J VIROL, V65, P5305, DOI 10.1128/JVI.65.10.5305-5313.1991; De Arruda LB, 2004, IMMUNOLOGY, V112, P126, DOI 10.1111/j.1365-2567.2004.01823.x; Delcayre A, 2005, BLOOD CELL MOL DIS, V35, P158, DOI 10.1016/j.bcmd.2005.07.003; Deml L, 2001, J VIROL, V75, P10991, DOI 10.1128/JVI.75.22.10991-11001.2001; Denzer K, 2000, J CELL SCI, V113, P3365; DUBEY C, 1995, J IMMUNOL, V155, P45; Durali D, 1998, J VIROL, V72, P3547, DOI 10.1128/JVI.72.5.3547-3553.1998; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; FELBER BK, 1989, P NATL ACAD SCI USA, V86, P1495, DOI 10.1073/pnas.86.5.1495; Ferre AL, 2010, J VIROL, V84, P11020, DOI 10.1128/JVI.00980-10; Ferre AL, 2010, J VIROL, V84, P10354, DOI 10.1128/JVI.00803-10; Ferre AL, 2009, BLOOD, V113, P3978, DOI 10.1182/blood-2008-10-182709; Fu TM, 1997, MOL MED, V3, P362, DOI 10.1007/BF03401683; Fuller DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033715; Graf M, 2000, J VIROL, V74, P10822, DOI 10.1128/JVI.74.22.10822-10826.2000; Hartman ZC, 2011, VACCINE, V29, P9361, DOI 10.1016/j.vaccine.2011.09.133; Kaur M, 2009, VACCINE, V27, P2128, DOI 10.1016/j.vaccine.2009.01.128; Kessler PD, 1996, P NATL ACAD SCI USA, V93, P14082, DOI 10.1073/pnas.93.24.14082; KLEIN MR, 1995, J EXP MED, V181, P1365, DOI 10.1084/jem.181.4.1365; Kotsopoulou E, 2000, J VIROL, V74, P4839, DOI 10.1128/JVI.74.10.4839-4852.2000; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Langlade-Demoyen P, 2003, EUR J IMMUNOL, V33, P720, DOI 10.1002/eji.200323287; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Lu Y, 2003, VACCINE, V21, P2178, DOI 10.1016/S0264-410X(03)00009-4; Maecker HT, 1998, J IMMUNOL, V161, P6532; Marques ETA, 2003, J BIOL CHEM, V278, P37926, DOI 10.1074/jbc.M303336200; McAdam S, 1998, AIDS, V12, P571, DOI 10.1097/00002030-199806000-00005; Midha S, 2009, EUR J IMMUNOL, V39, P159, DOI 10.1002/eji.200838058; Nanjundappa RH, 2012, VACCINE, V30, P3519, DOI 10.1016/j.vaccine.2012.03.075; Nanjundappa RH, 2011, VACCINE, V29, P3538, DOI 10.1016/j.vaccine.2011.02.095; Ngumbela KC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002356; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; Pissani F, 2012, VACCINE, V30, P5519, DOI 10.1016/j.vaccine.2012.06.042; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Pontesilli O, 1998, J INFECT DIS, V178, P1008, DOI 10.1086/515659; Porgador A, 1998, J EXP MED, V188, P1075, DOI 10.1084/jem.188.6.1075; Qiu JT, 2000, J VIROL, V74, P5997, DOI 10.1128/JVI.74.13.5997-6005.2000; Qiu JT, 1999, J VIROL, V73, P9145, DOI 10.1128/JVI.73.11.9145-9152.1999; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Schliehe C, 2012, J VIROL, V86, P9782, DOI 10.1128/JVI.00694-12; Schneider R, 1997, J VIROL, V71, P4892, DOI 10.1128/JVI.71.7.4892-4903.1997; SCHWARTZ S, 1992, J VIROL, V66, P7176, DOI 10.1128/JVI.66.12.7176-7182.1992; Shedlock DJ, 2000, J LEUKOCYTE BIOL, V68, P793; Stober D, 2002, EUR J IMMUNOL, V32, P1099, DOI 10.1002/1521-4141(200204)32:4<1099::AID-IMMU1099>3.3.CO;2-#; Sui YJ, 2010, P NATL ACAD SCI USA, V107, P9843, DOI 10.1073/pnas.0911932107; Thakur A, 2012, VACCINE, V30, P4907, DOI 10.1016/j.vaccine.2012.05.049; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Vaccari M, 2005, J IMMUNOL, V175, P3502, DOI 10.4049/jimmunol.175.6.3502; Vargas-Inchaustegui DA, 2012, J IMMUNOL, V189, P1878, DOI 10.4049/jimmunol.1201026; Wang QM, 2012, DNA CELL BIOL, V31, P489, DOI 10.1089/dna.2011.1309; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Zhang HF, 2011, CELL MOL IMMUNOL, V8, P23, DOI 10.1038/cmi.2010.59; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	67	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99887	10.1371/journal.pone.0099887	http://dx.doi.org/10.1371/journal.pone.0099887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932692	Green Submitted, gold, Green Published			2022-12-25	WOS:000337738600077
J	Mori, M; Saito, K; Ohta, Y				Mori, Mamiko; Saito, Koji; Ohta, Yasutaka			ARHGAP22 Localizes at Endosomes and Regulates Actin Cytoskeleton	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; CELL-MIGRATION; RHO GTPASES; FILAMIN-A; RAC; FILGAP; MORPHOLOGY; MOVEMENT; MOTILITY; POLARITY	Rho small GTPases control cell morphology and motility through the rearrangement of actin cytoskeleton. We have previously shown that FilGAP, a Rac-specific GAP, binds to the actin-cross-linking protein Filamin A (FLNa) and suppresses Rac-dependent lamellae formation and cell spreading. ARHGAP22 is a member of FilGAP family, and implicated in the regulation of tumor cell motility. However, little is known concerning the cellular localization and mechanism of regulation at the molecular level. Whereas FilGAP binds to FLNa and localizes to lamellae, we found that ARHGAP22 did not bind to FLNa. Forced expression of ARHGAP22 induced enlarged vesicular structures containing the endocytic markers EEA1, Rab5, and Rab11. Moreover, endogenous ARHGAP22 is co-localized with EEA1-and Rab11-positive endosomes but not with trans-Golgi marker TNG46. When constitutively activated Rac Q61L mutant was expressed, ARHGAP22 is co-localized with Rac Q61L at membrane ruffles, suggesting that ARHGAP22 is translocated from endosomes to membrane ruffles to inactivate Rac. Forced expression of ARHGAP22 suppressed lamellae formation and cell spreading. Conversely, knockdown of endogenous ARHGAP22 stimulated cell spreading. Thus, our findings suggest that ARHGAP22 controls cell morphology by inactivating Rac but its localization is not mediated by its interaction with FLNa.	[Mori, Mamiko; Saito, Koji; Ohta, Yasutaka] Kitasato Univ, Sch Sci, Dept Biosci, Div Cell Biol, Sagamihara, Kanagawa, Japan	Kitasato University	Ohta, Y (corresponding author), Kitasato Univ, Sch Sci, Dept Biosci, Div Cell Biol, Sagamihara, Kanagawa, Japan.	yohta@kitasato-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Kitasato University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kitasato University	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant for All Kitasato Project Study, and Kitasato University Research Grant for Young Researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitsebaomo J, 2004, J BIOL CHEM, V279, P17963, DOI 10.1074/jbc.M311721200; Akilesh S, 2011, J CLIN INVEST, V121, P4127, DOI 10.1172/JCI46458; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Ceresa BP, 2001, J BIOL CHEM, V276, P9649, DOI 10.1074/jbc.M010387200; Croft DR, 2008, CANCER CELL, V14, P349, DOI 10.1016/j.ccr.2008.10.009; Dinneen JL, 2004, TRAFFIC, V5, P606, DOI 10.1111/j.1398-9219.2004.00204.x; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041731; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Ladhani O, 2011, NEOPLASIA, V13, P633, DOI 10.1593/neo.11446; Lavelin I, 2005, J BIOL CHEM, V280, P7178, DOI 10.1074/jbc.M411990200; Magadan JG, 2006, MOL CELL BIOL, V26, P2595, DOI 10.1128/MCB.26.7.2595-2614.2006; Nakamura F, 2013, BIOCHEM J, V453, P17, DOI 10.1042/BJ20130290; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Osmani N, 2010, J CELL BIOL, V191, P1261, DOI 10.1083/jcb.201003091; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Rowland AF, 2011, MOL CELL BIOL, V31, P4789, DOI 10.1128/MCB.05583-11; Saito K, 2012, MOL BIOL CELL, V23, P4739, DOI 10.1091/mbc.E12-04-0310; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Schiefermeier N, 2011, CURR OPIN CELL BIOL, V23, P615, DOI 10.1016/j.ceb.2011.04.001; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Torres VA, 2011, CURR PROTEIN PEPT SC, V12, P43; Valnegri P, 2011, HUM MOL GENET, V20, P4797, DOI 10.1093/hmg/ddr418; Wegner CS, 2010, HISTOCHEM CELL BIOL, V133, P41, DOI 10.1007/s00418-009-0643-8; Winter JF, 2012, NAT CELL BIOL, V14, P666, DOI 10.1038/ncb2508	33	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100271	10.1371/journal.pone.0100271	http://dx.doi.org/10.1371/journal.pone.0100271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933155	Green Published, Green Submitted, gold			2022-12-25	WOS:000337738600104
J	Jiang, YN; Lou, JJ; Wang, SQ; Zhao, Y; Wang, C; Wang, DH				Jiang, Yanni; Lou, Jianjuan; Wang, Siqi; zhao, Yi; Wang, Cong; Wang, Dehang			Evaluation of the Role of Dynamic Contrast-Enhanced MR Imaging for Patients with BI-RADS 3-4 Microcalcifications	PLOS ONE			English	Article							ASSISTED BREAST BIOPSY; MAMMOGRAPHIC FEATURES; DATA SYSTEM; CANCER; LESIONS; MULTICENTER; MALIGNANCY; EXPERIENCE; RESOLUTION; ACCURACY	Objective: The purpose of study was to prospectively evaluate the diagnostic performance of dynamic contrast-enhanced MR imaging in the differentiation of malignant lesions from benign ones in patients with BI-RADS 3-4 microcalcifications detected by mammography. Materials and Methods: 93 women with 100 microcalcifications had undergone breast MRI from June 2010 to July 2013. Subsequently, 91 received open biopsy and 2 received stereotactic vacuum-assisted biopsy. All results were compared with histological findings. The PPV, NPV and area under curve (AUC) of the mammography and breast MRI were calculated. Results: There were 31 (31.0%) BI-RADS 3 microcalcifications and 69 (69.0%) BI-RADS 4. The PPV and NPV of mammography is 65.2% (45/69) and 90.3% (28/31). The PPV and NPV of breast MRI was 90.2% (46/51) and 95.9% (47/49). Among 31 BI-RADS 3 microcalcifications, the PPV and NPV of breast MRI was 100% (3/3) and 100% (28/28). Among 69 BI-RADS 4 microcalcifications, the PPV and NPV of breast MRI was 89.6% (43/48) and 90.5% (19/21). The AUC of mammography and breast MRI assessment were 0.738 (95% CI, 0.639-0.837) and 0.931 (95% CI, 0.874-0.988) (p<0.05). Conclusion: Dynamic contrast-enhanced MR imaging of breast is able to be applied to predict the risk of malignance before follow-up for BI-RADS 3 microcalcifications and biopsy for BI-RADS 4 microcalcifications.	[Jiang, Yanni; Lou, Jianjuan; Wang, Siqi; Wang, Dehang] Nanjing Med Univ, Affiliated Hosp 1, Div Radiol, Nanjing, Jiangsu, Peoples R China; [zhao, Yi] Nanjing Med Univ, Affiliated Hosp 1, Div Breast Surg, Nanjing, Jiangsu, Peoples R China; [Wang, Cong] Nanjing Med Univ, Affiliated Hosp 1, Div Pathol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Wang, DH (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Div Radiol, Nanjing, Jiangsu, Peoples R China.	wangdehang@hotmail.com						American College of Radiology, 2003, BREAST IM REP DAT SY; Atuegwu NC, 2014, MED PHYS, V41, DOI 10.1118/1.4870966; Baltzer PAT, 2010, AM J ROENTGENOL, V194, P1658, DOI 10.2214/AJR.09.3486; Bazzocchi M, 2006, AM J ROENTGENOL, V186, P1723, DOI 10.2214/AJR.04.1898; Berg WA, 2004, RADIOLOGY, V233, P830, DOI 10.1148/radiol.2333031484; El Khouli RH, 2008, SEMIN ROENTGENOL, V43, P265, DOI 10.1053/j.ro.2008.07.002; Gilles R, 1996, J COMPUT ASSIST TOMO, V20, P9, DOI 10.1097/00004728-199601000-00003; Houssami N, 2008, J CLIN ONCOL, V26, P3248, DOI 10.1200/JCO.2007.15.2108; Houssami N, 2009, CA-CANCER J CLIN, V59, P290, DOI 10.3322/caac.20028; Huang W, 2004, RADIOLOGY, V232, P585, DOI 10.1148/radiol.2322030547; Kettritz U, 2004, CANCER-AM CANCER SOC, V100, P245, DOI 10.1002/cncr.11887; Kneeshaw PJ, 2006, BREAST, V15, P29, DOI 10.1016/j.breast.2005.05.002; Koolen BB, 2013, Q J NUCL MED MOL IM, V57, P92; Koolen BB, 2014, NUCL MED COMMUN, V35, P446, DOI 10.1097/MNM.0000000000000072; Kuhl CK, 2007, RADIOLOGY, V244, P672, DOI 10.1148/radiol.2443051661; Kuhl CK, 1997, RADIOLOGY, V203, P137, DOI 10.1148/radiology.203.1.9122382; Kuhl CK, 2005, RADIOLOGY, V236, P789, DOI 10.1148/radiol.2363040811; Liberman L, 1998, AM J ROENTGENOL, V171, P35, DOI 10.2214/ajr.171.1.9648759; Liberman L, 2003, CANCER-AM CANCER SOC, V98, P377, DOI 10.1002/cncr.11491; Mendez A, 2004, ANN ONCOL, V15, P450, DOI 10.1093/annonc/mdh088; Mendez A, 2004, CANCER-AM CANCER SOC, V100, P710, DOI 10.1002/cncr.20017; Nakahara H, 2001, Breast Cancer, V8, P116, DOI 10.1007/BF02967490; Orel SG, 2001, RADIOLOGY, V220, P13, DOI 10.1148/radiology.220.1.r01jl3113; Orel SG, 1999, RADIOLOGY, V211, P845, DOI 10.1148/radiology.211.3.r99jn31845; Pages EB, 2012, RADIOLOGY, V264, P40, DOI 10.1148/radiol.12111917; Schnall MD, 2006, RADIOLOGY, V238, P42, DOI 10.1148/radiol.2381042117; Shimauchi A, 2010, AM J ROENTGENOL, V194, P1674, DOI 10.2214/AJR.09.3568; Tozaki M, 2006, AM J ROENTGENOL, V187, P330, DOI 10.2214/AJR.05.0998; Uematsu T, 2007, BREAST CANCER RES TR, V103, P269, DOI 10.1007/s10549-006-9373-y; Westerhof JP, 1998, RADIOLOGY, V207, P675, DOI 10.1148/radiology.207.3.9609890	30	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99669	10.1371/journal.pone.0099669	http://dx.doi.org/10.1371/journal.pone.0099669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927476	gold, Green Submitted, Green Published			2022-12-25	WOS:000338278100063
J	Olias, P; Adam, I; Meyer, A; Scharff, C; Gruber, AD				Olias, Philipp; Adam, Iris; Meyer, Anne; Scharff, Constance; Gruber, Achim D.			Reference Genes for Quantitative Gene Expression Studies in Multiple Avian Species	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; TRANSCRIPTION-PCR DATA; REAL-TIME PCR; HOUSEKEEPING GENES; JAPANESE-QUAIL; NORMALIZATION; SELECTION; VALIDATION; GENOME; MODEL	Quantitative real-time PCR (qPCR) rapidly and reliably quantifies gene expression levels across different experimental conditions. Selection of suitable reference genes is essential for meaningful normalization and thus correct interpretation of data. In recent years, an increasing number of avian species other than the chicken has been investigated molecularly, highlighting the need for an experimentally validated pan-avian primer set for reference genes. Here we report testing a set for 14 candidate reference genes (18S, ABL, GAPDH, GUSB, HMBS, HPRT, PGK1, RPL13, RPL19, RPS7, SDHA, TFRC, VIM, YWHAZ) on different tissues of the mallard (Anas platyrhynchos), domestic chicken (Gallus gallus domesticus), common crane (Grus grus), white-tailed eagle (Haliaeetus albicilla), domestic turkey (Meleagris gallopavo f. domestica), cockatiel (Nymphicus hollandicus), Humboldt penguin (Sphenicus humboldti), ostrich (Struthio camelus) and zebra finch (Taeniopygia guttata), spanning a broad range of the phylogenetic tree of birds. Primer pairs for six to 11 genes were successfully established for each of the nine species. As a proof of principle, we analyzed expression levels of 10 candidate reference genes as well as FOXP2 and the immediate early genes, EGR1 and CFOS, known to be rapidly induced by singing in the avian basal ganglia. We extracted RNA from microbiopsies of the striatal song nucleus Area X of adult male zebra finches after they had sang or remained silent. Using three different statistical algorithms, we identified five genes (18S, PGK1, RPS7, TFRC, YWHAZ) that were stably expressed within each group and also between the singing and silent conditions, establishing them as suitable reference genes. In conclusion, the newly developed pan-avian primer set allows accurate normalization and quantification of gene expression levels in multiple avian species.	[Olias, Philipp; Meyer, Anne; Gruber, Achim D.] Free Univ Berlin, Inst Vet Pathol, Berlin, Germany; [Adam, Iris; Scharff, Constance] Free Univ Berlin, Inst Biol, Dept Anim Behav, Berlin, Germany	Free University of Berlin; Free University of Berlin	Olias, P (corresponding author), Free Univ Berlin, Inst Vet Pathol, Berlin, Germany.	olias@borcim.wustl.edu; iris.adam@fu-berlin.de	Scharff, Constance/HHN-0673-2022; Gruber, Achim D./ABA-4514-2021	Adam, Iris/0000-0001-7561-7636; Olias, Philipp/0000-0002-7200-2414				Abruzzo LV, 2005, BIOTECHNIQUES, V38, P785, DOI 10.2144/05385MT01; Ahi EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066389; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arsenijevic T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037517; Ball GF, 2010, ILAR J, V51, P310, DOI 10.1093/ilar.51.4.310; Banerjee SB, 2012, P ROY SOC B-BIOL SCI, V279, P759, DOI 10.1098/rspb.2011.1265; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Bateson M, 2010, ILAR J, V51, P394, DOI 10.1093/ilar.51.4.394; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin Stephen A., 2009, P111; Castoe TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030953; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Chechi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032265; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; De Boever S, 2008, VET IMMUNOL IMMUNOP, V122, P312, DOI 10.1016/j.vetimm.2007.12.002; De Winter P, 2008, BRIT POULTRY SCI, V49, P566, DOI 10.1080/00071660802294558; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Ding ST, 2007, POULTRY SCI, V86, P1206, DOI 10.1093/ps/86.6.1206; Dridi S, 2005, DOMEST ANIM ENDOCRIN, V29, P646, DOI 10.1016/j.domaniend.2005.05.002; Dugas-Ford J, 2012, P NATL ACAD SCI USA, V109, P16974, DOI 10.1073/pnas.1204773109; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hibbeler S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-18; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Holmes DJ, 2003, EXP GERONTOL, V38, P1365, DOI 10.1016/j.exger.2003.10.018; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Khurshid N, 2009, J CHEM NEUROANAT, V37, P158, DOI 10.1016/j.jchemneu.2008.12.001; Kimpo RR, 1997, NEURON, V18, P315, DOI 10.1016/S0896-6273(00)80271-8; Koshiba-Takeuchi K, 2009, NATURE, V461, P95, DOI 10.1038/nature08324; Kuchipudi SV, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-230; Latham GJ, 2010, METHODS MOL BIOL, V667, P19, DOI 10.1007/978-1-60761-811-9_2; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Mukai M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008182; Naurin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046854; Nerren JR, 2010, VET IMMUNOL IMMUNOP, V136, P151, DOI 10.1016/j.vetimm.2010.02.017; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; O'Connell LA, 2012, SCIENCE, V336, P1154, DOI 10.1126/science.1218889; Olias P, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-10; Perfito N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034997; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Scharff C, 2013, CURR OPIN NEUROBIOL, V23, P29, DOI 10.1016/j.conb.2012.10.001; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teramitsu I, 2006, J NEUROSCI, V26, P7390, DOI 10.1523/JNEUROSCI.1662-06.2006; Thompson CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035119; Tomaszycki ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-24; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Van Bers NEM, 2012, MOL ECOL RESOUR, V12, P753, DOI 10.1111/j.1755-0998.2012.03141.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veazey KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027592; Wada K, 2006, P NATL ACAD SCI USA, V103, P15212, DOI 10.1073/pnas.0607098103; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Wolf JBW, 2010, MOL ECOL, V19, P162, DOI 10.1111/j.1365-294X.2009.04471.x; Yin RF, 2011, BIOCHEM BIOPH RES CO, V413, P537, DOI 10.1016/j.bbrc.2011.08.131; Yue Hua, 2010, Virologica Sinica, V25, P425, DOI 10.1007/s12250-010-3114-4	60	70	74	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99678	10.1371/journal.pone.0099678	http://dx.doi.org/10.1371/journal.pone.0099678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926893	gold, Green Published, Green Submitted			2022-12-25	WOS:000338278100066
J	Raich, JW; Clark, DA; Schwendenmann, L; Wood, TE				Raich, James W.; Clark, Deborah A.; Schwendenmann, Luitgard; Wood, Tana E.			Aboveground Tree Growth Varies with Belowground Carbon Allocation in a Tropical Rainforest Environment	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; SOIL RESPIRATION; SHOOT RATIOS; LA-SELVA; NITROGEN; ROOT; PLANTATIONS; LIMITATION; PASTURE; CO2	Young secondary forests and plantations in the moist tropics often have rapid rates of biomass accumulation and thus sequester large amounts of carbon. Here, we compare results from mature forest and nearby 15-20 year old tree plantations in lowland Costa Rica to evaluate differences in allocation of carbon to aboveground production and root systems. We found that the tree plantations, which had fully developed, closed canopies, allocated more carbon belowground - to their root systems - than did mature forest. This increase in belowground carbon allocation correlated significantly with aboveground tree growth but not with canopy production (i.e., leaf fall or fine litter production). In contrast, there were no correlations between canopy production and either tree growth or belowground carbon allocation. Enhanced allocation of carbon to root systems can enhance plant nutrient uptake, providing nutrients beyond those required for the production of short-lived tissues such as leaves and fine roots, and thus enabling biomass accumulation. Our analyses support this deduction at our site, showing that enhanced allocation of carbon to root systems can be an important mechanism promoting biomass accumulation during forest growth in the moist tropics. Identifying factors that control when, where and for how long this occurs would help us to improve models of forest growth and nutrient cycling, and to ascertain the role that young forests play in mitigating increased atmospheric carbon dioxide.	[Raich, James W.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Clark, Deborah A.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Schwendenmann, Luitgard] Univ Auckland, Sch Environm, Auckland 1, New Zealand; [Wood, Tana E.] US Dept Agr Forest Serv, Int Inst Trop Forestry, Rio Piedras, PR USA; [Wood, Tana E.] Fdn Puertorriquena Conservac, San Juan, PR USA	Iowa State University; University of Missouri System; University of Missouri Saint Louis; University of Auckland; United States Department of Agriculture (USDA); United States Forest Service	Raich, JW (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	jraich@iastate.edu		Clark, Deborah/0000-0002-4000-4925; Schwendenmann, Luitgard/0000-0002-2290-3003; Wood, Tana/0000-0001-6322-6224	U.S. National Science Foundation [DEB-9629245, BCE-0421178, EAR-0421178, DEB-0841872, DEB-0236502, DEB-0703561]; U.S. Department of Energy [DE-FG02-96ER62289]; Andrew W. Mellon Foundation; Conservation International's TEAM Initiative; University of Virginia	U.S. National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); Andrew W. Mellon Foundation; Conservation International's TEAM Initiative; University of Virginia	Funding for measurements of the mature forest plots was provided by the U.S. National Science Foundation (http://www.nsf.gov) grants DEB-9629245, BCE-0421178, EAR-0421178 and DEB-0841872; the U.S. Department of Energy (http://science.energy.gov/funding-opportunities/find-funding/) grant DE-FG02-96ER62289; the Andrew W. Mellon Foundation (http://www.mellon.org/grant_programs/programs); and Conservation International's TEAM Initiative (http://www.conservation.org). Plantation studies were funded by U.S. National Science Foundation grants DEB-0236502 and DEB-0703561. Leaf fall N studies were funded by the University of Virginia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 1997, ECOLOGY, V78, P1277, DOI 10.2307/2265879; Aragao LEOC, 2009, BIOGEOSCIENCES, V6, P2759, DOI 10.5194/bg-6-2759-2009; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Brown S., 1997, FAO Forestry Paper; BROWN S, 1990, J TROP ECOL, V6, P1, DOI 10.1017/S0266467400003989; Chamberlin T. C., 1890, SCIENCE, V15, P92, DOI DOI 10.1126/SCIENCE.NS-15.366.92; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Clark DA, 2001, ECOL APPL, V11, P356, DOI 10.1890/1051-0761(2001)011[0356:MNPPIF]2.0.CO;2; Clark DB, 2008, ECOL LETT, V11, P163, DOI 10.1111/j.1461-0248.2007.01134.x; Clark DB, 2000, FOREST ECOL MANAG, V137, P185, DOI 10.1016/S0378-1127(99)00327-8; Clark DA, 2013, J GEOPHYS RES-BIOGEO, V118, P783, DOI 10.1002/jgrg.20067; Davidson EA, 2002, AGR FOREST METEOROL, V113, P39, DOI 10.1016/S0168-1923(02)00101-6; dePury DGG, 1997, PLANT CELL ENVIRON, V20, P537, DOI 10.1111/j.1365-3040.1997.00094.x; Dybzinski R, 2011, AM NAT, V177, P153, DOI 10.1086/657992; Espeleta JF, 2007, ECOL MONOGR, V77, P377, DOI 10.1890/06-1257.1; Evans J., 2004, PLANTATION FOREST TR, V3rd; FISHER RF, 1995, SOIL SCI SOC AM J, V59, P544, DOI 10.2136/sssaj1995.03615995005900020039x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fu SL, 2002, PLANT SOIL, V238, P289, DOI 10.1023/A:1014488128054; Giardina CP, 2002, ECOSYSTEMS, V5, P487, DOI 10.1007/s10021-002-0130-8; Goll DS, 2012, BIOGEOSCIENCES, V9, P3547, DOI 10.5194/bg-9-3547-2012; GONZALEZ JE, 1994, FOREST ECOL MANAG, V70, P159, DOI 10.1016/0378-1127(94)90083-3; Haggar J, 1997, FOREST ECOL MANAG, V99, P55, DOI 10.1016/S0378-1127(97)00194-1; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Herman DJ, 2006, SOIL SCI SOC AM J, V70, P1504, DOI 10.2136/sssaj2005.0113; Johnson DW, 2006, ECOLOGY, V87, P64, DOI 10.1890/04-1781; Jones DL, 2009, PLANT SOIL, V321, P5, DOI 10.1007/s11104-009-9925-0; KELLER M, 1994, GLOBAL BIOGEOCHEM CY, V8, P399, DOI 10.1029/94GB01660; KIRA TATUO, 1967, JAP J ECOL, V17, P70; Kleber M, 2007, GEODERMA, V138, P1, DOI 10.1016/j.geoderma.2006.10.004; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Levy PE, 1999, TREE PHYSIOL, V19, P53; Litton CM, 2007, GLOBAL CHANGE BIOL, V13, P2089, DOI 10.1111/j.1365-2486.2007.01420.x; Malhi Y, 2011, PHILOS T R SOC B, V366, P3225, DOI 10.1098/rstb.2011.0062; MARSCHNER H, 1994, PLANT SOIL, V159, P89, DOI 10.1007/BF00000098; Marschner H, 1996, J EXP BOT, V47, P1255, DOI 10.1093/jxb/47.Special_Issue.1255; McMurtrie RE, 2013, NEW PHYTOL, V199, P981, DOI 10.1111/nph.12344; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Monsi M, 2005, ANN BOT-LONDON, V95, P549, DOI 10.1093/aob/mci052; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Raich JW, 2007, FOREST ECOL MANAG, V239, P128, DOI 10.1016/j.foreco.2006.11.016; RAICH JW, 1989, ECOLOGY, V70, P1346, DOI 10.2307/1938194; Rastetter EB, 1997, ECOL APPL, V7, P444; REINERS WA, 1994, ECOL APPL, V4, P363, DOI 10.2307/1941940; Russell AE, 2007, SOIL SCI SOC AM J, V71, P1389, DOI 10.2136/sssaj2006.0069; Russell AE, 2012, P NATL ACAD SCI USA, V109, P10398, DOI 10.1073/pnas.1204157109; Russell AE, 2010, ECOL APPL, V20, P1087, DOI 10.1890/09-0635.1; Ryan MG, 1979, ADV ECOL RES, V27, P213; Schwendenmann L, 2003, BIOGEOCHEMISTRY, V64, P111, DOI 10.1023/A:1024941614919; Silver WL, 2000, RESTOR ECOL, V8, P394, DOI 10.1046/j.1526-100x.2000.80054.x; Sollins Phillip, 1994, P34; SOLTIS DE, 1995, P NATL ACAD SCI USA, V92, P2647, DOI 10.1073/pnas.92.7.2647; THORNLEY JH, 1972, ANN BOT-LONDON, V36, P431, DOI 10.1093/oxfordjournals.aob.a084602; Tinker P.B., 2000, SOLUTE MOVEMENT RHIZ, V2nd, DOI [10.1093/oso/9780195124927.001.0001, DOI 10.1093/OSO/9780195124927.001.0001]; Valverde-Barrantes OJ, 2007, CAN J FOREST RES, V37, P1954, DOI 10.1139/X07-057; Veldkamp E, 2003, GLOBAL CHANGE BIOL, V9, P1171, DOI 10.1046/j.1365-2486.2003.00656.x; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Wardle DA, 2004, SCIENCE, V305, P509, DOI 10.1126/science.1098778; Wareing PF, 1979, CONTROL GROWTH DIFFE; Wood TE, 2006, ECOSYSTEMS, V9, P700, DOI 10.1007/s10021-005-0016-7	62	36	39	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100275	10.1371/journal.pone.0100275	http://dx.doi.org/10.1371/journal.pone.0100275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945351	Green Published, gold			2022-12-25	WOS:000340721500057
J	Iop, L; Bonetti, A; Naso, F; Rizzo, S; Cagnin, S; Bianco, R; Dal Lin, C; Martini, P; Poser, H; Franci, P; Lanfranchi, G; Busetto, R; Spina, M; Basso, C; Marchini, M; Gandaglia, A; Ortolani, F; Gerosa, G				Iop, Laura; Bonetti, Antonella; Naso, Filippo; Rizzo, Stefania; Cagnin, Stefano; Bianco, Roberto; Dal Lin, Carlo; Martini, Paolo; Poser, Helen; Franci, Paolo; Lanfranchi, Gerolamo; Busetto, Roberto; Spina, Michel; Basso, Cristina; Marchini, Maurizio; Gandaglia, Alessandro; Ortolani, Fulvia; Gerosa, Gino			Decellularized Allogeneic Heart Valves Demonstrate Self-Regeneration Potential after a Long-Term Preclinical Evaluation	PLOS ONE			English	Article							AORTIC-VALVE; INTERSTITIAL-CELLS; PEDIATRIC-PATIENTS; JUVENILE SHEEP; EARLY FAILURE; STEM-CELLS; CALCIFICATION; TISSUE; BIOPROSTHESES; CONDUITS	Tissue-engineered heart valves are proposed as novel viable replacements granting longer durability and growth potential. However, they require extensive in vitro cell-conditioning in bioreactor before implantation. Here, the propensity of non-preconditioned decellularized heart valves to spontaneous in body self-regeneration was investigated in a large animal model. Decellularized porcine aortic valves were evaluated for right ventricular outflow tract (RVOT) reconstruction in Vietnamese Pigs (n = 11) with 6 (n = 5) and 15 (n = 6) follow-up months. Repositioned native valves (n = 2 for each time) were considered as control. Tissue and cell components from explanted valves were investigated by histology, immunohistochemistry, electron microscopy, and gene expression. Most substitutes constantly demonstrated in vivo adequate hemodynamic performances and ex vivo progressive repopulation during the 15 implantation months without signs of calcifications, fibrosis and/or thrombosis, as revealed by histological, immunohistochemical, ultrastructural, metabolic and transcriptomic profiles. Colonizing cells displayed native-like phenotypes and actively synthesized novel extracellular matrix elements, as collagen and elastin fibers. New mature blood vessels, i.e. capillaries and vasa vasorum, were identified in repopulated valves especially in the medial and adventitial tunicae of regenerated arterial walls. Such findings correlated to the up-regulated vascular gene transcription. Neoinnervation hallmarks were appreciated at histological and ultrastructural levels. Macrophage populations with reparative M2 phenotype were highly represented in repopulated valves. Indeed, no aspects of adverse/immune reaction were revealed in immunohistochemical and transcriptomic patterns. Among differentiated elements, several cells were identified expressing typical stem cell markers of embryonic, hematopoietic, neural and mesenchymal lineages in significantly higher number and specific topographic distribution in respect to control valves. Following the longest follow-up ever realized in preclinical models, non-preconditioned decellularized allogeneic valves offer suitable microenvironment for in vivo cell homing and tissue remodeling. Manufactured with simple, timesaving and cost-effective procedures, these promising valve replacements hold promise to become an effective alternative, especially for pediatric patients.	[Iop, Laura; Naso, Filippo; Rizzo, Stefania; Bianco, Roberto; Dal Lin, Carlo; Basso, Cristina; Gandaglia, Alessandro; Gerosa, Gino] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Padua, Italy; [Bonetti, Antonella; Marchini, Maurizio; Ortolani, Fulvia] Univ Udine, Dept Expt & Clin Med, I-33100 Udine, Italy; [Cagnin, Stefano; Martini, Paolo; Lanfranchi, Gerolamo] Univ Padua, Dept Biol, Padua, Italy; [Cagnin, Stefano; Martini, Paolo; Lanfranchi, Gerolamo] Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy; [Poser, Helen; Franci, Paolo; Busetto, Roberto] Univ Padua, Dept Anim Med Prod & Hlth, Legnaro, Italy; [Spina, Michel] Univ Padua, Dept Biomed Sci, Padua, Italy	University of Padua; University of Udine; University of Padua; University of Padua; University of Padua; University of Padua	Iop, L (corresponding author), Univ Padua, Dept Cardiac Thorac & Vasc Sci, Padua, Italy.	laura.iop@unipd.it	cagnin, stefano/E-9095-2011; Gerosa, Gino/M-8106-2014; Martini, Paolo/AAG-7398-2020; Iop, Laura/A-3761-2015; Bianco, Roberto/AAC-2343-2019	cagnin, stefano/0000-0001-7271-4625; Gerosa, Gino/0000-0002-6261-699X; Martini, Paolo/0000-0002-0146-1031; Iop, Laura/0000-0002-7034-9414; Bianco, Roberto/0000-0002-6485-1205; Gandaglia, Alessandro/0000-0002-0227-5257; Naso, Filippo/0000-0002-8198-8799; basso, cristina/0000-0002-0195-9753; Poser, Helen/0000-0003-2323-7708; Rizzo, Stefania/0000-0001-5969-4412	Italian grant Azione Biotech III;  [RSF 286/08]	Italian grant Azione Biotech III; 	Italian grants Azione Biotech III and RSF 286/08 (Veneto Region) supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa E, 2009, CIRCULATION, V119, P1785, DOI 10.1161/CIRCULATIONAHA.108.827972; Arciniegas E, 2005, ENDOTHELIUM-J ENDOTH, V12, P193, DOI 10.1080/10623320500227283; Bertipaglia B, 2003, ANN THORAC SURG, V75, P1274, DOI 10.1016/S0003-4975(02)04706-9; BINET JP, 1965, LANCET, V2, P1275; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Bottio T, 2010, J HEART VALVE DIS, V19, P485; Cebotari S, 2011, CIRCULATION, V124, pS115, DOI 10.1161/CIRCULATIONAHA.110.012161; Cho HJ, 2009, CURR ATHEROSCLER REP, V11, P206, DOI 10.1007/s11883-009-0032-8; Cicha I, 2011, CARDIOVASC PATHOL, V20, P222, DOI 10.1016/j.carpath.2010.04.006; Conti CA, 2010, MED ENG PHYS, V32, P212, DOI 10.1016/j.medengphy.2009.12.003; Dohmen PM, 2006, J HEART VALVE DIS, V15, P823; Dohmen PM, 2006, CIRC RES, V99, pE10, DOI 10.1161/01.RES.0000234909.24367.a9; Gallo M, 2012, ARTIF ORGANS, V36, pE138, DOI 10.1111/j.1525-1594.2012.01447.x; GENDLER E, 1984, J BIOMED MATER RES, V18, P727, DOI 10.1002/jbm.820180703; Grande KJ, 1998, ANN BIOMED ENG, V26, P534, DOI 10.1114/1.122; Han M, 2009, LIFE SCI, V84, P394, DOI 10.1016/j.lfs.2008.11.017; Heinrich EM, 2012, CIRC RES, V110, P1014, DOI 10.1161/CIRCRESAHA.111.243394; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Hopkins RA, 2009, J THORAC CARDIOV SUR, V137, P907, DOI 10.1016/j.jtcvs.2008.12.009; IDE C, 1983, BRAIN RES, V288, P61, DOI 10.1016/0006-8993(83)90081-1; Immenschuh S, 2005, ANTIOXID REDOX SIGN, V7, P768, DOI 10.1089/ars.2005.7.768; Iop L, 2009, BIOMATERIALS, V30, P4104, DOI 10.1016/j.biomaterials.2009.04.031; Konertz W, 2011, J HEART VALVE DIS, V20, P341; Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971; Leen LLS, 2008, ARTERIOSCL THROM VAS, V28, P2131, DOI 10.1161/ATVBAHA.108.167965; Manginas A, 2009, J HEART LUNG TRANSPL, V28, P710, DOI 10.1016/j.healun.2009.04.006; Mangold A, 2009, THORAC CARDIOV SURG, V57, P191, DOI 10.1055/s-0029-1185395; Manji RA, 2006, CIRCULATION, V114, P318, DOI 10.1161/CIRCULATIONAHA.105.549311; Mayer J E Jr, 1995, Semin Thorac Cardiovasc Surg, V7, P130; Naso F, 2011, ACTA BIOMATER, V7, P1728, DOI 10.1016/j.actbio.2010.11.030; Pettenazzo E, 2001, J THORAC CARDIOV SUR, V121, P500, DOI 10.1067/mtc.2001.112464; Rattazzi M, 2008, ARTERIOSCL THROM VAS, V28, P2165, DOI 10.1161/ATVBAHA.108.174342; Ruffer A, 2010, EUR J CARDIO-THORAC, V38, P78, DOI 10.1016/j.ejcts.2010.01.044; Samouillan V, 1999, J BIOMED MATER RES, V46, P531, DOI 10.1002/(SICI)1097-4636(19990915)46:4<531::AID-JBM11>3.0.CO;2-2; Sartore S, 1999, Rev Physiol Biochem Pharmacol, V134, P235; Schoen FJ, 2012, ANNU REV PATHOL-MECH, V7, P161, DOI 10.1146/annurev-pathol-011110-130257; Shin DH, 2005, DEV DYNAM, V233, P1589, DOI 10.1002/dvdy.20479; Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Steinhoff G, 2000, CIRCULATION, V102, P50; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; THIENE G, 1994, EUR J CARDIO-THORAC, V8, P476, DOI 10.1016/1010-7940(94)90017-5; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wu FS, 2009, BIOCHEM BIOPH RES CO, V386, P549, DOI 10.1016/j.bbrc.2009.06.075	44	56	56	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99593	10.1371/journal.pone.0099593	http://dx.doi.org/10.1371/journal.pone.0099593			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940754	Green Published, gold			2022-12-25	WOS:000338508200031
J	Fanghanel, S; Wadhwani, P; Strandberg, E; Verdurmen, WPR; Burck, J; Ehni, S; Mykhailiuk, PK; Afonin, S; Gerthsen, D; Komarov, IV; Brock, R; Ulrich, AS				Fanghaenel, Susanne; Wadhwani, Parvesh; Strandberg, Erik; Verdurmen, Wouter P. R.; Buerck, Jochen; Ehni, Sebastian; Mykhailiuk, Pavel K.; Afonin, Sergii; Gerthsen, Dagmar; Komarov, Igor V.; Brock, Roland; Ulrich, Anne S.			Structure Analysis and Conformational Transitions of the Cell Penetrating Peptide Transportan 10 in the Membrane-Bound State	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; BETA-SHEET TRANSITION; AMINO-ACID; NMR ANALYSIS; ALPHA-SYNUCLEIN; LIPID-BILAYERS; DRUG-DELIVERY; SDS MICELLES; PGLA	Structure analysis of the cell-penetrating peptide transportan 10 (TP10) revealed an exemplary range of different conformations in the membrane-bound state. The bipartite peptide (derived N-terminally from galanin and C-terminally from mastoparan) was found to exhibit prominent characteristics of (i) amphiphilic alpha-helices, (ii) intrinsically disordered peptides, as well as (iii) beta-pleated amyloid fibrils, and these conformational states become interconverted as a function of concentration. We used a complementary approach of solid-state F-19-NMR and circular dichroism in oriented membrane samples to characterize the structural and dynamical behaviour of TP10 in its monomeric and aggregated forms. Nine different positions in the peptide were selectively substituted with either the L-or D-enantiomer of 3-(trifluoromethyl)-bicyclopent-[1.1.1]-1-ylglycine (CF3-Bpg) as a reporter group for F-19-NMR. Using the L-epimeric analogs, a comprehensive three-dimensional structure analysis was carried out in lipid bilayers at low peptide concentration, where TP10 is monomeric. While the N-terminal region is flexible and intrinsically unstructured within the plane of the lipid bilayer, the C-terminal alpha-helix is embedded in the membrane with an oblique tilt angle of similar to 55 degrees and in accordance with its amphiphilic profile. Incorporation of the sterically obstructive D-CF3-Bpg reporter group into the helical region leads to a local unfolding of the membrane-bound peptide. At high concentration, these helix-destabilizing C-terminal substitutions promote aggregation into immobile beta-sheets, which resemble amyloid fibrils. On the other hand, the obstructive D-CF3-Bpg substitutions can be accommodated in the flexible N-terminus of TP10 where they do not promote aggregation at high concentration. The cross-talk between the two regions of TP10 thus exerts a delicate balance on its conformational switch, as the presence of the alpha-helix counteracts the tendency of the unfolded N-terminus to self-assemble into beta-pleated fibrils.	[Fanghaenel, Susanne; Ehni, Sebastian; Ulrich, Anne S.] Karlsruhe Inst Technol KIT, Inst Organ Chem, Karlsruhe, Germany; [Fanghaenel, Susanne; Ehni, Sebastian; Ulrich, Anne S.] Karlsruhe Inst Technol KIT, DFG Ctr Funct Nanostruct CFN, Karlsruhe, Germany; [Wadhwani, Parvesh; Strandberg, Erik; Buerck, Jochen; Afonin, Sergii; Ulrich, Anne S.] KIT, Inst Biol Interfaces IBG2, Karlsruhe, Germany; [Verdurmen, Wouter P. R.; Brock, Roland] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem, NL-6525 ED Nijmegen, Netherlands; [Mykhailiuk, Pavel K.] Taras Shevchenko Natl Univ Kyiv, Dept Chem, Kiev, Ukraine; [Mykhailiuk, Pavel K.] Enamine Ltd, Kiev, Ukraine; [Gerthsen, Dagmar] KIT, Lab Electron Microscopy, Karlsruhe, Germany; [Komarov, Igor V.] Taras Shevchenko Natl Univ Kyiv, Inst High Technol, Kiev, Ukraine	Helmholtz Association; Karlsruhe Institute of Technology; German Research Foundation (DFG); Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Radboud University Nijmegen; Ministry of Education & Science of Ukraine; Taras Shevchenko National University Kiev; Enamine Ltd; Helmholtz Association; Karlsruhe Institute of Technology; Ministry of Education & Science of Ukraine; Taras Shevchenko National University Kiev	Ulrich, AS (corresponding author), Karlsruhe Inst Technol KIT, Inst Organ Chem, Karlsruhe, Germany.	anne.ulrich@kit.edu	Mykhailiuk, Pavel/K-8262-2012; Gerthsen, Dagmar/I-4448-2012; Gerthsen, Dagmar/N-6245-2019; Verdurmen, Wouter/H-7457-2016; Komarov, Igor V./C-5467-2015; Brock, Roland/K-2590-2012; Afonin, Sergii/T-2737-2019; Brock, Roland/O-9411-2019; Ulrich, Anne S./H-5519-2013	Mykhailiuk, Pavel/0000-0003-1821-9011; Verdurmen, Wouter/0000-0002-2463-277X; Komarov, Igor V./0000-0002-7908-9145; Brock, Roland/0000-0003-1395-6127; Afonin, Sergii/0000-0002-2356-4226; Ulrich, Anne S./0000-0001-5571-9483; Strandberg, Erik/0000-0002-2401-7478; Wadhwani, Parvesh/0000-0002-7290-5154	DFG-Center for Functional Nanostructures [TP E1.2]; Radboud University Medical Centre, Nijmegen	DFG-Center for Functional Nanostructures(German Research Foundation (DFG)); Radboud University Medical Centre, Nijmegen	We acknowledge the DFG-Center for Functional Nanostructures for financial support (TP E1.2, and Z-project). Wouter Verdurmen was supported by funds from the Radboud University Medical Centre, Nijmegen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonin S, 2007, J PEPT SCI, V13, P614, DOI 10.1002/psc.854; Afonin S, 2006, CHEMPHYSCHEM, V7, P2134, DOI 10.1002/cphc.200600306; Afonin S, 2008, J AM CHEM SOC, V130, P16512, DOI 10.1021/ja803156d; Aisenbrey C, 2008, EUR BIOPHYS J BIOPHY, V37, P247, DOI 10.1007/s00249-007-0237-0; Almeida PF, 2009, BIOCHEMISTRY-US, V48, P8083, DOI 10.1021/bi900914g; Alves ID, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024096; Ambroggio EE, 2005, BIOPHYS J, V88, P2706, DOI 10.1529/biophysj.104.055582; Barany-Wallje E, 2004, FEBS LETT, V567, P265, DOI 10.1016/j.febslet.2004.04.079; Barany-Wallje E, 2007, FEBS LETT, V581, P2389, DOI 10.1016/j.febslet.2007.04.046; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Bond PJ, 2010, PROTEIN PEPTIDE LETT, V17, P1313; Burck J, 2008, BIOPHYS J, V95, P3872, DOI 10.1529/biophysj.108.136085; Clark KS, 2011, BIOCHEMISTRY-US, V50, P7919, DOI 10.1021/bi200873u; Comellas G, 2012, J AM CHEM SOC, V134, P5090, DOI 10.1021/ja209019s; CORNELL BA, 1988, BIOPHYS J, V53, P67, DOI 10.1016/S0006-3495(88)83066-2; Doran TM, 2012, J MOL BIOL, V421, P315, DOI 10.1016/j.jmb.2012.01.055; Dunkin CM, 2011, J PHYS CHEM B, V115, P1188, DOI 10.1021/jp107763b; Dupont E, 2011, METHODS MOL BIOL, V683, P21, DOI 10.1007/978-1-60761-919-2_2; Eggenberger K, 2011, CHEMBIOCHEM, V12, P132, DOI 10.1002/cbic.201000402; Eisenberg D, 2006, ACCOUNTS CHEM RES, V39, P568, DOI 10.1021/ar0500618; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Fischer R, 2005, CHEMBIOCHEM, V6, P2126, DOI 10.1002/cbic.200500044; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Glaser RW, 2005, BIOPHYS J, V88, P3392, DOI 10.1529/biophysj.104.056424; Glaser RW, 2004, J MAGN RESON, V168, P153, DOI 10.1016/j.jmr.2004.02.008; Glaser RW, 2003, J MAGN RESON, V164, P104, DOI 10.1016/S1090-7807(03)00207-6; Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006; Grage S, 2005, NMR SPECTROSCOPY BIO, P215; Grage SL, 2004, CHEM PHYS LIPIDS, V132, P65, DOI 10.1016/j.chemphyslip.2004.09.006; Grasnick D, 2011, EUR BIOPHYS J BIOPHY, V40, P529, DOI 10.1007/s00249-011-0676-5; Hebda JA, 2009, ANNU REV BIOPHYS, V38, P125, DOI 10.1146/annurev.biophys.050708.133622; Henriques ST, 2006, BIOCHEM J, V399, P1, DOI 10.1042/BJ20061100; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; Huang R, 2012, J MOL BIOL, V416, P108, DOI 10.1016/j.jmb.2011.12.023; Ieronimo M, 2010, J AM CHEM SOC, V132, P8822, DOI 10.1021/ja101608z; Janek K, 2001, BIOCHEMISTRY-US, V40, P5457, DOI 10.1021/bi002005e; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Jones SW, 2005, BRIT J PHARMACOL, V145, P1093, DOI 10.1038/sj.bjp.0706279; Kerth A, 2004, BIOPHYS J, V86, P3750, DOI 10.1529/biophysj.103.035964; Khafagy ES, 2012, ADV DRUG DELIVER REV, V64, P531, DOI 10.1016/j.addr.2011.12.014; Khemtemourian L, 2011, J AM CHEM SOC, V133, P15598, DOI 10.1021/ja205007j; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kilk K, 2005, J CONTROL RELEASE, V103, P511, DOI 10.1016/j.jconrel.2004.12.006; Koren E, 2011, DRUG DELIV, V18, P377, DOI 10.3109/10717544.2011.567310; Kubyshkin VS, 2011, FLUORINE PHARM MEDIN, P91; Langel U., 2002, CELL PENETRATING PEP, V1st ed; Langel U, 2007, HDB CELL PENETRATING; Lindberg M, 2001, BIOCHEMISTRY-US, V40, P3141, DOI 10.1021/bi0008985; Lindberg M, 2001, FEBS LETT, V497, P39, DOI 10.1016/S0014-5793(01)02433-4; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Magzoub M, 2001, BBA-BIOMEMBRANES, V1512, P77, DOI 10.1016/S0005-2736(01)00304-2; McKeown AN, 2011, BIOCHEMISTRY-US, V50, P654, DOI 10.1021/bi1013358; Meier M, 2008, J AM CHEM SOC, V130, P1017, DOI 10.1021/ja077231r; Meier M, 2007, J MOL BIOL, V369, P277, DOI 10.1016/j.jmb.2007.02.082; Mikhailiuk PK, 2006, ANGEW CHEM INT EDIT, V45, P5659, DOI 10.1002/anie.200600346; Mueller J, 2008, BIOCONJUGATE CHEM, V19, P2363, DOI 10.1021/bc800194e; Mykhailiuk PK, 2010, J FLUORINE CHEM, V131, P217, DOI 10.1016/j.jfluchem.2009.10.004; Naito A, 2007, BBA-BIOMEMBRANES, V1768, P1900, DOI 10.1016/j.bbamem.2007.03.025; Nakase I, 2012, ACCOUNTS CHEM RES, V45, P1132, DOI 10.1021/ar200256e; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nelson R, 2006, ADV PROTEIN CHEM, V73, P235, DOI 10.1016/S0065-3233(06)73008-X; OHMAN A, 1995, BBA-BIOMEMBRANES, V1236, P259, DOI 10.1016/0005-2736(95)00056-9; Orcellet ML, 2011, CURR PROTEIN PEPT SC, V12, P188; Padari K, 2005, BIOCONJUGATE CHEM, V16, P1399, DOI 10.1021/bc050125z; Pooga M, 1998, FASEB J, V12, P67, DOI 10.1096/fasebj.12.1.67; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Pujals S, 2006, BBA-BIOMEMBRANES, V1758, P264, DOI 10.1016/j.bbamem.2006.01.006; RANCE M, 1983, J MAGN RESON, V52, P221, DOI 10.1016/0022-2364(83)90190-7; Saalik P, 2004, BIOCONJUGATE CHEM, V15, P1246, DOI 10.1021/bc049938y; Saalik P, 2011, J CONTROL RELEASE, V153, P117, DOI 10.1016/j.jconrel.2011.03.011; Saar K, 2005, ANAL BIOCHEM, V345, P55, DOI 10.1016/j.ab.2005.07.033; Salwiczek M, 2010, AMINO ACIDS, V39, P1589, DOI 10.1007/s00726-010-0581-8; Sciarretta KL, 2006, METHOD ENZYMOL, V413, P273, DOI 10.1016/S0076-6879(06)13015-3; Soomets U, 2000, BBA-BIOMEMBRANES, V1467, P165, DOI 10.1016/S0005-2736(00)00216-9; Splith K, 2011, EUR BIOPHYS J BIOPHY, V40, P387, DOI 10.1007/s00249-011-0682-7; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Sreerama N, 1999, PROTEINS, V36, P400, DOI 10.1002/(SICI)1097-0134(19990901)36:4<400::AID-PROT3>3.0.CO;2-B; Strandberg E, 2006, BIOPHYS J, V90, P1676, DOI 10.1529/biophysj.105.073858; Strandberg E, 2008, BIOCHEMISTRY-US, V47, P2601, DOI 10.1021/bi701944r; Strandberg E, 2009, BIOPHYS J, V96, P3223, DOI 10.1016/j.bpj.2009.02.040; Strandberg E, 2009, BBA-BIOMEMBRANES, V1788, P1667, DOI 10.1016/j.bbamem.2008.12.018; TATEMOTO K, 1983, FEBS LETT, V164, P124, DOI 10.1016/0014-5793(83)80033-7; Tremouilhac P, 2006, J BIOL CHEM, V281, P32089, DOI 10.1074/jbc.M604759200; Ulrich AS, 2005, PROG NUCL MAG RES SP, V46, P1, DOI 10.1016/j.pnmrs.2004.11.001; Ulrich AS, 1999, BIOPHYS J, V77, P829, DOI 10.1016/S0006-3495(99)76935-3; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Wadhwani P, 2014, BBA-BIOMEMBRANES, V1838, P940, DOI 10.1016/j.bbamem.2013.11.001; Wadhwani P, 2013, PHYS CHEM CHEM PHYS, V15, P8962, DOI 10.1039/c3cp50896j; Wadhwani P, 2012, J AM CHEM SOC, V134, P6512, DOI 10.1021/ja301328f; Wadhwani P, 2012, EUR BIOPHYS J BIOPHY, V41, P177, DOI 10.1007/s00249-011-0771-7; Wadhwani P, 2008, J AM CHEM SOC, V130, P16515, DOI 10.1021/ja804928q; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Yandek LE, 2008, BIOCHEMISTRY-US, V47, P3051, DOI 10.1021/bi702205r; Yandek LE, 2007, BIOPHYS J, V92, P2434, DOI 10.1529/biophysj.106.100198; Zhang M, 2013, P NATL ACAD SCI USA, V110, P4828, DOI 10.1073/pnas.1220253110; ZHANG S, 1990, CHEM PHYS LETT, V173, P481, DOI 10.1016/0009-2614(90)87239-N	99	36	36	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99653	10.1371/journal.pone.0099653	http://dx.doi.org/10.1371/journal.pone.0099653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937132	Green Published, gold			2022-12-25	WOS:000338503400030
J	Golden, M; Muhire, BM; Semegni, Y; Martin, DP				Golden, Michael; Muhire, Brejnev M.; Semegni, Yves; Martin, Darren P.			Patterns of Recombination in HIV-1M Are Influenced by Selection Disfavouring the Survival of Recombinants with Disrupted Genomic RNA and Protein Structures	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INTERSUBTYPE RECOMBINATION; REVERSE-TRANSCRIPTASE; TYPE-1 RECOMBINATION; ACCEPTOR RNA; HOT-SPOTS; IN-VIVO; ARCHITECTURE; MECHANISM; GP120	Genetic recombination is a major contributor to the ongoing diversification of HIV. It is clearly apparent that across the HIV-genome there are defined recombination hot and cold spots which tend to co-localise both with genomic secondary structures and with either inter-gene boundaries or intra-gene domain boundaries. There is also good evidence that most recombination breakpoints that are detectable within the genes of natural HIV recombinants are likely to be minimally disruptive of intra-protein amino acid contacts and that these breakpoints should therefore have little impact on protein folding. Here we further investigate the impact on patterns of genetic recombination in HIV of selection favouring the maintenance of functional RNA and protein structures. We confirm that chimaeric Gag p24, reverse transcriptase, integrase, gp120 and Nef proteins that are expressed by natural HIV-1 recombinants have significantly lower degrees of predicted folding disruption than randomly generated recombinants. Similarly, we use a novel single-stranded RNA folding disruption test to show that there is significant, albeit weak, evidence that natural HIV recombinants tend to have genomic secondary structures that more closely resemble parental structures than do randomly generated recombinants. These results are consistent with the hypothesis that natural selection has acted both in the short term to purge recombinants with disrupted RNA and protein folds, and in the longer term to modify the genome architecture of HIV to ensure that recombination prone sites correspond with those where recombination will be minimally deleterious.	[Golden, Michael] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Muhire, Brejnev M.; Martin, Darren P.] Univ Cape Town, Computat Biol Grp, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Semegni, Yves] Cape Peninsula Univ Technol, Dept Math & Phys, Cape Town, South Africa	University of Oxford; University of Cape Town; Cape Peninsula University of Technology	Golden, M (corresponding author), Univ Oxford, Dept Stat, Oxford OX1 3TG, England.	golden@stats.ox.ac.uk	Golden, Michael/Q-3600-2019; Martin, Darren P/C-4599-2008; Martin, Darren/ABE-3614-2021	Golden, Michael/0000-0002-3653-8019; 	National Research Foundation innovation grant [NBIG UID 86935]; University of Cape Town	National Research Foundation innovation grant; University of Cape Town	This study was supported by a National Research Foundation innovation grant (NBIG UID 86935). BM was funded on a University of Cape Town bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agniswamy J, 2012, BIOCHEMISTRY-US, V51, P1041, DOI 10.1021/bi201809s; Archer J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000178; Baird HA, 2006, NUCLEIC ACIDS RES, V34, P5203, DOI 10.1093/nar/gkl669; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P5380, DOI 10.1073/pnas.0500729102; Escriu F, 2007, PLOS PATHOG, V3, P67, DOI 10.1371/journal.ppat.0030008; Fan J, 2007, INFECT GENET EVOL, V7, P717, DOI 10.1016/j.meegid.2007.07.012; FELSENSTEIN J, 1974, GENETICS, V78, P737; Galetto R, 2004, J BIOL CHEM, V279, P36625, DOI 10.1074/jbc.M405476200; Galli A, 2010, J VIROL, V84, P7651, DOI 10.1128/JVI.00276-10; Hanson MN, 2005, J MOL BIOL, V353, P772, DOI 10.1016/j.jmb.2005.08.065; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; Lefeuvre P, 2007, PLOS PATHOG, V3, P1782, DOI 10.1371/journal.ppat.0030181; Magiorkinis G, 2003, J GEN VIROL, V84, P2715, DOI 10.1099/vir.0.19180-0; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Martin DP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002203; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, PLOS GENET, V1, P475, DOI 10.1371/journal.pgen.0010051; Minin VN, 2007, GENETICS, V175, P1773, DOI 10.1534/genetics.106.066258; Moumen A, 2003, J BIOL CHEM, V278, P15973, DOI 10.1074/jbc.M212306200; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Onafuwa A, 2003, J VIROL, V77, P4577, DOI 10.1128/JVI.77.8.4577-4587.2003; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Rizk G, 2009, COMPUT SCI, V2009, P1; Rokyta DR, 2009, MOL BIOL EVOL, V26, P2831, DOI 10.1093/molbev/msp199; Shen W, 2009, J BIOL CHEM, V284, P33883, DOI 10.1074/jbc.M109.055368; Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614; Simon-Loriere E, 2010, J VIROL, V84, P12675, DOI 10.1128/JVI.01302-10; Simon-Loriere E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000418; Su HP, 2010, J VIROL, V84, P7625, DOI 10.1128/JVI.00353-10; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Tu XY, 2010, NAT STRUCT MOL BIOL, V17, P1202, DOI 10.1038/nsmb.1908; Voigt CA, 2002, NAT STRUCT BIOL, V9, P553, DOI 10.1038/nsb805; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Woo J, 2014, VIROLOGY IN PRESS; Zhang JY, 2000, J VIROL, V74, P2313, DOI 10.1128/JVI.74.5.2313-2322.2000; Zhuang JL, 2002, J VIROL, V76, P11273, DOI 10.1128/JVI.76.22.11273-11282.2002	39	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100400	10.1371/journal.pone.0100400	http://dx.doi.org/10.1371/journal.pone.0100400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936864	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400108
J	Maidhof, R; Jacobsen, T; Papatheodorou, A; Chahine, NO				Maidhof, Robert; Jacobsen, Timothy; Papatheodorou, Angelos; Chahine, Nadeen O.			Inflammation Induces Irreversible Biophysical Changes in Isolated Nucleus Pulposus Cells	PLOS ONE			English	Article							INTERVERTEBRAL DISC CELLS; AQUAPORIN 1 AQP1; TNF-ALPHA; GENE-EXPRESSION; ARTICULAR CHONDROCYTES; TISSUE DEGENERATION; WATER CHANNEL; IN-VITRO; MIGRATION; MATRIX	Intervertebral disc degeneration is accompanied by elevated levels of inflammatory cytokines that have been implicated in disease etiology and matrix degradation. While the effects of inflammatory stimulation on disc cell metabolism have been well-studied, their effects on cell biophysical properties have not been investigated. The hypothesis of this study is that inflammatory stimulation alters the biomechanical properties of isolated disc cells and volume responses to step osmotic loading. Cells from the nucleus pulposus (NP) of bovine discs were isolated and treated with either lipopolysaccharide (LPS), an inflammatory ligand, or with the recombinant cytokine TNF-alpha for 24 hours. We measured cellular volume regulation responses to osmotic loading either immediately after stimulation or after a 1 week recovery period from the inflammatory stimuli. Cells from each group were tested under step osmotic loading and the transient volume-response was captured via time-lapse microscopy. Volume-responses were analyzed using mixture theory framework to investigate two biomechanical properties of the cell, the intracellular water content and the hydraulic permeability. Intracellular water content did not vary between treatment groups, but hydraulic permeability increased significantly with inflammatory treatment. In the 1 week recovery group, hydraulic permeability remained elevated relative to the untreated recovery control. Cell radius was also significantly increased both after 24 hours of treatment and after 1 week recovery. A significant linear correlation was observed between hydraulic permeability and cell radius in untreated cells at 24 hours and at 1-week recovery, though not in the inflammatory stimulated groups at either time point. This loss of correlation between cell size and hydraulic permeability suggests that regulation of volume change is disrupted irreversibly due to inflammatory stimulation. Inflammatory treated cells exhibited altered F-actin cytoskeleton expression relative to untreated cells. We also found a significant decrease in the expression of aquaporin-1, the predominant water channel in disc NP cells, with inflammatory stimulation. To our knowledge, this is the first study providing evidence that inflammatory stimulation directly alters the mechanobiology of NP cells. The cellular biophysical changes observed in this study are coincident with documented changes in the extracellular matrix induced by inflammation, and may be important in disease etiology.	[Maidhof, Robert; Jacobsen, Timothy; Papatheodorou, Angelos; Chahine, Nadeen O.] North Shore LIJ Hlth Syst, Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY 11030 USA; [Chahine, Nadeen O.] Hofstra North Shore LIJ Sch Med, Hempstead, NY USA	Northwell Health; Hofstra University; Northwell Health	Chahine, NO (corresponding author), North Shore LIJ Hlth Syst, Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY 11030 USA.	nchahine@nshs.edu	Chahine, Nadeen/AAF-9975-2019; Chahine, Nadeen/O-5496-2015	Chahine, Nadeen/0000-0002-0478-6042; 	National Science Foundation [1151605]; Feinstein Institute for Medical Research	National Science Foundation(National Science Foundation (NSF)); Feinstein Institute for Medical Research	This work was funded in part by National Science Foundation (www.nsf.gov) CAREER Award 1151605 (NOC) and The Feinstein Institute for Medical Research (www.feinsteininstitute.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2002, SPINE, V27, P911, DOI 10.1097/00007632-200205010-00005; Albro MB, 2007, J BIOMECH ENG-T ASME, V129, P503, DOI 10.1115/1.2746371; Albro MB, 2009, BIOPHYS J, V97, P2886, DOI 10.1016/j.bpj.2009.09.011; Alexopoulos LG, 2002, J MICROSC-OXFORD, V205, P125, DOI 10.1046/j.0022-2720.2001.00976.x; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; Ateshian GA, 2006, J BIOMECH, V39, P464, DOI 10.1016/j.jbiomech.2004.12.013; Bachmeier BE, 2007, ANN NY ACAD SCI, V1096, P44, DOI 10.1196/annals.1397.069; Burke JG, 2003, SPINE, V28, P2685, DOI 10.1097/01.BRS.0000103341.45133.F3; Burke JG, 2002, J BONE JOINT SURG BR, V84B, P196, DOI 10.1302/0301-620X.84B2.12511; Bush PG, 2001, J ORTHOP RES, V19, P768, DOI 10.1016/S0736-0266(01)00013-4; Cao L, 2011, BIOMECH MODEL MECHAN, V10, P1, DOI 10.1007/s10237-010-0214-x; Chao PG, 2005, J BIOMECH, V38, P1273, DOI 10.1016/j.jbiomech.2004.06.016; Demoor-Fossard M, 1999, MOL CELL BIOCHEM, V199, P69, DOI 10.1023/A:1006947015094; Frenkel SR, 1996, ARTHRITIS RHEUM, V39, P1905, DOI 10.1002/art.1780391118; Gov NS, 2005, BIOPHYS J, V88, P1859, DOI 10.1529/biophysj.104.045328; GRONOWICZ G, 1992, J PERIODONTAL RES, V27, P562, DOI 10.1111/j.1600-0765.1992.tb01737.x; Guilak F, 1999, SPINE, V24, P2475, DOI 10.1097/00007632-199912010-00009; Horner HA, 2002, SPINE, V27, P1018, DOI 10.1097/00007632-200205150-00004; Hu J, 2006, FASEB J, V20, P1892, DOI 10.1096/fj.06-5930fje; HUMZAH MD, 1988, ANAT RECORD, V220, P337, DOI 10.1002/ar.1092200402; KWANT W O, 1970, Journal of General Physiology, V55, P208, DOI 10.1085/jgp.55.2.208; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Liang HT, 2008, CLIN EXP PHARMACOL P, V35, P7, DOI 10.1111/j.1440-1681.2007.04808.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Massey CJ, 2012, J ORTHOP RES, V30, P122, DOI 10.1002/jor.21475; Mavrogonatou E, 2012, J CELL PHYSIOL, V227, P1179, DOI 10.1002/jcp.22840; Mobasheri A, 2010, ANN ANAT, V192, P116, DOI 10.1016/j.aanat.2010.01.001; Monzani E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006167; Musumeci G, 2013, TISSUE CELL, V45, P145, DOI 10.1016/j.tice.2012.10.004; Neidlinger-Wilke C, 2006, EUR SPINE J, V15, pS372, DOI 10.1007/s00586-006-0112-1; Neidlinger-Wilke C, 2012, J ORTHOP RES, V30, P112, DOI 10.1002/jor.21481; PEARCE RH, 1987, J ORTHOP RES, V5, P198, DOI 10.1002/jor.1100050206; Pritchard S, 2002, BIOPHYS J, V83, P2502, DOI 10.1016/S0006-3495(02)75261-2; Rajan N., 2012, SPINE PHILA PA 1976; Richardson SM, 2008, J MOL HISTOL, V39, P303, DOI 10.1007/s10735-008-9166-1; Roughley PJ, 2002, BIOCHEM SOC T, V30, P869, DOI 10.1042/BST0300869; Seguin CA, 2008, SPINE, V33, P356, DOI 10.1097/BRS.0b013e3181642a5e; Seguin CA, 2006, MATRIX BIOL, V25, P409, DOI 10.1016/j.matbio.2006.07.002; Setton LA, 2006, J BONE JOINT SURG AM, V88A, P52, DOI 10.2106/JBJS.F.00001; Sivan S, 2006, BIORHEOLOGY, V43, P283; Su X, 2004, RESP PHYSIOL NEUROBI, V142, P1, DOI 10.1016/j.resp.2004.05.001; URBAN JPG, 1988, SPINE, V13, P179, DOI 10.1097/00007632-198802000-00009; Urban JPG, 2002, BIOCHEM SOC T, V30, P858, DOI 10.1042/bst0300858; Urban JPG, 2000, AM ZOOL, V40, P53, DOI 10.1668/0003-1569(2000)040[0053:TNOTID]2.0.CO;2; Wuertz K, 2007, J ORTHOP RES, V25, P1513, DOI 10.1002/jor.20436	46	36	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99621	10.1371/journal.pone.0099621	http://dx.doi.org/10.1371/journal.pone.0099621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936787	Green Submitted, Green Published, gold			2022-12-25	WOS:000338503400027
J	Li, JQ; Wu, B; Xu, J; Liu, C				Li, Jianqin; Wu, Bin; Xu, Jiang; Liu, Chang			Genome-Wide Identification and Characterization of Long Intergenic Non-Coding RNAs in Ganoderma lucidum	PLOS ONE			English	Article							TRANSCRIPTION INITIATION; GENE; EXPRESSION; CHROMATIN; ARABIDOPSIS; EVOLUTION; SEQUENCE; REVEALS; COMPLEXITY; ASSOCIATE	Ganoderma lucidum is a white-rot fungus best-known for its medicinal activities. We have previously sequenced its genome and annotated the protein coding genes. However, long non-coding RNAs in G. lucidum genome have not been analyzed. In this study, we have identified and characterized long intergenic non-coding RNAs (lincRNA) in G. lucidum systematically. We developed a computational pipeline, which was used to analyze RNA-Seq data derived from G. lucidum samples collected from three developmental stages. A total of 402 lincRNA candidates were identified, with an average length of 609 bp. Analysis of their adjacent protein-coding genes (apcGenes) revealed that 46 apcGenes belong to the pathways of triterpenoid biosynthesis and lignin degradation, or families of cytochrome P450, mating type B genes, and carbohydrate-active enzymes. To determine if lincRNAs and these apcGenes have any interactions, the corresponding pairs of lincRNAs and apcGenes were analyzed in detail. We developed a modified 39 RACE method to analyze the transcriptional direction of a transcript. Among the 46 lincRNAs, 37 were found unidirectionally transcribed, and 9 were found bidirectionally transcribed. The expression profiles of 16 of these 37 lincRNAs were found to be highly correlated with those of the apcGenes across the three developmental stages. Among them, 11 are positively correlated (r>0.8) and 5 are negatively correlated (r<-0.8). The co-localization and co-expression of lincRNAs and those apcGenes playing important functions is consistent with the notion that lincRNAs might be important regulators for cellular processes. In summary, this represents the very first study to identify and characterize lincRNAs in the genomes of basidiomycetes. The results obtained here have laid the foundation for study of potential lincRNA-mediated expression regulation of genes in G. lucidum.	[Liu, Chang] Chinese Acad Med Sci, Inst Med Plant Dev, Ctr Bioinformat, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, C (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Ctr Bioinformat, Beijing 100730, Peoples R China.	cliu6688@yahoo.com	Liu, Chang/A-1148-2014		National Science Foundation of China [81373912, 81274015]; Chinese Academy of Medical Science [431118]; Basic Scientific Research Operation Grants for State-Level Public Welfare Scientific Research Initiatives [YZ-12-04]; research grant for returned Overseas Chinese Scholars, and Ministry of Human Resources [431207]; Program for Changjiang Scholars and Innovative Research Team in the University from Ministry of Education of China [IRT1150]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Medical Science; Basic Scientific Research Operation Grants for State-Level Public Welfare Scientific Research Initiatives; research grant for returned Overseas Chinese Scholars, and Ministry of Human Resources(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Program for Changjiang Scholars and Innovative Research Team in the University from Ministry of Education of China	This study was supported by the National Science Foundation of China granted to C. Liu (Grant No. 81373912), a start fund from the Chinese Academy of Medical Science (Grant No. 431118), the Basic Scientific Research Operation Grants for State-Level Public Welfare Scientific Research Initiatives (Grant No. YZ-12-04), a research grant for returned Overseas Chinese Scholars, and Ministry of Human Resources (Grant No. 431207). This study was also supported by the National Science Foundation of China (Grant No. 81274015) granted to B. Wu and the Program for Changjiang Scholars and Innovative Research Team in the University from Ministry of Education of China (Grant No. IRT1150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; Bertani S, 2011, MOL CELL, V43, P1040, DOI 10.1016/j.molcel.2011.08.019; Boh B, 2007, BIOTECHNOL ANN REV, V13, P265, DOI 10.1016/S1387-2656(07)13010-6; Bumgarner SL, 2009, P NATL ACAD SCI USA, V106, P18321, DOI 10.1073/pnas.0909641106; Burleigh SH, 1999, PLANT PHYSIOL, V119, P241, DOI 10.1104/pp.119.1.241; Burleigh SH, 1997, PLANT MOL BIOL, V34, P199, DOI 10.1023/A:1005841119665; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Costa FF, 2010, BIOESSAYS, V32, P599, DOI 10.1002/bies.200900112; CRESPI MD, 1994, EMBO J, V13, P5099, DOI 10.1002/j.1460-2075.1994.tb06839.x; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dinger ME, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000176; Djebali S, 2008, NAT METHODS, V5, P629, DOI 10.1038/nmeth.1216; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hainer SJ, 2011, GENE DEV, V25, P29, DOI 10.1101/gad.1975011; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Hirsch J, 2006, PLANT PHYSIOL, V140, P1192, DOI 10.1104/pp.105.073817; Houseley J, 2008, MOL CELL, V32, P685, DOI 10.1016/j.molcel.2008.09.027; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Jiang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052734; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kaushik K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083616; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Kurihara Y, 2009, P NATL ACAD SCI USA, V106, P2453, DOI 10.1073/pnas.0808902106; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Liu CM, 1997, PLANT MOL BIOL, V33, P867, DOI 10.1023/A:1005729309569; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; MacIntosh GC, 2001, PLANT PHYSIOL, V127, P765, DOI 10.1104/pp.010501; Maenner S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000276; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Martin AC, 2000, PLANT J, V24, P559, DOI 10.1046/j.1365-313x.2000.00893.x; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Park J, 2008, BIOINFORMATICS, V24, P1024, DOI 10.1093/bioinformatics/btn058; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Pollier J, 2013, NATURE, V504, P148, DOI 10.1038/nature12685; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Rymarquis LA, 2008, TRENDS PLANT SCI, V13, P329, DOI 10.1016/j.tplants.2008.02.009; Sanodiya BS, 2009, CURR PHARM BIOTECHNO, V10, P717, DOI 10.2174/138920109789978757; Shin H, 2006, PLANT J, V45, P712, DOI 10.1111/j.1365-313X.2005.02629.x; Sugiyama R, 2003, DNA RES, V10, P213, DOI 10.1093/dnares/10.5.213; Sun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075750; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Szell M, 2008, SEMIN CANCER BIOL, V18, P141, DOI 10.1016/j.semcancer.2008.01.007; Teramoto H, 1996, PLANT MOL BIOL, V32, P797, DOI 10.1007/BF00020478; Thiebaut M, 2008, MOL CELL, V31, P671, DOI 10.1016/j.molcel.2008.08.010; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wen Jiayu, 2007, In Silico Biology, V7, P485; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Wu B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-15; Xin MM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-61; Young RS, 2012, GENOME BIOL EVOL, V4, P427, DOI 10.1093/gbe/evs020	71	11	12	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99442	10.1371/journal.pone.0099442	http://dx.doi.org/10.1371/journal.pone.0099442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932683	Green Published, Green Submitted, gold			2022-12-25	WOS:000337738600035
J	Rosato, RR; Fernandez, R; Paz, LI; Singh, CR; Rosato, AE				Rosato, Roberto R.; Fernandez, Regina; Paz, Liliana I.; Singh, Christopher R.; Rosato, Adriana E.			TCA Cycle-Mediated Generation of ROS Is a Key Mediator for HeR-MRSA Survival under beta-Lactam Antibiotic Exposure	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; BACTERICIDAL ANTIBIOTICS; METHICILLIN RESISTANCE; ESCHERICHIA-COLI; CLINICAL STRAINS; CELL-DEATH; PHENOTYPIC-EXPRESSION; SUPEROXIDE-DISMUTASE; INDUCED MUTAGENESIS; HYDROGEN-PEROXIDE	Methicillin-resistant Staphylococcus aureus (MRSA) is a major multidrug resistant pathogen responsible for several difficult-to-treat infections in humans. Clinical Hetero-resistant (HeR) MRSA strains, mostly associated with persistent infections, are composed of mixed cell populations that contain organisms with low levels of resistance (hetero-resistant HeR) and those that display high levels of drug resistance (homo-resistant HoR). However, the full understanding of beta-lactam-mediated HeR/HoR selection remains to be completed. In previous studies we demonstrated that acquisition of the HoR phenotype during exposure to beta-lactam antibiotics depended on two key elements: (1) activation of the SOS response, a conserved regulatory network in bacteria that is induced in response to DNA damage, resulting in increased mutation rates, and (2) adaptive metabolic changes redirecting HeR-MRSA metabolism to the tricarboxylic acid (TCA) cycle in order to increase the energy supply for cell-wall synthesis. In the present work, we identified that both main mechanistic components are associated through TCA cycle-mediated reactive oxygen species (ROS) production, which temporally affects DNA integrity and triggers activation of the SOS response resulting in enhanced mutagenesis. The present work brings new insights into a role of ROS generation on the development of resistance to beta-lactam antibiotics in a model of natural occurrence, emphasizing the cytoprotective role in HeR-MRSA survival mechanism.	[Rosato, Roberto R.; Fernandez, Regina; Paz, Liliana I.; Singh, Christopher R.; Rosato, Adriana E.] Houston Methodist Res Inst, Ctr Mol & Translat Human Infect Dis Res, Houston, TX 77030 USA; [Rosato, Adriana E.] Houston Methodist Hosp, Dept Pathol & Genom Med, Houston, TX USA	The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston	Rosato, AE (corresponding author), Houston Methodist Res Inst, Ctr Mol & Translat Human Infect Dis Res, Houston, TX 77030 USA.	aerosato@HoustonMethodist.org		Rosato, Adriana E./0000-0001-6115-6955	National Institutes of Health [5R01AI080688-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by National Institutes of Health grant 5R01AI080688-03 to A. E. Rosato (principal investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba Y, 2013, ANTIMICROB AGENTS CH, V57, P4861, DOI 10.1128/AAC.00720-13; Baharoglu Z, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003421; Ballal A, 2009, J BACTERIOL, V191, P3301, DOI 10.1128/JB.01496-08; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; CHAMBERS HF, 1990, J INFECT DIS, V161, P1170, DOI 10.1093/infdis/161.6.1170; Chittezham TV, 2013, MBIO, V4, DOI [10.1128/mBio.00437-13, DOI 10.1128/MBIO.00437-13]; Chung M, 2008, ANTIMICROB AGENTS CH, V52, P2709, DOI 10.1128/AAC.00266-08; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Cuirolo A, 2009, J ANTIMICROB CHEMOTH, V64, P37, DOI 10.1093/jac/dkp164; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; Dengler V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073512; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; Ender M, 2008, INT J MED MICROBIOL, V298, P607, DOI 10.1016/j.ijmm.2008.01.015; Fernandez JL, 2008, APPL ENVIRON MICROB, V74, P5925, DOI 10.1128/AEM.00318-08; FIGUEIREDO AMS, 1991, J INFECT DIS, V164, P883, DOI 10.1093/infdis/164.5.883; Finan JE, 2002, ANTIMICROB AGENTS CH, V46, P24, DOI 10.1128/AAC.46.1.24-30.2002; Forbes BA, 2008, DIAGN MICR INFEC DIS, V61, P387, DOI 10.1016/j.diagmicrobio.2008.04.003; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Goldstein F, 2007, ANTIMICROB AGENTS CH, V51, P2514, DOI 10.1128/AAC.00040-07; Gutierrez A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2607; HACKBARTH CJ, 1994, ANTIMICROB AGENTS CH, V38, P2568, DOI 10.1128/AAC.38.11.2568; HARTMAN BJ, 1984, J BACTERIOL, V158, P513, DOI 10.1128/JB.158.2.513-516.1984; HARTMAN BJ, 1986, ANTIMICROB AGENTS CH, V29, P85, DOI 10.1128/AAC.29.1.85; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Keaton MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071025; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kim C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082814; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Ledala N, 2014, J BACTERIOL, V196, P2178, DOI 10.1128/JB.01475-14; Liu YL, 2012, ANTIMICROB AGENTS CH, V56, P6048, DOI 10.1128/AAC.00754-12; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mosel M, 2013, ANTIMICROB AGENTS CH, V57, P5755, DOI 10.1128/AAC.00754-13; MURAKAMI K, 1989, J BACTERIOL, V171, P874, DOI 10.1128/jb.171.2.874-879.1989; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; NEWTON GL, 1993, J BACTERIOL, V175, P2734, DOI 10.1128/JB.175.9.2734-2742.1993; NOVOGRODSKY A, 1982, P NATL ACAD SCI-BIOL, V79, P1171, DOI 10.1073/pnas.79.4.1171; Plata KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061083; Plata KB, 2011, ANTIMICROB AGENTS CH, V55, P3176, DOI 10.1128/AAC.01119-09; REPINE JE, 1981, J BIOL CHEM, V256, P7094; Rohrer S, 2003, J MED MICROBIOL, V52, P605, DOI 10.1099/jmm.0.05176-0; TOMASZ A, 1991, ANTIMICROB AGENTS CH, V35, P124, DOI 10.1128/AAC.35.1.124; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; Wang XH, 2009, ANTIMICROB AGENTS CH, V53, P1395, DOI 10.1128/AAC.01087-08; Werth BJ, 2013, ANTIMICROB AGENTS CH, V57, P2664, DOI 10.1128/AAC.02308-12; Wilhelm J, 2009, MOL CELL BIOCHEM, V328, P167, DOI 10.1007/s11010-009-0086-5; Yeom J, 2010, J BIOL CHEM, V285, P22689, DOI 10.1074/jbc.M110.127456	53	35	35	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99605	10.1371/journal.pone.0099605	http://dx.doi.org/10.1371/journal.pone.0099605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932751	Green Published, Green Submitted, gold			2022-12-25	WOS:000337738600046
J	Xu, B; Li, Z; Yue, J; Jin, L; Li, YF; Ai, JH; Zhang, HW; Zhu, GJ				Xu, Bei; Li, Zhou; Yue, Jing; Jin, Lei; Li, Yufeng; Ai, Jihui; Zhang, Hanwang; Zhu, Guijin			Effect of Dehydroepiandrosterone Administration in Patients with Poor Ovarian Response According to the Bologna Criteria	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; GROWTH-FACTOR-I; ANDROGEN SUPPLEMENTATION; WOMEN; DHEA; STIMULATION; IVF; EXPRESSION; IMPROVES; HORMONE	Background: Dehydroepiandrosterone (DHEA) is now widely used as an adjuvant to IVF treatment protocols in poor responders. However, clinical evidence for DHEA on improvement of ovarian response and IVF outcome is still limited, the validity of the results of the earlier studies, especially the varied inclusion criteria, is a subject of debate. Recently, the ESHRE Working Group developed a new definition, the Bologna criteria. The aim of the current study was to investigate the potential effect of DHEA treatment on in vitro fertilization (IVF) outcome of poor ovarian responders that fulfill the Bologna criteria. Methods: This study investigated 386 poor ovarian responders that fulfill the Bologna criteria. Patients underwent IVF-ET treatment with the GnRH antagonist protocol. The study group contained 189 patients, who received 75 mg of DHEA daily (25 mg three times daily) before the IVF cycle. The control group was composed of 197 patients who received infertility treatment, but did not receive DHEA. The IVF outcome parameters in each group were compared. Results: The study and control groups did not show statistically significant differences in terms of patient demographics characteristics, mean numbers of oocytes retrieved, mature oocytes, fertilization rate, cleavage rate, or embryo availability. While the DHEA group demonstrated significantly higher implantation rates (18.7% vs. 10.1%; P<0.01) and ongoing PRs (26.7% vs. 15.8%; P<0.05) as compared with the control. Conclusions: DHEA pre-treatment does not significantly increase oocyte yield. However, the ongoing PRs in this subgroup of women are significantly higher after DHEA administration, suggesting that DHEA may increase IVF results by improving oocyte and embryo quality.	[Xu, Bei; Li, Zhou; Yue, Jing; Jin, Lei; Li, Yufeng; Ai, Jihui; Zhang, Hanwang; Zhu, Guijin] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Reprod Med Ctr, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Zhu, GJ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Reprod Med Ctr, Wuhan 430074, Peoples R China.	zhu_guijin@sina.com		Li, Yufeng/0000-0003-3906-8144	National Natural Sciences Foundation of China [30901601, 81170619]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by research grants from the National Natural Sciences Foundation of China (30901601, 81170619). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CY, 2008, FERTIL STERIL, V89, P1760, DOI 10.1016/j.fertnstert.2007.05.003; Barad D, 2005, FERTIL STERIL, V84, P374, DOI 10.1016/j.fertnstert.2005.01.132; Barad D, 2007, J ASSIST REPROD GEN, V24, P629, DOI 10.1007/s10815-007-9178-x; Barad D, 2006, HUM REPROD, V21, P2845, DOI 10.1093/humrep/del254; Bosdou JK, 2012, HUM REPROD UPDATE, V18, P127, DOI 10.1093/humupd/dmr051; Casson PR, 1998, FERTIL STERIL, V70, P107, DOI 10.1016/S0015-0282(98)00121-6; Feigenberg T, 2009, REPROD BIOMED ONLINE, V19, P888, DOI 10.1016/j.rbmo.2009.09.012; Ferraretti AP, 2011, HUM REPROD, V26, P1616, DOI 10.1093/humrep/der092; Gleicher N, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-140; Gleicher N, 2010, REPROD BIOMED ONLINE, V21, P440, DOI 10.1016/j.rbmo.2010.06.042; Gleicher N, 2010, REPROD BIOMED ONLINE, V21, P360, DOI 10.1016/j.rbmo.2010.04.006; Gleicher N, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-108; Harper AJ, 1999, SEMIN REPROD ENDOCR, V17, P327; HILLIER SG, 1994, MOL CELL ENDOCRINOL, V100, P51, DOI 10.1016/0303-7207(94)90278-X; IVF Worldwide Survey, POOR RESP DEF DIAGN; Kara M, 2014, EUR J OBSTET GYN R B, V173, P63, DOI 10.1016/j.ejogrb.2013.11.008; Keay SD, 1997, BRIT J OBSTET GYNAEC, V104, P521, DOI 10.1111/j.1471-0528.1997.tb11525.x; Kolibianakis EM, 2011, HUM REPROD, V26, P730, DOI 10.1093/humrep/deq397; Loutradis D, 2008, CURR OPIN OBSTET GYN, V20, P374, DOI 10.1097/GCO.0b013e328305b9b8; Mamas L, 2009, FERTIL STERIL, V91, P644, DOI 10.1016/j.fertnstert.2007.11.055; Menezo Y, 2010, ZYGOTE, V18, P357, DOI 10.1017/S0967199410000286; Narkwichean A, 2014, HUM REPROD, V29, P146, DOI 10.1093/humrep/det408; Narkwichean A, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-44; Nielsen ME, 2011, MOL HUM REPROD, V17, P63, DOI 10.1093/molehr/gaq073; Pandian Z, 2010, COCHRANE DB SYST REV, V1; Pitteloud N, 2005, DIABETES CARE, V28, P1636, DOI 10.2337/diacare.28.7.1636; Polyzos NP, 2011, FERTIL STERIL, V96, P1058, DOI 10.1016/j.fertnstert.2011.09.048; Sen A, 2010, MOL ENDOCRINOL, V24, P1393, DOI 10.1210/me.2010-0006; Sonmezer M, 2009, REPROD BIOMED ONLINE, V19, P508; Sunkara SK, 2012, HUM REPROD, V27, P637, DOI 10.1093/humrep/der464; Sunkara SK, 2011, REPROD BIOMED ONLINE, V22, P545, DOI 10.1016/j.rbmo.2011.01.015; Tarlatzis BC, 2003, HUM REPROD UPDATE, V9, P61, DOI 10.1093/humupd/dmg007; Vendola K, 1999, BIOL REPROD, V61, P353, DOI 10.1095/biolreprod61.2.353; Vendola KA, 1998, J CLIN INVEST, V101, P2622, DOI 10.1172/JCI2081; Weil S, 1999, J CLIN ENDOCR METAB, V84, P2951, DOI 10.1210/jc.84.8.2951; Weil SJ, 1998, J CLIN ENDOCR METAB, V83, P2479, DOI 10.1210/jc.83.7.2479; Wiser A, 2010, HUM REPROD, V25, P2496, DOI 10.1093/humrep/deq220; Younis JS, 2012, HUM REPROD, V27, P1874, DOI 10.1093/humrep/des118	38	32	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99858	10.1371/journal.pone.0099858	http://dx.doi.org/10.1371/journal.pone.0099858			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932478	gold, Green Published, Green Submitted			2022-12-25	WOS:000337738600073
J	Ikuo, M; Nagano, G; Saito, Y; Mao, H; Sekimizu, K; Kaito, C				Ikuo, Mariko; Nagano, Gentaro; Saito, Yuki; Mao, Han; Sekimizu, Kazuhisa; Kaito, Chikara			Inhibition of Exotoxin Production by Mobile Genetic Element SCCmec-Encoded psm-mec RNA Is Conserved in Staphylococcal Species	PLOS ONE			English	Article							AGR LOCUS; EPIDERMIDIS; VIRULENCE; AUREUS; BACTEREMIA; RESISTANCE; INFECTION; EVOLUTION; PEPTIDES; CAPACITY	Staphylococcal species acquire antibiotic resistance by incorporating the mobile-genetic element SCCmec. We previously found that SCCmec-encoded psm-mec RNA suppresses exotoxin production as a regulatory RNA, and the psm-mec translation product increases biofilm formation in Staphylococcus aureus. Here, we examined whether the regulatory role of psm-mec on host bacterial virulence properties is conserved among other staphylococcal species, S. epidermidis and S. haemolyticus, both of which are important causes of nosocomial infections. In S. epidermidis, introduction of psm-mec decreased the production of cytolytic toxins called phenol-soluble modulins (PSMs) and increased biofilm formation. Introduction of psm-mec with a stop-codon mutation that did not express PSM-mec protein but did express psm-mec RNA also decreased PSM production, but did not increase biofilm formation. Thus, the psm-mec RNA inhibits PSM production, whereas the PSM-mec protein increases biofilm formation in S. epidermidis. In S. haemolyticus, introduction of psm-mec decreased PSM production, but did not affect biofilm formation. The mutated psm-mec with a stop-codon also caused the same effect. Thus, the psm-mec RNA also inhibits PSM production in S. haemolyticus. These findings suggest that the inhibitory role of psm-mec RNA on exotoxin production is conserved among staphylococcal species, although the stimulating effect of the psm-mec gene on biofilm formation is not conserved.	[Ikuo, Mariko; Nagano, Gentaro; Saito, Yuki; Mao, Han; Sekimizu, Kazuhisa; Kaito, Chikara] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Kaito, C (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, Tokyo, Japan.	kaito@mol.f.u-tokyo.ac.jp	Kaito, Chikara/G-1248-2017; Kaito, Chikara/W-1815-2019	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386	Genome Pharmaceutical Institute;  [23249009];  [24590519];  [25117507]	Genome Pharmaceutical Institute; ; ; 	This study was supported by Grants-in-Aid for Scientific Research (23249009, 24590519, 25117507). This study was supported in part by the Genome Pharmaceutical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brzychczy-Wloch M, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-41; Chabelskaya S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000927; Chatterjee SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028781; Cheung GYC, 2014, FEMS MICROBIOL REV, V38, P698, DOI 10.1111/1574-6976.12057; Cheung GYC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001133; Cheung GYC, 2010, CURR OPIN INFECT DIS, V23, P208, DOI 10.1097/QCO.0b013e328337fecb; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Dufour P, 2002, J BACTERIOL, V184, P1180, DOI 10.1128/jb.184.4.1180-1186.2002; Fischetti VA, 2006, GRAM POSITIVE PATHOG, Vxiii; Fowler VG, 2004, J INFECT DIS, V190, P1140, DOI 10.1086/423145; Kaito C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003269; Kaito C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001267; Kaito C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003921; Kiedrowski MR, 2011, ANN NY ACAD SCI, V1241, P104, DOI 10.1111/j.1749-6632.2011.06281.x; Kretschmer D, 2012, J INNATE IMMUN, V4, P201, DOI 10.1159/000332142; Lindsay JA, 2010, INT J MED MICROBIOL, V300, P98, DOI 10.1016/j.ijmm.2009.08.013; McNamara PJ, 1998, J BACTERIOL, V180, P2609, DOI 10.1128/JB.180.10.2609-2615.1998; Monecke S, 2012, MOL CELL PROBE, V26, P99, DOI 10.1016/j.mcp.2012.01.001; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Paulander W, 2012, MBIO, V3, DOI 10.1128/mBio.00459-12; Peschel A, 2013, NAT REV MICROBIOL, V11, P667, DOI 10.1038/nrmicro3110; Pfeiffer V, 2007, MOL MICROBIOL, V66, P1174, DOI 10.1111/j.1365-2958.2007.05991.x; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Queck SY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000533; Raimundo O, 2002, J HOSP INFECT, V51, P33, DOI 10.1053/jhin.2002.1203; Sakoulas G, 2002, ANTIMICROB AGENTS CH, V46, P1492, DOI 10.1128/AAC.46.5.1492-1502.2002; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; SCHLEIFER KH, 1975, INT J SYST BACTERIOL, V25, P50, DOI 10.1099/00207713-25-1-50; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; SCHWALBE RS, 1987, NEW ENGL J MED, V316, P927, DOI 10.1056/NEJM198704093161507; Somerville GA, 2002, J BACTERIOL, V184, P1430, DOI 10.1128/JB.184.5.1430-1437.2002; Traber K, 2006, MOL MICROBIOL, V59, P1519, DOI 10.1111/j.1365-2958.2006.04986.x; Traber KE, 2008, MICROBIOL-SGM, V154, P2265, DOI 10.1099/mic.0.2007/011874-0; Vuong C, 2004, CELL MICROBIOL, V6, P753, DOI 10.1111/j.1462-5822.2004.00401.x; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wang R, 2011, J CLIN INVEST, V121, P238, DOI 10.1172/JCI42520; Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x	39	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100260	10.1371/journal.pone.0100260	http://dx.doi.org/10.1371/journal.pone.0100260			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926994	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100123
J	Steen, V; Skagen, SK; Noon, BR				Steen, Valerie; Skagen, Susan K.; Noon, Barry R.			Vulnerability of Breeding Waterbirds to Climate Change in the Prairie Pothole Region, USA	PLOS ONE			English	Article							SPECIES DISTRIBUTION; NORTH-DAKOTA; WETLANDS; WATERFOWL; DISTRIBUTIONS; PREDICTION; FUTURE; SHIFTS	The Prairie Pothole Region (PPR) of the north-central U.S. and south-central Canada contains millions of small prairie wetlands that provide critical habitat to many migrating and breeding waterbirds. Due to their small size and the relatively dry climate of the region, these wetlands are considered at high risk for negative climate change effects as temperatures increase. To estimate the potential impacts of climate change on breeding waterbirds, we predicted current and future distributions of species common in the PPR using species distribution models (SDMs). We created regional-scale SDMs for the U.S. PPR using Breeding Bird Survey occurrence records for 1971-2011 and wetland, upland, and climate variables. For each species, we predicted current distribution based on climate records for 1981-2000 and projected future distributions to climate scenarios for 2040-2049. Species were projected to, on average, lose almost half their current habitat (-46%). However, individual species projections varied widely, from +8% (Upland Sandpiper) to -100% (Wilson's Snipe). Variable importance ranks indicated that land cover (wetland and upland) variables were generally more important than climate variables in predicting species distributions. However, climate variables were relatively more important during a drought period. Projected distributions of species responses to climate change contracted within current areas of distribution rather than shifting. Given the large variation in species-level impacts, we suggest that climate change mitigation efforts focus on species projected to be the most vulnerable by enacting targeted wetland management, easement acquisition, and restoration efforts.	[Steen, Valerie; Skagen, Susan K.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA; [Steen, Valerie; Noon, Barry R.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO USA; [Steen, Valerie; Noon, Barry R.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO USA	United States Department of the Interior; United States Geological Survey; Colorado State University; Colorado State University	Steen, V (corresponding author), US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA.	valerie.steen@gmail.com	Steen, Valerie/P-9913-2016	Steen, Valerie/0000-0002-1417-8139	U.S. Geological Survey; National Climate Change and Wildlife Science Center (NCCWSC); Plains and Prairie Pothole Landscape Cooperative (PPPLCC)	U.S. Geological Survey(United States Geological Survey); National Climate Change and Wildlife Science Center (NCCWSC); Plains and Prairie Pothole Landscape Cooperative (PPPLCC)	We thank the U.S. Geological Survey, National Climate Change and Wildlife Science Center (NCCWSC) and the Plains and Prairie Pothole Landscape Cooperative (PPPLCC) for research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, WETLAND ECOLOGY PRIN; Beale CM, 2012, PHILOS T R SOC B, V367, P247, DOI 10.1098/rstb.2011.0178; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Beyersbergen G. W., 2004, NO PRAIRIE PARKLAND; Braunisch V, 2013, ECOGRAPHY, V36, P971, DOI 10.1111/j.1600-0587.2013.00138.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen C., 2004, USING RANDOM FOREST, V110, P24; Cook Benjamin I., 2014, Climate Dynamics, V43, P2607, DOI 10.1007/s00382-014-2075-y; Coulson DP, 2009, CLIMATE SCENARIOS CO; Coulson DP, 2010, HIST CLIMATE 1940 20; Cowardin L. M., 1995, 2 US DEP INT NAT BIO; Cowardin L. M., 1979, CLASSIFICATION WETLA; Dahl TE, 1990, WETLANDS LOSSES US 1; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; GIORGI F, 1991, REV GEOPHYS, V29, P191, DOI 10.1029/90RG02636; Gleason RA, 2011, ECOL APPL, V21, pS65, DOI 10.1890/09-0216.1; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; JOHNSON DH, 1988, WILDLIFE MONOGR, P1; Johnson R., 1997, WETLAND RESOURCES E; Johnson RR, 2008, J SOIL WATER CONSERV, V63, p84A, DOI 10.2489/63.3.84A; Johnson WC, 2010, BIOSCIENCE, V60, P128, DOI 10.1525/bio.2010.60.2.7; Kantrud H. A., 1989, PRAIRIE BASIN WETLAN; KANTRUD HA, 1977, J WILDLIFE MANAGE, V41, P243, DOI 10.2307/3800601; Klemp J.B., 2008, NCAR TECHNICAL NOTE, DOI [10.5065/D6DZ069T, DOI 10.5065/1DFH-6P97, 10.5065/D68S4MVH]; Kundzewicz ZW, 2007, CONTRIBUTION WORKING, P173; LARSON DL, 1995, CLIMATIC CHANGE, V30, P169, DOI 10.1007/BF01091840; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; MARTIN AH, 2012, NY TIMES BK REV 0415, P22; Masson-Delmotte V, 2018, SPEC REP GLOB WARM 1; Matthews SN, 2011, ECOGRAPHY, V34, P933, DOI 10.1111/j.1600-0587.2011.06803.x; National Center Atmospheric Research Staff, 2014, CLIM DAT GUID REGR O; Niemuth ND, 2003, WATERBIRDS, V26, P233, DOI 10.1675/1524-4695(2003)026[0233:ROWTNO]2.0.CO;2; Peterson AT, 2003, GLOBAL CHANGE BIOL, V9, P647, DOI 10.1046/j.1365-2486.2003.00616.x; POIANI KA, 1991, BIOSCIENCE, V41, P611, DOI 10.2307/1311698; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; R Core Team, 2021, R LANG ENV STAT COMP; SAUER JR, 2007, N AM BREEDING BIRD S; Schroeder Boris, 2000, Zeitschrift fuer Oekologie und Naturschutz, V8, P195; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sorenson LG, 1998, CLIMATIC CHANGE, V40, P343, DOI 10.1023/A:1005441608819; Stewart R.E., 1971, RES PUBLICATION, V92; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Weller M.W., 1965, 43 IOW STAT U AM US; Winter TC, 1998, CLIMATIC CHANGE, V40, P189, DOI 10.1023/A:1005448416571	48	27	28	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e96747	10.1371/journal.pone.0096747	http://dx.doi.org/10.1371/journal.pone.0096747			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927165	gold, Green Submitted, Green Published			2022-12-25	WOS:000338278100005
J	Kagawa, S; Natsuizaka, M; Whelan, KA; Facompre, N; Naganuma, S; Ohashi, S; Kinugasa, H; Egloff, AM; Basu, D; Gimotty, PA; Klein-Szanto, AJ; Bass, AJ; Wong, KK; Diehl, JA; Rustgi, AK; Nakagawa, H				Kagawa, S.; Natsuizaka, M.; Whelan, K. A.; Facompre, N.; Naganuma, S.; Ohashi, S.; Kinugasa, H.; Egloff, A. M.; Basu, D.; Gimotty, P. A.; Klein-Szanto, A. J.; Bass, A. J.; Wong, K-K; Diehl, J. A.; Rustgi, A. K.; Nakagawa, H.			Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor-suppressor activities	ONCOGENE			English	Article							HUMAN ESOPHAGEAL KERATINOCYTES; TO-MESENCHYMAL TRANSITION; ZEB TRANSCRIPTION FACTORS; EPITHELIAL-CELLS; TGF-BETA; PREMATURE SENESCENCE; SQUAMOUS CANCER; NOTCH; CARCINOMA; P53	Notch activity regulates tumor biology in a context-dependent and complex manner. Notch may act as an oncogene or a tumor-suppressor gene even within the same tumor type. Recently, Notch signaling has been implicated in cellular senescence. Yet, it remains unclear as to how cellular senescence checkpoint functions may interact with Notch-mediated oncogenic and tumor-suppressor activities. Herein, we used genetically engineered human esophageal keratinocytes and esophageal squamous cell carcinoma cells to delineate the functional consequences of Notch activation and inhibition along with pharmacological intervention and RNA interference experiments. When expressed in a tetracycline-inducible manner, the ectopically expressed activated form of Notch1 (ICN1) displayed oncogene-like characteristics inducing cellular senescence corroborated by the induction of G0/G1 cell-cycle arrest, Rb dephosphorylation, flat and enlarged cell morphology and senescence-associated beta-galactosidase activity. Notch-induced senescence involves canonical CSL/RBPJ-dependent transcriptional activity and the p16(INK4A)-Rb pathway. Loss of p16(INK4A) or the presence of human papilloma virus (HPV) E6/E7 oncogene products not only prevented ICN1 from inducing senescence but permitted ICN1 to facilitate anchorage-independent colony formation and xenograft tumor growth with increased cell proliferation and reduced squamous-cell differentiation. Moreover, Notch1 appears to mediate replicative senescence as well as transforming growth factor-beta-induced cellular senescence in non-transformed cells and that HPV E6/E7 targets Notch1 for inactivation to prevent senescence, revealing a tumor-suppressor attribute of endogenous Notch1. In aggregate, cellular senescence checkpoint functions may influence dichotomous Notch activities in the neoplastic context.	[Kagawa, S.; Natsuizaka, M.; Whelan, K. A.; Naganuma, S.; Ohashi, S.; Kinugasa, H.; Rustgi, A. K.; Nakagawa, H.] Univ Penn, Div Gastroenterol, Dept Med, Philadelphia, PA 19104 USA; [Kagawa, S.; Natsuizaka, M.; Whelan, K. A.; Naganuma, S.; Ohashi, S.; Kinugasa, H.; Gimotty, P. A.; Diehl, J. A.; Rustgi, A. K.; Nakagawa, H.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Natsuizaka, M.] Hokkaido Univ, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan; [Facompre, N.; Basu, D.] Univ Penn, Dept Otorhinolaryngol, Philadelphia, PA 19104 USA; [Facompre, N.; Basu, D.] Univ Penn, Dept Head & Neck Surg, Philadelphia, PA 19104 USA; [Facompre, N.; Basu, D.] Philadelphia VA Med Ctr, Philadelphia, PA USA; [Naganuma, S.] Kochi Univ, Sch Med, Dept Pathol, Kochi 780, Japan; [Ohashi, S.] Kyoto Univ, Grad Sch Med, Dept Therapeut Oncol, Kyoto, Japan; [Kinugasa, H.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama 7008530, Japan; [Egloff, A. M.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Gimotty, P. A.] Univ Penn, Div Biostat, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Klein-Szanto, A. J.] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Bass, A. J.; Wong, K-K] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Bass, A. J.; Wong, K-K] Dana Farber Canc Inst, Div Cellular & Mol Oncol, Boston, MA 02115 USA; [Diehl, J. A.] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Rustgi, A. K.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Hokkaido University; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; Kochi University; Kyoto University; Okayama University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; Pennsylvania Medicine; Fox Chase Cancer Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of Pennsylvania; University of Pennsylvania	Nakagawa, H (corresponding author), Univ Penn, Div Gastroenterol, Dept Med, 956 BRB,421 Curie Blvd, Philadelphia, PA 19104 USA.	nakagawh@mail.med.upenn.edu	Gimotty, Phyllis/GWZ-4136-2022; Ohashi, Shinya/AAD-8920-2022	Gimotty, Phyllis/0000-0002-3850-9799; Natsuizaka, Mitsuteru/0000-0002-1819-1955	NIH [P01CA098101, U01CA143056, R01DK077005, K26 RR032714]; Pennsylvania CURE Program Grant [F32-CA174176, F32-DE024685, K08DE022842]; Trio/ACS Career Award; VA CPPF Grant [K07CA137140]; University of Pennsylvania University Research Foundation Award; University of Pennsylvania; Abramson Cancer Center Pilot Project Grant; American Cancer Society [RP-10-033-01-CCE]; NATIONAL CANCER INSTITUTE [P30CA016520, K07CA137140, F31CA174176, P01CA098101, U01CA143056, F32CA174146] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR032714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE022842, F32DE024685, R21DE024396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077005, P30DK050306] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K26OD011179] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania CURE Program Grant; Trio/ACS Career Award; VA CPPF Grant; University of Pennsylvania University Research Foundation Award; University of Pennsylvania; Abramson Cancer Center Pilot Project Grant; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr Hiroshi Shirasawa (Chiba University, Chiba, Japan) for the gift of EN60 cells. We are grateful to the Molecular Pathology & Imaging, Molecular Biology/Gene Expression and Cell Culture Core Facilities of the NIH/NIDDK Center for Molecular Studies in Digestive and Liver Diseases (P30-DK050306) and of the NIH P01CA098101. This study was supported in part by NIH Grants P01CA098101 (to SK, MN, KAW, DB, HK, SN, SO, PAG, AJK-S, AB, K-KW, JAD, HN and AKR), U01CA143056 (to AKR), R01DK077005 (to HN), K26 RR032714 (to HN), Pennsylvania CURE Program Grant (to HN), F32-CA174176 (to KAW), F32-DE024685 to (NF), K08DE022842, Trio/ACS Career Award and VA CPPF Grant (to DB), K07CA137140 (to AME), University of Pennsylvania University Research Foundation Award (to HN), University of Pennsylvania, Abramson Cancer Center Pilot Project Grant (to HN), and the American Cancer Society RP-10-033-01-CCE (to AKR).	Agrawal N, 2012, CANCER DISCOV, V2, P899, DOI 10.1158/2159-8290.CD-12-0189; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Cui H, 2013, CANCER RES, V73, P3451, DOI 10.1158/0008-5472.CAN-12-3902; Demehri S, 2009, CANCER CELL, V16, P55, DOI 10.1016/j.ccr.2009.05.016; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Dotto GP, 2009, NAT REV CANCER, V9, P587, DOI 10.1038/nrc2675; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Harada H, 2003, MOL CANCER RES, V1, P729; Hijioka H, 2010, INT J ONCOL, V36, P817, DOI 10.3892/ijo_00000558; Jeffries S, 2000, MOL CELL BIOL, V20, P3928, DOI 10.1128/MCB.20.11.3928-3941.2000; Jia LQ, 1997, MOL CARCINOGEN, V19, P243, DOI 10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D; Kim SH, 2006, CANCER RES, V66, P10415, DOI 10.1158/0008-5472.CAN-06-2104; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kurz DJ, 2000, J CELL SCI, V113, P3613; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Lee DK, 2002, J BIOL CHEM, V277, P38557, DOI 10.1074/jbc.M206786200; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Li T, 2007, J NEUROSCI, V27, P10849, DOI 10.1523/JNEUROSCI.2152-07.2007; Lin S, 2012, MOL BIOL CELL, V23, P1569, DOI 10.1091/mbc.E11-10-0849; Ling H, 2013, CANCER RES, V73, P5963, DOI 10.1158/0008-5472.CAN-13-0409; LIU QY, 1995, ONCOGENE, V10, P619; Liu ZJ, 2012, ATHEROSCLEROSIS, V225, P296, DOI 10.1016/j.atherosclerosis.2012.04.010; Lowell S, 2000, CURR BIOL, V10, P491, DOI 10.1016/S0960-9822(00)00451-6; Maruo S, 2011, P NATL ACAD SCI USA, V108, P1919, DOI 10.1073/pnas.1019599108; McElhinny AS, 2008, ONCOGENE, V27, P5138, DOI 10.1038/onc.2008.228; Mroz EA, 2008, CANCER RES, V68, P6049, DOI 10.1158/0008-5472.CAN-08-1279; Nakagawa H, 2003, GASTROINTESTINAL CAN, P241; Natsugoe S, 2002, CLIN CANCER RES, V8, P1838; Natsuizaka M, 2012, FASEB J, V26, P2620, DOI 10.1096/fj.11-198598; Natsuizaka M, 2010, CARCINOGENESIS, V31, P1344, DOI 10.1093/carcin/bgq108; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Ohashi S, 2011, CANCER RES, V71, P6836, DOI 10.1158/0008-5472.CAN-11-0846; Ohashi S, 2010, GASTROENTEROLOGY, V139, P2113, DOI 10.1053/j.gastro.2010.08.040; Ohashi S, 2010, CANCER RES, V70, P4174, DOI 10.1158/0008-5472.CAN-09-4614; Okawa T, 2007, GENE DEV, V21, P2788, DOI 10.1101/gad.1544507; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Oyama K, 2007, ONCOGENE, V26, P2353, DOI 10.1038/sj.onc.1210025; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Pascal T, 2005, FEBS LETT, V579, P3651, DOI 10.1016/j.febslet.2005.05.056; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; Proweller A, 2006, CANCER RES, V66, P7438, DOI 10.1158/0008-5472.CAN-06-0793; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Rangarajan A, 2001, VIROLOGY, V286, P23, DOI 10.1006/viro.2001.0867; Sashiyama H, 2001, INT J ONCOL, V19, P97; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Takaoka M, 2004, ONCOGENE, V23, P6760, DOI 10.1038/sj.onc.1207923; Talora C, 2002, GENE DEV, V16, P2252, DOI 10.1101/gad.988902; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tremain R, 2000, ONCOGENE, V19, P1698, DOI 10.1038/sj.onc.1203471; Venkatesh D, 2011, ARTERIOSCL THROM VAS, V31, P876, DOI 10.1161/ATVBAHA.110.221945; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Weijzen S, 2003, J CELL PHYSIOL, V194, P356, DOI 10.1002/jcp.10217; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Yugawa T, 2007, MOL CELL BIOL, V27, P3732, DOI 10.1128/MCB.02119-06; ZAGOURAS P, 1995, P NATL ACAD SCI USA, V92, P6414, DOI 10.1073/pnas.92.14.6414; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104	67	49	51	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 30	2015	34	18					2347	2359		10.1038/onc.2014.169	http://dx.doi.org/10.1038/onc.2014.169			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CH2AH	24931169	Green Accepted, Green Submitted			2022-12-25	WOS:000353824800008
J	Sirajuddin, S; Barupala, D; Helling, S; Marcus, K; Stemmler, TL; Rosenzweig, AC				Sirajuddin, Sarah; Barupala, Dulmini; Helling, Stefan; Marcus, Katrin; Stemmler, Timothy L.; Rosenzweig, Amy C.			Effects of Zinc on Particulate Methane Monooxygenase Activity and Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-ABSORPTION; CYTOCHROME-C-OXIDASE; METHYLOCOCCUS-CAPSULATUS BATH; BACTERIAL REACTION CENTERS; CRYSTAL-STRUCTURE; METAL CENTERS; CRYSTALLOGRAPHIC LOCATION; RIBONUCLEOTIDE REDUCTASE; BIOLOGICAL OXIDATION; PROTON-TRANSFER	Particulate methane monooxygenase (pMMO) is a membrane-bound metalloenzyme that oxidizes methane to methanol in methanotrophic bacteria. Zinc is a known inhibitor of pMMO, but the details of zinc binding and the mechanism of inhibition are not understood. Metal binding and activity assays on membrane-bound pMMO from Methylococcus capsulatus (Bath) reveal that zinc inhibits pMMO at two sites that are distinct from the copper active site. The 2.6 angstrom resolution crystal structure of Methylocystis species strain Rockwell pMMO reveals two previously undetected bound lipids, and metal soaking experiments identify likely locations for the two zinc inhibition sites. The first is the crystallographic zinc site in the pmoC subunit, and zinc binding here leads to the ordering of 10 previously unobserved residues. A second zinc site is present on the cytoplasmic side of the pmoC subunit. Parallels between these results and zinc inhibition studies of several respiratory complexes suggest that zinc might inhibit proton transfer inpMMO.	[Sirajuddin, Sarah; Rosenzweig, Amy C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Sirajuddin, Sarah; Rosenzweig, Amy C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Barupala, Dulmini; Stemmler, Timothy L.] Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48201 USA; [Helling, Stefan; Marcus, Katrin] Ruhr Univ Bochum, Med Proteome Ctr, Dept Funct Prote, D-44801 Bochum, Germany	Northwestern University; Northwestern University; Wayne State University; Ruhr University Bochum	Stemmler, TL (corresponding author), Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48201 USA.	timothy.stemmler@wayne.edu; amyr@northwestern.edu			United States Department of Energy [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor Grant [085P1000817]; National Institutes of Health from NCI [Y1-CO-1020]; NIGMS [Y1-GM-1104]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, NCRR, Biomedical Technology Program; United States Department of Energy, Division of Materials Sciences and Division of Chemical Sciences [DE-AC02-98CH10886]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070473] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor Grant; National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NCRR, Biomedical Technology Program; United States Department of Energy, Division of Materials Sciences and Division of Chemical Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and Michigan Technology Tri-Corridor Grant 085P1000817. GM/CA-CAT has been funded in whole or in part with Federal funds from the National Institutes of Health Grant Y1-CO-1020 from NCI and Grant Y1-GM-1104 from NIGMS. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource and at the National Synchrotron Light Source. SSRL is a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by National Institutes of Health, NCRR, Biomedical Technology Program. NSLS, located at Brookhaven National Laboratory, is supported by the United States Department of Energy, Division of Materials Sciences and Division of Chemical Sciences, under Contract DE-AC02-98CH10886.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Ankudinov AL, 1997, PHYS REV B, V56, pR1712, DOI 10.1103/PhysRevB.56.R1712; Axelrod HL, 2000, P NATL ACAD SCI USA, V97, P1542, DOI 10.1073/pnas.97.4.1542; Balasubramanian R, 2010, NATURE, V465, P115, DOI 10.1038/nature08992; Berry EA, 2000, BBA-BIOENERGETICS, V1459, P440, DOI 10.1016/S0005-2728(00)00182-1; BOWMAN JP, 1991, FEMS MICROBIOL ECOL, V85, P15, DOI 10.1016/0378-1097(91)90627-M; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Chen CL, 2004, J INORG BIOCHEM, V98, P2125, DOI 10.1016/j.jinorgbio.2004.09.021; Choi DW, 2003, J BACTERIOL, V185, P5755, DOI 10.1128/JB.185.19.5755-5764.2003; Conrado RJ, 2014, SCIENCE, V343, P621, DOI 10.1126/science.1246929; Cook SA, 2002, ARCH BIOCHEM BIOPHYS, V398, P32, DOI 10.1006/abbi.2001.2628; Cook SA, 1996, J INORG BIOCHEM, V63, P273, DOI 10.1016/0162-0134(95)00239-1; Culpepper MA, 2012, CRIT REV BIOCHEM MOL, V47, P483, DOI 10.3109/10409238.2012.697865; Culpepper MA, 2012, J AM CHEM SOC, V134, P7640, DOI 10.1021/ja302195p; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fang JS, 2000, FEMS MICROBIOL LETT, V189, P67, DOI 10.1016/S0378-1097(00)00253-6; Faxen K, 2006, BBA-BIOENERGETICS, V1757, P388, DOI 10.1016/j.bbabio.2006.05.010; Giachini L, 2007, BIOPHYS J, V93, P2934, DOI 10.1529/biophysj.107.110957; Hakemian AS, 2008, BIOCHEMISTRY-US, V47, P6793, DOI 10.1021/bi800598h; Hakemian AS, 2007, ANNU REV BIOCHEM, V76, P223, DOI 10.1146/annurev.biochem.76.061505.175355; Helling Stefan, 2012, Methods Mol Biol, V893, P345, DOI 10.1007/978-1-61779-885-6_21; Kuznetsova SS, 2005, BIOCHEMISTRY-MOSCOW+, V70, P128, DOI 10.1007/s10541-005-0091-6; Lee DW, 2011, BIOCHEMISTRY-US, V50, P4263, DOI 10.1021/bi200230e; LEE PA, 1981, REV MOD PHYS, V53, P769, DOI 10.1103/RevModPhys.53.769; Lieberman RL, 2006, INORG CHEM, V45, P8372, DOI 10.1021/ic060739v; Lieberman RL, 2003, P NATL ACAD SCI USA, V100, P3820, DOI 10.1073/pnas.0536703100; Lieberman RL, 2005, NATURE, V434, P177, DOI 10.1038/nature03311; Lukehart, 2007, APPL PHYS METHODS IN, P513; Martinho M, 2007, J AM CHEM SOC, V129, P15783, DOI 10.1021/ja077682b; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; Mills DA, 2002, J BIOL CHEM, V277, P14894, DOI 10.1074/jbc.M111922200; Monson CF, 2012, J AM CHEM SOC, V134, P7773, DOI 10.1021/ja212138e; Muramoto K, 2007, P NATL ACAD SCI USA, V104, P7881, DOI 10.1073/pnas.0610031104; Murrell JC, 2000, TRENDS MICROBIOL, V8, P221, DOI 10.1016/S0966-842X(00)01739-X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paddock ML, 1999, P NATL ACAD SCI USA, V96, P6183, DOI 10.1073/pnas.96.11.6183; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Qin L, 2007, BIOCHEMISTRY-US, V46, P6239, DOI 10.1021/bi700173w; Reidegeld KA, 2008, PROTEOMICS, V8, P1129, DOI 10.1002/pmic.200701073; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; Rosenzweig AC, 2008, BIOCHEM SOC T, V36, P1134, DOI 10.1042/BST0361134; Segel I. H, 1975, ENZYME KINETICS, P465; Semrau JD, 2010, FEMS MICROBIOL REV, V34, P496, DOI 10.1111/j.1574-6976.2010.00212.x; SHIEMKE AK, 1995, ARCH BIOCHEM BIOPHYS, V321, P421, DOI 10.1006/abbi.1995.1413; Shiemke AK, 2004, J BACTERIOL, V186, P928, DOI 10.1128/JB.186.4.928-937.2004; Smith SM, 2011, BIOCHEMISTRY-US, V50, P10231, DOI 10.1021/bi200801z; Smith SM, 2011, METHOD ENZYMOL, P195, DOI 10.1016/B978-0-12-386905-0.00013-9; Stemmler TL, 1997, BIOCHEMISTRY-US, V36, P9847, DOI 10.1021/bi9702795; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Takeguchi M, 1999, J MOL CATAL A-CHEM, V137, P161, DOI 10.1016/S1381-1169(98)00123-X; Tinberg CE, 2011, ACCOUNTS CHEM RES, V44, P280, DOI 10.1021/ar1001473; Utschig LM, 1998, BIOCHEMISTRY-US, V37, P8278, DOI 10.1021/bi980395n; Voegtli WC, 2003, J AM CHEM SOC, V125, P15822, DOI 10.1021/ja0370387; Vygodina TV, 2008, FEBS LETT, V582, P4158, DOI 10.1016/j.febslet.2008.11.018; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200; WANG S, 1994, INORG CHEM, V33, P1589, DOI 10.1021/ic00086a006; WHITTENB.R, 1970, J GEN MICROBIOL, V61, P205, DOI 10.1099/00221287-61-2-205; Yamashita S, 2014, STRUCTURE, V22, P315, DOI 10.1016/j.str.2013.12.002	63	46	47	1	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21782	21794		10.1074/jbc.M114.581363	http://dx.doi.org/10.1074/jbc.M114.581363			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24942740	hybrid, Green Published			2022-12-25	WOS:000340558300051
J	Abraham, V; Ouskova, V; Kunes, P				Abraham, Vojtech; Ouskova, Veronika; Kunes, Petr			Present-Day Vegetation Helps Quantifying Past Land Cover in Selected Regions of the Czech Republic	PLOS ONE			English	Article							RELEVANT SOURCE AREA; POLLEN PRODUCTIVITY; QUANTITATIVE RECONSTRUCTION; HOLOCENE VEGETATION; CULTURAL LANDSCAPE; PLANT ABUNDANCE; CENTRAL-EUROPE; REVEALS-MODEL; KOTLINA BASIN; FOREST	The REVEALS model is a tool for recalculating pollen data into vegetation abundances on a regional scale. We explored the general effect of selected parameters by performing simulations and ascertained the best model setting for the Czech Republic using the shallowest samples from 120 fossil sites and data on actual regional vegetation (60 km radius). Vegetation proportions of 17 taxa were obtained by combining the CORINE Land Cover map with forest inventories, agricultural statistics and habitat mapping data. Our simulation shows that changing the site radius for all taxa substantially affects REVEALS estimates of taxa with heavy or light pollen grains. Decreasing the site radius has a similar effect as increasing the wind speed parameter. However, adjusting the site radius to 1 m for local taxa only (even taxa with light pollen) yields lower, more correct estimates despite their high pollen signal. Increasing the background radius does not affect the estimates significantly. Our comparison of estimates with actual vegetation in seven regions shows that the most accurate relative pollen productivity estimates (PPEs) come from Central Europe and Southern Sweden. The initial simulation and pollen data yielded unrealistic estimates for Abies under the default setting of the wind speed parameter (3 m/s). We therefore propose the setting of 4 m/s, which corresponds to the spring average in most regions of the Czech Republic studied. Ad hoc adjustment of PPEs with this setting improves the match 3-4-fold. We consider these values (apart from four exceptions) to be appropriate, because they are within the ranges of standard errors, so they are related to original PPEs. Setting a 1 m radius for local taxa (Alnus, Salix, Poaceae) significantly improves the match between estimates and actual vegetation. However, further adjustments to PPEs exceed the ranges of original values, so their relevance is uncertain.	[Abraham, Vojtech; Kunes, Petr] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Abraham, Vojtech] Univ South Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic; [Ouskova, Veronika] Nat Conservat Agcy Czech Republ, Prague, Czech Republic; [Kunes, Petr] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic	Charles University Prague; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Abraham, V (corresponding author), Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic.	vojtech.abraham@gmail.com	Abraham, Vojtěch/E-6784-2016; Kuneš, Petr/C-7099-2008	Abraham, Vojtěch/0000-0001-6738-0392; Kuneš, Petr/0000-0001-9605-8204	Czech Science Foundation (GACR) [P504/12/0649, 13-11193S]; European Research Council under the European Union [278065]	Czech Science Foundation (GACR)(Grant Agency of the Czech Republic); European Research Council under the European Union(European Research Council (ERC))	The work was supported by projects No. P504/12/0649 and 13-11193S from Czech Science Foundation (GACR) http://www.gacr.cz/ and by institutional resources of MSMT. PK has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement No. 278065 http://erc.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham V, 2006, PRIROZENA VEGETACE J; Abraham V, 2008, BIOARCHEOLOGIE CESKE, P443; Abraham V, 2012, REV PALAEOBOT PALYNO, V179, P1, DOI 10.1016/j.revpalbo.2012.04.004; ANDERSEN S T, 1974, Grana, V14, P57, DOI 10.1080/00173137409429894; Behre K.E., 1981, POLLEN SPORES, V23, P225; Boublik Karel, 2007, Tuexenia, P73; Brizova E, 1999, ACTA PALAEOBOT S, V2, P549; Brizova E, 2009, B GEOSCI, V84, P637, DOI 10.3140/bull.geosci.1140; Brostrom A, 2004, HOLOCENE, V14, P368, DOI 10.1191/0959683604hl713rp; Brostrom A, 2008, VEG HIST ARCHAEOBOT, V17, P461, DOI 10.1007/s00334-008-0148-8; Chaloupkova K, 1995, PYLOVA ANAL ADRSPASS; Chytry M, 2001, KATALOG BIOTOPU; Chytry M., 2007, VEGETACE CESKE REPUB; Chytry M., 2009, VEGETACE CESKE REPUB; Chytry M., 2013, VEGETACE CESKE REPUB; Chytry M, 2012, PRESLIA, V84, P427; Czech Hydrometeorological Institute, 2005, CLIMATE ATLAS CZECHI; DreslerovuY D., 2004, ANCIENT LANDSCAPE SE, P121; Engel Z, 2010, QUATERNARY SCI REV, V29, P913, DOI 10.1016/j.quascirev.2009.12.008; European Enviromental Agency, 2012, CORINE LAND COVER 20; Feranec J., 2000, INT J APPL EARTH OBS, V2, P129, DOI DOI 10.1016/S0303-2434(00)85006-0; Filippov P, 2008, PRIRUCKA HODNOCENI B; Forest management institute, 2007, AGG INF FORST INV SL; Fredh D, 2013, BIOGEOSCIENCES, V10, P3159, DOI 10.5194/bg-10-3159-2013; Fyfe RM, 2013, QUATERNARY SCI REV, V73, P132, DOI 10.1016/j.quascirev.2013.05.014; Gaillard MJ, 2010, CLIM PAST, V6, P483, DOI 10.5194/cp-6-483-2010; Hartel H, 2008, MAPOVANI BIOTOPU CES; Hellman S, 2008, J QUATERNARY SCI, V23, P21, DOI 10.1002/jqs.1126; Hellman SEV, 2008, VEG HIST ARCHAEOBOT, V17, P445, DOI 10.1007/s00334-008-0149-7; Hjelle KL, 2012, HOLOCENE, V22, P313, DOI 10.1177/0959683611423690; JACOBSON GL, 1981, QUATERNARY RES, V16, P80, DOI 10.1016/0033-5894(81)90129-0; JANKOVSKA V, 1987, FOLIA GEOBOT PHYTOTX, V22, P199, DOI 10.1007/BF02853194; JANKOVSKA V, 1990, FOLIA GEOBOT PHYTOTX, V25, P1; JANKOVSKA V, 1992, FOLIA GEOBOT PHYTOTX, V27, P137, DOI 10.1007/BF02856245; Jankovska V, 1980, PALAOGEOBOTANISHE RE; Jankovska V, 1996, FLOODPLAIN ECOLOGY M, P53; Jankovska V, 1971, FOLIA GEOBOT PHYTOTX, V6, P281, DOI 10.1007/BF02851832; Kozakova R, 2014, VEG HIST ARCHAEOBOTA; Kunes P., 2000, GEOLINES, V11, P112; Kunes P, 2011, J BIOGEOGR, V38, P2150, DOI 10.1111/j.1365-2699.2011.02557.x; Kunes P, 2009, PRESLIA, V81, P209; Marquer L, 2014, QUATERNARY SCI REV, V90, P199, DOI 10.1016/j.quascirev.2014.02.013; Matthias I, 2012, VEG HIST ARCHAEOBOT, V21, P471, DOI 10.1007/s00334-012-0373-z; Mazier F, 2012, REV PALAEOBOT PALYNO, V187, P38, DOI 10.1016/j.revpalbo.2012.07.017; Mazier F, 2008, VEG HIST ARCHAEOBOT, V17, P479, DOI 10.1007/s00334-008-0143-0; Nielsen AB, 2004, J BIOGEOGR, V31, P1693, DOI 10.1111/j.1365-2699.2004.01080.x; Nielsen AB, 2012, QUATERNARY SCI REV, V47, P131, DOI 10.1016/j.quascirev.2012.05.011; Overballe-Petersen MV, 2013, J VEG SCI, V24, P755, DOI 10.1111/jvs.12007; PARSONS RW, 1981, REV PALAEOBOT PALYNO, V32, P127, DOI 10.1016/0034-6667(81)90001-4; Peichlova M, 1979, HIST VEGETACE BROUMO; Pesa V, 2012, SPUREN GERMANEN, P128; Petr L, 2013, FOLIA GEOBOT; Petr L, 2008, BIOARCHEOLOGIE CESKE, P73; Pokorny P., 2005, FERRANTIA, V44, P101; Pokorny P, 2009, GRANA, V48, P77, DOI 10.1080/00173130902759816; Poska A, 2011, REV PALAEOBOT PALYNO, V167, P30, DOI 10.1016/j.revpalbo.2011.07.001; Poska A, 2010, VEG HIST ARCHAEOBOT, V19, P91, DOI 10.1007/s00334-009-0230-x; Prentice C., 1988, VEGETATION HIST, P17, DOI [10.1007/978-94-009-3081-0_2, DOI 10.1007/978-94-009-3081-0_2]; PRENTICE IC, 1983, BIOMETRICS, V39, P1051, DOI 10.2307/2531338; PRENTICE IC, 1985, QUATERNARY RES, V23, P76, DOI 10.1016/0033-5894(85)90073-0; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reitalu T, 2013, J BIOGEOGR, V40, P1524, DOI 10.1111/jbi.12092; RYBNICEK K, 1968, Folia Geobotanica and Phytotaxonomica, V3, P117; RYBNICEK K, 1983, HYDROBIOLOGIA, V103, P247; Rybnicek K, 2008, VEG HIST ARCHAEOBOT, V17, P701, DOI 10.1007/s00334-008-0160-z; RYBNICKOVA E, 1985, FOLIA GEOBOT PHYTOTX, V20, P419, DOI 10.1007/BF02853288; RYBNICKOVA E, 1975, Folia Geobotanica and Phytotaxonomica, V10, P157; RYBNICKOVA E, 1988, FOLIA GEOBOT PHYTOTX, V23, P285, DOI 10.1007/BF02854824; Rybnickova E, 1975, PFAFFENSCHLAG, P183; RybnuikovuY E., 1974, ENTWICKLUNG VEGETATI; Skrzypek G, 2009, REV PALAEOBOT PALYNO, V156, P507, DOI 10.1016/j.revpalbo.2009.04.014; Soepboer W, 2007, HOLOCENE, V17, P65, DOI 10.1177/0959683607073279; Soepboer W, 2010, QUATERNARY SCI REV, V29, P472, DOI 10.1016/j.quascirev.2009.09.027; Speranza A, 2000, HOLOCENE, V10, P575, DOI 10.1191/095968300668946885; Speranza A, 2000, QUATERNARY SCI REV, V19, P1589, DOI 10.1016/S0277-3791(99)00108-0; Speranza A, 2000, SOLAR ANTHR FORCING; Stalling H, 1987, UNTERSUNCHUNGEN SPAT; Strandberg G, 2013, CLIM PAST DISCUSS, V9, P5785, DOI [10.5194/cpd-9-5785-2013, DOI 10.5194/CPD-9-5785-2013]; Sugita S, 1999, HOLOCENE, V9, P409, DOI 10.1191/095968399666429937; SUGITA S, 1994, J ECOL, V82, P881, DOI 10.2307/2261452; Sugita S, 2007, HOLOCENE, V17, P229, DOI 10.1177/0959683607075837; Sugita S, 2007, HOLOCENE, V17, P243, DOI 10.1177/0959683607075838; Sugita S, 2010, QUATERNARY RES, V74, P289, DOI 10.1016/j.yqres.2010.07.008; Svobodova H, 2002, QUATERN INT, V91, P123, DOI 10.1016/S1040-6182(01)00106-9; Svobodova H., 1997, Verhandlungen der Zoologisch-Botanischen Gesellschaft in Osterreich, V134, P317; Svobodova H, 2001, VEG HIST ARCHAEOBOT, V10, P185, DOI 10.1007/PL00006930; Svobodova H, 1991, VYVOJ VEGETACE JIZNI; Svobodova H, 2004, OPERA CORCONTICA, V41, P124; Svobodova H, 2002, OPERA CORCONTICA, V39, P5; Svobodova H, 1989, PAMATKY ARCHEOL, V80, P188	90	24	24	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100117	10.1371/journal.pone.0100117	http://dx.doi.org/10.1371/journal.pone.0100117			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936973	Green Submitted, gold, Green Published			2022-12-25	WOS:000338503400077
J	Tsubokura, M; Kato, S; Nomura, S; Gilmour, S; Nihei, M; Sakuma, Y; Oikawa, T; Kanazawa, Y; Kami, M; Hayano, R				Tsubokura, Masaharu; Kato, Shigeaki; Nomura, Shuhei; Gilmour, Stuart; Nihei, Masahiko; Sakuma, Yu; Oikawa, Tomoyoshi; Kanazawa, Yukio; Kami, Masahiro; Hayano, Ryugo			Reduction of High Levels of Internal Radio-Contamination by Dietary Intervention in Residents of Areas Affected by the Fukushima Daiichi Nuclear Plant Disaster: A Case Series	PLOS ONE			English	Article							CHERNOBYL ACCIDENT; EXPOSURE; CS-137; RADIOCESIUM; INGESTION; CHILDREN; UKRAINE; ADULTS; OBLAST	Maintaining low levels of chronic internal contamination among residents in radiation-contaminated areas after a nuclear disaster is a great public health concern. However, the efficacy of reduction measures for individual internal contamination remains unknown. To reduce high levels of internal radiation exposure in a group of individuals exposed through environmental sources, we performed careful dietary intervention with identification of suspected contaminated foods, as part of mass voluntary radiation contamination screenings and counseling program in Minamisoma Municipal General Hospital and Hirata Central Hospital. From a total of 30,622 study participants, only 9 residents displayed internal cesium-137 (Cs-137) levels of more than 50 Bq/kg. The median level of internal Cs-137 contamination in these residents at the initial screening was 4,830 Bq/body (range: 2,130-15,918 Bq/body) and 69.6 Bq/kg (range: 50.7-216.3 Bq/kg). All these residents with high levels of internal contamination consumed homegrown produce without radiation inspection, and often collected mushrooms in the wild or cultivated them on bed-logs in their homes. They were advised to consume distributed food mainly and to refrain from consuming potentially contaminated foods without radiation inspection and local produces under shipment restrictions such as mushrooms, mountain vegetables, and meat of wild life. A few months after the intervention, re-examination of Cs levels revealed remarkable reduction of internal contamination in all residents. Although the levels of internal radiation exposure appear to be minimal amongst most residents in Fukushima, a subset of the population, who unknowingly consumed highly contaminated foodstuffs, experienced high levels of internal contamination. There seem to be similarities in dietary preferences amongst residents with high internal contamination levels, and intervention based on pre-and post-test counseling and dietary advice from medical care providers about risky food intake appears to be a feasible option for changing residents' dietary practices, subsequently resulting in a reduction in Cs internal contamination levels.	[Tsubokura, Masaharu; Kami, Masahiro] Univ Tokyo, Inst Med Sci, Div Social Commun Syst Adv Clin Res, Minato Ku, Tokyo, Japan; [Kato, Shigeaki] Soma Cent Hosp, Dept Radiat Protect, Soma, Fukushima, Japan; [Nomura, Shuhei] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Gilmour, Stuart] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, Tokyo, Japan; [Nihei, Masahiko; Sakuma, Yu] Hirata Cent Hosp, Hirata Radioact Inspect Ctr, Hirata, Fukushima, Japan; [Oikawa, Tomoyoshi; Kanazawa, Yukio] Minamisoma Municipal Gen Hosp, Dept Radiat Protect, Fukushima, Japan; [Hayano, Ryugo] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; Imperial College London; University of Tokyo; University of Tokyo	Tsubokura, M (corresponding author), Univ Tokyo, Inst Med Sci, Div Social Commun Syst Adv Clin Res, Minato Ku, Tokyo, Japan.	tsubokura-tky@umin.ac.jp	Nomura, Shuhei/HCH-5356-2022; Tsubokura, Masaharu/AAV-4364-2021; Hayano, Ryugo/F-7889-2012; Tsubokura, Masaharu/D-7300-2017	Tsubokura, Masaharu/0000-0001-8027-202X; Hayano, Ryugo/0000-0002-1214-7806; Tsubokura, Masaharu/0000-0001-8027-202X; Nomura, Shuhei/0000-0002-2963-7297				Balonov MI, 2007, RADIAT PROT DOSIM, V127, P491, DOI 10.1093/rpd/ncm301; Fukushima prefecture, 2013, RES INTERNAL RAD EXP; Hamada N, 2012, J RADIAT RES, V53, P641, DOI 10.1093/jrr/rrs032; Hayano RS, 2013, P JPN ACAD B-PHYS, V89, P157, DOI 10.2183/pjab.89.157; Hoshi M, 2000, HEALTH PHYS, V79, P182, DOI 10.1097/00004032-200008000-00011; International Commission on Radiological Protection, 2009, ICRP PUBL, V110 39; Ishikawa K, 2012, J AM GERIATR SOC, V60, P2357, DOI 10.1111/jgs.12012; Kramer GH, 2005, HEALTH PHYS, V88, P350, DOI 10.1097/01.HP.0000152106.93202.05; Likhtarev IA, 1996, HEALTH PHYS, V70, P297, DOI 10.1097/00004032-199603000-00001; Likhtarev IA, 2000, HEALTH PHYS, V79, P341, DOI 10.1097/00004032-200010000-00002; Ministry of Agriculture Forestry and Fisheries, 2012, QUEST ANSW RIC MEAT; Nagataki S, 2013, RAD RES; Nomura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060192; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Ruhm W, 1999, HEALTH PHYS, V77, P373, DOI 10.1097/00004032-199910000-00004; Sato O, 2013, J RADIOL PROT, V33, P823, DOI 10.1088/0952-4746/33/4/823; Sugimoto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065331; Tonnessen A, 2002, J TRAUMA STRESS, V15, P453, DOI 10.1023/A:1020961604434; Tsubokura M, 2013, JAMA PEDIAT; Tsubokura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081909; Tsubokura M, 2012, JAMA-J AM MED ASSOC, V308, P669, DOI 10.1001/jama.2012.9839; Yasutaka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075308	22	42	44	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100302	10.1371/journal.pone.0100302	http://dx.doi.org/10.1371/journal.pone.0100302			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932486	Green Published, Green Submitted, gold			2022-12-25	WOS:000337738600107
J	Zhang, YH; Shao, L; Xu, YX; Cui, YG; Liu, JY; Chian, RC				Zhang, Yihui; Shao, Li; Xu, Yixin; Cui, Yigui; Liu, Jiayin; Chian, Ri-Cheng			Effect of Anti-Mullerian Hormone in Culture Medium on Quality of Mouse Oocytes Matured In Vitro	PLOS ONE			English	Article							RIBONUCLEIC-ACID EXPRESSION; INHIBITING SUBSTANCE; FOLLICULAR-FLUID; OVARIAN-FOLLICLES; SECRETED FACTORS; RAT OVARY; MATURATION; RECEPTOR; GROWTH; PREDICTORS	Anti-mullerian hormone (AMH) is thought to reflect the growth of follicles and the ovarian function. However, the role of AMH in culture medium during in vitro maturation (IVM) on oocyte quality and subsequent development potential is unclear. The objective of this study is to investigate the effect of recombinant human AMH (rh-AMH) supplemented into IVM medium on oocyte quality. Cumulus-oocyte complexes (COCs) were obtained from ICR mice and cultured in vitro with the different concentrations (0-1,000 ng/ml) of rh-AMH. Following 16-18 h of culture, quantitative PCR and ELISA were performed to analyze GDF9 and BMP15 mRNA expression and protein production from the oocytes. Subsequently, in vitro fertilization (IVF) and early embryonic development were employed to further evaluate the quality of in vitro matured oocytes. The results showed that AMH was only expressed in cumulus cells but not in the oocytes. However, AMH most specific receptor, AMHR-II, was expressed in both oocytes and cumulus cells. The levels of GDF9 and BMP15 expression and blastocyst formation rate were significantly increased (p<0.05) when the IVM medium was supplemented with 100 ng/ml of rh-AMH. With AdH1-SiRNA/AMH for knocking down of AMH expression during IVM significantly reduced (p<0.05) the levels of GDF9 and BMP15 expression and blastocysts formation rate. These results suggest that AHM improves oocytes quality by up-regulating GDF9 and BMP15 expressions during IVM.	[Zhang, Yihui; Shao, Li; Xu, Yixin; Cui, Yigui; Liu, Jiayin; Chian, Ri-Cheng] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Chian, Ri-Cheng] McGill Univ, Dept Obstet & Gynecol, Div Res, Montreal, PQ H3A 2T5, Canada	Nanjing Medical University; McGill University	Liu, JY (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	jyliu_nj@126.com; ri-cheng.chian@mcgill.ca			Natural Sciences Foundation of China [NSFC81270746]	Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from Natural Sciences Foundation of China, No. NSFC81270746 to Ri-Cheng Chian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anckaert E, 2013, HUM REPROD UPDATE, V19, P52, DOI 10.1093/humupd/dms042; Andersen CY, 2006, J CLIN ENDOCR METAB, V91, P4064, DOI 10.1210/jc.2006-1066; BAARENDS WM, 1995, ENDOCRINOLOGY, V136, P4951, DOI 10.1210/en.136.11.4951; BEZARD J, 1987, J REPROD FERTIL, V80, P509, DOI 10.1530/jrf.0.0800509; Carlsson IB, 2006, HUM REPROD, V21, P2223, DOI 10.1093/humrep/del165; Chian RC, 2013, FERTIL STERIL, V99, P1173, DOI 10.1016/j.fertnstert.2013.01.141; Das M, 2008, HUM REPROD, V23, P2122, DOI 10.1093/humrep/den185; di Clemente N, 2010, MOL ENDOCRINOL, V24, P2193, DOI 10.1210/me.2010-0273; DICLEMENTE N, 1994, MOL ENDOCRINOL, V8, P1006, DOI 10.1210/me.8.8.1006; Dunning KR, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.096271; Durlinger ALL, 2002, ENDOCRINOLOGY, V143, P1076, DOI 10.1210/en.143.3.1076; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Durlinger ALL, 2002, REPRODUCTION, V124, P601, DOI 10.1530/reprod/124.5.601; Fanchin R, 2007, J CLIN ENDOCR METAB, V92, P1796, DOI 10.1210/jc.2006-1053; Ficicioglu C, 2006, FERTIL STERIL, V85, P592, DOI 10.1016/j.fertnstert.2005.09.019; Fortune JE, 2003, ANIM REPROD SCI, V78, P135, DOI 10.1016/S0378-4320(03)00088-5; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gilchrist RB, 2011, REPROD FERT DEVELOP, V23, P23, DOI 10.1071/RD10225; Hattori Y, 2013, EUR J OBSTET GYN R B, V169, P252, DOI 10.1016/j.ejogrb.2013.03.021; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HIROBE S, 1992, ENDOCRINOLOGY, V131, P854, DOI 10.1210/en.131.2.854; HIROBE S, 1994, BIOL REPROD, V50, P1238, DOI 10.1095/biolreprod50.6.1238; Hussein TS, 2006, DEV BIOL, V296, P514, DOI 10.1016/j.ydbio.2006.06.026; Hutt KJ, 2007, REPROD BIOMED ONLINE, V14, P758, DOI 10.1016/S1472-6483(10)60679-7; Josso Nathalie, 2006, Pediatr Endocrinol Rev, V3, P347; Juengel JL, 2004, ANIM REPROD SCI, V82-3, P447, DOI 10.1016/j.anireprosci.2004.04.021; Juengel JL, 2005, HUM REPROD UPDATE, V11, P144, DOI 10.1093/humupd/dmh061; Kevenaar ME, 2006, ENDOCRINOLOGY, V147, P3228, DOI 10.1210/en.2005-1588; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; La Marca A, 2010, HUM REPROD UPDATE, V16, P113, DOI 10.1093/humupd/dmp036; Li HWR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061095; MacLaughlin DT, 2002, ADV EXP MED BIOL, V511, P25; Mehta Bindu N, 2013, J Hum Reprod Sci, V6, P99, DOI 10.4103/0974-1208.117168; Nelson SM, 2007, HUM REPROD, V22, P2414, DOI 10.1093/humrep/dem204; Nilsson E, 2007, REPRODUCTION, V134, P209, DOI 10.1530/REP-07-0119; Nilsson EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020087; Park JH, 2011, REPROD SCI, V18, P334, DOI 10.1177/1933719110388294; Patrelli TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044571; Qiao J, 2011, HUM REPROD UPDATE, V17, P17, DOI 10.1093/humupd/dmq032; Sedes L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081551; Shen CX, 2003, FEBS LETT, V539, P111, DOI 10.1016/S0014-5793(03)00209-6; Silberstein T, 2006, HUM REPROD, V21, P159, DOI 10.1093/humrep/dei270; Smitz JEJ, 2011, SEMIN REPROD MED, V29, P24, DOI 10.1055/s-0030-1268701; Takahashi C, 2008, FERTIL STERIL, V89, P586, DOI 10.1016/j.fertnstert.2007.03.080; TAKAHASHI M, 1986, MOL CELL ENDOCRINOL, V47, P225, DOI 10.1016/0303-7207(86)90116-4; Trounson A, 2001, REPRODUCTION, V121, P51, DOI 10.1530/rep.0.1210051; TSAFRIRI A, 1988, BIOL REPROD, V38, P481, DOI 10.1095/biolreprod38.2.481; UENO S, 1989, ENDOCRINOLOGY, V125, P1060, DOI 10.1210/endo-125-2-1060; UENO S, 1989, ENDOCRINOLOGY, V124, P1000, DOI 10.1210/endo-124-2-1000; Veiga-Lopez A, 2012, FERTIL STERIL, V97, P748, DOI 10.1016/j.fertnstert.2011.12.028; Visser JA, 2006, REPRODUCTION, V131, P1, DOI 10.1530/rep.1.00529; Visser JA, 2005, MOL CELL ENDOCRINOL, V234, P81, DOI 10.1016/j.mce.2004.09.008; Wilson T, 2001, BIOL REPROD, V64, P1225, DOI 10.1095/biolreprod64.4.1225; Wunder DM, 2008, FERTIL STERIL, V90, P2203, DOI 10.1016/j.fertnstert.2007.10.078; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854	55	17	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99393	10.1371/journal.pone.0099393	http://dx.doi.org/10.1371/journal.pone.0099393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932501	Green Published, Green Submitted, gold			2022-12-25	WOS:000337738600031
J	Arts, MR; Baron, M; Chokr, N; Fritzler, MJ; Servant, MJ				Arts, Monique R.; Baron, Murray; Chokr, Nidaa; Fritzler, Marvin J.; Servant, Marc J.		CSRG	Systemic Sclerosis Immunoglobulin Induces Growth and a Pro-Fibrotic State in Vascular Smooth Muscle Cells through the Epidermal Growth Factor Receptor	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; RNA-POLYMERASE-III; ANGIOTENSIN-II; STIMULATORY AUTOANTIBODIES; PDGF RECEPTOR; FACTOR-BETA; ACTIVATION; PHOSPHORYLATION; TRANSACTIVATION; EXPRESSION	Objective: It has been suggested that autoantibodies in systemic sclerosis (SSc) may induce the differentiation of cultured fibroblasts into myofibroblasts through platelet-derived growth factor receptor (PDGFR) activation. The present study aims to characterize the effects of SSc IgG on vascular smooth muscle cells (VSMCs) and to determine if stimulatory autoantibodies directed to the PDGFR can be detected, and whether they induce a profibrotic response in primary cultured VSMCs. Methods: Cultured VSMCs were exposed to IgG fractions purified from SSc-patient or control sera. VSMC responses were then analyzed for ERK1/2 and Akt phosphorylation, PDGFR immunoprecipitation, cellular proliferation, protein synthesis, and pro-fibrotic changes in mRNA expression. Results: Stimulatory activity in IgG fractions was more prevalent and intense in the SSc samples. SSc IgG immunoprecipitated the PDGFR with greater avidity than control IgG. Interestingly, activation of downstream signaling events (e.g. Akt, ERK1/2) was independent of PDGFR activity, but required functional EGFR. We also detected increased protein synthesis in response to SSc IgG (p<0.001) and pro-fibrotic changes in gene expression (Tgfb1 + 200%; Tgfb2-23%; p<0.001)) in VSMCs treated with SSc IgG. Conclusion: When compared to control IgG, SSc IgG have a higher stimulation index in VSMCs. Although SSc IgG interact with the PDGFR, the observed remodeling signaling events occur through the EGFR in VSMC. Our data thus favour a model of transactivation of the EGFR by SSc-derived PDGFR autoantibodies and suggest the use of EGFR inhibitors in future target identification studies in the field of SSc.	[Arts, Monique R.; Chokr, Nidaa; Servant, Marc J.] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; [Arts, Monique R.; Baron, Murray] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; [Fritzler, Marvin J.] Univ Calgary, Dept Med, Calgary, AB, Canada	Universite de Montreal; McGill University; University of Calgary	Servant, MJ (corresponding author), Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada.	marc.servant@umontreal.ca	Pope, Janet/G-3342-2011; Baron, Murray/AAF-9486-2019	Pope, Janet/0000-0003-1479-5302; 	Canadian Institutes of Health Research (CIHR) [MOP 53282]; Canada Research Chair in Signaling Networks in Inflammation; CIHR Strategic Training Initiative in Health Research grant [SKI 83345]; Arthritis Society Research Chair; CIHR [FRN 83518]; Scleroderma Society of Canada; Scleroderma Society of Ontario; Sclerodermie Quebec; Cure Scleroderma Foundation; INOVA Diagnostics Inc (San Diego, CA); Dr. Fooke Laboratorien GmbH (Neuss, Germany); Euroimmun (Lubeck, Germany); Mikrogen GmbH; Fonds de la recherche en sante du Quebec (FRSQ); Canadian Arthritis Network (CAN); Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, QC; Pfizer; Actelion pharmaceuticals	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Signaling Networks in Inflammation; CIHR Strategic Training Initiative in Health Research grant(Canadian Institutes of Health Research (CIHR)); Arthritis Society Research Chair; CIHR(Canadian Institutes of Health Research (CIHR)); Scleroderma Society of Canada; Scleroderma Society of Ontario; Sclerodermie Quebec; Cure Scleroderma Foundation; INOVA Diagnostics Inc (San Diego, CA); Dr. Fooke Laboratorien GmbH (Neuss, Germany); Euroimmun (Lubeck, Germany); Mikrogen GmbH; Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canadian Arthritis Network (CAN); Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, QC; Pfizer(Pfizer); Actelion pharmaceuticals	MJS holds Canadian Institutes of Health Research (CIHR) Grant MOP 53282 and a Canada Research Chair in Signaling Networks in Inflammation. MRA and NC received Canadian Scleroderma Research Group (CSRG) Studentship awards, which are funded by a CIHR Strategic Training Initiative in Health Research grant (SKI 83345). MJF holds the Arthritis Society Research Chair. The CSRG is funded by the CIHR (FRN 83518), the Scleroderma Society of Canada and its provincial Chapters, Scleroderma Society of Ontario, Sclerodermie Quebec, Cure Scleroderma Foundation, INOVA Diagnostics Inc. (San Diego, CA), Dr. Fooke Laboratorien GmbH (Neuss, Germany), Euroimmun (Lubeck, Germany), Mikrogen GmbH (Neuried, Cover Letter 2 Germany), Fonds de la recherche en sante du Quebec (FRSQ), the Canadian Arthritis Network (CAN), and the Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, QC. The CSRG has also received eductional grants from Pfizer and Actelion pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Balada E, 2008, ANN RHEUM DIS, V67, P1027, DOI 10.1136/ard.2007.085480; Baroni SS, 2006, NEW ENGL J MED, V354, P2667; Black PC, 2011, J UROLOGY, V185, P693, DOI 10.1016/j.juro.2010.09.082; Bokemeyer D, 2000, KIDNEY INT, V58, P549, DOI 10.1046/j.1523-1755.2000.t01-1-00201.x; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Bussone G, 2012, ANN RHEUM DIS, V71, P596, DOI 10.1136/annrheumdis-2011-200195; Chan SY, 2008, J MOL CELL CARDIOL, V44, P14, DOI 10.1016/j.yjmcc.2007.09.006; Classen JF, 2009, ARTHRITIS RHEUM-US, V60, P1137, DOI 10.1002/art.24381; COUNTAWAY JL, 1989, J BIOL CHEM, V264, P13642; Daoussis D, 2011, INT J RHEUMATOL, V2011, DOI 10.1155/2011/214013; DECKER SJ, 1989, J BIOL CHEM, V264, P9204; Demoulin J-B, 2014, CYTOKINE GROWTH FACT; Dimmeler S, 2000, CIRC RES, V86, P4, DOI 10.1161/01.RES.86.1.4; Douillette A, 2006, J BIOL CHEM, V281, P13275, DOI 10.1074/jbc.M512815200; Doyon P, 2010, J BIOL CHEM, V285, P30708, DOI 10.1074/jbc.M110.126433; Duprez DA, 2006, J HYPERTENS, V24, P983, DOI 10.1097/01.hjh.0000226182.60321.69; Eguchi S, 1998, J BIOL CHEM, V273, P8890, DOI 10.1074/jbc.273.15.8890; Furst DE, 1998, J RHEUMATOL, V25, P84; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Graves Lee M, 2002, Mol Interv, V2, P208, DOI 10.1124/mi.2.4.208; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Hsu VM, 2008, J RHEUMATOL, V35, P458; Khimdas S, 2011, ARTHRIT CARE RES, V63, P142, DOI 10.1002/acr.20336; KOVALENKO M, 1994, CANCER RES, V54, P6106; Kurasawa K, 2010, MOD RHEUMATOL, V20, P458, DOI 10.1007/s10165-010-0310-x; Kuwana M, 2005, ARTHRITIS RHEUM-US, V52, P2425, DOI 10.1002/art.21232; Lambova S, 2010, AUTOIMMUN REV, V9, P761, DOI 10.1016/j.autrev.2010.06.006; Levitzki A, 2006, ANNU REV BIOCHEM, V75, P93, DOI 10.1146/annurev.biochem.75.103004.142657; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loizos N, 2009, ARTHRITIS RHEUM-US, V60, P1145, DOI 10.1002/art.24365; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Matchkov VV, 2012, BASIC CLIN PHARMACOL, V110, P42, DOI 10.1111/j.1742-7843.2011.00818.x; Medsger TA, 2003, CLIN EXP RHEUMATOL, V21, pS42; Moinzadeh P, 2013, J EXPT PHARM, V2013, P15; Mouthon L, 2012, NAT REV RHEUMATOL, V8, P72, DOI 10.1038/nrrheum.2011.203; Mukerjee D, 2004, RHEUMATOLOGY, V43, P461, DOI 10.1093/rheumatology/keh067; Overbeek MJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3315; Pardanani A, 2004, BLOOD, V104, P1931, DOI 10.1182/blood-2004-01-0246; Planque S, 2003, FASEB J, V17, P136, DOI 10.1096/fj.01-0847com; Pope J, 2011, ARTHRITIS RHEUM-US, V63, P3547, DOI 10.1002/art.30549; Prelog M, 2005, ARTHRITIS RHEUM-US, V52, P1804, DOI 10.1002/art.21109; Prey S, 2012, BRIT J DERMATOL, V167, P1138, DOI 10.1111/j.1365-2133.2012.11186.x; Riemekasten G, 2011, ANN RHEUM DIS, V70, P530, DOI 10.1136/ard.2010.135772; Saito Y, 2001, MOL CELL BIOL, V21, P6387, DOI 10.1128/MCB.21.19.6387-6394.2001; Saito Y, 2001, J MOL CELL CARDIOL, V33, P3, DOI 10.1006/jmcc.2000.1272; Santiago M, 2007, J RHEUMATOL, V34, P1528; Servant MJ, 2000, J CELL BIOL, V148, P543, DOI 10.1083/jcb.148.3.543; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Skhirtladze C, 2008, ARTHRITIS RHEUM, V58, P1475, DOI 10.1002/art.23436; Svegliati S, 2007, BLOOD, V110, P237, DOI 10.1182/blood-2007-01-071043; Tinhofer I, 1996, J BIOL CHEM, V271, P30505, DOI 10.1074/jbc.271.48.30505; Tse KF, 2001, LEUKEMIA, V15, P1001, DOI 10.1038/sj.leu.2402199; Ushio-Fukai M, 1999, J BIOL CHEM, V274, P22699, DOI 10.1074/jbc.274.32.22699; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; WALKER F, 1991, J BIOL CHEM, V266, P2746; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2	57	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100035	10.1371/journal.pone.0100035	http://dx.doi.org/10.1371/journal.pone.0100035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927197	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100109
J	Das, RK; Banerjee, S; Shapiro, BH				Das, Rajat Kumar; Banerjee, Sarmistha; Shapiro, Bernard H.			Irreversible perinatal imprinting of adult expression of the principal sex-dependent drug-metabolizing enzyme CYP2C11	FASEB JOURNAL			English	Article						growth hormone; sexual dimorphisms; SOCS2; STAT5b; testosterone; development	CIRCULATING GROWTH-HORMONE; SEXUALLY DIMORPHIC EXPRESSION; MONOSODIUM GLUTAMATE; GENDER-DIFFERENCES; MALE-RATS; HEPATIC CYTOCHROME-P-450; SUBOPTIMAL ACTIVATION; REGULATING EXPRESSION; SIGNAL-TRANSDUCTION; GONADAL-STEROIDS	We proposed to determine whether, like other sexual dimorphisms, drug metabolism is permanently imprinted by perinatal hormones, resulting in its irreversible sex-dependent expression. We treated newborn male rats with monosodium glutamate (MSG), a total growth hormone (GH) blocker, and, using cultured hepatocytes, examined expression of adult CYP2C11, the predominant cytochrome-P450 expressed only in males, as well as the signal transduction pathway by which episodic GH solely regulates the isoform's expression. In addition, adolescent hypophysectomized (hypox) male rats served as controls in which GH was eliminated after the critical imprinting period. Whereas renaturalization of the masculine episodic GH profile restored normal male-like levels of CYP2C11, as well as CYP2C12, in hepatocytes from hypox rats, the cells derived from the MSG-treated rats were completely unresponsive. Moreover, GH exposure of hepatocytes from hypox rats resulted in normal induction, activation, nuclear translocation, and binding to the CYP2C11 promoter of the signal transducers mediating GH regulation of CYP2C11 expression, which dramatically contrasted with the complete unresponsiveness of the MSG-derived hepatocytes, also associated with hypermethylation of GH-response elements in the CYP2C11 promoter. Lastly, neonatal MSG treatment had no adverse effect on postnatal and adult testosterone levels. The results demonstrate that the sexually dimorphic expression of CYP2C11 is irreversibly imprinted shortly after birth by a hormone other than the customary testosterone, but likely by GH.	[Das, Rajat Kumar; Banerjee, Sarmistha; Shapiro, Bernard H.] Univ Penn, Sch Vet Med, Labs Biochem, Philadelphia, PA 19104 USA	University of Pennsylvania	Shapiro, BH (corresponding author), Univ Penn, Sch Vet Med, Labs Biochem, 3800 Spruce St, Philadelphia, PA 19104 USA.	shapirob@vet.upenn.edu			U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061285] Funding Source: NIH RePORTER	U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors acknowledge Drs. Ravindra N. Dhir and Chellappagounder Thangavel for their generous help and valuable suggestions. This work was supported by the U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute	Adler N. T., 1981, NEUROENDOCRINOLOGY R, P555; AGRAWAL AK, 1995, AM J PHYSIOL-ENDOC M, V268, pE439, DOI 10.1152/ajpendo.1995.268.3.E439; Agrawal AK, 2000, J PHARMACOL EXP THER, V293, P1027; Agrawal AK, 2000, J PHARMACOL EXP THER, V292, P228; ANDERSON PJB, 1982, J ENDOCRINOL, V92, P419, DOI 10.1677/joe.0.0920419; BAKKE JL, 1978, NEUROENDOCRINOLOGY, V26, P220, DOI 10.1159/000122829; BANDIERA S, 1992, ARCH BIOCHEM BIOPHYS, V296, P286, DOI 10.1016/0003-9861(92)90574-G; BARTKE A, 1973, ENDOCRINOLOGY, V92, P1223, DOI 10.1210/endo-92-4-1223; Bengtsson B. A., 1999, GROWTH HORMONE, P359; Burman P, 1997, J CLIN ENDOCR METAB, V82, P550, DOI 10.1210/jc.82.2.550; CHUNG LWK, 1980, MOL PHARMACOL, V18, P543; Csaba G, 2008, CELL BIOCHEM FUNCT, V26, P1, DOI 10.1002/cbf.1412; DADA MO, 1984, ENDOCRINOLOGY, V115, P996, DOI 10.1210/endo-115-3-996; DANNAN GA, 1986, J BIOL CHEM, V261, P728; Das RK, 2013, ENDOCR RES, V38, P105, DOI 10.3109/07435800.2012.723294; Das RK, 2013, J ENDOCRINOL, V216, P87, DOI 10.1530/JOE-12-0255; Dhir RN, 2007, DRUG METAB DISPOS, V35, P2102, DOI 10.1124/dmd.107.017475; Dhir RN, 2006, J PHARMACOL EXP THER, V316, P87, DOI 10.1124/jpet.105.093773; DOHLER KD, 1975, ENDOCRINOLOGY, V97, P898; Elfarra AA, 1998, DRUG METAB DISPOS, V26, P779; Enokida H, 2004, CANCER RES, V64, P5956, DOI 10.1158/0008-5472.CAN-04-0081; Gathercole LL, 2013, VITAM HORM, V91, P1, DOI 10.1016/B978-0-12-407766-9.00001-8; GOLDMAN AS, 1970, H-S Z PHYSIOL CHEM, V351, P426; Greenhalgh CJ, 2004, GROWTH HORM IGF RES, V14, P200, DOI 10.1016/j.ghir.2003.12.011; GUSTAFSSON J, 1974, ENDOCRINOLOGY, V95, P891, DOI 10.1210/endo-95-3-891; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Herrington J, 2000, ONCOGENE, V19, P2585, DOI 10.1038/sj.onc.1203526; Hines M, 2011, ANNU REV NEUROSCI, V34, P69, DOI 10.1146/annurev-neuro-061010-113654; Hubina E, 2004, HORM METAB RES, V36, P247; JANSSON JO, 1985, ENDOCRINOLOGY, V117, P1881, DOI 10.1210/endo-117-5-1881; JANSSON JO, 1985, ENDOCR REV, V6, P128, DOI 10.1210/edrv-6-2-128; JENNES L, 1984, BRAIN RES, V308, P245, DOI 10.1016/0006-8993(84)91063-1; Johansson A. G., 1999, Journal of Endocrinological Investigation, V22, P58; Johansson AG, 1999, J CLIN ENDOCR METAB, V84, P2002, DOI 10.1210/jc.84.6.2002; Jorgensen JOL, 2005, FRONT HORM RES, V33, P1, DOI 10.1159/000088338; Karlsson H, 1999, MOL CELL ENDOCRINOL, V154, P37, DOI 10.1016/S0303-7207(99)00101-X; Kaufhold A, 2002, J PHARMACOL EXP THER, V302, P490, DOI 10.1124/jpet.102.034785; KRAMER RE, 1979, J PHARMACOL EXP THER, V208, P19; Kuromaru R, 1998, J CLIN ENDOCR METAB, V83, P3890, DOI 10.1210/jc.83.11.3890; Landsman T, 2005, J BIOL CHEM, V280, P37471, DOI 10.1074/jbc.M504125200; LEGRAVEREND C, 1992, FASEB J, V6, P711, DOI 10.1096/fasebj.6.2.1537461; LEMKEYJOHNSTON N, 1974, J NEUROPATH EXP NEUR, V33, P74, DOI 10.1097/00005072-197401000-00006; LeRoith D, 2005, J CLIN INVEST, V115, P233, DOI 10.1172/JCI200524228; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Luczak ED, 2009, ANNU REV PHYSIOL, V71, P1, DOI 10.1146/annurev.physiol.010908.163156; MACGEOCH C, 1984, J BIOL CHEM, V259, P5433; MACLEOD JN, 1987, XENOBIOTICA, V17, P1095, DOI 10.3109/00498258709044208; MORGAN ET, 1985, J BIOL CHEM, V260, P1895; Nebert DW, 2000, PHARMACOLOGY, V61, P124, DOI 10.1159/000028393; OHNO S, 1979, P140; OMALLEY K, 1971, BMJ-BRIT MED J, V3, P607, DOI 10.1136/bmj.3.5775.607; Pampori NA, 1999, ENDOCRINOLOGY, V140, P1245, DOI 10.1210/en.140.3.1245; Pampori NA, 1996, MOL PHARMACOL, V50, P1148; PAMPORI NA, 1991, BIOCHEM PHARMACOL, V41, P1299, DOI 10.1016/0006-2952(91)90101-A; PAMPORI NA, 1991, ACTA ENDOCRINOL-COP, V124, P283, DOI 10.1530/acta.0.1240283; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; RESKO JA, 1968, J ENDOCRINOL, V40, P485, DOI 10.1677/joe.0.0400485; RYAN DE, 1990, PHARMACOL THERAPEUT, V45, P153, DOI 10.1016/0163-7258(90)90029-2; Shapiro B H, 1985, Prog Clin Biol Res, V171, P151; SHAPIRO BH, 1989, ENDOCRINOLOGY, V125, P2935, DOI 10.1210/endo-125-6-2935; SHAPIRO BH, 1995, INT J BIOCHEM CELL B, V27, P9, DOI 10.1016/1357-2725(94)00056-5; SHAPIRO BH, 1980, SCIENCE, V209, P418, DOI 10.1126/science.7384816; SHAPIRO BH, 1985, LIFE SCI, V36, P1169, DOI 10.1016/0024-3205(85)90234-6; Soares DV, 2004, GROWTH HORM IGF RES, V14, P436, DOI 10.1016/j.ghir.2004.06.004; Span JPT, 2001, J CLIN ENDOCR METAB, V86, P4161, DOI 10.1210/jc.86.9.4161; Steyn FJ, 2011, ENDOCRINOLOGY, V152, P3165, DOI 10.1210/en.2011-0253; Strom SC, 1996, METHOD ENZYMOL, V272, P388, DOI 10.1016/S0076-6879(96)72044-X; Tarnopolsky MA, 1999, MOD NUTR SER, P179; Thangavel C, 2006, DRUG METAB DISPOS, V34, P410, DOI 10.1124/dmd.105.007716; Thangavel C, 2004, MOL CELL ENDOCRINOL, V220, P31, DOI 10.1016/j.mce.2004.04.002; Thangavel C, 2008, DRUG METAB DISPOS, V36, P1884, DOI 10.1124/dmd.108.021451; Thangavel C, 2007, ENDOCRINOLOGY, V148, P2894, DOI 10.1210/en.2006-1333; Thangavel C, 2011, ENDOCRINOLOGY, V152, P4813, DOI 10.1210/en.2011-1274; Verma AS, 2005, MOL PHARMACOL, V67, P891, DOI 10.1124/mol.104.005454; Wani JH, 1996, TOXICOL APPL PHARM, V137, P295, DOI 10.1006/taap.1996.0083; WAXMAN DJ, 1985, BIOCHEMISTRY-US, V24, P4409, DOI 10.1021/bi00337a023; WAXMAN DJ, 1991, P NATL ACAD SCI USA, V88, P6868, DOI 10.1073/pnas.88.15.6868; Waxman DJ, 2000, PRINCIPLES OF MOLECULAR REGULATION, P55	78	8	8	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2014	28	9					4111	4122		10.1096/fj.13-248864	http://dx.doi.org/10.1096/fj.13-248864			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN8HU	24942648	Green Published			2022-12-25	WOS:000340845900028
J	Ge, XD; Antoine, DJ; Lu, YK; Arriazu, E; Leung, TM; Klepper, AL; Branch, AD; Fiel, MI; Nieto, N				Ge, Xiaodong; Antoine, Daniel J.; Lu, Yongke; Arriazu, Elena; Leung, Tung-Ming; Klepper, Arielle L.; Branch, Andrea D.; Fiel, Maria Isabel; Nieto, Natalia			High Mobility Group Box-1 (HMGB1) Participates in the Pathogenesis of Alcoholic Liver Disease (ALD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN PROTEIN HMGB1; GROUP CHROMOSOMAL-PROTEINS; KINASE-C; ACETAMINOPHEN HEPATOTOXICITY; CYTOKINE ACTIVITY; CELL RECRUITMENT; IN-VIVO; RELEASE; DNA; ACTIVATION	Growing clinical and experimental evidence suggests that sterile inflammation contributes to alcoholic liver disease (ALD). High mobility group box-1 (HMGB1) is highly induced during liver injury; however, a link between this alarmin and ALD has not been established. Thus, the aim of this work was to determine whether HMGB1 contributes to the pathogenesis of ALD. Liver biopsies from patients with ALD showed a robust increase in HMGB1 expression and translocation, which correlated with disease stage, compared with healthy explants. Similar findings were observed in chronic ethanol-fed wild-type (WT) mice. Using primary cell culture, we validated the ability of hepatocytes from ethanol-fed mice to secrete a large amount of HMGB1. Secretion was time- and dose-dependent and responsive to prooxidants and antioxidants. Selective ablation of Hmgb1 in hepatocytes protected mice from alcohol-induced liver injury due to increased carnitine palmitoyltransferase-1, phosphorylated 5'AMP-activated protein kinase-alpha, and phosphorylated peroxisome proliferator-activated receptor-alpha expression along with elevated LDL plus VLDL export. Native and post-translationally modified HMGB1 were detected in humans and mice with ALD. In liver and serum from control mice and in serum from healthy volunteers, the lysine residues within the peptides containing nuclear localization signals (NLSs) 1 and 2 were non-acetylated, and all cysteine residues were reduced. However, in livers from ethanol-fed mice, in addition to all thiol/non-acetylated isoforms of HMGB1, we observed acetylated NLS1 and NLS2, a unique phosphorylation site in serine 35, and an increase in oxidation of HMGB1 to the disulfide isoform. In serum from ethanol-fed mice and from patients with ALD, there was disulfide-bonded hyperacetylated HMGB1, disulfide-bonded non-acetylated HMGB1, and HMGB1 phosphorylated in serine 35. Hepatocytes appeared to be a major source of these HMGB1 isoforms. Thus, hepatocyte HMGB1 participates in the pathogenesis of ALD and undergoes post-translational modifications (PTMs) that could condition its toxic effects.	[Ge, Xiaodong; Lu, Yongke; Arriazu, Elena; Leung, Tung-Ming; Klepper, Arielle L.; Branch, Andrea D.; Nieto, Natalia] Icahn Sch Med Mt Sinai, Dept Med, Div Liver Dis, New York, NY 10029 USA; [Fiel, Maria Isabel] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Antoine, Daniel J.] Univ Liverpool, Med Res Council Ctr Drug Safety Sci Mol & Clin Ph, Liverpool L69 3GE, Merseyside, England	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Liverpool	Nieto, N (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Liver Dis, Box 1123,1425 Madison Ave,Rm 11-70, New York, NY 10029 USA.	natalia.nieto@mssm.edu		Arriazu, Elena/0000-0003-4182-2417	National Institutes of Health United States Public Health Service from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) [U01 AA021887, P20 AA017067, P20 AA017067-01S1, P20 AA017067-03S1]; National Institute on Drug Abuse (NIDA) [R01 DA031095]; National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01 DK090317]; Wellcome Trust; Medical Research Council Centre for Drug Safety Science; MRC [MR/L006758/1] Funding Source: UKRI; Medical Research Council [MR/L006758/1] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA021887, P20AA017067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031095] Funding Source: NIH RePORTER	National Institutes of Health United States Public Health Service from the National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council Centre for Drug Safety Science(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health United States Public Health Service Grants U01 AA021887 (to N. N.) and P20 AA017067, P20 AA017067-01S1, and P20 AA017067-03S1 (to N. N. and M. I. F) from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and R01 DA031095 from the National Institute on Drug Abuse (NIDA) and R01 DK090317 from the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) (to A. D. B). This work was also supported by a Wellcome Trust research fellowship and the Medical Research Council Centre for Drug Safety Science (to D. J. A).	Agresti A, 2003, CURR OPIN GENET DEV, V13, P170, DOI 10.1016/S0959-437X(03)00023-6; Antoine DJ, 2014, MOL MED, V20, P135, DOI 10.2119/molmed.2014.00022; Antoine DJ, 2012, J HEPATOL, V56, P1070, DOI 10.1016/j.jhep.2011.12.019; Antoine DJ, 2009, TOXICOL SCI, V112, P521, DOI 10.1093/toxsci/kfp235; Antoine DJ, 2010, MOL MED, V16, P479, DOI 10.2119/molmed.2010.00126; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Bonaldi T, 2002, EMBO J, V21, P6865, DOI 10.1093/emboj/cdf692; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Carneiro VC, 2009, BIOCHEM BIOPH RES CO, V390, P1245, DOI 10.1016/j.bbrc.2009.10.129; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Cubero FJ, 2012, AM J PHYSIOL-GASTR L, V303, pG228, DOI 10.1152/ajpgi.00465.2011; Dhupar R, 2011, SHOCK, V35, P293, DOI 10.1097/SHK.0b013e3181f6aab0; EINCK L, 1985, EXP CELL RES, V156, P295, DOI 10.1016/0014-4827(85)90539-7; Evankovich J, 2010, J BIOL CHEM, V285, P39888, DOI 10.1074/jbc.M110.128348; Ge XD, 2014, HEPATOLOGY, V59, P1600, DOI 10.1002/hep.26931; Hoppe G, 2006, EXP CELL RES, V312, P3526, DOI 10.1016/j.yexcr.2006.07.020; Huang H, 2014, HEPATOLOGY, V59, P1984, DOI 10.1002/hep.26976; Hubscher SG, 2006, HISTOPATHOLOGY, V49, P450, DOI 10.1111/j.1365-2559.2006.02416.x; Kang HJ, 2009, LAB INVEST, V89, P948, DOI 10.1038/labinvest.2009.47; Krohn NM, 2002, J BIOL CHEM, V277, P32438, DOI 10.1074/jbc.M203814200; Krynetski EY, 2003, CANCER RES, V63, P100; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lee H, 2012, BIOCHEM BIOPH RES CO, V424, P321, DOI 10.1016/j.bbrc.2012.06.116; Leung TM, 2012, HEPATOLOGY, V55, P1596, DOI 10.1002/hep.25543; Li JH, 2003, MOL MED, V9, P37, DOI 10.1007/BF03402105; Li W, 2013, MOL MED, V19, P203, DOI 10.2119/molmed.2013.00064; LIEBER CS, 1982, ALCOHOL CLIN EXP RES, V6, P523, DOI 10.1111/j.1530-0277.1982.tb05017.x; Liu SG, 2006, AM J PHYSIOL-CELL PH, V290, pC990, DOI 10.1152/ajpcell.00308.2005; Lu B, 2014, P NATL ACAD SCI USA, V111, P3068, DOI 10.1073/pnas.1316925111; Lu B, 2013, PROTEIN CELL, V4, P163, DOI 10.1007/s13238-012-2118-2; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Lu W, 2000, J BIOL CHEM, V275, P35006, DOI 10.1074/jbc.M004735200; Nystrom S, 2013, EMBO J, V32, P86, DOI 10.1038/emboj.2012.328; Oh YJ, 2009, J IMMUNOL, V182, P5800, DOI 10.4049/jimmunol.0801873; Prasad R, 2007, MOL CELL, V27, P829, DOI 10.1016/j.molcel.2007.06.029; Qi ML, 2007, NAT CELL BIOL, V9, P402, DOI 10.1038/ncb1553; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schierbeck H, 2011, MOL MED, V17, P1039, DOI 10.2119/molmed.2010.00264; Soop A, 2013, SCAND J IMMUNOL, V78, P205, DOI 10.1111/sji.12076; Stemmer C, 2002, J BIOL CHEM, V277, P1092, DOI 10.1074/jbc.M109503200; STERNER R, 1979, J BIOL CHEM, V254, P1577; Taira J, 2013, J BIOCHEM, V154, P299, DOI 10.1093/jb/mvt056; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Travers AA, 2003, EMBO REP, V4, P131, DOI 10.1038/sj.embor.embor741; Ueda T, 2004, BIOCHEMISTRY-US, V43, P9901, DOI 10.1021/bi035975l; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; Xiao DM, 2000, J NEUROCHEM, V74, P392, DOI 10.1046/j.1471-4159.2000.0740392.x; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82	56	99	103	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22672	22691		10.1074/jbc.M114.552141	http://dx.doi.org/10.1074/jbc.M114.552141			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24928512	hybrid, Green Published			2022-12-25	WOS:000341017200014
J	Hu, XM; Lu, XD; Liu, RZ; Ai, NP; Cao, ZH; Li, YN; Liu, JF; Yu, B; Liu, K; Wang, HP; Zhou, C; Wang, Y; Han, AD; Ding, F; Chen, RC				Hu, Xiangming; Lu, Xiaodong; Liu, Runzhong; Ai, Nanping; Cao, Zhenhua; Li, Yannan; Liu, Jiangfang; Yu, Bin; Liu, Kai; Wang, Huiping; Zhou, Chao; Wang, Yu; Han, Aidong; Ding, Feng; Chen, Ruichuan			Histone Cross-talk Connects Protein Phosphatase 1 alpha (PP1 alpha) and Histone Deacetylase (HDAC) Pathways to Regulate the Functional Transition of Bromodomain-containing 4 (BRD4) for Inducible Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; P-TEFB; H3 PHOSPHORYLATION; TRANSCRIPTION ELONGATION; CHROMATIN MODIFICATION; ACETYLATED CHROMATIN; BET; INHIBITION; RELEASE; BINDING	Transcription elongation has been recognized as a rate-limiting step for the expression of signal-inducible genes. Through recruitment of positive transcription elongation factor P-TEFb, the bromodomain-containing protein BRD4 plays critical roles in regulating the transcription elongation of a vast array of inducible genes that are important for multiple cellular processes. The diverse biological roles of BRD4 have been proposed to rely on its functional transition between chromatin targeting and transcription regulation. The signaling pathways and the molecular mechanism for regulating this transition process, however, are largely unknown. Here, we report a novel role of phosphorylated Ser(10) of histone H3 (H3S10ph) in governing the functional transition of BRD4. We identified that the acetylated lysines 5 and 8 of nucleosomal histone H4 (H4K5ac/K8ac) is the BRD4 binding site, and the protein phosphatase PP1 alpha and class I histone deacetylase (HDAC1/2/3) signaling pathways are essential for the stress-induced BRD4 release from chromatin. In the unstressed state, phosphorylated H3S10 prevents the deacetylation of nucleosomal H4K5ac/K8ac by HDAC1/2/3, thereby locking up the majority of BRD4 onto chromatin. Upon stress, PP1 alpha-mediated dephosphorylation of H3S10ph allows the deacetylation of nucleosomal H4K5ac/K8ac by HDAC1/2/3, thereby leading to the release of chromatin-bound BRD4 for subsequent recruitment of P-TEFb to enhance the expression of inducible genes. Therefore, our study revealed a novel mechanism that the histone cross-talk between H3S10ph and H4K5ac/K8ac connects PP1 alpha and HDACs to govern the functional transition of BRD4. Combined with previous studies on the regulation of P-TEFb activation, the intricate signaling network for the tight control of transcription elongation is established.	[Hu, Xiangming; Lu, Xiaodong; Liu, Runzhong; Ai, Nanping; Cao, Zhenhua; Li, Yannan; Liu, Jiangfang; Yu, Bin; Liu, Kai; Wang, Huiping; Zhou, Chao; Wang, Yu; Han, Aidong; Ding, Feng; Chen, Ruichuan] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361101, Peoples R China	Xiamen University	Ding, F (corresponding author), Tsinghua Univ, Yangtze Delta Reg Inst, Dept Biotechnol & Biomed, 705 Yatai Rd, Jiaxing 314006, Zhejiang, Peoples R China.	fding7@gmail.com; chenrc@xmu.edu.cn	Liu, Runzhong/B-8217-2012; Ding, Feng/AAH-7335-2019; wang, hui/GRS-4730-2022	Lu, xiaodong/0000-0003-4731-0762	National Natural Science Foundation of China [31270809, 81361120386, 30930046, 81171192, 31170752, 81070307]; 973 program [2013CB917802]; Natural Science Foundation of Fujian Province [2010J01231]; China Postdoctoral Science Foundation [2013M530304]; XMU Basic Training Program of Undergraduate Students Grant [CXB2011019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); XMU Basic Training Program of Undergraduate Students Grant	This work was supported by National Natural Science Foundation of China Grants 31270809, 81361120386, and 30930046 (to R. C.), 81171192 (to R. L.), and 31170752 and 81070307 (to F. D.), 973 program Grant 2013CB917802 (to R. C.), Natural Science Foundation of Fujian Province Grant 2010J01231 (to F. D.), China Postdoctoral Science Foundation project Grant 2013M530304 (to X. H.), and XMU Basic Training Program of Undergraduate Students Grant CXB2011019 (to Y. W).	Ai NP, 2011, NUCLEIC ACIDS RES, V39, P9592, DOI 10.1093/nar/gkr698; Alsarraj J, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/670632; Anand P, 2013, CELL, V154, P569, DOI 10.1016/j.cell.2013.07.013; Banerjee T, 2011, MOL CELL BIOL, V31, P4858, DOI 10.1128/MCB.05631-11; Beckers T, 2007, INT J CANCER, V121, P1138, DOI 10.1002/ijc.22751; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; Blobel GA, 2011, CANCER CELL, V20, P287, DOI 10.1016/j.ccr.2011.08.019; Chadee DN, 1999, J BIOL CHEM, V274, P24914, DOI 10.1074/jbc.274.35.24914; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Chen RC, 2011, METHODS, V53, P85, DOI 10.1016/j.ymeth.2010.04.005; Chiang CM, 2009, BIOL REP, V1, P98, DOI DOI 10.3410/B1-98; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Devaiah BN, 2013, TRANSCR-AUSTIN, V4, P13, DOI 10.4161/trns.22542; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dey A, 2009, MOL BIOL CELL, V20, P4899, DOI 10.1091/mbc.E09-05-0380; Diribarne G, 2009, RNA BIOL, V6, P122, DOI 10.4161/rna.6.2.8115; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Fujita T, 2010, J RECEPT SIG TRANSD, V30, P31, DOI 10.3109/10799890903517921; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; He SH, 2013, J CELL PHYSIOL, V228, P1525, DOI 10.1002/jcp.24311; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kanazawa S, 2003, ONCOGENE, V22, P5707, DOI 10.1038/sj.onc.1206800; Karn J, 2013, CELL CYCLE, V12, P545, DOI 10.4161/cc.23679; Koch F, 2008, TRENDS BIOCHEM SCI, V33, P265, DOI 10.1016/j.tibs.2008.04.006; Lenasi T, 2010, RNA BIOL, V7, P145, DOI 10.4161/rna.7.2.11057; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; Mochizuki K, 2008, J BIOL CHEM, V283, P9040, DOI 10.1074/jbc.M707603200; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Nowak SJ, 2003, MOL CELL BIOL, V23, P6129, DOI 10.1128/MCB.23.17.6129-6138.2003; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Rodriguez RM, 2012, J MOL MED, V90, P587, DOI 10.1007/s00109-011-0837-0; Rossetto D, 2012, EPIGENETICS-US, V7, P1098, DOI 10.4161/epi.21975; Sawicka A, 2012, BIOCHIMIE, V94, P2193, DOI 10.1016/j.biochi.2012.04.018; Schroder S, 2012, J BIOL CHEM, V287, P1090, DOI 10.1074/jbc.M111.282855; Segura MF, 2013, CANCER RES, V73, P6264, DOI 10.1158/0008-5472.CAN-13-0122-T; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Spiltoir JI, 2013, J MOL CELL CARDIOL, V63, P175, DOI 10.1016/j.yjmcc.2013.07.017; Voigt P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-133; Wang HP, 2011, ANAL BIOCHEM, V418, P304, DOI 10.1016/j.ab.2011.07.008; Wang RR, 2012, J BIOL CHEM, V287, P10738, DOI 10.1074/jbc.M111.323493; Wang W, 2013, TRANSCR-AUSTIN, V4, P39, DOI 10.4161/trns.22874; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang GT, 2012, J BIOL CHEM, V287, P28840, DOI 10.1074/jbc.M112.359505; Zhang WS, 2012, J BIOL CHEM, V287, P43137, DOI 10.1074/jbc.M112.413047; Zhao R, 2011, NAT CELL BIOL, V13, P1295, DOI 10.1038/ncb2341; Zhou MS, 2009, J VIROL, V83, P1036, DOI 10.1128/JVI.01316-08; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	63	35	35	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23154	23167		10.1074/jbc.M114.570812	http://dx.doi.org/10.1074/jbc.M114.570812			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24939842	Green Published, hybrid			2022-12-25	WOS:000341017200052
J	Abibi, A; Ferguson, AD; Fleming, PR; Gao, N; Hajec, LI; Hu, J; Laganas, VA; McKinney, DC; McLeod, SM; Prince, DB; Shapiro, AB; Buurman, ET				Abibi, Ayome; Ferguson, Andrew D.; Fleming, Paul R.; Gao, Ning; Hajec, Laurel I.; Hu, Jun; Laganas, Valerie A.; McKinney, David C.; McLeod, Sarah M.; Prince, D. Bryan; Shapiro, Adam B.; Buurman, Ed T.			The Role of a Novel Auxiliary Pocket in Bacterial Phenylalanyl-tRNA Synthetase Druggability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; STRUCTURAL BASIS; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; INHIBITORS; MECHANISM; DISCOVERY; AMINOACYLATION; RESISTANCE; SUBUNITS	The antimicrobial activity of phenyl-thiazolylurea-sulfonamides against Staphylococcus aureus PheRS are dependent upon phenylalanine levels in the extracellular fluids. Inhibitor efficacy in animal models of infection is substantially diminished by dietary phenylalanine intake, thereby reducing the perceived clinical utility of this inhibitor class. The search for novel antibacterial compounds against Gram-negative pathogens led to a re-evaluation of this phenomenon, which is shown here to be unique to S. aureus. Inhibition of macromolecular syntheses and characterization of novel resistance mutations in Escherichia coli demonstrate that antimicrobial activity of phenylthiazolylurea-sulfonamides is mediated by PheRS inhibition, validating this enzyme as a viable drug discovery target for Gram-negative pathogens. A search for novel inhibitors of PheRS yielded three novel chemical starting points. NMR studies were used to confirm direct target engagement for phenylalanine-competitive hits. The crystallographic structure of Pseudomonas aeruginosa PheRS defined the binding modes of these hits and revealed an auxiliary hydrophobic pocket that is positioned adjacent to the phenylalanine binding site. Three viable inhibitor-resistant mutants were mapped to this pocket, suggesting that this region is a potential liability for drug discovery.	[Abibi, Ayome; Gao, Ning; Hajec, Laurel I.; Laganas, Valerie A.; McLeod, Sarah M.; Shapiro, Adam B.; Buurman, Ed T.] AstraZeneca R&D Boston, Infect Innovat Med Unit, Dept Biosci, Waltham, MA 02451 USA; [Fleming, Paul R.; McKinney, David C.] AstraZeneca R&D Boston, Infect Innovat Med Unit, Dept Chem, Waltham, MA 02451 USA; [Ferguson, Andrew D.; Hu, Jun; Prince, D. Bryan] AstraZeneca R&D Boston, Discovery Sci, Dept Struct & Biophys, Waltham, MA 02451 USA	AstraZeneca; AstraZeneca; AstraZeneca	Buurman, ET (corresponding author), AstraZeneca R&D Boston, Infect Innovat Med Unit, Dept Biosci, 35 Gatehouse Dr, Waltham, MA 02451 USA.	Ed.Buurman@astrazeneca.com		Gao, Ning/0000-0003-1605-4137; McKinney, David/0000-0003-1787-1841; Shapiro, Adam/0000-0002-2662-6146				Arnez JG, 1997, TRENDS BIOCHEM SCI, V22, P211, DOI 10.1016/S0968-0004(97)01052-9; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALTZINGER M, 1982, BIOCHEMISTRY-US, V21, P2467, DOI 10.1021/bi00539a028; Beyer D, 2004, ANTIMICROB AGENTS CH, V48, P525, DOI 10.1128/AAC.48.2.525-532.2004; Bricogne G, 2009, BUSTER VERSION 2 8 0; Buurman ET, 2012, J BACTERIOL, V194, P5504, DOI 10.1128/JB.01103-12; Buurman ET, 2011, J BIOL CHEM, V286, P40734, DOI 10.1074/jbc.M111.274068; Buurman ET, 2006, ANTIMICROB AGENTS CH, V50, P385, DOI 10.1128/AAC.50.1.385-387.2006; Clinical and Laboratory Standards Institute, 2009, METH DIL ANT SUSC TE, V29; CUSACK S, 1995, NAT STRUCT BIOL, V2, P824, DOI 10.1038/nsb1095-824; Dalvit C, 2001, J BIOMOL NMR, V21, P349, DOI 10.1023/A:1013302231549; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Evdokimov AG, 2008, J STRUCT BIOL, V162, P152, DOI 10.1016/j.jsb.2007.11.002; FRASER TH, 1975, P NATL ACAD SCI USA, V72, P3044, DOI 10.1073/pnas.72.8.3044; Gentry DR, 2003, ANTIMICROB AGENTS CH, V47, P1784, DOI 10.1128/AAC.47.6.1784-1789.2003; Hernandez V, 2013, ANTIMICROB AGENTS CH, V57, P1394, DOI 10.1128/AAC.02058-12; Hilliard JJ, 1999, ANTIMICROB AGENTS CH, V43, P1693, DOI 10.1128/AAC.43.7.1693; HUGHES J, 1978, BIOCHEM J, V176, P305, DOI 10.1042/bj1760305; IBBA M, 1994, BIOCHEMISTRY-US, V33, P7107, DOI 10.1021/bi00189a013; Jarvest RL, 2005, BIOORG MED CHEM LETT, V15, P2305, DOI 10.1016/j.bmcl.2005.03.003; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAST P, 1991, J MOL BIOL, V222, P99, DOI 10.1016/0022-2836(91)90740-W; KHODYREVA SN, 1985, BIOCHIM BIOPHYS ACTA, V830, P206, DOI 10.1016/0167-4838(85)90029-9; Kotik-Kogan O, 2005, STRUCTURE, V13, P1799, DOI 10.1016/j.str.2005.08.013; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Margolis PS, 2000, ANTIMICROB AGENTS CH, V44, P1825, DOI 10.1128/AAC.44.7.1825-1831.2000; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P3322, DOI 10.1128/AAC.44.12.3322-3327.2000; Mermershtain I, 2011, PROTEIN SCI, V20, P160, DOI 10.1002/pro.549; Montgomery JI, 2009, BIOORG MED CHEM LETT, V19, P665, DOI 10.1016/j.bmcl.2008.12.054; Moor N, 2006, BIOCHEMISTRY-US, V45, P10572, DOI 10.1021/bi060491l; MOSYAK L, 1995, NAT STRUCT BIOL, V2, P537, DOI 10.1038/nsb0795-537; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Raczniak G, 2001, TOXICOLOGY, V160, P181, DOI 10.1016/S0300-483X(00)00454-6; Reck F, 2011, J MED CHEM, V54, P7834, DOI 10.1021/jm2008826; Reshetnikova L, 1999, J MOL BIOL, V287, P555, DOI 10.1006/jmbi.1999.2617; Rodova M, 1999, BIOCHEM BIOPH RES CO, V255, P765, DOI 10.1006/bbrc.1999.0141; SAMBROOK J, 2001, MOL CLONING LAB MANU, V2; SANNI A, 1991, P NATL ACAD SCI USA, V88, P8387, DOI 10.1073/pnas.88.19.8387; Schramm VL, 2013, ACS CHEM BIOL, V8, P71, DOI 10.1021/cb300631k; Seah C, 2012, ANTIMICROB AGENTS CH, V56, P1916, DOI 10.1128/AAC.05325-11; Silver LL, 2007, NAT REV DRUG DISCOV, V6, P41, DOI 10.1038/nrd2202; SPRINZL M, 1975, P NATL ACAD SCI USA, V72, P3049, DOI 10.1073/pnas.72.8.3049; STOTT K, 1995, J AM CHEM SOC, V117, P4199, DOI 10.1021/ja00119a048; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wendrich TM, 2002, MOL CELL, V10, P779, DOI 10.1016/S1097-2765(02)00656-1; Yu XY, 2004, BIOORG MED CHEM LETT, V14, P1343, DOI 10.1016/j.bmcl.2003.11.082; Yu XY, 2004, BIOORG MED CHEM LETT, V14, P1339, DOI 10.1016/j.bmcl.2003.11.081	53	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21651	21662		10.1074/jbc.M114.574061	http://dx.doi.org/10.1074/jbc.M114.574061			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24936059	hybrid, Green Published			2022-12-25	WOS:000340558300039
J	Satagopan, S; Chan, S; Perry, LJ; Tabita, FR				Satagopan, Sriram; Chan, Sum; Perry, L. Jeanne; Tabita, F. Robert			Structure-Function Studies with the Unique Hexameric Form II Ribulose-1,5-bisphosphate Carboxylase/Oxygenase (Rubisco) from Rhodopseudomonas palustris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE 1,5-BISPHOSPHATE CARBOXYLASE; RHODOSPIRILLUM-RUBRUM; CRYSTAL-STRUCTURE; LARGE-SUBUNIT; CATALYTIC-PROPERTIES; REGULATORY TWIST; OXYGENASE; EVOLUTION; PROTEINS; SUBSTITUTIONS	The first x-ray crystal structure has been solved for an activated transition-state analog-bound form II ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco). This enzyme, from Rhodopseudomonas palustris, assembles as a unique hexamer with three pairs of catalytic large subunit homodimers around a central 3-fold symmetry axis. This oligomer arrangement is unique among all known Rubisco structures, including the form II homolog from Rhodospirillum rubrum. The presence of a transition-state analog in the active site locked the activated enzyme in a "closed" conformation and revealed the positions of critical active site residues during catalysis. Functional roles of two form II-specific residues (Ile(165) and Met(331)) near the active site were examined via site-directed mutagenesis. Substitutions at these residues affect function but not the ability of the enzyme to assemble. Random mutagenesis and suppressor selection in a Rubisco deletion strain of Rhodobacter capsulatus identified a residue in the amino terminus of one subunit (Ala(47)) that compensated for a negative change near the active site of a neighboring subunit. In addition, substitution of the native carboxyl-terminal sequence with the last few dissimilar residues from the related R. rubrum homolog increased the enzyme's k(cat) for carboxylation. However, replacement of a longer carboxyl-terminal sequence with termini from either a form III or a form I enzyme, which varied both in length and sequence, resulted in complete loss of function. From these studies, it is evident that a number of subtle interactions near the active site and the carboxyl terminus account for functional differences between the different forms of Rubiscos found in nature.	[Satagopan, Sriram; Tabita, F. Robert] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Chan, Sum; Perry, L. Jeanne] Univ Calif Los Angeles, Dept Energy DOE, Inst Genom & Prote, Los Angeles, CA 90095 USA	University System of Ohio; Ohio State University; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Tabita, FR (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	tabita.1@osu.edu	Satagopan, Sriram/B-3198-2011	Satagopan, Sriram/0000-0002-4867-531X	National Institutes of Health [GM095742]; Department of Energy [DE-FC02-02ER63421]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095742] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM095742. This work was also supported by Department of Energy Grant DE-FC02-02ER63421 (to the Protein Expression Technology Center Core Facility at UCLA).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersson I, 1996, J MOL BIOL, V259, P160, DOI 10.1006/jmbi.1996.0310; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Andersson I, 2008, J EXP BOT, V59, P1555, DOI 10.1093/jxb/ern091; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burisch C, 2007, FEBS LETT, V581, P741, DOI 10.1016/j.febslet.2007.01.043; Chene P, 1997, BIOCHEM BIOPH RES CO, V232, P482, DOI 10.1006/bbrc.1997.6318; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabiola F, 2002, PROTEIN SCI, V11, P1415, DOI 10.1110/ps.4890102; Guadalupe-Medina V, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-125; Harpel MR, 1998, PROTEIN SCI, V7, P730, DOI 10.1002/pro.5560070322; Horken KM, 1999, J BACTERIOL, V181, P3935, DOI 10.1128/JB.181.13.3935-3941.1999; Joshi GS, 2013, J BACTERIOL, V195, P1381, DOI 10.1128/JB.02060-12; Kitano K, 2001, STRUCTURE, V9, P473, DOI 10.1016/S0969-2126(01)00608-6; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUEHN GD, 1978, BIOCHEM J, V175, P909, DOI 10.1042/bj1750909; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LEE GJ, 1993, PROTEIN SCI, V2, P1147, DOI 10.1002/pro.5560020709; Li LA, 1997, J BACTERIOL, V179, P3793, DOI 10.1128/jb.179.11.3793-3796.1997; Liggins JR, 2009, BIOCHEMISTRY-US, V48, P2226, DOI 10.1021/bi802159e; MORELL MK, 1990, FEBS LETT, V265, P41, DOI 10.1016/0014-5793(90)80879-N; Mueller-Cajar O, 2008, PHOTOSYNTH RES, V98, P667, DOI 10.1007/s11120-008-9324-z; Nakano T, 2010, BIOCHEM BIOPH RES CO, V392, P212, DOI 10.1016/j.bbrc.2010.01.017; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paoli GC, 1998, ARCH MICROBIOL, V170, P8, DOI 10.1007/s002030050609; Parry MAJ, 2008, J EXP BOT, V59, P1569, DOI 10.1093/jxb/ern084; Parry MAJ, 2013, J EXP BOT, V64, P717, DOI 10.1093/jxb/ers336; Peterhansel C, 2012, CURR OPIN BIOTECH, V23, P204, DOI 10.1016/j.copbio.2011.12.013; RANTY B, 1990, EMBO J, V9, P1365, DOI 10.1002/j.1460-2075.1990.tb08251.x; Romagnoli S, 2006, J BACTERIOL, V188, P2780, DOI 10.1128/JB.188.8.2780-2791.2006; Saff EB, 1997, MATH INTELL, V19, P5, DOI 10.1007/BF03024331; Satagopan S, 2004, J BIOL CHEM, V279, P14240, DOI 10.1074/jbc.M313215200; Satagopan S, 2009, BIOCHEMISTRY-US, V48, P9076, DOI 10.1021/bi9006385; Satagopan S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-85; SCHNEIDER G, 1990, J MOL BIOL, V211, P989, DOI 10.1016/0022-2836(90)90088-4; Smith SA, 2004, J BIOL CHEM, V279, P25632, DOI 10.1074/jbc.M401360200; Smith SA, 2003, J MOL BIOL, V331, P557, DOI 10.1016/S0022-2836(03)00786-1; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; SPREITZER RJ, 1988, PLANT PHYSIOL, V86, P987, DOI 10.1104/pp.86.4.987; Sugawara H, 1999, J BIOL CHEM, V274, P15655, DOI 10.1074/jbc.274.22.15655; Tabita FR, 2008, PHILOS T R SOC B, V363, P2629, DOI 10.1098/rstb.2008.0023; Tabita FR, 2008, J EXP BOT, V59, P1515, DOI 10.1093/jxb/erm361; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; Taylor TC, 1996, NAT STRUCT BIOL, V3, P95, DOI 10.1038/nsb0196-95; TERZAGHI BE, 1986, BIOCHEM J, V235, P839, DOI 10.1042/bj2350839; van Lun M, 2011, J MOL BIOL, V411, P1083, DOI 10.1016/j.jmb.2011.06.052; WHITMAN W, 1976, BIOCHEM BIOPH RES CO, V71, P1034, DOI 10.1016/0006-291X(76)90758-0; Whitney SM, 1999, PLANT PHYSIOL, V121, P579, DOI 10.1104/pp.121.2.579; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; YEATES TO, 1995, J MOL BIOL, V249, P804, DOI 10.1006/jmbi.1995.0339; ZHU GH, 1990, PLANT PHYSIOL, V93, P244, DOI 10.1104/pp.93.1.244	55	30	30	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21433	21450		10.1074/jbc.M114.578625	http://dx.doi.org/10.1074/jbc.M114.578625			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24942737	hybrid, Green Published			2022-12-25	WOS:000340558300022
J	Jinadasa, T; Szabo, EZ; Numata, M; Orlowski, J				Jinadasa, Tushare; Szabo, Eloed Z.; Numata, Masayuki; Orlowski, John			Activation of AMP-activated Protein Kinase Regulates Hippocampal Neuronal pH by Recruiting Na+/H+ Exchanger NHE5 to the Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR PH; ENERGY SENSOR; PHARMACOLOGICAL-PROPERTIES; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; PYRAMIDAL NEURONS; CA1 NEURONS; BRAIN; ACIDOSIS; CA2+	Strict regulation of intra-and extracellular pH is an important determinant of nervous system function as many voltage-, ligand-, and H+-gated cationic channels are exquisitely sensitive to transient fluctuations in pH elicited by neural activity and pathophysiologic events such as hypoxia-ischemia and seizures. Multiple Na+/H+ exchangers (NHEs) are implicated in maintenance of neural pH homeostasis. However, aside from the ubiquitous NHE1 isoform, their relative contributions are poorly understood. NHE5 is of particular interest as it is preferentially expressed in brain relative to other tissues. In hippocampal neurons, NHE5 regulates steady-state cytoplasmic pH, but intriguingly the bulk of the transporter is stored in intracellular vesicles. Here, we show that NHE5 is a direct target for phosphorylation by the AMP-activated protein kinase (AMPK), a key sensor and regulator of cellular energy homeostasis in response to metabolic stresses. In NHE5-transfected non-neuronal cells, activation of AMPK by the AMP mimetic AICAR or by antimycin A, which blocks aerobic respiration and causes acidification, increased cell surface accumulation and activity of NHE5, and elevated intracellular pH. These effects were effectively blocked by the AMPK antagonist compound C, the NHE inhibitor HOE694, and mutation of a predicted AMPK recognition motif in the NHE5 C terminus. This regulatory pathway was also functional in primary hippocampal neurons, where AMPK activation of NHE5 protected the cells from sustained antimycin A-induced acidification. These data reveal a unique role for AMPK and NHE5 in regulating the pH homeostasis of hippocampal neurons during metabolic stress.	[Jinadasa, Tushare; Orlowski, John] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Szabo, Eloed Z.] Hosp Sick Children, Toronto, ON M5S 3E2, Canada; [Numata, Masayuki] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of British Columbia	Orlowski, J (corresponding author), McGill Univ, McIntyre Med Sci Bldg, Montreal, PQ H3G 1Y6, Canada.	john.orlowski@mcgill.ca		Orlowski, John/0000-0001-7371-175X	Canadian Foundation for Innovation (CFI); Ministere du developpement economique, innovation et exportation Quebec (MDEIE)	Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ministere du developpement economique, innovation et exportation Quebec (MDEIE)	We thank Annie Boucher, Claire M. Brown, Emily C. Deane, Micaela Das Gupta, Khalid Hassan, Alina Ilie, Viktoria Lukashova, and Hans Zaun for technical assistance. Images were collected and/or image processing and analysis was performed in the McGill University Life Sciences Complex Advanced BioImaging Facility (ABIF). Purchase of equipment in the facility was made possible with funding from the Canadian Foundation for Innovation (CFI) and the Ministere du developpement economique, innovation et exportation Quebec (MDEIE). We also acknowledge the services provided by Genome Quebec.	Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; AMATO A, 1994, J NEUROPHYSIOL, V72, P1686, DOI 10.1152/jn.1994.72.4.1686; Amos BJ, 1998, NEUROSCIENCE, V86, P1109, DOI 10.1016/S0306-4522(98)00072-4; Attaphitaya S, 1999, J BIOL CHEM, V274, P4383, DOI 10.1074/jbc.274.7.4383; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Baird NR, 1999, J BIOL CHEM, V274, P4377, DOI 10.1074/jbc.274.7.4377; Baxter KA, 1996, J PHYSIOL-LONDON, V493, P457, DOI 10.1113/jphysiol.1996.sp021396; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; Benziane B, 2012, J BIOL CHEM, V287, P23451, DOI 10.1074/jbc.M111.331926; Bevensee MO, 1996, J PHYSIOL-LONDON, V494, P315, DOI 10.1113/jphysiol.1996.sp021494; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Broussard JA, 2013, NAT PROTOC, V8, P265, DOI 10.1038/nprot.2012.147; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chen LM, 2008, NEUROSCIENCE, V153, P162, DOI 10.1016/j.neuroscience.2008.02.018; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Church J, 1998, J PHYSIOL-LONDON, V511, P119, DOI 10.1111/j.1469-7793.1998.119bi.x; Cox GA, 1997, CELL, V91, P139, DOI 10.1016/S0092-8674(01)80016-7; Day RN, 2012, BIOESSAYS, V34, P341, DOI 10.1002/bies.201100098; Deane EC, 2013, J NEUROSCI, V33, P595, DOI 10.1523/JNEUROSCI.2583-12.2013; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; Diarra A, 1999, NEUROSCIENCE, V93, P1003, DOI 10.1016/S0306-4522(99)00230-4; Diering GH, 2011, MOL BIOL CELL, V22, P2246, DOI 10.1091/mbc.E11-01-0066; Dietrich CJ, 2010, J NEUROSCI, V30, P16044, DOI 10.1523/JNEUROSCI.6364-09.2010; Ding D, 2000, EXP NEUROL, V162, P1, DOI 10.1006/exnr.2000.7226; Emerling BM, 2007, FEBS LETT, V581, P5727, DOI 10.1016/j.febslet.2007.11.038; ENDRES W, 1986, NEUROSCI LETT, V72, P54, DOI 10.1016/0304-3940(86)90617-8; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Fryer LGD, 2002, FEBS LETT, V531, P189, DOI 10.1016/S0014-5793(02)03501-9; Gadalla AE, 2004, J NEUROCHEM, V88, P1272, DOI 10.1046/j.1471-4159.2003.02253.x; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Handa N, 2011, ACTA CRYSTALLOGR D, V67, P480, DOI 10.1107/S0907444911010201; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; IRWIN RP, 1994, J NEUROSCI, V14, P1352, DOI 10.1523/JNEUROSCI.14-03-01352.1994; Jang IS, 2006, J NEUROCHEM, V99, P1224, DOI 10.1111/j.1471-4159.2006.04168.x; Kim MS, 2005, J MOL MED, V83, P514, DOI 10.1007/s00109-005-0659-z; Kintner DB, 2010, J BIOL CHEM, V285, P35155, DOI 10.1074/jbc.M110.101212; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu CL, 2004, NEUROSCIENCE, V127, P113, DOI 10.1016/j.neuroscience.2004.03.062; Liu YF, 2013, STAT INTERFACE, V6, P1; Luckermann M, 1997, J NEUROPHYSIOL, V77, P1844, DOI 10.1152/jn.1997.77.4.1844; Lukashova V, 2013, ADV EXP MED BIOL, V961, P397, DOI 10.1007/978-1-4614-4756-6_34; Ma E, 1997, NEUROSCIENCE, V79, P591, DOI 10.1016/S0306-4522(96)00674-4; Matsuda T, 1996, EUR J NEUROSCI, V8, P951, DOI 10.1111/j.1460-9568.1996.tb01582.x; NEDERGAARD M, 1991, J NEUROSCI, V11, P2489; NEDERGAARD M, 1991, AM J PHYSIOL, V260, pR581, DOI 10.1152/ajpregu.1991.260.3.R581; ORLOWSKI J, 1993, J BIOL CHEM, V268, P16369; Pizzonia JH, 1996, J NEUROSCI RES, V44, P191, DOI 10.1002/(SICI)1097-4547(19960415)44:2<191::AID-JNR12>3.0.CO;2-9; Ponticos M, 1998, EMBO J, V17, P1688, DOI 10.1093/emboj/17.6.1688; Potter WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008996; Putnam RW, 2004, AM J PHYSIOL-CELL PH, V287, pC1493, DOI 10.1152/ajpcell.00282.2004; RALEYSUSMAN KM, 1993, BRAIN RES, V614, P308, DOI 10.1016/0006-8993(93)91049-X; RALEYSUSMAN KM, 1991, J BIOL CHEM, V266, P2739; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; Rotte A, 2010, BIOCHEM BIOPH RES CO, V398, P677, DOI 10.1016/j.bbrc.2010.06.135; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Saybasili H, 1998, BRAIN RES, V786, P128, DOI 10.1016/S0006-8993(97)01461-3; SCHWIENING CJ, 1994, J PHYSIOL-LONDON, V475, P59, DOI 10.1113/jphysiol.1994.sp020049; SIESJO BK, 1985, J CEREBR BLOOD F MET, V5, P47, DOI 10.1038/jcbfm.1985.7; Silver IA, 1997, NEUROSCIENCE, V78, P589, DOI 10.1016/S0306-4522(96)00600-8; SIMON RP, 1984, J CEREBR BLOOD F MET, V4, P350, DOI 10.1038/jcbfm.1984.52; Spasic MR, 2009, NEUROSCIENTIST, V15, P309, DOI 10.1177/1073858408327805; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; STYS PK, 1991, ANN NY ACAD SCI, V639, P328, DOI 10.1111/j.1749-6632.1991.tb17321.x; Szabo EZ, 2000, J BIOL CHEM, V275, P6302, DOI 10.1074/jbc.275.9.6302; Szabo EZ, 2005, P NATL ACAD SCI USA, V102, P2790, DOI 10.1073/pnas.0407444102; Szaszi K, 2002, J BIOL CHEM, V277, P42623, DOI 10.1074/jbc.M206629200; Takahashi KI, 1996, NEUROSCI RES, V24, P109, DOI 10.1016/0168-0102(95)00989-2; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; Terunuma M, 2010, P NATL ACAD SCI USA, V107, P13918, DOI 10.1073/pnas.1000853107; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Tombaugh GC, 1996, J PHYSIOL-LONDON, V493, P719, DOI 10.1113/jphysiol.1996.sp021417; TOMBAUGH GC, 1990, BRAIN RES, V506, P343, DOI 10.1016/0006-8993(90)91277-N; Trapp S, 1996, J PHYSIOL-LONDON, V496, P695, DOI 10.1113/jphysiol.1996.sp021720; TRAYNELIS SF, 1991, J PHYSIOL-LONDON, V433, P727, DOI 10.1113/jphysiol.1991.sp018453; Turnley AM, 1999, J NEUROCHEM, V72, P1707, DOI 10.1046/j.1471-4159.1999.721707.x; Velisek L, 1998, HIPPOCAMPUS, V8, P24, DOI 10.1002/(SICI)1098-1063(1998)8:1<24::AID-HIPO3>3.0.CO;2-7; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Weisova P, 2009, J NEUROSCI, V29, P2997, DOI 10.1523/JNEUROSCI.0354-09.2009; WICK AN, 1957, J BIOL CHEM, V224, P963; WITTERS LA, 1991, BIOCHEM BIOPH RES CO, V181, P1486, DOI 10.1016/0006-291X(91)92107-U; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiang ZM, 2000, BRAIN RES, V881, P77, DOI 10.1016/S0006-8993(00)02795-5; Xiong ZQ, 2000, J NEUROSCI, V20, P1290; Yao H, 1999, J CLIN INVEST, V104, P637, DOI 10.1172/JCI6785; Ying WH, 1999, J NEUROCHEM, V73, P1549, DOI 10.1046/j.1471-4159.1999.0731549.x; Zhan RZ, 1998, BRAIN RES, V780, P86, DOI 10.1016/S0006-8993(97)01149-9	97	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20879	20897		10.1074/jbc.M114.555284	http://dx.doi.org/10.1074/jbc.M114.555284			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24936055	hybrid, Green Published			2022-12-25	WOS:000339396600042
J	Garcia, TI; Matos, I; Shen, YJ; Pabuwal, V; Coelho, MM; Wakamatsu, Y; Schartl, M; Walter, RB				Garcia, Tzintzuni I.; Matos, Isa; Shen, Yingjia; Pabuwal, Vagmita; Coelho, Maria Manuela; Wakamatsu, Yuko; Schartl, Manfred; Walter, Ronald B.			Novel Method for Analysis of Allele Specific Expression in Triploid Oryzias latipes Reveals Consistent Pattern of Allele Exclusion	PLOS ONE			English	Article							COPY-NUMBER ALTERATION; RNA-SEQ DATA; GENE-EXPRESSION; SQUALIUS-ALBURNOIDES; VARIANT DETECTION; MEDAKA; GENOME; TRANSPLANTATION; GENERATION; EVOLUTION	Assessing allele-specific gene expression (ASE) on a large scale continues to be a technically challenging problem. Certain biological phenomena, such as X chromosome inactivation and parental imprinting, affect ASE most drastically by completely shutting down the expression of a whole set of alleles. Other more subtle effects on ASE are likely to be much more complex and dependent on the genetic environment and are perhaps more important to understand since they may be responsible for a significant amount of biological diversity. Tools to assess ASE in a diploid biological system are becoming more reliable. Non-diploid systems are, however, not uncommon. In humans full or partial polyploid states are regularly found in both healthy (meiotic cells, polynucleated cell types) and diseased tissues (trisomies, non-disjunction events, cancerous tissues). In this work we have studied ASE in the medaka fish model system. We have developed a method for determining ASE in polyploid organisms from RNAseq data and we have implemented this method in a software tool set. As a biological model system we have used nuclear transplantation to experimentally produce artificial triploid medaka composed of three different haplomes. We measured ASE in RNA isolated from the livers of two adult, triploid medaka fish that showed a high degree of similarity. The majority of genes examined (82%) shared expression more or less evenly among the three alleles in both triploids. The rest of the genes (18%) displayed a wide range of ASE levels. Interestingly the majority of genes (78%) displayed generally consistent ASE levels in both triploid individuals. A large contingent of these genes had the same allele entirely suppressed in both triploids. When viewed in a chromosomal context, it is revealed that these genes are from large sections of 4 chromosomes and may be indicative of some broad scale suppression of gene expression.	[Garcia, Tzintzuni I.; Shen, Yingjia; Pabuwal, Vagmita; Walter, Ronald B.] Texas State Univ, Dept Chem & Biochem, Mol Biosci Res Grp, San Marcos, TX 78666 USA; [Matos, Isa; Wakamatsu, Yuko; Schartl, Manfred] Univ Wurzburg, Biozentrum, D-97070 Wurzburg, Germany; [Matos, Isa; Coelho, Maria Manuela] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal; [Schartl, Manfred] Univ Clin Wurzburg, Ctr Comprehens Canc, Wurzburg, Germany	Texas State University System; Texas State University San Marcos; University of Wurzburg; Universidade de Lisboa; University of Wurzburg	Walter, RB (corresponding author), Texas State Univ, Dept Chem & Biochem, Mol Biosci Res Grp, San Marcos, TX 78666 USA.	RWalter@txstate.edu	Walter, Ronald/AAI-5522-2020; Coelho, Maria M/B-8672-2009	Coelho, Maria M/0000-0003-3288-1693; Schartl, Manfred/0000-0001-9882-5948	NIH, ORIP, Division of Comparative Medicine [R24-OD-011120, R24-OD-011199]; Graduate Training programme 1048 of the Deutsche Forschungsgemeinschaft; International Graduate School for Life Sciences of the University of Wurzburg; Fundacao para a Ciencia e Tecnologia PhD grant [SFRH/BD/61217/2009]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011120] Funding Source: NIH RePORTER	NIH, ORIP, Division of Comparative Medicine; Graduate Training programme 1048 of the Deutsche Forschungsgemeinschaft; International Graduate School for Life Sciences of the University of Wurzburg; Fundacao para a Ciencia e Tecnologia PhD grant; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided partly by the NIH, ORIP, Division of Comparative Medicine (http://dpcpsi.nih.gov/orip/CM/index) grants R24-OD-011120 and R24-OD-011199. IM was supported by the Graduate Training programme 1048 of the Deutsche Forschungsgemeinschaft (http://www.dfg.de), and by the International Graduate School for Life Sciences of the University of Wurzburg (http://www.graduateschools.uni-wuerzburg.de/life_sciences). Support was also provided by the Fundacao para a Ciencia e Tecnologia PhD grant SFRH/BD/61217/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bubenshchikova E, 2005, CLONING STEM CELLS, V7, P255, DOI 10.1089/clo.2005.7.255; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doyle JJ, 2008, ANNU REV GENET, V42, P443, DOI 10.1146/annurev.genet.42.110807.091524; Hyodo-Taguchi Y., 1996, FISH BIOL J MEDAKA, V8, P11; Inacio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041158; IWAMATSU T, 1983, J EXP ZOOL, V228, P83, DOI 10.1002/jez.1402280109; Johnson NA, 2000, J THEOR BIOL, V205, P527, DOI 10.1006/jtbi.2000.2070; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Levine M, 2002, NATURE, V415, P848, DOI 10.1038/415848a; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Madlung A, 2012, POLYPLOIDY ITS EFFEC; Matos I, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-101; MCFADDEN DE, 1993, HUM GENET, V92, P465, DOI 10.1007/BF00216452; Meynert AM, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-195; Mochida K, 2004, MOL GENET GENOMICS, V270, P371, DOI 10.1007/s00438-003-0939-7; Nanda I, 2003, GENETICS, V163, P245; Niwa K, 1999, DEV GROWTH DIFFER, V41, P163; Pala I, 2008, CURR BIOL, V18, P1344, DOI 10.1016/j.cub.2008.07.096; Pala I, 2010, P ROY SOC B-BIOL SCI, V277, P3519, DOI 10.1098/rspb.2010.1071; Rapp RA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-18; Sakaizumi M., 1987, Korean Journal of Limnology, V20, P13; Santini F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-194; Skelly DA, 2011, GENOME RES, V21, P1728, DOI 10.1101/gr.119784.110; Stevenson KR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-536; Tang FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021208; Wakamatsu Yuko, 1993, Molecular Marine Biology and Biotechnology, V2, P325; Yoo MJ, 2013, HEREDITY, V110, P171, DOI 10.1038/hdy.2012.94; Zhai RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060668	33	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100250	10.1371/journal.pone.0100250	http://dx.doi.org/10.1371/journal.pone.0100250			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945156	Green Submitted, Green Published, gold			2022-12-25	WOS:000340721500053
J	Xu, W; Zhu, X; Tan, TT; Li, WZ; Shan, AS				Xu, Wei; Zhu, Xin; Tan, Tingting; Li, Weizhong; Shan, Anshan			Design of Embedded-Hybrid Antimicrobial Peptides with Enhanced Cell Selectivity and Anti-Biofilm Activity	PLOS ONE			English	Article							ACINETOBACTER-BAUMANNII; ANTIBACTERIAL PEPTIDE; BIOLOGICAL-ACTIVITY; MOLECULAR-BASIS; PORE FORMATION; MEMBRANE; MECHANISMS; CECROPIN; DEFENSE; CHARGE	Antimicrobial peptides have attracted considerable attention because of their broad-spectrum antimicrobial activity and their low prognostic to induce antibiotic resistance which is the most common source of failure in bacterial infection treatment along with biofilms. The method to design hybrid peptide integrating different functional domains of peptides has many advantages. In this study, we designed an embedded-hybrid peptide R-FV-I16 by replacing a functional defective sequence RR7 with the anti-biofilm sequence FV7 embedded in the middle position of peptide RI16. The results demonstrated that the synthetic hybrid the peptide R-FV-I16 had potent antimicrobial activity over a wide range of Gram-negative and Gram-positive bacteria, as well as anti-biofilm activity. More importantly, R-FV-I16 showed lower hemolytic activity and cytotoxicity. Fluorescent assays demonstrated that R-FV-I16 depolarized the outer and the inner bacterial membranes, while scanning electron microscopy and transmission electron microscopy further indicated that this peptide killed bacterial cells by disrupting the cell membrane, thereby damaging membrane integrity. Results from SEM also provided evidence that R-FV-I16 inherited anti-biofilm activity from the functional peptide sequence FV7. Embedded-hybrid peptides could provide a new pattern for combining different functional domains and showing an effective avenue to screen for novel antimicrobial agents.	[Xu, Wei; Zhu, Xin; Tan, Tingting; Li, Weizhong; Shan, Anshan] Northeast Agr Univ, Inst Anim Nutr, Lab Mol Nutr & Immun, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Shan, AS (corresponding author), Northeast Agr Univ, Inst Anim Nutr, Lab Mol Nutr & Immun, Harbin, Heilongjiang, Peoples R China.	asshan@neau.edu.cn	Shan, Anshan/U-9119-2019	Xu, Wei/0000-0002-6370-7930	National Basic Research Program [2012CB124703]; National Natural Research Foundation of China [31272453]; Program for Innovative Research Team of Universities in Heilongjiang Province	National Basic Research Program(National Basic Research Program of China); National Natural Research Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team of Universities in Heilongjiang Province	This study was supported by the National Basic Research Program (Grant No. 2012CB124703), the National Natural Research Foundation of China (Grant No. 31272453), and the Program for Innovative Research Team of Universities in Heilongjiang Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquila M, 2013, CELL CALCIUM, V53, P180, DOI 10.1016/j.ceca.2012.11.012; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Brogden KA, 2003, INT J ANTIMICROB AG, V22, P465, DOI 10.1016/S0924-8579(03)00180-8; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Dashper SG, 2005, ANTIMICROB AGENTS CH, V49, P2322, DOI 10.1128/AAC.49.6.2322-2328.2005; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; de la Fuente-Nunez C, 2012, ANTIMICROB AGENTS CH, V56, P2696, DOI 10.1128/AAC.00064-12; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Fox MA, 2012, PEPTIDES, V33, P197, DOI 10.1016/j.peptides.2012.01.013; Gotz F, 2004, CURR OPIN MICROBIOL, V7, P477, DOI 10.1016/j.mib.2004.08.014; Hamley IW, 2011, SOFT MATTER, V7, P4122, DOI 10.1039/c0sm01218a; Hancock RD, 2001, COORDIN CHEM REV, V212, P1, DOI 10.1016/S0010-8545(00)00418-5; Hauser CAE, 2011, P NATL ACAD SCI USA, V108, P1361, DOI 10.1073/pnas.1014796108; Hawrani A, 2008, J BIOL CHEM, V283, P18636, DOI 10.1074/jbc.M709154200; Huang JF, 2011, PEPTIDES, V32, P1488, DOI 10.1016/j.peptides.2011.05.023; HUGHES DE, 1962, J GEN MICROBIOL, V29, P39, DOI 10.1099/00221287-29-1-39; Jiang ZQ, 2008, BIOPOLYMERS, V90, P369, DOI 10.1002/bip.20911; Jiang ZQ, 2011, CHEM BIOL DRUG DES, V77, P225, DOI 10.1111/j.1747-0285.2011.01086.x; Jin XB, 2010, ACTA BIOCH BIOPH SIN, V42, P259, DOI 10.1093/abbs/gmq021; Jin Y, 2005, ANTIMICROB AGENTS CH, V49, P4957, DOI 10.1128/AAC.49.12.4957-4964.2005; KATSU T, 1989, BIOCHIM BIOPHYS ACTA, V983, P135, DOI 10.1016/0005-2736(89)90226-5; Khew ST, 2008, BIOMATERIALS, V29, P3034, DOI 10.1016/j.biomaterials.2008.03.023; Laverty G, 2011, INT J MOL SCI, V12, P6566, DOI 10.3390/ijms12106566; Lee JK, 2013, BBA-BIOMEMBRANES, V1828, P443, DOI 10.1016/j.bbamem.2012.09.005; Liu LH, 2009, NAT NANOTECHNOL, V4, P457, DOI [10.1038/NNANO.2009.153, 10.1038/nnano.2009.153]; Liu LP, 1998, J BIOL CHEM, V273, P23645, DOI 10.1074/jbc.273.37.23645; Liu YF, 2013, BIOMATERIALS, V34, P237, DOI 10.1016/j.biomaterials.2012.09.032; LOH B, 1984, ANTIMICROB AGENTS CH, V26, P546, DOI 10.1128/AAC.26.4.546; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Lv YF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115448, 10.1371/journal.pone.0086364]; Maisetta G, 2008, PEPTIDES, V29, P1, DOI 10.1016/j.peptides.2007.10.013; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P3423, DOI 10.1021/bi00010a034; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Mihajlovic M, 2012, BBA-BIOMEMBRANES, V1818, P1274, DOI 10.1016/j.bbamem.2012.01.016; Mulet X, 2011, ANTIMICROB AGENTS CH, V55, P4560, DOI 10.1128/AAC.00519-11; Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08; Pitts B, 2003, J MICROBIOL METH, V54, P269, DOI 10.1016/S0167-7012(03)00034-4; Saising J, 2012, ANTIMICROB AGENTS CH, V56, P5804, DOI 10.1128/AAC.01296-12; Saugar JM, 2006, ANTIMICROB AGENTS CH, V50, P1251, DOI 10.1128/AAC.50.4.1251-1256.2006; Schmidtchen A, 2014, ADV COLLOID INTERFAC, V205, P265, DOI 10.1016/j.cis.2013.06.009; Scocchi M, 2005, FEBS J, V272, P4398, DOI 10.1111/j.1742-4658.2005.04852.x; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shai Y, 2002, CURR PHARM DESIGN, V8, P715, DOI 10.2174/1381612023395367; Stark M, 2002, ANTIMICROB AGENTS CH, V46, P3585, DOI 10.1128/AAC.46.11.3585-3590.2002; Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738, DOI 10.1128/AAC.41.8.1738; STORICI P, 1994, FEBS LETT, V337, P303, DOI 10.1016/0014-5793(94)80214-9; Takahashi D, 2010, BIOCHIMIE, V92, P1236, DOI 10.1016/j.biochi.2010.02.023; Teixeira V, 2012, PROG LIPID RES, V51, P149, DOI 10.1016/j.plipres.2011.12.005; Wang KR, 2008, PEPTIDES, V29, P963, DOI 10.1016/j.peptides.2008.01.015; Weiner JH, 1999, BACTERIAL CYTOPLASMI; Wiradharma N, 2008, ADV FUNCT MATER, V18, P943, DOI 10.1002/adfm.200700884; WU CSC, 1981, BIOCHEMISTRY-US, V20, P566, DOI 10.1021/bi00506a019; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; Xue R, 2008, BBA-BIOMEMBRANES, V1778, P1444, DOI 10.1016/j.bbamem.2008.02.005; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao XB, 2010, CHEM SOC REV, V39, P3480, DOI 10.1039/b915923c; Zhu X, 2014, ACTA BIOMATER, V10, P244, DOI 10.1016/j.actbio.2013.08.043	60	62	65	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e98935	10.1371/journal.pone.0098935	http://dx.doi.org/10.1371/journal.pone.0098935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945359	Green Published, gold, Green Submitted			2022-12-25	WOS:000340721500009
J	Enns, GM; Moore, T; Le, A; Atkuri, K; Shah, MK; Cusmano-Ozog, K; Niemi, AK; Cowan, TM				Enns, Gregory M.; Moore, Tereza; Le, Anthony; Atkuri, Kondala; Shah, Monisha K.; Cusmano-Ozog, Kristina; Niemi, Anna-Kaisa; Cowan, Tina M.			Degree of Glutathione Deficiency and Redox Imbalance Depend on Subtype of Mitochondrial Disease and Clinical Status	PLOS ONE			English	Article							OXIDATIVE STRESS; OXIDIZED GLUTATHIONE; CHAIN DISORDERS; PROGRESSION; SUPEROXIDE; METABOLISM; APOPTOSIS; BLOOD; CELL; DNA	Mitochondrial disorders are associated with decreased energy production and redox imbalance. Glutathione plays a central role in redox signaling and protecting cells from oxidative damage. In order to understand the consequences of mitochondrial dysfunction on in vivo redox status, and to determine how this varies by mitochondrial disease subtype and clinical severity, we used a sensitive tandem mass spectrometry assay to precisely quantify whole blood reduced (GSH) and oxidized (GSSG) glutathione levels in a large cohort of mitochondrial disorder patients. Glutathione redox potential was calculated using the Nernst equation. Compared to healthy controls (n = 59), mitochondrial disease patients (n = 58) as a group showed significant redox imbalance (redox potential -251 mV +/- 9.7, p<0.0001) with an increased level of oxidation by similar to 9 mV compared to controls (-260 mV +/- 6.4). Underlying this abnormality were significantly lower whole blood GSH levels (p = 0.0008) and GSH/GSSG ratio (p = 0.0002), and significantly higher GSSG levels (p<0.0001) in mitochondrial disease patients compared to controls. Redox potential was significantly more oxidized in all mitochondrial disease subgroups including Leigh syndrome (n = 15), electron transport chain abnormalities (n = 10), mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (n = 8), mtDNA deletion syndrome (n = 7), mtDNA depletion syndrome (n = 7), and miscellaneous other mitochondrial disorders (n = 11). Patients hospitalized in metabolic crisis (n = 7) showed the greatest degree of redox imbalance at -242 mV +/- 7. Peripheral whole blood GSH and GSSG levels are promising biomarkers of mitochondrial dysfunction, and may give insights into the contribution of oxidative stress to the pathophysiology of the various mitochondrial disorders. In particular, evaluation of redox potential may be useful in monitoring of clinical status or response to redox-modulating therapies in clinical trials.	[Enns, Gregory M.; Shah, Monisha K.; Cusmano-Ozog, Kristina; Niemi, Anna-Kaisa] Stanford Univ, Lucile Packard Childrens Hosp, Div Med Genet, Dept Pediat, Stanford, CA 94305 USA; [Moore, Tereza; Le, Anthony; Cowan, Tina M.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Atkuri, Kondala] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Lucile Packard Children's Hospital (LPCH); Stanford University; Stanford University; Stanford University	Enns, GM (corresponding author), Stanford Univ, Lucile Packard Childrens Hosp, Div Med Genet, Dept Pediat, Stanford, CA 94305 USA.	greg.enns@stanford.edu		cusmano, kristina/0000-0002-0346-6864	Stanford NIH/NCRR CTSA award [UL1 RR025744]; Lucile Packard Foundation for Children's Health; United Mitochondrial Disease foundation; Help Mito Kids and Edison Pharmaceuticals, Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER	Stanford NIH/NCRR CTSA award; Lucile Packard Foundation for Children's Health; United Mitochondrial Disease foundation; Help Mito Kids and Edison Pharmaceuticals, Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The project described in this publication was supported by the Stanford NIH/NCRR CTSA award number UL1 RR025744 and by the Lucile Packard Foundation for Children's Health. Michael and Ellen Michelson, Bobbie and Mike Wilsey, the United Mitochondrial Disease foundation, Help Mito Kids and Edison Pharmaceuticals, Inc. provided additional support for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MA, 2010, J NEUROPATH EXP NEUR, V69, P155, DOI 10.1097/NEN.0b013e3181cb5af4; Atkuri KR, 2009, P NATL ACAD SCI USA, V106, P3941, DOI 10.1073/pnas.0813409106; Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Cadenas Enrique, 2004, Molecular Aspects of Medicine, V25, P17, DOI 10.1016/j.mam.2004.02.005; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Circu ML, 2012, BBA-MOL CELL RES, V1823, P1767, DOI 10.1016/j.bbamcr.2012.06.019; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Ellerby LM, 1996, J NEUROCHEM, V67, P1259; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Forman HJ, 2003, BIOFACTORS, V17, P1, DOI 10.1002/biof.5520170101; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; Go YM, 2010, ANTIOXID REDOX SIGN, V13, P489, DOI 10.1089/ars.2009.3021; Hansen JM, 2004, TOXICOL SCI, V82, P308, DOI 10.1093/toxsci/kfh231; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; Hargreaves IP, 2005, J INHERIT METAB DIS, V28, P81, DOI 10.1007/s10545-005-4160-1; Haun Florian, 2013, J Cell Death, V6, P27; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Ikawa M, 2012, EUR NEUROL, V67, P232, DOI 10.1159/000336568; Iuso A, 2006, J BIOL CHEM, V281, P10374, DOI 10.1074/jbc.M513387200; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2; Kerr DS, 2013, NEUROTHERAPEUTICS, V10, P307, DOI 10.1007/s13311-013-0176-7; Kerr DS, 2010, MOL GENET METAB, V99, P246, DOI 10.1016/j.ymgme.2009.11.005; Kirlin WG, 1999, FREE RADICAL BIO MED, V27, P1208, DOI 10.1016/S0891-5849(99)00145-8; LENNON SV, 1991, CELL PROLIFERAT, V24, P203, DOI 10.1111/j.1365-2184.1991.tb01150.x; Makino Y, 1999, J BIOL CHEM, V274, P3182, DOI 10.1074/jbc.274.5.3182; Martinelli D, 2012, MOL GENET METAB, V107, P383, DOI 10.1016/j.ymgme.2012.09.007; Merad-Boudia M, 1998, BIOCHEM PHARMACOL, V56, P645, DOI 10.1016/S0006-2952(97)00647-3; Moore T, 2013, J CHROMATOGR B, V929, P51, DOI 10.1016/j.jchromb.2013.04.004; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; Pastore A, 2001, CLIN CHEM, V47, P1467; Pastore A, 2014, J INHERIT METAB DIS, V37, P125, DOI 10.1007/s10545-013-9605-3; Pastore A, 2013, MOL GENET METAB, V109, P208, DOI 10.1016/j.ymgme.2013.03.011; Phoenix C, 2006, NEUROMUSCULAR DISORD, V16, P814, DOI 10.1016/j.nmd.2006.08.006; Piemonte F, 2001, EUR J CLIN INVEST, V31, P1007, DOI 10.1046/j.1365-2362.2001.00922.x; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930; Salmi H, 2012, ACTA PAEDIATR, V101, pe505, DOI 10.1111/j.1651-2227.2012.02799.x; Sandhu JK, 2005, BIOCHEM J, V391, P191, DOI 10.1042/BJ20050272; Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Stacpoole PW, 2011, MITOCHONDRION, V11, P679, DOI 10.1016/j.mito.2011.05.002; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wright AF, 2004, NAT GENET, V36, P1153, DOI 10.1038/ng1448; Zhang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069282; Zimmermann AK, 2007, J BIOL CHEM, V282, P29296, DOI 10.1074/jbc.M702853200	50	31	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100001	10.1371/journal.pone.0100001	http://dx.doi.org/10.1371/journal.pone.0100001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941115	Green Submitted, Green Published, gold			2022-12-25	WOS:000338508200063
J	Kurtz, BE				Kurtz, Bruce E.			An Electrical Analogy Relating the Atlantic Multidecadal Oscillation to the Atlantic Meridional Overturning Circulation	PLOS ONE			English	Article							ANTARCTIC CIRCUMPOLAR CURRENT; SEA-SURFACE TEMPERATURE; THERMOHALINE CIRCULATION; CLIMATE VARIABILITY; NORTH-AMERICAN; HEAT-TRANSPORT; DYNAMICS; MODELS	The Atlantic meridional overturning circulation (AMOC) is the northward flow of surface water to subpolar latitudes where deepwater is formed, balanced by southward abyssal flow and upwelling in the vicinity of the Southern Ocean. It is generally accepted that AMOC flow oscillates with a period of 60-80 years, creating a regular variation in North Atlantic sea surface temperature known as the Atlantic multidecadal oscillation (AMO). This article attempts to answer two questions: how is the AMOC driven and why does it oscillate? Using methods commonly employed by chemical engineers for analyzing processes involving flowing liquids, apparently not previously applied to trying to understand the AMOC, an equation is developed for AMOC flow as a function of the meridional density gradient or the corresponding temperature gradient. The equation is based on the similarity between the AMOC and an industrial thermosyphon loop cooler, which circulates a heat transfer liquid without using a mechanical pump. Extending this equation with an analogy between the flow of heat and electricity explains why the AMOC flow oscillates and what determines its period. Calculated values for AMOC flow and AMO oscillation period are in good agreement with measured values.				kurtz36ti@gmail.com		Kurtz, Bruce/0000-0001-5108-3510				ALLEN PC, 1980, P NATL ACAD SCI USA, V77, P39, DOI 10.1073/pnas.77.1.39; Allen PC, 1980, P NATL ACAD SCI USA, V78, P31; Bird R. B., 2002, TRANSPORT PHENOMENA, P178; Bower AS, 2009, NATURE, V459, P243, DOI 10.1038/nature07979; Chu PC, 2010, P MTS IEEE OC 10 SEA, V10, P1001; Cunningham SA, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001147; Delworth T.L., 2007, GEOPHYS MONOGR SER, P131, DOI DOI 10.1029/173GM10; Delworth TL, 2000, CLIM DYNAM, V16, P661, DOI 10.1007/s003820000075; Edwards M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057212; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Fitzgerald AE, 1981, BASIC ELECT ENG, P166; Gray ST, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019932; HALL MM, 1982, DEEP-SEA RES, V29, P339, DOI 10.1016/0198-0149(82)90099-1; Hu Q, 2011, J CLIMATE, V24, P5555, DOI 10.1175/2011JCLI4060.1; Jeffreys H, 1925, Q J ROY METEOR SOC, V51, P347; JOHNSON GC, 1989, DEEP-SEA RES, V36, P39, DOI 10.1016/0198-0149(89)90017-4; Kaplan A, 1998, J GEOPHYS RES-OCEANS, V103, P18567, DOI 10.1029/97JC01734; Kerr RA, 2000, SCIENCE, V288, P1984, DOI 10.1126/science.288.5473.1984; Knight JR, 2009, J CLIMATE, V22, P1610, DOI 10.1175/2008JCLI2628.1; Knight JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024233; Knudsen MF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1186; Kuhlbrodt T, 2007, REV GEOPHYS, V45, DOI 10.1029/2004RG000166; Kuhlbrodt T, 2008, TELLUS A, V60, P819, DOI 10.1111/j.1600-0870.2008.00357.x; Kumar S, 2013, J CLIMATE, V26, P3511, DOI 10.1175/JCLI-D-12-00535.1; Latif M, 2004, J CLIMATE, V17, P1605, DOI 10.1175/1520-0442(2004)017<1605:RMAPMC>2.0.CO;2; Lozier MS, 2010, SCIENCE, V328, P1507, DOI 10.1126/science.1189250; Macias D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081591; Marotzke J., 1988, Tellus, Series A (Dynamic Meteorology and Oceanography), V40A, P162, DOI 10.1111/j.1600-0870.1988.tb00414.x; Marotzke J, 1997, J PHYS OCEANOGR, V27, P1713, DOI 10.1175/1520-0485(1997)027<1713:BMATDO>2.0.CO;2; Marshall J, 2003, J PHYS OCEANOGR, V33, P2341, DOI 10.1175/1520-0485(2003)033<2341:RSFTAC>2.0.CO;2; Nilsson J, 2001, TELLUS A, V53, P629, DOI 10.1034/j.1600-0870.2001.00263.x; Polyakov IV, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023740; Polyakov IV, 2005, J CLIMATE, V18, P4562, DOI 10.1175/JCLI3548.1; Rahmstorf S, 1996, CLIM DYNAM, V12, P799, DOI 10.1007/s003820050144; Rintoul S. R., 2001, ANTARCTIC CIRCUMPOLA, P271; Schewe J, 2010, CLIM DYNAM, V34, P547, DOI 10.1007/s00382-009-0572-1; SCHLESINGER ME, 1994, NATURE, V367, P723, DOI 10.1038/367723a0; Schloesser F, 2012, PROG OCEANOGR, V101, P33, DOI 10.1016/j.pocean.2012.01.002; Srokosz M, 2012, B AM METEOROL SOC, V93, P1663, DOI 10.1175/BAMS-D-11-00151.1; STOMMEL H, 1961, TELLUS, V13, P224, DOI 10.1111/j.2153-3490.1961.tb00079.x; Stommel H, 1959, CONTRIBUTION, P140; Straneo F, 2006, J PHYS OCEANOGR, V36, P1822, DOI 10.1175/JPO2932.1; Sutton RT, 2005, SCIENCE, V309, P115, DOI 10.1126/science.1109496; Wang CZ, 2010, CLIM DYNAM, V34, P953, DOI 10.1007/s00382-009-0560-5; Wang XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022740; Wei W, 2012, J CLIMATE, V25, P6989, DOI 10.1175/JCLI-D-11-00667.1; Wu ZH, 2011, CLIM DYNAM, V37, P759, DOI 10.1007/s00382-011-1128-8; Wunsch C, 2005, TELLUS A, V57, P84, DOI 10.1111/j.1600-0870.2005.00093.x; Wunsch C, 2002, SCIENCE, V298, P1179, DOI 10.1126/science.1079329; Wyatt MG, 2012, CLIM DYNAM, V38, P929, DOI 10.1007/s00382-011-1071-8; Zhang R, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028683	51	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100306	10.1371/journal.pone.0100306	http://dx.doi.org/10.1371/journal.pone.0100306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940739	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200094
J	Lima, CKF; Silva, RM; Lacerda, RB; Santos, BLR; Silva, RV; Amaral, LS; Quintas, LEM; Fraga, CAM; Barreiro, EJ; Guimaraes, MZP; Miranda, ALP				Lima, Cleverton K. F.; Silva, Rafael M.; Lacerda, Renata B.; Santos, Bruna L. R.; Silva, Rafaela V.; Amaral, Luciana S.; Quintas, Luis E. M.; Fraga, Carlos A. M.; Barreiro, Eliezer J.; Guimaraes, Marilia Z. P.; Miranda, Ana L. P.			LASSBio-1135: A Dual TRPV1 Antagonist and Anti-TNF-Alpha Compound Orally Effective in Models of Inflammatory and Neuropathic Pain	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; DORSAL-ROOT GANGLIA; RECEPTOR POTENTIAL VANILLOID-1; MECHANICAL ALLODYNIA; CAPSAICIN; KINASE; ACTIVATION; ARTHRITIS; NEURONS; HYPERNOCICEPTION	LASSBio-1135 is an imidazo[1,2-a]pyridine derivative with high efficacy in screening models of nociception and inflammation, presumed as a weak COX-2 inhibitor. In order to tease out its mechanism of action, we investigated others possible target for LASSBio-1135, such as TNF-alpha and TRPV1, to better characterize it as a multitarget compound useful in the treatment of chronic pain. TRPV1 modulation was assessed in TRPV1-expressing Xenopus oocytes against capsaicin and low pH-induced current. Modulation of TNF-alpha production was evaluated in culture of macrophages stimulated with LPS. In vivo efficacy of LASSBio-1135 was investigated in carrageenan and partial sciatic ligation-induced thermal hyperalgesia and mechanical allodynia. Corroborating its previous demonstration of efficacy in a model of capsaicin-induced hyperalgesia, LASSBio-1135 blocks capsaicin-elicited currents in a non-competitive way with an IC50 of 580 nM as well as low pH-induced current at 50 mu M. As an additional action, LASSBio-1135 inhibited TNF-alpha release in these cells stimulated by LPS with an IC50 of 546 nM by reducing p38 MAPK phosphorilation. Oral administration of 100 mu mol.Kg(-1) LASSBio-1135 markedly reduced thermal hyperalgesia induced by carrageenan, however at mu mol.Kg(-1) only a partial reduction was observed at the 4th h. Neutrophil recruitment and TNF-alpha production after carrageenan stimulus was also inhibited by the treatment with LASSBio-1135. Modulating TRPV1 and TNF-alpha production, two key therapeutic targets of neuropathic pain, 100 mu mol.Kg(-1) LASSBio-1135 was orally efficacious in reversing thermal hyperalgesia and mechanical allodynia produced by partial sciatic ligation 7-11 days after surgery without provoking hyperthermia, a common side effect of TRPV1 antagonists. In conclusion LASSBio-1135, besides being a weak COX-2 inhibitor, is a noncompetitive TRPV1 antagonist and a TNF-alpha inhibitor. As a multitarget compound, LASSBio-1135 is orally efficacious in a model of neuropathic pain without presenting hyperthermia.	[Lima, Cleverton K. F.; Santos, Bruna L. R.; Silva, Rafaela V.; Miranda, Ana L. P.] Univ Fed Rio de Janeiro, Fac Farm, LEFEx, Rio De Janeiro, Brazil; [Silva, Rafael M.; Amaral, Luciana S.; Quintas, Luis E. M.; Fraga, Carlos A. M.; Guimaraes, Marilia Z. P.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Lacerda, Renata B.; Fraga, Carlos A. M.; Barreiro, Eliezer J.] Univ Fed Rio de Janeiro, Fac Farm, LASSBio, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Miranda, ALP (corresponding author), Univ Fed Rio de Janeiro, Fac Farm, LEFEx, Rio De Janeiro, Brazil.	analu@pharma.ufrj.br	Silva, Rafaela Vieira/AGP-2596-2022; Guimaraes, Marilia ZP/C-3255-2009; Quintas, Luis Eduardo M/C-3308-2009; Barreiro, Eliezer J/B-1131-2011; lacerda, renata/V-4003-2019; Fraga, Carlos/G-3495-2012	Silva, Rafaela Vieira/0000-0002-8687-2154; Guimaraes, Marilia ZP/0000-0001-6397-8506; Quintas, Luis Eduardo M/0000-0002-0767-1240; Barreiro, Eliezer J/0000-0003-1759-0038; Fraga, Carlos/0000-0001-6733-7079	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Instituto Nacional de Ciencia e Tecnologia em Farmacos e Medicamentos	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional de Ciencia e Tecnologia em Farmacos e Medicamentos	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BR), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (BR), and Instituto Nacional de Ciencia e Tecnologia em Farmacos e Medicamentos (BR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Badger AM, 1996, J PHARMACOL EXP THER, V279, P1453; Blum CA, 2010, J MED CHEM, V53, P3330, DOI 10.1021/jm100051g; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Carlton SM, 2001, NEUROSCI LETT, V310, P53, DOI 10.1016/S0304-3940(01)02093-6; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen Y, 2009, EXP NEUROL, V220, P383, DOI 10.1016/j.expneurol.2009.09.030; CUNHA FQ, 1992, BRIT J PHARMACOL, V107, P660, DOI 10.1111/j.1476-5381.1992.tb14503.x; Cunha TM, 2008, J LEUKOCYTE BIOL, V83, P824, DOI 10.1189/jlb.0907654; Cunha TM, 2005, P NATL ACAD SCI USA, V102, P1755, DOI 10.1073/pnas.0409225102; Dubovy P, 2006, CELL MOL NEUROBIOL, V26, P1205, DOI 10.1007/s10571-006-9006-3; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Gallily R, 1997, J PHARMACOL EXP THER, V283, P918; Garcia-Martinez C, 2002, P NATL ACAD SCI USA, V99, P2374, DOI 10.1073/pnas.022285899; George A, 2005, EXP NEUROL, V192, P163, DOI 10.1016/j.expneurol.2004.11.002; Gunthorpe MJ, 2009, DRUG DISCOV TODAY, V14, P56, DOI 10.1016/j.drudis.2008.11.005; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; Hudson LJ, 2001, EUR J NEUROSCI, V13, P2105, DOI 10.1046/j.0953-816x.2001.01591.x; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Keeble J, 2005, ARTHRITIS RHEUM, V52, P3248, DOI 10.1002/art.21297; Lacerda RB, 2009, BIOORGAN MED CHEM, V17, P74, DOI 10.1016/j.bmc.2008.11.018; Lavich TR, 2005, BRAZ J MED BIOL RES, V38, P445, DOI 10.1590/S0100-879X2005000300016; Ledeboer A, 2007, EXPERT OPIN INV DRUG, V16, P935, DOI 10.1517/13543784.16.7.935; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lehto SG, 2008, J PHARMACOL EXP THER, V326, P218, DOI 10.1124/jpet.107.132233; Leung L, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-27; Miller Richard J, 2009, Handb Exp Pharmacol, P417, DOI 10.1007/978-3-540-79090-7_12; Nicol GD, 1997, J NEUROSCI, V17, P975; Romano CL, 2009, J ORTHOP TRAUMATOL, V10, P185, DOI 10.1007/s10195-009-0077-z; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Sena J, 2008, GEN COMP ENDOCR, V157, P165, DOI 10.1016/j.ygcen.2008.04.012; Szabo A, 2005, J PHARMACOL EXP THER, V314, P111, DOI 10.1124/jpet.104.082487; Tributino JLM, 2010, BRIT J PHARMACOL, V159, P1716, DOI 10.1111/j.1476-5381.2010.00672.x; Tsuji F, 2010, EUR J PHARMACOL, V627, P332, DOI 10.1016/j.ejphar.2009.10.044; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; von Banchet GS, 2009, PAIN, V145, P151, DOI 10.1016/j.pain.2009.06.002; Walker KM, 2003, J PHARMACOL EXP THER, V304, P56, DOI 10.1124/jpet.102.042010; Watabiki T, 2011, BIOL PHARM BULL, V34, P1105, DOI 10.1248/bpb.34.1105; WATKINS LR, 2004, DRUG DISCOV TODAY TH, V1, P83; Wei XH, 2007, EXP NEUROL, V205, P471, DOI 10.1016/j.expneurol.2007.03.012; Wong GY, 2009, BRAIN RES REV, V60, P267, DOI 10.1016/j.brainresrev.2008.12.006; Zwerina J, 2006, ARTHRITIS RHEUM-US, V54, P463, DOI 10.1002/art.21626; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	45	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99510	10.1371/journal.pone.0099510	http://dx.doi.org/10.1371/journal.pone.0099510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941071	Green Submitted, Green Published, gold			2022-12-25	WOS:000338508200027
J	Rakai, BD; Chrusch, MJ; Spanswick, SC; Dyck, RH; Antle, MC				Rakai, Brooke D.; Chrusch, Michael J.; Spanswick, Simon C.; Dyck, Richard H.; Antle, Michael C.			Survival of Adult Generated Hippocampal Neurons Is Altered in Circadian Arrhythmic Mice	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; CELL-PROLIFERATION; SLEEP-DEPRIVATION; DENTATE GYRUS; NEUROGENESIS; BRAIN; BMAL1; DISRUPTION; DEFICIENT; COMPONENT	The subgranular zone of the hippocampal formation gives rise to new neurons that populate the dentate gyrus throughout life. Cells in the hippocampus exhibit rhythmic clock gene expression and the circadian clock is known to regulate the cycle of cell division in other areas of the body. These facts suggest that the circadian clock may regulate adult neurogenesis in the hippocampus as well. In the present study, neurogenesis in the hippocampal subgranular zone was examined in arrhythmic Bmal1 knockout (-KO) mice and their rhythmic heterozygous and wildtype littermates. Proliferation and survival of newly generated subgranular zone cells were examined using bromodeoxyuridine labelling, while pyknosis (a measure of cell death) and hippocampal volume were examined in cresyl violet stained sections. There was no significant difference in cellular proliferation between any of the groups, yet survival of proliferating cells, 6 weeks after the bromodeoxyuridine injection, was significantly greater in the BMAL1-KO animals. The number of pyknotic cells was significantly decreased in Bmal1-KO animals, yet hippocampal volume remained the same across genotypes. These findings suggest that while a functional circadian clock is not necessary for normal proliferation of neuronal precursor cells, the normal pruning of newly generated neurons in the hippocampus may require a functional circadian clock.	[Rakai, Brooke D.; Chrusch, Michael J.; Spanswick, Simon C.; Dyck, Richard H.; Antle, Michael C.] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada; [Rakai, Brooke D.; Spanswick, Simon C.; Dyck, Richard H.; Antle, Michael C.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada; [Chrusch, Michael J.] Univ Calgary, Dept Neurosci, Calgary, AB T2N 1N4, Canada; [Dyck, Richard H.] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 1N4, Canada; [Antle, Michael C.] Univ Calgary, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Antle, MC (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	antlem@ucalgary.ca		Antle, Michael/0000-0001-5178-4683; Dyck, Richard/0000-0002-3254-8332	Natural Sciences and Engineering Research Council of Canada [311874-2010]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funded by the Natural Sciences and Engineering Research Council of Canada (Grant #311874-2010) (http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2004, MOL BRAIN RES, V124, P178, DOI 10.1016/j.molbrainres.2004.02.015; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Antle MC, 2005, TRENDS NEUROSCI, V28, P145, DOI 10.1016/j.tins.2005.01.003; Antle MC, 2005, DEV BRAIN RES, V157, P8, DOI 10.1016/j.devbrainres.2005.02.017; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; Borgs L, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-30; Bouchard-Cannon P, 2013, CELL REP, V5, P961, DOI 10.1016/j.celrep.2013.10.037; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Bunger MK, 2005, GENESIS, V41, P122, DOI 10.1002/gene.20102; Cain SW, 2009, NEUROBIOL LEARN MEM, V91, P81, DOI 10.1016/j.nlm.2008.10.005; Cain SW, 2004, BEHAV BRAIN RES, V150, P201, DOI 10.1016/j.bbr.2003.07.001; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Gilhooley MJ, 2011, NEUROSCI LETT, V489, P177, DOI 10.1016/j.neulet.2010.12.011; Golini RS, 2012, HIPPOCAMPUS, V22, P1720, DOI 10.1002/hipo.22007; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Grechez-Cassiau A, 2008, J BIOL CHEM, V283, P4535, DOI 10.1074/jbc.M705576200; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hill MN, 2006, EUR J NEUROSCI, V24, P1845, DOI 10.1111/j.1460-9568.2006.05061.x; Holmes MM, 2004, J NEUROSCI RES, V76, P216, DOI 10.1002/jnr.20039; Jilg A, 2010, HIPPOCAMPUS, V20, P377, DOI 10.1002/hipo.20637; Kochman LJ, 2006, NEUROSCI LETT, V406, P256, DOI 10.1016/j.neulet.2006.07.058; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lee JH, 2011, P NATL ACAD SCI USA, V108, P12036, DOI 10.1073/pnas.1108125108; Lee JH, 2011, P NATL ACAD SCI USA, V108, P10668, DOI 10.1073/pnas.1106284108; Lin FW, 2013, CELL BIOCHEM FUNCT, V31, P166, DOI 10.1002/cbf.2871; Marin-Burgin A, 2012, BEHAV BRAIN RES, V227, P391, DOI 10.1016/j.bbr.2011.07.001; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Meerlo P, 2009, SLEEP MED REV, V13, P187, DOI 10.1016/j.smrv.2008.07.004; Mirescu C, 2006, P NATL ACAD SCI USA, V103, P19170, DOI 10.1073/pnas.0608644103; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Mueller AD, 2011, NEUROSCIENCE, V193, P170, DOI 10.1016/j.neuroscience.2011.07.019; Mueller AD, 2008, AM J PHYSIOL-REG I, V294, pR1693, DOI 10.1152/ajpregu.00858.2007; Namihira M, 1999, NEUROSCI LETT, V267, P69, DOI 10.1016/S0304-3940(99)00324-9; Fonzo LSN, 2009, HIPPOCAMPUS, V19, P869, DOI 10.1002/hipo.20571; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Segall LA, 2010, J MOL NEUROSCI, V42, P168, DOI 10.1007/s12031-010-9341-1; Shieh KR, 2003, NEUROSCIENCE, V118, P831, DOI 10.1016/S0306-4522(03)00004-6; Smith JM, 2010, NEUROSCI LETT, V473, P192, DOI 10.1016/j.neulet.2010.02.039; Smith VM, 2008, NEUROSCIENCE, V157, P513, DOI 10.1016/j.neuroscience.2008.09.030; Thompson EB, 1998, ANNU REV PHYSIOL, V60, P575, DOI 10.1146/annurev.physiol.60.1.575; Valentinuzzi VS, 2004, J BIOL RHYTHM, V19, P312, DOI 10.1177/0748730404265688; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Wang LMC, 2009, ASN NEURO, V1, DOI 10.1042/AN20090020; Yamamoto S, 2001, J COMP NEUROL, V430, P518	49	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99527	10.1371/journal.pone.0099527	http://dx.doi.org/10.1371/journal.pone.0099527			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941219	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200028
J	Wu, G; Cheng, M; Huang, H; Yang, B; Jiang, H; Huang, CX				Wu, Gang; Cheng, Mian; Huang, He; Yang, Bo; Jiang, Hong; Huang, Congxin			A Variant of IL6R Is Associated with the Recurrence of Atrial Fibrillation after Catheter Ablation in a Chinese Han Population	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; C-REACTIVE PROTEIN; INFLAMMATION; PREDICTOR; MARKERS; IMPACT; HEART	Background: Recent studies have identified a variant, rs4845625, in the interleukin-6 receptor (IL6R) gene associated with Atrial Fibrillation (AF). Levels of circulating interleukin-6 and other proinflammatory molecules have consistently been associated with a risk for AF and its recurrence after catheter ablation. This study tested the hypothesis that variant rs4845625 is associated with AF recurrence after catheter ablation in a Chinese Han population. Methods: A total of 278 consecutive patients (mean age 59.4 +/- 11.5 years, 43% female) with paroxysmal (36.0%), persistent (59.7%), and permanent (4.3%) AF who underwent catheterablation from 2007-2011, were included in this study. Patients were monitored for 12 months for a recurrence of AF. The SNP rs4845625 was genotyped using high resolution melting analysis. Results: In our study cohort, an early recurrence of AF (ERAF), defined as a recurrence within the first 4 weeks, was observed in 42.8% of the patients, whereas late recurrence of AF (LRAF) (between 3 and 12 months) occurred in 25.9% of the patients. No significant differences in baseline clinical or echocardiographic characteristics were observed between patients with ERAF and LRAF. In contrast, the presence of the T allele of rs4845625 was associated with an increase in the risk for both ERAF (odds ratio [OR]: 1.84, 95% confidence interval [CI]: 1.31-2.59, p = 4.10x10(-4)) and LRAF (OR: 1.92, 95% CI: 1.30-2.81, p = 0.001). Furthermore, this association was significant after adjustments for age, sex, hypertension, diabetes and other risk factors. No significant relationship between rs4845625 and serum levels of IL6 was observed. Conclusions: In this study, a variant of the IL6R gene, rs4845625, was found confer risk to AF recurrence after catheter ablation in a Chinese Han population. Our findings indicated that the IL6R pathway or inflammation may play important rols in the recurrence of AF after catheter ablation.	[Wu, Gang; Huang, He; Yang, Bo; Jiang, Hong; Huang, Congxin] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Hubei, Peoples R China; [Cheng, Mian] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Geriatr, Wuhan 430074, Hubei, Peoples R China	Wuhan University; Huazhong University of Science & Technology	Huang, CX (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Hubei, Peoples R China.	circulationline@tom.com			National Natural Science Foundation of China [81270305]; National Science & Technology Pillar Program of China [2011BAI11B12]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program of China	This study was funded by National Natural Science Foundation of China (NO: 81270305) and National Science & Technology Pillar Program of China (NO: 2011BAI11B12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Guo YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031489; Henningsen KMA, 2009, SCAND CARDIOVASC J, V43, P285, DOI 10.1080/14017430802653676; Hu YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057593, 10.1371/journal.pone.0056362, 10.1371/journal.pone.0073264, 10.1371/journal.pone.0056440]; Hu YF, 2011, HEART RHYTHM, V8, P650, DOI 10.1016/j.hrthm.2010.12.036; Issac TT, 2007, J AM COLL CARDIOL, V50, P2021, DOI 10.1016/j.jacc.2007.06.054; Kannel WB, 1998, AM J CARDIOL, V82, p2N, DOI 10.1016/S0002-9149(98)00583-9; Kornej J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044165; Liu J, 2011, PACE, V34, P398, DOI 10.1111/j.1540-8159.2010.02978.x; Marcus GM, 2008, HEART RHYTHM, V5, P215, DOI 10.1016/j.hrthm.2007.10.007; Marcus GM, 2008, AM HEART J, V155, P303, DOI 10.1016/j.ahj.2007.09.006; Marcus GM, 2010, HEART RHYTHM, V7, P149, DOI 10.1016/j.hrthm.2009.10.004; Narducci ML, 2011, EUROPACE, V13, P1133, DOI 10.1093/europace/eur068; Okumura Y, 2011, J CARDIOVASC ELECTR, V22, P987, DOI 10.1111/j.1540-8167.2011.02059.x; Schnabel RB, 2011, CIRC-CARDIOVASC GENE, V4, P557, DOI 10.1161/CIRCGENETICS.110.959197; Shoemaker MB, 2013, HEART RHYTHM, V10, P394, DOI 10.1016/j.hrthm.2012.11.012; Smit MD, 2012, EUROPACE, V14, P810, DOI 10.1093/europace/eur402; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Zhang XL, 2012, EXP THER MED, V4, P741, DOI 10.3892/etm.2012.650; Zoller B, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-121	22	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99623	10.1371/journal.pone.0099623	http://dx.doi.org/10.1371/journal.pone.0099623			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940886	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200032
J	Brown, GP; Shine, R				Brown, Gregory P.; Shine, Richard			Immune Response Varies with Rate of Dispersal in Invasive Cane Toads (Rhinella marina)	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; CHAUNUS BUFO MARINUS; ECOLOGICAL IMMUNOLOGY; TRADE-OFFS; PARASITES; STRESS; HOST; RESISTANCE; DEFENSE; SYSTEM	What level of immunocompetence should an animal maintain while undertaking long-distance dispersal? Immune function (surveillance and response) might be down-regulated during prolonged physical exertion due to energy depletion, and/or to avoid autoimmune reactions arising from damaged tissue. On the other hand, heightened immune vigilance might be favored if the organism encounters novel pathogens as it enters novel environments. We assessed the links between immune defense and long-distance movement in a population of invasive cane toads (Rhinella marina) in Australia. Toads were radio-tracked for seven days to measure their activity levels and were then captured and subjected to a suite of immune assays. Toads that moved further showed decreased bacteria-killing ability in their plasma and decreased phagocytic activity in their whole blood, but a heightened skin-swelling response to phytohemagglutinin. Baseline and post-stress corticosterone levels were unrelated to distance moved. Thus, long-distance movement in cane toads is associated with a dampened response in some systems and enhanced response in another. This pattern suggests that sustained activity is accompanied by trade-offs among immune components rather than an overall down or up-regulation. The finding that high mobility is accompanied by modification of the immune system has important implications for animal invasions.	[Brown, Gregory P.; Shine, Richard] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney	Shine, R (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	rick.shine@sydney.edu.au	Brown, Gregory P./F-9897-2011	Brown, Gregory P./0000-0002-2924-9040	Australian Research Council [FF0561365]	Australian Research Council(Australian Research Council)	Funded by Australian Research Council (www.arc.gov.au) grant FF0561365 to R. Shine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford RA, 2009, WILDLIFE RES, V36, P23, DOI 10.1071/WR08021; Allen LC, 2009, J COMP PHYSIOL B, V179, P315, DOI 10.1007/s00360-008-0315-3; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Barton DP, 1997, AUST J ECOL, V22, P316, DOI 10.1111/j.1442-9993.1997.tb00677.x; Baucom RS, 2011, FUNCT ECOL, V25, P18, DOI 10.1111/j.1365-2435.2010.01742.x; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Brown GP, 2007, P NATL ACAD SCI USA, V104, P17698, DOI 10.1073/pnas.0705057104; Brown GP, 2006, BIOL CONSERV, V133, P88, DOI 10.1016/j.biocon.2006.05.020; Brown GP, 2011, FUNCT ECOL, V25, P1339, DOI 10.1111/j.1365-2435.2011.01888.x; Brown GP, 2011, METHODS ECOL EVOL, V2, P341, DOI 10.1111/j.2041-210X.2011.00090.x; Buehler DM, 2010, INTEGR COMP BIOL, V50, P346, DOI 10.1093/icb/icq055; Dubey S, 2008, MOL ECOL, V17, P4418, DOI 10.1111/j.1365-294X.2008.03922.x; Dunn AM, 2012, FUNCT ECOL, V26, P1234, DOI 10.1111/1365-2435.12022; Dunn AM, 2009, ADV PARASIT, V68, P161, DOI 10.1016/S0065-308X(08)00607-6; Fellous S, 2011, BIOL LETTERS, V7, P327, DOI 10.1098/rsbl.2010.0862; Freidenreich DJ, 2012, EXERC IMMUNOL REV, V18, P8; Hartigan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018871; Hasselquist D, 2007, J EXP BIOL, V210, P1123, DOI 10.1242/jeb.02712; Hilker FM, 2005, BIOL INVASIONS, V7, P817, DOI 10.1007/s10530-005-5215-9; Jessop TS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1444; Kelehear C, 2012, PARASITOLOGY, V139, P1596, DOI 10.1017/S0031182012000832; Koch AJ, 2010, AM J LIFESTYLE MED, V4, P244, DOI 10.1177/1559827609360190; Kurtz J, 2002, EVOL ECOL RES, V4, P431; Lee KA, 2005, OECOLOGIA, V145, P244, DOI 10.1007/s00442-005-0113-5; Lee KA, 2004, TRENDS ECOL EVOL, V19, P523, DOI 10.1016/j.tree.2004.07.012; LEVER C., 2001, CANE TOAD HIST ECOLO; Lindstrom T, 2013, P NATL ACAD SCI USA, V110, P13452, DOI 10.1073/pnas.1303157110; Llewellyn D, 2011, PHYSIOL BIOCHEM ZOOL, V84, P77, DOI 10.1086/657609; Llewellyn D, 2012, BIOL INVASIONS, V14, P999, DOI 10.1007/s10530-011-0135-3; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lowe WH, 2009, ECOLOGY, V90, P1456, DOI 10.1890/08-1903.1; Martin LB, 2012, J EXP BIOL, V215, P4097, DOI 10.1242/jeb.073049; Martin LB, 2010, OECOLOGIA, V164, P339, DOI 10.1007/s00442-010-1654-9; Matson KD, 2006, PHYSIOL BIOCHEM ZOOL, V79, P556, DOI 10.1086/501057; Moller AP, 2004, J ANIM ECOL, V73, P1035, DOI 10.1111/j.0021-8790.2004.00879.x; Moller AP, 2004, J EVOLUTION BIOL, V17, P603, DOI 10.1111/j.1420-9101.2004.00694.x; Moller AP, 2001, ECOL LETT, V4, P484, DOI 10.1046/j.1461-0248.2001.00259.x; O'Neal Dawn M., 2011, P7; Owen JC, 2008, J ETHOL, V26, P383, DOI 10.1007/s10164-008-0092-1; Pedersen BK, 2000, PHYSIOL REV, V80, P1055, DOI 10.1152/physrev.2000.80.3.1055; Perez-Tris J, 2005, ECOL LETT, V8, P838, DOI 10.1111/j.1461-0248.2005.00788.x; Phillips BL, 2010, J EVOLUTION BIOL, V23, P2595, DOI 10.1111/j.1420-9101.2010.02118.x; Phillips BL, 2010, ECOLOGY, V91, P872, DOI 10.1890/09-0530.1; Phillips BL, 2008, AM NAT, V172, pS34, DOI 10.1086/588255; Phillips BL, 2007, AUSTRAL ECOL, V32, P169, DOI 10.1111/j.1442-9993.2007.01664.x; Pizzatto L, 2012, J WILDLIFE DIS, V48, P951, DOI 10.7589/2012-02-050; Prenter J, 2004, TRENDS ECOL EVOL, V19, P385, DOI 10.1016/j.tree.2004.05.002; Raberg L, 1998, P ROY SOC B-BIOL SCI, V265, P1637, DOI 10.1098/rspb.1998.0482; Sears BF, 2011, TRENDS PARASITOL, V27, P382, DOI 10.1016/j.pt.2011.05.004; Segerstrom SC, 2007, CURR DIR PSYCHOL SCI, V16, P326, DOI 10.1111/j.1467-8721.2007.00522.x; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Shilton CM, 2008, VET PATHOL, V45, P85, DOI 10.1354/vp.45-1-85; Shine R, 2008, PHILOS T R SOC B, V363, P363, DOI 10.1098/rstb.2007.2144; Shine R, 2011, P NATL ACAD SCI USA, V108, P5708, DOI 10.1073/pnas.1018989108; Smith MA, 2006, ECOGRAPHY, V29, P649, DOI 10.1111/j.2006.0906-7590.04584.x; Smith MA, 2005, ECOGRAPHY, V28, P110; Snoeijs T, 2004, P ROY SOC B-BIOL SCI, V271, pS199, DOI 10.1098/rsbl.2003.0148; SPEARE R, 1990, AUST WILDLIFE RES, V17, P387; Suhonen J, 2010, OECOLOGIA, V162, P541, DOI 10.1007/s00442-009-1470-2; Urban MC, 2007, P ROY SOC B-BIOL SCI, V274, P1413, DOI 10.1098/rspb.2007.0114; Viney ME, 2005, TRENDS ECOL EVOL, V20, P665, DOI 10.1016/j.tree.2005.10.003; Wang Y, 2011, ECOL APPL, V21, P729, DOI 10.1890/09-2406.1; Weber TP, 2007, EMERG INFECT DIS, V13, P1139, DOI 10.3201/eid1308.070319; White TA, 2012, FUNCT ECOL, V26, P1313, DOI 10.1111/1365-2435.12012; Wright K. M., 2001, Amphibian medicine and captive husbandry, P129; Zou JW, 2008, ECOGRAPHY, V31, P663, DOI 10.1111/j.0906-7590.2008.05540.x	66	41	41	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99734	10.1371/journal.pone.0099734	http://dx.doi.org/10.1371/journal.pone.0099734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936876	Green Submitted, Green Published, gold			2022-12-25	WOS:000338503400036
J	Jha, AK; Jackson, WM; Healy, KE				Jha, Amit K.; Jackson, Wesley M.; Healy, Kevin E.			Controlling Osteogenic Stem Cell Differentiation via Soft Bioinspired Hydrogels	PLOS ONE			English	Article							SEMIINTERPENETRATING POLYMER NETWORKS; TISSUE ENGINEERING APPLICATIONS; POLY(ACRYLIC ACID) CHAINS; OSTEOBLASTIC DIFFERENTIATION; LIGAND DENSITY; BONE-FORMATION; EXPRESSION; STIFFNESS; ADHESION; MECHANOTRANSDUCTION	Osteogenic differentiation of human mesenchymal stem cells (hMSCs) is guided by various physical and biochemical factors. Among these factors, modulus (i.e., rigidiy) of the ECM has gained significant attention as a physical osteoinductive signal that can contribute to endochondral ossification of a cartilaginous skeletal template. However, MSCs also participate in intramembranous bone formation, which occurs de novo from within or on a more compliant tissue environment. To further understand the role of the matrix interactions in this process, we evaluated osteogenic differentiation of hMSCs cultured on low moduli (102, 390 or 970 Pa) poly(N-isopropylacrylamide) (p(NIPAAm)) based semi-interpenetrating networks (sIPN) modified with the integrin engaging peptide bsp-RGD(15) (0, 105 or 210 mu M). Cell adhesion, proliferation, and osteogenic differentiation of hMSCs, as measured by alkaline phosphatase (ALP), runt-related transcription factor 2 (RUNX2), bone sialoprotein-2 (iBSP), and osteocalcien (OCN) protein expression, was highest on substrates with the highest modulus and peptide concentrations. However, within this range of substrate stiffness, many osteogenic cellular functions were enhanced by increasing either the modulus or the peptide density. These findings suggest that within a compliant and low modulus substrate, a high affinity adhesive ligand serves as a substitute for a rigid matrix to foster osteogenic differentiation.	[Jha, Amit K.; Jackson, Wesley M.; Healy, Kevin E.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Healy, Kevin E.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Healy, KE (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	kehealy@berkeley.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R01AR043187, R01AR047304]; National Heart, Lung and Blood Institute of the National Institutes of Health [R01HL096525]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043187, R01AR047304] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Numbers R01AR043187 and R01AR047304 and the National Heart, Lung and Blood Institute of the National Institutes of Health under award number R01HL096525. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111; Barber TA, 2005, BIOMATERIALS, V26, P6897, DOI 10.1016/j.biomaterials.2005.04.043; Barber TA, 2007, J BIOMED MATER RES A, V80A, P306, DOI 10.1002/jbm.a.30927; Barber TA, 2006, J ORTHOP RES, V24, P1366, DOI 10.1002/jor.20165; Bearinger JP, 1998, J BIOMAT SCI-POLYM E, V9, P629, DOI 10.1163/156856298X00064; BIANCO P, 1991, CALCIFIED TISSUE INT, V49, P421, DOI 10.1007/BF02555854; Bidarra SJ, 2010, BIOMACROMOLECULES, V11, P1956, DOI 10.1021/bm100264a; Born AK, 2009, EUR CELLS MATER, V18, P49; Chu C, 2009, TISSUE ENG PT A, V15, P255, DOI 10.1089/ten.tea.2008.0100; Chung EH, 2006, J BIOMED MATER RES A, V79A, P815, DOI 10.1002/jbm.a.30809; Collins JM, 2010, SMALL, V6, P355, DOI 10.1002/smll.200901757; Coquelin L, 2012, TISSUE ENG PT A, V18, P1921, DOI [10.1089/ten.TEA.2011.0645, 10.1089/ten.tea.2011.0645]; Docheva D, 2008, J CELL MOL MED, V12, P537, DOI 10.1111/j.1582-4934.2007.00138.x; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Forgacs G, 1998, BIOPHYS J, V74, P2227, DOI 10.1016/S0006-3495(98)77932-9; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Gronthos S, 1999, J BONE MINER RES, V14, P47, DOI 10.1359/jbmr.1999.14.1.47; Han SJ, 2012, BIOPHYS J, V103, P640, DOI 10.1016/j.bpj.2012.07.023; Harbers GM, 2005, J BIOMED MATER RES A, V75A, P855, DOI 10.1002/jbm.a.30482; Harbers GM, 2005, LANGMUIR, V21, P8374, DOI 10.1021/la050396y; Ho JE, 2007, J BIOMED MATER RES A, V83A, P1200, DOI 10.1002/jbm.a.31355; Hsiong SX, 2008, J BIOMED MATER RES A, V85A, P145, DOI 10.1002/jbm.a.31521; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Kasza KE, 2011, CURR OPIN CELL BIOL, V23, P30, DOI 10.1016/j.ceb.2010.10.014; Khanna R, 2011, J NANOTECHNOLOGY ENG, V2; Khatiwala CB, 2007, J CELL PHYSIOL, V211, P661, DOI 10.1002/jcp.20974; Khatiwala CB, 2009, J BONE MINER RES, V24, P886, DOI [10.1359/jbmr.081240, 10.1359/JBMR.081240]; Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]; Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013; Kim S, 2005, J BIOMED MATER RES A, V75A, P73, DOI 10.1002/jbm.a.30375; Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467; Kimura Y, 2010, TISSUE ENG PT A, V16, P1263, DOI [10.1089/ten.tea.2009.0322, 10.1089/ten.TEA.2009.0322]; Kisiel M, 2013, BIOMATERIALS, V34, P704, DOI 10.1016/j.biomaterials.2012.10.015; Mari-Buye N, 2013, TISSUE ENG PT A, V19, P870, DOI [10.1089/ten.tea.2012.0077, 10.1089/ten.TEA.2012.0077]; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]; Morimoto D, 2009, RHEUMATOLOGY, V48, P643, DOI 10.1093/rheumatology/kep044; Oliveira SM, 2010, J BIOMED MATER RES A, V94A, P371, DOI 10.1002/jbm.a.32694; Petrie TA, 2008, BIOMATERIALS, V29, P2849, DOI 10.1016/j.biomaterials.2008.03.036; Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b; Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3; Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008; Saha K, 2007, J BIOMED MATER RES A, V81A, P240, DOI 10.1002/jbm.a.30986; Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05; Shih YRV, 2011, J BONE MINER RES, V26, P730, DOI 10.1002/jbmr.278; Shui CX, 2003, J BONE MINER RES, V18, P213, DOI 10.1359/jbmr.2003.18.2.213; Stile RA, 2004, J BIOMAT SCI-POLYM E, V15, P865, DOI 10.1163/1568562041271129; Stile RA, 2001, BIOMACROMOLECULES, V2, P185, DOI 10.1021/bm0000945; Stile RA, 2002, BIOMACROMOLECULES, V3, P591, DOI 10.1021/bm0101466; Sun J, 2012, SOFT MATTER, V8, P2398, DOI 10.1039/c2sm06869a; Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]; Wall ST, 2010, J BIOMED MATER RES A, V95A, P1055, DOI 10.1002/jbm.a.32904; Wang LS, 2010, BIOMATERIALS, V31, P8608, DOI 10.1016/j.biomaterials.2010.07.075; Wise JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012987; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Wu LC, 2011, BIOMATERIALS, V32, P5341, DOI 10.1016/j.biomaterials.2011.04.014	58	30	32	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e98640	10.1371/journal.pone.0098640	http://dx.doi.org/10.1371/journal.pone.0098640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937602	Green Published, Green Submitted, gold			2022-12-25	WOS:000338503400008
J	Kang, M; Jeong, CW; Choi, WS; Park, YH; Cho, SY; Lee, S; Lee, SB; Ku, JH; Hong, SK; Byun, SS; Jeong, H; Kwak, C; Kim, HH; Lee, E; Lee, SE				Kang, Minyong; Jeong, Chang Wook; Choi, Woo Suk; Park, Yong Hyun; Cho, Sung Yong; Lee, Sangchul; Lee, Seung Bae; Ku, Ja Hyeon; Hong, Sung Kyu; Byun, Seok-Soo; Jeong, Hyeon; Kwak, Cheol; Kim, Hyeon Hoe; Lee, Eunsik; Lee, Sang Eun		Seoul Natl Univ	Pre- and Post-Operative Nomograms to Predict Recurrence-Free Probability in Korean Men with Clinically Localized Prostate Cancer	PLOS ONE			English	Article							RADICAL PROSTATECTOMY; PATHOLOGICAL STAGE; PREOPERATIVE NOMOGRAM; BIOCHEMICAL RECURRENCE; ANTIGEN RECURRENCE; DISEASE RECURRENCE; MANAGEMENT; OUTCOMES	Objectives: Although the incidence of prostate cancer (PCa) is rapidly increasing in Korea, there are few suitable prediction models for disease recurrence after radical prostatectomy (RP). We established pre- and post-operative nomograms estimating biochemical recurrence (BCR)-free probability after RP in Korean men with clinically localized PCa. Patients and Methods: Our sampling frame included 3,034 consecutive men with clinically localized PCa who underwent RP at our tertiary centers from June 2004 through July 2011. After inappropriate data exclusion, we evaluated 2,867 patients for the development of nomograms. The Cox proportional hazards regression model was used to develop pre- and postoperative nomograms that predict BCR-free probability. Finally, we resampled from our study cohort 200 times to determine the accuracy of our nomograms on internal validation, which were designated with concordance index (c-index) and further represented by calibration plots. Results: Over a median of 47 months of follow-up, the estimated BCR-free rate was 87.8% (1 year), 83.8% (2 year), and 72.5% (5 year). In the pre-operative model, Prostate-Specific Antigen (PSA), the proportion of positive biopsy cores, clinical T3a and biopsy Gleason score (GS) were independent predictive factors for BCR, while all relevant predictive factors (PSA, extra-prostatic extension, seminal vesicle invasion, lymph node metastasis, surgical margin, and pathologic GS) were associated with BCR in the post-operative model. The c-index representing predictive accuracy was 0.792 (pre-) and 0.821 (post-operative), showing good fit in the calibration plots. Conclusions: In summary, we developed pre- and post-operative nomograms predicting BCR-free probability after RP in a large Korean cohort with clinically localized PCa. These nomograms will be provided as the mobile application-based SNUH Prostate Cancer Calculator. Our nomograms can determine patients at high risk of disease recurrence after RP who will benefit from adjuvant therapy.	[Kang, Minyong; Jeong, Chang Wook; Choi, Woo Suk; Ku, Ja Hyeon; Kwak, Cheol; Kim, Hyeon Hoe; Lee, Eunsik] Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea; [Park, Yong Hyun; Lee, Sangchul; Hong, Sung Kyu; Byun, Seok-Soo; Lee, Sang Eun] Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea; [Cho, Sung Yong; Lee, Seung Bae; Jeong, Hyeon] Seoul Natl Univ, Boramae Hosp, Dept Urol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Lee, SE (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea.	selee@snubh.org	Kang, Minyong/AAO-6484-2020; Ku, Ja Hyeon/E-6682-2016					Byun SS, 2012, YONSEI MED J, V53, P543, DOI 10.3349/ymj.2012.53.3.543; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Chatterjee S, 1998, STAT PROBABIL LETT, V40, P307, DOI 10.1016/S0167-7152(98)00116-3; Cho YM, 2014, WORLD J UROL, V32, P399, DOI 10.1007/s00345-013-1111-6; Chung JS, 2011, YONSEI MED J, V52, P74, DOI 10.3349/ymj.2011.52.1.74; Chung JS, 2010, J KOREAN MED SCI, V25, P1443, DOI 10.3346/jkms.2010.25.10.1443; Fichtner J, 2000, BJU INT, V86, P181, DOI 10.1046/j.1464-410x.2000.00701.x; Freedland SJ, 2007, J UROLOGY, V177, P1985, DOI 10.1016/j.juro.2007.01.137; Haas GP, 2008, CAN J UROL, V15, P3866; Iasonos A, 2008, J CLIN ONCOL, V26, P1364, DOI 10.1200/JCO.2007.12.9791; Iremashvili V, 2012, INT J UROL, V19, P853, DOI 10.1111/j.1442-2042.2012.03058.x; Jeong CW, 2012, INT J UROL, V19, P846, DOI 10.1111/j.1442-2042.2012.03040.x; Jeong CW, 2013, KOREAN J UROL, V11, P133; Kattan MW, 1997, CANCER-AM CANCER SOC, V79, P528, DOI 10.1002/(SICI)1097-0142(19970201)79:3<528::AID-CNCR15>3.3.CO;2-D; Kattan MW, 1999, J CLIN ONCOL, V17, P1499, DOI 10.1200/JCO.1999.17.5.1499; Kattan MW, 1998, JNCI-J NATL CANCER I, V90, P766, DOI 10.1093/jnci/90.10.766; Kim KH, 2014, BJU INT, V113, P598, DOI 10.1111/bju.12280; Kotb AF, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/485189; Li XG, 2012, CHINESE MED J-PEKING, V125, P1529, DOI 10.3760/cma.j.issn.0366-6999.2012.09.002; Naito S, 2005, JPN J CLIN ONCOL, V35, P365, DOI 10.1093/jjco/hyi113; Sengupta S, 2006, J UROLOGY, V175, P1684, DOI 10.1016/S0022-5347(05)00978-X; Shariat SF, 2008, CANCER-AM CANCER SOC, V113, P3075, DOI 10.1002/cncr.23908; Shariat SF, 2008, CLIN CANCER RES, V14, P4400, DOI 10.1158/1078-0432.CCR-07-4713; Shariat SF, 2008, J CLIN ONCOL, V26, P1526, DOI 10.1200/JCO.2007.12.4669; Shariat SF, 2009, FUTURE ONCOL, V5, P1555, DOI [10.2217/fon.09.121, 10.2217/FON.09.121]; Song C, 2005, J KOREAN MED SCI, V20, P262, DOI 10.3346/jkms.2005.20.2.262; Song C, 2006, UROLOGY, V68, P820, DOI 10.1016/j.urology.2006.04.029; Stephenson AJ, 2006, J CLIN ONCOL, V24, P3973, DOI 10.1200/JCO.2005.04.0756; Stephenson AJ, 2006, JNCI-J NATL CANCER I, V98, P715, DOI 10.1093/jnci/djj190; Stephenson AJ, 2006, BJU INT, V98, P39, DOI 10.1111/j.1464-410X.2006.06173.x; Swanson GP, 2011, J CANCER, V2, P1, DOI 10.7150/jca.2.1; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Yan Y, 2000, CANCER, V88, P1122, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1122::AID-CNCR24>3.0.CO;2-Q	33	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100053	10.1371/journal.pone.0100053	http://dx.doi.org/10.1371/journal.pone.0100053			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936784	Green Submitted, gold, Green Published			2022-12-25	WOS:000338503400067
J	Guo, ZQ; Doll, K; Dastjerdi, R; Karlovsky, P; Dehne, HW; Altincicek, B				Guo, Zhiqing; Doell, Katharina; Dastjerdi, Raana; Karlovsky, Petr; Dehne, Heinz-Wilhelm; Altincicek, Boran			Effect of Fungal Colonization of Wheat Grains with Fusarium spp. on Food Choice, Weight Gain and Mortality of Meal Beetle Larvae (Tenebrio molitor)	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ENTOMOPATHOGENIC FUNGUS; BEAUVERIA-BASSIANA; ARTEMIA-SALINA; F-GRAMINEARUM; ANIMAL HEALTH; TOXICITY; MYCOTOXINS; METABOLITES; FUMONISINS	Species of Fusarium have significant agro-economical and human health-related impact by infecting diverse crop plants and synthesizing diverse mycotoxins. Here, we investigated interactions of grain-feeding Tenebrio molitor larvae with four grain-colonizing Fusarium species on wheat kernels. Since numerous metabolites produced by Fusarium spp. are toxic to insects, we tested the hypothesis that the insect senses and avoids Fusarium-colonized grains. We found that only kernels colonized with F. avenaceum or Beauveria bassiana (an insect-pathogenic fungal control) were avoided by the larvae as expected. Kernels colonized with F. proliferatum, F. poae or F. culmorum attracted T. molitor larvae significantly more than control kernels. The avoidance/preference correlated with larval feeding behaviors and weight gain. Interestingly, larvae that had consumed F. proliferatum- or F. poae-colonized kernels had similar survival rates as control. Larvae fed on F. culmorum-, F. avenaceum-or B. bassiana-colonized kernels had elevated mortality rates. HPLC analyses confirmed the following mycotoxins produced by the fungal strains on the kernels: fumonisins, enniatins and beauvericin by F. proliferatum, enniatins and beauvericin by F. poae, enniatins by F. avenaceum, and deoxynivalenol and zearalenone by F. culmorum. Our results indicate that T. molitor larvae have the ability to sense potential survival threats of kernels colonized with F. avenaceum or B. bassiana, but not with F. culmorum. Volatiles potentially along with gustatory cues produced by these fungi may represent survival threat signals for the larvae resulting in their avoidance. Although F. proliferatum or F. poae produced fumonisins, enniatins and beauvericin during kernel colonization, the larvae were able to use those kernels as diet without exhibiting increased mortality. Consumption of F. avenaceum-colonized kernels, however, increased larval mortality; these kernels had higher enniatin levels than F. proliferatum or F. poae-colonized ones suggesting that T. molitor can tolerate or metabolize those toxins.	[Guo, Zhiqing; Dehne, Heinz-Wilhelm; Altincicek, Boran] Univ Bonn, Inst Crop Sci & Resource Conservat INRES Phytomed, Bonn, Germany; [Doell, Katharina; Dastjerdi, Raana; Karlovsky, Petr] Univ Gottingen, D-37073 Gottingen, Germany	University of Bonn; University of Gottingen	Altincicek, B (corresponding author), Univ Bonn, Inst Crop Sci & Resource Conservat INRES Phytomed, Bonn, Germany.	boran.altincicek@uni-bonn.de	dastjerdi, raana/J-5398-2017	Karlovsky, Petr/0000-0002-6532-5856; Altincicek, Boran/0000-0003-2019-452X	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [AL902/4-1]; PLANTFOODSEC project from the European Union [261752]; Chinese Scholarship Council	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); PLANTFOODSEC project from the European Union; Chinese Scholarship Council(China Scholarship Council)	The authors greatly appreciate financial support by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG, AL902/4-1 to B. A.), the PLANTFOODSEC project from the European Union Seventh Framework Programme (FP7/2007-2013) under Grant Agreement number 261752 and the Chinese Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adejumo TO, 2007, FOOD ADDIT CONTAM, V24, P993, DOI 10.1080/02652030701317285; Adejumo TO, 2007, INT J FOOD MICROBIOL, V116, P350, DOI 10.1016/j.ijfoodmicro.2007.02.009; Altincicek B, 2013, PLOS ONE, V8, DOI DOI 10.1371/journal.pone.0052004; Brandfass C, 2008, INT J MOL SCI, V9, P2306, DOI 10.3390/ijms9112306; CONOVER WJ, 1981, TECHNOMETRICS, V23, P351, DOI 10.2307/1268225; D'Mello JPF, 1999, ANIM FEED SCI TECH, V80, P183, DOI 10.1016/S0377-8401(99)00059-0; DESJARDINS AE, 2006, FUSARIUM MYCOTOXINS; Doll K, 2013, P ROYAL SOC B, P280; DOWD PF, 1989, MYCOLOGIA, V81, P646, DOI 10.2307/3760143; Fornelli F, 2004, J INVERTEBR PATHOL, V85, P74, DOI 10.1016/j.jip.2004.01.002; GAUMANN E, 1947, EXPERIENTIA, V3, P202, DOI 10.1007/BF02163993; Geiser DM, 2004, EUR J PLANT PATHOL, V110, P473, DOI 10.1023/B:EJPP.0000032386.75915.a0; Glenn AE, 2007, ANIM FEED SCI TECH, V137, P213, DOI 10.1016/j.anifeedsci.2007.06.003; Gortz A, 2009, AUFTRETEN FUSARIUM K; GROVE JF, 1980, MYCOPATHOLOGIA, V70, P103, DOI 10.1007/BF00443075; GUPTA S, 1991, MYCOPATHOLOGIA, V115, P185, DOI 10.1007/BF00462223; Hamill R. L, 1969, TETRAHEDRON LETT, V49, P4255; Hegedus DD, 1996, J INVERTEBR PATHOL, V67, P21, DOI 10.1006/jipa.1996.0004; Jurado M, 2006, SYST APPL MICROBIOL, V29, P681, DOI 10.1016/j.syapm.2006.01.014; Knorr E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004751; Leslie J. F., 2006, FUSARIUM LAB MANUAL, DOI 10.1002/9780470278376; Mburu DM, 2013, J CHEM ECOL, V39, P101, DOI 10.1007/s10886-012-0207-6; McCormick SP, 2011, TOXINS, V3, P802, DOI 10.3390/toxins3070802; Meyling NV, 2006, ECOL ENTOMOL, V31, P162, DOI 10.1111/j.0307-6946.2006.00781.x; MOORE KC, 1983, J INVERTEBR PATHOL, V42, P413, DOI 10.1016/0022-2011(83)90187-8; Morales-Ramos JA, 2011, ENVIRON ENTOMOL, V40, P1285, DOI 10.1603/EN10239; Moretti A, 2007, INT J FOOD MICROBIOL, V118, P158, DOI 10.1016/j.ijfoodmicro.2007.07.004; NELSON PE, 1993, ANNU REV PHYTOPATHOL, V31, P233, DOI 10.1146/annurev.py.31.090193.001313; Cambuim IIF, 2007, BRAZ J MICROBIOL, V38, P285, DOI 10.1590/S1517-83822007000200018; Nucci M, 2007, CLIN MICROBIOL REV, V20, P695, DOI 10.1128/CMR.00014-07; Nutz S, 2011, ANAL BIOANAL CHEM, V401, P717, DOI 10.1007/s00216-011-5089-x; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; Ormond EL, 2011, FEMS MICROBIOL ECOL, V77, P229, DOI 10.1111/j.1574-6941.2011.01100.x; Parry DW, 1996, PLANT PATHOL, V45, P383, DOI 10.1046/j.1365-3059.1996.d01-133.x; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; Pestka JJ, 2007, ANIM FEED SCI TECH, V137, P283, DOI 10.1016/j.anifeedsci.2007.06.006; Placinta CM, 1999, ANIM FEED SCI TECH, V78, P21, DOI 10.1016/S0377-8401(98)00278-8; Proctor RH, 1995, MOL PLANT MICROBE IN, V8, P1995; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Rohlfs M, 2011, FUNGAL GENET BIOL, V48, P23, DOI 10.1016/j.fgb.2010.08.008; Rohlfs Marko, 2009, Mycotoxin Res, V25, P103, DOI 10.1007/s12550-009-0015-1; Schilling AG, 1996, PHYTOPATHOLOGY, V86, P515, DOI 10.1094/Phyto-86-515; Staaden S, 2010, SOIL BIOL BIOCHEM, V42, P1766, DOI 10.1016/j.soilbio.2010.06.014; STRONGMAN DB, 1988, J CHEM ECOL, V14, P753, DOI 10.1007/BF01018770; Summerell BA, 2010, FUNGAL DIVERS, V44, P3, DOI 10.1007/s13225-010-0060-2; TEETORBARSCH GH, 1983, MYCOPATHOLOGIA, V84, P3, DOI 10.1007/BF00436991; Trienens M, 2012, FUNGAL ECOL, V5, P191, DOI 10.1016/j.funeco.2011.07.009; Utermark J, 2007, APPL ENVIRON MICROB, V73, P637, DOI 10.1128/AEM.01440-06; Voss KA, 2007, ANIM FEED SCI TECH, V137, P299, DOI 10.1016/j.anifeedsci.2007.06.007; Waalwijk C, 2004, EUR J PLANT PATHOL, V110, P481, DOI 10.1023/B:EJPP.0000032387.52385.13; Wang QG, 2012, MOLECULES, V17, P2367, DOI 10.3390/molecules17032367; Waskiewicz A, 2010, FOOD ADDIT CONTAM A, V27, P608, DOI 10.1080/19440040903551947	53	13	14	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100112	10.1371/journal.pone.0100112	http://dx.doi.org/10.1371/journal.pone.0100112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932485	Green Published, Green Submitted, gold			2022-12-25	WOS:000337738600096
J	Koumura, T; Urakubo, H; Ohashi, K; Fujii, M; Kuroda, S				Koumura, Takuya; Urakubo, Hidetoshi; Ohashi, Kaoru; Fujii, Masashi; Kuroda, Shinya			Stochasticity in Ca2+ Increase in Spines Enables Robust and Sensitive Information Coding	PLOS ONE			English	Article							CEREBELLAR PURKINJE-CELLS; SMALL SUBCELLULAR VOLUMES; LONG-TERM DEPRESSION; DENDRITIC SPINES; REWARD PROBABILITY; CLIMBING FIBER; MOTOR CONTROL; DYNAMICS; PLASTICITY; INDUCTION	A dendritic spine is a very small structure (similar to 0.1 mu m(3)) of a neuron that processes input timing information. Why are spines so small? Here, we provide functional reasons; the size of spines is optimal for information coding. Spines code input timing information by the probability of Ca2+ increases, which makes robust and sensitive information coding possible. We created a stochastic simulation model of input timing-dependent Ca2+ increases in a cerebellar Purkinje cell's spine. Spines used probability coding of Ca2+ increases rather than amplitude coding for input timing detection via stochastic facilitation by utilizing the small number of molecules in a spine volume, where information per volume appeared optimal. Probability coding of Ca2+ increases in a spine volume was more robust against input fluctuation and more sensitive to input numbers than amplitude coding of Ca2+ increases in a cell volume. Thus, stochasticity is a strategy by which neurons robustly and sensitively code information.	[Koumura, Takuya; Kuroda, Shinya] Univ Tokyo, Undergrad Dept Bioinformat & Syst Biol, Bunkyo Ku, Tokyo, Japan; [Urakubo, Hidetoshi; Ohashi, Kaoru; Fujii, Masashi; Kuroda, Shinya] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; University of Tokyo	Kuroda, S (corresponding author), Univ Tokyo, Undergrad Dept Bioinformat & Syst Biol, Bunkyo Ku, Tokyo, Japan.	skuroda@bs.s.u-tokyo.ac.jp	Koumura, Takuya/GYQ-5737-2022; Fujii, Masashi/S-1516-2019	Fujii, Masashi/0000-0002-1586-6435; Koumura, Takuya/0000-0002-8380-9598; Urakubo, Hidetoshi/0000-0002-1816-0040	Ministry of Education, Culture, Sports, Science, and Technology of Japan; CREST from the Japan Science and Technology; Human Frontier Science Project [RGP0061/2011]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST from the Japan Science and Technology; Human Frontier Science Project(Human Frontier Science Program)	This work was supported by the National Project "Next Generation Integrated Living Matter Simulation" and "Bioinformatics for Brain Sciences" of the Ministry of Education, Culture, Sports, Science, and Technology of Japan (www.jsps.go.jp), the Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics, CREST, from the Japan Science and Technology (www.jst.go.jp), and by a Human Frontier Science Project (www.hfsp.org) grant (RGP0061/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes G, 2012, J NEUROSCI, V32, P9288, DOI 10.1523/JNEUROSCI.5976-11.2012; BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bhalla US, 2004, BIOPHYS J, V87, P733, DOI 10.1529/biophysj.104.040469; Bhalla US, 2004, BIOPHYS J, V87, P745, DOI 10.1529/biophysj.104.040501; Bogacki P., 1989, APPL MATH LETT, V2, P321, DOI [10.1016/0893-9659(89)90079-7, DOI 10.1016/0893-9659(89)90079-7]; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; De Schutter E, 2012, NEURAL NETW; Doi T, 2005, J NEUROSCI, V25, P950, DOI 10.1523/JNEUROSCI.2727-04.2005; EILERS J, 1995, P NATL ACAD SCI USA, V92, P10272, DOI 10.1073/pnas.92.22.10272; Enoki R, 2009, NEURON, V62, P242, DOI 10.1016/j.neuron.2009.02.026; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; HARRIS KM, 1988, J NEUROSCI, V8, P4455; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; ITO M, 1970, INT J NEUROL, V7, P162; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Kawato M, 2011, CURR OPIN NEUROBIOL, V21, P791, DOI 10.1016/j.conb.2011.05.014; Kitamura K, 2011, J NEUROSCI, V31, P10847, DOI 10.1523/JNEUROSCI.2525-10.2011; Komorowski M, 2011, P NATL ACAD SCI USA, V108, P8645, DOI 10.1073/pnas.1015814108; Kuroda S, 2001, J NEUROSCI, V21, P5693, DOI 10.1523/JNEUROSCI.21-15-05693.2001; Mauk MD, 1998, NEURON, V20, P359, DOI 10.1016/S0896-6273(00)80978-2; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; NAPPER RMA, 1988, J COMP NEUROL, V274, P168, DOI 10.1002/cne.902740204; O'Connor DH, 2005, P NATL ACAD SCI USA, V102, P9679, DOI 10.1073/pnas.0502332102; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; RAPP M, 1994, J PHYSIOL-LONDON, V474, P101, DOI 10.1113/jphysiol.1994.sp020006; Skupin A, 2008, BIOPHYS J, V94, P2404, DOI 10.1529/biophysj.107.119495; Skupin A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000870; STEINMETZ JE, 1990, BEHAV BRAIN RES, V38, P97, DOI 10.1016/0166-4328(90)90008-3; Stuart G., 1999, DENDRITES; TAKACS J, 1994, J NEUROSCI RES, V38, P515, DOI 10.1002/jnr.490380505; Tanaka K, 2008, NEURON, V59, P608, DOI 10.1016/j.neuron.2008.06.026; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; Thomas J, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00214; Thurley K, 2011, BIOPHYS J, V101, P2638, DOI 10.1016/j.bpj.2011.10.030; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; van Duuren E, 2009, J NEUROSCI, V29, P8965, DOI 10.1523/JNEUROSCI.0005-09.2009; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792	40	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99040	10.1371/journal.pone.0099040	http://dx.doi.org/10.1371/journal.pone.0099040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932482	Green Published, gold, Green Submitted			2022-12-25	WOS:000337738600018
J	Bu, ZQ; Zhao, FF; Wang, KY; Guo, YH; Su, YC; Zhai, J; Sun, YP				Bu, Zhiqin; Zhao, Feifei; Wang, Keyan; Guo, Yihong; Su, Yingchun; Zhai, Jun; Sun, Yingpu			Serum Progesterone Elevation Adversely Affects Cumulative Live Birth Rate in Different Ovarian Responders during In Vitro Fertilization and Embryo Transfer: A Large Retrospective Study	PLOS ONE			English	Article							ONGOING PREGNANCY RATES; ENDOMETRIAL RECEPTIVITY; PREMATURE LUTEINIZATION; BLASTOCYST TRANSFER; HORMONE ANTAGONIST; CYCLES; IVF; METAANALYSIS; STIMULATION; MORPHOLOGY	In order to explore the relationship between serum progesterone (P) level on the day of human chorionic gonadotrophin (HCG) administration and cumulative live birth rate in patients with different ovarian response during in vitro fertilization (IVF), we carried out this retrospective cohort study including a total of 4,651 patients undergoing their first IVF cycles from January 2011 to December 2012. All patients with a final live birth outcome (4,332 patients) were divided into three groups according to ovarian response: poor ovarian responder (<= 5 oocytes, 785 patients), intermediate ovarian responder (6-19 oocytes, 3065 patients) and high ovarian responder (>= 20 oocytes, 482 patients). The thresholds for serum P elevation were 1.60 ng/ml, 2.24 ng/ml, and 2.50 ng/ml for poor, intermediate, and high ovarian responders, respectively. Cumulative live birth rate per oocyte retrieval cycle was calculated in each group. The relationship between serum P level and cumulative live birth rate was evaluated by both univariate and multivariate logistic regression analysis. Cumulative live birth rate per oocyte retrieval cycle was inversely associated with serum P level in patients with different ovarian response. For all responders, patients with elevated P level had significantly higher number of oocytes retrieved, but lower high quality embryo rate, and lower cumulative live birth rate compared with patients with normal serum P level. In addition, serum P level adversely affected cumulative live birth rate by both univariate and multivariate logistic regression analysis, independent of ovarian response. Serum P elevation on the day of HCG administration adversely affects cumulative live birth rate per oocyte retrieval cycle in patients with different ovarian response.	[Bu, Zhiqin; Zhao, Feifei; Guo, Yihong; Su, Yingchun; Zhai, Jun; Sun, Yingpu] Zhengzhou Univ, Affiliated Hosp 1, Reprod Med Ctr, Zhengzhou, Henan, Peoples R China; [Wang, Keyan] Zhengzhou Univ, Sch Publ Hlth, Zhengzhou, Henan, Peoples R China	Zhengzhou University; Zhengzhou University	Sun, YP (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Reprod Med Ctr, Zhengzhou, Henan, Peoples R China.	syp2008@vip.sina.com			National Natural Science Foundation of China [31271605, U1304315]; Youth Foundation of The First Affiliated Hospital of Zhengzhou University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Foundation of The First Affiliated Hospital of Zhengzhou University	This work was supported by the National Natural Science Foundation of China (Grant NO. 31271605 and U1304315) and Youth Foundation of The First Affiliated Hospital of Zhengzhou University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban B, 2001, HUM REPROD, V16, P2357, DOI 10.1093/humrep/16.11.2357; Bosch E, 2010, HUM REPROD, V25, P2092, DOI 10.1093/humrep/deq125; Doldi N, 1999, HUM REPROD, V14, P601, DOI 10.1093/humrep/14.3.601; Forman EJ, 2012, HUM REPROD, V27, P1217, DOI 10.1093/humrep/des020; Garcia-Velasco JA, 2011, FERTIL STERIL, V96, P590, DOI 10.1016/j.fertnstert.2011.06.022; Garrido N, 2011, FERTIL STERIL, V96, P40, DOI 10.1016/j.fertnstert.2011.05.008; Griesinger G, 2013, FERTIL STERIL, V100, P1622, DOI 10.1016/j.fertnstert.2013.08.045; Huang CC, 2012, HUM REPROD, V27, P2036, DOI 10.1093/humrep/des141; Kotze DJ, 2010, J ASSIST REPROD GEN, V27, P309, DOI 10.1007/s10815-010-9403-x; Labarta E, 2011, HUM REPROD, V26, P1813, DOI 10.1093/humrep/der126; Li HWR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061095; Li R, 2008, REPROD BIOMED ONLINE, V16, P627, DOI 10.1016/S1472-6483(10)60475-0; Melo MAB, 2006, HUM REPROD, V21, P1503, DOI 10.1093/humrep/dei474; Papanikolaou EG, 2009, FERTIL STERIL, V91, P949, DOI 10.1016/j.fertnstert.2006.12.064; Roque M, 2013, FERTIL STERIL, V99, P156, DOI 10.1016/j.fertnstert.2012.09.003; Segal S, 2009, FERTIL STERIL, V91, P1755, DOI 10.1016/j.fertnstert.2008.02.009; Shapiro BS, 2011, FERTIL STERIL, V96, P516, DOI 10.1016/j.fertnstert.2011.02.059; SILVERBERG KM, 1994, FERTIL STERIL, V61, P508; Valbuena D, 2001, FERTIL STERIL, V76, P962, DOI 10.1016/S0015-0282(01)02018-0; Venetis CA, 2013, HUM REPROD UPDATE, V19, P433, DOI 10.1093/humupd/dmt014; Xu B, 2012, FERTIL STERIL, V97, P1321, DOI 10.1016/j.fertnstert.2012.03.014; Zhang HJ, 2012, CHINESE MED J-PEKING, V125, P2837, DOI 10.3760/cma.j.issn.0366-6999.2012.16.007; Zhang YL, 2013, SYST BIOL REPROD MED, V59, P34, DOI 10.3109/19396368.2012.731470	23	44	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100011	10.1371/journal.pone.0100011	http://dx.doi.org/10.1371/journal.pone.0100011			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926883	gold, Green Published, Green Submitted			2022-12-25	WOS:000338278100106
J	de Abreu, LA; Vaz, ID; Moreira, LA; da Fonseca, RN; Logullo, C				de Abreu, Leonardo Araujo; Vaz, Itabajara da Silva, Jr.; Moreira, Luciano A.; da Fonseca, Rodrigo Nunes; Logullo, Carlos			The Modulation of the Symbiont/Host Interaction between Wolbachia pipientis and Aedes fluviatilis Embryos by Glycogen Metabolism	PLOS ONE			English	Article							SYNTHASE KINASE-3; AEGYPTI; DROSOPHILA; DENGUE; GENE; EGG; EMBRYOGENESIS; INHIBITION; MOSQUITOS; BACTERIA	Wolbachia pipientis, a maternally transmitted bacterium that colonizes arthropods, may affect the general aspects of insect physiology, particularly reproduction. Wolbachia is a natural endosymbiont of Aedes fluviatilis, whose effects in embryogenesis and reproduction have not been addressed so far. In this context, we investigated the correlation between glucose metabolism and morphological alterations during A. fluviatilis embryo development in Wolbachia-positive (W+) and Wolbachia-negative (W-) mosquito strains. While both strains do not display significant morphological and larval hatching differences, larger differences were observed in hexokinase activity and glycogen contents during early and mid-stages of embryogenesis, respectively. To investigate if glycogen would be required for parasite-host interaction, we reduced Glycogen Synthase Kinase-3 (GSK-3) levels in adult females and their eggs by RNAi. GSK-3 knock-down leads to embryonic lethality, lower levels of glycogen and total protein and Wolbachia reduction. Therefore, our results suggest that the relationship between A. fluviatilis and Wolbachia may be modulated by glycogen metabolism.	[de Abreu, Leonardo Araujo; Logullo, Carlos] Univ Estadual Norte Fluminense Darcy Ribeiro UENF, Lab Sanidade Anim, Lab Quim & Funcao Prot & Peptideos, Campos Goytacazes, Rio De Janeiro, Brazil; [de Abreu, Leonardo Araujo; Logullo, Carlos] Univ Estadual Norte Fluminense Darcy Ribeiro UENF, Unidade Expt Anim RJ, Campos Goytacazes, Rio De Janeiro, Brazil; [Moreira, Luciano A.] Fiocruz MS, Lab Malaria, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [de Abreu, Leonardo Araujo; da Fonseca, Rodrigo Nunes] Univ Fed Rio de Janeiro UFRJ Macae, LIBHM, Nucleo Pesquisas Ecol & Socioambientais Macae NUP, Rio De Janeiro, Brazil; [Vaz, Itabajara da Silva, Jr.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-90046900 Porto Alegre, RS, Brazil	Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense; Fundacao Oswaldo Cruz; Universidade Federal do Rio Grande do Sul	Logullo, C (corresponding author), Univ Estadual Norte Fluminense Darcy Ribeiro UENF, Lab Sanidade Anim, Lab Quim & Funcao Prot & Peptideos, Campos Goytacazes, Rio De Janeiro, Brazil.	carloslogullo@yahoo.com.br	vaz, itabajara/F-5244-2014; Costa, Evenilton Pessoa/F-9692-2012; da Fonseca, Rodrigo Nunes/S-3964-2018; Costa, Evenilton Pessoa/X-2273-2019; Nunes-da-Fonseca, Rodrigo/ABI-1404-2022; Silva Vaz Jr., Itabajara/A-5943-2009	vaz, itabajara/0000-0003-0309-9328; Costa, Evenilton Pessoa/0000-0003-3316-2834; da Fonseca, Rodrigo Nunes/0000-0001-9576-2849; Costa, Evenilton Pessoa/0000-0003-3316-2834; Nunes-da-Fonseca, Rodrigo/0000-0001-9576-2849; Silva Vaz Jr., Itabajara/0000-0003-0309-9328; ARAUJO DE ABREU, LEONARDO/0000-0003-0659-8931	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Coordenacao de Aperfeicoamento do Pessoal de nivel Superior (CAPES); Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Coordenacao de Aperfeicoamento do Pessoal de nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, INCT de Entomologia Molecular), Fundacao de Coordenacao de Aperfeicoamento do Pessoal de nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Baton LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059619; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Brownstin JS, 2003, J INVERTEBR PATHOL, V84, P24, DOI 10.1016/S0022-2011(03)00082-X; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2009, CELL, V139, P227, DOI 10.1016/j.cell.2009.09.027; Consoli R. A. G B., 1976, THESIS U FEDERAL MIN; CONSOLI RAGB, 1978, B ENTOMOL RES, V68, P123, DOI 10.1017/S0007485300007203; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Darby AC, 2012, GENOME RES, V22, P2467, DOI 10.1101/gr.138420.112; DAVIS Nelson C., 1931, American Journal of Tropical Medicine, V11, P21; Dedeine F, 2001, P NATL ACAD SCI USA, V98, P6247, DOI 10.1073/pnas.101304298; Emily-Fenouil F, 1998, DEVELOPMENT, V125, P2489; Fabres A, 2010, PARASITOLOGY, V137, P1537, DOI 10.1017/S0031182010000284; Ferkey DM, 2000, DEV BIOL, V225, P471, DOI 10.1006/dbio.2000.9816; Forattini O P, 2002, CULICIDOLOGICA MED; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Fraga A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065125; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Galina A, 2000, PHYTOCHEMISTRY, V53, P29, DOI 10.1016/S0031-9422(99)00456-2; Gentile C, 2005, MEM I OSWALDO CRUZ, V100, P645; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Henschel A, 2004, NUCLEIC ACIDS RES, V32, pW113, DOI 10.1093/nar/gkh408; Horn T, 2010, NUCLEIC ACIDS RES, V38, pW332, DOI 10.1093/nar/gkq317; Ikeya T, 2009, P ROY SOC B-BIOL SCI, V276, P3799, DOI 10.1098/rspb.2009.0778; Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; KOSE H, 1995, MECH DEVELOP, V51, P275, DOI 10.1016/0925-4773(95)00372-X; McMeniman CJ, 2011, J MED ENTOMOL, V48, P76, DOI 10.1603/ME09188; Melnikow E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002151; Monnerat AT, 2002, MEM I OSWALDO CRUZ, V97, P589, DOI 10.1590/S0074-02762002000400026; Moraes J, 2007, COMP BIOCHEM PHYS A, V146, P528, DOI 10.1016/j.cbpa.2006.05.009; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Naito Y, 2005, NUCLEIC ACIDS RES, V33, pW589, DOI 10.1093/nar/gki419; Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002055, 10.1371/journal.pntd.0002056]; Sinkins SP, 2000, INSECT TRANSGENESIS, P271; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TRPIS M, 1973, B WORLD HEALTH ORGAN, V48, P447; Verheyen EM, 2010, DEV DYNAM, V239, P34, DOI 10.1002/dvdy.22019; Vital W, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-25; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Worthington CC, 1988, WORTH ENZ MAN ENZ RE; Yamazaki H, 2003, BIOCHEM BIOPH RES CO, V304, P229, DOI 10.1016/S0006-291X(03)00582-5; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	47	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98966	10.1371/journal.pone.0098966	http://dx.doi.org/10.1371/journal.pone.0098966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926801	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100025
J	Liu, WX; Maurer, HP; Li, GL; Tucker, MR; Gowda, M; Weissmann, EA; Hahn, V; Wurschum, T				Liu, Wenxin; Maurer, Hans Peter; Li, Guoliang; Tucker, Matthew R.; Gowda, Manje; Weissmann, Elmar A.; Hahn, Volker; Wuerschum, Tobias			Genetic Architecture of Winter Hardiness and Frost Tolerance in Triticale	PLOS ONE			English	Article							LOW-TEMPERATURE TOLERANCE; QUANTITATIVE TRAIT LOCI; CROSS-VALIDATION; CANDIDATE GENES; PLANT HEIGHT; AESTIVUM L.; VERNALIZATION; RESISTANCE; QTL; EPISTASIS	Abiotic stress experienced by autumn-sown crops during winter is of great economic importance as it can have a severe negative impact on yield. In this study, we investigated the genetic architecture of winter hardiness and frost tolerance in triticale. To this end, we used a large mapping population of 647 DH lines phenotyped for both traits in combination with genome-wide marker data. Employing multiple-line cross QTL mapping, we identified nine main effect QTL for winter hardiness and frost tolerance of which six were overlapping between both traits. Three major QTL were identified on chromosomes 5A, 1B and 5R. In addition, an epistasis scan revealed the contribution of epistasis to the genetic architecture of winter hardiness and frost tolerance in triticale. Taken together, our results show that winter hardiness and frost tolerance are complex traits that can be improved by phenotypic selection, but also that genomic approaches hold potential for a knowledge-based improvement of these important traits in elite triticale germplasm.	[Liu, Wenxin; Li, Guoliang] China Agr Univ, Crop Genet & Breeding Dept, Beijing 100094, Peoples R China; [Maurer, Hans Peter; Gowda, Manje; Hahn, Volker; Wuerschum, Tobias] Univ Hohenheim, State Plant Breeding Inst, Stuttgart, Germany; [Tucker, Matthew R.] Univ Adelaide, ARC Ctr Excellence Plant Cell Walls, Urrbrae, Australia; [Weissmann, Elmar A.] Saatzucht Dr Hege GbR Domane Hohebuch, Waldenburg, Germany	China Agricultural University; University Hohenheim; University of Adelaide; KWS Saat AG	Wurschum, T (corresponding author), Univ Hohenheim, State Plant Breeding Inst, Stuttgart, Germany.	tobias.wuerschum@uni-hohenheim.de	Gowda, Manje/AAH-4207-2019; Gowda, Manje/AAG-2251-2019; Tucker, Matthew R/C-6207-2008; Liu, Wenxin/AAI-3539-2020	Gowda, Manje/0000-0003-4434-6364; Tucker, Matthew R/0000-0003-4661-6700; Li, Guoliang/0000-0002-1190-9725; Wurschum, Tobias/0000-0002-7397-7731	German Federal Ministry of Education and Research (BMBF) [0315414]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This research was funded by the German Federal Ministry of Education and Research (BMBF) under the promotional reference 0315414. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alheit KV, 2014, THEOR APPL GENET, V127, P251, DOI 10.1007/s00122-013-2214-6; Alheit KV, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-235; Alheit KV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-380; [Anonymous], 2010, R LANG ENV STAT COMP; Baga M, 2007, FUNCT INTEGR GENOMIC, V7, P53, DOI 10.1007/s10142-006-0030-7; Blanc G, 2006, THEOR APPL GENET, V113, P206, DOI 10.1007/s00122-006-0287-1; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Busemeyer L, 2013, SCI REP-UK, V3, DOI 10.1038/srep02442; Campoli C, 2009, MOL GENET GENOMICS, V282, P141, DOI 10.1007/s00438-009-0451-9; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Dhillon T, 2013, THEOR APPL GENET, V126, P2777, DOI 10.1007/s00122-013-2171-0; Dhillon T, 2010, PLANT PHYSIOL, V153, P1846, DOI 10.1104/pp.110.159079; Doerge RW, 1996, GENETICS, V142, P285; Fowler DB, 2008, CROP SCI, V48, P1147, DOI 10.2135/cropsci2007.10.0581; Galiba G, 2009, PLANT SCI, V176, P12, DOI 10.1016/j.plantsci.2008.09.016; Gilmour AR, 2009, ASREML USER GUIDE RE; Holland JB, 2002, THEOR APPL GENET, V105, P113, DOI 10.1007/s00122-001-0845-5; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; LANDER ES, 1989, GENETICS, V121, P185; Li YL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-146; Limin AE, 2002, ANN BOT-LONDON, V89, P579, DOI 10.1093/aob/mcf102; LIMIN AE, 1985, CAN J PLANT SCI, V65, P487, DOI 10.4141/cjps85-070; Limin AE, 2006, PLANTA, V224, P360, DOI 10.1007/s00425-006-0219-y; Liu W, 2013, HEREDITY, V110, P71, DOI 10.1038/hdy.2012.63; Liu WX, 2012, THEOR APPL GENET, V125, P987, DOI 10.1007/s00122-012-1889-4; Mahfoozi S, 2001, ANN BOT-LONDON, V87, P751, DOI 10.1006/anbo.2001.1403; Miller AK, 2006, MOL GENET GENOMICS, V275, P193, DOI 10.1007/s00438-005-0076-6; Pearce S, 2013, THEOR APPL GENET, V126, P2683, DOI 10.1007/s00122-013-2165-y; PLASCHKE J, 1993, THEOR APPL GENET, V85, P1049, DOI 10.1007/BF00215046; Reif JC, 2011, THEOR APPL GENET, V123, P283, DOI 10.1007/s00122-011-1583-y; SAS Institute, 2008, SAS STAT 9 2 US GUID; Sieber AN, 2014, PLANT BREEDING, V133, P465, DOI 10.1111/pbr.12181; Snape JW, 1997, ACTA AGRON HUNG, V45, P268; Steinhoff J, 2012, THEOR APPL GENET, V125, P1539, DOI 10.1007/s00122-012-1933-4; Steinhoff J, 2011, CROP SCI, V51, P2505, DOI 10.2135/cropsci2011.03.0181; SUTKA J, 1989, EUPHYTICA, V42, P41, DOI 10.1007/BF00042613; Sutka J, 2001, EUPHYTICA, V119, P167, DOI 10.1023/A:1017520720183; Toth B, 2003, THEOR APPL GENET, V107, P509, DOI 10.1007/s00122-003-1275-3; Utz HF, 2000, GENETICS, V154, P1839; Vagujfalvi A, 2005, MOL GENET GENOMICS, V274, P506, DOI 10.1007/s00438-005-0047-y; Vagujfalvi A, 2003, MOL GENET GENOMICS, V269, P60, DOI 10.1007/s00438-003-0806-6; Vagujfalvi A, 2000, MOL GEN GENET, V263, P194, DOI 10.1007/s004380051160; Williams E, 2011, BIOMETRICAL J, V53, P19, DOI 10.1002/bimj.201000102; Wurschum T, 2014, HEREDITY, V112, P463, DOI 10.1038/hdy.2013.126; Wurschum T, 2012, HEREDITY, V108, P332, DOI 10.1038/hdy.2011.78; Wurschum T, 2014, IN VITRO CELL DEV-PL, V50, P143, DOI 10.1007/s11627-013-9539-3; Wurschum T, 2013, THEOR APPL GENET, V126, P435, DOI 10.1007/s00122-012-1991-7; Wurschum T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-109; Wurschum T, 2012, THEOR APPL GENET, V125, P201, DOI 10.1007/s00122-012-1887-6; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Zhao YS, 2013, J EXP BOT, V64, P4453, DOI 10.1093/jxb/ert259	51	9	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99848	10.1371/journal.pone.0099848	http://dx.doi.org/10.1371/journal.pone.0099848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927281	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100086
J	Oliver, TR; Middlebrooks, CD; Tinker, SW; Allen, EG; Bean, LJH; Begum, F; Feingold, E; Chowdhury, R; Cheung, V; Sherman, SL				Oliver, Tiffany Renee; Middlebrooks, Candace D.; Tinker, Stuart W.; Allen, Emily Graves; Bean, Lora J. H.; Begum, Ferdouse; Feingold, Eleanor; Chowdhury, Reshmi; Cheung, Vivian; Sherman, Stephanie L.			An Examination of the Relationship between Hotspots and Recombination Associated with Chromosome 21 Nondisjunction	PLOS ONE			English	Article							DOWN-SYNDROME; HUMAN GENOME; CONFIGURATIONS; POPULATIONS; PRDM9; MAP	Trisomy 21, resulting in Down Syndrome (DS), is the most common autosomal trisomy among live-born infants and is caused mainly by nondisjunction of chromosome 21 within oocytes. Risk factors for nondisjunction depend on the parental origin and type of meiotic error. For errors in the oocyte, increased maternal age and altered patterns of recombination are highly associated with nondisjunction. Studies of normal meiotic events in humans have shown that recombination clusters in regions referred to as hotspots. In addition, GC content, CpG fraction, Poly(A)/Poly(T) fraction and gene density have been found to be significant predictors of the placement of sex-averaged recombination in the human genome. These observations led us to ask whether the altered patterns of recombination associated with maternal nondisjunction of chromosome 21 could be explained by differences in the relationship between recombination placement and recombination-related genomic features (i.e., GC content, CpG fraction, Poly(A)/Poly(T) fraction or gene density) on 21q or differential hot-spot usage along the nondisjoined chromosome 21. We found several significant associations between our genomic features of interest and recombination, interestingly, these results were not consistent among recombination types (single and double proximal or distal events). We also found statistically significant relationships between the frequency of hotspots and the distribution of recombination along nondisjoined chromosomes. Collectively, these findings suggest that factors that affect the accessibility of a specific chromosome region to recombination may be altered in at least a proportion of oocytes with MI and MII errors.	[Oliver, Tiffany Renee; Middlebrooks, Candace D.; Tinker, Stuart W.; Allen, Emily Graves; Bean, Lora J. H.; Sherman, Stephanie L.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Oliver, Tiffany Renee] Spelman Coll, Dept Biol, Atlanta, GA 30314 USA; [Begum, Ferdouse; Feingold, Eleanor] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Feingold, Eleanor; Chowdhury, Reshmi] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Cheung, Vivian] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Cheung, Vivian] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	Emory University; Spelman College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Oliver, TR (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	Toliver4@spelman.edu	Oliver, Tiffany R/H-8855-2016; Cheung, Vivian G./AAT-3115-2020	Oliver, Tiffany R/0000-0002-8212-3121; Feingold, Eleanor/0000-0003-2898-6484	 [R01 HD38979];  [R01 HL083300];  [UL1TR000454]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD038979] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083300] Funding Source: NIH RePORTER	; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by R01 HD38979, R01 HL083300 and UL1TR000454. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2010, NAT GENET; Berg IL, 2011, P NATL ACAD SCI USA, V108, P12378, DOI 10.1073/pnas.1109531108; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Fledel-Alon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020321; Freeman SB, 2007, PUBLIC HEALTH REP, V122, P62, DOI 10.1177/003335490712200109; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Holmquist GP, 2006, CYTOGENET GENOME RES, V114, P96, DOI 10.1159/000093326; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Lamb NE, 1996, NAT GENET, V14, P400, DOI 10.1038/ng1296-400; Lamb NE, 1997, HUM MOL GENET, V6, P1391, DOI 10.1093/hmg/6.9.1391; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Oliver TR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000033; Oliver TR, 2011, HUM GENET; Oliver TR, HUM GENET; Polk Deborah E, 2008, BMC Oral Health, V8, P18, DOI 10.1186/1472-6831-8-18; Sherman SL, 2007, MENT RETARD DEV D R, V13, P221, DOI 10.1002/mrdd.20157; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974	21	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99560	10.1371/journal.pone.0099560	http://dx.doi.org/10.1371/journal.pone.0099560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926858	Green Accepted, gold, Green Published			2022-12-25	WOS:000338278100049
J	Tixier, F; Groves, AM; Goh, V; Hatt, M; Ingrand, P; Le Rest, CC; Visvikis, D				Tixier, Florent; Groves, Ashley M.; Goh, Vicky; Hatt, Mathieu; Ingrand, Pierre; Le Rest, Catherine Cheze; Visvikis, Dimitris			Correlation of Intra-Tumor F-18-FDG Uptake Heterogeneity Indices with Perfusion CT Derived Parameters in Colorectal Cancer	PLOS ONE			English	Article							CELL LUNG-CANCER; POSITRON-EMISSION-TOMOGRAPHY; VASCULAR PARAMETERS; GLUCOSE-METABOLISM; TEXTURAL FEATURES; THERAPY RESPONSE; RECTAL-CANCER; FDG UPTAKE; HEAD; QUANTIFICATION	Application of textural features analysis to 18F-fluorodeoxyglucose (F-18-FDG) positron emission tomography (PET) images has been used to characterize intra-tumor uptake heterogeneity and has been shown to reflect disease outcome. A current hypothesis is that F-18-FDG uptake heterogeneity may reflect the physiological tracer uptake related to tumor perfusion. The purpose of our study was to investigate the correlations between intra-tumor uptake heterogeneity and vascular parameters derived from dynamic contrast enhanced (DCE) computed tomography (CT) obtained from an integrated F-18-FDG PET/perfusion CT examination. Methods: Thirty patients with proven colorectal cancer prospectively underwent integrated F-18-FDG PET/DCE-CT to assess the metabolic-flow phenotype. Both CT blood flow parametric maps and PET images were analyzed. Correlations between PET heterogeneity and perfusion CT were assessed by Spearman's rank correlation analysis. Results: Blood flow visualization provided by DCE-CT images was significantly correlated with F-18-FDG PET metabolically active tumor volume as well as with uptake heterogeneity for patients with stage III/IV tumors (|rho|:0.66 to 0.78; p-value < 0.02). Conclusion: The positive correlation found with tumor blood flow indicates that intra-tumor heterogeneity of F-18-FDG PET accumulation reflects to some extent tracer distribution and consequently indicates that F-18-FDG PET intra-tumor heterogeneity may be associated with physiological processes such as tumor vascularization.	[Tixier, Florent; Hatt, Mathieu; Visvikis, Dimitris] CHRU Morvan, UMR1101, LaTIM, INSERM, Brest, France; [Groves, Ashley M.] UCL, Inst Nucl Med, London, England; [Goh, Vicky] St Thomas Hosp, Kings Coll London, Div Imaging Sci & Biomed Engn, London, England; [Ingrand, Pierre] CHU La Miletrie, INSERM, CIC 1402, Poitiers, France; [Le Rest, Catherine Cheze] CHU La Miletrie, Dept Nucl Med, Poitiers, France	CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; CHU Poitiers; Universite de Poitiers	Tixier, F (corresponding author), CHRU Morvan, UMR1101, LaTIM, INSERM, Brest, France.	florent.tixier@univ-brest.fr	Hatt, Mathieu/M-8917-2017; Tixier, Florent/AAE-2952-2019; Visvikis, Dimitris/AAM-7868-2021; Visvikis, Dimitris/AAM-7865-2021; VISVIKIS, Dimitris/H-4277-2014; Goh, Vicky/AAG-2708-2020	Hatt, Mathieu/0000-0002-8938-8667; VISVIKIS, Dimitris/0000-0003-0831-3637; Goh, Vicky/0000-0002-2321-8091	French Ministry of Education and Research	French Ministry of Education and Research	This study was supported by a fellowship from the French Ministry of Education and Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2011, EUR J NUCL MED MOL I, V38, P987, DOI 10.1007/s00259-011-1787-z; Bellomi M, 2007, RADIOLOGY, V244, P486, DOI 10.1148/radiol.2442061189; Bisdas S, 2008, AM J NEURORADIOL, V29, P1376, DOI 10.3174/ajnr.A1111; Chowdhury FU, 2010, POSTGRAD MED J, V86, P174, DOI 10.1136/pgmj.2009.079087; Cook GJR, 2013, J NUCL MED, V54, P19, DOI 10.2967/jnumed.112.107375; de Geus-Oei LF, 2009, J NUCL MED, V50, p43S, DOI 10.2967/jnumed.108.057224; Dimitrakopoulou-Strauss A, 2003, Q J NUCL MED, V47, P8; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; Garcia-Figueiras R, 2013, AM J ROENTGENOL, V200, P8, DOI 10.2214/AJR.11.8476; Goh V, 2009, CLIN RADIOL, V64, P368, DOI 10.1016/j.crad.2008.08.018; Goh V, 2008, AM J ROENTGENOL, V191, pW288, DOI 10.2214/AJR.07.3985; Goh V, 2008, RADIOLOGY, V249, P510, DOI 10.1148/radiol.2492071365; Goh V, 2012, J NUCL MED, V53, P687, DOI 10.2967/jnumed.111.098525; Groves AM, 2011, EUR J NUCL MED MOL I, V36, P416; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hatt M, 2013, EUR J NUCL MED MOL I, V40, P1662, DOI 10.1007/s00259-013-2486-8; Hatt M, 2009, IEEE T MED IMAGING, V28, P881, DOI 10.1109/TMI.2008.2012036; Hendlisz A, 2012, ANN ONCOL, V23, P1687, DOI 10.1093/annonc/mdr554; Henson JS, 1997, AJCC CANC STAGING MA; Herbertson RA, 2009, CLIN RADIOL, V64, P225, DOI 10.1016/j.crad.2008.08.008; Hirasawa S, 2007, ACAD RADIOL, V14, P312, DOI 10.1016/j.acra.2006.12.017; Janssen MHM, 2012, INT J RADIAT ONCOL, V82, P849, DOI 10.1016/j.ijrobp.2010.10.029; Kan ZX, 2005, RADIOLOGY, V237, P151, DOI 10.1148/radiol.2363041293; Kanda T, 2012, EUR J RADIOL, V81, P2075, DOI 10.1016/j.ejrad.2011.07.003; Kunkel M, 2003, CANCER, V97, P1015, DOI 10.1002/cncr.11159; Larson Steven M., 1999, Clin Positron Imaging, V2, P159, DOI 10.1016/S1095-0397(99)00016-3; Lazanyi KS, 2010, LUNG CANCER, V70, P280, DOI 10.1016/j.lungcan.2010.03.004; Liebig C, 2009, J CLIN ONCOL, V27, P5131, DOI 10.1200/JCO.2009.22.4949; Miles KA, 2006, EUR J NUCL MED MOL I, V33, P22, DOI 10.1007/s00259-005-1932-7; Pugachev A, 2005, INT J RADIAT ONCOL, V62, P545, DOI 10.1016/j.ijrobp.2005.02.009; Rajendran JG, 2006, CLIN CANCER RES, V12, P5435, DOI 10.1158/1078-0432.CCR-05-1773; Rajpopat M, 2012, DIAGNOSTIC IMAGING E, V1, P11; Tepper JE, 2002, J CLIN ONCOL, V20, P1744, DOI 10.1200/JCO.2002.07.132; Thibault G., 2009, PROC PATTERN RECOGNI, P140; Tixier F, 2012, J NUCL MED, V53, P693, DOI 10.2967/jnumed.111.099127; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Tsushima Y, 2002, ACAD RADIOL, V9, P922, DOI 10.1016/S1076-6332(03)80462-2; van Velden FHP, 2011, EUR J NUCL MED MOL I, V38, P1636, DOI 10.1007/s00259-011-1845-6; Vikram Raghu, 2008, Cancer Imaging, V8 Spec No A, pS46, DOI 10.1102/1470-7330.2008.9009; WEIDNER N, 1995, AM J PATHOL, V147, P9; Willaime JMY, 2013, PHYS MED BIOL, V58, P187, DOI 10.1088/0031-9155/58/2/187; Win T, 2013, CLIN CANCER RES, V19, P3591, DOI 10.1158/1078-0432.CCR-12-1307	42	29	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99567	10.1371/journal.pone.0099567	http://dx.doi.org/10.1371/journal.pone.0099567			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926986	Green Submitted, gold, Green Published			2022-12-25	WOS:000338278100050
J	Michalski, R; Zielonka, J; Gapys, E; Marcinek, A; Joseph, J; Kalyanaraman, B				Michalski, Radoslaw; Zielonka, Jacek; Gapys, Ewa; Marcinek, Andrzej; Joseph, Joy; Kalyanaraman, Balaraman			Real-time Measurements of Amino Acid and Protein Hydroperoxides Using Coumarin Boronic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XYLENOL ORANGE; BIOLOGICAL-SYSTEMS; TYROSINE PEROXIDE; REACTIVE OXYGEN; SINGLET OXYGEN; SIDE-CHAIN; SUPEROXIDE; OXIDATION; PEROXYNITRITE; RADICALS	Hydroperoxides of amino acid and amino acid residues (tyrosine, cysteine, tryptophan, and histidine) in proteins are formed during oxidative modification induced by reactive oxygen species. Amino acid hydroperoxides are unstable intermediates that can further propagate oxidative damage in proteins. The existing assays (oxidation of ferrous cation and iodometric assays) cannot be used in real-time measurements. In this study, we show that the profluorescent coumarin boronic acid (CBA) probe reacts with amino acid and protein hydroperoxides to form the corresponding fluorescent product, 7-hydroxycoumarin. 7-Hydroxycoumarin formation was catalase-independent. Based on this observation, we have developed a fluorometric, real-time assay that is adapted to a multiwell plate format. This is the first report showing real-time monitoring of amino acid and protein hydroperoxides using the CBA-based assay. This approach was used to detect protein hydroperoxides in cell lysates obtained from macrophages exposed to visible light and photosensitizer (rose bengal). We also measured the rate constants for the reaction between amino acid hydroperoxides (tyrosyl, tryptophan, and histidine hydroperoxides) and CBA, and these values (7-23 M-1 s(-1)) were significantly higher than that measured for H2O2 (1.5 M-1 s(-1)). Using the CBA-based competition kinetics approach, the rate constants for amino acid hydroperoxides with ebselen, a glutathione peroxidase mimic, were also determined, and the values were within the range of 1.1-1.5 x 10(3) M-1 s(-1). Both ebselen and boronates may be used as small molecule scavengers of amino acid and protein hydroperoxides. Here we also show formation of tryptophan hydroperoxide from tryptophan exposed to co-generated fluxes of nitric oxide and superoxide. This observation reveals a new mechanism for amino acid and protein hydroperoxide formation in biological systems.	[Michalski, Radoslaw; Zielonka, Jacek; Joseph, Joy; Kalyanaraman, Balaraman] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Michalski, Radoslaw; Zielonka, Jacek; Joseph, Joy; Kalyanaraman, Balaraman] Med Coll Wisconsin, Free Rad Res Ctr, Milwaukee, WI 53226 USA; [Michalski, Radoslaw; Zielonka, Jacek; Gapys, Ewa; Marcinek, Andrzej] Lodz Univ Technol, Inst Appl Radiat Chem, PL-90924 Lodz, Poland	Medical College of Wisconsin; Medical College of Wisconsin; Lodz University of Technology	Kalyanaraman, B (corresponding author), Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	balarama@mcw.edu	Zielonka, Jacek/N-9546-2014; Michalski, Radoslaw/X-1505-2018; Marcinek, Andrzej/M-1775-2018	Zielonka, Jacek/0000-0002-2524-0145; Michalski, Radoslaw/0000-0001-5601-0839; Marcinek, Andrzej/0000-0002-9852-7593	National Institutes of Health [R01 HL073056, R01 HL063119]; Jagiellonian Centre for Experimental Therapeutics (JCET) [POIG.01.01.02-00-069/09]; European Union from the resources of the European Regional Development Fund under the Innovative Economy Programme; Foundation for Polish Science (FNP) within the "Homing Plus" program; European Union within European Regional Development Fund, through the Innovative Economy Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073056, R01HL063119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jagiellonian Centre for Experimental Therapeutics (JCET); European Union from the resources of the European Regional Development Fund under the Innovative Economy Programme; Foundation for Polish Science (FNP) within the "Homing Plus" program; European Union within European Regional Development Fund, through the Innovative Economy Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL073056 and R01 HL063119 (to B. K.). This work was also supported by a grant coordinated by Jagiellonian Centre for Experimental Therapeutics (JCET), POIG.01.01.02-00-069/09 (supported by the European Union from the resources of the European Regional Development Fund under the Innovative Economy Programme).; Supported by a grant from the Foundation for Polish Science (FNP) within the "Homing Plus" program supported by the European Union within European Regional Development Fund, through the Innovative Economy Program.	Agon VV, 2006, FREE RADICAL BIO MED, V40, P698, DOI 10.1016/j.freeradbiomed.2005.09.039; Alvarez B, 1996, CHEM RES TOXICOL, V9, P390, DOI 10.1021/tx950133b; Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; Bou R, 2008, ANAL BIOCHEM, V377, P1, DOI 10.1016/j.ab.2008.02.029; d'Alessandro N, 2000, J CHEM SOC PERK T 2, P1862, DOI 10.1039/b003346o; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; FOOTE CS, 1971, J AM CHEM SOC, V93, P3795, DOI 10.1021/ja00744a055; Fu S, 1998, BIOCHEM J, V333, P519, DOI 10.1042/bj3330519; Fu SL, 1998, J BIOL CHEM, V273, P28603, DOI 10.1074/jbc.273.44.28603; Gay C, 1999, ANAL BIOCHEM, V273, P143, DOI 10.1006/abio.1999.4207; Gay C, 1999, ANAL BIOCHEM, V273, P149, DOI 10.1006/abio.1999.4208; Gay C, 2000, ANAL BIOCHEM, V284, P217, DOI 10.1006/abio.2000.4696; Gay CA, 2003, ANAL BIOCHEM, V315, P29, DOI 10.1016/S0003-2697(02)00606-1; Gay CA, 2002, ANAL BIOCHEM, V304, P42, DOI 10.1006/abio.2001.5566; Gebicki S, 1999, BIOCHEM J, V338, P629, DOI 10.1042/0264-6021:3380629; Gebicki S, 2002, REDOX REP, V7, P235, DOI 10.1179/135100002125000541; Gieseg S, 2000, BIOCHEM J, V350, P215, DOI 10.1042/0264-6021:3500215; Golding JP, 2013, BRIT J CANCER, V109, P976, DOI 10.1038/bjc.2013.391; Gracanin M, 2009, FREE RADICAL BIO MED, V47, P92, DOI 10.1016/j.freeradbiomed.2009.04.015; Hilf R, 2007, J BIOENERG BIOMEMBR, V39, P85, DOI 10.1007/s10863-006-9064-8; Hunter GA, 2011, BBA-PROTEINS PROTEOM, V1814, P1467, DOI 10.1016/j.bbapap.2010.12.015; JIN FM, 1993, J CHEM SOC PERK T 2, P1583, DOI 10.1039/p29930001583; Kim CH, 2011, INT J NANOMED, V6, P1357, DOI 10.2147/IJN.S21395; Lippert AR, 2011, ACCOUNTS CHEM RES, V44, P793, DOI 10.1021/ar200126t; Luxford C, 1999, BIOCHEM J, V344, P125, DOI 10.1042/0264-6021:3440125; Luxford C, 2000, CHEM RES TOXICOL, V13, P665, DOI 10.1021/tx000053u; Luxford C, 2002, BIOGERONTOLOGY, V3, P95, DOI 10.1023/A:1015228001561; Moller MN, 2012, J AM CHEM SOC, V134, P16773, DOI 10.1021/ja307215z; Morgan PE, 2004, FREE RADICAL BIO MED, V36, P484, DOI 10.1016/j.freeradbiomed.2003.11.021; Morgan PE, 2008, FREE RADICAL BIO MED, V45, P1279, DOI 10.1016/j.freeradbiomed.2008.08.004; Morgan PE, 2012, FREE RADICAL BIO MED, V52, P328, DOI 10.1016/j.freeradbiomed.2011.10.448; Nagy P, 2009, J BIOL CHEM, V284, P14723, DOI 10.1074/jbc.M809396200; Nokes B, 2013, J SURG RES, V181, P262, DOI 10.1016/j.jss.2013.02.002; Pattison DI, 2012, PHOTOCH PHOTOBIO SCI, V11, P38, DOI 10.1039/c1pp05164d; Peskin AV, 2010, BIOCHEM J, V432, P313, DOI 10.1042/BJ20101156; PICHORNER H, 1995, ARCH BIOCHEM BIOPHYS, V323, P429, DOI 10.1006/abbi.1995.0064; Pietraforte D, 1997, BIOCHEM J, V321, P743, DOI 10.1042/bj3210743; Rahmanto AS, 2012, IUBMB LIFE, V64, P863, DOI 10.1002/iub.1084; Rahmanto AS, 2011, FREE RADICAL BIO MED, V51, P2288, DOI 10.1016/j.freeradbiomed.2011.09.027; Rahmanto AS, 2010, FREE RADICAL BIO MED, V49, P1505, DOI 10.1016/j.freeradbiomed.2010.08.006; Rahmanto AS, 2010, FREE RADICAL BIO MED, V48, P1071, DOI 10.1016/j.freeradbiomed.2010.01.025; ROUGEE M, 1988, PHOTOCHEM PHOTOBIOL, V47, P485, DOI 10.1111/j.1751-1097.1988.tb08835.x; Ryan K, 2012, J NEUROSCI, V32, P11250, DOI 10.1523/JNEUROSCI.0907-12.2012; SIES H, 1993, FREE RADICAL BIO MED, V14, P313, DOI 10.1016/0891-5849(93)90028-S; Sikora A, 2009, FREE RADICAL BIO MED, V47, P1401, DOI 10.1016/j.freeradbiomed.2009.08.006; Winterbourn CC, 1997, ARCH BIOCHEM BIOPHYS, V338, P15, DOI 10.1006/abbi.1996.9773; Winterbourn CC, 2004, BIOCHEM J, V381, P241, DOI 10.1042/BJ20040259; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Wright A, 2003, FREE RADICAL BIO MED, V34, P637, DOI 10.1016/S0891-5849(02)01361-8; Wright A, 2000, REDOX REP, V5, P159, DOI 10.1179/135100000101535573; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zielonka J, 2012, CHEM RES TOXICOL, V25, P1793, DOI 10.1021/tx300164j; Zielonka J, 2012, J BIOL CHEM, V287, P2984, DOI 10.1074/jbc.M111.309062; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080	55	50	51	3	57	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22536	22553		10.1074/jbc.M114.553727	http://dx.doi.org/10.1074/jbc.M114.553727			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24928516	Green Published, hybrid			2022-12-25	WOS:000340593500062
J	Mei, H; Campbell, JM; Paddock, CM; Lertkiatmongkol, P; Mosesson, MW; Albrecht, R; Newman, PJ				Mei, Heng; Campbell, Jay M.; Paddock, Cathy M.; Lertkiatmongkol, Panida; Mosesson, Michael W.; Albrecht, Ralph; Newman, Peter J.			Regulation of Endothelial Cell Barrier Function by Antibody-driven Affinity Modulation of Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-BILAYER NANODISCS; FLUID SHEAR-STRESS; TRANSENDOTHELIAL MIGRATION; INTEGRIN ACTIVATION; HEMOPHILIC BINDING; SURFACE EXPRESSION; CYTOPLASMIC DOMAIN; MEMBRANE-PROTEINS; ENDOTOXIC-SHOCK; IN-VIVO	PECAM-1 is a 130-kDa member of the immunoglobulin (Ig) superfamily that is expressed on the surface of platelets and leukocytes, and at the intracellular junctions of confluent endothelial cell monolayers. Previous studies have shown that PECAM-1/PECAM-1 homophilic interactions play a key role in leukocyte transendothelial migration, in allowing PECAM-1 to serve as a mechanosensory complex in endothelial cells, in its ability to confer cytoprotection to proapoptotic stimuli, and in maintaining endothelial cell junctional integrity. To examine the adhesive properties of full-length PECAM-1 in a native lipid environment, we purified it from platelets and assembled it into phospholipid nanodiscs. PECAM-1-containing nanodiscs retained not only their ability to bind homophilically to PECAM-1-expressing cells, but exhibited regulatable adhesive interactions that could be modulated by ligands that bind membrane-proximal Ig Domain 6. This property was exploited to enhance the rate of barrier restoration in endothelial cell monolayers subjected to inflammatory challenge. The finding that the adhesive properties of PECAM-1 are regulatable suggests novel approaches for controlling endothelial cell migration and barrier function in a variety of vascular permeability disorders.	[Mei, Heng; Paddock, Cathy M.; Lertkiatmongkol, Panida; Mosesson, Michael W.; Newman, Peter J.] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA; [Campbell, Jay M.] Univ Wisconsin, Ctr Mat Sci, Madison, WI 54701 USA; [Albrecht, Ralph] Univ Wisconsin, Dept Anim Sci, Madison, WI 54701 USA; [Albrecht, Ralph] Univ Wisconsin, Dept Pediat, Madison, WI 54701 USA; [Albrecht, Ralph] Univ Wisconsin, Dept Pharmaceut Sci, Madison, WI 54701 USA; [Lertkiatmongkol, Panida; Newman, Peter J.] Med Coll Wisconsin, Dept Pharmacol, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Medical College of Wisconsin	Newman, PJ (corresponding author), Blood Ctr Wisconsin, Blood Res Inst, 638 North 18th St, Milwaukee, WI 53201 USA.	peter.newman@bcw.edu			National Institutes of Health [HL40926]; AHA [13POST16840095]; Blood Research Institute, Blood Center of Wisconsin; Institute of Hematology, Union Hospital, Huazhong University of Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044612, R01HL040926] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Blood Research Institute, Blood Center of Wisconsin; Institute of Hematology, Union Hospital, Huazhong University of Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL40926 (to P. J. N.) and AHA Grant 13POST16840095 (to H. M.). This work is the result of an ongoing jointly-sponsored Research Partnership between the Blood Research Institute, Blood Center of Wisconsin and the Institute of Hematology, Union Hospital, Huazhong University of Science and Technology, Professor Yu Hu, M.D., Ph.D., Director.	ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059; Arevalo E, 2008, P NATL ACAD SCI USA, V105, P371, DOI 10.1073/pnas.0707815105; BALDASSARE JJ, 1985, J CLIN INVEST, V75, P35, DOI 10.1172/JCI111693; BALDWIN HS, 1994, DEVELOPMENT, V120, P2539; Bergom C, 2006, CANCER BIOL THER, V5, P1699, DOI 10.4161/cbt.5.12.3467; Bird IN, 1999, J CELL SCI, V112, P1989; Cao GY, 2002, AM J PHYSIOL-CELL PH, V282, pC1181, DOI 10.1152/ajpcell.00524.2001; Carrithers M, 2005, AM J PATHOL, V166, P185, DOI 10.1016/S0002-9440(10)62243-2; Collins C, 2012, CURR BIOL, V22, P2087, DOI 10.1016/j.cub.2012.08.051; Conway DE, 2013, CURR BIOL, V23, P1024, DOI 10.1016/j.cub.2013.04.049; DeLisser HM, 1997, AM J PATHOL, V151, P671; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Evans PC, 2001, TRANSPLANTATION, V71, P457, DOI 10.1097/00007890-200102150-00020; FAWCETT J, 1995, J CELL BIOL, V128, P1229, DOI 10.1083/jcb.128.6.1229; FERRERO E, 1995, FEBS LETT, V374, P323, DOI 10.1016/0014-5793(95)01110-Z; Fornasa G, 2012, CARDIOVASC RES, V94, P30, DOI 10.1093/cvr/cvs076; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; Gao CJ, 2001, BLOOD, V98, p796A; GOLDBERGER A, 1994, TISSUE ANTIGENS, V44, P285, DOI 10.1111/j.1399-0039.1994.tb02397.x; GOLDBERGER A, 1994, J BIOL CHEM, V269, P17183; Graesser D, 2002, J CLIN INVEST, V109, P383, DOI 10.1172/JCI13595; Hornemann S, 2009, J BIOL CHEM, V284, P22713, DOI 10.1074/jbc.M109.000430; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Kuckleburg CJ, 2012, J IMMUNOL, V188, P2419, DOI 10.4049/jimmunol.1102540; LIAO F, 1995, J EXP MED, V182, P1337, DOI 10.1084/jem.182.5.1337; Maas M, 2005, AM J PHYSIOL-HEART C, V288, pH159, DOI 10.1152/ajpheart.00500.2004; MOSESSON MW, 1995, J STRUCT BIOL, V115, P88, DOI 10.1006/jsbi.1995.1033; MULLER WA, 1992, J EXP MED, V175, P1401, DOI 10.1084/jem.175.5.1401; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; MULLER WA, 1989, J EXP MED, V170, P399, DOI 10.1084/jem.170.2.399; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Newman DK, 2002, BIOCHEM BIOPH RES CO, V296, P1171, DOI 10.1016/S0006-291X(02)02060-0; Newman PJ, 1999, J CLIN INVEST, V103, P5, DOI 10.1172/JCI5928; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Newton JP, 1997, J BIOL CHEM, V272, P20555, DOI 10.1074/jbc.272.33.20555; Newton-Nash DK, 1999, J IMMUNOL, V163, P682; Osawa M, 2002, J CELL BIOL, V158, P773, DOI 10.1083/jcb.200205049; Paddock C, 2011, BLOOD, V117, P6012, DOI 10.1182/blood-2010-11-317867; Patil S, 2001, BLOOD, V97, P1727, DOI 10.1182/blood.V97.6.1727; Privratsky JR, 2011, J CELL SCI, V124, P1477, DOI 10.1242/jcs.082271; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Sachs UJH, 2007, J BIOL CHEM, V282, P23603, DOI 10.1074/jbc.M701120200; Sheibani N, 1997, MOL BIOL CELL, V8, P1329, DOI 10.1091/mbc.8.7.1329; Stroncek D, 2002, VOX SANG, V83, P359, DOI 10.1111/j.1423-0410.2002.tb05334.x; Sun J, 2000, J CELL SCI, V113, P1459; Sun J, 1996, J BIOL CHEM, V271, P18561, DOI 10.1074/jbc.271.31.18561; Sun QH, 1996, J BIOL CHEM, V271, P11090, DOI 10.1074/jbc.271.19.11090; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; VAPORCIYAN AA, 1993, SCIENCE, V262, P1580, DOI 10.1126/science.8248808; Varon D, 1998, BLOOD, V91, P500, DOI 10.1182/blood.V91.2.500.500_500_507; von Vietinghoff S, 2007, BLOOD, V109, P4487, DOI 10.1182/blood-2006-10-055327; Wakelin MW, 1996, J EXP MED, V184, P229, DOI 10.1084/jem.184.1.229; YAN HC, 1995, CELL ADHES COMMUN, V3, P45, DOI 10.3109/15419069509081277; Yan R, 2011, BIOCHEMISTRY-US, V50, P10598, DOI 10.1021/bi201351d; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; ZEHNDER JL, 1992, J BIOL CHEM, V267, P5243; ZEHNDER JL, 1995, BLOOD, V85, P1282, DOI 10.1182/blood.V85.5.1282.bloodjournal8551282; Zhao TM, 2001, J CELL BIOL, V152, P65, DOI 10.1083/jcb.152.1.65; Zhou Z, 1999, Angiogenesis, V3, P181, DOI 10.1023/A:1009092107382	59	24	26	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20836	20844		10.1074/jbc.M114.557454	http://dx.doi.org/10.1074/jbc.M114.557454			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24936065	Green Published, hybrid			2022-12-25	WOS:000339396600038
J	Alam-Faruque, Y; Hill, DP; Dimmer, EC; Harris, MA; Foulger, RE; Tweedie, S; Attrill, H; Howe, DG; Thomas, SR; Davidson, D; Woolf, AS; Blake, JA; Mungall, CJ; O'Donovan, C; Apweiler, R; Huntley, RP				Alam-Faruque, Yasmin; Hill, David P.; Dimmer, Emily C.; Harris, Midori A.; Foulger, Rebecca E.; Tweedie, Susan; Attrill, Helen; Howe, Douglas G.; Thomas, Stephen Randall; Davidson, Duncan; Woolf, Adrian S.; Blake, Judith A.; Mungall, Christopher J.; O'Donovan, Claire; Apweiler, Rolf; Huntley, Rachael P.			Representing Kidney Development Using the Gene Ontology	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; TRANSCRIPTION FACTOR; EXPRESSION; APOPTOSIS; DATABASE; PAX2; DIFFERENTIATION; TOOL	Gene Ontology (GO) provides dynamic controlled vocabularies to aid in the description of the functional biological attributes and subcellular locations of gene products from all taxonomic groups (www.geneontology.org). Here we describe collaboration between the renal biomedical research community and the GO Consortium to improve the quality and quantity of GO terms describing renal development. In the associated annotation activity, the new and revised terms were associated with gene products involved in renal development and function. This project resulted in a total of 522 GO terms being added to the ontology and the creation of approximately 9,600 kidney-related GO term associations to 940 UniProt Knowledgebase (UniProtKB) entries, covering 66 taxonomic groups. We demonstrate the impact of these improvements on the interpretation of GO term analyses performed on genes differentially expressed in kidney glomeruli affected by diabetic nephropathy. In summary, we have produced a resource that can be utilized in the interpretation of data from small- and large-scale experiments investigating molecular mechanisms of kidney function and development and thereby help towards alleviating renal disease.	[Alam-Faruque, Yasmin; Dimmer, Emily C.; Foulger, Rebecca E.; O'Donovan, Claire; Apweiler, Rolf; Huntley, Rachael P.] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Cambridge, England; [Hill, David P.; Blake, Judith A.] Jackson Lab, Bar Harbor, ME 04609 USA; [Harris, Midori A.] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England; [Harris, Midori A.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Tweedie, Susan; Attrill, Helen] Univ Cambridge, Dept Genet, FlyBase, Cambridge CB2 3EH, England; [Howe, Douglas G.] Univ Oregon, Zebrafish Model Organism Database ZFIN, Eugene, OR 97403 USA; [Thomas, Stephen Randall] Univ Paris 11, CNRS, IR4M UMR8081, F-91405 Orsay, France; [Davidson, Duncan] Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Woolf, Adrian S.] Univ Manchester, Fac Med & Human Sci, Inst Human Dev, Manchester, Lancs, England; [Mungall, Christopher J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA	European Molecular Biology Laboratory (EMBL); Jackson Laboratory; University of Cambridge; University of Cambridge; University of Cambridge; University of Oregon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Saclay; University of Edinburgh; University of Manchester; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Alam-Faruque, Y (corresponding author), European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Cambridge, England.	yasmin.alamfaruque@gmail.com	Mungall, Chris/I-6006-2019; Woolf, Adrian S./AAZ-1075-2020; Huntley, Rachael/J-4951-2019; Huntley, Rachael/R-1036-2016; Tweedie, Susan/B-3695-2019	Mungall, Chris/0000-0002-6601-2165; Woolf, Adrian S./0000-0001-5541-1358; Huntley, Rachael/0000-0001-6718-3559; Huntley, Rachael/0000-0001-6718-3559; Tweedie, Susan/0000-0003-1818-8243; Harris, Midori/0000-0003-4148-4606; Attrill, Helen/0000-0003-3212-6364; Blake, Judith/0000-0001-8522-334X; Apweiler, Rolf/0000-0001-7078-200X; Foulger, Rebecca/0000-0001-8682-8754; O'Donovan, Claire/0000-0001-8051-7429	Kidney Research UK (KRUK) [RP26/2008]; National Institutes of Health (NIH) - National Human Genome Research Institute (NIHGR) [R01HG02273]; European Molecular Biology Laboratory (EMBL); British Heart Foundation (BHF) [RG/13/5/30112]; NIH-NHGRI grant [U41HG002273, U41HG00330, HG000739, U41HG002659]; Medical Research Council (MRC) [G1000968, MR/L2744/1]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; VPH NoE [EU FP7] [23920]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG000739, U41HG000330, P41HG002659, R01HG002273, U41HG002273, U41HG002659] Funding Source: NIH RePORTER; MRC [G1000968] Funding Source: UKRI; British Heart Foundation [RG/13/5/30112] Funding Source: researchfish; Medical Research Council [G1000968] Funding Source: researchfish	Kidney Research UK (KRUK)(Kidney Research UK (KRUK)); National Institutes of Health (NIH) - National Human Genome Research Institute (NIHGR); European Molecular Biology Laboratory (EMBL); British Heart Foundation (BHF)(British Heart Foundation); NIH-NHGRI grant; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); VPH NoE [EU FP7]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	YA-F was supported by Kidney Research UK (KRUK; http://www.kidneyresearchuk.org) grant [RP26/2008]. The UniProt-GO Annotation Project is supported by the National Institutes of Health (NIH; www.nih.gov/) - National Human Genome Research Institute (NIHGR; www.genome.gov) grant [R01HG02273], the European Molecular Biology Laboratory (EMBL; www.embl.de) core funding and the British Heart Foundation (BHF; www.bhf.org.uk) grant [RG/13/5/30112]. The GO Consortium is supported by NIH-NHGRI grant [U41HG002273]. The Mouse Genome Informatics group is supported by NIH-NHGRI grant [U41HG00330]. FlyBase is supported by NIH-NHGRI grant [HG000739]. ST is supported by Medical Research Council (MRC; http://www.mrc.ac.uk) grant [G1000968]. DGH is supported by the NIH-NHGRI grant [U41HG002659]. ASW is supported by MRC grant [MR/L2744/1]. CJM was supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. SRT was supported by VPH NoE [EU FP7, Grant 23920]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRASS CK, 1995, WESTERN J MED, V162, P318; Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Alam-Faruque Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027541; Alam-Faruque Y, 2010, ORGANOGENESIS, V6, P71, DOI 10.4161/org.6.2.11294; Alarcon P, 2008, DEVELOPMENT, V135, P3197, DOI 10.1242/dev.023697; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Baelde HJ, 2004, AM J KIDNEY DIS, V43, P636, DOI 10.1053/j.ajkd.2003.12.028; Balakrishnan R, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat054; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Baylis C, 2008, AM J PHYSIOL-RENAL, V294, pF1, DOI 10.1152/ajprenal.00424.2007; Blake JA, 2014, NUCLEIC ACIDS RES, V42, pD810, DOI 10.1093/nar/gkt1225; Brunskill EW, 2008, DEV CELL, V15, P781, DOI 10.1016/j.devcel.2008.09.007; Carroll TJ, 1999, DEV BIOL, V214, P46, DOI 10.1006/dbio.1999.9414; Dessapt-Baradez C, 2014, J AM SOC NEPHROL, V25, P33, DOI 10.1681/ASN.2012121218; Dihazi H, 2005, MOL CELL PROTEOMICS, V4, P1445, DOI 10.1074/mcp.M400184-MCP200; Dimmer Emily, 2007, V406, P495; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Dow JAT, 2010, AM J PHYSIOL-RENAL, V299, pF1237, DOI 10.1152/ajprenal.00521.2010; Dziarmaga A, 2006, J AM SOC NEPHROL, V17, P1568, DOI 10.1681/ASN.2005101074; Feltrin E, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-6; Fierlbeck W, 2003, J AM SOC NEPHROL, V14, P1349, DOI 10.1097/01.ASN.0000061779.70530.06; Harding SD, 2011, DEVELOPMENT, V138, P2845, DOI 10.1242/dev.063594; Hills CE, 2011, CYTOKINE GROWTH F R, V22, P131, DOI 10.1016/j.cytogfr.2011.06.002; Hirschman J, 2010, MOL GENET GENOMICS, V283, P415, DOI 10.1007/s00438-010-0525-8; Howe DG, 2013, NUCLEIC ACIDS RES, V41, pD854, DOI 10.1093/nar/gks938; James RG, 2006, DEVELOPMENT, V133, P2995, DOI 10.1242/dev.02442; Janech MG, 2007, AM J PHYSIOL-RENAL, V292, pF501, DOI 10.1152/ajprenal.00298.2006; Khodiyar VK, 2011, DEV BIOL, V354, P9, DOI 10.1016/j.ydbio.2011.03.011; KRIZ W, 1988, KIDNEY INT, V33, P1; Kumar D, 2004, MOL CELL BIOCHEM, V259, P67, DOI 10.1023/B:MCBI.0000021346.03260.7e; Lan Y, 2004, DEVELOPMENT, V131, P3207, DOI 10.1242/dev.01175; Little MH, 2007, GENE EXPR PATTERNS, V7, P680, DOI 10.1016/j.modgep.2007.03.002; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Meehan TF, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-6; Mungall CJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r5; Mungall CJ, 2011, J BIOMED INFORM, V44, P80, DOI 10.1016/j.jbi.2010.02.002; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Narlis M, 2007, J AM SOC NEPHROL, V18, P1121, DOI 10.1681/ASN.2006070739; Nowik M, 2008, PHYSIOL GENOMICS, V32, P322, DOI 10.1152/physiolgenomics.00160.2007; Raciti D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r84; Reggiani L, 2007, GENE DEV, V21, P2358, DOI 10.1101/gad.450707; Salomon R, 2001, KIDNEY INT, V59, P457, DOI 10.1046/j.1523-1755.2001.059002457.x; Siu KWM, 2009, J PROTEOME RES, V8, P3797, DOI 10.1021/pr800389e; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Tang SCW, 2006, J AM SOC NEPHROL, V17, P1633, DOI 10.1681/ASN.2005101113; Tena JJ, 2007, DEV BIOL, V301, P518, DOI 10.1016/j.ydbio.2006.08.063; Tilton RG, 2007, PROTEOMICS, V7, P1729, DOI 10.1002/pmic.200700017; Verzola D, 2007, KIDNEY INT, V72, P1262, DOI 10.1038/sj.ki.5002531; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015; Welsh GI, 2010, CURR OPIN NEPHROL HY, V19, P379, DOI 10.1097/MNH.0b013e32833ad5e4; Wu GZ, 2004, EUR J BIOCHEM, V271, P3715, DOI 10.1111/j.1432-1033.2004.04312.x; Yasuda Yoshinari, 2006, Clin Exp Nephrol, V10, P91, DOI 10.1007/s10157-006-0421-z; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366	55	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99864	10.1371/journal.pone.0099864	http://dx.doi.org/10.1371/journal.pone.0099864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941002	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200047
J	Kerckhof, FM; Courtens, ENP; Geirnaert, A; Hoefman, S; Ho, A; Vilchez-Vargas, R; Pieper, DH; Jauregui, R; Vlaeminck, SE; Van de Wiele, T; Vandamme, P; Heylen, K; Boon, N				Kerckhof, Frederiek-Maarten; Courtens, Emilie N. P.; Geirnaert, Annelies; Hoefman, Sven; Ho, Adrian; Vilchez-Vargas, Ramiro; Pieper, Dietmar H.; Jauregui, Ruy; Vlaeminck, Siegfried E.; Van de Wiele, Tom; Vandamme, Peter; Heylen, Kim; Boon, Nico			Optimized Cryopreservation of Mixed Microbial Communities for Conserved Functionality and Diversity	PLOS ONE			English	Article							HETEROTROPHIC GROUNDWATER COMMUNITY; ROTATING BIOLOGICAL CONTACTOR; LONG-TERM STORAGE; OXIDIZING BACTERIA; METHANOTROPHIC COMMUNITIES; FECAL MICROBIOTA; METHANE; IMPACT; RNA; PRESERVATION	The use of mixed microbial communities (microbiomes) for biotechnological applications has steadily increased over the past decades. However, these microbiomes are not readily available from public culture collections, hampering their potential for widespread use. The main reason for this lack of availability is the lack of an effective cryopreservation protocol. Due to this critical need, we evaluated the functionality as well as the community structure of three different types of microbiomes before and after cryopreservation with two cryoprotective agents (CPA). Microbiomes were selected based upon relevance towards applications: (1) a methanotrophic co-culture (MOB), with potential for mitigation of greenhouse gas emissions, environmental pollutants removal and bioplastics production; (2) an oxygen limited autotrophic nitrification/denitrification (OLAND) biofilm, with enhanced economic and ecological benefits for wastewater treatment, and (3) fecal material from a human donor, with potential applications for fecal transplants and pre/probiotics research. After three months of cryopreservation at -80 degrees C, we found that metabolic activity, in terms of the specific activity recovery of MOB, aerobic ammonium oxidizing bacteria (AerAOB) and anaerobic AOB (AnAOB, anammox) in the OLAND mixed culture, resumes sooner when one of our selected CPA [dimethyl sulfoxide (DMSO) and DMSO plus trehalose and tryptic soy broth (DMSO+TT)] was added. However, the activity of the fecal community was not influenced by the CPA addition, although the preservation of the community structure (as determined by 16S rRNA gene sequencing) was enhanced by addition of CPA. In summary, we have evaluated a cryopreservation protocol that succeeded in preserving both community structure and functionality of value-added microbiomes. This will allow individual laboratories and culture collections to boost the use of microbiomes in biotechnological applications.	[Kerckhof, Frederiek-Maarten; Courtens, Emilie N. P.; Geirnaert, Annelies; Ho, Adrian; Vilchez-Vargas, Ramiro; Vlaeminck, Siegfried E.; Van de Wiele, Tom; Boon, Nico] Univ Ghent, Fac Biosci Engn, Lab Microbial Ecol & Technol, B-9000 Ghent, Belgium; [Hoefman, Sven; Vandamme, Peter; Heylen, Kim] Univ Ghent, Fac Sci, Microbiol Lab, B-9000 Ghent, Belgium; [Pieper, Dietmar H.; Jauregui, Ruy] Helmholtz Ctr Infect Res, Microbial Interact & Proc Res Grp, Dept Med Microbiol, Braunschweig, Germany	Ghent University; Ghent University; Helmholtz Association; Helmholtz-Center for Infection Research	Boon, N (corresponding author), Univ Ghent, Fac Biosci Engn, Lab Microbial Ecol & Technol, B-9000 Ghent, Belgium.	nico.boon@ugent.be	Ho, Adrian/J-3586-2013; Van de Wiele, Tom/C-8638-2011; Vandamme, Peter AR/B-7967-2009; Kerckhof, Frederiek-Maarten/E-5059-2011; Vlaeminck, Siegfried E./B-4203-2014; Ho, Adrian/AAT-3848-2021; Boon, Nico/B-4083-2011; Vandamme, Peter/ABG-3431-2021; Heylen, Kim/G-4085-2011; Geirnaert, Annelies/E-3857-2019	Van de Wiele, Tom/0000-0001-6854-5689; Vandamme, Peter AR/0000-0002-5581-7937; Kerckhof, Frederiek-Maarten/0000-0002-4472-6810; Vlaeminck, Siegfried E./0000-0002-2596-8857; Boon, Nico/0000-0002-7734-3103; Vandamme, Peter/0000-0002-5581-7937; Geirnaert, Annelies/0000-0002-3390-6701; Jauregui, Ruy/0000-0002-3484-8937; Ho Kah Wye, Adrian/0000-0003-1082-2078; Vilchez-Vargas, Ramiro/0000-0001-6535-8212	Geconcerteerde Onderzoeksactie (GOA) of Ghent University [BOF09/GOA/005]; Research Foundation Flanders (FWO-Vlaanderen); "Strategisch Basisonderzoek - SBO" of the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT-Vlaanderen) [100016]	Geconcerteerde Onderzoeksactie (GOA) of Ghent University; Research Foundation Flanders (FWO-Vlaanderen)(FWO); "Strategisch Basisonderzoek - SBO" of the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	FMK, AH and NB were supported by research grants from the Geconcerteerde Onderzoeksactie (GOA) of Ghent University (BOF09/GOA/005). ENPC was supported as doctoral candidate (Aspirant) and SEV and KH as a postdoctoral fellow from the Research Foundation Flanders (FWO-Vlaanderen). AG was supported by a research grant of the "Strategisch Basisonderzoek - SBO" of the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT-Vlaanderen, project nr. 100016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agler MT, 2011, TRENDS BIOTECHNOL, V29, P70, DOI 10.1016/j.tibtech.2010.11.006; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Bodrossy L, 2003, ENVIRON MICROBIOL, V5, P566, DOI 10.1046/j.1462-2920.2003.00450.x; Bohorquez LC, 2012, MICROB ECOL, V63, P103, DOI 10.1007/s00248-011-9943-3; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Camarinha-Silva A, 2014, ENVIRON MICROBIOL, V16, P2939, DOI 10.1111/1462-2920.12362; Cayrou C, 2013, APMIS, V121, P1082, DOI 10.1111/apm.12087; Chiellini C, 2013, CURR MICROBIOL, V67, P77, DOI 10.1007/s00284-013-0333-6; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; De Clippeleir H, 2012, ENVIRON SCI TECHNOL, V46, P8826, DOI 10.1021/es301717b; De Weirdt R, 2010, FEMS MICROBIOL ECOL, V74, P601, DOI 10.1111/j.1574-6941.2010.00974.x; Dejonghe W, 2001, ENVIRON MICROBIOL, V3, P649, DOI 10.1046/j.1462-2920.2001.00236.x; Egli K, 2003, MICROB ECOL, V45, P419, DOI 10.1007/s00248-002-2037-5; Eller G, 2005, FEMS MICROBIOL ECOL, V51, P279, DOI 10.1016/j.femsec.2004.09.007; Emerson D, 2009, NAT REV MICROBIOL, V7, P758, DOI 10.1038/nrmicro2246; Fuller BJ, 2004, CRYOLETTERS, V25, P375; Greenberg A.E., 1984, P AWWA WAT QUAL TECH, P11; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Hamilton MJ, 2012, AM J GASTROENTEROL, V107, P761, DOI 10.1038/ajg.2011.482; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Helm J, 2006, J APPL MICROBIOL, V101, P387, DOI 10.1111/j.1365-2672.2006.02960.x; Heylen K, 2012, APPL MICROBIOL BIOT, V94, P565, DOI 10.1007/s00253-011-3797-y; Heylen K, 2012, APPL ENVIRON MICROB, V78, P3010, DOI 10.1128/AEM.07501-11; Ho A, ISME J IN PRESS; Ho A, 2013, ENV MICROBIOL REP, V5, P335, DOI 10.1111/j.1758-2229.2012.00370.x; Ho A, 2013, APPL ENVIRON MICROB, V79, P2841, DOI 10.1128/AEM.03426-12; Ho A, 2011, ISME J, V5, P750, DOI 10.1038/ismej.2010.163; Hoefman S, 2013, RES MICROBIOL, V164, P288, DOI 10.1016/j.resmic.2013.01.007; Hoefman S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034196; Hollister EB, 2010, APPL MICROBIOL BIOT, V88, P389, DOI 10.1007/s00253-010-2789-7; Hrsak D, 1998, J APPL MICROBIOL, V85, P448, DOI 10.1046/j.1365-2672.1998.853505.x; Hrsak D, 2000, APPL ENVIRON MICROB, V66, P4433; Hubalek Z, 2003, CRYOBIOLOGY, V46, P205, DOI 10.1016/s0011-2240(03)00046-4; Iguchi H, 2011, APPL ENVIRON MICROB, V77, P8509, DOI 10.1128/AEM.05834-11; Jiang H, 2010, BIOCHEM ENG J, V49, P277, DOI 10.1016/j.bej.2010.01.003; Kleerebezem R, 2007, CURR OPIN BIOTECH, V18, P207, DOI 10.1016/j.copbio.2007.05.001; Konietschke F, 2009, SIMULTANE KONFIDEZIN; Konietschke F, 2012, ELECTRON J STAT, V6, P738, DOI 10.1214/12-EJS691; Krause S, 2012, ENV MICROBIOL REP, V4, P203, DOI 10.1111/j.1758-2229.2011.00322.x; Kuai LP, 1998, APPL ENVIRON MICROB, V64, P4500; Laurin V, 2006, WATER RES, V40, P1836, DOI 10.1016/j.watres.2006.03.002; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Marshall CW, 2013, CURR OPIN BIOTECH, V24, P391, DOI 10.1016/j.copbio.2013.03.016; Murase J, 2007, ENVIRON MICROBIOL, V9, P3025, DOI 10.1111/j.1462-2920.2007.01414.x; Ott M, 2010, 2007 ACM/IEEE SC07 CONFERENCE, P466; Pieja AJ, 2012, BIORESOURCE TECHNOL, V107, P385, DOI 10.1016/j.biortech.2011.12.044; Possemiers S, 2009, CURR PHARM DESIGN, V15, P2051, DOI 10.2174/138161209788489159; Prakash O, 2013, FEMS MICROBIOL LETT, V339, P1, DOI 10.1111/1574-6968.12034; Pynaert K, 2003, APPL ENVIRON MICROB, V69, P3626, DOI 10.1128/AEM.69.6.3626-3635.2003; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Read S, 2011, APPL MICROBIOL BIOT, V90, P861, DOI 10.1007/s00253-011-3223-5; Rechner AR, 2004, FREE RADICAL BIO MED, V36, P212, DOI 10.1016/j.freeradbiomed.2003.09.022; Rothrock MJ, 2011, APPL MICROBIOL BIOT, V92, P147, DOI 10.1007/s00253-011-3316-1; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smith D, 2008, CRYOLETTERS, V29, P63; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stock M, 2013, RES MICROBIOL, V164, P1045, DOI 10.1016/j.resmic.2013.08.006; Su Y, 2014, APPL MICROBIOL BIOT, V98, P3121, DOI 10.1007/s00253-013-5297-8; Van den Abbeele P, 2013, MICROB BIOTECHNOL, V6, P335, DOI 10.1111/1751-7915.12049; Van den Abbeele P, 2012, MICROB BIOTECHNOL, V5, P106, DOI 10.1111/j.1751-7915.2011.00308.x; van der Ha D, 2013, ANTON LEEUW INT J G, V103, P527, DOI 10.1007/s10482-012-9835-7; van der Ha D, 2011, WATER RES, V45, P2845, DOI 10.1016/j.watres.2011.03.005; van der Ha D, 2010, APPL MICROBIOL BIOT, V87, P2355, DOI 10.1007/s00253-010-2702-4; Vekeman B, 2013, SYST APPL MICROBIOL, V36, P579, DOI 10.1016/j.syapm.2013.07.002; Vlaeminck SE, 2012, MICROB BIOTECHNOL, V5, P433, DOI 10.1111/j.1751-7915.2012.00341.x; Vlaeminck SE, 2007, APPL MICROBIOL BIOT, V74, P1376, DOI 10.1007/s00253-006-0770-2; Vlaeminck SE, 2010, APPL ENVIRON MICROB, V76, P900, DOI 10.1128/AEM.02337-09; Vogelsang C, 1999, WATER RES, V33, P164, DOI 10.1016/S0043-1354(98)00200-0; Waite DW, 2013, ZOO BIOL, V32, P620, DOI 10.1002/zoo.21098; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; WHITTENB.R, 1970, J GEN MICROBIOL, V61, P205, DOI 10.1099/00221287-61-2-205; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840	74	50	53	4	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99517	10.1371/journal.pone.0099517	http://dx.doi.org/10.1371/journal.pone.0099517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937032	Green Published, gold			2022-12-25	WOS:000338503400021
J	Silva, ART; Santos, ACF; Farfel, JM; Grinberg, LT; Ferretti, REL; Campos, AHJFM; Cunha, IW; Begnami, MD; Rocha, RM; Carraro, DM; Pereira, CAD; Jacob, W; Brentani, H				Silva, Aderbal R. T.; Feio Santos, Ana Cecilia; Farfel, Jose M.; Grinberg, Lea T.; Ferretti, Renata E. L.; Froes Marques Campos, Antonio Hugo Jose; Cunha, Isabela Werneck; Begnami, Maria Dirlei; Rocha, Rafael M.; Carraro, Dirce M.; de Braganca Pereira, Carlos Alberto; Jacob-Filho, Wilson; Brentani, Helena			Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; AMYLOID BETA-PEPTIDE; HUMAN BRAIN; MITOCHONDRIAL-DNA; INFORMANT QUESTIONNAIRE; NUCLEAR-LOCALIZATION; ALTERED DISTRIBUTION; ENTORHINAL CORTEX; TUMOR SUPPRESSION; POSTMORTEM DELAY	Alzheimer's disease (AD) is characterized by progressive cognitive decline associated with a featured neuropathology (neuritic plaques and neurofibrillary tangles). Several studies have implicated oxidative damage to DNA, DNA repair, and altered cell-cycle regulation in addition to cell death in AD post-mitotic neurons. However, there is a lack of studies that systematically assess those biological processes in patients with AD neuropathology but with no evidence of cognitive impairment. We evaluated markers of oxidative DNA damage (8-OHdG, H2AX), DNA repair (p53, BRCA1, PTEN), and cell-cycle (Cdk1, Cdk4, Cdk5, Cyclin B1, Cyclin D1, p(27Kip1), phospho-Rb and E2F1) through immunohistochemistry and cell death through TUNEL in autopsy hippocampal tissue samples arrayed in a tissue microarray (TMA) composed of three groups: I) "clinical-pathological AD" (CP-AD) - subjects with neuropathological AD (Braak >= IV and CERAD = B or C) and clinical dementia (CDR >= 2, IQCODE >= 3.8); II) "pathological AD" (P-AD) - subjects with neuropathological AD (Braak >= IV and CERAD = B or C) and without cognitive impairment (CDR 0, IQCODE < 3.2); and III) "normal aging" (N) - subjects without neuropathological AD (Braak <= II and CERAD 0 or A) and with normal cognitive function (CDR 0, IQCODE<3.2). Our results show that high levels of oxidative DNA damage are present in all groups. However, significant reductions in DNA repair and cell-cycle inhibition markers and increases in cell-cycle progression and cell death markers in subjects with CP-AD were detected when compared to both P-AD and N groups, whereas there were no significant differences in the studied markers between P-AD individuals and N subjects. This study indicates that, even in the setting of pathological AD, healthy cognition may be associated with a preserved repair to DNA damage, cell-cycle regulation, and cell death in post-mitotic neurons.	[Silva, Aderbal R. T.; Feio Santos, Ana Cecilia; Brentani, Helena] Univ Sao Paulo, Sch Med, Dept & Inst Psychiat, Lab Clin Pathol,Lab Med Invest 23, Sao Paulo, Brazil; [Farfel, Jose M.; Grinberg, Lea T.; Ferretti, Renata E. L.; Jacob-Filho, Wilson] Univ Sao Paulo, Sch Med, LIM 22, Brazilian Brain Bank,Aging Brain Study Grp, Sao Paulo, Brazil; [Farfel, Jose M.; Ferretti, Renata E. L.; Jacob-Filho, Wilson] Univ Sao Paulo, Sch Med, Div Geriatr, Sao Paulo, Brazil; [Grinberg, Lea T.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA; [Froes Marques Campos, Antonio Hugo Jose; Cunha, Isabela Werneck; Begnami, Maria Dirlei] AC Camargo Canc Ctr, Dept Pathol, Sao Paulo, Brazil; [Rocha, Rafael M.; Carraro, Dirce M.] AC Camargo Canc Ctr, Res Ctr CIPE, Sao Paulo, Brazil; [de Braganca Pereira, Carlos Alberto] Univ Sao Paulo, Math & Stat Inst, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of California System; University of California San Francisco; A.C.Camargo Cancer Center; A.C.Camargo Cancer Center; Universidade de Sao Paulo	Brentani, H (corresponding author), Univ Sao Paulo, Sch Med, Dept & Inst Psychiat, Lab Clin Pathol,Lab Med Invest 23, Sao Paulo, Brazil.	helena.brentani@gmail.com	de Lucena Ferretti-Rebustini, Renata Eloah/ABF-5144-2020; Jacob-Filho, Wilson WJF/H-5837-2012; Begnami, Maria/D-9663-2012; Cunha, Isabela/H-3013-2012; Farfel, Jose/C-8936-2012; Faria, Carolina Pereira de Morais/HHT-0142-2022; de Lucena Ferretti-Rebustini, Renata Eloah/C-8126-2012; carraro, dirce/C-9179-2009; Campos, Antonio Hugo/AAB-9287-2019; Brentani, Helena/G-6839-2011; Pereira, Carlos Alberto de Braganca/O-5022-2015; Ruy T. Silva, Aderbal/K-6503-2012	de Lucena Ferretti-Rebustini, Renata Eloah/0000-0002-6159-5787; Begnami, Maria/0000-0003-0848-7813; Cunha, Isabela/0000-0002-2029-5139; Farfel, Jose/0000-0003-2057-3669; de Lucena Ferretti-Rebustini, Renata Eloah/0000-0002-6159-5787; carraro, dirce/0000-0001-5667-1418; Campos, Antonio Hugo/0000-0001-5322-7549; Brentani, Helena/0000-0001-5192-4682; Pereira, Carlos Alberto de Braganca/0000-0001-6315-7484; grinberg, lea/0000-0002-6809-0618; Ruy T. Silva, Aderbal/0000-0003-1158-5617	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/01652-6, 2009/02030-9, 2009/01527-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research is supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - www.fapesp.br) grants 2011/01652-6, 2009/02030-9, 2009/01527-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KW, 2008, J NEUROSCI RES, V86, P2476, DOI 10.1002/jnr.21690; Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Anderson AJ, 1996, J NEUROSCI, V16, P1710, DOI 10.1523/jneurosci.16-05-01710.1996; Appert-Collin A, 2006, LIFE SCI, V79, P484, DOI 10.1016/j.lfs.2006.01.032; Arnold SE, 2013, NEUROBIOL AGING, V34, P157, DOI 10.1016/j.neurobiolaging.2012.03.004; Barreto PD, 2013, AM J ALZHEIMERS DIS, V28, P304, DOI 10.1177/1533317513488926; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Bennett DA, 2006, NEUROEPIDEMIOLOGY, V27, P169, DOI 10.1159/000096129; Bennett S, 2009, J ALZHEIMERS DIS, V17, P245, DOI 10.3233/JAD-2009-1041; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Bucholtz N, 2013, DNA REPAIR AMST; Busser J, 1998, J NEUROSCI, V18, P2801; Chang CJ, 2008, MOL CELL BIOL, V28, P3281, DOI 10.1128/MCB.00310-08; Cotman CW, 1996, BRAIN PATHOL, V6, P493, DOI 10.1111/j.1750-3639.1996.tb00878.x; Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.00220.x; DRAGUNOW M, 1995, NEUROREPORT, V6, P1053, DOI 10.1097/00001756-199505090-00026; Evans Teresa A, 2007, Int J Med Sci, V4, P140; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fagan AM, 2009, ANN NEUROL, V65, P176, DOI 10.1002/ana.21559; Ferretti Renata Eloah de Lucena, 2010, Dement. neuropsychol., V4, P138, DOI 10.1590/S1980-57642010DN40200011; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fuller GN, 1997, HISTOLOGY PATHOLOGIS, P1200; Gabbita SP, 1998, J NEUROCHEM, V71, P2034, DOI 10.1046/j.1471-4159.1998.71052034.x; GALASKO D, 1994, ARCH NEUROL-CHICAGO, V51, P888, DOI 10.1001/archneur.1994.00540210060013; Gao C, 2012, REV NEUROSCIENCE, V23, P1, DOI [10.1515/RNS.2011.061, 10.1515/rns.2011.061]; GEARING M, 1995, NEUROLOGY, V45, P461, DOI 10.1212/WNL.45.3.461; Giovanni A, 2000, J BIOL CHEM, V275, P11553, DOI 10.1074/jbc.275.16.11553; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; Grinberg Lea Tenenholz, 2007, Cell and Tissue Banking, V8, P151, DOI 10.1007/s10561-006-9022-z; Hernandez-Ortega K, 2007, J NEUROSCI RES, V85, P1744, DOI 10.1002/jnr.21301; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hoerndli FJ, 2007, EUR J NEUROSCI, V26, P60, DOI 10.1111/j.1460-9568.2007.05618.x; Iacono D, 2009, NEUROLOGY, V73, P665, DOI 10.1212/WNL.0b013e3181b01077; Isella V, 2006, J NEUROL NEUROSUR PS, V77, P166, DOI 10.1136/jnnp.2005.069765; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Jordan-Sciutto KL, 2002, J NEUROPATH EXP NEUR, V61, P358, DOI 10.1093/jnen/61.4.358; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Jorm AF, 1997, ALZ DIS ASSOC DIS, V11, P158, DOI 10.1097/00002093-199709000-00008; Katsel P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068361; Kitamura Y, 1997, BIOCHEM BIOPH RES CO, V232, P418, DOI 10.1006/bbrc.1997.6301; KUKULL WA, 1990, NEUROLOGY, V40, P1364, DOI 10.1212/WNL.40.9.1364; Lovell MA, 2011, MECH AGEING DEV, V132, P443, DOI 10.1016/j.mad.2011.08.003; Lu PJ, 1999, NATURE, V399, P784; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; LUCASSEN PJ, 1995, J HISTOCHEM CYTOCHEM, V43, P1163, DOI 10.1177/43.11.7560899; Lucassen PJ, 1997, J NEUROPATH EXP NEUR, V56, P887, DOI 10.1097/00005072-199708000-00007; Lyras L, 1997, J NEUROCHEM, V68, P2061; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Majd S, 2008, BRAIN RES, V1218, P224, DOI 10.1016/j.brainres.2008.04.050; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McShea A, 1997, AM J PATHOL, V150, P1933; MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416; MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mosch B, 2007, J NEUROSCI, V27, P6859, DOI 10.1523/JNEUROSCI.0379-07.2007; MULLAART E, 1990, NEUROBIOL AGING, V11, P169, DOI 10.1016/0197-4580(90)90542-8; Murray IVJ, 2011, EXP BIOL MED, V236, P772, DOI 10.1258/ebm.2011.010355; Myung NH, 2008, AGE, V30, P209, DOI 10.1007/s11357-008-9050-7; Nagy Z, 1997, ACTA NEUROPATHOL, V94, P6, DOI 10.1007/s004010050665; Nunomura A, 1999, J NEUROSCI, V19, P1959; O'Brien RJ, 2009, J ALZHEIMERS DIS, V18, P665, DOI 10.3233/JAD-2009-1179; Ogawa O, 2003, AGING CELL, V2, P105, DOI 10.1046/j.1474-9728.2003.00042.x; Pei JJ, 1998, BRAIN RES, V797, P267, DOI 10.1016/S0006-8993(98)00296-0; Pratico D, 2008, TRENDS PHARMACOL SCI, V29, P609, DOI 10.1016/j.tips.2008.09.001; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Ramalho RM, 2004, J NEUROCHEM, V90, P567, DOI 10.1111/j.1471-4159.2004.02517.x; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Riudavets MA, 2007, NEUROBIOL AGING, V28, P1484, DOI 10.1016/j.neurobiolaging.2007.05.005; Roe CM, 2008, ARCH NEUROL-CHICAGO, V65, P1467, DOI 10.1001/archneur.65.11.1467; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; Schmitt FA, 2000, NEUROLOGY, V55, P370, DOI 10.1212/WNL.55.3.370; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Shao C, 2008, FREE RADICAL BIO MED, V45, P813, DOI 10.1016/j.freeradbiomed.2008.06.003; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Silva ART, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048751; Simpson JE, 2010, NEUROPATH APPL NEURO, V36, P25, DOI 10.1111/j.1365-2990.2009.01030.x; Sohur US, 2006, PHILOS T R SOC B, V361, P1477, DOI 10.1098/rstb.2006.1887; Sonoda Y, 2010, NEUROSCI LETT, V471, P20, DOI 10.1016/j.neulet.2009.12.078; Sperling R.A., 2011, DEFINING PRECLINICAL; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, pS69, DOI 10.1097/00002093-200607001-00010; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sultana R, 2007, NEUROCHEM RES, V32, P655, DOI 10.1007/s11064-006-9123-x; Tang YF, 2006, CANCER RES, V66, P736, DOI 10.1158/0008-5472.CAN-05-1557; Thakur A, 2008, INT J CLIN EXP PATHO, V1, P134; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Tyas SL, 2007, AM J EPIDEMIOL, V165, P1231, DOI 10.1093/aje/kwm085; VICTOROFF J, 1995, AM J PSYCHIAT, V152, P1476; Villemagne VL, 2008, NEUROPSYCHOLOGIA, V46, P1688, DOI 10.1016/j.neuropsychologia.2008.02.008; Vincent I, 1997, J NEUROSCI, V17, P3588; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang J, 2005, J NEUROCHEM, V93, P953, DOI 10.1111/j.1471-4159.2005.03053.x; Wang JQ, 2006, J NEUROCHEM, V96, P825, DOI 10.1111/j.1471-4159.2005.03615.x; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]; Weissman L, 2007, NUCLEIC ACIDS RES, V35, P5545, DOI 10.1093/nar/gkm605; West MJ, 2004, NEUROBIOL AGING, V25, P1205, DOI 10.1016/j.neurobiolaging.2003.12.005; White L, 2009, J ALZHEIMERS DIS, V18, P713, DOI 10.3233/JAD-2009-1178; Yang Y, 2003, J NEUROSCI, V23, P2557; Zhang J, 2008, CELL CYCLE, V7, P3487, DOI 10.4161/cc.7.22.7045; Zhang J, 2008, P NATL ACAD SCI USA, V105, P8772, DOI 10.1073/pnas.0711355105; Zhang J, 2012, J BIOL CHEM, V287, P25985, DOI 10.1074/jbc.M112.343152; Zhang J, 2010, J NEUROSCI, V30, P5219, DOI 10.1523/JNEUROSCI.5628-09.2010	109	61	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99897	10.1371/journal.pone.0099897	http://dx.doi.org/10.1371/journal.pone.0099897			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936870	Green Published, Green Submitted, gold			2022-12-25	WOS:000338503400052
J	Lee, JH; Guo, Z; Myler, LR; Zheng, ST; Paull, TT				Lee, Ji-Hoon; Guo, Zhi; Myler, Logan R.; Zheng, Suting; Paull, Tanya T.			Direct Activation of ATM by Resveratrol under Oxidizing Conditions	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; PROTEIN-KINASE; DNA; APOPTOSIS; PATHWAYS; PHOSPHORYLATION; GENISTEIN; TARGETS; CELLS; P53	Resveratrol has been widely reported to reduce cancer progression in model systems and to selectively induce cell death in transformed cell lines. Many enzymes have been reported to respond to resveratrol in mammalian cells, including the Ataxia-Telangiectasia Mutated (ATM) protein kinase that acts in DNA damage recognition, signaling, and repair. Here we investigate the responses of ATM to resveratrol exposure in normal and transformed human cell lines and find that ATM autophosphorylation and substrate phosphorylation is stimulated by resveratrol in a manner that is promoted by reactive oxygen species (ROS). We observe direct stimulatory effects of resveratrol on purified ATM in vitro and find that the catalytic efficiency of the kinase on a model substrate is increased by resveratrol. In the purified system we also observe a requirement for oxidation, as the effect of resveratrol on ATM signaling is substantially reduced by agents that prevent disulfide bond formation in ATM. These results demonstrate that resveratrol effects on ATM are direct, and suggest a mechanism by which the oxidizing environment of transformed cells promotes ATM activity and blocks cell proliferation.	[Lee, Ji-Hoon; Myler, Logan R.; Zheng, Suting; Paull, Tanya T.] Univ Texas Austin, Howard Hughes Med Inst, Dept Mol Biosci, Austin, TX 78712 USA; [Lee, Ji-Hoon; Myler, Logan R.; Zheng, Suting; Paull, Tanya T.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Guo, Zhi] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Guo, Zhi] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Guo, Zhi] Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	Paull, TT (corresponding author), Univ Texas Austin, Howard Hughes Med Inst, Dept Mol Biosci, Austin, TX 78712 USA.	tpaull@utexas.edu	Lee, Jihoon/AAK-3497-2021	Lee, Jihoon/0000-0001-7387-935X; Paull, Tanya/0000-0002-2991-651X	NIH [CA132813]; CPRIT [RP100670]; NATIONAL CANCER INSTITUTE [R01CA132813] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH CA132813 and CPRIT RP100670. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de la Lastral CA, 2007, BIOCHEM SOC T, V35, P1156, DOI 10.1042/BST0351156; Athar M, 2009, ARCH BIOCHEM BIOPHYS, V486, P95, DOI 10.1016/j.abb.2009.01.018; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bandele OJ, 2007, BIOCHEMISTRY-US, V46, P6097, DOI 10.1021/bi7000664; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Bensimon A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001034; Catalgol B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00141; Delmas D, 2011, CURR MED CHEM, V18, P1100, DOI 10.2174/092986711795029708; Ditch S, 2012, TRENDS BIOCHEM SCI, V37, P15, DOI 10.1016/j.tibs.2011.10.002; Gatz SA, 2008, CARCINOGENESIS, V29, P519, DOI 10.1093/carcin/bgm283; Guo Z, 2010, CELL CYCLE, V9, P4805, DOI 10.4161/cc.9.24.14323; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Heiss EH, 2007, J BIOL CHEM, V282, P26759, DOI 10.1074/jbc.M703229200; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Li YB, 2006, PHARMACOL RES, V53, P6, DOI 10.1016/j.phrs.2005.08.002; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Piotrowska H, 2012, MUTAT RES-REV MUTAT, V750, P60, DOI 10.1016/j.mrrev.2011.11.001; Pirola L, 2008, IUBMB LIFE, V60, P323, DOI 10.1002/iub.47; Podhorecka M, 2011, ANN HEMATOL, V90, P173, DOI 10.1007/s00277-010-1045-7; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Shimizu T, 2006, BIOCHEM PHARMACOL, V71, P742, DOI 10.1016/j.bcp.2005.12.018; Tyagi A, 2005, CARCINOGENESIS, V26, P1978, DOI 10.1093/carcin/bgi165; Weng CJ, 2012, CANCER TREAT REV, V38, P76, DOI 10.1016/j.ctrv.2011.03.001; Yang Y, 2013, CURR MED CHEM, V20, P3677, DOI 10.2174/0929867311320999165; Ye RQ, 2004, DNA REPAIR, V3, P235, DOI 10.1016/j.dnarep.2003.10.014; Ye RQ, 2001, J BIOL CHEM, V276, P4828, DOI 10.1074/jbc.M004894200	31	24	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e97969	10.1371/journal.pone.0097969	http://dx.doi.org/10.1371/journal.pone.0097969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933654	Green Submitted, Green Published, gold			2022-12-25	WOS:000337738600006
J	Mdzinarishvili, T; Sherman, S				Mdzinarishvili, Tengiz; Sherman, Simon			Heuristic Modeling of Carcinogenesis for the Population with Dichotomous Susceptibility to Cancer: A Pancreatic Cancer Example	PLOS ONE			English	Article							MULTISTAGE CARCINOGENESIS; AGE DISTRIBUTION	At present, carcinogenic models imply that all individuals in a population are susceptible to cancer. These models either ignore a fall of the cancer incidence rate at old ages, or use some poorly identifiable parameters for its accounting. In this work, a new heuristic model is proposed. The model assumes that, in a population, only a small fraction (pool) of individuals is susceptible to cancer and decomposes the problem of the carcinogenic modeling on two sequentially solvable problems: (i) determination of the age-specific hazard rate in individuals susceptible to cancer (individual hazard rate) from the observed hazard rate in the population (population hazard rate); and (ii) modelling of the individual hazard rate by a chosen "up'' of the theoretical hazard function describing cancer occurrence in individuals in time (age). The model considers carcinogenesis as a failure of individuals susceptible to cancer to resist cancer occurrence in aging and uses, as the theoretical hazard function, the three-parameter Weibull hazard function, often utilized in a failure analysis. The parameters of this function, providing the best fit of the modeled and observed individual hazard rates (determined from the population hazard rates), are the outcomes of the modeling. The model was applied to the pancreatic cancer data. It was shown that, in the populations stratified by gender, race and the geographic area of living, the modeled and observed population hazard rates of pancreatic cancer occurrence have similar turnovers at old ages. The sizes of the pools of individuals susceptible to this cancer: (i) depend on gender, race and the geographic area of living; (ii) proportionally influence the corresponding population hazard rates; and (iii) do not influence the individual hazard rates. The model should be further tested using data on other types of cancer and for the populations stratified by different categorical variables.	[Mdzinarishvili, Tengiz; Sherman, Simon] Univ Nebraska Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Sherman, S (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA.	ssherm@unmc.edu			NIH [1 R01 CA140940-04]; NATIONAL CANCER INSTITUTE [P30CA036727, R01CA140940] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by the 1 R01 CA140940-04 (NIH, SS the PI) grant. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalen OO, 1999, CANCER CAUSE CONTROL, V10, P285, DOI 10.1023/A:1008916718152; Anfinsen KP, 2011, CANCER EPIDEM BIOMAR, V20, P1770, DOI 10.1158/1055-9965.EPI-11-0136; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Byrne HM, 2006, PHILOS T R SOC A, V364, P1563, DOI 10.1098/rsta.2006.1786; COOK PJ, 1969, INT J CANCER, V4, P93, DOI 10.1002/ijc.2910040113; Doll R, 2004, INT J EPIDEMIOL, V33, P1183, DOI 10.1093/ije/dyh359; Gordon RA, 2003, TOXICOL IND HEALTH, V19, P125, DOI 10.1191/0748233703th195oa; Gsteiger S, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-13; Holford TR, 2005, ENCY BIOSTATISTICS, P17; Kleinbaum DG, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4419-6646-9; Luebeck EG, 2013, CANCER RES, V73, P1086, DOI 10.1158/0008-5472.CAN-12-2198; Luebeck EG, 2002, P NATL ACAD SCI USA, V99, P15095, DOI 10.1073/pnas.222118199; Manton K, 2009, CANC MORTALITY MORBI; MATLAB, 2010, VERS 7 10 0 R2010A; Mdzinarishvili T, 2013, CANCER INFORM, V12, P67, DOI 10.4137/CIN.S8063; Mdzinarishvili T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034362; Mdzinarishvili T, 2010, CANCER INFORM, V9, P179; Meza R, 2008, P NATL ACAD SCI USA, V105, P16284, DOI 10.1073/pnas.0801151105; Moger TA, 2004, BIOSTATISTICS, V5, P1, DOI 10.1093/biostatistics/5.1.1; Morgenthaler S, 2004, J MATH BIOL, V49, P455, DOI 10.1007/s00285-004-0271-9; Ries LAG, 2007, NIH PUB, V07-6215, P59; Schollnberger H, 2010, CANCER RES, V70, P6797, DOI 10.1158/0008-5472.CAN-09-4392; Selvin S, 2004, STAT ANAL EPIDEMIOLO, P263; Surveillance Epidemiology and End Results (SEER) Program, 2011, SEER STAT DAT INC SE; Weisstein EW, ERROR PROPAGATION	25	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100087	10.1371/journal.pone.0100087	http://dx.doi.org/10.1371/journal.pone.0100087			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932779	Green Submitted, gold, Green Published			2022-12-25	WOS:000337738600092
J	Koppensteiner, R; Samartzis, EP; Noske, A; von Teichman, A; Dedes, I; Gwerder, M; Imesch, P; Ikenberg, K; Moch, H; Fink, D; Stucki, M; Dedes, KJ				Koppensteiner, Romana; Samartzis, Eleftherios P.; Noske, Aurelia; von Teichman, Adriana; Dedes, Ioannis; Gwerder, Myriam; Imesch, Patrick; Ikenberg, Kristian; Moch, Holger; Fink, Daniel; Stucki, Manuel; Dedes, Konstantin J.			Effect of MRE11 Loss on PARP-Inhibitor Sensitivity in Endometrial Cancer In Vitro	PLOS ONE			English	Article							STRAND BREAK REPAIR; MICROSATELLITE INSTABILITY; COLORECTAL-CANCER; REPLICATION FORKS; DNA-REPAIR; CELL-LINE; MUTATIONS; EXPRESSION; COMPLEX; CARCINOMA	Aim of the study: To evaluate the frequency of MRE11/RAD50/NBS1 (MRN)-complex loss of protein expression in endometrial cancers (EC) and to determine whether loss of MRE11 renders the cancer cells sensitive to Poly(ADP-ribose) polymerase (PARP)-inhibitory treatment. Methods: MRN expression was examined in 521 samples of endometrial carcinomas and in 10 cancer cell lines. A putative mutation hotspot in the form of an intronic poly(T) allele in MRE11 was sequenced in selected cases (n = 26). Sensitivity to the PARP-inhibitor, BMN673 was tested in colony formation assays before and after MRE11 silencing using siRNA. Homologous recombination (HR) DNA repair was evaluated by RAD51-foci formation assay upon irradiation and drug treatment. Results: Loss of MRE11 protein was found in 30.7% of EC tumours and significantly associated with loss of RAD50, NBS1 and mismatch repair protein expression. One endometrial cell line showed a markedly reduced MRE11 expression due to a homozygous poly(T) mutation of MRE11, thereby exhibiting an increased sensitivity to BMN673. MRE11 depletion sensitizes MRE11 expressing EC cell lines to the treatment with BMN673. The increased sensitivity to PARP-inhibition correlates with reduced RAD51 foci formation upon ionizing radiation in MRE11-depleted cells. Conclusion: Loss of the MRE11 protein predicts sensitivity to PARP-inhibitor sensitivity in vitro, defining it as an additional synthetic lethal gene with PARP. The high incidence of MRE11 loss in ECs can be potentially exploited for PARP-inhibitor therapy. Furthermore, MRE11 protein expression using immunohistochemistry could be investigated as a predictive biomarker for PARP-inhibitor treatment.	[Koppensteiner, Romana; Samartzis, Eleftherios P.; Dedes, Ioannis; Gwerder, Myriam; Imesch, Patrick; Fink, Daniel; Stucki, Manuel; Dedes, Konstantin J.] Univ Zurich Hosp, Div Gynaecol, CH-8091 Zurich, Switzerland; [Noske, Aurelia; von Teichman, Adriana; Ikenberg, Kristian; Moch, Holger] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Dedes, KJ (corresponding author), Univ Zurich Hosp, Div Gynaecol, CH-8091 Zurich, Switzerland.	Konstantin.Dedes@usz.ch	Stucki, Manuel/H-4739-2017; Dedes, Konstantin/AAK-1281-2021; Samartzis, Eleftherios P./AAJ-5650-2020	Samartzis, Eleftherios P./0000-0002-8246-5842; Dedes, Ioannis/0000-0001-7265-4765	Julius Muller Foundation; Zurich Cancer League	Julius Muller Foundation; Zurich Cancer League	This study was partially funded by the Julius Muller Foundation and Zurich Cancer League. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KE, 2006, ONCOGENE, V25, P3894, DOI 10.1038/sj.onc.1209426; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Bilbao C, 2010, EUR J CANCER, V46, P2821, DOI 10.1016/j.ejca.2010.06.116; Brough R, 2011, CURR OPIN GENET DEV, V21, P34, DOI 10.1016/j.gde.2010.10.009; Choudhury A, 2010, CANCER RES, V70, P7017, DOI 10.1158/0008-5472.CAN-10-1202; Daemen A, 2012, BREAST CANCER RES TR, V135, P505, DOI 10.1007/s10549-012-2188-0; De Bono JS, 2013, J CLIN ONCOL, V31; Dedes KJ, 2011, NAT REV CLIN ONCOL, V8, P261, DOI 10.1038/nrclinonc.2010.216; Dedes KJ, 2011, CELL CYCLE, V10, P1192, DOI 10.4161/cc.10.8.15273; Dedes KJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001538; Dellinger TH, 2009, EXPERT REV ANTICANC, V9, P905, DOI [10.1586/era.09.54, 10.1586/ERA.09.54]; Esteller M, 1998, ONCOGENE, V17, P2413, DOI 10.1038/sj.onc.1202178; Forster MD, 2011, NAT REV CLIN ONCOL, V8, P302, DOI 10.1038/nrclinonc.2011.42; Fraser M, 2012, CLIN CANCER RES, V18, P1015, DOI 10.1158/1078-0432.CCR-11-2189; Gao JF, 2008, HISTOL HISTOPATHOL, V23, P1495, DOI 10.14670/HH-23.1495; Gaymes TJ, 2013, HAEMATOLOGICA, V98, P1397, DOI 10.3324/haematol.2012.079251; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Giannini G, 2004, ONCOGENE, V23, P2640, DOI 10.1038/sj.onc.1207409; Giannini G, 2002, EMBO REP, V3, P248, DOI 10.1093/embo-reports/kvf044; Hecht JL, 2006, J CLIN ONCOL, V24, P4783, DOI 10.1200/JCO.2006.06.7173; Lamarche BJ, 2010, FEBS LETT, V584, P3682, DOI 10.1016/j.febslet.2010.07.029; McPherson LA, 2014, CANCER LETT, V343, P217, DOI 10.1016/j.canlet.2013.10.034; Miturski R, 2002, EXP BIOL MED, V227, P579, DOI 10.1177/153537020222700805; Miyasaka A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-179; Mo B, 2006, BIOL REPROD, V75, P387, DOI 10.1095/biolreprod.106.051870; NOZAWA S, 1989, AM J OBSTET GYNECOL, V161, P1079, DOI 10.1016/0002-9378(89)90787-4; Oplustilova L, 2012, CELL CYCLE, V11, P3837, DOI 10.4161/cc.22026; Ottini L, 2004, CARCINOGENESIS, V25, P2337, DOI 10.1093/carcin/bgh257; Pichierri P, 2004, EMBO J, V23, P3154, DOI 10.1038/sj.emboj.7600277; Price JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063313; Santin AD, 1996, INT J CANCER, V65, P688; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Unoki M, 2003, ONCOGENE, V22, P2172, DOI 10.1038/sj.onc.1206222; Vilar E, 2011, CANCER RES, V71, P2632, DOI 10.1158/0008-5472.CAN-10-1120; Walsh PS, 1996, NUCLEIC ACIDS RES, V24, P2807, DOI 10.1093/nar/24.14.2807; Wild PJ, 2012, EMBO MOL MED, V4, P808, DOI 10.1002/emmm.201101063; Xiao YH, 1997, NUCLEIC ACIDS RES, V25, P2985, DOI 10.1093/nar/25.15.2985; Ying SM, 2012, CANCER RES, V72, P2814, DOI 10.1158/0008-5472.CAN-11-3417; Yuan SSF, 2012, JNCI-J NATL CANCER I, V104, P1485, DOI 10.1093/jnci/djs355; Zhao SM, 2013, P NATL ACAD SCI USA, V110, P2916, DOI 10.1073/pnas.1222577110	42	56	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100041	10.1371/journal.pone.0100041	http://dx.doi.org/10.1371/journal.pone.0100041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927325	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100110
J	Seidel, A; Parker, H; Turner, R; Dickerhof, N; Khalilova, IS; Wilbanks, SM; Kettle, AJ; Jameson, GNL				Seidel, Antonia; Parker, Heather; Turner, Rufus; Dickerhof, Nina; Khalilova, Irada S.; Wilbanks, Sigurd M.; Kettle, Anthony J.; Jameson, Guy N. L.			Uric Acid and Thiocyanate as Competing Substrates of Lactoperoxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEADY-STATE KINETICS; HUMAN-BLOOD PLASMA; CATALYZED OXIDATION; HYDROGEN-PEROXIDE; CYTOCHROME-C; COMPOUND-II; MAMMALIAN PEROXIDASES; LIPID-PEROXIDATION; CYSTIC-FIBROSIS; HOST-DEFENSE	The physiological function of urate is poorly understood. It may act as a danger signal, an antioxidant, or a substrate for heme peroxidases. Whether it reacts sufficiently rapidly with lactoperoxidase (LPO) to act as a physiological substrate remains unknown. LPO is a mammalian peroxidase that plays a key role in the innate immune defense by oxidizing thiocyanate to the bactericidal and fungicidal agent hypothiocyanite. We now demonstrate that urate is a good substrate for bovine LPO. Urate was oxidized by LPO to produce the electrophilic intermediates dehydrourate and 5-hydroxyisourate, which decayed to allantoin. In the presence of superoxide, high yields of hydroperoxides were formed by LPO and urate. Using stopped-flow spectroscopy, we determined rate constants for the reaction of urate with compound I (k(1) = 1.1 x 10(7) M-1 s(-1)) and compound II (k(2) = 8.5 x 10(3) M-1 s(-1)). During urate oxidation, LPO was diverted from its peroxidase cycle because hydrogen peroxide reacted with compound II to give compound III. At physiologically relevant concentrations, urate competed effectively with thiocyanate, the main substrate of LPO for oxidation, and inhibited production of hypothiocyanite. Similarly, hypothiocyanite-dependent killing of Pseudomonas aeruginosa was inhibited by urate. Allantoin was present in human saliva and associated with the concentration of LPO. When hydrogen peroxide was added to saliva, oxidation of urate was dependent on its concentration and peroxidase activity. Our findings establish urate as a likely physiological substrate for LPO that will influence host defense and give rise to reactive electrophilic metabolites.	[Seidel, Antonia; Jameson, Guy N. L.] Univ Otago, Dept Chem, Dunedin 9054, New Zealand; [Parker, Heather; Turner, Rufus; Dickerhof, Nina; Khalilova, Irada S.; Kettle, Anthony J.] Univ Otago, Ctr Free Rad Res, Dept Pathol, Christchurch 8140, New Zealand; [Wilbanks, Sigurd M.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand	University of Otago; University of Otago; University of Otago	Jameson, GNL (corresponding author), Univ Otago, Dept Chem, POB 56, Dunedin 9054, New Zealand.	gjameson@chemistry.otago.ac.nz	Khalilova, Irada/I-5103-2015; Jameson, Guy N. L./J-3258-2015; Khalilova, Irada/AGF-0824-2022	Khalilova, Irada/0000-0002-4238-3113; Jameson, Guy N. L./0000-0001-9416-699X; Dickerhof, Nina/0000-0003-2269-4595; Kettle, Tony/0000-0002-8218-7766; Wilbanks, Sigurd/0000-0001-7565-8913	University of Otago; Health Research Council of New Zealand; University of Otago International Doctoral Scholarship	University of Otago; Health Research Council of New Zealand(Health Research Council of New Zealand); University of Otago International Doctoral Scholarship	This work was supported by grants from the University of Otago and the Health Research Council of New Zealand.; Funded by a University of Otago International Doctoral Scholarship.	Alvarez-Lario B, 2010, RHEUMATOLOGY, V49, P2010, DOI 10.1093/rheumatology/keq204; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; BEERS RF, 1952, J BIOL CHEM, V195, P133; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; CANELLAKIS ES, 1955, J BIOL CHEM, V213, P397; CANNON PJ, 1966, NEW ENGL J MED, V275, P457, DOI 10.1056/NEJM196609012750902; Chapman ALP, 2013, J BIOL CHEM, V288, P6465, DOI 10.1074/jbc.M112.418970; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Conner GE, 2007, FEBS LETT, V581, P271, DOI 10.1016/j.febslet.2006.12.025; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Ford ES, 2007, CIRCULATION, V115, P2526, DOI 10.1161/CIRCULATIONAHA.106.657627; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; Fridovich I., 1985, HDB METHODS OXYGEN R, P51; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Furtmuller PG, 2005, J INORG BIOCHEM, V99, P1220, DOI 10.1016/j.jinorgbio.2005.02.021; Furtmuller PG, 2002, BIOCHEMISTRY-US, V41, P11895, DOI 10.1021/bi026326x; Ghibaudi E, 2003, J INORG BIOCHEM, V94, P146, DOI 10.1016/S0162-0134(02)00594-9; Goodarzynejad H, 2010, LABMEDICINE, V41, P40, DOI 10.1309/LMKDB9PBKZGUS20T; Harwood DT, 2009, J CHROMATOGR B, V877, P3393, DOI 10.1016/j.jchromb.2009.04.018; Horsley A, 2011, J ROY SOC MED, V104, pS36, DOI 10.1258/jrsm.2011.s11106; Ihalin R, 2006, ARCH BIOCHEM BIOPHYS, V445, P261, DOI 10.1016/j.abb.2005.07.004; Jantschko W, 2005, ARCH BIOCHEM BIOPHYS, V434, P51, DOI 10.1016/j.abb.2004.10.014; Jantschko W, 2002, ARCH BIOCHEM BIOPHYS, V398, P12, DOI 10.1006/abbi.2001.2674; Johnson RJ, 2004, NEW ENGL J MED, V350, P1071, DOI 10.1056/NEJMp048015; Kang DH, 2002, J AM SOC NEPHROL, V13, P2888, DOI 10.1097/01.ASN.0000034910.58454.FD; KETTLE AJ, 1994, J BIOL CHEM, V269, P17146; KETTLE AJ, 1994, METHOD ENZYMOL, V233, P502; KLAND MJ, 1957, J AM CHEM SOC, V79, P6187, DOI 10.1021/ja01580a022; Krishnan E, 2011, CURR OPIN RHEUMATOL, V23, P174, DOI 10.1097/BOR.0b013e3283432dd3; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; Lardinois OM, 1999, J BIOL CHEM, V274, P35441, DOI 10.1074/jbc.274.50.35441; Lehto S, 1998, STROKE, V29, P635, DOI 10.1161/01.STR.29.3.635; Lorentzen D, 2011, FREE RADICAL BIO MED, V50, P1144, DOI 10.1016/j.freeradbiomed.2011.02.013; Lovstad RA, 2004, BIOMETALS, V17, P631, DOI 10.1007/s10534-004-1228-6; MARGOLIASH E, 1959, BIOCHEM J, V71, P570, DOI 10.1042/bj0710570; MARQUEZ LA, 1990, J BIOL CHEM, V265, P5666; Marquez LA, 1997, BIOCHEMISTRY-US, V36, P9349, DOI 10.1021/bi970595j; MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8; MCCORD JM, 1968, J BIOL CHEM, V243, P5753; Meotti FC, 2011, J BIOL CHEM, V286, P12901, DOI 10.1074/jbc.M110.172460; Merriman TR, 2011, JOINT BONE SPINE, V78, P35, DOI 10.1016/j.jbspin.2010.02.027; METODIEWA D, 1990, BIOCHEM BIOPH RES CO, V169, P1211, DOI 10.1016/0006-291X(90)92025-U; Monzani E, 1997, BIOCHEMISTRY-US, V36, P1918, DOI 10.1021/bi961868y; Nagy P, 2006, BIOCHEMISTRY-US, V45, P12610, DOI 10.1021/bi061015y; NIRMALA J, 1975, INDIAN J BIOCHEM BIO, V12, P47; ODAJIMA T, 1970, BIOCHIM BIOPHYS ACTA, V206, P71, DOI 10.1016/0005-2744(70)90083-5; OGINO N, 1979, BIOCHEM BIOPH RES CO, V87, P184, DOI 10.1016/0006-291X(79)91664-4; Paul K. G., 1985, Immunology Series, V27, P15; PEDEN DB, 1990, P NATL ACAD SCI USA, V87, P7638, DOI 10.1073/pnas.87.19.7638; PRUITT KM, 1988, BIOCHEMISTRY-US, V27, P240, DOI 10.1021/bi00401a036; Queiroz RF, 2011, BIOCHEM J, V439, P423, DOI 10.1042/BJ20110555; Schmid R., 1982, NONFORMAL KINETICS, P32; Sharma Sujata, 2013, Int J Biochem Mol Biol, V4, P108; Shi Y, 2010, J CLIN INVEST, V120, P1809, DOI 10.1172/JCI43132; Stamp LK, 2012, RHEUMATOLOGY, V51, P1796, DOI 10.1093/rheumatology/kes193; Stevenson WS, 2010, P NATL ACAD SCI USA, V107, P16625, DOI 10.1073/pnas.1010390107; Tahboub YR, 2005, J BIOL CHEM, V280, P26129, DOI 10.1074/jbc.M503027200; THOMAS EL, 1994, J DENT RES, V73, P544, DOI 10.1177/00220345940730021001; Turner R, 2012, J CHROMATOGR B, V891, P85, DOI 10.1016/j.jchromb.2012.02.009; Tuynman A, 1998, EUR J BIOCHEM, V258, P906, DOI 10.1046/j.1432-1327.1998.2580906.x; UOTILA J, 1992, CLIN EXP HYPERTENS B, V11, P71, DOI 10.3109/10641959209031034; van Dalen CJ, 2001, BIOCHEM J, V358, P233, DOI 10.1042/0264-6021:3580233; van der Vliet A, 1999, AM J PHYSIOL-LUNG C, V276, pL289, DOI 10.1152/ajplung.1999.276.2.L289; vanDalen CJ, 1997, BIOCHEM J, V327, P487; VILJA P, 1991, J IMMUNOL METHODS, V141, P277, DOI 10.1016/0022-1759(91)90154-8; VOLK KJ, 1990, J PHARMACEUT BIOMED, V8, P205, DOI 10.1016/0731-7085(90)80028-N; WAYNER DDM, 1987, BIOCHIM BIOPHYS ACTA, V924, P408, DOI 10.1016/0304-4165(87)90155-3; Wijkstrom-Frei C, 2003, AM J RESP CELL MOL, V29, P206, DOI 10.1165/rcmb.2002-0152OC; Winterbourn CC, 2003, BIOCHEM BIOPH RES CO, V305, P729, DOI 10.1016/S0006-291X(03)00810-6; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182	70	19	19	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21937	21949		10.1074/jbc.M113.544957	http://dx.doi.org/10.1074/jbc.M113.544957			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24928513	Green Published, hybrid			2022-12-25	WOS:000340593500011
J	Chung, L; Bailey, D; Leen, EN; Emmott, EP; Chaudhry, Y; Roberts, LO; Curry, S; Locker, N; Goodfellow, IG				Chung, Liliane; Bailey, Dalan; Leen, Eoin N.; Emmott, Edward P.; Chaudhry, Yasmin; Roberts, Lisa O.; Curry, Stephen; Locker, Nicolas; Goodfellow, Ian G.			Norovirus Translation Requires an Interaction between the C Terminus of the Genome-linked Viral Protein VPg and Eukaryotic Translation Initiation Factor 4G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE NOROVIRUS; EIF4E PHOSPHORYLATION; INFECTED-CELLS; BINDS; VIRUS; CALICIVIRUS; PURIFICATION; RECRUITMENT; EXPRESSION; RECOVERY	Viruses have evolved a variety of mechanisms to usurp the host cell translation machinery to enable translation of the viral genome in the presence of high levels of cellular mRNAs. Noroviruses, a major cause of gastroenteritis in man, have evolved a mechanism that relies on the interaction of translation initiation factors with the virus-encoded VPg protein covalently linked to the 5' end of the viral RNA. To further characterize this novel mechanism of translation initiation, we have used proteomics to identify the components of the norovirus translation initiation factor complex. This approach revealed that VPg binds directly to the eIF4F complex, with a high affinity interaction occurring between VPg and eIF4G. Mutational analyses indicated that the C-terminal region of VPg is important for the VPg-eIF4G interaction; viruses with mutations that alter or disrupt this interaction are debilitated or non-viable. Our results shed new light on unusual mechanisms of protein-directed translation	[Chung, Liliane; Bailey, Dalan; Chaudhry, Yasmin; Goodfellow, Ian G.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Virol Sect, London W2 1PG, England; [Bailey, Dalan] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Birmingham B15 2TT, W Midlands, England; [Leen, Eoin N.; Curry, Stephen] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Emmott, Edward P.; Chaudhry, Yasmin; Goodfellow, Ian G.] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Virol, Cambridge CB2 2QQ, England; [Roberts, Lisa O.; Locker, Nicolas] Univ Surrey, Fac Hlth & Med Sci, Sch Biosci & Med, Guildford GU2 7HX, Surrey, England	Imperial College London; University of Birmingham; Imperial College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Surrey	Goodfellow, IG (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Virol, Hills Rd, Cambridge CB2 2QQ, England.	ig299@cam.ac.uk		Curry, Stephen/0000-0002-0552-8870; Goodfellow, Ian/0000-0002-9483-510X; Emmott, Edward/0000-0002-3239-8178; Bailey, Dalan/0000-0002-5640-2266; Leen, Eoin/0000-0002-1845-5949; Locker, Nicolas/0000-0002-0053-2897	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I012303/1]; Wellcome Trust [WT097997MA]; BBSRC [BB/I01232X/1];  [BB/J001708/1]; Biotechnology and Biological Sciences Research Council [BB/I01232X/1, BB/I012303/1, BB/J001708/1] Funding Source: researchfish; BBSRC [BB/J001708/1, BB/I012303/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/I012303/1) and the Wellcome Trust (WT097997MA) (to I. G.) funding from the BBSRC (BB/I01232X/1; to L. R. and N. L.) as well as BB/J001708/1 (to S. C.).	Arias A, 2012, JOVE-J VIS EXP, DOI 10.3791/4145; Bailey D, 2012, JOVE-J VIS EXP, DOI 10.3791/3643; Bartolini L, 2011, NEUROPEDIATRICS, V42, P167, DOI 10.1055/s-0031-1286349; Caddy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081596; Chan CMV, 2011, J PAEDIATR CHILD H, V47, P373, DOI 10.1111/j.1440-1754.2010.01986.x; Chaudhry Y, 2007, J GEN VIROL, V88, P2091, DOI 10.1099/vir.0.82940-0; Chaudhry Y, 2006, J BIOL CHEM, V281, P25315, DOI 10.1074/jbc.M602230200; Coldwell MJ, 2006, MOL CELL BIOL, V26, P8448, DOI 10.1128/MCB.01248-06; Daughenbaugh KF, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-33; Daughenbaugh KF, 2003, EMBO J, V22, P2852, DOI 10.1093/emboj/cdg251; Dobrikov M, 2011, MOL CELL BIOL, V31, P2947, DOI 10.1128/MCB.05589-11; Duizer E, 2004, J GEN VIROL, V85, P79, DOI 10.1099/vir.0.19478-0; Feoktistova K, 2013, P NATL ACAD SCI USA, V110, P13339, DOI 10.1073/pnas.1303781110; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Goodfellow I, 2005, EMBO REP, V6, P968, DOI 10.1038/sj.embor.7400510; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; Imataka H, 1997, MOL CELL BIOL, V17, P6940, DOI 10.1128/MCB.17.12.6940; Jiang J, 2011, CURR OPIN VIROL, V1, P347, DOI 10.1016/j.coviro.2011.09.010; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Khan MA, 2008, J BIOL CHEM, V283, P1340, DOI 10.1074/jbc.M703356200; Korneeva NL, 2000, J BIOL CHEM, V275, P41369, DOI 10.1074/jbc.M007525200; LAMPHEAR BJ, 1993, J BIOL CHEM, V268, P19200; Leen EN, 2013, J VIROL, V87, P5318, DOI 10.1128/JVI.03151-12; LeFebvre AK, 2006, J BIOL CHEM, V281, P22917, DOI 10.1074/jbc.M605418200; Liu BL, 1999, J VIROL, V73, P819, DOI 10.1128/JVI.73.1.819-825.1999; Locker N, 2006, RNA, V12, P683, DOI 10.1261/rna.2227906; MADER S, 1995, MOL CELL BIOL, V15, P4990; Mesquita JR, 2010, EMERG INFECT DIS, V16, P980, DOI 10.3201/eid1606.091861; Morino S, 2000, MOL CELL BIOL, V20, P468, DOI 10.1128/MCB.20.2.468-477.2000; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Pinto P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032739; Raught B, 2000, EMBO J, V19, P434, DOI 10.1093/emboj/19.3.434; Reineke LC, 2011, CURR OPIN VIROL, V1, P363, DOI 10.1016/j.coviro.2011.10.009; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Shveygert M, 2010, MOL CELL BIOL, V30, P5160, DOI 10.1128/MCB.00448-10; Sosnovtsev SV, 2006, J VIROL, V80, P7816, DOI 10.1128/JVI.00532-06; Stuart RL, 2010, PEDIATR INFECT DIS J, V29, P644, DOI 10.1097/INF.0b013e3181d824e1; Thorne LG, 2014, J GEN VIROL, V95, P278, DOI 10.1099/vir.0.059634-0; Turcios-Ruiz RM, 2008, J PEDIATR-US, V153, P339, DOI 10.1016/j.jpeds.2008.04.015; Vashist S, 2012, J VIROL, V86, P11977, DOI 10.1128/JVI.00432-12; Villa N, 2013, J BIOL CHEM, V288, P32932, DOI 10.1074/jbc.M113.517011; Ward VK, 2007, P NATL ACAD SCI USA, V104, P11050, DOI 10.1073/pnas.0700336104; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wolf S, 2009, VET MICROBIOL, V133, P184, DOI 10.1016/j.vetmic.2008.06.019; Yunus MA, 2010, J VIROL METHODS, V169, P112, DOI 10.1016/j.jviromet.2010.07.006	49	33	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21738	21750		10.1074/jbc.M114.550657	http://dx.doi.org/10.1074/jbc.M114.550657			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24928504	Green Published, hybrid			2022-12-25	WOS:000340558300047
J	Luth, ES; Stavrovskaya, IG; Bartels, T; Kristal, BS; Selkoe, DJ				Luth, Eric S.; Stavrovskaya, Irina G.; Bartels, Tim; Kristal, Bruce S.; Selkoe, Dennis J.			Soluble, Prefibrillar alpha-Synuclein Oligomers Promote Complex I-dependent, Ca2+-induced Mitochondrial Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; SUBSTANTIA-NIGRA-NEURONS; PARKINSONS-DISEASE; RESPIRATORY-CHAIN; DOPAMINERGIC-NEURONS; VESICLE PERMEABILIZATION; CALCIUM HOMEOSTASIS; OXIDATIVE STRESS; TRANSGENIC MICE; OXIDANT STRESS	alpha-Synuclein (alpha Syn) aggregation and mitochondrial dysfunction both contribute to the pathogenesis of Parkinson disease (PD). Although recent studies have suggested that mitochondrial association of alpha Syn may disrupt mitochondrial function, it is unclear what aggregation state of alpha Syn is most damaging to mitochondria and what conditions promote or inhibit the effect of toxic alpha Syn species. Because the neuronal populations most vulnerable in PD are characterized by large cytosolic Ca2+ oscillations that burden mitochondria, we examined mitochondrial Ca2+ stress in an in vitro system comprising isolated mitochondria and purified recombinant human alpha Syn in various aggregation states. Using fluorimetry to simultaneously measure four mitochondrial parameters, we observed that soluble, prefibrillar alpha Syn oligomers, but not monomeric or fibrillar alpha Syn, decreased the retention time of exogenously added Ca2+, promoted Ca2+-induced mitochondrial swelling and depolarization, and accelerated cytochrome c release. Inhibition of the permeability transition pore rescued these alpha Syn-induced changes in mitochondrial parameters. Interestingly, the mitotoxic effects of alpha Syn were specifically dependent upon both electron flow through complex I and mitochondrial uptake of exogenous Ca2+. Our results suggest that soluble prefibrillar alpha Syn oligomers recapitulate several mitochondrial phenotypes previously observed in animal and cell models of PD: complex I dysfunction, altered membrane potential, disrupted Ca2+ homeostasis, and enhanced cytochrome c release. These data reveal how the association of oligomeric alpha Syn with mitochondria can be detrimental to the function of cells with high Ca2+-handling requirements.	[Luth, Eric S.; Bartels, Tim; Selkoe, Dennis J.] Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Boston, MA 02115 USA; [Stavrovskaya, Irina G.; Kristal, Bruce S.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Selkoe, DJ (corresponding author), Harvard Inst Med, Ctr Neurol Dis, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	dselkoe@rics.bwh.harvard.edu	Bartels, Tim/AAD-6128-2021	Bartels, Tim/0000-0002-4071-5612	Fidelity Biosciences Research Initiative; Parkinson's Disease Foundation Grant [PDF-IRG-1204]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083845] Funding Source: NIH RePORTER	Fidelity Biosciences Research Initiative; Parkinson's Disease Foundation Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Fidelity Biosciences Research Initiative (to D. J. S.) and Parkinson's Disease Foundation Grant PDF-IRG-1204 (to T. B.).	Baranov SV, 2008, J BIOL CHEM, V283, P665, DOI 10.1074/jbc.M703484200; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; BERNARDI P, 1992, J BIOL CHEM, V267, P2934; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004; Buttner S, 2013, EMBO J, V32, P3041, DOI 10.1038/emboj.2013.228; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Cali T, 2012, J BIOL CHEM, V287, P18478, DOI [10.1074/jbc.M111.304733, 10.1074/jbc.M111.302794]; Camilleri A, 2013, BBA-BIOMEMBRANES, V1828, P2532, DOI 10.1016/j.bbamem.2013.06.026; CHANCE B, 1955, J BIOL CHEM, V217, P429; CHANCE B, 1971, BIOCHEM J, V122, P225, DOI 10.1042/bj1220225; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061; Choubey V, 2011, J BIOL CHEM, V286, P10814, DOI 10.1074/jbc.M110.132514; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Cullen V, 2011, ANN NEUROL, V69, P940, DOI 10.1002/ana.22400; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; De Franceschi G, 2011, J BIOL CHEM, V286, P22262, DOI 10.1074/jbc.M110.202937; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Drescher M, 2010, J AM CHEM SOC, V132, P4080, DOI 10.1021/ja909247j; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Foehring RC, 2009, J NEUROPHYSIOL, V102, P2326, DOI 10.1152/jn.00038.2009; FRY M, 1981, J BIOL CHEM, V256, P1874; Giehm L, 2011, P NATL ACAD SCI USA, V108, P3246, DOI 10.1073/pnas.1013225108; Goldberg JA, 2012, NAT NEUROSCI, V15, P1414, DOI 10.1038/nn.3209; Guardia-Laguarta C, 2014, J NEUROSCI, V34, P249, DOI 10.1523/JNEUROSCI.2507-13.2014; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; JANETZKY B, 1994, NEUROSCI LETT, V169, P126, DOI 10.1016/0304-3940(94)90372-7; Kara E, 2013, NEUROSCI LETT, V546, P67, DOI 10.1016/j.neulet.2013.04.058; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Kim Han-Joon, 2013, Exp Neurobiol, V22, P77, DOI 10.5607/en.2013.22.2.77; Kristal BS, 2001, FREE RADICAL BIO MED, V30, P924, DOI 10.1016/S0891-5849(01)00484-1; Kristal BS, 1996, J BIOL CHEM, V271, P6033, DOI 10.1074/jbc.271.11.6033; Kristal BS, 1997, J NEUROCHEM, V69, P524; LAI JCK, 1976, BIOCHEM J, V154, P423, DOI 10.1042/bj1540423; LANGSTON JW, 1983, NEW ENGL J MED, V309, P310; Lee M, 2001, J NEUROCHEM, V76, P998, DOI 10.1046/j.1471-4159.2001.00149.x; Lemasters JJ, 1998, BIOFACTORS, V8, P283, DOI 10.1002/biof.5520080316; Liu GW, 2009, NEUROSCI LETT, V454, P187, DOI 10.1016/j.neulet.2009.02.056; Loeb V, 2010, J BIOL CHEM, V285, P7334, DOI 10.1074/jbc.M109.061051; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Martin LJ, 2014, NEUROBIOL AGING, V35, P1132, DOI 10.1016/j.neurobiolaging.2013.11.008; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Nasstrom T, 2011, FREE RADICAL BIO MED, V50, P428, DOI 10.1016/j.freeradbiomed.2010.11.027; Natalello A, 2011, PROTEINS, V79, P611, DOI 10.1002/prot.22909; Parihar MS, 2008, CELL MOL LIFE SCI, V65, P1272, DOI 10.1007/s00018-008-7589-1; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Petit PX, 1998, FEBS LETT, V426, P111, DOI 10.1016/S0014-5793(98)00318-4; PETRONILLI V, 1993, J BIOL CHEM, V268, P1011; Reeve AK, 2012, ARCH NEUROL-CHICAGO, V69, P385, DOI 10.1001/archneurol.2011.2675; Rhinn H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2032; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Scorrano L, 1999, J BIOL CHEM, V274, P22581, DOI 10.1074/jbc.274.32.22581; Shavali S, 2008, NEUROSCI LETT, V439, P125, DOI 10.1016/j.neulet.2008.05.005; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Starkov AA, 2010, METHODS MOL BIOL, V648, P245, DOI 10.1007/978-1-60761-756-3_16; Stavrovskaya IG, 2010, FREE RADICAL BIO MED, V49, P567, DOI 10.1016/j.freeradbiomed.2010.04.037; Stichel CC, 2007, HUM MOL GENET, V16, P2377, DOI 10.1093/hmg/ddm083; Surmeier DJ, 2013, J BIOL CHEM, V288, P10736, DOI 10.1074/jbc.R112.410530; Telford JE, 2009, J BIOL CHEM, V284, P9109, DOI 10.1074/jbc.M809101200; Thomas B, 2012, ANTIOXID REDOX SIGN, V16, P855, DOI 10.1089/ars.2010.3849; Tompkins MM, 1997, BRAIN RES, V775, P24, DOI 10.1016/S0006-8993(97)00874-3; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Westphal CH, 2013, J BIOL CHEM, V288, P1829, DOI 10.1074/jbc.M112.418871; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	82	179	185	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21490	21507		10.1074/jbc.M113.545749	http://dx.doi.org/10.1074/jbc.M113.545749			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24942732	Green Published, hybrid			2022-12-25	WOS:000340558300026
J	Bao, ZL; Hua, J				Bao, Zhilong; Hua, Jian			Interaction of CPR5 with Cell Cycle Regulators UVI4 and OSD1 in Arabidopsis	PLOS ONE			English	Article							DEFENSE RESPONSES; PLANT DEVELOPMENT; GENE-EXPRESSION; PROTEIN; RESISTANCE; THALIANA; ENDOREPLICATION; COMPLEX; GROWTH; ENDOREDUPLICATION	The impact of cell cycle on plant immunity was indicated by the enhancement of disease resistance with overexpressing OSD1 and UVI4 genes that are negative regulators of cell cycle controller APC (anaphase promoting complex). CPR5 is another gene that is implicated in cell cycle regulation and plant immunity, but its mode of action is not known. Here we report the analysis of genetic requirement for the function of UVI4 and OSD1 in cell cycle progression control and in particular the involvement of CPR5 in this regulation. We show that the APC activator CCS52A1 partially mediates the function of OSD1 and UVI4 in female gametophyte development. We found that the cpr5 mutation suppresses the endoreduplication defect in the uvi4 single mutant and partially rescued the gametophyte development defect in the osd1 uvi4 double mutant while the uvi4 mutation enhances the cpr5 defects in trichome branching and plant disease resistance. In addition, cyclin B1 genes CYCB1;1, CYCB1;2, and CYCB1;4 are upregulated in cpr5. Therefore, CPR5 has a large role in cell cycle regulation and this role has a complex interaction with that of UVI4 and OSD1. This study further indicates an intrinsic link between plant defense responses and cell cycle progression.	[Bao, Zhilong; Hua, Jian] Cornell Univ, Dept Plant Biol, Ithaca, NY 14850 USA	Cornell University	Hua, J (corresponding author), Cornell Univ, Dept Plant Biol, Ithaca, NY 14850 USA.	jh299@cornell.edu	Bao, Zhilong/L-8048-2018	Bao, Zhilong/0000-0002-2670-8344	National Science Foundation (NSF) [IOS-0642289, IOS-0919914]; Plant Biology Department at Cornell University	National Science Foundation (NSF)(National Science Foundation (NSF)); Plant Biology Department at Cornell University	This work was supported by National Science Foundation (NSF) grants IOS-0642289 and IOS-0919914 and the Plant Biology Department at Cornell University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P229, DOI [10.1007/BF02672073, DOI 10.1007/BF02672073]; Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Bao ZL, 2013, P NATL ACAD SCI USA, V110, P2407, DOI 10.1073/pnas.1217024110; Boch J, 1998, MOL PLANT MICROBE IN, V11, P1196, DOI 10.1094/MPMI.1998.11.12.1196; Borghi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026360; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Breuer C, 2010, CURR OPIN PLANT BIOL, V13, P654, DOI 10.1016/j.pbi.2010.10.006; Brininstool G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-58; Chandran D, 2010, P NATL ACAD SCI USA, V107, P460, DOI 10.1073/pnas.0912492107; Chevalier C, 2011, ANN BOT-LONDON, V107, P1159, DOI 10.1093/aob/mcq257; Christensen CA, 1997, SEX PLANT REPROD, V10, P49, DOI 10.1007/s004970050067; Cromer L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002865; d'Erfurth I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000989; d'Erfurth I, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000124; De Veylder L, 2011, TRENDS PLANT SCI, V16, P624, DOI 10.1016/j.tplants.2011.07.001; del Pozo JC, 2006, PLANT CELL, V18, P2224, DOI 10.1105/tpc.105.039651; Gao GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019406; Hase Y, 2006, PLANT J, V46, P317, DOI 10.1111/j.1365-313X.2006.02696.x; Heyman J, 2011, PLANT CELL; Inagaki S, 2011, INT REV CEL MOL BIO, V291, P227, DOI 10.1016/B978-0-12-386035-4.00007-0; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Iwata E, 2011, PLANT CELL; Iwata E, 2012, PLANT SIGNAL BEHAV, V7, P1079, DOI 10.4161/psb.21133; Kasili R, 2010, GENETICS, V185, P257, DOI 10.1534/genetics.109.113274; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Kirik V, 2001, CURR BIOL, V11, P1891, DOI 10.1016/S0960-9822(01)00590-5; Lageix S, 2007, J VIROL, V81, P4177, DOI 10.1128/JVI.02103-06; Lammens T, 2008, P NATL ACAD SCI USA, V105, P14721, DOI 10.1073/pnas.0806510105; Larson-Rabin Z, 2009, PLANT PHYSIOL, V149, P874, DOI 10.1104/pp.108.132449; Marrocco K, 2010, CURR OPIN PLANT BIOL, V13, P631, DOI 10.1016/j.pbi.2010.07.004; Menges M, 2003, PLANT MOL BIOL, V53, P423, DOI 10.1023/B:PLAN.0000019059.56489.ca; Menges M, 2002, J BIOL CHEM, V277, P41987, DOI 10.1074/jbc.M207570200; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Perazza D, 1999, GENETICS, V152, P461; Perazza D, 2011, PLANT PHYSIOL, V157, P1232, DOI 10.1104/pp.111.179804; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Shi DQ, 2005, PLANT CELL, V17, P2340, DOI 10.1105/tpc.105.033563; Stevens C, 2004, DNA REPAIR, V3, P1071, DOI 10.1016/j.dnarep.2004.03.034; Van Leene J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.53; Vanstraelen M, 2009, P NATL ACAD SCI USA, V106, P11806, DOI 10.1073/pnas.0901193106; Yang HJ, 2006, PLANT J, V48, P238, DOI 10.1111/j.1365-313X.2006.02869.x; Yang SH, 2004, PLANT CELL, V16, P1060, DOI 10.1105/tpc.020479; Yoshida S, 2002, PLANT J, V29, P427, DOI 10.1046/j.0960-7412.2001.01228.x; Zheng BL, 2011, PLANT CELL, V23, P1033, DOI 10.1105/tpc.111.083980; Zhu Y, 2011, PLANT J, V66, P443, DOI 10.1111/j.1365-313X.2011.04504.x; Zhu Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000844	46	18	18	5	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100347	10.1371/journal.pone.0100347	http://dx.doi.org/10.1371/journal.pone.0100347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945150	Green Submitted, Green Published, gold			2022-12-25	WOS:000340721500065
J	Deitch, JS; Alexander, GM; Bensinger, A; Yang, S; Jiang, JT; Heiman-Patterson, TD				Deitch, Jeffrey S.; Alexander, Guillermo M.; Bensinger, Andrew; Yang, Steven; Jiang, Juliann T.; Heiman-Patterson, Terry D.			Phenotype of Transgenic Mice Carrying a Very Low Copy Number of the Mutant Human G93A Superoxide Dismutase-1 Gene Associated with Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							FAMILIAL ALS; MOUSE MODEL; SOD1; MUTATIONS; SURVIVAL	Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease of the motor neuron. While most cases of ALS are sporadic, 10% are familial (FALS) with 20% of FALS caused by a mutation in the gene that codes for the enzyme Cu/Zn superoxide dismutase (SOD1). There is variability in sporadic ALS as well as FALS where even within the same family some siblings with the same mutation do not manifest disease. A transgenic (Tg) mouse model of FALS containing 25 copies of the mutant human SOD1 gene demonstrates motor neuron pathology and progressive weakness similar to ALS patients, leading to death at approximately 130 days. The onset of symptoms and survival of these transgenic mice are directly related to the number of copies of the mutant gene. We report the phenotype of a very low expressing (VLE) G93A SOD1 Tg carrying only 4 copies of the mutant G93ASOD1 gene. While weakness can start at 9 months, only 74% of mice 18 months or older demonstrate disease. The VLE mice show decreased motor neurons compared to wild-type mice as well as increased cytoplasmic translocation of TDP-43. In contrast to the standard G93A SOD1 Tg mouse which always develops motor weakness leading to death, not all VLE animals manifested clinical disease or shortened life span. In fact, approximately 20% of mice older than 24 months had no motor symptoms and only 18% of VLE mice older than 22 months reached end stage. Given the variable penetrance of clinical phenotype, prolonged survival, and protracted loss of motor neurons the VLE mouse provides a new tool that closely mimics human ALS. This tool will allow the study of pathologic events over time as well as the study of genetic and environmental modifiers that may not be causative, but can exacerbate or accelerate motor neuron disease.	[Deitch, Jeffrey S.; Alexander, Guillermo M.; Jiang, Juliann T.; Heiman-Patterson, Terry D.] Drexel Univ, Coll Med, Dept Neurol, Philadelphia, PA 19104 USA; [Bensinger, Andrew; Yang, Steven] Philadelphia Coll Osteopath Med, Philadelphia, PA USA	Drexel University	Heiman-Patterson, TD (corresponding author), Drexel Univ, Coll Med, Dept Neurol, Philadelphia, PA 19104 USA.	theiman@drexelmed.edu			ALS Hope Foundation	ALS Hope Foundation	Funding for this study was made possible through the ALS Hope Foundation support of transgenic mouse colonies and exploratory research, http://www.alshopefoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chalabi A, 2013, NAT REV NEUROL, V9, P617, DOI 10.1038/nrneurol.2013.203; Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Camu W, 1999, J NEUROL SCI, V165, pS21, DOI 10.1016/S0022-510X(99)00022-2; Cleveland DW, 1999, NEURON, V24, P515, DOI 10.1016/S0896-6273(00)81108-3; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; DalCanto MC, 1997, ACTA NEUROPATHOL, V93, P537; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; Felbecker A, 2010, J NEUROL NEUROSUR PS, V81, P572, DOI 10.1136/jnnp.2009.192310; Gurney ME, 1997, J NEUROL SCI, V152, pS67, DOI 10.1016/S0022-510X(97)00247-5; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Heiman-Patterson TD, 2011, AMYOTROPH LATERAL SC, V12, P79, DOI 10.3109/17482968.2010.550626; Henriques A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015445; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001	16	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99879	10.1371/journal.pone.0099879	http://dx.doi.org/10.1371/journal.pone.0099879			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945277	gold, Green Submitted, Green Published			2022-12-25	WOS:000340721500031
J	Rivero-Juarez, A; Lopez-Cortes, LF; Camacho, A; Torres-Cornejo, A; Gordon, A; Ruiz-Valderas, R; Torre-Cisneros, J; Pineda, JA; Viciana, P; Rivero, A				Rivero-Juarez, Antonio; Lopez-Cortes, Luis F.; Camacho, Angela; Torres-Cornejo, Almudena; Gordon, Ana; Ruiz-Valderas, Rosa; Torre-Cisneros, Julian; Pineda, Juan A.; Viciana, Pompeyo; Rivero, Antonio			HCV Viral Decline at Week 2 of Peg-IFN-Alpha-2a/RBV Therapy as a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; INTERFERON PLUS RIBAVIRIN; HEPATITIS-C; VIRUS; ALPHA-2A; WORLD; LOAD; HIV	Background: Optimizing HCV genotype 1 therapy in terms of response prediction and tailoring treatment is undoubtedly the cornerstone of treating HIV co-infected patients in clinical practice. Accordingly, our aim was to analyze the predictive value of HCV viral decline for sustained virological response (SVR), measured at a time point as early as week 2 of therapy with pegylated interferon alpha-2a plus ribavirin (Peg-IFN/RBV). Methods: Previously untreated HIV/HCV genotype 1 co-infected patients were included in this study. The HCV RNA titer was measured at week 2 after starting treatment with Peg-IFN/RBV. The likelihood of reaching SVR when HCV RNA viral titers declined at week 2 was evaluated relative to predictive baseline factors. Results: A total of 192 HIV/HCV genotype-1 co-infected patients were enrolled in the study and began therapy. One hundred and sixty-three patients completed a full course of Peg-IFN/RBV treatment for 2 weeks and 59 of these (36.2%) reached SVR. An HCV RNA viral load decline of >= 1.5 log IU/mL at week 2 had the maximum positive predictive value for SVR (83.3%; 95% CI: 68.5%-92.9%) and was identified as the strongest independent predictive factor for reaching SVR across all baseline predictive factors. Conclusions: HCV viral decline at week 2 had a high predictive value for identifying patients with a high and low likelihood of reaching SVR using dual therapy, regardless of strong predictive baseline factors. This finding may be useful for developing a predictive tool to help tailor HCV genotype 1 therapy in HIV co-infected patients.	[Rivero-Juarez, Antonio; Camacho, Angela; Gordon, Ana; Torre-Cisneros, Julian; Rivero, Antonio] Hosp Univ Reina Sofia Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Unidad Enfermedades Infecciosas, Cordoba, Spain; [Lopez-Cortes, Luis F.; Torres-Cornejo, Almudena; Ruiz-Valderas, Rosa; Viciana, Pompeyo] Univ Seville, CSIC, Hosp Univ Virgen del Rocio,Inst Biomed Sevilla IB, Unidad Clin Enfermedades Infecciosas Microbiol &, Seville, Spain; [Pineda, Juan A.] Hosp Univ Valme, Inst Biomed Sevilla IBiS, Unidad Enfermedades Infecciosas & Microbiol Clin, Seville, Spain	Hospital Universitario Reina Sofia - Cordoba; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Hospital Valme	Rivero, A (corresponding author), Hosp Univ Reina Sofia Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Unidad Enfermedades Infecciosas, Cordoba, Spain.	ariveror@gmail.com	Rivero, Antonio/ABE-5294-2020; Gordon, Ana/Q-5853-2018; IBIS, VIH/O-8856-2015; Espejo, Angela Camacho/AAM-9991-2021; Pineda, Juan A./AAO-9312-2021; Rivero-Juarez, Antonio/E-4528-2019; DE LA TORRE CISNEROS, JULIAN/AAL-5723-2021; Lopez.Cortes, Luis Fernando/W-8323-2019	Gordon, Ana/0000-0002-4911-1436; Pineda, Juan A./0000-0002-3751-0296; Rivero-Juarez, Antonio/0000-0002-5813-6889; Lopez.Cortes, Luis Fernando/0000-0002-3804-3458; Rivero Roman, Antonio/0000-0002-8643-4250; Rivero, Antonio/0000-0001-5005-8268	Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia [0036-2010, 0157-2011, 0430-2012, AI-0021]	Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia)	This work was partly supported by grants from the Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia (grants for health research projects; refs. 0036-2010, 0157-2011, 0430-2012). A.R. was the recipient of a research extension grant from the Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia (ref. AI-0021). A.R.-J. is the recipient of a Post-Doctoral Research Grant from the Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2013, J VIRAL HEPATITIS, V20, P367, DOI 10.1111/j.1365-2893.2012.01613.x; Andriulli A, 2014, J HEPATOL, V60, P16, DOI 10.1016/j.jhep.2013.07.040; Dogan UB, 2013, EUR J GASTROEN HEPAT, V25, P1317, DOI 10.1097/MEG.0b013e328362797b; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Marcellin P, 2012, HEPATOLOGY, V56, P2039, DOI 10.1002/hep.25892; Marcellin P, 2012, J HEPATOL, V56, P1276, DOI 10.1016/j.jhep.2011.12.026; Neukam K, 2013, AIDS, V27, P2715, DOI 10.1097/01.aids.0000432459.36970.a9; Neukam K, 2013, J INFECTION, V67, P59, DOI 10.1016/j.jinf.2013.03.010; Pascale A, 2013, J HEPATOL, V58, P391, DOI 10.1016/j.jhep.2012.09.023; Pearlman BL, 2014, HEPATOLOGY, V59, P71, DOI 10.1002/hep.26624; Pineda JA, 2011, AIDS, V25, P1415, DOI 10.1097/QAD.0b013e328348a7ac; Pineda JA, 2010, CLIN INFECT DIS, V51, P788, DOI 10.1086/656235; Rivero-Juarez A, 2014, J INFECTION, V68, P372, DOI 10.1016/j.jinf.2013.11.009; Rivero-Juarez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061992; Vergara S, 2007, CLIN INFECT DIS, V45, P969, DOI 10.1086/521857; WHO, 2014, GUID SCREEN CAR TREA	16	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99468	10.1371/journal.pone.0099468	http://dx.doi.org/10.1371/journal.pone.0099468			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945348	Green Published, gold, Green Submitted			2022-12-25	WOS:000340721500020
J	Zhang, JJ; Huang, XW; Xiao, JJ; Yang, YJ; Zhou, YH; Wang, XF; Liu, QM; Yang, JM; Wang, MY; Qiu, LX; Zheng, YB; Zhang, P; Li, J; Wang, YN; Wei, QY; Jin, L; Wang, JC; Wang, MH				Zhang, Junjie; Huang, Xuewen; Xiao, Juanjuan; Yang, Yajun; Zhou, Yinghui; Wang, Xiaofeng; Liu, Qingmei; Yang, Jingmin; Wang, Mengyun; Qiu, Lixin; Zheng, Yabiao; Zhang, Ping; Li, Jin; Wang, Ya'nong; Wei, Qingyi; Jin, Li; Wang, Jiucun; Wang, Minghua			Pri-miR-124 rs531564 and pri-miR-34b/c rs4938723 Polymorphisms Are Associated with Decreased Risk of Esophageal Squamous Cell Carcinoma in Chinese Populations	PLOS ONE			English	Article							TUMOR-SUPPRESSIVE MICRORNAS; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; RNA-INTERFERENCE; GENETIC-VARIANTS; PROMOTER REGION; CERVICAL-CANCER; GASTRIC-CANCER; C-ELEGANS; MIR-124	MicroRNAs are a new class of small non-protein-coding RNAs that sometimes function as tumor suppressors or oncogenes. Aberrant expression and structural alteration of microRNAs have been reported to be involved in tumorigenesis and cancer development. Recently, rs531564/pri-miR-124-1, rs4938723/pri-miR-34b/c, rs7372209/pri-miR-26a-1, rs895819/pre-miR-27a, and rs11134527/pri-miR-218 were reported to be associated with risks of various cancers. In order to evaluate the relationship of these SNPs and esophageal squamous cell carcinoma (ESCC) risk, we conducted a case-control study with 1109 ESCC patients and 1275 control subjects to examine the potential association of these pri/pre-miRNA polymorphisms with ESCC susceptibility. As a result, two SNPs were associated with a significant risk of ESCC. We found that the GG genotype of pri-miR-124-1 rs531564 was associated to a significantly decreased risk of ESCC comparing with the CC/CG genotypes ( p = 0.005; OR = 0.61, 95% CI = 0.43-0.86). In addition, the CC genotype of pri-miR-34b/c rs4938723 was associated with a significant decreased risk of ESCC ( CC VS. TT/TC: p = 0.007, OR = 0.82, 95% CI = 0.71-0.95) in Chinese population. The present study provides the first evidence that pri-miR-124-1 rs531564 and pri-miR-34 rs4938723 were associated with the risk of ESCC in Chinese population.	[Zhang, Junjie; Xiao, Juanjuan; Zhou, Yinghui; Zheng, Yabiao; Zhang, Ping; Wang, Minghua] Soochow Univ, Coll Med, Dept Biochem & Mol Biol, Suzhou, Jiangsu, Peoples R China; [Huang, Xuewen] Huadong Sanat, Clin Lab, Wuxi, Jiangsu, Peoples R China; [Yang, Yajun; Wang, Xiaofeng; Liu, Qingmei; Yang, Jingmin; Jin, Li; Wang, Jiucun] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Yang, Yajun; Wang, Xiaofeng; Liu, Qingmei; Yang, Jingmin; Jin, Li; Wang, Jiucun] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Wang, Mengyun; Wei, Qingyi] Fudan Univ, Shanghai Canc Ctr, Canc Res Lab, Shanghai 200433, Peoples R China; [Wang, Mengyun; Qiu, Lixin; Li, Jin; Wei, Qingyi] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Qiu, Lixin; Li, Jin] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China; [Wang, Ya'nong] Fudan Univ, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcoma Surg, Shanghai 200433, Peoples R China	Soochow University - China; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Wang, JC (corresponding author), Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China.	jcwang@fudan.edu.cn; mhwang@suda.edu.cn	Wang, Jiucun/J-8744-2012; Jin, Li/C-1468-2009; Wei, Qingyi/T-8315-2019; Jin, Li/M-5063-2019	Wang, Jiucun/0000-0003-2765-0620; Jin, Li/0000-0002-4546-2415; Wei, Qingyi/0000-0002-3845-9445; 	National Natural Science Foundation fo China [81071957]; Ministry of Health [201002007]; Key Project in the National Science & Techonlogy Pillar Program [2011BAI09B00]; "China's Thousand Talents Program" at Fudan University	National Natural Science Foundation fo China(National Natural Science Foundation of China (NSFC)); Ministry of Health; Key Project in the National Science & Techonlogy Pillar Program; "China's Thousand Talents Program" at Fudan University	This work was supported by the grant from the National Natural Science Foundation fo China (grant number 81071957)(http://www.nsfc.gov.cn/), the Ministry of Health (grant number 201002007)(http://www.nhfpc.gov.cn/qjjys/index.shtml), the Key Project in the National Science & Techonlogy Pillar Program (grant number 2011BAI09B00)(http://kjzc.jhgl.org/), and the funds from "China's Thousand Talents Program'' at Fudan University (http://www.1000plan.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bracht J, 2004, RNA, V10, P1586, DOI 10.1261/rna.7122604; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Gao LB, 2013, BIOL CHEM, V394, P415, DOI 10.1515/hsz-2012-0297; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; He X, 2007, ONCOGENE, V26, P4961, DOI 10.1038/sj.onc.1210307; Hongo M, 2009, J GASTROEN HEPATOL, V24, P729, DOI 10.1111/j.1440-1746.2009.05824.x; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LJ, 2013, TUMOR BIOL, V34, P1919, DOI 10.1007/s13277-013-0736-9; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Qi L, 2012, NEUROSCI LETT, V515, P1, DOI 10.1016/j.neulet.2012.02.061; Shi DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046566; Shi TY, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-19; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Vizcaino AP, 2002, INT J CANCER, V99, P860, DOI 10.1002/ijc.10427; Wang XF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-223; Wilting SM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-167; Wong KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019027; Xia JT, 2012, J PATHOL, V227, P470, DOI 10.1002/path.4030; Xu Y, 2011, INT J CANCER, V128, P412, DOI 10.1002/ijc.25342; Yang HS, 2008, CANCER RES, V68, P2530, DOI 10.1158/0008-5472.CAN-07-5991; Ye YQ, 2008, CANCER PREV RES, V1, P460, DOI 10.1158/1940-6207.CAPR-08-0135; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhou XY, 2010, GYNECOL ONCOL, V117, P287, DOI 10.1016/j.ygyno.2010.01.020; Zhou Y, 2012, J CANCER RES CLIN, V138, P939, DOI 10.1007/s00432-012-1164-8; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	34	54	55	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100055	10.1371/journal.pone.0100055	http://dx.doi.org/10.1371/journal.pone.0100055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945256	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500042
J	Hattori, Y; Kitamura, A; Nagatsuka, K; Ihara, M				Hattori, Yorito; Kitamura, Akihiro; Nagatsuka, Kazuyuki; Ihara, Masafumi			A Novel Mouse Model of Ischemic Carotid Artery Disease	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; LASER SPECKLE; OCCLUSION; BRAIN; IMPAIRMENT; STENOSIS	Background: Carotid artery occlusive disease gradually develops over time, eventually leading to cerebral infarction and high mortality rate. Animal models replicating cerebral infarction resulting from carotid artery occlusive disease have thus been developed to test potential novel treatments, which could be subsequently administered clinically. Methods: Adult C57BL/6J male mice were subjected to ameroid constrictor (AC) placement to gradually narrow the bilateral common carotid arteries. Cerebral blood flow (CBF) was measured at several time points. At 7 and 28 days post-operation, post-mortem brain samples were analyzed for ischemic changes. Results: The mortality rate was 58.8% at 28 days post-operation. Surviving mice with AC showed continuous reduction of CBF by up to 70% of the baseline level at 28 days. Most of the mice (75%) showed multiple cerebral infarctions in the gray and white matter. Non-surviving mice showed critical CBF reduction below 20-30% of the baseline level before death. Conclusion: The application of the AC on the bilateral common carotid arteries in mice could offer a reliable model of severe cerebrovascular insufficiency due to carotid artery occlusive disease and may thus be useful in exploring pharmacological intervention in stroke through monitoring survival rate, infarct formation, and CBF profile.	[Hattori, Yorito; Ihara, Masafumi] Natl Cerebral & Cardiovasc Ctr, Dept Regenerat Med & Tissue Engn, Suita, Osaka, Japan; [Hattori, Yorito; Kitamura, Akihiro] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto, Japan; [Nagatsuka, Kazuyuki; Ihara, Masafumi] Natl Cerebral & Cardiovasc Ctr, Dept Stroke & Cerebrovasc Dis, Suita, Osaka, Japan	National Cerebral & Cardiovascular Center - Japan; Kyoto University; National Cerebral & Cardiovascular Center - Japan	Ihara, M (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Regenerat Med & Tissue Engn, Suita, Osaka, Japan.	ihara@ncvc.go.jp	Ihara, Masafumi/O-5020-2019	Ihara, Masafumi/0000-0002-7102-4048	Ministry of Health, Labor and Welfare [0605-1]; Takeda Science Foundation	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	The authors have grant support from the Ministry of Health, Labor and Welfare (M. I., No. 0605-1) and the Takeda Science Foundation (M. I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuRahma AF, 1998, CARDIOVASC SURG, V6, P579, DOI 10.1016/S0967-2109(98)00072-6; Ayata C, 2004, J CEREBR BLOOD F MET, V24, P744, DOI 10.1097/01.WCB.0000122745.72175.D5; Balestrini S, 2013, NEUROLOGY, V80, P2145, DOI 10.1212/WNL.0b013e318295d71a; Bink DI, 2013, J CEREBR BLOOD F MET, V33, P1666, DOI 10.1038/jcbfm.2013.140; Carare RO, 2013, NEUROPATH APPL NEURO, V39, P593, DOI 10.1111/nan.12042; Forrester KR, 2002, MED BIOL ENG COMPUT, V40, P687, DOI 10.1007/BF02345307; HATTORI H, 1992, ACTA NEUROPATHOL, V84, P437; Herrmann M, 2004, EXP BRAIN RES, V154, P176, DOI 10.1007/s00221-003-1655-6; Jiwa NS, 2010, J NEUROCHEM, V115, P814, DOI 10.1111/j.1471-4159.2010.06958.x; Kitagawa K, 1998, J CEREBR BLOOD F MET, V18, P570, DOI 10.1097/00004647-199805000-00012; Kitamura A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.033; Lai SL, 2005, J NEUROL SCI, V238, P101, DOI 10.1016/j.jns.2005.06.012; Moustafa RR, 2010, STROKE, V41, P1410, DOI 10.1161/STROKEAHA.110.580415; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Shibata M, 2007, STROKE, V38, P2826, DOI 10.1161/STROKEAHA.107.490151; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Yang GM, 1997, BRAIN RES, V752, P209, DOI 10.1016/S0006-8993(96)01453-9	17	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100257	10.1371/journal.pone.0100257	http://dx.doi.org/10.1371/journal.pone.0100257			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940742	Green Published, gold, Green Submitted			2022-12-25	WOS:000338508200087
J	Hayashi, K; Iwata, S; Ogose, A; Kawai, A; Ueda, T; Otsuka, T; Tsuchiya, H				Hayashi, Katsuhiro; Iwata, Shintaro; Ogose, Akira; Kawai, Akira; Ueda, Takafumi; Otsuka, Takanobu; Tsuchiya, Hiroyuki			Factors that Influence Functional Outcome after Total or Subtotal Scapulectomy: Japanese Musculoskeletal Oncology Group (JMOG) Study	PLOS ONE			English	Article							SHOULDER-GIRDLE; ALLOGRAFT RECONSTRUCTION; SURGICAL CLASSIFICATION; MALIGNANT-TUMORS; SCAPULAR TUMORS; RESECTION; PROSTHESIS; SARCOMA; SYSTEM; BONE	Background: Scapulectomy requires not only joint resection but also wide resection of the shoulder girdle muscles. Even the significance of reconstruction has not yet been determined because of the difficulties in comparing the different conditions. The purpose of this study was to investigate factors that influence functional outcomes after scapulectomy in a multicenter study. Methods: This retrospective study comprised 48 patients who underwent total or subtotal scapulectomy and were followed for at least one year after surgery. Patients were registered at the Japanese Musculoskeletal Oncology Group affiliated hospitals. Soft tissue reconstruction for joint stabilization was performed when there was enough remaining tissue for reconstruction of the rotator cuff and tendons. In 23 cases, humeral suspension was performed. The average follow-up period was 61.9 months. Multivariate analysis was performed using the patient's background to determine which factors influence the Enneking functional score or active range of motion. Results: The average functional score was 21.1 out of 30. Active shoulder range of motion was 42.7 degree in flexion, 39.7 degree in abduction, 49.6 degree of internal rotation and 16.8 degree of external rotation. The amount of remaining bone influenced functional outcome, which means that preserving the glenoid or the acromion lead to better function compared to total scapulectomy (p<0.01). Factors that influenced each functional measure include the amount of remaining bone, soft tissue reconstruction, the length of the resected humerus and nerve resection (p<0.05). Conclusion: Although shoulder function was almost eliminated following total or subtotal scapulectomy, minimal resection of bone, and soft tissue reconstruction should lead to better function.	[Hayashi, Katsuhiro; Tsuchiya, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan; [Iwata, Shintaro] Chiba Canc Ctr, Div Orthoped Surg, Chiba 2608717, Japan; [Ogose, Akira] Niigata Univ, Grad Sch Med & Dent Sci, Div Orthoped Surg, Niigata, Japan; [Kawai, Akira] Natl Canc Ctr Hosp, Dept Orthopaed Surg, Kashiwa, Chiba, Japan; [Ueda, Takafumi] Osaka Natl Hosp, Dept Orthopaed Surg, Osaka, Japan; [Hayashi, Katsuhiro; Otsuka, Takanobu] Nagoya City Univ, Sch Med, Dept Orthopaed Surg, Nagoya, Aichi 467, Japan	Kanazawa University; Chiba Cancer Center; Niigata University; National Cancer Center - Japan; Osaka National Hospital; Nagoya City University	Hayashi, K (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan.	hayashikatsu830@aol.com	Hayashi, K/C-4685-2015	Hayashi, K/0000-0001-8665-2154	Grants-in-Aid for Scientific Research [26293333] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Cleeman E, 2013, J SHOULDER ELB SURG, V14, P460; COELLO AJ, 1947, BRIT J TUBERC DIS CH, V41, P75, DOI 10.1016/S0366-0869(47)80032-2; De Nancrede CBG, 1909, ANN SURG, V50, P1, DOI 10.1097/00000658-190907000-00001; ENNEKING WF, 1993, CLIN ORTHOP RELAT R, P241; Griffin AM, 2008, ANN SURG ONCOL, V15, P2250, DOI 10.1245/s10434-008-9975-1; Hayashi K, 2011, INT J CLIN ONCOL, V16, P568, DOI 10.1007/s10147-011-0229-z; Kiss J, J SHOULDER ELBOW SUR, V16, P273; Linberg BE, 1999, CLIN ORTHOP RELAT R, P3; MALAWER MM, 1991, CLIN ORTHOP RELAT R, P33; MALAWER MM, 1991, ORTHOP CLIN N AM, V22, P7; Masamed R, 2008, AM J ROENTGENOL, V191, P482, DOI 10.2214/AJR.07.3286; Mavrogenis AF, 2009, J SURG ONCOL, V100, P611, DOI 10.1002/jso.21340; Mnaymneh WA, 2002, CLIN ORTHOP RELAT R, P223, DOI 10.1097/01.blo.0000030510.43495.e6; Pritsch T, 2007, CLIN ORTHOP RELAT R, P188, DOI 10.1097/01.blo.0000238840.26423.b6; Syme J, 1864, EXCISION SCAPULA; Tang XD, 2011, J SHOULDER ELB SURG, V20, P1163, DOI 10.1016/j.jse.2010.12.014; Tanzawa Y, 2009, J ORTHOP SCI, V14, P761, DOI 10.1007/s00776-009-1392-1; Vahanan NM, 2007, INT ORTHOP, V31, P831, DOI 10.1007/s00264-006-0261-1; Villalobos CE, 2009, ANN SURG ONCOL, V16, P2321, DOI 10.1245/s10434-009-0522-5; Watanabe K, 2013, J ORTHOP SCI, V18, P101, DOI 10.1007/s00776-012-0327-4; Wittig JC, 2002, CLIN ORTHOP RELAT R, P143; Zhang KW, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-45	22	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100119	10.1371/journal.pone.0100119	http://dx.doi.org/10.1371/journal.pone.0100119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937254	Green Submitted, Green Published, gold			2022-12-25	WOS:000338503400079
J	Yi, B; Hu, XF; Zhang, H; Huang, J; Liu, JS; Hu, J; Li, W; Huang, LH				Yi, Bin; Hu, Xiaofang; Zhang, Hao; Huang, Jing; Liu, Jishi; Hu, Jing; Li, Wei; Huang, Lihua			Nuclear NF-kappa B p65 in Peripheral Blood Mononuclear Cells Correlates with Urinary MCP-1, RANTES and the Severity of Type 2 Diabetic Nephropathy	PLOS ONE			English	Article							OXIDATIVE-STRESS; INFLAMMATION; ACTIVATION	Aims: To investigate if nuclear NF-kappa B p65 expression in ex vivo isolated peripheral blood mononuclear cells correlates with urinary MCP-1 or RANTES and the severity of type 2 diabetic nephropathy. Methods: According to their urinary albumin-to-creatinine ratio (uACR), 107 patients with type 2 diabetes (eGFR >60 ml/min) were divided into normal albuminuria group (DN0 group, 38 cases), microalbuminuria group (DN1 group, 38 cases), and macroalbuminuria group (DN2 group, 31 cases), compared with matched healthy normal control group (NC group, 30 cases). Nuclear NF-kappa B p65 protein expression levels in peripheral blood mononuclear cells were detected by western blotting. Real-time quantitative polymerase chain reaction was used to detect NF-kappa B p65 mRNA expression and ELISA assay was used to detect the levels of urinary MCP-1 and RANTES. Results: Nuclear NF-kappa B p65 protein and NF-kappa B p65 mRNA expression levels in peripheral blood mononuclear cells, urinary MCP-1/Cr and RANTES/Cr were all significantly higher in all diabetes groups as compared with NC group. In particular, the increase of nuclear NF-kappa B p65 protein and NF-kappa B p65 mRNA expressions, urinary MCP-1/Cr and RANTES/Cr all correlated with the severity of type 2 diabetic nephropathy as indicated by the increase in uACR. Pearson correlation analysis indicated that both urinary MCP-1/Cr and RANTES/Cr were positively correlated with nuclear NF-kappa B p65 protein or NF-kappa B p65 mRNA levels. Stepwise multiple regression analysis showed that nuclear NF-kappa B p65 protein or NF-kappa B p65 mRNA was an independent variable for urinary MCP-1/Cr, and MCP-1/Cr and RANTES/Cr were two independent variables for uACR. Conclusion: Our research demonstrates that nuclear NF-kappa B p65 protein and mRNA expressions in ex vivo isolated peripheral blood mononuclear cells well correlate with urinary MCP-1/Cr, RANTES/Cr and the severity of type 2 diabetic nephropathy.	[Yi, Bin; Hu, Xiaofang; Zhang, Hao; Huang, Jing; Liu, Jishi; Hu, Jing; Li, Wei] Cent S Univ, Xiangya Hosp 3, Dept Nephrol, Changsha, Hunan, Peoples R China; [Huang, Lihua] Cent S Univ, Xiangya Hosp 3, Ctr Med Expt, Changsha, Hunan, Peoples R China	Central South University; Central South University	Zhang, H (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Nephrol, Changsha, Hunan, Peoples R China.	zhanghaoliaoqing@163.com			National Natural Science Foundation of China [81100516]; Natural Science Foundation of Hunan Province [13JJ3033]; Scientific and Technological Project of Hunan Province [2011FJ3217]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Scientific and Technological Project of Hunan Province	This study was supported by the National Natural Science Foundation of China (NO. 81100516), the Natural Science Foundation of Hunan Province (NO. 13JJ3033), and the Scientific and Technological Project of Hunan Province (NO. 2011FJ3217). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkarian M, 2013, J AM SOC NEPHROL, V24, P302, DOI 10.1681/ASN.2012070718; Amann B, 2003, DIABETES CARE, V26, P2421, DOI 10.2337/diacare.26.8.2421; Bondar IA, 2008, TERAPEVT ARKH, V80, P52; Chen HM, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-69; Chen Pin, 2012, Zhonghua Nei Ke Za Zhi, V51, P460; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Dai CS, 2011, J BIOL CHEM, V286, P7052, DOI 10.1074/jbc.M110.174821; Hofmann MA, 1999, DIABETOLOGIA, V42, P222, DOI 10.1007/s001250051142; KIM J, 2013, NATL GEOGR, V224, P8; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Luis-Rodriguez D, 2012, WORLD J DIABETES, V3, P7, DOI 10.4239/wjd.v3.i1.7; Mezzano S, 2004, NEPHROL DIAL TRANSPL, V19, P2505, DOI 10.1093/ndt/gfh207; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Qiu-Yue W, 2009, DIABETES RES CLIN PR, V83, P215, DOI 10.1016/j.diabres.2008.09.048; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Ruster C, 2008, FRONT BIOSCI-LANDMRK, V13, P944, DOI 10.2741/2734; Takebayashi K, 2006, J CLIN ENDOCR METAB, V91, P2214, DOI 10.1210/jc.2005-1718; Tam FWK, 2009, CYTOKINE, V47, P37, DOI 10.1016/j.cyto.2009.04.001; Tan XY, 2008, J AM SOC NEPHROL, V19, P1741, DOI 10.1681/ASN.2007060666; Wu CC, 2010, CLIN CHIM ACTA, V411, P700, DOI 10.1016/j.cca.2010.01.036; Wu J, 2011, LAB INVEST, V91, P1459, DOI 10.1038/labinvest.2011.93; Zhang Z, 2007, KIDNEY INT, V72, P193, DOI 10.1038/sj.ki.5002296	22	34	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99633	10.1371/journal.pone.0099633	http://dx.doi.org/10.1371/journal.pone.0099633			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936866	Green Submitted, Green Published, gold			2022-12-25	WOS:000338503400028
J	Goode, G; Pratap, S; Eltom, SE				Goode, Gennifer; Pratap, Siddharth; Eltom, Sakina E.			Depletion of the Aryl Hydrocarbon Receptor in MDA-MB-231 Human Breast Cancer Cells Altered the Expression of Genes in Key Regulatory Pathways of Cancer	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; ACTIVATION; OVEREXPRESSION; TRANSCRIPTION; ANGIOGENESIS; LIGAND; SIGNAL; ABCC3; CCL2; P53	The aryl hydrocarbon receptor (AhR), a transcription factor that is best known for its role in mediating the toxic responses elicited by poly aromatic hydrocarbons as well as many other environmental factors; is also involved in breast cancer progression. We previously reported that stable knockdown of AhR decreased the tumorigenic properties of the highly metastatic MDA-MB-231 breast cancer cell line; whereas ectopic overexpression of AhR was sufficient to transform immortalized human mammary epithelial cells to exhibit malignant phenotypes. In the present study we investigated the genes that are differentially regulated by AhR and are controlling cellular processes linked to breast cancer. We used Affymetrix Human GeneChip 1.0-ST whole transcriptome arrays to analyze alterations of gene expression resulting from stable AhR knockdown in the MDA-MB-231 breast cancer cell line. The expression of 144 genes was significantly altered with >= 2.0-fold change and a multiple test corrected p-value <= 0.05, as a result of AhR knockdown. We demonstrate that AhR knockdown alters the expression of several genes known to be linked to cancer. These genes include those involved in tryptophan metabolism (KYNU), cell growth (MUC1 and IL8), cell survival (BIRC3 and BCL3), cell migration and invasion (S100A4 and ABI3), multi-drug resistance (ABCC3) and angiogenesis (VEGFA and CCL2). The identification of the genes and pathways affected by AhR depletion provides new insight into possible molecular events that could explain the reported phenotypic changes. In conclusion AhR knockdown alters the expression of genes known to enhance or inhibit cancer progression; tipping the balance towards a state that counteracts tumor progression.	[Goode, Gennifer; Eltom, Sakina E.] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Pratap, Siddharth] Meharry Med Coll, Micorarray & Bioinformat Core, Nashville, TN 37208 USA	Meharry Medical College; Meharry Medical College	Eltom, SE (corresponding author), Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA.	seltom@mmc.edu		Pratap, Siddharth/0000-0003-2200-0848	NIH [SC1-CA153326, G12-RR003032, G12-MD007586]; NATIONAL CANCER INSTITUTE [SC1CA153326] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003032] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research was supported by NIH grants SC1-CA153326 and G12-RR003032 (SEE) and G12-MD007586 (SP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson P, 2002, P NATL ACAD SCI USA, V99, P9990, DOI 10.1073/pnas.152706299; Brooks J, 2011, CURR CANCER DRUG TAR, V11, P654, DOI 10.2174/156800911795655967; Callero MA, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/923250; Cerutti JM, 2004, J CLIN INVEST, V113, P1234, DOI 10.1172/JCI200419617; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Dai Y, 2003, MOL PHARMACOL, V64, P1402, DOI 10.1124/mol.64.6.1402; Dale YR, 2006, MOL PHARMACOL, V70, P1481, DOI 10.1124/mol.106.027474; Eguchi H, 1997, J BIOL CHEM, V272, P17640, DOI 10.1074/jbc.272.28.17640; Eltom SE, 2006, P AM ASS CAN RES, V47; Fondevila C, 2004, BRIT J CANCER, V90, P206, DOI 10.1038/sj.bjc.6601455; Gao J, 2009, BIOINFORMATICS, V25, P137, DOI 10.1093/bioinformatics/btn501; Goode GD, 2013, INT J CANCER, V133, P2769, DOI 10.1002/ijc.28297; Hattrup CL, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1515; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ismail TM, 2010, J BIOL CHEM, V285, P914, DOI 10.1074/jbc.M109.010892; Kanno Y, 2007, BIOCHEM BIOPH RES CO, V364, P1026, DOI 10.1016/j.bbrc.2007.10.140; Lee HJ, 2004, J NEUROCHEM, V88, P647, DOI 10.1111/j.1471-4159.2004.02191.x; Li ZH, 2003, BIOCHEMISTRY-US, V42, P14258, DOI 10.1021/bi0354379; Low-Marchelli JM, 2013, CANCER RES, V73, P662, DOI 10.1158/0008-5472.CAN-12-0653; Ma O, 2009, CANCER RES, V69, P2559, DOI 10.1158/0008-5472.CAN-08-2929; Miyazaki K, 2000, BBA-GENE STRUCT EXPR, V1493, P237, DOI 10.1016/S0167-4781(00)00158-5; Moennikes O, 2004, CANCER RES, V64, P4707, DOI 10.1158/0008-5472.CAN-03-0875; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Ning Y, 2012, EXPERT OPIN THER TAR; O'Brien C, 2008, CANCER RES, V68, P5380, DOI 10.1158/0008-5472.CAN-08-0234; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Partanen L, 2012, GENE CHROMOSOME CANC, V51, P832, DOI 10.1002/gcc.21967; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Schlezinger JJ, 2006, BIOL CHEM, V387, P1175, DOI 10.1515/BC.2006.145; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; SWANSON HI, 1993, PHARMACOGENETICS, V3, P213, DOI 10.1097/00008571-199310000-00001; Wong PS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-234; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	36	18	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100103	10.1371/journal.pone.0100103	http://dx.doi.org/10.1371/journal.pone.0100103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932473	Green Published, Green Submitted, gold			2022-12-25	WOS:000337738600095
J	Zhang, YY; Chen, H; Sun, C; Wang, HZ; Liu, ML; Li, YY; Nie, XL; Du, MR; Li, DJ; Zhang, JP				Zhang, Yuan-yuan; Chen, Hui; Sun, Chan; Wang, Hua-zhao; Liu, Mei-lan; Li, Yi-yang; Nie, Xiao-lu; Du, Mei-rong; Li, Da-jin; Zhang, Jian-ping			Expression and Functional Characterization of NOD2 in Decidual Stromal Cells Isolated during the First Trimester of Pregnancy	PLOS ONE			English	Article							MATERNAL-FETAL INTERFACE; INTESTINAL EPITHELIAL-CELLS; TOLL-LIKE RECEPTORS; DENDRITIC CELLS; BACTERIAL PEPTIDOGLYCAN; OLIGOMERIZATION DOMAIN; TROPHOBLAST CELLS; HUMAN-ENDOMETRIUM; HUMAN MONOCYTES; TNF-ALPHA	NOD2, one of the cytosolic proteins that contain a nuclear oligomerization domain (NOD), is a pattern recognition receptor (PRR) involved in innate immune responses to intracellular pathogens. Little is known, however, about the effect of NOD2 expression on the maternal-fetal relationship. Our aim was to elucidate the functions of NOD2 in normal decidual stromal cells (DSCs) from the first trimester. Tissues and DSCs were isolated from 26 patients with normal pregnancies that required abortion. The expression of NOD2 in deciduas/decidual stromal cells (DSCs) was examined by real-time PCR, immunohistochemistry, and In-cell western. DSCs containing NOD2 were stimulated by its ligand, muramyl dipeptide (MDP). The secretion of various cytokines and chemokines were measured by ELISA and the apoptotic rate was determined by flow cytometry. Treatment with MDP significantly elevated the expression of both NOD2 mRNA and protein levels in DSCs. In addition, MDP activation of NOD2 significantly increased IL-1 beta and MCP-1 cytokine expression in a dose dependent manner but had no effect on IL-12 expression. IL-1 beta and TNF-alpha also significantly increased the expression of NOD2 in DSCs, suggesting a positive feedback loop mechanism. Moreover, MDP stimulation augmented DSC apoptosis. In summary, the results suggest that NOD2 expression in DSCs plays an important role in protecting the embryo and preventing infection in the maternal-fetal interface.	[Zhang, Yuan-yuan; Chen, Hui; Wang, Hua-zhao; Liu, Mei-lan; Nie, Xiao-lu; Zhang, Jian-ping] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Obstet & Gynecol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Yuan-yuan; Chen, Hui; Wang, Hua-zhao; Liu, Mei-lan; Nie, Xiao-lu; Zhang, Jian-ping] Sun Yat Sen Univ, Key Lab Malignant Tumor Gene Regulat & Target The, Guangdong Higher Educ Inst, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Chan; Du, Mei-rong; Li, Da-jin] Fudan Univ, Shanghai Med Coll, Lab Reprod Immunol Hosp, Shanghai 200433, Peoples R China; [Sun, Chan; Du, Mei-rong; Li, Da-jin] Fudan Univ, Shanghai Med Coll, Inst Obstet & Gynecol, Shanghai 200433, Peoples R China; [Li, Yi-yang] Jilin Univ, Hosp 1, Dept Obstet & Gynecol, Changchun 130023, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Fudan University; Fudan University; Jilin University	Li, DJ (corresponding author), Fudan Univ, Shanghai Med Coll, Lab Reprod Immunol Hosp, Shanghai 200433, Peoples R China.	djli@shmu.edu.cn; zjp2570@126.com			National Nature Science Foundation of China [81000259, 81170625, 81270754, 30973207, 81070746]; Guangdong Natural Science Foundation [S2013010014411, 10151008901000007, 10451008901004246]; Guangdong Province Science and technology plan project [2012B031800352, 2010A030400011-07]; Fundamental Research Funds for the Central Universities [09YKPY73, 12ykpy29]; Research Fund for the Doctoral Program of Higher Education of China [20090171120075]; Sun Yat - sen University 5010 project [2012006]; Sun Yat - sen Memorial Hospital of Sun Yat - sen University Sun Yat - sen talent program [YY002013001]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Province Science and technology plan project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Sun Yat - sen University 5010 project; Sun Yat - sen Memorial Hospital of Sun Yat - sen University Sun Yat - sen talent program	This study was supported partially by National Nature Science Foundation of China (Nos. 81000259, 81170625, 81270754, 30973207 and 81070746), Guangdong Natural Science Foundation (Nos. S2013010014411, 10151008901000007 and 10451008901004246), Guangdong Province Science and technology plan project (No. 2012B031800352, 2010A030400011-07), Fundamental Research Funds for the Central Universities (Youth Program 09YKPY73, 12ykpy29), Research Fund for the Doctoral Program of Higher Education of China (No. 20090171120075), Sun Yat - sen University 5010 project (No. 2012006) and Sun Yat - sen Memorial Hospital of Sun Yat - sen University Sun Yat - sen talent program (YY002013001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2008, IMMUNOL INVEST, V37, P427, DOI 10.1080/08820130802191599; BULMER JN, 1988, REPROD NUTR DEV, V28, P1599, DOI 10.1051/rnd:19881006; Carneiro LAM, 2008, J PATHOL, V214, P136, DOI 10.1002/path.2271; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chaouat G, 2002, J REPROD IMMUNOL, V53, P241, DOI 10.1016/S0165-0378(01)00119-X; Costello MJ, 2007, AM J REPROD IMMUNOL, V57, P67, DOI 10.1111/j.1600-0897.2006.00447.x; Daher S, 2004, J REPROD IMMUNOL, V62, P151, DOI 10.1016/j.jri.2003.10.004; Du MR, 2014, J IMMUNOL, V192, P1502, DOI 10.4049/jimmunol.1203425; Egorina EM, 2006, J THROMB HAEMOST, V4, P614, DOI 10.1111/j.1538-7836.2005.01781.x; Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003; Fritz JH, 2005, EUR J IMMUNOL, V35, P2459, DOI 10.1002/eji.200526286; Gardner L, 2003, BIOL REPROD, V69, P1438, DOI 10.1095/biolreprod.103.017574; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Gurevich P, 2007, AM J REPROD IMMUNOL, V58, P460, DOI 10.1111/j.1600-0897.2007.00531.x; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; He YY, 2012, CLIN IMMUNOL, V145, P161, DOI 10.1016/j.clim.2012.07.017; Hess AP, 2007, BIOL REPROD, V76, P102, DOI 10.1095/biolreprod.106.054791; Houser Brandy L., 2012, Yale Journal of Biology and Medicine, V85, P105; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kabesch M, 2003, J ALLERGY CLIN IMMUN, V111, P813, DOI 10.1067/mai.2003.1336; KING A, 1989, HUM IMMUNOL, V24, P195, DOI 10.1016/0198-8859(89)90060-8; King AE, 2009, MOL HUM REPROD, V15, P311, DOI 10.1093/molehr/gap020; Krikun G, 2007, HISTOL HISTOPATHOL, V22, P847, DOI 10.14670/HH-22.847; Lamont RF, 2003, HOSP MED, V64, P644, DOI 10.12968/hosp.2003.64.11.2343; Lee KH, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.410027; Meresman GF, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-126; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Mitchell JA, 2007, J ENDOCRINOL, V193, P323, DOI 10.1677/JOE-07-0067; Mulla MJ, 2009, AM J REPROD IMMUNOL, V61, P294, DOI 10.1111/j.1600-0897.2009.00694.x; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Oh HM, 2005, CELL IMMUNOL, V237, P37, DOI 10.1016/j.cellimm.2005.09.006; Opitz B, 2005, CIRC RES, V96, P319, DOI 10.1161/01.RES.0000155721.83594.2c; Rosenstiel P, 2003, GASTROENTEROLOGY, V124, P1001, DOI 10.1053/gast.2003.50157; Rull K, 2013, PLACENTA, V34, P141, DOI 10.1016/j.placenta.2012.11.032; Saini V, 2011, CLIN CHIM ACTA, V412, P702, DOI 10.1016/j.cca.2011.01.002; Sanguansermsri D, 2008, ASIAN PAC J ALLERGY, V26, P171; Schatz F, 2012, AM J REPROD IMMUNOL, V68, P146, DOI 10.1111/j.1600-0897.2012.01148.x; Takahashi Y, 2006, J VET MED SCI, V68, P471, DOI 10.1292/jvms.68.471; Uehara A, 2007, J DENT RES, V86, P249, DOI 10.1177/154405910708600310; van Rijn BB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001865; von Dadelszen P, 2002, ACTA OBSTET GYN SCAN, V81, P642, DOI 10.1034/j.1600-0412.2002.810710.x; Wei DH, 2014, EXP THER MED, V7, P191, DOI 10.3892/etm.2013.1399	44	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99612	10.1371/journal.pone.0099612	http://dx.doi.org/10.1371/journal.pone.0099612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932916	Green Published, gold, Green Submitted			2022-12-25	WOS:000337738600048
J	Diao, YF; Oqani, RK; Li, XX; Lin, T; Kang, JW; Jin, DI				Diao, Yun Fei; Oqani, Reza K.; Li, Xiao Xia; Lin, Tao; Kang, Jung Won; Jin, Dong Il			Changes in Histone H3 Lysine 36 Methylation in Porcine Oocytes and Preimplantation Embryos	PLOS ONE			English	Article							RNA-POLYMERASE-II; CELL NUCLEAR TRANSFER; CLONED MOUSE EMBRYOS; GENOME-WIDE; TRANSCRIPTIONAL ELONGATION; CHROMATIN MODIFICATIONS; H3K36 METHYLATION; GENE-EXPRESSION; STEM-CELLS; IN-VITRO	Histone H3 lysine 36 (H3K36) methylation is known to be associated with transcriptionally active genes, and is considered a genomic marker of active loci. To investigate the changes in H3K36 methylation in pig, we determined the mono-, di-, and tri-methylations of H3K36 (H3K36me1, H3K36me2 and H3K36me3, respectively) in porcine fetal fibroblasts, oocytes and preimplantation embryos by immunocytochemistry using specific antibodies and confocal microscopy. These analyses revealed that only H3K36me3 in porcine fetal fibroblasts consistently colocalized with transcription sites identified as actively synthesizing RNA based on fluorouridine (FU) incorporation. Treatment of cells with flavopiridol, which blocks transcription elongation, completely abrogated both H3K36me3 signals and RNA synthesis. All three types of H3K36 methylation were present and did not significantly differ during oocyte maturation. In parthenogenetic embryos, H3K36me1 and -me2 were detected in 1-cell through blastocyst-stage embryos. In contrast, H3K36me3 was not detected in most 1-cell stage embryos. H3K36me3 signals became detectable in 2-cell stage embryos, peaked at the 4-cell stage, decreased at the 8-cell stage, and then became undetectable at blastocyst stages in both parthenogenetic and in vitro-fertilized (IVF) embryos. Unlike the case in IVF embryos, H3K36me3 could not be demethylated completely during the 1-cell stage in somatic cell nuclear transfer (SCNT) embryos. These results collectively indicate that H3K36me3, but not H3K36me1 or -me2, is associated with transcription elongation in porcine fetal fibroblasts. H3K36me3 is developmentally regulated and may be a histone mark of embryonic gene activation in pig. Aberrant H3K36 tri-methylation occurred during the nuclear reprogramming of SCNT embryos.	[Diao, Yun Fei; Oqani, Reza K.; Li, Xiao Xia; Lin, Tao; Kang, Jung Won; Jin, Dong Il] Chungnam Natl Univ, Dept Anim Sci & Biotechnol, Res Ctr Transgen Cloned Pigs, Taejon, South Korea	Chungnam National University	Jin, DI (corresponding author), Chungnam Natl Univ, Dept Anim Sci & Biotechnol, Res Ctr Transgen Cloned Pigs, Taejon, South Korea.	dijin@cnu.ac.kr		Lin, Tao/0000-0001-9100-6042	BioGreen 21 Program of the Rural Development Administration [PJ009060]; Bio-industry Technology Development Program of the Ministry for Food and Agriculture, Republic of Korea [IPET312060-5]	BioGreen 21 Program of the Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Bio-industry Technology Development Program of the Ministry for Food and Agriculture, Republic of Korea	This work was supported by the BioGreen 21 Program of the Rural Development Administration (grant no. PJ009060) and the Bio-industry Technology Development Program (grant no. IPET312060-5) of the Ministry for Food and Agriculture, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES FL, 1991, MOL REPROD DEV, V29, P117, DOI 10.1002/mrd.1080290205; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; Bellier S, 1997, EMBO J, V16, P6250, DOI 10.1093/emboj/16.20.6250; Bjerregaard B, 2007, MOL REPROD DEV, V74, P35, DOI 10.1002/mrd.20594; Boskovic A, 2012, EPIGENETICS-US, V7, P747, DOI 10.4161/epi.20584; Breton A, 2010, J REPROD DEVELOP, V56, P379, DOI 10.1262/jrd.09-182A; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Diao YF, 2013, ANIM REPROD SCI, V141, P164, DOI 10.1016/j.anireprosci.2013.08.008; Dillon N, 2002, TRENDS GENET, V18, P252, DOI 10.1016/S0168-9525(02)02648-3; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Gerber M, 2003, J BIOL CHEM, V278, P26303, DOI 10.1074/jbc.R300014200; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hu M, 2010, P NATL ACAD SCI USA, V107, P2956, DOI 10.1073/pnas.0915033107; Hyttel P, 2000, BIOL REPROD, V63, P1848, DOI 10.1095/biolreprod63.6.1848; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kanka J, 2003, THERIOGENOLOGY, V59, P3, DOI 10.1016/S0093-691X(02)01267-0; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Latham KE, 2001, FRONT BIOSCI, V6, pD748, DOI 10.2741/Latham; Lee JS, 2007, MUTAT RES-FUND MOL M, V618, P130, DOI 10.1016/j.mrfmmm.2006.08.014; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Li XX, 2013, THERIOGENOLOGY, V79, P291, DOI 10.1016/j.theriogenology.2012.08.019; Lin CQ, 2011, GENE DEV, V25, P1486, DOI 10.1101/gad.2059211; Luo L, 2009, J CELL SCI, V122, P3729, DOI 10.1242/jcs.052555; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mason K, 2012, ANIM REPROD SCI, V134, P45, DOI 10.1016/j.anireprosci.2012.08.010; Miao F, 2005, MOL CELL BIOL, V25, P4650, DOI 10.1128/MCB.25.11.4650-4661.2005; Morris SA, 2005, EUKARYOT CELL, V4, P1446, DOI 10.1128/EC.4.8.1446-1454.2005; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Stabell M, 2007, BIOCHEM BIOPH RES CO, V359, P784, DOI 10.1016/j.bbrc.2007.05.189; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Venkatesh S, 2013, WIRES DEV BIOL, V2, P685, DOI 10.1002/wdev.109; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Wang FC, 2007, BIOL REPROD, V77, P1007, DOI 10.1095/biolreprod.107.063149; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; WORRAD DM, 1994, DEVELOPMENT, V120, P2347; Xie SQ, 2006, MOL BIOL CELL, V17, P1723, DOI 10.1091/mbc.E05-08-0726; Yuan W, 2009, J BIOL CHEM, V284, P15701, DOI 10.1074/jbc.M808431200; Zhang M, 2009, J BIOL CHEM, V284, P24981, DOI 10.1074/jbc.M109.011973; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	59	12	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100205	10.1371/journal.pone.0100205	http://dx.doi.org/10.1371/journal.pone.0100205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927323	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100118
J	Harjes, U; Bridges, E; McIntyre, A; Fielding, BA; Harris, AL				Harjes, Ulrike; Bridges, Esther; McIntyre, Alan; Fielding, Barbara A.; Harris, Adrian L.			Fatty Acid-binding Protein 4, a Point of Convergence for Angiogenic and Metabolic Signaling Pathways in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; AKT; EXPRESSION; RESISTANCE; ENERGY; FOXO1	Fatty acid-binding protein 4 (FABP4) is an adipogenic protein and is implicated in atherosclerosis, insulin resistance, and cancer. In endothelial cells, FABP4 is induced by VEGFA, and inhibition of FABP4 blocks most of the VEGFA effects. We investigated the DLL4-NOTCH-dependent regulation of FABP4 in human umbilical vein endothelial cells by gene/protein expression and interaction analyses following inhibitor treatment and RNA interference. We found that FABP4 is directly induced by NOTCH. Stimulation of NOTCH signaling with human recombinant DLL4 led to FABP4 induction, independently of VEGFA. FABP4 induction by VEGFA was reduced by blockade of DLL4 binding to NOTCH or inhibition of NOTCH signal transduction. Chromatin immunoprecipitation of the NOTCH intracellular domain showed increased binding to two specific regions in the FABP4 promoter. The induction of FABP4 gene expression was dependent on the transcription factor FOXO1, which was essential for basal expression of FABP4, and FABP4 up-regulation following stimulation of the VEGFA and/or the NOTCH pathway. Thus, we show that the DLL4-NOTCH pathway mediates endothelial FABP4 expression. This indicates that induction of the angiogenesis-restricting DLL4-NOTCH can have pro-angiogenic effects via this pathway. It also provides a link between DLL4-NOTCH and FOXO1-mediated regulation of endothelial gene transcription, and it shows that DLL4-NOTCH is a nodal point in the integration of pro-angiogenic and metabolic signaling in endothelial cells. This may be crucial for angiogenesis in the tumor environment.	[Harjes, Ulrike; Bridges, Esther; McIntyre, Alan; Harris, Adrian L.] Univ Oxford, Dept Oncol, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Fielding, Barbara A.] Churchill Hosp, Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Fielding, Barbara A.] Univ Surrey, Dept Nutr Sci, Surrey GU2 7WG, England	University of Oxford; University of Oxford; University of Surrey	Harris, AL (corresponding author), Univ Oxford, Dept Oncol, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	aharris.lab@imm.ox.ac.uk	Harris, Adrian L/ABA-3343-2020	Harris, Adrian L/0000-0003-1376-8409; Harjes, Ulrike/0000-0003-0376-1262; McIntyre, Alan/0000-0002-4791-7292	Cancer Research United Kingdom; Breast Cancer Research Foundation; National Health Service Biomedical Research Centre; Cancer Research UK [11359] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish	Cancer Research United Kingdom(Cancer Research UK); Breast Cancer Research Foundation; National Health Service Biomedical Research Centre; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by Cancer Research United Kingdom, Breast Cancer Research Foundation, and National Health Service Biomedical Research Centre.	Aragones G, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-72; Boiteux G, 2009, INT J CANCER, V124, P1820, DOI 10.1002/ijc.24112; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Castel D, 2013, GENE DEV, V27, P1059, DOI 10.1101/gad.211912.112; Cataltepe O, 2012, NEUROPATH APPL NEURO, V38, P400, DOI 10.1111/j.1365-2990.2011.01237.x; Chen XG, 2010, MOL CARCINOGEN, V49, P603, DOI 10.1002/mc.20628; Daly C, 2004, GENE DEV, V18, P1060, DOI 10.1101/gad.1189704; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Djousse L, 2012, LIPIDS, V47, P757, DOI 10.1007/s11745-012-3689-7; Elmasri H, 2012, ANGIOGENESIS, V15, P457, DOI 10.1007/s10456-012-9274-0; Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Endres K, 2003, EUR J BIOCHEM, V270, P2386, DOI 10.1046/j.1432-1033.2003.03606.x; Fan WQ, 2010, EMBO J, V29, P4223, DOI 10.1038/emboj.2010.268; Fukuda D, 2012, P NATL ACAD SCI USA, V109, pE1868, DOI 10.1073/pnas.1116889109; Hayashi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002401; Holm S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028785; Jenkins-Kruchten AE, 2003, J BIOL CHEM, V278, P47636, DOI 10.1074/jbc.M307680200; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kralisch S, 2013, DIABETOLOGIA, V56, P10, DOI 10.1007/s00125-012-2737-4; Li JL, 2011, CANCER RES, V71, P6073, DOI 10.1158/0008-5472.CAN-11-1704; Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Ohnuki H, 2012, BLOOD, V119, P2688, DOI 10.1182/blood-2011-03-345306; Pajvani UB, 2011, NAT MED, V17, P961, DOI 10.1038/nm.2378; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Roy Sanjit K, 2010, J Mol Signal, V5, P10, DOI 10.1186/1750-2187-5-10; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990	28	63	66	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23168	23176		10.1074/jbc.M114.576512	http://dx.doi.org/10.1074/jbc.M114.576512			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24939870	Green Published, hybrid			2022-12-25	WOS:000341017200053
J	Khalaf, O; Fauvet, B; Oueslati, A; Dikiy, I; Mahul-Mellier, AL; Ruggeri, FS; Mbefo, MK; Vercruysse, F; Dietler, G; Lee, SJ; Eliezer, D; Lashuel, HA				Khalaf, Ossama; Fauvet, Bruno; Oueslati, Abid; Dikiy, Igor; Mahul-Mellier, Anne-Laure; Ruggeri, Francesco Simone; Mbefo, Martial K.; Vercruysse, Filip; Dietler, Giovanni; Lee, Seung-Jae; Eliezer, David; Lashuel, Hilal A.			The H50Q Mutation Enhances alpha-Synuclein Aggregation, Secretion, and Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; WILD-TYPE; IN-VITRO; POSTTRANSLATIONAL MODIFICATIONS; MITOCHONDRIAL FISSION; LEWY BODIES; BINDING; PHOSPHORYLATION; PROTEIN; DYNAMICS	Over the last two decades, the identification of missense mutations in the alpha-synuclein (alpha-Syn) gene SNCA in families with inherited Parkinson disease (PD) has reinforced the central role of alpha-Syn in PD pathogenesis. Recently, a new missense mutation (H50Q) in alpha-Syn was described in patients with a familial form of PD and dementia. Here we investigated the effects of this novel mutation on the biophysical properties of alpha-Syn and the consequences for its cellular function. We found that the H50Q mutation affected neither the structure of free or membrane-bound alpha-Syn monomer, its interaction with metals, nor its capacity to be phosphorylated in vitro. However, compared with the wild-type (WT) protein, the H50Q mutation accelerated alpha-Syn fibrillization in vitro. In cell-based models, H50Q mutation did not affect alpha-Syn subcellular localization or its ability to be phosphorylated by PLK2 and GRK6. Interestingly, H50Q increased alpha-Syn secretion from SHSY5Y cells into culture medium and induced more mitochondrial fragmentation in hippocampal neurons. Although the transient overexpression of WT or H50Q did not induce toxicity, both species induced significant cell death when added to the culture medium of hippocampal neurons. Strikingly, H50Q exhibited more toxicity, suggesting that the H50Q-related enhancement of alpha-Syn aggregation and secretion may play a role in the extracellular toxicity of this mutant. Together, our results provide novel insight into the mechanism by which this newly described PD-associated mutation may contribute to the pathogenesis of PD and related disorders.	[Khalaf, Ossama; Fauvet, Bruno; Oueslati, Abid; Mahul-Mellier, Anne-Laure; Mbefo, Martial K.; Vercruysse, Filip; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Lab Mol & Chem Biol Neurodegenerat, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Ruggeri, Francesco Simone; Dietler, Giovanni] Ecole Polytech Fed Lausanne, Lab Phys Living Matter, CH-1015 Lausanne, Switzerland; [Eliezer, David] Weill Cornell Med Coll, Dept Biochem, Program Struct Biol, New York, NY 10065 USA; [Lee, Seung-Jae] Konkuk Univ, Dept Biomed Sci & Technol, Seoul 143701, South Korea	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Cornell University; Konkuk University	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne, Lab Mol & Chem Biol Neurodegenerat, Brain Mind Inst, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	Lashuel, Hilal/M-3500-2017; Oueslati, Abid/ABG-8116-2020; Khalaf, Ossama/AAE-9775-2021; Dikiy, Igor/M-1031-2019; Ruggeri, Francesco Simone/C-8004-2012	Dikiy, Igor/0000-0002-8155-7788; Ruggeri, Francesco Simone/0000-0002-1232-1907; Oueslati, Abid/0000-0003-1122-7086; Khalaf, Ossama/0000-0002-8576-2260; Lee, Seung-Jae/0000-0002-5155-5335	National Institutes of Health [P41GM066354]; Keck Foundation; New York State Assembly; U.S. Department of Defense; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG019391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); New York State Assembly; U.S. Department of Defense(United States Department of Defense); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Nathalie Jordan and Trudy Ramlall for their excellent technical support. The 900 MHz NMR spectrometers were purchased with funds from National Institutes of Health Grant P41GM066354, the Keck Foundation, the New York State Assembly, and the U.S. Department of Defense.	Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Baba M, 1998, AM J PATHOL, V152, P879; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bussell R, 2005, PROTEIN SCI, V14, P862, DOI 10.1110/ps.041255905; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Choubey V, 2011, J BIOL CHEM, V286, P10814, DOI 10.1074/jbc.M110.132514; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dudzik CG, 2011, BIOCHEMISTRY-US, V50, P1771, DOI 10.1021/bi101912q; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Emmanouilidou E, 2010, NEUROBIOL AGING, V31, P953, DOI 10.1016/j.neurobiolaging.2008.07.008; Fares MB, 2014, HUM MOL GENET, V23, P4491, DOI 10.1093/hmg/ddu165; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Gui YX, 2012, NEUROBIOL AGING, V33, P2841, DOI 10.1016/j.neurobiolaging.2012.02.001; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hejjaoui M, 2012, J AM CHEM SOC, V134, P5196, DOI 10.1021/ja210866j; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Kara E, 2013, NEUROSCI LETT, V546, P67, DOI 10.1016/j.neulet.2013.04.058; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Khurana R, 2003, BIOPHYS J, V85, P1135, DOI 10.1016/S0006-3495(03)74550-0; Kim YS, 2006, J MOL BIOL, V360, P386, DOI 10.1016/j.jmb.2006.05.004; Knott AB, 2008, ANN NY ACAD SCI, V1147, P283, DOI 10.1196/annals.1427.030; Ko LW, 2008, J NEUROPATH EXP NEUR, V67, P1084, DOI 10.1097/NEN.0b013e31818c3618; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kowalik-Jankowska T, 2006, DALTON T, P5068, DOI 10.1039/b610619f; Kuwahara T, 2012, J BIOL CHEM, V287, P7098, DOI 10.1074/jbc.M111.237131; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Lee HJ, 2011, EXP MOL MED, V43, P216, DOI 10.3858/emm.2011.43.4.026; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee M, 2001, J NEUROCHEM, V76, P998, DOI 10.1046/j.1471-4159.2001.00149.x; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; Meuer K, 2007, CELL DEATH DIFFER, V14, P651, DOI 10.1038/sj.cdd.4402087; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Oueslati A, 2013, P NATL ACAD SCI USA, V110, pE3945, DOI 10.1073/pnas.1309991110; Oueslati A, 2012, J NEUROSCI, V32, P1536, DOI 10.1523/JNEUROSCI.3784-11.2012; Oueslati A, 2010, PROG BRAIN RES, V183, P115, DOI 10.1016/S0079-6123(10)83007-9; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Pandey N, 2006, EXP NEUROL, V197, P515, DOI 10.1016/j.expneurol.2005.10.019; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Proukakis C, 2013, MOVEMENT DISORD, V28, P705, DOI 10.1002/mds.25502; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Rospigliosi CC, 2009, J MOL BIOL, V388, P1022, DOI 10.1016/j.jmb.2009.03.065; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Steiner P, 2002, J CELL BIOL, V157, P1197, DOI 10.1083/jcb.200202022; Sung YH, 2006, BBA-PROTEINS PROTEOM, V1764, P5, DOI 10.1016/j.bbapap.2005.11.003; Sung YH, 2007, J MOL BIOL, V372, P689, DOI 10.1016/j.jmb.2007.07.008; Sweers KKM, 2012, SOFT MATTER, V8, P7215, DOI 10.1039/c2sm25426c; Tabrizi SJ, 2000, HUM MOL GENET, V9, P2683, DOI 10.1093/hmg/9.18.2683; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wislet-Gendebien S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-92; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang HY, 2013, BIOPHYS J, V104, P2706, DOI 10.1016/j.bpj.2013.04.050	62	125	129	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21856	21876		10.1074/jbc.M114.553297	http://dx.doi.org/10.1074/jbc.M114.553297			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24936070	Green Published, hybrid			2022-12-25	WOS:000340593500005
J	Sanchez, HA; Bienkowski, R; Slavi, N; Srinivas, M; Verselis, VK				Sanchez, Helmuth A.; Bienkowski, Rick; Slavi, Nefeli; Srinivas, Miduturu; Verselis, Vytas K.			Altered Inhibition of Cx26 Hemichannels by pH and Zn2+ in the A40V Mutation Associated with Keratitis-Ichthyosis-Deafness Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION CHANNEL; HORIZONTAL CELLS; XENOPUS-OOCYTES; SKIN-DISEASE; CONNEXIN26-CONTAINING CHANNELS; CONNEXIN HEMICHANNELS; FUNCTIONAL EXPRESSION; ZINC MODULATION; CA2+ REGULATION; ATP RELEASE	Excessive opening of undocked Cx26 hemichannels in the plasma membrane is associated with disease pathogenesis in keratitis-ichthyosis-deafness (KID) syndrome. Thus far, excessive opening of KID mutant hemichannels has been attributed, almost solely, to aberrant inhibition by extracellular Ca2+. This study presents two new possible contributing factors, pH and Zn2+. Plasma pH levels and micromolar concentrations of Zn2+ inhibit WT Cx26 hemichannels. However, A40V KID mutant hemichannels show substantially reduced inhibition by these factors. Using excised patches, acidification was shown to be effective from either side of the membrane, suggesting a protonation site accessible to H+ flux through the pore. Sensitivity to pH was not dependent on extracellular aminosulfonate pH buffers. Single channel recordings showed that acidification did not affect unitary conductance or block the hemichannel but rather promoted gating to the closed state with transitions characteristic of the intrinsic loop gating mechanism. Examination of two nearby KID mutants in the E1 domain, G45E and D50N, showed no changes in modulation by pH or Zn2+. N-bromo-succinimide, but not thiol-specific reagents, attenuated both pH and Zn2+ responses. Individually mutating each of the five His residues in WT Cx26 did not reveal a key His residue that conferred sensitivity to pH or Zn2+. From these data and the crystal structure of Cx26 that suggests that Ala-40 contributes to an intrasubunit hydrophobic core, the principal effect of the A40V mutation is probably a perturbation in structure that affects loop gating, thereby affecting multiple factors that act to close Cx26 hemichannels via this gating mechanism.	[Sanchez, Helmuth A.; Verselis, Vytas K.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA; [Bienkowski, Rick] Emory Univ, Dept Cell Biol, Sch Med, Atlanta, GA 30322 USA; [Slavi, Nefeli; Srinivas, Miduturu] SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA	Yeshiva University; Albert Einstein College of Medicine; Emory University; State University of New York (SUNY) System; SUNY Optometry	Verselis, VK (corresponding author), Albert Einstein Coll Med, Dept Neurosci, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	vytas.verselis@einstein.yu.edu		SANCHEZ RIQUELME, HELMUTH/0000-0003-0770-9082	National Institutes of Health [GM054179, EY013869, T32 NS007439]; NATIONAL EYE INSTITUTE [R01EY013869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM054179 (to V. K. V.), EY013869 (to M. S.), and T32 NS007439 (to H. A. S).	Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Beahm DL, 2002, BIOPHYS J, V82, P2016, DOI 10.1016/S0006-3495(02)75550-1; Bevans CG, 1999, J BIOL CHEM, V274, P3711, DOI 10.1074/jbc.274.6.3711; Bukauskas FF, 2004, BBA-BIOMEMBRANES, V1662, P42, DOI 10.1016/j.bbamem.2004.01.008; Chappell RL, 2004, BIOL BULL-US, V207, P188, DOI 10.2307/1543206; Dermietzel R, 2000, J NEUROSCI, V20, P8331, DOI 10.1523/JNEUROSCI.20-22-08331.2000; Di WL, 2001, J INVEST DERMATOL, V117, P958, DOI 10.1046/j.0022-202x.2001.01468.x; EBIHARA L, 1993, J GEN PHYSIOL, V102, P59, DOI 10.1085/jgp.102.1.59; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; Gossman DG, 2008, CELL COMMUN ADHES, V15, P305, DOI 10.1080/15419060802357217; HARRIS AL, 1981, J GEN PHYSIOL, V77, P95, DOI 10.1085/jgp.77.1.95; Hombach S, 2004, EUR J NEUROSCI, V19, P2633, DOI 10.1111/j.0953-816X.2004.03360.x; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Klaassen LJ, 2012, BRAIN RES, V1487, P25, DOI 10.1016/j.brainres.2012.04.059; Kumar Piyush, 2012, Dermatol Online J, V18, P1; Lee JR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001276; Lee JR, 2009, J INVEST DERMATOL, V129, P870, DOI 10.1038/jid.2008.335; Lee SH, 2006, YONSEI MED J, V47, P293, DOI 10.3349/ymj.2006.47.3.293; Levit NA, 2012, BBA-BIOMEMBRANES, V1818, P2014, DOI 10.1016/j.bbamem.2011.09.003; Locke D, 2011, J GEN PHYSIOL, V138, P321, DOI 10.1085/jgp.201110634; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lopez W, 2013, J GEN PHYSIOL, V142, P23, DOI 10.1085/jgp.201210893; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Mese G, 2011, MOL BIOL CELL, V22, P4776, DOI 10.1091/mbc.E11-09-0778; Mhaske PV, 2013, AM J PHYSIOL-CELL PH, V304, pC1150, DOI 10.1152/ajpcell.00374.2012; Miles E W, 1977, Methods Enzymol, V47, P431; Nakagawa S, 2010, CURR OPIN STRUC BIOL, V20, P423, DOI 10.1016/j.sbi.2010.05.003; Ripps H, 2004, CELL MOL NEUROBIOL, V24, P647, DOI 10.1023/B:CEMN.0000036403.43484.3d; Rubinos C, 2012, J GEN PHYSIOL, V139, P69, DOI 10.1085/jgp.201110678; Sanchez HA, 2013, J GEN PHYSIOL, V142, P3, DOI 10.1085/jgp.201310962; Sanchez HA, 2010, J GEN PHYSIOL, V136, P47, DOI 10.1085/jgp.201010433; Scott CA, 2012, BBA-BIOMEMBRANES, V1818, P1952, DOI 10.1016/j.bbamem.2011.09.004; Spande T F, 1970, Adv Protein Chem, V24, P97, DOI 10.1016/S0065-3233(08)60242-9; SPRAY DC, 1981, J GEN PHYSIOL, V77, P77, DOI 10.1085/jgp.77.1.77; Stefaniak AB, 2013, SKIN RES TECHNOL, V19, P59, DOI 10.1111/srt.12016; Stong BC, 2006, LARYNGOSCOPE, V116, P2205, DOI 10.1097/01.mlg.0000241944.77192.d2; Sun Z, 2009, J NEUROPHYSIOL, V101, P1774, DOI 10.1152/jn.90581.2008; Tao L, 2004, J BIOL CHEM, V279, P38544, DOI 10.1074/jbc.M405654200; Terrinoni A, 2010, BIOCHEM BIOPH RES CO, V394, P909, DOI 10.1016/j.bbrc.2010.03.073; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Trexler EB, 2000, BIOPHYS J, V79, P3036, DOI 10.1016/S0006-3495(00)76539-8; Trexler EB, 1999, J GEN PHYSIOL, V113, P721; Trexler EB, 1996, P NATL ACAD SCI USA, V93, P5836, DOI 10.1073/pnas.93.12.5836; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; Xu J, 2013, BBA-BIOMEMBRANES, V1828, P167, DOI 10.1016/j.bbamem.2012.06.024; Zhao HB, 2005, P NATL ACAD SCI USA, V102, P18724, DOI 10.1073/pnas.0506481102; Zoidl G, 2004, J BIOL CHEM, V279, P2913, DOI 10.1074/jbc.M304850200	47	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21519	21532		10.1074/jbc.M114.578757	http://dx.doi.org/10.1074/jbc.M114.578757			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24939841	hybrid, Green Published			2022-12-25	WOS:000340558300028
J	Brozzi, F; Gerlo, S; Grieco, FA; Nardelli, TR; Lievens, S; Gysemans, C; Marselli, L; Marchetti, P; Mathieu, C; Tavernier, J; Eizirik, DL				Brozzi, Flora; Gerlo, Sarah; Grieco, Fabio Arturo; Nardelli, Tarlliza Romanna; Lievens, Sam; Gysemans, Conny; Marselli, Lorella; Marchetti, Piero; Mathieu, Chantal; Tavernier, Jan; Eizirik, Decio L.			A Combined "Omics" Approach Identifies N-Myc Interactor as a Novel Cytokine-induced Regulator of IRE1 alpha Protein and c-Jun N-terminal Kinase in Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SIGNAL-TRANSDUCTION; INDUCED APOPTOSIS; CANDIDATE GENE; MESSENGER-RNAS; ISLET INFLAMMATION; ER STRESS; NOD MICE; TYPE-1; DEATH	Type 1 diabetes is an autoimmune disease with a strong inflammatory component. The cytokines interleukin-1 beta and interferon-gamma contribute to beta cell apoptosis in type 1 diabetes. These cytokines induce endoplasmic reticulum stress and the unfolded protein response (UPR), contributing to the loss of beta cells. IRE1 alpha, one of the UPR mediators, triggers insulin degradation and inflammation in beta cells and is critical for the transition from "physiological" to "pathological" UPR. The mechanisms regulating inositol-requiring protein 1 alpha (IRE1 alpha) activation and its signaling for beta cell "adaptation," "stress response," or "apoptosis" remain to be clarified. To address these questions, we combined mammalian protein-protein interaction trap-based IRE1 alpha interactome and functional genomic analysis of human and rodent beta cells exposed to pro-inflammatory cytokines to identify novel cytokine-induced regulators of IRE1 alpha. Based on this approach, we identified N-Myc interactor (NMI) as an IRE1 alpha-interacting/modulator protein in rodent and human pancreatic beta cells. An increased expression of NMI was detected in islets from nonobese diabetic mice with insulitis and in rodent or human beta cells exposed in vitro to the pro-inflammatory cytokines interleukin-1 beta and interferon-gamma. Detailed mechanistic studies demonstrated that NMI negatively modulates IRE1 alpha-dependent activation of JNK and apoptosis in rodent and human pancreatic beta cells. In conclusion, by using a combined omics approach, we identified NMI induction as a novel negative feedback mechanism that decreases IRE1 alpha-dependent activation of JNK and apoptosis in cytokine-exposed beta cells.	[Brozzi, Flora; Grieco, Fabio Arturo; Nardelli, Tarlliza Romanna; Eizirik, Decio L.] Univ Libre Bruxelles, Lab Expt Med, B-1070 Brussels, Belgium; [Brozzi, Flora; Grieco, Fabio Arturo; Nardelli, Tarlliza Romanna; Eizirik, Decio L.] Univ Libre Bruxelles, Ctr Diabet Res, B-1070 Brussels, Belgium; [Gerlo, Sarah; Lievens, Sam; Tavernier, Jan] Flanders Interuniv Inst Biotechnol VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Gerlo, Sarah; Lievens, Sam; Tavernier, Jan] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Nardelli, Tarlliza Romanna] Univ Estadual Campinas, Lab Endocrine Pancreas & Metab, BR-13083970 Sao Paulo, Brazil; [Gysemans, Conny; Mathieu, Chantal] KULeuven, Lab Clin & Expt Endocrinol, B-3000 Leuven, Belgium; [Marselli, Lorella; Marchetti, Piero] Univ Pisa, Dept Clin & Expt Med, Islet Cell Lab, I-56126 Pisa, Italy	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Flanders Institute for Biotechnology (VIB); Ghent University; Universidade Estadual de Campinas; KU Leuven; University of Pisa	Eizirik, DL (corresponding author), Univ Libre Bruxelles, Lab Expt Med, Route Lennik 808,CP618, B-1070 Brussels, Belgium.	deizirik@ulb.ac.be	Tavernier, Jan/AAG-3636-2019; Marchetti, Piero/J-7439-2013; mathieu, chantal/ABD-5505-2021	Marchetti, Piero/0000-0003-4907-0635; mathieu, chantal/0000-0002-4055-5233; gysemans, conny/0000-0003-3559-6089; Marselli, Lorella/0000-0002-6698-2962	Juvenile Diabetes Research Foundation [17-2013-515]; European Union Projects NAMIT and BetaBat, in the Framework Programme 7 of the European Community; Actions de Recherche Concertee de la Communaute Francaise; Fonds National de la Recherche Scientifique, Belgium; Ghent University GROUP-ID Multidisciplinary Research Platform; Katholieke Universiteit Leuven and the seventh Framework Program of the European Union	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Union Projects NAMIT and BetaBat, in the Framework Programme 7 of the European Community; Actions de Recherche Concertee de la Communaute Francaise; Fonds National de la Recherche Scientifique, Belgium(Fonds de la Recherche Scientifique - FNRS); Ghent University GROUP-ID Multidisciplinary Research Platform; Katholieke Universiteit Leuven and the seventh Framework Program of the European Union	This work was supported in part by Juvenile Diabetes Research Foundation International Grant 17-2013-515, European Union Projects NAMIT and BetaBat, in the Framework Programme 7 of the European Community, Actions de Recherche Concertee de la Communaute Francaise, and the Fonds National de la Recherche Scientifique, Belgium.; Postdoctoral fellow of the Research Foundation-Flanders and supported by the Ghent University GROUP-ID Multidisciplinary Research Platform.; Supported by the Katholieke Universiteit Leuven and the seventh Framework Program of the European Union with Natural Immunomodulators as Novel Immunotherapies for Type 1 Diabetes.	Allagnat F, 2012, CELL DEATH DIFFER, V19, P1836, DOI 10.1038/cdd.2012.67; Ammendrup A, 2000, DIABETES, V49, P1468, DOI 10.2337/diabetes.49.9.1468; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; BENDELAC A, 1987, J EXP MED, V166, P823, DOI 10.1084/jem.166.4.823; Bonny C, 2000, J BIOL CHEM, V275, P16466, DOI 10.1074/jbc.M908297199; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Cardozo AK, 2001, DIABETES, V50, P909, DOI 10.2337/diabetes.50.5.909; Chen MC, 2001, DIABETOLOGIA, V44, P325, DOI 10.1007/s001250051622; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Eizirik DL, 2013, DIABETOLOGIA, V56, P234, DOI 10.1007/s00125-012-2762-3; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Eizirik DL, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3110pe7; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; EIZIRIK DL, 1994, P NATL ACAD SCI USA, V91, P9253, DOI 10.1073/pnas.91.20.9253; EIZIRIK DL, 1994, J CLIN INVEST, V93, P1968, DOI 10.1172/JCI117188; Engin F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006534; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Grieco FA, 2014, DIABETOLOGIA, V57, P502, DOI 10.1007/s00125-013-3135-2; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Gurzov EN, 2011, TRENDS CELL BIOL, V21, P424, DOI 10.1016/j.tcb.2011.03.001; Gurzov EN, 2010, J BIOL CHEM, V285, P19910, DOI 10.1074/jbc.M110.122374; Gysemans CA, 2005, DIABETES, V54, P2396, DOI 10.2337/diabetes.54.8.2396; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Kim KH, 2012, P NATL ACAD SCI USA, V109, P7729, DOI 10.1073/pnas.1120251109; Koga S, 2012, BRAIN RES, V1436, P137, DOI 10.1016/j.brainres.2011.12.004; Kutlu B, 2003, DIABETES, V52, P2701, DOI 10.2337/diabetes.52.11.2701; Lee S, 2010, BRIT J CANCER, V103, P265, DOI 10.1038/sj.bjc.6605711; Lee SI, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3750; Lievens S, 2012, METHODS MOL BIOL, V812, P283, DOI 10.1007/978-1-61779-455-1_17; Lievens S, 2009, J PROTEOME RES, V8, P877, DOI 10.1021/pr8005167; Lipson KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001648; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Marhfour I, 2012, DIABETOLOGIA, V55, P2417, DOI 10.1007/s00125-012-2604-3; Marroqui L, 2014, DIABETES, V63, P2516, DOI 10.2337/db13-1443; Matsuzawa A, 2002, ANTIOXID REDOX SIGN, V4, P415, DOI 10.1089/15230860260196218; Miani M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.236; Miani M, 2012, ENDOCRINOLOGY, V153, P3017, DOI 10.1210/en.2011-2090; Moore F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031062; Moore F, 2012, METHODS MOL BIOL, V820, P179, DOI 10.1007/978-1-61779-439-1_11; Moore F, 2011, J BIOL CHEM, V286, P929, DOI 10.1074/jbc.M110.162131; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Ortis F, 2006, MOL ENDOCRINOL, V20, P1867, DOI 10.1210/me.2005-0268; Ortis F, 2010, DIABETES, V59, P358, DOI 10.2337/db09-1159; Overbergh L, 1999, CYTOKINE, V11, P305, DOI 10.1006/cyto.1998.0426; Pirot P, 2007, DIABETOLOGIA, V50, P1006, DOI 10.1007/s00125-007-0609-0; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; Rasschaert J, 2005, J BIOL CHEM, V280, P33984, DOI 10.1074/jbc.M502213200; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Rodriguez DA, 2012, EMBO J, V31, P2322, DOI 10.1038/emboj.2012.84; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Santin I, 2013, DIABETES OBES METAB, V15, P71, DOI 10.1111/dom.12162; Santin I, 2011, DIABETES, V60, P3279, DOI 10.2337/db11-0758; Schulz K, 1999, NITRIC OXIDE-BIOL CH, V3, P225, DOI 10.1006/niox.1999.0226; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001; Zhu MH, 1999, CELL, V96, P121, DOI 10.1016/S0092-8674(00)80965-4	69	33	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20677	20693		10.1074/jbc.M114.568808	http://dx.doi.org/10.1074/jbc.M114.568808			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24936061	Green Published, hybrid			2022-12-25	WOS:000339396600026
J	Daskin, JH; Bell, SC; Schwarzkopf, L; Alford, RA				Daskin, Joshua H.; Bell, Sara C.; Schwarzkopf, Lin; Alford, Ross A.			Cool Temperatures Reduce Antifungal Activity of Symbiotic Bacteria of Threatened Amphibians - Implications for Disease Management and Patterns of Decline	PLOS ONE			English	Article							SALAMANDER PLETHODON-CINEREUS; BATRACHOCHYTRIUM-DENDROBATIDIS; CUTANEOUS BACTERIA; PSEUDOMONAS-FLUORESCENS; ANTIBIOTIC PRODUCTION; IMMUNE DEFENSES; SKIN BACTERIA; RANA-MUSCOSA; CHYTRIDIOMYCOSIS; FROG	Chytridiomycosis, caused by the fungus Batrachochytrium dendrobatidis (Bd), is a widespread disease of amphibians responsible for population declines and extinctions. Some bacteria from amphibians' skins produce antimicrobial substances active against Bd. Supplementing populations of these cutaneous antifungal bacteria might help manage chytridiomycosis in wild amphibians. However, the activity of protective bacteria may depend upon environmental conditions. Biocontrol of Bd in nature thus requires knowledge of how environmental conditions affect their anti-Bd activity. For example, Bd-driven amphibian declines have often occurred at temperatures below Bd's optimum range. It is possible these declines occurred due to reduced anti-Bd activity of bacterial symbionts at cool temperatures. Better understanding of the effects of temperature on chytridiomycosis development could also improve risk evaluation for amphibian populations yet to encounter Bd. We characterized, at a range of temperatures approximating natural seasonal variation, the anti-Bd activity of bacterial symbionts from the skins of three species of rainforest tree frogs (Litoria nannotis, Litoria rheocola, and Litoria serrata). All three species declined during chytridiomycosis outbreaks in the late 1980s and early 1990s and have subsequently recovered to differing extents. We collected anti-Bd bacterial symbionts from frogs and cultured the bacteria at constant temperatures from 8 degrees C to 33 degrees C. Using a spectrophotometric assay, we monitored Bd growth in cell-free supernatants (CFSs) from each temperature treatment. CFSs from 11 of 24 bacteria showed reduced anti-Bd activity in vitro when they were produced at cool temperatures similar to those encountered by the host species during population declines. Reduced anti-Bd activity of metabolites produced at low temperatures may, therefore, partially explain the association between Bd-driven declines and cool temperatures. We show that to avoid inconsistent antifungal activity, bacteria evaluated for use in chytridiomycosis biocontrol should be tested over a range of environmental temperatures spanning those likely to be encountered in the field.	[Daskin, Joshua H.; Bell, Sara C.; Schwarzkopf, Lin; Alford, Ross A.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University	Daskin, JH (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	daskin@princeton.edu	Schwarzkopf, Lin/C-1242-2012; Alford, Ross A/H-1577-2011	Schwarzkopf, Lin/0000-0002-1009-670X; Alford, Ross A/0000-0002-3010-6768; Bell, Sara/0000-0003-1327-0360	Australian Research Council [DP0986537, DP130101635]; Australian-American Fulbright Commission	Australian Research Council(Australian Research Council); Australian-American Fulbright Commission	Research funding was provided by the Australian Research Council (http://www.arc.gov.au/) Discovery Grants "Understanding and managing resistance to the amphibian chytrid fungus Batrachochytrium dendrobatidis in Australian tropical rainforest frogs" (DP0986537) and "Understanding the tipping point between epidemic and endemic disease: amphibian chytridiomycosis as a model system" (DP130101635). JHD was supported by a U.S. Postgraduate Fulbright Scholarship from the Australian-American Fulbright Commission (http://www.fulbright.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker MH, 2009, APPL ENVIRON MICROB, V75, P6635, DOI 10.1128/AEM.01294-09; Bell S.C., 2012, ROLE CUTANEOUS BACTE; Bell SC, 2013, DIS AQUAT ORGAN, V103, P77, DOI 10.3354/dao02560; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Bletz MC, 2013, ECOL LETT, V16, P807, DOI 10.1111/ele.12099; Boyles JG, 2010, FRONT ECOL ENVIRON, V8, P92, DOI 10.1890/080187; BRONSTEIN JL, 1994, TRENDS ECOL EVOL, V9, P214, DOI 10.1016/0169-5347(94)90246-1; Brucker RM, 2008, J CHEM ECOL, V34, P1422, DOI 10.1007/s10886-008-9555-7; Brucker RM, 2008, J CHEM ECOL, V34, P39, DOI 10.1007/s10886-007-9352-8; Cundliffe E, 2006, J IND MICROBIOL BIOT, V33, P500, DOI 10.1007/s10295-006-0083-6; Daskin JH, 2012, P ROY SOC B-BIOL SCI, V279, P1457, DOI 10.1098/rspb.2011.2276; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Drummond AJ., 2010, GENEIOUS V5 3 3; Duffy B, 2003, ANNU REV PHYTOPATHOL, V41, P501, DOI 10.1146/annurev.phyto.41.052002.095606; Eskew EA, 2013, EMERG INFECT DIS, V19, P1; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Harris RN, 2009, DIS AQUAT ORGAN, V83, P11, DOI 10.3354/dao02004; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Humair B, 2009, ISME J, V3, P955, DOI 10.1038/ismej.2009.42; Kavitha A, 2009, RES J BIOTECHNOL, V4, P56; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kriger KM, 2008, AUSTRAL ECOL, V33, P1022, DOI 10.1111/j.1442-9993.2008.01872.x; Lam BA, 2010, BIOL CONSERV, V143, P529, DOI 10.1016/j.biocon.2009.11.015; Lane D.J., 1991, NUCL ACID TECHNIQUES, DOI [10.1099/ijs.0.060731-0, DOI 10.1099/ijs.0.060731-0]; Lauer A, 2008, ISME J, V2, P145, DOI 10.1038/ismej.2007.110; Lauer A, 2007, COPEIA, P630, DOI 10.1643/0045-8511(2007)2007[630:CCBFTE]2.0.CO;2; Lips KR, 1998, CONSERV BIOL, V12, P106, DOI 10.1046/j.1523-1739.1998.96359.x; Little AEF, 2008, ECOLOGY, V89, P1216, DOI 10.1890/07-0815.1; Longo AV, 2010, DIS AQUAT ORGAN, V92, P253, DOI 10.3354/dao02054; McDonald KR, 1999, REV DECLINING FROGS, P14; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Plowright RK, 2008, FRONT ECOL ENVIRON, V6, P420, DOI 10.1890/070086; Prado SS, 2010, APPL ENVIRON MICROB, V76, P1261, DOI 10.1128/AEM.02034-09; Puschendorf R, 2009, ENV EFFECTS HOST PAT; Puschendorf R, 2006, BIOL CONSERV, V132, P136, DOI 10.1016/j.biocon.2006.03.010; Raaijmakers JM, 2002, ANTON LEEUW INT J G, V81, P537, DOI 10.1023/A:1020501420831; Richards SJ, 2005, AUST J ZOOL, V53, P229, DOI 10.1071/ZO03036; Richards Stephen J., 1993, Pacific Conservation Biology, V1, P66; Rollins-Smith LA, 2002, BIOCHEM BIOPH RES CO, V297, P361, DOI 10.1016/S0006-291X(02)02217-9; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; Rowley JJL, 2006, WHY DOES CHYTRIDIOMY; Rowley JJL, 2013, SCI REPORTS; Salle A. J., 1961, LAB MANUAL FUNDAMENT; Savage AE, 2011, BIOL CONSERV, V144, P1910, DOI 10.1016/j.biocon.2011.03.018; Schouten A, 2004, MOL PLANT MICROBE IN, V17, P1201, DOI 10.1094/MPMI.2004.17.11.1201; Walke JB, 2011, BIOTROPICA, V43, P396, DOI 10.1111/j.1744-7429.2011.00787.x; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1; Woodhams DC, 2007, BIOL CONSERV, V138, P390, DOI 10.1016/j.biocon.2007.05.004; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8	55	51	52	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100378	10.1371/journal.pone.0100378	http://dx.doi.org/10.1371/journal.pone.0100378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941262	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000338508200099
J	Dressick, WJ; Soto, CM; Fontana, J; Baker, CC; Myers, JD; Frantz, JA; Kim, W				Dressick, Walter J.; Soto, Carissa M.; Fontana, Jake; Baker, Colin C.; Myers, Jason D.; Frantz, Jesse A.; Kim, Woohong			Preparation and Layer-by-Layer Solution Deposition of Cu(In,Ga)O-2 Nanoparticles with Conversion to Cu(In,Ga)S-2 Films	PLOS ONE			English	Article							FLAME SPRAY-PYROLYSIS; SOLAR-CELLS; POLYELECTROLYTE MULTILAYER; PHOTOVOLTAIC DEVICES; NANOCRYSTAL FILMS; EFFICIENCY; POLYDOPAMINE; SELENIZATION; PARTICLES; POWDERS	We present a method of Cu(In,Ga)S-2 (CIGS) thin film formation via conversion of layer-by-layer (LbL) assembled Cu-In-Ga oxide (CIGO) nanoparticles and polyelectrolytes. CIGO nanoparticles were created via a novel flame-spray pyrolysis method using metal nitrate precursors, subsequently coated with polyallylamine (PAH), and dispersed in aqueous solution. Multilayer films were assembled by alternately dipping quartz, Si, and/or Mo substrates into a solution of either polydopamine (PDA) or polystyrenesulfonate (PSS) and then in the CIGO-PAH dispersion to fabricate films as thick as 1-2 microns. PSS/CIGO-PAH films were found to be inadequate due to weak adhesion to the Si and Mo substrates, excessive particle diffusion during sulfurization, and mechanical softness ill-suited to further processing. PDA/CIGO-PAH films, in contrast, were more mechanically robust and more tolerant of high temperature processing. After LbL deposition, films were oxidized to remove polymer and sulfurized at high temperature under flowing hydrogen sulfide to convert CIGO to CIGS. Complete film conversion from the oxide to the sulfide is confirmed by X-ray diffraction characterization.	[Dressick, Walter J.; Soto, Carissa M.; Fontana, Jake] US Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA; [Baker, Colin C.; Myers, Jason D.; Frantz, Jesse A.; Kim, Woohong] US Naval Res Lab, Opt Sci Div, Washington, DC USA	United States Department of Defense; United States Navy; Naval Research Laboratory; United States Department of Defense; United States Navy; Naval Research Laboratory	Dressick, WJ (corresponding author), US Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA.	walter.dressick@nrl.navy.mil; rick.kim@nrl.navy.mil	Baker, Colin C/I-6657-2015	Baker, Colin/0000-0001-5662-1795; Dressick, Walter/0000-0001-9549-9219	Office of Naval Research under the Naval Research Laboratory Accelerated Research Initiative (ARI) 6.1 Program, ONR/ARI [ONR 61153N]	Office of Naval Research under the Naval Research Laboratory Accelerated Research Initiative (ARI) 6.1 Program, ONR/ARI	The authors thank the Office of Naval Research under the Naval Research Laboratory Accelerated Research Initiative (ARI) 6.1 Program, ONR/ARI (ONR 61153N), for financial support for this work. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2013, CHEM COMMUN, V49, P496, DOI 10.1039/c2cc37519b; Ariga K, 1999, APPL CLAY SCI, V15, P137, DOI 10.1016/S0169-1317(99)00012-5; Bandara N, 2013, J ADHES SCI TECHNOL, V27, P2139, DOI 10.1080/01694243.2012.697703; Bassim ND, 2012, J PHYS CHEM C, V116, P1694, DOI 10.1021/jp207912b; Carenco S, 2010, CHEM MATER, V22, P1340, DOI 10.1021/cm902007g; Contreras MA, 1999, PROG PHOTOVOLTAICS, V7, P311, DOI 10.1002/(SICI)1099-159X(199907/08)7:4<311::AID-PIP274>3.0.CO;2-G; Cotton F. A., 1988, ADV INORGANIC CHEM; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Dilena E, 2013, CHEM MATER, V25, P3180, DOI 10.1021/cm401563u; Dressick WJ, 2012, LANGMUIR, V28, P15831, DOI 10.1021/la3033176; Dressick WJ, 1996, COLLOID SURFACE A, V108, P101, DOI 10.1016/0927-7757(95)03392-0; Dressick WJ, 1999, J VAC SCI TECHNOL A, V17, P1432, DOI 10.1116/1.581833; Fontana J, 2013, ADV OPT MATER, V1, P100, DOI 10.1002/adom.201200039; GABOR AM, 1994, APPL PHYS LETT, V65, P198, DOI 10.1063/1.112670; Ghostine RA, 2013, LANGMUIR, V29, P11742, DOI 10.1021/la401632x; Gougaud C, 2013, J ELECTROCHEM SOC, V160, pD485, DOI 10.1149/2.105310jes; Gur I, 2005, SCIENCE, V310, P462, DOI 10.1126/science.1117908; Harvey TB, 2013, ACS APPL MATER INTER, V5, P9134, DOI 10.1021/am4025142; Hemati A, 2012, J NANOMATER, V2012, DOI 10.1155/2012/512409; Hibberd CJ, 2010, PROG PHOTOVOLTAICS, V18, P434, DOI 10.1002/pip.914; Hong S, 2012, ADV FUNCT MATER, V22, P4711, DOI 10.1002/adfm.201201156; ILER RK, 1966, J COLLOID INTERF SCI, V21, P569, DOI 10.1016/0095-8522(66)90018-3; Jiang C, 2013, IND ENG CHEM RES, V52, P13393, DOI 10.1021/ie401769h; Kaelin M, 2005, THIN SOLID FILMS, V480, P486, DOI 10.1016/j.tsf.2004.11.007; Kemell M, 2005, CRIT REV SOLID STATE, V30, P1, DOI 10.1080/10408430590918341; Kim HW, 2013, ACS APPL MATER INTER, V5, P233, DOI 10.1021/am302439g; Kim YJ, 2012, LANGMUIR, V28, P10620, DOI 10.1021/la3015699; Kostelansky CN, 2006, J PHYS CHEM B, V110, P21487, DOI 10.1021/jp062663u; Laine RM, 1999, KEY ENG MAT, V159-1, P17, DOI 10.4028/www.scientific.net/KEM.159-160.17; Liebscher J, 2013, LANGMUIR, V29, P10539, DOI 10.1021/la4020288; Lundin M, 2011, LANGMUIR, V27, P7537, DOI 10.1021/la200441u; Luther JM, 2008, NANO LETT, V8, P3488, DOI 10.1021/nl802476m; Lvov YM, 2011, LANGMUIR, V27, P1212, DOI 10.1021/la1041635; Madler L, 2002, J AEROSOL SCI, V33, P369, DOI 10.1016/S0021-8502(01)00159-8; Mitzi DB, 2008, ADV MATER, V20, P3657, DOI 10.1002/adma.200800555; Mitzi DB, 2009, THIN SOLID FILMS, V517, P2158, DOI 10.1016/j.tsf.2008.10.079; Panthani MG, 2008, J AM CHEM SOC, V130, P16770, DOI 10.1021/ja805845q; Peng S, 2006, J AM CHEM SOC, V128, P10676, DOI 10.1021/ja063969h; Porcel C, 2007, LANGMUIR, V23, P1898, DOI 10.1021/la062728k; Pratsinis SE, 1998, PROG ENERG COMBUST, V24, P197, DOI 10.1016/S0360-1285(97)00028-2; Ramanathan K, 2003, PROG PHOTOVOLTAICS, V11, P225, DOI 10.1002/pip.494; Ramasamy K, 2012, CHEM COMMUN, V48, P5703, DOI 10.1039/c2cc30792h; Sasaki T, 2001, CHEM MATER, V13, P4661, DOI 10.1021/cm010478h; Schaubroeck D, 2012, J ADHES SCI TECHNOL, V26, P2301, DOI 10.1163/156856111X623104; Schmidtke J, 2010, OPT EXPRESS, V18, pA477, DOI 10.1364/OE.18.00A477; Schmitt J, 1997, ADV MATER, V9, P61, DOI 10.1002/adma.19970090114; Shi JH, 2011, PROG PHOTOVOLTAICS, V19, P160, DOI 10.1002/pip.1001; Stewart RJ, 2011, J POLYM SCI POL PHYS, V49, P757, DOI 10.1002/polb.22256; Sun YG, 2013, CHEM SOC REV, V42, P2497, DOI 10.1039/c2cs35289c; Tan HL, 2003, LANGMUIR, V19, P9311, DOI 10.1021/la035094f; Tanaka Y, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2891083; Thomson JW, 2011, J AM CHEM SOC, V133, P5036, DOI 10.1021/ja1109997; Vasekar PS, 2009, SOL ENERG MAT SOL C, V93, P69, DOI 10.1016/j.solmat.2008.04.013; Vercelli B, 2010, CHEM MATER, V22, P2001, DOI 10.1021/cm903824e; Wang XF, 2011, REACT FUNCT POLYM, V71, P254, DOI 10.1016/j.reactfunctpolym.2010.09.007; Wei SH, 1998, APPL PHYS LETT, V72, P3199, DOI 10.1063/1.121548; Wu Y, 2008, NANO LETT, V8, P2551, DOI 10.1021/nl801817d; Zhang W, 2013, BIOMACROMOLECULES, V14, P394, DOI 10.1021/bm3015768; Zhou Y, 2013, J OPTIMIZ THEORY APP, V156, P1, DOI 10.1007/s10957-013-0271-2	59	5	6	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100203	10.1371/journal.pone.0100203	http://dx.doi.org/10.1371/journal.pone.0100203			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941104	Green Submitted, Green Published, gold			2022-12-25	WOS:000338508200083
J	Endres, S; Galgani, L; Riebesell, U; Schulz, KG; Engel, A				Endres, Sonja; Galgani, Luisa; Riebesell, Ulf; Schulz, Kai-Georg; Engel, Anja			Stimulated Bacterial Growth under Elevated pCO(2): Results from an Off-Shore Mesocosm Study	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; TRANSPARENT EXOPOLYMER PARTICLES; EMILIANIA-HUXLEYI; HETEROTROPHIC BACTERIA; AQUATIC ENVIRONMENTS; PHYTOPLANKTON BLOOMS; OCEAN ACIDIFICATION; CO2 CONCENTRATION; ENZYME-ACTIVITIES; CLIMATE-CHANGE	Marine bacteria are the main consumers of freshly produced organic matter. Many enzymatic processes involved in the bacterial digestion of organic compounds were shown to be pH sensitive in previous studies. Due to the continuous rise in atmospheric CO2 concentration, seawater pH is presently decreasing at a rate unprecedented during the last 300 million years but the consequences for microbial physiology, organic matter cycling and marine biogeochemistry are still unresolved. We studied the effects of elevated seawater pCO(2) on a natural plankton community during a large-scale mesocosm study in a Norwegian fjord. Nine Kiel Off-Shore Mesocosms for Future Ocean Simulations (KOSMOS) were adjusted to different pCO(2) levels ranging initially from ca. 280 to 3000 mu atm and sampled every second day for 34 days. The first phytoplankton bloom developed around day 5. On day 14, inorganic nutrients were added to the enclosed, nutrient-poor waters to stimulate a second phytoplankton bloom, which occurred around day 20. Our results indicate that marine bacteria benefit directly and indirectly from decreasing seawater pH. During the first phytoplankton bloom, 5-10% more transparent exopolymer particles were formed in the high pCO(2) mesocosms. Simultaneously, the efficiency of the protein-degrading enzyme leucine aminopeptidase increased with decreasing pH resulting in up to three times higher values in the highest pCO(2)/lowest pH mesocosm compared to the controls. In general, total and cell-specific aminopeptidase activities were elevated under low pH conditions. The combination of enhanced enzymatic hydrolysis of organic matter and increased availability of gel particles as substrate supported up to 28% higher bacterial abundance in the high pCO(2) treatments. We conclude that ocean acidification has the potential to stimulate the bacterial community and facilitate the microbial recycling of freshly produced organic matter, thus strengthening the role of the microbial loop in the surface ocean.	[Endres, Sonja; Galgani, Luisa; Riebesell, Ulf; Schulz, Kai-Georg; Engel, Anja] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Endres, Sonja; Galgani, Luisa] Helmholtz Ctr Polar & Marine Res AWI, Alfred Wegener Inst, Bremerhaven, Germany; [Schulz, Kai-Georg] So Cross Univ, Ctr Coastal Biogeochem, Sch Environm Sci & Management, Lismore, NSW 2480, Australia	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Southern Cross University	Endres, S (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany.	sendres@geomar.de	Galgani, Luisa/J-4026-2017; Riebesell, Ulf/AAC-9717-2020; Schulz, Kai G./Q-5608-2017; Schulz, Kai/AEZ-9073-2022	Galgani, Luisa/0000-0001-5239-6893; Schulz, Kai G./0000-0002-8481-4639; Schulz, Kai/0000-0002-8481-4639; Riebesell, Ulf/0000-0002-9442-452X; Engel, Anja/0000-0002-1042-1955	BMBF project BIOACID (Biological impacts of ocean acidification) [03F0608B]; BMBF project SOPRAN II (Surface Ocean Processes in the Anthropocene) [03F0611C-TP01]	BMBF project BIOACID (Biological impacts of ocean acidification); BMBF project SOPRAN II (Surface Ocean Processes in the Anthropocene)	This work was funded by the BMBF projects BIOACID (Biological impacts of ocean acidification, 03F0608B) and SOPRAN II (Surface Ocean Processes in the Anthropocene, 03F0611C-TP01). This is contribution to the international SOLAS programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2008, BIOGEOSCIENCES, V5, P1007, DOI 10.5194/bg-5-1007-2008; Amon RMW, 1996, LIMNOL OCEANOGR, V41, P41, DOI 10.4319/lo.1996.41.1.0041; AMON RMW, 1994, NATURE, V369, P549, DOI 10.1038/369549a0; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; AZAM F, 1994, MICROBIAL ECOL, V28, P167, DOI 10.1007/BF00166806; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Beardall J, 2004, PHYCOLOGIA, V43, P26, DOI 10.2216/i0031-8884-43-1-26.1; Borchard C, 2012, BIOGEOSCIENCES, V9, P3405, DOI 10.5194/bg-9-3405-2012; Boyd PW, 2011, NAT GEOSCI, V4, P273, DOI 10.1038/ngeo1150; Brussaard CPD, 2013, BIOGEOSCIENCES, V10, P719, DOI 10.5194/bg-10-719-2013; Caruso G, 2000, J APPL MICROBIOL, V89, P951, DOI 10.1046/j.1365-2672.2000.01198.x; CHO BC, 1988, NATURE, V332, P441, DOI 10.1038/332441a0; CHROST RJ, 1992, HYDROBIOLOGIA, V243, P61, DOI 10.1007/BF00007020; Chrost RJ, 2002, BOOK SOIL P, P35; CHROST RJ, 1989, J PLANKTON RES, V11, P223, DOI 10.1093/plankt/11.2.223; Cunha A., 2010, CURRENT RES TECHNOLO, V1, P124; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Dickson A., 2010, GUIDE BEST PRACTICES, P17, DOI DOI 10.2777/58454; Endres S, 2013, BIOGEOSCIENCES, V10, P567, DOI 10.5194/bg-10-567-2013; Engel A, 2004, AQUAT MICROB ECOL, V34, P93, DOI 10.3354/ame034093; Engel A, 2004, NATURE, V428, P929, DOI 10.1038/nature02453; Engel A, 2013, BIOGEOSCIENCES, V10, P1291, DOI 10.5194/bg-10-1291-2013; Engel A, 2002, J PLANKTON RES, V24, P49, DOI 10.1093/plankt/24.1.49; Engel A, 2014, J PLANKTON RES, V36, P641, DOI 10.1093/plankt/fbt125; Engel A, 2011, J PLANKTON RES, V33, P357, DOI 10.1093/plankt/fbq122; Fagerbakke KM, 1996, AQUAT MICROB ECOL, V10, P15, DOI 10.3354/ame010015; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; Grossart HP, 2006, LIMNOL OCEANOGR, V51, P1, DOI 10.4319/lo.2006.51.1.0001; HOPPE HG, 1983, MAR ECOL PROG SER, V11, P299, DOI 10.3354/meps011299; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Joint I, 2011, ISME J, V5, P1, DOI 10.1038/ismej.2010.79; Kattner G, 2011, MICROBIAL CARBON PUM, P60, DOI DOI 10.1126/SCIENCE.OPMS.SB0001; Kirchman DL, 2009, NAT REV MICROBIOL, V7, P451, DOI 10.1038/nrmicro2115; KIRCHMAN DL, 1994, MICROBIAL ECOL, V28, P255, DOI 10.1007/BF00166816; Long RA, 1996, AQUAT MICROB ECOL, V10, P213, DOI 10.3354/ame010213; Lovdal T, 2008, BIOGEOSCIENCES, V5, P371, DOI 10.5194/bg-5-371-2008; Lunau M, 2005, ENVIRON MICROBIOL, V7, P961, DOI 10.1111/j.1462-2920.2005.00767.x; Maas EW, 2013, AQUAT MICROB ECOL, V70, P1, DOI 10.3354/ame01633; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; Nagata T., 2008, MICROBIAL ECOLOGY OC, P207, DOI DOI 10.1002/9780470281840.CH7; OBERNOSTERER I, 1995, MAR ECOL PROG SER, V116, P247, DOI 10.3354/meps116247; Ogawa H, 2001, SCIENCE, V292, P917, DOI 10.1126/science.1057627; Parvathi A, 2011, ENVIRON MONIT ASSESS, V177, P227, DOI 10.1007/s10661-010-1629-7; Passow U, 2002, PROG OCEANOGR, V55, P287, DOI 10.1016/S0079-6611(02)00138-6; Passow U, 1995, LIMNOL OCEANOGR, V40, P1326, DOI 10.4319/lo.1995.40.7.1326; Passow U, 2001, CONT SHELF RES, V21, P327, DOI 10.1016/S0278-4343(00)00101-1; Passow U, 2012, MAR ECOL PROG SER, V470, P249, DOI 10.3354/meps09985; Piontek J, 2013, BIOGEOSCIENCES, V10, P297, DOI 10.5194/bg-10-297-2013; Piontek J, 2010, BIOGEOSCIENCES, V7, P1615, DOI 10.5194/bg-7-1615-2010; Piontek J, 2009, AQUAT MICROB ECOL, V54, P305, DOI 10.3354/ame01273; Riebesell U, 2013, BIOGEOSCIENCES, V10, P1835, DOI 10.5194/bg-10-1835-2013; Riebesell U., 2011, OCEAN ACIDIFICATION; Riebesell U, 2009, P NATL ACAD SCI USA, V106, P20602, DOI 10.1073/pnas.0813291106; Rochelle-Newall E, 2004, MAR ECOL PROG SER, V272, P25, DOI 10.3354/meps272025; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Schippers P, 2004, ECOL LETT, V7, P446, DOI 10.1111/j.1461-0248.2004.00597.x; Schulz KG, 2013, BIOGEOSCIENCES, V10, P161, DOI 10.5194/bg-10-161-2013; SMITH DC, 1992, NATURE, V359, P139, DOI 10.1038/359139a0; SUESS E, 1980, NATURE, V288, P260, DOI 10.1038/288260a0; Tanaka T, 2008, BIOGEOSCIENCES, V5, P669, DOI 10.5194/bg-5-669-2008; Thingstad TF, 2008, NATURE, V455, P387, DOI 10.1038/nature07235; Tipton KF, 2009, CONT ENZYME KINETICS; TROUSSELLIER M, 1995, ESTUAR COAST SHELF S, V40, P621, DOI 10.1006/ecss.1995.0042; TURLEY CM, 1994, J MAR BIOL ASSOC UK, V74, P259, DOI 10.1017/S0025315400035827; Verdugo P, 2004, MAR CHEM, V92, P67, DOI 10.1016/j.marchem.2004.06.017; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Wohlers J, 2009, P NATL ACAD SCI USA, V106, P7067, DOI 10.1073/pnas.0812743106; Wohlers-Zollner J, 2011, LIMNOL OCEANOGR, V56, P599, DOI 10.4319/lo.2011.56.2.0599; Wolf-Gladrow DA, 1999, TELLUS B, V51, P461, DOI 10.1034/j.1600-0889.1999.00023.x; Yamada N, 2010, J OCEANOGR, V66, P233, DOI 10.1007/s10872-010-0021-0; Ziervogel K, 2007, MAR CHEM, V104, P241, DOI 10.1016/j.marchem.2006.12.001; [No title captured]	73	48	48	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99228	10.1371/journal.pone.0099228	http://dx.doi.org/10.1371/journal.pone.0099228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941307	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000338508200015
J	Neselius, S; Brisby, H; Marcusson, J; Zetterberg, H; Blennow, K; Karlsson, T				Neselius, Sanna; Brisby, Helena; Marcusson, Jan; Zetterberg, Henrik; Blennow, Kaj; Karlsson, Thomas			Neurological Assessment and Its Relationship to CSF Biomarkers in Amateur Boxers	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; DIFFUSE AXONAL INJURY; WORD-ASSOCIATION TEST; CLOSED-HEAD-INJURY; COGNITIVE IMPAIRMENT; WORKING-MEMORY; FOOTBALL PLAYERS; HIGH-SCHOOL; INDIVIDUAL-DIFFERENCES	Background: Mild traumatic brain injury (TBI) or concussion is common in many sports. Today, neuropsychological evaluation is recommended in the monitoring of a concussion and in return-to-play considerations. To investigate the sensitivity of neuropsychological assessment, we tested amateur boxers post bout and compared with controls. Further the relationship between neuropsychological test results and brain injury biomarkers in the cerebrospinal fluid (CSF) were investigated. Method: Thirty amateur boxers on high elite level with a minimum of 45 bouts and 25 non-boxing matched controls were included. Memory tests (Rey Osterrieth Complex Figure, Listening Span, Digit Span, Controlled Word Association Test, and computerized testing of episodic memory), tests of processing speed and executive functions (Trail Making, Reaction Time, and Finger Tapping) were performed and related to previously published CSF biomarker results for the axonal injury marker neurofilament light (NFL). Results: The neurological assessment showed no significant differences between boxers and controls, although elevated CSF NFL, as a sign of axonal injury, was detected in about 80% of the boxers 1-6 days post bout. The investigation of the relationship between neuropsychological evaluation and CSF NFL concentrations revealed that boxers with persisting NFL concentration elevation after at least 14 days resting time post bout, had a significantly poorer performance on Trail Making A (p = 0.041) and Simple Reaction Time (p = 0.042) compared to other boxers. Conclusion: This is the first study showing traumatic axonal brain injury can be present without measureable cognitive impairment. The repetitive, subconcussive head trauma in amateur boxing causes axonal injury that can be detected with analysis of CSF NFL, but is not sufficient to produce impairment in memory tests, tests of processing speed, or executive functions. The association of prolonged CSF NFL increase in boxers with impairment of processing speed is an interesting observation, which needs to be verified in larger studies.	[Neselius, Sanna; Brisby, Helena] Sahlgrens Univ Hosp, Dept Orthopaed, Gothenburg, Sweden; [Neselius, Sanna; Brisby, Helena] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden; [Marcusson, Jan] Linkoping Univ Hosp, Geriatr Sect, S-58185 Linkoping, Sweden; [Marcusson, Jan] Linkoping Univ, Inst Clin & Expt Med, Linkoping, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Gothenburg, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, London, England; [Karlsson, Thomas] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Karlsson, Thomas] Linkoping Univ, Linnaeus Ctr HEAD, Linkoping, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Linkoping University; Linkoping University; Sahlgrenska University Hospital; University of Gothenburg; University of London; University College London; Linkoping University; Linkoping University	Neselius, S (corresponding author), Sahlgrens Univ Hosp, Dept Orthopaed, Gothenburg, Sweden.	sanna.neselius@vgregion.se			ALF Grants, County Council of Vastra Gotaland, Sweden; Gothenburg Medical Society, Sweden; ALF Grants, County Council of Ostergotland	ALF Grants, County Council of Vastra Gotaland, Sweden; Gothenburg Medical Society, Sweden; ALF Grants, County Council of Ostergotland	This work was supported by ALF Grants, County Council of Vastra Gotaland, Sweden; Gothenburg Medical Society, Sweden; and ALF Grants, County Council of Ostergotland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchison TB, 2004, CLIN NEUROPSYCHOL, V18, P249, DOI 10.1080/13854040490501475; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Benton AL, 1994, MULTILINGUAL APHASIA; Bianco M, 2013, BRIT J SPORT MED, V47, P452, DOI 10.1136/bjsports-2012-091771; BIGLER ED, 1989, J CLIN PSYCHOL, V45, P277, DOI 10.1002/1097-4679(198903)45:2<277::AID-JCLP2270450216>3.0.CO;2-M; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; BUTLER RJ, 1994, BRIT J SPORT MED, V28, P187, DOI 10.1136/bjsm.28.3.187; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Comper P, 2010, BRAIN INJURY, V24, P1257, DOI 10.3109/02699052.2010.506854; CORNELL DG, 1997, ARCH CLIN NEUROPSYCH, V12, P47; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; HAALAND KY, 1994, J CLIN EXP NEUROPSYC, V16, P448, DOI 10.1080/01688639408402655; Halstead W.C., 1947, BRAIN INTELLIGENCE Q; Hannay H. J., 1986, EXPT TECHNIQUES HUMA; Haut M W, 2000, Appl Neuropsychol, V7, P237, DOI 10.1207/S15324826AN0704_5; Heilbronner RL, 2009, ARCH CLIN NEUROPSYCH, V24, P11, DOI 10.1093/arclin/acp005; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jordan BD, 1996, AM J SPORT MED, V24, P704, DOI 10.1177/036354659602400526; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; KASTE M, 1982, LANCET, V2, P1186; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Lezak MD, 1984, SCANDINAVIAN J WO S1, V10, P25; Loring DW, 1990, NEUROLOGY, V74, P685; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Malek-Ahmadi M, 2011, DEMENT GERIATR COGN, V32, P235, DOI 10.1159/000334525; Malm J, 1998, NEUROLOGY, V51, P433, DOI 10.1212/WNL.51.2.433; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Mayers LB, 2011, J CLIN EXP NEUROPSYC, V33, P532, DOI 10.1080/13803395.2010.535506; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mitrushina M., 2005, HDB NORMATIVE DATA N; MURELIUS O, 1991, ACTA NEUROL SCAND, V83, P9; Neselius S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081249; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Porter MD, 2003, CLIN J SPORT MED, V13, P339, DOI 10.1097/00042752-200311000-00002; Prigatano GP, 2003, J INT NEUROPSYCH SOC, V9, P128, DOI 10.1017/S1355617703000134; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; Reitan R., 1992, NEUROPSYCHOLOGICAL E; REITAN RM, 1994, J CLIN PSYCHOL, V50, P47, DOI 10.1002/1097-4679(199401)50:1<47::AID-JCLP2270500106>3.0.CO;2-X; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rosen VM, 2002, NEUROPSYCHOLOGIA, V40, P2226, DOI 10.1016/S0028-3932(02)00132-X; Ross TP, 2003, ARCH CLIN NEUROPSYCH, V18, P153, DOI 10.1016/S0887-6177(01)00192-5; Spreen O, 1998, COMPENDIUM NEUROPSYC; Thomas JR, 1999, RES Q EXERCISE SPORT, V70, P11, DOI 10.1080/02701367.1999.10607726; Thomas M, 2011, PEDIATRICS, V128, pE1, DOI 10.1542/peds.2010-2743; Tulving E., 1985, CAN PSYCHOL, V1, P1; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Wechsler D., 1997, WAIS 3 WECHSLER ADUL, V3rd, DOI 10.1111/j.1749-6632.1989.tb21005.x; Wright MJ, 2010, J CLIN EXP NEUROPSYC, V32, P728, DOI 10.1080/13803390903512652; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277	65	26	26	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99870	10.1371/journal.pone.0099870	http://dx.doi.org/10.1371/journal.pone.0099870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941067	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200048
J	Peri, E; Cusumano, A; Amodeo, V; Wajnberg, E; Colazza, S				Peri, Ezio; Cusumano, Antonino; Amodeo, Valentina; Wajnberg, Eric; Colazza, Stefano			Intraguild Interactions between Two Egg Parasitoids of a True Bug in Semi-Field and Field Conditions	PLOS ONE			English	Article							TRISSOLCUS-BASALIS HYMENOPTERA; NEZARA-VIRIDULA HETEROPTERA; INTRINSIC COMPETITION; INTERSPECIFIC COMPETITION; BIOLOGICAL-CONTROL; LARVAL PARASITOIDS; SPATIAL DYNAMICS; HOST; PENTATOMIDAE; COEXISTENCE	Research on interspecific competitive interactions among insect parasitoids has often been characterized by laboratory studies in which host insects are exposed to female parasitoids of different species in various sequences and combinations. In the last years, an increasing number of studies have investigated interspecific interactions under field and semi-field conditions although just a few number of works focused on egg parasitoids. In this work, we undertook a two-year study to investigate interspecific interactions between Trissolcus basalis (Wollaston) (Hymenoptera: Platygastridae) and Ooencyrtus telenomicida (Vassiliev) (Hymenoptera: Encyrtidae), two egg parasitoids of the pest Nezara viridula (L.) (Heteroptera: Pentatomidae) that co-occur in cultivated crops. Under semi-field (in out-door mesh cages) and field conditions, we investigated: 1) the seasonal occurrence of competing parasitoid species on sentinel egg masses; 2) the impact achieved by competing species on the shared host on naturally laid egg masses; 3) the outcome of intraguild interactions under controlled conditions. Results from sentinel egg masses showed that T. basalis occurs in May and successfully parasitizes hosts until the end of September/beginning of October, whereas O. telenomicida is mainly occurring in July-August. In both years, it was found that T. basalis is predominant. From naturally laid egg masses, results indicated that T. basalis achieves higher impact on the hosts, even in those egg masses which are parasitized by more than one female of different species (= multiparasitism). Results from manipulating intraguild interactions showed that T. basalis achieves higher impact on N. viridula when released alone, but it suffers from competition with O. telenomicida. The ecological factors that play a role in intraguild interactions in the context of biological control perspective are discussed.	[Peri, Ezio; Cusumano, Antonino; Amodeo, Valentina; Colazza, Stefano] Univ Palermo, Dipartimento Sci Agr & Forestali, Palermo, Italy; [Wajnberg, Eric] INRA, Sophia Antipolis, France	University of Palermo; INRAE	Cusumano, A (corresponding author), Univ Palermo, Dipartimento Sci Agr & Forestali, Palermo, Italy.	cusumanoantonino@unipa.it	Wajnberg, Eric/A-4862-2009; Cusumano, Antonino/L-7375-2015	Wajnberg, Eric/0000-0002-6700-7114; Cusumano, Antonino/0000-0001-9663-9164; PERI, Ezio/0000-0002-1095-7258; colazza, stefano/0000-0001-8023-7814	Marie Curie International Research Staff Exchange Scheme (IRSES); project "Better Understanding of Bugs for Improved Environment" - BUGSIE [PIRSES-GA-2012-317981]; University of Palermo -Fondo Finalizzato alla Ricerca (FFR) bando	Marie Curie International Research Staff Exchange Scheme (IRSES)(European Commission); project "Better Understanding of Bugs for Improved Environment" - BUGSIE; University of Palermo -Fondo Finalizzato alla Ricerca (FFR) bando	This project was supported by the Marie Curie International Research Staff Exchange Scheme (IRSES) with the project "Better Understanding of Bugs for Improved Environment" - BUGSIE (PIRSES-GA-2012-317981). This work was supported by the University of Palermo -Fondo Finalizzato alla Ricerca (FFR) bando 2012. No additional internal or external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agboka K, 2002, J INSECT BEHAV, V15, P1, DOI 10.1023/A:1014471826914; Amarasekare P, 2000, ECOLOGY, V81, P1286, DOI 10.1890/0012-9658(2000)081[1286:COCPOA]2.0.CO;2; Amarasekare P, 2000, J ANIM ECOL, V69, P201, DOI 10.1046/j.1365-2656.2000.00378.x; Bin F, 1990, TRICHOGRAMMA OTHER E, P175, DOI [10.1016/j.chemosphere.2011.12.082, DOI 10.1016/J.CHEMOSPHERE.2011.12.082]; Bogran CE, 2002, ECOLOGY, V83, P653, DOI 10.1890/0012-9658(2002)083[0653:ICAIPF]2.0.CO;2; Boivin G, 2006, PROG BIOL CONTROL, V3, P123; Borer ET, 2004, ECOLOGY, V85, P667, DOI 10.1890/02-0566; Bretz F., 2010, MULTIPLE COMP USING; BUSCHMAN LL, 1980, FLA ENTOMOL, V63, P154, DOI 10.2307/3494669; CALTAGIRONE LE, 1981, ANNU REV ENTOMOL, V26, P213, DOI 10.1146/annurev.en.26.010181.001241; CLARKE AR, 1990, AUST J AGR RES, V41, P1127, DOI 10.1071/AR9901127; Colazza S, 1995, ENVIRON ENTOMOL, V24, P1703, DOI 10.1093/ee/24.6.1703; Colazza S, 2004, J EXP BIOL, V207, P47, DOI 10.1242/jeb.00732; Colazza S, 1999, BIOL CONTROL, V16, P310, DOI 10.1006/bcon.1999.0763; Correa-Ferreira SB, 1986, AN SOC ENTOMOL BRAS, V5, P189; CORREAFERREIRA BS, 1995, BIOL CONTROL, V5, P196, DOI 10.1006/bcon.1995.1024; Cusumano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064768; Cusumano A, 2012, BIOCONTROL, V57, P719, DOI 10.1007/s10526-012-9451-5; Cusumano A, 2012, ENTOMOL EXP APPL, V143, P155, DOI 10.1111/j.1570-7458.2012.01236.x; Cusumano A, 2011, BIOCONTROL, V56, P173, DOI 10.1007/s10526-010-9320-z; De Moraes CM, 2005, ECOL ENTOMOL, V30, P564, DOI 10.1111/j.0307-6946.2005.00723.x; De Moraes CM, 1999, ECOL ENTOMOL, V24, P402, DOI 10.1046/j.1365-2311.1999.00212.x; Denoth M, 2002, BIOL CONTROL, V24, P20, DOI 10.1016/S1049-9644(02)00002-6; Ehler LE, 2002, BIOCONTROL, V47, P309, DOI 10.1023/A:1014895028451; Cingolani MF, 2013, BIOCONTROL, V58, P37, DOI 10.1007/s10526-012-9484-9; Fisher R. A., 1954, STAT METHODS RES WOR, DOI DOI 10.1007/BF01603396; Follett Peter A., 2000, American Entomologist, V46, P82; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Harvey JA, 2013, ANNU REV ENTOMOL, V58, P333, DOI 10.1146/annurev-ento-120811-153622; Harvey JA, 2009, ENTOMOL EXP APPL, V130, P238, DOI 10.1111/j.1570-7458.2008.00816.x; Hawkins BA, 1994, PATTERN PROCESS HOST; Hoffmann M. P., 1991, California Agriculture, V45, P20; Hokyo N., 1965, NANKI SEIBUTSU, V7, P1; Irvin NA, 2006, BIOCONTROL SCI TECHN, V16, P359, DOI 10.1080/09583150500532048; JALALI SK, 1988, ENTOMOL EXP APPL, V46, P221, DOI 10.1007/BF00364192; Jones WA, 1996, J AGR ENTOMOL, V13, P243; Kidd D, 2012, J ANIM ECOL, V81, P47, DOI 10.1111/j.1365-2656.2011.01881.x; KOZIOL JA, 1978, J AM STAT ASSOC, V73, P753, DOI 10.2307/2286276; Lei GC, 1998, J ANIM ECOL, V67, P422, DOI 10.1046/j.1365-2656.1998.00204.x; Mainali BP, 2012, CROP PROT, V36, P37, DOI 10.1016/j.cropro.2012.01.016; Meiners T, 2013, CHEM ECOLOGY INSECT, P191, DOI DOI 10.1002/9781118409589.CH9; Mucheru OM, 2009, ENTOMOL EXP APPL, V130, P10, DOI 10.1111/j.1570-7458.2008.00788.x; Nechols J. R., 1992, Selection criteria and ecological consequences of importing natural enemies., P41; Peri E, 2011, BIOCONTROL, V207, P47; Peri E, 2006, J EXP BIOL, V209, P3629, DOI 10.1242/jeb.02416; Peri E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079054; R Core Team, 2016, R FDN STAT COMP; ROSENHEIM JA, 1995, BIOL CONTROL, V5, P303, DOI 10.1006/bcon.1995.1038; Rosenheim JA, 2006, PROG BIOL CONTROL, V3, P1; Salerno G, 2006, EUR J ENTOMOL, V103, P311, DOI 10.14411/eje.2006.040; SHEPARD BM, 1994, J AGR ENTOMOL, V11, P375; Shi ZH, 2004, J APPL ENTOMOL, V128, P437, DOI 10.1111/j.1439-0418.2004.00869.x; Sjaarda N., 1989, THESIS U CALIFORNIA; SOLUK DA, 1988, OIKOS, V52, P94, DOI 10.2307/3565987; Stiling P, 2005, BIOL CONTROL, V34, P236, DOI 10.1016/j.biocontrol.2005.02.017; TODD JW, 1989, ANNU REV ENTOMOL, V34, P273, DOI 10.1146/annurev.en.34.010189.001421; VANALEBEEK FAN, 1993, ENTOMOL EXP APPL, V69, P21, DOI 10.1007/BF02380670; Wajnberg E, 1994, BIOL CONTROL EGG PAR; ZWOLFER H, 1971, P405	59	18	18	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99876	10.1371/journal.pone.0099876	http://dx.doi.org/10.1371/journal.pone.0099876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941172	gold, Green Published			2022-12-25	WOS:000338508200049
J	Reisser, J; Shaw, J; Hallegraeff, G; Proietti, M; Barnes, DKA; Thums, M; Wilcox, C; Hardesty, BD; Pattiaratchi, C				Reisser, Julia; Shaw, Jeremy; Hallegraeff, Gustaaf; Proietti, Maira; Barnes, David K. A.; Thums, Michele; Wilcox, Chris; Hardesty, Britta Denise; Pattiaratchi, Charitha			Millimeter-Sized Marine Plastics: A New Pelagic Habitat for Microorganisms and Invertebrates	PLOS ONE			English	Article							DENSITY POLYETHYLENE; DEBRIS; MICROPLASTICS; OCEAN; ENVIRONMENT; INGESTION; SEA; BIODEGRADATION; ACCUMULATION; OVIPOSITION	Millimeter-sized plastics are abundant in most marine surface waters, and known to carry fouling organisms that potentially play key roles in the fate and ecological impacts of plastic pollution. In this study we used scanning electron microscopy to characterize biodiversity of organisms on the surface of 68 small floating plastics (length range = 1.7-24.3 mm, median = 3.2 mm) from Australia-wide coastal and oceanic, tropical to temperate sample collections. Diatoms were the most diverse group of plastic colonizers, represented by 14 genera. We also recorded 'epiplastic' coccolithophores (7 genera), bryozoans, barnacles (Lepas spp.), a dinoflagellate (Ceratium), an isopod (Asellota), a marine worm, marine insect eggs (Halobates sp.), as well as rounded, elongated, and spiral cells putatively identified as bacteria, cyanobacteria, and fungi. Furthermore, we observed a variety of plastic surface microtextures, including pits and grooves conforming to the shape of microorganisms, suggesting that biota may play an important role in plastic degradation. This study highlights how anthropogenic millimeter-sized polymers have created a new pelagic habitat for microorganisms and invertebrates. The ecological ramifications of this phenomenon for marine organism dispersal, ocean productivity, and biotransfer of plastic-associated pollutants, remains to be elucidated.	[Reisser, Julia; Pattiaratchi, Charitha] Univ Western Australia, Sch Environm Syst Engn, Perth, WA 6009, Australia; [Reisser, Julia; Thums, Michele; Pattiaratchi, Charitha] Univ Western Australia, Oceans Inst, Perth, WA 6009, Australia; [Reisser, Julia; Wilcox, Chris; Hardesty, Britta Denise] CSIRO, Wealth Oceans Flagship, Perth, WA, Australia; [Shaw, Jeremy] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6009, Australia; [Hallegraeff, Gustaaf] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Proietti, Maira] Univ Fed Rio Grande, Inst Oceanog, Rio Grande, Brazil; [Barnes, David K. A.] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England; [Thums, Michele] UWA Oceans Inst, Australian Inst Marine Sci, Perth, WA, Australia; [Wilcox, Chris; Hardesty, Britta Denise] CSIRO, Hobart, Tas, Australia	University of Western Australia; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; University of Tasmania; Universidade Federal do Rio Grande; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Australian Institute of Marine Science; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Reisser, J (corresponding author), Univ Western Australia, Sch Environm Syst Engn, Perth, WA 6009, Australia.	jureisser@gmail.com	Shaw, Jeremy A/B-4156-2011; Wilcox, Chris/A-3585-2010; Hardesty, Britta Denise/A-3189-2011; Thums, Michele/A-3850-2013; Reisser, Julia/K-2065-2013; Hallegraeff, Gustaaf/C-8351-2013; Pattiaratchi, Charitha/E-6916-2011	Shaw, Jeremy A/0000-0002-5140-457X; Wilcox, Chris/0000-0002-5983-657X; Hardesty, Britta Denise/0000-0003-1948-5098; Thums, Michele/0000-0002-8669-8440; Reisser, Julia/0000-0002-1785-1042; Proietti, Maira/0000-0002-5504-5770; Hallegraeff, Gustaaf/0000-0001-8464-7343; Pattiaratchi, Charitha/0000-0003-2229-6183	University of Western Australia; Commonwealth Scientific and Industrial Research; Australia's Marine National Facility; Austral Fisheries; Australian Institute of Marine Science; CSIRO's Flagship postgraduate scholarship; Shell social investment program; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	University of Western Australia; Commonwealth Scientific and Industrial Research; Australia's Marine National Facility; Austral Fisheries; Australian Institute of Marine Science; CSIRO's Flagship postgraduate scholarship; Shell social investment program; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was funded by University of Western Australia (http://www.uwa.edu.au) and Commonwealth Scientific and Industrial Research (http://www.csiro.au). It has also been supported by Australia's Marine National Facility, Austral Fisheries, Australian Institute of Marine Science, CSIRO's Flagship postgraduate scholarship (JR), and the Shell social investment program (BDH and CW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliani S, 2003, HYDROBIOLOGIA, V503, P59, DOI 10.1023/B:HYDR.0000008480.95045.26; Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; Artham T, 2009, J POLYM ENVIRON, V17, P170, DOI 10.1007/s10924-009-0135-x; Balasubramanian V, 2010, LETT APPL MICROBIOL, V51, P205, DOI 10.1111/j.1472-765X.2010.02883.x; Barnes David K. A., 2004, EFFECTS HUMAN TRANSP, P193; Barnes DKA, 2003, MAR ECOL PROG SER, V262, P289, DOI 10.3354/meps262289; Barnes DKA, 2002, NATURE, V416, P808, DOI 10.1038/416808a; Basheer C, 2004, MAR POLLUT BULL, V48, P1161, DOI 10.1016/j.marpolbul.2004.04.009; Boerger CM, 2010, MAR POLLUT BULL, V60, P2275, DOI 10.1016/j.marpolbul.2010.08.007; CARPENTE.EJ, 1972, SCIENCE, V178, P749, DOI 10.1126/science.178.4062.749; CARPENTER E J, 1970, Phycologia, V9, P269, DOI 10.2216/i0031-8884-9-3-269.1; CARPENTER EJ, 1972, SCIENCE, V175, P1240, DOI 10.1126/science.175.4027.1240; Carson HS, 2013, MAR POLLUT BULL, V75, P126, DOI 10.1016/j.marpolbul.2013.07.054; Carson HS, 2011, MAR POLLUT BULL, V62, P1708, DOI 10.1016/j.marpolbul.2011.05.032; Cheng L, 1976, MARINE INSECTS; Choy CA, 2013, MAR ECOL PROG SER, V485, P155, DOI 10.3354/meps10342; Cole M, 2013, ENVIRON SCI TECHNOL, V47, P6646, DOI 10.1021/es400663f; Congestri R, 2011, BENITHIC DIATOMS BIO, P227; Cooper DA, 2010, MAR POLLUT BULL, V60, P650, DOI 10.1016/j.marpolbul.2009.12.026; Corcoran PL, 2009, MAR POLLUT BULL, V58, P80, DOI 10.1016/j.marpolbul.2008.08.022; Eriksen M, 2013, MAR POLLUT BULL, V68, P71, DOI 10.1016/j.marpolbul.2012.12.021; Ferreira T., 2012, IMAGEJ USER GUIDE, Vp, P198; Fortuno J, 2010, RAPP COMM INT MER ME, V39, P358; Fossi MC, 2012, MAR POLLUT BULL, V64, P2374, DOI 10.1016/j.marpolbul.2012.08.013; Gassel M, 2013, MARINE POLLUTION B, V64, P2374; Goldstein MC, 2014, MAR BIOL, V161, P1441, DOI 10.1007/s00227-014-2432-8; Goldstein MC, 2012, BIOL LETTERS, V8, P817, DOI 10.1098/rsbl.2012.0298; GREGORY MR, 1978, NEW ZEAL J MAR FRESH, V12, P399, DOI 10.1080/00288330.1978.9515768; GREGORY MR, 1983, MAR ENVIRON RES, V10, P73, DOI 10.1016/0141-1136(83)90011-9; Gregory MR, 2009, PHILOS T R SOC B, V364, P2013, DOI 10.1098/rstb.2008.0265; HALLEGRAEFF GM, 2010, ALGAE AUSTR PHYTOPLA; Harrison JP, 2011, MAR TECHNOL SOC J, V45, P12, DOI 10.4031/MTSJ.45.2.2; Harshvardhan K, 2013, MAR POLLUT BULL, V77, P100, DOI 10.1016/j.marpolbul.2013.10.025; Hidalgo-Ruz V, 2012, ENVIRON SCI TECHNOL, V46, P3060, DOI 10.1021/es2031505; JOKIEL PL, 1990, ENDEAVOUR, V14, P66, DOI 10.1016/0160-9327(90)90074-2; Kawamura T, 1995, J EXP MAR BIOL ECOL, V194, P189, DOI 10.1016/0022-0981(95)00099-2; KENSLEY B, 1994, P BIOL SOC WASH, V107, P274; Kittelmann S, 2005, J EXP MAR BIOL ECOL, V327, P201, DOI 10.1016/j.jembe.2005.06.020; Law KL, 2014, ENVIRON SCI TECHNOL, V48, P4732, DOI 10.1021/es4053076; Law KL, 2010, SCIENCE, V329, P1185, DOI 10.1126/science.1192321; Lobelle D, 2011, MAR POLLUT BULL, V62, P197, DOI 10.1016/j.marpolbul.2010.10.013; Magalhaes WF, 2012, ZOOTAXA, P1; Majer AP, 2012, MAR POLLUT BULL, V64, P1143, DOI 10.1016/j.marpolbul.2012.03.029; Maso M, 2003, SCI MAR, V67, P107, DOI 10.3989/scimar.2003.67n1107; Mato Y, 2001, ENVIRON SCI TECHNOL, V35, P318, DOI 10.1021/es0010498; Moore CJ, 2001, MAR POLLUT BULL, V42, P1297, DOI 10.1016/S0025-326X(01)00114-X; Moret-Ferguson S, 2010, MAR POLLUT BULL, V60, P1873, DOI 10.1016/j.marpolbul.2010.07.020; Paulrud S, 2002, FUEL PROCESS TECHNOL, V76, P23, DOI 10.1016/S0378-3820(02)00008-5; Pham PH, 2012, J FISH DIS, V35, P73, DOI 10.1111/j.1365-2761.2011.01323.x; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Reisser J, 2014, DATA MILLIMETER SIZE; Reisser J, 2013, DATA MARINE PLASTIC; Reisser J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080466; Reisser Julia, 2010, Marine Biodiversity Records, V3, pe75; Rios LM, 2007, MAR POLLUT BULL, V54, P1230, DOI 10.1016/j.marpolbul.2007.03.022; Rochman CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03263; Rochman CM, 2013, NATURE, V494, P169, DOI 10.1038/494169a; Romagnoli T, 2014, TURKISH J BOT, V38; Sangale M, 2012, J BIOREMED BIODEG, V3; SCHOLZ J, 1995, FACIES, V32, P109, DOI 10.1007/BF02536866; Sivan A, 2011, CURR OPIN BIOTECH, V22, P422, DOI 10.1016/j.copbio.2011.01.013; SONG Y, 1991, MAR POLLUT BULL, V22, P608; Sudhakar M, 2007, POLYM DEGRAD STABIL, V92, P1743, DOI 10.1016/j.polymdegradstab.2007.03.029; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Thiel M, 2005, OCEANOGR MAR BIOL, V43, P279; Tiffany MA, 2011, CELL ORIG LIFE EXTRE, V19, P195, DOI 10.1007/978-94-007-1327-7_8; Totti C, 2009, POLAR BIOL, V32, P1681, DOI 10.1007/s00300-009-0668-4; von Moos N, 2012, ENVIRON SCI TECHNOL, V46, P11327, DOI 10.1021/es302332w; Webb HK, 2013, POLYMERS-BASEL, V5, P1, DOI 10.3390/polym5010001; WEISE W, 1978, MICROBIAL ECOL, V4, P175, DOI 10.1007/BF02015075; WINSTON JE, 1982, MAR POLLUT BULL, V13, P348, DOI 10.1016/0025-326X(82)90038-8; Wright SL, 2013, ENVIRON POLLUT, V178, P483, DOI 10.1016/j.envpol.2013.02.031; Wuchter C, 2003, HELGOLAND MAR RES, V57, P13, DOI 10.1007/s10152-002-0117-z; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	74	216	231	14	350	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100289	10.1371/journal.pone.0100289	http://dx.doi.org/10.1371/journal.pone.0100289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941218	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000338508200091
J	Jacques, J; Hotton, D; De la Dure-Molla, M; Petit, S; Asselin, A; Kulkarni, AB; Gibson, CW; Brookes, SJ; Berdal, A; Isaac, J				Jacques, Jaime; Hotton, Dominique; De la Dure-Molla, Muriel; Petit, Stephane; Asselin, Audrey; Kulkarni, Ashok B.; Gibson, Carolyn Winters; Brookes, Steven Joseph; Berdal, Ariane; Isaac, Juliane			Tracking Endogenous Amelogenin and Ameloblastin In Vivo	PLOS ONE			English	Article							PERIODONTAL-LIGAMENT CELLS; ENAMEL MATRIX PROTEINS; PRIMARY RNA TRANSCRIPT; RAT INCISOR; SUPRAMOLECULAR STRUCTURES; RECOMBINANT AMELOGENIN; PROGENITOR CELLS; BONE-FORMATION; ALVEOLAR BONE; STEM-CELLS	Research on enamel matrix proteins (EMPs) is centered on understanding their role in enamel biomineralization and their bioactivity for tissue engineering. While therapeutic application of EMPs has been widely documented, their expression and biological function in non-enamel tissues is unclear. Our first aim was to screen for amelogenin (AMELX) and ameloblastin (AMBN) gene expression in mandibular bones and soft tissues isolated from adult mice (15 weeks old). Using RT-PCR, we showed mRNA expression of AMELX and AMBN in mandibular alveolar and basal bones and, at low levels, in several soft tissues; eyes and ovaries were RNA-positive for AMELX and eyes, tongues and testicles for AMBN. Moreover, in mandibular tissues AMELX and AMBN mRNA levels varied according to two parameters: 1) ontogenic stage (decreasing with age), and 2) tissue-type (e. g. higher level in dental epithelial cells and alveolar bone when compared to basal bone and dental mesenchymal cells in 1 week old mice). In situ hybridization and immunohistodetection were performed in mandibular tissues using AMELX KO mice as controls. We identified AMELX-producing (RNA-positive) cells lining the adjacent alveolar bone and AMBN and AMELX proteins in the microenvironment surrounding EMPs-producing cells. Western blotting of proteins extracted by non-dissociative means revealed that AMELX and AMBN are not exclusive to mineralized matrix; they are present to some degree in a solubilized state in mandibular bone and presumably have some capacity to diffuse. Our data support the notion that AMELX and AMBN may function as growth factor-like molecules solubilized in the aqueous microenvironment. In jaws, they might play some role in bone physiology through autocrine/paracrine pathways, particularly during development and stress-induced remodeling.	[Jacques, Jaime; Hotton, Dominique; De la Dure-Molla, Muriel; Petit, Stephane; Asselin, Audrey; Berdal, Ariane; Isaac, Juliane] Univ Paris 05, Univ Paris 06, INSERM UMRS 1138, Lab Mol Oral Pathophysiol,Team Berdal,Cordeliers, Paris, France; [Jacques, Jaime; De la Dure-Molla, Muriel; Berdal, Ariane] Univ Paris 07, UFR Odontol, Paris, France; [Jacques, Jaime] Univ Talca, Dept Stomatol, Unit Periodontol, Talca, Chile; [De la Dure-Molla, Muriel; Berdal, Ariane] Hosp Rothschild, AP HP, Ctr Rare Malformat Face & Oral Cav MAFACE, Paris, France; [Kulkarni, Ashok B.] Natl Inst Dent & Craniofacial Res, Funct Genom Sect, Lab Cell & Dev Biol, NIH, Bethesda, MD USA; [Gibson, Carolyn Winters] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Brookes, Steven Joseph] Univ Leeds, Sch Dent, Dept Oral Biol, Leeds LS2 9JT, W Yorkshire, England; [Isaac, Juliane] CNRS URA 2578, Inst Pasteur, Dept Dev & Stem Cells Biol, Lab Morphogenesis Mol Genet, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universidad de Talca; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Rothschild - APHP; UDICE-French Research Universities; Sorbonne Universite; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Pennsylvania; University of Leeds; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Isaac, J (corresponding author), Univ Paris 05, Univ Paris 06, INSERM UMRS 1138, Lab Mol Oral Pathophysiol,Team Berdal,Cordeliers, Paris, France.	isaacjuliane@yahoo.fr	Berdal, Ariane/AAC-8745-2022; Isaac, Juliane/G-4944-2017; Isaac, Juliane/AAV-5765-2021; Isaac, Juliane/AAD-8395-2022; de La Dure - Molla, Muriel/H-5068-2017	Berdal, Ariane/0000-0001-5833-5813; Isaac, Juliane/0000-0001-7898-022X; Isaac, Juliane/0000-0001-7898-022X; BROOKES, STEVEN/0000-0002-9097-7311; de La Dure - Molla, Muriel/0000-0003-3557-2845	French National Research Agency [ANR-12-BSV1-0018]; National Commission for Scientific and Technological Research of Chile CONICYT; IDEX Sorbonne Paris - Cite; The Wellcome Trust [093113]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000664] Funding Source: NIH RePORTER	French National Research Agency(French National Research Agency (ANR)); National Commission for Scientific and Technological Research of Chile CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); IDEX Sorbonne Paris - Cite; The Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by the French National Research Agency (Osteodiversity project: ANR-12-BSV1-0018) and the National Commission for Scientific and Technological Research of Chile CONICYT grant. Financial support (Once upon a tooth) was obtained from IDEX Sorbonne Paris - Cite. S.J. Brookes was supported by The Wellcome Trust (grant no. 093113). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aioub M, 2007, BONE, V41, P851, DOI 10.1016/j.bone.2007.07.023; Alikhani M, 2012, J DENT RES, V91, P413, DOI 10.1177/0022034512438590; Amin HD, 2013, ACTA BIOMATER, V9, P4796, DOI 10.1016/j.actbio.2012.09.008; Amin HD, 2012, TISSUE ENG PT A, V18, P1193, DOI [10.1089/ten.TEA.2011.0375, 10.1089/ten.tea.2011.0375]; Athanassiou-Papaefthymiou M, EUR J ORAL SCI S1, V119, P35; Atsawasuwan P, 2013, J DENT RES, V92, P622, DOI 10.1177/0022034513487906; Atsawasuwan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052800; Bartlett JD, 2006, EUR J ORAL SCI, V114, P18, DOI 10.1111/j.1600-0722.2006.00292.x; Bartlett John D, 2013, ISRN Dent, V2013, P684607, DOI 10.1155/2013/684607; BERDAL A, 1993, DEV BIOL, V155, P172, DOI 10.1006/dbio.1993.1016; Beyeler M, 2010, EXP CELL RES, V316, P1202, DOI 10.1016/j.yexcr.2009.12.019; Bosshardt DD, 2008, J CLIN PERIODONTOL, V35, P87, DOI 10.1111/j.1600-051X.2008.01264.x; Brookes SJ, 2001, ARCH ORAL BIOL, V46, P201, DOI 10.1016/S0003-9969(00)00121-7; Coxon TL, 2012, CELLS TISSUES ORGANS, V196, P420, DOI 10.1159/000336440; Deutsch D, 2006, EUR J ORAL SCI, V114, P183, DOI 10.1111/j.1600-0722.2006.00301.x; FINCHAM AG, 1994, J STRUCT BIOL, V112, P103, DOI 10.1006/jsbi.1994.1011; Fukae M, 2006, EUR J ORAL SCI, V114, P212, DOI 10.1111/j.1600-0722.2006.00309.x; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Grandin HM, 2012, TISSUE ENG PART B-RE, V18, P181, DOI [10.1089/ten.teb.2011.0365, 10.1089/ten.TEB.2011.0365]; Gruenbaum-Cohen Y, 2009, J EXP ZOOL PART B, V312B, P445, DOI 10.1002/jez.b.21255; Hatakeyama J, 2006, J DENT RES, V85, P144, DOI 10.1177/154405910608500206; Hatakeyama J, 2003, J BIOL CHEM, V278, P35743, DOI 10.1074/jbc.M306284200; Haze A, 2007, ANAT REC, V290, P455, DOI 10.1002/ar.20520; Haze A, 2009, J CELL MOL MED, V13, P1110, DOI 10.1111/j.1582-4934.2009.00700.x; Huang YC, 2010, CELL TISSUE RES, V342, P205, DOI 10.1007/s00441-010-1064-7; Iizuka S, 2011, MOL CELL BIOL, V31, P783, DOI 10.1128/MCB.00912-10; Iwata T, 2007, J DENT RES, V86, P153, DOI 10.1177/154405910708600209; Izumikawa M, 2012, SCI WORLD J, V2012; Jedeon K, 2013, AM J PATHOL, V183, P108, DOI 10.1016/j.ajpath.2013.04.004; Kakegawa A, 2010, J PERIODONTAL RES, V45, P643, DOI 10.1111/j.1600-0765.2010.01279.x; Kawasaki K, 2009, ANNU REV GENET, V43, P119, DOI 10.1146/annurev-genet-102108-134242; Kitagawa M, 2011, ARCH ORAL BIOL, V56, P374, DOI 10.1016/j.archoralbio.2010.10.012; Kunimatsu R, 2011, J PERIODONTOL, V82, P1632, DOI 10.1902/jop.2011.110031; Kuroda S, 2011, EUR CELLS MATER, V22, P56, DOI 10.22203/eCM.v022a05; Landin Maria A. dos Santos Silva, 2012, Frontiers in Genetics, V3, P139, DOI 10.3389/fgene.2012.00139; LAU EC, 1992, BIOCHEM BIOPH RES CO, V188, P1253, DOI 10.1016/0006-291X(92)91366-X; Li W, 1998, ARCH ORAL BIOL, V43, P497, DOI 10.1016/S0003-9969(98)00013-2; Li Y, 2006, EUR J ORAL SCI, V114, P190, DOI 10.1111/j.1600-0722.2006.00286.x; Limeback H, 1989, TOOTH ENAMEL, P269; Lu XY, 2013, BONE, V54, P157, DOI 10.1016/j.bone.2013.01.041; Lyngstadaas SP, 2009, ORTHOD CRANIOFAC RES, V12, P243, DOI 10.1111/j.1601-6343.2009.01459.x; Matsuzawa M, 2009, J PERIODONTAL RES, V44, P289, DOI 10.1111/j.1600-0765.2008.01091.x; Molla M, 2010, AM J PATHOL, V177, P2516, DOI 10.2353/ajpath.2010.091224; Nielsen BS, 2011, CLIN EXP METASTAS, V28, P27, DOI 10.1007/s10585-010-9355-7; Nunez J, 2010, J PERIODONTAL RES, V45, P809, DOI 10.1111/j.1600-0765.2010.01291.x; Papagerakis P, 2003, BONE, V32, P228, DOI 10.1016/S8756-3282(02)00978-X; Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901; Saito K, 2008, BONE, V43, P371, DOI 10.1016/j.bone.2008.03.029; SIMMER JP, 1994, CALCIFIED TISSUE INT, V55, P302, DOI 10.1007/BF00310410; Smith CE, 2009, EUR J ORAL SCI, V117, P485, DOI 10.1111/j.1600-0722.2009.00666.x; Sodek J, 2000, PERIODONTOL 2000, V24, P99, DOI 10.1034/j.1600-0757.2000.2240106.x; Sonoda A, 2009, J BIOL CHEM, V284, P27176, DOI 10.1074/jbc.M109.033464; Spahr A, 2006, EUR J ORAL SCI, V114, P504, DOI 10.1111/j.1600-0722.2006.00403.x; Stahl J, 2013, MATRIX BIOL, V32, P432, DOI 10.1016/j.matbio.2013.05.004; Staines KA, 2012, J ENDOCRINOL, V214, P241, DOI 10.1530/JOE-12-0143; Tamburstuen MV, 2011, BONE, V48, P406, DOI 10.1016/j.bone.2010.09.007; Tamburstuen MV, 2010, EUR J ORAL SCI, V118, P451, DOI 10.1111/j.1600-0722.2010.00760.x; Uchida T, 1997, J HISTOCHEM CYTOCHEM, V45, P1329, DOI 10.1177/002215549704501002; Veis A, 2000, J BIOL CHEM, V275, P41263, DOI 10.1074/jbc.M002308200; Wald T, 2013, J BIOL CHEM, V288, P22333, DOI 10.1074/jbc.M113.456012; Wang HJ, 2005, J BONE MINER RES, V20, P1032, DOI 10.1359/JBMR.050111; Warotayanont R, 2008, BIOCHEM BIOPH RES CO, V367, P1, DOI 10.1016/j.bbrc.2007.12.048; Wazen RM, 2009, MATRIX BIOL, V28, P292, DOI 10.1016/j.matbio.2009.04.004; Wen X, 2011, BIOMATERIALS, V32, P6478, DOI 10.1016/j.biomaterials.2011.05.045; Zeichner-David M, 2006, EUR J ORAL SCI, V114, P244, DOI 10.1111/j.1600-0722.2006.00322.x; Zhang YB, 2011, EUR J ORAL SCI, V119, P280, DOI 10.1111/j.1600-0722.2011.00887.x; Zheng L, BONE, V55, P158; Zhou YL, 2000, J BIOL CHEM, V275, P12273, DOI 10.1074/jbc.275.16.12273	70	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99626	10.1371/journal.pone.0099626	http://dx.doi.org/10.1371/journal.pone.0099626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933156	Green Published, gold			2022-12-25	WOS:000337738600050
J	Jia, CL; Xiong, MQ; Wang, PW; Cui, JG; Du, XY; Yang, QB; Wang, WJ; Chen, Y; Zhang, T				Jia, Chenglin; Xiong, Minqi; Wang, Peiwei; Cui, Jingang; Du, Xiaoye; Yang, Qinbo; Wang, Wenjian; Chen, Yu; Zhang, Teng			Notoginsenoside R1 Attenuates Atherosclerotic Lesions in ApoE Deficient Mouse Model	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MICRORNA EXPRESSION; ENDOTHELIAL-CELLS; PANAX-NOTOGINSENG; ACTIVATION; MICE; INFLAMMATION; DISEASE	Aims: Atherosclerosis is the primary cause of cardiovascular diseases and stroke. The current study evaluated the interventional effects of a naturally occurring compound Notoginsenoside R1 (NR1) on atherosclerosis in ApoE(-/-) mice. Methods and Results: The atherosclerotic lesion was significantly alleviated by NR1 treatment and this attenuation was marked by reduction in lipid deposition, fibrosis and oxidative stress. Increased serum levels of GSH and SOD and decreased level of MDH were observed in NR1-treated ApoE(-/-) mice. NR1 treatment also significantly decreased the levels of CHO, TG, ox-LDL and increased the level of HDL. Additionally, the levels of inflammatory cytokines including IL-2, IL-6, TNF-alpha and gamma-IFN were markedly reduced in NR1-treated ApoE(-/-) mice. Furthermore, significantly increased aortic expression of miR-26a, miR-21, miR-126a, miR-132, miR-146 and miR-155 and decreased expression of miR-20a and miR-92a were observed in the vehicle-treated ApoE(-/-) mice. While NR1 treatment led to a significant reduction in the expression of miR-21, miR-26a, miR-126 and increased expression of miR-20a. Conclusion: Collectively, our results demonstrated for the first time the anti-atherosclerotic effects of NR1, which could be in part mediated through its multiple targeting effects on inflammation, oxidative stress, lipid metabolism and microRNA expression. These results therefore justify further evaluation of NR1 as a therapeutic agent treating atherosclerosis.	[Jia, Chenglin; Xiong, Minqi; Wang, Peiwei; Cui, Jingang; Du, Xiaoye; Yang, Qinbo; Chen, Yu; Zhang, Teng] Shanghai Univ Tradit Chinese Med, Yueyang Hosp, Shanghai, Peoples R China; [Wang, Peiwei; Cui, Jingang; Du, Xiaoye; Yang, Qinbo; Wang, Wenjian; Chen, Yu; Zhang, Teng] Shanghai Univ Tradit Chinese Med, Clin Res Inst Integrat Med, Shanghai, Peoples R China; [Wang, Wenjian] Fudan Univ, Inst Integrat Med, Shanghai 200433, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Fudan University	Chen, Y (corresponding author), Shanghai Univ Tradit Chinese Med, Yueyang Hosp, Shanghai, Peoples R China.	chenyu6639@gmail.com; zhangteng501@hotmail.com			Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Science and Technology Commission of Shanghai Municipality [11PJ1409000, 13PJ1407800]; Shu Guang Project; Shanghai Municipal Education Commission; Shanghai Education Development Foundation [13SG42]; National Natural Science Foundation of China [81273960]; Funding for Outstanding Junior Faculties at Shanghai Institutions of Higher Learning [ZZszy12048]; Three-year Projects to Promote Traditional Chinese Medicine, Shanghai [ZYSNXD-CC-ZDYJ050]; Key Disciplines of Clinical Integrative Medicine at the State Administration of Traditional Chinese Medicine of China	Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shu Guang Project(Chinese Academy of Sciences); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Education Development Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funding for Outstanding Junior Faculties at Shanghai Institutions of Higher Learning; Three-year Projects to Promote Traditional Chinese Medicine, Shanghai; Key Disciplines of Clinical Integrative Medicine at the State Administration of Traditional Chinese Medicine of China	This work was supported by the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (YC and TZ), Program for Pu Jiang Scholar at Science and Technology Commission of Shanghai Municipality (11PJ1409000, 13PJ1407800, YC and TZ), Shu Guang Project supported by Shanghai Municipal Education Commission and Shanghai Education Development Foundation (13SG42, YZ), National Natural Science Foundation of China (81273960) (TZ), Funding for Outstanding Junior Faculties at Shanghai Institutions of Higher Learning (ZZszy12048) (PW), Three-year Projects to Promote Traditional Chinese Medicine, Shanghai (NO. ZYSNXD-CC-ZDYJ050), and Key Disciplines of Clinical Integrative Medicine at the State Administration of Traditional Chinese Medicine of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali KM, 2012, BRIT J PHARMACOL, V167, P1177, DOI 10.1111/j.1476-5381.2012.02081.x; Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Dou L, 2012, CELL PHYSIOL BIOCHEM, V29, P875, DOI 10.1159/000315061; Fleissner F, 2010, CIRC RES, V107, P138, DOI 10.1161/CIRCRESAHA.110.216770; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; HE L, 2004, NAT REV GENET, V5, P522; Hulsmans M, 2011, FASEB J, V25, P2515, DOI 10.1096/fj.11-181149; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Ji W, 2007, J ETHNOPHARMACOL, V113, P318, DOI 10.1016/j.jep.2007.06.022; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Leeper NJ, 2011, J CELL PHYSIOL, V226, P1035, DOI 10.1002/jcp.22422; Li C, 2014, AM J PHYSIOL-GASTR L, V306, pG111, DOI 10.1152/ajpgi.00123.2013; Ling SH, 2008, INT J CARDIOL, V128, P350, DOI 10.1016/j.ijcard.2007.05.111; Liu WJ, 2010, SHOCK, V34, P314, DOI 10.1097/SHK.0b013e3181ceede4; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Manduteanu I, 2012, J CELL MOL MED, V16, P1978, DOI 10.1111/j.1582-4934.2012.01552.x; Meng X, 2014, FREE RADICAL RES, V48, P445, DOI 10.3109/10715762.2014.885117; Meng X, 2014, FREE RADICAL RES, V7, P7, DOI DOI 10.1111/1751-7915.12145; Nakamura Y, 2004, MOL CELL ENDOCRINOL, V219, P17, DOI 10.1016/j.mce.2004.02.013; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Post WS, 1999, CARDIOVASC RES, V43, P985, DOI 10.1016/S0008-6363(99)00153-4; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sun B, 2013, BRIT J PHARMACOL, V168, P1758, DOI 10.1111/bph.12063; Tamminen M, 1999, ARTERIOSCL THROM VAS, V19, P847, DOI 10.1161/01.ATV.19.4.847; Toth Peter P, 2003, Curr Atheroscler Rep, V5, P386, DOI 10.1007/s11883-003-0010-5; Toth PP, 2004, CIRCULATION, V109, P1809, DOI 10.1161/01.CIR.0000126889.97626.B8; Wan JB, 2009, J AGR FOOD CHEM, V57, P6692, DOI 10.1021/jf900529w; Zampetaki A, 2013, FREE RADICAL BIO MED, V64, P69, DOI 10.1016/j.freeradbiomed.2013.06.025; Zhang WJ, 1997, ARTERIOSCL THROM VAS, V17, P465, DOI 10.1161/01.ATV.17.3.465; Zheng LA, 2010, BIOCHEM BIOPH RES CO, V400, P483, DOI 10.1016/j.bbrc.2010.08.067	35	46	55	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99849	10.1371/journal.pone.0099849	http://dx.doi.org/10.1371/journal.pone.0099849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933211	Green Published, gold, Green Submitted			2022-12-25	WOS:000337738600072
J	Novak, P; Hribova, E; Neumann, P; Koblizkova, A; Dolezel, J; Macas, J				Novak, Petr; Hribova, Eva; Neumann, Pavel; Koblizkova, Andrea; Dolezel, Jaroslav; Macas, Jiri			Genome-Wide Analysis of Repeat Diversity across the Family Musaceae	PLOS ONE			English	Article							GENERATION SEQUENCING REVEALS; BANANA CULTIVARS; ACUMINATA GENOME; SIZE VARIATION; DNA; PHYLOGENY; EVOLUTION; ALIGNMENT; ELEMENTS; RETROTRANSPOSONS	Background: The banana family (Musaceae) includes genetically a diverse group of species and their diploid and polyploid hybrids that are widely cultivated in the tropics. In spite of their socio-economic importance, the knowledge of Musaceae genomes is basically limited to draft genome assemblies of two species, Musa acuminata and M. balbisiana. Here we aimed to complement this information by analyzing repetitive genome fractions of six species selected to represent various phylogenetic groups within the family. Results: Low-pass sequencing of M. acuminata, M. ornata, M. textilis, M. beccarii, M. balbisiana, and Ensete gilletii genomes was performed using a 454/Roche platform. Sequence reads were subjected to analysis of their overall intra-and interspecific similarities and, all major repeat families were quantified using graph-based clustering. Maximus/SIRE and Angela lineages of Ty1/copia long terminal repeat (LTR) retrotransposons and the chromovirus lineage of Ty3/gypsy elements were found to make up most of highly repetitive DNA in all species (14-34.5% of the genome). However, there were quantitative differences and sequence variations detected for classified repeat families as well as for the bulk of total repetitive DNA. These differences were most pronounced between species from different taxonomic sections of the Musaceae family, whereas pairs of closely related species (M. acuminata/M. ornata and M. beccarii/M. textilis) shared similar populations of repetitive elements. Conclusions: This study provided the first insight into the composition and sequence variation of repetitive parts of Musaceae genomes. It allowed identification of repetitive sequences specific for a single species or a group of species that can be utilized as molecular markers in breeding programs and generated computational resources that will be instrumental in repeat masking and annotation in future genome assembly projects.	[Novak, Petr; Neumann, Pavel; Koblizkova, Andrea; Macas, Jiri] Biol Ctr ASCR, Inst Plant Mol Biol, Ceske Budejovice, Czech Republic; [Hribova, Eva; Dolezel, Jaroslav] Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, Olomouc, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Novak, P (corresponding author), Biol Ctr ASCR, Inst Plant Mol Biol, Ceske Budejovice, Czech Republic.	petr@umbr.cas.cz	Macas, Jiri/G-8618-2014; Novak, Petr/A-3059-2013; Dolezel, Jaroslav/B-7716-2008; hribova, eva/F-7291-2014; Neumann, Pavel/H-7345-2013	Macas, Jiri/0000-0003-0829-1570; Novak, Petr/0000-0002-5068-9681; Dolezel, Jaroslav/0000-0002-6263-0492; Neumann, Pavel/0000-0001-6711-6639; Hribova, Eva/0000-0002-6868-4344	Ministry of Education, Youth, and Sports of the Czech Republic, INGO II [LG12021]; Bioversity International Bioversity International [LoA CfL 2012/43]; Ministry of Education, Youth, and Sports of the Czech Republic [LO1204]; Ministry of Education, Youth, and Sports of the Czech Republic KONTAKT II [LH11058]; Czech Science Foundation [GBP501/12/G090]; Academy of Sciences of the Czech Republic [RVO:60077344]	Ministry of Education, Youth, and Sports of the Czech Republic, INGO II; Bioversity International Bioversity International; Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Education, Youth, and Sports of the Czech Republic KONTAKT II; Czech Science Foundation(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	Funding was provided by the Ministry of Education, Youth, and Sports of the Czech Republic, INGO II No. LG12021, http://www.msmt.cz/ (JD); Bioversity International Bioversity International, LoA CfL 2012/43, www.bioversityinternational.org (JD), Ministry of Education, Youth, and Sports of the Czech Republic, LO1204, http://www.msmt.cz/ (JD); Ministry of Education, Youth, and Sports of the Czech Republic KONTAKT II LH11058, http://www.msmt.cz/ (JM); The Czech Science Foundation, GBP501/12/G090, www.gacr.cz (JM); and The Academy of Sciences of the Czech Republic, RVO:60077344, http://www.cas.cz/ (JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bartos J, 2005, CYTOGENET GENOME RES, V109, P50, DOI 10.1159/000082381; Carreel F, 1994, ETUDE DIVERSITE BANA; CHEESMAN E. E., 1950, Kew Bulletin, P27, DOI 10.2307/4119816; Cheesman EE, 2008, CLASSIFICATION BANAN; Christelova P, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr024; Christelova P, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-103; Cizkova J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054808; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Davey MW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-683; DOLEZEL J, 1994, BIOL PLANTARUM, V36, P351, DOI 10.1007/BF02920930; Ellis THN, 1998, MOL GEN GENET, V260, P9, DOI 10.1007/s004380050865; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gong ZY, 2012, PLANT CELL, V24, P3559, DOI 10.1105/tpc.112.100511; Hakkinen M, 2013, TAXON, V62, P809, DOI 10.12705/624.3; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Heckmann S, 2013, PLANT J, V73, P555, DOI 10.1111/tpj.12054; Heslop-Harrison JS, 2007, ANN BOT-LONDON, V100, P1073, DOI 10.1093/aob/mcm191; Hribova E, 2007, CYTOGENET GENOME RES, V119, P268, DOI 10.1159/000112073; Hribova E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017863; Hribova E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-204; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; JARRET RL, 1992, THEOR APPL GENET, V84, P579, DOI 10.1007/BF00224155; Kalendar R, 1999, THEOR APPL GENET, V98, P704, DOI 10.1007/s001220051124; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; LANDER E S, 1988, Genomics, V2, P231; Li LF, 2010, MOL PHYLOGENET EVOL, V57, P1, DOI 10.1016/j.ympev.2010.06.021; Loh JP, 2000, MOL PHYLOGENET EVOL, V17, P360, DOI 10.1006/mpev.2000.0848; Macas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027335; Martis MM, 2012, P NATL ACAD SCI USA, V109, P13343, DOI 10.1073/pnas.1204237109; Neumann P, 2006, GENETICS, V173, P1047, DOI 10.1534/genetics.106.056259; Neumann P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002777; Neumann P, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-4; Novak P, 2013, BIOINFORMATICS, V29, P792, DOI 10.1093/bioinformatics/btt054; Novak P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-378; Pagan HJT, 2012, GENOME BIOL EVOL, V4, P575, DOI 10.1093/gbe/evs038; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Piednoel M, 2012, MOL BIOL EVOL, V29, P3601, DOI 10.1093/molbev/mss168; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; PURUGGANAN MD, 1995, MOL ECOL, V4, P265, DOI 10.1111/j.1365-294X.1995.tb00218.x; Renny-Byfield S, 2011, MOL BIOL EVOL, V28, P2843, DOI 10.1093/molbev/msr112; Risterucci AM, 2009, THEOR APPL GENET, V119, P1093, DOI 10.1007/s00122-009-1111-5; Ruangsuttapha S, 2007, GENET RESOUR CROP EV, V54, P1565, DOI 10.1007/s10722-006-9169-2; Safar J, 2004, PLANT J, V39, P960, DOI 10.1111/j.1365-313X.2004.02179.x; SIMMONDS N. W., 1956, Kew Bulletin, P463, DOI 10.2307/4109131; SIMMONDS N. W., 1955, JOUR LINNEAN SOC BOT, V55, P302; Smit A, 1996, REPEATMASKER OPEN 30; Staton SE, 2012, PLANT J, V72, P142, DOI 10.1111/j.1365-313X.2012.05072.x; Tenaillon MI, 2011, GENOME BIOL EVOL, V3, P219, DOI 10.1093/gbe/evr008; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wang Y, 2013, PLANT J, V76, P557, DOI 10.1111/tpj.12313; Wong C, 2001, ANN BOT-LONDON, V88, P1017, DOI 10.1006/anbo.2001.1542; ZHANG HB, 1995, PLANT J, V7, P175, DOI 10.1046/j.1365-313X.1995.07010175.x; Zuccolo A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-152	55	48	49	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e98918	10.1371/journal.pone.0098918	http://dx.doi.org/10.1371/journal.pone.0098918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932725	gold, Green Submitted, Green Published			2022-12-25	WOS:000337738600014
J	Sanquetta, CR; Behling, A; Dalla Corte, AP; Netto, SP; Rodrigues, AL; Simon, AA				Sanquetta, Carlos Roberto; Behling, Alexandre; Dalla Corte, Ana Paula; Netto, Sylvio Pellico; Rodrigues, Aurelio Lourenco; Simon, Augusto Arlindo			A Model Based on Environmental Factors for Diameter Distribution in Black Wattle in Brazil	PLOS ONE			English	Article							PINUS-RADIATA; EUCALYPTUS-GRANDIS; WEIBULL FUNCTION; STAND STRUCTURE; GROWTH; WATER; DYNAMICS; YIELD; PRODUCTIVITY; EFFICIENCY	This article discusses the dynamics of a diameter distribution in stands of black wattle throughout its growth cycle using the Weibull probability density function. Moreover, the parameters of this distribution were related to environmental variables from meteorological data and surface soil horizon with the aim of finding a model for diameter distribution which their coefficients were related to the environmental variables. We found that the diameter distribution of the stand changes only slightly over time and that the estimators of the Weibull function are correlated with various environmental variables, with accumulated rainfall foremost among them. Thus, a model was obtained in which the estimators of the Weibull function are dependent on rainfall. Such a function can have important applications, such as in simulating growth potential in regions where historical growth data is lacking, as well as the behavior of the stand under different environmental conditions. The model can also be used to project growth in diameter, based on the rainfall affecting the forest over a certain time period.	[Sanquetta, Carlos Roberto; Behling, Alexandre; Dalla Corte, Ana Paula; Netto, Sylvio Pellico; Rodrigues, Aurelio Lourenco] Univ Fed Parana, Dept Forest Sci, BR-80060000 Curitiba, Parana, Brazil; [Simon, Augusto Arlindo] TANAC SA Forest Dept, Montenegro, RS, Brazil	Universidade Federal do Parana	Rodrigues, AL (corresponding author), Univ Fed Parana, Dept Forest Sci, BR-80060000 Curitiba, Parana, Brazil.	alourencorodrigues@gmail.com	Corte, Ana Paula Dalla/K-6833-2014	Corte, Ana Paula Dalla/0000-0001-8529-5554; Rodrigues, Aurelio/0000-0003-4070-8305	company TANAC SA; National Institute of Meteorology (INMET); CNPq	company TANAC SA; National Institute of Meteorology (INMET); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors would like to thank the company TANAC SA and the National Institute of Meteorology (INMET) for supporting this research, and CNPq for the masters' level scholarship that co-author Alexandre Behling received.	Allen H. L., 1999, Bosque, V20, P3; [Anonymous], 2009, ANALISE MULTIVARIADA; Arce JE, 1999, MODELOS DINAMICOS DI, P21; Arce Julio Eduardo, 2004, Ciênc. Florest., V14, P149, DOI 10.5902/198050981790; BENSON ML, 1992, FOREST ECOL MANAG, V52, P117, DOI 10.1016/0378-1127(92)90498-X; Binkley D, 2004, FOREST ECOL MANAG, V193, P5, DOI 10.1016/j.foreco.2004.01.019; Blake T., 1992, ECOPHYSIOL SHORT ROT, P66; Binoti DHB, 2010, REV ARVORE, V34, P147, DOI 10.1590/S0100-67622010000100016; BURKHART HE, 1997, EMPIRICAL PROCESS BA, P53; Campos J. C. C., 1981, Revista Arvore, V5, P1; CAO QV, 1984, FOREST SCI, V30, P129; Cao QV, 2004, FOREST SCI, V50, P682; Catalunha MJ., 2002, REV BRAS AGROMETEORO, V10, P153; Clutter J. L., 1965, DIAMETER DISTRIBUTIO; Clutter JL, 1983, TIMBER MANAGEMENT QU; Clutter JL, 1974, GROWTH MODELS TREE S, P136; Dalla Corte AP, 2004, REV ACAD, V2, P33, DOI [DOI 10.7213/CIENCIAANIMAL.V2I3.15093, 10.7213/cienciaanimal.v2i3.15093]; Retslaff FAD, 2012, REV ARVORE, V36, P719, DOI 10.1590/S0100-67622012000400013; Draper NR, 1980, APPL REGRESSION ANAL; Figura MR, 2010, THESIS; Finger CAG, 1982, THESIS; HUNTER IR, 1984, NEW ZEAL J FOR SCI, V14, P53; Johnson N.L., 1995, CONTINUOUS UNIVARIAT, VVolumes 1 and 2; Kayahara G, 1998, FOREST ECOL MANAG, V74, P161; Landsberg J., 2003, FBMIS, V1, P49; Leite Helio Garcia, 2006, Rev. Árvore, V30, P89, DOI 10.1590/S0100-67622006000100011; LEVINS R, 1966, AM SCI, V54, P421; Loetsch F., 1973, FOREST INVENTORY; Machado S. A., 2000, Cerne, V6, P55; Machado SA, 2009, SCI AGRARIA, V10, P103, DOI DOI 10.5380/RSA.V10I2.13575; Machado Sebastião do Amaral, 2006, Rev. Árvore, V30, P759, DOI 10.1590/S0100-67622006000500009; MAESTRI R., 1992, THESIS U FED PARANA; Miguel EP, 2010, CERNE, V16, P94, DOI 10.1590/S0104-77602010000100011; NAUTIYAL JC, 1984, FOREST SCI, V30, P761; Nogueira Gilciano Saraiva, 2005, Rev. Árvore, V29, P579, DOI 10.1590/S0100-67622005000400010; Palahi M, 2007, EUR J FOREST RES, V126, P563, DOI 10.1007/s10342-007-0177-3; Pearson K, 1905, BIOMETRIKA, V4, P169, DOI 10.1093/biomet/4.1-2.169; Pearson K, 1894, PHILOS T R SOC A, V186, P343, DOI DOI 10.1098/RSTA.1895.0010; Pereira A. B., 2004, Acta Scientiarum - Agronomy, V26, P437; Robert A, 2003, ECOL MODEL, V167, P287, DOI 10.1016/S0304-3800(03)00200-X; Ryan MG, 2010, FOREST ECOL MANAG, V259, P1695, DOI 10.1016/j.foreco.2010.01.013; Samuelson LJ, 2004, FOREST ECOL MANAG, V192, P59, DOI 10.1016/j.foreco.2004.01.005; SANDS R, 1990, FOREST ECOL MANAG, V30, P91, DOI 10.1016/0378-1127(90)90129-Y; SAS Institute Inc, 1989, SAS QC SOFTW REF VER; SCOLFORO J. R. S., 1998, MANEJO FLORESTAL; Scolforo JR, 1990, THESIS; SNOWDON P, 1992, FOREST ECOL MANAG, V52, P87, DOI 10.1016/0378-1127(92)90497-W; Snowdon P, 1998, NEW FOREST, V16, P101, DOI 10.1023/A:1006524609459; Soares C., 2000, SCI FOR, V58, P41, DOI DOI 10.1016/J.FORECO.2018.08.051; Soares TS, 2011, REV ARVORE, V35, P1027, DOI 10.1590/S0100-67622011000600008; Stape J. L., 2002, THESIS; Stape JL, 2010, FOREST ECOL MANAG, V259, P1684, DOI 10.1016/j.foreco.2010.01.012; Steinmetz S., 1999, Agropecuaria Clima Temperado, V2, P77; Vianello R.F., 2000, METEOROLOGIA BASICA; Villa Nova NA, 2003, REV BRASILEIRA AGROM, V11, P63; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; Williams TM, 2006, BIOMASS BIOENERG, V30, P370, DOI 10.1016/j.biombioe.2005.07.017	57	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100093	10.1371/journal.pone.0100093	http://dx.doi.org/10.1371/journal.pone.0100093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932909	Green Submitted, Green Published, gold			2022-12-25	WOS:000337738600093
J	Chan, PL; Rose, RJ; Murad, AMA; Zainal, Z; Low, ETL; Ooi, LCL; Ooi, SE; Yahya, S; Singh, R				Chan, Pek-Lan; Rose, Ray J.; Murad, Abdul Munir Abdul; Zainal, Zamri; Low, Eng-Ti Leslie; Ooi, Leslie Cheng-Li; Ooi, Siew-Eng; Yahya, Suzaini; Singh, Rajinder			Evaluation of Reference Genes for Quantitative Real-Time PCR in Oil Palm Elite Planting Materials Propagated by Tissue Culture	PLOS ONE			English	Article							ELAEIS-GUINEENSIS JACQ.; EXPRESSED SEQUENCE TAGS; INTERNAL CONTROL GENES; SOMATIC EMBRYOGENESIS; RT-PCR; TRANSCRIPTOME ANALYSIS; GOSSYPIUM-HIRSUTUM; NORMALIZATION; VALIDATION; SELECTION	Background: The somatic embryogenesis tissue culture process has been utilized to propagate high yielding oil palm. Due to the low callogenesis and embryogenesis rates, molecular studies were initiated to identify genes regulating the process, and their expression levels are usually quantified using reverse transcription quantitative real-time PCR (RT-qPCR). With the recent release of oil palm genome sequences, it is crucial to establish a proper strategy for gene analysis using RT-qPCR. Selection of the most suitable reference genes should be performed for accurate quantification of gene expression levels. Results: In this study, eight candidate reference genes selected from cDNA microarray study and literature review were evaluated comprehensively across 26 tissue culture samples using RT-qPCR. These samples were collected from two tissue culture lines and media treatments, which consisted of leaf explants cultures, callus and embryoids from consecutive developmental stages. Three statistical algorithms (geNorm, NormFinder and BestKeeper) confirmed that the expression stability of novel reference genes (pOP-EA01332, PD00380 and PD00569) outperformed classical housekeeping genes (GAPDH, NAD5, TUBULIN, UBIQUITIN and ACTIN). PD00380 and PD00569 were identified as the most stably expressed genes in total samples, MA2 and MA8 tissue culture lines. Their applicability to validate the expression profiles of a putative ethylene-responsive transcription factor 3-like gene demonstrated the importance of using the geometric mean of two genes for normalization. Conclusions: Systematic selection of the most stably expressed reference genes for RT-qPCR was established in oil palm tissue culture samples. PD00380 and PD00569 were selected for accurate and reliable normalization of gene expression data from RT-qPCR. These data will be valuable to the research associated with the tissue culture process. Also, the method described here will facilitate the selection of appropriate reference genes in other oil palm tissues and in the expression profiling of genes relating to yield, biotic and abiotic stresses.	[Chan, Pek-Lan; Low, Eng-Ti Leslie; Ooi, Leslie Cheng-Li; Ooi, Siew-Eng; Singh, Rajinder] MPOB, Adv Biotechnol & Breeding Ctr, Kajang, Selangor, Malaysia; [Rose, Ray J.] Univ Newcastle, Sch Environm & Life Sci, Australian Res Council Ctr Excellence Integrat Le, Callaghan, NSW 2308, Australia; [Murad, Abdul Munir Abdul; Zainal, Zamri] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Ukm Bangi, Selangor, Malaysia; [Yahya, Suzaini] Sime Darby Biotech Labs Sdn Bhd, Banting, Selangor, Malaysia	Malaysian Palm Oil Board; University of Newcastle; Universiti Kebangsaan Malaysia	Chan, PL (corresponding author), MPOB, Adv Biotechnol & Breeding Ctr, 6 Persiaran Inst, Kajang, Selangor, Malaysia.	chanpl@mpob.gov.my	Murad, Abdul/CAG-9324-2022; Singh, Rajinder/P-9179-2015; Low, Eng Ti Leslie/AHD-7011-2022; Munir, Abdul/L-8575-2017	Singh, Rajinder/0000-0001-9933-4884; Low, Eng Ti Leslie/0000-0003-3414-8401; Munir, Abdul/0000-0001-6402-7198; Ooi, Siew-Eng/0000-0002-6621-5456; Ooi, Leslie/0000-0002-6996-2801	Malaysian Palm Oil Board (MPOB) [R000999000-RB01-J]	Malaysian Palm Oil Board (MPOB)	The research work was supported by Malaysian Palm Oil Board (MPOB) through research grant R000999000-RB01-J. The funder had no role in study design, data collection and analysis, or preparation of the manuscript. The MPOB Director-General supported publication of the manuscript and did not influence the content.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2013, PALM OIL FACTS FIGUR; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Baker WJ, 2011, ANN BOT-LONDON, V108, P1417, DOI 10.1093/aob/mcr020; Barsalobres-Cavallari CF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-1; BOWLER C, 1989, EMBO J, V8, P31, DOI 10.1002/j.1460-2075.1989.tb03345.x; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chan PL, 2010, ELECTRON J BIOTECHN, V13, DOI 10.2225/vol13-issue1-fulltext-14; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Choo YM, 2005, PALM OIL DEV, V42, P3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corley RHV, 2003, OIL PALM VEGETATIVE; de Vega-Bartol JJ, 2013, PLANT CELL REP, V32, P715, DOI 10.1007/s00299-013-1407-4; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; Dussert S, 2013, PLANT PHYSIOL, V162, P1337, DOI 10.1104/pp.113.220525; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Gantasala Nagavara Prasad, 2013, BMC Res Notes, V6, P312, DOI 10.1186/1756-0500-6-312; Han B, 2013, BIOMETALS, V26, P403, DOI 10.1007/s10534-013-9623-5; Han XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043084; Ho CL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-381; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Jouannic S, 2005, FEBS LETT, V579, P2709, DOI 10.1016/j.febslet.2005.03.093; Kushairi A., 2010, INT SEM ADV OIL PALM; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046487; Thuc LV, 2011, MOL BIOTECHNOL, V48, P156, DOI 10.1007/s12033-010-9356-4; Li Q, 2012, PLANT CELL REP, V31, P1789, DOI 10.1007/s00299-012-1282-4; Lin HC, 2009, PLANT MOL BIOL, V70, P173, DOI 10.1007/s11103-009-9464-3; Lin YL, 2010, PLANT SCI, V178, P359, DOI 10.1016/j.plantsci.2010.02.005; Low E. T. L., 2009, THESIS U PUTRA MALAY; Low ETL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-62; Ma LM, 2013, MAR GENOM, V11, P67, DOI 10.1016/j.margen.2013.08.002; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Maksup S, 2013, CHINESE SCI BULL, V58, P1919, DOI 10.1007/s11434-013-5726-1; Mantiri FR, 2008, PLANT PHYSIOL, V146, P1622, DOI 10.1104/pp.107.110379; McCarty DR, 1986, MAIZE GEN COOP NEWSL, V60, P61; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Ooi SE, 2012, PLANT CELL TISS ORG, V110, P201, DOI 10.1007/s11240-012-0143-8; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Piyatrakul P, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-244; Podevin N, 2012, MOL BREEDING, V30, P1237, DOI 10.1007/s11032-012-9711-1; Roowi SH, 2010, MOL BIOTECHNOL, V46, P1, DOI 10.1007/s12033-010-9262-9; Rozen S, 2000, Methods Mol Biol, V132, P365; Shearman JR, 2013, GENOMICS, V101, P306, DOI 10.1016/j.ygeno.2013.02.012; Singh R, 2013, NATURE, V500, P335, DOI 10.1038/nature12309; Tranbarger TJ, 2011, PLANT PHYSIOL, V156, P564, DOI 10.1104/pp.111.175141; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang LJ, 2013, PLANT PHYSIOL BIOCH, V70, P304, DOI 10.1016/j.plaphy.2013.05.038; Wang M, 2013, GENE, V530, P44, DOI 10.1016/j.gene.2013.07.084; Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301; Willis LB, 2008, J OIL PALM RES, P1; Wooi K. C., 1995, P 1993 ISOPB INT S R, P21; Xiao D, 2012, FUNCT PLANT BIOL, V39, P342, DOI 10.1071/FP11246; Yeap WC, 2014, PLANT CELL TISS ORG, V116, P55, DOI 10.1007/s11240-013-0382-3; Yeap WC, 2012, PLANT CELL REP, V31, P1829, DOI 10.1007/s00299-012-1297-x; Zamzuri I., 2007, OIL PALM B, V55, P26; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	63	23	24	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99774	10.1371/journal.pone.0099774	http://dx.doi.org/10.1371/journal.pone.0099774			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927412	Green Published, gold			2022-12-25	WOS:000338278100078
J	Hectors, SJCG; Jacobs, I; Strijkers, GJ; Nicolay, K				Hectors, Stefanie J. C. G.; Jacobs, Igor; Strijkers, Gustav J.; Nicolay, Klaas			Multiparametric MRI Analysis for the Identification of High Intensity Focused Ultrasound-Treated Tumor Tissue	PLOS ONE			English	Article							PERCUTANEOUS RADIOFREQUENCY ABLATION; CONTRAST-ENHANCED MRI; IMAGING FOLLOW-UP; MAGNETIZATION-TRANSFER; UTERINE FIBROIDS; THERMAL DOSIMETRY; CELL CARCINOMA; BREAST-CANCER; LIVER-TUMORS; IN-VIVO	Purpose: In this study endogenous magnetic resonance imaging (MRI) biomarkers for accurate segmentation of High Intensity Focused Ultrasound (HIFU)-treated tumor tissue and residual or recurring non-treated tumor tissue were identified. Methods: Multiparametric MRI, consisting of quantitative T-1, T-2, Apparent Diffusion Coefficient (ADC) and Magnetization Transfer Ratio (MTR) mapping, was performed in tumor-bearing mice before (n = 14), 1 h after (n = 14) and 72 h (n = 7) after HIFU treatment. A non-treated control group was included (n = 7). Cluster analysis using the Iterative Self Organizing Data Analysis (ISODATA) technique was performed on subsets of MRI parameters (feature vectors). The clusters resulting from the ISODATA segmentation were divided into a viable and non-viable class based on the fraction of pixels assigned to the clusters at the different experimental time points. ISODATA-derived non-viable tumor fractions were quantitatively compared to histology-derived non-viable tumor volume fractions. Results: The highest agreement between the ISODATA-derived and histology-derived non-viable tumor fractions was observed for feature vector {T-1, T-2, ADC}. R-1 (1/T-1), R-2 (1/T-2), ADC and MTR each were significantly increased in the ISODATA-defined non-viable tumor tissue at 1 h after HIFU treatment compared to viable, non-treated tumor tissue. R1, ADC and MTR were also significantly increased at 72 h after HIFU. Conclusions: This study demonstrates that non-viable, HIFU-treated tumor tissue can be distinguished from viable, non-treated tumor tissue using multiparametric MRI analysis. Clinical application of the presented methodology may allow for automated, accurate and objective evaluation of HIFU treatment.	[Hectors, Stefanie J. C. G.; Jacobs, Igor; Strijkers, Gustav J.; Nicolay, Klaas] Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR, NL-5600 MB Eindhoven, Netherlands; [Hectors, Stefanie J. C. G.; Jacobs, Igor; Strijkers, Gustav J.; Nicolay, Klaas] Ctr Imaging Res & Educ, Eindhoven, Netherlands; [Strijkers, Gustav J.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	Eindhoven University of Technology; University of Amsterdam; Academic Medical Center Amsterdam	Hectors, SJCG (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR, POB 513, NL-5600 MB Eindhoven, Netherlands.	s.j.c.g.hectors@tue.nl		Hectors, Stefanie/0000-0001-9457-6606; Nicolay, Klaas/0000-0002-4179-616X; Strijkers, Gustav/0000-0001-6700-5058	Center for Translational Molecular Medicine, project VOLTA [05T-201]	Center for Translational Molecular Medicine, project VOLTA	This work was supported by the Center for Translational Molecular Medicine (www.ctmm.nl), project VOLTA (grant 05T-201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alic L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022835; Aulino P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-363; Carano RAD, 2004, MAGNET RESON MED, V51, P542, DOI 10.1002/mrm.10731; Dewhirst MW, 2003, INT J HYPERTHER, V19, P267, DOI 10.1080/0265673031000119006; Dromain C, 2002, RADIOLOGY, V223, P255, DOI 10.1148/radiol.2231010780; Graham SJ, 1999, MAGNET RESON MED, V42, P1061, DOI 10.1002/(SICI)1522-2594(199912)42:6<1061::AID-MRM10>3.0.CO;2-T; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; Henning EC, 2007, MAGN RESON MED, V57, P501, DOI 10.1002/mrm.21161; Hesley GK, 2013, CARDIOVASC INTER RAD, V36, P5, DOI 10.1007/s00270-012-0367-3; Hijnen NM, 2013, J THER ULTRASOUND, V1, DOI 10.1186/2050-5736-1-8; Hijnen NM, 2012, INT J HYPERTHER, V28, P141, DOI 10.3109/02656736.2011.648137; Hundt W, 2009, TECHNOL CANCER RES T, V8, P85, DOI 10.1177/153303460900800201; Hynynen K, 2010, ULTRASONICS, V50, P221, DOI 10.1016/j.ultras.2009.08.015; Jacobs MA, 2000, JMRI-J MAGN RESON IM, V11, P425, DOI 10.1002/(SICI)1522-2586(200004)11:4<425::AID-JMRI11>3.0.CO;2-0; Jacobs MA, 2009, J MAGN RESON IMAGING, V29, P649, DOI 10.1002/jmri.21677; Karlsson M, 1999, MAGN RESON IMAGING, V17, P1481, DOI 10.1016/S0730-725X(99)00078-8; Kennedy JE, 2005, NAT REV CANCER, V5, P321, DOI 10.1038/nrc1591; Kirkham APS, 2008, RADIOLOGY, V246, P833, DOI 10.1148/radiol.2463062080; Leslie T, 2012, BRIT J RADIOL, V85, P1363, DOI 10.1259/bjr/56737365; Leslie TA, 2008, BRIT J RADIOL, V81, P564, DOI 10.1259/bjr/27118953; Levitt M, 1981, J MAGN RESON, V43, P56; McSheehy PMJ, 2010, CLIN CANCER RES, V16, P212, DOI 10.1158/1078-0432.CCR-09-0686; Merckel LG, 2013, CARDIOVASC INTER RAD, V36, P292, DOI 10.1007/s00270-012-0526-6; Merkle EM, 2005, RADIOLOGY, V235, P1065, DOI 10.1148/radiol.2353040871; Murat Francois-Joseph, 2007, Cancer Control, V14, P244; Ogawara K, 2008, INT J PHARMACEUT, V359, P234, DOI 10.1016/j.ijpharm.2008.03.025; Omran MGH, 2007, INTELL DATA ANAL, V11, P583, DOI 10.3233/IDA-2007-11602; Peng HH, 2009, J MAGN RESON IMAGING, V30, P596, DOI 10.1002/jmri.21860; Pilatou MC, 2009, J MAGN RESON IMAGING, V29, P404, DOI 10.1002/jmri.21688; Rieke V, 2008, J MAGN RESON IMAGING, V27, P376, DOI 10.1002/jmri.21265; Rouviere O, 2012, NAT REV CLIN ONCOL, V9, P721, DOI 10.1038/nrclinonc.2012.136; Rouviere O, 2010, EUR RADIOL, V20, P48, DOI 10.1007/s00330-009-1520-5; Schmitz AC, 2008, EUR RADIOL, V18, P1431, DOI 10.1007/s00330-008-0906-0; Seip R, 2010, IEEE T BIO-MED ENG, V57, P61, DOI 10.1109/TBME.2009.2028874; ter Haar G, 2007, PROG BIOPHYS MOL BIO, V93, P111, DOI 10.1016/j.pbiomolbio.2006.07.005; Voogt MJ, 2012, EUR RADIOL, V22, P411, DOI 10.1007/s00330-011-2262-8; Wijlemans JW, 2013, INVEST RADIOL, V48, P381, DOI 10.1097/RLI.0b013e3182820257; WOLFE DA, 1976, BIOMETRIKA, V63, P214, DOI 10.1093/biomet/63.1.214; WOLFF SD, 1994, RADIOLOGY, V192, P593, DOI 10.1148/radiology.192.3.8058919; Yarmolenko PS, 2011, INT J HYPERTHER, V27, P320, DOI 10.3109/02656736.2010.534527; Zhang YY, 2011, EUR J RADIOL, V79, P347, DOI 10.1016/j.ejrad.2010.06.039	41	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99936	10.1371/journal.pone.0099936	http://dx.doi.org/10.1371/journal.pone.0099936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927280	Green Published, gold			2022-12-25	WOS:000338278100094
J	Lee, J; Lee, JP; Park, JI; Hwang, JH; Jang, HM; Choi, JY; Kim, YL; Yang, CW; Kang, SW; Kim, NH; Kim, YS; Lim, CS				Lee, Jeonghwan; Lee, Jung Pyo; Park, Ji In; Hwang, Jin Ho; Jang, Hye Min; Choi, Ji-Young; Kim, Yong-Lim; Yang, Chul Woo; Kang, Shin-Wook; Kim, Nam-Ho; Kim, Yon Su; Lim, Chun Soo		CRC ESRD Investigators	Early Nephrology Referral Reduces the Economic Costs among Patients Who Start Renal Replacement Therapy: A Prospective Cohort Study in Korea	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; DIALYSIS; OUTCOMES; IMPACT; CARE; MORTALITY; COMORBIDITY; ACCESS; HEALTH	Background: The nature of cost-saving effects of early referral to a nephrologist in patients with chronic kidney disease (CKD) is not fully evaluated. We evaluated the health care costs before and after dialysis according to the referral time. Methods: A total of 879 patients who were newly diagnosed as having end-stage renal disease from August 2008 to June 2011 were prospectively enrolled. The early referral (ER) group was defined as patients who were referred to a nephrologist more than a year before dialysis and had visited a nephrology clinic 2 or more times. Patients whose referral time was less than a year were considered the late referral (LR) group. Information about medical costs was acquired from the claim data of the Korea Health Insurance Review and Assessment Service. Results: The total medical costs during the first 12 months after the initiation of dialysis were not different between the 526 ER patients and the 353 LR patients. However, the costs of the ER patients during the first month were significantly lower than those of the LR patients (ER vs. LR: 3029 +/- 2219 vs. 3438 +/- 2821 US dollars [USD], P = 0.025). The total 12-month health care costs before the initiation of dialysis were significantly lower in the ER group (ER vs. LR: 6206 +/- 5873 vs. 8610 +/- 7820 USD, P<0.001). In the multivariate analysis, ER significantly lowered the health care costs during the 12 months before (2534.0 +/- 436.2 USD, P<0.001) and the first month (428.5 +/- 172.3 USD, P = 0.013) after the initiation of dialysis. Conclusions: The ER of patients with CKD to a nephrologist is associated with decreased medical costs during the pretreatment period of renal replacement therapy and the early period of dialysis initiation.	[Lee, Jeonghwan] Hallym Univ, Hangang Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea; [Lee, Jeonghwan; Lee, Jung Pyo; Park, Ji In; Hwang, Jin Ho; Jang, Hye Min; Choi, Ji-Young; Kim, Yong-Lim; Yang, Chul Woo; Kang, Shin-Wook; Kim, Nam-Ho; Kim, Yon Su; Lim, Chun Soo; CRC ESRD Investigators] CRC ESRD, Taegu, South Korea; [Lee, Jung Pyo; Lim, Chun Soo] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Park, Ji In; Kim, Yon Su; Lim, Chun Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Hwang, Jin Ho] Chung Ang Univ Hosp, Dept Internal Med, Seoul, South Korea; [Jang, Hye Min] Kyungpook Natl Univ, Dept Stat, Taegu, South Korea; [Choi, Ji-Young; Kim, Yong-Lim] Kyungpook Natl Univ, Dept Internal Med, Sch Med, Taegu, South Korea; [Yang, Chul Woo] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Nam-Ho] Chonnam Natl Univ, Dept Internal Med, Sch Med, Kwangju, South Korea	Hallym University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Chung Ang University; Chung Ang University Hospital; Kyungpook National University; Kyungpook National University; Catholic University of Korea; Yonsei University; Yonsei University Health System; Chonnam National University	Lim, CS (corresponding author), CRC ESRD, Taegu, South Korea.	cslimjy@snu.ac.kr	Lee, Jeonghwan/C-5214-2011; Hwang, Jin Ho/E-7203-2015	Lee, Jeonghwan/0000-0003-3199-635X; Park, Ji In/0000-0003-4662-3759; Hwang, Jin Ho/0000-0003-0829-0922	Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea. (HI10C2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora P, 1999, J AM SOC NEPHROL, V10, P1281; Astor BC, 2001, AM J KIDNEY DIS, V38, P494, DOI 10.1053/ajkd.2001.26833; Avorn J, 2002, J CLIN EPIDEMIOL, V55, P711, DOI 10.1016/S0895-4356(02)00415-8; Avron J, 2002, ARCH INTERN MED, V162, P2002; Caskey FJ, 2003, NEPHROL DIAL TRANSPL, V18, P1330, DOI 10.1093/ndt/gfg156; Chae JW, 2011, NEPHRON CLIN PRACT, V117, pC379, DOI 10.1159/000321525; Chan MR, 2007, AM J MED, V120, P1063, DOI 10.1016/j.amjmed.2007.04.024; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen SC, 2010, AM J MED SCI, V339, P123, DOI 10.1097/MAJ.0b013e3181c0678a; Choi JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084257; Collins AJ, 2013, AM J KIDNEY DIS, V61, pE1, DOI 10.1053/j.ajkd.2012.11.031; Collins AJ, 2009, AM J KIDNEY DIS, V53, pS1, DOI 10.1053/j.ajkd.2008.10.005; DAVIES SJ, 1995, AM J KIDNEY DIS, V26, P353, DOI 10.1016/0272-6386(95)90657-6; Eadington DW, 1996, NEPHROL DIAL TRANSPL, V11, P2124, DOI 10.1093/oxfordjournals.ndt.a027123; Hommel K, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-108; Ifudu O, 1996, AM J KIDNEY DIS, V28, P841, DOI 10.1016/S0272-6386(96)90383-2; INNES A, 1992, NEPHROL DIAL TRANSPL, V7, P467; Ismail N, 1998, NEPHROL DIAL TRANSPL, V13, P246, DOI 10.1093/ndt/13.2.246; James MT, 2010, LANCET, V375, P1296, DOI 10.1016/S0140-6736(09)62004-3; Jin Dong Chan, 2011, Korean Journal of Internal Medicine, V26, P123, DOI 10.3904/kjim.2011.26.2.123; Jones C, 2006, NEPHROL DIAL TRANSPL, V21, P2133, DOI 10.1093/ndt/gfl198; JUNGERS P, 1993, KIDNEY INT, V43, pS170; JUNGERS P, 1993, NEPHROL DIAL TRANSPL, V8, P1089; Kazmi WH, 2004, NEPHROL DIAL TRANSPL, V19, P1808, DOI 10.1093/ndt/gfg573; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kessler M, 2003, AM J KIDNEY DIS, V42, P474, DOI 10.1016/S0272-6386(03)00805-9; Kim do H, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055323, DOI 10.1371/J0URNAL.P0NE.0055323]; Kim S, 2009, J KOREAN MED SCI, V24, pS11, DOI 10.3346/jkms.2009.24.S1.S11; Kinchen KS, 2002, ANN INTERN MED, V137, P479, DOI 10.7326/0003-4819-137-6-200209170-00007; Ledoux F, 2001, REV MED INTERNE, V22, P245, DOI 10.1016/S0248-8663(00)00325-8; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 1997, AM J KIDNEY DIS, V29, P533, DOI 10.1016/S0272-6386(97)90334-6; Metcalfe W, 2000, KIDNEY INT, V57, P2539, DOI 10.1046/j.1523-1755.2000.00113.x; Obialo CI, 2005, AM J KIDNEY DIS, V46, P881, DOI 10.1053/j.ajkd.2005.08.003; Roderick P, 2002, NEPHROL DIAL TRANSPL, V17, P1252, DOI 10.1093/ndt/17.7.1252; Roderick P, 2002, QJM-INT J MED, V95, P363, DOI 10.1093/qjmed/95.6.363; Roubicek C, 2000, AM J KIDNEY DIS, V36, P35, DOI 10.1053/ajkd.2000.8241; Schmidt RJ, 1998, AM J KIDNEY DIS, V32, P278, DOI 10.1053/ajkd.1998.v32.pm9708613; Seok Su Jin, 2010, Korean Journal of Internal Medicine, V25, P188, DOI 10.3904/kjim.2010.25.2.188; Smart NA, 2011, AM J MED, V124, P1073, DOI 10.1016/j.amjmed.2011.04.026; Smith DH, 2004, J AM SOC NEPHROL, V15, P1300, DOI 10.1097/01.ASN.0000125670.64996.BB; Stack AG, 2003, AM J KIDNEY DIS, V41, P310, DOI 10.1053/ajkd.2003.50038; Stehman-Breen CO, 2000, KIDNEY INT, V57, P639, DOI 10.1046/j.1523-1755.2000.t01-1-00885.x; Winkelmayer WC, 2002, TRANSPLANTATION, V73, P1918, DOI 10.1097/00007890-200206270-00012; Winkelmayer WC, 2001, KIDNEY INT, V60, P1547, DOI 10.1046/j.1523-1755.2001.00958.x; Yokoyama Y, 2009, NEPHRON CLIN PRACT, V113, pC191, DOI 10.1159/000232601	47	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99460	10.1371/journal.pone.0099460	http://dx.doi.org/10.1371/journal.pone.0099460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927081	gold, Green Submitted, Green Published			2022-12-25	WOS:000338278100043
J	Liu, JL; Zhang, B; Song, SJ; Ma, M; Si, SY; Wang, YH; Xu, BX; Feng, K; Wu, JG; Guo, YC				Liu, JunLi; Zhang, Bing; Song, ShuJun; Ma, Ming; Si, ShaoYan; Wang, YiHu; Xu, BingXin; Feng, Kai; Wu, JiGong; Guo, YanChuan			Bovine Collagen Peptides Compounds Promote the Proliferation and Differentiation of MC3T3-E1 Pre-Osteoblasts	PLOS ONE			English	Article							ALKALINE-PHOSPHATASE; ANTIOXIDANT ACTIVITY; BONE; EXPRESSION; CELLS; HYDROLYSATE; DISEASE; RATS; MINERALIZATION; GELATIN	Objective: Collagen peptides (CP) compounds, as bone health supplements, are known to play a role in the treatment of osteoporosis. However, the molecular mechanisms of this process remain unclear. This study aimed to investigate the effects of bovine CP compounds on the proliferation and differentiation of MC3T3-E1 cells. Methods: Mouse pre-osteoblast cell line MC3T3-E1 subclone 4 cells were treated with bovine CP compounds. Cell proliferation was analyzed by MTT assays and the cell cycle was evaluated by flow cytometry scanning. Furthermore, MC3T3-E1 cell differentiation was analyzed at the RNA level by real-time PCR and at the protein level by western blot analysis for runt-related transcription factor 2 (Runx2), a colorimetric p-nitrophenyl phosphate assay for alkaline phosphatase (ALP), and ELISA for osteocalcin (OC). Finally, alizarin red staining for mineralization was measured using Image Software Pro Plus 6.0. Results: Cell proliferation was very efficient after treatment with different concentrations of bovine CP compounds, and the best concentration was 3 mg/mL. Bovine CP compounds significantly increased the percentage of MC3T3-E1 cells in G(2)/S phase. Runx2 expression, ALP activity, and OC production were significantly increased after treatment with bovine CP compounds for 7 or 14 days. Quantitative analyses with alizarin red staining showed significantly increased mineralization of MC3T3-E1 cells after treatment with bovine CP compounds for 14 or 21 days. Conclusions: Bovine CP compounds increased osteoblast proliferation, and played positive roles in osteoblast differentiation and mineralized bone matrix formation. Taking all the experiments together, our study indicates a molecular mechanism for the potential treatment of osteoarthritis and osteoporosis.	[Liu, JunLi; Song, ShuJun; Si, ShaoYan; Xu, BingXin; Feng, Kai; Wu, JiGong] 306 Hosp PLA, Dept Pathol & Expt Med, Beijing, Peoples R China; [Zhang, Bing; Ma, Ming; Wang, YiHu; Guo, YanChuan] Chinese Acad Sci, Tech Inst Phys & Chem, Key Lab Photochem Convers & Optoelect Mat, Beijing, Peoples R China	Chinese Academy of Sciences; Technical Institute of Physics & Chemistry, CAS	Guo, YC (corresponding author), Chinese Acad Sci, Tech Inst Phys & Chem, Key Lab Photochem Convers & Optoelect Mat, Beijing, Peoples R China.	guoyanchuan79@163.com			Technical institute of Physics and Chemistry, CAS [LHS-DBSW2013-01]	Technical institute of Physics and Chemistry, CAS(Chinese Academy of Sciences)	This work was supported by The cooperation project from Technical institute of Physics and Chemistry, CAS (Grant No. LHS-DBSW2013-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 1996, Cas Lek Cesk, V135, P74; Aleman A, 2011, FOOD RES INT, V44, P1044, DOI 10.1016/j.foodres.2011.03.010; Aleman A, 2011, LWT-FOOD SCI TECHNOL, V44, P407, DOI 10.1016/j.lwt.2010.09.003; Banerjee P, 2014, CHEM-BIOL INTERACT, V211, P1, DOI 10.1016/j.cbi.2014.01.002; Bello AE, 2006, CURR MED RES OPIN, V22, P2221, DOI 10.1185/030079906X148373; BERESFORD JN, 1993, AM J MED GENET, V45, P163, DOI 10.1002/ajmg.1320450205; Clark KL, 2008, CURR MED RES OPIN, V24, P1485, DOI 10.1185/030079908X291967 ; Dennison E, 2006, RHEUM DIS CLIN N AM, V32, P617, DOI 10.1016/j.rdc.2006.08.003; FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235; Jackix ED, 2010, J MED FOOD, V13, P1385, DOI 10.1089/jmf.2009.0256; Ji CH, 1998, J CELL BIOCHEM, V69, P353, DOI 10.1002/(SICI)1097-4644(19980601)69:3<353::AID-JCB12>3.3.CO;2-W; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kawaguchi T, 2012, BIOL PHARM BULL, V35, P422, DOI 10.1248/bpb.35.422; Kim HK, 2013, MOLECULES, V18, P15474, DOI 10.3390/molecules181215474; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Lee KE, 2013, GENET MOL RES, V12, P4567, DOI 10.4238/2013.October.15.5; Li Yinqing, 2010, Zhongguo Zhong Yao Za Zhi, V35, P759; Moskowitz RW, 2000, SEMIN ARTHRITIS RHEU, V30, P87, DOI 10.1053/sarh.2000.9622; Nomura Y, 2005, NUTRITION, V21, P1120, DOI 10.1016/j.nut.2005.03.007; Orimo Hideo, 2010, Journal of Nippon Medical School, V77, P4; Patti A, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/846480; Proksch E, 2014, SKIN PHARMACOL PHYS, V27, P113, DOI 10.1159/000355523; Schadow S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053955; STEIN GS, 1990, FASEB J, V4, P3111, DOI 10.1096/fasebj.4.13.2210157; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Takeda S, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-35; WEINREB M, 1990, J BONE MINER RES, V5, P831; Yamada S, 2013, DENT MATER J, V32, P88, DOI 10.4012/dmj.2012-220; Yamakawa K, 2003, J RHEUMATOL, V30, P1032; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zheng ZH, 2009, J BIOMED MATER RES A, V89A, P453, DOI 10.1002/jbm.a.31979	32	47	53	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99920	10.1371/journal.pone.0099920	http://dx.doi.org/10.1371/journal.pone.0099920			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926875	gold, Green Submitted, Green Published			2022-12-25	WOS:000338278100090
J	Moffett, RC; Vasu, S; Thorens, B; Drucker, DJ; Flatt, PR				Moffett, R. Charlotte; Vasu, Srividya; Thorens, Bernard; Drucker, Daniel J.; Flatt, Peter R.			Incretin Receptor Null Mice Reveal Key Role of GLP-1 but Not GIP in Pancreatic Beta Cell Adaptation to Pregnancy	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; ALPHA-CELLS; INSULIN-SECRETION; GLUCOSE-HOMEOSTASIS; ISLET; MASS; PROGLUCAGON; PHYSIOLOGY; EXPRESSION; PROLIFERATION	Islet adaptations to pregnancy were explored in C57BL6/J mice lacking functional receptors for glucagon-like peptide 1 (GLP-1) and gastric inhibitory polypeptide (GIP). Pregnant wild type mice and GIPRKO mice exhibited marked increases in islet and beta cell area, numbers of medium/large sized islets, with positive effects on Ki67/Tunel ratio favouring beta cell growth and enhanced pancreatic insulin content. Alpha cell area and glucagon content were unchanged but prohormone convertases PC2 and PC1/3 together with significant amounts of GLP-1 and GIP were detected in alpha cells. Knockout of GLP-1R abolished these islet adaptations and paradoxically decreased pancreatic insulin, GLP-1 and GIP. This was associated with abolition of normal pregnancy-induced increases in plasma GIP, L-cell numbers, and intestinal GIP and GLP-1 stores. These data indicate that GLP-1 but not GIP is a key mediator of beta cell mass expansion and related adaptations in pregnancy, triggered in part by generation of intra-islet GLP-1.	[Moffett, R. Charlotte; Vasu, Srividya; Flatt, Peter R.] Univ Ulster, SAAD Ctr Pharm & Diabet, Coleraine BT52 1SA, Londonderry, North Ireland; [Thorens, Bernard] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Drucker, Daniel J.] Univ Toronto, Mt Sinai Hosp, Lunenfield Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada	Ulster University; University of Lausanne; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Vasu, S (corresponding author), Univ Ulster, SAAD Ctr Pharm & Diabet, Cromore Rd, Coleraine BT52 1SA, Londonderry, North Ireland.	s.vasu@ulster.ac.uk	Drucker, Daniel J/A-4092-2010	Flatt, Peter/0000-0001-8548-7943; Moffett, R Charlotte/0000-0002-7196-7863	EFSD/Boehringer Ingelheim Grant; Department of Education and Learning, Northern Ireland; Canada Research Chairs Program; BBDC-Novo Nordisk Chair in Incretin Biology; CIHR [82700]	EFSD/Boehringer Ingelheim Grant; Department of Education and Learning, Northern Ireland; Canada Research Chairs Program(Canada Research Chairs); BBDC-Novo Nordisk Chair in Incretin Biology; CIHR(Canadian Institutes of Health Research (CIHR))	The study was supported in part by an EFSD/Boehringer Ingelheim Grant and a research scholarship to RCM from Department of Education and Learning, Northern Ireland. DJD is supported by the Canada Research Chairs Program, a BBDC-Novo Nordisk Chair in Incretin Biology, and CIHR grant 82700. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2010, VITAM HORM, V84, P203, DOI [10.1016/S0083-6729(10)84011-7, 10.1016/B978-0-12-381517-0.00007-2]; Anini Y, 2003, ENDOCRINOLOGY, V144, P3244, DOI 10.1210/en.2003-0143; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Barnett AH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4382; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Campbell RK, 2011, CLIN THER, V33, P511, DOI 10.1016/j.clinthera.2011.04.015; Campbell RK, 2009, J AM PHARM ASSOC, V49, pS10, DOI 10.1331/JAPhA.2009.09076; Chen GF, 2011, ENDOCRINE, V39, P118, DOI 10.1007/s12020-010-9421-6; Combettes MMJ, 2006, CURR OPIN PHARMACOL, V6, P598, DOI 10.1016/j.coph.2006.08.003; Dalle Stephane, 2011, Curr Mol Pharmacol, V4, P187; Derosa G, 2012, CURR CLIN PHARMACOL, V7, P214, DOI 10.2174/157488412800958686; Devlieger R, 2008, ACTA OBSTET GYN SCAN, V87, P1266, DOI 10.1080/00016340802443863; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Drucker DJ, 2003, ENDOCRINOLOGY, V144, P5145, DOI 10.1210/en.2003-1147; EISSELE R, 1992, EUR J CLIN INVEST, V22, P283, DOI 10.1111/j.1365-2362.1992.tb01464.x; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; FLATT PR, 1981, DIABETOLOGIA, V20, P573; Friedrichsen BN, 2006, J ENDOCRINOL, V188, P481, DOI 10.1677/joe.1.06160; Fujita Y, 2010, GASTROENTEROLOGY, V138, P1966, DOI 10.1053/j.gastro.2010.01.049; Fukami A, 2013, DIABETES, V62, P510, DOI 10.2337/db12-0294; Girard J, 2008, DIABETES METAB, V34, P550, DOI 10.1016/j.diabet.2008.09.001; GREENBAUM CJ, 1991, J CLIN INVEST, V88, P767, DOI 10.1172/JCI115375; Grigoryan M, 2012, ENDOCRINOLOGY, V153, P3076, DOI 10.1210/en.2012-1120; Hansen AMK, 2011, DIABETOLOGIA, V54, P1379, DOI 10.1007/s00125-011-2080-1; Hansotia T, 2005, REGUL PEPTIDES, V128, P125, DOI 10.1016/j.regpep.2004.07.019; Herbach N, 2005, REGUL PEPTIDES, V125, P103, DOI 10.1016/j.regpep.2004.08.021; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003; Irwin N, 2013, BIOCHEM PHARMACOL, V85, P81, DOI 10.1016/j.bcp.2012.10.008; Irwin N, 2010, EXPERT OPIN INV DRUG, V19, P1039, DOI 10.1517/13543784.2010.513381; Irwin N, 2009, BEST PRACT RES CL EN, V23, P499, DOI 10.1016/j.beem.2009.03.001; Jacovetti C, 2012, J CLIN INVEST, V122, P3541, DOI 10.1172/JCI64151; Karaca M, 2009, DIABETES METAB, V35, P77, DOI 10.1016/j.diabet.2008.09.007; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; Kilimnik G, 2010, ISLETS, V2, P149, DOI 10.4161/isl.2.3.11396; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Larsen MO, 2009, DAN MED BULL, V56, P153; Ling Z, 2001, VIRCHOWS ARCH, V438, P382, DOI 10.1007/s004280000374; Marchetti P, 2012, DIABETOLOGIA, V55, P3262, DOI 10.1007/s00125-012-2716-9; McIntosh CHS, 2010, VITAM HORM, V84, P21, DOI [10.1016/S0083-6729(10)84016-6, 10.1016/B978-0-12-381517-0.00002-3]; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; MOJSOV S, 1990, J BIOL CHEM, V265, P8001; Nadal A, 2009, J PHYSIOL-LONDON, V587, P5031, DOI 10.1113/jphysiol.2009.177188; Nauck MA, 2013, DIABETOLOGIA, V56, P1878, DOI 10.1007/s00125-013-2953-6; Nie Y, 2000, J CLIN INVEST, V105, P955, DOI 10.1172/JCI7456; PARSONS JA, 1995, ENDOCRINOLOGY, V136, P2013, DOI 10.1210/en.136.5.2013; Pederson RA, 1998, DIABETES, V47, P1046, DOI 10.2337/diabetes.47.7.1046; Preitner F, 2004, J CLIN INVEST, V113, P635, DOI 10.1172/JCI200420518; Rieck S, 2010, TRENDS ENDOCRIN MET, V21, P151, DOI 10.1016/j.tem.2009.11.001; Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144; Schraenen A, 2010, DIABETOLOGIA, V53, P2589, DOI 10.1007/s00125-010-1913-7; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Sugiyama C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043745; Tolhurst G, 2009, J PHYSIOL-LONDON, V587, P27, DOI 10.1113/jphysiol.2008.164012; Whalley NM, 2011, J ENDOCRINOL, V211, P99, DOI 10.1530/JOE-11-0094; Wideman RD, 2007, DIABETES, V56, P2744, DOI 10.2337/db07-0563; Wu TZ, 2010, VITAM HORM, V84, P81, DOI [10.1016/S0083-6729(10)84015-4, 10.1016/B978-0-12-381517-0.00003-5]; Xiao XW, 2013, J CLIN INVEST, V123, P2207, DOI 10.1172/JCI66323; Xu E, 2006, CELL METAB, V3, P47, DOI 10.1016/j.cmet.2005.11.015; Xue Y, 2010, ENDOCRINE, V37, P83, DOI 10.1007/s12020-009-9273-0	62	52	52	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e96863	10.1371/journal.pone.0096863	http://dx.doi.org/10.1371/journal.pone.0096863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927416	gold, Green Published, Green Submitted			2022-12-25	WOS:000338278100007
J	Wolfram, D; Starzl, R; Hackl, H; Barclay, D; Hautz, T; Zelger, B; Brandacher, G; Lee, WPA; Eberhart, N; Vodovotz, Y; Pratschke, J; Pierer, G; Schneeberger, S				Wolfram, Dolores; Starzl, Ravi; Hackl, Hubert; Barclay, Derek; Hautz, Theresa; Zelger, Bettina; Brandacher, Gerald; Lee, W. P. Andrew; Eberhart, Nadine; Vodovotz, Yoram; Pratschke, Johann; Pierer, Gerhard; Schneeberger, Stefan			Insights from Computational Modeling in Inflammation and Acute Rejection in Limb Transplantation	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ALLOGRAFT-REJECTION; FACTOR-ALPHA; BINDING-PROTEIN; SKIN; CELLS; MECHANISMS; DISCOVERY; CYTOKINES; DISEASE	Acute skin rejection in vascularized composite allotransplantation (VCA) is the major obstacle for wider adoption in clinical practice. This study utilized computational modeling to identify biomarkers for diagnosis and targets for treatment of skin rejection. Protein levels of 14 inflammatory mediators in skin and muscle biopsies from syngeneic grafts [n = 10], allogeneic transplants without immunosuppression [n = 10] and allografts treated with tacrolimus [n = 10] were assessed by multiplexed analysis technology. Hierarchical Clustering Analysis, Principal Component Analysis, Random Forest Classification and Multinomial Logistic Regression models were used to segregate experimental groups. Based on Random Forest Classification, Multinomial Logistic Regression and Hierarchical Clustering Analysis models, IL-4, TNF-alpha and IL-12p70 were the best predictors of skin rejection and identified rejection well in advance of histopathological alterations. TNF-alpha and IL-12p70 were the best predictors of muscle rejection and also preceded histopathological alterations. Principal Component Analysis identified IL-1 alpha, IL-18, IL-1 beta, and IL-4 as principal drivers of transplant rejection. Thus, inflammatory patterns associated with rejection are specific for the individual tissue and may be superior for early detection and targeted treatment of rejection.	[Wolfram, Dolores; Eberhart, Nadine; Pierer, Gerhard] Med Univ Innsbruck, Dept Plast Reconstruct & Aesthet Surg, A-6020 Innsbruck, Austria; [Starzl, Ravi] Carnegie Mellon Univ, Language Technol Inst, Pittsburgh, PA 15213 USA; [Hackl, Hubert] Med Univ Innsbruck, Div Bioinformat, Bioctr, A-6020 Innsbruck, Austria; [Barclay, Derek; Vodovotz, Yoram] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA; [Hautz, Theresa; Pratschke, Johann; Schneeberger, Stefan] Med Univ Innsbruck, Dept Visceral Transplant & Thorac Surg, A-6020 Innsbruck, Austria; [Zelger, Bettina] Med Univ Innsbruck, Dept Pathol, A-6020 Innsbruck, Austria; [Brandacher, Gerald; Lee, W. P. Andrew; Schneeberger, Stefan] Johns Hopkins Univ, Sch Med, Dept Plast & Reconstruct Surg, Baltimore, MD USA	Medical University of Innsbruck; Carnegie Mellon University; Medical University of Innsbruck; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical University of Innsbruck; Medical University of Innsbruck; Johns Hopkins University	Wolfram, D (corresponding author), Med Univ Innsbruck, Dept Plast Reconstruct & Aesthet Surg, A-6020 Innsbruck, Austria.	dolores.wolfram@i-med.ac.at	Hackl, Hubert/B-3168-2018; Brandacher, Gerald/L-7540-2016; Schneeberger, Stefan/S-9329-2019	Hackl, Hubert/0000-0003-4055-3841; Schneeberger, Stefan/0000-0002-2619-8639; Hautz, Theresa/0000-0003-0388-0202; Wolfram, Dolores/0000-0003-0920-7211; Brandacher, Gerald/0000-0001-7790-441X	Armed Forces Institute for Advanced Regenerative Medicine Program (TATRC, DOD) Program, Department of Defense [WX81XWH-07-1-0415]; Austrian Research Fund (Erwin Schrodinger Stipendium); Austrian Society of Plastic and Reconstructive Surgery; Pennsylvania Department of Health Commonwealth Universal Research Enhancement (CURE) program	Armed Forces Institute for Advanced Regenerative Medicine Program (TATRC, DOD) Program, Department of Defense; Austrian Research Fund (Erwin Schrodinger Stipendium); Austrian Society of Plastic and Reconstructive Surgery; Pennsylvania Department of Health Commonwealth Universal Research Enhancement (CURE) program	Funding for this work was provided by the Armed Forces Institute for Advanced Regenerative Medicine Program (TATRC, DOD) Program, Department of Defense grant WX81XWH-07-1-0415, the Austrian Research Fund (Erwin Schrodinger Stipendium), the Austrian Society of Plastic and Reconstructive Surgery and the and the Pennsylvania Department of Health Commonwealth Universal Research Enhancement (CURE) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azhar N, 2013, ANAL SERUM INFLAMMAT; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bohra R, 2013, TRANSPL INT, V26, P225, DOI 10.1111/tri.12003; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BUBNOVA LN, 1992, TRANSPLANT P, V24, P2545; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carmi Y, 2009, J IMMUNOL, V183, P4705, DOI 10.4049/jimmunol.0901511; Cendales LC, 2008, AM J TRANSPLANT, V8, P1396, DOI 10.1111/j.1600-6143.2008.02243.x; Chow CC, 2005, SHOCK, V24, P74, DOI 10.1097/01.shk.0000168526.97716.f3; Coin L, 2003, P NATL ACAD SCI USA, V100, P4516, DOI 10.1073/pnas.0737502100; Dey BR, 1998, BLOOD, V91, P3315, DOI 10.1182/blood.V91.9.3315.3315_3315_3322; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Goriely S, 2008, CURR OPIN ORGAN TRAN, V13, P4, DOI 10.1097/MOT.0b013e3282f406c4; Grenz A, 2000, CLIN CHEM LAB MED, V38, P1183, DOI 10.1515/CCLM.2000.184; GREWAL HP, 1993, TRANSPLANT P, V25, P132; Hautz T, 2010, AM J TRANSPLANT, V10, P1200, DOI 10.1111/j.1600-6143.2010.03075.x; Hautz T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/757310; IMAGAWA DK, 1990, TRANSPLANTATION, V50, P219, DOI 10.1097/00007890-199008000-00009; Kanitakis J, 2000, TRANSPLANTATION, V69, P1380, DOI 10.1097/00007890-200004150-00029; Kanitakis J, 2008, J CUTAN PATHOL, V35, P738, DOI 10.1111/j.1600-0560.2007.00889.x; Mesarovic M. D., 2004, Systems Biology, V1, P19, DOI 10.1049/sb:20045010; Mi Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019424; Namas RA, 2012, MOL MED, V18, P1366, DOI 10.2119/molmed.2012.00106; NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Page EK, 2012, TRANSPL INT, V25, P707, DOI 10.1111/j.1432-2277.2012.01456.x; Piccotti JR, 1996, J IMMUNOL, V157, P1951; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Robert C, 1999, NEW ENGL J MED, V341, P1817, DOI 10.1056/NEJM199912093412407; Sarwal MM, 2006, IMMUNOL REV, V210, P138, DOI 10.1111/j.0105-2896.2006.00359.x; Schneeberger S, 2008, AM J TRANSPLANT, V8, P688, DOI 10.1111/j.1600-6143.2007.02105.x; Schon MP, 2005, EXPERT OPIN THER TAR, V9, P225, DOI 10.1517/14728222.9.2.225; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tak PP, 2006, EUR J DRUG METAB PH, V31, P109; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; van de Veerdonk FL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00167; Veenbergen S, 2010, ANN RHEUM DIS, V69, P276, DOI 10.1136/ard.2008.100867; Verma ND, 2006, TRANSPLANTATION, V82, P1324, DOI 10.1097/01.tp.0000239519.56358.c1; Vodovotz Y, 2006, IMMUNOL RES, V36, P237, DOI 10.1385/IR:36:1:237; WALSH LJ, 1991, P NATL ACAD SCI USA, V88, P4220, DOI 10.1073/pnas.88.10.4220; Warren HS, 2009, MOL MED, V15, P220, DOI 10.2119/molmed.2009.00027; Yuan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060714	43	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99926	10.1371/journal.pone.0099926	http://dx.doi.org/10.1371/journal.pone.0099926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926998	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100091
J	Crapeau, M; Merhi, A; Andre, B				Crapeau, Myriam; Merhi, Ahmad; Andre, Bruno			Stress Conditions Promote Yeast Gap1 Permease Ubiquitylation and Down-regulation via the Arrestin-like Bul and Aly Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIVESICULAR BODY PATHWAY; AMINO ACID PERMEASES; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEIN; INDUCED DEGRADATION; URACIL PERMEASE; UBIQUITIN; ENDOCYTOSIS; LIGASE; TRAFFICKING	Gap1, the yeast general amino acid permease, is a convenient model for studying how the intracellular traffic of membrane transporters is regulated. Present at the plasma membrane under poor nitrogen supply conditions, it undergoes ubiquitylation, endocytosis, and degradation upon activation of the TORC1 kinase complex in response to an increase in internal amino acids. This down-regulation is stimulated by TORC1-dependent phosphoinhibition of the Npr1 kinase, resulting in activation by dephosphorylation of the arrestin-like Bul1 and Bul2 adaptors recruiting the Rsp5 ubiquitin ligase to Gap1. We report here that Gap1 is also down-regulated when cells are treated with the TORC1 inhibitor rapamycin or subjected to various stresses and that a lack of the Tco89 subunit of TORC1 causes constitutive Gap1 down-regulation. Both the Bul1 and Bul2 and the Aly1 and Aly2 arrestin-like adaptors of Rsp5 promote this down-regulation without undergoing dephosphorylation. Furthermore, they act via the C-terminal regions of Gap1 not involved in ubiquitylation in response to internal amino acids, whereas a Gap1 mutant altered in the N-terminal tail and resistant to ubiquitylation by internal amino acids is efficiently down-regulated under stress via the Bul and Aly adaptors. Although the Bul proteins mediate Gap1 ubiquitylation of two possible lysines, Lys-9 and Lys-16, the Aly proteins promote ubiquitylation of the Lys-16 residue only. This stress-induced pathway of Gap1 down-regulation targets other permeases as well, and it likely allows cells facing adverse conditions to retrieve amino acids from permease degradation.	[Crapeau, Myriam; Merhi, Ahmad; Andre, Bruno] Univ Libre Brussels, Inst Biol & Med Mol, B-6041 Gosselies, Belgium		Andre, B (corresponding author), Inst Biol & Med Mol, Lab Physiol Mol Cellule, CP300,11 Rue Pr Jeener & Brachet, B-6041 Gosselies, Belgium.	bran@ulb.ac.be		Merhi, Ahmad/0000-0001-7046-2508	Fonds National de la Recherche Scientifique [3.4.592.08.F]; Actions de Recherche Concertees Grant AUWB of the Federation Wallonie-Bruxelles [2010- 15-2]	Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Actions de Recherche Concertees Grant AUWB of the Federation Wallonie-Bruxelles	This work was supported by Fonds National de la Recherche Scientifique Grant 3.4.592.08.F and Actions de Recherche Concertees Grant AUWB 2010- 15-2 of the Federation Wallonie-Bruxelles.	Abe F, 2003, MOL CELL BIOL, V23, P7566, DOI 10.1128/MCB.23.21.7566-7584.2003; Babst M, 2014, J CELL BIOL, V205, P11, DOI 10.1083/jcb.201310113; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Becuwe M, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/242764; Becuwe M, 2012, J CELL BIOL, V196, P247, DOI 10.1083/jcb.201109113; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Brohee S, 2010, BBA-BIOMEMBRANES, V1798, P1908, DOI 10.1016/j.bbamem.2010.06.008; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; Dupre S, 2004, BBA-MOL CELL RES, V1695, P89, DOI 10.1016/j.bbamcr.2004.09.024; Erpapazoglou Z, 2008, TRAFFIC, V9, P1372, DOI 10.1111/j.1600-0854.2008.00766.x; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; Ghaddar K, 2014, J BIOL CHEM, V289, P7232, DOI 10.1074/jbc.M113.525915; GRENSON M, 1966, BIOCHIM BIOPHYS ACTA, V127, P325, DOI 10.1016/0304-4165(66)90387-4; GRENSON M, 1970, J BACTERIOL, V103, P770, DOI 10.1128/JB.103.3.770-777.1970; Halova L, 2013, J CELL BIOL, V203, P595, DOI 10.1083/jcb.201305103; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Holst B, 2000, MOL MICROBIOL, V37, P108, DOI 10.1046/j.1365-2958.2000.01968.x; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; JACOBS P, 1980, J MOL BIOL, V139, P691, DOI 10.1016/0022-2836(80)90055-8; Jones CB, 2012, TRAFFIC, V13, P468, DOI 10.1111/j.1600-0854.2011.01314.x; Kakiuchi K, 2007, BIOCHEMISTRY-US, V46, P7781, DOI 10.1021/bi700501t; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Krampe S, 2002, FEBS LETT, V513, P193, DOI 10.1016/S0014-5793(02)02297-4; Lauwers E, 2007, MOL BIOL CELL, V18, P3068, DOI 10.1091/mbc.E07-03-0196; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Mayordomo I, 2003, FEBS LETT, V544, P160, DOI 10.1016/S0014-5793(03)00498-8; Merhi A, 2012, MOL CELL BIOL, V32, P4510, DOI 10.1128/MCB.00463-12; Merhi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018457; Nikko E, 2003, J BIOL CHEM, V278, P50732, DOI 10.1074/jbc.M306953200; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; O'Donnell AF, 2013, J BIOL CHEM, V288, P24063, DOI 10.1074/jbc.M113.478511; O'Donnell AF, 2010, MOL BIOL CELL, V21, P3552, DOI 10.1091/mbc.E10-07-0636; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Snowdon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050458; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; Springael JY, 1999, J CELL SCI, V112, P1375; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Zhao YY, 2013, ELIFE, V2, DOI 10.7554/eLife.00459	49	63	64	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22103	22116		10.1074/jbc.M114.582320	http://dx.doi.org/10.1074/jbc.M114.582320			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24942738	Green Published, hybrid			2022-12-25	WOS:000340593500026
J	Bhardwaj, N; Saxena, RK				Bhardwaj, Nitin; Saxena, Rajiv K.			Elimination of Young Erythrocytes from Blood Circulation and Altered Erythropoietic Patterns during Paraquat Induced Anemic Phase in Mice	PLOS ONE			English	Article							OXIDATIVE STRESS; EXPRESSION; CLEARANCE; SURVIVAL; RISK; SOD1	Paraquat a widely used herbicide causes a variety of toxic effects on humans and animals. The present study is focused on the interaction of paraquat with the mouse erythroid system. Administration of paraquat (10 mg/kg body weight i.p. on alternate days in C57Bl/6 mice) induced a significant fall in blood erythrocyte count on 7, 14, and 21 day time points but the erythrocyte count reverted back to normal by 28th day indicating the emergence of refractoriness to paraquat. A marked surge in the blood reticulocyte count was observed in paraquat treated mice that also subsided by 28th day. Young erythrocytes in circulation were randomly eliminated from blood circulation in paraquat treated mice and a significant elevation in the level of reactive oxygen species (ROS) was also observed maximally the erythrocytes of this age group. Cells representing various stages of erythroid differentiation in bone marrow and spleen were identified and enumerated flow cytometrically based on their expression of Ter119 and transferrin (CD71) receptor. Proliferative activity of erythroid cells, their relative proportion as well as their absolute numbers fell significantly in bone marrow of paraquat treated mice but all these parameters were significantly elevated in spleens of paraquat treated mice. These changes were essentially restricted to the cells belonging to the two earliest stages of erythroid differentiation. Taken together our results indicate that paraquat treatment causes a transient anemia in mice resulting from random elimination of young circulating erythrocytes as well as depressed erythropoietic activity in bone marrow. Spleen erythropoietic activity however was elevated in paraquat treated mice.	[Bhardwaj, Nitin; Saxena, Rajiv K.] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Saxena, Rajiv K.] South Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India	Jawaharlal Nehru University, New Delhi; South Asian University (SAU)	Saxena, RK (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	rajivksaxena@hotmail.com			Department of Science and technology, Government of India [SR/SO/HS-133/2007, SR/S0/HS/0261/2012]; University Grants Commission, India	Department of Science and technology, Government of India(Department of Science & Technology (India)); University Grants Commission, India(University Grants Commission, India)	Work funded by grants from Department of Science and technology, Government of India (Grants SR/SO/HS-133/2007 and SR/S0/HS/0261/2012). NB received a fellowship from University Grants Commission, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISMUTH C, 1990, DRUG SAFETY, V5, P243, DOI 10.2165/00002018-199005040-00002; BULLIVANT CM, 1966, BMJ-BRIT MED J, V1, P1272, DOI 10.1136/bmj.1.5498.1272; Dawson AH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000357; Eddleston M, 2000, QJM-INT J MED, V93, P715, DOI 10.1093/qjmed/93.11.715; Eisler R, 1990, 85121 PAT WILDL RES; Hattangadi SM, 2007, J CLIN INVEST, V117, P2075, DOI 10.1172/JCI32559; Hong SY, 2000, TOXICOL LETT, V118, P53, DOI 10.1016/S0378-4274(00)00264-2; Iuchi Y, 2007, BIOCHEM J, V402, P219, DOI 10.1042/BJ20061386; Iuchi Y, 2009, BIOCHEM J, V422, P313, DOI 10.1042/BJ20090176; JOENJE H, 1987, CANCER GENET CYTOGEN, V25, P37, DOI 10.1016/0165-4608(87)90157-9; Kalfa TA, 2010, HAEMATOL-HEMATOL J, V95, P27, DOI 10.3324/haematol.2009.006239; Khandelwal S, 2008, EXP GERONTOL, V43, P764, DOI 10.1016/j.exger.2008.05.002; Khandelwal S, 2007, J BIOSCIENCES, V32, P1139, DOI 10.1007/s12038-007-0115-z; Khandelwal S, 2007, TRANSFUSION, V47, P1725, DOI 10.1111/j.1537-2995.2007.01348.x; Khandelwal S, 2006, EXP GERONTOL, V41, P855, DOI 10.1016/j.exger.2006.06.045; Kono M, 2009, CLIN CHIM ACTA, V404, P105, DOI 10.1016/j.cca.2009.03.017; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Liou HH, 1997, NEUROLOGY, V48, P1583, DOI 10.1212/WNL.48.6.1583; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; MORLEY SJ, 1990, BIOCHIMIE, V72, P259, DOI 10.1016/0300-9084(90)90081-Q; Paulson RF, 2011, CURR OPIN HEMATOL, V18, P139, DOI 10.1097/MOH.0b013e32834521c8; Prasad K, 2009, EXP NEUROL, V215, P358, DOI 10.1016/j.expneurol.2008.11.003; Prihartono N, 2011, ASIA-PAC J PUBLIC HE, V23, P369, DOI 10.1177/1010539511403605; Sachar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022032; Saxena RK, 2012, TRANSFUS MED HEMOTH, V39, P335, DOI 10.1159/000342524; Saxena RK, 2009, CURR SCI INDIA, V97, P500; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; Tsiftsoglou AS, 2009, IUBMB LIFE, V61, P800, DOI 10.1002/iub.226; U. S. EPA, 1997, 738F96018 US EPA; VANHOVE L, 1990, CLIN LAB HAEMATOL, V12, P287; Wu DC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011303	33	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99364	10.1371/journal.pone.0099364	http://dx.doi.org/10.1371/journal.pone.0099364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945144	Green Published, Green Submitted, gold			2022-12-25	WOS:000340721500017
J	Gedaly, R; Galuppo, R; Daily, MF; Shah, M; Maynard, E; Chen, CG; Zhang, XP; Esser, KA; Cohen, DA; Evers, BM; Jiang, JY; Spear, BT				Gedaly, Roberto; Galuppo, Roberto; Daily, Michael F.; Shah, Malay; Maynard, Erin; Chen, Changguo; Zhang, Xiping; Esser, Karyn A.; Cohen, Donald A.; Evers, B. Mark; Jiang, Jieyun; Spear, Brett T.			Targeting the Wnt/beta-Catenin Signaling Pathway in Liver Cancer Stem Cells and Hepatocellular Carcinoma Cell Lines with FH535	PLOS ONE			English	Article							ALPHA-FETOPROTEIN ENHANCER; BETA-CATENIN; INHIBITION; ACTIVATION; SORAFENIB; CYCLE; PI3K/AKT/MTOR; TRANSCRIPTION; RAS/RAF/MAPK; APOPTOSIS	Activation of the Wnt/beta-catenin pathway has been observed in at least 1/3 of hepatocellular carcinomas (HCC), and a significant number of these have mutations in the beta-catenin gene. Therefore, effective inhibition of this pathway could provide a novel method to treat HCC. The purposed of this study was to determine whether FH535, which was previously shown to block the beta-catenin pathway, could inhibit beta-catenin activation of target genes and inhibit proliferation of Liver Cancer Stem Cells (LCSC) and HCC cell lines. Using beta-catenin responsive reporter genes, our data indicates that FH535 can inhibit target gene activation by endogenous and exogenously expressed beta-catenin, including the constitutively active form of beta-catenin that contains a Serine37Alanine mutation. Our data also indicate that proliferation of LCSC and HCC lines is inhibited by FH535 in a dose-dependent manner, and that this correlates with a decrease in the percentage of cells in S phase. Finally, we also show that expression of two well-characterized targets of beta-catenin, Cyclin D1 and Survivin, is reduced by FH535. Taken together, this data indicates that FH535 has potential therapeutic value in treatment of liver cancer. Importantly, these results suggest that this therapy may be effective at several levels by targeting both HCC and LCSC.	[Gedaly, Roberto; Galuppo, Roberto; Daily, Michael F.; Shah, Malay; Maynard, Erin; Chen, Changguo] Univ Kentucky, Dept Surg, Lexington, KY 40506 USA; [Zhang, Xiping; Esser, Karyn A.] Univ Kentucky, Dept Physiol, Lexington, KY USA; [Cohen, Donald A.; Jiang, Jieyun; Spear, Brett T.] Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY USA; [Cohen, Donald A.; Evers, B. Mark; Jiang, Jieyun; Spear, Brett T.] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Gedaly, R (corresponding author), Univ Kentucky, Dept Surg, Lexington, KY 40506 USA.	rgeda2@uky.edu		Spear, Brett/0000-0002-4343-9393	National Center for Research Resources (NCRR) [UL1RR033173, TL1 RR033172, KL2 RR033171]; Office of the Director, National Institutes of Health (NIH) [DK074816]; NIH Roadmap for Medical Research; Flow Cytometry and Cell Sorting Shared Resource of the University of Kentucky Markey Cancer Center [P30CA177558]; NATIONAL CANCER INSTITUTE [P30CA177558] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR033171, TL1RR033172, UL1RR033173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074816] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of the Director, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flow Cytometry and Cell Sorting Shared Resource of the University of Kentucky Markey Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This publication was supported by grant number UL1RR033173 [TL1 RR033172, KL2 RR033171] from the National Center for Research Resources (NCRR), DK074816 (BTS) funded by the Office of the Director, National Institutes of Health (NIH), and supported by the NIH Roadmap for Medical Research. This research also was supported by the Flow Cytometry and Cell Sorting Shared Resource of the University of Kentucky Markey Cancer Center (P30CA177558). The content is solely the responsibility of the authors and does not necessarily represent the official views of NCRR and NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Chang JS, 2005, LIFE SCI, V76, P1883, DOI 10.1016/j.lfs.2004.11.003; Clinkenbeard EL, 2012, HEPATOLOGY, V56, P1892, DOI 10.1002/hep.25819; Fabregat I, 2009, WORLD J GASTROENTERO, V15, P513, DOI 10.3748/wjg.15.513; Fujikawa T, 2007, J GASTROEN HEPATOL, V22, P436, DOI 10.1111/j.1440-1746.2006.04541.x; Gedaly R, 2013, J SURG RES, V185, P225, DOI 10.1016/j.jss.2013.05.016; Gedaly R, 2012, J SURG RES, V176, P542, DOI 10.1016/j.jss.2011.10.045; Gedaly R, 2010, ANTICANCER RES, V30, P4951; Ghous Z, 2008, ANTICANCER RES, V28, P3757; GODBOUT R, 1988, GENE DEV, V2, P949, DOI 10.1101/gad.2.8.949; GROUPP ER, 1994, J BIOL CHEM, V269, P22178; Handeli S, 2008, MOL CANCER THER, V7, P521, DOI 10.1158/1535-7163.MCT-07-2063; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Hui AM, 1998, HEPATO-GASTROENTEROL, V45, P1635; Jennings BH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-205; Ji JF, 2012, SEMIN ONCOL, V39, P461, DOI 10.1053/j.seminoncol.2012.05.011; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Lopez-Terrada D, 2009, HUM PATHOL, V40, P1512, DOI 10.1016/j.humpath.2009.07.003; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nambotin SB, 2011, ANTI-CANCER AGENT ME, V11, P549; Olmeda D, 2003, MOL BIOL CELL, V14, P2844, DOI 10.1091/mbc.E03-01-0865; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Palacino JJ, 2001, J BIOL CHEM, V276, P38563, DOI 10.1074/jbc.M105376200; Sameh M. A., 2011, INT J HEPATOL, V2011, P1; Shi ZD, 2012, J NEUROIMMUNE PHARM, V7, P892, DOI 10.1007/s11481-012-9354-3; Su SJ, 2003, NUTR CANCER, V45, P113, DOI 10.1207/S15327914NC4501_13; Sun YN, 2000, P NATL ACAD SCI USA, V97, P12613, DOI 10.1073/pnas.220158597; Takigawa Y, 2008, CURR DRUG TARGETS, V9, P1013, DOI 10.2174/138945008786786127; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tong CM, 2011, J GASTROEN HEPATOL, V26, P1229, DOI 10.1111/j.1440-1746.2011.06762.x; Wachter J, 2012, INT J BIOL SCI, V8, P15, DOI 10.7150/ijbs.8.15; Welzel TM, 2013, AM J GASTROENTEROL, V108, P1314, DOI 10.1038/ajg.2013.160; Whitfield JF, 2009, CANCER LETT, V275, P9, DOI 10.1016/j.canlet.2008.07.001; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908; Zaffaroni N, 2007, CELL ONCOL, V29, P453	39	81	85	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99272	10.1371/journal.pone.0099272	http://dx.doi.org/10.1371/journal.pone.0099272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940873	Green Submitted, Green Published, gold			2022-12-25	WOS:000338508200018
J	Le Roux, DS; Ikin, K; Lindenmayer, DB; Manning, AD; Gibbons, P				Le Roux, Darren S.; Ikin, Karen; Lindenmayer, David B.; Manning, Adrian D.; Gibbons, Philip			The Future of Large Old Trees in Urban Landscapes	PLOS ONE			English	Article							COARSE WOODY DEBRIS; CONSERVATION IMPLICATIONS; KEYSTONE STRUCTURES; SCATTERED TREES; NEST BOXES; HOLLOWS; FORESTS; REGENERATION; DECLINE; BIODIVERSITY	Large old trees are disproportionate providers of structural elements (e. g. hollows, coarse woody debris), which are crucial habitat resources for many species. The decline of large old trees in modified landscapes is of global conservation concern. Once large old trees are removed, they are difficult to replace in the short term due to typically prolonged time periods needed for trees to mature (i.e. centuries). Few studies have investigated the decline of large old trees in urban landscapes. Using a simulation model, we predicted the future availability of native hollow-bearing trees (a surrogate for large old trees) in an expanding city in southeastern Australia. In urban greenspace, we predicted that the number of hollow-bearing trees is likely to decline by 87% over 300 years under existing management practices. Under a worst case scenario, hollow-bearing trees may be completely lost within 115 years. Conversely, we predicted that the number of hollow-bearing trees will likely remain stable in semi-natural nature reserves. Sensitivity analysis revealed that the number of hollow-bearing trees perpetuated in urban greenspace over the long term is most sensitive to the: (1) maximum standing life of trees; (2) number of regenerating seedlings ha 21; and (3) rate of hollow formation. We tested the efficacy of alternative urban management strategies and found that the only way to arrest the decline of large old trees requires a collective management strategy that ensures: (1) trees remain standing for at least 40% longer than currently tolerated lifespans; (2) the number of seedlings established is increased by at least 60%; and (3) the formation of habitat structures provided by large old trees is accelerated by at least 30% (e. g. artificial structures) to compensate for short term deficits in habitat resources. Immediate implementation of these recommendations is needed to avert long term risk to urban biodiversity.	[Le Roux, Darren S.; Ikin, Karen; Lindenmayer, David B.; Manning, Adrian D.; Gibbons, Philip] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia	Australian National University	Le Roux, DS (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	darren_lrx@yahoo.com	Ikin, Karen/G-2845-2012; Gibbons, Philip/I-8248-2012; Manning, Adrian/AAX-7288-2021; Lindenmayer, David B/P-7183-2017; Manning, Adrian/AAG-2949-2019	Manning, Adrian/0000-0003-0989-9203; Lindenmayer, David B/0000-0002-4766-4088; 	Australian National University; Land Development Agency (ACT Government); Environmental Decision Hub of the Australian Government's National Environmental Research Program	Australian National University(Australian National University); Land Development Agency (ACT Government); Environmental Decision Hub of the Australian Government's National Environmental Research Program	Darren Le Roux was funded by an Australian Postgraduate Award from the Australian National University and a top-up scholarship from the Land Development Agency (ACT Government). The authors also received funding from The Environmental Decision Hub of the Australian Government's National Environmental Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACT Government, 2011, POP RES DENS CANB; [ACT Government Territory and Municipal Services], 2012, CANB TREE AUD METH F; ACT Government, 2013, MAN TREES PUBL LAND; Adkins M. F., 2006, Australian Forestry, V69, P107; Andersson R, 2004, BIOL CONSERV, V118, P443, DOI 10.1016/j.biocon.2003.09.020; [Anonymous], 2004, WOODL WILDL ACT LOWL; Banks J.C.G., 1997, COMING AGE FOREST AG, P17; Banks John C. G., 2003, Urban Forestry & Urban Greening, V1, P151, DOI 10.1078/1618-8667-00015; Blewett CM, 2005, CONDOR, V107, P678, DOI 10.1650/0010-5422(2005)107[0678:EOUSOS]2.0.CO;2; BULL EL, 1986, WILDLIFE SOC B, V14, P142; CAREY A B, 1981, Wildlife Society Bulletin, V9, P14; Carpaneto GM, 2010, J INSECT CONSERV, V14, P555, DOI 10.1007/s10841-010-9283-5; Cockle KL, 2011, FRONT ECOL ENVIRON, V9, P377, DOI 10.1890/110013; Cohen JE, 2003, SCIENCE, V302, P1172, DOI 10.1126/science.1088665; Department of the Environment and Heritage, 2006, EPBC POL STAT 3 5 WH; Fischer J, 2010, P NATL ACAD SCI USA, V107, P19597, DOI 10.1073/pnas.1008476107; Fischer J, 2009, P NATL ACAD SCI USA, V106, P10386, DOI 10.1073/pnas.0900110106; Gibbons P, 2008, CONSERV BIOL, V22, P1309, DOI 10.1111/j.1523-1739.2008.00997.x; Gibbons P., 2000, Pacific Conservation Biology, V6, P218; Gibbons P, 2002, BIOL CONSERV, V103, P1, DOI 10.1016/S0006-3207(01)00109-4; Gibbons P., 2002, TREE HOLLOWS WILDLIF, DOI [10.1071/9780643090033, DOI 10.1071/9780643090033]; Gibbons P, 2008, BIOL CONSERV, V141, P2483, DOI 10.1016/j.biocon.2008.07.009; Gibbons Philip, 2002, Ecological Management & Restoration, V3, P205, DOI 10.1046/j.1442-8903.2002.00114.x; Gibbons P, 2010, FOREST ECOL MANAG, V260, P975, DOI 10.1016/j.foreco.2010.06.016; Goodburn JM, 1998, CAN J FOREST RES, V28, P427, DOI 10.1139/cjfr-28-3-427; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hane ME, 2012, FOREST ECOL MANAG, V282, P167, DOI 10.1016/j.foreco.2012.06.037; Harper MJ, 2005, WILDLIFE RES, V32, P509, DOI 10.1071/WR04106; Harper MJ, 2005, BIOL CONSERV, V122, P181, DOI 10.1016/j.biocon.2004.07.003; Laurance WF, 1997, SCIENCE, V278, P1117, DOI 10.1126/science.278.5340.1117; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Lehvavirta S, 2002, J VEG SCI, V13, P57, DOI 10.1111/j.1654-1103.2002.tb02023.x; Lindenmayer D., 2013, CONSTR LETT IN PRESS, V1, P1, DOI DOI 10.1111/C0N1.12013; Lindenmayer DB, 2012, SCIENCE, V338, P1305, DOI 10.1126/science.1231070; Lindenmayer DB, 2010, CAN J FOREST RES, V40, P48, DOI 10.1139/X09-185; Lindenmayer DB, 2009, BIOL CONSERV, V142, P33, DOI 10.1016/j.biocon.2008.09.026; LINDENMAYER DB, 1990, BIOL CONSERV, V54, P133, DOI 10.1016/0006-3207(90)90138-F; Lutz JA, 2009, FOREST ECOL MANAG, V257, P2296, DOI 10.1016/j.foreco.2009.03.009; Manning AD, 2013, ANIM CONSERV, V16, P395, DOI 10.1111/acv.12006; Manning AD, 2004, BIOL CONSERV, V120, P363, DOI 10.1016/j.biocon.2004.03.008; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Manning Adrian D., 2007, Ecological Management & Restoration, V8, P221, DOI 10.1111/j.1442-8903.2007.00371.x; MCCARTHY MA, 1995, BIOL CONSERV, V73, P93, DOI 10.1016/0006-3207(95)00046-7; Mcdonald RI, 2008, BIOL CONSERV, V141, P1695, DOI 10.1016/j.biocon.2008.04.025; Mooney C.Z., 1997, MONTE CARLO SIMULATI; Nagendra H, 2010, URBAN FOR URBAN GREE, V9, P129, DOI 10.1016/j.ufug.2009.12.005; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; Nowak David J., 2004, Urban Forestry & Urban Greening, V2, P139, DOI 10.1078/1618-8667-00030; Pauleit S, 2005, LANDSCAPE URBAN PLAN, V71, P295, DOI [10.1016/S0169-2046(04)00083-0, 10.1016/j.landurbplan.2004.03.009]; Pauleit S, 2003, P I CIVIL ENG-MUNIC, V156, P43, DOI 10.1680/muen.2003.156.1.43; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pincetl S, 2010, ENVIRON MANAGE, V45, P227, DOI 10.1007/s00267-009-9412-7; Pulido FJ, 2001, FOREST ECOL MANAG, V146, P1, DOI 10.1016/S0378-1127(00)00443-6; Ranius T, 2002, BIOL CONSERV, V103, P85, DOI 10.1016/S0006-3207(01)00124-0; Ranius T, 2009, FOREST ECOL MANAG, V257, P303, DOI 10.1016/j.foreco.2008.09.007; Rayner L, 2011, AUSTRAL ECOL, V36, P252, DOI 10.1111/j.1442-9993.2010.02145.x; Rhodes M, 2006, APPL NETWORK ANAL CO; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; SCHONAU APG, 1989, FOREST ECOL MANAG, V29, P245, DOI 10.1016/0378-1127(89)90097-2; Shepherd K. R., 1957, Australian Forestry, V21, P70; Sodhi NS, 2010, BIOL CONSERV, V143, P2375, DOI 10.1016/j.biocon.2009.12.029; Stagoll K, 2012, CONSERV LETT, V5, P115, DOI 10.1111/j.1755-263X.2011.00216.x; Terho M, 2009, URBAN FOR URBAN GREE, V8, P77, DOI 10.1016/j.ufug.2009.02.004; Theobald DM, 1997, LANDSCAPE URBAN PLAN, V39, P25, DOI 10.1016/S0169-2046(97)00041-8; Thor G, 2010, BIODIVERS CONSERV, V19, P2307, DOI 10.1007/s10531-010-9843-8; Tonnesen AS, 1997, WEST N AM NATURALIST, V57, P55; Webb JK, 1997, BIOL CONSERV, V81, P21, DOI 10.1016/S0006-3207(96)00160-7; Weinberg A, 2011, BIOL CONSERV, V144, P227, DOI 10.1016/j.biocon.2010.08.020; WELLINGTON AB, 1985, J ECOL, V73, P645, DOI 10.2307/2260501; White JW, 2014, OIKOS, V123, P385, DOI 10.1111/j.1600-0706.2013.01073.x; Whitford K. R., 1995, Australian Forestry, V58, P172; Wu Chunxia, 2008, Urban Forestry & Urban Greening, V7, P65, DOI 10.1016/j.ufug.2008.01.002	72	58	64	6	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99403	10.1371/journal.pone.0099403	http://dx.doi.org/10.1371/journal.pone.0099403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941258	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200022
J	Mitra, S; Wade, MS; Sun, XG; Moldobaeva, N; Flores, C; Ma, SF; Zhang, W; Garcia, JGN; Jacobson, JR				Mitra, Sumegha; Wade, Michael S.; Sun, Xiaoguang; Moldobaeva, Nurgul; Flores, Carlos; Ma, Shwu-Fan; Zhang, Wei; Garcia, Joe G. N.; Jacobson, Jeffrey R.			GADD45a Promoter Regulation by a Functional Genetic Variant Associated with Acute Lung Injury	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; COLONY-ENHANCING FACTOR; POLYMORPHISMS; SEPSIS; EXPRESSION; RISK; SUSCEPTIBILITY; TRANSCRIPTION; DEFINITIONS; HAPLOTYPE	Rationale: Growth arrest DNA damage inducible alpha (GADD45a) is a stress-induced gene we have shown to participate in the pathophysiology of ventilator-induced lung injury (VILI) via regulation of mechanical stress-induced Akt ubiquitination and phosphorylation. The regulation of GADD45a expression by mechanical stress and its relationship with acute lung injury (ALI) susceptibility and severity, however, remains unknown. Objectives: We examined mechanical stress-dependent regulatory elements (MSRE) in the GADD45a promoter and the contribution of promoter polymorphisms in GADD45a expression and ALI susceptibility. Methods and Results: Initial studies in GADD45a knockout and heterozygous mice confirmed the relationship of GADD45a gene dose to VILI severity. Human lung endothelial cells (EC) transfected with a luciferase vector containing the full length GADD45a promoter sequence (-771 to +223) demonstrated a >4 fold increase in GADD45a expression in response to 18% cyclic stretch (CS, 4 h) compared to static controls while specific promoter regions harboring CS-dependent MSRE were identified using vectors containing serial deletion constructs of the GADD45a promoter. In silico analyses of GADD45a promoter region (-371 to -133) revealed a potential binding site for specificity protein 1 (SP1), a finding supported by confirmed SP1 binding with the GADD45a promoter and by the significant attenuation of CS-dependent GADD45a promoter activity in response to SP1 silencing. Separately, case-control association studies revealed a significant association of a GADD45a promoter SNP at -589 (rs581000, G>C) with reduced ALI susceptibility. Subsequently, we found allelic variation of this SNP is associated with both differential GADD45a expression in mechanically stressed EC (18% CS, 4 h) and differential binding site of interferon regulatory factor 7 (IRF7) at this site. Conclusion: These results strongly support a functional role for GADD45a in ALI/VILI and identify a specific gene variant that confers risk for ALI.	[Mitra, Sumegha; Wade, Michael S.; Sun, Xiaoguang; Moldobaeva, Nurgul; Zhang, Wei; Jacobson, Jeffrey R.] Univ Illinois, Dept Med, Div Pulm Crit Care Sleep & Allergy, Chicago, IL 60607 USA; [Flores, Carlos] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Resp, Madrid, Spain; [Flores, Carlos] Hosp Univ Nuestra Senora Candelaria, Res Unit, Tenerife, Spain; [Ma, Shwu-Fan] Univ Illinois, Div Pulm Crit Care & Sleep, Chicago, IL USA; [Zhang, Wei] Univ Illinois, Dept Pediat, Chicago, IL USA; [Garcia, Joe G. N.] Univ Arizona, Arizona Hlth Sci Ctr, Tucson, AZ USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Arizona; University of Arizona Health Sciences	Jacobson, JR (corresponding author), Univ Illinois, Dept Med, Div Pulm Crit Care Sleep & Allergy, Chicago, IL 60607 USA.	jrjacob@uic.edu	Flores, Carlos/R-1159-2019	Flores, Carlos/0000-0001-5352-069X; Mitra, Sumegha/0000-0002-5567-3347	NCATS NIH HHS [UL1 TR000430] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Altemeier WA, 2005, J IMMUNOL, V175, P3369, DOI 10.4049/jimmunol.175.5.3369; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Cao YX, 2003, J CELL BIOCHEM, V89, P887, DOI 10.1002/jcb.10555; Flores C, 2008, TRANSL RES, V152, P11, DOI 10.1016/j.trsl.2008.05.006; Gao L, 2006, AM J RESP CELL MOL, V34, P487, DOI 10.1165/rcmb.2005-0404OC; Gao L, 2007, TRANSL RES, V150, P18, DOI 10.1016/j.trsl.2007.02.007; Grigoryev DN, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r34; Han YJ, 2012, J MOL MED, V90, P299, DOI 10.1007/s00109-011-0820-9; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Hong SB, 2008, AM J RESP CRIT CARE, V178, P605, DOI 10.1164/rccm.200712-1822OC; Lin Z, 2000, CLIN GENET, V58, P181, DOI 10.1034/j.1399-0004.2000.580305.x; Liu YX, 2012, CLIN CHEM LAB MED, V50, P1917, DOI 10.1515/cclm-2012-0238; Ma SF, 2011, AM J RESP CELL MOL, V45, P1203, DOI 10.1165/rcmb.2011-0179OC; Marshall RP, 2002, AM J RESP CRIT CARE, V166, P646, DOI 10.1164/rccm.2108086; Meyer NJ, 2009, FASEB J, V23, P1325, DOI 10.1096/fj.08-119073; Mitra S, 2006, MATURITAS, V55, P27, DOI 10.1016/j.maturitas.2006.01.003; Mitra S, 2011, AM J RESP CRIT CARE, V184, P1030, DOI 10.1164/rccm.201103-0447OC; Moss M, 2002, CRIT CARE MED, V30, P1679, DOI 10.1097/00003246-200208000-00001; Nemeth E, 2000, AM J OBSTET GYNECOL, V182, P50, DOI 10.1016/S0002-9378(00)70490-X; Ney L, 2000, NEW ENGL J MED, V343, P812; O'Mahony DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051104; Pino-Yanes M, 2011, AM J RESP CELL MOL, V45, P740, DOI 10.1165/rcmb.2010-0292OC; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Seefried L, 2010, EUR CELLS MATER, V20, P344; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Song ZJ, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-168; Tejera P, 2012, J MED GENET, V49, P671, DOI 10.1136/jmedgenet-2012-100972; Weale ME, 2003, AM J HUM GENET, V73, P551, DOI 10.1086/378098; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC	35	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100169	10.1371/journal.pone.0100169	http://dx.doi.org/10.1371/journal.pone.0100169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940746	gold, Green Submitted, Green Published			2022-12-25	WOS:000338508200080
J	Guariglia, P; Matano, A; Piccardi, L				Guariglia, Paola; Matano, Alessandro; Piccardi, Laura			Bisecting or Not Bisecting: This Is the Neglect Question. Line Bisection Performance in the Diagnosis of Neglect in Right Brain-Damaged Patients	PLOS ONE			English	Article							HORIZONTAL SPACE MISREPRESENTATION; UNILATERAL SPATIAL NEGLECT; VISUAL NEGLECT; VISUOSPATIAL NEGLECT; HEMINEGLECT DISORDER; HEMISPATIAL NEGLECT; EYE-MOVEMENTS; HEMIANOPIA; STROKE; REHABILITATION	In the present study we analysed the bisecting behaviour of 287 chronic right brain-damaged patients by taking into account the presence and severity of extrapersonal and/or personal neglect diagnosed with the hemineglect battery. We also analysed right brain-damaged patients who had (or did not have) neglect according to their line bisection performance. Our results showed that performance of the line bisection task correlates with performance of cancellation tasks, reading and perceptual tasks, but not with the presence of personal neglect. Personal neglect seems to be unrelated to line bisection behaviour. Indeed, patients affected by extrapersonal and personal neglect do not show more severe neglect in line bisection than patients with only extrapersonal neglect. Furthermore, we observed that 20.56% of the patients were considered affected or not by neglect on the line bisection task compared with the other spatial tasks of the hemineglect battery. We conclude that using a battery with multiple tests is the only way to guarantee a reliable diagnosis and effectively plan for rehabilitative training.	[Guariglia, Paola] Univ Enna Kore, Dipartimento Sci Uomo & Soc, Enna, Italy; [Matano, Alessandro; Piccardi, Laura] IRCCS Fdn Santa Lucia, Unita Neuropsicol, Rome, Italy; [Piccardi, Laura] Univ Aquila, Dipartimento Med Clin Sanita Pubbl Sci Vita & Amb, I-67100 Laquila, Italy	Universita Kore di ENNA; IRCCS Santa Lucia; University of L'Aquila	Guariglia, P (corresponding author), Univ Enna Kore, Dipartimento Sci Uomo & Soc, Enna, Italy.	paola.guariglia@unikore.it	Piccardi, laura/AAC-7587-2022	Piccardi, Laura/0000-0002-1322-5538				ALBERT ML, 1973, NEUROLOGY, V23, P658, DOI 10.1212/WNL.23.6.658; [Anonymous], 1989, PSYCHOL ASSESSMENT; Azouvi P, 2002, J NEUROL NEUROSUR PS, V73, P160, DOI 10.1136/jnnp.73.2.160; Azouvi P, 2006, RESTOR NEUROL NEUROS, V24, P273; Baas U, 2011, NEUROPSYCHOLOGIA, V49, P898, DOI 10.1016/j.neuropsychologia.2011.01.043; BINDER J, 1992, ARCH NEUROL-CHICAGO, V49, P1187, DOI 10.1001/archneur.1992.00530350109026; BISIACH E, 1986, NEUROPSYCHOLOGIA, V24, P759, DOI 10.1016/0028-3932(86)90075-8; Bisiach E, 1978, CORTEX; Bowen A, 1999, STROKE, V30, P1196, DOI 10.1161/01.STR.30.6.1196; Buxbaum LJ, 2004, NEUROLOGY, V62, P749, DOI 10.1212/01.WNL.0000113730.73031.F4; Ciurli P, 1996, ESAME LINGUAGGIO 2; Committeri G, 2007, BRAIN, V130, P431, DOI 10.1093/brain/awl265; Diller L, 1977, Adv Neurol, V18, P63; Doricchi F, 1999, NEUROLOGY, V52, P1845, DOI 10.1212/WNL.52.9.1845; Doricchi F, 2005, BRAIN, V128, P1386, DOI 10.1093/brain/awh461; Doricchi F, 2003, J NEUROL NEUROSUR PS, V74, P116, DOI 10.1136/jnnp.74.1.116; Doricchi F, 2002, NEUROPSYCHOLOGIA, V40, P1118, DOI 10.1016/S0028-3932(02)00011-8; Doricchi F, 2002, NEUROPSYCHOLOGIA, V40, P1107, DOI 10.1016/S0028-3932(02)00010-6; GROSSI D, 1989, BRAIN COGNITION, V10, P18, DOI 10.1016/0278-2626(89)90072-9; GUARIGLIA C, 1992, NEUROPSYCHOLOGIA, V30, P1001, DOI 10.1016/0028-3932(92)90051-M; Guariglia C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067390; HALLIGAN PW, 1991, NATURE, V350, P498, DOI 10.1038/350498a0; Halligan PW, 2003, TRENDS COGN SCI, V7, P125, DOI 10.1016/S1364-6613(03)00032-9; HALLIGAN PW, 1992, CORTEX, V28, P525, DOI 10.1016/S0010-9452(13)80225-0; Jehkonen M, 1998, LANCET, V351, P727, DOI 10.1016/S0140-6736(05)78497-X; Machner B, 2009, J NEUROL, V256, P289, DOI 10.1007/s00415-009-0148-3; MASSIRONI M, 1988, NEUROPSYCHOLOGIA, V26, P161, DOI 10.1016/0028-3932(88)90039-5; Molenberghs P, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00078; Molenberghs P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023017; Ota H, 2001, NEUROLOGY, V57, P2064, DOI 10.1212/WNL.57.11.2064; Pizzamiglio L, 2004, CORTEX, V40, P441, DOI 10.1016/S0010-9452(08)70138-2; Raven J. C., 1938, STANDARD PROGRESSIVE; Rorden C, 2006, BRAIN RES, V1080, P17, DOI 10.1016/j.brainres.2004.10.071; Saj A, 2012, BRAIN, V135, DOI 10.1093/brain/awr227; Saj A, 2012, NEUROPSYCHOLOGY, V26, P37, DOI 10.1037/a0025733; Schuett S, 2009, VISION RES, V49, P1668, DOI 10.1016/j.visres.2009.04.004; Spinnler H., 1987, ITAL J NEUROL SCI, V6, P1; Vallar G, 1998, TRENDS COGN SCI, V2, P87, DOI 10.1016/S1364-6613(98)01145-0; Verdon V, 2010, BRAIN, V133, P880, DOI 10.1093/brain/awp305; WILSON B, 1987, ARCH PHYS MED REHAB, V68, P98; Zihl J, 2009, NEUROPSYCHOLOGIA, V47, P2417, DOI 10.1016/j.neuropsychologia.2009.04.009; ZOCCOLOTTI P, 1989, INT J NEUROSCI, V47, P209, DOI 10.3109/00207458908987435; Zoccolotti P., 1991, NEUROPSYCHOL REHABIL, V1, P33, DOI [10.1080/09602019108401378, DOI 10.1080/09602019108401378]	43	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99700	10.1371/journal.pone.0099700	http://dx.doi.org/10.1371/journal.pone.0099700			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937472	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400032
J	Niemuth, ND; Fleming, KK; Reynolds, RE				Niemuth, Neal D.; Fleming, Kathleen K.; Reynolds, Ronald E.			Waterfowl Conservation in the US Prairie Pothole Region: Confronting the Complexities of Climate Change	PLOS ONE			English	Article							NORTH-DAKOTA; LAND-USE; WETLANDS; TRENDS; UNCERTAINTY; HYDROLOGY; DYNAMICS; SURVIVAL; FISH; SIZE	The Prairie Pothole Region (PPR) is the most important waterfowl production area in North America. However, waterfowl populations there are predicted to decline because of climate-related drying of wetlands. Consequently, changes in the geographic focus of PPR waterfowl conservation have been recommended, which could have long-lasting and costly impacts. We used a 40-year dataset of pond counts collected in the PPR to test hypotheses about climate-related drying. We assessed May (1974-2013) and July (1974-2003) pond numbers in 20 waterfowl survey strata to determine if trends in pond numbers were consistent with predictions of drying. We also assessed trends in precipitation and temperature for the 20 strata and developed models describing May pond numbers from 1974 through 2010 as a function of precipitation, temperature, the previous year's pond numbers, and location. None of the 20 strata showed significant declines in May pond numbers, although seven strata showed increases over time. July pond numbers declined significantly in one stratum, and increased in seven strata. An index to hydroperiod showed significant increasing trends in three strata, and no strata had decreasing trends. Precipitation increased significantly in two strata and decreased in two from 1974 to 2010; no strata showed significant changes in temperature. The best linear model described pond numbers within all strata as a function of precipitation, temperature, the previous year's pond numbers, and the latitude and longitude of the stratum, and explained 62% of annual variation in pond numbers. We hypothesize that direct effects of climate change on prairie pothole wetlands and waterfowl may be overshadowed by indirect effects such as intensified land use and increased pressure to drain wetlands. We recommend that an adaptive, data-driven approach be used to resolve uncertainties regarding direct and indirect effects of climate change on prairie wetlands and waterfowl, and guide future conservation efforts.	[Niemuth, Neal D.; Reynolds, Ronald E.] US Fish & Wildlife Serv, Habitat & Populat Evaluat Team, Bismarck, ND 58501 USA; [Fleming, Kathleen K.] US Fish & Wildlife Serv, Div Migratory Bird Management, Laurel, MD USA	United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service	Niemuth, ND (corresponding author), US Fish & Wildlife Serv, Habitat & Populat Evaluat Team, Bismarck, ND 58501 USA.	Neal_Niemuth@fws.gov						Ando AW, 2012, P NATL ACAD SCI USA, V109, P6484, DOI 10.1073/pnas.1114653109; [Anonymous], 2009, CLIMATE CHANGE IMPAC, DOI DOI 10.1111/j.1365-2664.2010.01827.x; [Anonymous], 2012, KIKA; Batt B.D.J., 1989, P204; BETHKE RW, 1995, ECOL APPL, V5, P588, DOI 10.2307/1941969; Bouffard SH, 1997, WILDLIFE SOC B, V25, P146; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.2307/3802723, DOI 10.2307/3802723]; Conly FM, 2001, ENVIRON MONIT ASSESS, V67, P195, DOI 10.1023/A:1006486607040; Cowardin LM, 1995, 2 NAT BIOL SERV; Cox RR, 1998, J WILDLIFE MANAGE, V62, P124, DOI 10.2307/3802270; Doherty KE, 2013, WILDLIFE SOC B, V37, P546, DOI 10.1002/wsb.284; Fargione JE, 2009, BIOSCIENCE, V59, P767, DOI 10.1525/bio.2009.59.9.8; Felton A, 2009, BIODIVERS CONSERV, V18, P2243, DOI 10.1007/s10531-009-9652-0; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; HARRIS SW, 1963, ECOLOGY, V44, P331, DOI 10.2307/1932180; Hintze J, 2007, NUMBER CRUNCHER STAT; Horn DJ, 2005, ECOL APPL, V15, P1367, DOI 10.1890/03-5254; Johnson RR, 2008, J SOIL WATER CONSERV, V63, p84A, DOI 10.2489/63.3.84A; Johnson WC, 2010, BIOSCIENCE, V60, P128, DOI 10.1525/bio.2010.60.2.7; Johnson WC, 2005, BIOSCIENCE, V55, P863, DOI 10.1641/0006-3568(2005)055[0863:VONPWT]2.0.CO;2; Kantrud H.A., 1989, US FISH WILDLIFE SER, V85; KLETT AT, 1988, J WILDLIFE MANAGE, V52, P431, DOI 10.2307/3801586; KRAPU GL, 1983, AUK, V100, P689, DOI 10.1093/auk/100.3.689; Krapu GL, 2004, WILDLIFE SOC B, V32, P127, DOI 10.2193/0091-7648(2004)32[127:LWCMLI]2.0.CO;2; LaBaugh J. W., 1989, Northern prairie wetlands., P56; Laingen Chris, 2012, PAPERS APPL GEOGRAPH, V35, P173; LARSON DL, 1995, CLIMATIC CHANGE, V30, P169, DOI 10.1007/BF01091840; LEITCH WG, 1985, J WILDLIFE MANAGE, V49, P212, DOI 10.2307/3801873; Liu GM, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011539; Loesch CR, 2012, J FISH WILDL MANAG, V3, P1, DOI 10.3996/032011-JFWM-020; Matsuura K., 2012, TERRESTRIAL PRECIPIT; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Millett B, 2009, CLIMATIC CHANGE, V93, P243, DOI 10.1007/s10584-008-9543-5; Murkin HR, 1997, ECOL APPL, V7, P1144; Murkin HR, 1989, NO PRAIRIE WETLANDS, P317; Nichols JD, 2011, J WILDLIFE MANAGE, V75, P6, DOI 10.1002/jwmg.33; Niemuth ND, 2010, WETLANDS, V30, P1053, DOI 10.1007/s13157-010-0111-1; Pietz PJ, 2000, CONDOR, V102, P936, DOI 10.1650/0010-5422(2000)102[0936:EOWCOC]2.0.CO;2; POIANI KA, 1991, BIOSCIENCE, V41, P611, DOI 10.2307/1311698; Prairie Habitat Joint Venture, 2008, PRAIR HAB JOINT VENT; R Core Team, 2021, R LANG ENV STAT COMP; Rashford BS, 2011, CONSERV BIOL, V25, P276, DOI 10.1111/j.1523-1739.2010.01618.x; Reynolds RE, 2001, J WILDLIFE MANAGE, V65, P765, DOI 10.2307/3803027; Reynolds RE, 2006, WILDLIFE SOC B, V34, P963, DOI 10.2193/0091-7648(2006)34[963:TFBADP]2.0.CO;2; Ringelman J., 2005, PRAIRIE POTHOLE JOIN; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Service Wildlife, 2011, WAT POP STAT 2011; SMITH GW, 1995, 5 US DEP INT NAT BIO; Sohl TL, 2004, PHOTOGRAMM ENG REM S, V70, P439, DOI 10.14358/PERS.70.4.439; Sorenson LG, 1998, CLIMATIC CHANGE, V40, P343, DOI 10.1023/A:1005441608819; Stephens SE, 2005, ECOL APPL, V15, P2137, DOI 10.1890/04-1162; U.S. Department of the Interior and Environment Canada, 1986, N AM WAT MAN PLAN; van der Valk AG, 2005, HYDROBIOLOGIA, V539, P171, DOI 10.1007/s10750-004-4866-3; VANDERVALK AG, 1978, ECOLOGY, V59, P322, DOI 10.2307/1936377; Walker J, 2013, J WILDLIFE MANAGE, V77, P392, DOI 10.1002/jwmg.466; WILEN BO, 1995, VEGETATIO, V118, P153, DOI 10.1007/BF00045197; Winter T. C., 1989, Northern prairie wetlands., P16; Woodhouse CA, 1998, B AM METEOROL SOC, V79, P2693, DOI 10.1175/1520-0477(1998)079<2693:YODVIT>2.0.CO;2; Zhang H, 2011, J HYDROL, V396, P94, DOI 10.1016/j.jhydrol.2010.10.037; Zhang XB, 2000, ATMOS OCEAN, V38, P395, DOI 10.1080/07055900.2000.9649654	60	38	38	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100034	10.1371/journal.pone.0100034	http://dx.doi.org/10.1371/journal.pone.0100034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937641	Green Submitted, Green Published, gold			2022-12-25	WOS:000338503400065
J	Tong, ZC; Zhang, LD; Ling, JQ; Jian, YT; Huang, LJ; Deng, DM				Tong, Zhongchun; Zhang, Luodan; Ling, Junqi; Jian, Yutao; Huang, Lijia; Deng, Dongmei			An In Vitro Study on the Effect of Free Amino Acids Alone or in Combination with Nisin on Biofilms as well as on Planktonic Bacteria of Streptococcus mutans	PLOS ONE			English	Article							CELL-WALL; LIPID-II; EXOPOLYSACCHARIDE; CHLORHEXIDINE; TRIGGER; MATRIX	Free D-amino acids (D-AAs) are one of the most striking features of the peptidoglycan composition in bacteria and play a key role in regulating and disassembling bacterial biofilms. Previous studies have indicated that the antimicrobial peptide nisin can inhibit the growth of the cariogenic bacteria Streptococcus mutans. The present study investigated the effect of free amino acids either alone or in combination with nisin on biofilm and on planktonic S. mutans bacteria. The results of the MIC and MBC analyses showed that D-cysteine (Cys), D- or L-aspartic acid (Asp), and D-or L-glutamic acid (Glu) significantly improve the antibacterial activity of nisin against S. mutans and that the mixture of D-Cys, D-Asp, and D-Glu (3D-AAs) and the mixture of L-Cys, L-Asp, and L-Glu (3L-AAs) at a concentration of 40 mM can prevent S. mutans growth. Crystal violet staining showed that the D- or L-enantiomers of Cys, Asp, and Glu at a concentration of 40 mM can inhibit the formation of S. mutans biofilms, and their mixture generated a stronger inhibition than the components alone. Furthermore, the mixture of the three D-AAs or L-AAs may improve the antibacterial activity of nisin against S. mutans biofilms. This study underscores the potential of free amino acids for the enhancement of the antibacterial activity of nisin and the inhibition of the cariogenic bacteria S. mutans and biofilms.	[Tong, Zhongchun; Zhang, Luodan; Ling, Junqi; Huang, Lijia] Sun Yat Sen Univ, Guanghua Sch Stomatol, Dept Operat Dent & Endodont, Guangzhou 510275, Guangdong, Peoples R China; [Tong, Zhongchun; Ling, Junqi; Jian, Yutao] Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Dongmei] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Cariol Endodontol Pedodontol, Amsterdam, Netherlands; [Deng, Dongmei] Vrije Univ Amsterdam, Amsterdam, Netherlands	Sun Yat Sen University; Sun Yat Sen University; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Ling, JQ (corresponding author), Sun Yat Sen Univ, Guanghua Sch Stomatol, Dept Operat Dent & Endodont, Guangzhou 510275, Guangdong, Peoples R China.	Junqi_Ling@hotmail.com	Deng, Dongmei/V-9230-2017		National Natural Science Foundation of China [81371132]; Bairenjihua Research Fund by Sun Yat-Sen University [985[2012]245]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bairenjihua Research Fund by Sun Yat-Sen University	This work was supported by National Natural Science Foundation of China (No. 81371132) and the Bairenjihua Research Fund by Sun Yat-Sen University (No 985[2012]245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abee T, 2011, CURR OPIN BIOTECH, V22, P172, DOI 10.1016/j.copbio.2010.10.016; Banas JA, 2004, FRONT BIOSCI-LANDMRK, V9, P1267, DOI 10.2741/1305; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Brandenburg KS, 2013, ANTIMICROB AGENTS CH, V57, P1921, DOI 10.1128/AAC.00007-13; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Cava F, 2011, EMBO J, V30, P3442, DOI 10.1038/emboj.2011.246; Cava F, 2011, CELL MOL LIFE SCI, V68, P817, DOI 10.1007/s00018-010-0571-8; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hasper HE, 2004, BIOCHEMISTRY-US, V43, P11567, DOI 10.1021/bi049476b; Hochbaum AI, 2011, J BACTERIOL, V193, P5616, DOI 10.1128/JB.05534-11; Kanisavaran ZM, 2008, INT DENT J, V58, P247, DOI 10.1922/IDJ_1910Mohamadi11; Kleinberg I, 2002, CRIT REV ORAL BIOL M, V13, P108, DOI 10.1177/154411130201300202; Kolodkin-Gal I, 2012, CELL, V149, P684, DOI 10.1016/j.cell.2012.02.055; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Koo H, 2013, J DENT RES, V92, P1065, DOI 10.1177/0022034513504218; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Mohammadi Z, 2009, AUST ENDOD J, V35, P131, DOI 10.1111/j.1747-4477.2009.00164.x; Sanchez CJ, 2013, BIOMATERIALS, V34, P7533, DOI 10.1016/j.biomaterials.2013.06.026; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Tong ZC, 2011, PEPTIDES, V32, P2021, DOI 10.1016/j.peptides.2011.09.002; Tong ZC, 2010, PEPTIDES, V31, P2003, DOI 10.1016/j.peptides.2010.07.016; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Vollmer W, 2010, TRENDS MICROBIOL, V18, P59, DOI 10.1016/j.tim.2009.12.004; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Zhou L, 2013, ORAL DIS, V19, P494, DOI 10.1111/odi.12031; Zhou L, 2010, ARCH ORAL BIOL, V55, P401, DOI 10.1016/j.archoralbio.2010.03.013	30	34	35	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99513	10.1371/journal.pone.0099513	http://dx.doi.org/10.1371/journal.pone.0099513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936873	Green Submitted, Green Published, gold			2022-12-25	WOS:000338503400020
J	Del Rey, MJ; Fare, R; Izquierdo, E; Usategui, A; Rodriguez-Fernandez, JL; Suarez-Fueyo, A; Canete, JD; Pablos, JL				Del Rey, Manuel J.; Fare, Regina; Izquierdo, Elena; Usategui, Alicia; Rodriguez-Fernandez, Jose L.; Suarez-Fueyo, Abel; Canete, Juan D.; Pablos, Jose L.			Clinicopathological Correlations of Podoplanin (gp38) Expression in Rheumatoid Synovium and Its Potential Contribution to Fibroblast Platelet Crosstalk	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; LYMPHATIC ENDOTHELIAL-CELLS; FOLLICULAR DENDRITIC CELLS; LECTIN RECEPTOR CLEC-2; STROMAL CELLS; IN-VIVO; LYMPHOID-TISSUES; ARTHRITIS; INFLAMMATION; SYNOVIOCYTES	Introduction: Synovial fibroblasts (SF) undergo phenotypic changes in rheumatoid arthritis (RA) that contribute to inflammatory joint destruction. This study was undertaken to evaluate the clinical and functional significance of ectopic podoplanin (gp38) expression by RA SF. Methods: Expression of gp38 and its CLEC2 receptor was analyzed by immunohistochemistry in synovial arthroscopic biopsies from RA patients and normal and osteoarthritic controls. Correlation between gp38 expression and RA clinicopathological variables was analyzed. In patients rebiopsied after anti-TNF-alpha therapy, changes in gp38 expression were determined. Platelet-SF coculture and gp38 silencing in SF were used to analyze the functional contribution of gp38 to SF migratory and invasive properties, and to SF platelet crosstalk. Results: gp38 was abundantly but variably expressed in RA, and it was undetectable in normal synovial tissues. Among clinicopathologigal RA variables, significantly increased gp38 expression was only found in patients with lymphoid neogenesis (LN), and RF or ACPA autoantibodies. Cultured synovial but not dermal fibroblasts showed strong constitutive gp38 expression that was further induced by TNF-alpha. In RA patients, anti-TNF-alpha therapy significantly reduced synovial gp38 expression. In RA synovium, CLEC2 receptor expression was only observed in platelets. gp38 silencing in cultured SF did not modify their migratory and invasive properties but reduced the expression of IL-6 and IL-8 genes induced by SF-platelet interaction. Conclusions: In RA, synovial expression of gp38 is strongly associated to LN and it is reduced after anti-TNF-alpha therapy. Interaction between gp38 and CLEC2 platelet receptor is feasible in RA synovium in vivo and can specifically contribute to gene expression by SF.	[Del Rey, Manuel J.; Fare, Regina; Usategui, Alicia; Suarez-Fueyo, Abel; Pablos, Jose L.] Hosp 12 Octubre i 12, Serv Reumatol, Inst Invest, Madrid, Spain; [Izquierdo, Elena; Rodriguez-Fernandez, Jose L.] CSIC, Ctr Invest Biol, Madrid, Spain; [Canete, Juan D.] Hosp Clin Barcelona, Serv Reumatol, Unitat Artritis, Barcelona, Spain; [Canete, Juan D.] Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain	Hospital Universitario 12 de Octubre; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Pablos, JL (corresponding author), Hosp 12 Octubre i 12, Serv Reumatol, Inst Invest, Madrid, Spain.	jlpablos@h12o.es	Del Rey, Manuel/O-6114-2014; Izquierdo, Elena/Z-1861-2019; crespillo, Juan D. cañete/M-4428-2017; Suarez Fueyo, Abel/E-5746-2017; Rodriguez-Fernandez, Jose Luis/Q-5021-2019; Usategui, Alicia/O-6476-2014; Cañete, Juan D/AAV-8910-2021; Suarez-Fueyo, Abel/D-1691-2013	Del Rey, Manuel/0000-0002-8180-1584; Izquierdo, Elena/0000-0002-3355-2798; crespillo, Juan D. cañete/0000-0003-2606-0573; Rodriguez-Fernandez, Jose Luis/0000-0001-8874-1425; Usategui, Alicia/0000-0001-8874-9523; Cañete, Juan D/0000-0003-2606-0573; Suarez-Fueyo, Abel/0000-0002-8696-0197; Pablos, Jose L./0000-0001-7229-6005	Instituto de Salud Carlos III [FIS 12/439, RETICS RD12/0009 RIER]; Instituto de Salud Carlos III (Rio Hortega program); Comunidad de Madrid [S2010/BMD2350]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Instituto de Salud Carlos III (Rio Hortega program); Comunidad de Madrid(Comunidad de Madrid)	This study was supported by Instituto de Salud Carlos III (FIS 12/439, RETICS RD12/0009 RIER, and Rio Hortega program to R. F.), and Comunidad de Madrid (S2010/BMD2350, RAPHYME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton SE, 2012, IMMUNITY, V37, P276, DOI 10.1016/j.immuni.2012.05.022; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Benito-Miguel M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040620; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Boulaftali Y, 2013, J CLIN INVEST, V123, P908, DOI 10.1172/JCI65154; Bradfield PF, 2003, ARTHRITIS RHEUM, V48, P2472, DOI 10.1002/art.11219; Canete JD, 2009, ANN RHEUM DIS, V68, P751, DOI 10.1136/ard.2008.089284; Choi YS, 2013, J IMMUNOL, V190, P3049, DOI 10.4049/jimmunol.1203032; del Rey MJ, 2009, ARTHRITIS RHEUM-US, V60, P2926, DOI 10.1002/art.24844; Dulauroy S, 2012, NAT MED, V18, P1262, DOI 10.1038/nm.2848; Ekwall AKH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3274; FARR AG, 1992, J EXP MED, V176, P1477, DOI 10.1084/jem.176.5.1477; Genovese MC, 2013, J RHEUMATOL, V40, P768, DOI 10.3899/jrheum.120687; Hsu J, 2013, IMMUNOL LETT, V150, P97, DOI 10.1016/j.imlet.2012.12.007; Izquierdo E, 2011, ARTHRITIS RHEUM-US, V63, P2575, DOI 10.1002/art.30433; Kawase A, 2008, INT J CANCER, V123, P1053, DOI 10.1002/ijc.23611; Kopf M, 1998, J EXP MED, V188, P1895, DOI 10.1084/jem.188.10.1895; Lee A, 2013, ARTHRITIS RHEUM-US, V65, P928, DOI 10.1002/art.37853; Lindhout E, 1999, J IMMUNOL, V162, P5949; Link A, 2011, AM J PATHOL, V178, P1662, DOI 10.1016/j.ajpath.2010.12.039; Manzo A, 2005, EUR J IMMUNOL, V35, P1347, DOI 10.1002/eji.200425830; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; MullerLadner U, 1996, AM J PATHOL, V149, P1607; Navarro A, 2011, AM J PHYSIOL-LUNG C, V300, pL32, DOI 10.1152/ajplung.00171.2010; Naylor AJ, 2013, CLIN EXP IMMUNOL, V171, P30, DOI 10.1111/j.1365-2249.2012.04634.x; Neidhart M, 2003, ARTHRITIS RHEUM, V48, P1873, DOI 10.1002/art.11166; Neumann E, 2010, TRENDS MOL MED, V16, P458, DOI 10.1016/j.molmed.2010.07.004; Osada M, 2012, J BIOL CHEM, V287, P22241, DOI 10.1074/jbc.M111.329987; Peduto L, 2009, J IMMUNOL, V182, P5789, DOI 10.4049/jimmunol.0803974; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Pretzel D, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2618; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Suzuki-Inoue K, 2010, J BIOL CHEM, V285, P24494, DOI 10.1074/jbc.M110.130575; Timmer TCG, 2007, ARTHRITIS RHEUM-US, V56, P2492, DOI 10.1002/art.22748; Uhrin P, 2010, BLOOD, V115, P3997, DOI 10.1182/blood-2009-04-216069; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Victoratos P, 2009, IMMUNITY, V30, P130, DOI 10.1016/j.immuni.2008.10.019; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Zimmer G, 1999, BIOCHEM J, V341, P277, DOI 10.1042/0264-6021:3410277; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	44	36	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99607	10.1371/journal.pone.0099607	http://dx.doi.org/10.1371/journal.pone.0099607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932813	gold, Green Published			2022-12-25	WOS:000337738600047
J	Hammerle, H; Amman, F; Vecerek, B; Stulke, J; Hofacker, I; Blasi, U				Haemmerle, Hermann; Amman, Fabian; Vecerek, Branislav; Stuelke, Joerg; Hofacker, Ivo; Blaesi, Udo			Impact of Hfq on the Bacillus subtilis Transcriptome	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS RNAIII; SMALL REGULATORY RNA; STREPTOCOCCUS-PNEUMONIAE; MESSENGER-RNA; STATIONARY-PHASE; NONCODING RNAS; IDENTIFICATION; PROTEIN; BINDING; SPORULATION	The RNA chaperone Hfq acts as a central player in post-transcriptional gene regulation in several Gram-negative Bacteria, whereas comparatively little is known about its role in Gram-positive Bacteria. Here, we studied the function of Hfq in Bacillus subtilis, and show that it confers a survival advantage. A comparative transcriptome analysis revealed mRNAs with a differential abundance that are governed by the ResD-ResE system required for aerobic and anaerobic respiration. Expression of resD was found to be up-regulated in the hfq(-) strain. Furthermore, several genes of the GerE and ComK regulons were de-regulated in the hfq(-) background. Surprisingly, only six out of >100 known and predicted small RNAs (sRNAs) showed altered abundance in the absence of Hfq. Moreover, Hfq positively affected the transcript abundance of genes encoding type I toxin-antitoxin systems. Taken the moderate effect on sRNA levels and mRNAs together, it seems rather unlikely that Hfq plays a central role in RNA transactions in Bacillus subtilis.	[Haemmerle, Hermann; Vecerek, Branislav; Blaesi, Udo] Univ Vienna, Ctr Mol Biol, Max F Perutz Labs, Dept Microbiol Immunobiol & Genet, Vienna, Austria; [Amman, Fabian; Hofacker, Ivo] Univ Vienna, Inst Theoret Chem, Vienna, Austria; [Stuelke, Joerg] Univ Gottingen, Inst Microbiol & Genet, Dept Gen Microbiol, D-37073 Gottingen, Germany	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Vienna; University of Gottingen	Blasi, U (corresponding author), Univ Vienna, Ctr Mol Biol, Max F Perutz Labs, Dept Microbiol Immunobiol & Genet, Vienna, Austria.	Udo.Blaesi@univie.ac.at	Vecerek, Branislav/H-2545-2014; Stülke, Jörg/AAD-1600-2021; Hofacker, Ivo L/A-2378-2013	Vecerek, Branislav/0000-0001-9520-6324; Hofacker, Ivo L/0000-0001-7132-0800; Stulke, Jorg/0000-0001-5881-5390; Amman, Fabian/0000-0002-8646-859X	Austrian Science Fund [RNA-REG F43, AF4311]; doctoral program RNA-Biology [W-1207]	Austrian Science Fund(Austrian Science Fund (FWF)); doctoral program RNA-Biology	The work was supported by the Austrian Science Fund (www.fwf.ac.at/en) through the Special Research Program RNA-REG F43, subproject AF4311 (UB), and the doctoral program RNA-Biology W-1207 (HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebo P, 2012, RNA, V18, P530, DOI 10.1261/rna.027359.111; Afonyushkin T, 2005, NUCLEIC ACIDS RES, V33, P1678, DOI 10.1093/nar/gki313; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beich-Frandsen M, 2011, NUCLEIC ACIDS RES, V39, P4900, DOI 10.1093/nar/gkq1346; Bernhart SH, 2006, BIOINFORMATICS, V22, P614, DOI 10.1093/bioinformatics/btk014; Boisset S, 2007, GENE DEV, V21, P1353, DOI 10.1101/gad.423507; Chevalier C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000809; Christiansen JK, 2006, RNA, V12, P1383, DOI 10.1261/rna.49706; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Commichau FM, 2007, MOL MICROBIOL, V65, P642, DOI 10.1111/j.1365-2958.2007.05816.x; Cui MQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071933; Dambach M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055156; Dunn AK, 1999, GENE, V226, P297, DOI 10.1016/S0378-1119(98)00544-7; Durand S, 2012, RNA BIOL, V9, P1491, DOI 10.4161/rna.22358; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; Geissmann T, 2009, NUCLEIC ACIDS RES, V37, P7239, DOI 10.1093/nar/gkp668; Geng H, 2007, J BACTERIOL, V189, P1745, DOI 10.1128/JB.01502-06; Gottesman S, 2006, COLD SPRING HARB SYM, V71, P1, DOI 10.1101/sqb.2006.71.016; Gyan S, 2006, J BACTERIOL, V188, P7062, DOI 10.1128/JB.00601-06; Hartig E, 2012, ADV MICROB PHYSIOL, V61, P195, DOI 10.1016/B978-0-12-394423-8.00005-6; Halfmann A, 2007, MOL MICROBIOL, V66, P110, DOI 10.1111/j.1365-2958.2007.05900.x; Hamoen LW, 2003, MICROBIOL-SGM, V149, P9, DOI 10.1099/mic.0.26003-0; Heidrich N, 2007, NUCLEIC ACIDS RES, V35, P4331, DOI 10.1093/nar/gkm439; Heidrich N, 2006, MOL MICROBIOL, V62, P520, DOI 10.1111/j.1365-2958.2006.05384.x; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Huntzinger E, 2005, EMBO J, V24, P824, DOI 10.1038/sj.emboj.7600572; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Jahn N, 2012, MOL MICROBIOL, V83, P579, DOI 10.1111/j.1365-2958.2011.07952.x; Jousselin A, 2009, TRENDS MICROBIOL, V17, P399, DOI 10.1016/j.tim.2009.06.003; Kumar R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-350; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Larsson JT, 2005, MICROBIOL-SGM, V151, P3323, DOI 10.1099/mic.0.28124-0; Lehnik-Habrink M, 2010, MOL MICROBIOL, V77, P958, DOI 10.1111/j.1365-2958.2010.07264.x; Leisner M, 2008, CURR OPIN MICROBIOL, V11, P553, DOI 10.1016/j.mib.2008.09.020; Liu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013069; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Mann B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002788; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Moll I, 2003, RNA, V9, P1308, DOI 10.1261/rna.5850703; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakano MM, 1998, J BACTERIOL, V180, P5344, DOI 10.1128/JB.180.20.5344-5350.1998; Nakano MM, 1996, J BACTERIOL, V178, P3796, DOI 10.1128/jb.178.13.3796-3802.1996; Nakano MM, 1998, ANNU REV MICROBIOL, V52, P165, DOI 10.1146/annurev.micro.52.1.165; Nielsen JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019019; Nielsen JS, 2008, J BACTERIOL, V190, P6264, DOI 10.1128/JB.00740-08; Nielsen JS, 2010, NUCLEIC ACIDS RES, V38, P907, DOI 10.1093/nar/gkp1081; Oliver HF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-641; Olsen AS, 2010, J MOL BIOL, V404, P173, DOI 10.1016/j.jmb.2010.09.038; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Robertson GT, 1999, MOL MICROBIOL, V34, P690, DOI 10.1046/j.1365-2958.1999.01629.x; Rochat T, 2012, BIOCHIMIE, V94, P1554, DOI 10.1016/j.biochi.2012.01.016; Schnorpfeil A, 2013, MOL MICROBIOL, V89, P334, DOI 10.1111/mmi.12277; Schultz D, 2009, P NATL ACAD SCI USA, V106, P21027, DOI 10.1073/pnas.0912185106; Silvaggi JM, 2006, J BACTERIOL, V188, P532, DOI 10.1128/JB.188.2.532-541.2006; Silvaggi JM, 2005, J BACTERIOL, V187, P6641, DOI 10.1128/JB.187.19.6641-6650.2005; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sledjeski DD, 2001, J BACTERIOL, V183, P1997, DOI 10.1128/JB.183.6.1997-2005.2001; Smaidone GT, 2012, J BACTERIOL, V194, P2586, DOI 10.1128/JB.05567-11; Someya T, 2012, NUCLEIC ACIDS RES, V40, P1856, DOI 10.1093/nar/gkr892; Sonnleitner E, 2006, MOL MICROBIOL, V59, P1542, DOI 10.1111/j.1365-2958.2006.05032.x; Sun XG, 2002, NUCLEIC ACIDS RES, V30, P3662, DOI 10.1093/nar/gkf508; Tafer H, 2011, BIOINFORMATICS, V27, P1934, DOI 10.1093/bioinformatics/btr281; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Tsui HCT, 2010, J BACTERIOL, V192, P264, DOI 10.1128/JB.01204-09; Vecerek B, 2008, NUCLEIC ACIDS RES, V36, P133, DOI 10.1093/nar/gkm985; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wang E, 2008, MOL MICROBIOL, V69, P466, DOI 10.1111/j.1365-2958.2008.06295.x; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3	71	30	33	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e98661	10.1371/journal.pone.0098661	http://dx.doi.org/10.1371/journal.pone.0098661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932523	Green Submitted, Green Published, gold			2022-12-25	WOS:000337738600010
J	Han, HY; Dong, H; Zhu, SH; Zhao, QP; Jiang, LL; Wang, YG; Li, LJ; Wu, YL; Huang, B				Han, Hongyu; Dong, Hui; Zhu, Shunhai; Zhao, Qiping; Jiang, Lianlian; Wang, Yange; Li, Liujia; Wu, Youlin; Huang, Bing			Molecular Characterization and Analysis of a Novel Protein Disulfide Isomerase-Like Protein of Eimeria tenella	PLOS ONE			English	Article							SUBTRACTIVE HYBRIDIZATION; TOXOPLASMA-GONDII; APICAL ORGANELLES; IGA ANTIBODIES; HOST-CELL; GENE; IDENTIFICATION; THIOREDOXIN; EXPRESSION; LEISHMANIA	Protein disulfide isomerase (PDI) and PDI-like proteins are members of the thioredoxin superfamily. They contain thioredoxin-like domains and catalyze the physiological oxidation, reduction and isomerization of protein disulfide bonds, which are involved in cell function and development in prokaryotes and eukaryotes. In this study, EtPDIL, a novel PDI-like gene of Eimeria tenella, was cloned using rapid amplification of cDNA ends (RACE) according to the expressed sequence tag (EST). The EtPDIL cDNA contained 1129 nucleotides encoding 216 amino acids. The deduced EtPDIL protein belonged to thioredoxin-like superfamily and had a single predicted thioredoxin domain with a non-classical thioredoxin-like motif (SXXC). BLAST analysis showed that the EtPDIL protein was 55-59% identical to PDI-like proteins of other apicomplexan parasites. The transcript and protein levels of EtPDIL at different development stages were investigated by real-time quantitative PCR and western blot. The messenger RNA and protein levels of EtPDIL were higher in sporulated oocysts than in unsporulated oocysts, sporozoites or merozoites. Protein expression was barely detectable in unsporulated oocysts. Western blots showed that rabbit antiserum against recombinant EtPDIL recognized only a native 24 kDa protein from parasites. Immunolocalization with EtPDIL antibody showed that EtPDIL had a disperse distribution in the cytoplasm of whole sporozoites and merozoites. After sporozoites were incubated in complete medium, EtPDIL protein concentrated at the anterior of the sporozoites and appeared on the surface of parasites. Specific staining was more intense and mainly located on the parasite surface after merozoites released from mature schizonts invaded DF-1 cells. After development of parasites in DF-1 cells, staining intensified in trophozoites, immature schizonts and mature schizonts. Antibody inhibition of EtPDIL function reduced the ability of E. tenella to invade DF-1 cells. These results suggested that EtPDIL might be involved in sporulation in external environments and in host cell adhesion, invasion and development of E. tenella.	[Han, Hongyu; Dong, Hui; Zhu, Shunhai; Zhao, Qiping; Jiang, Lianlian; Wang, Yange; Li, Liujia; Wu, Youlin; Huang, Bing] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr, Shanghai, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Huang, B (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr, Shanghai, Peoples R China.	hb@shvri.ac.cn			National Science Foundation of China [31201699]; Central Public Welfare Research Institutions; Basic Scientific Research Business Expenses [2014JB03]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central Public Welfare Research Institutions; Basic Scientific Research Business Expenses	This work was supported by grants from National Science Foundation of China (No. 31201699) and Central Public Welfare Research Institutions and Basic Scientific Research Business Expenses (No. 2014JB03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Ben Achour Y, 2002, INFECT IMMUN, V70, P3576, DOI 10.1128/IAI.70.7.3576-3585.2002; Ben Khalaf N, 2012, PARASITOL RES, V110, P1911, DOI 10.1007/s00436-011-2717-5; Blackman MJ, 2001, MOL BIOCHEM PARASIT, V117, P11, DOI 10.1016/S0166-6851(01)00328-0; Blake DP, 2014, TRENDS PARASITOL, V30, P12, DOI 10.1016/j.pt.2013.10.003; Blunt DS, 1996, GENE, V181, P221, DOI 10.1016/S0378-1119(96)00460-X; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Chapman HD, 2013, ADV PARASIT, V83, P93, DOI 10.1016/B978-0-12-407705-8.00002-1; Clissold PM, 2003, BIOESSAYS, V25, P603, DOI 10.1002/bies.10287; d'Aloisio E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-101; Dalloul RA, 2005, AVIAN DIS, V49, P1, DOI 10.1637/7306-11150R; Darby NJ, 1996, BIOCHEMISTRY-US, V35, P10517, DOI 10.1021/bi960763s; Davids BJ, 2004, MOL BIOCHEM PARASIT, V136, P173, DOI 10.1016/j.molbiopara.2004.03.011; Dong H, 2014, PARASITOL RES, V113, P735, DOI 10.1007/s00436-013-3703-x; Ebel T, 2002, MOL BIOCHEM PARASIT, V121, P265, DOI 10.1016/S0166-6851(02)00036-1; Galligan JJ, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-6; GILLIN FD, 1990, P NATL ACAD SCI USA, V87, P4463, DOI 10.1073/pnas.87.12.4463; Han HY, 2013, PARASITOLOGY, V140, P746, DOI 10.1017/S0031182012002107; Han HY, 2010, J PARASITOL, V96, P95, DOI 10.1645/GE-2221.1; HAWKINS HC, 1991, BIOCHEM J, V275, P349, DOI 10.1042/bj2750349; Hu Y, 2012, PARASITOL RES, V111, P983, DOI 10.1007/s00436-012-2922-x; Jahn D, 2009, PARASITOL RES, V105, P655, DOI 10.1007/s00436-009-1437-6; Jiang LL, 2012, PARASITOL RES, V110, P865, DOI 10.1007/s00436-011-2568-0; Jiang LL, 2013, PLOS ONE, V7; Kimura T, 2005, J BIOL CHEM, V280, P31438, DOI 10.1074/jbc.M503377200; Lal K, 2009, PROTEOMICS, V9, P1142, DOI 10.1002/pmic.200800404; Laurindo FRM, 2012, FREE RADICAL BIO MED, V52, P1954, DOI 10.1016/j.freeradbiomed.2012.02.037; Li LD, 2012, EXP PARASITOL, V132, P465, DOI 10.1016/j.exppara.2012.09.014; Liao M, 2007, INSECT BIOCHEM MOLEC, V37, P641, DOI 10.1016/j.ibmb.2007.03.015; Mahajan B, 2006, INT J PARASITOL, V36, P1037, DOI 10.1016/j.ijpara.2006.04.012; MANDEL R, 1993, P NATL ACAD SCI USA, V90, P4112, DOI 10.1073/pnas.90.9.4112; Meek B, 2002, FEBS LETT, V522, P104, DOI 10.1016/S0014-5793(02)02911-3; Meek B, 2002, INT IMMUNOL, V14, P1291, DOI 10.1093/intimm/dxf091; Miska KB, 2004, J PARASITOL, V90, P1245, DOI 10.1645/GE-309R; Mouray E, 2007, BIOCHIMIE, V89, P337, DOI 10.1016/j.biochi.2006.11.001; Naguleswaran A, 2005, INT J PARASITOL, V35, P1459, DOI 10.1016/j.ijpara.2005.06.006; Ng ST, 2002, EXP PARASITOL, V101, P168, DOI 10.1016/S0014-4894(02)00109-1; Norgaard P, 2001, BIOCHEM J, V358, P269, DOI 10.1042/0264-6021:3580269; Novo C, 2009, INT J BIOL MACROMOL, V45, P399, DOI 10.1016/j.ijbiomac.2009.07.001; Padilla A, 2003, J BIOL CHEM, V278, P1872, DOI 10.1074/jbc.M210322200; Peroval M, 2006, INT J PARASITOL, V36, P1205, DOI 10.1016/j.ijpara.2006.04.006; Podell S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-37; Rainey-Barger EK, 2007, MOL BIOL CELL, V18, P1253, DOI 10.1091/mbc.E06-11-1004; Riemer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017037; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; Rigobello MP, 2001, BIOCHEM J, V356, P567, DOI 10.1042/0264-6021:3560567; Rubotham J, 2005, J BIOL CHEM, V280, P10410, DOI 10.1074/jbc.M409375200; Shirley MW, 2007, VACCINE, V25, P5540, DOI 10.1016/j.vaccine.2006.12.030; Shirley MW, 2005, ADV PARASIT, V60, P285, DOI 10.1016/S0065-308X(05)60005-X; Stolf BS, 2011, THESCIENTIFICWORLDJO, V11, P1749, DOI 10.1100/2011/289182; TACHIKAWA H, 1995, FEBS LETT, V369, P212, DOI 10.1016/0014-5793(95)00750-4; Tomley F, 1997, METHODS, V13, P171, DOI 10.1006/meth.1997.0509; van Lith M, 2005, J BIOL CHEM, V280, P1376, DOI 10.1074/jbc.M408651200; Walker KW, 1996, BIOCHEMISTRY-US, V35, P1972, DOI 10.1021/bi952157n; Wang HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070884; Wang HM, 2000, CURR GENET, V37, P57, DOI 10.1007/s002940050009; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017	58	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99914	10.1371/journal.pone.0099914	http://dx.doi.org/10.1371/journal.pone.0099914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932912	gold, Green Published, Green Submitted			2022-12-25	WOS:000337738600080
J	Li, P; Xu, XY; Cao, EH; Yu, B; Li, WC; Fan, M; Huang, M; Shi, LN; Zeng, R; Su, X; Shi, Y				Li, Pei; Xu, Xiaoyong; Cao, Ehong; Yu, Bo; Li, Wanchun; Fan, Ming; Huang, Mei; Shi, Lining; Zeng, Rong; Su, Xin; Shi, Yi			Vitamin D Deficiency Causes Defective Resistance to Aspergillus fumigatus in Mice via Aggravated and Sustained Inflammation	PLOS ONE			English	Article							INHIBITS NEUTROPHIL RECRUITMENT; PATTERN-RECOGNITION RECEPTORS; ACUTE LUNG INJURY; HOST-DEFENSE; INVASIVE ASPERGILLOSIS; INFECTIOUS-DISEASES; CYTOKINE PRODUCTION; FUNGAL-INFECTIONS; HAMSTER MODEL; TUBERCULOSIS	Background: Vitamin D plays an important role in pulmonary resistance and immunity, and its deficiency has been linked to various respiratory infections. Little is known about the effect of vitamin D deficiency on host pulmonary defense to Aspergillus fumigatus (A. fumigatus). Methods: Mice raised on vitamin D sufficient or deficient diets were infected intratracheally with A. fumigatus conidia. Mortality, fungal growth, weight loss and lung histology were monitored. Alveolar macrophages (AMs) were stimulated with A. fumigatus conidia in vitro. The kinetics of pro-inflammatory cytokines (TNF-alpha, IL-1 beta and IL-6), chemokines (CXCL1, CCL3), and pattern recognition receptors (Toll-like receptor [TLR] 2, TLR 4 and dectin-1) expression in the lungs and AMs were measured. Results: Upon A. fumigatus infection, vitamin D deficient mice showed higher mortality, greater fungal load, and more weight loss than its sufficient counterparts. Vitamin D deficient mice demonstrated aggravated and prolonged histological evidence of lung inflammation as well as enhanced BAL cell counts, dominated by neutrophils after A. fumigatus inoculation. Increased basal levels of pro-inflammatory cytokines in the lungs and AMs from naive vitamin D deficient mice were observed. Upon A. fumigatus exposure, vitamin D deficiency led to enhanced and sustained expression of TNF-alpha, IL-1 beta, IL-6, CXCL1 and CCL3 both in vivo and in vitro. Up-regulation of TLR2, TLR4 and dectin-1 was observed in the lungs and AMs from vitamin D deficient mice both at baseline and after A. fumigatus exposure. Conclusions: Vitamin D deficiency causes defective pulmonary resistance to A. fumigatus in mice, possibly by the enhanced basal expression of pattern recognition receptors and pro-inflammatory cytokines, which induced excessive inflammatory response in response to A. fumigatus challenge.	[Li, Pei; Xu, Xiaoyong; Cao, Ehong; Su, Xin; Shi, Yi] Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp & Crit Care Med, Nanjing 210008, Jiangsu, Peoples R China; [Yu, Bo; Li, Wanchun] Nanjing Univ, Sch Med, Jinling Hosp, Dept Pathol, Nanjing 210008, Jiangsu, Peoples R China; [Fan, Ming; Huang, Mei] Nanjing Univ, Sch Med, Jinling Hosp, Dept Clin Microbiol, Nanjing 210008, Jiangsu, Peoples R China; [Shi, Lining; Zeng, Rong] Nanjing Univ, Sch Med, Dept Clin Lab, Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University	Su, X (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp & Crit Care Med, Nanjing 210008, Jiangsu, Peoples R China.	suxinjs@hotmail.com; shiyi56@126.com	Su, Xin/X-2589-2018	su, Xin/0000-0002-3910-9156	National Natural Science Foundation of China (NSFC) [81270064]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (NSFC 81270064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JS, 1985, J EXP MED, V161, P755, DOI 10.1084/jem.161.4.755; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Barnes PD, 2007, BRIT J HAEMATOL, V139, P519, DOI 10.1111/j.1365-2141.2007.06812.x; Bellocchio S, 2004, J IMMUNOL, V172, P3059, DOI 10.4049/jimmunol.172.5.3059; Bretz C, 2008, INFECT IMMUN, V76, P952, DOI 10.1128/IAI.00927-07; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002689; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; CHEN SF, 1995, J STEROID BIOCHEM, V52, P67; Cheng XW, 2011, RESP PHYSIOL NEUROBI, V175, P185, DOI 10.1016/j.resp.2010.11.004; CIMOLAI N, 1992, MICROBIOL IMMUNOL, V36, P465, DOI 10.1111/j.1348-0421.1992.tb02045.x; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Dini C, 2012, ANN I SUPER SANITA, V48, P319, DOI 10.4415/ANN_12_03_13; Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959; Gombart AF, 2009, FUTURE MICROBIOL, V4, P1151, DOI 10.2217/FMB.09.87; Gonzalez-Juarrero M, 2003, J IMMUNOL, V171, P3128, DOI 10.4049/jimmunol.171.6.3128; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Hansdottir S, 2011, VITAM HORM, V86, P217, DOI 10.1016/B978-0-12-386960-9.00009-5; Hansdottir S, 2010, J IMMUNOL, V184, P965, DOI 10.4049/jimmunol.0902840; Heaney RP, 2012, NEW ENGL J MED, V367, P77, DOI 10.1056/NEJMe1206858; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Hughes DA, 2009, CLIN EXP IMMUNOL, V158, P20, DOI 10.1111/j.1365-2249.2009.04001.x; Khoo AL, 2011, CLIN EXP IMMUNOL, V164, P72, DOI 10.1111/j.1365-2249.2010.04315.x; Khoo AL, 2012, CRIT REV MICROBIOL, V38, P122, DOI 10.3109/1040841X.2011.622716; Khoo AL, 2011, CYTOKINE, V55, P294, DOI 10.1016/j.cyto.2011.04.016; Khoo AL, 2011, J INFECT DIS, V203, P122, DOI 10.1093/infdis/jiq008; Kreindler JL, 2010, J CLIN INVEST, V120, P3242, DOI 10.1172/JCI42388; Laaksi I, 2007, AM J CLIN NUTR, V86, P714, DOI 10.1093/ajcn/86.3.714; Lagishetty V, 2010, ENDOCRINOLOGY, V151, P2423, DOI 10.1210/en.2010-0089; Legrand F, 2008, CLIN INFECT DIS, V46, P696, DOI 10.1086/527390; Matsumoto K, 1995, Verh K Acad Geneeskd Belg, V57, P109; Mehrad B, 1999, J IMMUNOL, V162, P1633; Miceli MH, 2007, CANCER-AM CANCER SOC, V110, P112, DOI 10.1002/cncr.22738; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Sadeghi K, 2006, EUR J IMMUNOL, V36, P361, DOI 10.1002/eji.200425995; Science M., 2013, CLIN INFECT DIS; Segal BH, 2007, ONCOLOGIST, V12, P7, DOI 10.1634/theoncologist.12-S2-7; Shreiner AB, 2012, INFECT IMMUN, V80, P388, DOI 10.1128/IAI.05530-11; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Takano Y, 2012, STEROIDS, V77, P1535, DOI 10.1016/j.steroids.2012.09.008; Takano Y, 2011, STEROIDS, V76, P1305, DOI 10.1016/j.steroids.2011.06.009; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thacher TD, 2011, MAYO CLIN PROC, V86, P50, DOI 10.4065/mcp.2010.0567; Tighe RM, 2011, J IMMUNOL, V187, P4800, DOI 10.4049/jimmunol.1101312; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; van de Veerdonk FL, 2008, CURR OPIN MICROBIOL, V11, P305, DOI 10.1016/j.mib.2008.06.002; van Schoor NM, 2011, BEST PRACT RES CL EN, V25, P671, DOI 10.1016/j.beem.2011.06.007; Vieth R, 2006, PROG BIOPHYS MOL BIO, V92, P26, DOI 10.1016/j.pbiomolbio.2006.02.003; Wayse V, 2004, EUR J CLIN NUTR, V58, P563, DOI 10.1038/sj.ejcn.1601845; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; White JH, 2010, J STEROID BIOCHEM, V121, P234, DOI 10.1016/j.jsbmb.2010.03.034; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6; Xue ML, 2002, IMMUNOL CELL BIOL, V80, P340, DOI 10.1046/j.1440-1711.80.4august.1.x; ZARRABEITIA MT, 1992, BONE, V13, P185, DOI 10.1016/8756-3282(92)90010-T; Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412	55	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99805	10.1371/journal.pone.0099805	http://dx.doi.org/10.1371/journal.pone.0099805			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926881	gold, Green Published, Green Submitted			2022-12-25	WOS:000338278100082
J	Song, GX; Zhang, J; Wang, K				Song, Genxin; Zhang, Jing; Wang, Ke			Selection of Optimal Auxiliary Soil Nutrient Variables for Cokriging Interpolation	PLOS ONE			English	Article							REGRESSION; NITROGEN	In order to explore the selection of the best auxiliary variables (BAVs) when using the Cokriging method for soil attribute interpolation, this paper investigated the selection of BAVs from terrain parameters, soil trace elements, and soil nutrient attributes when applying Cokriging interpolation to soil nutrients (organic matter, total N, available P, and available K). In total, 670 soil samples were collected in Fuyang, and the nutrient and trace element attributes of the soil samples were determined. Based on the spatial autocorrelation of soil attributes, the Digital Elevation Model (DEM) data for Fuyang was combined to explore the coordinate relationship among terrain parameters, trace elements, and soil nutrient attributes. Variables with a high correlation to soil nutrient attributes were selected as BAVs for Cokriging interpolation of soil nutrients, and variables with poor correlation were selected as poor auxiliary variables (PAVs). The results of Cokriging interpolations using BAVs and PAVs were then compared. The results indicated that Cokriging interpolation with BAVs yielded more accurate results than Cokriging interpolation with PAVs (the mean absolute error of BAV interpolation results for organic matter, total N, available P, and available K were 0.020, 0.002, 7.616, and 12.4702, respectively, and the mean absolute error of PAV interpolation results were 0.052, 0.037, 15.619, and 0.037, respectively). The results indicated that Cokriging interpolation with BAVs can significantly improve the accuracy of Cokriging interpolation for soil nutrient attributes. This study provides meaningful guidance and reference for the selection of auxiliary parameters for the application of Cokriging interpolation to soil nutrient attributes.	[Wang, Ke] Zhejiang Univ, Inst Agr Remote Sensing & Informat Tech, Hangzhou 310003, Zhejiang, Peoples R China; Zhejiang Univ, Minist Educ, Key Lab Environm Remediat Ecol & Hlth, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wang, K (corresponding author), Zhejiang Univ, Inst Agr Remote Sensing & Informat Tech, Hangzhou 310003, Zhejiang, Peoples R China.	kwang@zju.edu.cn			National Natural Science Fund of China [31172023]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Fund of China (Grant No. 31172023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON PM, 1994, REMOTE SENS ENVIRON, V50, P335, DOI 10.1016/0034-4257(94)90083-3; Behrens T, 2014, GEODERMA, V213, P578, DOI 10.1016/j.geoderma.2013.07.031; Bo L, 2013, J ENV PROT SCI, V39; Brimelow JC, 2010, AGR FOREST METEOROL, V150, P100, DOI 10.1016/j.agrformet.2009.09.006; Eldeiry AA, 2010, J IRRIG DRAIN ENG, V136, P355, DOI 10.1061/(ASCE)IR.1943-4774.0000208; Jiang Yong, 2006, Yingyong Shengtai Xuebao, V17, P97; Juan P, 2011, J GEOCHEM EXPLOR, V108, P62, DOI 10.1016/j.gexplo.2010.10.003; KE-LIN H., 2001, ADV WATER RESOURCE, V12, P460; Kunkel ML, 2011, GEODERMA, V165, P1, DOI 10.1016/j.geoderma.2011.06.011; Laurent L, 2013, COMPUT MECH, V51, P151, DOI 10.1007/s00466-012-0711-0; Lei F, 2010, T CSAE, V10, P39; [连纲 LIAN Gang], 2008, [地理科学, Scientia Geographica Sinica], V28, P554; Lin QH, 2013, FOREST ECOL MANAG, V308, P214, DOI 10.1016/j.foreco.2013.07.028; Lu Qiao, 2011, Proceedings of the 2011 International Conference on Remote Sensing, Environment and Transportation Engineering (RSETE 2011), P8124, DOI 10.1109/RSETE.2011.5964041; Mouazen AM, 2010, GEODERMA, V158, P23, DOI 10.1016/j.geoderma.2010.03.001; [邱扬 Qiu Yang], 2002, [地理学报, Acta Geographica Sinica], V57, P587; Shi WJ, 2012, J GEOGR SCI, V22, P752, DOI 10.1007/s11442-012-0960-z; SONG G., 2013, IEEE, P1; Tittonell P, 2010, EUR J AGRON, V32, P10, DOI 10.1016/j.eja.2009.05.008; Vachaud G., 1985, J HYDRUL ENG ASCE, V9, P10; Wang K, 2013, APPL GEOGR, V42, P73, DOI 10.1016/j.apgeog.2013.04.002; Willmott C.J., 1981, PHYS GEOGR, V2, P184, DOI [10.1080/02723646.1981.10642213, DOI 10.1080/02723646.1981.10642213]; XIAOQING Z., 2013, CHINESE AGR SCI, V29, P160; Xu HongWei, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P13; Yan L, 2004, ACTA PEDOL SIN, V41, P434; Yao RJ, 2012, ENVIRON MONIT ASSESS, P1; Yao XL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056537, 10.1371/journal.pone.0054660]; Zeiner M, 2013, ENVIRON MONIT ASSESS, V185, P223, DOI 10.1007/s10661-012-2546-8; Zhang SW, 2012, GEODERMA, V171, P35, DOI 10.1016/j.geoderma.2011.07.012; Zhang W, 2004, SPAA STAT ANAL ADV T; Zhao ChunJiang, 2003, Transactions of the Chinese Society of Agricultural Engineering, V19, P7	31	5	6	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99695	10.1371/journal.pone.0099695	http://dx.doi.org/10.1371/journal.pone.0099695			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927129	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100068
J	van de Put, MAJ; Croonen, D; Nolte, IM; Japing, WJ; Hooymans, JM; Los, LI				van de Put, Mathijs A. J.; Croonen, Danna; Nolte, Ilja M.; Japing, Wouter J.; Hooymans, JohannaM. M.; Los, Leonoor I.			Postoperative Recovery of Visual Function after Macula-Off Rhegmatogenous Retinal Detachment	PLOS ONE			English	Article							CONTRAST SENSITIVITY; CENTRAL VISION; SURGERY; DURATION; FAILURE; HEIGHT; ACUITY	Purpose: To determine which factors affect the recovery of visual function in macula-off rhegmatogenous retinal detachment (RRD). Methods: In a prospective study of forty-five patients with a primary macula-off RRD of 24 hours to 6 weeks duration, the height of the macular detachment was determined by ultrasonography. At 12 months postoperatively, best corrected visual acuity (BCVA), contrast acuity, and color confusion indexes (CCI) were obtained. Results: Macular detachment was present for 2-32 (median 7) days before repair. A shorter duration of macular detachment was correlated with a better CCI sature (p = 0.0026) and lower LogMAR BCVA (better Snellen visual acuity)(p = 0.012). Also, a smaller height of macular detachment was correlated with a lower LogMAR BCVA (p = 0.0034). A younger age and lower pre-operative LogMAR BCVA at presentation were both correlated with better postoperative contrast acuity in the total group (age: p = 1.7 x 10(-4) and pre-operative LogMAR BCVA: p = 0.0034). Conclusion: Functional recovery after macula-off RRD is affected by the duration and the height of the macular detachment. Recovery of contrast acuity is also affected by age and BCVA at presentation.	[van de Put, Mathijs A. J.; Croonen, Danna; Japing, Wouter J.; Hooymans, JohannaM. M.; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Nolte, Ilja M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Hooymans, JohannaM. M.; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Grad Sch Med Sci, WJ Kolff Inst, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	van de Put, MAJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.	m.a.j.van.de.put@umcg.nl			Stichting Blindenhulp; Professor Mulder Stichting; Stichting Nederlands Oogheelkundig Onderzoek	Stichting Blindenhulp; Professor Mulder Stichting; Stichting Nederlands Oogheelkundig Onderzoek	This work was supported by Grant/financial supports: Stichting Blindenhulp, Professor Mulder Stichting, Stichting Nederlands Oogheelkundig Onderzoek. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON C, 1981, ACTA OPHTHALMOL, V59, P161; BOWMAN KJ, 1982, ACTA OPHTHALMOL, V60, P907; Burton T C, 1982, Trans Am Ophthalmol Soc, V80, P475; CHIGNELL AH, 1973, BRIT J OPHTHALMOL, V57, P525, DOI 10.1136/bjo.57.8.525; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; D'Amico DJ, 2008, NEW ENGL J MED, V359, P2346, DOI 10.1056/NEJMcp0804591; Davies E W, 1972, Trans Ophthalmol Soc U K, V92, P335; Diederen RMH, 2007, OPHTHALMOLOGY, V114, P705, DOI 10.1016/j.ophtha.2006.09.004; Doyle E, 2007, EYE, V21, P534, DOI 10.1038/sj.eye.6702260; GRIZZARD WS, 1994, GRAEF ARCH CLIN EXP, V232, P1, DOI 10.1007/BF00176431; GUNDRY MF, 1974, AM J OPHTHALMOL, V77, P310, DOI 10.1016/0002-9394(74)90735-1; Hassan TS, 2002, OPHTHALMOLOGY, V109, P146, DOI 10.1016/S0161-6420(01)00886-7; Jay B, 1965, Trans Ophthalmol Soc U K, V85, P101; Kreissig I, 1981, Dev Ophthalmol, V2, P77; Kreissig I, 1977, Mod Probl Ophthalmol, V18, P415; Lecleire-Collet A, 2005, RETINA-J RET VIT DIS, V25, P44, DOI 10.1097/00006982-200501000-00006; Lewis GP, 2004, AM J OPHTHALMOL, V137, P1085, DOI 10.1016/j.ajo.2004.01.045; LIEM ATA, 1994, OPHTHALMOLOGY, V101, P1945; MACHEMER R, 1968, AM J OPHTHALMOL, V66, P396, DOI 10.1016/0002-9394(68)91523-7; Mantyjarvi M, 2001, J CATARACT REFR SURG, V27, P261, DOI 10.1016/S0886-3350(00)00562-9; Mervin K, 1999, AM J OPHTHALMOL, V128, P155, DOI 10.1016/S0002-9394(99)00104-X; Minihan M, 2001, BRIT J OPHTHALMOL, V85, P546, DOI 10.1136/bjo.85.5.546; Mitry D, 2012, BR J OPHTHALMOL, P1; Mowatt L, 2010, EYE, V24, P323, DOI 10.1038/eye.2009.74; Pastor JC, 2008, BRIT J OPHTHALMOL, V92, P378, DOI 10.1136/bjo.2007.129437; Rachal WF, 1979, ARCH OPHTHALMOL-CHIC, V18, P415; Reese AB., 1937, AM J OPHTHALMOL, V20, P591, DOI [10.1016/S0002-9394(37)91116-4, DOI 10.1016/S0002-9394(37)91116-4]; Ross W, 2005, OPHTHALMOLOGY, V112, P1213, DOI 10.1016/j.ophtha.2005.01.040; Ross WH, 1998, OPHTHALMOLOGY, V105, P2149, DOI 10.1016/S0161-6420(98)91142-3; Rosser DA, 2003, INVEST OPHTH VIS SCI, V44, P3278, DOI 10.1167/iovs.02-1100; SHARMA T, 1994, RETINA-J RET VIT DIS, V14, P338, DOI 10.1097/00006982-199414040-00008; TANI P, 1981, AM J OPHTHALMOL, V92, P611, DOI 10.1016/S0002-9394(14)74651-3; van de Put MAJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062518; Van de Put MAJ, 2013, OPHTHALMOLOGY, V120, P616, DOI 10.1016/j.ophtha.2012.09.001; Wilkinson Charles Patton, 2009, Trans Am Ophthalmol Soc, V107, P55; zgur S, 2007, RETINA, V27, P359	36	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99787	10.1371/journal.pone.0099787	http://dx.doi.org/10.1371/journal.pone.0099787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927502	Green Submitted, Green Published, gold			2022-12-25	WOS:000338278100079
J	Yam, H; Rahim, AA; Mohamad, S; Mahadi, NM; Manaf, UA; Shu-Chien, AC; Najimudin, N				Yam, Hokchai; Rahim, Ainihayati Abdul; Mohamad, Suriani; Mahadi, Nor Muhammad; Manaf, Uyub Abdul; Shu-Chien, Alexander Chong; Najimudin, Nazalan			The Multiple Roles of Hypothetical Gene BPSS1356 in Burkholderia pseudomallei	PLOS ONE			English	Article							ARGININE DEIMINASE SYSTEM; RNA-POLYMERASE HOLOENZYME; CYSTIC-FIBROSIS LUNG; IN-VITRO; PSEUDOMONAS-AERUGINOSA; IDENTIFICATION; MELIOIDOSIS; GLYCEROL; PROTEIN; GROWTH	Burkholderia pseudomallei is an opportunistic pathogen and the causative agent of melioidosis. It is able to adapt to harsh environments and can live intracellularly in its infected hosts. In this study, identification of transcriptional factors that associate with the beta' subunit (RpoC) of RNA polymerase was performed. The N-terminal region of this subunit is known to trigger promoter melting when associated with a sigma factor. A pull-down assay using histidine-tagged B. pseudomallei RpoC N-terminal region as bait showed that a hypothetical protein BPSS1356 was one of the proteins bound. This hypothetical protein is conserved in all B. pseudomallei strains and present only in the Burkholderia genus. A BPSS1356 deletion mutant was generated to investigate its biological function. The mutant strain exhibited reduced biofilm formation and a lower cell density during the stationary phase of growth in LB medium. Electron microscopic analysis revealed that the Delta BPSS1356 mutant cells had a shrunken cytoplasm indicative of cell plasmolysis and a rougher surface when compared to the wild type. An RNA microarray result showed that a total of 63 genes were transcriptionally affected by the BPSS1356 deletion with fold change values of higher than 4. The expression of a group of genes encoding membrane located transporters was concurrently down-regulated in DBPSS1356 mutant. Amongst the affected genes, the putative ion transportation genes were the most severely suppressed. Deprivation of BPSS1356 also down-regulated the transcriptions of genes for the arginine deiminase system, glycerol metabolism, type III secretion system cluster 2, cytochrome bd oxidase and arsenic resistance. It is therefore obvious that BPSS1356 plays a multiple regulatory roles on many genes.	[Yam, Hokchai; Rahim, Ainihayati Abdul; Manaf, Uyub Abdul; Shu-Chien, Alexander Chong; Najimudin, Nazalan] Univ Sains Malaysia, Sch Biol Sci, Minden, Pulau Pinang, Malaysia; [Rahim, Ainihayati Abdul] Univ Malaysia Kelantan, Fac Agro Based Ind, Jeli, Kelantan, Malaysia; [Mohamad, Suriani] Univ Sains Malaysia, Sch Pharmaceut Sci, Minden, Pulau Pinang, Malaysia; [Mahadi, Nor Muhammad] Malaysia Genome Inst, Comparat Genom & Genet Res Ctr, Kajang, Selangor, Malaysia	Universiti Sains Malaysia; Universiti Malaysia Kelantan; Universiti Sains Malaysia	Najimudin, N (corresponding author), Univ Sains Malaysia, Sch Biol Sci, Minden, Pulau Pinang, Malaysia.	nazalan@usm.my	Yam, Hok Chai/AAJ-2029-2020; Najimudin, Nazalan/B-2952-2011; Shu-Chien, Alexander Chong/D-4041-2009	Shu-Chien, Alexander Chong/0000-0003-3014-442X; Abdul Rahim, Ainihayati/0000-0002-4847-5393	Malaysian Ministry of Science, Technology and Innovation (MOSTI); Universiti Sains Malaysia (USM) [07-05-MGI-GMB008]	Malaysian Ministry of Science, Technology and Innovation (MOSTI)(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Universiti Sains Malaysia (USM)(Universiti Sains Malaysia)	The research is funded by the Malaysian Ministry of Science, Technology and Innovation (MOSTI) to the Malaysia Genome Institute (GENOMalaysia) and Universiti Sains Malaysia (USM) under the Genomics and Molecular Biology Initiatives Programme (Project No. 07-05-MGI-GMB008). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Brisson D, 2001, BIOESSAYS, V23, P534, DOI 10.1002/bies.1073; Burmann BM, 2010, SCIENCE, V328, P501, DOI 10.1126/science.1184953; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; CASIANOCOLON A, 1988, APPL ENVIRON MICROB, V54, P1318; Chantratita N, 2012, J PROTEOMICS, V75, P1031, DOI 10.1016/j.jprot.2011.10.015; Charalambous K, 2011, BIOCHEMISTRY-US, V50, P6742, DOI 10.1021/bi200942y; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; COLE ST, 1988, J BACTERIOL, V170, P2448, DOI 10.1128/jb.170.6.2448-2456.1988; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Coutinho CP, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00012; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Darst SA, 2001, CURR OPIN STRUC BIOL, V11, P155; Degnan BA, 2000, INFECT IMMUN, V68, P2441, DOI 10.1128/IAI.68.5.2441-2448.2000; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fulde M, 2011, MICROBIOL-SGM, V157, P572, DOI 10.1099/mic.0.043067-0; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Gruening P, 2006, J BACTERIOL, V188, P361, DOI 10.1128/JB.188.2.361-369.2006; HAGENBUCH B, 1991, P NATL ACAD SCI USA, V88, P10629, DOI 10.1073/pnas.88.23.10629; HAGENBUCH B, 1994, J CLIN INVEST, V93, P1326, DOI 10.1172/JCI117091; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hames C, 2009, J BACTERIOL, V191, P747, DOI 10.1128/JB.01103-08; Hayden HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036507; Hoboth C, 2009, J INFECT DIS, V200, P118, DOI 10.1086/599360; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Kabus A, 2007, APPL ENVIRON MICROB, V73, P861, DOI 10.1128/AEM.01818-06; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kung C, 2004, MOL MICROBIOL, V53, P373, DOI 10.1111/j.1365-2958.2004.04180.x; Lee YH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-28; Lenn T, 2008, MOL MICROBIOL, V70, P1397, DOI 10.1111/j.1365-2958.2008.06486.x; Loisel-Meyer S, 2005, INFECT IMMUN, V73, P7768, DOI 10.1128/IAI.73.11.7768-7771.2005; Matulef K, 2007, MOL MEMBR BIOL, V24, P342, DOI 10.1080/09687680701413874; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Munch R, 2005, BIOINFORMATICS, V21, P4187, DOI 10.1093/bioinformatics/bti635; Nielsen KK, 2005, APPL ENVIRON MICROB, V71, P2949, DOI 10.1128/AEM.71.6.2949-2954.2005; Pappas CJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002102; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Pumirat P, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-171; Rainbow L, 2002, J MED MICROBIOL, V51, P374, DOI 10.1099/0022-1317-51-5-374; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Rojas-Jimenez K, 2005, MOL PLANT MICROBE IN, V18, P1175, DOI 10.1094/MPMI-18-1175; Ryan S, 2009, ENVIRON MICROBIOL, V11, P432, DOI 10.1111/j.1462-2920.2008.01782.x; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Sanders OI, 1997, J BACTERIOL, V179, P3365, DOI 10.1128/jb.179.10.3365-3367.1997; Sawasdidoln C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009196; Schell MA, 2011, J PROTEOME RES, V10, P2417, DOI 10.1021/pr1012398; Schwarz H, 1995, MICROBIOL-UK, V141, P3161, DOI 10.1099/13500872-141-12-3161; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; Silver S, 2005, APPL ENVIRON MICROB, V71, P599, DOI 10.1128/AEM.71.2.599-608.2005; Stroud RM, 2003, CURR OPIN STRUC BIOL, V13, P424, DOI 10.1016/S0959-440X(03)00114-3; Subsin B, 2003, J BACTERIOL, V185, P7008, DOI 10.1128/JB.185.23.7008-7014.2003; Sun GW, 2010, TRENDS MICROBIOL, V18, P561, DOI 10.1016/j.tim.2010.09.002; Taweechaisupapong S, 2005, MICROB PATHOGENESIS, V39, P77, DOI 10.1016/j.micpath.2005.06.001; Thomas F, 2011, J MICROBIOL METH, V84, P61, DOI 10.1016/j.mimet.2010.10.016; Trunck LA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000519; Tunpiboonsak S, 2010, J MICROBIOL, V48, P63, DOI 10.1007/s12275-010-9138-5; VANDERWAUVEN C, 1988, ARCH MICROBIOL, V150, P400, DOI 10.1007/BF00408314; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Velapatino B, 2012, MICROBES INFECT, V14, P335, DOI 10.1016/j.micinf.2011.11.011; Warawa J, 2005, FEMS MICROBIOL LETT, V242, P101, DOI 10.1016/j.femsle.2004.10.045; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; WONG MH, 1995, J BIOL CHEM, V270, P27228, DOI 10.1074/jbc.270.45.27228; Yam H, 2012, PROTEIN J, V31, P246, DOI 10.1007/s10930-012-9398-5; Young BA, 2004, SCIENCE, V303, P1382, DOI 10.1126/science.1092462; Young BA, 2001, CELL, V105, P935, DOI 10.1016/S0092-8674(01)00398-1; Zuniga M, 2002, MOL PHYLOGENET EVOL, V25, P429, DOI 10.1016/S1055-7903(02)00277-4	71	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99218	10.1371/journal.pone.0099218	http://dx.doi.org/10.1371/journal.pone.0099218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927285	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100030
J	Jaworski, E; Narayanan, A; Van Duyne, R; Shabbeer-Meyering, S; Iordanskiy, S; Saifuddin, M; Das, R; Afonso, PV; Sampey, GC; Chung, M; Popratiloff, A; Shrestha, B; Sehgal, M; Jain, P; Vertes, A; Mahieux, R; Kashanchi, F				Jaworski, Elizabeth; Narayanan, Aarthi; Van Duyne, Rachel; Shabbeer-Meyering, Shabana; Iordanskiy, Sergey; Saifuddin, Mohammed; Das, Ravi; Afonso, Philippe V.; Sampey, Gavin C.; Chung, Myung; Popratiloff, Anastas; Shrestha, Bindesh; Sehgal, Mohit; Jain, Pooja; Vertes, Akos; Mahieux, Renaud; Kashanchi, Fatah			Human T-lymphotropic Virus Type 1-infected Cells Secrete Exosomes That Contain Tax Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HTLV-I TAX; DNA-DAMAGE RESPONSE; MOLECULAR-MECHANISMS; CEREBROSPINAL-FLUID; PROTEOMICS ANALYSIS; MEDIATED TRANSFER; MESSENGER-RNAS; INFECTED-CELLS; LEUKEMIA-CELLS; HUMAN SALIVA	Human T-lymphotropic virus type 1 (HTLV-1) is the causative agent of adult T-cell leukemia and HTLV-1-associated myelopathy/tropical spastic paraparesis. The HTLV-1 transactivator protein Tax controls many critical cellular pathways, including host cell DNA damage response mechanisms, cell cycle progression, and apoptosis. Extracellular vesicles called exosomes play critical roles during pathogenic viral infections as delivery vehicles for host and viral components, including proteins, mRNA, and microRNA. We hypothesized that exosomes derived from HTLV-1-infected cells contain unique host and viral proteins that may contribute to HTLV-1-induced pathogenesis. We found exosomes derived from infected cells to contain Tax protein and proinflammatory mediators as well as viral mRNA transcripts, including Tax, HBZ, and Env. Furthermore, we observed that exosomes released from HTLV-1-infected Tax-expressing cells contributed to enhanced survival of exosome-recipient cells when treated with Fas antibody. This survival was cFLIP-dependent, with Tax showing induction of NF-kappa B in exosome-recipient cells. Finally, IL-2-dependent CTLL-2 cells that received Tax-containing exosomes were protected from apoptosis through activation of AKT. Similar experiments with primary cultures showed protection and survival of peripheral blood mononuclear cells even in the absence of phytohemagglutinin/IL-2. Surviving cells contained more phosphorylated Rb, consistent with the role of Tax in regulation of the cell cycle. Collectively, these results suggest that exosomes may play an important role in extracellular delivery of functional HTLV-1 proteins and mRNA to recipient cells.	[Jaworski, Elizabeth; Narayanan, Aarthi; Van Duyne, Rachel; Shabbeer-Meyering, Shabana; Iordanskiy, Sergey; Saifuddin, Mohammed; Das, Ravi; Sampey, Gavin C.; Chung, Myung; Kashanchi, Fatah] George Mason Univ, Sch Syst Biol, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA; [Van Duyne, Rachel; Iordanskiy, Sergey] George Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA; [Shrestha, Bindesh; Vertes, Akos] George Washington Univ, Med Ctr, Ctr Microscopy & Image Anal, Washington, DC 20037 USA; [Popratiloff, Anastas] George Washington Univ, Dept Chem, Washington, DC 20037 USA; [Mahieux, Renaud] Univ Lyon 1, Ecole Normale Super Lyon, Equipe Labelisee Ligue Natl Canc,Equipe Oncogenes, Int Ctr Res Infectiol,CNRS,INSERM,U1111,UMR5308, F-69364 Lyon 07, France; [Afonso, Philippe V.] Inst Pasteur, Dept Virol, Unite Epidemiol & Physiopathol Virus Oncogenes, F-75015 Paris, France; [Afonso, Philippe V.] CNRS, UMR3569, F-75015 Paris, France; [Sehgal, Mohit; Jain, Pooja] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Drexel Inst Biotechnol & Virol Res, Doylestown, PA 18902 USA	George Mason University; George Washington University; George Washington University; George Washington University; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Drexel University	Kashanchi, F (corresponding author), George Mason Univ, Discovery Hall,Rm 182,10900 Univ Blvd MS 1H8, Manassas, VA 20110 USA.	fkashanc@gmu.edu	Van Duyne, Rachel/I-7365-2019; Van Duyne, Rachel/ABI-2429-2020; Afonso, Philippe V/ABB-5692-2021; Afonso, Philippe/D-2234-2014; Vertes, Akos/B-7159-2008; Shrestha, Bindesh/B-8821-2008	Van Duyne, Rachel/0000-0003-2914-6874; Afonso, Philippe V/0000-0002-4828-3797; Afonso, Philippe/0000-0002-4828-3797; Vertes, Akos/0000-0001-5186-5352; Sehgal, Mohit/0000-0001-5544-3675; Das, Ravi/0000-0002-4301-0642; Shrestha, Bindesh/0000-0002-7595-3506; mahieux, renaud/0000-0002-5129-6804	National Institutes of Health (NIH), NCI [R01 CA054559]; NIH, NIAID [R01 AI077414]; NIH [AI078859, AI074410, AI043894]; United States Department of Energy [DE-SC0001599, DE-FG02-01ER15129]; George Mason University; equipe labelisee Ligue Contre le Cancer; NATIONAL CANCER INSTITUTE [R01CA054559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078859, R21AI074410, R01AI043894, R01AI077414] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); George Mason University; equipe labelisee Ligue Contre le Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NCI, Grant R01 CA054559 and NIH, NIAID, Grant R01 AI077414 (supporting P. J. and M. S.) and NIH Grants AI078859, AI074410, and AI043894 (to F. K.). This work was also supported by United States Department of Energy Grant DE-SC0001599 (to F. K.), an indirect account at George Mason University, and equipe labelisee Ligue Contre le Cancer (to R. M.). This work was also supported by the United States Department of Energy through Grant DE-FG02-01ER15129 (to A. V.) for conducting the LAESI-MS measurements.	Ahuja J, 2006, J NEUROVIROL, V12, P47, DOI 10.1080/13550280600614981; Ahuja J, 2007, BIOMED PHARMACOTHER, V61, P201, DOI 10.1016/j.biopha.2007.02.006; Alefantis T, 2005, J BIOMED SCI, V12, P961, DOI 10.1007/s11373-005-9026-x; Araya N, 2011, VIRUSES-BASEL, V3, P1532, DOI 10.3390/v3091532; Arenz C, 2001, CHEMBIOCHEM, V2, P141, DOI 10.1002/1439-7633(20010202)2:2<141::AID-CBIC141>3.0.CO;2-P; Banerjee P, 2007, J VIROL, V81, P1690, DOI 10.1128/JVI.01513-06; Belgnaoui SM, 2010, J BIOL CHEM, V285, P32897, DOI 10.1074/jbc.M110.146373; Bellon M, 2008, BLOOD, V112, P2946, DOI 10.1182/blood-2008-01-134692; BHAT NK, 1993, VIROLOGY, V196, P15, DOI 10.1006/viro.1993.1450; Bobrie A, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18397; Borges FT, 2013, J AM SOC NEPHROL, V24, P385, DOI 10.1681/ASN.2012101031; Starling ALB, 2013, ACTA TROP, V125, P75, DOI 10.1016/j.actatropica.2012.09.012; Boxus M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-76; Cabezas SC, 2013, CELL MICROBIOL, V15, P412, DOI 10.1111/cmi.12046; Callahan MK, 2003, J IMMUNOL, V170, P4840, DOI 10.4049/jimmunol.170.9.4840; Cartier L, 2005, ARCH VIROL, V150, P743, DOI 10.1007/s00705-004-0443-3; Carvalho EM, 2001, J ACQ IMMUN DEF SYND, V27, P1, DOI 10.1097/00126334-200105010-00001; Ceccarelli S, 2007, INT J CANCER, V121, P1494, DOI 10.1002/ijc.22844; Chandhasin C, 2008, J VIROL, V82, P6952, DOI 10.1128/JVI.02331-07; Chen CL, 2012, J PROTEOME RES, V11, P5611, DOI 10.1021/pr3008732; Cheng H, 2012, PROTEIN CELL, V3, P581, DOI 10.1007/s13238-012-2047-0; Chiba M, 2012, ONCOL REP, V28, P1551, DOI 10.3892/or.2012.1967; Chlichlia K, 2010, CHEM-BIOL INTERACT, V188, P359, DOI 10.1016/j.cbi.2010.06.005; Cook LB, 2013, VIROLOGY, V435, P131, DOI 10.1016/j.virol.2012.09.028; Cowan EP, 1997, J VIROL, V71, P6982, DOI 10.1128/JVI.71.9.6982-6989.1997; Currer R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00406; de la Fuente C, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-43; Dear JW, 2013, PROTEOMICS, V13, P1572, DOI 10.1002/pmic.201200285; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Durkin SS, 2008, J BIOL CHEM, V283, P36311, DOI 10.1074/jbc.M804931200; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Giri PK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002461; Gourzones C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-271; Graner MW, 2009, FASEB J, V23, P1541, DOI 10.1096/fj.08-122184; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; GRASSMANN R, 1989, P NATL ACAD SCI USA, V86, P3351, DOI 10.1073/pnas.86.9.3351; Grossman WJ, 1997, BLOOD, V90, P783, DOI 10.1182/blood.V90.2.783.783_783_794; Guerreiro JB, 2006, CLIN EXP IMMUNOL, V145, P296, DOI 10.1111/j.1365-2249.2006.03150.x; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Haller K, 2002, MOL CELL BIOL, V22, P3327, DOI 10.1128/MCB.22.10.3327-3338.2002; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Honegger A, 2013, INT J CANCER, V133, P1631, DOI 10.1002/ijc.28164; Hu G, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.114; IJICHI S, 1993, MED HYPOTHESES, V41, P542, DOI 10.1016/0306-9877(93)90111-3; Ijichi S, 1997, Nihon Rinsho, V55, P926; Inlora J, 2011, J VIROL, V85, P3802, DOI 10.1128/JVI.02383-10; Islam A, 2007, J BIOL CHEM, V282, P9591, DOI 10.1074/jbc.M607122200; Iwanaga R, 2001, ONCOGENE, V20, P2055, DOI 10.1038/sj.onc.1204304; Iwanaga Y, 1999, J VIROL, V73, P1271, DOI 10.1128/JVI.73.2.1271-1277.1999; Jain P, 2007, J BIOL CHEM, V282, P34581, DOI 10.1074/jbc.M707317200; Jaworski E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096778; Jeong SJ, 2005, ONCOGENE, V24, P6719, DOI 10.1038/sj.onc.1208825; Jeong SJ, 2008, VIROLOGY, V370, P264, DOI 10.1016/j.virol.2007.09.003; Jin DY, 1997, NUCLEIC ACIDS RES, V25, P379, DOI 10.1093/nar/25.2.379; Kadiu I, 2012, J IMMUNOL, V189, P744, DOI 10.4049/jimmunol.1102244; Kamoi K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00270; KASHANCHI F, 1992, NUCLEIC ACIDS RES, V20, P4673, DOI 10.1093/nar/20.17.4673; Kawakami A, 1999, BLOOD, V94, P3847, DOI 10.1182/blood.V94.11.3847.423a24_3847_3854; Kehn K, 2005, ONCOGENE, V24, P525, DOI 10.1038/sj.onc.1208105; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Khatua AK, 2009, J VIROL, V83, P512, DOI 10.1128/JVI.01658-08; Kim YM, 2010, ONCOGENE, V29, P2142, DOI 10.1038/onc.2009.498; KIMATA JT, 1994, VIROLOGY, V204, P656, DOI 10.1006/viro.1994.1581; Kinjo T, 2010, J VIROL, V84, P5431, DOI 10.1128/JVI.02460-09; Kooij G, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00074; Kooij G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008212; Krueger A, 2006, BLOOD, V107, P3933, DOI 10.1182/blood-2005-06-2567; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; LINDHOLM P F, 1990, New Biologist, V2, P1034; LINDHOLM PF, 1992, J VIROL, V66, P1294, DOI 10.1128/JVI.66.3.1294-1302.1992; Liu MH, 2008, J VIROL, V82, P8442, DOI 10.1128/JVI.00091-08; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Macaire H, 2012, J BIOL CHEM, V287, P21357, DOI 10.1074/jbc.M112.340992; Macovei A, 2006, BIOCHEM BIOPH RES CO, V346, P1083, DOI 10.1016/j.bbrc.2006.06.023; Maeda Y, 2011, LEUKEMIA LYMPHOMA, V52, P150, DOI 10.3109/10428194.2010.527406; Majone F, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-15; Manuel SL, 2009, J LEUKOCYTE BIOL, V86, P1205, DOI 10.1189/jlb.0309172; MARRIOTT SJ, 1991, NEW BIOL, V3, P678; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mathivanan S, 2010, MOL CELL PROTEOMICS, V9, P197, DOI 10.1074/mcp.M900152-MCP200; Matsuoka M, 2011, ONCOGENE, V30, P1379, DOI 10.1038/onc.2010.537; Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11; Meckes DG, 2010, P NATL ACAD SCI USA, V107, P20370, DOI 10.1073/pnas.1014194107; Michael A, 2010, ORAL DIS, V16, P34, DOI 10.1111/j.1601-0825.2009.01604.x; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Montanheiro P, 2007, J NEUROIMMUNOL, V188, P138, DOI 10.1016/j.jneuroim.2007.05.015; Mori N, 2004, INT J CANCER, V111, P548, DOI 10.1002/ijc.20266; Narayanan A, 2013, J BIOL CHEM, V288, P20014, DOI 10.1074/jbc.M112.438895; NIMER SD, 1989, ONCOGENE, V4, P671; NISHIMOTO N, 1990, J NEUROL SCI, V97, P183, DOI 10.1016/0022-510X(90)90217-B; Norris PJ, 2010, VIRULENCE, V1, P19, DOI 10.4161/viru.1.1.9868; Ohno S, 2013, ADV DRUG DELIVER REV, V65, P398, DOI 10.1016/j.addr.2012.07.019; Okamoto K, 2006, GENES CELLS, V11, P177, DOI 10.1111/j.1365-2443.2006.00927.x; PAL R, 1991, AIDS RES HUM RETROV, V7, P707, DOI 10.1089/aid.1991.7.707; Pant S, 2012, BIOCHEM PHARMACOL, V83, P1484, DOI 10.1016/j.bcp.2011.12.037; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Poliakov A, 2009, PROSTATE, V69, P159, DOI 10.1002/pros.20860; POPOVIC M, 1983, P NATL ACAD SCI-BIOL, V80, P5402, DOI 10.1073/pnas.80.17.5402; Principe S, 2013, PROTEOMICS, V13, P1667, DOI 10.1002/pmic.201200561; Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968; Rahman S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034490; Rood IM, 2010, KIDNEY INT, V78, P810, DOI 10.1038/ki.2010.262; SAIFUDDIN M, 1995, J EXP MED, V182, P501, DOI 10.1084/jem.182.2.501; Saito K, 2010, VIROLOGY, V403, P173, DOI 10.1016/j.virol.2010.04.018; SALAHUDDIN SZ, 1983, VIROLOGY, V129, P51, DOI 10.1016/0042-6822(83)90395-1; Santiago F, 1999, J VIROL, V73, P9917, DOI 10.1128/JVI.73.12.9917-9927.1999; Schmitt I, 1998, J VIROL, V72, P633, DOI 10.1128/JVI.72.1.633-640.1998; Schneider A, 2013, CELL TISSUE RES, V352, P33, DOI 10.1007/s00441-012-1428-2; Shrestha B, 2012, CHEM COMMUN, V48, P3700, DOI 10.1039/c2cc17225a; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; SPEAR GT, 1995, J IMMUNOL, V155, P4376; Sripadi P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012590; Suetsugu A, 2013, ADV DRUG DELIVER REV, V65, P383, DOI 10.1016/j.addr.2012.08.007; Takashima H, 1996, ANN RHEUM DIS, V55, P632, DOI 10.1136/ard.55.9.632; Tauro BJ, 2013, MOL CELL PROTEOMICS, V12, P587, DOI 10.1074/mcp.M112.021303; Testa JS, 2010, J IMMUNOL, V185, P6608, DOI 10.4049/jimmunol.1001768; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Vajente N, 2009, APOPTOSIS, V14, P153, DOI 10.1007/s10495-008-0289-3; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wahlgren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049723; Wang GH, 2012, J BIOL CHEM, V287, P21384, DOI 10.1074/jbc.M112.340513; Watanabe T, 2011, INT J HEMATOL, V94, P430, DOI 10.1007/s12185-011-0934-4; Welton JL, 2010, MOL CELL PROTEOMICS, V9, P1324, DOI 10.1074/mcp.M000063-MCP201; Wurdinger T, 2012, ADV VIROL, V2012, DOI 10.1155/2012/767694; Xiao DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046874; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Yamano Y, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00389; Yang LP, 2011, J VIROL, V85, P3001, DOI 10.1128/JVI.00086-10; Yasunaga J, 2011, INT J HEMATOL, V94, P435, DOI 10.1007/s12185-011-0937-1	134	106	112	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22284	22305		10.1074/jbc.M114.549659	http://dx.doi.org/10.1074/jbc.M114.549659			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24939845	Green Published, hybrid			2022-12-25	WOS:000340593500041
J	McKown, RL; Frazier, EVC; Zadrozny, KK; Deleault, AM; Raab, RW; Ryan, DS; Sia, RK; Lee, JK; Laurie, GW				McKown, Robert L.; Frazier, Erin V. Coleman; Zadrozny, Kaneil K.; Deleault, Andrea M.; Raab, Ronald W.; Ryan, Denise S.; Sia, Rose K.; Lee, Jae K.; Laurie, Gordon W.			A Cleavage-potentiated Fragment of Tear Lacritin Is Bactericidal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI-CELLS; ANTIMICROBIAL PEPTIDE; STAPHYLOCOCCUS-AUREUS; ANTIBACTERIAL FACTOR; STRESS; DERMCIDIN; SECRETION; SWEAT; SUSCEPTIBILITY; POLYAMINES	Antimicrobial peptides are important as the first line of innate defense, through their tendency to disrupt bacterial membranes or intracellular pathways and potentially as the next generation of antibiotics. How they protect wet epithelia is not entirely clear, with most individually inactive under physiological conditions and many preferentially targeting Gram-positive bacteria. Tears covering the surface of the eye are bactericidal for Gram-positive and -negative bacteria. Here we narrow much of the bactericidal activity to a latent C-terminal fragment in the prosecretory mitogen lacritin and report that the mechanism combines membrane permeabilization with rapid metabolic changes, including reduced levels of dephosphocoenzyme A, spermidine, putrescine, and phosphatidylethanolamines and elevated alanine, leucine, phenylalanine, tryptophan, proline, glycine, lysine, serine, glutamate, cadaverine, and pyrophosphate. Thus, death by metabolic stress parallels cellular attempts to survive. Cleavage-dependent appearance of the C-terminal cationic amphipathic alpha-helix is inducible within hours by Staphylococcus epidermidis and slowly by another mechanism, in a chymotrypsin-or leupeptin protease-inhibitable manner. Although bactericidal at low micromolar levels, within a biphasic 1-10 nM dose optimum, the same domain is mitogenic and cytoprotective for epithelia via a syndecan-1 targeting mechanism dependent on heparanase. Thus, the C terminus of lacritin is multifunctional by dose and proteolytic processing and appears to play a key role in the innate protection of the eye, with wider potential benefit elsewhere as lacritin flows from exocrine secretory cells.	[McKown, Robert L.; Frazier, Erin V. Coleman; Zadrozny, Kaneil K.; Deleault, Andrea M.; Raab, Ronald W.] James Madison Univ, Dept Integrated Sci & Technol, Harrisonburg, VA 22807 USA; [Ryan, Denise S.; Sia, Rose K.] Warfighter Refract Eye Surg Program & Res Ctr Ft, Ft Belvoir, VA 22060 USA; [Lee, Jae K.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA; [Lee, Jae K.] Univ Virginia, Dept Syst & Informat Engn, Charlottesville, VA 22908 USA; [Laurie, Gordon W.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA; [Laurie, Gordon W.] Univ Virginia, Dept Ophthalmol, Charlottesville, VA 22908 USA; [Laurie, Gordon W.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA	James Madison University; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Laurie, GW (corresponding author), Univ Virginia, Dept Cell Biol, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	glaurie@virginia.edu	Laurie, Gordon W/A-5244-2008	Laurie, Gordon W/0000-0002-5311-2650	National Institutes of Health [RO1 EY013143, EY018222]; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018222, R01EY013143, R01EY024327] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 EY013143 and EY018222 (to G. W. L.). G. W. L. is co-founder of TearSolutions, LLC, which seeks to take a lacritin C-terminal peptide through phase II human trials for treating dry eye.	Baechle D, 2006, J BIOL CHEM, V281, P5406, DOI 10.1074/jbc.M504670200; Bashir A, 2014, APPL ENVIRON MICROB, V80, P2773, DOI 10.1128/AEM.00078-14; BENJAMIN WJ, 1983, INVEST OPHTH VIS SCI, V24, P1624; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Bernheim J., 1893, BEITR AUGENHEILK VON; Biville F, 1996, RES MICROBIOL, V147, P597, DOI 10.1016/0923-2508(96)84015-0; Brown-Elliott BA, 2012, CORNEA, V31, P900, DOI 10.1097/ICO.0b013e31823f8bb9; Butovich IA, 2013, EXP EYE RES, V117, P4, DOI 10.1016/j.exer.2013.05.010; Cerovsky V, 2008, CHEMBIOCHEM, V9, P2815, DOI 10.1002/cbic.200800476; Chan YR, 2009, J IMMUNOL, V182, P4947, DOI 10.4049/jimmunol.0803282; Chen LY, 2011, J PROTEOME RES, V10, P4876, DOI 10.1021/pr2004874; Chen X, 2011, J CELL BIOL, V192, P825, DOI 10.1083/jcb.201008090; ELLISON RT, 1991, J CLIN INVEST, V88, P1080, DOI 10.1172/JCI115407; Farris R L, 1986, Trans Am Ophthalmol Soc, V84, P250; Fleiszig SMJ, 2003, INFECT IMMUN, V71, P3866, DOI 10.1128/IAI.71.7.3866-3874.2003; Fleming A, 1922, P R SOC LOND B-CONTA, V93, P306, DOI 10.1098/rspb.1922.0023; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; FORD LC, 1976, AM J OPHTHALMOL, V81, P30, DOI 10.1016/0002-9394(76)90188-4; FRIEDLAND BR, 1972, AM J OPHTHALMOL, V74, P52, DOI 10.1016/0002-9394(72)91125-7; Geiger T, 2014, J BACTERIOL, V196, P894, DOI 10.1128/JB.01201-13; GILBARD JP, 1978, ARCH OPHTHALMOL-CHIC, V96, P677; Graham Joanna E, 2007, Invest Ophthalmol Vis Sci, V48, P5616; Haneburger I, 2012, J MOL BIOL, V424, P15, DOI 10.1016/j.jmb.2012.08.023; Imura Y, 2008, BIOPHYS J, V95, P5757, DOI 10.1529/biophysj.108.133488; Iwalokun BA, 2011, J OPHTHALMIC INFLAMM, V1, P95, DOI 10.1007/s12348-011-0024-z; JANSSEN PT, 1984, INVEST OPHTH VIS SCI, V25, P1156; Joshi GS, 2011, MOL MICROBIOL, V82, P9, DOI 10.1111/j.1365-2958.2011.07809.x; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Karimian F, 2011, CORNEA, V30, P620, DOI 10.1097/ICO.0b013e3181e16f7c; Karnati R, 2013, EXP EYE RES, V117, P39, DOI 10.1016/j.exer.2013.05.020; Koo BS, 2005, J PROTEOME RES, V4, P719, DOI 10.1021/pr0498133; Levitin F, 2005, J BIOL CHEM, V280, P33374, DOI 10.1074/jbc.M506047200; Ma PS, 2006, J CELL BIOL, V174, P1097, DOI 10.1083/jcb.200511134; Malhotra S, 2005, Indian J Pathol Microbiol, V48, P538; McDermott AM, 2013, EXP EYE RES, V117, P53, DOI 10.1016/j.exer.2013.07.014; Melanowski WH, 1937, AM J OPHTHALMOL; Morimoto-Tochigi A, 2010, INVEST OPHTH VIS SCI, V51, P4395, DOI 10.1167/iovs.09-4573; Moser C, 2002, INFECT IMMUN, V70, P3068, DOI 10.1128/IAI.70.6.3068-3072.2002; Nagaoka I, 2000, INFLAMM RES, V49, P73, DOI 10.1007/s000110050561; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; O'Toole N, 2003, PROTEIN SCI, V12, P327, DOI 10.1110/ps.0227803; Paulmann M, 2012, J BIOL CHEM, V287, P8434, DOI 10.1074/jbc.M111.332270; Porter D, 2003, P NATL ACAD SCI USA, V100, P10931, DOI 10.1073/pnas.1932980100; Rieg S, 2006, J INVEST DERMATOL, V126, P354, DOI 10.1038/sj.jid.5700041; Romantsov T, 2009, BBA-BIOMEMBRANES, V1788, P2092, DOI 10.1016/j.bbamem.2009.06.010; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; Samudre S, 2011, INVEST OPHTH VIS SCI, V52, P6265, DOI 10.1167/iovs.10-6220; Sanghi S, 2001, J MOL BIOL, V310, P127, DOI 10.1006/jmbi.2001.4748; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Schroll C, 2014, VET MICROBIOL, V170, P144, DOI 10.1016/j.vetmic.2014.01.034; Seifert K, 2012, INVEST OPHTH VIS SCI, V53, P6610, DOI 10.1167/iovs.11-8729; Sitaramamma T, 1998, Indian Journal of Ophthalmology, V46, P239; Sochacki KA, 2011, P NATL ACAD SCI USA, V108, pE77, DOI 10.1073/pnas.1101130108; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050300; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Steffen H, 2006, ANTIMICROB AGENTS CH, V50, P2608, DOI 10.1128/AAC.00181-06; Stromstedt A. A., BIOCH BIOPHYS ACTA, V1788, P1916; Tam C, 2012, J CLIN INVEST, V122, P3665, DOI 10.1172/JCI64416; Tkachenko AG, 2012, RES MICROBIOL, V163, P83, DOI 10.1016/j.resmic.2011.10.009; Tossi A, 2000, BIOPOLYMERS, V55, P4; Veldhuizen EJA, 2008, MOL IMMUNOL, V45, P386, DOI 10.1016/j.molimm.2007.06.001; Velez VF, 2013, INVEST OPHTH VIS SCI, V54, P2123, DOI 10.1167/iovs.12-11488; Wang JH, 2006, J CELL BIOL, V174, P689, DOI 10.1083/jcb.200605140; Wang N, 2013, J BIOL CHEM, V288, P18146, DOI 10.1074/jbc.M112.436584; Wikstrom M, 2009, J BIOL CHEM, V284, P954, DOI 10.1074/jbc.M804482200; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Zaidi TS, 2006, INFECT IMMUN, V74, P975, DOI 10.1128/IAI.74.2.975-983.2006; Zhang YH, 2013, J BIOL CHEM, V288, P12090, DOI 10.1074/jbc.M112.422717; Zhou L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001291; Zugasti O, 2009, NAT IMMUNOL, V10, P249, DOI 10.1038/ni.1700	70	25	26	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22172	22182		10.1074/jbc.M114.570143	http://dx.doi.org/10.1074/jbc.M114.570143			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24942736	Green Published, hybrid			2022-12-25	WOS:000340593500032
J	Kelly, JF; Stout, RL; Greene, MC; Slaymaker, V				Kelly, John F.; Stout, Robert L.; Greene, M. Claire; Slaymaker, Valerie			Young Adults, Social Networks, and Addiction Recovery: Post Treatment Changes in Social Ties and Their Role as a Mediator of 12-Step Participation	PLOS ONE			English	Article							MULTIVARIATE PROCESS MODEL; SUBSTANCE-ABUSE PATIENTS; SELF-HELP GROUPS; DRINKING OUTCOMES; BEHAVIOR-CHANGE; FRIENDSHIP NETWORKS; EMERGING ADULTHOOD; ALCOHOL; SUPPORT; MECHANISMS	Background: Social factors play a key role in addiction recovery. Research with adults indicates individuals with substance use disorder (SUD) benefit from mutual-help organizations (MHOs), such as Alcoholics Anonymous, via their ability to facilitate adaptive network changes. Given the lower prevalence of sobriety-conducive, and sobriety-supportive, social contexts in the general population during the life-stage of young adulthood, however, 12-step MHOs may play an even more crucial recovery-supportive social role for young adults, but have not been investigated. Greater knowledge could enhance understanding of recovery-related change and inform young adults' continuing care recommendations. Methods: Emerging adults (N = 302; 18-24 yrs; 26% female; 95% White) enrolled in a study of residential treatment effectiveness were assessed at intake, 1, 3, 6, and 12 months on 12-step attendance, peer network variables ("high [relapse] risk'' and "low [relapse] risk'' friends), and treatment outcomes (Percent Days Abstinent; Percent Days Heavy Drinking). Hierarchical linear models tested for change in social risk over time and lagged mediational analyses tested whether 12-step attendance conferred recovery benefits via change in social risk. Results: High-risk friends were common at treatment entry, but decreased during follow-up; low-risk friends increased. Contrary to predictions, while substantial recovery-supportive friend network changes were observed, this was unrelated to 12-step participation and, thus, not found to mediate its positive influence on outcome. Conclusions: Young adult 12-step participation confers recovery benefit; yet, while encouraging social network change, 12-step MHOs may be less able to provide social network change directly for young adults, perhaps because similar-aged peers are less common in MHOs. Findings highlight the importance of both social networks and 12-step MHOs and raise further questions as to how young adults benefit from 12-step MHOs.	[Kelly, John F.; Greene, M. Claire] Massachusetts Gen Hosp, Dept Psychiat, Ctr Addict Med, Boston, MA 02114 USA; [Kelly, John F.; Greene, M. Claire] Harvard Univ, Sch Med, Boston, MA USA; [Stout, Robert L.] Pacific Inst Res & Evaluat, Providence, RI USA; [Slaymaker, Valerie] Hazelden Fdn, Ctr City, MN USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Pacific Institute for Research & Evaluation (PIRE)	Kelly, JF (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Ctr Addict Med, Boston, MA 02114 USA.	jkelly11@mgh.harvard.edu	Kelly, John/Q-6780-2019	Kelly, John/0000-0001-6915-0750; Stout, Robert/0000-0003-2596-241X	National Institute of Alcohol Abuse and Alcoholism (NIAAA) [1R21AA018185-01A2]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA018185] Funding Source: NIH RePORTER	National Institute of Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was was supported by the National Institute of Alcohol Abuse and Alcoholism (NIAAA) Grant Number: 1R21AA018185-01A2 and by an anonymous donation to the Hazelden Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, Alcohol Clin Exp Res, V17, P1130; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Beattie MC, 1999, ADDICT BEHAV, V24, P593, DOI 10.1016/S0306-4603(98)00120-8; Beattie MC, 2001, J STUD ALCOHOL, V62, P518, DOI 10.15288/jsa.2001.62.518; Bergman BG, 2013, ALCOHOL CLIN EXP RES; Blonigen DM, 2013, SUBST ABUS, V34, P4, DOI 10.1080/08897077.2012.691448; Bond J, 2003, J STUD ALCOHOL, V64, P579, DOI 10.15288/jsa.2003.64.579; BROWN SA, 1989, ADDICT BEHAV, V14, P291, DOI 10.1016/0306-4603(89)90060-9; Delucchi KL, 2008, ADDICT BEHAV, V33, P134, DOI 10.1016/j.addbeh.2007.04.027; Dennis Michael, 2007, Addict Sci Clin Pract, V4, P45; Fenster J, 2006, DRUG ALCOHOL DEPEN, V83, P238, DOI 10.1016/j.drugalcdep.2005.11.017; Hser YI, 2011, CURR CLIN PSYCHIAT, P9, DOI 10.1007/978-1-60327-960-4_2; Humphreys K, 1999, ANN BEHAV MED, V21, P54, DOI 10.1007/BF02895034; Humphreys K, 1997, PSYCHIATR SERV, V48, P1445; Humphreys K, 1997, AM J COMMUN PSYCHOL, V25, P1, DOI 10.1023/A:1024613507082; Kaskutas LA, 2002, ADDICTION, V97, P891, DOI 10.1046/j.1360-0443.2002.00118.x; Kelly J.F., 2013, ADDICTIONS COMPREHEN; Kelly JF, 2002, J STUD ALCOHOL, V63, P293, DOI 10.15288/jsa.2002.63.293; Kelly JF, 2000, PSYCHOL ADDICT BEHAV, V14, P376; Kelly JF, 2013, J SUBST ABUSE TREAT; Kelly JF, 2008, PRACT RESOUR MENT, P61, DOI 10.1016/B978-012088520-6.50005-6; Kelly JF, 2013, DRUG ALCOHOL DEPEN, V129, P151, DOI 10.1016/j.drugalcdep.2012.10.005; Kelly JF, 2012, ADDICTION, V107, P289, DOI 10.1111/j.1360-0443.2011.03593.x; Kelly JF, 2011, DRUG ALCOHOL DEPEN, V114, P119, DOI 10.1016/j.drugalcdep.2010.09.009; Kelly JF, 2010, ADDICTION, V105, P626, DOI 10.1111/j.1360-0443.2009.02820.x; Kelly JF, 2009, ADDICT RES THEORY, V17, P236, DOI 10.1080/16066350902770458; Labbe AK, 2013, DRUG ALCOHOL DEPEND; Litt MD, 2009, J CONSULT CLIN PSYCH, V77, P229, DOI 10.1037/a0015252; Little R.J.A., 2002, STAT ANAL MISSING DA; Longabaugh R, 1998, ADDICTION, V93, P1313, DOI 10.1046/j.1360-0443.1998.93913133.x; Longabaugh R, 2010, J STUD ALCOHOL DRUGS, V71, P837, DOI 10.15288/jsad.2010.71.837; MacKinnon DavidP., 2012, STAT MEDIATION ANAL; Maisto SA, 2003, PSYCHOL ADDICT BEHAV, V17, P98, DOI 10.1037/0893-164X.17.2.98; Marlatt G.A, 2005, RELAPSE PREVENTION M; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; Miller WR, 1996, PSYCHOL ADDICT BEHAV, V10, P81, DOI 10.1037/0893-164X.10.2.81; MILLER WR, 1994, J STUD ALCOHOL, P112, DOI 10.15288/jsas.1994.s12.112; Moos RH, 2003, AM J COMMUN PSYCHOL, V31, P1, DOI 10.1023/A:1023041101850; Moos RH, 2007, DRUG ALCOHOL DEPEN, V88, P109, DOI 10.1016/j.drugalcdep.2006.10.010; Moos RH, 2011, CURR CLIN PSYCHIAT, P45, DOI 10.1007/978-1-60327-960-4_4; Morgenstern J, 1997, J CONSULT CLIN PSYCH, V65, P768, DOI 10.1037/0022-006X.65.5.768; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Richter S S, 1991, J Subst Abuse, V3, P371; SARASON IG, 1983, J PERS SOC PSYCHOL, V44, P127, DOI 10.1037/0022-3514.44.1.127; Slesnick Natasha, 2004, Alcohol Treat Q, V22, P21; Stout RL, 2012, J STUD ALCOHOL DRUGS, V73, P489, DOI 10.15288/jsad.2012.73.489; Substance Abuse and Mental Health Services Administration, 2013, RES 2012 NAT SURV DR; Tarter R. E., 2002, ETIOLOGY SUBSTANCE U; Tonigan JS, 1997, J STUD ALCOHOL, V58, P358, DOI 10.15288/jsa.1997.58.358; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; Zywiak WH, 2002, J STUD ALCOHOL, V63, P114	52	54	54	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100121	10.1371/journal.pone.0100121	http://dx.doi.org/10.1371/journal.pone.0100121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN6QP	24945357	Green Published, gold, Green Submitted			2022-12-25	WOS:000340721500045
J	van Straten, G; van Steenbeek, FG; Grinwis, GCM; Favier, RP; Kummeling, A; van Gils, IH; Fieten, H; Koerkamp, MJAG; Holstege, FCP; Rothuizen, J; Spee, B				van Straten, Giora; van Steenbeek, Frank G.; Grinwis, Guy C. M.; Favier, Robert P.; Kummeling, Anne; van Gils, Ingrid H.; Fieten, Hille; Koerkamp, Marian J. A. Groot; Holstege, Frank C. P.; Rothuizen, Jan; Spee, Bart			Aberrant Expression and Distribution of Enzymes of the Urea Cycle and Other Ammonia Metabolizing Pathways in Dogs with Congenital Portosystemic Shunts	PLOS ONE			English	Article							CARBAMOYL-PHOSPHATE SYNTHETASE; GENE-EXPRESSION; RAT-LIVER; GLUTAMINE-SYNTHETASE; IRISH WOLFHOUNDS; ORNITHINE CYCLE; MOUSE-LIVER; IMMUNOHISTOCHEMICAL LOCALIZATION; HEPATOCELLULAR EXPRESSION; NITROGEN-METABOLISM	The detoxification of ammonia occurs mainly through conversion of ammonia to urea in the liver via the urea cycle and glutamine synthesis. Congenital portosystemic shunts (CPSS) in dogs cause hyperammonemia eventually leading to hepatic encephalopathy. In this study, the gene expression of urea cycle enzymes (carbamoylphosphate synthetase (CPS1), ornithine carbamoyltransferase (OTC), argininosuccinate synthetase (ASS1), argininosuccinate lyase (ASL), and arginase (ARG1)), N-acetylglutamate synthase (NAGS), Glutamate dehydrogenase (GLUD1), and glutamate-ammonia ligase (GLUL) was evaluated in dogs with CPSS before and after surgical closure of the shunt. Additionally, immunohistochemistry was performed on urea cycle enzymes and GLUL on liver samples of healthy dogs and dogs with CPSS to investigate a possible zonal distribution of these enzymes within the liver lobule and to investigate possible differences in distribution in dogs with CPSS compared to healthy dogs. Furthermore, the effect of increasing ammonia concentrations on the expression of the urea cycle enzymes was investigated in primary hepatocytes in vitro. Gene-expression of CPS1, OTC, ASL, GLUD1 and NAGS was down regulated in dogs with CPSS and did not normalize after surgical closure of the shunt. In all dogs GLUL distribution was localized pericentrally. CPS1, OTC and ASS1 were localized periportally in healthy dogs, whereas in CPSS dogs, these enzymes lacked a clear zonal distribution. In primary hepatocytes higher ammonia concentrations induced mRNA levels of CPS1. We hypothesize that the reduction in expression of urea cycle enzymes, NAGS and GLUD1 as well as the alterations in zonal distribution in dogs with CPSS may be caused by a developmental arrest of these enzymes during the embryonic or early postnatal phase.	[van Straten, Giora; van Steenbeek, Frank G.; Favier, Robert P.; Kummeling, Anne; van Gils, Ingrid H.; Fieten, Hille; Rothuizen, Jan; Spee, Bart] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Grinwis, Guy C. M.] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [Koerkamp, Marian J. A. Groot; Holstege, Frank C. P.] Univ Med Ctr Utrecht, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center	van Straten, G (corresponding author), Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands.	G.vanStraten@uu.nl	Holstege, Frank/AAM-9944-2021; Kummeling, Anne/GNW-3198-2022; van Steenbeek, F.G./AFL-0046-2022	van Steenbeek, F.G./0000-0001-5460-6540; Groot Koerkamp, Marian JA/0000-0002-0867-0821; Grinwis, Guy/0000-0002-1583-9648				ADCOCK MW, 1984, J BIOL CHEM, V259, P3471; [Anonymous], 2006, WSAVA STANDARDS CLIN; Arends B, 2009, STEM CELLS DEV, V18, P351, DOI 10.1089/scd.2008.0043; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Berent AC, 2009, VET CLIN N AM-SMALL, V39, P513, DOI 10.1016/j.cvsm.2009.02.004; Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; Christoffels VM, 1998, MOL CELL BIOL, V18, P6305, DOI 10.1128/MCB.18.11.6305; DEGROOT CJ, 1986, BIOCHIM BIOPHYS ACTA, V866, P61, DOI 10.1016/0167-4781(86)90101-6; Dingemanse MA, 1996, HEPATOLOGY, V24, P407; Fossum TW, 2007, SMALL ANIMAL SURG, P531; Gebhardt R, 2007, PROG HISTOCHEM CYTO, V41, P201, DOI 10.1016/j.proghi.2006.12.001; GLUECKSOHNWAELSCH S, 1975, DEV BIOL, V45, P369, DOI 10.1016/0012-1606(75)90075-5; HAUSSINGER D, 1990, BIOCHEM J, V267, P281; Haussinger D, 1990, J PARENTER ENTERAL N, V14, p56S; Heibel SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029527; IMAMURA Y, 1990, FEBS LETT, V260, P119, DOI 10.1016/0014-5793(90)80081-S; Janzen JWG, 1987, J HISTOCHEM CYTOCHEM, V35, P49, DOI 10.1177/35.1.2878950; JANZEN JWG, 1988, J HISTOCHEM CYTOCHEM, V36, P1223, DOI 10.1177/36.10.2458406; JANZEN JWG, 1984, J HISTOCHEM CYTOCHEM, V32, P557, DOI 10.1177/32.6.6373912; Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201; JUNGERMANN K, 1989, PHYSIOL REV, V69, P708, DOI 10.1152/physrev.1989.69.3.708; Koga H, 2010, AM J MED GENET A, V152A, P2387, DOI 10.1002/ajmg.a.33566; Krebs H. A., 1964, METABOLIC FATE AMINO, P125; LAMERS WH, 1987, DIFFERENTIATION, V35, P228, DOI 10.1111/j.1432-0436.1987.tb00173.x; MATSUBASA T, 1994, J BIOCHEM, V116, P1044, DOI 10.1093/oxfordjournals.jbchem.a124626; MCINTYRE P, 1985, DNA-J MOLEC CELL BIO, V4, P147, DOI 10.1089/dna.1985.4.147; MEIJER AJ, 1990, PHYSIOL REV, V70, P701, DOI 10.1152/physrev.1990.70.3.701; MEYER HP, 1994, RES VET SCI, V57, P58, DOI 10.1016/0034-5288(94)90082-5; MEYER HP, 1995, VET REC, V136, P13, DOI 10.1136/vr.136.1.13; MOORMAN AFM, 1990, HISTOCHEM J, V22, P457, DOI 10.1007/BF01007229; MOORMAN AFM, 1989, HEPATOLOGY, V9, P367, DOI 10.1002/hep.1840090305; MORRIS SM, 1989, ARCH BIOCHEM BIOPHYS, V269, P175, DOI 10.1016/0003-9861(89)90097-0; MORRIS SM, 1988, BIOCHEM GENET, V26, P769, DOI 10.1007/BF02395522; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; MULTHAUPT H, 1987, HISTOCHEMISTRY, V87, P465, DOI 10.1007/BF00496818; Notenboom RGE, 1996, DEVELOPMENT, V122, P321; POWERSLEE SG, 1987, J BIOL CHEM, V262, P15683; RABIER D, 1983, BIOCHIMIE, V65, P1, DOI 10.1016/S0300-9084(83)80022-4; Roskams T., 2007, MACSWEENS PATHOLOGY, V1, P1; ROTHUIZEN J, 1982, RES VET SCI, V33, P22, DOI 10.1016/S0034-5288(18)32353-1; RUPPERT S, 1992, GENE DEV, V6, P1430, DOI 10.1101/gad.6.8.1430; SHIOJIRI N, 1995, LAB INVEST, V72, P740; SIGSGAARD I, 1988, LIVER, V8, P193; Stringer MD, 2008, CLIN ANAT, V21, P147, DOI 10.1002/ca.20574; Takiguchi M, 1995, BIOCHEM J, V312, P649, DOI 10.1042/bj3120649; Tobias KM, 2003, J AM VET MED ASSOC, V223, P1636, DOI 10.2460/javma.2003.223.1636; TOBIAS KM, 2003, TXB SMALL ANIMAL SUR, P727; TOMOMURA M, 1992, BIOCHIM BIOPHYS ACTA, V1138, P167, DOI 10.1016/0925-4439(92)90058-U; TOMOMURA M, 1994, BBA-MOL BASIS DIS, V1226, P307, DOI 10.1016/0925-4439(94)90042-6; TONJES RR, 1992, EMBO J, V11, P127, DOI 10.1002/j.1460-2075.1992.tb05035.x; Torre C, 2011, INT J BIOCHEM CELL B, V43, P271, DOI 10.1016/j.biocel.2009.11.004; Torre C, 2010, PROG MOL BIOL TRANSL, V97, P127, DOI 10.1016/B978-0-12-385233-5.00005-2; Ubbink GJ, 1998, AM J VET RES, V59, P1553; Ubbink GJ, 1998, VET REC, V142, P209, DOI 10.1136/vr.142.9.209; Uchino T, 1999, J PEDIATR-US, V135, P254, DOI 10.1016/S0022-3476(99)70031-4; van Steenbeek FG, 2009, J VET INTERN MED, V23, P950, DOI 10.1111/j.1939-1676.2009.0319.x; van Steenbeek FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057662; van Steenbeek FG, 2012, MAMM GENOME, V23, P76, DOI 10.1007/s00335-011-9364-0; van Straten G, 2005, J VET INTERN MED, V19, P321, DOI 10.1892/0891-6640(2005)19[321:ICEPSI]2.0.CO;2; VANDENINGH TSGAM, 1995, VET QUART, V17, P70, DOI 10.1080/01652176.1995.9694536; Wolschrijn CF, 2000, VET QUART, V22, P94, DOI 10.1080/01652176.2000.9695032; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; YOKOTA S, 1986, HISTOCHEM J, V18, P451, DOI 10.1007/BF01675338	63	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100077	10.1371/journal.pone.0100077	http://dx.doi.org/10.1371/journal.pone.0100077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945279	gold, Green Published, Green Submitted			2022-12-25	WOS:000340721500043
J	Yu, DD; Xu, L; Liu, XH; Fan, Y; Lu, LB; Yao, YG				Yu, Dandan; Xu, Ling; Liu, Xiao-Hong; Fan, Yu; Lu, Long-Bao; Yao, Yong-Gang			Diverse Interleukin-7 mRNA Transcripts in Chinese Tree Shrew (Tupaia belangeri chinensis)	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; PHYLOGENETIC POSITION; EXPRESSION ANALYSIS; IL-7; CELLS; CLONING; MURINE; VIRUS; IDENTIFICATION; TRANSDUCTION	Interleukin-7 (IL7) is a pleiotropic cytokine that is actively involved in the immune system. The Chinese tree shrew (Tupaia belangeri chinensis) has been proposed as an alternative experimental animal to primates in biomedical research. However, there is a lack of biological knowledge about the immune system of the tree shrew. In this study, we cloned the IL7 gene (tIL7) in the Chinese tree shrew and quantified the expression of mRNA transcripts in eight tissues (heart, liver, spleen, lung, kidney, intestine, skeletal muscle and brain) from 20 individuals. Eleven tIL7 mRNA transcripts were identified in different tissues. The canonical form (tIL7c) had a length of 1817 bp and encoded a predicted gene product with 177 amino acids. Phylogenetic analyses based on the amino acid sequences revealed a considerably large genetic difference between tree shrew and human. Quantification of mRNA expression of transcripts tIL7c, tIL7-sv1, tIL7-sv2 and tIL7-sv3 showed that these transcripts were expressed in all tissues, albeit the expression levels varied in different tissues. Transcripts tIL7c, tIL7-sv1, and tIL7-sv2 had the lowest expression in brain, and tIL7-sv3 had a dramatically high mRNA expression in skeletal muscle and heart. The mRNA expression levels of tIL7c and tIL7-sv1 were significantly increased upon ploy(I: C) stimulation in tree shrew primary renal cells. As with human full-length IL7, tIL7c, tIL7-sv1, tIL7-sv2 and tIL7-sv3 showed similar a subcellular localization pattern. Our results identified diverse tIL7 transcripts in the Chinese tree shrew, which may play a potential role in modulating IL7-regulated biological effects.	[Yu, Dandan; Xu, Ling; Liu, Xiao-Hong; Fan, Yu; Yao, Yong-Gang] Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Xu, Ling; Fan, Yu; Yao, Yong-Gang] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China; [Lu, Long-Bao; Yao, Yong-Gang] Chinese Acad Sci, Kunming Inst Zool, Expt Anim Core Facil, Kunming, Peoples R China; [Lu, Long-Bao; Yao, Yong-Gang] Chinese Acad Sci, Kunming Inst Zool, Kunming Primate Res Ctr, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology	Yao, YG (corresponding author), Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China.	ygyaozh@gmail.com	Yao, Yong-Gang/AAH-2303-2021; hong, liu/AAW-5380-2021	Yao, Yong-Gang/0000-0002-2955-0693; Liu, Xiaohong/0000-0002-5420-2391; Fan, Yu/0000-0002-5978-5004	National 863 Project of China [2012AA021801, 2012AA022402]; Chinese Academy of Sciences [KSCX2-EW-R-11, KSCX2-EW-J23]; Yunnan Province [2013FB071]	National 863 Project of China(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Yunnan Province	This study was supported by the National 863 Project of China (2012AA021801 and 2012AA022402) and grants from Chinese Academy of Sciences (KSCX2-EW-R-11, KSCX2-EW-J23 and One-Three-Five Strategic Planning Project) and Yunnan Province (2013FB071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpdogan O, 2005, TRENDS IMMUNOL, V26, P56, DOI 10.1016/j.it.2004.11.002; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Alves NL, 2009, P NATL ACAD SCI USA, V106, P1512, DOI 10.1073/pnas.0809559106; Amako Y, 2010, J VIROL, V84, P303, DOI 10.1128/JVI.01448-09; Arrode-Bruses G, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-83; BARCHAM GJ, 1995, GENE, V154, P265, DOI 10.1016/0378-1119(94)00857-O; Brack M, 1998, J COMP PATHOL, V118, P301, DOI 10.1016/S0021-9975(07)80006-5; Cao J, 2003, J MED PRIMATOL, V32, P123, DOI 10.1034/j.1600-0684.2003.00022.x; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Chen Shi-Yi, 2011, Zoological Research, V32, P17, DOI 10.3724/SP.J.1141.2011.01017; Cook RF, 2008, VET IMMUNOL IMMUNOP, V125, P126, DOI 10.1016/j.vetimm.2008.05.006; Fan Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2416; Fuchs E., 2010, The UFAW handbook on the care and management of laboratory and other research animals, P262; GOODWIN RG, 1989, P NATL ACAD SCI USA, V86, P302, DOI 10.1073/pnas.86.1.302; Hara T, 2012, J IMMUNOL, V189, P1577, DOI 10.4049/jimmunol.1200586; Haugen F, 2010, AM J PHYSIOL-CELL PH, V298, pC807, DOI 10.1152/ajpcell.00094.2009; HEUFLER C, 1993, J EXP MED, V178, P1109, DOI 10.1084/jem.178.3.1109; Jiang Q, 2005, CYTOKINE GROWTH F R, V16, P513, DOI 10.1016/j.cytogfr.2005.05.004; Jin JO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077605; Kock J, 2001, J VIROL, V75, P5084, DOI 10.1128/JVI.75.11.5084-5089.2001; Kono T, 2008, FEBS J, V275, P1213, DOI 10.1111/j.1742-4658.2008.06281.x; Kroemer RT, 1996, PROTEIN ENG, V9, P493, DOI 10.1093/protein/9.6.493; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lum JJ, 2004, J VIROL, V78, P6033, DOI 10.1128/JVI.78.11.6033-6042.2004; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Mazzucchelli RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007637; Milne CD, 2006, SEMIN IMMUNOL, V18, P20, DOI 10.1016/j.smim.2005.10.003; Moors M, 2010, GENES IMMUN, V11, P11, DOI 10.1038/gene.2009.77; Murphy WJ, 2004, TRENDS GENET, V20, P631, DOI 10.1016/j.tig.2004.09.005; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; Or R, 1998, CYTOKINES CELL MOL T, V4, P287; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Peng YZ, 1991, BIOL CHINESE TREE SH, P46; RABB GB, 1966, DIABETES, V15, P327, DOI 10.2337/diab.15.5.327; Repass JF, 2009, GENESIS, V47, P281, DOI 10.1002/dvg.20497; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSEN A, 1985, MED MICROBIOL IMMUN, V173, P257, DOI 10.1007/BF02124943; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Shalapour S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031939; Siewe BT, 2010, DEV COMP IMMUNOL, V34, P828, DOI 10.1016/j.dci.2010.03.003; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Takahashi K, 1997, HUM IMMUNOL, V55, P103, DOI 10.1016/S0198-8859(97)00094-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ueha S, 2001, BBA-GENE STRUCT EXPR, V1517, P468, DOI 10.1016/S0167-4781(00)00304-3; Vudattu NK, 2009, GENES IMMUN, V10, P132, DOI 10.1038/gene.2008.90; WATANABE M, 1995, J CLIN INVEST, V95, P2945, DOI 10.1172/JCI118002; Xu Lin, 2013, Zoological Research, V34, P59, DOI 10.3724/SP.J.1141.2013.02059; Xu Ling, 2013, Zoological Research, V34, P70, DOI 10.3724/SP.J.1141.2013.02070; Xu L, 2012, J GENET GENOMICS, V39, P131, DOI 10.1016/j.jgg.2012.02.003; Yan R, 1984, J GUANGXI MED U, V1, P10; Yan RQ, 1996, J CANCER RES CLIN, V122, P283, DOI 10.1007/BF01261404; Yu Q, 2006, J EXP MED, V203, P165, DOI 10.1084/jem.20051836	52	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99859	10.1371/journal.pone.0099859	http://dx.doi.org/10.1371/journal.pone.0099859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945249	Green Published, gold, Green Submitted			2022-12-25	WOS:000340721500030
J	Yuasa, D; Ohashi, K; Shibata, R; Takeshita, K; Kikuchi, R; Takahashi, R; Kataoka, Y; Miyabe, M; Joki, Y; Kambara, T; Uemura, Y; Matsuo, K; Hayakawa, S; Hiramatsu-Ito, M; Ito, M; Ikeda, N; Murohara, T; Ouchi, N				Yuasa, Daisuke; Ohashi, Koji; Shibata, Rei; Takeshita, Kyosuke; Kikuchi, Ryosuke; Takahashi, Ryotaro; Kataoka, Yoshiyuki; Miyabe, Megumi; Joki, Yusuke; Kambara, Takahiro; Uemura, Yusuke; Matsuo, Kazuhiro; Hayakawa, Satoko; Hiramatsu-Ito, Mizuho; Ito, Masanori; Ikeda, Nobuo; Murohara, Toyoaki; Ouchi, Noriyuki			Association of Circulating C1q/TNF-Related Protein 1 Levels with Coronary Artery Disease in Men	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; RISK-FACTORS; INFLAMMATORY DISEASE; ADIPOSE-TISSUE; OBESITY; EXPRESSION; CTRP1; ADIPOKINE	Objective: Obesity is a major risk factor for cardiovascular disease. Recent evidence demonstrates that dysregulation of fat-derived hormones, also known as adipokines, is linked with the pathogenesis of obesity-related disorders including coronary artery disease (CAD). Here, we investigated whether circulating level of an adipokine C1q/TNF-related protein (CTRP) 1 is associated with the prevalence of CAD. Methods and Results: Consecutive 76 male CAD patients were enrolled from inpatients that underwent coronary angiography. Sixty four healthy male subjects served as controls. Plasma CTRP1 concentration was determined by enzyme-linked immunosorbent assay. CTRP1 levels were correlated positively with systolic blood pressure (BP) and triglyceride levels, and negatively with HDL cholesterol levels in all subjects. Plasma levels of CTRP1 were significantly higher in CAD patients than in control subjects (CAD: 443.3 +/- 18.6 ng/ml, control: 307.8 +/- 21.5 ng/ml, p<0.001). Multiple logistic regression analysis with body mass index, systolic BP, glucose, total cholesterol, HDL cholesterol, triglyceride, adiponectin and CTRP1 revealed that CTRP1 levels, together with systolic BP and HDL cholesterol, correlated with CAD. Conclusions: Our data indicate the close association of high CTRP1 levels with CAD prevalence, suggesting that CTRP1 represents a novel biomarker for CAD.	[Yuasa, Daisuke; Shibata, Rei; Takeshita, Kyosuke; Kikuchi, Ryosuke; Kataoka, Yoshiyuki; Miyabe, Megumi; Joki, Yusuke; Kambara, Takahiro; Uemura, Yusuke; Matsuo, Kazuhiro; Hayakawa, Satoko; Hiramatsu-Ito, Mizuho; Ito, Masanori; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan; [Ohashi, Koji; Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Nagoya, Aichi 4648601, Japan; [Takahashi, Ryotaro; Ikeda, Nobuo] Chunichi Hosp, Dept Cardiol, Nagoya, Aichi, Japan	Nagoya University; Nagoya University	Ohashi, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Nagoya, Aichi 4648601, Japan.	ohashik@med.nagoya-u.ac.jp; nouchi@med.nagoya-u.ac.jp	Kikuchi, Ryosuke/AAX-4971-2021; Takeshita, Kyosuke/B-7008-2012; OUCHI, Noriyuki/I-7306-2014; Murohara, Toyoaki/M-4958-2014; OHASHI, Koji/I-7307-2014; Takeshita, Kyosuke/AAD-9515-2020	Takeshita, Kyosuke/0000-0002-8283-3799; Takeshita, Kyosuke/0000-0002-8283-3799; Hiramatsu-Ito, Mizuho/0000-0003-1740-1794	Takeda Science Foundation; Uehara Memorial Foundation; Daiichi-Sankyo Foundation of Life Science; SENSHIN Medical Research Foundation; Suzuken Memorial Foundation	Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Daiichi-Sankyo Foundation of Life Science; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Suzuken Memorial Foundation	This work was supported by Grant-in-Aid for Scientific Research, Grant-in-Aid for Challenging Exploratory Research and grants from Takeda Science Foundation, the Uehara Memorial Foundation, Daiichi-Sankyo Foundation of Life Science, and SENSHIN Medical Research Foundation to N. Ouchi. R. Shibata was supported with the Grant-in-Aid for Young Scientists B and the Uehara Memorial Foundation. K. Ohashi was supported with the Grant-in-Aid for Scientific Research C and Suzuken Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Chalupova L, 2013, CLIN BIOCHEM, V46, P73, DOI 10.1016/j.clinbiochem.2012.09.006; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jeon JH, 2008, FASEB J, V22, P1502, DOI 10.1096/fj.07-9412com; Kastorini CM, 2013, AM J CARDIOL, V112, P349, DOI 10.1016/j.amjcard.2013.03.039; Kim KY, 2006, FEBS LETT, V580, P3953, DOI 10.1016/j.febslet.2006.06.034; Lasser G, 2006, BLOOD, V107, P423, DOI 10.1182/blood-2005-04-1425; Liu LJ, 2014, AM J CARDIOL, V113, P84, DOI 10.1016/j.amjcard.2013.08.042; Long Y, 2013, AM J CARDIOL, V111, P68, DOI 10.1016/j.amjcard.2012.08.045; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Shibata R, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-37; Shibata R, 2011, ATHEROSCLEROSIS, V219, P811, DOI 10.1016/j.atherosclerosis.2011.08.017; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101	24	39	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99846	10.1371/journal.pone.0099846	http://dx.doi.org/10.1371/journal.pone.0099846			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945145	gold, Green Published, Green Submitted			2022-12-25	WOS:000340721500029
J	Chang, SW; Fann, CSJ; Su, WH; Wang, YC; Weng, CC; Yu, CJ; Hsu, CL; Hsieh, AR; Chien, RN; Chu, CM; Tai, DI				Chang, Su-Wei; Fann, Cathy Shen-Jang; Su, Wen-Hui; Wang, Yu Chen; Weng, Chia Chan; Yu, Chia-Jung; Hsu, Chia-Lin; Hsieh, Ai-Ru; Chien, Rong-Nan; Chu, Chia-Ming; Tai, Dar-In			A Genome-Wide Association Study on Chronic HBV Infection and Its Clinical Progression in Male Han-Taiwanese	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; PEGINTERFERON ALPHA-2A; LAMIVUDINE TREATMENT; COST-EFFECTIVENESS; ENTECAVIR THERAPY; POLYMORPHISMS; GENE; PREVALENCE; EXPRESSION; RELATIVES	It is common to observe the clustering of chronic hepatitis B surface antigen (HBsAg) carriers in families. Intra-familial transmission of hepatitis B virus (HBV) could be the reason for the familial clustering of HBsAg carriers. Additionally, genetic and gender factors have been reported to be involved. We conducted a three-stage genome-wide association study to identify genetic factors associated with chronic HBV susceptibility. A total of 1,065 male controls and 1,623 male HBsAg carriers were included. The whole-genome genotyping was done on Illumina HumanHap550 beadchips in 304 healthy controls and HumanHap610 beadchips in 321 cases. We found that rs9277535 (HLA-DPB1, P = 4.87x10(-14)), rs9276370 (HLA-DQA2, P = 1.9x10(-12)), rs7756516 and rs7453920 (HLA-DQB2, P = 1.48610(-11) and P = 6.66x10(-15) respectively) were significantly associated with persistent HBV infection. A novel SNP rs9366816 near HLA-DPA3 also showed significant association (P = 2.58x10(-10)). The "T-T-G-G-T" haplotype of the five SNPs further signified their association with the disease (P = 1.48x10(-12); OR = 1.49). The "T-T" haplotype composed of rs7756516 and rs9276370 was more prevalent in severe disease subgroups and associated with non-sustained therapeutic response (P = 0.0262). The "G-C" haplotype was associated with sustained therapeutic response (P = 0.0132; OR = 2.49). We confirmed that HLA-DPB1, HLA-DQA2 and HLA-DQB2 loci were associated with persistent HBV infection in male Taiwan Han-Chinese. In addition, the HLA-DQA2 and -DQB2 complex was associated with clinical progression and therapeutic response.	[Chang, Su-Wei] Chang Gung Univ, Coll Med, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan; [Fann, Cathy Shen-Jang; Hsu, Chia-Lin] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Su, Wen-Hui] Chang Gung Univ, Chang Gung Mol Med Res Ctr, Grad Inst Biomed Sci, Dept Biomed Sci, Taoyuan, Taiwan; [Wang, Yu Chen; Weng, Chia Chan; Chien, Rong-Nan; Chu, Chia-Ming; Tai, Dar-In] Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Div Hepatol, Linkou, Taiwan; [Yu, Chia-Jung] Chang Gung Univ, Coll Med & Mol Med, Res Ctr, Dept Cell & Mol Biol, Taoyuan, Taiwan; [Hsieh, Ai-Ru] China Med Univ, Grad Inst Biostat, Taichung, Taiwan	Chang Gung University; Academia Sinica - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; China Medical University Taiwan	Tai, DI (corresponding author), Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Div Hepatol, Linkou, Taiwan.	tai48978@adm.cgmh.org.tw	Fann, Cathy SJ/F-9410-2010	Fann, Cathy SJ/0000-0001-9025-2276; HSIEH, AIRU/0000-0003-3900-9101; HSU, CHIA-LIN/0000-0001-5785-0733; Su, Wen-Hui/0000-0003-1037-4615	Chang Gung Memorial hospital [CMRPG360771-3, CMRPG3B0221]; National Science Council, Taipei Taiwan [NSC101-2314-B-182A-025-MY3, NSC102-2314-B-001-003-MY2]	Chang Gung Memorial hospital(Chang Gung Memorial Hospital); National Science Council, Taipei Taiwan	This study was supported by grants from the Chang Gung Memorial hospital (CMRPG360771-3 and CMRPG3B0221) and the National Science Council (NSC101-2314-B-182A-025-MY3 and NSC102-2314-B-001-003-MY2), Taipei Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qahtani AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080445; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BEASLEY RP, 1982, J INFECT DIS, V146, P198, DOI 10.1093/infdis/146.2.198; BURK RD, 1994, J INFECT DIS, V170, P1418, DOI 10.1093/infdis/170.6.1418; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; Chen CC, 2005, INT J EPIDEMIOL, V34, P1310, DOI 10.1093/ije/dyi191; Chen CH, 2004, J HEPATOL, V40, P653, DOI 10.1016/j.jhep.2003.12.002; CHUNG DC, 1988, J MED VIROL, V26, P411, DOI 10.1002/jmv.1890260408; Dai CY, 2013, J ANTIMICROB CHEMOTH, V68, P2332, DOI 10.1093/jac/dkt193; de Man RA, 2001, HEPATOLOGY, V34, P578, DOI 10.1053/jhep.2001.26815; Hu ZB, 2013, NAT GENET, V45, P1499, DOI 10.1038/ng.2809; Jeng WJ, 2013, HEPATOLOGY, V58, P1888, DOI 10.1002/hep.26549; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Liaw YF, 2011, HEPATOLOGY, V54, P1591, DOI 10.1002/hep.24555; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; LINCHU M, 1990, TRANSFUSION, V30, P471, DOI 10.1046/j.1537-2995.1990.30590296383.x; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; O'Brien TR, 2011, GENES IMMUN, V12, P428, DOI 10.1038/gene.2011.11; Pan LP, 2014, HUM MOL GENET, V23, P2210, DOI 10.1093/hmg/ddt586; Pan WH, 2006, HUM HERED, V61, P27, DOI 10.1159/000091834; Shaw CK, 1999, TISSUE ANTIGENS, V53, P51, DOI 10.1034/j.1399-0039.1999.530106.x; Singh R, 2007, WORLD J GASTROENTERO, V13, P1770, DOI 10.3748/wjg.v13.i12.1770; Stephens R, 1999, J MOL BIOL, V291, P789, DOI 10.1006/jmbi.1999.3004; Sullivan SD, 2007, J GASTROEN HEPATOL, V22, P1494, DOI 10.1111/j.1440-1746.2006.04539.x; SUNG J-L, 1977, Gastroenterologia Japonica, V12, P58; Tai DI, 2010, AM J GASTROENTEROL, V105, P1102, DOI 10.1038/ajg.2009.669; Tai DI, 2009, HEPATOLOGY, V49, P1859, DOI 10.1002/hep.22878; Tai DI, 2002, J GASTROEN HEPATOL, V17, P682, DOI 10.1046/j.1440-1746.2002.02747.x; Tai DI, 1999, AM J TROP MED HYG, V61, P716, DOI 10.4269/ajtmh.1999.61.716; Thomas R, 2012, J VIROL, V86, P6979, DOI 10.1128/JVI.00406-12; Tsay Pei-Kwei, 2009, Chang Gung Med J, V32, P155; Veenstra DL, 2008, VALUE HEALTH, V11, P131, DOI 10.1111/j.1524-4733.2007.00221.x; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017608; Yu MW, 2003, J NATL CANCER I, V95, P1485, DOI 10.1093/jnci/djg051	35	46	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99724	10.1371/journal.pone.0099724	http://dx.doi.org/10.1371/journal.pone.0099724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940741	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200038
J	Kovac, M; Bauer, A; Stahl, G				Kovac, Marko; Bauer, Arthur; Stahl, Goran			Merging National Forest and National Forest Health Inventories to Obtain an Integrated Forest Resource Inventory - Experiences from Bavaria, Slovenia and Sweden	PLOS ONE			English	Article							STATISTICAL POWER; EUROPE	Backgrounds, Material and Methods: To meet the demands of sustainable forest management and international commitments, European nations have designed a variety of forest-monitoring systems for specific needs. While the majority of countries are committed to independent, single-purpose inventorying, a minority of countries have merged their single-purpose forest inventory systems into integrated forest resource inventories. The statistical efficiencies of the Bavarian, Slovene and Swedish integrated forest resource inventory designs are investigated with the various statistical parameters of the variables of growing stock volume, shares of damaged trees, and deadwood volume. The parameters are derived by using the estimators for the given inventory designs. The required sample sizes are derived via the general formula for non-stratified independent samples and via statistical power analyses. The cost effectiveness of the designs is compared via two simple cost effectiveness ratios. Results: In terms of precision, the most illustrative parameters of the variables are relative standard errors; their values range between 1% and 3% if the variables' variations are low (s%<80%) and are higher in the case of higher variations. A comparison of the actual and required sample sizes shows that the actual sample sizes were deliberately set high to provide precise estimates for the majority of variables and strata. In turn, the successive inventories are statistically efficient, because they allow detecting the mean changes of variables with powers higher than 90%; the highest precision is attained for the changes of growing stock volume and the lowest for the changes of the shares of damaged trees. Two indicators of cost effectiveness also show that the time input spent for measuring one variable decreases with the complexity of inventories. Conclusion: There is an increasing need for credible information on forest resources to be used for decision making and national and international policy making. Such information can be cost-efficiently provided through integrated forest resource inventories.	[Kovac, Marko] Slovenian Forestry Inst, Dept Forest & Landscape Planning & Monitoring, Ljubljana, Slovenia; [Bauer, Arthur] Bavarian State Minist Food Agr & Forestry, Div Forestry, Dept Food Agr & Forestry Cham, Waldmunchen, Germany; [Stahl, Goran] Swedish Univ Agr Sci SLU, Dept Forest Resource Management, Umea, Sweden	Slovenian Forestry Institute; Swedish University of Agricultural Sciences	Kovac, M (corresponding author), Slovenian Forestry Inst, Dept Forest & Landscape Planning & Monitoring, Vecna Pot 2, Ljubljana, Slovenia.	marko.kovac@gozdis.si			project JGS 4 (MAE); research program PS 1001 (SRA)	project JGS 4 (MAE); research program PS 1001 (SRA)	The Slovene part of research was financed by the project JGS 4 (MAE; http://www.mko.gov.si/en/areas_of_work/forestry/) and the research program PS 1001 (SRA; http://www.arrs.gov.si/en/dobrodoslica.asp). The Bavarian and Swedish parts of research were part of regular research activities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrini MC, 2009, J ENVIRON MONITOR, V11, P782, DOI 10.1039/b818170p; [Anonymous], 2004, MEMORANDUM UNDERSTAN; Axelsson AL, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P541, DOI 10.1007/978-90-481-3233-1_35; Barth A, 2006, SCAND J FOREST RES, V21, P94, DOI 10.1080/14004080500486922; Bechtold WA, 2005, SRS80 GTR USDAF FOR; Bernasconi A, 1996, BEIHEFT SCHWEIZ FORS, V76; Bernstein S., 1999, SCHAUMS OUTLINE SERI; Braun Von R, 1975, ALLG FORST JAGDZTG, V146, P2; Cerny M, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P145, DOI 10.1007/978-90-481-3233-1_8; Chirici G, 2012, FOREST SCI, V58, P257, DOI 10.5849/forsci.12-003; Christensen P, 2013, ENVIRON MONIT ASSESS, V185, P7279, DOI 10.1007/s10661-013-3100-z; CLRTAP, 1979, 1979 GEN CONV LONG R; Cochran WG., 1963, SAMPLING TECHNIQUES; *COST E43, 2007, HARM NAT FOR INV EUR; De Vries P.G., 1986, SAMPLING THEORY FORE; DETSKY AS, 1990, ANN INTERN MED, V113, P147, DOI 10.7326/0003-4819-113-2-147; Eichhorn J., 2016, UNECE ICP FOR PROGR; FAO, 2010, 163 FAO; FECS, 2012, FOR FOR SYST COND SU; Ferretti M, 2010, IFOREST, V3, P1, DOI 10.3832/ifor0518-003; Forest Europe, 2013, IMPR PAN EUR IND SUS; Foster JR, 2001, FOREST ECOL MANAG, V151, P211, DOI 10.1016/S0378-1127(01)00591-6; Gillis MD, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P97; Gillis MD, 2001, ENVIRON MONIT ASSESS, V67, P121, DOI 10.1023/A:1006405820244; Gschwantner T, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P57; Gulder HJ, 1993, FORSTLICHE FORSCHUNG, V132; Hladnik D, 2012, RES REPORTS FORESTRY, V97, P31; Hocevar M., 2003, Obmocni gozdnogospodarski nacrti in razvojne perspektive slovenskega gozdarstva: zbornik referatov XXI. gozdarski studijski dnevi, 27-28 marec 2003, P103; Hocevar M., 2002, Zbornik Gozdarstva in Lesarstva, P119; Hocevar M, 1997, RES REPORTS FORESTRY, V52, P93; KANDLER O, 1992, ENVIRON TOXICOL CHEM, V11, P1077, DOI [10.1897/1552-8618(1992)11[1077:HDADOC]2.0.CO;2, 10.1002/etc.5620110805]; Kennel E, 1983, FORSTLICHE FORSCHUNG, V57; Kovac M, 2010, STUDIA FORESTALIA SL, V136, P7; Kovac M, 2009, OHRANITVENO GOSPODAR, P46; Kovac M, 2010, STUDIA FORESTALIA SL, V136, P23; Kruger S, 1994, BERICHTE BAYERISCHEN; Kusar G, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P505, DOI 10.1007/978-90-481-3233-1_33; Loetsch F., 1964, FOREST INVENTORY, V1; Matern B, 1960, MEDDELANDEN FRAN STA, V49; McRoberts RE, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P567, DOI 10.1007/978-90-481-3233-1_37; Muller-Edzards C, 1997, STUDIES TEMPORAL DEV; Phillips C, 2009, WHAT IS COST EFFECTI; Polley H, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P223, DOI 10.1007/978-90-481-3233-1_13; Schieck J, 2002, STAT POWER ALBERTA F; Schnell A, 2005, ZWEITE BUNDESWALDINV, V49; Schreuder H.T., 1993, SAMPLING METHODS MUL; Schreuder HT, 2004, RMRSRN17 USDAF FOR S; Skogsdata, 2012, FOR STAT 2012; Solar M, 1985, POSKODBE GOZDOV ZARA; StatSoft Inc., 2011, STAT DAT AN SOFTW SY; Taylor LB, 1993, CONSERV BIOL, V7, P489; Thorell K. E., 1931, J FOREST, V4, P585; Tomppo E, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P185, DOI 10.1007/978-90-481-3233-1_11; Tomppo E, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P1, DOI 10.1007/978-90-481-3233-1_1; Tomppo EO, 2012, FOREST SCI, V58, P191, DOI 10.5849/forsci.10-091; Tzschupke W, 1986, ALLG FORST Z, V41, P790; Wagner F., 2003, IPCC GOOD PRACTICE G; Zohrer F, 1980, FORTSTINVENTUR LEITF	58	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100157	10.1371/journal.pone.0100157	http://dx.doi.org/10.1371/journal.pone.0100157			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941120	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200077
J	Schulze, M; Junkes, C; Mueller, P; Speck, S; Ruediger, K; Dathe, M; Mueller, K				Schulze, Martin; Junkes, Christof; Mueller, Peter; Speck, Stephanie; Ruediger, Karin; Dathe, Margitta; Mueller, Karin			Effects of Cationic Antimicrobial Peptides on Liquid-Preserved Boar Spermatozoa	PLOS ONE			English	Article							PLASMA-MEMBRANE; TRYPTOPHAN-RICH; ARGININE-RICH; IN-VITRO; SPERM; PHOSPHOLIPIDS; CAPACITATION; CHOLESTEROL; MECHANISMS; SEMEN	Antibiotics are mandatory additives in semen extenders to control bacterial contamination. The worldwide increase in resistance to conventional antibiotics requires the search for alternatives not only for animal artificial insemination industries, but also for veterinary and human medicine. Cationic antimicrobial peptides are of interest as a novel class of antimicrobial additives for boar semen preservation. The present study investigated effects of two synthetic cyclic hexapeptides (c-WFW, c-WWW) and a synthetic helical magainin II amide derivative (MK5E) on boar sperm during semen storage at 16 degrees C for 4 days. The standard extender, Beltsville Thawing Solution (BTS) containing 250 mu g/mL gentamicin (standard), was compared to combinations of BTS with each of the peptides in a split-sample procedure. Examination revealed peptide-and concentration-dependent effects on sperm integrity and motility. Negative effects were more pronounced for MK5E than in hexapeptide-supplemented samples. The cyclic hexapeptides were partly able to stimulate a linear progressive sperm movement. When using low concentrations of cyclic hexapeptides (4 mu M c-WFW, 2 mM c-WWW) sperm quality was comparable to the standard extender over the course of preservation. C-WFW-supplemented boar semen resulted in normal fertility rates after AI. In order to investigate the interaction of peptides with the membrane, electron spin resonance spectroscopic measurements were performed using spin-labeled lipids. C-WWW and c-WFW reversibly immobilized an analog of phosphatidylcholine (PC), whereas MK5E caused an irreversible increase of PC mobility. These results suggest testing the antimicrobial efficiency of non-toxic concentrations of selected cyclic hexapeptides as potential candidates to supplement/replace common antibiotics in semen preservation.	[Schulze, Martin; Ruediger, Karin] Inst Reprod Farm Anim Schonow Inc, Bernau, Brandenburg, Germany; [Junkes, Christof; Dathe, Margitta] Leibniz Inst Mol Pharmacol, Berlin, Germany; [Mueller, Peter] Humboldt Univ, Dept Biol, Berlin, Germany; [Speck, Stephanie] Univ Leipzig, Inst Anim Hyg & Vet Publ Hlth, D-04109 Leipzig, Sachsen, Germany; [Mueller, Karin] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Humboldt University of Berlin; Leipzig University; Leibniz Institut fur Zoo und Wildtierforschung	Schulze, M (corresponding author), Inst Reprod Farm Anim Schonow Inc, Bernau, Brandenburg, Germany.	m.schulze@ifn-schoenow.de	郑, 丽丽/HGE-2239-2022; Schulze, Martin/AAR-3244-2020		AiF Inc. [PRO INNO II: KF0140502MD6]; Association for Biotechnology Research (FBF) Germany	AiF Inc.; Association for Biotechnology Research (FBF) Germany	This research was partially supported by the AiF Inc. PRO INNO II: KF0140502MD6 and by the Association for Biotechnology Research (FBF) Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althouse GC, 2005, THERIOGENOLOGY, V63, P573, DOI 10.1016/j.theriogenology.2004.09.031; Appelt C, 2005, CHEMBIOCHEM, V6, P1654, DOI 10.1002/cbic.200500095; Bagheri M, 2011, ANTIMICROB AGENTS CH, V55, P788, DOI 10.1128/AAC.01098-10; Broekhuijse MLWJ, 2012, J ANIM SCI, V90, P779, DOI 10.2527/jas.2011-4311; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Choi YH, 1998, BIOL REPROD, V59, P1328, DOI 10.1095/biolreprod59.6.1328; Clara A, 2004, FERTIL STERIL, V81, P1357, DOI 10.1016/j.fertnstert.2003.09.073; Clinical and Laboratory Standards Institute (CLSI), 2008, M31A3 CLSI, V28; Conover WJ, 1999, PRACTICAL NONPARAMET, P367; Dathe M, 2004, BIOCHEMISTRY-US, V43, P9140, DOI 10.1021/bi035948v; Dathe M, 2001, FEBS LETT, V501, P146, DOI 10.1016/S0014-5793(01)02648-5; DEWAAL A, 1991, FEBS LETT, V293, P219, DOI 10.1016/0014-5793(91)81191-A; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Fellmann P, 1994, Methods Mol Biol, V27, P161; Hancock R. E. W., 2002, Current Drug Targets - Infectious Disorders, V2, P79, DOI 10.2174/1568005024605855; Junkes C, 2008, J PEPT SCI, V14, P535, DOI 10.1002/psc.940; Junkes C, 2011, EUR BIOPHYS J BIOPHY, V40, P515, DOI 10.1007/s00249-011-0671-x; Kurz A, 2005, REPRODUCTION, V130, P615, DOI 10.1530/rep.1.00561; Lohner K, 2005, COMB CHEM HIGH T SCR, V8, P241, DOI 10.2174/1386207053764576; MORSE PD, 1977, BIOCHEM BIOPH RES CO, V77, P1486, DOI 10.1016/S0006-291X(77)80146-0; Mortimer ST, 1997, HUM REPROD, V12, P1006; Muller K, 2008, BIOL REPROD, V78, P390, DOI 10.1095/biolreprod.107.064253; MULLER K, 1994, BIOCHEMISTRY-US, V33, P9968; Muller K, 1997, ADV EXP MED BIOL, V424, P243; Reddy KVR, 1996, CONTRACEPTION, V53, P205, DOI 10.1016/0010-7824(96)00038-8; Rossi LM, 2008, J PHARM SCI-US, V97, P1060, DOI 10.1002/jps.21053; Schulze M, 2013, THERIOGENOLOGY, V80, P990, DOI 10.1016/j.theriogenology.2013.07.026; Schulze M, 2013, ANIM REPROD SCI, V140, P70, DOI 10.1016/j.anireprosci.2013.05.012; Shadan S, 2004, BIOL REPROD, V71, P253, DOI 10.1095/biolreprod.103.026435; Toke O, 2005, BIOPOLYMERS, V80, P717, DOI 10.1002/bip.20286; Waterhouse KE, 2006, REPRODUCTION, V131, P887, DOI 10.1530/rep.1.01049; Wieprecht T, 1997, BIOCHEMISTRY-US, V36, P6124, DOI 10.1021/bi9619987; Yanagimachi R., 1988, P135; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Zhao XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066557	35	26	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100490	10.1371/journal.pone.0100490	http://dx.doi.org/10.1371/journal.pone.0100490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940997	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200103
J	Yim, N; Ryu, SW; Han, EC; Yoon, J; Choi, K; Choi, C				Yim, Nambin; Ryu, Seung-Wook; Han, Eun Chun; Yoon, Jonghee; Choi, Kyungsun; Choi, Chulhee			Mutant Ubiquitin UBB+1 Induces Mitochondrial Fusion by Destabilizing Mitochondrial Fission-Specific Proteins and Confers Resistance to Oxidative Stress-Induced Cell Death in Astrocytic Cells	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISORDERS; ABERRANT UBIQUITIN; MAMMALIAN-CELLS; INHIBITION; PROTEASOME; DYSFUNCTION; BRAIN; HSP70; ACCUMULATION	Mutant ubiquitin UBB+1 is observed in a variety of aging-related neurodegenerative diseases and acts as a potent inhibitor of the ubiquitin proteasome system (UPS). In the present study, we investigated the relationship between impaired UPS (using ectopic expression of UBB+1) and mitochondrial dynamics in astrocytes, which are the most abundant glial cells in the central nervous system. Immunocytochemistry and fluorescence recovery after photobleaching revealed that ectopic expression of UBB+1 induced mitochondrial elongation. We further demonstrated that overexpression of UBB+1 destabilized mitochondrial fission-specific proteins including Drp1, Fis1, and OPA3, but not the mitochondrial fusion-specific proteins Mfn1, Mfn2, and OPA1. The reduction in mitochondrial fission-specific proteins by UBB+1 was prevented by inhibiting the 26 S proteasome using chemical inhibitors, including MG132, lactacystin and epoxomicin. We then assessed the involvement of proteases that target mitochondrial proteins by using various protease inhibitors. Finally, we confirmed that either overexpression of UBB+1 or inhibiting the proteasome can protect astrocytic cells from H2O2-induced cell death compared with control cells. Our results suggest that UBB+1 destabilizes mitochondrial fission-specific proteins, leading to mitochondrial fusion and the subsequent resistance to oxidative stress. We therefore propose a protective role of UBB+1 overexpression or the proteasome inhibition in astrocytes in degenerative brains.	[Yim, Nambin; Ryu, Seung-Wook; Yoon, Jonghee; Choi, Kyungsun; Choi, Chulhee] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Cell Signaling & BioImaging Lab, Taejon 305701, South Korea; [Han, Eun Chun; Choi, Chulhee] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea; [Ryu, Seung-Wook; Choi, Chulhee] Korea Adv Inst Sci & Technol, KI BioCentury, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Choi, K (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Cell Signaling & BioImaging Lab, Taejon 305701, South Korea.	ccbioks@kaist.ac.kr; cchoi@kaist.ac.kr	Choi, Chulhee/C-1642-2011	Choi, Chulhee/0000-0001-5542-9136; Yoon, Jonghee/0000-0003-3886-2792	National Research Foundation of Korea (NRF) - Korean government (MEST) [2012R1A2A4A01007108]	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2012R1A2A4A01007108 to C. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Azem A, 1997, J BIOL CHEM, V272, P20901, DOI 10.1074/jbc.272.33.20901; Calabrese V, 2001, NEUROCHEM RES, V26, P739, DOI 10.1023/A:1010955807739; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Choi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067891; de Pril R, 2004, HUM MOL GENET, V13, P1803, DOI 10.1093/hmg/ddh188; De Vrij FMS, 2001, FASEB J, V15, P2680, DOI 10.1096/fj.01-0438com; Dennissen FJA, 2011, FEBS LETT, V585, P2568, DOI 10.1016/j.febslet.2011.06.037; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Fischer DF, 2009, NEUROBIOL AGING, V30, P847, DOI 10.1016/j.neurobiolaging.2008.06.009; Fischer DF, 2003, FASEB J, V17, P2014, DOI 10.1096/fj.03-0205com; Germain M, 2005, EMBO J, V24, P1546, DOI 10.1038/sj.emboj.7600592; Hayashi M, 2006, NAT MED, V12, P128, DOI 10.1038/nm1327; Hol EM, 2005, TRENDS MOL MED, V11, P488, DOI 10.1016/j.molmed.2005.09.001; Hope AD, 2003, J NEUROCHEM, V86, P394, DOI 10.1046/j.1471-4159.2003.01844.x; Irmler M, 2012, ACTA NEUROPATHOL, V124, P187, DOI 10.1007/s00401-012-1003-7; Itoh K, 2013, TRENDS CELL BIOL, V23, P64, DOI 10.1016/j.tcb.2012.10.006; Kageyama Y, 2011, CURR OPIN CELL BIOL, V23, P427, DOI 10.1016/j.ceb.2011.04.009; Kawai A, 2001, J CELL SCI, V114, P3565; Kienlen-Campard P, 2006, J NEUROSCI RES, V84, P1311, DOI 10.1002/jnr.21025; Ko S, 2010, J BIOL CHEM, V285, P36070, DOI 10.1074/jbc.M110.145219; Lee J, 2010, BIOCHEM BIOPH RES CO, V391, P33, DOI 10.1016/j.bbrc.2009.10.155; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Lindsten K, 2002, J CELL BIOL, V157, P417, DOI 10.1083/jcb.200111034; Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005; Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018; Nedergaard M, 2005, GLIA, V50, P281, DOI 10.1002/glia.20205; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Ryu SW, 2010, CELL MOL LIFE SCI, V67, P2839, DOI 10.1007/s00018-010-0365-z; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Shutt TE, 2013, BBA-MOL CELL RES, V1833, P417, DOI 10.1016/j.bbamcr.2012.05.024; Song S, 2003, MOL CELL, V12, P553, DOI 10.1016/j.molcel.2003.08.005; Tamura Y, 2011, CELL, V145, DOI 10.1016/j.cell.2011.06.018; Tan Z, 2007, CELL DEATH DIFFER, V14, P1721, DOI 10.1038/sj.cdd.4402180; van Leeuwen FW, 2002, INT J BIOCHEM CELL B, V34, P1502, DOI 10.1016/S1357-2725(02)00043-2; van Tijn P, 2007, J CELL SCI, V120, P1615, DOI 10.1242/jcs.03438; van Tijn P, 2012, NEUROCHEM INT, V61, P739, DOI 10.1016/j.neuint.2012.07.007; van Tijn P, 2010, J NEUROSCI RES, V88, P2325, DOI 10.1002/jnr.22396; Voloboueva LA, 2007, J NEUROCHEM, V102, P1383, DOI 10.1111/j.1471-4159.2007.04634.x; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Zhang Y, 2010, J CEREBR BLOOD F MET, V30, P566, DOI 10.1038/jcbfm.2009.228	46	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99937	10.1371/journal.pone.0099937	http://dx.doi.org/10.1371/journal.pone.0099937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941066	gold, Green Submitted, Green Published			2022-12-25	WOS:000338508200055
J	Benod, C; Villagomez, R; Filgueira, CS; Hwang, PK; Leonard, PG; Poncet-Montange, G; Rajagopalan, S; Fletterick, RJ; Gustafsson, JA; Webb, P				Benod, Cindy; Villagomez, Rosa; Filgueira, Carly S.; Hwang, Peter K.; Leonard, Paul G.; Poncet-Montange, Guillaume; Rajagopalan, Senapathy; Fletterick, Robert J.; Gustafsson, Jan-Ake; Webb, Paul			The Human Orphan Nuclear Receptor Tailless (TLX, NR2E1) Is Druggable	PLOS ONE			English	Article							NEURAL STEM-CELLS; HISTONE DEMETHYLASE LSD1; BRAIN; TUMOR; PROLIFERATION; ASSOCIATION; PROGRESSION; EPENDYMOMA; SIGNATURES; LRH-1	Nuclear receptors (NRs) are an important group of ligand-dependent transcriptional factors. Presently, no natural or synthetic ligand has been identified for a large group of orphan NRs. Small molecules to target these orphan NRs will provide unique resources for uncovering regulatory systems that impact human health and to modulate these pathways with drugs. The orphan NR tailless (TLX, NR2E1), a transcriptional repressor, is a major player in neurogenesis and Neural Stem Cell (NSC) derived brain tumors. No chemical probes that modulate TLX activity are available, and it is not clear whether TLX is druggable. To assess TLX ligand binding capacity, we created homology models of the TLX ligand binding domain (LBD). Results suggest that TLX belongs to an emerging class of NRs that lack LBD helices alpha 1 and alpha 2 and that it has potential to form a large open ligand binding pocket (LBP). Using a medium throughput screening strategy, we investigated direct binding of 20,000 compounds to purified human TLX protein and verified interactions with a secondary (orthogonal) assay. We then assessed effects of verified binders on TLX activity using luciferase assays. As a result, we report identification of three compounds (ccrp1, ccrp2 and ccrp3) that bind to recombinant TLX protein with affinities in the high nanomolar to low micromolar range and enhance TLX transcriptional repressive activity. We conclude that TLX is druggable and propose that our lead compounds could serve as scaffolds to derive more potent ligands. While our ligands potentiate TLX repressive activity, the question of whether it is possible to develop ligands to de-repress TLX activity remains open.	[Benod, Cindy; Villagomez, Rosa; Filgueira, Carly S.; Rajagopalan, Senapathy; Webb, Paul] HMRI, Dept Genom Med, Houston, TX 77030 USA; [Hwang, Peter K.; Fletterick, Robert J.] Univ Calif San Francisco, Dept Biophys & Biochem, San Francisco, CA 94143 USA; [Leonard, Paul G.; Poncet-Montange, Guillaume] Univ Texas Houston, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Leonard, Paul G.] Univ Texas Houston, MD Anderson Canc Ctr, Ctr Biomol Struct & Funct, Houston, TX 77030 USA; [Gustafsson, Jan-Ake] Univ Houston Ctr Nucl Receptors & Cell Signaling, Houston, TX USA	University of California System; University of California San Francisco; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Webb, P (corresponding author), HMRI, Dept Genom Med, Houston, TX 77030 USA.	PWebb@houstonmethodist.org	Filgueira, Carly/B-7077-2009	Filgueira, Carly/0000-0002-3246-303X; Poncet-Montange, Guillaume/0000-0002-9884-7378	ETF [300-9-1958]; National Institutes of Health (NIH) [UO1 GM094614-01, DK41482]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094614] Funding Source: NIH RePORTER	ETF; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research was supported by: 1) an ETF grant to P.W. and J.A.G.: TETF (Texas Emerging Technology Fund) Superiority grant 300-9-1958 (governor.state.tx.us/ecodev/etf/); 2) National Institutes of Health (NIH) grant UO1 GM094614-01 to P.W.; and 3) NIH grant DK41482 to P. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad MC, 2008, J STEROID BIOCHEM, V108, P44, DOI 10.1016/j.jsbmb.2007.06.006; Achanta P, 2010, ANTI-CANCER AGENT ME, V10, P121, DOI 10.2174/187152010790909290; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Benod C, 2013, J BIOL CHEM, V288, P19830, DOI 10.1074/jbc.M112.411686; Blumberg B, 1998, GENE DEV, V12, P3149, DOI 10.1101/gad.12.20.3149; Catherinot V, 2004, BIOINFORMATICS, V20, P3694, DOI 10.1093/bioinformatics/bth429; Chavali PL, 2011, J BIOL CHEM, V286, P9393, DOI 10.1074/jbc.M110.167445; Elmi M, 2010, MOL CELL NEUROSCI, V45, P121, DOI 10.1016/j.mcn.2010.06.003; Estruch SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037963; Eswar N., 2006, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0506-15; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Haffner CD, 2004, J MED CHEM, V47, P2010, DOI 10.1021/jm030565g; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Li SX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043324; Li WW, 2008, MOL ENDOCRINOL, V22, P56, DOI 10.1210/me.2007-0290; Liu HK, 2010, GENE DEV, V24, P683, DOI 10.1101/gad.560310; Modena P, 2006, J CLIN ONCOL, V24, P5223, DOI 10.1200/JCO.2006.06.3701; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Park HJ, 2010, MOL CELLS, V30, P403, DOI 10.1007/s10059-010-0122-z; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Qu QH, 2010, NAT CELL BIOL, V12, P31, DOI 10.1038/ncb2001; Qu QH, 2009, J CELL PHYSIOL, V221, P5, DOI 10.1002/jcp.21862; Sablin EP, 2008, P NATL ACAD SCI USA, V105, P18390, DOI 10.1073/pnas.0808936105; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Sharma MK, 2007, CANCER RES, V67, P890, DOI 10.1158/0008-5472.CAN-06-0973; Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Sim FJ, 2006, J NEUROSCI, V26, P12544, DOI 10.1523/JNEUROSCI.0829-06.2006; Sladek FM, 2003, EXPERT OPIN THER TAR, V7, P679; Sun GQ, 2007, P NATL ACAD SCI USA, V104, P15282, DOI 10.1073/pnas.0704089104; Sun GQ, 2010, ADV DRUG DELIVER REV, V62, P1299, DOI 10.1016/j.addr.2010.08.003; Sun GQ, 2010, MOL CELL BIOL, V30, P1997, DOI 10.1128/MCB.01116-09; Tan MHE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074359; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Yokoyama A, 2008, MOL CELL BIOL, V28, P3995, DOI 10.1128/MCB.02030-07; YU RT, 1994, NATURE, V370, P375, DOI 10.1038/370375a0; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhi XY, 2014, P NATL ACAD SCI USA, V111, P839, DOI 10.1073/pnas.1322827111	45	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99440	10.1371/journal.pone.0099440	http://dx.doi.org/10.1371/journal.pone.0099440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936658	Green Published, gold, Green Submitted			2022-12-25	WOS:000338503400018
J	Maripuu, M; Wikgren, M; Karling, P; Adolfsson, R; Norrback, KF				Maripuu, Martin; Wikgren, Mikael; Karling, Pontus; Adolfsson, Rolf; Norrback, Karl-Fredrik			Relative Hypo-and Hypercortisolism Are Both Associated with Depression and Lower Quality of Life in Bipolar Disorder: A Cross-Sectional Study	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; DEXAMETHASONE-SUPPRESSION TEST; WEEKLY SYMPTOMATIC STATUS; NATURAL-HISTORY; CORTISOL METABOLISM; PROSPECTIVE COHORT; MAJOR DEPRESSION; DOUBLE-BLIND; HORMONE TEST; STRESS	Background: Depression in unipolar and bipolar disorders is associated with hypothalamic-pituitary-adrenal-axis (HPA-axis) hyperactivity. Also, unipolar disorder has recently been shown to exhibit HPA-axis hypoactivity. We studied for the first time how HPA-axis hypo-and hyperactivity relate to depression and disease burden in bipolar disorder. We were interested in studying hypocortisolism; characterized by increased HPA-axis negative feedback sensitivity and lower basal cortisol levels together with the opposite HPA-axis regulatory pattern of hypercortisolism. Methods: This cross-sectional study includes 145 type 1 and 2 bipolar outpatients and 145 matched controls. A dexamethasone-suppression-test (DST) measures the negative feedback sensitivity and a weight-adjusted very-low-dose DST was employed, which is sensitive in identifying hypocortisolism and hypercortisolism. The 25th and 75th percentiles of control post-DST values were used as cut-offs identifying patients exhibiting relative hypo-, and hypercortisolism. Self-report questionnaires were employed: Beck-Depression-Inventory (BDI), Montgomery-Asberg-Depression-Rating-Scale (MADRS-S), World-Health-Organization-Quality-of-Life-Assessment-100 and Global-Assessment-of-Functioning. Results: Patients exhibiting relative hypocortisolism expectedly exhibited lowered basal cortisol levels (p = 0.046). Patients exhibiting relative hypercortisolism expectedly exhibited elevated basal levels (p<0.001). Patients exhibiting relative hypocortisolism showed 1.9-2.0 (BDI, p = 0.017, MADRS-S, p = 0.37) and 6.0 (p<0.001) times increased frequencies of depression and low overall life quality compared with patients exhibiting mid post-DST values (eucortisolism). Adjusted Odds Ratios (OR:s) for depression ranged from 3.8-4.1 (BDI, p = 0.006, MADRS-S, p = 0.011) and was 23.4 (p<0.001) for life quality. Patients exhibiting relative hypercortisolism showed 1.9-2.4 (BDI, p = 0.017, MADRS-S, p = 0.003) and 4.7 (p<0.001) times higher frequencies of depression and low overall life quality compared with patients exhibiting eucortisolism. Adjusted OR: s for depression ranged from 2.2-2.7 (BDI, p = 0.068, MADRS-S, p = 0.045) and was 6.3 (p = 0.008) for life quality. Limitations: The cross-sectional design and lack of pre-established reference values of the DST employed. Conclusions: Relative hypocortisolism and relative hypercortisolism were associated with depression and lower life quality, providing novel insights into the detrimental role of stress in bipolar disorder.	[Maripuu, Martin; Wikgren, Mikael; Adolfsson, Rolf; Norrback, Karl-Fredrik] Umea Univ, Dept Clin Sci, Div Psychiat, Umea, Sweden; [Karling, Pontus] Umea Univ, Dept Publ Hlth & Clin Med, Div Med, Umea, Sweden	Umea University; Umea University	Maripuu, M (corresponding author), Umea Univ, Dept Clin Sci, Div Psychiat, Umea, Sweden.	martin.maripuu@psychiat.umu.se		Adolfsson, Rolf/0000-0001-9785-8473	Swedish Research Council [2006-4472, 2009-5269]; Medical Faculty of Umea University; County Council of Jamtland, Sweden; County Council of Vasterbotten, Sweden; County Council of Norrbotten, Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Faculty of Umea University; County Council of Jamtland, Sweden; County Council of Vasterbotten, Sweden; County Council of Norrbotten, Sweden	The research was funded by the Swedish Research Council (grants 2006-4472; 2009-5269), the Medical Faculty of Umea University and the County Councils of Jamtland, Vasterbotten and Norrbotten, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrogio AG, 2008, PITUITARY, V11, P219, DOI 10.1007/s11102-008-0114-6; Angst J, 2000, BIOL PSYCHIAT, V48, P445, DOI 10.1016/S0006-3223(00)00909-4; ARANA GW, 1995, AM J PSYCHIAT, V152, P265; ASBERG M, 1978, ACTA PSYCHIAT SCAND, P5; Association A.P., 1994, DIAGN STAT MAN MENT, V4th; BEALE MD, 1995, AM J PSYCHIAT, V152, P959; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Belmaker RH, 2004, NEW ENGL J MED, V351, P476, DOI 10.1056/NEJMra035354; BODLUND O, 1994, ACTA PSYCHIAT SCAND, V90, P342, DOI 10.1111/j.1600-0447.1994.tb01604.x; Bouwer C, 2000, DEPRESS ANXIETY, V12, P44, DOI 10.1002/1520-6394(2000)12:1<44::AID-DA6>3.0.CO;2-C; Bremmer MA, 2007, BIOL PSYCHIAT, V62, P479, DOI 10.1016/j.biopsych.2006.11.033; Brenner K, 2011, SCHIZOPHR RES, V128, P23, DOI 10.1016/j.schres.2011.01.016; Brown ES, 2009, ANN NY ACAD SCI, V1179, P41, DOI 10.1111/j.1749-6632.2009.04981.x; Bschor T, 2003, J PSYCHIATR RES, V37, P135, DOI 10.1016/S0022-3956(02)00088-2; Bschor T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027613; CARROLL BJ, 1982, BRIT J PSYCHIAT, V140, P292, DOI 10.1192/bjp.140.3.292; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; da Rocha NS, 2009, COMPR PSYCHIAT, V50, P549, DOI 10.1016/j.comppsych.2008.11.015; Daban C, 2005, PSYCHIAT CLIN N AM, V28, P469, DOI 10.1016/j.psc.2005.01.005; Dantzer R, 2012, BIOL PSYCHIAT, V71, P4, DOI 10.1016/j.biopsych.2011.10.025; DeBattista C, 2000, AM J PSYCHIAT, V157, P1334, DOI 10.1176/appi.ajp.157.8.1334; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Fountoulakis Konstantinos N, 2008, Ann Gen Psychiatry, V7, P22, DOI 10.1186/1744-859X-7-22; Fries E, 2005, PSYCHONEUROENDOCRINO, V30, P1010, DOI 10.1016/j.psyneuen.2005.04.006; Gustafsson PE, 2012, PSYCHONEUROENDOCRINO, V37, P789, DOI 10.1016/j.psyneuen.2011.09.011; Heim C, 2000, PSYCHONEUROENDOCRINO, V25, P1, DOI 10.1016/S0306-4530(99)00035-9; Hirschfeld RMA, 2004, EUR NEUROPSYCHOPHARM, V14, pS83, DOI 10.1016/j.euroneuro.2004.03.001; IsHak WW, 2012, BIPOLAR DISORD, V14, P6, DOI 10.1111/j.1399-5618.2011.00969.x; IsHak WW, 2011, HARVARD REV PSYCHIAT, V19, P229, DOI 10.3109/10673229.2011.614099; Judd Lewis L, 2003, Curr Psychiatry Rep, V5, P417, DOI 10.1007/s11920-003-0077-2; Judd LL, 2005, ARCH GEN PSYCHIAT, V62, P1322, DOI 10.1001/archpsyc.62.12.1322; Judd LL, 2002, ARCH GEN PSYCHIAT, V59, P530, DOI 10.1001/archpsyc.59.6.530; Judd LL, 2003, ARCH GEN PSYCHIAT, V60, P261, DOI 10.1001/archpsyc.60.3.261; Karling P, 2007, SCAND J GASTROENTERO, V42, P1294, DOI 10.1080/00365520701395945; Kaushik M L, 2003, Indian J Med Sci, V57, P249; Kenna HA, 2011, PSYCHIAT CLIN NEUROS, V65, P549, DOI 10.1111/j.1440-1819.2011.02260.x; Kupfer DJ, 2002, J CLIN PSYCHIAT, V63, P120, DOI 10.4088/JCP.v63n0206; Michalak EE, 2008, CNS DRUGS, V22, P389, DOI 10.2165/00023210-200822050-00003; Michalak Erin E, 2005, Health Qual Life Outcomes, V3, P72, DOI 10.1186/1477-7525-3-72; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Morrison MF, 2000, BIOL PSYCHIAT, V47, P144, DOI 10.1016/S0006-3223(99)00099-2; Nemeroff CB, 1996, MOL PSYCHIATR, V1, P336; Nilsson LG, 1997, AGING NEUROPSYCHOL C, V4, P1, DOI 10.1080/13825589708256633; Nilsson LG, 2004, AGING NEUROPSYCHOL C, V11, P134, DOI 10.1080/13825580490511026; Oldehinkel AJ, 2001, PSYCHIAT RES, V104, P39, DOI 10.1016/S0165-1781(01)00300-6; Patten SB, 2000, DRUG SAFETY, V22, P111, DOI 10.2165/00002018-200022020-00004; Penninx BWJH, 2007, AM J GERIAT PSYCHIAT, V15, P522, DOI 10.1097/JGP.0b013e318033ed80; Pfennig A, 2005, BIOL PSYCHIAT, V57, P336, DOI 10.1016/j.biopsych.2004.11.017; Plihal W, 1996, PSYCHONEUROENDOCRINO, V21, P515, DOI 10.1016/S0306-4530(96)00011-X; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; Quiroz JA, 2004, MOL PSYCHIATR, V9, P756, DOI 10.1038/sj.mp.4001521; Rapaport MH, 2005, AM J PSYCHIAT, V162, P1171, DOI 10.1176/appi.ajp.162.6.1171; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Rask E, 2002, J CLIN ENDOCR METAB, V87, P3330, DOI 10.1210/jc.87.7.3330; Rush AJ, 1996, J CLIN PSYCHIAT, V57, P470, DOI 10.4088/JCP.v57n1006; Rybakowski JK, 1999, J PSYCHIAT RES, V33, P363, DOI 10.1016/S0022-3956(99)00014-X; Schmider J, 1995, BIOL PSYCHIAT, V38, P797, DOI 10.1016/0006-3223(95)00064-X; Schmidt LA, 1999, PSYCHONEUROENDOCRINO, V24, P461, DOI 10.1016/S0306-4530(99)00007-4; Sonino N, 2001, CNS DRUGS, V15, P361, DOI 10.2165/00023210-200115050-00003; Sonino N, 1998, PSYCHOTHER PSYCHOSOM, V67, P140, DOI 10.1159/000012274; Sonino N, 2010, REV ENDOCR METAB DIS, V11, P95, DOI 10.1007/s11154-009-9123-7; Spijker AT, 2012, NEUROENDOCRINOLOGY, V95, P179, DOI 10.1159/000329846; Stetler C, 2011, PSYCHOSOM MED, V73, P114, DOI 10.1097/PSY.0b013e31820ad12b; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; TYRER P, 1984, J NEUROL NEUROSUR PS, V47, P970, DOI 10.1136/jnnp.47.9.970; van Aken MO, 2005, J CLIN ENDOCR METAB, V90, P3279, DOI 10.1210/jc.2004-1375; Watson S, 2004, BRIT J PSYCHIAT, V184, P496, DOI 10.1192/bjp.184.6.496; Wikgren M, 2012, BIOL PSYCHIAT, V71, P294, DOI 10.1016/j.biopsych.2011.09.015; Wittchen HU, 2003, INT J NEUROPSYCHOPH, V6, P145, DOI 10.1017/S146114570300333X; Yehuda R, 2009, ANN NY ACAD SCI, V1179, P56, DOI 10.1111/j.1749-6632.2009.04979.x	72	39	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e98682	10.1371/journal.pone.0098682	http://dx.doi.org/10.1371/journal.pone.0098682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ5PV	24932586	Green Published, gold, Green Submitted			2022-12-25	WOS:000337738600011
J	Ohnishi, N; Tahara, Y; Kuriki, D; Haraguchi, A; Shibata, S				Ohnishi, Nobuaki; Tahara, Yu; Kuriki, Daisuke; Haraguchi, Atsushi; Shibata, Shigenobu			Warm Water Bath Stimulates Phase-Shifts of the Peripheral Circadian Clocks in PER2::LUCIFERASE Mouse	PLOS ONE			English	Article							AMBIENT-TEMPERATURE CYCLES; REV-ERB-ALPHA; BODY-TEMPERATURE; ACTIVITY RHYTHMS; LIVER CLOCK; ENTRAINMENT; OSCILLATIONS; PROTEIN; LOOP	Circadian clocks in the peripheral tissues of mice are known to be entrained by pulse stimuli such as restricted feeding, novel wheel running, and several other agents. However, there are no reports on high temperature pulse-mediated entrainment on the phase-shift of peripheral clocks in vivo. Here we show that temperature treatment of mice for two days at 41 degrees C, instead of 37 degrees C, for 1-2 h during the inactive period, using a temperature controlled water bath stimulated phase-advance of peripheral clocks in the kidney, liver, and submandibular gland of PER2::LUCIFERASE mice. On the other hand, treatment for 2 days at 35 degrees C ambient room temperature for 2 h did not cause a phase-advance. Maintenance of mice at 41 degrees C in a water bath, sustained the core body temperature at 40-41 degrees C. However, the use of 37 degrees C water bath or the 35 degrees C ambient room temperature elevated the core body temperature to 38.5 degrees C, suggesting that at least a core body temperature of 40-41 degrees C is necessary to cause phase-advance under light-dark cycle conditions. The temperature pulse stimulation at 41 degrees C, instead of 37 degrees C water bath for 2 h led to the elevated expression of Per1 and Hsp70 in the peripheral tissue of mice. In summary, the present study demonstrates that transient high temperature pulse using water bath during daytime causes phase-advance in mouse peripheral clocks in vivo. The present results suggest that hot water bath may affect the phase of peripheral clocks.	[Ohnishi, Nobuaki; Tahara, Yu; Kuriki, Daisuke; Haraguchi, Atsushi; Shibata, Shigenobu] Waseda Univ, Sch Adv Sci & Engn, Lab Physiol & Pharmacol, Tokyo, Japan	Waseda University	Shibata, S (corresponding author), Waseda Univ, Sch Adv Sci & Engn, Lab Physiol & Pharmacol, Tokyo, Japan.	shibatas@waseda.jp	Haraguchi, Atsushi/ABC-6337-2020; Tahara, Yu/Q-4324-2018	Haraguchi, Atsushi/0000-0003-4162-2474; Tahara, Yu/0000-0002-3015-8883	Ministry of Education, Culture, Sports, Science and Technology of Japan [23300278]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Scientific Research (B) (23300278) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Chappuis S, 2013, MOL METAB, V2, P184, DOI 10.1016/j.molmet.2013.05.002; FRANCIS AJP, 1988, PHYSIOL BEHAV, V43, P471, DOI 10.1016/0031-9384(88)90121-7; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gerhart-Hines Z, 2013, NATURE, V503, P410, DOI 10.1038/nature12642; Goldman BD, 1997, J BIOL RHYTHM, V12, P348, DOI 10.1177/074873049701200407; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Itokawa M, 2013, NUTR RES, V33, P109, DOI 10.1016/j.nutres.2012.12.004; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; LINDBERG RG, 1974, CHRONOBIOLOGIA, V1, P356; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Marchant EG, 1996, PHYSIOL BEHAV, V60, P657, DOI 10.1016/S0031-9384(96)80045-X; Morf J, 2012, SCIENCE, V338, P379, DOI 10.1126/science.1217726; Pohl H, 1998, BIOL RHYTHM RES, V29, P311, DOI 10.1076/brhm.29.3.311.1436; Rajaratnam SMW, 1998, PHYSIOL BEHAV, V63, P271, DOI 10.1016/S0031-9384(97)00440-X; REEBS SG, 1989, J BIOL RHYTHM, V4, P39, DOI 10.1177/074873048900400103; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Refinetti R, 2010, J BIOL RHYTHM, V25, P247, DOI 10.1177/0748730410372074; Roenneberg T, 2010, J BIOL RHYTHM, V25, P329, DOI 10.1177/0748730410379082; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Sujino M, 2012, ENDOCRINOLOGY, V153, P2277, DOI 10.1210/en.2011-1794; Tahara Y, 2012, CURR BIOL, V22, P1029, DOI 10.1016/j.cub.2012.04.009; Tahara Y, 2011, J BIOL RHYTHM, V26, P230, DOI 10.1177/0748730411405958; Tamaru T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024521; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	33	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100272	10.1371/journal.pone.0100272	http://dx.doi.org/10.1371/journal.pone.0100272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933288	Green Published, Green Submitted, gold			2022-12-25	WOS:000337738600105
J	Boitano, S; Hoffman, J; Tillu, DV; Asiedu, MN; Zhang, ZY; Sherwood, CL; Wang, Y; Dong, XZ; Price, TJ; Vagner, J				Boitano, Scott; Hoffman, Justin; Tillu, Dipti V.; Asiedu, Marina N.; Zhang, Zhenyu; Sherwood, Cara L.; Wang, Yan; Dong, Xinzhong; Price, Theodore J.; Vagner, Josef			Development and Evaluation of Small Peptidomimetic Ligands to Protease-Activated Receptor-2 (PAR(2)) through the Use of Lipid Tethering	PLOS ONE			English	Article							AGONISTS; ANTAGONISTS; SENSITIZES; MECHANISMS; ALLODYNIA; RESPONSES; PEPTIDES; POTENT; GPCRS; PAR2	Protease-activated receptor-2 (PAR(2)) is a G-Protein Coupled Receptor (GPCR) activated by proteolytic cleavage to expose an attached, tethered ligand (SLIGRL). We evaluated the ability for lipid-tethered-peptidomimetics to activate PAR(2) with in vitro physiological and Ca2+ signaling assays to determine minimal components necessary for potent, specific and full PAR(2) activation. A known PAR(2) activating compound containing a hexadecyl (Hdc) lipid via three polyethylene glycol (PEG) linkers (2at-LIGRL-PEG(3)-Hdc) provided a potent agonist starting point (physiological EC50 = 1.4 nM; 95% CI: 1.2-2.3 nM). In a set of truncated analogs, 2at-LIGR-PEG(3)-Hdc retained potency (EC50 = 2.1 nM; 1.3-3.4 nM) with improved selectivity for PAR(2) over Mas1 related G-protein coupled receptor type C11, a GPCR that can be activated by the PAR(2) peptide agonist, SLIGRL-NH2. 2at-LIG-PEG(3)-Hdc was the smallest full PAR(2) agonist, albeit with a reduced EC50 (46 nM; 20-100 nM). 2at-LI-PEG(3)-Hdc retained specific activity for PAR(2) with reduced EC50 (310 nM; 260-360 nM) but displayed partial PAR(2) activation in both physiological and Ca2+ signaling assays. Further truncation (2at-L-PEG(3)-Hdc and 2at-PEG(3)-Hdc) eliminated in vitro activity. When used in vivo, full and partial PAR(2) in vitro agonists evoked mechanical hypersensitivity at a 15 pmole dose while 2at-L-PEG(3)-Hdc lacked efficacy. Minimum peptidomimetic PAR(2) agonists were developed with known heterocycle substitutes for Ser(1) (isoxazole or aminothiazoyl) and cyclohexylalanine (Cha) as a substitute for Leu(2). Both heterocycle-tetrapeptide and heterocycle-dipeptides displayed PAR(2) specificity, however, only the heterocycle-tetrapeptides displayed full PAR(2) agonism. Using the lipid-tethered-peptidomimetic approach we have developed novel structure activity relationships for PAR(2) that allows for selective probing of PAR(2) function across a broad range of physiological systems.	[Boitano, Scott; Hoffman, Justin; Sherwood, Cara L.] Univ Arizona, Arizona Resp Ctr, Tucson, AZ 85721 USA; [Boitano, Scott; Hoffman, Justin; Sherwood, Cara L.] Univ Arizona, Dept Physiol, Tucson, AZ USA; [Boitano, Scott; Hoffman, Justin; Zhang, Zhenyu; Sherwood, Cara L.; Price, Theodore J.; Vagner, Josef] Univ Arizona, Collaborat Res Inst BIO5, Tucson, AZ USA; [Tillu, Dipti V.; Asiedu, Marina N.; Price, Theodore J.] Univ Arizona, Dept Pharmacol, Tucson, AZ USA; [Wang, Yan] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China; [Dong, Xinzhong] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona; Sichuan University; Johns Hopkins University	Boitano, S (corresponding author), Univ Arizona, Arizona Resp Ctr, Tucson, AZ 85721 USA.	sboitano@email.arizona.edu; tjp140130@utdallas.edu; vagner@email.arizona.edu	wang, yan/AAZ-4988-2021; Price, Theodore/M-3810-2018	Price, Theodore/0000-0002-6971-6221	National Institutes of Health (NIH)/NINDS [NS073664]; NIH/NIEHS Superfund Research [ES04940]; NIH/NINDS [NS065926, NS054791]; NIH/NIAID [AI083403]; NIH/NIGMS [GM087369]; Technology and Research Initiative Fund from Arizona State; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083403, R56AI083403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004940, T32ES007091, P30ES006694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073664, R01NS065926, R01NS054791] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NIEHS Superfund Research; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Technology and Research Initiative Fund from Arizona State; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This manuscript was developed through a multi-principal investigator collaboration between S.B., T.J.P. and J.V. This work was primarily supported by a multi-principal investigator grant from the National Institutes of Health (NIH)/NINDS, NS073664 (S.B., T.J.P., J.V.). This work was additionally supported by the following grants: NIH/NIEHS Superfund Research Grant ES04940 (S.B.; Raina Maier, P.I.); NIH/NINDS Grant NS065926 (T.J.P.); NIH/NIAID Grant AI083403 (S.B.; Michael O. Daines, P.I.); NIH/NIGMS Grant GM087369 (X.D.); NIH/NINDS Grant NS054791 (X.D.); and the Technology and Research Initiative Fund from Arizona State Proposition 301 (J.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Al-Ani B, 2004, MOL PHARMACOL, V65, P149, DOI 10.1124/mol.65.1.149; Amadesi S, 2004, J NEUROSCI, V24, P4300, DOI 10.1523/JNEUROSCI.5679-03.2004; Amadesi S, 2006, J PHYSIOL-LONDON, V575, P555, DOI 10.1113/jphysiol.2006.111534; Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; Barry GD, 2006, CURR MED CHEM, V13, P243, DOI 10.2174/092986706775476070; Barry GD, 2010, J MED CHEM, V53, P7428, DOI 10.1021/jm100984y; Blackhart BD, 1996, J BIOL CHEM, V271, P16466, DOI 10.1074/jbc.271.28.16466; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Dai Y, 2004, J NEUROSCI, V24, P4293, DOI 10.1523/JNEUROSCI.0454-04.2004; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Flynn AN, 2013, FASEB J, V27, P1498, DOI 10.1096/fj.12-217323; Flynn AN, 2011, J BIOL CHEM, V286, P19076, DOI 10.1074/jbc.M110.185264; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hollenberg MD, 2014, BRIT J PHARMACOL, V171, P1180, DOI 10.1111/bph.12544; Hollenberg MD, 1996, MOL PHARMACOL, V49, P229; Jalink K, 2010, BIOESSAYS, V32, P13, DOI 10.1002/bies.200900153; Kawabata A, 2006, BRIT J PHARMACOL, V148, P54, DOI 10.1038/sj.bjp.0706708; Kawabata A, 1999, J PHARMACOL EXP THER, V288, P358; Lam DK, 2010, PAIN, V149, P263, DOI 10.1016/j.pain.2010.02.010; LaMotte RH, 2014, NAT REV NEUROSCI, V15, P19, DOI 10.1038/nrn3641; Liu Q, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001925; Maryanoff BE, 2001, ARCH BIOCHEM BIOPHYS, V386, P195, DOI 10.1006/abbi.2000.2207; McGuire JJ, 2004, J PHARMACOL EXP THER, V309, P1124, DOI 10.1124/jpet.103.064584; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Nichols HL, 2012, P NATL ACAD SCI USA, V109, P16660, DOI 10.1073/pnas.1208881109; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Ramachandran R, 2011, J BIOL CHEM, V286, P24638, DOI 10.1074/jbc.M110.201988; Ramachandran R, 2009, MOL PHARMACOL, V76, P791, DOI 10.1124/mol.109.055509; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; Stallaert W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029420; Vergnolle N, 2001, NAT MED, V7, P821, DOI 10.1038/89945; Zhang L, 2012, CURR MED CHEM, V19, P1602; Zheng H, 2010, IUBMB LIFE, V62, P112, DOI 10.1002/iub.293	37	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99140	10.1371/journal.pone.0099140	http://dx.doi.org/10.1371/journal.pone.0099140			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927179	gold, Green Published, Green Submitted			2022-12-25	WOS:000338278100029
J	Ma, DL; He, HZ; Chan, DSH; Wong, CY; Leung, CH				Ma, Dik-Lung; He, Hong-Zhang; Chan, Daniel Shiu-Hin; Wong, Chun-Yuen; Leung, Chung-Hang			A Colorimetric and Luminescent Dual-Modal Assay for Cu(II) Ion Detection Using an Iridium(III) Complex	PLOS ONE			English	Article							SWITCH-ON PROBE; SELECTIVE ELECTROCHEMICAL SENSOR; LABEL-FREE; FLUORESCENT SENSOR; AQUEOUS-SOLUTION; LIVING CELLS; COPPER(II) ION; PHOSPHORESCENT; CU2+; CHEMOSENSOR	A novel iridium(III) complex-based chemosensor bearing the 5,6-bis(salicylideneimino)-1,10-phenanthroline ligand receptor was developed, which exhibited a highly sensitive and selective color change from colorless to yellow and a visible turn-off luminescence response upon the addition of Cu(II) ions. The interactions of this iridium(III) complex with Cu2+ ions and thirteen other cations have been investigated by UV-Vis absorption titration, emission titration, and H-1 NMR titration.	[Ma, Dik-Lung; He, Hong-Zhang; Chan, Daniel Shiu-Hin] Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China; [Wong, Chun-Yuen] City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China; [Leung, Chung-Hang] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China	Hong Kong Baptist University; City University of Hong Kong; University of Macau	Ma, DL (corresponding author), Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China.	edmondma@hkbu.edu.hk	Wong, Chun-Yuen/H-2272-2011	Wong, Chun-Yuen/0000-0003-4780-480X; Ma, Dik-Lung/0000-0002-9515-340X	Hong Kong Baptist University [FRG2/12-13/021, FRG2/13-14/008]; Centre for Cancer and Inflammation Research, the School of Chinese Medicine (CCIR-SCM, HKBU); Health and Medical Research Fund [HMRF/13121482]; Research Grants Council [HKBU/201811, HKBU/204612, HKBU/201913]; French National Research Agency/Research Grants Council Joint Research Scheme [A-HKBU201/12]; Science and Technology Development Fund, Macao SAR [103/2012/A3]; University of Macau [MYRG091(Y3-L2)-ICMS12-LCH, MYRG121(Y3-L2)-ICMS12-LCH, MRG007/LCH/2014/ICMS, MRG023/LCH/2013/ICMS]	Hong Kong Baptist University; Centre for Cancer and Inflammation Research, the School of Chinese Medicine (CCIR-SCM, HKBU); Health and Medical Research Fund; Research Grants Council(Hong Kong Research Grants Council); French National Research Agency/Research Grants Council Joint Research Scheme(French National Research Agency (ANR)); Science and Technology Development Fund, Macao SAR; University of Macau	This work is supported by Hong Kong Baptist University (FRG2/12-13/021 and FRG2/13-14/008), the Centre for Cancer and Inflammation Research, the School of Chinese Medicine (CCIR-SCM, HKBU), the Health and Medical Research Fund (HMRF/13121482), the Research Grants Council (HKBU/201811, HKBU/204612, and HKBU/201913), the French National Research Agency/Research Grants Council Joint Research Scheme (A-HKBU201/12), the Science and Technology Development Fund, Macao SAR (103/2012/A3) and the University of Macau (MYRG091(Y3-L2)-ICMS12-LCH, MYRG121(Y3-L2)-ICMS12-LCH, MRG007/LCH/2014/ICMS and MRG023/LCH/2013/ICMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araya JC, 2010, NEW J CHEM, V34, P21, DOI 10.1039/b9nj00515c; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Beija M, 2009, CHEM SOC REV, V38, P2410, DOI 10.1039/b901612k; BENESI HA, 1949, J AM CHEM SOC, V71, P2703, DOI 10.1021/ja01176a030; Brandel J, 2010, CHEM COMMUN, V46, P3958, DOI 10.1039/c002401e; Burdette SC, 2001, J AM CHEM SOC, V123, P7831, DOI 10.1021/ja010059l; Chan DSH, 2009, CHEM COMMUN, P7479, DOI 10.1039/b913995h; Charbonniere LJ, 2003, INORG CHEM, V42, P3466, DOI 10.1021/ic020671t; Chen XY, 2009, ORG LETT, V11, P4426, DOI 10.1021/ol901787w; Chen XQ, 2012, CHEM REV, V112, P1910, DOI 10.1021/cr200201z; Chen XQ, 2006, ANAL CHIM ACTA, V575, P217, DOI 10.1016/j.aca.2006.05.097; Chen XQ, 2009, ANAL CHIM ACTA, V632, P9, DOI 10.1016/j.aca.2007.08.025; Cheng PPH, 2006, J PHYS CHEM B, V110, P4637, DOI 10.1021/jp057028n; DEMAS JN, 1971, J PHYS CHEM-US, V75, P991, DOI 10.1021/j100678a001; Domaille DW, 2010, J AM CHEM SOC, V132, P1194, DOI 10.1021/ja907778b; Gill MR, 2009, NAT CHEM, V1, P662, DOI [10.1038/nchem.406, 10.1038/NCHEM.406]; Gray NF., 2008, DRINKING WATER QUALI; He HZ, 2014, CHEM COMMUN, V50, P5313, DOI 10.1039/c3cc47444e; He HZ, 2013, METHODS, V64, P218, DOI 10.1016/j.ymeth.2013.08.011; He HZ, 2013, METHODS, V64, P212, DOI 10.1016/j.ymeth.2013.07.021; He HZ, 2013, METHODS, V64, P205, DOI 10.1016/j.ymeth.2013.07.023; He HZ, 2013, BIOSENS BIOELECTRON, V41, P871, DOI 10.1016/j.bios.2012.08.060; He HZ, 2012, CHEM COMMUN, V48, P9462, DOI 10.1039/c2cc32253f; Hirayama T, 2012, P NATL ACAD SCI USA, V109, P2228, DOI 10.1073/pnas.1113729109; Ho ML, 2006, ORG BIOMOL CHEM, V4, P98, DOI 10.1039/b511943j; HORROCKS WD, 1981, ACCOUNTS CHEM RES, V14, P384, DOI 10.1021/ar00072a004; Huang WS, 2004, CHEM MATER, V16, P2480, DOI 10.1021/cm0498943; Jung JY, 2013, CHEM COMMUN, V49, P176, DOI 10.1039/c2cc36626f; Kaur N, 2007, CHEM COMMUN, P3069, DOI 10.1039/b703529b; Kim HB, 2013, B KOREAN CHEM SOC, V34, P653, DOI 10.5012/bkcs.2013.34.2.653; Kramer R, 1998, ANGEW CHEM INT EDIT, V37, P772, DOI 10.1002/(SICI)1521-3773(19980403)37:6<772::AID-ANIE772>3.0.CO;2-Z; Lamansky S, 2001, INORG CHEM, V40, P1704, DOI 10.1021/ic0008969; Leung KH, 2013, ACS APPL MATER INTER, V5, P12249, DOI 10.1021/am404314p; Leung KH, 2013, CHEM COMMUN, V49, P5630, DOI 10.1039/c3cc41129j; Leung KH, 2013, CHEM COMMUN, V49, P771, DOI 10.1039/c2cc37710a; Li CK, 2004, INORG CHEM, V43, P7421, DOI 10.1021/ic049094u; Li XH, 2014, CHEM REV, V114, P590, DOI 10.1021/cr300508p; Lin HW, 2010, DALTON T, V39, P5130, DOI 10.1039/c000449a; Liu Y, 2011, INORG CHEM, V50, P5969, DOI 10.1021/ic102481x; Lowry MS, 2006, CHEM-EUR J, V12, P7970, DOI 10.1002/chem.200600618; Ma BL, 2010, SENSOR ACTUAT B-CHEM, V145, P451, DOI 10.1016/j.snb.2009.12.054; Ma DL, 2014, NANOSCALE, V6, P8489, DOI 10.1039/c4nr00541d; Ma DL, 2013, CHEM SOC REV, V42, P3427, DOI 10.1039/c2cs35472a; Ma DL, 2012, COORDIN CHEM REV, V256, P3087, DOI 10.1016/j.ccr.2012.07.005; Ma DL, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr106; Man BYW, 2011, CHEM SCI, V2, P917, DOI 10.1039/c0sc00636j; Man BYW, 2010, CHEM COMMUN, V46, P8534, DOI 10.1039/c0cc01201g; Miller EW, 2006, NAT PROTOC, V1, P824, DOI 10.1038/nprot.2006.140; NONOYAMA M, 1974, B CHEM SOC JPN, V47, P767, DOI 10.1246/bcsj.47.767; Pellegrin Y, 2005, CHEM-EUR J, V11, P3698, DOI 10.1002/chem.200401064; Quang D. T., 2010, CHEM REV, V110, P6280, DOI DOI 10.1021/CR100154P; Shi HF, 2010, CHEM-EUR J, V16, P12158, DOI 10.1002/chem.201000748; Singh AK, 2006, ANAL CHIM ACTA, V575, P25, DOI 10.1016/j.aca.2006.05.076; Singh LP, 2004, TALANTA, V64, P313, DOI 10.1016/j.talanta.2004.02.020; Sun Y, 2008, INORG CHEM, V47, P6427, DOI 10.1021/ic800560x; Tamayo AB, 2003, J AM CHEM SOC, V125, P7377, DOI 10.1021/ja034537z; Wang W, 2013, DALTON T, V42, P1827, DOI 10.1039/c2dt32279j; Xu ZC, 2010, J AM CHEM SOC, V132, P601, DOI 10.1021/ja907334j; Xue L, 2009, ORG LETT, V11, P1655, DOI 10.1021/ol900315r; Yang WR, 2001, ANALYST, V126, P1573, DOI 10.1039/b102898g; Yang YM, 2013, CHEM REV, V113, P192, DOI 10.1021/cr2004103; You Y, 2013, CURR OPIN CHEM BIOL, V17, P699, DOI 10.1016/j.cbpa.2013.05.023; You Y, 2011, J AM CHEM SOC, V133, P11488, DOI 10.1021/ja204997c; Zhao QA, 2010, CHEM SOC REV, V39, P3007, DOI 10.1039/b915340c; Zhou Y, 2009, ORG LETT, V11, P4442	65	28	28	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99930	10.1371/journal.pone.0099930	http://dx.doi.org/10.1371/journal.pone.0099930			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927177	Green Submitted, Green Published, gold			2022-12-25	WOS:000338278100093
J	Zhao, YL; Wang, HM; Chen, W; Li, YH				Zhao, Yunlei; Wang, Hongmei; Chen, Wei; Li, Yunhai			Genetic Structure, Linkage Disequilibrium and Association Mapping of Verticillium Wilt Resistance in Elite Cotton (Gossypium hirsutum L.) Germplasm Population	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEAT; QUANTITATIVE TRAIT LOCI; FIBER QUALITY; NUCLEOTIDE DIVERSITY; COMPUTER-PROGRAM; GENOME STRUCTURE; UPLAND COTTON; YIELD; QTL; SSR	Understanding the population structure and linkage disequilibrium in an association panel can effectively avoid spurious associations and improve the accuracy in association mapping. In this study, one hundred and fifty eight elite cotton (Gossypium hirsutum L.) germplasm from all over the world, which were genotyped with 212 whole genome-wide marker loci and phenotyped with an disease nursery and greenhouse screening method, were assayed for population structure, linkage disequilibrium, and association mapping of Verticillium wilt resistance. A total of 480 alleles ranging from 2 to 4 per locus were identified from all collections. Model-based analysis identified two groups (G1 and G2) and seven subgroups (G1a-c, G2a-d), and differentiation analysis showed that subgroup having a single origin or pedigree was apt to differentiate with those having a mixed origin. Only 8.12% linked marker pairs showed significant LD (P<0.001) in this association panel. The LD level for linked markers is significantly higher than that for unlinked markers, suggesting that physical linkage strongly influences LD in this panel, and LD level was elevated when the panel was classified into groups and subgroups. The LD decay analysis for several chromosomes showed that different chromosomes showed a notable change in LD decay distances for the same gene pool. Based on the disease nursery and greenhouse environment, 42 marker loci associated with Verticillium wilt resistance were identified through association mapping, which widely were distributed among 15 chromosomes. Among which 10 marker loci were found to be consistent with previously identified QTLs and 32 were new unreported marker loci, and QTL clusters for Verticillium wilt resistanc on Chr.16 were also proved in our study, which was consistent with the strong linkage in this chromosome. Our results would contribute to association mapping and supply the marker candidates for marker-assisted selection of Verticillium wilt resistance in cotton.	[Zhao, Yunlei; Wang, Hongmei; Chen, Wei; Li, Yunhai] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Wang, HM (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China.	wanghm@cricaas.com.cn		Liang, Peng/0000-0001-8485-1694; Liu, Jin/0000-0002-2026-2513	National Natural Science Foundation of China [31000733]; National Hi-Tech Research and Development Program of China [2012AA101108-02-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	This research was supported by the National Natural Science Foundation of China (Grant No. 31000733) and by the National Hi-Tech Research and Development Program of China (Grant No. 2012AA101108-02-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurakhmonov IY, 2009, GENETICA, V136, P401, DOI 10.1007/s10709-008-9337-8; Abdurakhmonov IY, 2008, MOL DIVERSITY ASS MA; [Anonymous], GENOMICS, V92, P478; Bolek Y, 2005, PLANT SCI, V168, P1581, DOI 10.1016/j.plantsci.2005.02.008; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Caldwell KS, 2006, GENETICS, V172, P557, DOI 10.1534/genetics.104.038489; Chen Guang, 2006, Acta Genetica Sinica, V33, P733, DOI 10.1016/S0379-4172(06)60106-6; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Bertini CHCD, 2006, GENET MOL BIOL, V29, P321, DOI 10.1590/S1415-47572006000200021; Ersoz E.S., 2007, GENOMICS ASSISTED CR, P97, DOI DOI 10.1007/978-1-4020-6295-7_5; Esbroeck G. van., 1998, Journal of Cotton Science, V2, P121; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Guo WZ, 2007, GENETICS, V176, P527, DOI 10.1534/genetics.107.070375; Ha C, 2011, PLOS ONE, V6; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; He DH, 2005, EUPHYTICA, V144, P141, DOI 10.1007/s10681-005-5297-6; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Iqbal MJ, 2001, THEOR APPL GENET, V103, P547, DOI 10.1007/PL00002908; Jiang F, 2009, SCI CHINA SER C, V52, P872, DOI 10.1007/s11427-009-0110-8; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Lacape JM, 2007, MOL BREEDING, V19, P45, DOI 10.1007/s11032-006-9042-1; Lacape JM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-132; Lacape JM, 2009, THEOR APPL GENET, V119, P281, DOI 10.1007/s00122-009-1037-y; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lijavetzky D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-424; Liu AZ, 2006, GENETICS, V173, P321, DOI 10.1534/genetics.105.051110; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu S, 2000, CROP SCI, V40, P1459, DOI 10.2135/cropsci2000.4051459x; Ma XX, 2008, J INTEGR PLANT BIOL, V50, P491, DOI 10.1111/j.1744-7909.2008.00636.x; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Moiana L. D., 2012, African Journal of Biotechnology, V11, P11640; Morrell PL, 2005, P NATL ACAD SCI USA, V102, P2442, DOI 10.1073/pnas.0409804102; Nordborg M, 2002, NAT GENET, V30, P190, DOI 10.1038/ng813; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Pritchard JK, 2000, GENETICS, V155, P945; Qin HD, 2008, THEOR APPL GENET, V117, P883, DOI 10.1007/s00122-008-0828-x; Rungis D, 2005, AUST J AGR RES, V56, P301, DOI 10.1071/AR04190; Schneider S, 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Shen XL, 2007, EUPHYTICA, V155, P371, DOI 10.1007/s10681-006-9338-6; Song BH, 2009, GENETICS, V181, P1021, DOI 10.1534/genetics.108.095364; Stich B, 2005, THEOR APPL GENET, V111, P723, DOI 10.1007/s00122-005-2057-x; Wang Baohua, 2007, Journal of Genetics and Genomics, V34, P35, DOI 10.1016/S1673-8527(07)60005-8; WANG HM, 2007, J INTE PL BIO, V50, P174; Wang HM, 2008, J INTEGR PLANT BIOL, V50, P174, DOI 10.1111/j.1744-7909.2007.00612.x; Whitt Sr, 2003, METH MOL B, V236, P123; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yang C, 2008, PLANT SCI, V174, P290, DOI 10.1016/j.plantsci.2007.11.016; Yu JW, 2007, J INTEGR PLANT BIOL, V49, P716, DOI 10.1111/j.1744-7909.2007.00459.x; Yu JW, 2013, THEOR APPL GENET, V126, P275, DOI 10.1007/s00122-012-1980-x; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Yu JZ, 2012, G3-GENES GENOM GENET, V2, P43, DOI 10.1534/g3.111.001552; Yu Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-15; Zhang J, 2007, WORLD COTT RES C 4 L, P1014; Zhang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057220; Zhang TZ, 2003, THEOR APPL GENET, V106, P262, DOI 10.1007/s00122-002-1101-3; Zhang XueYong, 2007, Agricultural Sciences in China, V6, P255, DOI 10.1016/S1671-2927(07)60043-1; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	61	101	119	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86308	10.1371/journal.pone.0086308	http://dx.doi.org/10.1371/journal.pone.0086308			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466016	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000082
J	Yang, F; Ning, K; Chang, XZ; Yuan, X; Tu, QC; Yuan, T; Deng, Y; Hemme, CL; Van Nostrand, J; Cui, XP; He, ZL; Chen, ZG; Guo, DW; Yu, JB; Zhang, Y; Zhou, JZ; Xu, J				Yang, Fang; Ning, Kang; Chang, Xingzhi; Yuan, Xiao; Tu, Qichao; Yuan, Tong; Deng, Ye; Hemme, Christopher L.; Van Nostrand, Joy; Cui, Xinping; He, Zhili; Chen, Zhenggang; Guo, Dawei; Yu, Jiangbo; Zhang, Yue; Zhou, Jizhong; Xu, Jian			Saliva Microbiota Carry Caries-Specific Functional Gene Signatures	PLOS ONE			English	Article							WHOLE-SALIVA; STREPTOCOCCI; COMMUNITY; ASSOCIATION; EXPERIENCE; TOOL	Human saliva microbiota is phylogenetically divergent among host individuals yet their roles in health and disease are poorly appreciated. We employed a microbial functional gene microarray, HuMiChip 1.0, to reconstruct the global functional profiles of human saliva microbiota from ten healthy and ten caries-active adults. Saliva microbiota in the pilot population featured a vast diversity of functional genes. No significant distinction in gene number or diversity indices was observed between healthy and caries-active microbiota. However, co-presence network analysis of functional genes revealed that caries-active microbiota was more divergent in non-core genes than healthy microbiota, despite both groups exhibited a similar degree of conservation at their respective core genes. Furthermore, functional gene structure of saliva microbiota could potentially distinguish caries-active patients from healthy hosts. Microbial functions such as Diaminopimelate epimerase, Prephenate dehydrogenase, Pyruvate-formate lyase and N-acetylmuramoyl-L-alanine amidase were significantly linked to caries. Therefore, saliva microbiota carried disease-associated functional signatures, which could be potentially exploited for caries diagnosis.	[Yang, Fang; Yuan, Xiao; Chen, Zhenggang; Guo, Dawei; Yu, Jiangbo; Zhang, Yue] Qingdao Municipal Hosp, Oral Res Ctr, Qingdao, Shandong, Peoples R China; [Ning, Kang; Chang, Xingzhi; Xu, Jian] Chinese Acad Sci, CAS Key Lab Biofuels, Shandong Key Lab Energy Genet, Qingdao, Shandong, Peoples R China; [Ning, Kang; Chang, Xingzhi; Xu, Jian] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, BioEnergy Genome Ctr, Qingdao, Shandong, Peoples R China; [Tu, Qichao; Yuan, Tong; Deng, Ye; Hemme, Christopher L.; Van Nostrand, Joy; He, Zhili; Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA; [Cui, Xinping] Univ Calif Riverside, Dept Stat, Riverside, CA 92521 USA	Qingdao Municipal Hospital; Chinese Academy of Sciences; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; University of Oklahoma System; University of Oklahoma - Norman; University of California System; University of California Riverside	Zhou, JZ (corresponding author), Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA.	jzhou@ou.edu; xujian@qibebt.ac.cn	He, Zhili/C-2879-2012; 吴, 昊/AAB-1620-2020; Xu, Jian/G-8430-2012; Zhang, Qiang/B-6233-2012; Deng, Ye/X-4358-2019; Van Nostrand, Joy D/F-1740-2016; Ning, Kang/ABD-3446-2020	He, Zhili/0000-0001-8225-7333; Xu, Jian/0000-0002-0548-8477; Deng, Ye/0000-0002-7584-0632; Van Nostrand, Joy D/0000-0001-9548-6450; Tu, Qichao/0000-0002-3245-7545; Ning, Kang/0000-0003-3325-5387; Yang, Fulin/0000-0002-5530-0954; YANG, Fang/0000-0002-6783-972X	Ministry of Science and Technology of China [2011IM030100, 2009AA02Z310]; National Science Foundation of China [31271410, 31300424]; Qingdao [2011-WSZD029, KJZD-12-16-nsh, VII2013W002]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qingdao	This work was supported in part by grants 2011IM030100 and 2009AA02Z310 from Ministry of Science and Technology of China, grants 31271410 and 31300424 from National Science Foundation of China, and grants 2011-WSZD029, KJZD-12-16-nsh and VII2013W002 from Qingdao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Amerongen AV, 2004, CARIES RES, V38, P247, DOI 10.1159/000077762; Baldini C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3523; Baum B J, 2011, Adv Dent Res, V23, P360, DOI 10.1177/0022034511420433; Bergandi L, 2007, EUR J ORAL SCI, V115, P93, DOI 10.1111/j.1600-0722.2007.00437.x; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Brinkmann O, 2011, ORAL ONCOL, V47, P51, DOI 10.1016/j.oraloncology.2010.10.009; Denny P, 2008, J PROTEOME RES, V7, P1994, DOI 10.1021/pr700764j; Doel JJ, 2004, EUR J ORAL SCI, V112, P424, DOI 10.1111/j.1600-0722.2004.00153.x; Farrell JJ, 2011, GUT; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041294; Fonteles CSR, 2009, ARCH ORAL BIOL, V54, P80, DOI 10.1016/j.archoralbio.2008.07.011; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; He Z, 2012, CURR OPIN BIOTECHNOL; He ZL, 2012, CURR OPIN BIOTECH, V23, P49, DOI 10.1016/j.copbio.2011.11.001; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; Holgerson PL, 2005, ACTA ODONTOL SCAND, V63, P233, DOI 10.1080/00016350510019883; Huang S, 2011, BMC ORAL HEALTH, V11, DOI 10.1186/1472-6831-11-33; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jiang Q, 2012, MOL CELL BIOCH; Kanasi E, 2010, J DENT RES, V89, P378, DOI 10.1177/0022034509360010; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Ku HK, 2011, INT J BIOL MACROMOL, V49, P761, DOI 10.1016/j.ijbiomac.2011.07.009; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; Lu ZM, 2012, ISME J, V6, P451, DOI 10.1038/ismej.2011.91; Martínez-Pabón María C, 2010, Acta odontol. latinoam., V23, P249; Mirzaii-Dizgah Iraj, 2011, J Contemp Dent Pract, V12, P114; Morgan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010209; MORMANN JE, 1983, CARIES RES, V17, P353; Nasidze I, 2009, ANAL BIOCHEM, V391, P64, DOI 10.1016/j.ab.2009.04.034; Qi X, 2008, 3 NATL SAMPLING EPID; Quinque D, 2006, ANAL BIOCHEM, V353, P272, DOI 10.1016/j.ab.2006.03.021; Smith AMV, 2007, CARIES RES, V41, P445, DOI 10.1159/000107930; Takahashi-Abbe S, 2003, ORAL MICROBIOL IMMUN, V18, P293, DOI 10.1034/j.1399-302X.2003.00081.x; Tao RC, 2005, ANTIMICROB AGENTS CH, V49, P3883, DOI 10.1128/AAC.49.9.3883-3888.2005; Thanyasrisung P, 2009, ORAL MICROBIOL IMMUN, V24, P451, DOI 10.1111/j.1399-302X.2009.00536.x; Thomadaki K, 2011, J DENT RES, V90, P1325, DOI 10.1177/0022034511420721; VANWUYCKHUYSE BC, 1995, J DENT RES, V74, P686, DOI 10.1177/00220345950740021001; Xiao H, 2011, MOL CELL PROTEOMICS; Xie G, 2010, MOL ORAL MICROBIOL, V25, P391, DOI 10.1111/j.2041-1014.2010.00587.x; Yamamoto Y, 2000, INFECT IMMUN, V68, P4773, DOI 10.1128/IAI.68.8.4773-4777.2000; Yang F, 2012, ISME J, V6, P1, DOI 10.1038/ismej.2011.71; Zahir S, 2006, J Indian Soc Pedod Prev Dent, V24, P27; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zhang Q, 2007, J DENT, V35, P177, DOI 10.1016/j.jdent.2006.07.004	47	98	102	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e76458	10.1371/journal.pone.0076458	http://dx.doi.org/10.1371/journal.pone.0076458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24941017	Green Submitted, Green Published, gold			2022-12-25	WOS:000331262600001
J	Zhang, XC; Zhu, XL; Wang, X; Zhu, XZ; Zhong, MT; Yi, JY; Rao, HY; Yao, SQ				Zhang, Xiaocui; Zhu, Xueling; Wang, Xiang; Zhu, Xiongzhao; Zhong, Mingtian; Yi, Jinyao; Rao, Hengyi; Yao, Shuqiao			First-Episode Medication-Naive Major Depressive Disorder Is Associated with Altered Resting Brain Function in the Affective Network	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; POSITRON-EMISSION-TOMOGRAPHY; ORBITOFRONTAL CORTEX; SPONTANEOUS FLUCTUATIONS; TRYPTOPHAN DEPLETION; REGIONAL HOMOGENEITY; NEGATIVE AFFECT; DEFAULT MODE; STATE; CONNECTIVITY	Background: Major depressive disorder (MDD) has been associated with abnormal structure and function of the brain's affective network, including the amygdala and orbitofrontal cortex (OFC). However, it is unclear if alterations of resting-state function in this affective network are present at the initial onset of MDD. Aims: To examine resting-state function of the brain's affective network in first-episode, medication-naive patients with MDD compared to healthy controls (HCs). Methods: Resting-state functional magnetic resonance imaging (rs-fMRI) was performed on 32 first-episode, medication-naive young adult patients with MDD and 35 matched HCs. The amplitude of low-frequency fluctuations (ALFF) of the blood oxygen level-dependent (BOLD) signal and amygdala-seeded functional connectivity (FC) were investigated. Results: Compared to HC, MDD patients showed reduced ALFF in the bilateral OFC and increased ALFF in the bilateral temporal lobe extending to the insular and left fusiform cortices. Enhanced anti-correlation of activity between the left amygdala seed and the left OFC was found in MDD patients but not in HCs. Conclusions: Reduced ALFF in the OFC suggests hypo-functioning of emotion regulation in the affective network. Enhanced anti-correlation of activity between the amygdala and OFC may reflect dysfunction of the amygdala-OFC network and additionally represent a pathological process of MDD.	[Zhang, Xiaocui; Zhu, Xueling; Wang, Xiang; Zhu, Xiongzhao; Yi, Jinyao; Yao, Shuqiao] Cent S Univ, Xiangya Hosp 2, Inst Med Psychol, Changsha, Hunan, Peoples R China; [Zhang, Xiaocui; Rao, Hengyi] Univ Penn, Ctr Funct Neuroimaging, Dept Neurol, Philadelphia, PA 19104 USA; [Zhong, Mingtian] S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Rao, Hengyi] Sun Yat Sen Univ, Dept Psychol, Guangzhou 510275, Guangdong, Peoples R China	Central South University; University of Pennsylvania; Pennsylvania Medicine; South China Normal University; Sun Yat Sen University	Yao, SQ (corresponding author), Cent S Univ, Xiangya Hosp 2, Inst Med Psychol, Changsha, Hunan, Peoples R China.	shuqiaoyao@163.com	Rao, Hengyi/K-5152-2019; Rao, Hengyi/AAQ-4919-2020; Rao, Hengyi/A-7064-2009; Zhong, Mingtian/AAA-3305-2022	Rao, Hengyi/0000-0003-2735-2500; Rao, Hengyi/0000-0003-2735-2500; 	National Natural Science Foundation of China [30670709, 81071104, 30700236, 81301211, 31070984]; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This work was supported by the National Natural Science Foundation of China (Grant No. 30670709, 81071104 awarded to Shuqiao Yao, Grant No. 30700236 awarded to Xiang Wang, Grant No. 81301211 awarded to Xueling Zhu and Grant No. 31070984 awarded to Hengyi Rao). This work is partly supported by China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BIVER F, 1994, BIOL PSYCHIAT, V36, P381, DOI 10.1016/0006-3223(94)91213-0; Bremner JD, 2002, BIOL PSYCHIAT, V51, P273, DOI 10.1016/S0006-3223(01)01336-1; Bremner JD, 2003, JAMA-J AM MED ASSOC, V289, P3125, DOI 10.1001/jama.289.23.3125; Bremner JD, 1997, ARCH GEN PSYCHIAT, V54, P364; BROZOSKI TJ, 1979, SCIENCE, V205, P929, DOI 10.1126/science.112679; de Almeida JRC, 2009, BIOL PSYCHIAT, V66, P451, DOI 10.1016/j.biopsych.2009.03.024; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Dichter GS, 2009, SOC COGN AFFECT NEUR, V4, P59, DOI 10.1093/scan/nsn037; Dougherty DD, 2004, ARCH GEN PSYCHIAT, V61, P795, DOI 10.1001/archpsyc.61.8.795; DREVETS WC, 1992, J NEUROSCI, V12, P3628; DREVETS WC, 1995, J CEREB BLOOD FLOW M, V15, pS93; Fales CL, 2008, BIOL PSYCHIAT, V63, P377, DOI 10.1016/j.biopsych.2007.06.012; First M. B., 2002, STRUCTURED CLIN INTE; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Galynker II, 1998, J NUCL MED, V39, P608; Gan ZY, 2011, J AFFECT DISORDERS, V134, P119, DOI 10.1016/j.jad.2011.05.054; Goncalves SI, 2006, NEUROIMAGE, V30, P203, DOI 10.1016/j.neuroimage.2005.09.062; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Guo WB, 2011, PROG NEURO-PSYCHOPH, V35, P1297, DOI 10.1016/j.pnpbp.2011.02.006; Hahn T, 2011, ARCH GEN PSYCHIAT, V68, P361, DOI 10.1001/archgenpsychiatry.2010.178; Jiao Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025159; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Lacerda ALT, 2004, BIOL PSYCHIAT, V55, P353, DOI 10.1016/j.biopsych.2003.08.021; Liu ZF, 2010, PSYCHIAT RES-NEUROIM, V182, P211, DOI 10.1016/j.pscychresns.2010.03.004; Lui S, 2010, ARCH GEN PSYCHIAT, V67, P783, DOI 10.1001/archgenpsychiatry.2010.84; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Monkul ES, 2012, HUM BRAIN MAPP, V33, P272, DOI 10.1002/hbm.21212; Murray EA, 2007, ANN NY ACAD SCI, V1121, P273, DOI 10.1196/annals.1401.021; Nagafusa Y, 2012, J AFFECT DISORDERS, V140, P296, DOI 10.1016/j.jad.2012.03.026; Neumeister A, 2004, ARCH GEN PSYCHIAT, V61, P765, DOI 10.1001/archpsyc.61.8.765; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Price JL, 2007, ANN NY ACAD SCI, V1121, P54, DOI 10.1196/annals.1401.008; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rajkowska G, 2000, BIOL PSYCHIAT, V48, P766, DOI 10.1016/S0006-3223(00)00950-1; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; Scheuerecker J, 2010, J PSYCHIATR NEUROSCI, V35, P311, DOI 10.1503/jpn.090076; Shimamura AP, 2000, PSYCHOBIOLOGY, V28, P207; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Steingard RJ, 2000, BIOL PSYCHIAT, V48, P1053, DOI 10.1016/S0006-3223(00)00942-2; Tang Y, 2013, PSYCHOL MED, V43, P1921, DOI 10.1017/S0033291712002759; Tao H, 2013, MOL PSYCHIATR, V18, P101, DOI 10.1038/mp.2011.127; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Versace A, 2010, BIOL PSYCHIAT, V67, P422, DOI 10.1016/j.biopsych.2009.11.025; Victor TA, 2010, ARCH GEN PSYCHIAT, V67, P1128, DOI 10.1001/archgenpsychiatry.2010.144; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wu QZ, 2011, HUM BRAIN MAPP, V32, P1290, DOI 10.1002/hbm.21108; Yang HJ, 2004, J AFFECT DISORDERS, V82, P419, DOI 10.1016/j.jad.2004.04.008; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhong MT, 2012, PSYCHIAT RES-NEUROIM, V201, P107, DOI 10.1016/j.pscychresns.2011.06.003; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035	69	206	219	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85241	10.1371/journal.pone.0085241	http://dx.doi.org/10.1371/journal.pone.0085241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24933024	Green Submitted, Green Published, gold			2022-12-25	WOS:000329866300057
J	Park, S; Ang, RR; Duffy, SP; Bazov, J; Chi, KN; Black, PC; Ma, HS				Park, Sunyoung; Ang, Richard R.; Duffy, Simon P.; Bazov, Jenny; Chi, Kim N.; Black, Peter C.; Ma, Hongshen			Morphological Differences between Circulating Tumor Cells from Prostate Cancer Patients and Cultured Prostate Cancer Cells	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; LABEL-FREE ISOLATION; PERIPHERAL-BLOOD; IMMUNOCYTOCHEMICAL DETECTION; BONE-MARROW; SEPARATION; SIZE; PROGRESSION; SURVIVAL; MICROCHANNEL	Circulating tumor cell (CTC) enumeration promises to be an important predictor of clinical outcome for a range of cancers. Established CTC enumeration methods primarily rely on affinity capture of cell surface antigens, and have been criticized for underestimation of CTC numbers due to antigenic bias. Emerging CTC capture strategies typically distinguish these cells based on their assumed biomechanical characteristics, which are often validated using cultured cancer cells. In this study, we developed a software tool to investigate the morphological properties of CTCs from patients with castrate resistant prostate cancer and cultured prostate cancer cells in order to establish whether the latter is an appropriate model for the former. We isolated both CTCs and cultured cancer cells from whole blood using the CellSearch (R) system and examined various cytomorphological characteristics. In contrast with cultured cancer cells, CTCs enriched by CellSearch (R) system were found to have significantly smaller size, larger nuclear-cytoplasmic ratio, and more elongated shape. These CTCs were also found to exhibit significantly more variability than cultured cancer cells in nuclear-cytoplasmic ratio and shape profile.	[Park, Sunyoung; Ang, Richard R.; Duffy, Simon P.; Ma, Hongshen] Univ British Columbia, Dept Mech Engn, Vancouver, BC V6T 1W5, Canada; [Duffy, Simon P.] Kwantlen Polytech Univ, Dept Biol, Surrey, BC, Canada; [Bazov, Jenny; Chi, Kim N.; Ma, Hongshen] Vancouver Gen Hosp, Vancouver Prostate Ctr, Vancouver, BC, Canada; [Chi, Kim N.; Black, Peter C.] BC Canc Agcy, Vancouver Canc Ctr, Vancouver, BC, Canada; [Chi, Kim N.; Black, Peter C.; Ma, Hongshen] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Ma, HS (corresponding author), Univ British Columbia, Dept Mech Engn, Vancouver, BC V6T 1W5, Canada.	hongma@mech.ubc.ca	Black, Peter/AAE-8424-2020	Black, Peter/0000-0002-2919-7068; Dobrowski, Solomon/0000-0003-2561-3850; Miller, Carol/0000-0002-3091-5602	Natural Science and Engineering Research Council of Canada; Canadian Institutes of Health Research; Vancouver Prostate Centre's Translational Research Initiative for Accelerated Discovery and Development; Terry Fox Research Institute; Movember Global Action Plan (GAP) Prostate Cancer Biomarker Initiative; Engineers-in-Scrubs training program at UBC; Prostate Cancer Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Vancouver Prostate Centre's Translational Research Initiative for Accelerated Discovery and Development; Terry Fox Research Institute; Movember Global Action Plan (GAP) Prostate Cancer Biomarker Initiative; Engineers-in-Scrubs training program at UBC; Prostate Cancer Canada	This work was supported by grants from Natural Science and Engineering Research Council of Canada, Canadian Institutes of Health Research, Prostate Cancer Canada, Vancouver Prostate Centre's Translational Research Initiative for Accelerated Discovery and Development, Engineers-in-Scrubs training program at UBC, Terry Fox Research Institute, and an award from the Movember Global Action Plan (GAP) Prostate Cancer Biomarker Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alazzam A, 2011, ELECTROPHORESIS, V32, P1327, DOI 10.1002/elps.201000625; Alix-Panabieres C, 2012, ANNU REV MED, V63, P199, DOI 10.1146/annurev-med-062310-094219; Andreopoulou E, 2012, INT J CANCER, V130, P1590, DOI 10.1002/ijc.26111; Armstrong AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490; Bhagat AAS, 2008, LAB CHIP, V8, P1906, DOI 10.1039/b807107a; Borgen E, 1999, CYTOTHERAPY, V1, P377, DOI 10.1080/0032472031000141283; BREIER A, 1994, GEN PHYSIOL BIOPHYS, V13, P287; Chi KN, 2012, J CLIN ONCOL, V30; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Coumans FAW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061770; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Danila DC, 2007, CLIN CANCER RES, V13, P7053, DOI 10.1158/1078-0432.CCR-07-1506; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Desitter I, 2011, ANTICANCER RES, V31, P427; DONG C, 1991, BIORHEOLOGY, V28, P557; Fehm T, 2005, CYTOTHERAPY, V7, P171, DOI 10.1080/14653240510027082; Gascoyne PRC, 2009, ELECTROPHORESIS, V30, P1388, DOI 10.1002/elps.200800373; Gerhardt T, 2011, LAB CHIP, V11, P2731, DOI 10.1039/c1lc20092e; Hofman V, 2011, INT J CANCER, V129, P1651, DOI 10.1002/ijc.25819; Huang SB, 2013, LAB CHIP, V13, P1371, DOI 10.1039/c3lc41256c; Hur SC, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3576780; Hyun KA, 2013, BIOSENS BIOELECTRON, V40, P206, DOI 10.1016/j.bios.2012.07.021; Jin C, 2013, LAB CHIP; Joosse SA, 2012, CLIN CANCER RES, V18, P993, DOI 10.1158/1078-0432.CCR-11-2100; Kraeft SK, 2000, CLIN CANCER RES, V6, P434; Lazar DC, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016002; Ligthart ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067148; Lin HK, 2010, CLIN CANCER RES, V16, P5011, DOI 10.1158/1078-0432.CCR-10-1105; Marrinucci D, 2007, HUM PATHOL, V38, P514, DOI 10.1016/j.humpath.2006.08.027; Marrinucci D, 2010, J ONCOL, V2010, DOI 10.1155/2010/861341; Matrone MA, 2010, CANCER RES, V70, P7737, DOI 10.1158/0008-5472.CAN-10-1569; McFaul SM, 2012, LAB CHIP, V12, P2369, DOI 10.1039/c2lc21045b; Mehes G, 2001, AM J PATHOL, V159, P17, DOI 10.1016/S0002-9440(10)61667-7; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Miller MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/617421; Otsuka K, 2013, ANTICANCER RES, V33, P625; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; Pierga JY, 2004, CLIN CANCER RES, V10, P1392, DOI 10.1158/1078-0432.CCR-0102-03; Raimondi C, 2011, BREAST CANCER RES TR, V130, P449, DOI 10.1007/s10549-011-1373-x; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Rosenberg R, 2002, CYTOMETRY, V49, P150, DOI 10.1002/cyto.10161; Shaffer DR, 2007, CLIN CANCER RES, V13, P2023, DOI 10.1158/1078-0432.CCR-06-2701; SHI YA, 1993, BIOTECHNOL BIOENG, V41, P745, DOI 10.1002/bit.260410709; Shim S, 2011, INTEGR BIOL-UK, V3, P850, DOI 10.1039/c1ib00032b; Sim TS, 2011, LAB CHIP, V11, P93, DOI [10.1039/c0lc00109k, 10.1039/c01c00109k]; Song H, 2003, BIOTECHNOL PROGR, V19, P1742, DOI 10.1021/bp034061n; Sun JS, 2012, LAB CHIP, V12, P3952, DOI 10.1039/c2lc40679a; Tan SJ, 2010, BIOSENS BIOELECTRON, V26, P1701, DOI 10.1016/j.bios.2010.07.054; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; WEISS L, 1992, CANCER METAST REV, V11, P227, DOI 10.1007/BF01307179; Willipinski-Stapelfeldt B, 2005, CLIN CANCER RES, V11, P8006, DOI 10.1158/1078-0432.CCR-05-0632; Yap TA, 2010, NAT REV CANCER, V10, P514, DOI 10.1038/nrc2870; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zhe XN, 2011, AM J CANCER RES, V1, P740; Zheng SY, 2011, BIOMED MICRODEVICES, V13, P203, DOI 10.1007/s10544-010-9485-3; Zhou J, 2013, LAB CHIP, V13, P1919, DOI 10.1039/c3lc50101a	56	129	139	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85264	10.1371/journal.pone.0085264	http://dx.doi.org/10.1371/journal.pone.0085264			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416373	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500231
J	Zhang, LF; Qi, J; Zuo, GL; Jia, P; Shen, X; Shao, J; Kang, H; Yang, HL; Deng, LF				Zhang, Lian-Fang; Qi, Jin; Zuo, GuiLai; Jia, Peng; Shen, Xing; Shao, Jin; Kang, Hui; Yang, HuiLin; Deng, LianFu			Osteoblast-Secreted Factors Promote Proliferation and Osteogenic Differentiation of Bone Marrow Stromal Cells via VEGF/Heme-Oxygenase-1 Pathway	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; HEME OXYGENASE-1; FACTOR VEGF; IN-VITRO; MOUSE; ANGIOGENESIS; INHIBITION; EXPRESSION; SURVIVAL	The hypoxia-inducible factors (HIF alpha) are the critical factors that couple angiogenesis and osteogenesis by activating transcription of VEGF in osteoblasts. Mice lacking von Hippel-Lindau gene (Vhl), thus overexpressing HIF alpha in osteoblasts develop extremely dense and highly vascularized long bones. Here we provide evidence that osteoblasts lacking Vhl overexpress and secrete high levels of VEGF, which subsequently promotes the proliferation and osteogenic differentiation of bone marrow stromal cells (BMSC) by promoting expression of Heme oxygenase-1 (HO-1) in BMSC. Conditioned medium from osteoblasts Vhl (CM-CRE) promoted the proliferation and osteogenic differentiation of BMSC, in comparison with conditioned medium derived from normal osteoblasts (CM-GFP). Recombinant VEGF stimulated the proliferation and osteogenic differentiation of BMSC culturing in CM-GFP. By contrast, VEGF-neutralizing antibody inhibited the proliferation and osteogenic differentiation of BMSC culturing in CM-CRE. Treatment with a HO-1 inhibitor, SnPP, significantly inhibited VEGF-induced BMSC proliferation and osteogenic differentiation. On the contrary, activation of HO-1 with CoPP reversed the suppressing of VEGF-antibody on the proliferation and osteogesis of BMSC culturing in CM-CRE. These studies suggest that osteoblasts promote the proliferation and osteogenic differentiation of BMCS by VEGF/HO-1 pathway.	[Zhang, Lian-Fang; Qi, Jin; Zuo, GuiLai; Jia, Peng; Shen, Xing; Shao, Jin; Kang, Hui; Deng, LianFu] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai Inst Traumatol & Orthopaed,Shanghai Key, Shanghai 200030, Peoples R China; [Zhang, Lian-Fang; Yang, HuiLin] Soochow Univ, Affiliated Hosp 1, Dept Orthopaed, Suzhou, Peoples R China	Shanghai Jiao Tong University; Soochow University - China	Deng, LF (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai Inst Traumatol & Orthopaed,Shanghai Key, Shanghai 200030, Peoples R China.	deng_lianfu@hotmail.com		Xu, Yunan/0000-0001-6484-6118	International Cooperation and Exchange of the National Natural Science Foundation of China [81061160510]; Foundation of Science and Technology Commission of Shanghai Municipality [12JC1408200, 13431900702]; Graduate Student Innovation Fund of Shanghai Jiao Tong University School of Medicine [BXJ201242]	International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Graduate Student Innovation Fund of Shanghai Jiao Tong University School of Medicine	This work was supported by the funds from the International Cooperation and Exchange of the National Natural Science Foundation of China (No. 81061160510), the Foundation of Science and Technology Commission of Shanghai Municipality (No. 12JC1408200, No. 13431900702), and the Graduate Student Innovation Fund of Shanghai Jiao Tong University School of Medicine (No. BXJ201242). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM NG, 1985, EXP HEMATOL, V13, P838; ABRAHAM NG, 1991, BLOOD REV, V5, P19, DOI 10.1016/0268-960X(91)90004-V; Armour KE, 2001, ENDOCRINOLOGY, V142, P760, DOI 10.1210/en.142.2.760; Ball SG, 2007, J CELL BIOL, V177, P489, DOI 10.1083/jcb.200608093; Barbagallo I, 2010, J BONE MINER METAB, V28, P276, DOI 10.1007/s00774-009-0134-y; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bussolati B, 2004, BLOOD, V103, P761, DOI 10.1182/blood-2003-06-1974; Carlevaro MF, 2000, J CELL SCI, V113, P59; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Dennis JE, 1999, J BONE MINER RES, V14, P700, DOI 10.1359/jbmr.1999.14.5.700; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Garrett IR, 2001, CURR PHARM DESIGN, V7, P715, DOI 10.2174/1381612013397762; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Hiltunen MO, 2003, FASEB J, V17, P1147, DOI 10.1096/fj.02-0514fje; Hsiao FSH, 2010, CELL PROLIFERAT, V43, P235, DOI 10.1111/j.1365-2184.2010.00674.x; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Kweider N, 2011, J BIOL CHEM, V286, P42863, DOI 10.1074/jbc.M111.286880; Lin H, 2008, J CELL PHYSIOL, V216, P458, DOI 10.1002/jcp.21414; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Marinissen MJ, 2006, J BIOL CHEM, V281, P11332, DOI 10.1074/jbc.M512199200; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153; Penna C, 2013, J CELL MOL MED, V17, P192, DOI 10.1111/j.1582-4934.2012.01662.x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Sass G, 2003, HEPATOLOGY, V38, P909, DOI 10.1053/jhep.2003.50386; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Sun J, 2012, CELLS TISSUES ORGANS, V196, P510, DOI 10.1159/000339245; Sun SK, 2003, STEM CELLS, V21, P527, DOI 10.1634/stemcells.21-5-527; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Vanella L, 2010, BONE, V46, P236, DOI 10.1016/j.bone.2009.10.012; Wagner M, 2003, KIDNEY INT, V63, P1564, DOI 10.1046/j.1523-1755.2003.00897.x; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Yeh LCC, 1999, MOL CELL ENDOCRINOL, V153, P113, DOI 10.1016/S0303-7207(99)00076-3; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238	38	84	96	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99946	10.1371/journal.pone.0099946	http://dx.doi.org/10.1371/journal.pone.0099946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24416319	Green Published, Green Submitted, gold			2022-12-25	WOS:000338508200058
J	Erickson, ZT; Falkenberg, EA; Metz, GAS				Erickson, Zachary T.; Falkenberg, Erin A.; Metz, Gerlinde A. S.			Lifespan Psychomotor Behaviour Profiles of Multigenerational Prenatal Stress and Artificial Food Dye Effects in Rats	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RAT; ADHD SYMPTOMS; DISORDER ADHD; ANIMAL-MODEL; ANXIETY; CORTICOSTERONE; HYPERACTIVITY; ADDITIVES; DOPAMINE; TOXICITY	The consumption of artificial food dye (AFD) during childhood and adolescence has been linked to behavioural changes, such as hyperactivity. It is possible that the vulnerability to AFDs is modified by prenatal stress. Common consequences of prenatal stress include hyperactivity, thus potentially leading to synergistic actions with AFDs. Here, we investigated the compounding effect of multigenerational prenatal stress (MPS) and AFD consumption on the development of hyperactivity and anxiety-related behaviours across the lifespan in male rats. MPS treatment involved a family history of four consecutive generations of prenatal stress (F4 generation). AFD treatment included a 4%-concentration of FD&C Red 40, FD&C Yellow 5, FD&C Yellow 6, and FD&C Blue 1 in the drinking water from postnatal days 22 to 50 to resemble juvenile and adolescent dietary exposure. Using several exploration tasks, animals were tested in motor activity and anxiety-like behaviours from adolescence to 13 months of age. MPS resulted in hyperactivity both early (50 days) and later in life (13 months), with normalized activity patterns at reproductive age. AFD consumption resulted in hyperactivity during consumption, which subsided following termination of treatment. Notably, both MPS and AFD promoted risk-taking behaviour in young adults (3 months). There were few synergistic effects between MPS and AFD in this study. The findings suggest that AFDs exert the most noticeable effects at the time of exposure. MPS, however, results in a characteristic lifespan profile of behavioural changes, indicating that development and aging represent particularly vulnerable periods in life during which a family history of prenatal stress may precipitate.	[Erickson, Zachary T.; Falkenberg, Erin A.; Metz, Gerlinde A. S.] Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Metz, GAS (corresponding author), Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada.	gerlinde.metz@uleth.ca			Alberta Innovates-Health Solutions [200700595]; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research [102652]	Alberta Innovates-Health Solutions; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors acknowledge support by the Alberta Innovates-Health Solutions Interdisciplinary Team Grant #200700595 "Preterm Birth and Healthy Outcomes" (GM), grants from Alberta Innovates-Health Solutions (GM), the Natural Sciences and Engineering Research Council of Canada (GM), and the Canadian Institutes of Health Research #102652 (GM). GM is an AHFMR Senior Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold LE, 2012, NEUROTHERAPEUTICS, V9, P599, DOI 10.1007/s13311-012-0133-x; Bateman B, 2004, ARCH DIS CHILD, V89, P506, DOI 10.1136/adc.2003.031435; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Crespi EJ, 2005, AM J HUM BIOL, V17, P44, DOI 10.1002/ajhb.20098; Fernandez F, 2004, NEUROPSYCHOPHARMACOL, V29, P59, DOI 10.1038/sj.npp.1300308; Field T, 2008, INFANT BEHAV DEV, V31, P590, DOI 10.1016/j.infbeh.2008.07.007; FLORES CM, 1990, J NEUROIMMUNOL, V28, P219, DOI 10.1016/0165-5728(90)90015-F; Food and Drug Administration/Center for Food Safety and Applied Nutrition, 2011, BACKGR INF FOOD ADV; Gatzke-Kopp LM, 2011, NEUROSCI BIOBEHAV R, V35, P794, DOI 10.1016/j.neubiorev.2010.09.013; Glover V, 2011, J CHILD PSYCHOL PSYC, V52, P356, DOI 10.1111/j.1469-7610.2011.02371.x; Hao Y, 2013, NONGENETIC INHERITAN, V1, P9, DOI DOI 10.2478/NGI-2013-0001; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Holmes MC, 2006, J NEUROSCI, V26, P3840, DOI 10.1523/JNEUROSCI.4464-05.2006; Jadavji NM, 2011, NEUROENDOCRINOLOGY, V94, P278, DOI 10.1159/000329988; Jankord R, 2011, ENDOCRINOLOGY, V152, P629, DOI 10.1210/en.2010-0658; Kanarek RB, 2011, NUTR REV, V69, P385, DOI 10.1111/j.1753-4887.2011.00385.x; Korosi A, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.027.2009; Laloux C, 2012, PSYCHONEUROENDOCRINO, V37, P1646, DOI 10.1016/j.psyneuen.2012.02.010; Lau K, 2006, TOXICOL SCI, V90, P178, DOI 10.1093/toxsci/kfj073; Li Q, 2007, NEUROCHEM INT, V50, P848, DOI 10.1016/j.neuint.2007.02.005; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Matthews SG, 2010, ENDOCRINOLOGY, V151, P7, DOI 10.1210/en.2009-0916; McCann D, 2007, LANCET, V370, P1560, DOI 10.1016/S0140-6736(07)61306-3; Metz GA, 2005, EUR J NEUROSCI, V22, P1190, DOI 10.1111/j.1460-9568.2005.04285.x; Metz GA, 2007, REV NEUROSCIENCE, V18, P209; Nosek K, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-23; O'Connor TG, 2003, J CHILD PSYCHOL PSYC, V44, P1025, DOI 10.1111/1469-7610.00187; Park M, 2009, J TOXICOL ENV HEAL A, V72, P1412, DOI 10.1080/15287390903212816; Prediger RDS, 2005, INT J NEUROPSYCHOPH, V8, P583, DOI 10.1017/S1461145705005341; REISEN CA, 1986, NEUROTOXICOL TERATOL, V8, P317; Sagvolden T, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-6; Sandman CA, 2013, J PSYCHOSOM RES, V75, P327, DOI 10.1016/j.jpsychores.2013.07.009; Schab DW, 2004, J DEV BEHAV PEDIATR, V25, P423, DOI 10.1097/00004703-200412000-00007; Smith LK, 2008, EUR J NEUROSCI, V27, P2133, DOI 10.1111/j.1460-9568.2008.06177.x; Stevens LJ, 2011, CLIN PEDIATR, V50, P279, DOI 10.1177/0009922810384728; Tanaka T, 2006, FOOD CHEM TOXICOL, V44, P179, DOI 10.1016/j.fct.2005.06.011; Tanaka T, 2008, REPROD TOXICOL, V26, P156, DOI 10.1016/j.reprotox.2008.07.001; Vallee M, 1999, EUR J NEUROSCI, V11, P2906, DOI 10.1046/j.1460-9568.1999.00705.x; Van den Bergh BRH, 2004, CHILD DEV, V75, P1085, DOI 10.1111/j.1467-8624.2004.00727.x; VORHEES CV, 1983, TOXICOLOGY, V28, P207, DOI 10.1016/0300-483X(83)90118-X; Ward ID, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S9; Wilson CA, 2013, BEHAV BRAIN RES, V238, P279, DOI 10.1016/j.bbr.2012.10.003; Zucchi Fabiola C. R., 2012, Frontiers in Genetics, V3, P96, DOI 10.3389/fgene.2012.00096	43	44	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e92132	10.1371/journal.pone.0092132	http://dx.doi.org/10.1371/journal.pone.0092132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	25222738	Green Published, Green Submitted, gold			2022-12-25	WOS:000338503400001
J	Apitzsch, JC; Westphal, S; Penzkofer, T; Kuhl, CK; Knuchel, R; Mahnken, AH				Apitzsch, Jonas Christoph; Westphal, Saskia; Penzkofer, Tobias; Kuhl, Christiane Katharina; Knuechel, Ruth; Mahnken, Andreas H.			The Use of Contrast-Enhanced Post Mortem CT in the Detection of Cardiovascular Deaths	PLOS ONE			English	Article							DECLINING AUTOPSY RATE; POSTMORTEM ANGIOGRAPHY; VIRTOPSY; RATES	Objectives: To evaluate the diagnostic value of contrast enhanced post mortem computed tomography (PMCT) in comparison to non-enhanced post mortem CT in the detection of cardiovascular causes of death (COD). Background: As autopsy rates decline, new methods to determine CODs are necessary. So contrast enhanced PMCT shall be evaluated in comparison to established non-enhanced PMCT in order to further improve the method. Methods: In a prospective study, 20 corpses were examined using a 64-row multisclice CT (MSCT) before and after intraarterial perfusion with a newly developed, barium-bearing contrast agent and ventilation of the lungs. The cause of death was determined in enhanced and unenhanced scans and a level of confidence (LOC) was given by three experienced radiologists on a scale between 0 and 4. Results were compared to autopsy results as gold standard. Autopsy was performed blinded to PMCT-findings. Results: The method allowed visualization of different types of cause of death. There was a significant improvement in LOC in enhanced scans compared to unenhanced scans as well as an improvement in the detection of COD. The cause of death could be determined in 19 out of 20 patients. Conclusions: PMCT is feasible and appears to be robust for diagnosing cardiovascular causes of death. When compared with unenhanced post-mortem CT intraarterial perfusion and pulmonary ventilation significantly improve visualization and diagnostic accuracy. These promising results warrant further studies.	[Apitzsch, Jonas Christoph] Philipps Univ Hosp Marburg, Dept Diagnost & Intervent Radiol, Marburg, Germany; [Westphal, Saskia; Knuechel, Ruth] RWTH Aachen Univ Hosp, Dept Pathol, Aachen, Germany; [Penzkofer, Tobias] Rhein Westfal TH Aachen, Helmholtz Inst, Aachen, Germany; [Penzkofer, Tobias; Kuhl, Christiane Katharina; Mahnken, Andreas H.] RWTH Aachen Univ Hosp, Dept Diagnost & Intervent Radiol, Aachen, Germany	Philipps University Marburg; RWTH Aachen University; RWTH Aachen University Hospital; Helmholtz Association; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University Hospital	Apitzsch, JC (corresponding author), Philipps Univ Hosp Marburg, Dept Diagnost & Intervent Radiol, Marburg, Germany.	apitzsch@med.uni-marburg.de	Penzkofer, Tobias/AAW-8839-2020; Penzkofer, Tobias/AFN-1192-2022; Kuhl, Christiane K/H-3301-2013	Penzkofer, Tobias/0000-0001-9591-8575; Kuhl, Christiane K/0000-0001-8696-2363; Malvick, Dean/0000-0002-0131-8411; von Stillfried, Saskia/0000-0002-5260-8494; Mahnken, Andreas H./0000-0001-8077-9306				Brinkmann B, 2002, DEUT MED WOCHENSCHR, V127, P791, DOI 10.1055/s-2002-25021; Chariot P, 2000, ARCH PATHOL LAB MED, V124, P739; Davies DJ, 2004, MED J AUSTRALIA, V180, P281, DOI 10.5694/j.1326-5377.2004.tb05926.x; Ebert LC, 2012, J FORENSIC LEG MED, V19, P126, DOI 10.1016/j.jflm.2011.12.007; Grabherr S, 2008, AM J ROENTGENOL, V190, P345, DOI 10.2214/AJR.07.2261; Grabherr Silke, 2006, AJR Am J Roentgenol, V187, pW515, DOI 10.2214/AJR.05.1394; Grabherr S, 2007, AM J ROENTGENOL, V188, P832, DOI 10.2214/AJR.06.0787; Grabherr S, 2011, INT J LEGAL MED, V125, P791, DOI 10.1007/s00414-010-0526-5; Harrington DE, 2010, SOC SCI MED, V70, P191, DOI 10.1016/j.socscimed.2009.09.018; Ishiko T, 1989, Gan To Kagaku Ryoho, V16, P1920; Jackowski C, 2005, J FORENSIC SCI, V50, P1175; Jackowski C, 2006, J FORENSIC SCI, V51, P1134, DOI 10.1111/j.1556-4029.2006.00207.x; Lindstrom P, 1997, J INTERN MED, V242, P157, DOI 10.1046/j.1365-2796.1997.00178.x; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; McNamara JJ, 1971, JAMA, V216, P1185; Michiue T, 2012, FORENSIC SCI INT, V220, P232, DOI 10.1016/j.forsciint.2012.03.007; Roberts ISD, 2012, LANCET, V379, P136, DOI 10.1016/S0140-6736(11)61483-9; Ross S, 2008, AM J ROENTGENOL, V190, P1380, DOI 10.2214/AJR.07.3082; Ross SG, 2012, RADIOLOGY, V264, P250, DOI 10.1148/radiol.12092415; Ruder TD, 2011, LEGAL MED, V13, P91, DOI 10.1016/j.legalmed.2010.11.005; Smith M, 1999, ARCH PATHOL LAB MED, V123, P885; START RD, 1993, J PATHOL, V171, P63, DOI 10.1002/path.1711710113; Thali MJ, 2005, J FORENSIC SCI, V50, P428; Westphal SE, 2012, VIRCHOWS ARCH; ZAPATA MG, 1989, Z RECHTSMED, V103, P27, DOI 10.1007/BF01255843	25	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e93101	10.1371/journal.pone.0093101	http://dx.doi.org/10.1371/journal.pone.0093101			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759757	Green Published, Green Submitted, gold			2022-12-25	WOS:000335298200006
J	Yang, FL; Zhang, Q; Wang, RY; Zhou, J				Yang, Fulin; Zhang, Qiang; Wang, Runyuan; Zhou, Jing			Evapotranspiration Measurement and Crop Coefficient Estimation over a Spring Wheat Farmland Ecosystem in the Loess Plateau	PLOS ONE			English	Article							WATER-VAPOR; WINTER-WHEAT; MAIZE; TRANSPIRATION; MODEL; HEAT; FLUX; GRASSLAND; EXCHANGE; REGION	Evapotranspiration (ET) is an important component of the surface energy balance and hydrological cycle. In this study, the eddy covariance technique was used to measure ET of the semi-arid farmland ecosystem in the Loess Plateau during 2010 growing season (April to September). The characteristics and environmental regulations of ET and crop coefficient (Kc) were investigated. The results showed that the diurnal variation of latent heat flux (LE) was similar to single-peak shape for each month, with the largest peak value of LE occurring in August (151.4 W m(-2)). The daily ET rate of the semi-arid farmland in the Loess Plateau also showed clear seasonal variation, with the maximum daily ET rate of 4.69 mm day(-1). Cumulative ET during 2010 growing season was 252.4 mm, and lower than precipitation. Radiation was the main driver of farmland ET in the Loess Plateau, which explained 88% of the variances in daily ET (p<0.001). The farmland Kc values showed the obvious seasonal fluctuation, with the average of 0.46. The correlation analysis between daily Kc and its major environmental factors indicated that wind speed (Ws), relative humidity (RH), soil water content (SWC), and atmospheric vapor pressure deficit (VPD) were the major environmental regulations of daily Kc. The regression analysis results showed that Kc exponentially decreased with Ws increase, an exponentially increased with RH, SWC increase, and a linearly decreased with VPD increase. An experiential Kc model for the semi-arid farmland in the Loess Plateau, driven by Ws, RH, SWC and VPD, was developed, showing a good consistency between the simulated and the measured Kc values.	[Yang, Fulin; Zhang, Qiang; Wang, Runyuan] CMA, Inst Arid Meteorol, Key Open Lab Arid Climat Change & Disaster Reduct, Key Lab Arid Climat Change & Reducing Disaster Ga, Lanzhou, Peoples R China; [Zhou, Jing] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China	China Meteorological Administration; Lanzhou University	Zhang, Q (corresponding author), CMA, Inst Arid Meteorol, Key Open Lab Arid Climat Change & Disaster Reduct, Key Lab Arid Climat Change & Reducing Disaster Ga, Lanzhou, Peoples R China.	zhangqiang@cma.gov.cn	He, Zhili/C-2879-2012; 吴, 昊/AAB-1620-2020; Xu, Jian/G-8430-2012; Zhang, Qiang/B-6233-2012; Deng, Ye/X-4358-2019; Van Nostrand, Joy D/F-1740-2016; Ning, Kang/ABD-3446-2020	He, Zhili/0000-0001-8225-7333; Xu, Jian/0000-0002-0548-8477; Deng, Ye/0000-0002-7584-0632; Van Nostrand, Joy D/0000-0001-9548-6450; Tu, Qichao/0000-0002-3245-7545; Ning, Kang/0000-0003-3325-5387; Yang, Fulin/0000-0002-5530-0954; YANG, Fang/0000-0002-6783-972X	National Basic Research Program of China [2012CB955304, 2013CB430206]; National Natural Science Foundation of China [31300376, 40830957, 41275118, 41305134]; Natural Science Foundation of Gansu province [1208RJYA025]; China Postdoctoral Science Foundation [2012M512044]; Meteorological Research Program of Gansu Provincial Meteorological Service; Science Research Foundation for Drought Meteorology [IAM201312]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Gansu province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Meteorological Research Program of Gansu Provincial Meteorological Service; Science Research Foundation for Drought Meteorology	This research was jointly supported by National Basic Research Program of China (2012CB955304, 2013CB430206), National Natural Science Foundation of China (31300376, 40830957, 41275118, 41305134), Natural Science Foundation of Gansu province (1208RJYA025), China Postdoctoral Science Foundation (2012M512044), Meteorological Research Program of Gansu Provincial Meteorological Service (2012-15), and Science Research Foundation for Drought Meteorology (IAM201312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[张永强 Zhang Yongqiang], 2002, [地理学报, Acta Geographica Sinica], V57, P333; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Baldocchi D, 1998, AGR FOREST METEOROL, V90, P1, DOI 10.1016/S0168-1923(97)00072-5; Burba GG, 2005, AGR FOREST METEOROL, V135, P190, DOI 10.1016/j.agrformet.2005.11.017; Ding RS, 2013, AGR FOREST METEOROL, V168, P140, DOI 10.1016/j.agrformet.2012.08.003; Falge E, 2001, AGR FOREST METEOROL, V107, P71, DOI 10.1016/S0168-1923(00)00235-5; [郭家选 GUO JiaXuan], 2006, [生态学报, Acta Ecologica Sinica], V26, P130; Jung M, 2010, NATURE, V467, P951, DOI 10.1038/nature09396; Kang SZ, 2003, AGR WATER MANAGE, V59, P239, DOI 10.1016/S0378-3774(02)00150-6; Kimura R, 2006, ACTA OECOL, V29, P45, DOI 10.1016/j.actao.2005.07.003; Kite G, 2000, J HYDROL, V229, P59, DOI 10.1016/S0022-1694(99)00199-7; Lei HM, 2010, AGR FOREST METEOROL, V150, P581, DOI 10.1016/j.agrformet.2010.01.022; Li SG, 2005, HYDROL PROCESS, V19, P517, DOI 10.1002/hyp.5673; Li Yi-Jun, 2007, Zhiwu Shengtai Xuebao, V31, P1132; Li YL, 2003, AGR WATER MANAGE, V61, P1, DOI 10.1016/S0378-3774(02)00177-4; [李志 Li Zhi], 2012, [生态学报, Acta Ecologica Sinica], V32, P4139; Li Zhi, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P106; Liu CM, 2002, AGR FOREST METEOROL, V111, P109, DOI 10.1016/S0168-1923(02)00015-1; Lockwood JG, 1999, CLIMATIC CHANGE, V41, P193, DOI 10.1023/A:1005469416067; Papale D, 2006, BIOGEOSCIENCES, V3, P571, DOI 10.5194/bg-3-571-2006; Pauwels VRN, 2006, AGR WATER MANAGE, V82, P1, DOI 10.1016/j.agwat.2005.06.001; Qin Z, 2004, SCI CHINA SER D, V34, P183; Suyker AE, 2008, AGR FOREST METEOROL, V148, P417, DOI 10.1016/j.agrformet.2007.10.005; Trezza R, 2013, REMOTE SENS-BASEL, V5, P5397, DOI 10.3390/rs5105397; Villalobos FJ, 2013, AGR FOREST METEOROL, V171, P93, DOI 10.1016/j.agrformet.2012.11.010; Wang GY, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013372; Wang KC, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000373; Wang YouQi, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P6; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Xuan SL, 2011, ADV ATMOS SCI, V28, P387, DOI 10.1007/s00376-010-0111-3; Yang FL, 2011, J HYDROL, V396, P139, DOI 10.1016/j.jhydrol.2010.11.001; Yang K, 2008, SCI CHINA SER D, V51, P721, DOI 10.1007/s11430-008-0036-1; [杨晓光 Yang Xiaohua], 2003, [中国生态农业学报, Chinese journal of eco-agriculture], V11, P66; Yu GR, 2006, AGR FOREST METEOROL, V137, P125, DOI 10.1016/j.agrformet.2006.02.011; Yu WY, 2008, ACTA ECOL SINICA, V28, P4894; Zhang BZ, 2013, IRRIGATION SCI, V31, P1303, DOI 10.1007/s00271-013-0405-1; Zhang Q, 2011, CHINESE J GEOPHYS-CH, V54, P1727, DOI 10.3969/j.issn.0001-5733.2011.07.005; 信忠保, 2007, [中国科学. D辑, 地球科学, Science in China. Series D, Earth Sciences], V37, P1504	38	98	102	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100031	10.1371/journal.pone.0100031	http://dx.doi.org/10.1371/journal.pone.0100031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941017	Green Published, gold, Green Submitted			2022-12-25	WOS:000338508200068
J	Li, X; Wu, LH; Liu, W; Jin, YC; Chen, Q; Wang, LL; Fan, XH; Li, Z; Cheng, YY				Li, Xiang; Wu, Leihong; Liu, Wei; Jin, Yecheng; Chen, Qian; Wang, Linli; Fan, Xiaohui; Li, Zheng; Cheng, Yiyu			A Network Pharmacology Study of Chinese Medicine QiShenYiQi to Reveal Its Underlying Multi-Compound, Multi-Target, Multi-Pathway Mode of Action	PLOS ONE			English	Article							PPAR-GAMMA AGONISTS; SIGNALING PATHWAYS; HEME OXYGENASE-1; RAW264.7; EXPRESSION; MECHANISMS; PROTEIN; LIPOPOLYSACCHARIDE; INFLAMMATION; THERAPEUTICS	Chinese medicine is a complex system guided by traditional Chinese medicine (TCM) theories, which has proven to be especially effective in treating chronic and complex diseases. However, the underlying modes of action (MOA) are not always systematically investigated. Herein, a systematic study was designed to elucidate the multi-compound, multi-target and multi-pathway MOA of a Chinese medicine, QiShenYiQi (QSYQ), on myocardial infarction. QSYQ is composed of Astragalus membranaceus (Huangqi), Salvia miltiorrhiza (Danshen), Panax notoginseng (Sanqi), and Dalbergia odorifera (Jiangxiang). Male Sprague Dawley rat model of myocardial infarction were administered QSYQ intragastrically for 7 days while the control group was not treated. The differentially expressed genes (DEGs) were identified from myocardial infarction rat model treated with QSYQ, followed by constructing a cardiovascular disease (CVD)-related multilevel compound-target-pathway network connecting main compounds to those DEGs supported by literature evidences and the pathways that are functionally enriched in ArrayTrack. 55 potential targets of QSYQ were identified, of which 14 were confirmed in CVD-related literatures with experimental supporting evidences. Furthermore, three sesquiterpene components of QSYQ, Trans-nerolidol, (3S, 6S, 7R)-3,7,11-trimethyl-3,6-epoxy-1,10-dodecadien-7-ol and (3S, 6R, 7R)-3,7,11-trimethyl- 3,6-epoxy-1,10-dodecadien-7-ol from Dalbergia odorifera T. Chen, were validated experimentally in this study. Their anti-inflammatory effects and potential targets including extracellular signal-regulated kinase-1/2, peroxisome proliferator-activated receptor-gamma and heme oxygenase-1 were identified. Finally, through a three-level compound-target-pathway network with experimental analysis, our study depicts a complex MOA of QSYQ on myocardial infarction.	[Li, Xiang; Wu, Leihong; Liu, Wei; Jin, Yecheng; Chen, Qian; Wang, Linli; Fan, Xiaohui; Cheng, Yiyu] Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Zheng] Tianjin Univ Tradit Chinese Med, State Key Lab Modern Chinese Med, Tianjin, Peoples R China	Zhejiang University; Tianjin University of Traditional Chinese Medicine	Fan, XH (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China.	fanxh@zju.edu.cn; lizheng1@gmail.com	Wu, Leihong/AAM-9483-2020; FAN, Xiaohui/F-6458-2010; Bligh, S W Annie/AAI-9786-2020	Wu, Leihong/0000-0002-4093-3708; FAN, Xiaohui/0000-0002-6336-3007; Bligh, S W Annie/0000-0002-4757-2159; LI, Xiaojun/0000-0003-0336-8081	National Basic Research Program of China [2012CB518405]; National Natural Science Foundation of China [81373893]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Basic Research Program of China (no. 2012CB518405) and the National Natural Science Foundation of China (no. 81373893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Microarray test was performed by National Engineering Center for Biochip at Shanghai by Dr. Huasheng Xiao's team.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; Aramoto H, 2004, AM J PHYSIOL-HEART C, V287, pH1590, DOI 10.1152/ajpheart.00767.2003; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Campbell IW, 2005, CURR MOL MED, V5, P349, DOI 10.2174/1566524053766068; Chao W, 2009, AM J PHYSIOL-HEART C, V296, pH1, DOI 10.1152/ajpheart.00995.2008; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chen T, 2011, JIANGXI MED J, V46, P3; Cheung F, 2011, NATURE, V480, pS82, DOI 10.1038/480S82a; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Diez D, 2010, MOL BIOSYST, V6, P289, DOI 10.1039/b912078e; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Finck BN, 2007, CARDIOVASC RES, V73, P269, DOI 10.1016/j.cardiores.2006.08.023; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hirota SA, 2009, RECENT PATENTS INFLA, V3, P1, DOI 10.2174/187221309787158434; Hong SeChul, 2012, Journal of Medicinal Plants Research, V6, P4494; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Humar R, 2002, FASEB J, V16, DOI 10.1096/fj.01-0658com; Jeong JB, 2013, FOOD CHEM TOXICOL, V55, P229, DOI 10.1016/j.fct.2012.12.062; Ji HY, 2010, INFLAMM RES, V59, P921, DOI 10.1007/s00011-010-0203-7; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jiang WY, 2005, TRENDS PHARMACOL SCI, V26, P558, DOI 10.1016/j.tips.2005.09.006; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kim BC, 2006, J ETHNOPHARMACOL, V106, P364, DOI 10.1016/j.jep.2006.01.009; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kronke G, 2007, ARTERIOSCL THROM VAS, V27, P1276, DOI 10.1161/ATVBAHA.107.142638; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee M, 2012, STRAD, V123, P7; Li YF, 2008, J PHARMACEUT BIOMED, V47, P407, DOI 10.1016/j.jpba.2007.12.037; Li YF, 2008, CHROMATOGRAPHIA, V67, P293, DOI 10.1365/s10337-007-0479-0; Lin HY, 2003, BIOCHEM PHARMACOL, V66, P1821, DOI 10.1016/S0006-2952(03)00422-2; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Martin H, 2009, MUTAT RES-FUND MOL M, V669, P1, DOI 10.1016/j.mrfmmm.2009.06.009; Miksa M, 2007, J IMMUNOL, V179, P6263, DOI 10.4049/jimmunol.179.9.6263; Murphy GJ, 2000, TRENDS PHARMACOL SCI, V21, P469, DOI 10.1016/S0165-6147(00)01559-5; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Palojoki E, 2001, AM J PHYSIOL-HEART C, V280, pH2726, DOI 10.1152/ajpheart.2001.280.6.H2726; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Robinson ES, 2010, SEMIN NEPHROL, V30, P591, DOI 10.1016/j.semnephrol.2010.09.007; Sawle P, 2005, BRIT J PHARMACOL, V145, P800, DOI 10.1038/sj.bjp.0706241; Suefuji H, 1997, AM HEART J, V134, P253, DOI 10.1016/S0002-8703(97)70132-7; Suh SJ, 2006, ARCH BIOCHEM BIOPHYS, V447, P136, DOI 10.1016/j.abb.2006.01.016; Tang S, 2011, INFLAMMATION, V34, P111, DOI 10.1007/s10753-010-9214-3; Tao Y, 2010, FITOTERAPIA, V81, P393, DOI 10.1016/j.fitote.2009.11.012; Terzic A, 2011, CTS-CLIN TRANSL SCI, V4, P225, DOI 10.1111/j.1752-8062.2011.00295.x; Timmers L, 2008, CIRC RES, V102, P257, DOI 10.1161/CIRCRESAHA.107.158220; Tong WD, 2003, ENVIRON HEALTH PERSP, V111, P1819, DOI 10.1289/ehp.6497; von Knethen A, 2011, FREE RADICAL BIO MED, V51, P396, DOI 10.1016/j.freeradbiomed.2011.04.033; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001; Waldman SA, 2011, CLIN PHARMACOL THER, V90, P483, DOI 10.1038/clpt.2011.213; Wang Linli, 2013, Evid Based Complement Alternat Med, V2013, P652373, DOI 10.1155/2013/652373; [魏万林 WEI Wan-lin], 2009, [中国循环杂志, Chinese Circulation Journal], V24, P182; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Wu Leihong, 2013, Database (Oxford), V2013, pbat047, DOI 10.1093/database/bat047; Xing B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-4; Yamaguchi F, 1997, J MOL CELL CARDIOL, V29, P753, DOI 10.1006/jmcc.1996.0319; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yan F. F., 2007, SHANGHAI J TRADITION, V41, P59; Yaoita H, 2000, CARDIOVASC RES, V45, P630, DOI 10.1016/S0008-6363(99)00349-1; Zaytseva YY, 2011, ANTICANCER RES, V31, P813; Zhang L, 2010, INT J CARDIOL, V143, P105, DOI 10.1016/j.ijcard.2008.11.210; Zhang YF, 2012, CURR DRUG METAB, V13, P510, DOI 10.2174/1389200211209050510; Zhao S, 2012, ANNU REV PHARMACOL, V52, P505, DOI 10.1146/annurev-pharmtox-010611-134520; Zheng XH, 2007, AM J CHINESE MED, V35, P831, DOI 10.1142/S0192415X07005302; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008; 朱明丹, 2013, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V24, P22; 刘梅, 2009, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V20, P829	80	220	235	12	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e95004	10.1371/journal.pone.0095004	http://dx.doi.org/10.1371/journal.pone.0095004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24587076	Green Published, Green Submitted, gold			2022-12-25	WOS:000336838000010
J	Liu, N; Lin, ZF; Guan, LL; Gaughan, G; Lin, GZ				Liu, Nan; Lin, Zhifang; Guan, Lanlan; Gaughan, Gerald; Lin, Guizhu			Antioxidant Enzymes Regulate Reactive Oxygen Species during Pod Elongation in Pisum sativum and Brassica chinensis	PLOS ONE			English	Article							HYDROXYL RADICALS; HYDROGEN-PEROXIDE; CELL-WALL; ROOT; SUPEROXIDE; GROWTH; LEAVES; H2O2	Previous research has focused on the involvement of reactive oxygen species (ROS) in cell wall loosening and cell extension in plant vegetative growth, but few studies have investigated ROS functions specifically in plant reproductive organs. In this study, ROS levels and antioxidant enzyme activities were assessed in Pisum sativum and Brassica chinensis pods at five developmental stages. In juvenile pods, the high levels of O-2(-) and OH indicates that they had functions in cell wall loosening and cell elongation. In later developmental stages, high levels of. OH were also related to increases in cell wall thickness in lignified tissues. Throughout pod development, most of the O-2(-) was detected on plasma membranes of parenchyma cells and outer epidermis cells of the mesocarp, while most of the H2O2 was detected on plasma membranes of most cells throughout the mesocarp. This suggests that these sites are presumably the locations of ROS generation. The antioxidant enzymes superoxide dismutase (SOD), peroxidase (POD), and catalase (CAT) apparently contributed to ROS accumulation in pod wall tissues. Furthermore, specifically SOD and POD were found to be associated with pod growth through the regulation of ROS generation and transformation. Throughout pod development, O-2(-) decreases were associated with increased SOD activity, while changes in H2O2 accumulation were associated with changes in CAT and POD activities. Additionally, high POD activity may contribute to the generation of. OH in the early development of pods. It is concluded that the ROS are produced in different sites of plasma membranes with the regulation of antioxidant enzymes, and that substantial ROS generation and accumulation are evident in cell elongation and cell wall loosening in pod wall cells.	[Liu, Nan; Lin, Zhifang; Guan, Lanlan; Lin, Guizhu] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Gaughan, Gerald] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lin, ZF (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	linzhif@scbg.ac.cn	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	China Scholarship Council [201204910138]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The current study was supported by China Scholarship Council (No. 201204910138, http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; BARRETO JC, 1994, LIFE SCI, V56, pPL89, DOI 10.1016/0024-3205(94)00925-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carol RJ, 2006, J EXP BOT, V57, P1829, DOI 10.1093/jxb/erj201; Derbyshire P, 2007, J EXP BOT, V58, P2079, DOI 10.1093/jxb/erm074; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fry SC, 2001, BIOCHEM J, V357, P729, DOI 10.1042/0264-6021:3570729; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; GILBERT DL, 1981, OXYGEN LIVING PROCES; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Ivakov A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00439; Ivanchenko MG, 2013, ANN BOT, DOI [10.1093/aob/mct181, DOI 10.1093/A0B/MCT181]; Johnansen DA, 1940, PLANT MICROTECHNIQUE; Kranner I, 2010, J PLANT PHYSIOL, V167, P805, DOI 10.1016/j.jplph.2010.01.019; Kukavica B, 2009, PLANT CELL PHYSIOL, V50, P304, DOI 10.1093/pcp/pcn199; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Liu N, 2013, J PLANT GROWTH REGUL, V32, P83, DOI 10.1007/s00344-012-9278-4; Liu N, 2010, ECOTOX ENVIRON SAFE, V73, P1238, DOI 10.1016/j.ecoenv.2010.06.017; Muller K, 2009, PLANT PHYSIOL, V150, P1855, DOI 10.1104/pp.109.139204; Perl RT., 2002, OXIDATIVE STRESS PLA, P1; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1122, DOI 10.1111/j.1365-3040.2004.01217.x; Barcelo AR, 2009, SIGNAL COMMUN PLANTS, P73, DOI 10.1007/978-3-642-00390-5_5; Schopfer P, 2006, BIOFACTORS, V28, P73, DOI 10.1002/biof.5520280202; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Yang XF, 2001, ANALYST, V126, P928, DOI 10.1039/b100085n; ZENG S-X, 1991, Acta Phytophysiologica Sinica, V17, P177; [张玲玲 ZHANG LingLing], 2006, [生态学报, Acta Ecologica Sinica], V26, P1330, DOI 10.1016/S1872-2032(06)60025-5	32	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87588	10.1371/journal.pone.0087588	http://dx.doi.org/10.1371/journal.pone.0087588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000330631800048
J	Hobbelen, PHF; Paveley, ND; van den Bosch, F				Hobbelen, Peter H. F.; Paveley, Neil D.; van den Bosch, Frank			The Emergence of Resistance to Fungicides	PLOS ONE			English	Article							STRESS-INDUCED MUTAGENESIS; MYCOSPHAERELLA-GRAMINICOLA; PESTICIDE RESISTANCE; SPRAY HETEROGENEITY; SEPTORIA-TRITICI; SELECTION; MIXTURES; PATHOGEN; MODEL; POPULATIONS	Many studies exist about the selection phase of fungicide resistance evolution, where a resistant strain is present in a pathogen population and is differentially selected for by the application of fungicides. The emergence phase of the evolution of fungicide resistance - where the resistant strain is not present in the population and has to arise through mutation and subsequently invade the population - has not been studied to date. Here, we derive a model which describes the emergence of resistance in pathogen populations of crops. There are several important examples where a single mutation, affecting binding of a fungicide with the target protein, shifts the sensitivity phenotype of the resistant strain to such an extent that it cannot be controlled effectively('qualitative' or 'single-step' resistance). The model was parameterized for this scenario for Mycosphaerella graminicola on winter wheat and used to evaluate the effect of fungicide dose rate on the time to emergence of resistance for a range of mutation probabilities, fitness costs of resistance and sensitivity levels of the resistant strain. We also evaluated the usefulness of mixing two fungicides of differing modes of action for delaying the emergence of resistance. The results suggest that it is unlikely that a resistant strain will already have emerged when a fungicide with a new mode of action is introduced. Hence, 'anti-emergence' strategies should be identified and implemented. For all simulated scenarios, the median emergence time of a resistant strain was affected little by changing the dose rate applied, within the range of doses typically used on commercial crops. Mixing a single-site acting fungicide with a multi-site acting fungicide delayed the emergence of resistance to the single-site component. Combining the findings with previous work on the selection phase will enable us to develop more efficient anti-resistance strategies.	[Hobbelen, Peter H. F.; van den Bosch, Frank] Rothamsted Res, Harpenden, Herts, England; [Paveley, Neil D.] ADAS UK Ltd, Malton, N Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	van den Bosch, F (corresponding author), Rothamsted Res, Harpenden, Herts, England.	frank.vandenbosch@rothamsted.ac.uk	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Biological and Biotechnological Research Council of the United Kingdom; Department for Environment, Food and Rural Affairs of the United Kingdom [PS2712]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Biological and Biotechnological Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs of the United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives support from the Biological and Biotechnological Research Council of the United Kingdom. Part of this research was funded by the Department for Environment, Food and Rural Affairs of the United Kingdom (project number PS2712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch CPD, 1997, J APPL ECOL, V34, P1032, DOI 10.2307/2405292; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Carnegie SF, 2008, POTATO RES, V51, P113, DOI 10.1007/s11540-008-9094-1; DOSTER MA, 1990, PHYTOPATHOLOGY, V80, P1190, DOI 10.1094/Phyto-80-1190; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Fraaije BA, 2005, PHYTOPATHOLOGY, V95, P933, DOI 10.1094/PHYTO-95-0933; Fraaije BA, 2012, MOL PLANT PATHOL, V13, P263, DOI 10.1111/j.1364-3703.2011.00746.x; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Genet JL, 2006, PEST MANAG SCI, V62, P188, DOI 10.1002/ps.1146; Grabski C., 1985, BRIT CROP PROT C MON, V31, P315; Grimmer M, 2011, RESISTANCE 2011, P94; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; Hall RJ, 2007, B MATH BIOL, V69, P525, DOI 10.1007/s11538-006-9139-z; Hall RJ, 2004, B MATH BIOL, V66, P825, DOI 10.1016/j.bulm.2003.11.006; HOARE FA, 1986, PLANT PATHOL, V35, P506, DOI 10.1111/j.1365-3059.1986.tb02048.x; Hobbelen PHF, 2013, PHYTOPATHOLOGY, V103, P690, DOI 10.1094/PHYTO-06-12-0142-R; Hobbelen PHF, 2011, PHYTOPATHOLOGY, V101, P1224, DOI 10.1094/PHYTO-10-10-0290; Hobbelen PHF, 2011, PLANT PATHOL, V60, P304, DOI 10.1111/j.1365-3059.2010.02380.x; Horsten JAHM, 1979, THESIS WAGENINGEN U; HUNTER T, 1987, ANN APPL BIOL, V110, P515, DOI 10.1111/j.1744-7348.1987.tb04169.x; Iwasa Y, 2004, J THEOR BIOL, V226, P205, DOI 10.1016/j.jtbi.2003.08.014; JOSEPOVITS G, 1989, CROP PROT, V8, P106, DOI 10.1016/0261-2194(89)90084-7; Kang JM, 2006, FASEB J, V20, P2476, DOI 10.1096/fj.06-6209com; LaMondia J. A., 2001, Journal of Environmental Horticulture, V19, P51; Mavroeidi VI, 2006, PLANT PATHOL, V55, P715, DOI 10.1111/j.1365-3059.2006.01441.x; McCartney C, 2007, CROP PROT, V26, P1272, DOI 10.1016/j.cropro.2006.10.027; Metcalfe RJ, 2000, PLANT PATHOL, V49, P546, DOI 10.1046/j.1365-3059.2000.00486.x; MILGROOM MG, 1990, PHYTOPATHOLOGY, V80, P410, DOI 10.1094/Phyto-80-410; Parnell S, 2006, PHYTOPATHOLOGY, V96, P549, DOI 10.1094/PHYTO-96-0549; Parnell S, 2005, PHYTOPATHOLOGY, V95, P632, DOI 10.1094/PHYTO-95-0632; Paveley ND, 2011, HGCA WHEAT DIS MANAG; Robert C, 2008, FUNCT PLANT BIOL, V35, P997, DOI 10.1071/FP08066; SANDERS PL, 1985, PLANT DIS, V69, P939; SANOAMUANG N, 1995, MYCOL RES, V99, P677, DOI 10.1016/S0953-7562(09)80527-3; Serra MC, 2007, THEOR POPUL BIOL, V72, P167, DOI 10.1016/j.tpb.2007.01.005; Serra MC, 2006, J APPL PROBAB, V43, P296, DOI 10.1239/jap/1143936262; Shaw MW, 2000, PHYTOPATHOLOGY, V90, P333, DOI 10.1094/PHYTO.2000.90.4.333; SHAW MW, 1993, CROP PROT, V12, P120, DOI 10.1016/0261-2194(93)90138-9; Tenaillon O, 2004, TRENDS MICROBIOL, V12, P264, DOI 10.1016/j.tim.2004.04.002; Thornley JHM., 1990, PLANT CROP MODELLING; Thygesen K, 2009, EUR J PLANT PATHOL, V123, P435, DOI 10.1007/s10658-008-9381-3; Turechek WW, 2004, PLANT HLTH PROG; VALI RJ, 1992, PLANT DIS, V76, P919, DOI 10.1094/PD-76-0919; van den Bosch F, 2011, PLANT PATHOL, V60, P597, DOI 10.1111/j.1365-3059.2011.02439.x; van den Bosch F, 2008, ANNU REV PHYTOPATHOL, V46, P123, DOI 10.1146/annurev.phyto.011108.135838; WAGGONER PE, 1987, PHYTOPATHOLOGY, V77, P393; Zhang CQ, 2008, ANN APPL BIOL, V153, P205, DOI 10.1111/j.1744-7348.2008.00248.x	48	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91910	10.1371/journal.pone.0091910	http://dx.doi.org/10.1371/journal.pone.0091910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300044
J	da Silva, VCP; Bertin, A; Blin, A; Germain, JF; Bernardi, D; Rignol, G; Botton, M; Malausa, T				Pacheco da Silva, Vitor C.; Bertin, Aline; Blin, Aurelie; Germain, Jean-Francois; Bernardi, Daniel; Rignol, Guylene; Botton, Marcos; Malausa, Thibaut			Molecular and Morphological Identification of Mealybug Species (Hemiptera: Pseudococcidae) in Brazilian Vineyards	PLOS ONE			English	Article							FERRISIA FULLAWAY HEMIPTERA; SCALE INSECTS HEMIPTERA; EXPORT GRAPE PRODUCTION; MULTIPLEX PCR; PEST; PHYLOGENY; MARKERS	Mealybugs (Hemiptera: Pseudococcidae) are pests constraining the international trade of Brazilian table grapes. They damage grapes by transmitting viruses and toxins, causing defoliation, chlorosis, and vigor losses and favoring the development of sooty mold. Difficulties in mealybug identification remain an obstacle to the adequate management of these pests. In this study, our primary aim was to identify the principal mealybug species infesting the major table grape-producing regions in Brazil, by morphological and molecular characterization. Our secondary aim was to develop a rapid identification kit based on species-specific Polymerase Chain Reactions, to facilitate the routine identification of the most common pest species. We surveyed 40 sites infested with mealybugs and identified 17 species: Dysmicoccus brevipes (Cockerell), Dysmicoccus sylvarum Williams and Granara de Willink, Dysmicoccus texensis (Tinsley), Ferrisia cristinae Kaydan and Gullan, Ferrisia meridionalis Williams, Ferrisia terani Williams and Granara de Willink, Phenacoccus baccharidis Williams, Phenacoccus parvus Morrison, Phenacoccus solenopsis Tinsley, Planococcus citri (Risso), Pseudococcus viburni (Signoret), Pseudococcus cryptus Hempel, four taxa closely related each of to Pseudococcus viburni, Pseudococcus sociabilis Hambleton, Pseudococcus maritimus (Ehrhorn) and Pseudococcus meridionalis Prado, and one specimen from the genus Pseudococcus Westwood. The PCR method developed effectively identified five mealybug species of economic interest on grape in Brazil: D. brevipes, Pl. citri, Ps. viburni, Ph. solenopsis and Planococcus ficus (Signoret). Nevertheless, it is not possible to assure that this procedure is reliable for taxa that have not been sampled already and might be very closely related to the target species.	[Pacheco da Silva, Vitor C.; Botton, Marcos] Embrapa Uva & Vinho, Bento Goncalves, Brazil; [Bertin, Aline; Bernardi, Daniel] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Blin, Aurelie; Rignol, Guylene; Malausa, Thibaut] INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, F-06903 Sophia Antipolis, France; [Germain, Jean-Francois] ANSES, Lab Sante Vegetaux, Unite Entomol & Plantes Invas, Montferrier Sur Lez, France	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Malausa, T (corresponding author), INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, BP 167, F-06903 Sophia Antipolis, France.	tmalausa@sophia.inra.fr	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	European Union [265865, 269196, 324475]; French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS) [1001001]; Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	European Union(European Commission); French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS); Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Union Seventh Framework Programme FP7-KBBE #265865 "PURE'', FP7-IRSES #269196 "IPRABIO'' and FP7-IAPP #324475 "COLBICS'' and by the French grants Agropolis Fondation (http://www.agropolis-fondation.fr/) (RTRA - Montpellier, BIOFIS project number 1001001) and 'Bibliotheque du Vivant'. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Rabou S, 2012, B ENTOMOL RES, V102, P515, DOI 10.1017/S0007485312000041; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Ben-Dov Y, 2012, SCALENET DATABASE SC; Bertin S, 2010, PHYTOPARASITICA, V38, P401, DOI 10.1007/s12600-010-0109-5; Beuning LL, 1999, J ECON ENTOMOL, V92, P463, DOI 10.1093/jee/92.2.463; Camargo UA, 2011, REV BRAS FRUTIC, V33, P144, DOI 10.1590/S0100-29452011000500017; Cavalieri V, 2008, ZOOTAXA, P65, DOI 10.11646/zootaxa.1816.1.6; Charles J. G., 2006, New Zealand Plant Protection, V59, P330; Charles JG, 2011, BIOCONTROL, V56, P155, DOI 10.1007/s10526-010-9322-x; Correa L. R. B., 2005, Laranja, V26, P265; Correa MCG, 2012, B ENTOMOL RES, V102, P524, DOI 10.1017/S0007485312000053; Correa M, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2926.1.2; Santa-Cecilia LVC, 2009, ACTA SCI-AGRON, V31, P13, DOI 10.4025/actasciagron.v31i1.6603; Culik Mark Paul, 2007, Biota Neotrop., V7, P61, DOI 10.1590/S1676-06032007000300006; Culik MP, 2005, ZOOTAXA, P1; Daane KM, 2008, CALIF AGR, V62, P167, DOI 10.3733/ca.v062n04p167; Daane Kent M., 2012, P271; Daane KM, 2011, ENVIRON ENTOMOL, V40, P1595, DOI 10.1603/EN11075; Granara De Willink María Cristina, 2007, Rev. Soc. Entomol. Argent., V66, P29; Demontis MA, 2007, J APPL ENTOMOL, V131, P59, DOI 10.1111/j.1439-0418.2006.01126.x; Foldi Imre, 2005, Nouvelle Revue d'Entomologie, V22, P305; GARAU R, 1995, VITIS, V34, P67; Gimpel William F. Jr, 1996, Contributions on Entomology International, V2, P1; Golino D. A., 2002, California Agriculture, V56, P196, DOI 10.3733/ca.v056n06p196; Gonzalez R. H., 2004, Revista Fruticola, V25, P41; Gullan PJ, 2010, SYST ENTOMOL, V35, P329, DOI 10.1111/j.1365-3113.2009.00513.x; Gullan PJ, 2003, ANN ENTOMOL SOC AM, V96, P723, DOI 10.1603/0013-8746(2003)096[0723:ANPSOT]2.0.CO;2; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kaydan MB, 2012, ZOOTAXA, P1; Kuniyuki Hugo, 2006, Summa phytopathol., V32, P151, DOI 10.1590/S0100-54052006000200009; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; Martelli G P, 2002, Arch Virol, V147, P2039, DOI 10.1007/s007050200048; Mello LMR, 2013, VITICULTURA BRASILEI; Miller DR, 2002, P ENTOMOL SOC WASH, V104, P825; Morandi Filho WJ, 2008, ARQ I BIOL-SAO PAULO, V76, P427; Morse GE, 2006, SYST ENTOMOL, V31, P338, DOI 10.1111/j.1365-3113.2005.00316.x; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Saccaggi DL, 2008, B ENTOMOL RES, V98, P27, DOI 10.1017/S000748530700538X; SANTA-CECÍLIA LENIRA V.C., 2002, Neotrop. entomol., V31, P333, DOI 10.1590/S1519-566X2002000200024; Selwyn B, 2007, J AGRAR CHANGE, V7, P526, DOI 10.1111/j.1471-0366.2007.00155.x; Selwyn B, 2010, J AGRAR CHANGE, V10, P537, DOI 10.1111/j.1471-0366.2009.00245.x; Souza B., 2008, Coffee Science, V3, P104; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Villard P, 2013, MOL ECOL RESOUR, V13, P755, DOI 10.1111/1755-0998.12116; Walton V. M., 2004, South African Journal of Enology and Viticulture, V25, P54; Walton VM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.4701; Willians DJ, 1992, MEALYBUGS CENTRAL S; Yokogawa T, 2009, GENES GENET SYST, V84, P57, DOI 10.1266/ggs.84.57	50	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103267	10.1371/journal.pone.0103267	http://dx.doi.org/10.1371/journal.pone.0103267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	24941042	gold, Green Published, Green Submitted			2022-12-25	WOS:000339992600050
J	Ramos, JE; Pecl, GT; Moltschaniwskyj, NA; Strugnell, JM; Leon, RI; Semmens, JM				Ramos, Jorge E.; Pecl, Gretta T.; Moltschaniwskyj, Natalie A.; Strugnell, Jan M.; Leon, Rafael I.; Semmens, Jayson M.			Body Size, Growth and Life Span: Implications for the Polewards Range Shift of Octopus tetricus in South-Eastern Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMON OCTOPUS; REPRODUCTIVE-CYCLE; UPWELLING SYSTEM; VULGARIS; SQUID; EVOLUTIONARY; ECOLOGY; AGE; TEMPERATURE	Understanding the response of any species to climate change can be challenging. However, in short-lived species the faster turnover of generations may facilitate the examination of responses associated with longer-term environmental change. Octopus tetricus, a commercially important species, has undergone a recent polewards range shift in the coastal waters of south-eastern Australia, thought to be associated with the southerly extension of the warm East Australian Current. At the cooler temperatures of a polewards distribution limit, growth of a species could be slower, potentially leading to a bigger body size and resulting in a slower population turnover, affecting population viability at the extreme of the distribution. Growth rates, body size, and life span of O. tetricus were examined at the leading edge of a polewards range shift in Tasmanian waters (40 degrees S and 147 degrees E) throughout 2011. Octopus tetricus had a relatively small body size and short lifespan of approximately 11 months that, despite cooler temperatures, would allow a high rate of population turnover and may facilitate the population increase necessary for successful establishment in the new extended area of the range. Temperature, food availability and gender appear to influence growth rate. Individuals that hatched during cooler and more productive conditions, but grew during warming conditions, exhibited faster growth rates and reached smaller body sizes than individuals that hatched into warmer waters but grew during cooling conditions. This study suggests that fast growth, small body size and associated rapid population turnover may facilitate the range shift of O. tetricus into Tasmanian waters.	[Ramos, Jorge E.; Pecl, Gretta T.; Leon, Rafael I.; Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Moltschaniwskyj, Natalie A.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia; [Strugnell, Jan M.] La Trobe Univ, Dept Genet, La Trobe Inst Mol Sci, Bundoora, Vic, Australia	University of Tasmania; University of Newcastle; La Trobe University	Ramos, JE (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	jeramos@utas.edu.au	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Consejo Nacional de Ciencia y Tecnologia of Mexico [308672]; University of Tasmania; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Tasmania; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J. Ramos was awarded the scholarship 308672 by Consejo Nacional de Ciencia y Tecnologia of Mexico, a Tasmania Graduate Research scholarship from the University of Tasmania and a Bookend Lynchpin Ocean Scholarship 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amundsen PA, 2012, BIOL INVASIONS, V14, P1501, DOI 10.1007/s10530-012-0175-3; Anderson RC, 2008, MAR ECOL PROG SER, V371, P199, DOI 10.3354/meps07649; Arenas M, 2012, MOL BIOL EVOL, V29, P207, DOI 10.1093/molbev/msr187; Arkhipkin AI, 2005, MAR FRESHWATER RES, V56, P371, DOI 10.1071/MF04274; Barratt IM, 2010, ICES J MAR SCI, V67, P1452, DOI 10.1093/icesjms/fsq047; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Calosi P, 2013, INTEGR COMP BIOL, V53, P660, DOI 10.1093/icb/ict041; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Canali E, 2011, MAR ECOL PROG SER, V441, P141, DOI 10.3354/meps09399; Carrasco JF, 2006, AQUAC RES, V37, P1601, DOI 10.1111/j.1365-2109.2006.01594.x; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1105, DOI 10.1098/rstb.1996.0096; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Dia M.A., 1988, THESIS U W BRITTANY THESIS U W BRITTANY; Domain F, 2000, J MAR BIOL ASSOC UK, V80, P699, DOI 10.1017/S0025315400002526; Doubleday Z, 2006, J EXP MAR BIOL ECOL, V338, P35, DOI 10.1016/j.jembe.2006.06.027; Edgar G, 2000, AUSTR MARINE LIFE PL; Engel Katharina, 2011, Communicative & Integrative Biology, V4, P247, DOI 10.4161/cib.4.3.14885; Forsythe J.W., 1987, P135; FORSYTHE JW, 1988, MAR BIOL, V98, P369, DOI 10.1007/BF00391113; Forsythe JW, 2004, MAR FRESHWATER RES, V55, P331, DOI 10.1071/MF03146; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Fulton EA, 2011, ICES J MAR SCI, V68, P1329, DOI 10.1093/icesjms/fsr032; Guzik MT, 2005, MOL PHYLOGENET EVOL, V37, P235, DOI 10.1016/j.ympev.2005.05.009; Hanlon R. T., 1996, CEPHALOPOD BEHAV; Harrington JJ, 2006, FISH RES, V77, P10, DOI 10.1016/j.fishres.2005.09.003; Hermosilla CA, 2010, ICES J MAR SCI, V67, P1458, DOI 10.1093/icesjms/fsq054; Herwig JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043679; Hill KL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032912; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hoving HJT, 2013, GLOBAL CHANGE BIOL, V19, P2089, DOI 10.1111/gcb.12198; Jackson GD, 2004, MAR FRESHWATER RES, V55, P357, DOI 10.1071/MF03152; Jackson GD, 2003, MAR BIOL, V142, P925, DOI 10.1007/s00227-002-1005-4; Jackson GD, 2001, MAR ECOL PROG SER, V218, P167, DOI 10.3354/meps218167; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Katsanevakis S, 2006, ICES J MAR SCI, V63, P151, DOI 10.1016/j.icesjms.2005.07.004; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leporati SC, 2008, MAR ECOL PROG SER, V367, P213, DOI 10.3354/meps07558; Leporati SC, 2008, MAR BIOL, V155, P375, DOI 10.1007/s00227-008-1033-9; Leporati SC, 2007, MAR BIOL, V151, P1375, DOI 10.1007/s00227-006-0575-y; Lourenco S, 2012, FISH RES, V127, P116, DOI 10.1016/j.fishres.2012.04.006; Mangold K., 1983, P335; Mangold K., 1987, P157; Mather JA, 2012, CURR ZOOL, V58, P597, DOI 10.1093/czoolo/58.4.597; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Moreno A, 2012, J MAR BIOL ASSOC UK, V92, P1619, DOI 10.1017/S0025315411002141; Norman M.D., 2000, GUIDE SQUID CUTTLEFI; Okei N, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P468; Oosthuizen A, 2003, J MAR BIOL ASSOC UK, V83, P535, DOI 10.1017/S0025315403007458h; Otero J, 2008, MAR ECOL PROG SER, V362, P181, DOI 10.3354/meps07437; Otero J, 2007, FISH RES, V85, P122, DOI 10.1016/j.fishres.2007.01.007; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pecl GT, 2008, REV FISH BIOL FISHER, V18, P373, DOI 10.1007/s11160-007-9077-3; Pecl GT, 2004, MAR FRESHWATER RES, V55, P387, DOI 10.1071/MF03153; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/NCLIMATE1958, 10.1038/nclimate1958]; R Core Team, 2021, R LANG ENV STAT COMP; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosas C, 2008, AQUACULTURE, V275, P291, DOI 10.1016/j.aquaculture.2008.01.015; Sandery PA, 2007, ESTUAR COAST SHELF S, V74, P684, DOI 10.1016/j.ecss.2007.05.011; Scandol J, 2008, STATUS FISHERIES RES, P193; Schwarz R, 2010, FISH RES, V106, P177, DOI 10.1016/j.fishres.2010.06.008; Semmens J, 2011, J EXP BIOL, V214, P2799, DOI 10.1242/jeb.051631; Semmens JM, 2004, MAR FRESHWATER RES, V55, P367, DOI 10.1071/MF03155; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Spiess A, 2013, QPCR MODELLING ANAL; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tasmania Wild Fisheries Management Branch Tasmania Department of Primary Industries and Water, 2009, SACL FISH MAN PLAN R; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Villanueva R, 1995, CAN J FISH AQUAT SCI, V52, P2639, DOI 10.1139/f95-853; VILLANUEVA R, 1992, J EXP MAR BIOL ECOL, V159, P157, DOI 10.1016/0022-0981(92)90034-8; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wolf BM, 1997, J SHELLFISH RES, V16, P533	85	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103480	10.1371/journal.pone.0103480	http://dx.doi.org/10.1371/journal.pone.0103480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	24941042	Green Published, gold, Green Accepted			2022-12-25	WOS:000339812700029
J	Wu, KL; Zeng, SJ; Lin, DI; da Silva, JAT; Bu, ZY; Zhang, JX; Duan, J				Wu, Kunlin; Zeng, Songjun; Lin, Danni; da Silva, Jaime A. Teixeira; Bu, Zhaoyang; Zhang, Jianxia; Duan, Ju			In Vitro Propagation and Reintroduction of the Endangered Renanthera imschootiana Rolfe	PLOS ONE			English	Article							ASYMBIOTIC SEED-GERMINATION; CALCIUM HYPOCHLORITE; ESTABLISHMENT; REGENERATION; GROWTH; ORCHID	Renanthera imschootiana Rolfe is an endangered tropical epiphytic orchid that is threatened with extinction due to over-collection and the loss of suitable habitats. In vitro propagation is a useful way to mass produce plants for re-establishment in the wild and for commercial propagation. Seeds collected 150 days after pollination (DAP) were the optimum stage for in vitro culture. Seed germination reached 93.1% on quarter-strength MS (i.e., MS containing a quarter of macro-and micronutrients) medium containing 0.5 mg l(-1) a-naphthaleneacetic acid (NAA), 20% coconut water (CW), 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 1.0 g l(-1) activated charcoal (AC). Quarter-strength MS medium supplemented with 1.0 mg l(-1) BA, 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 20% CW was suitable for the sub-culture of protocorm-like bodies (PLBs) in which the PLB proliferation ratio was 2.88. Quarter-strength MS medium containing 1.0 mg l(-1) NAA, 1.0 g l(-1) peptone, 100 g l(-1) banana homogenate (BH), and 1.0 g l(-1) AC was suitable for plantlet formation and 95.67% of plantlets developed from PLBs within 60 days of culture. Hyponex N016 medium supplemented with 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 20 g l(-1) sucrose, 150 g l(-1) BH, and 1.0 g l(-1) AC was suitable for the in vitro growth of plantlets about 2-cm in height. Plantlets 3-cm in height or taller were transplanted to Chilean sphagnum moss, and 95% of plantlets survived after 60 days in a greenhouse. Three hundred transplanted of seedlings 360-days old were reintroduced into three natural habitats. Highest percentage survival (79.67%) was observed in Yuanjiang Nature Reserve two years after reintroduction, followed by Huolu Mountain forest park (71.33%). This protocol is an efficient means for the large-scale propagation and in vitro and in vivo germplasm conservation of R. imschootiana.	[Wu, Kunlin; Zeng, Songjun; Lin, Danni; Zhang, Jianxia] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Duan, Ju] Chinese Acad Sci, South China Bot Garden, Key Lab S China Agr Plant Mol Anal & Gene Improve, Guangzhou, Guangdong, Peoples R China; [da Silva, Jaime A. Teixeira] Kagawa Ken, Takamatsu, Kagawa, Japan; [Bu, Zhaoyang] Guangxi Acad Agr Sci, Flower Res Inst, Nanning 150931, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Guangxi Academy of Agricultural Sciences	Zeng, SJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	zengsongjun@scib.ac.cn; yangnv@126.com	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences [211026]; Guangzhou Key Technology Research and Development Program [Y233051001]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences; Guangzhou Key Technology Research and Development Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a fund of the Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences (No. 211026), and the Guangzhou Key Technology Research and Development Program (Y233051001). Songjun Zeng received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd J., 1995, HDB BOT GARDENS REIN; [Anonymous], 2014, WORLD CHECKLIST SELE; Arditti J., 1993, MICROPROPAGATION ORC; Arditti J, 1982, ORCHID BIOL REV PERS, P352; Chu Chin-Chang, 1994, Lindleyana, V9, P153; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; da Silva JAT, 2006, PLANT CELL TISS ORG, V84, P135, DOI 10.1007/s11240-005-9003-0; da Silva JAT, 2005, PROPAG ORNAM PLANTS, V5, P129; DASILVA JAT, 2012, ASIAN AUSTRALASIAN J, V6, P121; DeMarie E., 1991, HORTSCIENCE, V26, P272; Dix L., 1982, PLANT CELL TISSUE OR, V12, P39; Ernst R., 1975, American Orchid Society Bulletin, V44, P12; Ernst R., 1974, American Orchid Society Bulletin, V43, P35; Goh C. J., 1982, Orchid Review, V90, P295; GOH CJ, 1990, SCI HORTIC-AMSTERDAM, V44, P315, DOI 10.1016/0304-4238(90)90132-X; HARVAIS G, 1973, CAN J BOT, V51, P327, DOI 10.1139/b73-040; Hossain MM, 2013, CRIT REV PLANT SCI, V32, P69, DOI 10.1080/07352689.2012.715984; Kauth P.J., 2008, FLORICULTURE ORNAMEN, P375; Kishor R, 2009, EUPHYTICA, V165, P247, DOI 10.1007/s10681-008-9755-9; Knudson Lewis, 1946, AMER ORCHID SOC BULL, V15, P214; Lee YI, 2006, ANN BOT-LONDON, V98, P1311, DOI 10.1093/aob/mcl222; Lin DL, 2008, J FOOD DRUG ANAL, V16, P1; Lo SF, 2004, IN VITRO CELL DEV-PL, V40, P528, DOI 10.1079/IVP2004571; McNaughton S.J., 1989, P109; Miyoshi K, 1998, PHYSIOL PLANTARUM, V102, P481, DOI 10.1034/j.1399-3054.1998.1020401.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mweetwa AM, 2008, SCI HORTIC-AMSTERDAM, V117, P257, DOI 10.1016/j.scienta.2008.03.035; NAGASHIMA T, 1982, J JPN SOC HORTIC SCI, V51, P94, DOI 10.2503/jjshs.51.94; PIERIK RLM, 1988, SCI HORTIC-AMSTERDAM, V34, P139, DOI 10.1016/0304-4238(88)90084-2; Raghavan V., 1977, CRC HDB SERIES NUTR, P361; Ren H, 2012, ORYX, V46, P391, DOI 10.1017/S0030605311000615; Rout TM, 2009, ECOL APPL, V19, P515, DOI 10.1890/07-1989.1; SEENI S, 1992, PLANT CELL TISS ORG, V29, P167, DOI 10.1007/BF00034349; Seeni S, 2000, PLANT CELL TISS ORG, V61, P1, DOI 10.1023/A:1006444614657; Teixeira da Silva J., 2013, FLORIC ORNAM BIOTECH, V7, P1, DOI DOI 10.1016/0168-1656(90)90117-T; Thomale H., 1954, ORCHIDEEN, P62; Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003; Tsi Z. H., 1999, FLORA REIPUBLICAE PO, V19, P291; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; van der Kinderen G., 1987, LINDLEYANA, V2, P84; VANWAES JM, 1986, PHYSIOL PLANTARUM, V66, P435, DOI 10.1111/j.1399-3054.1986.tb05947.x; Vyas S, 2009, SCI HORTIC-AMSTERDAM, V121, P32, DOI 10.1016/j.scienta.2009.01.012; Wu KL, 2012, SCI HORTIC-AMSTERDAM, V135, P194, DOI 10.1016/j.scienta.2011.11.028; Wu KunLin, 2010, Acta Horticulturae Sinica, V37, P685; Wu Z.Y., 2009, FLORA CHINA, V25; YAM T W, 1990, Lindleyana, V5, P256; Yong JWH, 2009, MOLECULES, V14, P5144, DOI 10.3390/molecules14125144; Zeng SJ, 2015, CRIT REV BIOTECHNOL, V35, P279; Zeng SJ, 2011, HORTSCIENCE, V46, P460, DOI 10.21273/HORTSCI.46.3.460; Zeng SJ, 2012, SCI HORTIC-AMSTERDAM, V138, P198, DOI 10.1016/j.scienta.2012.02.026	51	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110033	10.1371/journal.pone.0110033	http://dx.doi.org/10.1371/journal.pone.0110033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000343943100017
